Citrus Sinensis ID: 042075
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.932 | 0.953 | 0.450 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.939 | 0.947 | 0.458 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.934 | 0.935 | 0.436 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.862 | 0.759 | 0.349 | 1e-135 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.805 | 0.848 | 0.356 | 1e-132 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.904 | 0.848 | 0.328 | 1e-125 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.908 | 0.834 | 0.315 | 1e-125 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.894 | 0.838 | 0.319 | 1e-123 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.851 | 0.704 | 0.324 | 1e-119 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.822 | 0.678 | 0.334 | 1e-119 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/993 (45%), Positives = 614/993 (61%), Gaps = 30/993 (3%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAG 98
+ETDR ALL+FKS+++ D V SWN S C W GVTC R+ ++RVT L+L L+L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRK-NKRVTHLELGRLQLGG 80
Query: 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNL 158
IS +GNLSFL LDL+ N F IP E +L RL+ L + N + G IP + +CS L
Sbjct: 81 VISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRL 140
Query: 159 IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218
+ +RL SN L G +PSELGSL+ + ++ NN+ G +P S GNL+ + L LS NNL+G
Sbjct: 141 LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEG 200
Query: 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQN 278
IP L + +L + N SG P +++N+SS+ + G N G + D+G L N
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260
Query: 279 LQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGS 338
L F++G N TG+IP +SN S LE +N N LTG +P + L + NSLGS
Sbjct: 261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGS 320
Query: 339 GEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAA 398
RDL FL SLTN T+L+ I N GG LP I+N S L L L I G+IP
Sbjct: 321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 399 FGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLF-NLQL 457
G + L +L + N LSG +P ++G+L NLR L L NR G IP IGN+ + L L
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPN 517
S N +G +P+SLG L + + +N L GTIP +++ + LL L++S N L G +P
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL-RLDMSGNSLIGSLPQ 499
Query: 518 EVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLD 577
++G L+NL L++ +NKL G++P+TLG+C+ +E L ++GN G IP L L G+ +D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVD 558
Query: 578 LSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHE 637
LS N+LSG IPE+ F LEYLNLS N+ EG VP +G+F NA+ S++GN LCGG
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 638 FRLPTC-SPKKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLV--RKRKENQNPSSP 694
F+L C S S K+ + LK + +S I L L L + L+ RKRK+N+ ++P
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678
Query: 695 INS-----FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH 749
S ISY +L NAT+GF+S+N++G+GSFG+VYK +L K +VAVKV N+
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 750 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 809
GA KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+F+AL++EFM N SL+ WLHP
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 810 EDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869
E E R+L LL+RL+I IDVA L YLH C PI HCDLKPSNVLLD+++ AHV D
Sbjct: 799 E-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSD 857
Query: 870 FGLATFL-----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
FGLA L Q SS +G+IGY APEYG+G + SINGDVYS+GILLLE+ T
Sbjct: 858 FGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTG 917
Query: 925 KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIEC 984
K+PT+ +F G+ L+++ K+ALP+ ++DIVD ++L + +EC
Sbjct: 918 KRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGF------------PVVEC 965
Query: 985 LVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
L + +G+ C ESP +R+ + VV +L SI+
Sbjct: 966 LTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/1005 (45%), Positives = 610/1005 (60%), Gaps = 34/1005 (3%)
Query: 31 VTASTVA-GNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTIL 89
V A T+ ETD+ ALLEFKS+++ V GSWN+S+ C W GV C + H+RVT +
Sbjct: 28 VCAQTIRLTEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLK-HRRVTGV 86
Query: 90 DLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP 149
DL LKL G +S VGNLSFL+ L+L +N FH IPSE L RLQ L + NN GG IP
Sbjct: 87 DLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIP 146
Query: 150 ANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFL 209
+S+CS+L + LSSN L +P E GSLSK+ S+ NNLTG P S GNL+S+ L
Sbjct: 147 VVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQML 206
Query: 210 FLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIP 269
N ++G IP LK ++ +A N+ +G P I+N+SS+ N G +
Sbjct: 207 DFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLR 266
Query: 270 LDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSH 328
D G L NLQ +G N TG IP +SN S+L + SN LTG++P +LQ L
Sbjct: 267 PDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLL 326
Query: 329 FVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDS 388
+ NSLG+ DL+FL +LTN ++L++ ++ N GG LP I+N ST L L L
Sbjct: 327 LGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGG 386
Query: 389 NKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIG 448
N I G+IP G V L L++ N L+G +PP++GEL LR++ L N G IP S+G
Sbjct: 387 NLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLG 446
Query: 449 NLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELS 507
N+ L L L N +GSIPSSLG L ++L N L G+IP +L+ L S L+VL +S
Sbjct: 447 NISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPS-LVVLNVS 505
Query: 508 RNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSL 567
N L GP+ ++G LK L L+V NKL G+IP+TL +C+ LE L +QGN GPIP +
Sbjct: 506 FNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DI 564
Query: 568 SSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLG 627
L GL LDLS+NNLSG IPE++ F L+ LNLS N+F+G VPTEGVFRN S SV G
Sbjct: 565 RGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFG 624
Query: 628 NLKLCGGTHEFRLPTCS---PKK--SKHKRLTLALKLALAIISGLIGLSLALSFLIICLV 682
N+ LCGG +L CS P++ S K +T+ + +A + L + L + + +
Sbjct: 625 NINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVK 684
Query: 683 RKRK---ENQNPSSPINSF-PNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTI 738
R EN SP+ SF ISY LY T GF+S+NLIG+G+FG+V+KG L
Sbjct: 685 SVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKA 744
Query: 739 VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 798
VA+KV NL GA KSFIAEC L IRHRNLVK++T CS D++GNDF+ALV+EFM N
Sbjct: 745 VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNG 804
Query: 799 SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858
+L+ WLHP E ET R+L L RL+I IDVA AL YLH C PI HCD+KPSN+L
Sbjct: 805 NLDMWLHPDEIE-ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNIL 863
Query: 859 LDEEMIAHVGDFGLATFL-----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYS 913
LD+++ AHV DFGLA L H Q SS +G+IGY APEYG+G SI GDVYS
Sbjct: 864 LDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYS 923
Query: 914 YGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD-HVVDIVDSTLLSDDEDLAVHGNQR 972
+GI+LLE+ T K+PT+ +F + LH+F K+AL +DI D T+L R
Sbjct: 924 FGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL------------R 971
Query: 973 QRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
A+ + +ECL + R+GV+CS ESP +R+ M + +L SI+
Sbjct: 972 GAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/1015 (43%), Positives = 599/1015 (59%), Gaps = 50/1015 (4%)
Query: 39 NETDRLALLEFKSKIT-HDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLA 97
NETD ALLEFKS+++ ++ V SWN S FC W GVTC RR+ +RV L+L KL
Sbjct: 28 NETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRR-ERVISLNLGGFKLT 86
Query: 98 GYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSN 157
G IS +GNLSFL++L+L +NSF IP + RL RLQ L + N + G IP+++S+CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 158 LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD 217
L V LSSN L +PSELGSLSK+ +S NNLTG+ P S GNL+S+ L + N +
Sbjct: 147 LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMR 206
Query: 218 GSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277
G IPD L +V +A N SG P +++NISS+ N G + D G+ L
Sbjct: 207 GEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLP 266
Query: 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSL 336
NL+ +G NQ TGAIP ++N S+LE F ++SN L+G +P KL+ L I NSL
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326
Query: 337 GSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP 396
G+ L F+ ++ N T+L++ + N GG LPA I+N STTL L L N I G IP
Sbjct: 327 GNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIP 386
Query: 397 AAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNL 455
G V L L + N LSG +P + G+L NL+ + L N G IP GN+ +L L
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
L+ N G IP SLG+ L + + N L GTIP ++L + SL + +LS N LTG
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYI-DLSNNFLTGHF 505
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
P EVG L+ L L NKL G++P+ +G C+ +E L MQGN G IP +S L L
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKN 564
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGT 635
+D S NNLSG+IP +L L LNLS N FEG VPT GVFRNA+ SV GN +CGG
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 636 HEFRLPTCSPKKSKHKRLTLALKLALAIISGL-IGLSLALSFLIIC-----LVRKRKENQ 689
E +L C + S KR L+++ ++SG+ IG++ L +I+ + RK+K N
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVR--KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNA 682
Query: 690 NPSSPINS------FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV 743
+ +P +S +SY+ L++AT F+S NLIG+G+FG+V+KG+L +VAVKV
Sbjct: 683 SDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKV 742
Query: 744 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 803
NLL HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+ALV+EFM SL+ W
Sbjct: 743 LNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMW 802
Query: 804 LHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863
L + + + RSL ++L+I IDVA AL YLH C P+ HCD+KPSN+LLD+++
Sbjct: 803 LQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDL 861
Query: 864 IAHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
AHV DFGLA L ++ SS +G+IGY APEYG+G + SI GDVYS+GILL
Sbjct: 862 TAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILL 921
Query: 919 LELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARI 978
LE+ + KKPTD F GD NLH++ K+ L S S A+
Sbjct: 922 LEMFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTSSGGSNAID---------- 962
Query: 979 NSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQR-IVSNMQRD 1032
E L + ++G+ CS E P DRM V +L SI++ + ++ RD
Sbjct: 963 ----EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTITESPRD 1013
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-135, Method: Compositional matrix adjust.
Identities = 344/985 (34%), Positives = 512/985 (51%), Gaps = 94/985 (9%)
Query: 96 LAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSC 155
L G I +G L+ L LDL N +IP +F L LQ L L N + G+IPA I +C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215
S+L+++ L N+L GKIP+ELG+L +++ + N LT SIP S L+ ++ L LS N+
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
L G I + G+L++L LT+ N +G P SI N+ ++TV G N I G +P D+G
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L NL+ S N LTG IP +ISN + L++ ++ N++TGE+P L+ I RN
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNH 442
Query: 336 LGSGEHRDLNFLCS-------------------LTNATRLKWFHININNFGGLLPACISN 376
+GE D F CS + +L+ ++ N+ G +P I N
Sbjct: 443 F-TGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGN 501
Query: 377 FSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQE 436
L +L L SN G IP L L M++N L G IP + +++ L L L
Sbjct: 502 LK-DLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560
Query: 437 NRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL 495
N+F G IP L+ L L L N GSIP+SL L D+S+N LTGTIP +LL
Sbjct: 561 NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620
Query: 496 G-LSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSC-------- 546
L ++ + L S N LTG IP E+G L+ ++ +++ N G IPR+L +C
Sbjct: 621 ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680
Query: 547 --------IKLELLQ---------MQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 589
I E+ Q + N G IP S ++ L LDLS NNL+G+IPE
Sbjct: 681 SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740
Query: 590 FLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSK 649
L L++L L++N+ +G VP GVF+N + + ++GN LCG + T K S
Sbjct: 741 SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSH 800
Query: 650 HKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRK-ENQNPSSPIN-----SFPNISY 703
+ T + + L + L+ + L + L C +++K EN + SS +
Sbjct: 801 FSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEP 860
Query: 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNT 761
+ L ATD F SAN+IG+ S +VYKG L++G T++AVKV NL A K F E T
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYTEAKT 919
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
L ++HRNLVKIL G ++ KALV FM N +LE+ +H AP +
Sbjct: 920 LSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIH-------GSAAPIG-S 967
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL--- 878
LL+++D+ + +A + YLH PIVHCDLKP+N+LLD + +AHV DFG A L
Sbjct: 968 LLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRED 1027
Query: 879 -SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG--D 935
S ++S F +G+IGY+APE+ +V+ DV+S+GI+++EL+T+++PT + E D
Sbjct: 1028 GSTTASTSAF-EGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQD 1086
Query: 936 MNLHNFAKTALPD---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIG 992
M L + ++ + +V ++D L D V Q E + ++
Sbjct: 1087 MTLRQLVEKSIGNGRKGMVRVLDMEL----GDSIVSLKQE----------EAIEDFLKLC 1132
Query: 993 VACSMESPEDRMDMTNVVHQLQSIK 1017
+ C+ PEDR DM ++ L ++
Sbjct: 1133 LFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 332/932 (35%), Positives = 494/932 (53%), Gaps = 100/932 (10%)
Query: 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL-SSISFLFLSRN 214
+ +I + +S +L G+I + +L+ + +S N G IPP G+L ++ L LS N
Sbjct: 66 TQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSEN 125
Query: 215 NLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF---NISSITVFDAGINQIQGVIPLD 271
L G+IP G L LV L + NRL+G+IP +F + SS+ D N + G IPL+
Sbjct: 126 LLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLN 185
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP--YLEKLQRLSHF 329
L+ L+F + N+LTG +P ++SN++NL+ + SN L+GE+P + K+ +L
Sbjct: 186 YHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFL 245
Query: 330 VITRNSLGSGEHRDLN---FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLL 386
++ N S + + N F SL N++ L+ + N+ GG + + + + S L + L
Sbjct: 246 YLSYNHFVS-HNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHL 304
Query: 387 DSNKIFGNIPAAFG------------------------KFVKLLRLEMWNNRLSGTIPPA 422
D N+I G+IP K KL R+ + NN L+G IP
Sbjct: 305 DQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPME 364
Query: 423 IGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDL 481
+G++ L L + N G+IP S GNL +L L L N L G++P SLG+ L I+DL
Sbjct: 365 LGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDL 424
Query: 482 SNNNLTGTIPPQLLG-LSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIP 540
S+NNLTGTIP +++ L +L + L LS N L+GPIP E+ + + +++ N+L G+IP
Sbjct: 425 SHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
Query: 541 RTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYL 600
LGSCI LE L + N +PSSL L L LD+S N L+G IP L++L
Sbjct: 485 PQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHL 544
Query: 601 NLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLA 660
N S N G V +G F +I S LG+ LCG + C K KHK ++ L +
Sbjct: 545 NFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--AC---KKKHKYPSVLLPVL 599
Query: 661 LAIISGLIGLSLALSFLIICLVRKRK----------------ENQNPSSPINSFPNISYQ 704
L++I+ + L LV++ + E QN + P +P ISYQ
Sbjct: 600 LSLIA-----TPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP--KYPRISYQ 652
Query: 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-SFIAECNTLK 763
L AT GF +++LIG+G FG VYKG+L T VAVKV + F SF EC LK
Sbjct: 653 QLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILK 711
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
RHRNL++I+T CS F ALV M N SLE L+P E + ++L+L+
Sbjct: 712 RTRHRNLIRIITTCSKP-----GFNALVLPLMPNGSLERHLYP------GEYSSKNLDLI 760
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL------- 876
Q ++I DVA ++YLHH +VHCDLKPSN+LLD+EM A V DFG++ +
Sbjct: 761 QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETV 820
Query: 877 ----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932
+S T + GS+GYIAPEYG+G S +GDVYS+G+LLLE+V+ ++PTD++
Sbjct: 821 STDDSVSFGSTDGLLC-GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLV 879
Query: 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI--ECLVAMAR 990
+LH F K+ PD + I++ A+ + Q + K+ E ++ M
Sbjct: 880 NEGSSLHEFMKSHYPDSLEGIIEQ---------ALSRWKPQGKPEKCEKLWREVILEMIE 930
Query: 991 IGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022
+G+ C+ +P R DM +V H++ +K L
Sbjct: 931 LGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 360/1097 (32%), Positives = 532/1097 (48%), Gaps = 163/1097 (14%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNE-SIHFCQWHGVTCSRRQHQR-VTILDLKSLKL 96
NE R+ LLEFK+ +D G SWN+ + C W G+ C+ H R VT +DL + L
Sbjct: 25 NEEGRV-LLEFKA-FLNDSNGYLASWNQLDSNPCNWTGIACT---HLRTVTSVDLNGMNL 79
Query: 97 AGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCS 156
+G +S + L L+ L++ N IP + R L+VL L N G IP ++
Sbjct: 80 SGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMII 139
Query: 157 NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL------------- 203
L ++ L N L G IP ++G+LS ++ + NNLTG IPPS L
Sbjct: 140 TLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGF 199
Query: 204 -----------SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS 252
S+ L L+ N L+GS+P L+NL +L + QNRLSG IP S+ NIS
Sbjct: 200 SGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNIS 259
Query: 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK 312
+ V N G IP +IG L ++ + NQLTG IP I N + + N+
Sbjct: 260 RLEVLALHENYFTGSIPREIG-KLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQ 318
Query: 313 LTGEVPY-------------------------LEKLQRLSHFVITRNSLGSGEHRDLNFL 347
LTG +P L +L L ++ N L ++L FL
Sbjct: 319 LTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFL 378
Query: 348 CSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR 407
L + L+ F N G +P I F + VL + +N + G IPA F +F L+
Sbjct: 379 PYLVD---LQLFD---NQLEGKIPPLIG-FYSNFSVLDMSANSLSGPIPAHFCRFQTLIL 431
Query: 408 LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSI 466
L + +N+LSG IP + ++L +L L +N+ G++P + NL+ L L+L N+L G+I
Sbjct: 432 LSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNI 491
Query: 467 PSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN----- 521
+ LG+ + L + L+NNN TG IPP++ L+ ++ +S NQLTG IP E+G+
Sbjct: 492 SADLGKLKNLERLRLANNNFTGEIPPEIGNLTK-IVGFNISSNQLTGHIPKELGSCVTIQ 550
Query: 522 -------------------LKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
L LE+L + +N+L GEIP + G +L LQ+ GN L
Sbjct: 551 RLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSEN 610
Query: 563 IPSSLSSLRGLSV-LDLSQNNLSGKIPEFLVGFQLLEYL--------------------- 600
IP L L L + L++S NNLSG IP+ L Q+LE L
Sbjct: 611 IPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSL 670
Query: 601 ---NLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLT--L 655
N+SNN+ G VP VF+ ++ GN LC P SK L
Sbjct: 671 LICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGS 730
Query: 656 ALKLALAIISGLIGLSLALSFLIICLVRKRK-------ENQNPSSPINS--FPN--ISYQ 704
+ L I +IG ++FL +C KR+ E+Q ++S FP +YQ
Sbjct: 731 QRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQ 790
Query: 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK--SFIAECNTL 762
L +AT F+ ++G G+ G+VYK + G+ ++AVK N GA SF AE +TL
Sbjct: 791 GLVDATRNFSEDVVLGRGACGTVYKAEMSGGE-VIAVKKLNSRGEGASSDNSFRAEISTL 849
Query: 763 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
IRHRN+VK+ C Y N L++E+M SL E L + E L+
Sbjct: 850 GKIRHRNIVKLYGFC----YHQNS-NLLLYEYMSKGSLGEQL-------QRGEKNCLLDW 897
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
R I + A L YLHHDC+P IVH D+K +N+LLDE AHVGDFGLA + LS+++
Sbjct: 898 NARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK 957
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942
+ S A GS GYIAPEY +V+ D+YS+G++LLEL+T K P + +G +L N+
Sbjct: 958 SMSAVA-GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWV 1015
Query: 943 KTALPDHV--VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP 1000
+ ++ + + +++ D+ L ++D+ VH + + +I + C+ SP
Sbjct: 1016 RRSIRNMIPTIEMFDARLDTNDKR-TVHE---------------MSLVLKIALFCTSNSP 1059
Query: 1001 EDRMDMTNVVHQLQSIK 1017
R M VV + +
Sbjct: 1060 ASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 347/1100 (31%), Positives = 533/1100 (48%), Gaps = 162/1100 (14%)
Query: 41 TDRLALLEFKSKITHDPLGVFGSWNESIHF-CQWHGVTCSRRQHQR------VTILDLKS 93
+D LLE K++ D L +WN C W GV CS + VT LDL S
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 94 LKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS 153
+ L+G +S +G L L L+L N+ +IP E +L+V+ L+NN GG IP I+
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEIN 154
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSIS------ 207
S L + +N+L G +P E+G L +E NNLTG +P S GNL+ ++
Sbjct: 155 KLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQ 214
Query: 208 ------------------FLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF 249
L L++N + G +P G L L + + QN+ SG IP I
Sbjct: 215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274
Query: 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN 309
N++S+ N + G IP +IG +++L+ + +NQL G IP + S + +
Sbjct: 275 NLTSLETLALYGNSLVGPIPSEIG-NMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFS 333
Query: 310 SNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLT----------------- 351
N L+GE+P L K+ L + +N L +L+ L +L
Sbjct: 334 ENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGF 393
Query: 352 -NATRLKWFHININNFGGLLPACISNFS-----------------------TTLEVLLLD 387
N T ++ + N+ G++P + +S + L +L L
Sbjct: 394 QNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLG 453
Query: 388 SNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI 447
SN+IFGNIP + LL+L + NRL+G P + +L NL + L +NRF G +PP I
Sbjct: 454 SNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEI 513
Query: 448 GNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLEL 506
G KL L L+ N ++P+ + + L ++S+N+LTG IP ++ +L L+L
Sbjct: 514 GTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIAN-CKMLQRLDL 572
Query: 507 SRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSS 566
SRN G +P E+G+L LE+L + EN+ G IP T+G+ L LQM GN G IP
Sbjct: 573 SRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQ 632
Query: 567 LSSLRGLSV-LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE----------- 614
L L L + ++LS N+ SG+IP + LL YL+L+NN G +PT
Sbjct: 633 LGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCN 692
Query: 615 -------------GVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLAL 661
+F+N ++TS LGN LCGG L +C P S ++ +LK
Sbjct: 693 FSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHIS-SLKAGS 747
Query: 662 A--------IISGLIGLSLALSFLIICLVRKRKENQNP----------SSPINSFPN--I 701
A + S + G+SL L +++ +R E P S I P
Sbjct: 748 ARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERF 807
Query: 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV------FNLLHHGAFKSF 755
+ +++ AT GF + ++G G+ G+VYK ++ GKTI K+ N + SF
Sbjct: 808 TVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSF 867
Query: 756 IAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEE 815
AE TL IRHRN+V++ + C +QG++ L++E+M SL E LH
Sbjct: 868 RAEILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLH--------GG 916
Query: 816 APRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875
S++ R I + A L+YLHHDC+P I+H D+K +N+L+DE AHVGDFGLA
Sbjct: 917 KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKV 976
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ + +++ S A GS GYIAPEY +V+ D+YS+G++LLEL+T K P + +G
Sbjct: 977 IDMPLSKSVSAVA-GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG 1035
Query: 936 MNLHNFAKTALPDHVV--DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGV 993
+L + + + DH + +I+D L ++D+ ++ ++ + +I V
Sbjct: 1036 -DLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNH---------------MITVTKIAV 1079
Query: 994 ACSMESPEDRMDMTNVVHQL 1013
C+ SP DR M VV L
Sbjct: 1080 LCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-123, Method: Compositional matrix adjust.
Identities = 348/1089 (31%), Positives = 526/1089 (48%), Gaps = 165/1089 (15%)
Query: 46 LLEFKSKITHDPLGVFGSWNESIHF-CQWHGVTCSRRQHQRVTI---------------- 88
LLE KSK D +WN + C W GV CS +
Sbjct: 34 LLEIKSKFV-DAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPS 92
Query: 89 ---------LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLAL 139
LDL L+G I +GN S L++L L+NN F EIP E +L L+ L +
Sbjct: 93 IGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLII 152
Query: 140 HNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS 199
+NN I G +P I + +L ++ SN + G++P +G+L ++ F N ++GS+P
Sbjct: 153 YNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSE 212
Query: 200 FGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDA 259
G S+ L L++N L G +P G LK L + + +N SG IP I N +S+
Sbjct: 213 IGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLAL 272
Query: 260 GINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNAS------------------ 301
NQ+ G IP ++G LQ+L+F + RN L G IP I N S
Sbjct: 273 YKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPL 331
Query: 302 ------NLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSL---- 350
LE+ + N+LTG +P L L+ LS ++ N+L +L L
Sbjct: 332 ELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQ 391
Query: 351 --------TNATRLKWF------HININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP 396
T +L W+ ++ N+ G +P+ + S + +L L +N + GNIP
Sbjct: 392 LFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMI-ILNLGTNNLSGNIP 450
Query: 397 AAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNL 455
L++L + N L G P + + N+ + L +NRF G+IP +GN L L
Sbjct: 451 TGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRL 510
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
QL+ N G +P +G L +++S+N LTG +P ++ +L L++ N +G +
Sbjct: 511 QLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFN-CKMLQRLDMCCNNFSGTL 569
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
P+EVG+L LE+L + N L G IP LG+ +L LQM GN G IP L SL GL +
Sbjct: 570 PSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQI 629
Query: 576 -LDLSQNNLSGKIPEFLVGFQLLEY------------------------LNLSNNDFEGM 610
L+LS N L+G+IP L +LE+ N S N G
Sbjct: 630 ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGP 689
Query: 611 VPTEGVFRNASITSVLGNLKLCG-------GTHEFRLPTCSPKKSKHKRLTLALKLALAI 663
+P + RN S++S +GN LCG T F P+ S K R + + + A+
Sbjct: 690 IP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFA-PSQSTGKPGGMRSSKIIAITAAV 745
Query: 664 ISGLIGLSLALSFLIICLVRK-------RKENQNPS--SPINSFP---NISYQNLYNATD 711
I G+ SL L LI+ L+R+ ++ PS S FP ++Q+L ATD
Sbjct: 746 IGGV---SLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATD 802
Query: 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-----FKSFIAECNTLKNIR 766
F + ++G G+ G+VYK +L G T+ AVK H G SF AE TL NIR
Sbjct: 803 NFDESFVVGRGACGTVYKAVLPAGYTL-AVKKLASNHEGGNNNNVDNSFRAEILTLGNIR 861
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
HRN+VK+ C ++QG++ L++E+M SL E LH + +L+ +R
Sbjct: 862 HRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILH---------DPSCNLDWSKRF 907
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
I + A L+YLHHDC+P I H D+K +N+LLD++ AHVGDFGLA + + H+++ S
Sbjct: 908 KIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA 967
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946
A GS GYIAPEY +V+ D+YSYG++LLEL+T K P + +G ++ N+ ++ +
Sbjct: 968 IA-GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYI 1025
Query: 947 PDHVVD--IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004
+ ++D+ L +DE + H ++ + +I + C+ SP R
Sbjct: 1026 RRDALSSGVLDARLTLEDERIVSH----------------MLTVLKIALLCTSVSPVARP 1069
Query: 1005 DMTNVVHQL 1013
M VV L
Sbjct: 1070 SMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 327/1007 (32%), Positives = 491/1007 (48%), Gaps = 127/1007 (12%)
Query: 82 QHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHN 141
+ ++ L L + +L G I + +L L+ LDL N+ EIP EF + +L L L N
Sbjct: 261 EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLAN 320
Query: 142 N-------------------------SIGGEIPANISSCSNLIRVRLSSNELVGKIPSEL 176
N + GEIP +S C +L ++ LS+N L G IP L
Sbjct: 321 NHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEAL 380
Query: 177 GSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMA 236
L ++ + N L G++ PS NL+++ +L L NNL+G +P L+ L L +
Sbjct: 381 FELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLY 440
Query: 237 QNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPA 296
+NR SG IP I N +S+ + D N +G IP IG L+ L + +N+L G +P +
Sbjct: 441 ENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQNELVGGLPAS 499
Query: 297 ISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATR 355
+ N L + + N+L+G +P L+ L ++ NSL G D L SL N TR
Sbjct: 500 LGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSL-QGNLPD--SLISLRNLTR 556
Query: 356 LKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRL 415
+ H +N G + P C S+ + +V +N IP G L RL + N+L
Sbjct: 557 INLSHNRLN--GTIHPLCGSSSYLSFDV---TNNGFEDEIPLELGNSQNLDRLRLGKNQL 611
Query: 416 SGTIPPAIGELQNLRELRLQENRFLGNIPPS-IGNLKLFNLQLSYNFLQGSIPSSLGQSE 474
+G IP +G+++ L L + N G IP + KL ++ L+ NFL G IP LG+
Sbjct: 612 TGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLS 671
Query: 475 TLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534
L + LS+N ++P +L + LL VL L N L G IP E+GNL L +LN+ +N+
Sbjct: 672 QLGELKLSSNQFVESLPTELFNCTKLL-VLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQ 730
Query: 535 LRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGL-SVLDLSQNNLSGKIPEFLVG 593
G +P+ +G KL L++ N L G IP + L+ L S LDLS NN +G IP +
Sbjct: 731 FSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGT 790
Query: 594 FQLLEYLNLSNNDFEGMVPT----------------------EGVFRNASITSVLGNLKL 631
LE L+LS+N G VP + F S LGN L
Sbjct: 791 LSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGL 850
Query: 632 CGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLS-LALSFLIICLVRKRKEN-- 688
CG L C+ +S +K+ L+ + ++ IIS + L+ + L L+I L K++ +
Sbjct: 851 CGSP----LSRCNRVRSNNKQQGLSAR-SVVIISAISALTAIGLMILVIALFFKQRHDFF 905
Query: 689 -----------------QNPSSPI----NSFPNISYQNLYNATDGFTSANLIGAGSFGSV 727
Q P+ S +I ++++ AT + +IG+G G V
Sbjct: 906 KKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKV 965
Query: 728 YKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787
YK L+ G+T+ K+ + KSF E TL IRHR+LVK++ CS +
Sbjct: 966 YKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGL 1022
Query: 788 KALVFEFMHNRSLEEWLHPITREDET--EEAPRSLNLLQRLDIGIDVACALSYLHHDCQP 845
L++E+M N S+ +WLH ED+ E+ + L+ RL I + +A + YLHHDC P
Sbjct: 1023 NLLIYEYMKNGSIWDWLH----EDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078
Query: 846 PIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL---SHAQTSSIFAKGSIGYIAPEYGLG 902
PIVH D+K SNVLLD M AH+GDFGLA L ++ +++ FA S GYIAPEY
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFA-CSYGYIAPEYAYS 1137
Query: 903 SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP------DHVVDIVDS 956
+ + DVYS GI+L+E+VT K PTD +F +M++ + +T L D ++D
Sbjct: 1138 LKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLK 1197
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDR 1003
LL +ED A + I + C+ SP++R
Sbjct: 1198 PLLPFEEDAACQ-------------------VLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 315/942 (33%), Positives = 469/942 (49%), Gaps = 92/942 (9%)
Query: 91 LKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA 150
L +L+G I A + N LK+LDL NN+ +IP +L L L L+NNS+ G + +
Sbjct: 344 LSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSS 403
Query: 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLF 210
+IS+ +NL L N L GK+P E+G L K+E + N +G +P GN + + +
Sbjct: 404 SISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEID 463
Query: 211 LSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270
N L G IP + G LK+L L + +N L G IP+S+ N +TV D NQ+ G IP
Sbjct: 464 WYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPS 523
Query: 271 DIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFV 330
GF L L+ F + N L G +P ++ N NL +SNK G + L F
Sbjct: 524 SFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFD 582
Query: 331 ITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK 390
+T N G D+ L +T L + N F G +P S L +L + N
Sbjct: 583 VTEN----GFEGDIPL--ELGKSTNLDRLRLGKNQFTGRIPRTFGKISE-LSLLDISRNS 635
Query: 391 IFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450
+ G IP G KL +++ NN LSG IP +G+L L EL+L N+F+G++P I +L
Sbjct: 636 LSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSL 695
Query: 451 -KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRN 509
+ L L N L GSIP +G + L ++L N L+G +P + LS L L LSRN
Sbjct: 696 TNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF-ELRLSRN 754
Query: 510 QLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSS 569
LTG IP E+G L++L+ L + N G IPS++S+
Sbjct: 755 ALTGEIPVEIGQLQDLQ-----------------------SALDLSYNNFTGRIPSTIST 791
Query: 570 LRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNL 629
L L LDLS N L G++P + + L YLNLS N+ EG + + F + +GN
Sbjct: 792 LPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNA 849
Query: 630 KLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLS-LALSFLIICLVRKRKEN 688
LCG L C+ SK++R +L+ K + IIS + L+ +AL L+I L K+ +
Sbjct: 850 GLCGSP----LSHCNRAGSKNQR-SLSPK-TVVIISAISSLAAIALMVLVIILFFKQNHD 903
Query: 689 ----------------QNPSSPI----NSFPNISYQNLYNATDGFTSANLIGAGSFGSVY 728
+ +P+ + +I + ++ AT +IG+G G VY
Sbjct: 904 LFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVY 963
Query: 729 KGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788
K L G+TI K+ + KSF E TL IRHR+LVK++ CS + +
Sbjct: 964 KAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADGLN 1020
Query: 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848
L++E+M N S+ +WLH +E + L RL I + +A + YLH+DC PPIV
Sbjct: 1021 LLIYEYMANGSVWDWLHA----NENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIV 1076
Query: 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH---AQTSSIFAKGSIGYIAPEYGLGSEV 905
H D+K SNVLLD + AH+GDFGLA L ++ +++++FA GS GYIAPEY +
Sbjct: 1077 HRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFA-GSYGYIAPEYAYSLKA 1135
Query: 906 SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDL 965
+ DVYS GI+L+E+VT K PT+ MF+ + ++ + +T L D
Sbjct: 1136 TEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVL---------------DTPP 1180
Query: 966 AVHGNQRQRQARINSKIECLVAMA----RIGVACSMESPEDR 1003
++ + + S + C A I + C+ P++R
Sbjct: 1181 GSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.912 | 0.977 | 0.578 | 0.0 | |
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.962 | 0.979 | 0.562 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.964 | 0.975 | 0.543 | 0.0 | |
| 224119102 | 1007 | predicted protein [Populus trichocarpa] | 0.944 | 0.969 | 0.545 | 0.0 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.968 | 0.977 | 0.524 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.879 | 0.943 | 0.555 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.953 | 0.960 | 0.531 | 0.0 | |
| 255570308 | 1033 | receptor-kinase, putative [Ricinus commu | 0.956 | 0.956 | 0.539 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.973 | 0.978 | 0.514 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.961 | 0.982 | 0.517 | 0.0 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1047 bits (2707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/956 (57%), Positives = 694/956 (72%), Gaps = 13/956 (1%)
Query: 75 GVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRL 134
GV C RR HQRVT+LDL+S KL G IS H+GNLSFL+VL L N F+HEIP E LRRL
Sbjct: 1 GVKCGRR-HQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRL 59
Query: 135 QVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG 194
Q+L L NNS+ GEIPAN+SSCS L+ + + N LVGKIP+ELGSLSK++Y + N+L+G
Sbjct: 60 QMLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSG 119
Query: 195 SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
IP SFGNLSS+ L ++NN+ G+IP + L L ++ + N LSGTIP S+ N+SS+
Sbjct: 120 GIPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSL 179
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314
F N + G +P ++G TL NLQ S+ N+ TG+IP ++SNASNLE F N N LT
Sbjct: 180 IFFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLT 239
Query: 315 GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACI 374
G+VP LEKLQRL F +T N+LG+GE DL FL SLTN + L+ +N+NNFGG+LP I
Sbjct: 240 GKVPSLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESI 299
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRL 434
N+ST L LLLD NKI G+IPA G V L RLEMW N+LSG+IP IG+LQNLR L L
Sbjct: 300 GNWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLML 359
Query: 435 QENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ 493
+N+ G +P S+GNL+ L L L N+ QG IPSSLG+ + L +DLS NNL+GTIPPQ
Sbjct: 360 IKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQ 419
Query: 494 LLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQ 553
++ LSSL I L++S N+LTG +P EVGNLKNL +L+V N L G IP ++GSC LE L
Sbjct: 420 VVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLS 479
Query: 554 MQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFL--VGFQLLEYLNLSNNDFEGMV 611
M+GNF QG IPSS SSLRG+ +LDLS NNLSGKIPEFL + FQL +NLS NDFEG++
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQL---VNLSYNDFEGIL 536
Query: 612 PTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLS 671
PTEGVF+N S TS++GN KLCGG EF+LP C+ ++ K + L+LALK+ +A +SGL+ ++
Sbjct: 537 PTEGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAIT 596
Query: 672 LALSFLIICLVRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGI 731
LSFLI +RK+K SS S +SYQ+L ATDGF+S+NLIG GSFGSVYKGI
Sbjct: 597 CVLSFLIFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGI 656
Query: 732 LDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791
LD T +AVKV NLL GA KSFIAEC L+NIRHRNLVK+LTACSGVDYQGNDFKA+V
Sbjct: 657 LDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVV 716
Query: 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCD 851
+EFM N SLE+WLHP E PR LN LQRL+I IDVACAL YLHH CQ PIVHCD
Sbjct: 717 YEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCD 776
Query: 852 LKPSNVLLDEEMIAHVGDFGLATFLP-----LSHAQTSSIFAKGSIGYIAPEYGLGSEVS 906
LKPSNVLLD EM HVGDFG+A FLP + Q+SSI +G+IGY APEYG+GSEVS
Sbjct: 777 LKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVS 836
Query: 907 INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLA 966
+GDVYS+GILLLE+ T K+PT+ MF+ +N+HNF KTA+P+ V +I D LL + ++
Sbjct: 837 TSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMD 896
Query: 967 VHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022
+QR R A + ECL+++ IG+ACS E P +R ++T+ +L S+++I LG
Sbjct: 897 NTTSQR-RMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFLG 951
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1041 bits (2693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/1021 (56%), Positives = 703/1021 (68%), Gaps = 27/1021 (2%)
Query: 16 LVFYFSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHG 75
L F L L+ + A + GN TDRLALL+FK+KIT DPLG WN+S HFCQW+G
Sbjct: 8 LPFQLYLKLLLSSFTLAACVINGNLTDRLALLDFKAKITDDPLGFMPLWNDSTHFCQWYG 67
Query: 76 VTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQ 135
VTCSRR HQRV IL+L+SL+LAG IS H+GNLSFL+ L L NNSF H IP E RLRRLQ
Sbjct: 68 VTCSRR-HQRVAILNLRSLQLAGSISPHIGNLSFLRDLYLQNNSFSHGIPPEVGRLRRLQ 126
Query: 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS 195
L L NNS+ G IP+NIS+CS L + + N+L G+IP EL L+K++ S+ N +GS
Sbjct: 127 RLRLSNNSLTGNIPSNISACSKLSEIYFAYNQLEGEIPEELSLLAKLQVISIQKNYFSGS 186
Query: 196 IPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 255
IPPS GNLSS+ L N L G+IPD G L NL+ ++++ N LSGTIP SI+N+SSI
Sbjct: 187 IPPSIGNLSSLQVLSAPENYLSGNIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSIN 246
Query: 256 VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTG 315
+ NQIQG +P ++G TL NLQ F++ RN G+IP + SNASNL ++ NKLTG
Sbjct: 247 TLNIVYNQIQGRLPSNLGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTG 306
Query: 316 EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACIS 375
VP LE+L L + N LG E DL+F+ SL N T L I+ N F G+LP IS
Sbjct: 307 RVPSLEQLHNLQILGLGYNYLGL-EANDLDFVSSLVNCTNLWRLEIHNNKFHGVLPESIS 365
Query: 376 NFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQ 435
NFSTT L++ N I G IP++ V L RLEM NN+LSG IP G L L+ L L
Sbjct: 366 NFSTTFSQLVIAENNIAGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLF 425
Query: 436 ENRFLGNIPPSIGNLKLFNLQLSY--NFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ 493
N+ G IP S+GNL + L LS+ N LQG IPSSL + E L ++DL+ NNL+G+IP Q
Sbjct: 426 GNKLSGTIPSSLGNLTML-LTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQ 484
Query: 494 LLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQ 553
+ GLSSL I L+LS N TG IP EVGNLK+LE L + +N L G IP +LGSCIKLE+L
Sbjct: 485 VFGLSSLSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLA 544
Query: 554 MQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613
+QGNF G +PSSLSSLRGL VLD S NNLSG+IPEFL F LLE LNLS N+FEG VP
Sbjct: 545 LQGNFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPV 604
Query: 614 EGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLA 673
EG+FRNAS T V+GN KLCGG EF L C+ K K+LTL LK+ ++ I L+GLS
Sbjct: 605 EGIFRNASTTLVMGNDKLCGGIPEFHLAKCNAKSP--KKLTLLLKIVISTICSLLGLSFI 662
Query: 674 LSFLIICLVRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILD 733
L F + +RK+KE + N+S+Q+L ATDGF+SANLIG GSFG VYKG LD
Sbjct: 663 LIFALTFWLRKKKEEPTSDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLD 722
Query: 734 EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793
EG +AVKV NLLHHGA SFIAEC L+NIRHRNLVK+LTACSG+DYQGNDFKALV+E
Sbjct: 723 EGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYE 782
Query: 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853
+M N SLEEWLHPI R +E E PRSLNLLQRL+I IDVA AL YLH+ C PIVHCDLK
Sbjct: 783 YMVNGSLEEWLHPIPRTEEV-EPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLK 841
Query: 854 PSNVLLDEEMIAHVGDFGLATFLPLSH-----AQTSSIFAKGSIGYIAPEYGLGSEVSIN 908
PSNVLLD EM HV DFGLA L S +Q+SSI +G++G+ PEYG+GS VS
Sbjct: 842 PSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTY 901
Query: 909 GDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVH 968
GDVYSYGILLLEL T K+PTD MF+ D+NLHNFA+ A D + ++ D LL ++ AV
Sbjct: 902 GDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILL---QETAV- 957
Query: 969 GNQRQRQARINSKI-----ECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQ 1023
R+ R+NS+ ECL +M RIGVACS E P++RM + +VV L +I++ L+
Sbjct: 958 -----RETRLNSRKCQRLEECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLVRI 1012
Query: 1024 R 1024
R
Sbjct: 1013 R 1013
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/1023 (54%), Positives = 697/1023 (68%), Gaps = 27/1023 (2%)
Query: 7 CSFFALYAVLVFYFSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNE 66
CS F + VF SL + VT S NETD LAL++FK+KI DPLG+ SWN
Sbjct: 3 CSAFC-FRSFVFLLSL------ISVTCSDYT-NETDLLALIQFKNKIVDDPLGIMSSWNS 54
Query: 67 SIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPS 126
+IHFCQWHGV+C RR HQRV +L L+SLKL+G IS H+GNLSFL+ L L NNSF HEIP
Sbjct: 55 TIHFCQWHGVSCGRR-HQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPP 113
Query: 127 EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186
+ RLR LQ+ +LHNNSI G+IP +IS CSNLI +++ N L G+IP ELGSL K++ +
Sbjct: 114 QVGRLRSLQIFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLT 173
Query: 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNN-LDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245
+ N LTG+IPPS GNLSS+ L L +N L G++P T G LKNL L + NRLSG IP
Sbjct: 174 LEVNGLTGTIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIP 233
Query: 246 SSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEV 305
SIFN+SS+T D G N G +P DIG +L NL+FFS+ NQ TG+IP +ISNASN+E+
Sbjct: 234 PSIFNLSSLTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIEL 293
Query: 306 FQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININN 365
QV+ N LTGEVP LEKL RL+ F + N LGSG+ DL+FL SLTNAT L++ I NN
Sbjct: 294 LQVSLNNLTGEVPTLEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNN 353
Query: 366 FGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE 425
FGG LP ISN ST L V+ L N I G+IPA K V L ++ NN++SG IP +IGE
Sbjct: 354 FGGELPKQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGE 413
Query: 426 LQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484
LQNL L L N G IP S+GNL KL L L N L+GSIPSSLG + L ++ L N
Sbjct: 414 LQNLEGLVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGN 473
Query: 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLG 544
NL+G IPP L G+ SLL + S+N +G +P E+G L NLE L+V N L GEIP +LG
Sbjct: 474 NLSGDIPPGLFGIFSLLYIC-FSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLG 532
Query: 545 SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604
CI LE L M NF G IPS+LSSLRG+ + S NNLSGKIPEF GF LE L+LS
Sbjct: 533 GCISLEDLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSY 592
Query: 605 NDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAII 664
N+FEGM+P EG+F+N++ SV+GN +LCGG E LP C K + KRL L LK+A+ I
Sbjct: 593 NNFEGMIPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRC--KVHQPKRLKLKLKIAIFAI 650
Query: 665 SGLIGLSLALSFLIICLVRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSF 724
+ L+ L+L ++ L +C R+++ SS N +SYQ L AT+GF+S+NL+G GSF
Sbjct: 651 TVLLALALVVTCLFLCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSF 710
Query: 725 GSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784
GSVYKG+LD+ ++AVKV NL+ GA +SFIAEC L+NIRHRNLVK+LTACS +DY G
Sbjct: 711 GSVYKGMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHG 770
Query: 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQ 844
NDFKA+V+EFM N SLE+WLHP T LQRL+I IDVACAL YLHH C+
Sbjct: 771 NDFKAIVYEFMANGSLEDWLHPTGTGGGTTLTLNL---LQRLNIAIDVACALEYLHHHCE 827
Query: 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-----QTSSIFAKGSIGYIAPEY 899
PI HCDLKPSNVLLD+E+ HVGDFGLA FL + +++SI +G+IGY PEY
Sbjct: 828 MPIAHCDLKPSNVLLDDELTGHVGDFGLAKFLSGASLDYPTNESTSIGVRGTIGYAPPEY 887
Query: 900 GLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLL 959
G+G EVS GD YSYGILLLE+ T K+PTD MF NLHNF K A+P+ V I D TLL
Sbjct: 888 GVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLL 947
Query: 960 SDDE--DLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
++ D H R +R +ECL ++ RIG++CS+E P +RM +++ V QL S++
Sbjct: 948 QEEPTGDDDKHEISSMRNSR---PLECLNSILRIGISCSVEFPRERMKISDAVAQLHSVR 1004
Query: 1018 NIL 1020
N L
Sbjct: 1005 NEL 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/997 (54%), Positives = 695/997 (69%), Gaps = 21/997 (2%)
Query: 32 TASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDL 91
+A ++ NETDRLALL+FKSKITHDPLG+ WN SIHFC W GVTCS++ HQRV +LDL
Sbjct: 25 SALSIGRNETDRLALLDFKSKITHDPLGIMRLWNSSIHFCHWFGVTCSQK-HQRVAVLDL 83
Query: 92 KSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPAN 151
+SLKL+G +S ++GNLSFL+ L L +NSF HEIP++ L RLQ+LALHNNS GEIPA+
Sbjct: 84 QSLKLSGSVSPYIGNLSFLRNLYLQHNSFSHEIPAQIGHLHRLQILALHNNSFTGEIPAS 143
Query: 152 ISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211
+SS NL+ + L +N+L G+IP E GS K+ + NNL G+IPPS GN+SS+ L+L
Sbjct: 144 MSSSYNLVSLILDNNKLTGEIPKEFGSFLKLTDLYIDDNNLVGTIPPSLGNISSLQELWL 203
Query: 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271
NNL G++P T L NL L++ NR SGTIP S+ N+SS+ F G+N QG +P D
Sbjct: 204 DDNNLFGNLPATLSKLVNLRVLSLFNNRFSGTIPPSMLNLSSLRTFQVGLNHFQGNLPPD 263
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVI 331
+G +L NL+FFS+ NQ TG++P +ISN SNLE+ ++N NKL G++P LEKLQRL I
Sbjct: 264 LGISLPNLEFFSIYSNQFTGSVPVSISNLSNLEMLELNLNKLRGKMPSLEKLQRLLSITI 323
Query: 332 TRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI 391
N+LGSGE DL+FL SLTNAT L+ I NNF G LP ISN STTLE++ LDSN +
Sbjct: 324 ASNNLGSGEANDLSFLSSLTNATNLEELIITQNNFQGQLPPQISNLSTTLEIMGLDSNLL 383
Query: 392 FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL- 450
FG+IP + L E+ NN LSG IP IG+LQNL L L N F G+IP S+GNL
Sbjct: 384 FGSIPDGIENLISLNDFEVQNNHLSGIIPSTIGKLQNLEILGLALNNFSGDIPSSLGNLT 443
Query: 451 KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQ 510
L L L+ +QGSIPSSL L +DLS N +TG+IPP + GLSSL I L+LSRN
Sbjct: 444 NLIGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGSIPPGIFGLSSLSINLDLSRNH 503
Query: 511 LTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSL 570
L+G +P EVGNL+NLE+ + N + G+IP +L CI L+ L + NF +G +PSSLS+L
Sbjct: 504 LSGSLPKEVGNLENLEIFAISGNMISGKIPSSLAQCISLQFLYLDANFFEGSVPSSLSTL 563
Query: 571 RGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLK 630
RG+ + S NNLSGKI EF F+ LE L+LS N+FEGMVP G+F+NA+ TSV+GN K
Sbjct: 564 RGIQEFNFSHNNLSGKIHEFFQDFRSLEILDLSYNNFEGMVPFRGIFKNATATSVIGNSK 623
Query: 631 LCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRKENQN 690
LCGGT +F LP C+ K KRL+L +K+ + +IS L+ +++ ++ L + RK++
Sbjct: 624 LCGGTPDFELPPCNFKHP--KRLSLKMKITIFVISLLLAVAVLITGLFLFWSRKKRREFT 681
Query: 691 PSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG 750
PSS N +SYQ+L AT+GF+S NLIG GSFGSVYKGILD T VAVKV NL G
Sbjct: 682 PSSDGNVLLKVSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLRRQG 741
Query: 751 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE 810
A KSF+AEC L N+RHRNLVK++TACSGVDY GNDFKALV+EFM N SLE WLHP
Sbjct: 742 ASKSFMAECEALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSRAT 801
Query: 811 DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870
DE L+L QRL I IDVA AL Y HH C+ IVHCDLKP NVLLD+EM+ HVGDF
Sbjct: 802 DEVRGI---LDLTQRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDF 858
Query: 871 GLATFL---PLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
GLA FL L H+ +SSI +G+IGY PEYG G+EVS GDVYSYGILLLE+ T K
Sbjct: 859 GLAKFLLEDTLHHSTNPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSYGILLLEMFTGK 918
Query: 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 985
+PTD +F G +NLH++ KT LP+ V+ I D TL + GN ++ N ++CL
Sbjct: 919 RPTDDLFNG-LNLHSYVKTFLPEKVLQIADPTL----PQINFEGNSIEQ----NRVLQCL 969
Query: 986 VAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022
V++ G++CS+ESP++RM + +V+ QL S +N LLG
Sbjct: 970 VSVFTTGISCSVESPQERMGIADVIAQLFSARNELLG 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/1012 (52%), Positives = 702/1012 (69%), Gaps = 12/1012 (1%)
Query: 20 FSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCS 79
+SL L+ + + + GNETDRL+LL FK++I+ DPLG SWNES+HFC+W GV C
Sbjct: 12 YSLFLLIIQFSIASCLLVGNETDRLSLLAFKTQIS-DPLGKLSSWNESLHFCEWSGVICG 70
Query: 80 RRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLAL 139
R+ H+RV LDL S +LAG +S H+GNLSFL++L+L NSF + IP E RL R+Q L+L
Sbjct: 71 RK-HRRVVELDLHSSQLAGSLSPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSL 129
Query: 140 HNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS 199
NN+ GEIP NIS C+NL+ + L+SN L GK+P+E GSLSK++ + N+L G IPPS
Sbjct: 130 GNNTFSGEIPVNISRCTNLLSIGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPS 189
Query: 200 FGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDA 259
+GNLS + + RNNL G IPD+ G LK L + T N LSGTIPSSI+N+SS+ F A
Sbjct: 190 YGNLSELQIIRGVRNNLQGGIPDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSA 249
Query: 260 GINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY 319
+NQ+ G++P ++G TL NL F++ NQ G IP +SNAS + Q+ +N TG+VP
Sbjct: 250 PLNQLYGILPPELGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVPS 309
Query: 320 LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFST 379
L L L V+ N+LG+ E DL FL L N T L+ IN NNFGG+LP + NFST
Sbjct: 310 LAGLHNLQRLVLNFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFST 369
Query: 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF 439
L ++++ N + G+IP GK + L L + N+L+G IP +IG+LQ L + N+
Sbjct: 370 KLRIMIIGENNLRGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKI 429
Query: 440 LGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
GNIP S+GN+ L + N LQG IPSSLG + L ++ L NNL+G+IP ++LG+S
Sbjct: 430 SGNIPSSLGNITSLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGIS 489
Query: 499 SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF 558
SL + L+L+ NQL GP+P+EVG L +L LNV++N+L GEIP L SC+ LE L + NF
Sbjct: 490 SLSMYLDLAENQLIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNF 549
Query: 559 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFR 618
QG IP SLSSLR L +L+LS NNLSGKIP+FL F+LL L+LS N+ EG VP +GVF
Sbjct: 550 FQGSIPESLSSLRALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFA 609
Query: 619 NASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALSFLI 678
AS S+LGN KLCGG + L C+ KKS+ + + +KL +AI G +G+ L +S+++
Sbjct: 610 RASGFSMLGNKKLCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYML 669
Query: 679 ICLVRKRKENQNPSSPINS-FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKT 737
L++++K SP S F ++Y++L AT GF+ ANLIGAGSFGSVYKGIL
Sbjct: 670 FFLLKEKKSRPASGSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGA 729
Query: 738 IVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN 797
VAVKVFNLL GA KSF+AEC L NIRHRNLVK+LTACSG+D+QGNDFKALV+EFM N
Sbjct: 730 AVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVN 789
Query: 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857
SLEEWLHP+ DE R L+LLQRL+I IDVA AL YLH+ CQ + HCDLKPSNV
Sbjct: 790 GSLEEWLHPVQISDEA-HVRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNV 848
Query: 858 LLDEEMIAHVGDFGLATFLP-LSHA----QTSSIFAKGSIGYIAPEYGLGSEVSINGDVY 912
LLD +M AHVGDFGLA LP SH QTSSI KG+IGY APEYGLGSEVS GDVY
Sbjct: 849 LLDGDMTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVY 908
Query: 913 SYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQR 972
SYGILLLE+ T ++PT+ +F+ +NLHNFAKTALP V +++D L+++ E+ + G+
Sbjct: 909 SYGILLLEVFTGRRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETS--GDAS 966
Query: 973 QRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQR 1024
+R + I + +ECL A+ ++GVACS E P +RM++++V +L+ I++ILLG +
Sbjct: 967 RRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQ 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2585), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/943 (55%), Positives = 657/943 (69%), Gaps = 34/943 (3%)
Query: 28 FLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVT 87
F T+S ++GNETD ALLEFKSKITHDP V SWNE+IHFCQW GVTC H+RVT
Sbjct: 26 FSSTTSSAISGNETDLQALLEFKSKITHDPFQVLRSWNETIHFCQWQGVTCGLL-HRRVT 84
Query: 88 ILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE 147
+LDL SLK++G IS ++GNLSFL+ L++ NNSF HEIP + LRRL+ L L+NNS+GG+
Sbjct: 85 VLDLHSLKISGSISPYIGNLSFLRALNIQNNSFGHEIPQQIGYLRRLEELRLNNNSVGGK 144
Query: 148 IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSIS 207
IP NIS CSNL+ + L N+L G +P ELG LS ++ S+ N LTGSIP S GNLS +
Sbjct: 145 IPTNISRCSNLVFISLGKNKLEGNVPEELGVLSNLQVLSIFGNKLTGSIPHSLGNLSQLQ 204
Query: 208 FLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGV 267
L L+ N + G +P++ GWL+NL L++ NRLSGTIPSS+FN+SSI D G N G
Sbjct: 205 RLSLAENRMVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDIGENNFHGN 264
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLS 327
+P DIGF L N+++F++ N+ TG IP ++SNA+NLE + N LTGEVP L KL RL
Sbjct: 265 LPSDIGFLLPNIRWFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGEVPSLAKLDRLR 324
Query: 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLD 387
F +T N+LG+G+ DL+FL SLTN T L+ +N NNFGG+LP I+N STTL +LLLD
Sbjct: 325 VFSLTSNNLGTGKADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIANLSTTLRILLLD 384
Query: 388 SNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI 447
+N+I G+IP+ V L E+WNN+LSG IP +IG+LQNL L L N G+IP S+
Sbjct: 385 NNRIIGSIPSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALNSNMLSGHIPSSL 444
Query: 448 GNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLEL 506
GNL L L + N L G IPS LG+ + + + LS NN +G+IPP+++ +SSL I L+L
Sbjct: 445 GNLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEVISISSLSIYLDL 504
Query: 507 SRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSS 566
S+N LTG +P EVGNLK+L +V NKL GEIPRTLGSCI LE+L M GN QG IPSS
Sbjct: 505 SQNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNMAGNNFQGLIPSS 564
Query: 567 LSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVL 626
LSSLR L +LDLS N+LS GMVP++G+F+NAS TSV
Sbjct: 565 LSSLRALQILDLSNNHLS------------------------GMVPSKGIFKNASATSVE 600
Query: 627 GNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRK 686
GN LCGG EF+LP C+ + K RLT LK ++ ISG+ L L L + R++K
Sbjct: 601 GNNMLCGGIPEFQLPVCNSARHKKNRLTPVLKTVISAISGMAFLIL---MLYLFWFRQKK 657
Query: 687 ENQNPSS-PINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
N+ + +SYQNL+ ATDGF+SAN+IG GSFGSVYKG LD T++AVKVFN
Sbjct: 658 VNETTADFSEKKIMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVFN 717
Query: 746 LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH 805
L+ G FKSF+AEC L+NIRHRNL+K+LTACS +DY GNDFKALV+EFM N SLEEWLH
Sbjct: 718 LMRRGGFKSFLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWLH 777
Query: 806 PITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865
P +E E R LN LQRL+I IDVA AL YLHH C+P IVHCDLKPSN+LLDEE+
Sbjct: 778 PPVATNEAELETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELTG 837
Query: 866 HVGDFGLATFLPLS----HAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
HVGDFGLA FL + + Q+SSI +G++GY PEYG+ SEVS GDVYSYGILLLE+
Sbjct: 838 HVGDFGLARFLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSYGILLLEM 897
Query: 922 VTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDED 964
T K+P D MF+ NLHNF K ALP+ VV+IVD LL + E+
Sbjct: 898 FTGKRPMDDMFKDGFNLHNFVKAALPNQVVEIVDPNLLPEIEE 940
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/996 (53%), Positives = 691/996 (69%), Gaps = 11/996 (1%)
Query: 36 VAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLK 95
GNETDRL+LL KS+IT+DP G+ SWNES+HFC W GV C +R H+RV +DL S +
Sbjct: 29 TGGNETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKR-HRRVVEIDLHSAQ 87
Query: 96 LAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSC 155
L G +S H+GNLSFL++L L NN F H IP E L RL++L+L NN+ G+IP NIS C
Sbjct: 88 LVGSLSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHC 147
Query: 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215
SNL+ + LS N L GK+P ELGSLSK++ F +N L G IP SFGNLS+I +F + N
Sbjct: 148 SNLLILSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNY 207
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
L G IP++ G LK+L + + +N ++G IP SI+N+SS+ F +NQ+ G +P D+G T
Sbjct: 208 LQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLT 267
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L NL+ + N+ +G+IPP SNAS + V ++++N LTG VP L L +L ++ N
Sbjct: 268 LPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVPDLSSLSKLRWLIVDVNY 327
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
LG+G DL+FL L N T L+ IN NNFGGLLP ISNFS L+ + N+I G+I
Sbjct: 328 LGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSI 387
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFN 454
P+ G + L L + N+L+G IP +IG+LQNL L L N+ GNIP S+GN+ L
Sbjct: 388 PSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLE 447
Query: 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514
+ LS N LQG IPSSLG + L I+ L NNL+G+IP +++ + S +L LS NQLTG
Sbjct: 448 VYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGS 507
Query: 515 IPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLS 574
+P EVG L NL N+ N+L GEIPRTLGSC+ LE L M+GN QGPIP SLSSLR L
Sbjct: 508 LPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQ 567
Query: 575 VLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGG 634
+L+LS NNLSG+IP+FL +LL L+LS N+ EG VP +G+F AS S+LGN KLCGG
Sbjct: 568 ILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGG 627
Query: 635 THEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRKENQNPSSP 694
+ L C+ KKS+ + + LKL +AI G +G+ L +S+++ ++++K SP
Sbjct: 628 MPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASGSP 687
Query: 695 INS-FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK 753
S F ++Y++L AT+GF+ ANLIGAGSFGSVYKGIL VAVKVFNLL GA K
Sbjct: 688 WESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASK 747
Query: 754 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 813
SF+AEC L NIRHRNLVK+LTACSG+D+QGNDFKALV+EFM N SLEEWLHP DE
Sbjct: 748 SFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEA 807
Query: 814 EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
R L+LLQRL+I IDVA AL YLH+ CQ IVHCDLKPSNVLLD ++ AHVGDFGLA
Sbjct: 808 HRR-RDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLA 866
Query: 874 TFLP-LSHA----QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928
LP SH QTSSI KG+IGY APEYGLGSEVS GDVYSYGILLLE+ T ++PT
Sbjct: 867 RLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPT 926
Query: 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAM 988
D +F+ +NLHNFAKTALP V +++D L+++ E+ + G+ +R + I + +ECL A+
Sbjct: 927 DGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETS--GDASRRMSHIGNHMECLAAI 984
Query: 989 ARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQR 1024
++GVACS E P +RM++++V +L+ I++ILLG +
Sbjct: 985 VKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQ 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2545), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/1014 (53%), Positives = 695/1014 (68%), Gaps = 26/1014 (2%)
Query: 28 FLGV----TASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQH 83
F G+ T+ GNETD+LALL FK++IT DPL + SWN + HFC W GVTC R H
Sbjct: 17 FFGILCLSTSGEAHGNETDKLALLSFKAQITDDPLELLQSWNATSHFCDWRGVTCGNR-H 75
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
QRV L+L SLKL+G + H+GNLSFL+VLDLHNNS EIPSE LRRLQVL L NNS
Sbjct: 76 QRVVKLELYSLKLSGSLPHHIGNLSFLRVLDLHNNSLSGEIPSEIGYLRRLQVLNLRNNS 135
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203
I G+IPANISSCS+L+ + N L+G IPS LG LSK+ +F V N LTGSIP SFGNL
Sbjct: 136 IVGKIPANISSCSSLLHFNVGGNRLMGDIPSALGKLSKLVFFGVDRNTLTGSIPSSFGNL 195
Query: 204 SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263
SS+ L + N ++G+IPD G L N+++ + N SG IP IFN+SS+ D +N
Sbjct: 196 SSLQVLAIHVNKMNGNIPDELGRLTNVLDFIVHTNNFSGAIPPPIFNLSSLVRMDLSVNN 255
Query: 264 IQGVIPLDIGFTLQNLQFFSVGRN-QLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEK 322
+G +P ++G +L NLQFFSV N + TG IP +ISNASNL F + NK TGEVP LE
Sbjct: 256 FRGNLPSNMGISLPNLQFFSVLMNYEFTGPIPISISNASNLLYFNLAGNKFTGEVPTLEN 315
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLE 382
L L +T N LGS DL+FLC+LTN T + IN+NNFGG LP CI NFST L
Sbjct: 316 LHELEALSLTSNHLGSAGTNDLSFLCTLTNGTNFRRLAINLNNFGGDLPGCIGNFSTRLR 375
Query: 383 VLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGN 442
+L + N I G++PA G V L +M NN+ SG++PP+I +LQ L+ L LQ N+F G
Sbjct: 376 LLSMSDNMISGSMPAEIGNLVSLDVFDMGNNQFSGSLPPSITKLQQLKVLYLQANKFSGE 435
Query: 443 IPPSIGNLKLFN-LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
IP +GNL L L L+ N +G IP SLG+ + L ++DL+NNNL G+IPP+L LSSL
Sbjct: 436 IPHYLGNLTLLTELMLNDNSFRGMIPLSLGRCQNLLLLDLANNNLNGSIPPELFDLSSLS 495
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561
L LS N L G + +V NL NL +L V N L GEIP +LGSCI+LE L M+ N +G
Sbjct: 496 AYLRLSHNHLVGALSEKVQNLNNLGVLYVDHNFLSGEIPSSLGSCIRLERLNMRDNSFKG 555
Query: 562 PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNAS 621
IPSSLS+LRGL V+DLS NNLSG+IPEFL F L+ LNLS NDFEG+VPTEGVF+NAS
Sbjct: 556 SIPSSLSALRGLQVVDLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPTEGVFKNAS 615
Query: 622 ITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALSFLIICL 681
TSV+GN KLCGG +F L C+ + S ++R L LK +A ++ L+G L LSFL+I
Sbjct: 616 STSVMGNNKLCGGVSDFHLLACNIRSSTNRR--LKLKAIIASVAVLLGALLMLSFLLI-- 671
Query: 682 VRKRKENQNP--SSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIV 739
+R RK++Q P SS I +SYQNL++AT GF+S+NLI G FGSVY+G+L E +V
Sbjct: 672 LRSRKKSQAPALSSEI-PLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGVLGESGQLV 730
Query: 740 AVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS 799
AVKV N+ H A KSF+ EC LK+IRHRNLVK+LTACS +DYQGNDFKALV+EFM N S
Sbjct: 731 AVKVLNVQHQTAAKSFMVECEVLKSIRHRNLVKVLTACSSIDYQGNDFKALVYEFMVNGS 790
Query: 800 LEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
LEEWLHP+ D ++E P+ L+LLQRL+I ID+A AL YL + C+ IVHCDLKPSNVLL
Sbjct: 791 LEEWLHPVV-VDGSDEPPKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCDLKPSNVLL 849
Query: 860 DEEMIAHVGDFGLATFL-----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSY 914
D E+ HV DFG+A FL S +SS+ +G+IGY PEYG+G +VSI GD+YSY
Sbjct: 850 DAELTGHVSDFGIAKFLLKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVSIFGDIYSY 909
Query: 915 GILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQR 974
GILLLE+ T K+PT+ MF+ +NLH FAK+ALPD V +I+D LL + G R
Sbjct: 910 GILLLEMFTGKRPTNDMFKEGLNLHKFAKSALPDGVAEILDPVLLQES------GEIDSR 963
Query: 975 QARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRIVSN 1028
R ++CL+++ IGV+CS E P DR+ ++V +L SI++ LL + +N
Sbjct: 964 SIRTKKIMDCLISIVDIGVSCSAELPGDRVCTSDVALKLSSIRSKLLWTELRTN 1017
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2544), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/1018 (51%), Positives = 690/1018 (67%), Gaps = 12/1018 (1%)
Query: 14 AVLVFYFSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQW 73
++ + + L L L ++ + GNETDRL+LL FK+ IT DPL + SWNES+HFC+W
Sbjct: 7 SIFILLWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNESLHFCKW 66
Query: 74 HGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRR 133
G+TC R HQRV +DL+S +L+G ++A +GNLSFL+VL+L NNS H IP E RL R
Sbjct: 67 SGITCGSR-HQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFR 125
Query: 134 LQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT 193
L+ L L NS GEIP NIS CSNL+ +RL N L GK+P+EL SLSK++ F N LT
Sbjct: 126 LRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAELKSLSKLQMFEFEINYLT 185
Query: 194 GSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253
G I PSF NLSS+ ++ +RNN G IP++ G LK+L ++ + SG IP SIFN+SS
Sbjct: 186 GEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSS 245
Query: 254 ITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313
+T+ INQ+ G +P D+G +L L+ + N+ +G+IPP ISNASNL V+ N
Sbjct: 246 LTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNF 305
Query: 314 TGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC 373
TG+VP L +L LS+ I +N+LG+GE DL+FL +L N T L+ I NN GG+LP
Sbjct: 306 TGKVPSLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEM 365
Query: 374 ISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELR 433
+SNFST L + NKI G IP+ ++L L N L+G+IP ++G+L+NL +L
Sbjct: 366 LSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLY 425
Query: 434 LQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP 492
L +N G+IP S+GN+ L + L N L+GSIPSSLG + + ++DLS NNL+GTIP
Sbjct: 426 LNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPK 485
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELL 552
+L+ + SL I L+LS NQ TG +P EVG L NL L+V +NKL GEIP++LGSC +LE L
Sbjct: 486 ELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETL 545
Query: 553 QMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVP 612
+QGN QG IP SLSSLRG++ L+LS NNL+G+IP F F+ LE L+LS NDFEG VP
Sbjct: 546 YLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVP 605
Query: 613 TEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSL 672
EGVF+NAS S+ GN LCGG E LP C+ KS + + L+L + + + L
Sbjct: 606 AEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVL 665
Query: 673 AL-SFLIICLVRKRKENQNPSSPINS-FPNISYQNLYNATDGFTSANLIGAGSFGSVYKG 730
L S L+ C ++ RK + S ++ F +SYQNL ATDGF+SANLIGAGSFGSVYKG
Sbjct: 666 LLTSALLFCCLKMRKNKEASGSSLDIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKG 725
Query: 731 ILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790
IL +TI+AVKV NL H GA +SF+ EC L N+RHRNLVK+LTACS D++ NDFKAL
Sbjct: 726 ILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDFKAL 785
Query: 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHC 850
V+E+M N SLEEWLHP D+ ++ PR L+L++RL I IDVA AL YLH+ CQ P+VHC
Sbjct: 786 VYEYMVNGSLEEWLHPTQNPDQ-DQPPRILSLIERLSISIDVASALDYLHNQCQVPVVHC 844
Query: 851 DLKPSNVLLDEEMIAHVGDFGLATFL---PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI 907
DLKPSN+LLD +M AHVGDFGLA FL P + +SSI +G++GY APEYG+GS+VS
Sbjct: 845 DLKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSPSSSIGIRGTVGYAAPEYGMGSDVST 904
Query: 908 NGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLL-SDDEDL- 965
GDVY+YGILLLEL T KKPTD MF+ +NLH AK A+PD + D LL ++DE
Sbjct: 905 YGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRLALAADPFLLITEDEGTS 964
Query: 966 --AVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021
A + R + + CL ++ +IGV CS ESP DRMD+++V ++L I+NILL
Sbjct: 965 ASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDISDVANELVRIRNILL 1022
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/1024 (51%), Positives = 683/1024 (66%), Gaps = 31/1024 (3%)
Query: 7 CSFFALYAVLVFYFSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNE 66
C L L F FSLH GNETDRL+LL FK++IT DPL SWN
Sbjct: 12 CPLLLLIIQLSFSFSLH-------------EGNETDRLSLLAFKAQIT-DPLDALSSWNA 57
Query: 67 SIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPS 126
S HFC+W GV C R HQR+ L+L+S +L G +S H+GNLSFL+VL+L N F +IP
Sbjct: 58 STHFCKWSGVICGHR-HQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQ 116
Query: 127 EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186
E RL RLQ L L NN+ GEIP NISSCSNL+ + L SN L GKIP++LGSLSK+ F
Sbjct: 117 ELGRLFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFV 176
Query: 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPS 246
+ NNL G IP SFGNLSS+ F ++N L G IP++ G LK L +A+N LSGTIPS
Sbjct: 177 LQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPS 236
Query: 247 SIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVF 306
SI NISS+ G NQ+ G +P D+G L NL + + N L G IP +SNAS + +
Sbjct: 237 SICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLV 296
Query: 307 QVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNF 366
++ N LTG++P L L L ++ N LG+GE DL+FL +L N+T L+ IN NNF
Sbjct: 297 DLSYNNLTGKIPDLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNF 356
Query: 367 GGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGEL 426
GG+LP +SNFST L+ + N+I G+IP G + L L + N+L G IP +IG+L
Sbjct: 357 GGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKL 416
Query: 427 QNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNN 485
QNL L L EN+ G+IP S+GN+ L + + N LQG+IP+SLG L I+DLS NN
Sbjct: 417 QNLAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNN 476
Query: 486 LTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGS 545
L+G IP ++LG+SSL ++L L NQLTG +P+EVG L NL L V +N+L GEIP++L S
Sbjct: 477 LSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDS 536
Query: 546 CIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
C LE L + GNF +GP+P LSSLR L +L LS NNLSG+IP+FL F+LLE L+LS N
Sbjct: 537 CKSLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYN 595
Query: 606 DFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIIS 665
DFEG VP +GVF N S SV GN KLCGG + LP C+ + + L L +AI
Sbjct: 596 DFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPC 655
Query: 666 GLIGLSLALSFLIICLVRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFG 725
G +G+ L SFL+ + + E + S +SF ++YQ+L ATDGF+S+NL+GAG+FG
Sbjct: 656 GFLGIVLMTSFLLFYSRKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFG 715
Query: 726 SVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785
SVY+G L +VAVKV NLL GA KSF+AEC L NIRHRNLVK++TACS D+QGN
Sbjct: 716 SVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGN 775
Query: 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQP 845
DFKALV+EFM N SLEEWLHP+ D T E R+L+L+QRL+I IDVA AL YLH+ CQ
Sbjct: 776 DFKALVYEFMVNGSLEEWLHPVHISDVTPET-RNLDLVQRLNIAIDVASALDYLHNHCQV 834
Query: 846 PIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP-----LSHAQTSSIFAKGSIGYIAPEYG 900
P+VHCDLKPSNVLL ++M A VGDFGLA FLP L ++SS+ KG+IGY APEYG
Sbjct: 835 PVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEASNQLPADESSSVGLKGTIGYAAPEYG 894
Query: 901 LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLS 960
+GSEVS GDVYSYGILLLE+ T ++PTD MF+ NLHN+AK LPD+V++ VD TL
Sbjct: 895 MGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLRE 954
Query: 961 DDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020
+E N ++ +EC+V++ ++G+ACS E P +RM + NVV +L I+ +L
Sbjct: 955 HEE-----MNHNDDSHKV---MECMVSIIKVGLACSAELPGERMGIANVVVELHRIREML 1006
Query: 1021 LGQR 1024
G++
Sbjct: 1007 DGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.964 | 0.971 | 0.420 | 3.3e-198 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.932 | 0.953 | 0.420 | 2.3e-197 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.930 | 0.952 | 0.413 | 1.5e-193 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.944 | 0.965 | 0.406 | 1.6e-191 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.939 | 0.946 | 0.414 | 1.1e-188 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.936 | 0.937 | 0.413 | 2.1e-187 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.687 | 0.873 | 0.387 | 4.3e-125 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.863 | 0.760 | 0.335 | 1.5e-122 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.575 | 0.475 | 0.310 | 6.9e-115 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.578 | 0.590 | 0.300 | 1.4e-106 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1919 (680.6 bits), Expect = 3.3e-198, P = 3.3e-198
Identities = 434/1031 (42%), Positives = 569/1031 (55%)
Query: 5 VSCSFFALYAVLVFYFSLHLVPEFLGVTASTVA-GNETDRLALLEFKSKITHDPLGVFGS 63
V C L V S+ L + V A T+ ETD+ ALLEFKS+++ V GS
Sbjct: 3 VPCIVMRLILVSALLVSVSLEHSDM-VCAQTIRLTEETDKQALLEFKSQVSETSRVVLGS 61
Query: 64 WNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHE 123
WN+S+ C W GV C + H+RVT +DL LKL G +S VGNLSFL+ L+L +N FH
Sbjct: 62 WNDSLPLCSWTGVKCGLK-HRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGA 120
Query: 124 IPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183
IPSE L RLQ L + NN GG IP +S+CS+L + LSSN L +P E GSLSK+
Sbjct: 121 IPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLV 180
Query: 184 YFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243
S+ NNLTG P S GNL+S+ L N ++G IP LK ++ +A N+ +G
Sbjct: 181 LLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGV 240
Query: 244 IPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNL 303
P I+N+SS+ N G + D G L NLQ +G N TG IP +SN S+L
Sbjct: 241 FPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSL 300
Query: 304 EVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHIN 362
+ SN LTG++P +LQ L + NSLG+ DL+FL +LTN ++L++ ++
Sbjct: 301 RQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVG 360
Query: 363 INNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPA 422
N GG LP I+N ST L L L N I G+IP G V L L++ N L+G +PP+
Sbjct: 361 FNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPS 420
Query: 423 IGXXXXXXXXXXXXXXFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDL 481
+G G IP S+GN+ L L L N +GSIPSSLG L ++L
Sbjct: 421 LGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNL 480
Query: 482 SNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541
N L G+IP + N L GP+ ++G LK L L+V NKL G+IP+
Sbjct: 481 GTNKLNGSIPHELMELPSLVVLNVSF-NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQ 539
Query: 542 TLGSCIKLELLQMQGNFLQGPIPXXXXXXXXXXXXXXXQNNLSGKIPEFLVGFQLLEYLN 601
TL +C+ LE L +QGN GPIP +NNLSG IPE++ F L+ LN
Sbjct: 540 TLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLS-KNNLSGTIPEYMANFSKLQNLN 598
Query: 602 LSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRXXXXXXXXX 661
LS N+F+G VPTEGVFRN S SV GN+ LCGG +L CS + +
Sbjct: 599 LSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITIC 658
Query: 662 XXXXXXXXXXXXXXXXXXCLVRKRKEXXXXXXXXXXXXXX---------XYQNLYNATDG 712
C + R + Y LY T G
Sbjct: 659 VSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGG 718
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
F+S+NLIG+G+FG+V+KG L VA+KV NL GA KSFIAEC L IRHRNLVK
Sbjct: 719 FSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVK 778
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
++T CS D++GNDF+ALV+EFM N +L+ WLHP E ET R+L L RL+I IDV
Sbjct: 779 LVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIE-ETGNPSRTLGLFARLNIAIDV 837
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-----PLSHAQTSSIF 887
A AL YLH C PI HCD+KPSN+LLD+++ AHV DFGLA L H Q SS
Sbjct: 838 ASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAG 897
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947
+G+IGY APEYG+G SI GDVYS+GI+LLE+ T K+PT+ +F + LH+F K+AL
Sbjct: 898 VRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQ 957
Query: 948 DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
+DI D T+L A H N +ECL + R+GV+CS ESP +R+ M
Sbjct: 958 KRQALDITDETILRGA--YAQHFNM----------VECLTLVFRVGVSCSEESPVNRISM 1005
Query: 1007 TNVVHQLQSIK 1017
+ +L SI+
Sbjct: 1006 AEAISKLVSIR 1016
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1911 (677.8 bits), Expect = 2.3e-197, P = 2.3e-197
Identities = 418/993 (42%), Positives = 570/993 (57%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAG 98
+ETDR ALL+FKS+++ D V SWN S C W GVTC R+ ++RVT L+L L+L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRK-NKRVTHLELGRLQLGG 80
Query: 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNL 158
IS +GNLSFL LDL+ N F IP E +L RL+ L + N + G IP + +CS L
Sbjct: 81 VISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRL 140
Query: 159 IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218
+ +RL SN L G +PSELGSL+ + ++ NN+ G +P S GNL+ + L LS NNL+G
Sbjct: 141 LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEG 200
Query: 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQN 278
IP L + +L + N SG P +++N+SS+ + G N G + D+G L N
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260
Query: 279 LQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGS 338
L F++G N TG+IP +SN S LE +N N LTG +P + L + NSLGS
Sbjct: 261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGS 320
Query: 339 GEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAA 398
RDL FL SLTN T+L+ I N GG LP I+N S L L L I G+IP
Sbjct: 321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 399 FGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNIPPSIGNLKLFN-LQL 457
G + L +L + N LSG +P ++G G IP IGN+ + L L
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTGPIPN 517
S N +G +P+SLG L + + +N L GTIP + N L G +P
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSG-NSLIGSLPQ 499
Query: 518 EVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPXXXXXXXXXXXXX 577
++G L+NL L++ +NKL G++P+TLG+C+ +E L ++GN G IP
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDL 559
Query: 578 XXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHE 637
N+LSG IPE+ F LEYLNLS N+ EG VP +G+F NA+ S++GN LCGG
Sbjct: 560 S-NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 638 FRLPTC-SPKKSKHKRXXXXXXXXXXXXXXXXXXXXXXXXXXXCLV--RKRKEXXXX--- 691
F+L C S S K+ L+ RKRK+
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678
Query: 692 --XXXXXXXXXXXYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH 749
Y +L NAT+GF+S+N++G+GSFG+VYK +L K +VAVKV N+
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 750 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 809
GA KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+F+AL++EFM N SL+ WLHP
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP-EE 797
Query: 810 EDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869
+E R+L LL+RL+I IDVA L YLH C PI HCDLKPSNVLLD+++ AHV D
Sbjct: 798 VEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSD 857
Query: 870 FGLATFL-----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
FGLA L Q SS +G+IGY APEYG+G + SINGDVYS+GILLLE+ T
Sbjct: 858 FGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTG 917
Query: 925 KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIEC 984
K+PT+ +F G+ L+++ K+ALP+ ++DIVD ++L H R +EC
Sbjct: 918 KRPTNELFGGNFTLNSYTKSALPERILDIVDESIL--------HIGLRVGFP----VVEC 965
Query: 985 LVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
L + +G+ C ESP +R+ + VV +L SI+
Sbjct: 966 LTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1875 (665.1 bits), Expect = 1.5e-193, P = 1.5e-193
Identities = 411/994 (41%), Positives = 563/994 (56%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAG 98
+E+DR ALLE KS+++ +WN S C W V C R+ H+RVT LDL L+L G
Sbjct: 22 DESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRK-HKRVTRLDLGGLQLGG 80
Query: 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNL 158
IS +GNLSFL LDL NNSF IP E L RL+ LA+ N + GEIPA++S+CS L
Sbjct: 81 VISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRL 140
Query: 159 IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218
+ + L SN L +PSELGSL K+ Y + N+L G P NL+S+ L L N+L+G
Sbjct: 141 LYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEG 200
Query: 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI-TVFDAGINQIQGVIPLDIGFTLQ 277
IPD L +V+LT+ N SG P + +N+SS+ ++ G N G + D G L
Sbjct: 201 EIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLG-NGFSGNLKPDFGNLLP 259
Query: 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV-PYLEKLQRLSHFVITRNSL 336
N+ S+ N LTGAIP ++N S LE+F + N++TG + P KL+ L + + NSL
Sbjct: 260 NIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSL 319
Query: 337 GSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP 396
GS DL FL +LTN + L ++ N GG LP I N ST L VL L N I+G+IP
Sbjct: 320 GSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIP 379
Query: 397 AAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNIPPSIGNL-KLFNL 455
G + L L + +N L+G +P ++G F G IP IGNL +L L
Sbjct: 380 HDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKL 439
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTGPI 515
LS N +G +P SLG + + + N L GTIP + N L+G +
Sbjct: 440 YLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMES-NSLSGSL 498
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPXXXXXXXXXXX 575
PN++G L+NL L + N L G +P+TLG C+ +E++ +Q N G IP
Sbjct: 499 PNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGVKNV 558
Query: 576 XXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGT 635
NNLSG I E+ F LEYLNLS+N+FEG VPTEG+F+NA++ SV GN LCG
Sbjct: 559 DLS-NNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSI 617
Query: 636 HEFRLPTCSPKKSK-HKRXXXXXXXXXXXXXXXXXXXXXXXXXXXCLVRKRKEXXXXXXX 694
E +L C + R +KRK
Sbjct: 618 KELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNS 677
Query: 695 XXXXXXX-----XYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH 749
Y +L NATDGF+S+N++G+GSFG+V+K +L IVAVKV N+
Sbjct: 678 APFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRR 737
Query: 750 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 809
GA KSF+AEC +LK+IRHRNLVK+LTAC+ +D+QGN+F+AL++EFM N SL++WLHP
Sbjct: 738 GAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHP-EE 796
Query: 810 EDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869
+E R+L LL+RL+I IDVA L YLH C PI HCDLKPSN+LLD+++ AHV D
Sbjct: 797 VEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSD 856
Query: 870 FGLATFL-----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
FGLA L Q SS +G+IGY APEYG+G + SI+GDVYS+G+L+LE+ T
Sbjct: 857 FGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTG 916
Query: 925 KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI-E 983
K+PT+ +F G+ L+++ K ALP+ V+DI D ++L H R+ + E
Sbjct: 917 KRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL--------HSG-----LRVGFPVLE 963
Query: 984 CLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
CL + +G+ C ESP +R+ + +L SI+
Sbjct: 964 CLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1856 (658.4 bits), Expect = 1.6e-191, P = 1.6e-191
Identities = 415/1021 (40%), Positives = 580/1021 (56%)
Query: 16 LVFYFSLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHG 75
L+ FS HL+ LG T +ETDR ALLEFKS+++ V SWN S C W
Sbjct: 5 LLLSFSAHLL---LGADGFT---DETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKW 58
Query: 76 VTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQ 135
VTC R+ H+RVT L+L L+L G +S +GN+SFL LDL +N+F IP E L RL+
Sbjct: 59 VTCGRK-HKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLE 117
Query: 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS 195
L + NS+ G IPA +S+CS L+ + L SN L +PSELGSL+K+ + NNL G
Sbjct: 118 HLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGK 177
Query: 196 IPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 255
+P S GNL+S+ L + NN++G +PD L +V L ++ N+ G P +I+N+S++
Sbjct: 178 LPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALE 237
Query: 256 ---VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK 312
+F +G + G + D G L N++ ++G N L GAIP +SN S L+ F +N N
Sbjct: 238 DLFLFGSGFS---GSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNM 294
Query: 313 LTGEV-PYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371
+TG + P K+ L + ++ N LGS DL F+ SLTN T L+ + GG LP
Sbjct: 295 MTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALP 354
Query: 372 ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXX 431
I+N ST L L L N FG+IP G + L RL++ N L+G +P ++G
Sbjct: 355 TSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGL 414
Query: 432 XXXXXXXFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTI 490
G IP IGNL +L L LS N +G +P SLG+ + + + N L GTI
Sbjct: 415 LSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTI 474
Query: 491 PPQXXXXXXXXXXXXXXRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLE 550
P + N L+G +PN++G+L+NL L++ NK G +P+TLG+C+ +E
Sbjct: 475 PKEIMQIPTLVNLSMEG-NSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAME 533
Query: 551 LLQMQGNFLQGPIPXXXXXXXXXXXXXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGM 610
L +QGN G IP N+LSG IPE+ F LEYLNLS N+F G
Sbjct: 534 QLFLQGNSFDGAIPNIRGLMGVRRVDLS-NNDLSGSIPEYFANFSKLEYLNLSINNFTGK 592
Query: 611 VPTEGVFRNASITSVLGNLKLCGGTHEFRLPTC----SPKKSKHKRXXXXXXXXXXXXXX 666
VP++G F+N++I V GN LCGG + +L C P ++KH
Sbjct: 593 VPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHS-SHLKKVAILVSIGI 651
Query: 667 XXXXXXXXXXXXXCLVRKRKEXXXX-----XXXXXXXXXXXYQNLYNATDGFTSANLIGA 721
C RKR++ Y +L NAT+GF+S+N++G+
Sbjct: 652 ALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGS 711
Query: 722 GSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781
GSFG+V+K +L IVAVKV N+ GA KSF+AEC +LK+ RHRNLVK+LTAC+ D
Sbjct: 712 GSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTD 771
Query: 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH 841
+QGN+F+AL++E++ N S++ WLHP +E PR+L LL+RL+I IDVA L YLH
Sbjct: 772 FQGNEFRALIYEYLPNGSVDMWLHP-EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHV 830
Query: 842 DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-----QTSSIFAKGSIGYIA 896
C PI HCDLKPSNVLL++++ AHV DFGLA L Q SS +G+IGY A
Sbjct: 831 HCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAA 890
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDS 956
PEYG+G + SI+GDVYS+G+LLLE+ T K+PTD +F G++ LH++ K ALP+ V +I D
Sbjct: 891 PEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADK 950
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
+L L V G R A ECL + +G+ C E P +R+ + V +L SI
Sbjct: 951 AILHIG--LRV-GF---RTA------ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISI 998
Query: 1017 K 1017
+
Sbjct: 999 R 999
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1829 (648.9 bits), Expect = 1.1e-188, P = 1.1e-188
Identities = 412/993 (41%), Positives = 551/993 (55%)
Query: 42 DRLALLEFKSKITHDPLGVFGSWNESIH--FCQWHGVTCSRRQHQ---RVTILDLKSLKL 96
D LALL FKS + + SWN S H C W GV C RR+ + RV L L+S L
Sbjct: 32 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNL 91
Query: 97 AGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCS 156
+G IS +GNLSFL+ LDL +N EIP E RL RLQ+L L +NSI G IPA I +C+
Sbjct: 92 SGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACT 151
Query: 157 NLIRVRLSSNELVGKIPSELG-SLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215
L + LS N+L G IP E+G SL + + N L+G IP + GNL+S+ LS N
Sbjct: 152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
L G+IP + G L +L+ + + QN LSG IP+SI+N+SS+ F N++ G+IP + T
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRN 334
L L+ +G N+ G IP +++NAS+L V Q+ N +G + +L+ L+ + RN
Sbjct: 272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRN 331
Query: 335 SLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN 394
+ E D F+ LTN ++L+ ++ NN GG+LP SN ST+L L L+ NKI G+
Sbjct: 332 LFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGS 391
Query: 395 IPAAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNIPPSIGNLKLFN 454
IP G + L L + NN G++P ++G G+IP +IGNL N
Sbjct: 392 IPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELN 451
Query: 455 -LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTG 513
L L N G IP +L L + LS NNL+G IP + +N L G
Sbjct: 452 ILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEG 511
Query: 514 PIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPXXXXXXXXX 573
IP E+G+LKNL + N+L G+IP TLG C L L +Q N L G IP
Sbjct: 512 SIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGL 571
Query: 574 XXXXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCG 633
NNLSG+IP L +L LNLS N F G VPT G F AS S+ GN KLCG
Sbjct: 572 ETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCG 631
Query: 634 GTHEFRLPTCSPKKSKHKRXXXXXXXXXXXXXXXXXXXXXXXXXXXCLVRKRKEXXXXXX 693
G + LP C P K ++ K+
Sbjct: 632 GIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWH---KRTKKGAPSRT 688
Query: 694 XXXXXXXXXYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK 753
Y L ATDGF NL+G+GSFGSVYKG L+ + VAVKV L + A K
Sbjct: 689 SMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNI-QDHVAVKVLKLENPKALK 747
Query: 754 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 813
SF AEC L+N+RHRNLVKI+T CS +D +GNDFKA+V++FM N SLE+W+HP T D+
Sbjct: 748 SFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETN-DQA 806
Query: 814 EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
++ R LNL +R+ I +DVACAL YLH P+VHCD+K SNVLLD +M+AHVGDFGLA
Sbjct: 807 DQ--RHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLA 864
Query: 874 TFL----PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
L L TSS+ G+IGY APEYG+G S +GD+YSYGIL+LE+VT K+PTD
Sbjct: 865 RILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTD 924
Query: 930 IMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMA 989
F D+ L + + L V D+VD+ L+ D E+ ++ RI EC+V +
Sbjct: 925 STFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENW-LNSTNNSPCRRIT---ECIVWLL 980
Query: 990 RIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022
R+G++CS E P R +++ +L +IK L G
Sbjct: 981 RLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1817 (644.7 bits), Expect = 2.1e-187, P = 2.1e-187
Identities = 419/1013 (41%), Positives = 550/1013 (54%)
Query: 39 NETDRLALLEFKSKIT-HDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLA 97
NETD ALLEFKS+++ ++ V SWN S FC W GVTC RR+ +RV L+L KL
Sbjct: 28 NETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRR-ERVISLNLGGFKLT 86
Query: 98 GYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSN 157
G IS +GNLSFL++L+L +NSF IP + RL RLQ L + N + G IP+++S+CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 158 LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD 217
L V LSSN L +PSELGSLSK+ +S NNLTG+ P S GNL+S+ L + N +
Sbjct: 147 LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMR 206
Query: 218 GSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277
G IPD L +V +A N SG P +++NISS+ N G + D G+ L
Sbjct: 207 GEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLP 266
Query: 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSL 336
NL+ +G NQ TGAIP ++N S+LE F ++SN L+G +P KL+ L I NSL
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326
Query: 337 GSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP 396
G+ L F+ ++ N T+L++ + N GG LPA I+N STTL L L N I G IP
Sbjct: 327 GNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIP 386
Query: 397 AAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNIPPSIGNL-KLFNL 455
G V L L + N LSG +P + G G IP GN+ +L L
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTGPI 515
L+ N G IP SLG+ L + + N L GTIP Q N LTG
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIP-QEILQIPSLAYIDLSNNFLTGHF 505
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPXXXXXXXXXXX 575
P EVG L+ L L NKL G++P+ +G C+ +E L MQGN G IP
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNV 565
Query: 576 XXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGT 635
NNLSG+IP +L L LNLS N FEG VPT GVFRNA+ SV GN +CGG
Sbjct: 566 DFS-NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 636 HEFRLPTCSPKKSKHKRXXXXXXXXXXXXX--XXXXXXXXXXXXXXCLVRKRKEXXXXXX 693
E +L C + S KR C KRK+
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684
Query: 694 XXXXXXXX--------XYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
Y+ L++AT F+S NLIG+G+FG+V+KG+L +VAVKV N
Sbjct: 685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744
Query: 746 LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH 805
LL HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+ALV+EFM SL+ WL
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804
Query: 806 PITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865
+ + + RSL ++L+I IDVA AL YLH C P+ HCD+KPSN+LLD+++ A
Sbjct: 805 -LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTA 863
Query: 866 HVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920
HV DFGLA L ++ SS +G+IGY APEYG+G + SI GDVYS+GILLLE
Sbjct: 864 HVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLE 923
Query: 921 LVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINS 980
+ + KKPTD F GD NLH++ K+ L S S A+
Sbjct: 924 MFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTSSGGSNAID------------ 962
Query: 981 KIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRI-VSNMQRD 1032
E L + ++G+ CS E P DRM V +L SI++ + ++ RD
Sbjct: 963 --EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTITESPRD 1013
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 279/720 (38%), Positives = 393/720 (54%)
Query: 113 LDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKI 172
L L +++ I L L+ L L +N + G+IP +S S L ++ L+ N L G+I
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 173 PSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVN 232
P+ LG+L+ + ++ N L+G+IP S G L+ ++ L L+ N L GSIP +FG L+ L
Sbjct: 143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202
Query: 233 LTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292
L++A N LSG IP I+NISS+T+F+ N++ G +P + L +LQ + NQ G
Sbjct: 203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGR 262
Query: 293 IPPAISNASNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLT 351
IP +I NASN+ +F + N +G VP + +++ L + + E D F+ +LT
Sbjct: 263 IPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALT 322
Query: 352 NATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMW 411
N + L+ + FGG+LP +SN S++L L + NKI G++P G V L L +
Sbjct: 323 NCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLA 382
Query: 412 NNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSL 470
NN L+G++P + +G++P +IGNL +L N+++ +N G+IPS+L
Sbjct: 383 NNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTL 442
Query: 471 GQSETLTIIDLSNNNLTGTIPPQXXXXXXXXXXXXXXRNQLTGPIPNEVGNLKNLEMLNV 530
G L I+L +NN G IP + N L G IP E+G LKN+ +
Sbjct: 443 GNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHA 502
Query: 531 FENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPXXXXXXXXXXXXXXXQNNLSGKIPEF 590
NKL GE P T+G C L+ L +Q NFL G IP NNLSG+IP
Sbjct: 503 DSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMS 562
Query: 591 LVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKH 650
L LL LNLS N F G VPT GVF NAS + GN +CGG E LPTCS K K
Sbjct: 563 LGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKK 622
Query: 651 KRXXXXXXXXXXXXXXXXXXXXXXXXXXXCLVRKRKEXXXXXXXXXXXXXXXYQNLYNAT 710
K+ C R++KE Y+ L AT
Sbjct: 623 KKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGHPMIT-YKQLVKAT 681
Query: 711 DGFTSANLIGAGSFGSVYKGILD--EGK--TIVAVKVFNLLHHGAFKSFIAECNTLKNIR 766
DGF+S++L+G+GSFGSVYKG D +G+ ++VAV+V L A KSF AEC TL+N R
Sbjct: 682 DGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTR 741
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
HRNLVKI+T CS +D +GNDFKA+V++FM N SLE+WLHP T D+ E+ R L L QR+
Sbjct: 742 HRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETN-DQAEQ--RHLTLHQRV 798
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1205 (429.2 bits), Expect = 1.5e-122, P = 1.5e-122
Identities = 321/957 (33%), Positives = 477/957 (49%)
Query: 88 ILDLKSLKLA-----GYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142
+L+L+SL L G I A +GN S L L+L++N +IP+E L +LQ L ++ N
Sbjct: 239 LLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKN 298
Query: 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGN 202
+ IP+++ + L + LS N LVG I E+G L +E ++ NN TG P S N
Sbjct: 299 KLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITN 358
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGIN 262
L +++ L + NN+ G +P G L NL NL+ N L+G IPSSI N + + + D N
Sbjct: 359 LRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHN 418
Query: 263 QIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV-PYLE 321
Q+ G IP GF NL F S+GRN TG IP I N SNLE V N LTG + P +
Sbjct: 419 QMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIG 476
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTL 381
KLQ+L ++ NSL R++ N L +++ N F G +P +SN T L
Sbjct: 477 KLQKLRILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNL-TLL 529
Query: 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLG 441
+ L + SN + G IP L L++ NN+ SG IP F G
Sbjct: 530 QGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNG 589
Query: 442 NIPPSIGNLKLFN-LQLSYNFLQGSIPSSLGQS-ETLTI-IDLSNNNLTGTIPPQXXXXX 498
+IP S+ +L L N +S N L G+IP L S + + + ++ SNN LTGTIP +
Sbjct: 590 SIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLE 649
Query: 499 XXXXXXXXXRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL-LQMQGN 557
N +G IP + KN+ L+ +N L G IP + + + + L + N
Sbjct: 650 MVQEIDLS-NNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRN 708
Query: 558 FLQGPIPXXXXXXXXXXXXXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVF 617
G IP NNL+G+IPE L L++L L++N+ +G VP GVF
Sbjct: 709 SFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVF 768
Query: 618 RNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRXXXXXXXXXXXXXXXXXXXXXXXXX 677
+N + + ++GN LCG + P +KS H
Sbjct: 769 KNINASDLMGNTDLCGSKKPLK-PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLI 827
Query: 678 XXCLVRKRKEXXXXXXXXXXXXXXXYQ-------NLYNATDGFTSANLIGAGSFGSVYKG 730
C +K K+ + L ATD F SAN+IG+ S +VYKG
Sbjct: 828 LTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKG 887
Query: 731 ILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788
L++G T++AVKV NL A K F E TL ++HRNLVKIL G ++ K
Sbjct: 888 QLEDG-TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTK 942
Query: 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848
ALV FM N +LE+ +H AP +LL+++D+ + +A + YLH PIV
Sbjct: 943 ALVLPFMENGNLEDTIHG-------SAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIV 994
Query: 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH--AQTSSIFA-KGSIGYIAPEYGLGSEV 905
HCDLKP+N+LLD + +AHV DFG A L + T+S A +G+IGY+APE+ +V
Sbjct: 995 HCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKV 1054
Query: 906 SINGDVYSYGILLLELVTRKKPTDIMFEG--DMNLHNFAKTALPDH---VVDIVDSTLLS 960
+ DV+S+GI+++EL+T+++PT + E DM L + ++ + +V ++D L
Sbjct: 1055 TTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL-- 1112
Query: 961 DDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017
D +++ +Q +A IE + + + C+ PEDR DM ++ L ++
Sbjct: 1113 GDSIVSL----KQEEA-----IEDFLKLC---LFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 6.9e-115, Sum P(2) = 6.9e-115
Identities = 190/612 (31%), Positives = 290/612 (47%)
Query: 28 FLGVTASTVAGNETDRLALLEFKSKITHDPL--GVFGSWN-ESIHFCQWHGVTCSRRQHQ 84
F G+ + N D LLE K + +P WN ++I++C W GVTC
Sbjct: 14 FSGLGQPGIINN--DLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLF 71
Query: 85 RVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSI 144
RV L+L L L G IS G L LDL +N+ IP+ L L+ L L +N +
Sbjct: 72 RVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQL 131
Query: 145 GGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLS 204
GEIP+ + S N+ +R+ NELVG IP LG+L ++ +++ LTG IP G L
Sbjct: 132 TGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLV 191
Query: 205 SISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264
+ L L N L+G IP G +L T A+N L+GTIP+ + + ++ + + N +
Sbjct: 192 RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251
Query: 265 QGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKL 323
G IP +G + LQ+ S+ NQL G IP ++++ NL+ +++N LTGE+P +
Sbjct: 252 TGEIPSQLG-EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNM 310
Query: 324 QRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEV 383
+L V+ N L + + CS N T L+ ++ G +P +S + L+
Sbjct: 311 SQLLDLVLANNHLSGSLPKSI---CS--NNTNLEQLVLSGTQLSGEIPVELSKCQS-LKQ 364
Query: 384 LLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGNI 443
L L +N + G+IP A + V+L L + NN L GT+ P+I G +
Sbjct: 365 LDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKL 424
Query: 444 PPSIGNLKLFNLQLSY-NFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXXX 502
P I L+ + Y N G IP +G +L +ID+ N+ G IPP
Sbjct: 425 PKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNL 484
Query: 503 XXXXXRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
+N+L G +P +GN L +L++ +N+L G IP + G LE L + N LQG
Sbjct: 485 LHLR-QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGN 543
Query: 563 IPXXXXXXXXXXXXXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE-GVFRNAS 621
+P N L+G I L + +++NN FE +P E G +N
Sbjct: 544 LPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF-DVTNNGFEDEIPLELGNSQNLD 602
Query: 622 ITSVLGNLKLCG 633
LG +L G
Sbjct: 603 RLR-LGKNQLTG 613
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 1.4e-106, Sum P(2) = 1.4e-106
Identities = 187/623 (30%), Positives = 288/623 (46%)
Query: 28 FLGVTASTVAG--NETDRLALLEFKSKITHDPLGVFGSW--NESIHFCQWHGVTCSRRQH 83
++G T+S +A N + LL KS + DPL W +++ C W GV C+ +
Sbjct: 14 YIGSTSSVLASIDNVNELSVLLSVKSTLV-DPLNFLKDWKLSDTSDHCNWTGVRCN--SN 70
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
V LDL + L G IS + LS L ++ N F +P L+ + + NS
Sbjct: 71 GNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDI---SQNS 127
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203
G + + L+ + S N L G + +LG+L +E + N GS+P SF NL
Sbjct: 128 FSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNL 187
Query: 204 SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263
+ FL LS NNL G +P G L +L + N G IP NI+S+ D I +
Sbjct: 188 QKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGK 247
Query: 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEK 322
+ G IP ++G L++L+ + N TG IP I + + L+V + N LTGE+P + K
Sbjct: 248 LSGEIPSELG-KLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITK 306
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLE 382
L+ L + RN L SG + ++++ +L+ + N G LP+ + ++ L+
Sbjct: 307 LKNLQLLNLMRNKL-SG-----SIPPAISSLAQLQVLELWNNTLSGELPSDLGK-NSPLQ 359
Query: 383 VLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXXFLGN 442
L + SN G IP+ L +L ++NN +G IP + G+
Sbjct: 360 WLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGS 419
Query: 443 IPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQXXXXXXXX 501
IP G L KL L+L+ N L G IP + S +L+ ID S N + ++P
Sbjct: 420 IPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLP-STILSIHNL 478
Query: 502 XXXXXXRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561
N ++G +P++ + +L L++ N L G IP ++ SC KL L ++ N L G
Sbjct: 479 QAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTG 538
Query: 562 PIPXXXXXXXXXXXXXXXQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNAS 621
IP N+L+G +PE + LE LN+S N G VP G + +
Sbjct: 539 EIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTIN 598
Query: 622 ITSVLGNLKLCGGTHEFRLPTCS 644
+ GN LCGG LP CS
Sbjct: 599 PDDLRGNSGLCGGV----LPPCS 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4501 | 0.9322 | 0.9534 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01680029 | hypothetical protein (1021 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1033 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-122 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 8e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.004 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 398 bits (1023), Expect = e-122
Identities = 313/1042 (30%), Positives = 489/1042 (46%), Gaps = 163/1042 (15%)
Query: 28 FLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVT 87
FL + S + E + LL FKS I +DPL +WN S C W G+TC+ RV
Sbjct: 18 FLFLNFSMLHAEELE--LLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCN--NSSRVV 72
Query: 88 ILDLKSLKLAGYISAHV------------------------------------------- 104
+DL ++G IS+ +
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 105 ----GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIR 160
G++ L+ LDL NN EIP++ L+VL L N + G+IP ++++ ++L
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220
+ L+SN+LVG+IP ELG + +++ + YNNL+G IP G L+S++ L L NNL G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQ 280
P + G LKNL L + QN+LSG IP SIF++ + D N + G IP ++ LQNL+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-ELVIQLQNLE 311
Query: 281 FFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGE 340
+ N TG IP A+++ L+V Q+ SNK +GE I +N G+
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE--------------IPKNL---GK 354
Query: 341 HRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFG 400
H NN L VL L +N + G IP
Sbjct: 355 H----------------------NN---------------LTVLDLSTNNLTGEIPEGLC 377
Query: 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFN-LQLSY 459
L +L +++N L G IP ++G ++LR +RLQ+N F G +P L L L +S
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 460 NFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV 519
N LQG I S +L ++ L+ N G +P G S L L+LSRNQ +G +P ++
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFG-SKRLENLDLSRNQFSGAVPRKL 495
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLS 579
G+L L L + ENKL GEIP L SC KL L + N L G IP+S S + LS LDLS
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 580 QNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFR 639
QN LSG+IP+ L + L +N+S+N G +P+ G F + ++V GN+ LCGG
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615
Query: 640 LPTCSP-KKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRKENQNPSSPINSF 698
LP C +K+ + L ++ L+ L KR EN++ + + F
Sbjct: 616 LPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFF 675
Query: 699 PNISYQNLYNATDGFTSA----NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS 754
+ +++ + S+ N+I G G+ YKG + VK N ++ S
Sbjct: 676 DSKVSKSI--TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SS 732
Query: 755 FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETE 814
IA+ + ++H N+VK++ C + L+ E++ ++L E L
Sbjct: 733 EIAD---MGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVL---------- 774
Query: 815 EAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874
R+L+ +R I I +A AL +LH C P +V +L P +++D + H L
Sbjct: 775 ---RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRL 826
Query: 875 FLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
LP + F S Y+APE +++ D+Y +G++L+EL+T K P D F
Sbjct: 827 SLPGLLCTDTKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 935 DMNLHNFAKTALPDHVVDI-VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGV 993
++ +A+ D +D+ +D ++ D++V+ N+ +V + + +
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSI---RGDVSVNQNE-------------IVEVMNLAL 928
Query: 994 ACSMESPEDRMDMTNVVHQLQS 1015
C+ P R +V+ L+S
Sbjct: 929 HCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 70/247 (28%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILT 775
+G GSFG VY + +VA+KV + + E LK ++H N+V++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
++ D LV E+ L + L L+ + + A
Sbjct: 65 V-----FEDEDKLYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQILSA 109
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L YLH IVH DLKP N+LLDE+ + DFGLA L T+ + G+ Y+
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYM 163
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955
APE LG D++S G++L EL+T K P F GD L K
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPP 219
Query: 956 STLLSDD 962
+S +
Sbjct: 220 EWDISPE 226
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G FG+VY + VA+K+ + + E LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
GV ++ + LV E+ SL++ L +E L+ + L I + + L
Sbjct: 58 -GV-FEDENHLYLVMEYCEGGSLKDLL---------KENEGKLSEDEILRILLQILEGLE 106
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YLH I+H DLKP N+LLD + DFGL+ L + +I G+ Y+A
Sbjct: 107 YLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMA 161
Query: 897 PEYGLG-SEVSINGDVYSYGILLLEL 921
PE LG S D++S G++L EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 69/250 (27%), Positives = 109/250 (43%), Gaps = 30/250 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G+GSFG+VYK IVAVK+ ++ E L+ + H N+V+++
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ LV E+ L ++L L+ + I + + L
Sbjct: 65 --DAFEDKDHL-YLVMEYCEGGDLFDYL----------SRGGPLSEDEAKKIALQILRGL 111
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YLH + I+H DLKP N+LLDE + + DFGLA L S + ++ G+ Y+A
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMA 166
Query: 897 PE-YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN---LHNFAKTALPDHVVD 952
PE G+ DV+S G++L EL+T K P F G+ L + P D
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEFD 222
Query: 953 IVDSTLLSDD 962
+ S++
Sbjct: 223 EPKWSSGSEE 232
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG VYKG L + +T VAVK + F+ E + +K + H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
L C+ QG +V E+M L ++L + L L L + + +A
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIA 112
Query: 834 CALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
+ YL + VH DL N L+ E ++ + DFGL+ + K I
Sbjct: 113 KGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
++APE + + DV+S+G+LL E+ T
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 717 NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 769
+G G+FG VYKG L D T VAVK L A + F+ E +K + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 770 LVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+V++L C+ + Y LV E+M L ++L +R +L+L L
Sbjct: 58 VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLS 109
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
I +A + YL VH DL N L+ E+++ + DFGL+ +
Sbjct: 110 FAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
K I ++APE + DV+S+G+LL E+ T
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 75/307 (24%), Positives = 124/307 (40%), Gaps = 67/307 (21%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRNL 770
+G G+FG VYKG L D + VAVK L A + F+ E ++ + H N+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
VK+L C+ + +V E+M L ++L + P+ L+L L +
Sbjct: 64 VKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLR--------KNRPKELSLSDLLSFAL 110
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+A + YL +H DL N L+ E ++ + DFGL+ L K
Sbjct: 111 QIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKL 166
Query: 891 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPTDIMFEGDMNLHNFAKTAL 946
I ++APE G + S DV+S+G+LL E+ T ++P M+
Sbjct: 167 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP-----YPGMS--------- 209
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
V++ + G + + C + ++ + C E PEDR
Sbjct: 210 NAEVLEYLKK------------GYRLPKPP------NCPPELYKLMLQCWAEDPEDRPTF 251
Query: 1007 TNVVHQL 1013
+ +V L
Sbjct: 252 SELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 68/307 (22%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRNL 770
+G G+FG VYKG L + K VAVK L A + F+ E ++ + H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
VK+L C+ + +V E+M L +L + L+L L +
Sbjct: 64 VKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFAL 109
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+A + YL +H DL N L+ E ++ + DFGL+ L K
Sbjct: 110 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKL 165
Query: 891 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPTDIMFEGDMNLHNFAKTAL 946
I ++APE G + S DV+S+G+LL E+ T ++P M+
Sbjct: 166 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQP-----YPGMS--------- 208
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
+ V++ + + G + + C + + + C E PEDR
Sbjct: 209 NEEVLEYLKN------------GYRLPQPP------NCPPELYDLMLQCWAEDPEDRPTF 250
Query: 1007 TNVVHQL 1013
+ +V L
Sbjct: 251 SELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ G + G T VAVK L G +F+ E +K +RH LV++
Sbjct: 14 LGAGQFGEVWMGTWN-GTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
CS + Y +V E+M SL ++L + E + L L Q +D+ +A
Sbjct: 70 CSEEEPIY-------IVTEYMSKGSLLDFL----KSGEG----KKLRLPQLVDMAAQIAE 114
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
++YL +H DL N+L+ E ++ + DFGLA + T+ AK I +
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKW 170
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVT 923
APE +I DV+S+GILL E+VT
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 70/205 (34%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
IG G FG V G G+ VAVK A ++F+AE + + +RH NLV++L
Sbjct: 13 TIGKGEFGDVMLGDY-RGQK-VAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLL--- 66
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS-LNLLQRLDIGIDVACAL 836
GV QGN +V E+M SL ++L +R R+ + L Q+L +DV +
Sbjct: 67 -GVVLQGNPL-YIVTEYMAKGSLVDYLR--SRG-------RAVITLAQQLGFALDVCEGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL + VH DL NVL+ E+++A V DFGLA K + + A
Sbjct: 116 EYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-----GKLPVKWTA 167
Query: 897 PEYGLGSEVSINGDVYSYGILLLEL 921
PE + S DV+S+GILL E+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 74/209 (35%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V++G+ + T VAVK L G K F+AE +K +RH L+++
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C+ + Y +V E M SL E+L A R+L L Q +D+ VA
Sbjct: 70 CTLEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVAS 114
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
++YL +H DL NVL+ E I V DFGLA + + AK I +
Sbjct: 115 GMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKW 170
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVT 923
APE L + SI DV+S+GILL E+VT
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/218 (29%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
F IG G FG VYK VA+KV L + I E LK +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE-DETEEAPRSLNLLQRLDIGID 831
+ Y D +V EF SL++ L + E++ A LL+
Sbjct: 62 YYGS-----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK------- 109
Query: 832 VACALSYLH--HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
L YLH I+H D+K +N+LL + + DFGL+ LS + +
Sbjct: 110 ---GLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQ--LSDTKARNTMV- 158
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE G D++S GI +EL K P
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKIL 774
L+G GSFGSVY + + ++AVK L ++ E L +++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 775 TACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
G + +F E++ SL L + E ++++ +
Sbjct: 66 ----GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--------PVIRKY--TRQIL 111
Query: 834 CALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
L+YLH + IVH D+K +N+L+D + + + DFG A L + +G+
Sbjct: 112 EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE G E D++S G ++E+ T K P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL 770
+ +LIG G+FG VYKG+ E VA+K +L + A KS + E + LKN++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
VK + + + +D ++ E+ N SL + + E+ A +LQ
Sbjct: 62 VKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ------ 110
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
L+YLH + ++H D+K +N+L ++ + + DFG+AT L +S+ G
Sbjct: 111 ----GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--G 161
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ ++APE S S D++S G ++EL+T P
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 60/309 (19%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRN 769
FT +G+G FG V++G L + + VA+K+ +LL F+ E LK +RH++
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRHKH 63
Query: 770 LVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
L+ + CS + Y ++ E M SL +L R E + L + +D
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFL----RSPEG----QVLPVASLID 108
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ VA ++YL + +H DL N+L+ E+++ V DFGLA + +S
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD-- 163
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947
K + APE S DV+S+GILL E+ T + + + G MN H
Sbjct: 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ---VPYPG-MNNH-------- 211
Query: 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007
V D + R+ +C + +I + C PEDR
Sbjct: 212 -EVYDQIT------------------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFK 252
Query: 1008 NVVHQLQSI 1016
+ +L +I
Sbjct: 253 ALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.0 bits (245), Expect = 5e-22
Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 36/288 (12%)
Query: 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRH- 767
+ +G GSFG VY + +VA+KV + F+ E L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+VK+ +Q LV E++ SLE+ L I R+ L+ + L
Sbjct: 58 PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALF 105
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSI 886
I + AL YLH I+H D+KP N+LLD + + + DFGLA LP + +S
Sbjct: 106 ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 887 FAK----GSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKP------TDIMFE 933
G+ GY+APE LG S + D++S GI L EL+T P + +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSK 981
+ +L + + DL + + R++S
Sbjct: 223 TLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+ +G G +G VY+G+ + VAVK + F+ E +K I+H NLV++L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ + F ++ EFM +L ++L RE +E ++ LL + ++ A+
Sbjct: 71 CT----REPPF-YIITEFMTYGNLLDYL----RECNRQEVN-AVVLLY---MATQISSAM 117
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL + +H DL N L+ E + V DFGL+ + T+ AK I + A
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 173
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVT 923
PE ++ SI DV+++G+LL E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 777
+G GS G VYK I A+K ++ F+ + E TL++ +VK C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
G Y+ + ++V E+M SL + L + + E A + +L+ L
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILK----------GLD 113
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
YLH I+H D+KPSN+L++ + + DFG++ L + Q ++ G++ Y++P
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSP 169
Query: 898 EYGLGSEVSINGDVYSYGILLLELVTRKKP 927
E G S D++S G+ LLE K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 717 NLIGAGSFGSVYKGI-LDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 773
N IG G+FG VY + LD G ++AVK + K E L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 774 LTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
GV+ K +F E+ +LEE L DE +L LL+
Sbjct: 64 ---YYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE-------- 110
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
L+YLH IVH D+KP+N+ LD + +GDFG A L ++ T +
Sbjct: 111 --GLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLA 164
Query: 893 G---YIAPEYGLGSEVSING---DVYSYGILLLELVTRKKP 927
G Y+APE G + +G D++S G ++LE+ T K+P
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 33/234 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G+G FG V+ G GK VA+K ++ GA FI E + + H NLV++
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ Q F +V E+M N L +L E L LD+ DV A+
Sbjct: 68 CT---KQRPIF--IVTEYMANGCLLNYL---------RERKGKLGTEWLLDMCSDVCEAM 113
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL + +H DL N L+ E+ + V DFGLA ++ L TSS K + +
Sbjct: 114 EYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAP 169
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950
PE S S DV+S+G+L+ E+ + EG M F+ + + + V
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFS---------EGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G G FG V+ G + G T VA+K L G ++F+ E +K +RH LV++
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
S + +V E+M SL ++L E + L L Q +D+ +A +
Sbjct: 70 VS------EEPIYIVTEYMSKGSLLDFL--------KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+Y+ + VH DL+ +N+L+ E ++ V DFGLA + + T+ AK I + A
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 171
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKK 926
PE L +I DV+S+GILL EL T+ +
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G G FG V+ G + G T VAVK L G +SF+ E +K +RH LV++
Sbjct: 14 LGNGQFGEVWMGTWN-GNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
S + +V E+M SL ++L + R+L L +D+ VA +
Sbjct: 70 VS------EEPIYIVTEYMSKGSLLDFL--------KDGEGRALKLPNLVDMAAQVAAGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+Y+ + +H DL+ +N+L+ + ++ + DFGLA + + T+ AK I + A
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTA 171
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKK 926
PE L +I DV+S+GILL ELVT+ +
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 69/268 (25%), Positives = 107/268 (39%), Gaps = 60/268 (22%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 774
IG GSFG VY + +K +L + + + E LK + H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDV 832
++ +V E+ L + + +E + EE Q LD + +
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE--------QILDWFVQL 112
Query: 833 ACALSYLH--HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
AL YLH I+H D+KP N+ L + +GDFG++ L ++ AK
Sbjct: 113 CLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKT 162
Query: 891 SIG---YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
+G Y++PE Y S D++S G +L EL T K P FEG+ NL
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS------DIWSLGCVLYELCTLKHP----FEGE-NLLEL 211
Query: 942 AK-------TALPDHV----VDIVDSTL 958
A +P ++V S L
Sbjct: 212 ALKILKGQYPPIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G G FG V+ G + G T VA+K L G ++F+ E +K +RH LV +
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
S + +V EFM SL ++L E + L L Q +D+ +A +
Sbjct: 70 VS------EEPIYIVTEFMGKGSLLDFL--------KEGDGKYLKLPQLVDMAAQIADGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+Y+ + +H DL+ +N+L+ + ++ + DFGLA + + T+ AK I + A
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTA 171
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKK 926
PE L +I DV+S+GILL ELVT+ +
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 30/210 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ G + G T VA+K L G+ ++F+AE N +K ++H LV++
Sbjct: 14 LGAGQFGEVWMGYYN-GHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + ++ E+M N SL ++L +T E + L + + +D+ +A +
Sbjct: 70 VT------QEPIYIITEYMENGSLVDFL-------KTPEGIK-LTINKLIDMAAQIAEGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+++ + +H DL+ +N+L+ E + + DFGLA + + T+ AK I + A
Sbjct: 116 AFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTA 171
Query: 897 PE---YGLGSEVSINGDVYSYGILLLELVT 923
PE YG +I DV+S+GILL E+VT
Sbjct: 172 PEAINYGT---FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG G FG V G D VAVK + ++F+AE + + +RH NLV++L
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL---- 65
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
GV + +V E+M SL ++L R + L +DV A+ Y
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC--------LLKFSLDVCEAMEY 117
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE 898
L + VH DL NVL+ E+ +A V DFGL A ++ K + + APE
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPE 169
Query: 899 YGLGSEVSINGDVYSYGILLLEL 921
+ S DV+S+GILL E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 21/218 (9%)
Query: 717 NLIGAGSFGSVYKGILD--EGKT--IVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLV 771
+G G FG V D T VAVK N +S F E L+ + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K C G L+ E++ + SL ++L + +NL + L
Sbjct: 70 KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQ--------RHRDQ-INLKRLLLFSSQ 117
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ + YL +H DL N+L++ E + + DFGLA LP S
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 892 -IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928
I + APE S+ S DV+S+G+ L EL T P+
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 5e-18
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 776
+G G++G VYK + IVA+K L + G + + E + LK ++H N+VK+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL-- 64
Query: 777 CSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
D + K LVFE+ + L+++L P S NL++ I +
Sbjct: 65 ----DVIHTERKLYLVFEYC-DMDLKKYLDKRPG-------PLSPNLIKS--IMYQLLRG 110
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIFAKGSIGY 894
L+Y H I+H DLKP N+L++ + + + DFGLA F T + ++ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWY 164
Query: 895 IAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
APE LGS+ S D++S G + E++T K +F GD
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK----PLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
+G GSFG V + + A+KV ++ + + E N L I H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ +Q + LV E+ L L R E E A R ++ A
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-ERA--------RF-YAAEIVLA 105
Query: 836 LSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
L YLH I++ DLKP N+LLD + + DFGLA L ++T++ F G+ Y
Sbjct: 106 LEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FC-GTPEY 159
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+APE LG D +S G+LL E++T K P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
IG+G FG V+ G E K VA+K + GA + FI E + + H LV++
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ LVFEFM + L ++L R + + +L L + +DV +
Sbjct: 68 CTE-----RSPICLVFEFMEHGCLSDYL----RAQRGKFSQETL-----LGMCLDVCEGM 113
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+YL ++H DL N L+ E + V DFG+ F+ L TSS K + + +
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSS 169
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKK 926
PE S+ S DV+S+G+L+ E+ + K
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 56/160 (35%), Positives = 79/160 (49%), Gaps = 22/160 (13%)
Query: 535 LRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGF 594
LRG IP + L+ + + GN ++G IP SL S+ L VLDLS N+ +G IPE L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 595 QLLEYLNLSNNDFEGMVPTE--GVFRNASITSVLGNLKLCG--GTHEFRLPTCSPKKSKH 650
L LNL+ N G VP G + + + N LCG G L C P
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-----LRACGP----- 539
Query: 651 KRLTLALKLALAIISGLIGLSLALSFLIICLV--RKRKEN 688
L++ K+ +A G+S+A FL+IC + KR++N
Sbjct: 540 -HLSVGAKIGIAF-----GVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 719 IGAGSFGSVYKG-----ILDEGKTIVAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G G+FG V+ G + K +VAVK + A K F E L N +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP----ITREDETEEAPRSLNLLQRLDI 828
C+ +G D +VFE+M + L ++L + L L Q L I
Sbjct: 73 FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 829 GIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA------------- 873
+ +A + YL H VH DL N L+ +++ +GDFG++
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 874 -TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926
T LP I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 183 HTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+IG G+FG V + K + A+K N + G+ ++ + E L+ + H LV +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ +Q + LV + + L H + +EE + ++
Sbjct: 66 WYS-----FQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKF--------WICEIV 110
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL YLH I+H D+KP N+LLDE+ H+ DF +AT + TS+ G+ G
Sbjct: 111 LALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPG 164
Query: 894 YIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930
Y+APE G V D +S G+ E + K+P
Sbjct: 165 YMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G++G VYK IVA+K L G K+ + E LK + H N++K+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
V D LVFEFM L + + R+ E+ L Q L L
Sbjct: 66 ---VFRHKGDL-YLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLL-------QGL 111
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIFAKGSIGYI 895
++ H I+H DLKP N+L++ E + + DFGLA +F T + + Y
Sbjct: 112 AFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYR 165
Query: 896 APEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
APE LG + S D++S G + EL++R+ +F G
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G GS+GSVYK I E +VA+KV + + I E + LK +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK----- 62
Query: 778 SGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
Y G+ FK +V E+ S+ + + IT ++L + I
Sbjct: 63 ----YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITN--------KTLTEEEIAAILYQTL 109
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
L YLH +H D+K N+LL+EE A + DFG++ L + A+ +++ G+
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPF 164
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE + D++S GI +E+ K P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ G + T VAVK L G ++F+ E N +K ++H LV++
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ + Y ++ E+M SL ++L +++E + + L + +D +A
Sbjct: 70 VTKEEPIY-------IITEYMAKGSLLDFL-------KSDEGGK-VLLPKLIDFSAQIAE 114
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
++Y+ + +H DL+ +NVL+ E ++ + DFGLA + + T+ AK I +
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKW 170
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926
APE +I DV+S+GILL E+VT K
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 59/234 (25%), Positives = 89/234 (38%), Gaps = 57/234 (24%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS-----FIAECNTLKNIRHRNLVK- 772
IG GSFG+V K I+ K + +G ++E N L+ ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 773 --------------ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR 818
++ C G D K +E + E
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC------------------KKERKYIEEEF 106
Query: 819 SLNLLQRLDIGIDVACALSYLHH--DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876
+L +L + AL H+ D ++H DLKP+N+ LD +GDFGLA L
Sbjct: 107 IWRILTQLLL------ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160
Query: 877 PLSHAQTSSIFAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
S FAK +G Y++PE D++S G L+ EL P
Sbjct: 161 G-----HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 717 NLIGAGSFGSVYKGIL------DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIR 766
N +G+G+FG VY+G G VAVK L GA K F+ E + + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT---LRKGATDQEKKEFLKEAHLMSNFN 57
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H N+VK+L C + N+ + ++ E M L L + P L L + L
Sbjct: 58 HPNIVKLLGVC--LL---NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELL 109
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-----MIAHVGDFGLATFLPLSHA 881
DI +DVA YL Q +H DL N L+ E+ + +GDFGLA + S
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ ++APE L + + DV+S+G+L+ E++T
Sbjct: 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS--FIAECNTLKNIRHRNLVKILTA 776
+G G FG V G G+ VA+K ++ G+ FI E + + H LV++
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ Q + +V E+M N L +L E + Q L++ DV +
Sbjct: 68 CTK---QRPIY--IVTEYMSNGCLLNYL---------REHGKRFQPSQLLEMCKDVCEGM 113
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+YL +H DL N L+D++ V DFGL+ ++ L TSS+ +K + +
Sbjct: 114 AYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSP 169
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKK 926
PE L S+ S DV+++G+L+ E+ + K
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
T +IG G FG+V +G K VAVK N+ ++F+ E + + H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L + + G +V E M +L +L R ++++Q L +DV
Sbjct: 64 LLGV---ILHNG---LYIVMELMSKGNLVNFLRTRGRA--------LVSVIQLLQFSLDV 109
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A + YL +VH DL N+L+ E+ +A V DFGLA + S + K
Sbjct: 110 AEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVK--- 162
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLEL 921
+ APE + S DV+SYG+LL E+
Sbjct: 163 -WTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 717 NLIGAGSFGSVYKGILDE-GKT--IVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 769
+IG G FG V +G L GK VA+K L G+ F+ E + + H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++++ GV + ++ E+M N SL+++L RE++ + + Q + +
Sbjct: 67 IIRLE----GVVTKSRPV-MIITEYMENGSLDKFL----RENDGK-----FTVGQLVGML 112
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
+A + YL VH DL N+L++ ++ V DFGL+ L S A ++ K
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169
Query: 890 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 923
I + APE Y + S DV+S+GI++ E+++
Sbjct: 170 IPIRWTAPEAIAYRKFTSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G GSFG VY+G+ E +T VA+K V F+ E + +K ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 773 ILTACSGVDYQGNDFKALV-FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+L GV G LV E M L+ +L E E L + + + +
Sbjct: 74 LL----GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+A ++YL VH DL N ++ E++ +GDFG+ + + + KG
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGG 179
Query: 892 IG-----YIAPEYGLGSEV-SINGDVYSYGILLLELVT 923
G ++APE L V + DV+S+G++L E+ T
Sbjct: 180 KGLLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 719 IGAGSFGSVYKGI-LDEGKTI---VAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G+G+FG+VYKG+ + EG+ + VA+KV A K + E + ++ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
L C Q L+ + M L +++ R + + L L+ + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYV----RNHKDNIGSQYL-----LNWCVQIA 119
Query: 834 CALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+SYL +VH DL NVL+ + DFGLA L + + + K
Sbjct: 120 KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTD 929
I ++A E L + DV+SYG+ + EL+T KP +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 57/216 (26%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 718 LIGAGSFGSVYKGILDE--GKTI-VAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLV 771
+G GSFG V +G GK I VAVK L F+ E + ++ H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
++ GV +V E SL + L ++A + D +
Sbjct: 60 RLY----GVVLT--HPLMMVTELAPLGSLLDRLR--------KDALGHFLISTLCDYAVQ 105
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAKG 890
+A + YL +H DL N+LL + +GDFGL LP + K
Sbjct: 106 IANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 891 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 923
+ APE S S DV+ +G+ L E+ T
Sbjct: 163 PFAWCAPESLRTRTFSHAS---DVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 44/230 (19%)
Query: 719 IGAGSFGSVYK----GIL-DEGKTIVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRN 769
IG G+FG V++ G+L E T+VAVK +L A F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDHPN 69
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------------HPITREDETEEAP 817
+VK+L C+ G L+FE+M L E+L H + + P
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 818 RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
L+ ++L I VA ++YL + VH DL N L+ E M+ + DFG
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG------ 175
Query: 878 LSHAQTSSIFAKGS------IGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
LS S+ + K S I ++ PE + + DV++YG++L E+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-KSFIAECNTLKNIRHRN 769
+ + +G G+ GSV K L I A+K + K + E K+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI-TREDETEEAPRSLNLLQRLDI 828
+VK A +D + + E+ SL+ + R E L ++
Sbjct: 61 IVKYYGAF--LDESSSSIG-IAMEYCEGGSLDSIYKKVKKRGGRIGEKV-----LGKIAE 112
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
V LSYLH I+H D+KPSN+LL + + DFG++ L S A T +
Sbjct: 113 S--VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--- 164
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y+APE G SI DV+S G+ LLE+ + P
Sbjct: 165 -GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 28/240 (11%)
Query: 710 TDGFTSANLIGAGSFGSVYKGI-LDEGKTIVA---VKVFNLLHHGAFKSFIAECNTLKNI 765
F IG G F VYK I L +G+ +VA V++F ++ A + + E + LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGR-VVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
H N++K L + + N+ +V E L + ++
Sbjct: 60 DHPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-- 112
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
+ + AL ++H I+H D+KP+NV + + +GD GL F ++T++
Sbjct: 113 ----VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTA 162
Query: 886 IFAK-GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-MNLHNFAK 943
+ G+ Y++PE + + D++S G LL E+ + P F GD MNL++ K
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTAC 777
+GAG+ G V K + I+AVK L + A K + E + L +V A
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
Y D ++ E+M SL++ L +E + I + V L+
Sbjct: 69 ----YNNGDI-SICMEYMDGGSLDKIL---------KEVQGRIPERILGKIAVAVLKGLT 114
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
YLH + I+H D+KPSN+L++ + DFG++ L S A+T G+ Y+AP
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAP 168
Query: 898 EYGLGSEVSINGDVYSYGILLLELVTRKKP 927
E G++ S+ D++S G+ L+EL T + P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-15
Identities = 40/87 (45%), Positives = 55/87 (63%), Gaps = 1/87 (1%)
Query: 412 NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSL 470
N L G IP I +L++L+ + L N GNIPPS+G++ L L LSYN GSIP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 471 GQSETLTIIDLSNNNLTGTIPPQLLGL 497
GQ +L I++L+ N+L+G +P L G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 718 LIGAGSFGSVYK-GILDEGKTIVAVKVFNLLHHGAF--------KSF---IAECNTLK-N 764
+G+G+FG VYK + G+ ++A+K N+ H+ AF KS ++E +K
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINV-HNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 765 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQ 824
+RH N+V+ + ND +V + + L E + + + + R N
Sbjct: 66 LRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN--- 117
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
I + + AL YLH + + IVH DL P+N++L E+ + DFGLA TS
Sbjct: 118 ---IFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ G+I Y PE DV+++G +L ++ T + P
Sbjct: 173 VV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 37/222 (16%)
Query: 719 IGAGSFGSV----YKGILDEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKI 773
+G G FG V Y D +VAVK S + E N LK + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR-SLNLLQRLDIGIDV 832
CS QG L+ E++ SL ++L P+ LNL Q L +
Sbjct: 72 KGCCSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFAQQI 116
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-------TSS 885
++YLH +H DL NVLLD + + +GDFGLA +P H S
Sbjct: 117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+F + A E ++ S DV+S+G+ L EL+T
Sbjct: 174 VF------WYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ ++ T VAVK + G+ ++F+AE N +K ++H LVK+
Sbjct: 14 LGAGQFGEVWMATYNK-HTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + ++ EFM SL ++L + DE + P L + +D +A +
Sbjct: 70 VT------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEGM 115
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+++ Q +H DL+ +N+L+ ++ + DFGLA + + T+ AK I + A
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 171
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVT 923
PE +I DV+S+GILL+E+VT
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 75/311 (24%), Positives = 125/311 (40%), Gaps = 46/311 (14%)
Query: 713 FTSANLIGAGSFGSVYKGIL--DEGKTI-VAVKVFNL--LHHGAFKSFIAECNTLKNIRH 767
++G G FGSV +G L D+G + VAVK L + + F++E +K+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 768 RNLVKILTAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
N++K++ C Q ++ FM + L +L P L L L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTLL 116
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSS 885
+D+A + YL + +H DL N +L E+M V DFGL+ + +
Sbjct: 117 KFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945
I AK + +IA E + DV+++G+ + E+ TR + + G N
Sbjct: 174 I-AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP---YPGVEN-------- 221
Query: 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005
+ D HGN R+ +CL + + +C P+DR
Sbjct: 222 --------------HEIYDYLRHGN------RLKQPEDCLDELYDLMYSCWRADPKDRPT 261
Query: 1006 MTNVVHQLQSI 1016
T + L++I
Sbjct: 262 FTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVK---I 773
IG G++G VYK + +VA+K + + G + I E L+ +RH N+V+ I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 774 LTACSGVDYQGNDFKALVFEFMHN--RSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+T+ +G+ + +VFE+M + L + P + E++ LL+
Sbjct: 67 VTSKG----KGSIY--MVFEYMDHDLTGLLD--SPEVKFTESQIKCYMKQLLE------- 111
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ--TSSIFAK 889
L YLH + I+H D+K SN+L++ + + + DFGLA ++ T+ +
Sbjct: 112 ---GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-- 163
Query: 890 GSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRK 925
++ Y PE LG+ EV D++S G +L EL K
Sbjct: 164 -TLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 66/216 (30%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTA 776
IG G+FG VYKG+L +G T VAVK K F+ E LK H N+VK++
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C V Q +V E + SL +L R+ + L + + L + +D A +
Sbjct: 61 C--VQKQP---IYIVMELVPGGSLLTFL----RKKKNR-----LTVKKLLQMSLDAAAGM 106
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS----- 891
YL +H DL N L+ E + + DFG +S + I+
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFG------MSREEEGGIYTVSDGLKQI 157
Query: 892 -IGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 923
I + APE YG + DV+SYGILL E +
Sbjct: 158 PIKWTAPEALNYG---RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 718 LIGAGSFGSV----YKGILDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLV 771
+G G+FGSV Y + D +VAVK L H A + F E LK+++H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 772 KILTACSGVDYQ-GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
K GV Y G LV E++ SL ++L + E + + L ++ G+
Sbjct: 69 KY----KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHRKLLLYASQICKGM 121
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL-------SHAQT 883
+ + Y VH DL N+L++ E +GDFGL LP
Sbjct: 122 EYLGSKRY---------VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
S IF + APE S+ S+ DV+S+G++L EL T
Sbjct: 173 SPIF------WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 57/223 (25%), Positives = 108/223 (48%), Gaps = 14/223 (6%)
Query: 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF-NLLHHGAFKS----FIAECN 760
+ + D T ++L+ G+FG ++ GIL + K +VF + A + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
L + H+N++ IL C + + +++ +M+ +L+ +L R E P++L
Sbjct: 61 LLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQ-QCRLGE-ANNPQAL 114
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ Q + + I +AC +SYLH + ++H D+ N ++DEE+ + D L+ L
Sbjct: 115 STQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ ++A E + E S DV+S+G+LL EL+T
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTI---VAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVK 772
L+G+G FG+V+KGI + EG +I VA+K + F+ + ++ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L C G Q LV + SL + + R+ P+ L L+ + +
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHV----RQHRDSLDPQRL-----LNWCVQI 118
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A + YL +VH +L N+LL + I + DFG+A L + K I
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
++A E L + DV+SYG+ + E+++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 719 IGAGSFGSVYKG-----ILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG V+ + ++ K +VAVK A + F E L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITR--EDETEEAPRSLNLLQRLDI 828
C+ +VFE+M + L +L P + + AP L L Q L I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA--------------T 874
+A + YL VH DL N L+ + ++ +GDFG++ T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 875 FLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926
LP I ++ PE L + + D++S+G++L E+ T K
Sbjct: 185 MLP--------------IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 717 NLIGAGSFGSVYKGI-LDEGKTIVAVK--VFNLLHHGAFKSFIAECNTLKNIR---HRNL 770
IG G++G+VYK L+ G+ VA+K L G S + E LK + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGR-FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS-------LNLL 823
V++L C G LVFE + + L +L + P+ +L+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL---------SKCPKPGLPPETIKDLM 113
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
++L G+D +LH IVH DLKP N+L+ + + DFGLA A T
Sbjct: 114 RQLLRGVD------FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT 164
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
S + ++ Y APE L S + D++S G + EL R+
Sbjct: 165 SVVV---TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 714 TSANLIGAGSFGSVYKGILD-EGKTIVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRN 769
T +IGAG FG V++GIL G+ VAV + L K F++E + + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL-NLLQRLDI 828
++++ GV + ++ E+M N +L+++L R+ + E + L +L+ +
Sbjct: 68 IIRL----EGVVTKFKPA-MIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAA 118
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL---PLSHAQTSS 885
G+ ++Y VH DL N+L++ + V DFGL+ L P TS
Sbjct: 119 GMKYLSDMNY---------VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K I + APE + + DV+S+GI++ E+++
Sbjct: 170 --GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVK 772
+G G+FG VYKG L T VA+K + F E + +++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWL---HPI---TREDETEEAPRSLNLLQRL 826
+L C+ ++FE++ + L E+L P E E SL+ L
Sbjct: 73 LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 827 DIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH---- 880
I I +A + YL HH VH DL N L+ E + + DFGL+ S
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR-DIYSADYYR 181
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
Q+ S+ + ++ PE L + + D++S+G++L E+
Sbjct: 182 VQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILT 775
N IG+G+ G+VYK I + A+KV H + I E L+++ H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
C + + + L+ EFM SLE I E D+ +
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADE------------QFLADVARQILSG 180
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT-----SSIFAKG 890
++YLH + IVH D+KPSN+L++ + DFG++ L AQT SS+ G
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSV---G 230
Query: 891 SIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+I Y++PE G+ GD++S G+ +LE + P + +GD
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 75/253 (29%), Positives = 111/253 (43%), Gaps = 48/253 (18%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLV 771
L+G+GSFGSVY+G+ LD+G AVK +L G A K E L ++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 772 KIL-TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ L T D + E + SL + L + E L Q L
Sbjct: 66 QYLGTEREE------DNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL--- 113
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
L YLH VH D+K +N+L+D + + DFG+A + + + S KG
Sbjct: 114 ----GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSF--KG 163
Query: 891 SIGYIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
S ++APE YGL + D++S G +LE+ T K P EG + +
Sbjct: 164 SPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPPWS-QLEGVAAVFKIGR 216
Query: 944 T----ALPDHVVD 952
+ +PDH+ D
Sbjct: 217 SKELPPIPDHLSD 229
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
FT IG GSFG VYKGI + K +VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 773 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
+L+ C Y G+ K ++ E++ S + L P E ET A +L+
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREILKG 113
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
LD YLH + + +H D+K +NVLL E+ + DFG+A L + + ++
Sbjct: 114 LD----------YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE S D++S GI +EL + P
Sbjct: 161 FV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 32/88 (36%), Positives = 58/88 (65%)
Query: 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220
+ L + L G IP+++ L ++ ++S N++ G+IPPS G+++S+ L LS N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSI 248
P++ G L +L L + N LSG +P+++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 719 IGAGSFGSV-----YKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG V Y + K +VAVK A K F E L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP------ITREDETEEAPRSLNLLQRLD 827
C D D +VFE+M + L ++L I + + +A L L Q L
Sbjct: 73 YGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
I +A + YL VH DL N L+ ++ +GDFG++ + +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926
I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 45/232 (19%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG+G++G VYK +VA+KV L F+ E + LK RH N+V +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y D +V E+ SL++ +TR L+ LQ + + L+Y
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQ-VTR--------GPLSELQIAYVCRETLKGLAY 116
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-----GSIG 893
LH + +H D+K +N+LL E+ + DFG++ AQ ++ AK G+
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPY 166
Query: 894 YIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
++APE + V G D+++ GI +EL + P MF +LH
Sbjct: 167 WMAPEV---AAVERKGGYDGKCDIWALGITAIELAELQPP---MF----DLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 40/233 (17%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL 770
F IG G++G VYK +VA+K L G + I E + LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 771 VKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETEEAPRSLNL----LQR 825
VK+L D + K LVFEF+H + L++++ D + + L L L +
Sbjct: 62 VKLL------DVIHTENKLYLVFEFLH-QDLKKFM------DASPLSGIPLPLIKSYLFQ 108
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TF-LPLSHAQT 883
L G+ A + H ++H DLKP N+L++ E + DFGLA F +P+ T
Sbjct: 109 LLQGL----AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 158
Query: 884 SSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ ++ Y APE LG + S D++S G + E+VTR+ +F GD
Sbjct: 159 HEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 29/228 (12%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNL 770
+T IG G++G VYKG + IVA+K L G + I E + LK ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V + V Q + L+FEF+ + L+++L + + + L Q L
Sbjct: 62 VCLQD----VLMQESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ--- 112
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TF-LPLSHAQTSSIFA 888
+ + H ++H DLKP N+L+D + + + DFGLA F +P+ T +
Sbjct: 113 ----GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVV- 163
Query: 889 KGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
++ Y APE LGS S D++S G + E+ T KKP +F GD
Sbjct: 164 --TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKV--FNLLHHGAFKSFIAECNTLKNIRHRNL 770
F N IG G++G VY+ IVA+K + G S + E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHN---RSLEEWLHPITREDETEEAPRSLNLLQRLD 827
V++ G + D LV E+ L+ P + E++ L LL+
Sbjct: 69 VELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFS---ESQVKCLMLQLLR--- 119
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSI 886
L YLH + I+H DLK SN+LL ++ + DFGLA T+ + T +
Sbjct: 120 -------GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 887 FAKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRK 925
++ Y APE LG D+++ G +L EL+ K
Sbjct: 170 V---TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 37/166 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-------HRNLV 771
+G G+FGSVY E +VA+K F S+ EC L+ ++ H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE----TEEAPRSLNLLQRLD 827
K+ ++ ND VFE+M E L+ + ++ + +E RS+ + Q
Sbjct: 62 KLKEV-----FRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSI-IYQ--- 107
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
+ L+++H H DLKP N+L+ + + DFGLA
Sbjct: 108 ----ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLV 771
+ LIG G++G+VY+G +VA+K+ NL S I E L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 772 KILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLH--PITREDETEEAPRSLNLLQR 825
I Y G+ K ++ E+ S+ + PI A + ++++ R
Sbjct: 63 NI------TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI--------AEKYISVIIR 108
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
+V AL Y+H ++H D+K +N+L+ + DFG+A L + ++ S+
Sbjct: 109 -----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 886 IFAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE G D++S GI + E+ T P
Sbjct: 161 FV--GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 16/216 (7%)
Query: 719 IGAGSFGSV-----YKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG V Y ++ K +VAVK A K F E L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITREDETEEAPRSLNLLQRLDIGI 830
C +G+ +VFE+M + L ++L P P L Q L I
Sbjct: 73 YGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+A + YL VH DL N L+ E ++ +GDFG++ + +
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926
I ++ PE + + + DV+S G++L E+ T K
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G++G VYK IVA+K L G + I E + LK + H N+V++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
V + N LVFEF+ + L++++ +S L Q L +
Sbjct: 66 ---VVHSENKL-YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY-LYQLLQ-------GI 112
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TF-LPLSHAQTSSIFAKGSIGY 894
+Y H ++H DLKP N+L+D E + DFGLA F +P+ T + ++ Y
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV---TLWY 165
Query: 895 IAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
APE LGS + S D++S G + E+V R+ +F GD
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP----LFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 37/89 (41%), Positives = 52/89 (58%)
Query: 137 LALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI 196
L L N + G IP +IS +L + LS N + G IP LGS++ +E +SYN+ GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 197 PPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
P S G L+S+ L L+ N+L G +P G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKILT 775
++G G++G V K IVA+K F K+ + E L+ +RH N+V +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 776 AC--SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
A G Y LVFE++ LE E +P L +
Sbjct: 68 AFRRKGRLY-------LVFEYVERTLLEL----------LEASPGGLPPDAVRSYIWQLL 110
Query: 834 CALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ--TSSIFAKG 890
A++Y H H+ I+H D+KP N+L+ E + + DFG A L A T + +
Sbjct: 111 QAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR- 165
Query: 891 SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVT 923
Y APE +G DV++ G ++ EL+
Sbjct: 166 --WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G+G FG V+ G + VA+K N GA + FI E + + H LV++
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ Q +V EFM N L +L R+ + + + L L + DV +
Sbjct: 68 CT----QQKPL-YIVTEFMENGCLLNYL----RQRQGKLSKDML-----LSMCQDVCEGM 113
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL + +H DL N L+ + V DFG+ ++ L TSS AK + +
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSP 169
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
PE S+ S DV+S+G+L+ E+ T K + FE N
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTI---VAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVK 772
++G+G+FG+VYKGI + EG+T+ VA+K+ N A F+ E + ++ H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L C Q LV + M + L +++H E ++ L+ + +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVH---------EHKDNIGSQLLLNWCVQI 118
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A + YL + +VH DL NVL+ + DFGLA L + ++ K I
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTD 929
++A E + + DV+SYG+ + EL+T KP D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 31/216 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
I G++G V+ I A+KV ++ + E + L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ +QG LV E++ L L + DE ++ A
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----------A 105
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF--------LPLSHAQTSSIF 887
L YLH I+H DLKP N+L+D + DFGL+ L + I
Sbjct: 106 LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
G+ YIAPE LG S D +S G +L E +
Sbjct: 163 --GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 709 ATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKS---FIAECN 760
A + T + +G GSFG VY+GI DE +T VA+K N + + F+ E +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
+K ++V++L GV QG ++ E M L+ +L + E E
Sbjct: 62 VMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+L + + + ++A ++YL+ + VH DL N ++ E+ +GDFG+ +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---- 169
Query: 881 AQTSSIFAKGSIG-----YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + KG G +++PE + DV+S+G++L E+ T
Sbjct: 170 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 718 LIGAGSFGSVYKGILDE-GK--TIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK- 772
+IGAG FG V +G L GK VA+K + + F++E + + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 773 --ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL-NLLQRLDIG 829
++T V ++ EFM N +L+ +L R+++ + L +L+ + G
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAG 118
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL---PLSHAQTSSI 886
+ ++Y VH DL N+L++ ++ V DFGL+ FL TSS+
Sbjct: 119 MKYLSEMNY---------VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K I + APE + + DV+SYGI++ E+++
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTA 776
L+G G+FG V+KG L + KT VAVK K F++E LK H N+VK++
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C+ + ++ M ++L + ++ + L Q + +D A +
Sbjct: 61 CTQ--------RQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAGM 106
Query: 837 SYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS---- 891
+YL +C +H DL N L+ E + + DFG+ S + I++
Sbjct: 107 AYLESKNC----IHRDLAARNCLVGENNVLKISDFGM------SRQEDDGIYSSSGLKQI 156
Query: 892 -IGYIAPE---YGLGSEVSINGDVYSYGILLLE 920
I + APE YG S S DV+SYGILL E
Sbjct: 157 PIKWTAPEALNYGRYSSES---DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 63/231 (27%), Positives = 92/231 (39%), Gaps = 48/231 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G+ G V+K E VA+K L L G + E L+ +H +VK+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
V G+ F LV E+M L E L R + +S + L +
Sbjct: 67 ---VFPHGSGF-VLVMEYM-PSDLSEVLRDEERPLPEAQV-KSY-MRMLLK-------GV 112
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA------TFLPLSHAQTSSIFAKG 890
+Y+H I+H DLKP+N+L+ + + + DFGLA SH
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-------A 162
Query: 891 SIGYIAPE--YG---LGSEVSINGDVYSYGILLLELVTRKKP-----TDIM 931
+ Y APE YG V D+++ G + EL+ P DI
Sbjct: 163 TRWYRAPELLYGARKYDPGV----DLWAVGCIFAELL-NGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 719 IGAGSFGSV----YKGILDEGKTIVAVKVFNLLHHGAFKSFIA----ECNTLKNIRHRNL 770
+G G FG V Y D VAVK L + + IA E L+N+ H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS---LNLLQRLD 827
VK C+ + GN K L+ EF+ + SL+E+L PR+ +NL Q+L
Sbjct: 69 VKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL------------PRNKNKINLKQQLK 113
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT-------FLPLSH 880
+ + + YL VH DL NVL++ E +GDFGL + +
Sbjct: 114 YAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
S +F + APE + S+ I DV+S+G+ L EL+T
Sbjct: 171 DLDSPVF------WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 33/248 (13%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLHHGA-----FKSFIAECNTLKNIRHRNLV 771
L+G G+FG VY +D G+ +AVK + E LKN++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 772 KILTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ +D +F E+M S+++ L ET + +L+
Sbjct: 68 QYYGC------LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------ 115
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA-K 889
+ YLH + IVH D+K +N+L D +GDFG + L + + + +
Sbjct: 116 ----GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT----A 945
G+ +++PE G DV+S G ++E++T K P FE + A
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPQ 227
Query: 946 LPDHVVDI 953
LP HV
Sbjct: 228 LPSHVSPD 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 34/219 (15%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLV 771
+G G++ VYK E IVA+K L G + + E L+ ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-PITREDETEEAPRSLNLLQRLDIGI 830
+L + LVFEFM LE+ + + L L+
Sbjct: 66 GLLDV-----FGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLR------ 113
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
L YLH + I+H DLKP+N+L+ + + + DFGLA + + T +
Sbjct: 114 ----GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT- 165
Query: 890 GSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 925
Y APE G+ V + D++S G + EL+ R
Sbjct: 166 --RWYRAPELLFGARHYGVGV--DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG G+ G VYK VA+K L + I E +K+ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDS-- 83
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWL-HPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
Y D +V E+M SL + + R +E + A +LQ L
Sbjct: 84 ---YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ----------GLE 130
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
YLH ++H D+K N+LL ++ + DFG A L ++ +S+ G+ ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV--GTPYWMAP 185
Query: 898 EYGLGSEVSINGDVYSYGILLLELV 922
E + D++S GI+ +E+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-12
Identities = 33/93 (35%), Positives = 52/93 (55%)
Query: 109 FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL 168
F+ L L N IP++ +LR LQ + L NSI G IP ++ S ++L + LS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG 201
G IP LG L+ + +++ N+L+G +P + G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-12
Identities = 60/197 (30%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 739 VAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795
VA+K+ F E + H N+V +L SG VFE++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGE--APPGLLFAVFEYV 61
Query: 796 HNRSLEEWLHPITREDETEEAPRSLNL-LQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854
R+L E L D A + L LQ LD +ACA H+ IVH DLKP
Sbjct: 62 PGRTLREVL----AADGALPAGETGRLMLQVLD---ALACA-----HN--QGIVHRDLKP 107
Query: 855 SNVLL---DEEMIAHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVS 906
N+++ A V DFG+ T LP T + G+ Y APE G V+
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 907 INGDVYSYGILLLELVT 923
N D+Y++G++ LE +T
Sbjct: 168 PNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
FT IG GSFG V+KGI + + +VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 773 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
+L+ C Y G+ K ++ E++ S + L P DET+ A +L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKG 113
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
LD YLH + + +H D+K +NVLL E + DFG+A L+ Q
Sbjct: 114 LD----------YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKR 158
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE S D++S GI +EL + P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNL 770
F N IG GSFG V+K + K + A+K +L + I E L + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
++ S +D +V E+ N L + L P + + R I I
Sbjct: 62 IRYYE--SFLDKG---KLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+ L++LH I+H D+K N+ LD +GD G+A L ++ FA
Sbjct: 111 LLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANT 160
Query: 891 SIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
+G Y++PE + DV++ G++L E T K P D +G
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIR---HRNLVKI 773
IG G++G+VYK VA+K + G S + E LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ C+ LVFE + ++ L +L + P L D+
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKV--------PPPGLPAETIKDLMRQFL 118
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
L +LH +C IVH DLKP N+L+ + DFGLA A T + ++
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---TLW 172
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
Y APE L S + D++S G + E+ RK
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 719 IGAGSFGSVYKGILDEGKTI--VAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G FGSV +G L++ +I VAVK + + F++E +K H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 775 TAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
C V+ +G ++ FM + L H + P+ L + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
+ YL +H DL N +L+E M V DFGL+ + AK +
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
+IA E + DV+S+G+ + E+ TR
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 34/228 (14%)
Query: 719 IGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G G FG V K G T VAVK +L A + ++E N LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------------PITREDETEEAP 817
++K+ ACS + L+ E+ SL +L R + P
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 818 --RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875
R+L + + ++ + YL + +VH DL NVL+ E + DFGL+
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + + + ++A E + DV+S+G+LL E+VT
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 8e-12
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVK----VFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
IG+G++G V + VA+K VF+ L K + E L+++RH N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHENIIG 63
Query: 773 ILTACSGVDYQGNDFKAL--VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+L DF + V E M L + + + + T++ + L Q L
Sbjct: 64 LLDIL--RPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHIQYF-LYQIL---- 113
Query: 831 DVACALSYLH--HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
L YLH + ++H DLKPSN+L++ + DFGLA + + +
Sbjct: 114 ---RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-- 163
Query: 889 KGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVTRK 925
Y+ APE L S +I D++S G + EL+TRK
Sbjct: 164 ---TEYVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 717 NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVK 772
+IG G FG VY G L D K AVK N + + F+ E +K+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L C + +G+ +V +M + L ++ T P +L+ G+ V
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHN------PTVKDLI---GFGLQV 107
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT-------FLPLSHAQTSS 885
A + YL VH DL N +LDE V DFGLA + +H
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG--- 161
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
AK + ++A E + + DV+S+G+LL EL+TR P
Sbjct: 162 --AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-12
Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 1/83 (1%)
Query: 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN 521
L+G IP+ + + L I+LS N++ G IPP L ++SL VL+LS N G IP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL-EVLDLSYNSFNGSIPESLGQ 488
Query: 522 LKNLEMLNVFENKLRGEIPRTLG 544
L +L +LN+ N L G +P LG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 9e-12
Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 53/278 (19%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKI 773
+IG GSF +V E A+K+ + L+ K E L + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+Q + V E+ N L +++ DE + +L
Sbjct: 68 YYT-----FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL---------- 112
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP---LSHAQTSSIFAKG 890
AL YLH I+H DLKP N+LLD++M + DFG A L +
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 891 SIG---------------YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
S Y++PE + D+++ G ++ +++T K P F G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGS 225
Query: 936 MNLHNFAKTA---------LPDHVVDIVDSTLLSDDED 964
F K P D+++ L+ D +D
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 29/218 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTAC 777
IG G+ VY I VA+K +L E + H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
S V D LV ++ SL + + +EA + L + L L
Sbjct: 67 SFVV---GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-------GLE 116
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG---Y 894
YLH + Q +H D+K N+LL E+ + DFG++ L + K +G +
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCW 172
Query: 895 IAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
+APE +G + D++S+GI +EL T P
Sbjct: 173 MAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNI-RHRNLVK 772
++IG G+FG V K + + + + + + + + F E L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEA-------PRSLNLLQR 825
+L AC +++G + L E+ + +L ++L +R ET+ A +L+ Q
Sbjct: 73 LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 126
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
L DVA + YL Q +H DL N+L+ E +A + DFGL ++
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQE 175
Query: 886 IFAKGSIG-----YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
++ K ++G ++A E S + N DV+SYG+LL E+V+
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 719 IGAGSFGSVYKGILDE--GKTI-VAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 771
+G G+FGSV KG+ GK + VAVK L + F+ E + + + H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKT---LKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--HPITREDETEEAPRSLNLLQRLDIG 829
+++ C +G LV E L ++L + +E Q
Sbjct: 60 RLIGVC-----KGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL-----AHQ----- 103
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-PLSHAQTSSIFA 888
VA ++YL VH DL NVLL A + DFG++ L S ++
Sbjct: 104 --VAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
Query: 889 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ + + APE YG S S DV+SYG+ L E + KP
Sbjct: 159 RWPLKWYAPECINYGKFSSKS---DVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 64/228 (28%), Positives = 92/228 (40%), Gaps = 46/228 (20%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLV 771
FT IG GSFG VYK I +VA+KV +L I E L R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 772 KILTACSGVDYQG---NDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
K Y G K ++ E+ S + L P + DET
Sbjct: 63 K---------YYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETY------------- 99
Query: 828 IGI---DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
I +V L YLH + + +H D+K +N+LL EE + DFG++ Q +
Sbjct: 100 IAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS-------GQLT 149
Query: 885 SIFAK-----GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
S +K G+ ++APE S D++S GI +EL + P
Sbjct: 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 74/295 (25%), Positives = 120/295 (40%), Gaps = 50/295 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVK---VFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
IG G F VY+ VA+K +F+L+ A I E + LK + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ + N+ +V E L + ++ R + + + A
Sbjct: 70 SF----IEDNELN-IVLELADAGDLSRMIKHFKKQK------RLIPEKTVWKYFVQLCSA 118
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L ++H ++H D+KP+NV + + +GD GL F S T++ G+ Y+
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYM 173
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-MNLHNFAKTALPDHVVDIV 954
+PE + + D++S G LL E+ + P F GD MNL++ K ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKK------IEQC 223
Query: 955 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNV 1009
D L D H ++ RQ LV M C PE R D+T V
Sbjct: 224 DYPPLPSD-----HYSEELRQ---------LVNM------CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 713 FTSANL-----IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIR 766
FT+ +L IG G+FG+V K + TI+AVK K + + + + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 767 HRNLVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
+ I V + G F+ + E M + SL++ + E P +
Sbjct: 59 SSDCPYI------VKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPE--EI 108
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
L + I + AL+YL + + I+H D+KPSN+LLD + DFG++ L S A+
Sbjct: 109 LGK--IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVS---INGDVYSYGILLLELVTRKKP 927
T G Y+APE S + DV+S GI L E+ T K P
Sbjct: 165 TRDA---GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
FT IG GSFG V+KGI + + +VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 773 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLH--PITREDETEEAPRSLNLL 823
+L+ C Y G+ K ++ E++ S + L P DE + A +L
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF---DEFQIATMLKEIL 111
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
+ LD YLH + + +H D+K +NVLL E+ + DFG+A L + +
Sbjct: 112 KGLD----------YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931
++ G+ ++APE S D++S GI +EL + P M
Sbjct: 159 NTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 13/218 (5%)
Query: 713 FTSANLIGAGSFGSVYKGIL---DEGKTIVAVKVF--NLLHHGAFKSFIAECNTLKNIRH 767
FT ++G G FGSV + L D VAVK+ ++ + F+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 768 RNLVKILTACSGVDYQGN-DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
N++K++ +G ++ FM + L H E P +L L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLV 116
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
ID+A + YL +H DL N +L+E M V DFGL+ +
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
+K + ++A E + + + DV+++G+ + E++TR
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 294 PPAISNASNLEVFQV---NSNKLTGEVPYLEK----LQRLSHFVITRNSLGSGEHRDLNF 346
AI NA +EVF++ S L EV L+ L F + +H
Sbjct: 350 THAIINA--IEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGA 407
Query: 347 LCSLTNATRLKWF--HININNFG--GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKF 402
C + KWF + ++N G G +P IS L+ + L N I GNIP + G
Sbjct: 408 DCQFDSTKG-KWFIDGLGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSI 465
Query: 403 VKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNF 461
L L++ N +G+IP ++G+L +LR L L N G +P ++G L + S+NF
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH--RASFNF 522
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-11
Identities = 72/244 (29%), Positives = 107/244 (43%), Gaps = 71/244 (29%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFK------------SFIAECNTLKNI 765
+G G++G V+K I K +VA+K +F AF+ F+ E L +
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF-----DAFRNATDAQRTFREIMFLQE---LGD- 65
Query: 766 RHRNLVKILTACSGVDYQGNDFKA-------LVFEFMHNRSLEEWLHPITREDETEEAPR 818
H N+VK+L N KA LVFE+M E LH + R + E+ +
Sbjct: 66 -HPNIVKLL----------NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHK 109
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLP 877
+ Q L AL Y+H ++H DLKPSN+LL+ + + DFGLA +
Sbjct: 110 RYIMYQLLK-------ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 878 LSHAQTSSIFAKGSIGYIA------PEYGLGSEVSING-DVYSYGILLLELVTRKKPTDI 930
L + + Y+A PE LGS G D++S G +L E++ KP
Sbjct: 160 LEENPENPVLTD----YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP--- 211
Query: 931 MFEG 934
+F G
Sbjct: 212 LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
+G G FG V + + A K N L ++ + E L + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
A +Q LV M+ L ++ + E+ PR+ + +
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISG 109
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L +LH Q I++ DLKP NVLLD + + D GLA + L Q+ + G+ G++
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFM 164
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
APE G E + D ++ G+ L E++ + P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 62/184 (33%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 774
IG GSFG V AVKV +L K +AE N L KN++H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV--- 59
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
G+ Y L F + E + H + RE E PR+ R ++A
Sbjct: 60 ----GLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPE-PRA-----RF-YAAEIAS 107
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL YLH I++ DLKP N+LLD + + DFGL + H++T+S F G+ Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEY 162
Query: 895 IAPE 898
+APE
Sbjct: 163 LAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 78/324 (24%), Positives = 123/324 (37%), Gaps = 69/324 (21%)
Query: 709 ATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKS-FIAECNTL 762
D T +G G+FG VY+G+ D + VAVK +S F+ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 763 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TEEAPRSLN 821
H+N+V+ GV ++ + ++ E M L+ +L RE+ E P SL
Sbjct: 64 SKFNHQNIVR----LIGVSFERLP-RFILLELMAGGDLKSFL----RENRPRPERPSSLT 114
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD---EEMIAHVGDFGLATFLPL 878
+ L DVA YL + +H D+ N LL +A + DFG+A
Sbjct: 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA----- 166
Query: 879 SHAQTSSIFAKGS-----IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933
+S + KG I ++ PE L + DV+S+G+LL E I
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE---------IFSL 217
Query: 934 GDM---NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMAR 990
G M N V++ V R++ C + R
Sbjct: 218 GYMPYPGRTN-------QEVMEFV------------------TGGGRLDPPKGCPGPVYR 252
Query: 991 IGVACSMESPEDRMDMTNVVHQLQ 1014
I C +PEDR + ++ ++Q
Sbjct: 253 IMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA--ECNTLKNIRHRNLVKILT 775
L+G GS+G V K E IVA+K F IA E LK +RH NLV ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ LVFEF+ + L D+ E+ P L+ + +
Sbjct: 68 VFR----RKKRLY-LVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILRG 112
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+ + H I+H D+KP N+L+ + + + DFG A L + A + Y
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYR 167
Query: 896 APEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
APE +G ++ D+++ G L+ E++T + +F GD ++
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLT----GEPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 717 NLIGAGSFGSVYKGIL--DEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVK 772
++IG G+FG V + ++ D K A+K+ + F E L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 773 ILTACSGVDY---------QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+L AC Y GN + +F+ + E +E T S LL
Sbjct: 68 LLGACENRGYLYIAIEYAPYGN-----LLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
Q DVA + YL + +H DL NVL+ E + + + DFGL ++
Sbjct: 123 Q---FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL--------SRG 168
Query: 884 SSIFAKGSIG-----YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
++ K ++G ++A E S + DV+S+G+LL E+V+
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 35/233 (15%)
Query: 711 DGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKN 764
D T +G G+FG V K + VAVK+ ++E +K
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 765 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITREDETEEAPRSL 820
I +H+N++ +L C+ +G + +V E+ + +L ++L P E + + PR
Sbjct: 72 IGKHKNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPG-EYASPDDPRPP 125
Query: 821 --NLLQR--LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876
L Q+ + VA + +L +H DL NVL+ E+ + + DFGLA +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 877 PLSHAQTSSIFAKGSIG-----YIAPEYGLGSEV-SINGDVYSYGILLLELVT 923
H + K + G ++APE L V + DV+S+G+LL E+ T
Sbjct: 183 ---HHI--DYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G++ +VYKG IVA+K +L G + I E + +K ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
V + N LVFE+M L++++ +T +L+ + ++
Sbjct: 64 HDVIHTENKL-MLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TF-LPLSHAQTSSIFAKGSIGYI 895
+ H + ++H DLKP N+L+++ + DFGLA F +P++ + ++ Y
Sbjct: 115 FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYR 167
Query: 896 APEYGLGSEV-SINGDVYSYGILLLELVT 923
AP+ LGS S + D++S G ++ E++T
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 75/247 (30%), Positives = 112/247 (45%), Gaps = 48/247 (19%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHR 768
D F IG G++G VYK + +VA+K L + G + I E L+ + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 769 NLVK---ILTACSGVDYQGNDFKA------LVFEFM-HNRS--LEEWLHPITREDETEEA 816
N+V I+T DFK LVFE+M H+ LE L +E+
Sbjct: 67 NIVNLKEIVTD----KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDH 117
Query: 817 PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876
+S + Q L+ L+Y H + +H D+K SN+LL+ + + DFGLA
Sbjct: 118 IKSF-MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR-- 164
Query: 877 PLSHAQTSSIFAKGSIG--YIAPEYGLGSEV---SINGDVYSYGILLLELVTRKKPTDIM 931
L +++ S + I Y PE LG E +I DV+S G +L EL T+K +
Sbjct: 165 -LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI--DVWSCGCILGELFTKKP----I 217
Query: 932 FEGDMNL 938
F+ + L
Sbjct: 218 FQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-10
Identities = 21/42 (50%), Positives = 22/42 (52%), Gaps = 1/42 (2%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNES-IHFCQWHGVTCS 79
DR ALL FKS + DP G SWN S C W GVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNL----------LHHGAFKSFIAECNTLKNIRH 767
LIG G++G VY + ++AVK L K+ +E TLK++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+V G + ++ ++ E++ S+ L R +E + +L+
Sbjct: 68 LNIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE--- 119
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
L+YLH I+H DLK N+L+D + I + DFG++ + ++
Sbjct: 120 -------GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 888 AKGSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
+GS+ ++APE Y G + D++S G ++LE+ ++P
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 75/305 (24%), Positives = 123/305 (40%), Gaps = 56/305 (18%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTI---VAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVK 772
++G+G+FG+VYKGI + +G+ + VA+KV A K + E + + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L C Q LV + M L +++ RE++ + L L+ + +
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYV----RENKDRIGSQDL-----LNWCVQI 118
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A +SYL + +VH DL NVL+ + DFGLA L + + + K I
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVV 951
++A E L + DV+SYG+ + EL+T KP D +PD
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD----------GIPAREIPD--- 222
Query: 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011
LL E R+ C + + I V C M E R +V
Sbjct: 223 ------LLEKGE-------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263
Query: 1012 QLQSI 1016
+ +
Sbjct: 264 EFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 35/81 (43%), Positives = 50/81 (61%), Gaps = 2/81 (2%)
Query: 441 GNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSS 499
G IP I L L ++ LS N ++G+IP SLG +L ++DLS N+ G+IP L L+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 500 LLIVLELSRNQLTGPIPNEVG 520
L I L L+ N L+G +P +G
Sbjct: 492 LRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 52/220 (23%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKILTAC 777
IG G+FG V+ G L T VAVK K+ F+ E LK H N+V+++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 778 SGVD--------YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+ QG DF F+ E PR L + + + +
Sbjct: 63 TQKQPIYIVMELVQGGDFLT----FLRT-----------------EGPR-LKVKELIQMV 100
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
+ A + YL +H DL N L+ E+ + + DFG +S + ++A
Sbjct: 101 ENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFG------MSREEEDGVYAS 151
Query: 890 GS------IGYIAPE---YGLGSEVSINGDVYSYGILLLE 920
+ + APE YG S S DV+S+GILL E
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSSES---DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 69/253 (27%), Positives = 104/253 (41%), Gaps = 65/253 (25%)
Query: 700 NISYQNLYNATDG---FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA----- 751
+ L++ D FT IG GSFG+VY +VA+K + + G
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEK 58
Query: 752 FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA----LVFEF----------MHN 797
++ I E L+ +RH N + +Y+G + LV E+ +H
Sbjct: 59 WQDIIKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSASDILEVHK 109
Query: 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857
+ L+E E A LQ L+YLH + +H D+K N+
Sbjct: 110 KPLQE----------VEIAAICHGALQ----------GLAYLHSHER---IHRDIKAGNI 146
Query: 858 LLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSING--DVYSY 914
LL E + DFG A+ +S A + F G+ ++APE L E +G DV+S
Sbjct: 147 LLTEPGTVKLADFGSASL--VSPANS---FV-GTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 915 GILLLELVTRKKP 927
GI +EL RK P
Sbjct: 201 GITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 37/97 (38%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL YL ++H D+KPSN+LLD + DFG++ L S A+T S G Y
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAY 180
Query: 895 IAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 927
+APE + I DV+S GI L+EL T + P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 30/165 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVF------NLLHHGAFKSFIAECNTLKNIRHRNLVK 772
IG GS+G V+K E IVA+K F ++ A + E LK ++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
++ ++ LVFE+ + L +E E+ PR + I
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVL----------NELEKNPRGVPEHLIKKIIWQT 109
Query: 833 ACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876
A+++ H H+C +H D+KP N+L+ ++ + DFG A L
Sbjct: 110 LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+ C L +LH Q IV+ DLKP NVLLD+ + D GLA L G
Sbjct: 103 QIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---G 156
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ GY+APE G + D ++ G L E++ + P
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 50/219 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
+G GSFG V A+K+ + ++ + + E L++IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC- 834
+ +Q + LV E++ L L R E VA
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPE------------------PVARF 105
Query: 835 -------ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
AL YLH IV+ DLKP N+LLD + + DFG A + T
Sbjct: 106 YAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC-- 159
Query: 888 AKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELV 922
G+ Y+APE G G V D ++ GIL+ E++
Sbjct: 160 --GTPEYLAPEIILSKGYGKAV----DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 11/255 (4%)
Query: 103 HVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVR 162
+ L+ L LDL NN+ P L+ L L +N I +P+ + + NL +
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 163 LSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPD 222
LS N+L +P L +LS + +S N ++ +PP LS++ L LS N++ +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226
Query: 223 TFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFF 282
+ LKNL L ++ N+L +P SI N+S++ D NQI + +L NL+
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI---SSLGSLTNLREL 282
Query: 283 SVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHR 342
+ N L+ A+P LE + + LT + L+ L + I N S
Sbjct: 283 DLSGNSLSNALPLIALLLLLLE--LLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340
Query: 343 DLNFLCSLTNATRLK 357
SL N L
Sbjct: 341 LSIL-ESLNNLWTLD 354
|
Length = 394 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 775
+G G FG V + A+K H G + +E L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC- 834
++ + ++ E+ L L R L +AC
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTIL-------------RDRGLFDEYTARFYIACV 102
Query: 835 --ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A YLH+ I++ DLKP N+LLD + DFG A L S +T + G+
Sbjct: 103 VLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC--GTP 156
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
Y+APE L + D +S GILL EL+T + P
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 3/110 (2%)
Query: 73 WHGVTC---SRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFD 129
W G C S + + L L + L G+I + L L+ ++L NS IP
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 130 RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSL 179
+ L+VL L NS G IP ++ ++L + L+ N L G++P+ LG
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 65/233 (27%), Positives = 101/233 (43%), Gaps = 29/233 (12%)
Query: 719 IGAGSFGSVYKGI-LDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIR---HRNLVK 772
IG G++G V+K L G VA+K + G S I E L+++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS--LNLLQRLDIGI 830
+ C+ LVFE + ++ L +L + E + LL+ LD
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD--- 124
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+LH +VH DLKP N+L+ + DFGLA A TS +
Sbjct: 125 -------FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 171
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
++ Y APE L S + D++S G + E+ R+KP +F G ++ K
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 718 LIGAGSFGSVY--KGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
++G G+FG V+ + D+ I+ + + EC LK + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---- 62
Query: 776 ACSGVDYQGN--DFKAL--VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+Y N + KAL V E+ +L E++ E+ L +
Sbjct: 63 -----EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI--------LHFFVQ 109
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+ AL ++H I+H DLK N+LLD+ +M+ +GDFG++ L + + G
Sbjct: 110 ILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---G 163
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
+ YI+PE G + D+++ G +L EL + K+ +
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-10
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVK----VFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG+G++G V I VA+K F++ K + E L++ +H N++ I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA--KRTLRELKILRHFKHDNIIAIR 70
Query: 775 TACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPI--TREDETEEAPRSLNLLQRLDIGI 830
+ G DFK +V + M E LH I + + TEE R L Q L
Sbjct: 71 DI---LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYF-LYQLL---- 117
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK- 889
L Y+H ++H DLKPSN+L++E+ +GDFG+A L S + +
Sbjct: 118 ---RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 890 -GSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
+ Y APE L E + D++S G + E++ R++ +F G +H
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKNYVH 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 719 IGAGSFGSVYK----GILDEGKTI-VAVKVFNLLHHGAFK-SFIAECNTLKNI-RHRNLV 771
+GAG+FG V + G+ + VAVK+ H + + + ++E + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 772 KILTAC--SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+L AC G ++ E+ L +L R+ E+ L L L
Sbjct: 103 NLLGACTIGGPIL-------VITEYCCYGDLLNFLR---RKRES-----FLTLEDLLSFS 147
Query: 830 IDVACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
VA +++L +C +H DL NVLL I + DFGLA + S+
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNYVV 199
Query: 889 KGS----IGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
KG+ + ++APE + DV+SYGILL E+ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 718 LIGAGSFGSVYKGILD-EGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVK- 772
+IGAG FG V G L GK + V + L + F++E + + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 773 --ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
++T V +V E+M N SL+ +L + D + + +L+ + G+
Sbjct: 71 EGVVTKSKPV--------MIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGM 119
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL---PLSHAQTSSIF 887
+ Y VH DL N+L++ ++ V DFGL+ L P + T
Sbjct: 120 KYLSDMGY---------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG-- 168
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K I + APE + + DV+SYGI++ E+++
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 55/239 (23%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI------AECNTLKNIR 766
+TS +G+G++GSV I VA+K F+S I E LK+++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 767 HRNLVKIL----TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
H N++ +L +A SG ++Q DF LV +M L I +E+ + L +
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQTD-----LQKIMGHPLSEDKVQYL-V 123
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
Q L C L Y+H I+H DLKP N+ ++E+ + DFGLA HA
Sbjct: 124 YQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RHAD 168
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPTDIMFEG 934
GY+ + EV +N D++S G ++ E++T K +F+G
Sbjct: 169 AE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNI 765
+ D + +G GS+ +VYKG +VA+KV L G + I E + LK +
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--HPITREDETEEAPRSLNLL 823
+H N+V + + LVFE++H L +++ HP E + L L
Sbjct: 61 KHANIVLLHDII-----HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVK----LFLF 110
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL-SHAQ 882
Q L LSY+H Q I+H DLKP N+L+ + + DFGLA + SH
Sbjct: 111 QLLR-------GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160
Query: 883 TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELV 922
++ + ++ Y P+ LGS E S D++ G + +E++
Sbjct: 161 SNEVV---TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 758 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAP 817
E L+ + R +V + A Y+ D LV M+ L+ H + E
Sbjct: 50 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEG 102
Query: 818 RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
R++ ++ C L LH Q IV+ DLKP N+LLD+ + D GLA +P
Sbjct: 103 RAVFY------AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ G++GY+APE + + D ++ G LL E++ + P
Sbjct: 154 EGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 718 LIGAGSFGSVY----KGILDEGK-TIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLV 771
+G G FG V+ KGI +EG T+V VK F E + + + H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 772 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++L C + Y ++ E+ L+++L T+ + + P L+ Q++ +
Sbjct: 72 RLLGLCREAEPHY-------MILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALC 123
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+A + +L VH DL N L+ + V L LS +S +
Sbjct: 124 TQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVS------LLSLSKDVYNSEY 172
Query: 888 -----AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
A + ++APE + S DV+S+G+L+ E+ T
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 62/237 (26%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 769
F +G GS+GSVYK A+K +L + + + E L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 770 LVKILTA-------CSGVDYQ--GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
++ A C ++Y G+ KA+ + + E I R
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE--IWR----------- 107
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
I I + L LH + I+H DLK +N+LL + +GD G++ L
Sbjct: 108 -------IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---- 153
Query: 881 AQTSSIFAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
AK IG Y+APE G S D++S G LL E+ T P FE
Sbjct: 154 ---KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G+FG VYK E A K+ + + F+ E + L +H N+V + A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-- 70
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y + ++ EF +L+ + E E R L Q + + AL++
Sbjct: 71 ---YFYENKLWILIEFCDGGALDSIM------LELE---RGLTEPQIRYVCRQMLEALNF 118
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE 898
LH ++H DLK N+LL + + DFG++ S Q F G+ ++APE
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN-KSTLQKRDTFI-GTPYWMAPE 173
Query: 899 YGLGSEVSIN-----GDVYSYGILLLELVTRKKP 927
N D++S GI L+EL + P
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 713 FTSANLIGAGSFGSVYKGI-LDEGKTI---VAVKVF-NLLHHGAFKSFIAECNTLKNIRH 767
F ++G+G+FG+VYKG+ + EG+ + VA+K A K + E + ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
++ ++L C Q L+ + M L +++ RE + + L L+
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHKDNIGSQYL-----LN 113
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ +A ++YL + +VH DL NVL+ + DFGLA L + +
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTD 929
K I ++A E L + DV+SYG+ + EL+T KP D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 62/190 (32%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 416 SGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSET 475
S + L L L L NR NI + L +L L N + P
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN 141
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L +DLS+N + ++P L L +L L+LS N L+ +P + NL NL L++ NK+
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKN-LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKI 198
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQ 595
++P + LE L + N + + SSLS+L+ LS L+LS NN +PE +
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLS 255
Query: 596 LLEYLNLSNN 605
LE L+LSNN
Sbjct: 256 NLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G+ G+VYK + I+AVKV L + K ++E ++IL C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56
Query: 778 SG---VDYQGNDFK----ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ + G F ++ EFM SL D + P ++L R I +
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSL----------DVYRKIPE--HVLGR--IAV 102
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
V L+YL I+H D+KPSN+L++ + DFG++T L S A+T G
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----G 155
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ Y+APE G + I+ DV+S GI +EL + P
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 38/222 (17%)
Query: 718 LIGAGSFGSVYKGI--LDEGKTI-VAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKI 773
IG G FG VY+G+ E + I VAVK + + F+ E ++ H ++VK+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ + + +V E L +L + + A L Q ++
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQ-------LS 117
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL+YL VH D+ NVL+ +GDFGL+ +L +S K I
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIK 173
Query: 894 YIAPEYGLGSEVSIN-------GDVYSYGILLLELVTR-KKP 927
++APE SIN DV+ +G+ + E++ KP
Sbjct: 174 WMAPE-------SINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNL---------LHHGAFKSFIAECNTLKNIRHR 768
LIG+GSFGSVY G+ ++AVK L + E LK ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL--NLLQRL 826
N+V+ L + D+ N F E++ S+ L + +L N ++++
Sbjct: 67 NIVQYLGSSLDADHL-NIF----LEYVPGGSVAALL------NNYGAFEETLVRNFVRQI 115
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
G L+YLH+ I+H D+K +N+L+D + + DFG++ L + T +
Sbjct: 116 LKG------LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 887 FAK----GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
A+ GS+ ++APE + + D++S G L++E++T K P
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSF----IAECNTLKNIRHRNLVKIL 774
IG G+FG V+K + K IVA+K +L + F + E L+ ++H N+V ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 775 TACSGVDYQGNDFKA---LVFEFM-HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
C N +K LVFEF H+ L L + E + +++ L G
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKK---VMKMLLNG- 131
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
L Y+H + I+H D+K +N+L+ ++ I + DFGLA
Sbjct: 132 -----LYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G+FG VYK E + A KV + + ++ E + L + H N+VK+L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC---- 834
Y N+ L+ EF +++ + E R L Q I V C
Sbjct: 72 ---YYENNLWILI-EFCAGGAVDAVML---------ELERPLTEPQ-----IRVVCKQTL 113
Query: 835 -ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL+YLH + I+H DLK N+L + + DFG +S T +I + S
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG------VSAKNTRTIQRRDS-- 162
Query: 894 YIAPEYGLGSEVSI-----------NGDVYSYGILLLELVTRKKP 927
+I Y + EV + DV+S GI L+E+ + P
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 61/259 (23%), Positives = 96/259 (37%), Gaps = 79/259 (30%)
Query: 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI 765
L + T F +IG G++G VYK + +VA+K+ +++ + E N L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 766 -RHRNLVKILTACSGVDYQGNDFKA----------LVFEF--------------MHNRSL 800
H N+ + G K LV E + L
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 801 -EEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
EEW+ I RE L+YLH + ++H D+K N+LL
Sbjct: 111 KEEWIAYILRE---------------------TLRGLAYLH---ENKVIHRDIKGQNILL 146
Query: 860 DEEMIAHVG--DFGLATFLPLSHAQTSSIFAKGS-IG---YIAPE-----YGLGSEVSIN 908
+ A V DFG++ L S++ + + IG ++APE +
Sbjct: 147 TKN--AEVKLVDFGVSAQL------DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR 198
Query: 909 GDVYSYGILLLELVTRKKP 927
DV+S GI +EL K P
Sbjct: 199 SDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
I L L L G IP+ L++L ++ ++ N + G IP S+ +I+S+ V D N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI 297
G IP +G L +L+ ++ N L+G +P A+
Sbjct: 480 GSIPESLG-QLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 58/225 (25%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV------ 771
+G GS+ +VYKG +VA+K L H GA + I E + LK+++H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 772 ---KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN------- 821
K LT LVFE++ L++++ ++ L+
Sbjct: 73 HTKKTLT--------------LVFEYLD-TDLKQYM---------DDCGGGLSMHNVRLF 108
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL--ATFLPLS 879
L Q L L+Y H ++H DLKP N+L+ E + DFGL A +P S
Sbjct: 109 LFQLLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP-S 157
Query: 880 HAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVT 923
++ + ++ Y P+ LGS E S + D++ G + E+ T
Sbjct: 158 KTYSNEVV---TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
I + + AL YLH + ++H D+KPSNVL++ + DFG++ +L S A+T
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 888 AKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKPTD 929
G Y+APE + DV+S GI ++EL T + P D
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV----FNLLHHGAFKSFIAECNTLKNIR 766
D + + + +G+G++G V + VA+K F H K E LK++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA--KRTYRELRLLKHMD 72
Query: 767 HRN---LVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDE-TEEAPRSL 820
H N L+ + T S + DF+ LV M L+ I + + +++ + L
Sbjct: 73 HENVIGLLDVFTPASSL----EDFQDVYLVTHLMGAD-----LNNIVKCQKLSDDHIQFL 123
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ Q L L Y+H I+H DLKPSN+ ++E+ + DFGLA
Sbjct: 124 -VYQILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDD 170
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRK 925
T GY+A + E+ +N D++S G ++ EL+T K
Sbjct: 171 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G++ +V+KG + +VA+K L H GA + I E + LKN++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--- 69
Query: 778 SGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI---DVA 833
D + LVFE++ + L+++L NL+ ++ I +
Sbjct: 70 ---DIIHTERCLTLVFEYLDS-DLKQYLDNCG------------NLMSMHNVKIFMFQLL 113
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
LSY H I+H DLKP N+L++E+ + DFGLA + S+ ++
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLW 168
Query: 894 YIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
Y P+ LGS E S D++ G +L E+ T + MF G
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 39/271 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVF-----NLLHHGAFKSFIAECNTLKNIRH 767
+T ++G G++G+VY G+ ++G+ I +V L ++ E + LK+++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+V+ L C N ++ EF+ S+ L+ E + +L
Sbjct: 62 VNIVQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD--- 113
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLS--HAQTSS 885
++YLH++C +VH D+K +NV+L I + DFG A L H S+
Sbjct: 114 -------GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 886 IF--AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP------TDIMFEGDMN 937
+ G+ ++APE S D++S G + E+ T K P MF +
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY--IG 221
Query: 938 LHNFAKTALPDH----VVDIVDSTLLSDDED 964
H LPD +D V S L D +
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHE 252
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVK---VFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
IG G F VY+ + VA+K +F ++ A + + E + LK + H N++K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ + ++ +V E L + + ++ R + + + A
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSQMIKYFKKQK------RLIPERTVWKYFVQLCSA 118
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+ ++H ++H D+KP+NV + + +GD GL F S T++ G+ Y+
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYM 173
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-MNL 938
+PE + + D++S G LL E+ + P F GD MNL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 719 IGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNL 770
+G GSFG VY+G E +T VAVK N + + F+ E + +K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V++L GV +G +V E M + L+ +L + E E L + + +
Sbjct: 72 VRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++A ++YL+ VH DL N ++ + +GDFG+ + + + KG
Sbjct: 127 EIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-----YETDYYRKG 178
Query: 891 SIG-----YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
G ++APE + + D++S+G++L E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G++G VYK +A+K L G + I E + LK ++H N+V++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ-- 67
Query: 777 CSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
D ++ + LVFE++ + L++ + D + + ++ L++ I A
Sbjct: 68 ----DVVHSEKRLYLVFEYL-DLDLKKHM------DSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIA-HVGDFGLA-TFLPLSHAQTSSIFAKGSIG 893
+ H ++H DLKP N+L+D A + DFGLA F T + ++
Sbjct: 117 YCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLW 168
Query: 894 YIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
Y APE LGS S D++S G + E+V +K +F GD
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP----LFPGD 207
|
Length = 294 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVF----NLLHHGAFKSFIAECNTLKNIRHRNL 770
+G +FG +YKG L + +VA+K N G F+ E + + + H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAELHHPNI 69
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE---------DETEEAPRSLN 821
V +L GV Q ++FE+++ L E+L I R DE SL+
Sbjct: 70 VCLL----GVVTQEQPV-CMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLS-- 879
L I I +A + YL VH DL N+L+ E++ + D GL+ + +
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 880 -HAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
Q S+ I ++ PE + + S + D++S+G++L E+ +
Sbjct: 180 YRVQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS---FIAECNTLKNIRH 767
D +G G+FG V+ + A+KV + K E LK + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
++++ F ++ E++ L +L + L
Sbjct: 61 PFIIRLFWT-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLF 105
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
++ CAL YLH IV+ DLKP N+LLD+E + DFG A L +T ++
Sbjct: 106 YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC 159
Query: 888 AKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y+APE G V D ++ GIL+ E++ P
Sbjct: 160 --GTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 717 NLIGAGSFGSVYKGIL--DEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVK 772
++IG G+FG V K + D + A+K + F E L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 773 ILTACS--GVDYQGNDFKAL--VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
+L AC G Y ++ + +F+ + E + T S LL
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH---F 117
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
DVA + YL Q +H DL N+L+ E +A + DFGL ++ ++
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYV 166
Query: 889 KGSIG-----YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K ++G ++A E S + N DV+SYG+LL E+V+
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 44/228 (19%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRN 769
F + IG GSFG+VY +VAVK + + ++ I E L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 770 LVKILTACSGVDYQGNDFKA----LVFEFMHNRS---LEEWLHPITREDETEEAPRSLNL 822
+ +Y+G K LV E+ + LE P+ E E A +
Sbjct: 83 TI---------EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPL---QEVEIAAITHGA 130
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
LQ L+YLH ++H D+K N+LL E + DFG A S +
Sbjct: 131 LQ----------GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA-----SKSS 172
Query: 883 TSSIFAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKP 927
++ F G+ ++APE L E +G DV+S GI +EL RK P
Sbjct: 173 PANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 54/272 (19%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLVKIL 774
+GAG+ GSV K T++A KV +H GA K + E + R +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
A + + + EFM SL+ I ++ P + +L + I + V
Sbjct: 70 GA-----FLNENNICMCMEFMDCGSLDR----IYKK----GGPIPVEILGK--IAVAVVE 114
Query: 835 ALSYL---HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
L+YL H I+H D+KPSN+L++ + DFG++ L S A T F G+
Sbjct: 115 GLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT---FV-GT 165
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN-----------LH- 939
Y++PE G + ++ DV+S GI ++EL K P D + L
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA-FSNIDDDGQDDPMGILDLLQQ 224
Query: 940 -------NFAKTALPDHVVDIVDSTLLSDDED 964
+ P+ + D VD+ LL D +
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ C L +LH IV+ DLK N+LLD + + DFG+ L A+T + G
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--G 158
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ YIAPE LG + + + D +S+G+LL E++ + P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 24/185 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKI 773
+IG GSFG V + AVKV +L +AE N L KN++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV-- 59
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
G+ Y + L F + E + H + RE E PR+ R +VA
Sbjct: 60 -----GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLE-PRA-----RF-YAAEVA 106
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
A+ YLH I++ DLKP N+LLD + + DFGL + +T+S F G+
Sbjct: 107 SAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC-GTPE 161
Query: 894 YIAPE 898
Y+APE
Sbjct: 162 YLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSF----IAECNTLKNIR 766
D + N I G++G VY+ + IVA+K L + F + E N L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQ 62
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHN--RSLEEWLHPITREDETEEAPRSLNLLQ 824
H N+V + G + D +V E++ + +SL E + + E + L+
Sbjct: 63 HPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEVK------CLML 113
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL--PLSHAQ 882
+L G+ +LH + I+H DLK SN+LL+ I + DFGLA PL
Sbjct: 114 QLLSGVA------HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-Y 163
Query: 883 TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRK 925
T + ++ Y APE LG E S D++S G + EL+T+K
Sbjct: 164 TQLVV---TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 14/122 (11%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++A AL +LH I++ DLKP N+LLDEE + DFGL+ + H + + F G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-G 160
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-----MNLHNFAKTA 945
++ Y+APE + + D +S+G+L+ E++T P F+G M + AK
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLG 216
Query: 946 LP 947
+P
Sbjct: 217 MP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK- 889
++ C L LH + V+ DLKP N+LLD+ + D GLA +P + SI +
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----EGESIRGRV 162
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G++GY+APE +++ D + G L+ E++ + P
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKV-------FNLLHHGAFKSFIAECNTLKNIRHRNL 770
LIG G G VY VA+K LL K F+ E ++ H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGI 64
Query: 771 VKILTACSGVD--------YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
V + + CS D +G K+L+ SL + L E L+
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA------EKTSVGAFLS- 117
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF------- 875
I + + Y+H ++H DLKP N+LL + D+G A F
Sbjct: 118 -----IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 876 -LPLSHAQTSSIFAK--------GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--- 923
L + + + ++ G+ Y+APE LG S + D+Y+ G++L +++T
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 924 ---RKKPTDIMFE 933
RKK I +
Sbjct: 230 PYRRKKGRKISYR 242
|
Length = 932 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 59/244 (24%), Positives = 92/244 (37%), Gaps = 54/244 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHH-GAFKSFIAECNTLKNIRHRNLVKILT 775
+G G +G V+ + IVA+K LL + + E + L + LVK+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 776 ACSGVDY--------QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
A +Y G DF+ L+ + L ED R
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVL--------SEDHA-----------RFY 106
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT-FLPLSHAQTSSI 886
+ ++ A+ LH + +H DLKP N L+D + DFGL+ + +++
Sbjct: 107 M-AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----- 157
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD------MNLHN 940
GS Y+APE G D +S G +L E + P F G NL
Sbjct: 158 -VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGSTPNETWENLKY 212
Query: 941 FAKT 944
+ +T
Sbjct: 213 WKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNI 765
+ A + + +G GS+ +VYKGI +VA+KV ++ G + I E + LK +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
+H N+V + + VFE+MH L +++ + P L+
Sbjct: 61 KHANIVLLHDII-----HTKETLTFVFEYMHT-DLAQYM---------IQHPGGLHPYNV 105
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF-LPLSHAQTS 884
+ L+Y+H I+H DLKP N+L I+++G+ LA F L + + S
Sbjct: 106 RLFMFQLLRGLAYIHGQ---HILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPS 157
Query: 885 SIFAKG--SIGYIAPEYGLGS-EVSINGDVYSYGILLLELV 922
++ ++ Y P+ LG+ + S D++ G + +E++
Sbjct: 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 37/112 (33%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ AL++LH + I++ DLK NVLLD + + D+G+ L T+S F G
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFC-G 158
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG-DMNLHNF 941
+ YIAPE G E + D ++ G+L+ E++ + P DI+ + DMN ++
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+++ AL+YLH + I++ DLK NVLLD E + D+G+ L T+S F G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-G 158
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ YIAPE G + + D ++ G+L+ E++ + P DI+ D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/185 (32%), Positives = 89/185 (48%), Gaps = 24/185 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKI 773
+IG GSFG V AVKV +L+ K +AE N L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ +Q + V +F++ L + H + RE E PR+ R ++A
Sbjct: 62 HYS-----FQTTEKLYFVLDFVNGGEL--FFH-LQRERSFPE-PRA-----RFYAA-EIA 106
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL YLH IV+ DLKP N+LLD + + DFGL ++ + T++ F G+
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC-GTPE 161
Query: 894 YIAPE 898
Y+APE
Sbjct: 162 YLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 22/131 (16%)
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL--PLSHAQT 883
L + A+SY+H + I+H D+K N+ L + + +GDFG++ L S A+T
Sbjct: 104 LWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
G+ Y++PE G + + D+++ G +L EL+T K+ F
Sbjct: 161 ----VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR-------------TFDA 203
Query: 944 TALPDHVVDIV 954
T + VV IV
Sbjct: 204 TNPLNLVVKIV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G++ +VYKG +VA+K L H GA + I E + LK+++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
LVFE++ ++ L+++L ++ S+N+ + L+
Sbjct: 74 -----HTEKSLTLVFEYL-DKDLKQYL---------DDCGNSINMHNVKLFLFQLLRGLN 118
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
Y H + ++H DLKP N+L++E + DFGLA + S+ ++ Y P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPP 173
Query: 898 EYGLGS-EVSINGDVYSYGILLLELVT 923
+ LGS + S D++ G + E+ T
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVK 772
L+G G+FG VY +D G+ + A +V F+ K A EC LKN++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
C + + + E+M S+++ L E+ + +L+
Sbjct: 69 YY-GC--LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-------- 117
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-PLSHAQTSSIFAKGS 891
+SYLH + IVH D+K +N+L D +GDFG + L + + T G+
Sbjct: 118 --GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+++PE G DV+S G ++E++T K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 719 IGAGSFGSVYKGILDEGKT--IVAVKVF-NLLHHGAFK-SFIAECNTLKNIRHRNLVKIL 774
+G+G+FG+V KG+ K+ VAVK+ N + A K + E N ++ + + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHP---ITREDETEEAPRSLNLLQRLDIGID 831
C + LV E L ++L +T ++ TE L+ ++ +G
Sbjct: 63 GICEAESWM------LVMELAELGPLNKFLQKNKHVTEKNITE-------LVHQVSMG-- 107
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH----AQTSSIF 887
+ YL + VH DL NVLL + A + DFGL+ L A+T
Sbjct: 108 ----MKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH--- 157
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920
K + + APE + S DV+S+G+L+ E
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA------FKSFIAECNTLKNIR 766
+ +G G+F S Y+ + T++AVK + + + ++ E + +
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H ++++ G + + F V E+M S+ L E + LL+
Sbjct: 62 HPHIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-- 114
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSS 885
LSYLH + I+H D+K +N+L+D + DFG A L
Sbjct: 115 --------GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 886 IFAK--GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ G+I ++APE G + + DV+S G +++E+ T K P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 64/253 (25%), Positives = 99/253 (39%), Gaps = 35/253 (13%)
Query: 687 ENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYK----GI-LDEGKTIVAV 741
E + P P F D T +G G FG V GI D+ K V V
Sbjct: 1 EYELPEDPRWEFSR----------DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTV 50
Query: 742 KVFNLLHHGAFKSF---IAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHN 797
V L K ++E +K I +H+N++ +L AC+ Q +V E+
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASK 105
Query: 798 RSLEEWLH---PITRE---DETEEAPRSLNLLQRLDIGIDVACALSYL-HHDCQPPIVHC 850
+L E+L P E D + + VA + YL C +H
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHR 161
Query: 851 DLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGD 910
DL NVL+ E + + DFGLA + + + + ++APE + D
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221
Query: 911 VYSYGILLLELVT 923
V+S+G+L+ E+ T
Sbjct: 222 VWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
++ C L +LH I++ DLK NVLLD++ + DFG+ + S+
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ YIAPE G + + + D +S+G+LL E++ + P F G+
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ L +LH + I++ DLK NVLLD E + DFG+ + T+S F G
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC-G 158
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ YIAPE D ++ G+LL E++ + P FEGD
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 36/140 (25%), Positives = 57/140 (40%), Gaps = 18/140 (12%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+V + LH I+H D+KP N+L+D+ + DFG LS + G
Sbjct: 105 EVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG------LSRNGLENKKFVG 155
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFE----GDMNLHNF 941
+ Y+APE LG D +S G ++ E + P D +F+ +N
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215
Query: 942 AKTALPDHVVDIVDSTLLSD 961
K VD+++ L D
Sbjct: 216 VKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 75/278 (26%), Positives = 120/278 (43%), Gaps = 63/278 (22%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRN 769
F+ IG GSFG+VY +VA+K + + ++ I E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 770 LVKILTACSGVDYQGNDFKA----LVFEFMHNRS---LEEWLHPITREDETEEAPRSLNL 822
+ Y+G + LV E+ + LE P+ E E A +
Sbjct: 77 TI---------QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL---QEVEIAAVTHGA 124
Query: 823 LQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
LQ L+YLH H+ ++H D+K N+LL E + +GDFG A+ + ++
Sbjct: 125 LQ----------GLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170
Query: 882 QTSSIFAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKPTDIMFEGDMN- 937
+ + ++APE L E +G DV+S GI +EL RK P +F +MN
Sbjct: 171 FVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNA 219
Query: 938 ---LHNFAKTALP--------DHVVDIVDSTLLSDDED 964
L++ A+ P ++ + VDS L +D
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 719 IGAGSFGSVYKGI---LDEGK----TIVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 766
+G G FG V LD+ K T VAVK +L A I+E +K I +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITRE---DETEEAPRSL 820
H+N++ +L AC+ Q +V E+ +L E+L P E + T+ L
Sbjct: 83 HKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ + VA + YL +H DL NVL+ E+ + + DFGLA +
Sbjct: 138 SFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + + ++APE + DV+S+G+LL E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T IG G+ G+VY I VA+K NL + I E ++ +H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
L + Y D +V E++ SL + + T DE + A LQ
Sbjct: 81 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ-------- 126
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLPLSHAQTSSIFAKGS 891
AL +LH + ++H D+K N+LL + + DFG A P +++ + G+
Sbjct: 127 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GT 178
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE D++S GI+ +E+V + P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ C L LH + IV+ DLKP N+LLD+ + D GLA +P + G
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---G 163
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++GY+APE + + D + G L+ E++ K P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 42/237 (17%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH 767
N + F IG+G++G VYK + A+KV L F E +K+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+V + Y D + EF SL++ H E++ A S LQ
Sbjct: 66 SNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ--- 117
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
L YLH + +H D+K +N+LL + + DFG++ AQ ++
Sbjct: 118 -------GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATI 160
Query: 888 AK-----GSIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPTDIMFE 933
AK G+ ++APE + V G D+++ GI +EL + P MF+
Sbjct: 161 AKRKSFIGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 34/236 (14%)
Query: 693 SPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF 752
+ IN PN SY+ N+IG GSFG VY+ I + VA+K +L +
Sbjct: 58 NDINRSPNKSYK----------LGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQY 105
Query: 753 KSFIAECNTLKNIRHRNLVKI----LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 808
K+ E +KN+ H N++ + T C + + N F +V EF+ +++ +++
Sbjct: 106 KN--RELLIMKNLNHINIIFLKDYYYTECFKKN-EKNIFLNVVMEFI-PQTVHKYMKHYA 161
Query: 809 REDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHV 867
R + +L L + AL+Y+H I H DLKP N+L+D +
Sbjct: 162 RNNH------ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212
Query: 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELV 922
DFG A L S I ++ Y APE LG+ + + D++S G ++ E++
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 69/252 (27%), Positives = 106/252 (42%), Gaps = 27/252 (10%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
++G GSFG V L E + AVKV +L + + E L R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C +Q D V EF++ L + R DE R+ ++
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFY------AAEITS 107
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL +LH I++ DLK NVLLD E + DFG+ + + +T+S F G+ Y
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFC-GTPDY 162
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFEGDMNLHNFAKTALPDH 949
IAPE + D ++ G+LL E++ P D +FE +N T L
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQD 222
Query: 950 VVDIVDSTLLSD 961
VDI+ + + +
Sbjct: 223 AVDILKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 46/236 (19%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS----FIAEC----------NTL 762
+G G++G V K IVA+K ++ + + C +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 763 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
I+H N++ ++ Y DF LV + M + L++ + R E++ L +
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT---FLPLS 879
L L+ LH + +H DL P+N+ ++ + I + DFGLA + P S
Sbjct: 129 LN----------GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 880 HAQTSSIFAKG---------SIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRK 925
+ + ++ Y APE +G+E D++S G + EL+T K
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
++ C L +LH I++ DLK NV+LD + + DFG+ + S+
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC- 157
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ YIAPE G + + + D +S+G+LL E++ + P F GD
Sbjct: 158 -GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T IG G+ G+V+ I VA+K NL + I E +K +++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
L + + D +V E++ SL + + T DE + A LQ
Sbjct: 81 FLDS-----FLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQ-------- 126
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
AL +LH + ++H D+K NVLL + + DFG + ++ S++ G+
Sbjct: 127 --ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTP 179
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE D++S GI+ +E+V + P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 719 IGAGSFGSV----YKGILDEGKTIVAVKVFNLLHHGAFKSFIAE--CNTLKNIRHRNLVK 772
+G GS+G V ++ +GK V +K NL + + AE L ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ G D +V F L L +E + + P + Q ++ + +
Sbjct: 64 YRESWEGEDGL----LYIVMGFCEGGDLYHKL----KEQKGKLLPEN----QVVEWFVQI 111
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A AL YLH + I+H DLK NV L I VGD G+A L S++ G+
Sbjct: 112 AMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GTP 166
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
Y++PE + DV++ G + E+ T K
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKILT 775
IG G FG V G ++ G T V V L + + F+ E ++++H NL++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
C+ V LV EF L+ +L + + P +L QR+ ++A
Sbjct: 63 QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRM--ACEIALG 112
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS---- 891
L +LH + +H DL N LL ++ +GD+G LSH + +
Sbjct: 113 LLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG------LSHNKYKEDYYVTPDQLW 163
Query: 892 --IGYIAPEYGLGSEVSIN---------GDVYSYGILLLEL 921
+ +IAPE L EV N +V+S G+ + EL
Sbjct: 164 VPLRWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ C L L + IV+ DLKP N+LLD+ + D GLA +P + G
Sbjct: 110 ELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---G 163
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++GY+APE + + + D + G L+ E++ + P
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 53/231 (22%)
Query: 719 IGAGSFGSVYKGILDEGKT--IVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVK- 772
IG G++G VYK GK A+K F + G +S E L+ ++H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 773 ---ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT--REDETEEAPRSL--NLL-Q 824
L Y L+F++ + + I R+ + P S+ +LL Q
Sbjct: 68 VEVFLEHADKSVY-------LLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATF----- 875
L+ + YLH + ++H DLKP+N+L+ E + +GD GLA
Sbjct: 117 ILN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVT 923
PL+ + +I Y APE LG+ +I D+++ G + EL+T
Sbjct: 167 KPLADLDPVVV----TIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 65/279 (23%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-----FKSFIAECNTLKNIRH 767
FT IG GSFG+VY +VA+K + + G ++ I E L+ I+H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 768 RNLVKILTACSGVDYQGNDFKA----LVFEFMHNRS---LEEWLHPITREDETEEAPRSL 820
N ++Y+G + LV E+ + LE P+ E E A +
Sbjct: 85 PN---------SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPL---QEVEIAAITH 132
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
LQ L+YLH ++H D+K N+LL E + DFG A S
Sbjct: 133 GALQ----------GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA-----SI 174
Query: 881 AQTSSIFAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKPTDIMFEGDMN 937
A ++ F G+ ++APE L E +G DV+S GI +EL RK P +F +MN
Sbjct: 175 ASPANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMN 228
Query: 938 ----LHNFAKTALP--------DHVVDIVDSTLLSDDED 964
L++ A+ P D+ + VDS L +D
Sbjct: 229 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHR 768
D + IG G++G VYK +VA+K L G + + E + L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 769 N-LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+V++L + G LVFE++ + L++++ R P ++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGR---PLPAKTIKSFM 116
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGL--ATFLPLSHAQTS 884
+ A + H ++H DLKP N+L+D++ + + D GL A +P+ + T
Sbjct: 117 YQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTH 170
Query: 885 SIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
I ++ Y APE LGS S D++S G + E+ RK+P +F GD L
Sbjct: 171 EIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQP---LFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 52/242 (21%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
D F +IG G+FG V+ + + A+KV ++ AE + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+VK+ + +Q + LV E+M L L I ++ EE R
Sbjct: 61 PWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY------- 106
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTS- 884
++ AL +H + +H D+KP N+L+D + H+ DFGL + + +
Sbjct: 107 -IAELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYY 160
Query: 885 --------------------------SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
+ G+ YIAPE G+ + D +S G++L
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
Query: 919 LE 920
E
Sbjct: 221 YE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+ IG GS G V VAVK +L + E +++ +H N+V+
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ ++ Y D +V EF+ +L + + TR +E + A L +L+
Sbjct: 81 MYSS-----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLK-------- 126
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK--- 889
ALS+LH ++H D+K ++LL + + DFG AQ S +
Sbjct: 127 --ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPRRKS 174
Query: 890 --GSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE YG +EV D++S GI+++E+V + P
Sbjct: 175 LVGTPYWMAPEVISRLPYG--TEV----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 29/246 (11%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVK 772
L+G G+FG VY D G+ + +V F+ K A EC LKN+RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 773 ILTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
G + K +F E+M S+++ L E + +LQ
Sbjct: 69 YY----GCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ------- 117
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA-KG 890
+SYLH + IVH D+K +N+L D +GDFG + + + I + G
Sbjct: 118 ---GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA----KTAL 946
+ +++PE G DV+S ++E++T K P +E + A K L
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPML 230
Query: 947 PDHVVD 952
PD V D
Sbjct: 231 PDGVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 48/230 (20%)
Query: 719 IGAGSFGSV---YKGILDEGKTIVAV-KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG+G+ G V Y +LD I + + F H K E +K + H+N++ +L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNHKNIISLL 82
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID--- 831
F +SLEE+ + E +A NL Q + + +D
Sbjct: 83 NV-----------------FTPQKSLEEF-QDVYLVMELMDA----NLCQVIQMELDHER 120
Query: 832 -------VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
+ C + +LH I+H DLKPSN+++ + + DFGLA S T
Sbjct: 121 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
+ + Y APE LG N D++S G ++ E+V K I+F G
Sbjct: 178 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 54/220 (24%), Positives = 84/220 (38%), Gaps = 33/220 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKILT 775
IG G FG V G G + V V L F+ E + + H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 776 AC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C + Y LV EF L+ +L ++LQR+ +VA
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLR---SNRGMVAQMAQKDVLQRM--ACEVAS 111
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS--- 891
L +LH Q +H DL N L ++ +GD+GLA L K
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAV 164
Query: 892 -IGYIAPEYG-------LGSEVSINGDVYSYGILLLELVT 923
+ ++APE L + + +++S G+ + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 54/245 (22%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSV---YKGILDEGKTIVAVKV----FNLLHHG--AFK 753
YQNL IG+G+ G V Y + + VA+K F + H A++
Sbjct: 18 YQNL----------KPIGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYR 64
Query: 754 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFM-HNRSLEEWLHPITRE 810
+ +K + H+N++ +L + +F+ LV E M N L + +
Sbjct: 65 ELV----LMKLVNHKNIIGLLNVFTP-QKSLEEFQDVYLVMELMDAN------LCQVIQM 113
Query: 811 DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870
D E L L Q L C + +LH I+H DLKPSN+++ + + DF
Sbjct: 114 DLDHERMSYL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 162
Query: 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930
GLA S T + + Y APE LG N D++S G ++ E++ +
Sbjct: 163 GLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----V 215
Query: 931 MFEGD 935
+F G
Sbjct: 216 LFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G++ +V+KG + +VA+K L H GA + I E + LK+++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI---DVAC 834
+ LVFE++ ++ L++++ N++ ++ I +
Sbjct: 74 -----HTDKSLTLVFEYL-DKDLKQYMDDCG------------NIMSMHNVKIFLYQILR 115
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
L+Y H + ++H DLKP N+L++E + DFGLA + S+ ++ Y
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWY 170
Query: 895 IAPEYGLG-SEVSINGDVYSYGILLLELVT 923
P+ LG SE S D++ G + E+ +
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 769
D F + +GAG+ G V K I+A K+ +L A ++ I E L H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+ G Y + ++ E M SL++ L R E S+ +L+
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLR----- 114
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
L+YL Q I+H D+KPSN+L++ + DFG++ L S A +
Sbjct: 115 -----GLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 163
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y++PE G+ S+ D++S G+ L+EL + P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G+FG VYK E + A KV + ++ E L H +VK+L A
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC---- 834
+ + ++ EF +++ + E R L Q I V C
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAVDAIML---------ELDRGLTEPQ-----IQVICRQML 120
Query: 835 -ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLPLSHAQTSSIFAKGSI 892
AL YLH I+H DLK NVLL + + DFG+ A + + S I G+
Sbjct: 121 EALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTP 174
Query: 893 GYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKP 927
++APE + + D++S GI L+E+ + P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 23/220 (10%)
Query: 719 IGAGSFGSVYKGI---LDEGKTIVAVKV-FNLLHHGA----FKSFIAECNTLKNI-RHRN 769
+G G FG V +D+ K V V +L A ++E +K I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITRE---DETEEAPRSLNLL 823
++ +L AC+ Q LV E+ +L E+L P + D + L
Sbjct: 80 IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
+ VA + YL +H DL NVL+ E+ + + DFGLA +
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + + ++APE + DV+S+G+LL E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 700 NISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAEC 759
I + + + +D + IG G++G V+K + + + AVK+ + +H + AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEY 65
Query: 760 NTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR 818
N LK + H N+VK D + D LV E + S+ + + + E E P
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLP 877
+L +G L +LH + +H D+K +N+LL E + DFG+ A
Sbjct: 126 IAYILHEALMG------LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 878 LSHAQTSSIFAKGSIGYIAPEY-----GLGSEVSINGDVYSYGILLLEL 921
+ +S+ G+ ++APE L S DV+S GI +EL
Sbjct: 177 TRLRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 23/138 (16%)
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK---GSIGYI 895
+HH ++H D+K +N+LL + +GDFG F + A S + G+ Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG---FSKMYAATVSDDVGRTFCGTPYYV 212
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA-------LPD 948
APE S D++S G+LL EL+T K+P F+G+ N+ LP
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE-NMEEVMHKTLAGRYDPLPP 267
Query: 949 HV----VDIVDSTLLSDD 962
+ +IV + LLS D
Sbjct: 268 SISPEMQEIV-TALLSSD 284
|
Length = 496 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 719 IGAGSFGSVYKGILD-EGKTI-VAVKVFNLLHHGAFKSFIAECNTLKNIRHR----NLVK 772
+G+G+FG V KG+ K I VA+KV L + KS E I H+ +V+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS--LNLLQRLDIGI 830
++ C + LV E L ++L + +E S + L+ ++ +G
Sbjct: 60 MIGVCEA------EALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMG- 107
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-QTSSIFAK 889
+ YL VH DL NVLL + A + DFGL+ L + + K
Sbjct: 108 -----MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920
+ + APE + S DV+SYGI + E
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G+G++G VYK + AVK+ L F E +K +H N+V +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y + + E+ SL++ H E + A LQ L+Y
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ----------GLAY 121
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE 898
LH + +H D+K +N+LL + + DFG+A + + A+ S G+ ++APE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPE 176
Query: 899 YGLGSEVSING------DVYSYGILLLELVTRKKPTDIMFE 933
+ V NG D+++ GI +EL + P MF+
Sbjct: 177 V---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+++ AL++LH + I++ DLK NVLLD E + D+G+ + T+S F G
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFC-G 158
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931
+ YIAPE G + + D ++ G+L+ E++ + P DI+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T IG G+ G+VY I VA+K NL + I E ++ ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
L + Y D +V E++ SL + + T DE + A LQ LD
Sbjct: 81 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALD----- 129
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
+LH + ++H D+K N+LL + + DFG + ++ S++ G+
Sbjct: 130 -----FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTP 179
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE D++S GI+ +E+V + P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 60/185 (32%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKI 773
+IG GSFG V + AVKV +L K ++E N L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+Q D V ++++ L + + RE E PR+ R ++A
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLE-PRA-----RF-YAAEIA 106
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL YLH IV+ DLKP N+LLD + + DFGL + H T+S F G+
Sbjct: 107 SALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC-GTPE 161
Query: 894 YIAPE 898
Y+APE
Sbjct: 162 YLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 86/290 (29%)
Query: 707 YNATDGFTSANL-----IGAGSFGSVYK----GILDEGKTI-VAVKVFNLLHHGAFK-SF 755
YN F NL +GAG+FG V + G+ E + VAVK+ H + +
Sbjct: 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREAL 88
Query: 756 IAECNTLKNI-RHRNLVKILTACSGVDYQG------------------------------ 784
++E L ++ +H+N+V +L AC+ + G
Sbjct: 89 MSELKILSHLGQHKNIVNLLGACT---HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM 145
Query: 785 ---------NDFKALVFEFMHNRS--------LEEWLH--PIT---------REDETEEA 816
+D+K + E + RS + ++ P++ +++E E
Sbjct: 146 ALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED 205
Query: 817 PRSLNLLQRLDIGIDVACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875
L+L L VA + +L +C +H D+ NVLL + +A + DFGLA
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 876 LPLSHAQTSSIFAKGS----IGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
+ S+ KG+ + ++APE ++ DV+SYGILL E+
Sbjct: 262 I----MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 9e-07
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 38/170 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSF----IAECNTLKNIRHRNLVKIL 774
+G G+FG VYK + +VA+K +L H F + E LK ++H N+V ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 775 -TACSGVDYQGNDFKA--LVFEFM--------HNRSLEEWLHPITREDETEEAPRSLNLL 823
A D + +V +M N S+ + E+ +L
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-----------KLTESQIKCYML 122
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
Q L+ ++YLH + I+H D+K +N+L+D + I + DFGLA
Sbjct: 123 QLLE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRN 769
+G G+F ++YKG+L D +V +L H +F + + + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
LVK+ C + +V E++ L+ +LH +++L +LD+
Sbjct: 63 LVKLYGVCVRDENI------MVEEYVKFGPLDVFLH---------REKNNVSLHWKLDVA 107
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------MIAHVGDFGLA-TFLPLSHA 881
+A AL YL +VH ++ N+L+ + D G+ T L
Sbjct: 108 KQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 882 QTSSIFAKGSIGYIAPEY--GLGSEVSINGDVYSYGILLLELVTRKK 926
I +IAPE + ++I D +S+G LLE+ + +
Sbjct: 165 VER-------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 718 LIGAGSFGSVYKGILD---EGKTIVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRNL 770
++G G FG + +G L + + VA+ L G + F+AE TL H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V++ GV +GN +V E+M N +L+ +L R+ E + L Q + +
Sbjct: 69 VRL----EGVITRGNTM-MIVTEYMSNGALDSFL----RKHEGQ-----LVAGQLMGMLP 114
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA-- 888
+A + YL + VH L VL++ +++ + F L ++ +I+
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTM 166
Query: 889 --KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 923
K + + APE Y S S DV+S+GI++ E+++
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 719 IGAGSFGSVYK----GI---LDEGKTIVAVKVFNLLHHGAFKSF---IAECNTLKNI-RH 767
+G G FG V + GI + VAVK+ L + K I+E +K I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITRE---DETEEAPRSLN 821
+N++ +L C+ Q +V E+ +L E+L P + D T+ L+
Sbjct: 78 KNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 822 LLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ VA + YL C +H DL NVL+ E+ + + DFGLA +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + + ++APE + DV+S+GIL+ E+ T
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
++G G++G VY + +A+K + E ++HRN+V+ L +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
S N F + E + SL L ++ P N + + L
Sbjct: 75 SE-----NGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YLH + IVH D+K NVL++ + + DFG + L + T + G++ Y+A
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMA 177
Query: 897 PEY------GLGSEVSINGDVYSYGILLLELVTRKKP 927
PE G G+ D++S G ++E+ T K P
Sbjct: 178 PEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG GS G V + +VAVK +L + E +++ +H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y D +V EF+ +L + + TR +E + A L +L+ ALS
Sbjct: 86 ---YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLK----------ALSV 131
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE 898
LH ++H D+K ++LL + + DFG + + S+ G+ ++APE
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPE 186
Query: 899 ----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
G EV D++S GI+++E+V + P
Sbjct: 187 LISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLV 771
F L+G G++G VYKG + + A+KV ++ + E N LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 772 KILTACSGVDYQGNDFKA-LVFEFMHNRSL-------------EEWLHPITREDETEEAP 817
A + G D + LV EF S+ EEW+ I RE
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE------- 119
Query: 818 RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
+ LS+LH Q ++H D+K NVLL E + DFG++ L
Sbjct: 120 --------------ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSE-----VSINGDVYSYGILLLELVTRKKP 927
+ + ++ G+ ++APE E D++S GI +E+ P
Sbjct: 163 RTVGRRNTFI--GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-06
Identities = 66/224 (29%), Positives = 89/224 (39%), Gaps = 47/224 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVK 772
IG G++G V E VA+K AF + I TL+ I H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 773 ILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
I F +V+E M LH I R +T L +L G
Sbjct: 69 IKDIMPPP--HREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRG- 120
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
L Y+H ++H DLKPSN+LL+ + DFGL A+T+S KG
Sbjct: 121 -----LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL--------ARTTS--EKG 162
Query: 891 SI--------GYIAPEYGLG-SEVSINGDVYSYGILLLELVTRK 925
Y APE L SE + DV+S G + EL+ RK
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVK 772
+G FG VYKG L E VA+K G + F E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSLNLLQRL 826
+L GV + +++F + + L E+L + D+ + +L +
Sbjct: 73 LL----GVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 827 DIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
I +A + +L HH +VH DL NVL+ +++ + D GL F + A
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADYY 180
Query: 885 SIFAKG--SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ I +++PE + + SI+ D++SYG++L E+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 719 IGAGSFGSVY--KGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG GSFG +Y K D ++ + ++ E L ++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWL---HPITREDETEEAPRSLNLLQRLDIGIDVA 833
+Q N +V E+ L + + + ++ Q L + ++
Sbjct: 68 -----FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED-----------QILSWFVQIS 111
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
L ++H I+H D+K N+ L + M+A +GDFG+A L S A +
Sbjct: 112 LGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTCV 163
Query: 893 G---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
G Y++PE + D++S G +L EL T K P FEG+ NLH
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 769
D F + +GAG+ G V+K I+A K+ +L A ++ I E L H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+ G Y + ++ E M SL++ L R E +L ++ I
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIA 111
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
V L+YL + I+H D+KPSN+L++ + DFG++ L S A +
Sbjct: 112 --VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 163
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y++PE G+ S+ D++S G+ L+E+ + P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 770
D F +GAG+ G V K + I+A K+ +L A ++ I IR
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI--------IRE--- 49
Query: 771 VKILTACS--------GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
+K+L C+ G Y + ++ E M SL++ L R E N+
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE--------NI 100
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
L + I I V L+YL + I+H D+KPSN+L++ + DFG++ L S A
Sbjct: 101 LGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ F G+ Y++PE G+ ++ D++S G+ L+E+ + P
Sbjct: 157 S---FV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG GS G V VAVK +L + E +++ H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y D +V EF+ +L + + TR +E + A L++L+ ALSY
Sbjct: 88 ---YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLR----------ALSY 133
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-----GSIG 893
LH+ ++H D+K ++LL + + DFG AQ S K G+
Sbjct: 134 LHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC-------AQVSKEVPKRKSLVGTPY 183
Query: 894 YIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE G+EV D++S GI+++E++ + P
Sbjct: 184 WMAPEVISRLPYGTEV----DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 42/113 (37%), Positives = 58/113 (51%), Gaps = 17/113 (15%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT-FLPLSHAQTSSIFAK 889
++ AL +LH + IV+ D+K N+LLD E + DFGL+ FL +T S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167
Query: 890 GSIGYIAPEY-----GLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937
G+I Y+APE G G V D +S GIL+ EL+T P EG+ N
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP--FTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 44/134 (32%), Positives = 61/134 (45%), Gaps = 24/134 (17%)
Query: 801 EEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860
E + H RE TE R+ I ++ AL +LH Q I++ D+K N+LLD
Sbjct: 91 ELFTHLYQREHFTESE-------VRVYIA-EIVLALDHLH---QLGIIYRDIKLENILLD 139
Query: 861 EEMIAHVGDFGLAT-FLPLSHAQTSSIFAKGSIGYIAPEY------GLGSEVSINGDVYS 913
E + DFGL+ FL + S G+I Y+APE G V D +S
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFC--GTIEYMAPEVIRGGSGGHDKAV----DWWS 193
Query: 914 YGILLLELVTRKKP 927
G+L EL+T P
Sbjct: 194 LGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 775
IG GSFG V + + + I A+K H +AE L + +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-- 58
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+Q + LV F++ L L R D + + LL CA
Sbjct: 59 ---KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL----------CA 105
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L LH + +++ DLKP N+LLD + + DFGL L + ++ F G+ Y+
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFC-GTPEYL 160
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
APE LG + D ++ G+LL E++T P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T IG G+ G+VY + VA++ NL + I E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
L + Y D +V E++ SL + + T DE + A LQ
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ-------- 127
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
AL +LH + ++H D+K N+LL + + DFG + ++ S++ G+
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTP 180
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE D++S GI+ +E++ + P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 42/192 (21%)
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
LK + H+N++ +L F +SLEE+ + E +A N
Sbjct: 74 LKCVNHKNIISLLNV-----------------FTPQKSLEEF-QDVYLVMELMDA----N 111
Query: 822 LLQRLDIGID----------VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871
L Q + + +D + C + +LH I+H DLKPSN+++ + + DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168
Query: 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931
LA + T + + Y APE LG N D++S G ++ ELV ++
Sbjct: 169 LARTACTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVI 221
Query: 932 FEGDMNLHNFAK 943
F+G ++ + K
Sbjct: 222 FQGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 52/236 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI------AECNTLKNIRHRN--- 769
+G+G++G+V + VA+K + F+S + E LK+++H N
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAKRAYRELRLLKHMKHENVIG 78
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
L+ + T +D + +DF LV FM L + + ++ E + Q L
Sbjct: 79 LLDVFTPDLSLD-RFHDF-YLVMPFMGTD-----LGKLMKHEKLSEDRIQFLVYQMLK-- 129
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
L Y+H I+H DLKP N+ ++E+ + DFGLA QT S
Sbjct: 130 -----GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMT- 173
Query: 890 GSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPTDIMFEGDMNL 938
GY+ + EV +N D++S G ++ E++T K +F+G +L
Sbjct: 174 ---GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 48/230 (20%)
Query: 719 IGAGSFGSV---YKGILDEGKTIVAV-KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG+G+ G V Y IL+ I + + F H K E +K + H+N++ +L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNHKNIIGLL 89
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID--- 831
F +SLEE+ + E +A NL Q + + +D
Sbjct: 90 NV-----------------FTPQKSLEEF-QDVYIVMELMDA----NLCQVIQMELDHER 127
Query: 832 -------VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
+ C + +LH I+H DLKPSN+++ + + DFGLA S T
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
+ + Y APE LG N D++S G ++ E++ ++F G
Sbjct: 185 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 27/237 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
++G GSFG V L + A+KV +L + E L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C +Q D V E+++ L + I R + +E PRS R +V
Sbjct: 62 HCC----FQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDE-PRS-----RF-YAAEVTL 107
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL +LH + +++ DLK N+LLD E + DFG+ + + T++ F G+ Y
Sbjct: 108 ALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFC-GTPDY 162
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951
IAPE E + D ++ G+L+ E++ + P FE D N + ++ L D V+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPP----FEAD-NEDDLFESILHDDVL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 24/82 (29%), Positives = 45/82 (54%)
Query: 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNI 251
L G IP L + + LS N++ G+IP + G + +L L ++ N +G+IP S+ +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 252 SSITVFDAGINQIQGVIPLDIG 273
+S+ + + N + G +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-----SFIAECNTLKNIRHRNLVKI 773
+G GSFG+VY + +KV + G E L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ + D ++ E+ R L+ L + +T + +L +G+
Sbjct: 68 HAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH-- 120
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
Y+H Q I+H DLK N+ L ++ +GDFG++ L + ++ F G+
Sbjct: 121 ----YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFT-GTPY 170
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLEL 921
Y++PE D++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
L+G G+FG V A+K+ ++ + E LKN RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ +Q D V E+++ L + H ++RE E G ++
Sbjct: 62 YS-----FQTKDRLCFVMEYVNGGEL--FFH-LSRERVFSEDRTRF-------YGAEIVS 106
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL YLH IV+ DLK N++LD++ + DFGL ++ A T F G+ Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEY 161
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+APE ++ D + G+++ E++ + P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 7e-06
Identities = 22/60 (36%), Positives = 28/60 (46%)
Query: 548 KLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
L+ L + N L + L L VLDLS NNL+ PE G L L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 47/251 (18%)
Query: 697 SFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI 756
S +I L + F ++G G++G VYKG + + A+KV ++ +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 757 AECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMHNRSL-------------E 801
E N LK HRN+ A G+D + LV EF S+ E
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 802 EWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861
+W+ I RE + L++LH ++H D+K NVLL E
Sbjct: 121 DWIAYICRE---------------------ILRGLAHLHAH---KVIHRDIKGQNVLLTE 156
Query: 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEY-----GLGSEVSINGDVYSYGI 916
+ DFG++ L + + ++ G+ ++APE + D++S GI
Sbjct: 157 NAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214
Query: 917 LLLELVTRKKP 927
+E+ P
Sbjct: 215 TAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 42/129 (32%), Positives = 60/129 (46%), Gaps = 30/129 (23%)
Query: 831 DVAC--------ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
D AC AL +LH I++ DLKP N+LLD + + DFGL +
Sbjct: 100 DTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT 155
Query: 883 TSSIFAKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVT---------RKKPTD 929
+ F G+I Y+APE G G V D +S G L+ +++T RKK D
Sbjct: 156 VTHTFC-GTIEYMAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPPFTAENRKKTID 210
Query: 930 IMFEGDMNL 938
+ +G +NL
Sbjct: 211 KILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/231 (24%), Positives = 105/231 (45%), Gaps = 26/231 (11%)
Query: 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECN 760
+ ++L + TD + IG G++G VYK + ++ AVK+ + + + AE N
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYN 70
Query: 761 TLKNI-RHRNLVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETEE 815
L+++ H N+VK G+ Y+ + LV E + S+ E + + + +
Sbjct: 71 ILQSLPNHPNVVKFY----GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 816 APRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875
+L +G L +LH++ I+H D+K +N+LL E + DFG++
Sbjct: 127 EAMISYILYGALLG------LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEY-----GLGSEVSINGDVYSYGILLLEL 921
L + + ++ + G+ ++APE DV+S GI +EL
Sbjct: 178 LTSTRLRRNT--SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ C + +LH IV+ D+KP NVLLD++ + D GLA L T G+
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGT 157
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
GY+APE S D ++ G + E+V + P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G++G+V+K E IVA+K L G S + E LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 64
Query: 777 CSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
D +D K LVFE+ ++ L+++ + + E + L +
Sbjct: 65 ---YDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK---------G 111
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
L++ H ++H DLKP N+L+++ + DFGLA
Sbjct: 112 LAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 26/226 (11%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-KSFIAECNTLKNI 765
++ + + + IG G++G V VA+K + H F + + E L+
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 766 RHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+H N++ IL ++ F +V E M E L+ + + L
Sbjct: 61 KHENIIGILDIIRPPSFE--SFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLY 113
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
Q L L Y+H ++H DLKPSN+LL+ + DFGLA H T
Sbjct: 114 QILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 884 SSIFAKGSIG---YIAPEYGLGS-EVSINGDVYSYGILLLELVTRK 925
F + Y APE L S + D++S G +L E+++ +
Sbjct: 164 G--FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 7/120 (5%)
Query: 816 APRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875
A R++ + L I V A+ YLH + I+H D+K N+ ++ +GDFG A F
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF 231
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
P+ G+I APE D++S GI+L E+ T D +FE D
Sbjct: 232 -PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK--GS 891
C L Y+H ++H DLKP N+L++ + + DFGLA + + + + +
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 892 IGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934
Y APE L + DV+S G +L EL+ RK +F+G
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 27/245 (11%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVK 772
L+G G+FG VY D G+ + +V F+ K A EC LKN+ H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
D ++ E M S+++ L E + +L+
Sbjct: 69 YYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-------- 117
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-PLSHAQTSSIFAKGS 891
+SYLH + IVH D+K +N+L D +GDFG + L + + T G+
Sbjct: 118 --GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA----KTALP 947
+++PE G D++S G ++E++T K P FE + A LP
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPVLP 231
Query: 948 DHVVD 952
HV D
Sbjct: 232 PHVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ L ++H+ +V+ DLKP+N+LLDE + D GLA S G
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----G 157
Query: 891 SIGYIAPE-YGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ GY+APE G+ + D +S G +L +L+ P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIR 766
F ++G GSFG V + A+K+ ++ + + E L
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
+ L +C +Q D V E+++ L ++ I + + +E Q +
Sbjct: 59 KPPFLTQLHSC----FQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEP-------QAV 104
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
+++ L +LH + I++ DLK NV+LD E + DFG+ + T+
Sbjct: 105 FYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRT 160
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
F G+ YIAPE + D ++YG+LL E++ + P D
Sbjct: 161 FC-GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 31/188 (16%)
Query: 718 LIGAGSFGSVYKGILDEGKT---IVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLV 771
L+G G+FG V IL K A+K+ ++ + E L+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TEEAPRSLNLLQRLDIGI 830
+ + +Q +D V E+ + L + H ++RE +E+ R G
Sbjct: 59 ALKYS-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFSEDRARFY--------GA 102
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ AL YLH C +V+ DLK N++LD++ + DFGL +S T F G
Sbjct: 103 EIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-G 157
Query: 891 SIGYIAPE 898
+ Y+APE
Sbjct: 158 TPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFKSFI-AECNTLKNIRHRNLVKILT 775
+IG GS+G V I VA+K + ++ H + + I E L+ +RH ++V+I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 776 ACSGVDYQGNDFKAL--VFEFMHNRSLEEWLHPITR--EDETEEAPRSLNLLQRLDIGID 831
+ +FK + VFE M E LH + + +D T E + L Q L
Sbjct: 67 IM--LPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFF-LYQLLR---- 114
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
AL Y+H + H DLKP N+L + + + DFGLA + ++IF
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDY 166
Query: 892 IG---YIAPEY--GLGSEVSINGDVYSYGILLLELVTRK 925
+ Y APE S+ + D++S G + E++T K
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNL 770
F ++G G++G V K E K IVA+K F + + ++ + E L+ ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V++ A ++ LVFE++ LE LL+ + G+
Sbjct: 63 VELKEA-----FRRRGKLYLVFEYVEKNMLE--------------------LLEEMPNGV 97
Query: 831 DVACALSYLH------HDCQP-PIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
SY++ H C IVH D+KP N+L+ + + DFG A L
Sbjct: 98 PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
+ + + Y +PE LG+ D++S G +L EL
Sbjct: 158 YTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G++GSVYK + +A+K L L F I E + L H+ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 778 SGVDYQGNDF-KALVF---EFMHNRSLEEWLHPITRE-DETEEAPRSLNLLQRLDIGIDV 832
VD+ G F + V+ E+M SL++ + TE P ++L+R I V
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSLDK----LYAGGVATEGIPE--DVLRR--ITYAV 111
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
L +L + I+H D+KP+NVL++ + DFG++ L S A+T+ G
Sbjct: 112 VKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQ 165
Query: 893 GYIAPEY--GLGSE----VSINGDVYSYGILLLELVTRKKP 927
Y+APE G ++ DV+S G+ +LE+ + P
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 39/124 (31%), Positives = 48/124 (38%), Gaps = 42/124 (33%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAK 889
V AL YLH IV+ DLKP N+LL E H+ DF L+ + S K
Sbjct: 112 VLLALEYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 890 GSIG---------------------------YIAPE----YGLGSEVSINGDVYSYGILL 918
GS YIAPE G GS V D ++ GILL
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILL 222
Query: 919 LELV 922
E++
Sbjct: 223 YEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 65/262 (24%), Positives = 105/262 (40%), Gaps = 39/262 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
D F +IG G+FG V + + I A+K+ N +L F E N L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+ + + A +Q ++ LV ++ L L ED E + R
Sbjct: 61 QWITTLHYA-----FQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPED------MARFY 107
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
I ++ A+ +H Q VH D+KP NVLLD + DFG + SS+
Sbjct: 108 IA-EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV- 162
Query: 888 AKGSIGYIAPEY------GLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
A G+ YI+PE G+G + D +S G+ + E++ + P F + + +
Sbjct: 163 AVGTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP----FYAESLVETY 217
Query: 942 AKT-------ALPDHVVDIVDS 956
K P H+ D+ +
Sbjct: 218 GKIMNHEERFQFPSHITDVSEE 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 719 IGAGSFGSVYKGILDE-------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 771
+G G+F ++KGI E KT V +KV + H +SF + + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
C D +V E++ SL+ +L ++ +N+ +L++
Sbjct: 63 LNYGVCVCGDES-----IMVQEYVKFGSLDTYL---------KKNKNLINISWKLEVAKQ 108
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS-SIFAKG 890
+A AL +L + H ++ NVLL E G+ F+ LS S ++ K
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGN---PPFIKLSDPGISITVLPKE 162
Query: 891 ----SIGYIAPEYGLGSE-VSINGDVYSYGILLLEL 921
I ++ PE + +S+ D +S+G L E+
Sbjct: 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 16/93 (17%)
Query: 835 ALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL +LH +D IV+ DLKP N+LLD + DFGL+ L+ +T++ F G+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTE 161
Query: 894 YIAPEY-----GLGSEVSINGDVYSYGILLLEL 921
Y+APE G V D +S G+L+ E+
Sbjct: 162 YLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ AL +LH + I++ D+K N+LLD + DFGL+ + + F G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-G 168
Query: 891 SIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
+I Y+AP+ G + + D +S G+L+ EL+T P + +G+ N
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 8e-05
Identities = 62/222 (27%), Positives = 90/222 (40%), Gaps = 33/222 (14%)
Query: 419 IPPAIGELQNLRELRLQENRFLGNIPPSIGNL--------KLFNLQLSYNFLQGSIP--- 467
+ A+ +L+EL L N G IP + +L L L LS N L
Sbjct: 43 LASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVL 101
Query: 468 SSLGQSETLTIIDLSNNNLTGTIPP----QLLGLSSLLIVLELSRNQLTG----PIPNEV 519
SL +S +L + L+NN L L L L L L RN+L G + +
Sbjct: 102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIK----LELLQMQGNFLQ----GPIPSSLSSLR 571
++L+ LN+ N + R L +K LE+L + N L + +L+SL+
Sbjct: 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221
Query: 572 GLSVLDLSQNNLSGKI-----PEFLVGFQLLEYLNLSNNDFE 608
L VL+L NNL+ L L L+LS ND
Sbjct: 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG GS G V VAVK+ +L + E +++ +H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS-- 86
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y + ++ EF+ +L + + R +E + A ++LQ AL Y
Sbjct: 87 ---YLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQ----------ALCY 132
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-----GSIG 893
LH ++H D+K ++LL + + DFG AQ S K G+
Sbjct: 133 LHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKSLVGTPY 182
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE + D++S GI+++E+V + P
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G GS G V+ + + VAVK L + K + E ++ + H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEW----LHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ + E ++E+ L + + E L + Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
L Y+H ++H DLKP+NV ++ E+++ +GDFGLA + H ++G +
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD-PHYSHKGYLSEGLVT 181
Query: 894 --YIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950
Y +P L + + D+++ G + E++T K +F G H + L
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGA---HELEQMQL---- 230
Query: 951 VDIVDSTLLSDDEDL 965
I++S + +ED
Sbjct: 231 --ILESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 718 LIGAGSFGSVYKGILDEGKTI---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLV 771
L+G G+FG V IL K A+K+ ++ + E L+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TEEAPRSLNLLQRLDIGI 830
+ A +Q +D V E+ + L + H ++RE TEE R G
Sbjct: 59 ALKYA-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFTEERARFY--------GA 102
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ AL YLH +V+ D+K N++LD++ + DFGL +S T F G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-G 157
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ Y+APE ++ D + G+++ E++ + P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 262 NQ-IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-Y 319
NQ ++G IP DI L++LQ ++ N + G IPP++ + ++LEV ++ N G +P
Sbjct: 427 NQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 320 LEKLQRLSHFVITRNSLGSGE 340
L +L L + NSL SG
Sbjct: 486 LGQLTSLRILNLNGNSL-SGR 505
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 13/116 (11%)
Query: 813 TEEAPRSLNLLQRLDIGIDVACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871
+++ L L L VA + +L +C VH DL NVLL + I + DFG
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFG 282
Query: 872 LATFLPLSHAQTSSIFAKGS----IGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
LA + S+ +KGS + ++APE + + DV+SYGILL E+ +
Sbjct: 283 LARDI----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
V L YLH + IV+ DLK N+LLD E + DFGL + +S F G+
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFC-GT 164
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
++APE + + D + G+L+ E++ + P F GD
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++A L +LH I++ DLK NV+LD E + DFG+ + +T+ F G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFC-G 163
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
+ YIAPE + D +++G+LL E++ + P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 8/80 (10%)
Query: 848 VHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS----IGYIAPEYGLGS 903
VH DL NVL+ E + + DFGLA + + S+ +KGS + ++APE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI----MRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 904 EVSINGDVYSYGILLLELVT 923
+ DV+S+GILL E+ T
Sbjct: 317 LYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 35/249 (14%)
Query: 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 771
G+T + GS G V+ V +K+ G + + E L+N+ H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120
Query: 772 KIL-TACSGVDYQGNDFKALVFEFMHNRS-LEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++ T SG +V H S L +L T+ R L + Q L I
Sbjct: 121 RMKDTLVSG------AITCMVLP--HYSSDLYTYL---TKRS------RPLPIDQALIIE 163
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
+ L YLH I+H D+K N+ +++ +GD G A F P+ + +
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PV--VAPAFLGLA 217
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949
G++ APE + + D++S GI+L E++ P+ I + + K+ H
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAY--PSTIFEDPPSTPEEYVKSC-HSH 274
Query: 950 VVDIVDSTL 958
++ I+ STL
Sbjct: 275 LLKII-STL 282
|
Length = 357 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 53/234 (22%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 719 IGAGSFGSVY----KGIL----------DEGKTIVAVKVFNL-LHHGAFKSFIAECNTLK 763
+G G FG V+ +G+ D +VAVK+ + A F+ E +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR----S 819
+++ N++++L C +D ++ E+M N L ++L RE E+ S
Sbjct: 73 RLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLS--QREIESTFTHANNIPS 125
Query: 820 LNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLS 879
+++ L + + +A + YL VH DL N L+ + DFG++ L
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 880 HAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPTDIM 931
A I ++A E L + + DV+++G+ L E+ T +++P ++
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 28/82 (34%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE-YGLGSEV 905
+V+ DLKP+N+LLDE + D GLA S G+ GY+APE G
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAY 173
Query: 906 SINGDVYSYGILLLELVTRKKP 927
+ D +S G +L +L+ P
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 157 NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL 216
NL + LS+N L L ++ +S NNLT P +F L S+ L LS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 13/113 (11%)
Query: 814 EEAPRSLNLLQRLDIGIDVACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872
EE +L+ L VA +S+L +C +H DL N+LL I + DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 873 ATFLPLSHAQTSSIFAKGS----IGYIAPEYGLGSEVSINGDVYSYGILLLEL 921
A + S+ KG+ + ++APE + DV+SYGILL E+
Sbjct: 261 ARDI----RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 768 RNLVKILTACS--GVDYQGNDFKA-----LVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
R+ + L AC G+ +DFK+ L+ E+ L + + ++ E P
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLP--- 165
Query: 821 NLLQRLDIGI---DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
Q ++G+ + AL +H ++H DLK +N+ L I +GDFG +
Sbjct: 166 --FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 878 LSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
S + +S F G+ Y+APE S D++S G++L EL+T +P
Sbjct: 221 DSVSLDVASSFC-GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 769
F +G GSFG V A+K +L + E + L + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 770 LVKILTACSGVDYQGNDFKALVFEFM-------HNRSLEEWLHPITREDETEEAPRSLNL 822
+V ++ CS +Q + + EF+ H R + + + + E
Sbjct: 80 IVNMM--CS---FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------- 126
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
+ A YLH I++ DLKP N+LLD + V DFG A +P +
Sbjct: 127 ---------LVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DR 171
Query: 883 TSSIFAKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 927
T ++ G+ Y+APE G G V D ++ G+LL E + P
Sbjct: 172 TFTLC--GTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 64/244 (26%)
Query: 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV----FNLLHHGAFKSFIAEC 759
+ ++ + + + + +G+G++GSV + VAVK F + H K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYREL 67
Query: 760 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW-------------LHP 806
LK+++H N++ +L F RSLEE+ L+
Sbjct: 68 RLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVTHLMGADLNN 110
Query: 807 ITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866
I + + + + Q L L Y+H I+H DLKPSN+ ++E+
Sbjct: 111 IVKCQKLTDDHVQFLIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 160
Query: 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLL 919
+ DFGLA H GY+A + E+ +N D++S G ++
Sbjct: 161 ILDFGLA-----RHT------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 920 ELVT 923
EL+T
Sbjct: 210 ELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 74/244 (30%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI------AECNTLKNIRHRNLVK 772
+G+G++GSV + VAVK + F+S I E LK+++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSR----PFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 773 ILT----ACSGVDYQ---------GNDFKALV-FEFMHNRSLEEWLHPITREDETEEAPR 818
+L A S ++ G D +V + + + ++ ++ + R
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR--------- 129
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
L Y+H I+H DLKPSNV ++E+ + DFGLA
Sbjct: 130 ----------------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---- 166
Query: 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPTDIM 931
Q GY+A + E+ +N D++S G ++ EL+ K +
Sbjct: 167 ---QADDEMT----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----AL 215
Query: 932 FEGD 935
F G+
Sbjct: 216 FPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 9/168 (5%)
Query: 370 LPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNL 429
LP+ + N L+ L L N + ++P L L++ N++S +PP I L L
Sbjct: 155 LPSPLRNL-PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 430 RELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGT 489
EL L N + + S+ NLK + N +P S+G L +DLSNN + +
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI--S 268
Query: 490 IPPQLLGLSSLLIVLELSRNQLTGPIP--NEVGNLKNLEMLNVFENKL 535
L L++ L L+LS N L+ +P + L L + + K
Sbjct: 269 SISSLGSLTN-LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315
|
Length = 394 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 22/223 (9%)
Query: 718 LIGAGSFGSVYKGILDEGKTI---VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
LIG G FG VY+ I K+ NL + ++ + E NI + + +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74
Query: 775 TACSGVDYQGNDFKALVFEFMHNRS-----LEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+D+ G F R L E L T+E ++ L++ +I
Sbjct: 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK--NIM 132
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-----PLSHAQTS 884
D+ L Y+H + I H D+KP N+++D ++ D+G+A+ + +++
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+G++ Y + G+ V+ GD+ S G +L+ K P
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G++G VYK +GK + + G S E L+ ++H N++ A
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----ALQ 64
Query: 779 GVDYQGNDFKA-LVFEFMHNRSLEEW----LHPITREDETE-EAPRSL--NLLQRLDIGI 830
V +D K L+F++ + + W H ++ ++ + PRS+ +LL ++ GI
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATFL-----PLSHA 881
YLH + ++H DLKP+N+L+ E + D G A PL+
Sbjct: 122 ------HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRK 925
+ + Y APE LG+ D+++ G + EL+T +
Sbjct: 173 DPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++A L +LH I++ DLK NV+LD E + DFG+ + T+ F G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFC-G 163
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ YIAPE + D +++G+LL E++ + P FEG+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKT--IVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 772
L+G G+FG V ++ E T A+K+ ++ + E L+N RH
Sbjct: 2 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH----P 55
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TEEAPRSLNLLQRLDIGID 831
LTA +Q +D V E+ + L + H ++RE +E+ R G +
Sbjct: 56 FLTALK-YSFQTHDRLCFVMEYANGGEL--FFH-LSRERVFSEDRARFY--------GAE 103
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ AL YLH + +V+ DLK N++LD++ + DFGL + T F G+
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GT 159
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
Y+APE ++ D + G+++ E++ + P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 35/218 (16%)
Query: 422 AIGELQNLRELRLQENRFLGNIPPSIGNL----KLFNLQLSYN--------FLQGSIPSS 469
+ + L+EL L +N + + +L L L+L+ N L +
Sbjct: 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGL---SSLLIVLELSRNQLTGP----IPNEVGNL 522
L + L N L G L + L L L+ N + + +
Sbjct: 136 ---PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 523 KNLEMLNVFENKLRGE----IPRTLGSCIKLELLQMQGNFLQGPI-----PSSLSSLRGL 573
NLE+L++ N L E + TL S LE+L + N L + LS L
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISL 252
Query: 574 SVLDLSQNNL----SGKIPEFLVGFQLLEYLNLSNNDF 607
L LS N++ + + E L + L L+L N F
Sbjct: 253 LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 848 VHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI 907
+H DL N+LL E + + DFGLA + A+ + ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 908 NGDVYSYGILLLELVT 923
DV+S+G+LL E+ +
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-04
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRN 769
F I G+FG VY G + AVKV ++++ AE + L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V + + Q + LV E++ ++ LH DE ++ +
Sbjct: 66 IVHLYYS-----LQSANNVYLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYIS----- 111
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
+VA AL YLH + I+H DLKP N+L+ E + DFGL+
Sbjct: 112 -EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 9e-04
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 26/225 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
+ F +IG G+FG V L + A+K+ N +L F E + L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+ + + A +Q + LV ++ L L ED E L + +
Sbjct: 61 QWITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMV- 112
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
I ID L Y+H D +KP N+L+D + DFG L + S
Sbjct: 113 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSV 162
Query: 888 AKGSIGYIAPEYGLGSE-----VSINGDVYSYGILLLELVTRKKP 927
A G+ YI+PE E D +S G+ + E++ + P
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
Q LD + + AL ++H I+H D+K N+ L ++ +GDFG+A L +
Sbjct: 102 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NS 153
Query: 884 SSIFAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
+ A+ IG Y++PE + D+++ G +L E+ T K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 817 PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876
R L L Q + + A+ Y+H + I+H D+K NVL++ +GDFG A F
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 877 PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920
S + G++ APE G + + D++S G+++ E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 6/83 (7%)
Query: 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFL--PLSHAQTSSIFAKGSIGYIAPEYGLGSE 904
++H D+K N+ L + +GDFG A L P ++A T G+ Y+ PE
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV----GTPYYVPPEIWENMP 176
Query: 905 VSINGDVYSYGILLLELVTRKKP 927
+ D++S G +L EL T K P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 21/111 (18%)
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L Y+H +VH DLKPSN+L++E + DFGLA T + + Y
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTR---YYR 172
Query: 896 APEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
APE L EV D++S G + E++ K +F G +++ F
Sbjct: 173 APEIMLTWQKYDVEV----DIWSAGCIFAEMLEGKP----LFPGKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 67/324 (20%), Positives = 126/324 (38%), Gaps = 67/324 (20%)
Query: 666 GLIGLSLALSFLIICLVRKRKENQNPSSPINSFPNI--SYQNLYNATDGFTSANLIGAGS 723
GL L L L F + ++N+N + +N + I + L + + +IG G+
Sbjct: 2 GLNSLVLDLDFPAL------RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGA 55
Query: 724 FGSVYKGILDEGKTIVAVKV---FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780
FG V + + A+K+ F ++ F E + + +V++ A
Sbjct: 56 FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA---- 111
Query: 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI--------GIDV 832
+Q + + +V E+M L +NL+ D+ +V
Sbjct: 112 -FQDDKYLYMVMEYMPGGDL-------------------VNLMSNYDVPEKWAKFYTAEV 151
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
AL +H ++H D+KP N+LLD+ + DFG + +T + ++
Sbjct: 152 VLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVRCDTAV 204
Query: 893 G---YIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945
G YI+PE G D +S G+ L E++ P F D + ++K
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP----FYADSLVGTYSK-- 258
Query: 946 LPDHVVDIVDSTLLSDDEDLAVHG 969
++D +S +D +++ H
Sbjct: 259 ----IMDHKNSLNFPEDVEISKHA 278
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 24/76 (31%), Positives = 39/76 (51%)
Query: 848 VHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI 907
+H DL N+LL E + + DFGLA + A+ + ++APE +I
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 908 NGDVYSYGILLLELVT 923
DV+S+G+LL E+ +
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 738 IVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH 796
+VAVK+ + A F+ E L ++ N++++L C VD D ++ E+M
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC--VD---EDPLCMITEYME 102
Query: 797 NRSLEEWLHPITREDETEEA----PRSLNLL-----QRLDIGIDVACALSYLHHDCQPPI 847
N L ++L +D+ E P + L L + + +A + YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159
Query: 848 VHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI 907
VH DL N L+ E + + DFG++ L A I ++A E L + +
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 908 NGDVYSYGILLLEL--VTRKKP 927
DV+++G+ L E+ + +++P
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS 906
IV+ DLKP N+LLD++ + DFG A + T + G+ YIAPE L
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 907 INGDVYSYGILLLELVTRKKP 927
D ++ GI + E++ P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ--TSSIFAKGSIG 893
L YLH I+H D+KP N+L++ + + DFGLA ++ T + +
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ---Y 169
Query: 894 YIAPEYGLGSEVSING-DVYSYGILLLELVTRKKPTDIMFE 933
Y APE +GS + D++S G + EL+ R+ I+F+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 51/215 (23%), Positives = 82/215 (38%), Gaps = 33/215 (15%)
Query: 726 SVYKGILDEGKTIVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKILTACSGVDY 782
S+YKGI + V ++ F H G E L+ I N++KI G
Sbjct: 35 SIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY----GFII 88
Query: 783 QGND---FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYL 839
D +L+ E+ L E L + + L+ +LD+ ID L L
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVL----------DKEKDLSFKTKLDMAIDCCKGLYNL 138
Query: 840 HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL---PLSHAQTSSIFAKGSIGYIA 896
+ P + +L + L+ E + GL L P + F+ + I
Sbjct: 139 YKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIF 196
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931
EY +I D+YS G++L E+ T K P + +
Sbjct: 197 SEY------TIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 24/60 (40%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L +DLSNN LT GL +L VL+LS N LT P L +L L++ N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLK-VLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 28/162 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV--KILT 775
L+ G VY L +K+ GA E L+ + + L K+L
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLA 60
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ + L+ E++ +L+E ++ ++ DI +A
Sbjct: 61 SGESDGWS-----YLLMEWIEGETLDE-----------------VSEEEKEDIAEQLAEL 98
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
L+ LH + H DL P N+L+D+ I + D+ A + P
Sbjct: 99 LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 722 GSFGSVYKGIL--DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSG 779
GS G V+ DE + V VK K+ E + LK I HR ++ ++ A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR- 156
Query: 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS--LNLLQRLDIGIDVACALS 837
+K+ V M P + D RS L L Q + I + AL+
Sbjct: 157 -------WKSTVCMVM----------PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALA 199
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
YLH I+H D+K N+ LDE A +GDFG A L G++ +P
Sbjct: 200 YLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256
Query: 898 EYGLGSEVSINGDVYSYGILLLELVTRKKP 927
E D++S G++L E+ +
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G++G VYK +GK + + G S E L+ ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL----Q 64
Query: 779 GVDYQGNDFKA-LVFEFMHNRSLEEW----LHPITREDETE-EAPRSL--NLLQRLDIGI 830
V D K L+F++ + + W H ++ ++ + PR + +LL ++ GI
Sbjct: 65 KVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATFL-----PLSHA 881
YLH + ++H DLKP+N+L+ E + D G A PL+
Sbjct: 122 ------HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRK 925
+ + Y APE LG+ D+++ G + EL+T +
Sbjct: 173 DPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1033 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.82 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.71 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.64 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-117 Score=1141.50 Aligned_cols=914 Identities=32% Similarity=0.529 Sum_probs=776.4
Q ss_pred ChhhHHHHHHHHHhcccCCCCCCCCCCCCCCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCC
Q 042075 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNN 118 (1033)
Q Consensus 39 ~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n 118 (1033)
.++|+.||++||+++ .+|.+.+.+|+...+||.|.||+|++. ++|+.|||++++++|.+++.+..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~-~~~~~~~~~w~~~~~~c~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhC-CCCcccCCCCCCCCCCCcCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 458999999999999 478888999988889999999999863 58999999999999999999999999999999999
Q ss_pred CccccCCcccc-ccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCC
Q 042075 119 SFHHEIPSEFD-RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP 197 (1033)
Q Consensus 119 ~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 197 (1033)
+++|.+|..+. .+++|++|+|++|.++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence 99999998765 999999999999999998886 568999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcccccccc
Q 042075 198 PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277 (1033)
Q Consensus 198 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~ 277 (1033)
..|+++++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|..+.++++|++|++++|.+.+.+|..+. .++
T Consensus 182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~ 260 (968)
T PLN00113 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLK 260 (968)
T ss_pred hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998887654 799
Q ss_pred ccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc-hhhhccccceeeecCcCCCCCCccchhhcccccccCc
Q 042075 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRL 356 (1033)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L 356 (1033)
+|++|+|++|++++.+|..+.++++|+.|++++|++++.+|. +.++++|+.|++++|.+..... ..+.++++|
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~------~~~~~l~~L 334 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP------VALTSLPRL 334 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC------hhHhcCCCC
Confidence 999999999999999999999999999999999999987764 7899999999999999875332 235678899
Q ss_pred ceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccc
Q 042075 357 KWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQE 436 (1033)
Q Consensus 357 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 436 (1033)
+.++++.|.+.+.+|..+..+ ++|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|.++..+++|+.|+|++
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 999999999999999988776 7999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCc
Q 042075 437 NRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515 (1033)
Q Consensus 437 N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~ 515 (1033)
|++++.+|..+..++ |+.|++++|.+++.+|..+..+++|++|+|++|++.+.+|..+ ...++ +.|++++|++++.+
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~ 491 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAV 491 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccCCcc
Confidence 999999999999998 9999999999999999999999999999999999998888765 34555 99999999999999
Q ss_pred CCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCccccccc
Q 042075 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQ 595 (1033)
Q Consensus 516 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 595 (1033)
|..+.++++|+.|+|++|++++.+|..++++++|++|+|++|.++|.+|..+..+++|+.|||++|+++|.+|..+..++
T Consensus 492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 571 (968)
T PLN00113 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571 (968)
T ss_pred ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccceeecCCCcCcccCCCcccccccccccccccccccCCccccCCCCCCCCcccccchhhhhhhHHHHHHHHHHHHHHHH
Q 042075 596 LLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLALKLALAIISGLIGLSLALS 675 (1033)
Q Consensus 596 ~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 675 (1033)
+|++|++++|+++|.+|..+++.++...++.||+.+||++.....+.|.... +...+.. . + ++++++++++++++
T Consensus 572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--~~~~~~~-~-~-~~~~~~~~~~~~~~ 646 (968)
T PLN00113 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--KTPSWWF-Y-I-TCTLGAFLVLALVA 646 (968)
T ss_pred ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--ccceeee-e-h-hHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999987655445564321 1111111 1 1 11122222222222
Q ss_pred HhhheeeeccccCCCCCC-CCCC----------CCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEe
Q 042075 676 FLIICLVRKRKENQNPSS-PINS----------FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF 744 (1033)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~ 744 (1033)
+++++++++++....... .... ...++++++ ...|+..++||+|+||.||+|++..+++.||||++
T Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~ 723 (968)
T PLN00113 647 FGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723 (968)
T ss_pred HHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence 222222222211111100 0000 112233333 45677889999999999999999888999999998
Q ss_pred eccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHH
Q 042075 745 NLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQ 824 (1033)
Q Consensus 745 ~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~ 824 (1033)
+..... ...|++++++++|||||+++++|. .++..++||||+++|+|.++++ .++|.+
T Consensus 724 ~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~-------------~l~~~~ 781 (968)
T PLN00113 724 NDVNSI----PSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLR-------------NLSWER 781 (968)
T ss_pred cCCccc----cHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHh-------------cCCHHH
Confidence 643321 235688999999999999999964 3347899999999999999994 278999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCC
Q 042075 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE 904 (1033)
Q Consensus 825 ~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 904 (1033)
+.+|+.|+|+|++|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....+|+.|+|||++.+..
T Consensus 782 ~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCC
Confidence 99999999999999997767799999999999999999888875 6655432211 1124789999999999999
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHH
Q 042075 905 VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE 983 (1033)
Q Consensus 905 ~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1033)
++.++|||||||++|||+||+.||+..........+|.+...... ...++|+.+.... ....+
T Consensus 855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~ 918 (968)
T PLN00113 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----------------SVNQN 918 (968)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC----------------CccHH
Confidence 999999999999999999999999765555555566655443332 3334444332211 11223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 984 CLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 984 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
+..++.+++.+||+.||++||||+||+++|+++.+..
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 4567889999999999999999999999999987643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-61 Score=621.87 Aligned_cols=513 Identities=35% Similarity=0.541 Sum_probs=478.1
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCcccc-CCCCCcEEEcccccccCCCCCCcccccccceee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS-SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 186 (1033)
.+++.|+|++|+++|.+|..|..+++|++|+|++|+++|.+|..+. ++++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4789999999999999999999999999999999999999998876 999999999999999998886 5689999999
Q ss_pred ecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccC
Q 042075 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266 (1033)
Q Consensus 187 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 266 (1033)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|+.|+|++|.+.+
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCc-chhhhccccceeeecCcCCCCCCccch
Q 042075 267 VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLN 345 (1033)
Q Consensus 267 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~l~~N~l~~~~~~~~~ 345 (1033)
.+|..+. .+++|++|+|++|++++.+|..+.++++|++|++++|++++..| .+..+++|++|++++|.+.....
T Consensus 227 ~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p---- 301 (968)
T PLN00113 227 EIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP---- 301 (968)
T ss_pred cCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC----
Confidence 9998765 79999999999999999999999999999999999999998766 58999999999999998875322
Q ss_pred hhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhc
Q 042075 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE 425 (1033)
Q Consensus 346 ~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 425 (1033)
..+.++++|+.++++.|.+.+.+|..+..+ ++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|.++..
T Consensus 302 --~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 302 --ELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred --hhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 235678899999999999999999888776 79999999999999999999999999999999999999999999999
Q ss_pred CCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhh
Q 042075 426 LQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVL 504 (1033)
Q Consensus 426 l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L 504 (1033)
+++|+.|++++|++.+.+|..+..++ |+.|+|++|++++.+|..|..+++|+.|++++|++++.+|..+..+.++ +.|
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L 457 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QML 457 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cEE
Confidence 99999999999999999999999997 9999999999999999999999999999999999999999888888887 999
Q ss_pred hccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCcccccccccc
Q 042075 505 ELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584 (1033)
Q Consensus 505 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 584 (1033)
++++|++.+.+|..+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|..++++++|+.|+|++|+++
T Consensus 458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 999999999998876 4689999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccceeecCCCcCcccCCCc-cccccccccccccccccc
Q 042075 585 GKIPEFLVGFQLLEYLNLSNNDFEGMVPTE-GVFRNASITSVLGNLKLC 632 (1033)
Q Consensus 585 ~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc 632 (1033)
|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|...+
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 999999999999999999999999999975 334455566666676443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=424.13 Aligned_cols=289 Identities=38% Similarity=0.679 Sum_probs=242.7
Q ss_pred CCCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeee
Q 042075 697 SFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776 (1033)
Q Consensus 697 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 776 (1033)
....|++.++..||++|...++||+|+||.||+|...+ ++.||||++.........+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999984 48999998875443214569999999999999999999999
Q ss_pred eccccccCCCceeEEEEcccCCchhhhcccCCCCcccccccc-ccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR-SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 777 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
|.+.+ +..++|||||++|+|.++++. ... .++|.+|++||.++|+||+|||+.+.|.||||||||+
T Consensus 140 C~e~~----~~~~LVYEym~nGsL~d~L~~---------~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 140 CLEGG----EHRLLVYEYMPNGSLEDHLHG---------KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred EecCC----ceEEEEEEccCCCCHHHHhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 95433 258999999999999999974 112 7899999999999999999999998889999999999
Q ss_pred CeEecCCCcEEEeecccceecCC-CCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc-c
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPL-SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF-E 933 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~-~ 933 (1033)
|||+|+++++||+|||+|+.... ........ .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred HeeECCCCCEEccCccCcccCCccccceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 99999999999999999976544 22211110 59999999999999999999999999999999999999987554 3
Q ss_pred CCccHHHHHhhhCCc-chhhhcccccCC-CchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 934 GDMNLHNFAKTALPD-HVVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~-~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+...+..|+...+.+ .+.+++|+.+.. .+.. .++..++..++.+|++.+|++||+|.||++
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-----------------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD-----------------EKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCCh-----------------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 344577777766666 588999998752 2211 134567999999999999999999999999
Q ss_pred HHHHHHH
Q 042075 1012 QLQSIKN 1018 (1033)
Q Consensus 1012 ~L~~i~~ 1018 (1033)
+|+.+..
T Consensus 348 ~L~~~~~ 354 (361)
T KOG1187|consen 348 ELEGILS 354 (361)
T ss_pred HHHhhcc
Confidence 9966644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=379.95 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=205.7
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC-ceeEE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND-FKALV 791 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~~lv 791 (1033)
+..+.||+|..|+||+++++.+++.+|+|++... .....+++.+|++++++.+||+||.+||.| ..++ ...++
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~isI~ 156 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEISIC 156 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceEEee
Confidence 4567999999999999999999999999999543 344567899999999999999999999995 3444 59999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||++|+|+++++. .+.+++...-+|+.++++||.|||+ + +||||||||+|||++..|++|||||
T Consensus 157 mEYMDgGSLd~~~k~----------~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR----------VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred hhhcCCCCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccc
Confidence 999999999999953 3679999999999999999999996 5 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|.++.+.... ....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.............
T Consensus 224 GVS~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---- 295 (364)
T KOG0581|consen 224 GVSGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---- 295 (364)
T ss_pred cccHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh----
Confidence 9999875552 22355999999999999999999999999999999999999998654222222222221111
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKI-ECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+ +.+. + .+. .+.+++.+++..|+++||.+||+++|++++
T Consensus 296 ----~----~ppP-------------~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 ----D----EPPP-------------R--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----c----CCCC-------------C--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1110 0 011 356789999999999999999999999886
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=399.79 Aligned_cols=259 Identities=32% Similarity=0.458 Sum_probs=209.6
Q ss_pred CccceecccCceeEEEEEeCCCCeE-EEEEEeeccCch--hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTI-VAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+.+.||+|+||+||+|.++ |+. ||||++...... ..++|.+|+.+|++++|||||+++|+|... ....++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~i 117 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLCI 117 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceEE
Confidence 44566999999999999998 444 999999754322 256899999999999999999999998532 226899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-cEeccCCCCCeEecCCC-cEEEe
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP-IVHCDLKPSNVLLDEEM-IAHVG 868 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDlkp~NIll~~~~-~~kL~ 868 (1033)
||||+++|+|.++++.. ....+++..+++|+.|||+||+|||++ + ||||||||+|||++.++ ++||+
T Consensus 118 VtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 99999999999999641 457899999999999999999999999 7 99999999999999997 99999
Q ss_pred ecccceecCCCCccccccccccccccccccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL--GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|||+++...... .......||..|||||++. ...|+.|+||||||+++|||+||+.||......+ .....+.
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~~~~v~~--- 260 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-VASAVVV--- 260 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh---
Confidence 999998765432 2222245999999999999 5699999999999999999999999996432211 0110100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 1022 (1033)
...|+..+.++++.+..+|.+||..||++||++.|++..|+.+......
T Consensus 261 ---------------------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 ---------------------------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---------------------------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1112222333677899999999999999999999999999999886653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=379.70 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=204.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-------hhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.+.|.+.+.+|+|+||.|-+|..+.+++.||||++++... .......+|+++|++++|||||+++++ +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence 3568889999999999999999999999999999974211 122346799999999999999999999 5
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
+..+..|+||||++||+|.+.+ ...+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~v----------v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKV----------VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSND 312 (475)
T ss_pred ecCCceEEEEEEecCccHHHHH----------HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccC
Confidence 6666889999999999999999 3556677778889999999999999999 99999999999999755
Q ss_pred ---CcEEEeecccceecCCCCccccccccccccccccccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 863 ---MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV---SINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 863 ---~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
..+||+|||+|+......... ..+||+.|.|||++.+..+ ..++||||+|||+|-+++|.+||........
T Consensus 313 ~e~~llKItDFGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred CcceEEEecccchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 689999999999876444433 3569999999999887543 3478999999999999999999975443332
Q ss_pred cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 937 NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
-..+..+..+.... ....+..++..+++.+||..||++|||++|+++.
T Consensus 390 l~eQI~~G~y~f~p----------------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILKGRYAFGP----------------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhcCcccccC----------------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 33333322221110 0112456678999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=375.79 Aligned_cols=201 Identities=30% Similarity=0.505 Sum_probs=179.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
...+|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+.+|+.++|||||++++++ ..++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 356889999999999999999999999999999998755 455667789999999999999999999994 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC----
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---- 862 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---- 862 (1033)
+.|+|||||.||||.+|++. .+.+++.+++.++.|+|.||++||++ +||||||||+|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~----------~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRR----------RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCC
Confidence 99999999999999999963 45799999999999999999999999 99999999999999764
Q ss_pred --CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 863 --MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 863 --~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
-.+||+|||+|+.+.......+ .+|++.|||||++..++|+.|+|+||+|+|+|++++|+.||+.
T Consensus 150 ~~~~LKIADFGfAR~L~~~~~a~t---lcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPGSMAET---LCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCceEEecccchhhhCCchhHHHH---hhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 4689999999998875543333 4599999999999999999999999999999999999999973
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=392.12 Aligned_cols=258 Identities=30% Similarity=0.422 Sum_probs=215.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++.++.||+|.||+||.|.++ ....||+|.++... ...++|.+|+++|++++|++||+++++|... +..||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 356789999999999999998 44579999998643 3347889999999999999999999998532 2789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
|||+.|+|.+||+. ..+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+
T Consensus 281 E~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 99999999999964 3567789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
|+...++. ........-+..|.|||++..++++.|||||||||+||||+| |+.||.... ..+..
T Consensus 350 Ar~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~--------- 414 (468)
T KOG0197|consen 350 ARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVL--------- 414 (468)
T ss_pred ccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHH---------
Confidence 99544433 333333346778999999999999999999999999999999 888875321 11111
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
..-.++.|.+.|..|++.+.++|..||+.+|++|||++.+...++++.....
T Consensus 415 ------------------~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 415 ------------------ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred ------------------HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 1123455677777899999999999999999999999999999998876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=388.83 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=210.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeec---cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+|...+.||+|||+.||++++..+|+.||+|++.+ ......+...+|++|.+.++|||||+++++ |++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 579999999999999999999988999999999974 344566889999999999999999999999 677779
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
+|+|.|+|+.++|.++++ ..+.+++.+++.+.+||+.||.|||+. +|+|||||..|++++++.++||
T Consensus 93 VYivLELC~~~sL~el~K----------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHH----------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEe
Confidence 999999999999999994 467899999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|..+..+... ....+|||.|.|||++....++..+||||+|||+|.|++|++||+... -...+.....
T Consensus 160 gDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~---- 232 (592)
T KOG0575|consen 160 GDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKL---- 232 (592)
T ss_pred cccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHh----
Confidence 999999988654332 223569999999999999999999999999999999999999996320 0011111111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+..|.....+..+++.++|+.||.+|||+++|+..
T Consensus 233 ----------------------------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 ----------------------------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----------------------------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111122334567899999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.41 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=208.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeec--cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|.+.++||+|+||+||++....+|..||.|.++. .+....++...|+.+|++++|||||+++++-. .+++...+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhhH
Confidence 57889999999999999999999999999998873 34455678899999999999999999998521 23344589
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEecCCCcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kL 867 (1033)
+|||||.+|+|.+.++..+ ...+.+++.++++++.|++.||.++|+.. +. |+||||||.||+++.+|.+||
T Consensus 97 ivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred HHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceee
Confidence 9999999999999997532 35678999999999999999999999942 24 999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++.+........ ..+|||.||+||.+.+..|+.||||||+||++|||..-++||.. + ++....++...
T Consensus 170 GDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g----~-n~~~L~~KI~q 242 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG----D-NLLSLCKKIEQ 242 (375)
T ss_pred ccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc----c-cHHHHHHHHHc
Confidence 99999998865544332 35699999999999999999999999999999999999999852 2 33333222211
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+... -+ ..-.+..+.+++..|+..||+.||+...++..+..
T Consensus 243 gd~~~--------~p------------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYPP--------LP------------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCC--------Cc------------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11000 00 01234568999999999999999986555554433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=393.17 Aligned_cols=465 Identities=25% Similarity=0.381 Sum_probs=334.6
Q ss_pred EEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccc
Q 042075 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165 (1033)
Q Consensus 86 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 165 (1033)
.+.++.++++++ .+|++++.+..++.|+.++|+++ ++|.+++.+.+|+.|++++|.+. ++|+.++.+..|..|+..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 456677777776 56777888888888888888887 77888888888888888888887 7778888888888888888
Q ss_pred ccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCc
Q 042075 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245 (1033)
Q Consensus 166 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 245 (1033)
|+++ ..|..++++.+|..|++.+|++....|..+ +++.|++||...|-++ .+|..++.+.+|+.|+|.+|++. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 8887 777888888888888888888885544444 4888888888888887 78888999999999999999998 667
Q ss_pred ccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhcc
Q 042075 246 SSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325 (1033)
Q Consensus 246 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~ 325 (1033)
+|.+++.|++|+++.|+|+ .+|.+....+.+|..|||.+|+++ ..|..++-+++|++||+|+|.|++.++.++++ .
T Consensus 223 -ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-e
Confidence 8889999999999999998 888888888999999999999998 78999999999999999999999999999999 8
Q ss_pred ccceeeecCcCCCCCCccchhhcccccccCcceeee--cccccCCCCccccccccCcccEEEccCCCCCccCCccccCCC
Q 042075 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHI--NINNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV 403 (1033)
Q Consensus 326 L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l--~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~ 403 (1033)
|+.|.+.+|.+..+...-++ -....-|++++- ....++.. .. .+-..- ....+ .......+.
T Consensus 299 L~~L~leGNPlrTiRr~ii~----~gT~~vLKyLrs~~~~dglS~s--e~-----~~e~~~----t~~~~-~~~~~~~~i 362 (565)
T KOG0472|consen 299 LKFLALEGNPLRTIRREIIS----KGTQEVLKYLRSKIKDDGLSQS--EG-----GTETAM----TLPSE-SFPDIYAII 362 (565)
T ss_pred eeehhhcCCchHHHHHHHHc----ccHHHHHHHHHHhhccCCCCCC--cc-----cccccC----CCCCC-cccchhhhh
Confidence 99999999987643221110 001111222211 00000000 00 000000 00001 111233445
Q ss_pred CCCEEEcccCcccccCChhhhcCCC---CcEEEccccccccccCcccccce--eceeeccccccCCCCCCccCCCCcccE
Q 042075 404 KLLRLEMWNNRLSGTIPPAIGELQN---LRELRLQENRFLGNIPPSIGNLK--LFNLQLSYNFLQGSIPSSLGQSETLTI 478 (1033)
Q Consensus 404 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 478 (1033)
+.+.|+++.-+++ .+|++...-.. .+..+++.|++. ++|..+..++ ++.+.+++|.++ .+|..++.+++|..
T Consensus 363 ~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~ 439 (565)
T KOG0472|consen 363 TTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTF 439 (565)
T ss_pred hhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhccee
Confidence 5666666666666 45554433333 556666666666 5565555554 334444444443 44444555555555
Q ss_pred EecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeeccccc
Q 042075 479 IDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF 558 (1033)
Q Consensus 479 L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 558 (1033)
|+|++| -+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|+
T Consensus 440 L~L~NN-------------------------~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nq 492 (565)
T KOG0472|consen 440 LDLSNN-------------------------LLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQ 492 (565)
T ss_pred eecccc-------------------------hhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccc
Confidence 555544 444 56777777778888888888887 788888888888888888899
Q ss_pred ccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCc
Q 042075 559 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 559 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
+....|+.+.+|.+|..|||.+|.|. .||+.+++|++|++|++++|+|+
T Consensus 493 i~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 493 IGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 98666666999999999999999998 88999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.87 Aligned_cols=275 Identities=21% Similarity=0.293 Sum_probs=206.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+.|+...++|+|+||+||+++++++|+.||||++.... +...+-..+|+++|++++|+|+|.++++ +......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 56888899999999999999999999999999986433 3334567899999999999999999999 5566689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++|+|||+..-|.+.- .....++...+.+++.|+++|+.|+|++ ++|||||||+|||++.++.+|||
T Consensus 77 hLVFE~~dhTvL~eLe----------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELE----------RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecchHHHHHHH----------hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEec
Confidence 9999999775554443 3556788999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH--hhh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA--KTA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--~~~ 945 (1033)
|||+|+.+..+.. .++.++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+.|... .++.+.. +..
T Consensus 144 DFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~kt 217 (396)
T KOG0593|consen 144 DFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKT 217 (396)
T ss_pred cchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHH
Confidence 9999998874322 2233558999999999887 68999999999999999999999998633 2333222 111
Q ss_pred ---CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 ---LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ---~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+.+...+++...-.-..-.++. .. ....-....+.....+.+++..|++.||++|++.+|++..
T Consensus 218 LG~L~prhq~iF~~N~~F~Gv~lP~--~~-~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 218 LGNLIPRHQSIFSSNPFFHGVRLPE--PE-HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HcccCHHHHHHhccCCceeeeecCC--CC-CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1222222222111000000000 00 0000011122344568999999999999999999998863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=399.44 Aligned_cols=270 Identities=25% Similarity=0.404 Sum_probs=219.2
Q ss_pred CCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+-...+.||+|+||+||+|+.. .+...||||.++..... ...+|++|++++..++|||||+++|+|.+.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~----- 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG----- 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----
Confidence 3455688999999999999874 34577999999876655 678999999999999999999999998543
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcccccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEA----PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
+..++|+|||..|||.+||+.+......... +.+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 4789999999999999999765444333222 44599999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~ 940 (1033)
+..|||+|||+++.+-..+.+.......-+.+|||||.+..+++|.+|||||||||+||+++ |+.||......+ .+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-VIe- 716 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-VIE- 716 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-HHH-
Confidence 99999999999997655444333222234679999999999999999999999999999999 999986432211 110
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
. + +..+. ++.+..|+.++++||..||+.+|++||+++||-..|+...+..
T Consensus 717 ~-----------i------------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 717 C-----------I------------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred H-----------H------------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 0 0 11111 3445678999999999999999999999999999999886654
Q ss_pred h
Q 042075 1021 L 1021 (1033)
Q Consensus 1021 ~ 1021 (1033)
+
T Consensus 767 ~ 767 (774)
T KOG1026|consen 767 P 767 (774)
T ss_pred c
Confidence 4
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.73 Aligned_cols=474 Identities=26% Similarity=0.401 Sum_probs=303.1
Q ss_pred CCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceee
Q 042075 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 186 (1033)
-..|+.|++++|.++ .+.+.+.+|..|++|++++|+++ ..|++++.+..++.|+.|+|+++ .+|..++.+.+|..|+
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 344455555555554 33344555555555555555555 45555555555555555555554 4555555555555555
Q ss_pred ecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccC
Q 042075 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266 (1033)
Q Consensus 187 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 266 (1033)
.++|.+. .+|+.++.+..|..|+..+|+++ ..|+.+..+.+|..|++.+|++... |...-+++.|++||.-.|.++
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE- 196 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-
Confidence 5555555 44444555555555555555555 3444455555555555555555522 222222444555555444444
Q ss_pred ccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc-hhhhccccceeeecCcCCCCCCccch
Q 042075 267 VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLN 345 (1033)
Q Consensus 267 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~~ 345 (1033)
.+|.+++ .+.+|+.|||.+|+|. ..| .|..++.|.+|+++.|.|.-.+.. +..+.++..|+++.|++.+
T Consensus 197 tlP~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke------- 266 (565)
T KOG0472|consen 197 TLPPELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE------- 266 (565)
T ss_pred cCChhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc-------
Confidence 4444443 3555555555555555 334 555555555555555555533332 2344444444444444433
Q ss_pred hhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhc
Q 042075 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE 425 (1033)
Q Consensus 346 ~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 425 (1033)
+|..++-+ .+|++||+++|.|+ ..|..++++ +|+.|.+.+|.+..+-.+-+..
T Consensus 267 ------------------------~Pde~clL-rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~ 319 (565)
T KOG0472|consen 267 ------------------------VPDEICLL-RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISK 319 (565)
T ss_pred ------------------------CchHHHHh-hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcc
Confidence 33333332 46788888888887 456778888 8888888888876332222211
Q ss_pred CCC--CcEEE-------cccccc----ccc-cCcccccc----eeceeeccccccCCCCCCccCCCCc---ccEEecCCC
Q 042075 426 LQN--LRELR-------LQENRF----LGN-IPPSIGNL----KLFNLQLSYNFLQGSIPSSLGQSET---LTIIDLSNN 484 (1033)
Q Consensus 426 l~~--L~~L~-------L~~N~l----~~~-~p~~~~~l----~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N 484 (1033)
=+. |++|. ++.-.= .+. .+..+.+. +.+.|+++.=+++ .+|+....... .+..+++.|
T Consensus 320 gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskN 398 (565)
T KOG0472|consen 320 GTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKN 398 (565)
T ss_pred cHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccc
Confidence 000 22221 111100 001 12222222 2778999999998 45554433333 789999999
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCccc
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIP 564 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (1033)
++. ++|..+..+..+.+.+++++|.++ -+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|++. .+|
T Consensus 399 qL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP 474 (565)
T KOG0472|consen 399 QLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLP 474 (565)
T ss_pred hHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cch
Confidence 999 999999999999888999999997 78999999999999999999998 89999999999999999999999 899
Q ss_pred ccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccccccccccc
Q 042075 565 SSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNL 629 (1033)
Q Consensus 565 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~ 629 (1033)
..+..+..|+.+--++|++....|..+.+|.+|.+|||.+|.+.-.+|.-+.+.++....+.||+
T Consensus 475 ~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 475 ECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred HHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCc
Confidence 99999999999999999998666666999999999999999999888888888888888888885
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.05 Aligned_cols=274 Identities=23% Similarity=0.314 Sum_probs=213.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|...+++|+|.||.||+|++..+++.||||.++... ++......+|++.|+.++|+||+.++++ +...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 57888999999999999999999999999999998542 2334567899999999999999999999 5566689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
.+|+|||+ .+|+..++. ....++..++..++.++.+|++|||++ .|+||||||.|+|++++|.+||+
T Consensus 77 ~lVfEfm~-tdLe~vIkd---------~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKD---------KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEecc-ccHHHHhcc---------cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence 99999995 499999963 667899999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh---
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT--- 944 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--- 944 (1033)
|||+|+.+......... .+.|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|. ++.++++...-
T Consensus 144 DFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~ 217 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRA 217 (318)
T ss_pred cccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHH
Confidence 99999988765544433 2579999999998874 69999999999999999999887654 55555554332
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.-.+...++-+-.-..++..+..... .... .....+..+..+++..|+..||.+|+|++|++++
T Consensus 218 LGTP~~~~WP~~~~lpdY~~~~~~P~---~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 218 LGTPTPDQWPEMTSLPDYVKIQQFPK---PPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCcccCccccccccHHHHhcCCC---Cccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11122222222222233322221111 0011 0222345667999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.97 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=201.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.++||+|+||.||.++.+++++.+|+|++++.. ....+...+|..+|.+++||.||+++.. +++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 4568999999999999999999999999999999997532 3345678899999999999999999987 7778
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..|+|+||+.||.|..+|+ ..+.+++..+.-++.+|+.||.|||++ ||||||+||+|||+|++|++
T Consensus 98 ~kLylVld~~~GGeLf~hL~----------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQ----------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred CeEEEEEeccCCccHHHHHH----------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence 89999999999999999994 456789999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+|+|||+++..-..... ....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +..++....
T Consensus 165 ~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I 237 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKI 237 (357)
T ss_pred EEeccccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHH
Confidence 99999999854333222 22356999999999999999999999999999999999999999632 222222222
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1004 (1033)
...... . .+.-...+..+++.+.++.||++|.
T Consensus 238 ~~~k~~--------~-------------------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLP--------L-------------------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCC--------C-------------------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 211100 0 0001234578999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.79 Aligned_cols=263 Identities=29% Similarity=0.445 Sum_probs=208.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..+...+.+.||+|+||+||+|+|.++ ||||+++... +...+.|++|+..+++-+|.||+-+.|||....
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~----- 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP----- 461 (678)
T ss_pred CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----
Confidence 344556788999999999999999843 9999998543 346689999999999999999999999975433
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..||+.+|+|-+|+.+++. ....++..+.++||.|||+||.|||.+ +|||||||..||++.++++||
T Consensus 462 -~AIiTqwCeGsSLY~hlHv---------~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLHV---------QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred -eeeeehhccCchhhhhccc---------hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEE
Confidence 4899999999999999974 456789999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||++..-..-..........|...|||||+++.+ +|++.+||||||+|+|||++|..||.....+. .+-..-+
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-IifmVGr 607 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-IIFMVGR 607 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-eEEEecc
Confidence 9999999754322222222234488899999998753 68999999999999999999999986221111 1100000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.+...+ .......|++++.+|+..||.+++++||.+.+|+..|+++....
T Consensus 608 G~l~pd---------------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 608 GYLMPD---------------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccCcc---------------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 000000 01112356788999999999999999999999999999887643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.22 Aligned_cols=273 Identities=23% Similarity=0.268 Sum_probs=207.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchh-HHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|.++++||.|+||.||+|+...++..||||.++..-... ...-.+|+..|++++ |||||++.+++ .+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi-----~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI-----RDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh-----hccC
Confidence 4578999999999999999999999999999999997543322 223468999999998 99999999994 3344
Q ss_pred -ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 787 -FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 787 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
..|+||||| ..+|+++++. .+..+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+
T Consensus 83 ~~L~fVfE~M-d~NLYqLmK~---------R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~i 149 (538)
T KOG0661|consen 83 RILYFVFEFM-DCNLYQLMKD---------RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVI 149 (538)
T ss_pred ceEeeeHHhh-hhhHHHHHhh---------cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEeccccee
Confidence 899999999 4599999964 467899999999999999999999999 99999999999999988899
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+|+.+......+. ++.|+.|+|||++.. ..|+.+.||||+|||++|+.+-++.|....+ +.+..+-
T Consensus 150 KiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE----~Dqi~KI 222 (538)
T KOG0661|consen 150 KIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE----IDQIYKI 222 (538)
T ss_pred EecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH----HHHHHHH
Confidence 9999999998877666554 458999999998654 6789999999999999999999998864433 3332221
Q ss_pred --hCCcc-hhhhcccccCCCchhhhhccchhhhhh---hh-hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 --ALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQA---RI-NSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 --~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+... ..++.. ....+.....+-++. .. .-...+..+..+++.+|+++||++||||+|++++
T Consensus 223 c~VLGtP~~~~~~e------g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 223 CEVLGTPDKDSWPE------GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhCCCccccchh------HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11100 000000 000000000000000 00 0111256788999999999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.44 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=209.7
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.+...+|...+.||+|+|++|++|+.+.+++.||||++.+.. +...+....|-++|.++ .||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 556678999999999999999999999999999999986432 22335577899999999 89999999988 6
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
+++...|+|+||+++|+|.+++++ .+.+++...+.++.||+.|++|||++ |||||||||+|||+|+|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K----------~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d 210 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKK----------YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD 210 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHH----------hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC
Confidence 677799999999999999999964 46789999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCcc---------ccc--cccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 863 MIAHVGDFGLATFLPLSHAQ---------TSS--IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
+++||+|||.|+.+...... ... ...+||..|.+||++.....++.+|||+||||+|+|+.|.+||..
T Consensus 211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra- 289 (604)
T KOG0592|consen 211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA- 289 (604)
T ss_pred CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-
Confidence 99999999999987543221 111 346799999999999999999999999999999999999999852
Q ss_pred ccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 932 FEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...+..+.+ +++ ..+..+...++...+|+.+.|..||.+|+|++||.+
T Consensus 290 ---~NeyliFqk---------I~~--------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 290 ---ANEYLIFQK---------IQA--------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---ccHHHHHHH---------HHH--------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 222222211 110 011112223456889999999999999999988876
Q ss_pred H
Q 042075 1012 Q 1012 (1033)
Q Consensus 1012 ~ 1012 (1033)
+
T Consensus 338 H 338 (604)
T KOG0592|consen 338 H 338 (604)
T ss_pred C
Confidence 5
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=359.87 Aligned_cols=279 Identities=24% Similarity=0.294 Sum_probs=208.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+.|+.+++||+|.||.||+|++..+|+.||+|.++... ++...-..+||.||++++||||+++.+...+. ..+.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 345777889999999999999999999999999998544 44556678999999999999999999986432 2468
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+|+|||++ ||.-++. .....+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||
T Consensus 193 iYlVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEe
Confidence 9999999966 8988885 3566799999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+|+++....... .+..+.|..|+|||.+.+. .|+.++|+||.|||+.||++|++.|....+-+ .+....+-.-
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcG 337 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCG 337 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhC
Confidence 9999999886655432 3345589999999998875 69999999999999999999999986432211 1111111111
Q ss_pred -C-cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 -P-DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 -~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+ +..+...+ +. ....+... ....+..+ +.....+....+++..+|..||++|.||.++++
T Consensus 338 SP~e~~W~~~k--LP-~~~~~kp~-~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 338 SPTEDYWPVSK--LP-HATIFKPQ-QPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCChhcccccc--CC-cccccCCC-CcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 11111000 10 00000000 00000011 112234566889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=357.72 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=204.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+|...+.||+|+||+||++....+|+.+|||..........+.+.+|+.+|++++|||||+++|..... .....+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeE
Confidence 45678889999999999999999988999999998765433467789999999999999999999963211 113688
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-CCcEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~ 868 (1033)
+.|||+++|+|.+++.. ... .+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~--------~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKR--------YGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHH--------cCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 99999999999999953 222 699999999999999999999999 9999999999999999 7999999
Q ss_pred ecccceecCC-CCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 869 DFGLATFLPL-SHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 869 DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|||.++.... ...........||+.|||||++..+ ...+++||||+||++.||+||++||...... .........
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~ 237 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGR 237 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhc
Confidence 9999987654 1111222335699999999999853 3446999999999999999999999643111 111111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..... ..+...+.+..+++.+|++.||++||||+++++..-..
T Consensus 238 ~~~~P---------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 238 EDSLP---------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred cCCCC---------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 00000 11122455688999999999999999999999875443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=377.50 Aligned_cols=272 Identities=23% Similarity=0.392 Sum_probs=224.0
Q ss_pred CCCCCHHHHHHhhCC---------CCccceecccCceeEEEEEeCCCC---eEEEEEEeeccC-chhHHHHHHHHHHHHh
Q 042075 698 FPNISYQNLYNATDG---------FTSANLIGAGSFGSVYKGILDEGK---TIVAVKVFNLLH-HGAFKSFIAECNTLKN 764 (1033)
Q Consensus 698 ~~~~~~~~l~~~~~~---------y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~ 764 (1033)
...++|+|--.|... ..+.++||.|.||+||+|+.+..+ ..||||.+|... +....+|..|+.||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 344566655444433 356789999999999999997554 569999998654 3456789999999999
Q ss_pred cCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 042075 765 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQ 844 (1033)
Q Consensus 765 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 844 (1033)
++||||+++.|+ .......+||.|||++|+|+.||+. ....+++.+...+.++||.||+||.+.
T Consensus 687 FdHPNIIrLEGV-----VTks~PvMIiTEyMENGsLDsFLR~---------~DGqftviQLVgMLrGIAsGMkYLsdm-- 750 (996)
T KOG0196|consen 687 FDHPNIIRLEGV-----VTKSKPVMIITEYMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIASGMKYLSDM-- 750 (996)
T ss_pred CCCCcEEEEEEE-----EecCceeEEEhhhhhCCcHHHHHhh---------cCCceEeehHHHHHHHHHHHhHHHhhc--
Confidence 999999999999 4555578999999999999999974 446699999999999999999999998
Q ss_pred CCcEeccCCCCCeEecCCCcEEEeecccceecCCCCc-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
++|||||.++||||+.+..+|++|||+++.+.++.. ..+....+-+.+|.|||.+..++++.+|||||||+|+||.++
T Consensus 751 -~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS 829 (996)
T KOG0196|consen 751 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 829 (996)
T ss_pred -CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecc
Confidence 999999999999999999999999999998765542 222222234678999999999999999999999999999877
Q ss_pred -CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC
Q 042075 924 -RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002 (1033)
Q Consensus 924 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1002 (1033)
|..||..+...+ ++ +.-..+.|.+.+++|+.++.++|..||++|-.+
T Consensus 830 yGERPYWdmSNQd-----------------VI---------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~ 877 (996)
T KOG0196|consen 830 YGERPYWDMSNQD-----------------VI---------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNR 877 (996)
T ss_pred cCCCcccccchHH-----------------HH---------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhc
Confidence 999986443221 11 112334577788899999999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 042075 1003 RMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 1003 RPt~~evl~~L~~i~~ 1018 (1033)
||++.||+..|+++..
T Consensus 878 RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 878 RPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCHHHHHHHHHHHhc
Confidence 9999999999999764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.42 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=210.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
..|+..++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.| -.++..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence 4577778999999999999999999999999999877776677889999999999999999999984 44468999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|||||+||+|.+.+. ...+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+||
T Consensus 348 VMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence 999999999999983 34589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|++..+........ ..+||++|||||+.....|++|.||||||++++||+-|++||-. +..+.....-...
T Consensus 414 GFcaqi~~~~~KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~n--- 484 (550)
T KOG0578|consen 414 GFCAQISEEQSKRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATN--- 484 (550)
T ss_pred eeeeccccccCccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhc---
Confidence 99998866654332 35599999999999999999999999999999999999999842 2222211111000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+...+.....++.+++.+||+.||++||+|.|+++.
T Consensus 485 -----------------------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 -----------------------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -----------------------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 001111223456779999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.33 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=209.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+.. ..+.+.+.+|++|+++++|||||.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 57889999999999999999999999999999987543 3456789999999999999999999999 6777799
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++|.||+.| +|..++. ..+.++++.+..++.|++.||.|||+. +|.|||+||.||+++..+++|++
T Consensus 77 ~vVte~a~g-~L~~il~----------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE----------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeec
Confidence 999999976 9999993 567899999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||+|+.+...... ....+|||.|||||...+++|+..+|+||+|||+||+++|++||.. ..+.+.++....+
T Consensus 143 dFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 143 DFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKD 215 (808)
T ss_pred hhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcC
Confidence 99999976553322 2335699999999999999999999999999999999999999842 1222233322222
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+. .+.+....+..++...+.+||.+|.|..+++..
T Consensus 216 ~v~----------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 PVK----------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCC----------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111 011345668999999999999999999998865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=344.19 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=206.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+.|+..++||.|..++||+|+....++.||||++.-... ...+.+.+|+..|+.++||||++++.. |..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 4679999999999999999999999999999999975432 335889999999999999999999988 4556689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+||.||.+|++.+.++. .....+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+
T Consensus 100 WvVmpfMa~GS~ldIik~--------~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKT--------YYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHH--------HccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence 999999999999999965 3445599999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcccc-c-cccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 869 DFGLATFLPLSHAQTS-S-IFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
|||.+..+........ . ...+||++|||||++.. ..|+.|+||||||++..|+.+|..||...-.- ++...
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl~ 243 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLLL 243 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence 9998776644332111 1 33469999999999544 46999999999999999999999998632111 11111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+........ ....++ ++.......+.+++..|+++||++|||++++++.
T Consensus 244 tLqn~pp~~~--t~~~~~----------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TLQNDPPTLL--TSGLDK----------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhcCCCCCcc--cccCCh----------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111110000 000000 1112233479999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=343.03 Aligned_cols=291 Identities=21% Similarity=0.221 Sum_probs=215.4
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEee--ccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
.+.+.....|...+.||+|+||.|+.|.++.+|+.||||.+. .......++..+|++++++++|+||+.+.+.+....
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 345556677887899999999999999999999999999887 445556788899999999999999999999976644
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
...-...|+|+|+| +.+|.+.++ ....++...+.-+..|+++||+|+|+. +|+|||+||+|++++.
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik----------~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~ 160 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIK----------SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNA 160 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHH----------cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeecc
Confidence 45566789999999 679999994 445589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+...||+|||+|+...........+.++.|..|+|||++.. ..|+.+.||||.|||+.||++|++.|.. ...+.+
T Consensus 161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG----~d~v~Q 236 (359)
T KOG0660|consen 161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG----KDYVHQ 236 (359)
T ss_pred CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC----CchHHH
Confidence 99999999999998765422233344568999999998654 6899999999999999999999999753 222222
Q ss_pred HH--hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FA--KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~--~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ....+..-.+.+...-...............+..-....+...+...+++.+||..||.+|+|++|+++.
T Consensus 237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 21 1111111001000000000000000000000000011112344667899999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=365.80 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=206.2
Q ss_pred hCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.++||+|+||.||+|.+. .+++.||||+++... ....+.+.+|+.+++++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---- 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence 468999999999999999999852 345689999987432 23446789999999999 8999999999863
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc--------------------------------------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 812 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 812 (1033)
..++..++||||+++|+|.++++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 334468999999999999999964321000
Q ss_pred --ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcccccccccc
Q 042075 813 --TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890 (1033)
Q Consensus 813 --~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~g 890 (1033)
.......+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 001134588999999999999999999999 999999999999999999999999999986543332222222336
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhcc
Q 042075 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHG 969 (1033)
Q Consensus 891 t~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 969 (1033)
+..|+|||++.+..++.++|||||||++|||++ |..||....... .+..... +...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~-----------~~~~----------- 295 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLK-----------DGTR----------- 295 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHh-----------cCCC-----------
Confidence 788999999999999999999999999999997 999986321111 1110000 0000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 970 NQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
...+..+++++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 296 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 --------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00011234568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.25 Aligned_cols=244 Identities=23% Similarity=0.387 Sum_probs=202.9
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEc
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
..+-||.|+.|.||+|+.+ ++.||||+++.. -..+|+-|++++||||+.+.|+|... ..+||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeec
Confidence 3568999999999999997 678999987532 23578899999999999999998543 378999999
Q ss_pred ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 795 MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 795 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
|..|-|+++|+ .+..++..-...|..+||.||.|||.+ .|||||||.-||||..+..|||+|||-++
T Consensus 194 Ca~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 194 CAQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred cccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 99999999995 566788889999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhc
Q 042075 875 FLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIV 954 (1033)
Q Consensus 875 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1033)
..... .+...+.||..|||||++...+.++|+||||||||||||+||..||........ ++.+
T Consensus 261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------IwGV- 323 (904)
T KOG4721|consen 261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------IWGV- 323 (904)
T ss_pred hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------------EEec-
Confidence 76543 333445699999999999999999999999999999999999999853321110 0000
Q ss_pred ccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 955 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 955 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.......+.+.+|++.+.-++++||+..|..||++.+++..|+-...-
T Consensus 324 -----------------GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 324 -----------------GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred -----------------cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 011122334567889999999999999999999999999999876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=387.71 Aligned_cols=271 Identities=25% Similarity=0.393 Sum_probs=220.5
Q ss_pred CCccceecccCceeEEEEEeCCC-----CeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 713 FTSANLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
-+..+.||+|.||.||+|...+- ...||||.++.. +.....+|.+|..+|++++|||||+++|+|.+ ..
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~~ 768 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----SG 768 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----CC
Confidence 35567899999999999998542 234899988754 45567899999999999999999999999853 44
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++++|||+||+|..||++.+... .....++..+.+.++.|||+|++||+++ ++|||||.++|+|+++...||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 7899999999999999998754433 2367899999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+|+.+.....+.......-...|||||.+.++.++.|+|||||||++||++| |..||......+
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------- 912 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------- 912 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------
Confidence 999999996544433333222234578999999999999999999999999999999 888885321110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhchh
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRI 1025 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 1025 (1033)
++. ...++.|.+.+..|++.++++|..||+.+|++||++..+++++..+.....+..+
T Consensus 913 -------v~~---------------~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 913 -------VLL---------------DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred -------HHH---------------HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 000 0111225566778999999999999999999999999999999999888776654
Q ss_pred h
Q 042075 1026 V 1026 (1033)
Q Consensus 1026 ~ 1026 (1033)
.
T Consensus 971 ~ 971 (1025)
T KOG1095|consen 971 G 971 (1025)
T ss_pred c
Confidence 3
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.24 Aligned_cols=282 Identities=22% Similarity=0.229 Sum_probs=207.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+.|+..++|++|+||.||+|+++.+++.||+|+++... .+..-...+|+.+|.+++|||||.+-.+..+.. -+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence 456788899999999999999999999999999998543 233345689999999999999999999876543 346
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+|||||+. +|..++.. ..+++...++.-++.|+++|++|||.+ .|+|||+||+|+|+...|.+||
T Consensus 152 iy~VMe~~Eh-DLksl~d~---------m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMET---------MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred eeeeHHHHHh-hHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEe
Confidence 9999999966 99999963 447899999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+|+.+...... .+..+.|..|+|||.+.+. .|+.+.|+||+|||+.|++++++.|....+-+....-+..-..
T Consensus 219 aDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 999999988765332 2334579999999998875 6999999999999999999999998643322211111111111
Q ss_pred Cc-chhhhcccccCCCchhhhhccchhhhhhhhhhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE-CLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+. .++.-++..-....... ........+...... ..++-.+++..++.+||++|.||+|.++.
T Consensus 297 Pte~iwpg~~~lp~~k~~~f---~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTF---SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccCCCccccchhhcccc---CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11 11111111000000000 000000111111111 33567899999999999999999998764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=360.24 Aligned_cols=132 Identities=27% Similarity=0.330 Sum_probs=113.8
Q ss_pred CCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeec
Q 042075 109 FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVS 188 (1033)
Q Consensus 109 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 188 (1033)
.-++||+|+|.++..-+..|.++++|+.++|.+|.++ .||...+...+|+.|+|.+|.|+..-..++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3567999999999888888999999999999999998 889887778889999999999987667788899999999999
Q ss_pred ccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccC
Q 042075 189 YNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 189 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
.|.|+.+.-.+|..-.++++|+|++|+|+...-+.|..+.+|..|.|++|+++
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit 210 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT 210 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc
Confidence 99998555567877778999999999998877888888888888888888887
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=321.10 Aligned_cols=273 Identities=18% Similarity=0.244 Sum_probs=217.9
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
...++|++.+.+|+|||+-||.++.-.+++.||+|++.....+..+..++|++..++++|||++++++++.....+....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34578999999999999999999998899999999998777777888999999999999999999999986655556667
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|++++|+..|+|.+.+.... ..+..+++.+++.|+.++++||++||+. .|+++||||||.||++.+++.+++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred EEEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEE
Confidence 899999999999999996532 2445789999999999999999999998 445999999999999999999999
Q ss_pred eecccceecCCCCccc-------cccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 868 GDFGLATFLPLSHAQT-------SSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
.|||.++...-..... .......|..|+|||.+. +...++++|||||||++|+|+.|..||+..++....
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 9999998653221111 111123789999999864 456789999999999999999999999865543322
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+.-.+.. .+..++...-.++++.+++++|++.||.+||++.+++..++.+
T Consensus 251 laLAv~n-----------------------------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 LALAVQN-----------------------------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEEeeec-----------------------------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 2211110 0000000011346799999999999999999999999998765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=361.51 Aligned_cols=394 Identities=22% Similarity=0.214 Sum_probs=238.5
Q ss_pred cEEecccCCCCCCCCccccCC--CCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcc
Q 042075 135 QVLALHNNSIGGEIPANISSC--SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLS 212 (1033)
Q Consensus 135 ~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 212 (1033)
+.||++++.+....-..+.+. +.-+.||+|+|+|+..-+..|-++++|+.+++.+|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 457888887763222222221 23456888888888666777788888888888888887 777654445558888888
Q ss_pred cCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCC
Q 042075 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292 (1033)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 292 (1033)
+|.|+.+-.+.+..++.|+.||||.|.|+. +|..-|..-.++++|+|++|+|+..
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~-------------------------i~~~sfp~~~ni~~L~La~N~It~l 188 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISE-------------------------IPKPSFPAKVNIKKLNLASNRITTL 188 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhc-------------------------ccCCCCCCCCCceEEeecccccccc
Confidence 888887777777777778888888877773 3333333334555566666666555
Q ss_pred CCccCcCCCCccccccccccccCcCcc-hhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCc
Q 042075 293 IPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371 (1033)
Q Consensus 293 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip 371 (1033)
--..|.++.+|.+|.|+.|+++..++. +.++++|+.|++.+|.|...+.-.+
T Consensus 189 ~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltF--------------------------- 241 (873)
T KOG4194|consen 189 ETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTF--------------------------- 241 (873)
T ss_pred ccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhh---------------------------
Confidence 555666666666666666666655543 3335555555555555443221111
Q ss_pred cccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce
Q 042075 372 ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451 (1033)
Q Consensus 372 ~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 451 (1033)
+-.++|+.|.|..|.|.....++|..+.++++|+|+.|+++..-..++.+|+.|+.|+||+|.|..
T Consensus 242 ----qgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r---------- 307 (873)
T KOG4194|consen 242 ----QGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR---------- 307 (873)
T ss_pred ----cCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe----------
Confidence 111456666666666666666666666666666666666665556666666666666666666554
Q ss_pred eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcc
Q 042075 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVF 531 (1033)
Q Consensus 452 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (1033)
+.++++...++|++|||++|+|+ .+++.-+...+.|+.|+|++|.++..-...|..+++|+.|||+
T Consensus 308 -------------ih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 308 -------------IHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred -------------eecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 44445555555666666666665 3333333333333666666666654444556666666666666
Q ss_pred ccccccccCc---ccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCc
Q 042075 532 ENKLRGEIPR---TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 532 ~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
+|.|++.+-+ .|.+|++|+.|+|.+|+|....-.+|..++.|+.|||.+|.|-...|+.|..+ .|+.|-++.-.|-
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssfl 452 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFL 452 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceE
Confidence 6666655543 35566666666666666664444566666666666666666666666666666 6666665544444
Q ss_pred cc
Q 042075 609 GM 610 (1033)
Q Consensus 609 g~ 610 (1033)
+.
T Consensus 453 CD 454 (873)
T KOG4194|consen 453 CD 454 (873)
T ss_pred Ee
Confidence 33
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.92 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=212.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.-|+.++.||.|+.|.|..|++..+|+.+|||++... .......+.+|+.+|+-+.||||+++|++ ++...+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence 4578899999999999999999999999999999754 22334668899999999999999999999 677789
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
+|+|.||++||-|.+++ ...+++++.++.+++.||+.|+.|+|+. +|+|||+||+|+|+|..+++||
T Consensus 87 lylvlEyv~gGELFdyl----------v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKI 153 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYL----------VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKI 153 (786)
T ss_pred EEEEEEecCCchhHHHH----------HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEee
Confidence 99999999999999999 3567899999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+|..-..+.--.+. +|+++|.|||++.+.+|+ .++||||+|||+|.|+||+.||+ ++++.....+..
T Consensus 154 ADFGMAsLe~~gklLeTS---CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~ 225 (786)
T KOG0588|consen 154 ADFGMASLEVPGKLLETS---CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQ 225 (786)
T ss_pred eccceeecccCCcccccc---CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHH
Confidence 999999876555544443 499999999999999985 88999999999999999999996 444444433221
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. .++.+...+.+.++++.+|+..||++|.|++||+++-
T Consensus 226 ~G----------------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RG----------------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cC----------------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 1112234567789999999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.61 Aligned_cols=283 Identities=27% Similarity=0.349 Sum_probs=208.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc--CCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+..+..++||+|.||.||||+.. ++.||||++.. ...+.|++|-+|.+.. +|+||++++++-...+. ....+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccce
Confidence 34456789999999999999996 58999999874 3446788888888765 89999999987332221 23478
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC------CCCCcEeccCCCCCeEecCC
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD------CQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivHrDlkp~NIll~~~ 862 (1033)
++|+||.+.|+|.+||. ...++|.+..+|+..+++||+|||+. ++|+|+|||||++||||..|
T Consensus 284 wLVt~fh~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred eEEeeeccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 99999999999999994 46799999999999999999999986 47899999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCc--cccC
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE------VSINGDVYSYGILLLELVTRKKPTDI--MFEG 934 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~vl~elltg~~p~~~--~~~~ 934 (1033)
+++.|+|||+|..+..+.........+||.+|||||++.+.. .-.+.||||+|.|+|||+++...++. ..+-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999999988777666666677999999999987642 22468999999999999998765431 1111
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+..-+...- .+.++ ....+....++.-......-.....+.+.+..||..||+.|.|+.=|.+++.
T Consensus 433 qlpfe~evG~hP--t~e~m---------q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 433 QLPFEAEVGNHP--TLEEM---------QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred cCchhHHhcCCC--CHHHH---------HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 111111111000 00000 0111111111110111111134566899999999999999999999999999
Q ss_pred HHHHHhh
Q 042075 1015 SIKNILL 1021 (1033)
Q Consensus 1015 ~i~~~~~ 1021 (1033)
++....+
T Consensus 502 ~l~~~~~ 508 (534)
T KOG3653|consen 502 ELMMLWE 508 (534)
T ss_pred HHhccCC
Confidence 9977664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=356.33 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=206.8
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc----Cc-hhHHHHHHHHHHHHhcC-CCCceeEeeeecccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL----HH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 781 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 781 (1033)
....+|.+.+.||+|+||.|+.|.+..+++.||+|+++.. .. ...+.+.+|+.++++++ ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev----- 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV----- 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence 4467899999999999999999999999999999987643 11 23456778999999998 9999999999
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
+......++||||+.||+|.+++. ..+++.+.++..++.|++.|++|+|++ ||+||||||+||+++.
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~----------~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIV----------NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG 155 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHH----------HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence 445557999999999999999994 356788899999999999999999999 9999999999999999
Q ss_pred C-CcEEEeecccceecC-CCCccccccccccccccccccccCCCC-CC-cccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 862 E-MIAHVGDFGLATFLP-LSHAQTSSIFAKGSIGYIAPEYGLGSE-VS-INGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 862 ~-~~~kL~DfG~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+ +++||+|||++.... .+. .....+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. ..
T Consensus 156 ~~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~ 227 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SN 227 (370)
T ss_pred CCCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----cc
Confidence 9 999999999999774 222 222355999999999999977 86 779999999999999999999974 22
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIEC-LVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
............ ...+... ..++.+++.+|+..||.+|+|+.+|+ .-.-+
T Consensus 228 ~~~l~~ki~~~~----------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~ 278 (370)
T KOG0583|consen 228 VPNLYRKIRKGE----------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWF 278 (370)
T ss_pred HHHHHHHHhcCC----------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence 222222211110 0011112 45689999999999999999999999 44444
Q ss_pred HH
Q 042075 1017 KN 1018 (1033)
Q Consensus 1017 ~~ 1018 (1033)
+.
T Consensus 279 ~~ 280 (370)
T KOG0583|consen 279 QK 280 (370)
T ss_pred cc
Confidence 43
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.09 Aligned_cols=284 Identities=23% Similarity=0.286 Sum_probs=206.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
.|+..+++|+|+||.||+|...++++.||||..-..... -.+|+++|++++|||||++.-+|......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466778999999999999999999999999987643322 2479999999999999999988765443323456799
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-CcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~Df 870 (1033)
||||+. +|.++++... ..+..++...+.-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+|||||
T Consensus 101 leymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 999976 9999996421 2456788888999999999999999998 99999999999999966 89999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh--hhCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK--TALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~~ 947 (1033)
|.|+....+..... +..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.. +....+... +.+.
T Consensus 171 GSAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 171 GSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIKVLG 243 (364)
T ss_pred CcceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHHHhC
Confidence 99999876665543 3479999999998885 699999999999999999999999863 222222211 1111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
....+.+...-.... +.. ...........-.....+++..+++.++++++|.+|.++.|++.. +.++++
T Consensus 244 ~Pt~e~I~~mn~~y~-~~~-~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYT-EFK-FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CCCHHHHhhcCcccc-ccc-CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111111111111100 000 000000000001122345678999999999999999999999864 455543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.93 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=205.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
...|+..+.||+|+||.||+|.+..+++.||+|++... .....+++++|+.++.+++++||.++|+. +-.+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccH
Confidence 34677889999999999999999999999999999854 34456889999999999999999999998 4455588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
+++|||+.||++.+.++ ....+.+.++.-|.+++..|+.|||++ +.+|||||+.||++..+|.+|++
T Consensus 87 wiiMey~~gGsv~~lL~----------~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----------SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred HHHHHHhcCcchhhhhc----------cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence 99999999999999994 334457777888999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+..+....... ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+..... +.+...+.+..++
T Consensus 154 DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP 229 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPP 229 (467)
T ss_pred ecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCC
Confidence 999998776544333 335699999999999988999999999999999999999999853222 1111000111111
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. + + ..+.+.+.+++..|+++||+.||+|.++++.
T Consensus 230 ~--------L--------------------~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 R--------L--------------------D--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c--------c--------------------c--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0 0 0 0245669999999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=339.42 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=202.1
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------------hhHHHHHHHHHHHHhcCCCCceeE
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------------GAFKSFIAECNTLKNIRHRNLVKI 773 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 773 (1033)
+..+.|++.+.||+|.||.|-+|++..+++.||||++.+... ...++..+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456789999999999999999999999999999999963211 123578999999999999999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccc-cCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS-LNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
+++..+ ...+..|||+|||..|.+...- .... ++..++++++++++.||+|||.+ |||||||
T Consensus 174 iEvLDD---P~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 174 IEVLDD---PESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred EEeecC---cccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 998653 3456899999999888765432 2233 99999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeecccceecCCCCcc---ccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCC
Q 042075 853 KPSNVLLDEEMIAHVGDFGLATFLPLSHAQ---TSSIFAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRK 925 (1033)
Q Consensus 853 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~vl~elltg~ 925 (1033)
||+|+|++++|++||+|||.+.....+... ..-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999999876332111 1111245999999999987732 357789999999999999999
Q ss_pred CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 926 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
.||-.. ..+..+ .+ ++...+ ..+...+..+++.+++.++|.+||++|.+
T Consensus 317 ~PF~~~----~~~~l~-~K--------Ivn~pL------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 317 LPFFDD----FELELF-DK--------IVNDPL------------------EFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred CCcccc----hHHHHH-HH--------HhcCcc------------------cCCCcccccHHHHHHHHHHhhcChhheee
Confidence 998522 111111 11 111111 11112244567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042075 1006 MTNVVHQLQSI 1016 (1033)
Q Consensus 1006 ~~evl~~L~~i 1016 (1033)
..+|..+..--
T Consensus 366 l~~ik~Hpwvt 376 (576)
T KOG0585|consen 366 LPDIKLHPWVT 376 (576)
T ss_pred hhhheecceec
Confidence 99998765443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.08 Aligned_cols=204 Identities=25% Similarity=0.348 Sum_probs=177.4
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|.+.++||+|+||+||+|+-+.+|..+|+|++++.. ....+-...|-.+|...++|.||++|.. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998543 3445667889999999999999999988 6777
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
++.||||||++||++..+|. ....+++..+.-++.+++.|++.+|+. |+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----------~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----------RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----------hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence 79999999999999999994 456799999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCC---------------------ccc-----cc-------------------ccccccccccccccc
Q 042075 866 HVGDFGLATFLPLSH---------------------AQT-----SS-------------------IFAKGSIGYIAPEYG 900 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~---------------------~~~-----~~-------------------~~~~gt~~y~aPE~~ 900 (1033)
||+|||++.-+...+ ... .. ...+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 999999985432100 000 00 012499999999999
Q ss_pred CCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 901 LGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 901 ~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
.+..|+..+|.||+|||+|||+.|.+||..
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCS 390 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.74 Aligned_cols=274 Identities=23% Similarity=0.354 Sum_probs=209.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc--CCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+.+..+.||+|.||+||+|.++ |+.||||++...+ .+.+.+|.+|.+.+ +|+||+.+++.=.. +-..-...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEE
Confidence 34567789999999999999998 7889999997543 36677888888765 99999999886211 11112357
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEeccCCCCCeEecCCC
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD-----CQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~ 863 (1033)
++|.+|.+.|+|.|||. ...++....++++..+|.||+|||.. .+|.|+|||||+.||||.+++
T Consensus 285 wLvTdYHe~GSL~DyL~-----------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN-----------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEeeecccCCcHHHHHh-----------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 89999999999999994 36789999999999999999999976 378999999999999999999
Q ss_pred cEEEeecccceecCCCCc--cccccccccccccccccccCCCC------CCcccchHHHHHHHHHHHhC----------C
Q 042075 864 IAHVGDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLGSE------VSINGDVYSYGILLLELVTR----------K 925 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~vl~elltg----------~ 925 (1033)
.+.|+|+|+|........ .......+||.+|||||++...- --..+||||||.|+||+..+ +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999987755432 22333456999999999976531 22558999999999999874 3
Q ss_pred CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 926 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
.||......+..++++.+...-+..+..+.. ++. ..++...+.++|+.||..+|..|-|
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn--------------------rW~-s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN--------------------RWK-SDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCc--------------------ccc-cCHHHHHHHHHHHHhhcCCchhhhH
Confidence 5666555555555554433322222222222 221 2245678999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhh
Q 042075 1006 MTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 1006 ~~evl~~L~~i~~~~~~ 1022 (1033)
+-.+.+.|.++.+...+
T Consensus 493 ALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 493 ALRIKKTLAKLSNSDEK 509 (513)
T ss_pred HHHHHHHHHHHhcChhh
Confidence 99999999999865443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=343.33 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=204.9
Q ss_pred CCCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchh---HHHHHHHHHHHHhcCCCCceeE
Q 042075 697 SFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRNLVKI 773 (1033)
Q Consensus 697 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l 773 (1033)
....++.+++. ......||+|+++.||+|.+ +++.||||+++...... .+.+.+|+.++++++||||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34455666652 22236899999999999998 48899999987543322 4678899999999999999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
++++.+. .......++||||+++|+|.++++. ...+++....+++.|++.|++|||+.. +++|||||
T Consensus 84 ~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlk 150 (283)
T PHA02988 84 YGFIIDI-VDDLPRLSLILEYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLT 150 (283)
T ss_pred eeeEEec-ccCCCceEEEEEeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCC
Confidence 9987531 1223468999999999999999953 346889999999999999999999732 78899999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
|+||++++++.+||+|||+++....... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999986543221 1347899999999876 68999999999999999999999999632
Q ss_pred ccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 932 FEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ............. +...+..+++.+.+++.+||+.||++|||++|+++
T Consensus 226 ~-----~~~~~~~i~~~~~--------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 226 T-----TKEIYDLIINKNN--------------------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred C-----HHHHHHHHHhcCC--------------------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 1111111100000 00011124567899999999999999999999999
Q ss_pred HHHHHHH
Q 042075 1012 QLQSIKN 1018 (1033)
Q Consensus 1012 ~L~~i~~ 1018 (1033)
.|+.++.
T Consensus 275 ~l~~~~~ 281 (283)
T PHA02988 275 NLSLYKF 281 (283)
T ss_pred HHHHHHh
Confidence 9998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.75 Aligned_cols=197 Identities=25% Similarity=0.330 Sum_probs=176.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||.|+||.|.+++.+.+|..+|+|+++...- ...+...+|..+|+.+.||.++++++. +.+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCCe
Confidence 467889999999999999999999999999999975432 334567789999999999999999998 455669
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||++||-|..++++ .+++++..++-+|.||+.|++|||+. +|++||+||+|||+|++|.+||
T Consensus 119 lymvmeyv~GGElFS~Lrk----------~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK----------SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHHh----------cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEE
Confidence 9999999999999999964 45688889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
+|||+|+..... ....+|||.|+|||++....|..++|.|||||++|||+.|.+||..
T Consensus 186 tDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 186 TDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred EeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 999999976443 2235699999999999999999999999999999999999999863
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.46 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=206.6
Q ss_pred CCCccceecccCceeEEEEEeCCCC---eE-EEEEEeec---cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGK---TI-VAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
+-...++||+|+||.||+|+.+..+ .. ||||..+. .......++.+|+++|++++|||||++||++..
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~----- 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL----- 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----
Confidence 4455689999999999999986432 23 89999884 335667899999999999999999999999643
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++|||+|+||+|.+||++ ....++..++..++.+.|.||+|||++ +++||||.++|+|++.++.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k---------~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKK---------NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence 4478999999999999999964 334699999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++.-... ........-+..|+|||.+....|++++|||||||++||+++ |..||...... +...
T Consensus 301 vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~ 373 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKA 373 (474)
T ss_pred EEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHH
Confidence 999999998854311 111112235789999999999999999999999999999999 88898633211 1111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
.... ...+...+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 374 kI~~--------------------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 KIVK--------------------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHh--------------------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0000 011111222346678999999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.29 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=211.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchh-HHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+...+.++||+|-||+|.+++.. .+..||||+++...... ..+|.+|+++|.+++||||++++|+|... +..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence 34567789999999999999987 47999999998765444 48899999999999999999999998543 3789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+|||++|+|.+|+.++. ..........+|+.|||.||+||.+. ++||||+.++|+|+|.++++||+|
T Consensus 612 mI~EYmEnGDLnqFl~ahe--------apt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHE--------LPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhcc--------CcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecC
Confidence 9999999999999996521 12245556678999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccCCccHHHHHhhhCC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
||+++.+-.+..+......+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....++ ...+-.....+
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~ 758 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFR 758 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcC
Confidence 999997766666665555567889999999999999999999999999999876 67787533221 11111111111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.. .++.-...+..|+..++++|.+||..|-++||+++++...|.+.
T Consensus 759 ~~-----------------------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQ-----------------------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CC-----------------------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 11122234556888999999999999999999999999988764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=362.34 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=211.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeecccc-ccC-CC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD-YQG-ND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~-~~ 786 (1033)
..++++.++|.+|||+.||.|++...+..||+|++-..+....+.+.+|+++|++++ |+|||.+++...... -.. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 346778899999999999999999877999999987767778889999999999995 999999999422211 112 24
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
+++|.||||+||.|-+++.. .....+++.++++|+.|+++|+++||.. +|+|||||||-+|||++.+++.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~--------Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNT--------RLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred EEEeehhhccCCcHHHHHHH--------HHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 67899999999999999964 2334499999999999999999999986 78899999999999999999999
Q ss_pred EeecccceecCCCCccc-------ccccccccccccccccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 867 VGDFGLATFLPLSHAQT-------SSIFAKGSIGYIAPEYG---LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
|||||.|...-...... .......|+.|+|||++ .+...++|+|||||||+||-|+....||+....-.
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la- 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA- 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-
Confidence 99999997543322111 11112379999999985 56789999999999999999999999997431110
Q ss_pred cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 937 NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+++.. + .++........+.+||+.||+.||++||++-||++.+.++
T Consensus 266 ----------------Ilng~----Y--------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 266 ----------------ILNGN----Y--------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------------EEecc----c--------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 11110 0 1111112356799999999999999999999999999998
Q ss_pred HHHh
Q 042075 1017 KNIL 1020 (1033)
Q Consensus 1017 ~~~~ 1020 (1033)
....
T Consensus 312 ~~~~ 315 (738)
T KOG1989|consen 312 ANKP 315 (738)
T ss_pred hcCC
Confidence 8654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.86 Aligned_cols=271 Identities=20% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCCccceecccCceeEEEEEeCC----------------CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE----------------GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKI 773 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 773 (1033)
++|++.++||+|+||.||+|.+.. ++..||+|+++... .....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999998642 34579999987543 3334678999999999999999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccc---------cccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET---------EEAPRSLNLLQRLDIGIDVACALSYLHHDCQ 844 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 844 (1033)
++++. ..+..++||||+++|+|.+++......... ......+++.++.+++.||+.||+|||+.
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99953 345789999999999999998543221111 11234578899999999999999999999
Q ss_pred CCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-
Q 042075 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT- 923 (1033)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt- 923 (1033)
+|+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999986544332222222335788999999988899999999999999999987
Q ss_pred -CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC
Q 042075 924 -RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002 (1033)
Q Consensus 924 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1002 (1033)
+..||..... .................. ....+..++..+.+++.+||+.||++
T Consensus 237 ~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 237 CKEQPYGELTD--EQVIENAGEFFRDQGRQV-----------------------YLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred cCCCCCCcCCH--HHHHHHHHHHhhhccccc-----------------------cccCCCCCCHHHHHHHHHHccCCchh
Confidence 5566643211 111111110000000000 00001124567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 042075 1003 RMDMTNVVHQLQ 1014 (1033)
Q Consensus 1003 RPt~~evl~~L~ 1014 (1033)
|||+.||.+.|+
T Consensus 292 RPs~~~i~~~l~ 303 (304)
T cd05096 292 RPSFSDIHAFLT 303 (304)
T ss_pred CcCHHHHHHHHh
Confidence 999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.85 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=203.9
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||.||+|++.. +++.||||+++... ....+.+.+|+++++.+ +|+||++++++|.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 3478999999999999999998643 34579999987533 33446788999999999 8999999999953
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCC----------------------------------------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITRE---------------------------------------------------- 810 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 810 (1033)
..+..++||||+++|+|.++++.....
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 445789999999999999998542110
Q ss_pred --------ccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcc
Q 042075 811 --------DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882 (1033)
Q Consensus 811 --------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 882 (1033)
.........+++.++.+++.||++||+|||++ ||+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 00001224588999999999999999999999 9999999999999999999999999999866443322
Q ss_pred ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCC
Q 042075 883 TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSD 961 (1033)
Q Consensus 883 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 961 (1033)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+...........
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~------------ 335 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS------------ 335 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc------------
Confidence 22222235678999999998899999999999999999997 999986432111 1111111000000
Q ss_pred chhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 962 DEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.+...++++.+++.+||+.||++|||+.+|++.|+++
T Consensus 336 ------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 ------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0001235689999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.58 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=198.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|++|+++++++ ..++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 4778899999999999999999899999999986432 22234577899999999999999999984 445589
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--------MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHh--------hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999988743 1234588999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||++......... ....||..|+|||++.+..++.++||||+||++|||++|+.||....... ....... ....
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~ 219 (285)
T cd05631 145 DLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDR-RVKE 219 (285)
T ss_pred eCCCcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHH-Hhhc
Confidence 99999875433221 22348999999999999999999999999999999999999996422110 0011100 0000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
.. ...+...+..+.+++.+||+.||++||+ ++++++.
T Consensus 220 ~~---------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQ---------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cc---------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 0001123456889999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.62 Aligned_cols=284 Identities=20% Similarity=0.198 Sum_probs=200.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.++||+|+||.||+|++..+++.||||+++.. ......++.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999999989999999998642 223345688999999999999999999987544333334689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+. ++|.+++. ....+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|
T Consensus 81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence 9999995 68999884 234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcc-ccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ...........
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~ 224 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL 224 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence 9999864322211 11122458999999999866 6789999999999999999999999853211 00001111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhh-hhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQAR-INSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+................ ........ ........+.+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000000 00000000 00001234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.81 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=204.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeec--cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++.|++.+.||+|.|+.||++....+|+.+|+|++.. ......+++.+|++|.+.++||||+++.+. +...+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 4678889999999999999999999999999998852 334466889999999999999999999998 667779
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.|+|+|+|.|++|..-+- .+..+++..+-..+.||++||.|+|.+ +|||||+||+|+++-. .--
T Consensus 85 ~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCc
Confidence 999999999999987662 345678889999999999999999999 9999999999999953 336
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+|..+..+... ....|||+|||||++...+|+..+|||+.|||+|-++.|.+||.... ....+++..+.
T Consensus 152 vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-~~rlye~I~~g 227 (355)
T KOG0033|consen 152 VKLADFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYEQIKAG 227 (355)
T ss_pred eeecccceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhcc
Confidence 999999999988733332 33569999999999999999999999999999999999999996321 11122222221
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.-. .+. + ....++..+++++|+..||++|.|+.|.++.
T Consensus 228 ~yd~~-----~~~--------------------w---~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 228 AYDYP-----SPE--------------------W---DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccCCC-----Ccc--------------------c---CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11100 000 0 1234557899999999999999999998764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.70 Aligned_cols=284 Identities=23% Similarity=0.305 Sum_probs=207.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCC-ceeEeeeecccc-ccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRN-LVKILTACSGVD-YQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~ 785 (1033)
...|...++||+|+||+||+|+.+.+|+.||+|+++... ++......+|+.++++++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 445777889999999999999999999999999997543 345567789999999999999 999999975432 2233
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||++ -+|.+++....... ..++...+..+++||+.||+|||++ +|+||||||+||+++++|.+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcE
Confidence 47889999994 59999996532211 4567788999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+|+....+... ....++|..|+|||++.+. .|+...||||+|||++||+++++.|....+ +.+..+-
T Consensus 160 KlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~I 233 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRI 233 (323)
T ss_pred eeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHH
Confidence 99999999976533322 3334589999999999887 789999999999999999999998764332 3332221
Q ss_pred ---h-CCc-chhhhcccccCCCchhhhhccchhhhh-hh--hhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HH
Q 042075 945 ---A-LPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQ-AR--INSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQ 1014 (1033)
Q Consensus 945 ---~-~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~ 1014 (1033)
. .+. ..+..+... .++.. ....+. .+ ............+++.+|++++|++|.|++.++++ +.
T Consensus 234 f~~lGtP~e~~Wp~v~~~--~~~k~-----~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 234 FRLLGTPNEKDWPGVSSL--PDYKA-----PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred HHHcCCCCccCCCCcccc--ccccc-----cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 1 111 111111100 00000 000010 00 00001111467899999999999999999999986 55
Q ss_pred HH
Q 042075 1015 SI 1016 (1033)
Q Consensus 1015 ~i 1016 (1033)
.+
T Consensus 307 ~~ 308 (323)
T KOG0594|consen 307 EL 308 (323)
T ss_pred cc
Confidence 44
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.66 Aligned_cols=248 Identities=21% Similarity=0.305 Sum_probs=206.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+|++.+.||+|.||.|-+|.....|+.||||.+++.. ..+.-.+.+|++||+.++||||+.+|.+ |+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence 47888999999999999999998899999999987543 3334567899999999999999999999 777889
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
..+||||..+|.|++|+. ..+.+++.++.++++||+.|+.|+|.+ +|+|||+|.+|||+|+++++||
T Consensus 128 IvivMEYaS~GeLYDYiS----------er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKI 194 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYIS----------ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKI 194 (668)
T ss_pred EEEEEEecCCccHHHHHH----------HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeee
Confidence 999999999999999994 567899999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||++-.+.......+ ++|++-|.+||++.+.+|. +.+|-||+||++|.++.|..||+.. +...+++...
T Consensus 195 ADFGLSNly~~~kfLqT---FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs 266 (668)
T KOG0611|consen 195 ADFGLSNLYADKKFLQT---FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQIS 266 (668)
T ss_pred eccchhhhhccccHHHH---hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhh
Confidence 99999998876665554 4599999999999999884 8899999999999999999999732 2222222211
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.....+ ++-+....-++++||..+|++|.|+.+|...-
T Consensus 267 ~GaYrE-----------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 RGAYRE-----------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccccC-----------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111100 01122356789999999999999999998654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=346.81 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=201.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|...++||+|+||.|++|..+.+++.+|||++++. ..++.+..+.|.+|+... +||.+++++.+ ++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 346899999999999999999999999999999999864 345667888999999888 59999999998 777
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.++.|+||||+.||++..+. ....+++..+.-++..|+.||+|||++ |||+||||.+|||+|.+|+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~-----------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI-----------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE-----------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 88999999999999954444 346789999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++.--.... .....+||+.|||||++.+..|+.++|.|||||++|||+.|..||....++
T Consensus 507 ~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------- 574 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------- 574 (694)
T ss_pred EEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------
Confidence 99999999986432222 223356999999999999999999999999999999999999998632111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
++.|..+..++ ..|..++.+..++|++++..+|++|..+
T Consensus 575 -------e~FdsI~~d~~----------------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -------EVFDSIVNDEV----------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------HHHHHHhcCCC----------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12222221111 0122345678999999999999999866
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.62 Aligned_cols=279 Identities=22% Similarity=0.250 Sum_probs=201.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|+||+||+|+++.+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47999999999999999999999899999999987432 23346778999999999999999999984 455689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999877765542 234688999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh--hhC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK--TAL 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~ 946 (1033)
|||++.......... .....|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... ...
T Consensus 143 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07848 143 DFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPL 220 (287)
T ss_pred eccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCC
Confidence 999998764332211 122348999999999998899999999999999999999999986422111 0111000 000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+........... ........................+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSNP--RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhccc--hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110000000000 000000000000000000011124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.53 Aligned_cols=281 Identities=22% Similarity=0.306 Sum_probs=199.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++ ..+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~ 77 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCe
Confidence 45789999999999999999999998999999999874332 2234677899999999999999999984 44558
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||++ ++|.+++.. ....++..++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 144 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDK---------HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKL 144 (303)
T ss_pred EEEEEECCC-cCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 899999995 688887742 234588889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+........
T Consensus 145 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 222 (303)
T cd07869 145 ADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222 (303)
T ss_pred CCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhC
Confidence 99999975433221 1122348999999998765 45889999999999999999999999643221111111111100
Q ss_pred Ccc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 PDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... .............+....... ......+ ........+.+++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 223 TPNEDTWPGVHSLPHFKPERFTLYSP-KNLRQAW-NKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCChhhccchhhccccccccccccCC-ccHHHHh-hccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000000000000000000000 0000000 00012345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.02 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=203.0
Q ss_pred CCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
++|++.+.||+|+||.||+|++ .+++..||||+++... ....+.+.+|+.+++.+ +||||++++++| .
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----~ 109 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----T 109 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----c
Confidence 4789999999999999999974 3456789999987432 33446788999999999 899999999995 3
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCcc---------------------------------------------------
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDE--------------------------------------------------- 812 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------- 812 (1033)
..+..++||||+++|+|.++++.......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 44578999999999999999964221000
Q ss_pred --------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCC
Q 042075 813 --------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878 (1033)
Q Consensus 813 --------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~ 878 (1033)
.......+++.++.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 001123588999999999999999999999 999999999999999999999999999987644
Q ss_pred CCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccc
Q 042075 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDST 957 (1033)
Q Consensus 879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 957 (1033)
...........++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+........
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 336 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM--------- 336 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC---------
Confidence 332222222235678999999999999999999999999999998 888885321111 111111100000
Q ss_pred cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 958 LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 958 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus 337 ---------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ---------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00011235689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.79 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=198.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||++++++ +.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 47899999999999999999999899999999986432 2234668899999999999999999988 445568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.++++. ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN----------SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEE
Confidence 9999999999999999842 34688899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 143 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~ 212 (291)
T cd05612 143 TDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILA 212 (291)
T ss_pred EecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh
Confidence 9999998654321 123489999999999998999999999999999999999999853211 111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
.. . ..+......+.+++.+||+.||++||+ ++|+++.
T Consensus 213 ~~--------~--------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 213 GK--------L--------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CC--------c--------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 0 000112345889999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=306.92 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=208.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+.++|++.+.||+|-||.||.|+.+.++-.||+|++.+.. .....++.+|++|-+.++||||+++|++ +.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 3568899999999999999999999999999999986432 2345788999999999999999999999 4556
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+++||.++|.+...|+. .....+++.....++.|+|.|+.|+|.+ +|+||||||+|+|++.++..
T Consensus 95 ~riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence 689999999999999999963 3445677888889999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||.+..-+... ....+||..|.|||+..+..++..+|+|++|++.||++.|.+||+... .+..+.+..+..
T Consensus 164 kiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~ 238 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD 238 (281)
T ss_pred eccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc
Confidence 999999998644222 222459999999999999999999999999999999999999997443 222233222211
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
+ ..+........+++.+|+..+|.+|.+..|+++.-
T Consensus 239 ~--------------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 L--------------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred c--------------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1 11223445689999999999999999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=344.03 Aligned_cols=200 Identities=27% Similarity=0.340 Sum_probs=174.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||.||+|++..++..||+|+++... ....+++.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 468999999999999999999999999999999987543 23446789999999999999999999985 344578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence 999999999999999842 345888999999999999999999852 69999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999976533221 123489999999999999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.47 Aligned_cols=279 Identities=23% Similarity=0.300 Sum_probs=198.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 467999999999999999999999899999999987433 22345678999999999999999999984 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDN---------CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred EEEEeCCCc-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence 999999975 99998843 234578899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++........ .....+++.|+|||++.+ ..++.++||||+||++|||++|++||...... ..+....+ ...
T Consensus 146 DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~-~~~ 221 (288)
T cd07871 146 DFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFR-LLG 221 (288)
T ss_pred cCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhC
Confidence 99999765332211 122347999999998865 56899999999999999999999998632211 11111111 111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
....+.... .....+.......................+..+++.+|++.||++|||++|+++
T Consensus 222 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 222 TPTEETWPG-ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCChHHhhc-cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100000000 000000000000000000000000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=338.58 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=215.8
Q ss_pred CCccceecccCceeEEEEEeCCC----CeEEEEEEeec-cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 713 FTSANLIGAGSFGSVYKGILDEG----KTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+..+.||+|.||.||+|....- .-.||||..+. ......+.|..|+.+|+.++||||++++|+|.+. .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 34567899999999999998532 34599999886 3445578899999999999999999999998543 5
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++|||.++-|-|+.|++. ....++..+...++.||+.||+|||+. .+|||||..+||||.....+||
T Consensus 465 ~WivmEL~~~GELr~yLq~---------nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---------NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eeEEEecccchhHHHHHHh---------ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 8999999999999999964 456789999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+++.++.+..+..+. ..-+..|||||.+.-++++.++|||-|||.+||++. |..||......+..
T Consensus 533 aDFGLSR~~ed~~yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------- 602 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------- 602 (974)
T ss_pred cccchhhhccccchhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------
Confidence 9999999987776655542 335778999999999999999999999999999988 99999643322210
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
..-..+.|.+.++.|++.++.+|.+||++||.+||++.|+...|+++..
T Consensus 603 -----------------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -----------------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----------------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 0112234566677899999999999999999999999999999999876
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.54 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=210.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|..++++|+|+||.++.++++.+++.||+|.+.... ....+...+|+.++++++|||||.+.+. |..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCc
Confidence 467999999999999999999999999999999987433 3344577899999999999999999998 444455
Q ss_pred -eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 788 -KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 788 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
.+|||+|++||++.+.+.+ ..+..+++..+.+++.|++.|+.|||++ .|+|||||+.||+++.++.||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred eEEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCcee
Confidence 9999999999999999964 2356789999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+|+.......... ...||+.||+||.+.+.+|..|+||||+||++|||++-+++|... +....+.+..
T Consensus 147 LgDfGlaK~l~~~~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~ 219 (426)
T KOG0589|consen 147 LGDFGLAKILNPEDSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKIN 219 (426)
T ss_pred ecchhhhhhcCCchhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHh
Confidence 999999998876652222 245999999999999999999999999999999999999998632 2222222111
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
... .++. +.....++..++..|++.+|+.||++.+++.+-
T Consensus 220 ~~~----~~Pl-----------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 220 RGL----YSPL-----------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred hcc----CCCC-----------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 111 1111 112345689999999999999999999999883
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=338.15 Aligned_cols=280 Identities=23% Similarity=0.285 Sum_probs=199.3
Q ss_pred CCCCccceecccCceeEEEEEeC-CCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc---CCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-EGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~ 784 (1033)
++|++.+.||+|+||+||+|++. .+++.||+|+++... ......+.+|+.+++++ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999985 357889999987432 22234566788777766 6999999999986444445
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++||||++ ++|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 567899999996 699998853 2234588999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|++||...... ..+......
T Consensus 149 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV 224 (290)
T ss_pred EEEccccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH
Confidence 99999999987643321 12234899999999998889999999999999999999999998643211 111111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.......+.. ... ..... ... . ..............+.+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~-~~~-~~~~~-~~~-~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWP-RDV-ALPRQ-AFH-S-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhch-hhh-cccch-hcc-C-CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 000 00000 000 0 0000000011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.87 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=200.9
Q ss_pred CCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.+.||+|+||.||+|.+. ..+..||+|+++... ......+.+|+.++++++||||+++++++ ..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecCC
Confidence 46889999999999999999874 346789999987543 23346788999999999999999999985 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.+++.. ....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence 88999999999999999853 234689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
++|||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .......
T Consensus 148 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~ 221 (266)
T cd05064 148 ISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAV 221 (266)
T ss_pred ECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHH
Confidence 9999987654322211 1111235678999999999999999999999999999775 9999863211 1111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
. +. . +.+.+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 222 ~-~~-------~-------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 E-DG-------F-------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H-CC-------C-------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 00 0 0001123456689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=344.22 Aligned_cols=271 Identities=23% Similarity=0.327 Sum_probs=206.2
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||.||+|.... +++.||+|+++... ....+.+.+|+.+++++ +|+||++++++|.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---- 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT---- 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence 3579999999999999999997533 35789999987432 23346778899999999 8999999999874
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc--------------------------------------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 812 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 812 (1033)
..+...+++|||+++++|.+++........
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 334578899999999999999854221000
Q ss_pred -ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccc
Q 042075 813 -TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891 (1033)
Q Consensus 813 -~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt 891 (1033)
.......+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.............++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 000123689999999999999999999999 9999999999999999999999999999876443322222223467
Q ss_pred cccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccc
Q 042075 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGN 970 (1033)
Q Consensus 892 ~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 970 (1033)
..|+|||++.+..++.++|||||||++|||++ |..||......+ .+..... ....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~~~------------------- 294 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EGTR------------------- 294 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----ccCC-------------------
Confidence 78999999999999999999999999999998 999985321111 1111100 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 971 QRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 971 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
...+....+++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 295 -------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 295 -------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00011224568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.25 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=198.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 357899999999999999999999899999999987432 23346788999999999999999999984 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----------AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEE
Confidence 89999999999999999842 34578888999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++....... ...||+.|+|||++.+..++.++|||||||++|||++|+.||... ... .......
T Consensus 159 l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~-~~~~~i~ 228 (329)
T PTZ00263 159 VTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPF-RIYEKIL 228 (329)
T ss_pred EeeccCceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHH-HHHHHHh
Confidence 999999987643221 234899999999999999999999999999999999999998521 111 1111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
... . ..+......+.+++.+||+.||++||+ ++++++.
T Consensus 229 ~~~--------~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 AGR--------L--------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCC--------c--------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000 0 000012345789999999999999997 5777654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=344.93 Aligned_cols=243 Identities=21% Similarity=0.253 Sum_probs=194.1
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 47999999999999999899999999997432 23345678899999999999999999984 45568999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.+++. ....+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999999984 335688999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1033)
+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~--- 212 (323)
T cd05571 143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI--- 212 (323)
T ss_pred cccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC---
Confidence 753222111 122448999999999999999999999999999999999999985321 1111111100000
Q ss_pred cccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 954 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
..+....+++.+++.+||+.||++|| ++.++++.
T Consensus 213 -------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 -------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 00112245688999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=371.08 Aligned_cols=481 Identities=29% Similarity=0.394 Sum_probs=285.6
Q ss_pred EEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCc-cccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 89 LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPS-EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 89 l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
+|.+..++. .||..+..-..++.|+++.|.+- ..|- .+.+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 445555555 45655555555778888887765 3332 2333444888888888876 778888888888888888888
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCccc
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 247 (1033)
|. ..|.+..++.+|++|.|.+|++. ..|..+..+.+|++|+++.|++. .+|..+..++.++.+..++|.....++
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg-- 154 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG-- 154 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc--
Confidence 87 67777778888888888888777 77777888888888888888877 677777778888888888872221221
Q ss_pred ccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhcccc
Q 042075 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLS 327 (1033)
Q Consensus 248 l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~ 327 (1033)
.. .++.+++..|.+.+.++.++.. +.. .|+|.+|.+. -..+.++.+|+.|.++.|+++...- ..++|+
T Consensus 155 --~~-~ik~~~l~~n~l~~~~~~~i~~-l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~---~g~~l~ 222 (1081)
T KOG0618|consen 155 --QT-SIKKLDLRLNVLGGSFLIDIYN-LTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI---SGPSLT 222 (1081)
T ss_pred --cc-cchhhhhhhhhcccchhcchhh-hhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe---cCcchh
Confidence 11 2667777777777776665542 222 4777777775 2345666677777777777653211 224555
Q ss_pred ceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCE
Q 042075 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR 407 (1033)
Q Consensus 328 ~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~ 407 (1033)
.|+.+.|.+...... .--.+|.+++++.|++++. |.++... .+|+.+...+|+++ .+|..+...++|+.
T Consensus 223 ~L~a~~n~l~~~~~~--------p~p~nl~~~dis~n~l~~l-p~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDVH--------PVPLNLQYLDISHNNLSNL-PEWIGAC-ANLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred eeeeccCcceeeccc--------cccccceeeecchhhhhcc-hHHHHhc-ccceEecccchhHH-hhHHHHhhhhhHHH
Confidence 666666665521111 1123455555555555542 3444443 45555555555552 44555555555555
Q ss_pred EEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccc---eeceeeccccccCCCCCCccCCCCcccEEecCCC
Q 042075 408 LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL---KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484 (1033)
Q Consensus 408 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 484 (1033)
|++.+|.++ -+|+...+++.|++|+|..|+|. ..|+.+... .+..|+.+.|.++...--.=..++.|+.|++.+|
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 555555555 44445555555555555555555 333322221 1444555555554221111112345666666666
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCccc
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIP 564 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (1033)
+++...=+-+-+...+ +.|+|++|+|.......+.++..|++|+||+|+|+ .+|+++.++..|++|...+|+|. ..|
T Consensus 370 ~Ltd~c~p~l~~~~hL-KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHL-KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred cccccchhhhccccce-eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 6665444444444555 66666666666322234556666666666666666 56666666666666666666666 555
Q ss_pred ccccCcccCCccccccccccccCCcccccccccceeecCCCc
Q 042075 565 SSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNND 606 (1033)
Q Consensus 565 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 606 (1033)
.+..+++|+.+|+|.|+|+-..-......++|++|||++|.
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 56666666666666666664332222223666666666665
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=342.17 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=203.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe----EEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.+|++.+.||+|+||.||+|++..+++ .||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 479999999999999999999865554 48999987443 3445778899999999999999999999742
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++|+||+++|+|.++++. ....+++..++.++.||+.||+|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence 246799999999999999953 234588899999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+......
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~ 226 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK 226 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhC
Confidence 9999999987654333222222235678999999999999999999999999999998 9999853211 011111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.. +...+..+..++.+++.+||+.+|++||++.+++..+..+....
T Consensus 227 ~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 GE------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00 00001123345889999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.37 Aligned_cols=265 Identities=23% Similarity=0.403 Sum_probs=205.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCC-----eEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGK-----TIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
++|++.+.||+|+||.||+|.....+ +.||+|.++... .....++.+|+.++++++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46889999999999999999986544 679999987433 23346789999999999999999999985 34
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccc------cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDET------EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
.+..+++|||+++++|.+++.......+. ......+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 45789999999999999999643221110 11225689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMN 937 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~ 937 (1033)
+++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999986543332222222346788999999988899999999999999999998 99998532111 1
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
....... . .. ...+..++.++.+++.+||+.||++||+++||+++|++
T Consensus 235 ~~~~i~~---~--------~~-------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS---R--------QL-------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc---C--------Cc-------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1110000 0 00 00112345779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=345.67 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=201.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++ ..++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 46899999999999999999999889999999997432 23346688999999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence 999999999999999994 234688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..... ..
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~--~~ 214 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKY--WK 214 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHh--cc
Confidence 99999986533 112234899999999999999999999999999999999999998632111 00110000 00
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ........ .......++.+++.+||..+|++||+++|+++.
T Consensus 215 ~~----~~~~~~~~------------------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ET----LQRPVYDD------------------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc----ccCCCCCc------------------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 00000000 001234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.68 Aligned_cols=270 Identities=25% Similarity=0.350 Sum_probs=205.9
Q ss_pred hhCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcC-CCCceeEeeeecccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 781 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 781 (1033)
..++|++.+.||+|+||.||+|++.. .+..||||+++... ....+.+.+|+++++++. ||||++++++|.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 35688999999999999999998742 23579999997433 233467899999999995 999999999963
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCcc-------------------------------------------------
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------------------------- 812 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------- 812 (1033)
..+..++||||+++|+|.++++.......
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 44578999999999999999864321000
Q ss_pred -------------------------------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 813 -------------------------------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 813 -------------------------------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
.......+++.++..++.|+++|++|||+. +|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence 000123588899999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccC
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEG 934 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~ 934 (1033)
||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999987644332222222336788999999998899999999999999999997 99998633211
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+.. ... . .+...+..++.++.+++.+||+.||++||++.+|.+.|+
T Consensus 347 ~~~~~~-~~~----~--------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 347 STFYNK-IKS----G--------------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHH-Hhc----C--------------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 110000 000 0 000111234567899999999999999999999999998
Q ss_pred HHH
Q 042075 1015 SIK 1017 (1033)
Q Consensus 1015 ~i~ 1017 (1033)
++.
T Consensus 396 ~l~ 398 (400)
T cd05105 396 SLL 398 (400)
T ss_pred HHc
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.82 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=204.7
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhc-CCCCceeEeeeec
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNI-RHRNLVKILTACS 778 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 778 (1033)
.--+.|...+.+|+|..++|.++..+.++..+|+|++..... .-.+.-.+|+.||+++ .||+|+++.++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~-- 91 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV-- 91 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee--
Confidence 334568888999999999999999999999999999863221 1124556899999999 79999999999
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
|+.+...++|+|.|+.|.|.||+ .....+++.+..+|++|+.+|++|||.+ .|||||+||+|||
T Consensus 92 ---yes~sF~FlVFdl~prGELFDyL----------ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENIL 155 (411)
T KOG0599|consen 92 ---YESDAFVFLVFDLMPRGELFDYL----------TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENIL 155 (411)
T ss_pred ---ccCcchhhhhhhhcccchHHHHh----------hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhee
Confidence 67777999999999999999999 4567899999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
+|++.++||+|||+|+.+..+..... .+|||+|.|||.+.- ..|+..+|+||+|||+|.++.|.+||..
T Consensus 156 lddn~~i~isDFGFa~~l~~GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-- 230 (411)
T KOG0599|consen 156 LDDNMNIKISDFGFACQLEPGEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-- 230 (411)
T ss_pred eccccceEEeccceeeccCCchhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--
Confidence 99999999999999998877655443 459999999998642 3578889999999999999999999852
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+..+..++. +.-.+.-.+ +-.+......+++.+|++.||.+|.|++|+++.
T Consensus 231 RkQmlMLR~Im----eGkyqF~sp-----------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 231 RKQMLMLRMIM----EGKYQFRSP-----------------------EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHHHH----hcccccCCc-----------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111111111 110011111 111234568999999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.54 Aligned_cols=200 Identities=27% Similarity=0.345 Sum_probs=173.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.++||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||++++++|. .++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 468999999999999999999999899999999987542 334467899999999999999999999953 45589
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.++++. ...+++..+..++.|++.|++|||+.+ +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEe
Confidence 999999999999999942 345788899999999999999999742 79999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999875532211 123489999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.23 Aligned_cols=251 Identities=31% Similarity=0.476 Sum_probs=192.5
Q ss_pred ccceecccCceeEEEEEeC----CCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 715 SANLIGAGSFGSVYKGILD----EGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999997 4568899999965433 34688999999999999999999999975 334589
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. .....+++.++..|+.||++||+|||++ +++||||+++||++++++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKS--------KNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHH--------TCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccc--------cccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999999964 2346789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||++....................|+|||.+.+..++.++||||||+++||+++ |+.||.... ...+.......
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~~~~~ 221 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEKLKQG 221 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccc
Confidence 999987733332222233347789999999998889999999999999999999 678875321 11111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
. +...+..++..+.+++.+||+.||++|||+.+++++|
T Consensus 222 ~---------------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 Q---------------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp E---------------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c---------------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 0111112345689999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=340.38 Aligned_cols=240 Identities=23% Similarity=0.294 Sum_probs=191.1
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++ ..++..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 69999999999999989999999998743 233446778899999999999999999884 4456899999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999842 34588999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ..............
T Consensus 143 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~~----- 210 (312)
T cd05585 143 NMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEPL----- 210 (312)
T ss_pred CccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCCC-----
Confidence 432221 112245899999999999999999999999999999999999998532 11111111111000
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD---MTNVVH 1011 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 1011 (1033)
..+....+++.+++.+||+.||++||+ +.|++.
T Consensus 211 -----------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 -----------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 001123356889999999999999985 566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.85 Aligned_cols=266 Identities=22% Similarity=0.368 Sum_probs=202.6
Q ss_pred hhCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....++.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 4568999999999999999999864 235779999886432 23445688999999999999999999985
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
..+...++||||+++++|.++++..............+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 344578999999999999999964322211112234578889999999999999999998 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 941 (1033)
+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~ 230 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQV 230 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence 9999999999876543322222122235788999999998899999999999999999999 688875321 1111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
........... .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11000000000 00123456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.13 Aligned_cols=243 Identities=22% Similarity=0.264 Sum_probs=193.3
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|++++++++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4799999999999999989999999999743 223345677899999999999999999984 44568999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 999999999884 234688999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1033)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~~~--- 212 (323)
T cd05595 143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEI--- 212 (323)
T ss_pred ccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCC---
Confidence 75322211 11223489999999999999999999999999999999999999853211 111111100000
Q ss_pred cccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 954 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
..+....+++.+++.+||+.||++|| ++.++++.
T Consensus 213 -------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 -------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00012245688999999999999998 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.69 Aligned_cols=269 Identities=24% Similarity=0.405 Sum_probs=207.9
Q ss_pred CCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|.+.+.||+|+||.||++.. ..++..||+|.++.......+.+.+|++++++++||||++++++|. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4688999999999999999985 2346679999987665556678999999999999999999999953 44
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcc---ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDE---TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
+..++||||+++++|.+++........ .......+++.++..++.|++.||+|||++ |++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 578999999999999999964221100 112234589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 941 (1033)
+.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-----~~ 231 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EV 231 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HH
Confidence 9999999999986543322211122235778999999998899999999999999999998 89988532211 11
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
........... .+..++.++.+++.+||+.||.+|||+.|+.+.|+.+...
T Consensus 232 ~~~i~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVLQ---------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11000000000 0001235689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=328.16 Aligned_cols=262 Identities=20% Similarity=0.309 Sum_probs=206.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|+...+++.||||.++.. .......+.+|++++++++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 5799999999999999999999889999999987642 2333457889999999999999999999853 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.... .....++..++..++.|++.||+|||++ +++||||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 899999999999999885311 1234578899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.+.......... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+......
T Consensus 148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~ 222 (267)
T cd08228 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQ 222 (267)
T ss_pred CccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhc
Confidence 9999998764332211 123478899999999888899999999999999999999999853211 11111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.. .+. ......+..+.+++.+||+.+|++||++.+|++.+++++
T Consensus 223 ~~-----~~~---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CD-----YPP---------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC-----CCC---------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 000 001123456899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.21 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=203.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|++++++++||||++++++|. .++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 35788899999999999999999889999999987533 33567889999999999999999999853 4457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. .....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLRE--------CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence 9999999999999853 2334689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .........
T Consensus 149 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~--- 219 (263)
T cd05052 149 GLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE--- 219 (263)
T ss_pred ccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH---
Confidence 9998764332211 111224668999999988899999999999999999998 899975321 111111100
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.... ...+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 220 ------~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 ------KGYR------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CCCC------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0000 000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.38 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=197.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC-eEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK-TIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 347899999999999999999876544 78999998642 223346788999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLR----------RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 68999999999999999994 234688999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .. ......
T Consensus 171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~-~~~~~i 240 (340)
T PTZ00426 171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----PL-LIYQKI 240 (340)
T ss_pred EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----HH-HHHHHH
Confidence 999999998754321 12348999999999998889999999999999999999999986321 10 011110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
... .. . .+......+.+++.+|++.||++|+ +++|+++.
T Consensus 241 ~~~--------~~-~-------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 LEG--------II-Y-------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred hcC--------CC-C-------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000 00 0 0001234578999999999999995 88888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.50 Aligned_cols=243 Identities=22% Similarity=0.278 Sum_probs=194.3
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4799999999999999989999999999743 223446778899999999999999999884 45568999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 76 y~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLS----------RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence 999999999884 234689999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1033)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~~~~--- 212 (328)
T cd05593 143 KEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEDI--- 212 (328)
T ss_pred ccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhccCCc---
Confidence 75322211 1122358999999999999899999999999999999999999985321 1111111110000
Q ss_pred cccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 954 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
. .+.....++.+++.+||+.||++|| ++.|+++.
T Consensus 213 ---~----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 ---K----------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---c----------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 0011235588999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.41 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=213.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+.+..++||.|.||.||.|.|+.-.-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|.. +...||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYI 340 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYI 340 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEE
Confidence 3456778999999999999999988889999998753 3456899999999999999999999999853 336899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|+|||..|+|-+||+++. ...++.-..+.++.||+.||+||..+ .+|||||.++|.||.++..+|++||
T Consensus 341 iTEfM~yGNLLdYLRecn--------r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN--------RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred EEecccCccHHHHHHHhc--------hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence 999999999999997643 34466677889999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|+++.+..+. ++......-...|.|||.+....++.|+|||+|||++||+.| |-.||... ++.+.+
T Consensus 410 GLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY------- 476 (1157)
T KOG4278|consen 410 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY------- 476 (1157)
T ss_pred chhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHH-------
Confidence 9999876543 233333445778999999999999999999999999999999 88887532 111111
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
+++ ..+.|++.+..|++.++++|+.||+++|.+||++.|+-+.++.+-
T Consensus 477 --~LL------------------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 477 --GLL------------------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --HHH------------------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 111 223455566789999999999999999999999999999998764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=340.67 Aligned_cols=195 Identities=30% Similarity=0.398 Sum_probs=171.1
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-C-----CCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-H-----RNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~ 785 (1033)
+|.+.+.||+|+||.|.+|.+..+++.||||+++.... ...+...|+.+|+.++ | -|+|+++++ +...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 78999999999999999999999999999999986543 3466788999999996 4 389999999 5556
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC--
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-- 863 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-- 863 (1033)
++.|||+|.+ .-+|+++++. .....++...++.|+.||+.||.+||+. +|||+||||+|||+.+-+
T Consensus 261 ~HlciVfELL-~~NLYellK~--------n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKN--------NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred cceeeeehhh-hhhHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence 6999999988 5699999975 4556799999999999999999999999 999999999999997443
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
.+||+|||.|+....... .+..+..|+|||++.+.+|+.+.||||||||++||++|.+.|.
T Consensus 329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 799999999997543332 2447899999999999999999999999999999999988765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=345.30 Aligned_cols=274 Identities=19% Similarity=0.221 Sum_probs=197.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+|++.+.||+|+||.||+|.+..+++.||+|... .+.+.+|++++++++||||+++++++ ..+...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence 57999999999999999999999999999999743 24567899999999999999999985 44557899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|||++. ++|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 161 v~e~~~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 161 ILPRYK-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEecCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence 999994 68888884 234588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccC--C----ccHHHHHhh
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG--D----MNLHNFAKT 944 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~--~----~~~~~~~~~ 944 (1033)
|+|+....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ..+......
T Consensus 227 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 227 GAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred Ccccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 99975322211 1122245999999999999999999999999999999999999886422111 0 011111111
Q ss_pred hCCcchhhhcccccCCCchhhh---hccchhhh--hhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLA---VHGNQRQR--QARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.-.. ..+.. ........... ........ ...+....+.+.++.+++.+||+.||++|||++|+++.
T Consensus 306 ~g~~-p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 306 SGTH-PNEFP-IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hcCC-hhhcC-cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 00000 00000000000 00000000 01111223456678999999999999999999999863
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=353.55 Aligned_cols=255 Identities=20% Similarity=0.211 Sum_probs=202.4
Q ss_pred CCCccceecccCceeEEEEEeCCC-CeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEG-KTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.|.+.+.||+|++|.||+|....+ ++.||+|............+.+|+.+++.++||||++++++| ..++..|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 488999999999999999998776 788999987655555556778899999999999999999995 44568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++|+|.++++... .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence 999999999999885311 1334688999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~~ 288 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGKY 288 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC
Confidence 99987654332222233458999999999999999999999999999999999999985321 1111111100000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
++ .+..+..++.+++.+||+.||++||++.+++..
T Consensus 289 ----~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 ----DP-----------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CC-----------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 001123568999999999999999999999753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=353.70 Aligned_cols=267 Identities=22% Similarity=0.257 Sum_probs=207.7
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
+.....++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|+.++..++|+||+++++.+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344567999999999999999999999989999999998643 23445678899999999999999998876543221
Q ss_pred c---CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 783 Q---GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 783 ~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
. .....++||||+++|+|.++++... .....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl 176 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILL 176 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence 1 1123689999999999999995321 2345689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~ 251 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NME 251 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHH
Confidence 999999999999998764433222223345899999999999999999999999999999999999998532 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
............ ..+...++++.+++.+||+.||++||++.++++.
T Consensus 252 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLAGRYD---------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111110000 0011234568999999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.42 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=200.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe----EEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.+.||+|+||+||+|.+..+++ .|++|.+.... .....++..|+.++++++||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 468889999999999999999976665 47777775332 233467788888999999999999999853 2
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++++||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 346799999999999999953 234689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||.++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ....+....
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~ 226 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEK 226 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence 9999999987643332222223346788999999988899999999999999999998 9999853211 011111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
.... ..+..+...+.+++.+||..||++|||+.|+++.|..+..
T Consensus 227 ~~~~------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERL------------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcC------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0000 0000123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=340.62 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=192.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|+..++||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++ ..++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 356678899999999999999998999999999864432 3346788999999999999999999984 4556889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+.. ..++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence 999999999986543 234567788999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+++........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..+......
T Consensus 212 fG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCA 287 (353)
T ss_pred cccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHH
Confidence 9999876432211 122348999999998743 2345789999999999999999999862211 111111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ....+..+..++.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQ---------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccC---------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000011234568999999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.22 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=203.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||+||+|.+..+ ...||||+++... .....++.+|+.++++++||||+++++++ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 35789999999999999999998643 4579999987543 33446788999999999999999999984 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ....+++.++.+++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCE
Confidence 578999999999999999853 234689999999999999999999998 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~ 220 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKA 220 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Confidence 9999999987652222222222235678999999998899999999999999999998 9999853211 111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..... +.+.+..+++++.+++.+||+.+|++||++.||++.|+++
T Consensus 221 ~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 VEDGY---------------------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 0000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.82 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=202.7
Q ss_pred CC-CccceecccCceeEEEEEe----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GF-TSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+| ++.+.||+|+||+||++.. ..+++.||+|+++.... .....+.+|++++++++||||++++++|.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 44 8899999999999987653 34678899999875432 345678899999999999999999998642 234
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ..+++.++..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcE
Confidence 467899999999999999842 3489999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... +......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~ 223 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGP 223 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcc
Confidence 9999999987644322111 11123567799999998889999999999999999999999997532111 1111110
Q ss_pred hCCc----chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 945 ALPD----HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 945 ~~~~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.... ...+..+.. .+...+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 224 KQGQMTVVRLIELLERG------------------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccccchhhhhhhhhcC------------------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 000000000 001111234567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.77 Aligned_cols=365 Identities=29% Similarity=0.504 Sum_probs=194.7
Q ss_pred CCCCCEEEecCCCccc-cCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccccee
Q 042075 107 LSFLKVLDLHNNSFHH-EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 185 (1033)
|+..+-.|+++|.|+| ..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-..+..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 4455556666666663 45555555566666655555554 55555555555555555555554 333444445555555
Q ss_pred eecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 186 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++.+|++.. .-+|..+..+..|+.||||+|+++ ..|..+.+.+++-+|+||+|+|.
T Consensus 84 ~~R~N~LKn-----------------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie 139 (1255)
T KOG0444|consen 84 IVRDNNLKN-----------------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE 139 (1255)
T ss_pred hhhcccccc-----------------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc
Confidence 555554431 113444444555555555555555 44555555555666666666665
Q ss_pred CccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccch
Q 042075 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345 (1033)
Q Consensus 266 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 345 (1033)
.||..++.+|..|-+||||+|++. .+|+.+..+.+|++|+|++|.+.-.
T Consensus 140 -tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hf----------------------------- 188 (1255)
T KOG0444|consen 140 -TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHF----------------------------- 188 (1255)
T ss_pred -cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHH-----------------------------
Confidence 677777777777777777777777 5666677777777777777776410
Q ss_pred hhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCC-ccCCccccCCCCCCEEEcccCcccccCChhhh
Q 042075 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIF-GNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIG 424 (1033)
Q Consensus 346 ~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 424 (1033)
.+..++.+ ++|+.|.+++.+=+ ..+|.++..+.+|..+|+|.|.+. .+|+.+-
T Consensus 189 QLrQLPsm-------------------------tsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 189 QLRQLPSM-------------------------TSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred HHhcCccc-------------------------hhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 01122222 23344444443322 245556666666666666666665 5566666
Q ss_pred cCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhh
Q 042075 425 ELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVL 504 (1033)
Q Consensus 425 ~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L 504 (1033)
++++|+.|+||+|+|+ . +.-..+...+|+.|+||.|+++ .+|+.++.++.+ +.|
T Consensus 243 ~l~~LrrLNLS~N~it-e-----------------------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL-~kL 296 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKIT-E-----------------------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL-TKL 296 (1255)
T ss_pred hhhhhheeccCcCcee-e-----------------------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHH-HHH
Confidence 6666666666666655 1 1112223334444445555444 444444444444 444
Q ss_pred hccCcccc-CCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCcccccccc
Q 042075 505 ELSRNQLT-GPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNN 582 (1033)
Q Consensus 505 ~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 582 (1033)
++.+|+++ .-+|..++.|.+|+.+..++|++. ..|+.++.|.+|+.|.|++|+|- .+|+++.-|+.|+.|||.+|.
T Consensus 297 y~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 297 YANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 44444433 114444555555555555555554 44555555555555555555554 445555555555555555443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.50 Aligned_cols=265 Identities=26% Similarity=0.438 Sum_probs=204.4
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|.+.+.||+|+||.||+|.... +++.||||+++..... ..+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 3468889999999999999998743 3578999998754443 4578999999999999999999999953
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCcc----ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDE----TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
.....++||||+++++|.++++....... .......+++.++..++.|++.|++|||++ +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 44588999999999999999964321100 012345689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNL 938 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 938 (1033)
+.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~ 233 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EV 233 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence 9999999999999986533322111122235788999999999999999999999999999998 99998532111 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
..... ... ... .+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 234 ~~~~~---~~~--------~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECIT---QGR--------LLQ-------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHH---cCC--------cCC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11100 000 000 00113456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.15 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=201.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||.||+|... ++..||+|.++... ...+.+.+|+.++++++|+||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence 357899999999999999999976 56779999876433 2357889999999999999999999884 4455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. .....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 78 IITEYMAKGSLLDFLKS--------DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEecCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence 99999999999999853 2345678889999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+.......... .....++..|+|||++....++.++|||||||++|||++ |+.||...... ...........
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~- 222 (261)
T cd05072 147 FGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR- 222 (261)
T ss_pred CccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC-
Confidence 99998764432211 112235678999999988889999999999999999998 99998532111 11111100000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+....++.++.+++.+||+.+|++||+++++.+.|++
T Consensus 223 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 -----------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00001124568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=328.00 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=207.2
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+...+|++.++||+|+||.||+|.+.. ++.||+|+++.........+.+|+.+++.++||||+++++++. ..+.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCC
Confidence 345678999999999999999999986 8899999998665555678899999999999999999999853 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.++++. .....+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl 145 (261)
T cd05148 77 VYIITELMEKGSLLAFLRS--------PEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKV 145 (261)
T ss_pred eEEEEeecccCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEE
Confidence 8999999999999999964 2345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+........... ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...+... ....
T Consensus 146 ~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~~~~~-~~~~ 221 (261)
T cd05148 146 ADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQI-TAGY 221 (261)
T ss_pred ccccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH-HhCC
Confidence 99999986643322211 2236778999999988899999999999999999998 8999853211 0011100 0000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+...+..+++++.+++.+||+.||++|||++++.+.|+.+
T Consensus 222 ------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ------------------------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0001123346689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.53 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred CCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCC
Q 042075 713 FTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 786 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 786 (1033)
|.+.+.||+|+||.||+|....+ +..||+|+++... ....+.+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998643 4789999987432 2345678999999999999999999998754332 2233
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence 579999999999999998542211 1234689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.....
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~~~ 228 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYDYL 228 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence 999999987654433222222235678999999988899999999999999999999 8888753211 0111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.... . ...+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ~~~~--------~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGN--------R-------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCC--------C-------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0 000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=329.40 Aligned_cols=270 Identities=24% Similarity=0.406 Sum_probs=208.5
Q ss_pred CCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.+|.+.+.||+|+||.||+|++. .++..|++|.++.......+.+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 35788899999999999999863 245679999987655555678899999999999999999999953 44
Q ss_pred CceeEEEEcccCCchhhhcccCCCC------ccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITRE------DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
+..++||||+++++|.+++...... .........+++..++.++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 5789999999999999999643211 00112234589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNL 938 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 938 (1033)
++++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---- 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999986544322222222336788999999999899999999999999999999 99998532111
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
............. .+..++..+.+++.+||+.+|++||++++|+++|+++.+
T Consensus 233 -~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 -EVIECITQGRVLE---------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHHHHHhCCCCCC---------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111000000000 001134568999999999999999999999999999976
Q ss_pred Hh
Q 042075 1019 IL 1020 (1033)
Q Consensus 1019 ~~ 1020 (1033)
..
T Consensus 285 ~~ 286 (291)
T cd05094 285 AT 286 (291)
T ss_pred hc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.50 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=196.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|+++ ++..+|+|.++... ...+.+.+|++++++++||||++++++| ...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence 46888999999999999999987 45679999876432 2346788999999999999999999985 34457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence 9999999999999853 223588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~~ 218 (256)
T cd05114 145 GMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRGF 218 (256)
T ss_pred CCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCC
Confidence 9998653322211 112235678999999988889999999999999999999 8999853211 11111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. ..+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus 219 ------~~---------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 ------RL---------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CC---------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00 00001234689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=327.16 Aligned_cols=265 Identities=23% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCccceecccCceeEEEEEeCCCCe--EEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCCc
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKT--IVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDF 787 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 787 (1033)
|.+.++||+|+||.||+|++..+++ .||+|.++.. .....+.+.+|++++++++||||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999876654 6899988643 23445778999999999999999999998743221 12235
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++...+. ......+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRL----GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcc----cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 7899999999999998743111 12334589999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |+.||..... ........
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~--- 228 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLR--- 228 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH---
Confidence 99999987644332221222236778999999999899999999999999999999 7888853211 11111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.... ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 229 ~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNR---------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 000112345589999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.65 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=203.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCe----EEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.++||+|+||+||+|++..+++ .||+|+++... ......+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3578899999999999999999866655 48999987433 3345678899999999999999999998642
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
...+++|||+++|+|.++++. ....+++.+++.++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 246799999999999999853 234689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+.... ........
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~ 225 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE 225 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Confidence 99999999987654332222222235678999999988899999999999999999998 8999853211 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.... ...+..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 226 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 226 KGER------------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCc------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1000 000112345688999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.32 Aligned_cols=274 Identities=25% Similarity=0.375 Sum_probs=205.1
Q ss_pred CCCCccceecccCceeEEEEEe----CCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+|++.+.||+|+||+||+|.. ..+++.||+|.++.......+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788999999999999999984 34688999999876665666788999999999999999999998642 2344
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ ||+||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 68999999999999999853 234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|..|+..... .+.......
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~ 225 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGND 225 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccc
Confidence 999999987644332111 1111245569999999888999999999999999999998877532110 000000000
Q ss_pred CC-cc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 946 LP-DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 946 ~~-~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.. .. .....+ ......+...+..++.++.+++.+||+.+|++|||+.||++.|++++
T Consensus 226 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 226 KQGQMIVYHLIE---------------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccchHHHHH---------------HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00 00 000000 00000011112234567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=329.73 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=198.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+|++.++||+|+||+||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4888999999999999999998889999999986432 12234567899999999999999999984 445589
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--------MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence 999999999999988843 1234689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||++......... ....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......... ....
T Consensus 145 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~~~-~~~~ 219 (285)
T cd05605 145 DLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVER-RVKE 219 (285)
T ss_pred eCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHHHH-Hhhh
Confidence 99999875433221 123489999999999988999999999999999999999999863211 000011100 0000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
. ....+...+..+.+++.+||+.||++|| +++++++.
T Consensus 220 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 D---------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred c---------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 0000112345689999999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=368.95 Aligned_cols=485 Identities=27% Similarity=0.333 Sum_probs=326.8
Q ss_pred eEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcc
Q 042075 85 RVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 164 (1033)
.++.++++.|.+-..--+.+.+--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. .+|.+.+++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3566666665543211122233334778888888776 67777777888888888888877 777777788888888888
Q ss_pred cccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCC
Q 042075 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244 (1033)
Q Consensus 165 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 244 (1033)
.|.+. ..|..+..+.+|++|++|+|++. .+|..+..++.+..+..++|......+. .. ++.++|..|.+.+.+
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----TS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----cc-chhhhhhhhhcccch
Confidence 88777 77788888888888888888877 7777777777788888888732212222 22 777777778777777
Q ss_pred cccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhc
Q 042075 245 PSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQ 324 (1033)
Q Consensus 245 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~ 324 (1033)
+..+.+++. .|||..|.+. .... ..+.+|+.|....|++... --..++|+.|+.++|.++... ....-.
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~-~~dl---s~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~-~~p~p~ 241 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME-VLDL---SNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLD-VHPVPL 241 (1081)
T ss_pred hcchhhhhe--eeecccchhh-hhhh---hhccchhhhhhhhcccceE----EecCcchheeeeccCcceeec-cccccc
Confidence 777777666 6788888776 3222 2466777777777777622 123456777788888777322 223345
Q ss_pred cccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCC
Q 042075 325 RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK 404 (1033)
Q Consensus 325 ~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~ 404 (1033)
+|+.++++.|.+...+ ..+..+.+|+.+.+..|++ ..+|..++.. ++|+.|.+.+|.+. -+|+...+++.
T Consensus 242 nl~~~dis~n~l~~lp-------~wi~~~~nle~l~~n~N~l-~~lp~ri~~~-~~L~~l~~~~nel~-yip~~le~~~s 311 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-------EWIGACANLEALNANHNRL-VALPLRISRI-TSLVSLSAAYNELE-YIPPFLEGLKS 311 (1081)
T ss_pred cceeeecchhhhhcch-------HHHHhcccceEecccchhH-HhhHHHHhhh-hhHHHHHhhhhhhh-hCCCcccccce
Confidence 6777788888777654 1245667777777777777 4566666654 57788888888876 45666777778
Q ss_pred CCEEEcccCcccccCChhhhcCCC-CcEEEccccccccccCcccccc-e-eceeeccccccCCCCCCccCCCCcccEEec
Q 042075 405 LLRLEMWNNRLSGTIPPAIGELQN-LRELRLQENRFLGNIPPSIGNL-K-LFNLQLSYNFLQGSIPSSLGQSETLTIIDL 481 (1033)
Q Consensus 405 L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l-~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 481 (1033)
|++|+|..|+|....+..+.-+.. |+.|..+.|++. ..|..=+.. . |+.|.|.+|.++...-..+.+...|++|+|
T Consensus 312 L~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 312 LRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 888888888887333333333333 677777777776 344222222 2 777888888887776667777778888888
Q ss_pred CCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccC
Q 042075 482 SNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561 (1033)
Q Consensus 482 s~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (1033)
++|+|. .+|+....-...|+.|+||+|+|+ .+|+.+..+..|++|...+|++. ..| ++..+++|+.+|+|.|+|+.
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 888887 677665554445577888888887 67777888888888888888887 666 77788888888888888764
Q ss_pred c-ccccccCcccCCccccccccccccCCcccccccccceeecCCC
Q 042075 562 P-IPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605 (1033)
Q Consensus 562 ~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 605 (1033)
. +|... .-++|++|||++|.-.-.--..|..+.++..++++-|
T Consensus 467 ~~l~~~~-p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 467 VTLPEAL-PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhC-CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 3 23322 2277888888888633233445556666666666655
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.62 Aligned_cols=279 Identities=24% Similarity=0.276 Sum_probs=198.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc---CCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|++.+.||+|+||+||+|++..+++.||+|.++... ......+.+|+.+++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999987432 22234556777777665 799999999987654444456
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||++ ++|.+++.. .....+++.++..++.|++.||+|||+. ||+||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK--------VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 7899999997 489888853 2234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++......... ...+|..|+|||++.+..++.++||||+||++|||++|++||...... ..+........
T Consensus 149 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhC
Confidence 99999998664332211 234789999999999889999999999999999999999998532111 11111111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
......+. ........... . ...........+..+++.+++.+|++.||++|||+.|++.
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWP-RDVTLPRGAFS---P-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCc-ccccccccccC---C-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000000000 0 0000000011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=344.82 Aligned_cols=201 Identities=22% Similarity=0.299 Sum_probs=171.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|++++.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5889999999999999999999999999999997432 23446788999999999999999999995 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEe
Confidence 999999999999999842 34578889999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCc---------------------------------------------cccccccccccccccccccCCC
Q 042075 869 DFGLATFLPLSHA---------------------------------------------QTSSIFAKGSIGYIAPEYGLGS 903 (1033)
Q Consensus 869 DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 903 (1033)
|||+++....... ........||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999764311000 0000123599999999999988
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 904 EVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 904 ~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=336.78 Aligned_cols=245 Identities=23% Similarity=0.283 Sum_probs=191.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHH---HhcCCCCceeEeeeeccccccCCC
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTL---KNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ ++++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678899999999999999999899999999997432 22345666776665 456899999999984 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++++|..+++ ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence 8999999999999998874 23589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++........ .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 142 L~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~ 214 (324)
T cd05589 142 IADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIV 214 (324)
T ss_pred eCcccCCccCCCCCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 9999998753222211 1224589999999999999999999999999999999999999863211 11111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1011 (1033)
... . ..+...++.+.+++.+||+.||++|| ++.++++
T Consensus 215 ~~~--------~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 NDE--------V--------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hCC--------C--------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000 0 00111245578999999999999999 4566555
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.83 Aligned_cols=267 Identities=22% Similarity=0.375 Sum_probs=204.4
Q ss_pred CCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+|++.+.||+|+||.||+|.... +...||+|.+.... ....+++.+|+.+++.++||||+++++.|. .+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47888999999999999998742 33678999886443 234567889999999999999999999853 44
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcc--------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEecc
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDE--------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCD 851 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 851 (1033)
+..++||||+++++|.+++...+.... .......+++.++..++.|++.|++|||+. +|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 578999999999999999865322111 011234689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCc
Q 042075 852 LKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDI 930 (1033)
Q Consensus 852 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~ 930 (1033)
|||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543332222222336778999999988889999999999999999998 9999853
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
.. ..... +.+..... ...+..++.++.+++.+||+.+|++||+++|++
T Consensus 233 ~~-----~~~~~---------~~~~~~~~------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 233 IA-----PERLF---------NLLKTGYR------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CC-----HHHHH---------HHHhCCCC------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 21 11111 11110000 000112345688999999999999999999999
Q ss_pred HHHHHHHH
Q 042075 1011 HQLQSIKN 1018 (1033)
Q Consensus 1011 ~~L~~i~~ 1018 (1033)
+.|+++-.
T Consensus 281 ~~l~~~~~ 288 (290)
T cd05045 281 KELEKMMV 288 (290)
T ss_pred HHHHHHHh
Confidence 99998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.38 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||++++++|. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 47999999999999998889999999876433 334467899999999999999999999953 345789999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 99999999852 234578999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIV 954 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1033)
...............+..|+|||.+.+..++.++|||||||++|||++ |..||...... ..........+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~------- 214 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVR------- 214 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC-------
Confidence 443221111111123567999999998889999999999999999998 88887532110 00000000000
Q ss_pred ccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 955 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 955 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+..++.++.+++.+||+.+|++|||+.|+.+.|+
T Consensus 215 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 -----------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -----------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0001123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.87 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=199.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.++++++||||+++++++. .++..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence 47999999999999999999998899999999997654445567889999999999999999999853 4457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.++++. ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 84 v~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcC
Confidence 9999999999999842 34578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|++......... .....++..|+|||.+. ...++.++||||+||++|||++|+.||......+. ..........
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~ 227 (267)
T cd06646 151 GVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ 227 (267)
T ss_pred ccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC
Confidence 999866432211 11234888999999874 34578899999999999999999999852211100 0000000000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.+.. ......+..+.+++.+||+.+|++|||++++++.+
T Consensus 228 -------~~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 -------PPKL--------------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -------CCCC--------------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 00011235689999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.74 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=204.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+.|+..+.||.|.-|+||+|+.++++..+|+|++.+.. .....+.+.|-+||+.++||.++.+|+. ++.+.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 45677899999999999999999999999999997532 3445678889999999999999999999 677779
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+|||||+||+|....++ ...+.+++..++-++.+++-||+|||-. |||.|||||+||||.++|++.|
T Consensus 152 ~cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eEEEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEe
Confidence 9999999999999999865 4667899999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCC----------------------------------C--------------------ccccccccccccc
Q 042075 868 GDFGLATFLPLS----------------------------------H--------------------AQTSSIFAKGSIG 893 (1033)
Q Consensus 868 ~DfG~a~~~~~~----------------------------------~--------------------~~~~~~~~~gt~~ 893 (1033)
+||.++...... . ........+||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999987543110 0 0011122459999
Q ss_pred cccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhh
Q 042075 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQ 973 (1033)
Q Consensus 894 y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 973 (1033)
|.|||++.+...+.++|.|+|||++|||+.|+.||...... ..+ ..++...+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----~Tl---------~NIv~~~l--------------- 352 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----ETL---------RNIVGQPL--------------- 352 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----hhH---------HHHhcCCC---------------
Confidence 99999999999999999999999999999999998633211 111 11111111
Q ss_pred hhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 042075 974 RQARINSKIECLVAMARIGVACSMESPEDRMD----MTNVVH 1011 (1033)
Q Consensus 974 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 1011 (1033)
+.+...+...+..++|++.|.+||++|.. |.||.+
T Consensus 353 ---~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 353 ---KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ---cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 11111234567899999999999999998 777655
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=345.23 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=197.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999899999999997432 23345678899999999999999999984 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEE
Confidence 9999999999999999842 34589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccc------------------------------------cccccccccccccccccCCCCCCcccch
Q 042075 868 GDFGLATFLPLSHAQT------------------------------------SSIFAKGSIGYIAPEYGLGSEVSINGDV 911 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 911 (1033)
+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987643221100 0011348999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHH
Q 042075 912 YSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARI 991 (1033)
Q Consensus 912 wSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 991 (1033)
|||||++|||++|+.||..... .. ......... ... ..+ ......+++.++
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~----~~-~~~~i~~~~------~~~-~~~-----------------~~~~~s~~~~~l 273 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNP----QE-TYRKIINWK------ETL-QFP-----------------DEVPLSPEAKDL 273 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCH----HH-HHHHHHcCC------Ccc-CCC-----------------CCCCCCHHHHHH
Confidence 9999999999999999863211 11 111000000 000 000 000123457889
Q ss_pred HhhccCCCCCCCCC---HHHHHHH
Q 042075 992 GVACSMESPEDRMD---MTNVVHQ 1012 (1033)
Q Consensus 992 ~~~cl~~dP~~RPt---~~evl~~ 1012 (1033)
+.+|+. +|.+|++ +.|+++.
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999996 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=357.29 Aligned_cols=271 Identities=21% Similarity=0.301 Sum_probs=206.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.++||+|+||.||+|++..+++.||+|+++... ....+++.+|++++++++||||+++++++ ..++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 58999999999999999999999899999999986432 23346789999999999999999999985 34557
Q ss_pred eeEEEEcccCCchhhhcccCCCCc-cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITRED-ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
.++||||++||+|.++++...... .........++.++++++.||++||+|||+. ||+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 899999999999999986421111 1112234567888999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc----------------cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 867 VGDFGLATFLPLSHA----------------QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|+|||+++....... ........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987621110 0111123589999999999999999999999999999999999999853
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-CHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-DMTNV 1009 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev 1009 (1033)
....... ..... . .+.. .....+.++.+.+++.+|++.||++|| +++++
T Consensus 234 ~~~~ki~----~~~~i-------~------~P~~-------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKIS----YRDVI-------L------SPIE-------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhhh----hhhhc-------c------Chhh-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1110000 00000 0 0000 000112345688999999999999996 67778
Q ss_pred HHHHHHHHHH
Q 042075 1010 VHQLQSIKNI 1019 (1033)
Q Consensus 1010 l~~L~~i~~~ 1019 (1033)
++.|+...+.
T Consensus 284 l~~Le~~lq~ 293 (932)
T PRK13184 284 KQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHhc
Confidence 8888877553
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.80 Aligned_cols=269 Identities=24% Similarity=0.406 Sum_probs=209.6
Q ss_pred hCCCCccceecccCceeEEEEEeCC----CCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE----GKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||.||+|.+.. ++..|++|+++.. .....+.+.+|+.++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence 5689999999999999999999875 3688999988743 2344567889999999999999999999863 33
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
+...++++||+++++|.+++....... ......+++.++..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence 457899999999999999996432111 11235689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.... ...+.....
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~ 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK 233 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH
Confidence 99999999986544332222222336778999999988889999999999999999999 999985321 111111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
... +......+++++.+++.+||..||++|||+.|+++.|+++.+.
T Consensus 234 ~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGY------------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCC------------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 0000112345689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.75 Aligned_cols=201 Identities=24% Similarity=0.317 Sum_probs=173.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++.+++||+|+++++.+ .++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999999899999999997432 22345678899999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEE
Confidence 999999999999999994 234689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc---------------------------------ccccccccccccccccccCCCCCCcccchHHH
Q 042075 868 GDFGLATFLPLSHAQ---------------------------------TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSY 914 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 914 (1033)
+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999998754321100 00112359999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 042075 915 GILLLELVTRKKPTD 929 (1033)
Q Consensus 915 G~vl~elltg~~p~~ 929 (1033)
||++|||++|+.||.
T Consensus 223 Gvil~ell~G~~Pf~ 237 (363)
T cd05628 223 GVIMYEMLIGYPPFC 237 (363)
T ss_pred HHHHHHHHhCCCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.58 Aligned_cols=265 Identities=22% Similarity=0.379 Sum_probs=201.9
Q ss_pred CCCCccceecccCceeEEEEEe----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.+.||+|+||.||+|.. ..+++.||+|.++... ......+.+|++++++++||||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 4678899999999999999985 2356789999987433 33346788999999999999999999984 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCC-------ccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITRE-------DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
...++||||+++++|.+++...... .........+++.++..++.|++.||+|||++ +|+||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 5789999999999999998532110 00111234588999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMN 937 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~ 937 (1033)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ...
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQE 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence 99999999999999986543332222222335778999999988889999999999999999998 988875321 111
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
..+...... .. ..+..+++++.+++.+||+.||++||++.+|.++|..
T Consensus 235 ~~~~~~~~~---~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQ---LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCC---cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111000 00 0011234568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.10 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=207.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|....+++.||+|.++.. .....+++.+|++++++++|++++++++++ ..++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 5799999999999999999999989999999988632 223356788999999999999999999985 34457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.... .....+++.++..++.|++.|++|||+. ||+||||+|+||++++++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence 899999999999999985321 2345588999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.+.......... ....++..|+|||.+.+..++.++|||||||++|||++|+.||... .............
T Consensus 148 ~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~ 222 (267)
T cd08224 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCKKIEK 222 (267)
T ss_pred eccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHhhhhc
Confidence 9999987654332211 1234788999999998888999999999999999999999998522 1111111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.. .... .....+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 223 ~~--------~~~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CD--------YPPL------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC--------CCCC------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0000 00123456899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.64 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=203.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 35788999999999999999998643 4789999986443 23346788999999999999999999995 3
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.....++||||+++|+|.+++...............+++..+..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 44688999999999999999964322211112334578999999999999999999998 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... .....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~ 231 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVL 231 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHH
Confidence 999999999986543332222222336788999999988889999999999999999998 898885211 11111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
......... ..+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 100000000 001112456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=330.94 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=206.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
..++|++.+.||+|+||.||+|..... ...||+|+++... .....++.+|+++++++ +|+||++++++|
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 445788999999999999999998643 3789999987532 33446788999999999 899999999985
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
..++..++||||+++|+|.++++....... .......+++..++.++.|++.|++|||+. +|+||||||+
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 344578999999999999999964321100 002345789999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccC
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEG 934 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~ 934 (1033)
||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++||+++ |..||....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 239 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 239 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--
Confidence 99999999999999999987654332222222235678999999988899999999999999999998 888875221
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
..+......... +...+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 240 ---~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 240 ---VEELFKLLKEGY---------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred ---HHHHHHHHHcCC---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 111111000000 00011123456899999999999999999999999999
Q ss_pred HHH
Q 042075 1015 SIK 1017 (1033)
Q Consensus 1015 ~i~ 1017 (1033)
++.
T Consensus 290 ~~~ 292 (293)
T cd05053 290 RML 292 (293)
T ss_pred Hhh
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.84 Aligned_cols=271 Identities=23% Similarity=0.318 Sum_probs=203.7
Q ss_pred hCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence 357999999999999999999852 357889999997533 23446788999999999 6899999999863
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc--------------------------------------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 812 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 812 (1033)
..+...++||||+++|+|.++++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 334467899999999999999864221000
Q ss_pred -------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccc
Q 042075 813 -------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885 (1033)
Q Consensus 813 -------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 885 (1033)
.......+++.++..++.|+++|++|||++ +|+||||||+||++++++.+||+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 000123578899999999999999999999 9999999999999999999999999999865333222222
Q ss_pred cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchh
Q 042075 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDED 964 (1033)
Q Consensus 886 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 964 (1033)
....++..|+|||++.+..++.++||||||+++|||++ |..||....... ...........
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~----------------- 300 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR----------------- 300 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC-----------------
Confidence 22335678999999988899999999999999999997 898985321110 00000000000
Q ss_pred hhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 965 LAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
...+....+++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 301 -------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 -------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000123458999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.09 Aligned_cols=255 Identities=33% Similarity=0.480 Sum_probs=201.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|++|.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 457899999999999999999986 457899999875432 346788999999999999999999985 3445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence 99999999999999953 1235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++......... ......+..|+|||+..+..++.++||||||+++|||++ |+.||..... .......
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~--- 217 (261)
T cd05068 147 FGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQV--- 217 (261)
T ss_pred cceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHH---
Confidence 99998765322211 111123457999999998899999999999999999999 9999853211 0000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
+... +...+..++.++.+++.+||+.+|++||++.++++.|++
T Consensus 218 ------~~~~------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 ------DQGY------------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ------HcCC------------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000 000011234568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=337.57 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=192.9
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|++..+++.||+|+++.. .......+..|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 4799999999999999989999999999743 223345678899999999999999999884 45568999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
|+++|+|.+++. ....+++.++..++.||+.||+|||+ . +|+||||||+||++++++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred CCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCC
Confidence 999999999884 23468999999999999999999997 6 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~~-- 213 (325)
T cd05594 143 CKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI-- 213 (325)
T ss_pred CeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcCCC--
Confidence 8754322211 122348999999999999999999999999999999999999985321 1111111000000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
. .+....+++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ----~----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ----R----------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----C----------------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 0011235588999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=343.62 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=198.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||++++++ +..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecC
Confidence 356899999999999999999999999999999998642 12233557889999999999999999988 4456
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCE
Confidence 689999999999999999842 2477888899999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
||+|||.+......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....
T Consensus 182 kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~ 255 (370)
T cd05596 182 KLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGT 255 (370)
T ss_pred EEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HHHH
Confidence 99999999875433221 11224589999999998653 47899999999999999999999986321 1111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED--RMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1012 (1033)
........ .. + ..+.....+.++.+++.+|++.+|++ ||+++|+++.
T Consensus 256 ~~~i~~~~-~~-----~------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 YSKIMDHK-NS-----L------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHcCC-Cc-----C------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11110000 00 0 00000112456889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=343.76 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=201.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++.++||||++++++ +..++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence 47999999999999999999999899999999997432 2345678899999999999999999988 445668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEe
Confidence 9999999999999999953 25688999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCC---------------------------ccccccccccccccccccccCCCCCCcccchHHHHHHHHH
Q 042075 868 GDFGLATFLPLSH---------------------------AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920 (1033)
Q Consensus 868 ~DfG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~e 920 (1033)
+|||++....... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998664432 0011122448999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCC
Q 042075 921 LVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP 1000 (1033)
Q Consensus 921 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1000 (1033)
|++|+.||..... . ........ .. ... ..+.....++++.+++.+|+. ||
T Consensus 223 ll~g~~Pf~~~~~----~-~~~~~i~~-----~~-~~~------------------~~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 223 MLYGFPPFYSDTL----Q-ETYNKIIN-----WK-ESL------------------RFPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred hccCCCCCCCCCH----H-HHHHHHhc-----cC-Ccc------------------cCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 9999999863221 1 11110000 00 000 000000124568899999997 99
Q ss_pred CCCCC-HHHHHHH
Q 042075 1001 EDRMD-MTNVVHQ 1012 (1033)
Q Consensus 1001 ~~RPt-~~evl~~ 1012 (1033)
++||+ ++|+++.
T Consensus 273 ~~R~~s~~~ll~h 285 (350)
T cd05573 273 EDRLGSFEEIKSH 285 (350)
T ss_pred hhcCCCHHHHhcC
Confidence 99999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.43 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=201.2
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.++... ......+.+|+.++++++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 4678999999999999999999976 67889999886433 333456889999999999999999999853
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..++||||+++++|.+++....... .....+++.++++++.||+.|++|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC
Confidence 3446799999999999999996532111 1234689999999999999999999999 999999999999998654
Q ss_pred ---cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 864 ---IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
.+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||+..... ...
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 699999999987633222111111224568999999998999999999999999999997 99998632111 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.... ... +...+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 232 ~~~~------------~~~------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVT------------GGG------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH------------cCC------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1100 000 00001123456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.92 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=191.5
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||+|+||.||+++...+++.||+|++.... ......+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986321 12234556799999999999999999884 4556899999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYN--------VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 99999988853 2334588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
....... ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...............
T Consensus 145 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~---- 216 (277)
T cd05607 145 LKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVK---- 216 (277)
T ss_pred cCCCcee---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccc----
Confidence 6443221 12348999999999998889999999999999999999999986321111 111111111100000
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ......++.+++.+||+.||++||++.|+++.
T Consensus 217 ----~~-------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 217 ----FE-------------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ----cc-------------------cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 00 00123458999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.41 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=190.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCC-CceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~ 787 (1033)
+|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.+++..++|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 588999999999999999999989999999998743 233456778899999999765 577888774 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEE
Confidence 999999999999999984 234578899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~ 215 (324)
T cd05587 143 ADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQSIME 215 (324)
T ss_pred eecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc
Confidence 99999875322211 11224489999999999999999999999999999999999999863211 111111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
.. . . .+....+++.+++.+||+.||++|+++
T Consensus 216 ~~--------~-~-------------------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HN--------V-S-------------------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--------C-C-------------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 0 0 000123457899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=334.69 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=191.9
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||.||+|++..+++.||+|+++.. .....+.+..|.++++.+ +||||+++++++ ..++..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 4699999999999999989999999998743 223345677899998876 899999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence 9999999999884 234588899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~~-- 213 (321)
T cd05591 143 CKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDDV-- 213 (321)
T ss_pred ceecccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC--
Confidence 8754322221 1223489999999999999999999999999999999999999863211 111111110000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-------DMTNVVHQ 1012 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~ 1012 (1033)
..+.....++.+++.+||+.||++|| +++++++.
T Consensus 214 --------------------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 --------------------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00001234588999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.48 Aligned_cols=268 Identities=22% Similarity=0.364 Sum_probs=204.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe--EEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT--IVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.+.||+|+||.||+|....++. .+++|.++.. .....+.+.+|+.+++++ +||||+++++++ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 578999999999999999999876654 4788887742 233456789999999999 799999999985 3445
Q ss_pred ceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++||||+++++|.++++....... .......+++.++..++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 78999999999999999964321111 011234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
+++.+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~ 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CA 225 (297)
T ss_pred CCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HH
Confidence 999999999999864321111 111123567999999988889999999999999999997 999985321 11
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
......... . +...+..++..+.+++.+||+.+|.+||+++++++.|+.+.+.
T Consensus 226 ~~~~~~~~~---------~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 226 ELYEKLPQG---------Y------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHHHhcC---------C------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111110000 0 0000112345689999999999999999999999999998876
Q ss_pred hh
Q 042075 1020 LL 1021 (1033)
Q Consensus 1020 ~~ 1021 (1033)
..
T Consensus 279 ~~ 280 (297)
T cd05089 279 RK 280 (297)
T ss_pred hc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=345.09 Aligned_cols=201 Identities=23% Similarity=0.295 Sum_probs=171.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47899999999999999999999999999999986432 23346788899999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 34578889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc------------c---------------------------------cccccccccccccccccCC
Q 042075 868 GDFGLATFLPLSHAQ------------T---------------------------------SSIFAKGSIGYIAPEYGLG 902 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~ 902 (1033)
+|||+++.+...... . ......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 0 0001348999999999999
Q ss_pred CCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 903 SEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 903 ~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
..++.++|||||||++|||++|+.||.
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.86 Aligned_cols=254 Identities=20% Similarity=0.222 Sum_probs=199.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 47899999999999999999999999999999997532 23446688999999999999999999884 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEe
Confidence 9999999999999999953 234689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL------GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .. .
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~-~ 217 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AK-T 217 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HH-H
Confidence 999999876543322 122235899999999986 45678999999999999999999999853211 11 1
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ ... . .+.....+.++.+++..|++ +|++|||++++++.
T Consensus 218 ~~~i~~~~------~~~-~-----------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 218 YNNIMNFQ------RFL-K-----------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHcCC------Ccc-C-----------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11100000 000 0 00001123558899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=312.30 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=207.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
-|.++++||+|+||.||+|.++++|..||+|.+... ...+++.+|+.+|++.+.|+||++||. |......++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGS-----YFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGS-----YFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhh-----hccCCceEee
Confidence 366788999999999999999999999999988754 345788999999999999999999998 4455679999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
||||..|+..+.++ ..++++++.++..+.+..++||+|||.. .-+|||||+.|||++.+|.+||+|||
T Consensus 107 MEYCGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 107 MEYCGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG 174 (502)
T ss_pred hhhcCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence 99999999999996 3667899999999999999999999998 88999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
.|..+....... ..+.||+.|||||++..-.|+.++||||+|++..||..|++||.....-..
T Consensus 175 VAGQLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------- 237 (502)
T KOG0574|consen 175 VAGQLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------- 237 (502)
T ss_pred ccchhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------
Confidence 998664433222 234599999999999998999999999999999999999999863211100
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+ ..-...++..+..+++...++.+++++|+-..|++|-|+-++++.
T Consensus 238 -I--------------FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 -I--------------FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -e--------------EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0 000011122233455667889999999999999999999998875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=333.61 Aligned_cols=237 Identities=25% Similarity=0.286 Sum_probs=188.3
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|+++.+++.||||+++.. .....+.+..|..+++.. +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4799999999999999989999999998743 223446677888888877 799999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~----------~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQK----------SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 99999999998842 34588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~-- 213 (320)
T cd05590 143 CKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEV-- 213 (320)
T ss_pred CeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCC--
Confidence 8754322211 122348999999999999899999999999999999999999986321 1111111110000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
. .+.....++.+++.+||+.||++||++
T Consensus 214 -------~-------------------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 -------V-------------------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -------C-------------------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 000123457899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.07 Aligned_cols=249 Identities=23% Similarity=0.296 Sum_probs=193.5
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||+|+||+||+|.+..+++.||+|++..... ...+.+..|++++++++||||+++.+++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 6999999999999998999999999864321 2335677899999999999999999884 4456789999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9999998874311 2345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 147 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~------ 217 (280)
T cd05608 147 LKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS------ 217 (280)
T ss_pred cCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC------
Confidence 6443322 122348999999999999999999999999999999999999986321110 0111111000000
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
. ..+...++++.+++.+||+.||++|| +++++++.
T Consensus 218 --~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 --V--------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --C--------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0 00112345688999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.86 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=201.2
Q ss_pred CCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
++|.+.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+++++++ +||||++++++|.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----- 109 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----- 109 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-----
Confidence 4688999999999999999975 2345689999987543 33446788999999999 7999999999853
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..++||||+++|+|.++++. .....+++.++..++.|++.|++|||++ +|+||||||+||++++++
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGK 178 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCC
Confidence 44578999999999999999953 1223389999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
.++++|||.++...............++..|+|||.+.+..++.++||||+||++|||++ |..||......+ ......
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~ 257 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLI 257 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHH
Confidence 999999999986543322111112235778999999999899999999999999999998 999985322111 011110
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..... ...+...++++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 258 ~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYR------------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCc------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000 000001235689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.94 Aligned_cols=242 Identities=21% Similarity=0.292 Sum_probs=188.3
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999899999999997432 22334556677777655 899999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.++++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 99999999998842 34588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~--- 212 (316)
T cd05592 143 CKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDR--- 212 (316)
T ss_pred CeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC---
Confidence 986433221 11223489999999999998999999999999999999999999863211 11111100000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT-NVVH 1011 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 1011 (1033)
+. .+.....++.+++.+||+.||++||++. ++++
T Consensus 213 ---~~----------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 ---PH----------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CC----------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 0011234578999999999999999875 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.17 Aligned_cols=279 Identities=20% Similarity=0.290 Sum_probs=199.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ..++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeE
Confidence 467999999999999999999999899999999987433 22335677899999999999999999995 345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 146 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (309)
T ss_pred EEEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 999999975 88888743 234578899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++......... ....+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......+ ...
T Consensus 147 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~-~~~ 222 (309)
T cd07872 147 DFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFR-LLG 222 (309)
T ss_pred ccccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HhC
Confidence 999997643322211 12347899999998765 46889999999999999999999998633211 11111111 111
Q ss_pred cchhhhcccccCC-CchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....+........ ....... ................+++.+++.+|++.||++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNF--PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhc--CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 1000000000000 0000000 0000000001111244568899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=341.34 Aligned_cols=256 Identities=19% Similarity=0.237 Sum_probs=196.8
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
...++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence 3456899999999999999999999999999999998642 222345678899999999999999999984 45
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~ 180 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGH 180 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCC
Confidence 6689999999999999999842 2478888999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+||+|||+|......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...
T Consensus 181 ~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~----~~~- 254 (370)
T cd05621 181 LKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS----LVG- 254 (370)
T ss_pred EEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC----HHH-
Confidence 999999999876433221 11234599999999998654 37899999999999999999999985321 111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED--RMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1012 (1033)
.... +.+.... ...+...+....+.+++..|+..+|.+ ||++.|+++.
T Consensus 255 ~~~~--------i~~~~~~----------------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 TYSK--------IMDHKNS----------------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHH--------HHhCCcc----------------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110 1100000 000001122455788889999755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=347.06 Aligned_cols=285 Identities=20% Similarity=0.243 Sum_probs=199.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc---CCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ---GND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~ 786 (1033)
..+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.++++++||||+++++++....+. ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999998899999999875432 2345799999999999999999876432221 223
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IA 865 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~ 865 (1033)
..++||||+++ ++.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 56799999974 7777764311 2345689999999999999999999999 999999999999999664 79
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+|+......... ...||+.|+|||++.+. .++.++||||+||++|||++|.+||...... ..+....+.
T Consensus 211 kL~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~ 286 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQV 286 (440)
T ss_pred eeeccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Confidence 999999998664332221 23489999999987664 6899999999999999999999998632111 111111111
Q ss_pred hCCcc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 042075 945 ALPDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIK 1017 (1033)
Q Consensus 945 ~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~ 1017 (1033)
.-... ......+. ..+... ........+...+...++++.+++.+||++||++|||+.|+++. ++.++
T Consensus 287 ~~~p~~~~~~~~~~~----~~~~~~-~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 287 LGTPTEDQLKEMNPN----YADIKF-PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hCCCCHHHHHHhchh----hhcccC-CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 10000 00000000 000000 00000011111122344678999999999999999999999865 44443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.00 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=188.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 4799999999999999999999999999753 223345677899988877 899999999984 4456899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999998884 234689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc---cHHHHHhhhCCcc
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM---NLHNFAKTALPDH 949 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~ 949 (1033)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+. ....+.......
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~- 219 (329)
T cd05618 143 CKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE- 219 (329)
T ss_pred cccccCCCCc--cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-
Confidence 8753222111 1223589999999999999999999999999999999999999963221110 000000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
. +...+......+.+++.+||+.||++||++
T Consensus 220 ------~--------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 ------K--------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------C--------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0 000011223557899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.95 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=192.1
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||.||+|++..+++.||+|+++... ....+.+.+|..+++++ +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 47999999999999999999999999997532 23345678899999998 799999999984 4456889999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence 9999999999884 235689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC---ccHHHHHhhhCCcc
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD---MNLHNFAKTALPDH 949 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~ 949 (1033)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+ .....+.....
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--- 217 (329)
T cd05588 143 CKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--- 217 (329)
T ss_pred ccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---
Confidence 875322111 1122458999999999999999999999999999999999999996321111 00000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD------MTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~ 1011 (1033)
.... ...+.....++.+++.+||+.||++||+ ++++++
T Consensus 218 ----~~~~--------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 218 ----LEKQ--------------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----HcCC--------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0000 0001122456889999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=335.81 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=195.2
Q ss_pred CCCccceecccCceeEEEEEeC---CCCeEEEEEEeecc----CchhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 712 GFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLL----HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.. .....+.+.+|+.+++++ +||+|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 5889999999999999999874 46889999998742 122345678899999999 59999999988 45
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.++..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 5568899999999999999984 234588999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~ 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS 220 (332)
T ss_pred CEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH
Confidence 99999999998653322221 1224589999999998765 47899999999999999999999986322111 111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
...... ++. .+......+.+++.+||+.||++|| +++++++.
T Consensus 221 ~~~~~~------~~~----------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILKC------DPP----------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhcC------CCC----------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 110000 000 0112245688999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.93 Aligned_cols=268 Identities=22% Similarity=0.359 Sum_probs=203.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
..++|++.++||+|+||.||+|..++ .+..||+|.++.... .....+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 45789999999999999999997642 356799998764332 2335678899999999999999999985
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
...+..++||||+++|+|.++++...............++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 344578999999999999999965332222122234567788999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 941 (1033)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~ 230 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQV 230 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence 9999999999986543322222122235678999999998899999999999999999998 7888753211 111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..... +..... .+..+++.+.+++.+||+.||++|||+.++++.+++.
T Consensus 231 ~~~~~--------~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVM--------DGGYLD-------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHH--------cCCCCC-------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11100 000000 0112245699999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.49 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=200.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-----hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|.+.+.||+|++|.||+|....+++.||+|.++.... ...+.+.+|++++++++||||+++++++ ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 579999999999999999999988899999999864321 2235688999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 589999999999999999842 34578889999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.++.......... .....++..|+|||++.+..++.++||||+|+++|||++|+.||... .........
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~ 219 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI 219 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHHHHH
Confidence 9999999976543221111 12234788999999999988999999999999999999999998532 111111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... ...+......+.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQPTN---------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccCCC---------------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000 00011234568999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.02 Aligned_cols=271 Identities=18% Similarity=0.310 Sum_probs=201.2
Q ss_pred CCCCccceecccCceeEEEEEeCC----------------CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE----------------GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKI 773 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 773 (1033)
++|++.++||+|+||.||+|++.. +...||+|+++... ....+++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999986532 34579999987542 3345678999999999999999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccc-cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
++++ ..++..++||||+++++|.+++......... ......+++.++..++.|++.|++|||+. +|+||||
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 9985 3445789999999999999999653322111 12334688999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCc
Q 042075 853 KPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPTDI 930 (1033)
Q Consensus 853 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt--g~~p~~~ 930 (1033)
||+||++++++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986543322221122234678999999888889999999999999999998 6777753
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
.... +..... .+........ ...+.+..++..+.+++.+||+.||++||++.||.
T Consensus 237 ~~~~-----~~~~~~-----~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 237 LSDE-----QVIENT-----GEFFRDQGRQ---------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cChH-----HHHHHH-----HHHHhhcccc---------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 2111 111000 0000000000 00001112346789999999999999999999999
Q ss_pred HHHH
Q 042075 1011 HQLQ 1014 (1033)
Q Consensus 1011 ~~L~ 1014 (1033)
+.|+
T Consensus 292 ~~l~ 295 (296)
T cd05095 292 ATLL 295 (296)
T ss_pred HHHh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.35 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=201.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+. .+...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEE
Confidence 357899999999999999999998889999999987655555677889999999999999999999853 345889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. ||+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~d 159 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (296)
T ss_pred EeecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999842 3478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+.......... ....+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.... ...
T Consensus 160 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~-~~~ 232 (296)
T cd06654 160 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIA-TNG 232 (296)
T ss_pred cccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHh-cCC
Confidence 99987653322111 123488999999999888899999999999999999999999853211 11111000 000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .. ..+......+.+++.+||..+|++||++.|+++.
T Consensus 233 ~~-----~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 TP-----EL--------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC-----CC--------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 00 0011233558899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.24 Aligned_cols=286 Identities=18% Similarity=0.173 Sum_probs=201.8
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
..+...++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 44566789999999999999999999998899999999986432 2234567789999999999999999998643221
Q ss_pred -cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 783 -QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 783 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
......++++|++ +++|.++++ ...+++.++..++.||+.||+|||++ +|+||||||+||++++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~ 153 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNE 153 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECC
Confidence 2224578999988 789988873 23588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+..
T Consensus 154 ~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~ 227 (343)
T cd07878 154 DCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKR 227 (343)
T ss_pred CCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 9999999999998654322 12348999999999877 56899999999999999999999998532110 11111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+... ......+.................................+.+.+++.+|++.||++|||++|+++.
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 228 IMEV-VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHH-hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 0000000000000000000000000000000000000123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.66 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=206.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|++|.||+|+...+++.||||.+... ......++.+|+.+++.++||||+++++++ ..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 4788999999999999999999888999999987642 223346788999999999999999999985 34557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.+++|||+++++|.+++.... .....+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 899999999999999885311 2345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.+.......... ....++..|+|||++.+..++.++||||||+++|||++|..||..... ..........
T Consensus 148 ~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~- 221 (267)
T cd08229 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE- 221 (267)
T ss_pred CcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhhh-
Confidence 9999987654332211 123488899999999888899999999999999999999999853211 1111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
....+.. ......+++.+++.+||+.||++|||+.+|.+.++++.
T Consensus 222 ----~~~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 ----QCDYPPL---------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----cCCCCCC---------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000000 00123456899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=337.18 Aligned_cols=269 Identities=23% Similarity=0.325 Sum_probs=203.5
Q ss_pred hCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcC-CCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 782 (1033)
.++|.+.++||+|+||.||+|++. .+++.||+|+++... ....+.+.+|++++.++. ||||++++++|.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 346788899999999999999964 245689999997542 233457889999999997 999999999964
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc--------------------------------------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 812 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 812 (1033)
..+..++||||+++|+|.++++.......
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 34578999999999999999975321100
Q ss_pred --------------------------------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 813 --------------------------------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 813 --------------------------------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
.......+++.++..++.|++.||+|||+. +|+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 001123578889999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533222111122236788999999988889999999999999999998 8888753211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.+ .......... +...+..++.++.+++.+||..+|++||+++||++.|
T Consensus 348 ~~-~~~~~~~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 348 NE-QFYNAIKRGY------------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred hH-HHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 10 0000000000 0000112345689999999999999999999999999
Q ss_pred HHHH
Q 042075 1014 QSIK 1017 (1033)
Q Consensus 1014 ~~i~ 1017 (1033)
+++.
T Consensus 397 ~~~~ 400 (401)
T cd05107 397 GDLL 400 (401)
T ss_pred HHHh
Confidence 8863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.89 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=212.6
Q ss_pred CccceecccCceeEEEEEeCCCC----eEEEEEEeec-cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 714 TSANLIGAGSFGSVYKGILDEGK----TIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+..++||+|+||+||+|.+-..+ .+||+|++.. .......++.+|+-+|.+++|||+++++++|... .+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence 45689999999999999995444 4589998864 3445568899999999999999999999998643 37
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
.||++|++.|+|.+|++. .+..+.....+.|..|||+||.|||.+ ++|||||..+||||.+-..+||.
T Consensus 773 qlvtq~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHhcccchHHHHHHH---------hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEE
Confidence 799999999999999974 456788899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+|+....+.........+-.+.|||=|.+....|+.++|||||||++||++| |..||+.....
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------- 907 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------- 907 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------------
Confidence 9999998877665554444456788999999999999999999999999999999 99998632111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
++.+.+ +.+.|..+++.|...++.+|.+||..|++.||+++++..++.++.
T Consensus 908 -eI~dll------------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 908 -EIPDLL------------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -HhhHHH------------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 011111 122345666778889999999999999999999999999998874
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.26 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=202.1
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|.+..+++.|++|.++.. .....+++.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 478889999999999999999989999999998643 334557788999999999999999999985 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. .....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKM--------QRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcc
Confidence 99999999999999953 2235688999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.++......... ....++..|+|||+..+..++.++|||||||++|||++|+.||..... ...........
T Consensus 145 f~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 217 (256)
T cd08529 145 LGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGV 217 (256)
T ss_pred cccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence 99998765433221 123478899999999998999999999999999999999999863221 11111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ..+...+.++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FP---------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC---------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 0001234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.54 Aligned_cols=244 Identities=23% Similarity=0.256 Sum_probs=191.1
Q ss_pred cceecccCceeEEEEEeC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 716 ANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++ ..++..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 368999999999999873 468899999987422 22335677899999999999999999984 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+||||+++++|.+++. ....+.+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 76 YLILEYLSGGELFMHLE----------REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred EEEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEe
Confidence 99999999999999984 234578888899999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 143 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~~~ 215 (323)
T cd05584 143 DFGLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKILKG 215 (323)
T ss_pred eCcCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC
Confidence 99998754322221 122348999999999998889999999999999999999999986321 11111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
. . ..+....+++.+++.+||+.||++|| +++++++.
T Consensus 216 ~--------~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 K--------L--------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C--------C--------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 0 00111235588999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.28 Aligned_cols=284 Identities=19% Similarity=0.221 Sum_probs=199.5
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||+||+|.+..+++.||||++... .....+++.+|+++++.++||||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998643 223446788999999999999999999996543322223689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+. ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 9999996 58888773 335689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++......... .....+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+. ........
T Consensus 147 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~-~i~~~~g~ 223 (372)
T cd07853 147 FGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLD-LITDLLGT 223 (372)
T ss_pred ccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHH-HHHHHcCC
Confidence 99998654332211 1223478999999998774 5789999999999999999999998632211 0111 11111110
Q ss_pred chhhhcccccCCCchhhhhccch-hhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQ-RQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+.+................. ...........+..+++.+++.+||+.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000000000000 00000000111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.16 Aligned_cols=267 Identities=24% Similarity=0.388 Sum_probs=201.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeE--EEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTI--VAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.+.||+|+||.||+|.+..++.. +|+|.++.. .......+.+|++++.++ +||||+++++++ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 4788899999999999999998766654 577776532 233446788999999999 899999999995 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccc------cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDET------EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++||||+++++|.++++........ ......+++.+++.++.|++.|++|||+. ||+||||||+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence 789999999999999999643211110 11234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
+++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... .
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~ 230 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 230 (303)
T ss_pred CCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----H
Confidence 99999999999986432111 1111124678999999988889999999999999999998 9999853211 1
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
...... +... +...+...+.++.+++.+||+.+|++||+++++++.++++.+.
T Consensus 231 ~~~~~~-~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 ELYEKL-PQGY--------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHHH-hcCC--------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 0000 0000111235689999999999999999999999999887654
Q ss_pred h
Q 042075 1020 L 1020 (1033)
Q Consensus 1020 ~ 1020 (1033)
.
T Consensus 284 ~ 284 (303)
T cd05088 284 R 284 (303)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.52 Aligned_cols=272 Identities=23% Similarity=0.330 Sum_probs=203.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCC----------------CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG----------------KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 772 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 772 (1033)
.++|++.+.||+|+||.||+|.+... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45799999999999999999987643 3568999987543 334577889999999999999999
Q ss_pred EeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccc-cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEecc
Q 042075 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCD 851 (1033)
Q Consensus 773 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 851 (1033)
++++|. .++..++||||+++++|.+++......... ......+++..+..++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999953 345889999999999999999643211110 11234689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCC
Q 042075 852 LKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPTD 929 (1033)
Q Consensus 852 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt--g~~p~~ 929 (1033)
|||+||++++++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543332222223346788999999988889999999999999999998 667764
Q ss_pred ccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042075 930 IMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNV 1009 (1033)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 1009 (1033)
..... ..+. ............ .....+..++.++.+++.+||+.||++|||+.||
T Consensus 236 ~~~~~-~~~~-~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLTDQ-QVIE-NAGHFFRDDGRQ-----------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcChH-HHHH-HHHhcccccccc-----------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 32110 0000 000000000000 0000011234568999999999999999999999
Q ss_pred HHHHH
Q 042075 1010 VHQLQ 1014 (1033)
Q Consensus 1010 l~~L~ 1014 (1033)
++.|+
T Consensus 291 ~~~L~ 295 (296)
T cd05051 291 HLFLQ 295 (296)
T ss_pred HHHhc
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.07 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=189.2
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|++..+++.||||+++... .........|..+++.. +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 47999999999999999899999999987532 23345567788888765 999999999984 4455899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQS----------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999842 34578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...........
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~---- 211 (316)
T cd05619 143 CKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIRMD---- 211 (316)
T ss_pred ceECCCCCCc--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC----
Confidence 8754222211 122348999999999999999999999999999999999999985321 11111110000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT-NVVH 1011 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 1011 (1033)
.+.. +.....++.+++.+||+.||++||++. ++.+
T Consensus 212 --~~~~----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 --NPCY----------------------PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCC----------------------CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0000 001234578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.89 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=201.0
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEccc
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH 796 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~ 796 (1033)
-++|+|.||+||-|++..+...+|||.+........+-+..|+..-++++|.|||+++|.| ..+++.-|.||.++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 3799999999999999999999999999877777778899999999999999999999994 45568889999999
Q ss_pred CCchhhhcccCCCCcccccccccc--CHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEEeecccc
Q 042075 797 NRSLEEWLHPITREDETEEAPRSL--NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDFGLA 873 (1033)
Q Consensus 797 ~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DfG~a 873 (1033)
||+|.+.++. .-+++ .+.++--+..||++||.|||++ .|||||||-+||||+ -.|.+||+|||-+
T Consensus 656 GGSLSsLLrs---------kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 656 GGSLSSLLRS---------KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCcHHHHHHh---------ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccc
Confidence 9999999963 33444 6677778899999999999999 999999999999996 5789999999999
Q ss_pred eecCCCCccccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
+....-...+.. ..||..|||||++..+ .|+.++|||||||++.||.||++||-...... ..+.+...
T Consensus 724 KRLAginP~TET--FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGm----- 793 (1226)
T KOG4279|consen 724 KRLAGINPCTET--FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGM----- 793 (1226)
T ss_pred hhhccCCccccc--cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhcc-----
Confidence 876543333222 3399999999998765 48899999999999999999999996432221 11111000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
-+..++.+.+...+...++.+|..+||.+||+++++++.
T Consensus 794 ----------------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 794 ----------------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ----------------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 001223455677888999999999999999999998864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.96 Aligned_cols=271 Identities=21% Similarity=0.332 Sum_probs=199.4
Q ss_pred CCCCccceecccCceeEEEEEeCCC--------------CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEG--------------KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
++|++.+.||+|+||.||+|+.... ...||+|+++... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987532 2358999987532 334467899999999999999999999
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCcc--ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
++ ...+..++||||+++++|.+++........ .......+++..+..++.|++.|++|||+. +++|||||
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 95 344578999999999999999854211100 011223478899999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCcc
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPTDIM 931 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt--g~~p~~~~ 931 (1033)
|+||++++++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999976543322222222335778999999988899999999999999999998 56676532
Q ss_pred ccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 932 FEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ...... ........... ....+..+++.+.+++.+||+.||++||++++|++
T Consensus 237 ~~~-~~~~~~-~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDE-QVIENT-GEFFRNQGRQI-----------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChH-HHHHHH-HHhhhhccccc-----------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111 001100 00000000000 00000112456999999999999999999999999
Q ss_pred HHH
Q 042075 1012 QLQ 1014 (1033)
Q Consensus 1012 ~L~ 1014 (1033)
.|+
T Consensus 292 ~l~ 294 (295)
T cd05097 292 FLR 294 (295)
T ss_pred HHh
Confidence 886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.47 Aligned_cols=204 Identities=25% Similarity=0.269 Sum_probs=171.1
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 784 (1033)
...++|++.+.||+|+||.||+|.+..+++.||||+++.. .......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4567999999999999999999999888999999998743 2334467789999999999999999999864322 123
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+||++++++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence 3457999999965 6776663 2377888999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
+||+|||+++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 158 LKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEEeeCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999865433221 123489999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.24 Aligned_cols=242 Identities=20% Similarity=0.245 Sum_probs=190.8
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 5888999999999999999999899999999987432 22334567788888877 588999998884 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEE
Confidence 9999999999999998842 34588899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 143 ~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i~~ 215 (323)
T cd05616 143 ADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIME 215 (323)
T ss_pred ccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHHHh
Confidence 999999754322211 1223489999999999999999999999999999999999999863211 111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
.. . ..+.....++.+++.+|++.||++|++.
T Consensus 216 ~~--------~--------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--------V--------------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--------C--------------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 0 0001123457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=344.63 Aligned_cols=202 Identities=23% Similarity=0.306 Sum_probs=171.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++.+ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36999999999999999999999999999999986422 22346678999999999999999999984 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ...++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999943 34578888999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCc-----------------------------------------cccccccccccccccccccCCCCCC
Q 042075 868 GDFGLATFLPLSHA-----------------------------------------QTSSIFAKGSIGYIAPEYGLGSEVS 906 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 906 (1033)
+|||+|..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999753310000 0001123589999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCCc
Q 042075 907 INGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 907 ~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
.++|||||||++|||++|+.||..
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.41 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=198.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|... ++.||+|..+... ..+.+.+|+.++++++|+|++++++++ +..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence 47889999999999999999875 6789999986432 346788999999999999999999875 334457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.++++. .....+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 9999999999999853 2234588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|++........ ...++..|+|||++.+..++.++|||||||++|||++ |+.||... .............
T Consensus 147 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~ 216 (256)
T cd05082 147 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGY 216 (256)
T ss_pred ccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCC
Confidence 99886433221 1225678999999988889999999999999999998 99997521 1111111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
. ...+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 217 ~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 K---------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 000112345689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=319.17 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=197.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|++. ++..||+|.++... ...+.+.+|+.++++++||||++++++|. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 46888999999999999999886 35569999887433 23467899999999999999999999953 3446899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++|+|.+++.. ....+++.+++.++.||+.|++|||+. +++|+||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence 9999999999999853 223689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~ 218 (256)
T cd05113 145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQGL 218 (256)
T ss_pred ccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhcCC
Confidence 998865433221 1112235678999999988889999999999999999999 99998532110 1111000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
. .. .+...++.+.+++.+||+.+|++||++.++++.++
T Consensus 219 -~-------~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 -R-------LY-------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -C-------CC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 00 00012356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.22 Aligned_cols=273 Identities=23% Similarity=0.365 Sum_probs=206.8
Q ss_pred hCCCCccceecccCceeEEEEEeCC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++|.+.+.||+|+||.||+|++.. +...||+|.++... .....++.+|+++++++ +||||++++++|.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 3579999999999999999998643 23569999987532 33456788899999999 8999999999953
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..+..++||||+++|+|.+++........ .......+++.++++++.|++.||+|||+. |++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 44578999999999999999964321100 001234689999999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-- 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence 999999999999999999876543221111111224568999999998889999999999999999998 88887421
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
............. +...+..++.++.+++.+||+.+|++|||+.+|++.|
T Consensus 247 ---~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 247 ---PVEELFKLLKEGH---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred ---CHHHHHHHHHcCC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 1111111100000 0001112345688999999999999999999999999
Q ss_pred HHHHHHhhh
Q 042075 1014 QSIKNILLG 1022 (1033)
Q Consensus 1014 ~~i~~~~~~ 1022 (1033)
+++.+....
T Consensus 297 ~~~~~~~~~ 305 (307)
T cd05098 297 DRILALTSN 305 (307)
T ss_pred HHHHHHhhc
Confidence 999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.12 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=203.0
Q ss_pred CCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|...++||+|+||.||+|... .++..||+|.++.......+.+.+|++++++++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 46788899999999999999742 356789999987666666678999999999999999999999853 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCc-----cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITRED-----ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
+..++||||+++++|.+++....... ........+++.++..++.|++.|++|||+. +|+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 57899999999999999996432110 0111224689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||......+ ..
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI 234 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH
Confidence 999999999999986543322221222235778999999998899999999999999999998 899985321110 00
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
........ ...+..+++.+.+++.+||+.||++||++.||.+.|+
T Consensus 235 ~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE------------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000000 0001123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=319.11 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=200.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+++.+|++++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 35799999999999999999998754 5699999875332 3367899999999999999999998742 23578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. .....+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|
T Consensus 77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 77 IVTEYMSKGSLLDFLKG--------EMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEcCCCCcHHHHHhh--------ccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence 99999999999999953 1234578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.++......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||...... .......
T Consensus 146 fg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~~~-- 217 (262)
T cd05071 146 FGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVE-- 217 (262)
T ss_pred CCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHHh--
Confidence 99998664433211 112236778999999988899999999999999999999 88887532111 0000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
... ......+++..+.+++.+|++.+|++||+++++++.|++.
T Consensus 218 -------~~~------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 218 -------RGY------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------cCC------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000 0001123456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=321.75 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=201.0
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC-C
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG-N 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-~ 785 (1033)
.+.+.|++.+.||+|+||.||+|....+++.||+|+++... .....+.+|+.+++++ +||||+++++++....... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999999899999999987543 2346788999999999 7999999999975433221 3
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. .....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCE
Confidence 468899999999999999853 2234688999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+|+|||++........ ......|+..|+|||++. +..++.++||||+||++|||++|+.||..... ...
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~ 224 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRA 224 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHH
Confidence 9999999986543221 122244889999999976 34688899999999999999999999853211 110
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ...... ... ....++.++.+++.+||..+|.+|||+.|+++
T Consensus 225 ~~~-~~~~~~-----~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LFL-IPRNPA-----PRL---------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH-HhcCCC-----CCC---------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000000 000 00012356899999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=335.04 Aligned_cols=203 Identities=26% Similarity=0.271 Sum_probs=169.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 785 (1033)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999989999999998643 2334567889999999999999999999864322 1222
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||+++ ++.+.++ ..++...+..++.|++.||+|||++ ||+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence 357999999965 6666653 2367888999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
||+|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 163 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 163 KILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred EEecCCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999754332211 123489999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.28 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=206.6
Q ss_pred CccceecccCceeEEEEEeCC---CCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 714 TSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+..+.||+|.||.|++|.|+. +...||||.++..... ..++|.+|+.+|.+++|||++++||+..+ ....
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence 456789999999999999964 2345999999865544 66899999999999999999999998532 3578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|||.++.|+|.+.|++ .....+-......++.|||.||.||.++ ++||||+..+|+++-....+||+|
T Consensus 187 MV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred HHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeec
Confidence 99999999999999975 3456688888999999999999999999 999999999999999989999999
Q ss_pred cccceecCCCCccccc-cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 870 FGLATFLPLSHAQTSS-IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
||+.+.+......... ....-...|+|||.+....++.++|||+|||++|||+| |+.||-.....
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------- 322 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------- 322 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------------
Confidence 9999988655443322 22335678999999999999999999999999999999 78888522110
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+.+.+| .+.+...+..|+++++++|+.||..+|++|||+..+.+.+-.
T Consensus 323 -qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 323 -QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 0111111 223445566789999999999999999999999999865543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.08 Aligned_cols=265 Identities=21% Similarity=0.307 Sum_probs=201.0
Q ss_pred CCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.+|++.+.||+|+||.||+|.+.. .++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 357788999999999999998753 357899999875433 23466889999999999999999999953 4
Q ss_pred CCceeEEEEcccCCchhhhcccCCCC------ccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITRE------DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
.+..++++||+++++|.+++...... .........+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 45789999999999999998421110 00111234688999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMN 937 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~ 937 (1033)
+++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---- 232 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 232 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999886543322222222336789999999988889999999999999999998 8888753211
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
............. ..+..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 233 -~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QDVIEMIRNRQVL---------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111110000 0011245568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=323.76 Aligned_cols=272 Identities=22% Similarity=0.351 Sum_probs=207.5
Q ss_pred hhCCCCccceecccCceeEEEEEeC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILD-------EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSG 779 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 779 (1033)
..++|++.+.||+|+||.||+|+.. .++..||+|..+... ....+++.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3567889999999999999999752 234579999986432 33456789999999999 899999999985
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
...+..++||||+++|+|.+++........ .......+++.++..++.||++||+|||++ ||+|||||
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 344578999999999999999964321110 011234689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMF 932 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~ 932 (1033)
|+||++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~- 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI- 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence 9999999999999999999987644332222222335678999999988889999999999999999998 77887421
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.............. ...+..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 244 ----~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 ----PVEELFKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ----CHHHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 11111111100000 00011234568999999999999999999999999
Q ss_pred HHHHHHHh
Q 042075 1013 LQSIKNIL 1020 (1033)
Q Consensus 1013 L~~i~~~~ 1020 (1033)
|+++.+..
T Consensus 293 l~~~~~~~ 300 (304)
T cd05101 293 LDRILTLT 300 (304)
T ss_pred HHHHHHhh
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.52 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=188.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||.||+|+++.+++.||+|+++... .........|..++... +||+|+++++++ ..++..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997532 22345567788888765 899999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence 99999999998842 34578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...........
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~~~~~~~---- 211 (316)
T cd05620 143 CKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELFESIRVD---- 211 (316)
T ss_pred CeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC----
Confidence 875322211 1122448999999999999999999999999999999999999985321 11111110000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT-NVV 1010 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 1010 (1033)
.+.. +.....++.+++.+||+.||++||++. +++
T Consensus 212 --~~~~----------------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 --TPHY----------------------PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCC----------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 001234578999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=342.45 Aligned_cols=200 Identities=23% Similarity=0.314 Sum_probs=170.5
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|+++++||+|+||+||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5889999999999999999999999999999987432 23346788999999999999999999995 455689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----------MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999842 24578888999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCc---------------------------------------------cccccccccccccccccccCCC
Q 042075 869 DFGLATFLPLSHA---------------------------------------------QTSSIFAKGSIGYIAPEYGLGS 903 (1033)
Q Consensus 869 DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 903 (1033)
|||++........ ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753211000 0001123589999999999999
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 904 EVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 904 ~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
.++.++||||+||++|||++|+.||.
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCC
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.79 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=198.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++ ...+..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence 4788899999999999999999989999999998865555556788999999999999999999984 44568899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++. ....+++.++..++.|++.|++|||+. |++|+||||+||+++.++.++|+||
T Consensus 84 v~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 84 CMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 999999999999984 234688999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|.+......... .....|+..|+|||++. ...++.++||||+||++|||++|+.||....... ...........
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~ 227 (267)
T cd06645 151 GVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQ 227 (267)
T ss_pred eeeeEccCcccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCC
Confidence 998765432211 12234899999999874 4568899999999999999999999985321111 00000000000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +.. ......+..+.+++.+||+.+|++||+++++++.
T Consensus 228 ~-------~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 P-------PKL--------------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred C-------Ccc--------------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 000 0000123457899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.28 Aligned_cols=243 Identities=23% Similarity=0.268 Sum_probs=192.6
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|++..+++.||||+++... ......+..|.++++.+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999889999999997532 23345677899999888 799999999984 4456899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence 99999999998842 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++......... ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 143 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~~~-- 213 (318)
T cd05570 143 CKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILEDEV-- 213 (318)
T ss_pred CeecCcCCCcc--cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCC--
Confidence 87532222111 22348999999999999999999999999999999999999986321 1111111100000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM-----TNVVHQ 1012 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~ 1012 (1033)
..+...+..+.+++.+||+.||++||++ .++++.
T Consensus 214 --------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0001123568999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=347.22 Aligned_cols=203 Identities=24% Similarity=0.312 Sum_probs=166.0
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC------CCceeEeeee
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH------RNLVKILTAC 777 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 777 (1033)
+++....++|++.++||+|+||+||+|.+..+++.||||+++... ........|+.++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999998889999999986432 223455678888877754 4588888885
Q ss_pred ccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCC
Q 042075 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSN 856 (1033)
Q Consensus 778 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~N 856 (1033)
. ...++.++|||++ +++|.+++.+ ...+++.++..|+.||+.||+|||+ . |||||||||+|
T Consensus 201 ~----~~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~N 262 (467)
T PTZ00284 201 Q----NETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPEN 262 (467)
T ss_pred E----cCCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 3 2345789999988 7789888842 3468999999999999999999997 5 99999999999
Q ss_pred eEecCCC----------------cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHH
Q 042075 857 VLLDEEM----------------IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920 (1033)
Q Consensus 857 Ill~~~~----------------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~e 920 (1033)
||++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 9998765 4999999988643211 122458999999999999999999999999999999
Q ss_pred HHhCCCCCCc
Q 042075 921 LVTRKKPTDI 930 (1033)
Q Consensus 921 lltg~~p~~~ 930 (1033)
|++|+.||+.
T Consensus 338 lltG~~pf~~ 347 (467)
T PTZ00284 338 LYTGKLLYDT 347 (467)
T ss_pred HHhCCCCCCC
Confidence 9999999964
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.87 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=200.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 578899999999999999999989999999998643 234456788999999999999999999984 45568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. .....++...+..++.|++.|++|||++ +|+|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--------QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence 9999999999998853 2334578899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|.+.......... ....++..|+|||++.+..++.++||||||+++|+|++|+.||... ..............
T Consensus 145 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~ 217 (255)
T cd08219 145 GSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSY 217 (255)
T ss_pred Ccceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCC
Confidence 9998664332211 1234888999999998888999999999999999999999998632 11111111100000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .+...+..+.+++.+||+.||++||++.|++.+
T Consensus 218 ~~---------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KP---------------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC---------------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 001123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.18 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=201.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe---EEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT---IVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+|++.+.||+|+||.||+|++..+++ .||||+++.. ......++..|+.++++++||||+++++++ ..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 357889999999999999999876554 6999998754 334457899999999999999999999984 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ....+++.++..++.|++.|++|||++ |++||||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence 78999999999999999853 234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcccccccc---ccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 867 VGDFGLATFLPLSHAQTSSIFA---KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
|+|||.+............... ..+..|+|||++.+..++.++|||||||++||+++ |..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 9999998765433221111111 12457999999998899999999999999999886 99998532110 111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.... +.+.+.+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 225 ~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDY------------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCC------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0001123345689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.73 Aligned_cols=270 Identities=22% Similarity=0.275 Sum_probs=208.4
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecc
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 779 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 779 (1033)
+.++.+..+.++|++.+.||+|+||.||+|++..+++.||+|+.+.... ....+.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4556777788999999999999999999999998999999998864322 235678899999999 79999999998765
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
.....++..++||||+++++|.++++... .....+++..+..++.|+++|+.|||+. +|+||||||+||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili 157 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILL 157 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEE
Confidence 44455667899999999999999875311 1235678899999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
++++.+||+|||.++........ .....|+..|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~- 234 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP- 234 (286)
T ss_pred CCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-
Confidence 99999999999999865432211 122348999999998753 4578999999999999999999999853211
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... .........+ +.....++.+++.+||+.||++|||+.|+++.
T Consensus 235 ---~~~~~~~-~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 ---MRALFKI-PRNPPPTLHQ-------------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hHHHhhc-cccCCCcccC-------------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111000 0000000000 00123458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.33 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=201.1
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEee----ccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFN----LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
...+||+|+|-+||+|.+..+|..||--.++ ...+...++|..|+.+|+.++||||+++|+++.+.. +....+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 3568999999999999999899888743332 123445689999999999999999999999965433 345789
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEEee
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGD 869 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~D 869 (1033)
|+|.+..|+|+.|.++ .+.++...+..|++||++||.|||++ +|+|+|||||.+||+|+ ..|.|||+|
T Consensus 121 iTEL~TSGtLr~Y~kk----------~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKK----------HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeecccCCcHHHHHHH----------hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 9999999999999964 45577889999999999999999997 89999999999999997 458999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
+|+|+......... ..|||.|||||+.. ..|++.+||||||+++.||+|+.+||.........|.+......|..
T Consensus 190 LGLAtl~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 99999876554433 45999999999966 78999999999999999999999999755444444444433333333
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+..+-| +++.++|.+|+.. .++|||+.|+++.
T Consensus 265 l~kV~d------------------------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVKD------------------------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccCC------------------------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 333222 4589999999999 9999999999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.62 Aligned_cols=273 Identities=22% Similarity=0.355 Sum_probs=206.7
Q ss_pred CCCCccceecccCceeEEEEEeC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-------EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
++|.+.++||+|+||.||+|+.. .....||+|+++... ......+.+|+++++++ +||||++++++|.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc---
Confidence 57889999999999999999863 235679999987432 33456788999999999 6999999999853
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
.++..++||||+++|+|.+++........ .......+++.++.+++.|++.||+|||++ ||+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 89 --QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 34578999999999999999965321100 011235689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccC
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEG 934 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~ 934 (1033)
||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--- 240 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--- 240 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999986543222111111224567999999988899999999999999999999 88887522
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.............. ...+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 241 --~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 241 --PVEELFKLLREGHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred --CHHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111110000000 0001123456889999999999999999999999999
Q ss_pred HHHHHhhhc
Q 042075 1015 SIKNILLGQ 1023 (1033)
Q Consensus 1015 ~i~~~~~~~ 1023 (1033)
++.......
T Consensus 292 ~~~~~~~~~ 300 (314)
T cd05099 292 KVLAAVSEE 300 (314)
T ss_pred HHHHHhcCC
Confidence 998765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.55 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=197.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|+..+.||+|+||+||+|.+..+++.||+|.++... ......+.+|++++++++|++|+++.+++ ..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 3677889999999999999999899999999986432 22234577899999999999999999884 445688
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYN--------MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEEeccCccHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEe
Confidence 999999999999988843 2234689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||++......... ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..... ......
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~-~~~~~~ 219 (285)
T cd05632 145 DLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEV-DRRVLE 219 (285)
T ss_pred cCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHhhhc
Confidence 99999765432221 12348999999999998899999999999999999999999986321110 00111 000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
... ........++.+++..||+.||++||+ +.++++.
T Consensus 220 ~~~---------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 TEE---------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccc---------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000 001122345789999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=316.75 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=199.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+. ++..||+|.++.... ..+++.+|+.++++++|++++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence 357899999999999999999887 566799999875433 3467899999999999999999998742 23578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. .....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|
T Consensus 77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 77 IVTEYMSKGSLLDFLKD--------GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCC
Confidence 99999999999999853 2234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........
T Consensus 146 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~-- 217 (260)
T cd05070 146 FGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQVE-- 217 (260)
T ss_pred ceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH--
Confidence 99998754332211 111225678999999988889999999999999999999 8888853211 11111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
... +.+.+...+.++.+++.+||+.+|++|||+.++.+.|++
T Consensus 218 -------~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 218 -------RGY------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------cCC------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 000011234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.52 Aligned_cols=251 Identities=28% Similarity=0.386 Sum_probs=196.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+|++.+.||+|+||.||+|.++ ++..+|+|+++.... ..+.+.+|++++++++||||+++++++ ...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence 35888999999999999999987 567899999864322 335688899999999999999999985 34457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence 9999999999999853 223689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.++......... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+..... ..........
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~--- 218 (256)
T cd05059 145 GLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGY--- 218 (256)
T ss_pred ccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCC---
Confidence 9998654322111 111124457999999998899999999999999999999 89998532111 0000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
+...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 219 ---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 ---------------------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---------------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0000112345699999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=337.18 Aligned_cols=206 Identities=22% Similarity=0.295 Sum_probs=174.6
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 780 (1033)
.++....++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--- 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 34455668999999999999999999999999999999998642 222345678899999999999999999984
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++..++||||+++|+|.++++. ..++...+..++.||+.||+|||++ +|+||||||+||+++
T Consensus 113 --~~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~ 176 (371)
T cd05622 113 --QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD 176 (371)
T ss_pred --EcCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEC
Confidence 455689999999999999999842 2478888899999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+++.+||+|||+++......... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 177 ~~~~ikL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 177 KSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred CCCCEEEEeCCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 99999999999998764332211 1234599999999998654 37899999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.37 Aligned_cols=273 Identities=25% Similarity=0.361 Sum_probs=202.8
Q ss_pred CCCCccceecccCceeEEEEEe----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..|++.+.||+|+||.||+|+. ..+++.||+|.++... ....+.+.+|++++++++|||++++++++.. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3578899999999999999985 3468889999987443 3345678999999999999999999998643 223
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCE
Confidence 568999999999999999842 233589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++++.|+...... .......
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~ 225 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGP 225 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhccc
Confidence 99999999866433221 1111233677899999998888999999999999999999988765321110 0000000
Q ss_pred hCCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 945 ALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 945 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
...+. ....+. ......+.+.+..++.++.+++.+||+.+|++|||++++++.++++
T Consensus 226 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVR---------------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHH---------------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 000000 0000001111122456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=326.70 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=205.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch---hHHHHHHHHHHHHhcC-CCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG---AFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 784 (1033)
....|++.+.||+|.||.||+++.+.+|+.+|+|++++.... ..+.+.+|+.+|+++. |||||.++++ ++.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 345788999999999999999999999999999999754332 3468899999999997 9999999999 566
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE--- 861 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--- 861 (1033)
....++|||++.||.|.+.+.+ . .+++..+..++.|++.|++|||+. ||+|||+||+|+|+..
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~---------~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVK---------K--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHH---------c--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence 6689999999999999999953 1 399999999999999999999998 9999999999999963
Q ss_pred -CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 862 -EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 -~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
++.+|++|||+|.....+ ......+||+.|+|||++....|+..+||||+||++|.|++|.+||....+... ...
T Consensus 174 ~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~ 249 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLA 249 (382)
T ss_pred CCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHH
Confidence 347999999999987662 223335699999999999999999999999999999999999999864322111 111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+ ++-++.+ ........+++..|+..||.+|+|+.++++.
T Consensus 250 i~~~~~-----~f~~~~w-----------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDF-----DFTSEPW-----------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCC-----CCCCCCc-----------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111 1111111 1224558899999999999999999999995
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=317.99 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=201.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCe---EEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKT---IVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|+..+.||+|+||.||+|+...+++ .||+|..+... ....+.+.+|++++++++|||++++.+++ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 3578889999999999999999865443 79999887542 33456788999999999999999999995 344
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.++++. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence 578999999999999999853 234689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 866 HVGDFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
||+|||++........... ......+..|+|||++....++.++|||||||++||+++ |+.||..... .....
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~ 221 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK 221 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHH
Confidence 9999999986643322111 111123457999999988889999999999999999998 9999853211 11111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
... .. . +.+....++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 222 ~i~-~~-------~-------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 AIN-DG-------F-------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHh-cC-------C-------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 00 0 0000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.15 Aligned_cols=204 Identities=23% Similarity=0.256 Sum_probs=171.4
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 784 (1033)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3467899999999999999999999989999999998643 2334567889999999999999999999864322 123
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....|+||||+++ +|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence 3467999999964 7777763 2367888999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
+||+|||+++........ ....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 165 LKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EEEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 999999999865432221 123489999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.03 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=206.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.=|...+.||+|.|+.|-+|++.-+|++||||++.+.. ......+.+|++.|+-++|||||++|++ .+.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence 34777889999999999999999999999999997543 2334568899999999999999999999 5566689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe-cCCCcEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL-DEEMIAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kL 867 (1033)
|+|+|.-.+|+|.+|+-+ ....+.+.-+.+++.||+.|+.|+|+. .|||||+||+||.+ .+-|-|||
T Consensus 93 yLiLELGD~GDl~DyImK---------He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMK---------HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEEEecCCchHHHHHHh---------hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEe
Confidence 999999999999999953 456789999999999999999999999 99999999999877 46689999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
.|||++-.+.++....+. +|+..|-|||++.+..|+ +++||||+|||+|-+++|++||+...+.+
T Consensus 161 TDFGFSNkf~PG~kL~Ts---CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------- 226 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKLTTS---CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------- 226 (864)
T ss_pred eeccccccCCCcchhhcc---cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------
Confidence 999999888776665554 499999999999999987 66899999999999999999997432221
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.-++|-. +..+.....++.++|..||..||++|.+.+||...
T Consensus 227 --TLTmImDCK--------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 --TLTMIMDCK--------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --hhhhhhccc--------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111222221 11233456778999999999999999999998754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.66 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=193.7
Q ss_pred eecccCceeEEEEEeC--CCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEc
Q 042075 718 LIGAGSFGSVYKGILD--EGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
.||+|+||.||+|.+. .++..||+|+.+.... ...+.+.+|+.++++++||||++++++|. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 4899999999999875 4456799999875432 33467899999999999999999999853 2357899999
Q ss_pred ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 795 MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 795 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
+++++|.+++.. ....+++.++.+++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+.
T Consensus 76 ~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence 999999999852 234689999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 875 FLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 875 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
......... ......++..|+|||++.+..++.++|||||||++||+++ |..||...... ..........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------ 215 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK------ 215 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------
Confidence 654332211 1111224578999999988889999999999999999996 99998632111 1111110000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+...+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 216 ------------------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 ------------------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0001112346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=317.19 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++ ..+...++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 5789999999999999999999888899999999866555668899999999999999999999984 44568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
+|||+++++|.+++.. ....++..++..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 78 ~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 78 VMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence 9999999999999853 225688999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|.+........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~ 222 (262)
T cd06613 146 GVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFP 222 (262)
T ss_pred ccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCC
Confidence 99876543221 11223478899999998776 889999999999999999999999853211100 0000000000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+. ........+.++.+++.+||..+|++|||+++|+.
T Consensus 223 --------~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 --------PP-------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --------Cc-------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00011123456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=323.54 Aligned_cols=270 Identities=23% Similarity=0.280 Sum_probs=207.8
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecc
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 779 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 779 (1033)
++.+++..+.++|.+.+.||+|+||.||+|....+++.||+|++..... ....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4556777788999999999999999999999998999999999864322 235678899999999 89999999999765
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
.+....+..++||||+++++|.++++... .....+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence 44334457899999999999999885311 1335688999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
++++.+||+|||.+.......... ....++..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 999999999999988654322111 123478899999987543 3689999999999999999999998532111
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .+....+ ...... ..+.+....+.+++.+||+.+|++||++.|+++.
T Consensus 240 ~-~~~~~~~----~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 K-TLFKIPR----NPPPTL-------------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHHHhc----CCCCCC-------------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0110000 000000 0011123458999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.93 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=196.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.++||+|+||.||+|.+..+++.||+|++... .....+++.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence 3688899999999999999999889999999998643 2334467889999999999999999999954 345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999997553 256778889999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH--HHHHhhhCC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL--HNFAKTALP 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~--~~~~~~~~~ 947 (1033)
||++........ ....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .........
T Consensus 139 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 139 FGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred CCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 999986533221 12348999999999999899999999999999999999999986432211110 000000000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .+... .....+++.+++.+||+.+|++||+++|+++.
T Consensus 215 ~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 ED-----PPVLP---------------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cC-----CCCCC---------------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 00000 00123458899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.25 Aligned_cols=238 Identities=26% Similarity=0.274 Sum_probs=185.6
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHH-HHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ..++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999987432 222344555555 56778999999999884 4556889999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 9999999999984 234688899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.........
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~--- 212 (323)
T cd05575 143 CKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILNKP--- 212 (323)
T ss_pred CcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCC---
Confidence 875322221 112234899999999999999999999999999999999999998532 1111111111000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
.. .+...+..+.+++.+|++.||++||++.
T Consensus 213 -----~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -----LR--------------------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----CC--------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00 0001235588999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.96 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=197.8
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++++++|++|+++++.+ ..++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 3778899999999999999999999999999986432 12234567899999999999999999985 344588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. .....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~g~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--------MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999998843 1234588999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||++......... ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..... .... .
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~-~ 218 (285)
T cd05630 145 DLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLV-K 218 (285)
T ss_pred eccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhh-h
Confidence 99999765432221 12348999999999999999999999999999999999999996321110 00000 0000 0
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
.... ..+....+.+.+++.+||+.||++||| ++|++++
T Consensus 219 ~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 EVQE--------------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhh--------------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0000 000112355889999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.69 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=193.5
Q ss_pred eecccCceeEEEEEe--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 718 LIGAGSFGSVYKGIL--DEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
.||+|+||.||+|.+ ..+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999975 4567889999986433 234567899999999999999999999853 235789999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++++|.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence 9999999999842 34588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 874 TFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 874 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
.......... ......++..|+|||.+....++.++|||||||++|||++ |+.||...... ..........
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~----- 215 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE----- 215 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-----
Confidence 8764333211 1111224678999999988889999999999999999998 99998632111 1111111000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
+...+..+++++.+++.+||+.||++||++++|.+.|+.
T Consensus 216 -------------------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 -------------------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 000011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.26 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=199.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence 5789999999999999999999988999999999876666677889999999999999999999985 34458899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|..++.. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+||
T Consensus 87 v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 9999999999988742 234589999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|.+......... .....++..|+|||++. ...++.++|||||||++|||++|+.||..... .. .....
T Consensus 155 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~-~~~~~ 227 (292)
T cd06644 155 GVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MR-VLLKI 227 (292)
T ss_pred ccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HH-HHHHH
Confidence 998754322111 12234788999999874 34578899999999999999999999853211 11 00000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... +.. ..+.....++.+++.+||+.+|++||+++|+++.
T Consensus 228 ~~~~~-----~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 228 AKSEP-----PTL--------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCC-----ccC--------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 000 0011223458899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.68 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=199.5
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++.+++.+.....||+|+||.||+|++..+++.||+|.++.......+.+.+|+.++++++|+||+++++++. .+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence 3455666777789999999999999998889999999987665556678999999999999999999999853 44
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcccccccccc--CHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-C
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL--NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-E 862 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~ 862 (1033)
+..++||||+++++|.++++. ....+ ++..+..++.|++.|++|||+. +|+||||||+||+++. +
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHH---------hcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCC
Confidence 588999999999999999953 11233 7788889999999999999999 9999999999999986 6
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+.++|+|||.+......... .....++..|+|||++.+. .++.++||||||+++|||++|+.||....... ...
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~ 221 (268)
T cd06624 146 GVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAM 221 (268)
T ss_pred CeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhH
Confidence 79999999998765432221 1122378999999998664 37899999999999999999999985321110 000
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+...... .....+....+++.+++.+||+.+|++|||+.|+++.
T Consensus 222 ~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 FKVGMFK----------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhhhc----------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000000 0000111234568899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=328.93 Aligned_cols=243 Identities=21% Similarity=0.268 Sum_probs=190.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+|+..+.||+|+||+||+|++..+++.||+|+++.. .....+.+..|..+++.+. |++|++++++ +...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 477889999999999999999999999999998743 2233456778999998885 5778888887 445568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ....+++.++..++.|++.||+|||++ ||+||||||+||++++++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 999999999999999984 234688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~ 215 (323)
T cd05615 143 ADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSIME 215 (323)
T ss_pred eccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh
Confidence 999998754322211 1223489999999999998999999999999999999999999863211 111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
. .. ..+.....++.+++.+||+.+|++|++..
T Consensus 216 ~--------~~--------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 H--------NV--------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred C--------CC--------------------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 00 00011234578999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=353.06 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=201.6
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
+.....++|++.+.||+|+||+||+|++..+++.||+|++... .......+..|+.++++++||||+++++++..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d--- 83 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN--- 83 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---
Confidence 3444567899999999999999999999999999999998743 23345678899999999999999999998642
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC----CCCcEeccCCCCCeE
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC----QPPIVHCDLKPSNVL 858 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----~~~ivHrDlkp~NIl 858 (1033)
......|+||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 23456899999999999999995311 12356899999999999999999999852 125999999999999
Q ss_pred ecCC-----------------CcEEEeecccceecCCCCccccccccccccccccccccCC--CCCCcccchHHHHHHHH
Q 042075 859 LDEE-----------------MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLL 919 (1033)
Q Consensus 859 l~~~-----------------~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~ 919 (1033)
++.+ ..+||+|||++......... ....||+.|+|||++.+ ..++.++||||||||+|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 9642 35899999999865433221 22348999999999854 45889999999999999
Q ss_pred HHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCC
Q 042075 920 ELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMES 999 (1033)
Q Consensus 920 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 999 (1033)
||++|+.||... .....+........ .... ...+.++.+++..||+.+
T Consensus 235 ELLTGk~PF~~~----~~~~qli~~lk~~p-----~lpi-----------------------~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 235 ELCSGKTPFHKA----NNFSQLISELKRGP-----DLPI-----------------------KGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHCCCCCCcC----CcHHHHHHHHhcCC-----CCCc-----------------------CCCCHHHHHHHHHHhcCC
Confidence 999999998532 12222211110000 0000 012355899999999999
Q ss_pred CCCCCCHHHHHH
Q 042075 1000 PEDRMDMTNVVH 1011 (1033)
Q Consensus 1000 P~~RPt~~evl~ 1011 (1033)
|++||++.|++.
T Consensus 283 PeeRPSa~QlL~ 294 (1021)
T PTZ00266 283 AKERPSALQCLG 294 (1021)
T ss_pred hhHCcCHHHHhc
Confidence 999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=323.37 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=201.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.+|++.+.||.|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ..++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 4689999999999999999999889999999998765555567788999999999999999999985 34558999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999998842 3578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|++.......... ....++..|+|||.+.+..++.++|||||||++|++++|+.||..... ......... ...
T Consensus 160 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~~~~~~~~~-~~~ 232 (296)
T cd06655 160 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIAT-NGT 232 (296)
T ss_pred ccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-cCC
Confidence 9987654332211 123478899999999988899999999999999999999999853211 111110000 000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. . ...+...+..+.+++.+||..||++||++.++++.
T Consensus 233 ~-----~--------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 P-----E--------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred c-----c--------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0 00011234568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=328.54 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=189.4
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 47999999999999999899999999997532 23345678899999988 699999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence 9999999999884 234689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC-ccHHHHHhhhCCcchh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-MNLHNFAKTALPDHVV 951 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 951 (1033)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .............
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 217 (327)
T cd05617 143 CKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--- 217 (327)
T ss_pred ceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---
Confidence 875322211 1122458999999999999999999999999999999999999996322111 0111110000000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
.. ...+...+..+.+++.+||+.||++||++.
T Consensus 218 ----~~--------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 ----KP--------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ----CC--------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00 000111234578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=324.52 Aligned_cols=280 Identities=21% Similarity=0.255 Sum_probs=202.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||+|+||.||+|.+..++..||+|.++... .....++.+|++++++++||||++++++| ..++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence 46899999999999999999999899999999987542 23345688999999999999999999995 4456899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. ...+++..+..++.|+++||+|||+.+ +++||||||+||++++++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----------AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEcc
Confidence 99999999999999953 245788999999999999999999732 899999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+........ ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...............
T Consensus 144 fg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~ 217 (308)
T cd06615 144 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEG 217 (308)
T ss_pred CCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccc
Confidence 999875533211 12348899999999988889999999999999999999999986322 111111111110000
Q ss_pred hh-hhcccc-c--CCCchhhhhcc--chhhhhhhhhh-HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 950 VV-DIVDST-L--LSDDEDLAVHG--NQRQRQARINS-KIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 950 ~~-~~~d~~-l--~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. ...... . ........... ........... ......++.+++.+||+.+|++|||+.|+++.-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 000000 0 00000000000 00000000000 001345689999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.34 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=201.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 36899999999999999999999888999999999765555557788999999999999999999985 3455889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence 99999999999999842 3478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+.......... ....+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... . .....
T Consensus 159 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----~-~~~~~ 231 (297)
T cd06656 159 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----L-IATNG 231 (297)
T ss_pred CccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----e-eccCC
Confidence 99998654332221 12347889999999998889999999999999999999999985321110000 0 00000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+. ...+...+..+.+++.+||+.+|++||+++++++.
T Consensus 232 -----~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 -----TPE--------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -----CCC--------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00011234557899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.39 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=198.0
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHH--HHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|+||+||+|+...+++.||+|++......... ...+|+.++++++||||+++++++ ......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 67789999999999999999999999999999865443322 345699999999999999999995 34668899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999994 346689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+....... .......++..|+|||++. +..++.++||||+|+++|+|++|+.||..... ..............
T Consensus 143 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 143 GSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRP 218 (260)
T ss_dssp TTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTH
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccccc
Confidence 9998642211 2222344899999999988 78899999999999999999999999864300 00000000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. ...........++.+++.+||+.||++||++.++++
T Consensus 219 ~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LP------------------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HH------------------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc------------------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000011267999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.73 Aligned_cols=274 Identities=24% Similarity=0.343 Sum_probs=206.1
Q ss_pred CCCCccceecccCceeEEEEEeCC----CCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE----GKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+.|++.+.||+|+||.||+|+... +++.||||+++..... ..+.+.+|++++++++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 467888999999999999999753 4788999999755443 45789999999999999999999998642 235
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 578999999999999999953 223589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.+.......... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... +...
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~ 225 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI 225 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc
Confidence 999999998765332211 111122566799999998889999999999999999999999997532211100 0000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.........+... .....+...+..++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus 226 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 226 AQGQMIVTRLLEL--------------LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccccHHHHHHH--------------HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000000000 000011111223456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.87 Aligned_cols=251 Identities=29% Similarity=0.423 Sum_probs=201.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++. ..+..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 457889999999999999999985 78899999975543 4578899999999999999999999953 356789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRS--------RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence 99999999999999953 2223689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.++....... ....+..|+|||++....++.++||||||+++||+++ |+.||.... ...........
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~ 215 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPHVEKG 215 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHhcC
Confidence 999986633222 1225678999999988889999999999999999997 999985321 11111000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
. +...+...++++.+++.+||+.+|++|||++|++++|+.+
T Consensus 216 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 Y---------------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C---------------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 0000112345689999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.97 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=200.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||.||+|... +++.||+|.+..... ..+++.+|+.++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 357899999999999999999976 567899999875433 3467889999999999999999998742 34689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 77 IITEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEcc
Confidence 99999999999999853 2345689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+.......... .....++..|+|||++....++.++||||||+++||+++ |+.||..... .............
T Consensus 146 fg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYRM 222 (260)
T ss_pred CcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCCC
Confidence 99998765322211 112235678999999988889999999999999999999 9999863211 0111100000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
..+...+.++.+++.+||+.+|++||+++++...|+.
T Consensus 223 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001123569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.88 Aligned_cols=271 Identities=22% Similarity=0.351 Sum_probs=206.0
Q ss_pred CCCCccceecccCceeEEEEEeCC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
.+|++.+.||+|+||.||+|++.. .+..||+|+++... ....+++.+|+++++++ +||||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 468999999999999999998642 23468999887432 33457889999999999 8999999999963
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
.++..++||||+++|+|.+++....... ........+++.++..++.|++.||+|||++ ||+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 3457899999999999999996422100 0011335689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccC
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEG 934 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~ 934 (1033)
||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999986644322222222234578999999999999999999999999999998 88887522
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
............... ..+..++.++.+++.+||+.+|++||++.|+++.|+
T Consensus 241 --~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 241 --PVEELFKLLKEGHRM---------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred --CHHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111111000000 001122456899999999999999999999999999
Q ss_pred HHHHHhh
Q 042075 1015 SIKNILL 1021 (1033)
Q Consensus 1015 ~i~~~~~ 1021 (1033)
++.....
T Consensus 292 ~~~~~~~ 298 (334)
T cd05100 292 RVLTVTS 298 (334)
T ss_pred HHhhhcC
Confidence 9985443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.80 Aligned_cols=364 Identities=25% Similarity=0.397 Sum_probs=273.6
Q ss_pred CeEEEEEcCCCCCC-cccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEE
Q 042075 84 QRVTILDLKSLKLA-GYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVR 162 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 162 (1033)
.-|..+|+++|.++ +.+|..+..+++++.|.|...++. .+|.+++.|.+|++|.+++|++. .+-..++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 35889999999999 578999999999999999999998 89999999999999999999998 7788899999999999
Q ss_pred cccccccC-CCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccC
Q 042075 163 LSSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 163 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
+.+|++.. -+|..+..|..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..+...-|.+|+.|-.||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 99999963 47899999999999999999999 88999999999999999999999544456779999999999999999
Q ss_pred CCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccC-CCCCccCcCCCCccccccccccccCcCcch
Q 042075 242 GTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT-GAIPPAISNASNLEVFQVNSNKLTGEVPYL 320 (1033)
Q Consensus 242 ~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 320 (1033)
.+|..+..+..|+.|+||+|.+.. ........+++|+.|.+++.+=+ .-+|.++..+.+|..+|+|.|.+..
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~h-fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~----- 236 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNH-FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI----- 236 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhH-HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-----
Confidence 788888889999999999887751 11111113455666666655433 3455555556666666666555553
Q ss_pred hhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCcccc
Q 042075 321 EKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFG 400 (1033)
Q Consensus 321 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~ 400 (1033)
+|.++.++ .+|+.|+|++|+|+ .+.-..+
T Consensus 237 -------------------------------------------------vPecly~l-~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 237 -------------------------------------------------VPECLYKL-RNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred -------------------------------------------------chHHHhhh-hhhheeccCcCcee-eeeccHH
Confidence 33344333 35555555555555 2333445
Q ss_pred CCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEe
Q 042075 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIID 480 (1033)
Q Consensus 401 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 480 (1033)
...+|++|+||.|+++ .+|+++++|+.|+.|++.+|++.- . -+|+.++.+.+|+++.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F---------------------e-GiPSGIGKL~~Levf~ 322 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF---------------------E-GIPSGIGKLIQLEVFH 322 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc---------------------c-CCccchhhhhhhHHHH
Confidence 5567777777777777 677777777777777777777651 1 3566666666777777
Q ss_pred cCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccc
Q 042075 481 LSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534 (1033)
Q Consensus 481 Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (1033)
.++|.+. .+|..++.+..+ +.|.|+.|++- .+|+++.-|+.|+.|||.+|.
T Consensus 323 aanN~LE-lVPEglcRC~kL-~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKL-QKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhccccc-cCchhhhhhHHH-HHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 7777666 666666666666 66666666665 566666666666667766664
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=339.65 Aligned_cols=195 Identities=25% Similarity=0.333 Sum_probs=166.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+|.+.+.||+|+||.||+|++..+++.||||... ...+.+|++++++++|+||+++++++. .++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence 457999999999999999999999899999999643 234568999999999999999999853 345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|||++. ++|.+++.. ....+++.+++.|+.|+++||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 237 lv~e~~~-~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEccC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence 9999994 689888842 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99998764332222222345899999999999999999999999999999999988764
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.22 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=192.4
Q ss_pred ceecccCceeEEEEEeCC---CCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDE---GKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|.+.. +...||+|.+... .....+.+.+|+.+++.++||||++++++|. ..++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998643 3467999988543 2334567889999999999999999999763 3345678999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. .....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence 99999999999953 223467778899999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccCCccHHHHHhhhCCcc
Q 042075 873 ATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 873 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
++........ .......++..|+|||.+.+..++.++|||||||++|||++| .+||.... ............
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~ 219 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQGR 219 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhcCC
Confidence 9765332111 111122357789999999888999999999999999999995 55553211 111111000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
....+..+++.+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 ---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 ---------------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000011124568999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=320.42 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=197.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++. .++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 677889999999999999999889999999987655556678899999999999999999999853 345789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|..++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence 99999999998742 234689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+........ ......++..|+|||++. +..++.++|||||||++|||++|++||..... ...... ...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~-~~~ 222 (282)
T cd06643 150 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----MRVLLK-IAK 222 (282)
T ss_pred ccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----HHHHHH-Hhh
Confidence 875432221 112234889999999874 34578899999999999999999999863211 111100 000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... ..+...+..+.+++.+||+.||++||++.++++.
T Consensus 223 ~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 223 SEPPTL-------------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCCCCC-------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0001123568999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.90 Aligned_cols=239 Identities=24% Similarity=0.248 Sum_probs=188.6
Q ss_pred ceecccCceeEEEEEe---CCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 717 NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+.||+|+||.||+++. ..+++.||+|+++.... .....+.+|++++++++||||+++++++ ..++..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 6799999999999986 35689999999975322 2335577899999999999999999984 455689999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999984 234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 144 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~-- 214 (318)
T cd05582 144 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAK-- 214 (318)
T ss_pred CCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCC--
Confidence 99865433211 1223489999999999988899999999999999999999999863211 11111100000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
. ..+....+.+.+++.+||+.||++||++.+
T Consensus 215 ------~--------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 ------L--------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------C--------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 001112355889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=330.63 Aligned_cols=242 Identities=25% Similarity=0.256 Sum_probs=186.2
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHH-HHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ..++..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 47999999999999999899999999987432 122233444444 56778999999999984 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. ...++...+..++.||++||+|||+. ||+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence 99999999999842 34577888889999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~---- 211 (325)
T cd05602 143 CKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNK---- 211 (325)
T ss_pred CcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhC----
Confidence 975432221 12224589999999999999999999999999999999999999853211 1111111000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ........+.+++.+|++.||.+||++.+.+.
T Consensus 212 ----~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 212 ----PLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----CcC--------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 000 00112355889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.87 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=196.0
Q ss_pred ceecccCceeEEEEEeCCCC---eEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGK---TIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||.||+|.+...+ ..||+|.++.... ...+++.+|++++++++||||+++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999875544 7899999875433 34567899999999999999999999853 23579999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKK----------RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence 99999999999953 23689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcch
Q 042075 873 ATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 873 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...........+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~--- 216 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER--- 216 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc---
Confidence 98664433221 1111223567999999998899999999999999999998 9999863211 111111111000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
...+..++.++.+++.+||..+|++||++.++++.|+++.
T Consensus 217 ---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ---------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0001123456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.60 Aligned_cols=201 Identities=25% Similarity=0.296 Sum_probs=171.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+...+++.||+|+++.. .....+.+.+|+.+++.++|+||+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4799999999999999999999989999999998742 223345688999999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEE
Confidence 9999999999999999953 234688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+|||++.......... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||.
T Consensus 144 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 144 ADFGSCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 9999997654332221 122348999999999863 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.62 Aligned_cols=266 Identities=25% Similarity=0.379 Sum_probs=202.7
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++.... ...+++.+|+.++++++||||++++++|.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 4679999999999999999998742 578899999875432 33467889999999999999999999853
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCcc------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEecc
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDE------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCD 851 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 851 (1033)
.++..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 34578999999999999999964321111 011234588999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCc
Q 042075 852 LKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDI 930 (1033)
Q Consensus 852 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~ 930 (1033)
|||+||++++++.++|+|||.+.................+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543322211222225678999999988899999999999999999998 8888742
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
... ........... ... .+..++.++.+++.+||+.+|++|||+.|++
T Consensus 236 ~~~-----~~~~~~~~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 236 MAH-----EEVIYYVRDGN--------VLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CCH-----HHHHHHHhcCC--------CCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 211 11111110000 000 0112345689999999999999999999999
Q ss_pred HHHHH
Q 042075 1011 HQLQS 1015 (1033)
Q Consensus 1011 ~~L~~ 1015 (1033)
+.|++
T Consensus 284 ~~l~~ 288 (288)
T cd05050 284 RILQR 288 (288)
T ss_pred HHhhC
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=324.19 Aligned_cols=278 Identities=22% Similarity=0.290 Sum_probs=198.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++ ..++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 467999999999999999999999889999999987432 22335677899999999999999999995 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++ ++|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred EEEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence 99999996 589888853 234578899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||++......... .....+++.|+|||++.+. .++.++|||||||++|||++|++||...... ...........
T Consensus 147 dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~ 222 (301)
T cd07873 147 DFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILG 222 (301)
T ss_pred cCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcC
Confidence 99999764332211 1123378899999987654 5788999999999999999999998632111 11111111111
Q ss_pred cchhhhcccccCCCc-hhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDD-EDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
............... .... ...................+.+++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYN--YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCChhhchhhhccccccccc--cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100000000000000 0000 0000000000011123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.85 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=198.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|.+.+.||+|++|.||+|.+..+ ..||+|....... ..+.+.+|++++++++|||++++++++. .+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 5688999999999999999998754 4699998764332 3467889999999999999999998742 235789
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.++++. .....+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKE--------GDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence 9999999999999953 1234578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+......... ......++..|+|||...+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-- 221 (260)
T cd05069 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR-- 221 (260)
T ss_pred ccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence 999866433221 1112236678999999988899999999999999999999 89998532111 00000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
...+...+..+.+++.+||+.||++||++++|++.|++
T Consensus 222 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ----------------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=330.96 Aligned_cols=241 Identities=26% Similarity=0.258 Sum_probs=186.8
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHH-HHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|++..+++.||+|+++... ......+..|.. +++.++||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999899999999987431 223345555655 46778999999999884 4556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++.++..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence 9999999998884 335688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~~--- 212 (325)
T cd05604 143 CKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHKP--- 212 (325)
T ss_pred cccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcCC---
Confidence 875322211 1122458999999999999999999999999999999999999985321 111111111100
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
... .......+.+++.+|++.+|++||++.+.+
T Consensus 213 -----~~~--------------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 213 -----LVL--------------------RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -----ccC--------------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 000 001234578999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.50 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=202.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe----EEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.+|++.+.||+|+||.||+|.+..+++ .||+|..+... ......+.+|+.++++++||||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578899999999999999999865544 58999886543 3345678899999999999999999999743
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++|+|.+++.. ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence 468999999999999999853 234589999999999999999999998 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||.++...............++..|+|||.+....++.++||||||+++||+++ |+.||+.... ..+...
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~ 223 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDL 223 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Confidence 9999999987653332222111224568999999988899999999999999999998 9999863211 111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
..... . ...+..+...+.+++.+||..+|++||++.++++.|+++.+
T Consensus 224 ~~~~~--------~-------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 224 LEKGE--------R-------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HhCCC--------C-------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10000 0 00001123458899999999999999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=317.44 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=200.7
Q ss_pred CCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+|++.+.||+|+||.||+|++..+ +..||+|.++... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 5788999999999999999988533 3479999886432 33456789999999999999999999985 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEE
Confidence 78999999999999999953 234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 867 VGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
++|||.+.......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ........
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~ 224 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEE 224 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhC
Confidence 99999998764432211 1111123568999999998899999999999999999887 99998532110 01110000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.. +.+....+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 225 ~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GY------------------------------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC------------------------------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 0000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.39 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=195.3
Q ss_pred ceecccCceeEEEEEeCCCCe--EEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKT--IVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|++..++. .+|+|.++... ....+.+.+|+++++++ +||||++++++|. ..+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 468999999999999987665 46888876432 34456788999999999 8999999999953 345789999
Q ss_pred EcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 793 EFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
||+++|+|.++++....... .......+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 99999999999964321110 011234688999999999999999999998 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||.... ........
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~ 224 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKL 224 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHHH
Confidence 99999986322111 1111224567999999988889999999999999999997 999985321 11111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.... +...+..+..++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 225 ~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000 00001123356899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.80 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=202.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|.+... ...||||...... ....+.+.+|+.++++++||||++++++|.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 34688899999999999999987543 4568999887544 3445688999999999999999999998632
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++|+|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCe
Confidence 356899999999999999953 233589999999999999999999998 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++........... ...++..|+|||.+....++.++||||||+++||+++ |+.||......+ ..... ..
T Consensus 147 ~l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~-~~ 223 (270)
T cd05056 147 KLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGRI-EN 223 (270)
T ss_pred EEccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH-Hc
Confidence 99999999876443222111 1224568999999888889999999999999999996 999985332111 00000 00
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
. . +...+..++.++.+++.+|+..+|++|||+.++++.|+++..
T Consensus 224 ~--~----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 G--E----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred C--C----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0 000111234568999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.14 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=188.8
Q ss_pred ceecccCceeEEEEEeCC--CCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDE--GKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|.... ++..+|+|.++.... .....+.+|+.++++++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 468999999999998653 456799998875432 33457888999999999999999999854 3447899999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.++++.... ......++..+..++.|++.|++|||+. +++||||||+||++++++++||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhh-----cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 9999999999954211 1223467778889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCccccccccccccccccccccCCC-------CCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-------EVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+...............++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~ 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---T 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---H
Confidence 754333222222223467889999987542 35789999999999999996 999986332111 0000 0
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.........++... ....+.+.+++..|| .+|++|||++||++.|+
T Consensus 223 ~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQLKLPKPRLK----------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccCCCCCCccC----------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 10100011111100 012345788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=321.16 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=201.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++++ ..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 46799999999999999999999888999999999866666667899999999999999999999995 3455889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999853 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||.+.......... ....++..|+|||.+. ...++.++||||||+++|||++|+.||...... ........
T Consensus 147 ~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~- 222 (280)
T cd06611 147 FGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILK- 222 (280)
T ss_pred Cccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhc-
Confidence 99887543322211 1234889999999874 345788999999999999999999998632110 00100000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... +.+ ..+.....++.+++.+||+.+|++||++.++++.
T Consensus 223 ---~~~-----~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 ---SEP-----PTL--------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCC-----CCc--------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 000 0011123458899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.52 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=202.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCe----EEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|+..+.||+|+||.||+|.+..+++ .||+|.+..... ....++.+|+.++++++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3567889999999999999999876665 578888764332 334568899999999999999999998642
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
...++++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence 235799999999999999853 234578899999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||..... .....+..
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~ 225 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE 225 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH
Confidence 99999999987654332222222335778999999998899999999999999999997 8899853211 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.... ...+..+...+.+++.+||..+|++||+++++++.++++.+..
T Consensus 226 ~~~~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 226 KGER------------------------------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0000 0000112345889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.79 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=199.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5889999999999999999999889999999986432 334567889999999999999999988742 2334678
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~--------~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--------QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence 99999999999999953 2334689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+......... .....+++.|+|||+..+..++.++||||+|+++|||++|+.||+... ............
T Consensus 146 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~ 218 (257)
T cd08223 146 LGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGK 218 (257)
T ss_pred ccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcC
Confidence 9999876432221 122347899999999999999999999999999999999999985221 111111110000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ..+....+++.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LP---------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CC---------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0011234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.21 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=201.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .+++.+|++++++++||||+++++++ ..+...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEE
Confidence 3689999999999999999999998889999999875432 57899999999999999999999985 3446889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+++||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 75 l~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 75 IVMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred EEEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence 99999999999999852 345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+......... .....++..|+|||++.+..++.++||||||+++|||++|+.||........ ... ....
T Consensus 143 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~--~~~~ 214 (256)
T cd06612 143 FGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM--IPNK 214 (256)
T ss_pred cccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh--hccC
Confidence 9999876443211 1223378899999999988999999999999999999999999863211110 000 0000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. .....+......+.+++.+||+.||++|||++||++
T Consensus 215 --------~~----------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 215 --------PP----------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --------CC----------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 000011123356899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.44 Aligned_cols=206 Identities=21% Similarity=0.277 Sum_probs=162.9
Q ss_pred cceecccCceeEEEEEeC--CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 716 ANLIGAGSFGSVYKGILD--EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
.++||+|+||+||+|++. .+++.||+|.++... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999975 356889999986432 23457789999999999999999998642 23456889999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe----cCCCcEEEee
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGD 869 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~D 869 (1033)
|+. ++|.+++....... .......+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 985 58888875322111 112234689999999999999999999999 99999999999999 4567899999
Q ss_pred cccceecCCCCcc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 870 FGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 870 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
||+++........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999876433221 11223458999999999877 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=335.51 Aligned_cols=202 Identities=25% Similarity=0.319 Sum_probs=173.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+...+++.||+|+++... ......+.+|+.++.+++||+|+++++.+ ..++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47899999999999999999999899999999997432 23346788899999999999999999984 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence 999999999999999984 234688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc---------------------------------ccccccccccccccccccCCCCCCcccchHHH
Q 042075 868 GDFGLATFLPLSHAQ---------------------------------TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSY 914 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 914 (1033)
+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 00112358999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 042075 915 GILLLELVTRKKPTDI 930 (1033)
Q Consensus 915 G~vl~elltg~~p~~~ 930 (1033)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.50 Aligned_cols=254 Identities=21% Similarity=0.265 Sum_probs=195.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEee--ccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
...|++.++||+||.+.||++... +.+.||+|.+. ..+....+.|.+|+..|.++ .|.+||++++| .-.++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCc
Confidence 456899999999999999999986 45667777654 34455668899999999999 69999999999 45577
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
+.|+||||= ..+|..+|++. ........++.+..||+.|+.++|.+ ||||.||||.|+++- .|.+|
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~---------~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKK---------KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eEEEEeecc-cccHHHHHHhc---------cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEE
Confidence 999999965 66999999652 22233237888999999999999999 999999999999995 56899
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCC-----------CCCcccchHHHHHHHHHHHhCCCCCCccccCC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-----------EVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~ 935 (1033)
|+|||+|..+..+.........+||+.||+||.+... +.++++||||+|||+|+|+.|++||...
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---- 575 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---- 575 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----
Confidence 9999999988877766655566799999999987543 2578999999999999999999998521
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+..+.++...-.+.+ .. ...++.++|+.||+.||++|||+.|+++.
T Consensus 576 ---~n~~a-----Kl~aI~~P~~~Iefp~-------------~~----~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 ---INQIA-----KLHAITDPNHEIEFPD-------------IP----ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHH-----HHHhhcCCCccccccC-------------CC----CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11111 0112222211000000 00 01238999999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=325.92 Aligned_cols=238 Identities=25% Similarity=0.273 Sum_probs=184.6
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHH-HHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999899999999987432 222344555554 57888999999999884 4456899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence 9999999998884 234578888999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~--- 212 (321)
T cd05603 143 CKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILHKP--- 212 (321)
T ss_pred CccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhcCC---
Confidence 875322221 112234899999999999989999999999999999999999998532 1111111111000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
. ..+.....++.+++.+|++.||++||++.
T Consensus 213 -----~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -----L--------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----C--------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 00011234588999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.35 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=201.6
Q ss_pred ceecccCceeEEEEEeCCC---CeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|.+... +..||+|+++..... ..+.+.+|++.++.++|+||+++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4799999999999999865 889999999755433 3678899999999999999999999853 356889999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.++++...... .......+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999996421100 001146789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
+................++..|+|||.+....++.++||||+|+++|||++ |..||.... ...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~--- 223 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLRKG--- 223 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC---
Confidence 987654432222223447889999999988889999999999999999999 699986431 11111111000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.+...+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 224 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000111223567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=322.76 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=197.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|.-.+.||.|+||.||-|++..+.+.||||.+.... .....++.+|+..|++++|||+|.+-|+ |-.+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC-----yLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC-----YLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce-----eeccchH
Confidence 3556688999999999999999999999999987433 3445788999999999999999999998 4455578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+||||| -|+-.|++. ...+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+
T Consensus 102 WLVMEYC-lGSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHHH-hccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence 9999999 568888874 3556789999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|||.|....+... ++|||+|||||++. .+.|+-++||||+|++..|+..+++|.-.+..- ..+...++..
T Consensus 169 DFGSAsi~~PAns------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNe 241 (948)
T KOG0577|consen 169 DFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE 241 (948)
T ss_pred cccchhhcCchhc------ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcC
Confidence 9999987644332 45999999999865 468999999999999999999999996422110 0011111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.+ ...+....+.+++..||+.-|.+|||.+++++.
T Consensus 242 ---------sPtL---------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 ---------SPTL---------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---------CCCC---------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 0111 112345679999999999999999999998875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.53 Aligned_cols=266 Identities=22% Similarity=0.262 Sum_probs=205.3
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecc
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 779 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 779 (1033)
.+..++..+...|++.+.||+|+||.||+|++..+++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 466677778889999999999999999999998899999999986543 2345688899999999 79999999998753
Q ss_pred ccc-cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 780 VDY-QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 780 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
... ......++||||+++|+|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 221 234578999999999999999853 1234577888999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
+++++.++|+|||.+........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||.....
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999999999875532221 112234889999999875 34688899999999999999999999853211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ..... ......... ....++..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~----~~~~~------~~~~~~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 M----RALFL------IPRNPPPKL---------------------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred H----hhhhh------HhhCCCCCC---------------------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000 000000000 00123456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.40 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=201.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||.||+|... +++.||||.++.... ..+++.+|+.++++++|+||+++++++ ..+...+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 468999999999999999999986 557899999875332 346789999999999999999999984 3445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.|++|||++ +++||||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~--------~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--------GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhc--------cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence 99999999999999953 2335689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+......... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ......... ...
T Consensus 147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~-~~~- 222 (261)
T cd05034 147 FGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVER-GYR- 222 (261)
T ss_pred cccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCC-
Confidence 9999876432211 1111224568999999998889999999999999999999 9999852211 001111000 000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
...+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -----------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.34 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=196.2
Q ss_pred ceecccCceeEEEEEeCC-CC--eEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDE-GK--TIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|++|.||+|.+.. ++ ..||+|.++.... ...+++.+|+.++++++||||+++++++.+ ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999864 23 3699999876554 556789999999999999999999998532 5789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKD--------ALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhc--------ccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence 999999999999531 114689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcch
Q 042075 873 ATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 873 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
+......... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~- 217 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEG- 217 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcC-
Confidence 9876442211 11112347789999999998899999999999999999999 99998532111 1111000000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
. ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 -----~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 -----E--------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----C--------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 00001123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.96 Aligned_cols=276 Identities=23% Similarity=0.286 Sum_probs=197.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|+...+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 5888999999999999999998889999999986432 22346788999999999999999999995 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||++ ++|.+++... .....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence 9999997 6898888531 1235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC-
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP- 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 947 (1033)
||++......... .....+++.|+|||++.+. .++.++|||||||++|||++|++||......+. ..........
T Consensus 145 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~ 221 (285)
T cd07861 145 FGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTP 221 (285)
T ss_pred ccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 9999765432211 1122468899999987654 578999999999999999999999863211110 0000000000
Q ss_pred -cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 -DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 -~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+..+.... ...+.....................+++.+++.+||+.||++|||+.+|++
T Consensus 222 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 222 TEDVWPGVT-----SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred Chhhhhcch-----hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000000000000000000001123566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.71 Aligned_cols=285 Identities=18% Similarity=0.180 Sum_probs=197.7
Q ss_pred ccceeccc--CceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 715 SANLIGAG--SFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 715 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+.++||+| +|++||++.++.+++.||+|+++... ....+.+.+|+++++.++||||++++++| ..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 46789999 78999999999999999999987532 23345678899999999999999999995 34457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICT--------HFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence 9999999999999853 1223588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCc-----cccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 871 GLATFLPLSHA-----QTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 871 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
+.+........ ........++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~ 224 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLN 224 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhc
Confidence 87543321111 001112236778999999876 4689999999999999999999999964322111 111111
Q ss_pred hhCCcchh------h---------hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 944 TALPDHVV------D---------IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 944 ~~~~~~~~------~---------~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
...+.... + ..+....... ...................+..+++.+++.+||+.||++|||++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGEST-TVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred CCccccccccchhhhhcccCCcccCCcCCCCccc-ccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 00000000 0 0000000000 000000000000001112234567899999999999999999999
Q ss_pred HHHH--HHHHH
Q 042075 1009 VVHQ--LQSIK 1017 (1033)
Q Consensus 1009 vl~~--L~~i~ 1017 (1033)
+++. +.+++
T Consensus 304 ll~~p~f~~~~ 314 (327)
T cd08227 304 LLNHSFFKQIK 314 (327)
T ss_pred HhcChhhhhcc
Confidence 9874 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.49 Aligned_cols=201 Identities=25% Similarity=0.306 Sum_probs=172.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|..++..++|++|+++++++ ..++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4799999999999999999999989999999998642 223345678899999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEE
Confidence 9999999999999999953 234688889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+|||+++.......... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 144 ADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 99999987644332211 22348999999998865 467899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=331.85 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=164.1
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
....+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++. ....
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence 3446899999999999999999999988999999985422 2356999999999999999999853 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. ++|.+++.. ....+++.++..|+.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 132 ~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl 198 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTK---------RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198 (357)
T ss_pred eEEEEEccC-CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 899999994 688888842 345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
+|||.++....... .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 199 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 199 GDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999975332211 12234899999999999999999999999999999999865554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.65 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=186.3
Q ss_pred ceecccCceeEEEEEeCC--CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDE--GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||+||+|.... ....||+|.+.... ......+.+|+.+++.++||||++++++|. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 369999999999997542 34578888776433 233456889999999999999999999854 3457899999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.+++..... ......++.....++.||+.|++|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhccc-----cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 9999999999964211 1123456788899999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccccccccccccC-------CCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGL-------GSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
................++..|+|||++. ...++.++|||||||++|||++ |..||......+ .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~---- 222 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQV---- 222 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHH----
Confidence 7543322222222233677899999864 3457889999999999999999 778875321110 11111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
..........+.. ....++.+.+++..|| .||++|||++||++.|.
T Consensus 223 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 223 VREQDIKLPKPQL----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred hhccCccCCCCcc----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111001111110 1123355788899999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.34 Aligned_cols=276 Identities=23% Similarity=0.286 Sum_probs=199.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++|||++++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 47899999999999999999999889999999986432 22335678999999999999999999985 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|..+.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+
T Consensus 76 ~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEEC
Confidence 99999999998888763 234589999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.+.......... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. .... .....
T Consensus 143 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~-~~~~~ 218 (286)
T cd07847 143 DFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLI-RKTLG 218 (286)
T ss_pred ccccceecCCCcccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhC
Confidence 999998765433211 12237889999999876 4578999999999999999999999864322111 1111 11000
Q ss_pred c---chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 D---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ...+..+.... ................ ......+..+.+++.+||+.+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 219 DLIPRHQQIFSTNQF--FKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHhhhcccccc--cccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00011100000 0000000000000000 001123466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.05 Aligned_cols=240 Identities=22% Similarity=0.347 Sum_probs=184.8
Q ss_pred ceecccCceeEEEEEeCCC------------CeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 717 NLIGAGSFGSVYKGILDEG------------KTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
+.||+|+||.||+|+.... ...||+|++..........+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 4689999999999986422 3358999887655555567889999999999999999999964 3
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
+...++||||+++|+|..+++. ....+++..+..++.||++|++|||++ +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence 4477999999999999998853 234589999999999999999999999 9999999999999987664
Q ss_pred -------EEEeecccceecCCCCccccccccccccccccccccC-CCCCCcccchHHHHHHHHHHH-hCCCCCCccccCC
Q 042075 865 -------AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELV-TRKKPTDIMFEGD 935 (1033)
Q Consensus 865 -------~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~vl~ell-tg~~p~~~~~~~~ 935 (1033)
++++|||.+....... ...++..|+|||.+. +..++.++|||||||++|||+ +|+.||......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~- 216 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA- 216 (262)
T ss_pred cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-
Confidence 8999999987543221 123788999999886 467899999999999999997 588886421100
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
....+..... .. .....+.+.+++.+||+.||++||++.++++.+
T Consensus 217 -~~~~~~~~~~-----~~---------------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 -EKERFYEGQC-----ML---------------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHHHHhcCc-----cC---------------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000000 00 000124588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.39 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=194.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.+|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+ ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 47899999999999999999998889999999886432 1234568899999999999999999998532 223
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----------YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 567899999999999999842 33578899999999999999999998 99999999999999999999
Q ss_pred EEeecccceecCCCCc-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||++........ ........++..|+|||.+.+..++.++||||+||++||+++|+.||.... .......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~----~~~~~~~- 220 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE----AMAAIFK- 220 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc----hHHHHHH-
Confidence 9999999876532211 111112347889999999998889999999999999999999999986321 1111100
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...... . ...+....+.+.+++ +||..+|++||+++||++
T Consensus 221 ~~~~~~----~----------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPT----N----------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCC----C----------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000 0 000112234466676 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.64 Aligned_cols=275 Identities=20% Similarity=0.274 Sum_probs=196.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||.||+|++..+|+.||+|+++... ......+.+|++++++++||||++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 5888999999999999999999899999999986432 2223567789999999999999999998 44556899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+||++ ++|.+++.. ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence 9999996 588887742 234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.++......... ....++..|+|||++.+. .++.++|||||||++|||++|+.|+.........+..........
T Consensus 143 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99998654322211 123478899999998764 478999999999999999999998643222111111111110000
Q ss_pred c--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 949 H--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 949 ~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ....+... ............... ........+++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKL--PDYKPYPMYPATTSL---VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhc--ccccccCCCCCcchh---hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00000000 000000000000000 0011123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.56 Aligned_cols=281 Identities=22% Similarity=0.317 Sum_probs=196.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++++|++.+.||+|+||.||+|....+++.||+|+++... ......+.+|+.+++.++|+||+++++++ ..++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 5678999999999999999999998889999999986433 22234677899999999999999999985 34557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. +++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQ---------HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEE
Confidence 899999995 677776632 234577888899999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh-h
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT-A 945 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~ 945 (1033)
+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.||+........+.+.... .
T Consensus 145 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 222 (291)
T cd07870 145 ADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222 (291)
T ss_pred eccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC
Confidence 999999764332211 1223378899999998764 57889999999999999999999986432211111111000 0
Q ss_pred CCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.+.. ...... .......... ....................+.+++.+|++.||++|||++|++.
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 223 VPTEDTWPGVS-KLPNYKPEWF-LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CCChhhhhhhh-hcccccchhc-cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000000 0000000000 00000000000000011356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=332.55 Aligned_cols=278 Identities=19% Similarity=0.180 Sum_probs=197.7
Q ss_pred hCCCCccceecccCceeEEEEEeCC--CCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE--GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..+|.+.+.||+|+||.||+|...+ .++.||+|.+... ....+|++++++++||||+++++++ ..+..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 3579999999999999999998643 4678999987542 2346899999999999999999984 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. ++|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD----------RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhcC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence 899999995 68888883 335689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC--ccHHHHHhhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD--MNLHNFAKTA 945 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~ 945 (1033)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+..
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99999986654433322233458999999999999999999999999999999999999985432211 1111111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhh---hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN---SKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
-... .+.....................+....+ .......++.+++.+||..||++|||+.|++..
T Consensus 307 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 307 QVHP-LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCc-cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000000000000000000000000 001123567899999999999999999999876
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.09 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=194.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
++||+|+||.||+|.+.. ++.||+|.++..... ....+.+|++++++++||||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 479999999999999986 899999998754333 456789999999999999999999985 3445789999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+..
T Consensus 75 ~~~~l~~~l~~---------~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRK---------KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 99999999853 234578899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIV 954 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1033)
...............+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...........
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~------- 213 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR------- 213 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC-------
Confidence 542222111111224667999999988899999999999999999999 88887532111 11111000000
Q ss_pred ccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 955 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 955 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+...+.++.+++.+||..+|++|||+.|+++.|+
T Consensus 214 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 214 -----------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0001123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=308.19 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=202.0
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|+..+.||.|+||.||.++...+++.|++|.+... .....+++.+|++++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 588999999999999999999989999999988643 234456788999999999999999999995 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVR--------QKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence 99999999999999853 1245689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+......... .....+++.|+|||...+..++.++||||||+++|||++|+.||+... ............
T Consensus 145 ~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~ 217 (256)
T cd08221 145 FGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGN 217 (256)
T ss_pred CcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC
Confidence 9999876443321 122348999999999988889999999999999999999999985321 111111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .....+.++.+++.+||+.+|++||+++|+++.
T Consensus 218 ~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YTP---------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCC---------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 000 001234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.80 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=200.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||.|++|.||+|++..+++.||+|++.... ......+.+|++++++++|+||+++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 46889999999999999999999899999999987543 344567889999999999999999999853 445889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999842 2689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.++........ .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..........+.
T Consensus 142 ~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~- 216 (274)
T cd06609 142 FGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNPP- 216 (274)
T ss_pred cccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCCC-
Confidence 9999876543221 12234788999999999888999999999999999999999998632110 000000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... ...+.++.+++.+||..+|++|||++++++.
T Consensus 217 -------~~~~---------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 -------SLEG---------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -------CCcc---------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000 0023458899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.10 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=197.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch---------hHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG---------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 478889999999999999999888999999988643221 235688999999999999999999985
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
...+..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~ 142 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK 142 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC
Confidence 345588999999999999999942 34578889999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccc----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 863 MIAHVGDFGLATFLPLSHAQT----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+.++|+|||.++......... ......|+..|+|||.+.+..++.++||||+||++|||++|+.||..... .
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~ 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----L 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----H
Confidence 999999999998764321111 11123478899999999888899999999999999999999999863211 1
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...... .....+. .+...+..+.+++.+||+.||++||++.|+++
T Consensus 219 ~~~~~~------~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIFKI------GENASPE----------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHH------hccCCCc----------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 110000 0000000 01123456899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.13 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=192.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
++||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||++++++|. ..+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 47999999999999976 678899999875432 23356889999999999999999999963 345789999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ....+++.++..++.|++.|+.|+|+. +++||||||+||++++++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 99999999853 234578999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIV 954 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1033)
........ .....++..|+|||++.+..++.++||||||+++||+++ |..||..... ...........
T Consensus 143 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~~~~~----- 211 (250)
T cd05085 143 EDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQVEKGY----- 211 (250)
T ss_pred cccccccc-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHcCC-----
Confidence 43322211 111224678999999988889999999999999999998 9999853211 11101000000
Q ss_pred ccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 955 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 955 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
+...+..++.++.+++.+||+.+|++||++.|++++|.
T Consensus 212 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 ----------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00001123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.80 Aligned_cols=282 Identities=19% Similarity=0.212 Sum_probs=203.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......++.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999999989999999998643 22344668889999999999999999998765555555678
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++|+||++ +++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~lv~e~~~-~~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEehhcc-cCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence 99999996 48887773 24589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccc-cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 869 DFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|||++.......... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHc
Confidence 999998654332211 1122347899999998654 5688999999999999999999999853211 00000011111
Q ss_pred C----cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 P----DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +....+.+......... .................+++.+++.+||+.+|++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKS----LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhh----cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111111000000000 00000000000011234668999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=323.04 Aligned_cols=201 Identities=24% Similarity=0.288 Sum_probs=170.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.++||+|+||+||+++.+.+++.||+|++... .......+.+|+.++..++|++|+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4789999999999999999999989999999998642 222334578899999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.++++. ....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999953 234588889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 144 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred eecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 999999765332221 112245899999999876 3468899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.06 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=185.4
Q ss_pred ceecccCceeEEEEEeCCCCe-------EEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 717 NLIGAGSFGSVYKGILDEGKT-------IVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+.||+|+||.||+|.....+. .||+|..........+.+.+|+.+++.++||||+++++++. .++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 469999999999999865443 48888886555555577889999999999999999999954 345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc-----
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI----- 864 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~----- 864 (1033)
+||||+++|+|.++++. ....+++..++.++.||+.|++|||++ +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence 99999999999999953 223678999999999999999999999 9999999999999987765
Q ss_pred ---EEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCC-CCCCccccCCccHH
Q 042075 865 ---AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRK-KPTDIMFEGDMNLH 939 (1033)
Q Consensus 865 ---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~-~p~~~~~~~~~~~~ 939 (1033)
++++|||.+....... ...++..|+|||++.+ ..++.++|||||||++|||++|. .||... ... ...
T Consensus 144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~-~~~ 215 (258)
T cd05078 144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQ-KKL 215 (258)
T ss_pred CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHH-HHH
Confidence 6999999887543211 1237889999999876 45789999999999999999985 554311 000 000
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
..... .. ..+.....++.+++.+||+.||++|||++++++.|
T Consensus 216 ~~~~~------------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 216 QFYED------------RH--------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHc------------cc--------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000 00 00001124589999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.62 Aligned_cols=240 Identities=22% Similarity=0.322 Sum_probs=183.8
Q ss_pred eecccCceeEEEEEeCC------------------------CCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeE
Q 042075 718 LIGAGSFGSVYKGILDE------------------------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 773 (1033)
.||+|+||.||+|.... ....||+|+++.........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 124589998875544445678899999999999999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
+++|. .+...++||||+++|+|..++.. ....+++..+..++.||++||+|||++ +|+|||||
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 99964 34478999999999999999853 234678999999999999999999999 99999999
Q ss_pred CCCeEecCCC-------cEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHH-hC
Q 042075 854 PSNVLLDEEM-------IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELV-TR 924 (1033)
Q Consensus 854 p~NIll~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~ell-tg 924 (1033)
|+||++++.+ .+|++|||.+....... ...++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997643 48999999886432211 1236788999998865 56899999999999999984 69
Q ss_pred CCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC
Q 042075 925 KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004 (1033)
Q Consensus 925 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1004 (1033)
+.||...... ....+..... .. +......+.+++.+||+.+|++||
T Consensus 219 ~~p~~~~~~~--~~~~~~~~~~----------~~----------------------~~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 219 EVPLKERTPS--EKERFYEKKH----------RL----------------------PEPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCccccChH--HHHHHHHhcc----------CC----------------------CCCCChHHHHHHHHHcccChhhCc
Confidence 9988532111 0011100000 00 000123588999999999999999
Q ss_pred CHHHHHHHHH
Q 042075 1005 DMTNVVHQLQ 1014 (1033)
Q Consensus 1005 t~~evl~~L~ 1014 (1033)
|+.+|++.|+
T Consensus 265 s~~~il~~L~ 274 (274)
T cd05076 265 SFRTILRDLT 274 (274)
T ss_pred CHHHHHHhhC
Confidence 9999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=312.34 Aligned_cols=265 Identities=24% Similarity=0.260 Sum_probs=202.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ....++.+|++++++++||||++++++|.. ...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 468889999999999999999988999999999875332 345678999999999999999999998642 2345689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.... .....++...+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 9999999999999875311 1345578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||++......... ...++..|+|||.+.+..++.++||||+||++|||++|+.||+....................
T Consensus 149 fg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 9998754332211 123788999999999889999999999999999999999998743211011111111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .+... ........+++.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~~-----~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 225 NP-----ELKDE----------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ch-----hhccC----------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 00000 00000124568999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=314.74 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=203.3
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc-cCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY-QGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~ 785 (1033)
.++++|++.+.||+|++|.||+|.+..+++.|++|+++.... ..+++.+|+.+++++ .|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456899999999999999999999988899999999875443 346789999999999 79999999999765432 334
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.++++... .....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence 56899999999999999985311 1245689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
||+|||.+......... .....++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+
T Consensus 153 ~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~ 229 (275)
T cd06608 153 KLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK 229 (275)
T ss_pred EECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH
Confidence 99999998765432221 122348899999998753 34778999999999999999999998532111 01110
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ... + ....+....+++.+++.+||..||++|||+.|+++
T Consensus 230 ~~~----~~~-----~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPR----NPP-----P--------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhc----cCC-----C--------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 000 0 00011123456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.63 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+. ++..||+|.++... ...+.+.+|++++++++|+||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 468899999999999999999876 45679999876432 234678899999999999999999998532 4679
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
++|||+++++|.+++.. .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHh--------CCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 99999999999999953 2344678899999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+.......... .....++..|+|||++....++.++|||||||++||+++ |+.||..... .............
T Consensus 146 ~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM 222 (260)
T ss_pred CcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC
Confidence 99998654322211 112235678999999988889999999999999999999 8999853211 0111110000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.67 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=200.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..|+..+.||.|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++ ..+...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence 35778899999999999999998889999999987433 34457788999999999999999999995 3455899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence 99999999999999842 3478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+.......... ....++..|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 145 fg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~------ 211 (277)
T cd06640 145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLF------ 211 (277)
T ss_pred cccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhh------
Confidence 99997654332211 12347889999999988889999999999999999999999985321110 000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.... ........+..+.+++.+||+.+|++||+++++++.
T Consensus 212 ---~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 ---LIPKNN------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhcCC------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000 001112345678999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.60 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=198.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++ ..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4667788999999999999998889999999987432 34456789999999999999999999984 44568899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++||
T Consensus 80 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 80 IMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence 9999999999998842 3578899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|++......... .....++..|+|||++.+..++.++|||||||++|||++|+.||....... .... .....
T Consensus 146 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~----~~~~~ 217 (277)
T cd06642 146 GVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL----IPKNS 217 (277)
T ss_pred cccccccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh----hhcCC
Confidence 999765433211 112347889999999998889999999999999999999999985321110 0000 00000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+. .....+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ----~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 ----PPT----------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CCC----------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 011234568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.08 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=168.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|++|.||+|.++.+++.||+|.++.... .....+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 4689999999999999999999988899999999864322 2234567899999999999999999994 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++ +|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence 999999974 99998853 234678999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|||.++........ .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 146 dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 146 DFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99998754322111 111236888999998865 4588999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.50 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=203.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||+|+||+||+|.+..+++.||+|+..... ....+.+.+|+++++.++||||+++++++. ..+..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 57888999999999999999999889999999886433 334577899999999999999999999954 345889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ +++||||||+||++++++.++|+|
T Consensus 80 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEcc
Confidence 99999999999998842 345889999999999999999999732 899999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||++........ ....|+..|+|||++.+..++.++|||||||++||+++|+.||+.....+.. ......
T Consensus 148 ~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~ 217 (284)
T cd06620 148 FGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMG 217 (284)
T ss_pred CCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhH
Confidence 999875422211 1234899999999998889999999999999999999999999743221100 000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
+.+.+........ .+. ...+.+..+.+++.+||+.||++|||++|++++..-++
T Consensus 218 ~~~~~~~~~~~~~-------------~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 218 ILDLLQQIVQEPP-------------PRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHhhccC-------------CCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000000000000 000 00124456899999999999999999999998754333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.90 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=203.3
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
-|.|+..||.|+||.||+|..++++-..|.|++........++|.-|++||...+||+||++++. |..++..++.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~a-----yy~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSA-----YYFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHH-----HhccCceEEE
Confidence 45677889999999999999998888889999988888888999999999999999999999998 4455678999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
.|||.||-.+..+- .-+..+++.++.-+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence 99999999988874 3567799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccccccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYG-----LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
.+...... ......+.|||+|||||+. ...+|++++||||||+++.||..+.+|..... .+.-..+...
T Consensus 176 VSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaK 249 (1187)
T KOG0579|consen 176 VSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAK 249 (1187)
T ss_pred ccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhh
Confidence 87643221 2222335599999999985 45689999999999999999999999964211 1111111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+. .....+......+.+++.+||..||..||+++++++.
T Consensus 250 SeP--------------------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEP--------------------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCC--------------------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 000 0111122334568999999999999999999999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.23 Aligned_cols=254 Identities=21% Similarity=0.230 Sum_probs=196.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 57899999999999999999999899999999886321 12346788999999999999999999985321 23
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence 467899999999999999842 23478888999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCc-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.+........ ........++..|+|||++.+..++.++|||||||++|||++|+.||... .........
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~ 221 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI 221 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chHHHHHHH
Confidence 9999999876532211 11112234888999999998888999999999999999999999998532 111111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ....+......+.+++.+|+. +|++||+++|+++.
T Consensus 222 ~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQPT---------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCCC---------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000 000112234567889999995 99999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.78 Aligned_cols=277 Identities=23% Similarity=0.298 Sum_probs=199.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 478899999999999999999988899999998764322 2346688999999999999999999994 455689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.++.. ....+++.++..++.|+++|++|||+. +++||||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEE
Confidence 99999999999988763 233489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh--hh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK--TA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~ 945 (1033)
|||++......... .....++..|+|||++.+ ..++.++||||||+++|||++|++||...... ........ ..
T Consensus 143 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~ 219 (286)
T cd07846 143 DFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGN 219 (286)
T ss_pred eeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCC
Confidence 99999865443221 112347889999998765 45788999999999999999999998532110 00001000 00
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.........+.......... ................+..+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 220 LIPRHQEIFQKNPLFAGMRL---PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CchhhHHHhccchHhhcccc---ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00101010000000000000 0000000000011234567999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.91 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=195.2
Q ss_pred ceecccCceeEEEEEeCCCC------eEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 717 NLIGAGSFGSVYKGILDEGK------TIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|+.++++++||||++++++|. ..+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 46999999999999986433 689999876432 234567889999999999999999999853 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-----c
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-----I 864 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-----~ 864 (1033)
+||||+++++|.++++...... .....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 9999999999999996422111 1334578999999999999999999998 999999999999999877 8
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ........
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~ 227 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVT 227 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHh
Confidence 99999999976543322221122235788999999999999999999999999999998 9999852211 01110000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
... +...+...+..+.+++.+||+.+|++||++++|++.|.
T Consensus 228 ---~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 ---AGG---------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---cCC---------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 00011123466899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=307.02 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=200.8
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||.||+++...+++.||+|.+... .....+++.+|+.++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 588999999999999999999989999999998743 233456789999999999999999999984 4556899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--------QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence 99999999999999853 2234578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+.......... ....|+..|+|||+..+..++.++|||||||++|||++|+.||... .............
T Consensus 145 ~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~ 217 (256)
T cd08218 145 FGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGS 217 (256)
T ss_pred ccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCC
Confidence 99998654332211 1234788999999999888999999999999999999999998521 1111111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ...+.....++.+++.+||+.+|++||++.||++.
T Consensus 218 ~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 Y---------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C---------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 00011234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.03 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=197.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+|++.+.||+|+||.||+|.+. .++.+|+|+++.... ...++.+|++++++++||+++++++++ ......+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceE
Confidence 347888999999999999999986 467899998864322 346788999999999999999999984 4445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d 143 (256)
T cd05112 76 LVFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSD 143 (256)
T ss_pred EEEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECC
Confidence 99999999999999852 234578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ .
T Consensus 144 ~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~-~ 216 (256)
T cd05112 144 FGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETIN-A 216 (256)
T ss_pred CcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHh-C
Confidence 9998865432211 1111225678999999988889999999999999999998 9999853211 11111100 0
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. ....+ ...++++.+++.+||+.+|++|||+.|++++|
T Consensus 217 ~~-~~~~~-------------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 GF-RLYKP-------------------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CC-CCCCC-------------------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 00000 01235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.68 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=196.7
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
|.....||+|+||.||++....+++.||||.++.......+.+.+|+.++++++||||+++++.+ ..++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEEE
Confidence 44456799999999999999888999999998765555567789999999999999999999984 3456889999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.+++.. ..+++.++..++.||+.|++|||++ +|+||||||+||++++++.++|+|||+
T Consensus 99 e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 99 EFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred eCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 99999999998832 3478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....... ...
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~------~~~ 232 (292)
T cd06658 165 CAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----PLQAMRR------IRD 232 (292)
T ss_pred hhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH------HHh
Confidence 8755332221 122348899999999988889999999999999999999999985311 1111000 000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... ........+.+++.+||..||++|||++|+++.
T Consensus 233 ~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVK--------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCccc--------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000000 000123458899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.67 Aligned_cols=208 Identities=24% Similarity=0.303 Sum_probs=173.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC----eEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK----TIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
-..|+.++.||+|.||.||+|....+. +.+|+|.++... .+......+|+..++.++|||++.+..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 347899999999999999999765432 368999997542 234467789999999999999999999863 3
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE- 862 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~- 862 (1033)
.+...++++||.+. +|.+.++.++.. ..+.++...+..|..||+.|+.|||++ =|+|||+||.|||+..+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDG 169 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccC
Confidence 35689999999976 999999765542 335789999999999999999999999 89999999999999877
Q ss_pred ---CcEEEeecccceecCCCCcc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 863 ---MIAHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 863 ---~~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|.|||+|||+|+.+...-.. .....++.|..|+|||.+.+. .||++.||||.|||+.||+|-++.|..
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 89999999999987654322 233345589999999998885 689999999999999999999998864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=309.60 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=202.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||.|+||.||+|.+..+++.||+|+++.. .....+++..|++++++++||||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 588899999999999999999989999999998643 23345678899999999999999999987542 2345679
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH-----hCCCCCcEeccCCCCCeEecCCCc
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH-----HDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++|||+++++|.+++.... .....+++.+++.++.|++.|++||| +. +++||||||+||++++++.
T Consensus 78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN 148 (265)
T ss_pred EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence 9999999999999995421 23456899999999999999999999 66 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||.+.......... ....++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...+...
T Consensus 149 ~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~ 221 (265)
T cd08217 149 VKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK 221 (265)
T ss_pred EEEecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH
Confidence 9999999998765433211 12348899999999998889999999999999999999999986321 1111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... + ..+...+.++.+++.+|++.+|++||++.+|++.
T Consensus 222 ~~~~~~-----~----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 IKEGKF-----R----------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HhcCCC-----C----------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 100000 0 0011234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=320.44 Aligned_cols=205 Identities=21% Similarity=0.291 Sum_probs=162.2
Q ss_pred cceecccCceeEEEEEeCC--CCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 716 ANLIGAGSFGSVYKGILDE--GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
..+||+|+||+||+|+... +++.||+|.++... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3589999999999999754 56789999886432 23467889999999999999999998642 23457899999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe----cCCCcEEEee
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGD 869 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~D 869 (1033)
|++ ++|.+++....... .......+++..+..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 81 YAE-HDLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeC-CcHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 986 58888775322111 112334688999999999999999999999 99999999999999 5667999999
Q ss_pred cccceecCCCCcc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 870 FGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 870 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
||+++........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9999876433221 11122348999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=310.11 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=199.7
Q ss_pred CCccceecccCceeEEEEEeCC---CCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC-CC
Q 042075 713 FTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG-ND 786 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~ 786 (1033)
|++.+.||+|+||.||+|.+.. +++.||||+++.. .....+++.+|++++++++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998643 5788999998743 2334567889999999999999999999864322111 12
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++++||+++|+|.+++...... .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 347899999999999887421111 1223578899999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.++...............++..|++||.+....++.++|||||||++|||++ |++||..... .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~~ 228 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNYL 228 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHHH
Confidence 999999986643332222222335678999999988889999999999999999999 8888753211 1111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
.... .. ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 229 ~~~~-------~~--------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-------RL--------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-------cC--------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 00 00011235689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.10 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=198.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|+..+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 588899999999999999999889999999998643 233456788999999999999999999884 4556889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-CcEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~ 868 (1033)
+||||+++++|.+++.. .....+++..+..++.|+++|++|||++ +|+||||||+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--------RCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 99999999999999953 1234588999999999999999999999 99999999999999855 468999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||+... ...........
T Consensus 145 d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~ 216 (256)
T cd08220 145 DFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKIMSG 216 (256)
T ss_pred cCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHHHhc
Confidence 99999876443221 12347889999999998889999999999999999999999985321 11111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... .+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 217 ~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 TFAP---------------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCC---------------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 000124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=292.68 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=203.0
Q ss_pred hhCCCCcc-ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSA-NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+++|++. ++||-|-.|.|-.+..+.+++.+|+|++... ...++|++.--.. .|||||.++++|... +.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 45677665 5799999999999999999999999998532 4457888876666 799999999997543 56677
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CC
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EM 863 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~ 863 (1033)
...+|||.|+||.|...++. .....+++.++-.|+.||+.|+.|||+. .|.||||||+|+|... +-
T Consensus 133 cLLiVmE~meGGeLfsriq~--------~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQD--------RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeEeeeecccchHHHHHHHH--------cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCc
Confidence 88899999999999999964 3556799999999999999999999999 9999999999999964 44
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+|+.........+ .+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||....... +..-.+
T Consensus 202 ~lKLtDfGFAK~t~~~~~L~T---Pc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk 276 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGDLMT---PCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMK 276 (400)
T ss_pred ceEecccccccccCCCccccC---CcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHH
Confidence 799999999997654333332 447999999999999999999999999999999999999997432211 111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+...-.++-+ ++-.+.+++..++++.+|+.+|.+|.|+.|++..
T Consensus 277 ~rI~~gqy~FP~-----------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 277 RRIRTGQYEFPE-----------------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhhccCccCCC-----------------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111111111100 1122456778999999999999999999999864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.79 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=201.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|+..+.||+|++|.||+|.+..+++.||+|++.... ....+++.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence 46888899999999999999999889999999987543 34456788999999999999999999985 3346899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
+|+||+++++|.+++.. ....++...+..++.|++.|++|||+ . +++||||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKE---------VQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999953 22568889999999999999999999 7 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+.......... ..++..|+|||.+.+..++.++||||+|+++|+|++|+.||..............+.....
T Consensus 144 d~g~~~~~~~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd06605 144 DFGVSGQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219 (265)
T ss_pred ecccchhhHHHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence 999987553222111 3488899999999998999999999999999999999999864322111111111111100
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. +.. . ......++.+++.+||..||++|||+.|++..
T Consensus 220 ~~-----~~~---~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PP-----PRL---P------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CC-----CCC---C------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 000 0 00134568999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.64 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=198.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 4688999999999999999999989999999988753 233456788999999999999999999984 4456899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++.. .....+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999988531 11346899999999999999999999632 899999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
||.+........ ....++..|+|||.+.+. .++.++||||+||++|||++|+.||..... ........
T Consensus 147 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~ 220 (286)
T cd06622 147 FGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLS 220 (286)
T ss_pred cCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHH
Confidence 999876533221 112378899999997554 358899999999999999999999853211 00000000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.+... ...+.....++.+++.+||+.+|++||++++++..
T Consensus 221 --------~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 --------AIVDGDP-------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------HHhhcCC-------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0000000 00111244668899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.46 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=196.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc----------hhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH----------GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+.++++++|||++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 47788999999999999999988899999998763211 1234678899999999999999999985
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
...+..++||||+++++|.++++. ...+++..+..++.|++.|+.|||+. +++||||+|+||++++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~ 143 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----------YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA 143 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence 344578999999999999999953 24688899999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
++.++++|||.++...............++..|+|||.+.... ++.++||||+|+++||+++|..||.... ...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIA 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHH
Confidence 9999999999997653322111122234788999999987654 8899999999999999999999985211 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... .......+.. ....+++..+.+++.+||+.+|++||++++|++.
T Consensus 220 ~~~~~~-~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 AMFKLG-NKRSAPPIPP----------------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHhh-ccccCCcCCc----------------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111100 0000000000 0011234668999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.70 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=203.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+.|+.-++||+|+||.||-++.+.+|+.+|+|.+.+.. ........+|-.++++++.+.||.+-.. |+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 356788899999999999999999999999999875322 2233456789999999999999998766 67777
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++|+..|.||+|.-++.. .....+++..++-++.+|+.||++||.. +||.||+||+|||+|+.|+++
T Consensus 259 ~LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred ceEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 99999999999999999964 3456799999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|.|+|..+..+..... .+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+
T Consensus 328 ISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------------- 391 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------------- 391 (591)
T ss_pred eeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-------------
Confidence 999999998876655443 3599999999999999999999999999999999999999852111
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
..-++.+|.....+.+.+ +....++..++.+..|+.||++|....
T Consensus 392 -Kvk~eEvdrr~~~~~~ey---------------~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 392 -KVKREEVDRRTLEDPEEY---------------SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -hhhHHHHHHHHhcchhhc---------------ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111223333333332221 123456678899999999999997543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.79 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=184.0
Q ss_pred ceecccCceeEEEEEeCCC--CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEG--KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.||+|+||.||+|+...+ ...+++|.++... ....+.+.+|+.+++.++||||+++++.|. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 3699999999999986433 2346677665432 334578999999999999999999999964 3457899999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccc
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a 873 (1033)
|+++|+|.++++... ......++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence 999999999996421 1123467778889999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
................++..|+|||++.. ..++.++|||||||++|||++ |..||..... .......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~ 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHV 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence 64322211111122347889999998743 245789999999999999997 5667642211 1111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.........++.+... ..+.+.+++..|| .+|++||+++||++.|.
T Consensus 222 ~~~~~~~~~~~~~~~~----------------------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQLELP----------------------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCccCCC----------------------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111111111111 1245788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.91 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=194.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||.||++.. +++.||+|..+... ..+.+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4688999999999999999975 57789999986432 34678899999999999999999998532 24689
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. .....+++.++..++.|++.|++|||+. |++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRT--------RGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence 9999999999999953 2234578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+........ ....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... .........
T Consensus 145 g~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~--- 211 (254)
T cd05083 145 GLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVE--- 211 (254)
T ss_pred ccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh---
Confidence 99976432211 1224678999999988899999999999999999998 999985321 111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
... +...+..++.++.+++.+||+.+|++||+++++++.|++
T Consensus 212 ------~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 ------KGY------------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CCC------------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000 000011234568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=308.93 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=194.8
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC------chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+|++.+.||+|+||+||+|... +++.||+|.++... ....+.+.+|++++++++|+||++++++|. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 5888999999999999999875 78899999886322 123356889999999999999999999953 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----------FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeE
Confidence 689999999999999999942 23578899999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCc----cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 866 HVGDFGLATFLPLSHA----QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+|+|||.+........ ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~ 217 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAM 217 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHH
Confidence 9999999876432111 1111123488999999999988899999999999999999999999853211 1110
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
......... .+.. +.....++.+++.+||+.+|++||++.|+++
T Consensus 218 ~~~~~~~~~----~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 FYIGAHRGL----MPRL----------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhhhccCC----CCCC----------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0000 0112355899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=312.78 Aligned_cols=277 Identities=21% Similarity=0.238 Sum_probs=200.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 5889999999999999999998889999999987543 33456789999999999999999999985 3456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+ +++|.+++.. ....+++.++..++.||++||+|||+. +++|+||||+||++++++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 9999999853 235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+........ .......++..|+|||++.+. .++.++||||+||++|||++|.+||..... ...+..... ....
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~-~~~~ 219 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFR-TLGT 219 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHH-HcCC
Confidence 999987644332 111223488999999998654 468999999999999999999887753211 111111111 1100
Q ss_pred chhhhcccccC--CCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLL--SDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+... .+...... .............+...++.+++.+|++.+|++|||++++++.
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 220 PNEET-WPGLTSLPDYNKITF--PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CChHH-HhhccCcchhhcccC--CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000 00000000 0000000000111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=314.85 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|.+.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||++++++|. ..+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 68999999999999999999998888999999987555555577889999999999999999999853 4457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999999842 3478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|.+.......... ....+++.|+|||.+.+..++.++|||||||++||+++|+.||.......... .... ...
T Consensus 160 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~---~~~- 232 (293)
T cd06647 160 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT---NGT- 232 (293)
T ss_pred cceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhc---CCC-
Confidence 9887654332211 12348889999999988889999999999999999999999986321111000 0000 000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+ ........+..+.+++.+||+.+|++||++.+++.+
T Consensus 233 -----~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 -----P--------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----C--------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000011234568899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.86 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=200.4
Q ss_pred CCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
++|++.+.||+|+||.||+|+.+. +.+.|++|.+...... ..+.+.+|++++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 578899999999999999999753 3567999988654433 4577899999999999999999999853 4
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..++||||+++|+|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKD-EKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccc-ccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 457899999999999999996422110 011233689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
++++|||.+........ .......++..|+|||.+.+..++.++||||||+++||+++ |..||..... .....
T Consensus 156 ~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~ 229 (275)
T cd05046 156 VKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLN 229 (275)
T ss_pred EEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHH
Confidence 99999999875432221 11122236778999999988889999999999999999999 7888742211 11111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
........ +..+..++.++.+++.+||+.+|++||++.|+++.|.
T Consensus 230 ~~~~~~~~--------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLE--------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10000000 0001123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.79 Aligned_cols=241 Identities=23% Similarity=0.237 Sum_probs=183.5
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc---CCCCceeEeeeeccccccCCCceeEEE
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
||+|+||+||+|++..+++.||||++.... .........|..++.+. +||||++++++ +..+...++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence 699999999999999899999999986422 12233455677777665 69999999998 44556899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQ----------KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence 9999999999884 334688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+..........
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~- 214 (330)
T cd05586 143 SKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKV- 214 (330)
T ss_pred CcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence 8754322211 1224489999999998764 48999999999999999999999985321 1111111100000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD----MTNVVH 1011 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 1011 (1033)
.+. .....+++.+++.+||+.||++||+ +.|+++
T Consensus 215 -----~~~---------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -----RFP---------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----CCC---------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000 0012345789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.83 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=198.8
Q ss_pred CCccceecccCceeEEEEEeCCCC----eEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGK----TIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+++.+.||+|+||.||+|++...+ ..||+|+++..... ..+.+..|++++++++|+||+++++++. ..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 457789999999999999998665 88999999755433 5678899999999999999999999853 3457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.+++|||+++++|.+++.. .....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRK--------NRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHh--------hhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEE
Confidence 8999999999999999953 1112289999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+............ ...++..|+|||.+.+..++.++||||+|+++|||++ |+.||... ..........
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~ 218 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLK 218 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh
Confidence 999999876544322221 1236789999999988889999999999999999998 78887531 1111111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.... ...+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 219 ~~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGYR---------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCC---------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000 000111345689999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=316.32 Aligned_cols=257 Identities=21% Similarity=0.240 Sum_probs=197.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+++++.++||||+++++.+ ..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 47889999999999999999999999999999987542 23345788999999999999999999984 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN----------IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence 8999999999999999942 34588999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc-------------ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 868 GDFGLATFLPLSHAQ-------------TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
+|||.++........ .......++..|+|||.+.+..++.++|||||||++||+++|+.||...
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--- 219 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--- 219 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 999998742111000 0011123788899999998888999999999999999999999998521
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+.......... ..+. .....+..+.+++.+||+.||++||++.++.+.++
T Consensus 220 --~~~~~~~~~~~~~~---~~~~----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 220 --TPEELFGQVISDDI---EWPE----------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred --CHHHHHHHHHhccc---CCCC----------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11111111100000 0000 00013456899999999999999999655555444
Q ss_pred H
Q 042075 1015 S 1015 (1033)
Q Consensus 1015 ~ 1015 (1033)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.24 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=196.5
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
|.....||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++ ..++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence 33445799999999999999888999999998755444557788999999999999999999984 4456889999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 98 e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~ 163 (297)
T cd06659 98 EFLQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGF 163 (297)
T ss_pred ecCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechh
Confidence 9999999999873 24578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
+......... .....++..|+|||++.+..++.++|||||||++|||++|+.||.... ......... ...
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~~-~~~--- 233 (297)
T cd06659 164 CAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKRLR-DSP--- 233 (297)
T ss_pred Hhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHh-ccC---
Confidence 8755432221 122348899999999998889999999999999999999999985221 111110000 000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... .........+.+++.+||+.+|++||+++++++.
T Consensus 234 --~~~~--------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 --PPKL--------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --CCCc--------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0000123458899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.25 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=198.4
Q ss_pred CCCccceecccCceeEEEEEeCC-CCeEEEEEEeecc----------CchhHHHHHHHHHHHHh-cCCCCceeEeeeecc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDE-GKTIVAVKVFNLL----------HHGAFKSFIAECNTLKN-IRHRNLVKILTACSG 779 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 779 (1033)
+|++.+.||+|+||.||+|.+.. +++.||+|.+... ......++.+|+.++.+ ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 48889999999999999999987 6788999987532 22234567788888875 6999999999985
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeE
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIl 858 (1033)
..++..++||||+++++|.+++.... .....+++..+++++.|++.|+.|||+ . +++||||+|+||+
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil 146 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIM 146 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEE
Confidence 44568999999999999999884311 234568899999999999999999996 5 8999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+++++.+||+|||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||... ..
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~ 218 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NM 218 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CH
Confidence 9999999999999998754433 122234889999999999888999999999999999999999998522 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
.............. . . .....+.+.+++.+||+.||++||++.|+.++++
T Consensus 219 ~~~~~~~~~~~~~~----~----~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 LSLATKIVEAVYEP----L----P------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHhhccCCc----C----C------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111100000000 0 0 0012356899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.27 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=197.3
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|+..+.||+|++|.||+|....+++.|++|.+.... ....+.+.+|++++++++|+||+++++++ ..+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 5788899999999999999998889999999986433 23456789999999999999999999985 3445
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 78999999999999999842 24578999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.+........ .....++..|+|||.+.... ++.++|+|||||++|+|++|+.||..... ........
T Consensus 143 l~d~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~ 215 (258)
T cd06632 143 LADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIG 215 (258)
T ss_pred EccCccceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHH
Confidence 999999886543321 12234889999999987766 89999999999999999999999863221 11110000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...... ..+....+.+.+++.+||+.+|++||+++++++
T Consensus 216 ~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RSKELP---------------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hcccCC---------------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 001112355789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.76 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=192.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHH-HHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|+||.||+|++..+++.||+|+++... .....++..|+.+ ++..+||||+++++++ ..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence 47899999999999999999999899999999987542 2233455566665 5566999999999995 344578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++ |+|.+++.... .....+++..+..++.|++.|++|||+++ +++||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEe
Confidence 99999996 68888875321 12356899999999999999999999752 89999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG----SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
|||.+......... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 147 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 220 (283)
T cd06617 147 DFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLKQV 220 (283)
T ss_pred eccccccccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHHHH
Confidence 99999865332211 12347889999998765 4568999999999999999999999853211 11111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... .+.. . ....++++.+++.+||+.+|++||+++++++.
T Consensus 221 -~~~~-----~~~~---~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 -VEEP-----SPQL---P------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -HhcC-----CCCC---C------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000 0 00124568999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.47 Aligned_cols=278 Identities=25% Similarity=0.307 Sum_probs=197.1
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4888999999999999999998889999999886432 22335788999999999999999999984 4556899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+. ++|.+++.. .....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDA--------SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999995 689988853 2345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+......... .....++..|+|||++.+.. ++.++|||||||++|||+||+.||......+ ...+.....-..
T Consensus 144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~ 220 (284)
T cd07860 144 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP 220 (284)
T ss_pred ccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 9998765432211 11223688999999877644 6889999999999999999999985321111 111111110000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +...+............ ..................+.+++.+||+.||++|||++|+++.
T Consensus 221 ~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 221 D--EVVWPGVTSLPDYKPSF-PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred C--hhhhhhhhHHHHHHhhc-ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00000000000000000 0000000000011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=320.99 Aligned_cols=292 Identities=21% Similarity=0.190 Sum_probs=206.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|.+.+.||+|+||+||+|++..+++.||||.++.. .......+.+|+.++++++||||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 346899999999999999999999989999999998642 223345677899999999999999999986544333334
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+. ++|.+++. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence 6899999995 68988884 235689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++........ .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ...+. .....
T Consensus 149 L~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~-~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLK-LITEL 224 (337)
T ss_pred ECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHH-HHHHH
Confidence 9999999866433211 122347889999998765 4688999999999999999999999863211 00111 11111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
......+..+............................+++++.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 1000000000000000000000000000000001112355678999999999999999999999988 666543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=319.66 Aligned_cols=288 Identities=24% Similarity=0.251 Sum_probs=208.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~ 789 (1033)
.|...+.||+|+||.||+|+++.+|+.||||.++... ....++..+|++++++++|||||++++.=.+.. +-......
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455689999999999999999999999999997533 334577889999999999999999998722111 11134678
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--CCC--cE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEM--IA 865 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~ 865 (1033)
+|||||.||||+.+++. .+....+++.+.+.+..+++.||.|||++ |||||||||.||++- ++| .-
T Consensus 94 lvmEyC~gGsL~~~L~~-------PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS-------PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred EEEeecCCCcHHHHhcC-------cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence 99999999999999964 24567899999999999999999999999 999999999999983 434 57
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||.|+..+++.... ..+||..|.+||.... +.|+..+|.|||||++||..||..||.........+......
T Consensus 164 KLtDfG~Arel~d~s~~~---S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~ 240 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLFT---SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI 240 (732)
T ss_pred eeecccccccCCCCCeee---eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence 999999999887665332 3459999999999884 788999999999999999999999997543332222222221
Q ss_pred h--CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHH
Q 042075 945 A--LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM--DMTNVVHQLQSIKN 1018 (1033)
Q Consensus 945 ~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~evl~~L~~i~~ 1018 (1033)
. -+..+.-..++...+.. +.....+ ............+...+..++..+|++|- .+.+....+..|..
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv-~~s~~lP-----~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPV-EWSSTLP-----QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hccCCCceeEeeecccCCce-eeeccCC-----CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 11111111111110000 0000000 00011122334567788888999999999 77777777777654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.24 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=202.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+ ..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 47999999999999999999998889999999986432 23557889999999999999999999984 3455889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++.. .....+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-------YPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHh-------cccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999531 1124688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccc--cccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||.+.......... ......++..|+|||++... .++.++|||||||++|||++|+.||...... ..+......
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~-- 222 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN-- 222 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC--
Confidence 99987665433221 12223488999999998776 7899999999999999999999998632111 111111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .+...... .....++++.+++.+||+.||++||+++|+++.
T Consensus 223 --~-----~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 --D-----PPSLETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --C-----CCCcCCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000 011234668999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.75 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=204.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+.++++++|+|++++++++ ...+..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence 368899999999999999999998899999999876543 4457899999999999999999999995 3446899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
+||||+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----------VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999942 2568999999999999999999999 8 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+........
T Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~ 218 (264)
T cd06623 143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG 218 (264)
T ss_pred cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC
Confidence 999998764433222 123478899999999998999999999999999999999999864322 1111111111100
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE-CLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ... +.. .+..+.+++.+||+.+|++||++.|+++.
T Consensus 219 ~~-----~~~----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PP-----PSL----------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC-----CCC----------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 000 011 34568999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=312.99 Aligned_cols=279 Identities=23% Similarity=0.279 Sum_probs=200.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|++|.||+|.+..+++.||+|+++.. .....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 3689999999999999999999988999999998643 2233467899999999999999999999953 35578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++++.+..+.. ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEA----------SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence 99999999877776653 234588999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh--hh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK--TA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~ 945 (1033)
|||.+......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ....... ..
T Consensus 143 d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~ 220 (288)
T cd07833 143 DFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGP 220 (288)
T ss_pred eeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 99999876544321 11223478899999999887 88999999999999999999999986321111 0000000 00
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.+................... ............+..++.++.+++.+||..+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFP--EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHhhhcccCccccccccC--CCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000000000000000 0000000000011123677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.70 Aligned_cols=239 Identities=24% Similarity=0.400 Sum_probs=187.2
Q ss_pred ceecccCceeEEEEEeCCCC----------eEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 717 NLIGAGSFGSVYKGILDEGK----------TIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+.||+|+||.||+|.+..++ ..|++|+++..... ...+.+|+.++++++||||++++++|.. +
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 47999999999999998665 35888887644333 5788899999999999999999998643 3
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC---
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM--- 863 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~--- 863 (1033)
..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence 57899999999999999953 222688999999999999999999998 999999999999999887
Q ss_pred ----cEEEeecccceecCCCCccccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 042075 864 ----IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVT-RKKPTDIMFEGDM 936 (1033)
Q Consensus 864 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~ 936 (1033)
.+||+|||++...... ....++..|+|||++.+. .++.++|||||||++||+++ |..||..... .
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~ 213 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--S 213 (259)
T ss_pred CCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--h
Confidence 7999999999865431 112367789999998876 78999999999999999999 5777643211 0
Q ss_pred cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 937 NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
....+.. ........ ...++.+++.+||..+|++|||+.||++.|+
T Consensus 214 ~~~~~~~-----------~~~~~~~~---------------------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 EKERFYQ-----------DQHRLPMP---------------------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHHHh-----------cCCCCCCC---------------------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111100 00000000 0145899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=287.25 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=195.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+.+.+..||.|+.|.||+++.+.++...|||.+... ..++.+++...++++.+- ..|.||+.+|||. .+...+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHH
Confidence 334567899999999999999999999999999754 345567788888877665 5899999999953 444678
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+.||.| ..-++.+++. ..+++++.-+-++...+++||.||.++| +|+|||+||+|||+|+.|++|+||
T Consensus 168 IcMelM-s~C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred HHHHHH-HHHHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence 899988 3455666643 3456888888899999999999999886 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||++..+-++...... .|.+.|||||.+.. .+|+.++||||||++++|+.||+.||.....+-..+..... ..
T Consensus 236 FGIsGrlvdSkAhtrs---AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e 311 (391)
T KOG0983|consen 236 FGISGRLVDSKAHTRS---AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE 311 (391)
T ss_pred ccccceeecccccccc---cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC
Confidence 9999887666655543 38999999998764 46899999999999999999999999743222212211111 11
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
++ .+. ..+...+.+.+++..||.+|+.+||...++++.
T Consensus 312 PP--------~L~--------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PP--------LLP--------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CC--------CCC--------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 110 011135679999999999999999999998864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.33 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=199.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|++|+||+|....+++.||+|.+..... ...+.+..|++++++++||||+++++.+ ..+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 478899999999999999999998899999999875432 2446788999999999999999999984 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+.+++|.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--------CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence 8999999999999999853 2235689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccc---------------------------cccccccccccccccccCCCCCCcccchHHHHHHHHH
Q 042075 868 GDFGLATFLPLSHAQT---------------------------SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 920 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~e 920 (1033)
+|||++.......... ......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 9999987553221100 0112247889999999998889999999999999999
Q ss_pred HHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCC
Q 042075 921 LVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP 1000 (1033)
Q Consensus 921 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1000 (1033)
|++|+.||...... ..+.. +.+.... .......++++.+++.+||+.||
T Consensus 225 l~~g~~pf~~~~~~----~~~~~---------~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNRD----ETFSN---------ILKKEVT------------------FPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCchH----HHHHH---------HhcCCcc------------------CCCccccCHHHHHHHHHHccCCH
Confidence 99999998632111 11100 0000000 00000134669999999999999
Q ss_pred CCCCC----HHHHHH
Q 042075 1001 EDRMD----MTNVVH 1011 (1033)
Q Consensus 1001 ~~RPt----~~evl~ 1011 (1033)
++||| ++|++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.01 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=198.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC------chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+|+..+.||+|++|.||+|....+++.||+|+++... ....+.+.+|++++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4788899999999999999998899999999987432 12346788999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-c
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-I 864 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~ 864 (1033)
+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 588999999999999999842 34578899999999999999999999 999999999999998775 6
Q ss_pred EEEeecccceecCCCCccc--cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
+||+|||.+.......... ......++..|+|||.+.+..++.++||||+|+++|++++|+.||...... .......
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~ 221 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIF 221 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHH
Confidence 9999999997764432111 111234788999999998888999999999999999999999998532111 0011000
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+.... . .....+....+++.+++.+|+..+|++||++.|+++
T Consensus 222 ~~~~~---------~------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 KIASA---------T------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHhcc---------C------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00000 0 000111223466889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.09 Aligned_cols=250 Identities=21% Similarity=0.261 Sum_probs=197.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
.|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.++++++||||+++++++ ...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 355567999999999999999888999999998755545556788999999999999999999985 345578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
+||+++++|.+++.. ..+++.++..++.|++.|++|||++ +|+||||+|+||++++++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999999842 4578899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
.+.......... ....|+..|+|||...+..++.++|||||||++|||++|+.||.... .... ........
T Consensus 161 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~-~~~~~~~~-- 231 (285)
T cd06648 161 FCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQA-MKRIRDNL-- 231 (285)
T ss_pred cchhhccCCccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHH-HHHHHhcC--
Confidence 887543322111 12348899999999988889999999999999999999999985311 1111 11000000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.. ......+..+.+++.+||+.+|++||++.++++.
T Consensus 232 ---~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 232 ---PPKL--------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---CCCC--------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0000 0001133568999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.92 Aligned_cols=276 Identities=21% Similarity=0.238 Sum_probs=198.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch-----hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|++.+.||+|++|.||+|.+..+++.||||.++..... ....+..|++++++++|+||+++++++. .++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 478889999999999999999888999999999754322 3356778999999999999999999953 356
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+ +++|.+++.. ....+++.++..++.||++||+|||++ +|+||||||+||+++.++.++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 889999999 9999999953 113689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++......... ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.......
T Consensus 143 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~ 219 (298)
T cd07841 143 LADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEAL 219 (298)
T ss_pred EccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHc
Confidence 99999998765432211 11236788999998765 46789999999999999999998777532111 1111111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.........+......... .... ...............+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 220 GTPTEENWPGVTSLPDYVE---FKPF-PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCCchhhhhhccccccccc---cccc-CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000000 0000 0000000112335678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.24 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=199.3
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|.+.+.||+|+||.||+|....+++.||+|+++.... ...+.+.+|++++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 58889999999999999999988899999999875443 3567899999999999999999999984 3455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----------GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhh----------cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999842 33578889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccc--cccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 870 FGLATFLPLSHAQTSS--IFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||.+............ ....++..|+|||++.+.. ++.++||||||+++||+++|+.||..... ........
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~~ 219 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFHV 219 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHHH
Confidence 9999876443322111 1234788999999988766 88999999999999999999999863211 11100000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. .. .+.. +......+.+.+++.+||+.+|++||++.|++.
T Consensus 220 ~~-~~-----~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GA-GH-----KPPI--------------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hc-CC-----CCCC--------------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00 0000 000112455789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.94 Aligned_cols=285 Identities=19% Similarity=0.229 Sum_probs=202.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|++|.||+|....+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 478999999999999999999999899999999987432 233467788999999999999999998764332 23457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 899999995 68999884 234589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccc--cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||.+.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHH
Confidence 9999997654322211 1112348889999998765 46899999999999999999999998632111 00011111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhh-hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARI-NSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.......+..+........... ..........+ ......++++.+++.+||+.+|++||++++++..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYI-QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHH-hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1110000110000000000000 00000000000 0011235679999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.72 Aligned_cols=280 Identities=22% Similarity=0.233 Sum_probs=198.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++.+. ....
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 357899999999999999999999889999999987433 22234567899999999999999999986432 2368
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||++ ++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKI 147 (293)
T ss_pred EEEEehhcC-cCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEE
Confidence 999999997 599998853 223689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+.......... ....+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..... ...+........
T Consensus 148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~ 224 (293)
T cd07843 148 CDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLG 224 (293)
T ss_pred eecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhC
Confidence 9999998765432211 123378899999988764 468999999999999999999999863211 111111111000
Q ss_pred C--cchhhhcccccCCCchhhhhccchhhhhhhhhhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 P--DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE-CLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. +..+.............. . ...........+.. ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 225 TPTEKIWPGFSELPGAKKKTF--T-KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCchHHHHHhhccchhccccc--c-cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000000000000 0 00000000000001 3566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.80 Aligned_cols=245 Identities=24% Similarity=0.248 Sum_probs=197.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47899999999999999999999889999999986432 23456788999999999999999999984 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.++++. ...++...+..++.|++.||+|||+. +|+||||+|+||++++++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----------SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 8999999999999999853 35688999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~ 212 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILE 212 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc
Confidence 999999876443 122348899999999988889999999999999999999999985321 1111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1011 (1033)
... . .+......+.+++.+||+.||++|| +++|+++
T Consensus 213 ~~~------~----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GKV------R----------------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCc------c----------------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 000 0 0011234588999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.49 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=196.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcC---CCCceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+++.+|+.++++++ |||++++++++ ..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 478889999999999999999889999999998643 2344567889999999996 99999999985 34557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.++++. ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence 8999999999999999842 2688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+.......... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...... .
T Consensus 143 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~ 214 (277)
T cd06917 143 CDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-I 214 (277)
T ss_pred ccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-c
Confidence 9999998765433221 22348889999998765 4578999999999999999999999863211 000000 0
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... ..+.+.. ...+.++.+++.+||+.||++||++.|+++.
T Consensus 215 ~~~----~~~~~~~---------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 PKS----KPPRLED---------------------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccC----CCCCCCc---------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000 0000000 0123568999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=307.47 Aligned_cols=248 Identities=24% Similarity=0.302 Sum_probs=199.0
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 5889999999999999999999889999999987432 2345788999999999999999999988 4556689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++|+||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----------KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEe
Confidence 999999999999999942 24688999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ....+......
T Consensus 143 d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~- 216 (258)
T cd05578 143 DFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET- 216 (258)
T ss_pred ecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-
Confidence 9999886544321 12234788999999998888999999999999999999999998633211 01111110000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM--TNVV 1010 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 1010 (1033)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ---------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000111234668999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.93 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=198.0
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
-|++.+.||+|+||.||+|.+..+++.||+|+..... ....+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence 4778889999999999999998889999999986432 33446788999999999999999999995 44558899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+||
T Consensus 80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence 9999999999999842 3578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|.+.......... ....++..|+|||.+.+..++.++|||||||++|||++|..||...... ..... .....
T Consensus 146 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~ 217 (277)
T cd06641 146 GVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNN 217 (277)
T ss_pred ccceecccchhhh--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCC
Confidence 9987654322111 1234788999999998888999999999999999999999998532110 00000 00000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +. .....+.++.+++.+||+.+|++||++.++++.
T Consensus 218 ~----~~----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 P----PT----------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C----CC----------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00 001234568899999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=344.42 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=201.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+-+|.....||.|.||.||-|...++|+..|||.++.. .....+...+|..++..++|||+|++||+ .-..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHH
Confidence 445777888999999999999999999999999988632 23445678899999999999999999998 45566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..+|.||||++|+|.+.+. .+...++.....+..|++.|++|||++ |||||||||.||+++.+|.+|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~----------~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE----------HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH----------hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEE
Confidence 8899999999999999994 344456666777889999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc--cccccccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 867 VGDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
++|||.|..+..... ...-....||+.|||||++.+.. ...++||||+|||+.||+||+.||..... .+.-+
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIM 1451 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIM 1451 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHH
Confidence 999999998765421 11222345999999999987743 46789999999999999999999963321 12111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+. ..+..++.|.....+-.+++.+|++.||++|.++.|+++.
T Consensus 1452 y~V----------------------------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHV----------------------------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHH----------------------------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 110 0011112223355667899999999999999999877654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.28 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=198.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||.||+|.++.++..||+|.+.... ....+.+.+|+.++++++|+||+++++.+ ..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 5788999999999999999999889999999986432 23346788999999999999999999984 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~ 868 (1033)
+|+||+++++|.+++.. .....+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--------QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence 99999999999999853 2234578999999999999999999999 999999999999999875 56999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+.......... ....|++.|+|||+..+..++.++||||||+++|||++|+.||... ...+........
T Consensus 145 d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~ 217 (257)
T cd08225 145 DFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG 217 (257)
T ss_pred ccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc
Confidence 999998664332211 1234889999999998888999999999999999999999998532 111122111111
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 218 ~~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 YFAPI---------------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cCCCC---------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 10000 00123458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=309.80 Aligned_cols=249 Identities=26% Similarity=0.335 Sum_probs=194.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||+||+|....+++.||+|++.... ....+++.+|++++++++||||++++++|. .++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCC
Confidence 356889999999999999999998889999999986432 233457889999999999999999999964 345
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||++ |++.+++.. ....+++.++..++.|++.||.|||+. +|+||||+|+||++++++.++
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence 7899999996 577776632 234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||++....... ...++..|+|||++. ...++.++||||||+++|||++|+.||..... ......
T Consensus 156 L~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~~~~ 225 (307)
T cd06607 156 LADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYH 225 (307)
T ss_pred EeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHHHHH
Confidence 99999987653322 123788999999874 45688999999999999999999999853211 100000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. .... +.. .....+..+.+++.+||+.+|++||++.+++...
T Consensus 226 ~~-~~~~-----~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 226 IA-QNDS-----PTL---------------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred Hh-cCCC-----CCC---------------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 0000 000 0112345689999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=309.13 Aligned_cols=264 Identities=20% Similarity=0.242 Sum_probs=185.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccCchhH-----------HHHHHHHHHHHhcCCCCceeEee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLHHGAF-----------KSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
.++|.+.++||+|+||+||+|.+..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999876 66778886543221110 11223334456678999999998
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
++.... ......++++|++. .++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE 155 (294)
T ss_pred eeeEec-CCceEEEEEEehhc-cCHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 753221 11124467888773 466666532 22346778899999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
||+++.++.++|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432211 111223589999999999999999999999999999999999999964
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
...... ........+ ...+.... . ....+++.+.+++..||+.+|++||++.++.
T Consensus 236 ~~~~~~-~~~~~~~~~---~~~~~~~~------------------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHNGN-LIHAAKCDF---IKRLHEGK------------------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccchH-HHHHhHHHH---HHHhhhhh------------------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 321111 111000000 00000000 0 0112356689999999999999999999999
Q ss_pred HHH
Q 042075 1011 HQL 1013 (1033)
Q Consensus 1011 ~~L 1013 (1033)
+.+
T Consensus 291 ~~~ 293 (294)
T PHA02882 291 KIF 293 (294)
T ss_pred Hhh
Confidence 876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=316.58 Aligned_cols=204 Identities=24% Similarity=0.254 Sum_probs=171.4
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 784 (1033)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.... ...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3467899999999999999999999989999999998642 2334466778999999999999999999864322 123
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....|+||||+. ++|.+++.. .++..++..++.|++.||+|||+. ||+||||||+||++++++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 346799999995 588887732 278888999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
+||+|||.++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999987543322 1123478899999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=305.19 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=184.0
Q ss_pred eecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHh---cCCCCceeEeeeeccccccCCCceeEE
Q 042075 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKN---IRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
.||+|+||.||+|.+..+++.||+|.++.... .....+.+|..+++. .+||+|+.+++++ ..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 48999999999999988899999998864321 112334445444443 4799999999884 445578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
|||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLS----------QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence 99999999999884 234689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
++........ ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~--- 213 (279)
T cd05633 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT--- 213 (279)
T ss_pred cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhhc---
Confidence 9875533221 12348999999998864 568999999999999999999999986332111 1111000000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
.. ...+...+.++.+++.+||+.||++|| +++|+++.
T Consensus 214 ---~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 ---VN----------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CC----------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 000112345689999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=313.54 Aligned_cols=282 Identities=20% Similarity=0.206 Sum_probs=200.4
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
++...+++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 79 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI---- 79 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----
Confidence 4556788999999999999999999999989999999987532 2233467789999999999999999999863
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
......++||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||+|+||+++++
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 2344688999998 6689888742 3477888889999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+.++|+|||.+....... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~ 217 (328)
T cd07856 145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSI 217 (328)
T ss_pred CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999999999987543221 11237889999998766 56899999999999999999999998532110 00000
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..........+..+..............................+++.+++.+||+.+|++|||+++++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111111111100000000000000000000000011234678999999999999999999999776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.53 Aligned_cols=278 Identities=23% Similarity=0.252 Sum_probs=204.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-C-C----CceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-H-R----NLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 783 (1033)
+.+|.+...+|+|.||.|-++.+..++..||||+++.... ..++.+-|+++++++. + | -+|.+.++ ++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 6799999999999999999999999999999999985443 2356678999999993 2 2 36777777 66
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC--
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-- 861 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-- 861 (1033)
..++.|+|+|.+ |-++.++++. ....+++...+..|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 677999999988 7799999964 4567799999999999999999999999 9999999999999821
Q ss_pred ------------------CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 862 ------------------EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 862 ------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
+..++++|||.|+.....+. ..+.|..|+|||++.+-.++.++||||+||||+|+.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 23589999999997654442 2347999999999999999999999999999999999
Q ss_pred CCCCCCccccCCccHHHHHhhhCCcchhhhcccc---------cCCCchh------hhhccchhhhhhhhhhHHHHHHHH
Q 042075 924 RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDST---------LLSDDED------LAVHGNQRQRQARINSKIECLVAM 988 (1033)
Q Consensus 924 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~---------l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l 988 (1033)
|...|+.... .+.+ .+.+....+-...++.+. -..+++. ..+....+..............++
T Consensus 305 G~~LFqtHen-~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 305 GETLFQTHEN-LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred cceecccCCc-HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 9999864321 1111 112221111111111111 0000000 000111111111111223455679
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 042075 989 ARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 989 ~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+++++|+.+||.+|+|+.|++..
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999998763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.82 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=193.8
Q ss_pred CHHHHHHhhCCCCcccee--cccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeec
Q 042075 702 SYQNLYNATDGFTSANLI--GAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACS 778 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 778 (1033)
+..+.....++|++.+.+ |+|+||.||++..+.+++.+|+|+++...... .|+.....+ +||||+++++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~- 78 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSV- 78 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEE-
Confidence 344555556788888877 99999999999999899999999986432211 122222223 799999999985
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
..++..++||||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++||||||+||+
T Consensus 79 ----~~~~~~~iv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil 141 (267)
T PHA03390 79 ----TTLKGHVLIMDYIKDGDLFDLLKK----------EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVL 141 (267)
T ss_pred ----ecCCeeEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEE
Confidence 344589999999999999999942 23789999999999999999999999 9999999999999
Q ss_pred ecCCC-cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 859 LDEEM-IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 859 l~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
++.++ .++|+|||.+........ ..++..|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215 (267)
T ss_pred EeCCCCeEEEecCccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence 99988 999999999886543221 23789999999999989999999999999999999999999743222212
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-MTNVVH 1011 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 1011 (1033)
...+.... ... ........+.+.+++.+||+.+|++||+ ++|+++
T Consensus 216 ~~~~~~~~-~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 LESLLKRQ-QKK----------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhh-ccc----------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22221111 000 0001123456899999999999999996 588874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.20 Aligned_cols=208 Identities=23% Similarity=0.311 Sum_probs=169.7
Q ss_pred CCCccceecccCceeEEEEEeCC--CCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDE--GKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|++.++||+|++|.||+|.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. .+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58889999999999999999987 78999999987632 33446778899999999999999999996532 235
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC----C
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE----E 862 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~----~ 862 (1033)
..++||||+++ ++.+++..... .....++...+..++.|++.|++|||+. +|+||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 78999999964 77777643211 1224688999999999999999999999 9999999999999999 8
Q ss_pred CcEEEeecccceecCCCCc-cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 863 MIAHVGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
+.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999986543322 111222347889999998766 45789999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=309.41 Aligned_cols=285 Identities=22% Similarity=0.283 Sum_probs=198.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc---c
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---Q 783 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~ 783 (1033)
..++|++.+.||+|+||.||+|+...+++.||||++.... ......+.+|++++++++||||++++++|..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999999899999999886432 2223456789999999999999999998765331 1
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.....++||||+. +++.+++.. ....+++.++..++.|++.||+|||++ +++||||||+||++++++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG 156 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence 2345699999996 588888742 234689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCcc--ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
.+||+|||.+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~ 234 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLT 234 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 9999999999866432221 111223478889999987664 478899999999999999999999863211 11111
Q ss_pred HHhh---hCCcchhhhcccccCCCchhhhhccchh-hhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 941 FAKT---ALPDHVVDIVDSTLLSDDEDLAVHGNQR-QRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 941 ~~~~---~~~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.... ..+.......+..- ............ ....+. ........+.+++.+||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 235 LISQLCGSITPEVWPGVDKLE--LFKKMELPQGQKRKVKERL-KPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHhCCCChhhcccccchh--hhhhccCCCccchhhHHhc-ccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1111 11111100000000 000000000000 000000 00012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=307.84 Aligned_cols=285 Identities=20% Similarity=0.233 Sum_probs=197.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|.+..+++.||+|+.+... ......+.+|+.++++++ ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999999899999999876432 223456788999999994 699999999865443223334
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-CCcEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAH 866 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~k 866 (1033)
.|+||||+++ +|.+++..... .....+++..+..++.||++||+|||+. +|+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 7999999975 89888853211 1234689999999999999999999999 9999999999999998 88999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.+......... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .+......
T Consensus 152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~- 227 (295)
T cd07837 152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKL- 227 (295)
T ss_pred EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHH-
Confidence 9999999865332211 111236888999998765 457899999999999999999999985321110 01111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
......... +......... ....... ...........+++.+++.+||.+||++||+++|++.
T Consensus 228 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVW-PGVSKLRDWH-EFPQWKP-QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhC-cchhhccchh-hcCcccc-hhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 0000000000 0000000 0000011134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=315.85 Aligned_cols=288 Identities=22% Similarity=0.252 Sum_probs=201.4
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||++++++|.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 456899999999999999999999888999999988532 223345677899999999 99999999998642 223
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||++ ++|.++++. ..+++..+..++.||+.||+|||+. ||+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 46799999996 599988842 2678889999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc---ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 866 HVGDFGLATFLPLSHAQ---TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
||+|||.+......... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999999866433221 12222348899999998765 457899999999999999999999986322111 11111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSI 1016 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 1016 (1033)
.. .......+..+...........................+.+.++.+++.+||+.||++|||+.++++. +..+
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 226 IE-VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HH-HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 11 00000000000000000000000000000000000111245678999999999999999999999986 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=306.75 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=202.4
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
...+.|++.+.||+|++|.||+|.+..+++.||+|+++.... ..+.+.+|++++++++|+|++++++++. .++.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 456678899999999999999999988899999999976544 4567889999999999999999999854 3458
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++|+||+++++|.+++.. ....+++.++..++.|++.|++|||+. ||+|+||+|+||+++.++.++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEE
Confidence 8999999999999999953 113789999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.+......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... ...
T Consensus 158 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~~~~~~-~~~ 230 (286)
T cd06614 158 ADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----LRALFL-ITT 230 (286)
T ss_pred Cccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHh
Confidence 999988755432211 1122378899999999888899999999999999999999999852211 111100 000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... .......++..+.+++.+||+.+|.+||++.++++.
T Consensus 231 ~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 231 KGIP-------------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cCCC-------------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000 000011134568999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=305.17 Aligned_cols=281 Identities=23% Similarity=0.258 Sum_probs=199.1
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++|||++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999999889999999998653 33446788999999999999999999996432 1368999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++ +|.+++.. ....+++.++..++.|+++|++|||+. +++|+||||+||++++++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLDS---------PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence 9999974 89888843 224689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.... ...............
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~ 222 (287)
T cd07840 145 GLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPT 222 (287)
T ss_pred cceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCc
Confidence 999876544321 1122336788999998765 4578999999999999999999999863221 111111111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+..-.......... .......+......++.++.+++.+||..+|++||+++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 223 DENWPGVSKLPWFENLKPK-KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhhhhcccc-ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000000000000 0000000000011136779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=305.05 Aligned_cols=275 Identities=21% Similarity=0.266 Sum_probs=198.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+|++.+.||+|++|.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 5889999999999999999999899999999987543 223466778999999999999999999953 4457899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++ +|.+++... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999975 888888531 1234689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc-
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD- 948 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 948 (1033)
|.+......... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..........
T Consensus 145 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (284)
T cd07836 145 GLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPT 221 (284)
T ss_pred chhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCC
Confidence 999755332211 1123368899999987654 5789999999999999999999998643211 1111111110000
Q ss_pred --chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 949 --HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 949 --~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
....+.+.. ...... ...............+..+.+++.+|++.||++||+++|+++
T Consensus 222 ~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQLP--EYKPTF----PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcCc--hhcccc----cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 000000 000000011111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=305.77 Aligned_cols=277 Identities=25% Similarity=0.299 Sum_probs=196.0
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++|||++++++++ ..++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 678899999999999999998899999999987433 22335688899999999999999999995 34468999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||++ ++|.+++.. .....+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDS--------SPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 689999853 1224689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+......... .....++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ......+......
T Consensus 144 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 220 (283)
T cd07835 144 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPD 220 (283)
T ss_pred ccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 999765332211 1112368899999987664 57899999999999999999999985321111 1111111100000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .+.....++........ ............+.++.+++.+||+.||++|||++|+++.
T Consensus 221 -~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 221 -EDV-WPGVTSLPDYKPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred -hHH-hhhhhhchhhhhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000000000000 0000000111233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.55 Aligned_cols=273 Identities=20% Similarity=0.266 Sum_probs=205.7
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecc
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 779 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 779 (1033)
-.++|+.+-++ +.||+|+|+.|--+....++..||||++.+.......+..+|++++.+. .|+||++++++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief--- 144 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF--- 144 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH---
Confidence 35778877764 6899999999999999989999999999887666778899999999999 69999999999
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
++++...|+|||-|.||+|-..++ ....+++.++.++..+|+.||+|||.+ ||.|||+||+|||.
T Consensus 145 --FEdd~~FYLVfEKm~GGplLshI~----------~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC 209 (463)
T KOG0607|consen 145 --FEDDTRFYLVFEKMRGGPLLSHIQ----------KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILC 209 (463)
T ss_pred --hcccceEEEEEecccCchHHHHHH----------HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceee
Confidence 677789999999999999999995 456689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEeecccceecCCCC-----ccccccccccccccccccccC---C--CCCCcccchHHHHHHHHHHHhCCC
Q 042075 860 DEEM---IAHVGDFGLATFLPLSH-----AQTSSIFAKGSIGYIAPEYGL---G--SEVSINGDVYSYGILLLELVTRKK 926 (1033)
Q Consensus 860 ~~~~---~~kL~DfG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDvwSlG~vl~elltg~~ 926 (1033)
.+.. -+||+||.+..-+.... ....-...+|+..|||||+.. + ..|+.++|.||+|||+|-|++|.+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 7654 48999999876442221 112222356889999999743 2 358999999999999999999999
Q ss_pred CCCccccCCccHHHHHhhhCCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 927 PTDIMFEGDMNLHNFAKTALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 927 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
||......+-.+.+- ..-.. -...+.+...+.++. . ... -..+..+..+++...+..||.+|.+
T Consensus 290 PFvG~Cg~dCGWdrG---e~Cr~CQ~~LFesIQEGkYeF-----P----dkd---WahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 290 PFVGHCGADCGWDRG---EVCRVCQNKLFESIQEGKYEF-----P----DKD---WAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred CccCccCCcCCccCC---CccHHHHHHHHHHHhccCCcC-----C----hhh---hHHhhHHHHHHHHHHHhccHHhhhh
Confidence 997654433222110 00000 000111111111100 0 000 1124455678888888999999999
Q ss_pred HHHHHH
Q 042075 1006 MTNVVH 1011 (1033)
Q Consensus 1006 ~~evl~ 1011 (1033)
+.+++.
T Consensus 355 a~~vln 360 (463)
T KOG0607|consen 355 AAQVLN 360 (463)
T ss_pred hhhccC
Confidence 999887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=312.54 Aligned_cols=286 Identities=19% Similarity=0.266 Sum_probs=197.0
Q ss_pred ceeccc--CceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAG--SFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
..||+| +||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||++++++| ..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456666 99999999998899999999987432 33457788999999999999999999995 4455789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+.++++.++++. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKT--------YFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHH
Confidence 99999999999854 1234588999999999999999999999 999999999999999999999999986
Q ss_pred ceecCCCCccc-----cccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 873 ATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 873 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+.......... ......++..|+|||++.+. .++.++||||+||++|||++|+.||.................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence 54332111100 01112256679999998763 478999999999999999999999864322111111110000
Q ss_pred CCc--------chhhhcccc------cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPD--------HVVDIVDST------LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~--------~~~~~~d~~------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ......+.. ...................+......+.+.+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000000000 000000000000000011122223456678999999999999999999999986
Q ss_pred H--HHHHHH
Q 042075 1012 Q--LQSIKN 1018 (1033)
Q Consensus 1012 ~--L~~i~~ 1018 (1033)
. +..+++
T Consensus 308 ~~~~~~~~~ 316 (328)
T cd08226 308 HAFFKQVKE 316 (328)
T ss_pred CHHHHHHHH
Confidence 5 455544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=308.92 Aligned_cols=279 Identities=25% Similarity=0.262 Sum_probs=197.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.++++++|+||+++++++.+ ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4689999999999999999999998999999999874322 223456789999999999999999998642 22346
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. ++|.+++.. ....+++.++..++.|+++|++|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 799999996 488888853 225689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+.......... ....++..|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+.. .....
T Consensus 150 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~-~~~~~ 225 (309)
T cd07845 150 ADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDL-IIQLL 225 (309)
T ss_pred CccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHhc
Confidence 9999998765432111 11235788999999865 45789999999999999999999998632111 11111 11111
Q ss_pred CcchhhhcccccC--CCchhhhhccc-hhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLL--SDDEDLAVHGN-QRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ +... ........... ...... ......+.+.+++.+|++.||++|||++|+++.
T Consensus 226 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 226 GTPNESIW-PGFSDLPLVGKFTLPKQPYNNLKH---KFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCChhhc-hhhhcccccccccccCCCCCchHH---hccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 10000000 0000 00000000000 000000 001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=298.48 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=201.5
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+|+..+.||+|++|.||+|.+..+++.|++|+++.......+.+.+|++++++++|++++++++++ ..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 478889999999999999999888999999999765544567899999999999999999999985 344578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
+||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence 999999999999853 225689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .......
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~ 215 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFK-IATNGPP 215 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHH-HHhcCCC
Confidence 9987654332 1223488999999999888899999999999999999999999853211 000000 0000000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~-------------------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLR-------------------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcC-------------------------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 001123568999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.37 Aligned_cols=278 Identities=21% Similarity=0.257 Sum_probs=199.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..|...++||+|.||+||+|+..++++.||+|.++.. +++......+|+.+++.++|.|||+++++ ...+...
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCcee
Confidence 3567778999999999999999999999999998743 34456778999999999999999999998 5566788
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
.+|+|||. .+|..|.. .-.+.++.+.+..++.|+++|+.|+|++ .+.|||+||.|.+++.+|+.|++
T Consensus 77 tlvfe~cd-qdlkkyfd---------slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 77 TLVFEFCD-QDLKKYFD---------SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred EEeHHHhh-HHHHHHHH---------hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEec
Confidence 99999994 48888885 3566789999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|||+|+.+..+.... ...+.|..|++|.++.+.+ |+...|+||.|||+.|+.. |++.|.... .++.+.+..+..-
T Consensus 144 dfglarafgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg 220 (292)
T KOG0662|consen 144 DFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLG 220 (292)
T ss_pred ccchhhhcCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhC
Confidence 999999775543222 2234799999999998865 7899999999999999988 555554221 1112222221111
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...-..+-.-.-.+++...........+..- .+.....=.++++..+.-+|.+|.++++.++.
T Consensus 221 ~p~ed~wps~t~lpdyk~yp~ypattswsqi---vp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQI---VPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCccccCCCCcccCCccccchHHHH---hhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1100000000111122111111111111111 11112234577788888899999999987753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.28 Aligned_cols=276 Identities=18% Similarity=0.176 Sum_probs=193.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |+|++++++++.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 678899999999999999999889999999987532 222234457889999884 99999999996432 2257899
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||++ +++.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++ +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 999996 588887742 234689999999999999999999999 9999999999999999 99999999
Q ss_pred ccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.++......... ...++..|+|||++.. ..++.++||||+||++|||++|+.||...... .............
T Consensus 144 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCC
Confidence 9998664332222 1337889999997644 56789999999999999999999998632211 1111111111110
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..++............. ........-.......+.++.+++.+||+++|++||+++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 219 DAEVLKKFRKSRHMNYN--FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CHHHHHhhccccccccc--CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000000 00000000000112346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.64 Aligned_cols=276 Identities=21% Similarity=0.281 Sum_probs=223.0
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCC-----eEEEEEEeec-cCchhHHHHHHHHHHHHhcCCCCceeEeeee
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGK-----TIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 777 (1033)
+++.....+++....+-+|.||.||+|.+++.+ +.|.||.++. .++-....+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 444455567777888999999999999886543 3366776653 2334456788899999999999999999998
Q ss_pred ccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCe
Q 042075 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857 (1033)
Q Consensus 778 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 857 (1033)
. ++...+++++.++.-|+|..++..++..+ ....+.++..+...++.|++.|++|||++ +|||.||..+|.
T Consensus 357 i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 I----EDYATPFVLYPATGVGNLKSFLQICRGDD--PSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC 427 (563)
T ss_pred e----eccCcceEEEeccCcchHHHHHHHhccCC--CccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence 4 45567899999999999999998665322 34567789999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 042075 858 LLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDM 936 (1033)
Q Consensus 858 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~ 936 (1033)
++|+..++||+|=.+++..-+.....-......+..||+||.+....|+.++|||||||++|||+| |+.||......
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-- 505 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-- 505 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--
Confidence 999999999999999998876665544444446889999999999999999999999999999999 88997422110
Q ss_pred cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 937 NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
++. .--..+.|..++.+|++++..+|.-||+.+|++||+++|+..-|.++
T Consensus 506 ---Em~---------------------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 ---EME---------------------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ---HHH---------------------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 000 00123346667778999999999999999999999999999999998
Q ss_pred HHHh
Q 042075 1017 KNIL 1020 (1033)
Q Consensus 1017 ~~~~ 1020 (1033)
-..+
T Consensus 556 ~~ql 559 (563)
T KOG1024|consen 556 HTQL 559 (563)
T ss_pred HHHH
Confidence 6544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.45 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=204.3
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.....|.+.+.||+|.|+.|.+|++..++..||+|++++..- .....+.+|+++|+.++|||||+++.+ ....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeec
Confidence 445689999999999999999999999999999999975432 233558899999999999999999999 5566
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||+.+|.+.+|+.+ .......++..++.|+++|++|||++ .|||||||++||+++.+.++
T Consensus 128 ~~lylV~eya~~ge~~~yl~~----------~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVK----------HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred ceeEEEEEeccCchhHHHHHh----------cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 689999999999999999954 34455578889999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||++..+..+....+ .+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+...-
T Consensus 195 kIaDfgfS~~~~~~~~lqt---~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------- 260 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGLMLQT---FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------- 260 (596)
T ss_pred eeeccccceeecccccccc---cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------
Confidence 9999999998876554444 349999999999999877 4889999999999999999999973211
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.-++.+.+.+ |.+. -+..+..+++++++-.+|.+|++++++.+.
T Consensus 261 ------k~Lr~rvl~gk~--------------rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 ------KELRPRVLRGKY--------------RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------ccccchheeeee--------------cccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 011111111100 1111 122347889999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=313.52 Aligned_cols=289 Identities=20% Similarity=0.192 Sum_probs=200.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 785 (1033)
..++|.+.+.||+|+||.||+|++..+++.||||+++.. .......+.+|+.++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 358999999999999999999999888999999998642 22234567899999999999999999998653321 122
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++|+||+. .++.++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ceEEEEecccc-cCHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 35689999995 46766541 2478899999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+.....
T Consensus 157 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~- 229 (342)
T cd07879 157 KILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILK- 229 (342)
T ss_pred EEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-
Confidence 999999987643221 12347889999999876 4688999999999999999999999863211 001111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHHh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIKNIL 1020 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~~ 1020 (1033)
.......+..+..................+.............+.+++.+||+.||++||+++|++.. ++.++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00000000000000000000000000000000000001234568899999999999999999999965 77776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=312.41 Aligned_cols=291 Identities=20% Similarity=0.209 Sum_probs=207.3
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999987543 34457789999999999999999999986543322334689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 589888842 33789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 870 FGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
||.+......... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+ .+.... ....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~-~~~~ 224 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIV-EVLG 224 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH-HhcC
Confidence 9999876544310 111223478899999999887 78999999999999999999999986432111 011111 0000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
....+................................+..+.+++.+||+.+|++||+++++++. ++.++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000000000000000000000111245678999999999999999999999986 666544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.96 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=192.6
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++ ..++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence 4566789999999999999999899999999986432 234567889999999995 99999999985 3345788
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
++|||+. +++.++.... .......+++..+..++.|++.||+|||+.+ +|+||||||+||++++++.+||+|
T Consensus 80 ~~~e~~~-~~l~~l~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMD-ISLDKFYKYV-----YEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEeccc-CCHHHHHHHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEee
Confidence 9999985 4555543210 0012356899999999999999999999732 899999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||+++......... ...|+..|+|||++.+. .++.++||||+||++|||++|+.||.... ..... .....
T Consensus 152 fg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~-~~~~~ 224 (288)
T cd06616 152 FGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQ-LTQVV 224 (288)
T ss_pred cchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHH-Hhhhc
Confidence 99997654332221 12378899999998776 68999999999999999999999985321 11111 11110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... +.+.. .....++.++.+++.+||+.+|++|||+++|++.
T Consensus 225 ~~~~-----~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGDP-----PILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCC-----CcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000 0001234568999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.28 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=202.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|+..+.||+|++|.||+|.+..+++.|++|+++.... ...+.+.+|++++++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 47888999999999999999998899999999875442 45678899999999999999999999854321 25789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+||+++++|.+++.. ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999842 23789999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+................++..|+|||...+..++.++||||||+++|+|++|+.||.... ..............
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 221 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSSGE 221 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccccCC
Confidence 999987755433111223448899999999988889999999999999999999999986432 01111000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ...+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 222 ~---------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 P---------------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C---------------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 00111224668999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=306.55 Aligned_cols=246 Identities=21% Similarity=0.283 Sum_probs=195.0
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
..+||+|+||.||+|....+++.||||++..........+.+|+.++++++|+|++++++++ ..++..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence 46899999999999999889999999998655445567789999999999999999999985 3455889999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||.+..
T Consensus 100 ~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 100 EGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccccee
Confidence 99999998732 3478899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
....... .....++..|+|||.+.+..++.++||||+|+++|||++|..||.... ............+....
T Consensus 166 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~---- 237 (292)
T cd06657 166 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPKLK---- 237 (292)
T ss_pred ccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCCcccC----
Confidence 5432211 122347899999999888889999999999999999999999985211 00011111111111000
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 238 ------------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 ------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ------------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 001123457899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.79 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=196.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-----CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 4789999999999999999999888999999987532 123446788999999999999999999986322 23
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ...+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 467899999999999999842 24578889999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCc-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|+|||.++....... ........++..|+|||++.+..++.++|||||||++||+++|+.||.... ........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~ 221 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AMAAIFKI 221 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HHHHHHHH
Confidence 9999999986532111 111112348899999999988889999999999999999999999985321 11111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. ... +...+....+++.+++.+||. +|..||++.+++.
T Consensus 222 ~~-~~~--------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 AT-QPT--------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred Hc-CCC--------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 000 000111234568999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.56 Aligned_cols=249 Identities=27% Similarity=0.328 Sum_probs=193.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|+..+.||+|+||.||+|++..++..||+|++.... ......+.+|++++++++|||++++++++. .+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 3677889999999999999998889999999986432 233457889999999999999999999953 34578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++ |++.+++.. ....+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+
T Consensus 101 ~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 101 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence 99999996 477777642 234589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|||.+....... ...++..|+|||++. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 168 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~ 240 (317)
T cd06635 168 DFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE 240 (317)
T ss_pred cCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhcc
Confidence 999987543221 133788999999874 456889999999999999999999998532100 0000110000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+ . .......+.+.+++.+||+.+|++||++.++++....
T Consensus 241 ~~---------~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SP---------T---------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CC---------C---------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00 0 0011234568999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.48 Aligned_cols=278 Identities=23% Similarity=0.257 Sum_probs=198.0
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc---CCCCceeEeeeeccccccCCCc
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
|++.+.||+|+||.||+|+++.+++.||+|+++... ......+.+|+.+++++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999997432 22234566788877766 5999999999976544333335
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.+++|||++ ++|.+++.. .....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~--------~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSK--------CPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence 899999996 489888853 1223589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.+.......... ...++..|+|||++.+..++.++|||||||++|||++|++||..... ...+..+......
T Consensus 149 ~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC
Confidence 9999998764432221 12378899999999998999999999999999999999999863221 1112222111111
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.......... ..... ..... ..........+....+.+++.+||+.||++||++.|++.
T Consensus 225 ~~~~~~~~~~--~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNV--SLPRS--SFPSY-TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCc--ccchh--hcccc-cccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 00000 00000 000001111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=328.13 Aligned_cols=260 Identities=25% Similarity=0.331 Sum_probs=191.2
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc----
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---- 782 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 782 (1033)
+-..+|+..+.||+||||.||+++.+-+|+.||||++... .........+|+..+++++|||||+++..+.+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3445788889999999999999999999999999998743 33445678899999999999999999865321100
Q ss_pred ---------------------------------------------------c----------------------------
Q 042075 783 ---------------------------------------------------Q---------------------------- 783 (1033)
Q Consensus 783 ---------------------------------------------------~---------------------------- 783 (1033)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------CC--------CceeEEEEcccCCchhhhcccCCCCcccccccccc-CHHHHHHHHHH
Q 042075 784 -----------------------GN--------DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL-NLLQRLDIGID 831 (1033)
Q Consensus 784 -----------------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l-~~~~~~~i~~q 831 (1033)
.+ -..||-||||+..+++++++.. ... .....++++++
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----------~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----------HFNSQRDEAWRLFRE 705 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----------ccchhhHHHHHHHHH
Confidence 00 2347889999988888888531 111 46678899999
Q ss_pred HHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC----------------CCCccccccccccccccc
Q 042075 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP----------------LSHAQTSSIFAKGSIGYI 895 (1033)
Q Consensus 832 i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~ 895 (1033)
|++||.|+|++ |||||||||.||++|++..|||+|||+|+... .+......+..+||.-|+
T Consensus 706 IlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 706 ILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 99999999999 99999999999999999999999999998721 011112334466999999
Q ss_pred cccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchh
Q 042075 896 APEYGLGS---EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQR 972 (1033)
Q Consensus 896 aPE~~~~~---~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 972 (1033)
|||++.+. .|+.|+|+||+|||++||+. ||....+-...+.......+|.. .++.++
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~---------------- 842 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP---------------- 842 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc----------------
Confidence 99998775 49999999999999999995 56432222111221111112211 111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 973 QRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 973 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..+.=..++++|+++||.+||||.|++.
T Consensus 843 -----------~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 -----------EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -----------cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1122367999999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=311.12 Aligned_cols=288 Identities=18% Similarity=0.187 Sum_probs=203.9
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
...+++..+++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45677888999999999999999999999998889999999986432 2234667889999999999999999998643
Q ss_pred cc-ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 780 VD-YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 780 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
.. .......+++++++ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 152 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA 152 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence 22 12234567888877 7899888732 3588999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+++++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~ 226 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQ 226 (345)
T ss_pred EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 9999999999999988643221 12347889999998766 5688999999999999999999999853211 111
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhh-hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN-SKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+....... .....+.................. ........ .......++.+++.+|++.||++||++.+++..
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLV-GTPGAELLKKISSESARNYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHh-CCCCHHHHhhcccHhHHHHHHHhc-ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111111 000000000000000000000000 00000000 000124568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=311.18 Aligned_cols=288 Identities=19% Similarity=0.198 Sum_probs=203.1
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.++...++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 45566789999999999999999999999899999999985422 2234568899999999999999999998643221
Q ss_pred -cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 783 -QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 783 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
......++||||+ +++|.+++. ...+++..+..++.|+++|++|||+. ||+||||||+||++++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~ 153 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNE 153 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 1112468999999 779988873 23588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
++.++|+|||.+....... ....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||...... ..+..
T Consensus 154 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~ 227 (343)
T cd07880 154 DCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLME 227 (343)
T ss_pred CCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 9999999999998653322 12337889999998876 45889999999999999999999998632111 01111
Q ss_pred HHhhhC--CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 042075 941 FAKTAL--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSI 1016 (1033)
Q Consensus 941 ~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 1016 (1033)
...... +....+.+.. ..............+.........+..++.+++.+|++.||++|||+.++++. ++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQS---EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHhcCCCCHHHHHhhcc---hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 111000 0001111100 00000000000000000000111244568899999999999999999999943 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.00 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=189.6
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||+|+||+||+|.+..+++.||+|++.... ......+..|++++++++||||+++++++ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999899999999986432 22334567899999999999999999884 4556889999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. .....+++.++..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYN--------VGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHH--------cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999999853 1224689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
....... ....++..|+|||++.+..++.++||||+||++|+|++|+.||...... ............ .
T Consensus 145 ~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~------ 213 (277)
T cd05577 145 LKGGKKI---KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLE-M------ 213 (277)
T ss_pred hccCCcc---ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccc-c------
Confidence 5432211 1234788999999998888999999999999999999999998632211 011111110000 0
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVH 1011 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1011 (1033)
....+....+.+.+++.+||+.||++|| ++.+++.
T Consensus 214 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 ---------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---------------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000111245689999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.45 Aligned_cols=278 Identities=22% Similarity=0.268 Sum_probs=195.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|++|+||+|++..+++.||+|.++... ....+.+.+|++++++++||||+++++++ ..+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 57899999999999999999999889999999886432 22345688999999999999999999995 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-CCcEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL 867 (1033)
++||||++ +++.+++.. .....+++..+..++.||+.||+|||++ +++||||+|+||++++ ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEE
Confidence 99999995 588887742 1233457888889999999999999999 9999999999999985 567999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||++......... .....+++.|+|||++.+ ..++.++||||+||++|+|+||++||......+ .+..... ..
T Consensus 145 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~ 220 (294)
T PLN00009 145 ADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-IL 220 (294)
T ss_pred cccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-Hh
Confidence 999999765432211 112347889999998766 457899999999999999999999986322111 1111100 00
Q ss_pred Ccchhhhcccc-cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........+.. -..+.... .................+++.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSA---FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCChhhccccccchhhhhh---cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00000000 00000000000011234568899999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.77 Aligned_cols=243 Identities=24% Similarity=0.298 Sum_probs=191.7
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999999889999999987432 23446789999999999999999999984 4455889999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 99999999953 23488999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
...... .....++..|+|||.+.+..++.++|+||+|+++|||++|..||...... ......... +
T Consensus 143 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~--------~ 208 (262)
T cd05572 143 LKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDIL--------K 208 (262)
T ss_pred cCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHh--------c
Confidence 644321 12234788999999998888999999999999999999999998643211 111111100 0
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVH 1011 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1011 (1033)
.. .....+...++.+.+++.+||+.+|++||+ ++|+++
T Consensus 209 ~~------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 209 GN------------------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cC------------------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 00 000011112456899999999999999999 565554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=330.00 Aligned_cols=268 Identities=25% Similarity=0.371 Sum_probs=210.2
Q ss_pred hCCCCccceecccCceeEEEEEeCC-------CCeEEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++..+.+.+|+|.||.|++|.... ....||||..+.. ...+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 3344666799999999999998631 2567999998743 334568899999999999 79999999999854
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCcccccc----c--cccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEA----P--RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
.+..++|+||+..|+|.+++++.+........ . ..++..+.+.++.|||.||+||++. ++||||+.+
T Consensus 374 ----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 374 ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred ----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 55889999999999999999876511111111 1 3499999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCcccccccc-ccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMF 932 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~ 932 (1033)
+|||+.++..+||+|||+|+.............. .-+..|||||.+....|+.++||||||+++||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976554443321111 12456999999999999999999999999999999 888875311
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ..++.+ .-+.+.|...|..|.++++++|+.||+.+|++||++.|+.+.
T Consensus 527 ~-~~~l~~------------------------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 527 P-TEELLE------------------------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred c-HHHHHH------------------------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0 000000 112233445566678899999999999999999999999999
Q ss_pred HHHH
Q 042075 1013 LQSI 1016 (1033)
Q Consensus 1013 L~~i 1016 (1033)
++..
T Consensus 576 ~~~~ 579 (609)
T KOG0200|consen 576 FEKH 579 (609)
T ss_pred HHHH
Confidence 9985
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.81 Aligned_cols=284 Identities=23% Similarity=0.261 Sum_probs=200.3
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeecccc----
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---- 781 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 781 (1033)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999999889999999987432 223356778999999999999999999875422
Q ss_pred -ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 782 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 782 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
....+..++|+||+++ ++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 1123478999999976 77777642 234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
+++.+||+|||.+......... ......++..|+|||.+.+ ..++.++||||+||++|||++|++||..... ...+.
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~ 228 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLE 228 (302)
T ss_pred CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Confidence 9999999999999866433221 1111236788999998765 4578999999999999999999999863211 11111
Q ss_pred HHHhhhCCc---chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 940 NFAKTALPD---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 940 ~~~~~~~~~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
......... ...++........... ... ..+..+ ......+..+.+++.+||+.||++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKP---KKQ-YRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhccccccccccccccc---ccc-cccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111110000 0001100000000000 000 000000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.13 Aligned_cols=286 Identities=22% Similarity=0.283 Sum_probs=203.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEee--ccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc---CC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ---GN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~ 785 (1033)
..|....+||+|.||+||+|+.+.+++.||+|+.- ....+......+|++++..++|+|++.+++.|....-. ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999999999999998653 23344456678999999999999999999998754322 23
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||.+|+. +|...+. .....++..++.+++.++..||.|+|.. .|+|||+||+|+|++.+|.+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence 357999999965 8888884 2446789999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCc--cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 866 HVGDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
||+|||+|+.+..... ....+..+.|..|++||.+.+ +.|+++.|||+.|||+.||+||.+.++...+.. ....+
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq--ql~~I 241 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ--QLHLI 241 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH--HHHHH
Confidence 9999999976643322 233444557999999998876 579999999999999999999999876432211 11111
Q ss_pred h---hhCCcchhhhcccc-cCCCchhh-hhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 K---TALPDHVVDIVDST-LLSDDEDL-AVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~---~~~~~~~~~~~d~~-l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ..+.++++.-+|.. +....+.. ...+..+.-..+.. +..-.++..+++..++..||.+|+++++++..
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k-p~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK-PYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc-cccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 11222222222211 00000000 00000111111111 00112356899999999999999999999865
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.22 Aligned_cols=276 Identities=24% Similarity=0.266 Sum_probs=199.7
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|++|.||+|....+++.+++|+++.... .....+.+|++++++++|+||+++++++ ..++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 6778999999999999999988899999999874332 3456788999999999999999999984 44568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++ ++.+++.. ....+++.++..++.|++.|++|||+. +|+|+||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence 9999965 88888743 235689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+........ ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ..+..... .....
T Consensus 143 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~-~~~~~ 218 (283)
T cd05118 143 GLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFR-TLGTP 218 (283)
T ss_pred eeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HcCCC
Confidence 99987654431 11123478899999998776 7899999999999999999999998532211 11111111 11000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..+.... .........................+.+.++.+++.+||+.||.+||++++++.
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPK-FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhccc-chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 000000000000000000001112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=311.62 Aligned_cols=285 Identities=19% Similarity=0.231 Sum_probs=198.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccc--------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 781 (1033)
..+|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999999899999999987665555677889999999999999999998754321
Q ss_pred -ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 782 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 782 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
.......++||||++ ++|.+++. ...+++..+..++.||+.||+|||+. ||+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 111235789999996 58988873 23588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEeecccceecCCCCccc-cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 861 -EEMIAHVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 861 -~~~~~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+++.+|++|||.++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ .
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~ 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-Q 227 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 45678999999998653322111 1112237889999997654 568899999999999999999999986332111 0
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... ..+....+....................... ..........++.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 228 MQLILE-SVPVVREEDRNELLNVIPSFVRNDGGEPRRP-LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHH-hcCCCChHHhhhhhhhhhhhhhhcccccCCC-HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111110 0000000000000000000000000000000 000011234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.79 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=200.9
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||.||+|++..+++.||+|.++.. ......++.+|++++++++|+||+++++++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 588899999999999999999889999999998743 233456778899999999999999999884 3446899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.... .....+++..+..++.|++.|++|||+. |++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence 9999999999999985311 2245689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+........ ....++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... ...........
T Consensus 147 ~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 217 (256)
T cd08530 147 LGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQRGK 217 (256)
T ss_pred ccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC
Confidence 999987654411 113378899999999998999999999999999999999999863211 11111000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ..+.....++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YP---------------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC---------------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0011234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.37 Aligned_cols=276 Identities=21% Similarity=0.224 Sum_probs=195.1
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|++.+.||+|++|+||+|+...+++.||+|++..... .......+|+..+++++ |||++++++++ ..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6788999999999999999988899999999864322 22234567999999998 99999999985 34668999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+ +|+|.+++.. .....+++.++..++.|++.||+|||++ +++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKD--------RKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 8899998853 1234689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
|.+.......... ...++..|+|||++.. ..++.++||||||+++|||++|++||......+ .+... .......
T Consensus 144 ~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~-~~~~~~~ 218 (283)
T cd07830 144 GLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKI-CSVLGTP 218 (283)
T ss_pred ccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHH-HHhcCCC
Confidence 9998664432222 1337889999998754 567899999999999999999999985332111 11110 0000000
Q ss_pred hhh-hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVD-IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+ ..+............. ....... ..........+.+++.+||+.+|++|||++|++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 219 TKQDWPEGYKLASKLGFRFP-QFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ChhhhhhHhhhhcccccccc-ccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000 0000000000000000 0000000 00001124568999999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.92 Aligned_cols=275 Identities=19% Similarity=0.193 Sum_probs=190.0
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.+.+|.| |.||.++...+++.||||+++.. .....+.+.+|++++++++||||+++++++ ...+..+++|
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVS 78 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEE
Confidence 33444444 45555555557999999998754 334557899999999999999999999984 4456789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 79 e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~ 147 (314)
T cd08216 79 PLMAYGSCEDLLKT--------HFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRY 147 (314)
T ss_pred eccCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcc
Confidence 99999999999953 1234578889999999999999999999 999999999999999999999999998
Q ss_pred ceecCCCCc-----cccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 873 ATFLPLSHA-----QTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 873 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+........ ........++..|+|||++.. ..++.++|||||||++|||++|+.||............ ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~ 226 (314)
T cd08216 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGT 226 (314)
T ss_pred ceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hhcc
Confidence 875532211 111122336788999999866 35889999999999999999999998643211111111 1100
Q ss_pred CCcchhhhcccccCCCc-hhhh-----hccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDD-EDLA-----VHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+ ..++....... .... ....................++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 227 VP----CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred Cc----cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00000000000 0000 0000000011111222345678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.77 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=202.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++|||++++++.+ ...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence 58889999999999999999998899999999875432 4557788999999999999999999984 3446889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+|+||+++++|.+++.... .....+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence 9999999999999995411 1246789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+......... .....+++.|+|||...+..++.++||||+|+++|+|++|+.||+... ............
T Consensus 147 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 219 (258)
T cd08215 147 FGISKVLSSTVDL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ 219 (258)
T ss_pred ccceeecccCcce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence 9999876443311 122348889999999988889999999999999999999999985321 111111111100
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... + +...+.++.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~-----~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPP-----I----------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCC-----C----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 00123568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=293.72 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=200.2
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
+|++.+.||+|++|.||+|++..+++.|++|.+..... ...+.+.+|++++++++|||++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 58889999999999999999988899999999975543 45578899999999999999999999853 345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. ||+||||+|+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKK----------FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 99999999999999842 25689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ......... ...
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~-~~~ 215 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIV-QDD 215 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-ccC
Confidence 9999876543322 122347889999999888888999999999999999999999985321 111111100 000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. .. .+...++.+.+++.+||..+|++|||+.|++.
T Consensus 216 ~-----~~----------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 H-----PP----------------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-----CC----------------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 00 00112356889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=312.79 Aligned_cols=284 Identities=19% Similarity=0.188 Sum_probs=200.4
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-c
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-Q 783 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~ 783 (1033)
....++|++.+.||+|++|.||+|++..+++.||||++... .....+.+.+|+.++++++|||++++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 34567899999999999999999999988999999998642 22334667789999999999999999987533221 2
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.....++|+||+ +++|.+++.. ..+++.++..++.|+++|++|||+. ||+||||||+||++++++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 223489999998 6799998842 4589999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||..... ...+....
T Consensus 156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~ 229 (343)
T cd07851 156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIM 229 (343)
T ss_pred CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Confidence 9999999999865432 122347889999998765 4678999999999999999999999853211 00111110
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........++....................+...........+++.+++.+||+.+|++|||+.||++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 230 -NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 001100001111000000000000000000000000011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=326.77 Aligned_cols=204 Identities=20% Similarity=0.257 Sum_probs=157.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCC-eEEEEE------------------EeeccCchhHHHHHHHHHHHHhcCCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGK-TIVAVK------------------VFNLLHHGAFKSFIAECNTLKNIRHRN 769 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 769 (1033)
..++|++.+.||+|+||+||+|..+... ..+++| ..+ ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 3568999999999999999998764322 112222 111 11223456889999999999999
Q ss_pred ceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042075 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVH 849 (1033)
Q Consensus 770 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (1033)
|+++++++ ...+..|+|+|++ ++++.+++..... .........++..++.||+.||+|||++ +|+|
T Consensus 225 Iv~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH 290 (501)
T PHA03210 225 ILKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290 (501)
T ss_pred cCcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999995 4455789999998 4577777743111 1122344667788999999999999999 9999
Q ss_pred ccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 850 CDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 850 rDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
|||||+|||++.++.+||+|||+++.+........ ....||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987654332221 2235899999999999999999999999999999999988643
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.73 Aligned_cols=242 Identities=21% Similarity=0.234 Sum_probs=184.4
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHH-hcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLK-NIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||.||+|.+..+++.||+|+++.... .....+..|..++. ..+|+|++++++++ ..++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 579999999999999988899999999864321 12233445555444 45899999999985 4456899999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKT----------LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence 99999999999842 24588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhh
Q 042075 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952 (1033)
Q Consensus 873 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1033)
+...... ....++..|+|||.+.+..++.++||||+|+++|||++|..||..... ...........
T Consensus 144 ~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~--- 209 (260)
T cd05611 144 SRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRR--- 209 (260)
T ss_pred ceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc---
Confidence 8754321 123378899999999888899999999999999999999999853211 11111000000
Q ss_pred hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 953 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ... ......+++.+.+++.+||+.+|++||++.++.+
T Consensus 210 -----~-~~~---------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 210 -----I-NWP---------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred -----c-CCC---------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 0 000 0001123466899999999999999998765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=307.64 Aligned_cols=284 Identities=18% Similarity=0.168 Sum_probs=196.0
Q ss_pred CCCccceecccCceeEEEEEeCCC--CeEEEEEEeecc--CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEG--KTIVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|++.+.||+|+||.||+|++..+ ++.||+|+++.. .....+.+.+|+++++++ +||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 588899999999999999999877 889999998642 222346778899999999 599999999875322 12334
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++++||+. ++|.+++. ....+++.++..++.||+.||+|||+. ||+||||||+||++++++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 5789999885 68999884 335689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc--ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||.++........ .......|+..|+|||.+.+ ..++.++||||+||++|++++|+.||...... ........
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~ 224 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ 224 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence 9999999865432221 11122358999999998765 56899999999999999999999998632110 01111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .....+...................................+.+++.+|++.||++|||+.|+++.
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 VL-GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred Hh-CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000000000000000000000000000000001124568999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=297.64 Aligned_cols=243 Identities=20% Similarity=0.251 Sum_probs=183.9
Q ss_pred eecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHH---HHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECN---TLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
.||+|+||.||+|.+..+++.||+|.+..... .....+..|.. .++...||+|++++++ +..++..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence 48999999999999988899999999864321 11122334433 3444579999999988 4455688999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
|||++|++|.+++. ....+++.++..++.|+++|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999884 234689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
.+........ ....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ .........
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~--- 213 (278)
T cd05606 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT--- 213 (278)
T ss_pred CccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc---
Confidence 9876533221 123489999999998754 689999999999999999999999864311110 000000000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
.... .+...+.++.+++.+|+..+|++|| ++.++++.
T Consensus 214 ---~~~~----------------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 ---MAVE----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---cCCC----------------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0000 0111245689999999999999999 99998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.11 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=192.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|++|.||+|.+..+++.||||+++... ......+..|+.++.+. .||||++++++|. .+..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 357889999999999999999999889999999987533 23345566788777776 5999999999953 3457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
.++||||++ +++.++... ....+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+|
T Consensus 89 ~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 89 VFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred EEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEE
Confidence 899999984 577776632 23468999999999999999999997 5 899999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
|+|||.+.......... ...++..|+|||.+.+.. ++.++||||||+++|||++|+.||.........+...
T Consensus 156 L~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~- 231 (296)
T cd06618 156 LCDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI- 231 (296)
T ss_pred ECccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-
Confidence 99999987654332222 123788999999987654 7899999999999999999999985321111011110
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
....... . .. ...+.+++.+++.+||+.||++||++.++++.-
T Consensus 232 ---~~~~~~~-----~-~~-------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 232 ---LQEEPPS-----L-PP-------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---hcCCCCC-----C-CC-------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000000 0 00 001235689999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.13 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=191.7
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||.|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++. +..+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence 6899999999999998899999999875432 345678899999999999999999987 44566889999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.++++. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLEN----------VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99999999953 23689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCc------cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 876 LPLSHA------QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 876 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
...... ........++..|+|||......++.++||||||+++||+++|+.||..... ...........
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 217 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGK 217 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC
Confidence 433221 0112223478899999999888899999999999999999999999863211 11111000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
. ........+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 218 --------~------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 --------I------------------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --------c------------------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 0000001245689999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=325.93 Aligned_cols=206 Identities=26% Similarity=0.320 Sum_probs=180.0
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeec---cCchhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
++.-..++|.++++||+|+||.|..++.+.+++.||+|++.+ .......-|..|-++|..-+.+-|++++-.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA----- 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA----- 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----
Confidence 444456789999999999999999999999999999999975 334455678999999999999999999877
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
|+++.+.|+|||||+||+|-.++.+ ...+++.-++-++..|+-||+-+|+. |+|||||||+|||+|.
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk----------~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSK----------FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDK 210 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhh----------cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecc
Confidence 7888899999999999999999943 23688889999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
.|++||+|||.+-.+..+.... ....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||.
T Consensus 211 ~GHikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cCcEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 9999999999998776544333 334569999999998752 578999999999999999999999985
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=303.52 Aligned_cols=286 Identities=20% Similarity=0.209 Sum_probs=197.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccc---cC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 784 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++.+... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999998999999998864322 223467789999999999999999988643221 22
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++||||+.+ ++.+.+.. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 3467999999964 67776642 234689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccc---------cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 865 AHVGDFGLATFLPLSHAQT---------SSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
++|+|||++.......... ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997654322111 1112346888999998765 45889999999999999999999998632111
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.................+.+............. ........ .......+.+.+++.+|++.||++|||+.|++.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF-TNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHHhCCCChhhchhhhhcccccccccC-CCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111110000000000000000000000000 00000000 001122356899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=301.82 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=193.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+.|+..+.||+|+||.||+|++..+++.||+|.+... .....+++.+|+++++.++|+|++++++++. ....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCe
Confidence 3477788999999999999999888999999988632 2233457888999999999999999999853 3457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+. |++.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|
T Consensus 90 ~~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred eEEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEE
Confidence 899999996 588777642 234578999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||.+....... ...++..|+|||.+. ...++.++|||||||++|||++|+.||....... ........
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~ 229 (308)
T cd06634 157 GDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (308)
T ss_pred CCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc
Confidence 9999987654321 233788999999874 3567889999999999999999999975321100 00000000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
..+ .. ........+.+++.+||+.+|++||+++++++.-.
T Consensus 230 ~~~---------~~---------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 ESP---------AL---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCC---------Cc---------------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 000 00 00123455889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=282.30 Aligned_cols=200 Identities=25% Similarity=0.322 Sum_probs=173.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|...++||+|.||.|.+++-+.+++.+|+|++++.- ..+...-..|-++|+..+||.+..+-.. ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 467888999999999999999999999999999998542 2233344678899999999998887655 67788
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
+.|+||||+.||.|.-++. ....+++....-+...|+.||.|||++ +||.||+|.+|.|+|+||++|
T Consensus 242 rlCFVMeyanGGeLf~HLs----------rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLS----------RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred eEEEEEEEccCceEeeehh----------hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence 9999999999999999884 456688888888999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
|+|||+++.--... ......+|||.|.|||++....|+.++|.|.+|||+|||++|+.||.
T Consensus 309 itDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 309 ITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eeecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 99999998532222 22334669999999999999999999999999999999999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=297.92 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=190.2
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
|...+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||++++++++. .....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 666788999999999999998899999999986432 233456888999999999999999999953 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+. |++.+++.. ....+++.++..++.|++.|++|||+. ||+||||+|+||++++++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence 9999995 577777742 234588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||.+...... ....|+..|+|||++. ...++.++|||||||++|||++|..||..... .........
T Consensus 165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~ 234 (313)
T cd06633 165 FGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ 234 (313)
T ss_pred cCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHh
Confidence 9998643221 1234888999999974 45688999999999999999999999853211 111110000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... ....+..+.+++.+||+.+|++||++.+++..
T Consensus 235 -~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 -NDSPTLQ--------------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -cCCCCCC--------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00123458899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=298.66 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=199.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|.+.+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++ ||||++++++ +..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 4789999999999999999999989999999998642 2233467889999999998 9999999998 44556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----------YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 88999999999999999953 33699999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc------------------ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 867 VGDFGLATFLPLSHAQ------------------TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
++|||.+......... .......++..|+|||+..+..++.++||||+|+++|++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999998866433221 1112234788999999988888999999999999999999999998
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH--
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM-- 1006 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-- 1006 (1033)
.... ....+ +... +. ....+...++.+.+++.+||+.+|++||++
T Consensus 223 ~~~~----~~~~~-~~~~--------~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 223 RGSN----EYLTF-QKIL--------KL--------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCcc----HHHHH-HHHH--------hc--------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 6332 11100 0000 00 000011224568999999999999999999
Q ss_pred --HHHHH
Q 042075 1007 --TNVVH 1011 (1033)
Q Consensus 1007 --~evl~ 1011 (1033)
+++++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=304.58 Aligned_cols=279 Identities=19% Similarity=0.236 Sum_probs=194.5
Q ss_pred hCCCCc-cceecccCceeEEEEEeCCCCeEEEEEEeeccCchh--------------HHHHHHHHHHHHhcCCCCceeEe
Q 042075 710 TDGFTS-ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA--------------FKSFIAECNTLKNIRHRNLVKIL 774 (1033)
Q Consensus 710 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 774 (1033)
.++|.. .+.||+|+||+||+|.+..+++.||||+++...... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 346654 577999999999999998889999999986432211 12477899999999999999999
Q ss_pred eeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
+++ ..++..++||||++ |+|.+++. ....+++.....++.|++.||+|||+. +|+||||+|
T Consensus 87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~ 147 (335)
T PTZ00024 87 DVY-----VEGDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP 147 (335)
T ss_pred EEE-----ecCCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 995 44558899999996 68999884 234588999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCc------------cccccccccccccccccccCCC-CCCcccchHHHHHHHHHH
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHA------------QTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLEL 921 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~el 921 (1033)
+||+++.++.++|+|||.+........ ........++..|+|||.+.+. .++.++||||+||++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999986541110 1111122367889999998764 468999999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCC
Q 042075 922 VTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001 (1033)
Q Consensus 922 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 1001 (1033)
++|+.||......+ .+..............+-+.......... ... ....-.........++.+++.+||+.+|+
T Consensus 228 ~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 228 LTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEF---TPR-KPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccccc---CcC-CcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 99999986332111 11111110000000000000000000000 000 00000000112345688999999999999
Q ss_pred CCCCHHHHHHH
Q 042075 1002 DRMDMTNVVHQ 1012 (1033)
Q Consensus 1002 ~RPt~~evl~~ 1012 (1033)
+||+++|++..
T Consensus 303 ~R~s~~~~l~~ 313 (335)
T PTZ00024 303 ERISAKEALKH 313 (335)
T ss_pred hccCHHHHhcC
Confidence 99999999863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-34 Score=281.19 Aligned_cols=266 Identities=26% Similarity=0.311 Sum_probs=198.5
Q ss_pred CCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhc-CCCCceeEee
Q 042075 698 FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILT 775 (1033)
Q Consensus 698 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~ 775 (1033)
...|+.++++. ...||.|+||+|+|..++.+|+..|||+++.... .+.+++..|.+...+- +.||||++||
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 44555555543 3579999999999999999999999999985443 5567888898866555 7999999999
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
.+ ..++..++.||.| ..+++.+.+. ........+++.-.-+|....++||.||-+.. .|+|||+||+
T Consensus 131 a~-----F~EGdcWiCMELM-d~SlDklYk~-----vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPS 197 (361)
T KOG1006|consen 131 AL-----FSEGDCWICMELM-DISLDKLYKR-----VYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPS 197 (361)
T ss_pred hh-----hcCCceeeeHHHH-hhhHHHHHHH-----HHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChh
Confidence 95 3455789999999 4577665432 11234566888888889999999999998875 8999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
|||++..|.+||||||++..+..+...+. ..|...|||||.+.. ..|+.+|||||+|+++||+.||+.||..+..
T Consensus 198 NILldr~G~vKLCDFGIcGqLv~SiAkT~---daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 198 NILLDRHGDVKLCDFGICGQLVDSIAKTV---DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred heEEecCCCEeeecccchHhHHHHHHhhh---ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 99999999999999999987654433332 348899999998765 3489999999999999999999999864432
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.+..+-...+. +.+..+.+ ..+....+..++.-|+.+|-.+||...++.++
T Consensus 275 ---vfeql~~Vv~gdp------p~l~~~~~-----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 ---VFEQLCQVVIGDP------PILLFDKE-----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---HHHHHHHHHcCCC------CeecCccc-----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1222211111111 00111110 11234568999999999999999999998764
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=297.95 Aligned_cols=256 Identities=21% Similarity=0.236 Sum_probs=195.1
Q ss_pred CCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 712 GFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
+|++.+.||+|++|.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4788899999999999999864 357889999987432 22345678999999999 69999999988 44
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.+...++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 55678999999999999999842 34578899999999999999999998 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
.++|+|||+++......... .....++..|+|||.+.+.. .+.++||||||+++|||++|..||..... .......
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~ 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEI 220 (288)
T ss_pred CEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHH
Confidence 99999999987654332211 12234789999999987655 78899999999999999999999852111 0011111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+...... ...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 221 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SRRILKSK----------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHccC----------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11100000 00011123558899999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=294.34 Aligned_cols=273 Identities=23% Similarity=0.286 Sum_probs=197.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
|+..+.||+|++|.||+|+...+++.||+|+++... ....+.+..|+.++++++|+|++++++++ ...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 567789999999999999999889999999987543 33346778899999999999999999984 34468999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||++ ++|.+++.. ....+++.++..++.|++.|++|||+. +|+||||+|+||++++++.++|+||
T Consensus 76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence 999997 599999953 224689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC--
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP-- 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 947 (1033)
|.++......... ....++..|+|||.+.+. .++.++|||||||++||+++|++||...... ..+.+.......
T Consensus 143 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 219 (282)
T cd07829 143 GLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPT 219 (282)
T ss_pred CcccccCCCcccc--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCc
Confidence 9998654332211 112357789999998776 7899999999999999999999998532111 011111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+..+..+.... ......... . .... ..........+.+++.+||+.||++||++++++.
T Consensus 220 ~~~~~~~~~~~-~~~~~~~~~-~--~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 220 EESWPGVTKLP-DYKPTFPKF-P--PKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHhhcccc-ccccccccc-C--ccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 000000000 0 0000 0001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=293.76 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=192.5
Q ss_pred CCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 712 GFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|+.+++++ +|++|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----ee
Confidence 4788999999999999999874 368899999987432 22346678899999999 69999999988 44
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.+...++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++||||+|+||++++++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 55678999999999999999842 34578889999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
.+||+|||++.......... .....|+..|+|||.+... .++.++||||||+++|+|++|+.||..... .......
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEI 220 (290)
T ss_pred CEEEeeCccceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHH
Confidence 99999999998654332211 1123478999999998753 467899999999999999999999853211 1111111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
........ + ..+......+.+++.+||+.||++|| ++.++++.
T Consensus 221 ~~~~~~~~------~----------------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 SRRILKSE------P----------------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHhhccC------C----------------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11100000 0 00111235688999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.90 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=193.7
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-----CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
+|.+.+.||+|+||.||+|++...+..+++|+.+.. ......++..|+.++++++||||+++++++ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 588899999999999999999876666777776532 122334567899999999999999999984 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.... .....+++.++..++.|+++|++|||+. +++|+||||+||++++ +.++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 7899999999999999885311 2345689999999999999999999999 9999999999999975 5699
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||.+.......... ....++..|+|||...+..++.++|+||||+++|+|++|..||... . .........
T Consensus 146 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~-~~~~~~~~~ 218 (260)
T cd08222 146 IGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----N-FLSVVLRIV 218 (260)
T ss_pred ecccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----c-HHHHHHHHH
Confidence 99999988664332211 1234788999999988888899999999999999999999998521 1 111111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .+ ..+...+.++.+++.+||+.+|++||++.|+++.
T Consensus 219 ~~~-----~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 EGP-----TP----------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cCC-----CC----------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000 00 0011234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=323.57 Aligned_cols=147 Identities=29% Similarity=0.400 Sum_probs=130.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|.+.++||+|+||.||+|.+..+++.||||+++... ......+.+|+.+++.++||||+++++++ ...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 468999999999999999999999899999999987432 23346788999999999999999999884 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++++|.++++. ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence 89999999999999999842 23578889999999999999999998 999999999999999999999
Q ss_pred Eeecccce
Q 042075 867 VGDFGLAT 874 (1033)
Q Consensus 867 L~DfG~a~ 874 (1033)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=299.50 Aligned_cols=241 Identities=22% Similarity=0.229 Sum_probs=192.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++.|.....+|.|+|+.|-.+.+..+++..+||++.... .+..+|+.++... +||||+++.+. +.++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCcee
Confidence 457788888999999999999999999999999987542 3345677777766 89999999999 5566689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe-cCCCcEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL-DEEMIAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kL 867 (1033)
|+|||.+.|+-+.+.+.. ..... .++..|+.+|+.|++|||++ ||||||+||+|||+ ++.++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~----------~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS----------KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHh----------cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEE
Confidence 999999999888777742 12223 67788999999999999999 99999999999999 58999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||.++..... ....+-|..|.|||+.....|++++|+||||++||+|++|+.||...-.+ ..+....+
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~---- 527 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ---- 527 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc----
Confidence 999999976554 22234688999999999999999999999999999999999998643222 11110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........+++..+++.+||+.||.+||+|+++...
T Consensus 528 -----------------------------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 -----------------------------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----------------------------CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 000112345668999999999999999999998765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=262.39 Aligned_cols=279 Identities=20% Similarity=0.298 Sum_probs=207.7
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccC
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 784 (1033)
-+...++|++.+++|+|-|++||.|....+.++++||+++... .+.+.+|+.||+.++ ||||+++++...++ .
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~ 106 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---E 106 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---c
Confidence 3456789999999999999999999988889999999998543 467889999999995 99999999986543 2
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-C
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-M 863 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~ 863 (1033)
...+.+|+||+.+.+..... ..++..++.-++.++++||.|+|+. ||+|||+||.|+++|.. .
T Consensus 107 SktpaLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~r 170 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELR 170 (338)
T ss_pred ccCchhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhc
Confidence 44678999999998877766 3477788999999999999999999 99999999999999954 4
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
..+|+|+|+|.++-++..... .+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.|| +.+..++.+.+
T Consensus 171 kLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF---FhG~dN~DQLV 244 (338)
T KOG0668|consen 171 KLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLV 244 (338)
T ss_pred eeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc---cCCCCCHHHHH
Confidence 799999999998866555443 346888999999876 45889999999999999999999998 55555555554
Q ss_pred hh---hCCcchhhhcccc---cCCCchhhhhccchhhhhh--hhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 KT---ALPDHVVDIVDST---LLSDDEDLAVHGNQRQRQA--RINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~~---~~~~~~~~~~d~~---l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+- .-.+++...+++. +.+..+++.-...+..+.. .....--..++..+++...+.+|-++|||++|.+..
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 32 2222222222211 1111111110111111110 000001123567899999999999999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=286.80 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=199.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-------CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-------HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.++|-....||+|||++||+|.+-...+.||||+-... .....+...+|.+|-+.++||.||++|+++.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---- 537 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---- 537 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence 45788889999999999999999888999999986421 1122345678999999999999999999973
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-- 860 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-- 860 (1033)
-+.+..|-|+|||+|.+|+-|++ ..+.+++.++..|+.||+.||.||.+. .|+|||-|+||.|||+.
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLK----------QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLK----------QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eccccceeeeeecCCCchhHHHH----------hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence 34557899999999999999995 456789999999999999999999986 88999999999999995
Q ss_pred -CCCcEEEeecccceecCCCCccc-----cccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 861 -EEMIAHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 861 -~~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
..|.+||+|||+++.++.+.... -.....||..|.+||.+.-+ +.+.|+||||.|||+|..+.|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 45789999999999987654431 11224499999999986533 468899999999999999999999963
Q ss_pred cccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 931 MFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
..... ...+.. .++.. ....++..+....+..+++++||++.-++|....++.
T Consensus 687 nqsQQ----dILqeN------TIlkA-----------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQ----DILQEN------TILKA-----------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHH----HHHhhh------chhcc-----------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 32211 111100 00000 0011111223345678899999999999999888775
Q ss_pred H
Q 042075 1011 H 1011 (1033)
Q Consensus 1011 ~ 1011 (1033)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 4
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=290.26 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=193.0
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEE
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
.++||+|.||+||-|+++.+|+.||||++.+.. ......+++|+.||+.+.||.||.+... ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 479999999999999999999999999997532 3344788999999999999999999877 556669999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC---CcEEEeec
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---MIAHVGDF 870 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kL~Df 870 (1033)
-+.| +.-+.+-. ...+++++....-+..||+.||.|||.+ +|||+|+||+|||+... -.+|||||
T Consensus 644 Kl~G-DMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLHG-DMLEMILS--------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhcc-hHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence 9955 55554422 3556788888888999999999999999 99999999999999643 37999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh---hCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT---ALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~---~~~ 947 (1033)
|+|+++.+...... .+||+.|.|||++....|...-|+||.|||+|.-++|..||.. ++++.+.++. .++
T Consensus 712 GfARiIgEksFRrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNAaFMyP 784 (888)
T KOG4236|consen 712 GFARIIGEKSFRRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNAAFMYP 784 (888)
T ss_pred cceeecchhhhhhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhhccccccC
Confidence 99999876654433 4599999999999999999999999999999999999999852 2223222221 122
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...+ .|..+...+++...++..-++|-+.++.+.
T Consensus 785 p~PW------------------------------~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPW------------------------------SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCch------------------------------hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2211 233455678888888888888888876543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=300.27 Aligned_cols=269 Identities=22% Similarity=0.286 Sum_probs=217.9
Q ss_pred CCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeec
Q 042075 700 NISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACS 778 (1033)
Q Consensus 700 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 778 (1033)
.+.++.+...++.|++.++||.|.+|.||+++...+++.+|+|+.....+. .++...|.++++.. .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 345556666788899999999999999999999999999999998765443 36678899999998 7999999999987
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
-.+...++..++|||||.+|+.-|+++. ..+..+.|..+.-|++.++.|+.|||.+ .++|||||-.|||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn--------~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiL 155 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKN--------TKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVL 155 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhh--------hcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEE
Confidence 7666778899999999999999999975 2367799999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
+++++.||++|||.+...+...... ....||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-.+..
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EeccCcEEEeeeeeeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999999999998765443322 23459999999999753 3578889999999999999999999743211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+. .-.+.++.+...+..-.+++.+++..|+..|-++||++.++++.
T Consensus 234 ----mraLF--------------------------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 ----MRALF--------------------------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----hhhhc--------------------------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11110 01112222233344556789999999999999999999988753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=283.01 Aligned_cols=237 Identities=27% Similarity=0.303 Sum_probs=189.6
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
||+|+||.||++.+..+++.||+|+++.... ...+.+..|++++++++||||+++++. +..++..++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 6999999999999988899999999875322 245678899999999999999999988 45566899999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999943 23689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 876 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
...... ......++..|+|||...+...+.++|+||||+++||+++|+.||..... ...........
T Consensus 143 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~------ 209 (250)
T cd05123 143 LSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP------ 209 (250)
T ss_pred cccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC------
Confidence 644321 11223478899999999888889999999999999999999999853211 11111111000
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
. ..+...+..+.+++.+||..||++||++.+
T Consensus 210 --~--------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 --L--------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --C--------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 000112356889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=281.94 Aligned_cols=222 Identities=20% Similarity=0.115 Sum_probs=174.4
Q ss_pred cCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchh
Q 042075 722 GSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 801 (1033)
Q Consensus 722 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 801 (1033)
|.+|.||+|++..+++.||+|+++... .+.+|...+....||||+++++++ ...+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999987532 233455555566799999999984 4456889999999999999
Q ss_pred hhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCc
Q 042075 802 EWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881 (1033)
Q Consensus 802 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 881 (1033)
+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||.+.......
T Consensus 74 ~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 74 SHISK----------FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred HHHHH----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 99842 23589999999999999999999998 99999999999999999999999999886553321
Q ss_pred cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCC
Q 042075 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSD 961 (1033)
Q Consensus 882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 961 (1033)
....++..|+|||...+..++.++||||+|+++|||++|+.|++..... .......
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~~----- 195 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTTL----- 195 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccccccc-----
Confidence 1123677899999998888999999999999999999999886421000 0000000
Q ss_pred chhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 962 DEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
..+....+.+.+++.+|++.||++||++.+
T Consensus 196 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 196 -----------------NIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred -----------------CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 000112355889999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=254.63 Aligned_cols=220 Identities=24% Similarity=0.306 Sum_probs=178.5
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
++...+....+..||+|+||.|-+.++..+|+..|+|.++.. .....++..+|+++..+- .+|.+|++||. +.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hh
Confidence 444455556677899999999999999999999999998743 334456778888876665 79999999997 55
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.++..++.||.| ..+|..+-++ ....+..+++.-.-+|+..+++||.|||++. .|+|||+||+|||++.+|
T Consensus 116 regdvwIcME~M-~tSldkfy~~------v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRK------VLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG 186 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHH------HHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence 666899999999 5588877643 2245677899999999999999999999984 899999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG----SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
++|+||||++..+..+...+. ..|...|||||.+.. ..|+.|+||||+|+++.||.+++.||+..+..-..+.
T Consensus 187 qVKiCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred cEEEcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 999999999988765544332 238889999998653 4699999999999999999999999987655444444
Q ss_pred HHH
Q 042075 940 NFA 942 (1033)
Q Consensus 940 ~~~ 942 (1033)
+.+
T Consensus 264 qvV 266 (282)
T KOG0984|consen 264 QVV 266 (282)
T ss_pred HHh
Confidence 433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.71 Aligned_cols=284 Identities=22% Similarity=0.265 Sum_probs=206.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-----C---CCceeEeeeeccccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-----H---RNLVKILTACSGVDY 782 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~~ 782 (1033)
.+|.+.++||-|.|++||+|.+..+.+.||+|+.+.... ..+....||++|++++ | .+||+++++|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 589999999999999999999999999999999985433 3467789999999983 3 47999999986554
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE- 861 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~- 861 (1033)
..+.++|+|+|+. |.+|-.++.. ...+.++...+.+|++||+.||.|||.+| ||||-||||+|||+..
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 5667899999998 7899999965 45567999999999999999999999998 9999999999999800
Q ss_pred --------------------------------------------------------------------------------
Q 042075 862 -------------------------------------------------------------------------------- 861 (1033)
Q Consensus 862 -------------------------------------------------------------------------------- 861 (1033)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 042075 862 -------------------------------------------------------------------------------- 861 (1033)
Q Consensus 862 -------------------------------------------------------------------------------- 861 (1033)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred -----CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc---
Q 042075 862 -----EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFE--- 933 (1033)
Q Consensus 862 -----~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~--- 933 (1033)
+.++||+|||-|+.....- +....|..|+|||++.+..|++.+||||++|++|||+||.+.|+.-..
T Consensus 385 ~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 0024555555555432111 112268889999999999999999999999999999999999975321
Q ss_pred --CCccHHHHHhh--hCC-------cchhhhcccccCC-CchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCC
Q 042075 934 --GDMNLHNFAKT--ALP-------DHVVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001 (1033)
Q Consensus 934 --~~~~~~~~~~~--~~~-------~~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 1001 (1033)
+++.+..++.- .+| ...++++++.-.- ....+.......--...+..+.+.+.++.+++.-||+.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 12222222211 111 1122333322100 00000001111112234445667889999999999999999
Q ss_pred CCCCHHHHHHH
Q 042075 1002 DRMDMTNVVHQ 1012 (1033)
Q Consensus 1002 ~RPt~~evl~~ 1012 (1033)
+||||.+.++.
T Consensus 540 KR~tA~~cl~h 550 (590)
T KOG1290|consen 540 KRPTAAQCLKH 550 (590)
T ss_pred ccccHHHHhcC
Confidence 99999998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=305.12 Aligned_cols=278 Identities=19% Similarity=0.160 Sum_probs=173.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCCC----CeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeecc-cccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEG----KTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSG-VDYQ 783 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 783 (1033)
..++|.+.+.||+|+||.||+|++..+ +..||+|+++..... +....| .++...+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 899999987643221 111111 1222222233322222111 1113
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCcc----------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDE----------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
.+...++||||+++++|.++++....... ............+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45678999999999999999864211000 000111122345668999999999999999 99999999
Q ss_pred CCCeEecC-CCcEEEeecccceecCCCCccccccccccccccccccccCCC----------------------CCCcccc
Q 042075 854 PSNVLLDE-EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS----------------------EVSINGD 910 (1033)
Q Consensus 854 p~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 910 (1033)
|+|||+++ ++.+||+|||+|+.......... ....+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986543322221 224489999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC--cc---hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHH
Q 042075 911 VYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP--DH---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 985 (1033)
Q Consensus 911 vwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1033)
|||+||++|||+++..+++. ....+...... .. ......+.... +. ...........
T Consensus 362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~---~~---------~~~~~~~d~~~ 423 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASP---DL---------RRGFEVLDLDG 423 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccch---hh---------hhhhhhccccc
Confidence 99999999999997766432 11111111000 00 00011100000 00 00000000112
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 986 VAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 986 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+..+++.+|++.||++|||+.|+++.
T Consensus 424 ~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 424 GAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 345689999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=271.82 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=170.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 785 (1033)
..+|....+||+|+||.|-+|..+.+.+.+|||++++.- ....+--+.|-++|.-- +-|.++++..+ ++.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 447899999999999999999999999999999997532 22334445677777766 57888888887 5566
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
++.|+||||+.||+|.-.+++ -+.+.+..+.-+|..||-||-+||++ ||+.||||.+|||+|.+|++
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ----------~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ----------VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred hheeeEEEEecCchhhhHHHH----------hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCce
Confidence 699999999999999998854 34566677888999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
||+|||+++.--.+. .+....+||+.|+|||++..++|+..+|.|||||++|||+.|++||+.
T Consensus 490 Ki~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 490 KIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred EeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999998643322 223345699999999999999999999999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=264.13 Aligned_cols=201 Identities=25% Similarity=0.319 Sum_probs=166.7
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+..+.||-|+||.||.+.+..+|+.||.|++...- -...+++-+|++++..++|.|++..++.-.....+--.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 45678999999999999999999999999886322 2345778899999999999999999887433222222356888
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
+|.| ..+|.+.+ .....++...+.-+..||++||+|||+. +|.||||||.|.+++.+...||||||
T Consensus 136 TELm-QSDLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 136 TELM-QSDLHKII----------VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHH-Hhhhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 9988 45888877 4677899999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+|+.-+.+... ..+..+.|..|+|||++++. .|+.+.||||.|||+.|++.++..|+
T Consensus 202 LARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 202 LARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred cccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 99965443322 22334478999999999885 68999999999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=290.01 Aligned_cols=280 Identities=17% Similarity=0.180 Sum_probs=183.5
Q ss_pred hhCCCCccceecccCceeEEEEEeC----------------CCCeEEEEEEeeccCchhHHH--------------HHHH
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILD----------------EGKTIVAVKVFNLLHHGAFKS--------------FIAE 758 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 758 (1033)
..++|++.++||+|+||+||+|... ..++.||||.++.......++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 245679999987543322222 3346
Q ss_pred HHHHHhcCCCCc-----eeEeeeecccc---ccCCCceeEEEEcccCCchhhhcccCCCCc--------------ccccc
Q 042075 759 CNTLKNIRHRNL-----VKILTACSGVD---YQGNDFKALVFEFMHNRSLEEWLHPITRED--------------ETEEA 816 (1033)
Q Consensus 759 ~~~l~~l~h~ni-----v~l~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~ 816 (1033)
+.++.+++|.++ ++++++|.... ....+..++||||+++++|.++++...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 67777764321 112356899999999999999996421100 00112
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcccccccccccccccc
Q 042075 817 PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896 (1033)
Q Consensus 817 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 896 (1033)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......... .....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 23467888999999999999999999 99999999999999999999999999997654332211 112225889999
Q ss_pred ccccCCCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCccccCCccHHHHHhhhCCcchhhh
Q 042075 897 PEYGLGSE--------------------V--SINGDVYSYGILLLELVTRKK-PTDIMFEGDMNLHNFAKTALPDHVVDI 953 (1033)
Q Consensus 897 PE~~~~~~--------------------~--~~~sDvwSlG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1033)
||.+.... + ..+.||||+||++|||++|.. ||.....-...+.. .......+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----ccchHHHH
Confidence 99875432 1 134799999999999999875 65321100000000 00000000
Q ss_pred cccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 042075 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP---EDRMDMTNVVHQ 1012 (1033)
Q Consensus 954 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~ 1012 (1033)
.. .. .....+.......++..+++.+|+..+| .+|+|++|++++
T Consensus 454 r~--~~-------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RM--YK-------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred Hh--hc-------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 00 0000000111234567899999999766 689999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=257.26 Aligned_cols=202 Identities=25% Similarity=0.331 Sum_probs=176.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|...++||+|+|+.|-.++.+.+.+.+|+|++++. ..+..+-.+.|-.+..+. +||.+|-+..+ ++.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 35788999999999999999999999999999999843 344566778888888887 79999999988 6777
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++|.||++||+|.-+++ ....++++.+.-+...|+-||.|||++ ||+.||+|.+||++|..|++
T Consensus 324 srlffvieyv~ggdlmfhmq----------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred ceEEEEEEEecCcceeeehh----------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCce
Confidence 89999999999999988774 445689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
|++|+|+++.--.+... ....+||+.|.|||++.+..|...+|.|++||+++||+.|+.||+..
T Consensus 391 kltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 99999999864332222 22356999999999999999999999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=267.32 Aligned_cols=239 Identities=27% Similarity=0.332 Sum_probs=189.0
Q ss_pred CceeEEEEEeCCCCeEEEEEEeeccCchh-HHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchh
Q 042075 723 SFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 801 (1033)
Q Consensus 723 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 801 (1033)
+||.||+|....+++.||+|++....... .+.+.+|++.+++++|+|++++++++. .....+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999999889999999997654433 678999999999999999999999854 335789999999999999
Q ss_pred hhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCc
Q 042075 802 EWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881 (1033)
Q Consensus 802 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 881 (1033)
+++.. ...+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+........
T Consensus 76 ~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~ 142 (244)
T smart00220 76 DLLKK----------RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL 142 (244)
T ss_pred HHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc
Confidence 99843 22288999999999999999999999 999999999999999999999999999987654321
Q ss_pred cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCC
Q 042075 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSD 961 (1033)
Q Consensus 882 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 961 (1033)
.....++..|+|||...+..++.++||||+|+++|++++|..||...... ........... ... .
T Consensus 143 ---~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~~-~~~-------~ 207 (244)
T smart00220 143 ---LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKPK-PPF-------P 207 (244)
T ss_pred ---cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccC-CCC-------c
Confidence 12234788999999998888999999999999999999999998632111 11111000000 000 0
Q ss_pred chhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 962 DEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. .....+.++.+++.+||..+|++||++.++++
T Consensus 208 ~-----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 P-----------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred c-----------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 00003356899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=276.61 Aligned_cols=199 Identities=25% Similarity=0.321 Sum_probs=174.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+++++..||-|+||.|-++..+.....+|+|++++.. ....+....|-.+|...+.|.||++|.. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 34566778999999999999988665568999887532 3344567789999999999999999988 677779
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+.||-|-||.++..++ ..+.++..+..-++..+++|++|||++ +||.||+||+|.++|.+|-+||
T Consensus 495 vYmLmEaClGGElWTiLr----------dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILR----------DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred hhhhHHhhcCchhhhhhh----------hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEE
Confidence 999999999999999995 456678888888999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
.|||+|+.+..+....+ .+||+.|.|||++.+...+.++|.||+|+++||+++|.+||..
T Consensus 562 VDFGFAKki~~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred eehhhHHHhccCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999998876654443 4599999999999999999999999999999999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=272.90 Aligned_cols=214 Identities=22% Similarity=0.295 Sum_probs=175.3
Q ss_pred CHHHHHHhh---CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEee
Q 042075 702 SYQNLYNAT---DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 702 ~~~~l~~~~---~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
.|..++++. .-|..++.||-|+||+|.+++..++...||+|.+++.+ .......+.|-+||...+.+-||++|.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 344444432 34777899999999999999999899999999987543 223345678999999999999999997
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
. |++++..|+||+|++||++..+|- .-+.+.+.-++-++.++..|+++.|.. |+|||||||+
T Consensus 697 S-----FQDkdnLYFVMdYIPGGDmMSLLI----------rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPD 758 (1034)
T KOG0608|consen 697 S-----FQDKDNLYFVMDYIPGGDMMSLLI----------RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPD 758 (1034)
T ss_pred E-----eccCCceEEEEeccCCccHHHHHH----------HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCcc
Confidence 7 677889999999999999999983 445677888888999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCC---------CCc-c------------------------------ccccccccccccc
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPL---------SHA-Q------------------------------TSSIFAKGSIGYI 895 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~---------~~~-~------------------------------~~~~~~~gt~~y~ 895 (1033)
|||||.+|++||+|||+++-+.- +.. . ......+||+.|+
T Consensus 759 NILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 759 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred ceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 99999999999999999854311 000 0 0000123999999
Q ss_pred cccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 896 aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
|||++....|+.-+|.||.|||||||+.|++||-....
T Consensus 839 apevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 839 APEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred ChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 99999999999999999999999999999999964433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=285.43 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=183.3
Q ss_pred cceecccCcee-EEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeEEEE
Q 042075 716 ANLIGAGSFGS-VYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 716 ~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
.+++|.|+.|+ ||+|... ++.||||++-. +..+...+|+..++.- +|||||++++. ..+..+.||..|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE 583 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE 583 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence 46788998765 7999995 88999998742 3345678999999988 79999999987 667789999999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---C--CcEEEe
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---E--MIAHVG 868 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~--~~~kL~ 868 (1033)
.| ..+|.+++.....+.+ .... ...+.+..|++.||+|||+. +||||||||.||||+. + .+++|+
T Consensus 584 LC-~~sL~dlie~~~~d~~---~~~~---i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVE---MQSD---IDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred Hh-hhhHHHHHhccccchh---hccc---ccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence 99 5699999965311111 1111 45567889999999999998 9999999999999975 3 479999
Q ss_pred ecccceecCCCCcccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccCCccHHHHHhhhC
Q 042075 869 DFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|||+++....+..... .....||-+|+|||++....-+.++||||+|||+|+.++| ..||....+.+.++..-
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~----- 728 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG----- 728 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-----
Confidence 9999998866543222 2234599999999999998888999999999999999995 89996443322221100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. ... .+. ...++ +..++|.+|++++|..||+|.+|+.
T Consensus 729 -~~--~L~--~L~--------------------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 -NY--TLV--HLE--------------------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -cc--cee--eec--------------------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 000 000 00111 4689999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=270.21 Aligned_cols=207 Identities=25% Similarity=0.376 Sum_probs=176.2
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--------chhHHHHHHHHHHHHhcC---CCC
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--------HGAFKSFIAECNTLKNIR---HRN 769 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~n 769 (1033)
..++--.....+|+..+.+|+|+||.|+.|.++.....|+||.+.+.. +........|+.||..++ |+|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 344444455667999999999999999999999999999999886432 112234567999999996 999
Q ss_pred ceeEeeeeccccccCCCceeEEEEcc-cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042075 770 LVKILTACSGVDYQGNDFKALVFEFM-HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848 (1033)
Q Consensus 770 iv~l~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 848 (1033)
|++++++ +++++++|++||-. ++.+|.+++ +....+++.++.-|++|++.|+++||+. |||
T Consensus 631 IlKlLdf-----FEddd~yyl~te~hg~gIDLFd~I----------E~kp~m~E~eAk~IFkQV~agi~hlh~~---~iv 692 (772)
T KOG1152|consen 631 ILKLLDF-----FEDDDYYYLETEVHGEGIDLFDFI----------EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIV 692 (772)
T ss_pred hhhhhhe-----eecCCeeEEEecCCCCCcchhhhh----------hccCccchHHHHHHHHHHHhcccccccc---Cce
Confidence 9999999 77888999999975 567899999 3566799999999999999999999999 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p 927 (1033)
|||||-+||.++.+|-+||+|||.|.....+... ..+||..|.|||++.+.+|- ..-|||++|+++|.++....|
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 9999999999999999999999999876554433 35699999999999998874 668999999999999999998
Q ss_pred CC
Q 042075 928 TD 929 (1033)
Q Consensus 928 ~~ 929 (1033)
|.
T Consensus 769 yy 770 (772)
T KOG1152|consen 769 YY 770 (772)
T ss_pred Cc
Confidence 74
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=249.90 Aligned_cols=278 Identities=20% Similarity=0.210 Sum_probs=200.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeec--cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 785 (1033)
...+|.-.+.+|.|.- .|..|.+.-.++.||+|.... ......++..+|...+..+.|+||++++.++..... ...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567888889999998 888888888899999998743 223445778899999999999999999998653221 122
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||| ..+|.+.++ -.++-.++..|..|++.|++|||+. ||+||||||+||++..+..+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhe
Confidence 3578999999 569999884 2356678889999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||.|||+|+.-... ...+.++.|..|+|||++.+..+.+.+||||.||++.||++|+..|. +...+.+|.+..
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKII 230 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHH
Confidence 99999999864433 22233558999999999999889999999999999999999999875 444555554321
Q ss_pred CC-------------cchhhhcccccCCCchhhhhccch--hhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 946 LP-------------DHVVDIVDSTLLSDDEDLAVHGNQ--RQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 946 ~~-------------~~~~~~~d~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
-. +.....+.. .+.+......... .......+...-......+++.+||..||++|.++++++
T Consensus 231 ~~lgtpd~~F~~qL~~~~r~yv~~--~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 231 EQLGTPDPSFMKQLQPTVRNYVEN--RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHhcCCCHHHHHHhhHHHHHHhhc--ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 10 001111100 0000000000000 000000011111234578899999999999999999998
Q ss_pred HH
Q 042075 1011 HQ 1012 (1033)
Q Consensus 1011 ~~ 1012 (1033)
+.
T Consensus 309 ~H 310 (369)
T KOG0665|consen 309 RH 310 (369)
T ss_pred cC
Confidence 64
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=262.81 Aligned_cols=283 Identities=21% Similarity=0.214 Sum_probs=203.9
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC------CCCceeEeeeeccccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR------HRNLVKILTACSGVDY 782 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~ 782 (1033)
-..+|.+....|+|-|++|.+|.+..-+..||||+++..... .+.=.+|+++|+++. --|+++++.. |
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence 456899999999999999999999888899999999854322 244468999999994 2478888877 5
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
....+.|+|||-+ ..+|.+++++. .....+....+..++.|+.-||..|-.. ||+|.||||+||||++.
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 5667999999977 66999999753 3456688899999999999999999998 99999999999999876
Q ss_pred C-cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 863 M-IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~-~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
. .+||||||.|.......... +..+..|+|||++.+.+|++..|+||.||+|||+.||+..|......++.-..+
T Consensus 573 k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 4 68999999998765433211 225778999999999999999999999999999999999986543322110000
Q ss_pred -HhhhCCcc-------hhhhcccccCCCchh------------hhhccch-------hhhhhhhhhHHHHHHHHHHHHhh
Q 042075 942 -AKTALPDH-------VVDIVDSTLLSDDED------------LAVHGNQ-------RQRQARINSKIECLVAMARIGVA 994 (1033)
Q Consensus 942 -~~~~~~~~-------~~~~~d~~l~~~~~~------------~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~ 994 (1033)
.+..++.. ..+.+|..+.-.+.+ +....+. ...+.-....+....++.+++..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 01111110 111111111100000 0000000 00111222344566789999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 042075 995 CSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 995 cl~~dP~~RPt~~evl~~ 1012 (1033)
|+..||++|.|..|+++.
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=237.65 Aligned_cols=252 Identities=18% Similarity=0.230 Sum_probs=191.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+.|.+.+.+|+|.||.+-+|+++.+.+.+|+|.+.... ...++|.+|...--.+ .|.||+.-|++. ++..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 356899999999999999999999999999999886543 3457888888765555 689999988764 6777788
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--CCCcEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEMIAH 866 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~k 866 (1033)
++++||++.|+|..-+ ....+.+....+++.|++.|++|+|++ .+||||||.+||||- +..++|
T Consensus 98 vF~qE~aP~gdL~snv-----------~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNV-----------EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred EEeeccCccchhhhhc-----------CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence 9999999999999987 335678888899999999999999999 999999999999994 345899
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+||||..+..+.... ...-+..|.|||..... ...+.+|||.||+++|.++||+.||+.....+..|..|
T Consensus 164 lcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW 238 (378)
T ss_pred eeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence 999999986432221 12256779999975432 35788999999999999999999998555555555555
Q ss_pred HhhhCCcc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTALPDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+..-... +.+.+. -..+...++.++-+.++|++|-...++.++
T Consensus 239 ~~w~~rk~~~~P~~F~---------------------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 239 EQWLKRKNPALPKKFN---------------------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHhcccCccCchhhc---------------------------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 44222111 100000 112446778888889999999555555444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-28 Score=268.27 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=201.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|....++|.|.||.||||+++.+++..|+|+++........-.++|+-+++..+|||||.+++. |...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCcE
Confidence 4578899999999999999999999999999999998777777888999999999999999999998 55666899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+.||||.+|+|.+.-+ ....+++.++..+++...+|++|||+. |-+|||||-.||++++.|.+|++|
T Consensus 89 icMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence 9999999999999774 457799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccccccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYG---LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
||.+..+...... .....||+.|||||+. ..+.|...+|||+.|++..|+-.-++|-. +-..-..-+...
T Consensus 156 fgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf---dlhpmr~l~LmT-- 228 (829)
T KOG0576|consen 156 FGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF---DLHPMRALFLMT-- 228 (829)
T ss_pred cCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc---ccchHHHHHHhh--
Confidence 9998765433222 2234599999999974 34568999999999999999988887732 111000001000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
....++.-..+. ..-.+.+.++++.|+..+|++||+++.++.
T Consensus 229 ----kS~~qpp~lkDk-------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 ----KSGFQPPTLKDK-------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----ccCCCCCcccCC-------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 011111111111 112355889999999999999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=251.62 Aligned_cols=284 Identities=24% Similarity=0.305 Sum_probs=200.7
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCC---CCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
+....+.|..+++||+|.|++||+|.+.. ..+.||+|.+.... ...+..+|+++|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence 33455678999999999999999999876 68899999887543 346789999999999 68999999998
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD- 860 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~- 860 (1033)
+..++...+|+||++.....++.. .++..++..+++.+..||+++|++ |||||||||+|++.+
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR 167 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence 778889999999999988888874 367889999999999999999999 999999999999998
Q ss_pred CCCcEEEeecccceecCCCC-------------cc-----------------------------cccccccccccccccc
Q 042075 861 EEMIAHVGDFGLATFLPLSH-------------AQ-----------------------------TSSIFAKGSIGYIAPE 898 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE 898 (1033)
+.+.-.|+|||+|...+... .. .......||++|+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 45678999999997221100 00 0001123999999999
Q ss_pred ccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh----------CCcc--hhhh----cccccCCC
Q 042075 899 YGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA----------LPDH--VVDI----VDSTLLSD 961 (1033)
Q Consensus 899 ~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~~~~----~d~~l~~~ 961 (1033)
++... ..++++||||.|||+.-+++++.||-....+-..+.+.+... .... +++- ..+.....
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 98764 578999999999999999999999864443333333222111 1111 1110 00000000
Q ss_pred chhhh--hccchhhhhhhhhhHHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 962 DEDLA--VHGNQRQRQARINSKIEC-LVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 962 ~~~~~--~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+... .-...++.........++ +....+++.+|+..||.+|.|++|.++.
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 000000000011111122 2368899999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=238.90 Aligned_cols=211 Identities=29% Similarity=0.460 Sum_probs=180.7
Q ss_pred ecccCceeEEEEEeCCCCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccC
Q 042075 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN 797 (1033)
Q Consensus 719 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 797 (1033)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++. .....+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 68999999999999877999999998755432 3467899999999999999999999953 34588999999999
Q ss_pred CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-CCcEEEeecccceec
Q 042075 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVGDFGLATFL 876 (1033)
Q Consensus 798 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DfG~a~~~ 876 (1033)
++|.+++.. ....+++..+..++.+++++++|||+. +++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKE---------NEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 999999853 114688999999999999999999999 9999999999999999 899999999999876
Q ss_pred CCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcc
Q 042075 877 PLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955 (1033)
Q Consensus 877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 955 (1033)
..... ......+...|++||..... .++.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 54331 11123378899999998877 888999999999999998
Q ss_pred cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 956 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 956 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.++.+++..|++.+|++||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 127889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=237.04 Aligned_cols=199 Identities=31% Similarity=0.412 Sum_probs=170.3
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
|++.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56788999999999999999987899999999865544 567889999999999999999999985 334578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccc-cCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRS-LNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
+||+++++|.+++.. ... +++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLRK----------KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence 999999999999853 122 78899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccccccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|.+......... ......++..|++||.. ....++.++|||+||+++|||++|+.||+.
T Consensus 143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999876544211 11223377889999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-28 Score=252.05 Aligned_cols=239 Identities=20% Similarity=0.224 Sum_probs=122.1
Q ss_pred eeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEeccc-CCCC
Q 042075 75 GVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHN-NSIG 145 (1033)
Q Consensus 75 gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~ 145 (1033)
-|+|+..+ +...+.|+|..|+++-.-+.+|..+++|+.||||+|+|+-+-|.+|..|.+|..|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 37776543 12345666666666644444566666666666666666656666666666555544443 6666
Q ss_pred CCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcC---------
Q 042075 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL--------- 216 (1033)
Q Consensus 146 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--------- 216 (1033)
..--..|++|..|+.|.+..|++.-...+.|..|++|..|.+-+|.+..+.-..|..+.+++.+.+..|.+
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 33334556666666666666666655555666666666666666666522223566666666666666652
Q ss_pred ---CCcCCccccccCCCCcccccccccCCCCccccc-CCCceeEEeccCccccCccCccccccccccceeeecccccCCC
Q 042075 217 ---DGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292 (1033)
Q Consensus 217 ---~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 292 (1033)
....|-++++.....-..+.++++...-+..+. .+.++..=..+.....+..|..-|..|++|+.|+|++|+|++.
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i 289 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI 289 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh
Confidence 122333444444444444545444422222211 1112211122222233344444444555555555555555554
Q ss_pred CCccCcCCCCccccccccccc
Q 042075 293 IPPAISNASNLEVFQVNSNKL 313 (1033)
Q Consensus 293 ~p~~~~~l~~L~~L~Ls~N~l 313 (1033)
-+.+|..+..++.|.|..|+|
T Consensus 290 ~~~aFe~~a~l~eL~L~~N~l 310 (498)
T KOG4237|consen 290 EDGAFEGAAELQELYLTRNKL 310 (498)
T ss_pred hhhhhcchhhhhhhhcCcchH
Confidence 455555554444444444444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-27 Score=243.76 Aligned_cols=430 Identities=23% Similarity=0.269 Sum_probs=213.4
Q ss_pred EecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecc-ccc
Q 042075 114 DLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY-NNL 192 (1033)
Q Consensus 114 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l 192 (1033)
+-++-+++ ++|..+.. .-+.++|..|+|+...|.+|+.+.+|+.||||+|.|+.+-|++|.+|++|..|-+-+ |+|
T Consensus 52 dCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred EccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 34444444 55654432 345666777777755555666677777777777777666666666666666555444 666
Q ss_pred CCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccc
Q 042075 193 TGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDI 272 (1033)
Q Consensus 193 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~ 272 (1033)
+......|++|.+|+.|.+.-|++.-...+.|..+++|..|.+-.|.+...--.++..+.+++.+.+..|.+.
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i------- 201 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI------- 201 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-------
Confidence 6444456666666666666666666555666666666666666666666222224445555555554444432
Q ss_pred cccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhccccc
Q 042075 273 GFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTN 352 (1033)
Q Consensus 273 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~ 352 (1033)
..-+|+++- .+....|..++...-..-..+.++++....+. .+.|++.
T Consensus 202 --cdCnL~wla----~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~-------------------------kf~c~~e- 249 (498)
T KOG4237|consen 202 --CDCNLPWLA----DDLAMNPIETSGARCVSPYRLYYKRINQEDAR-------------------------KFLCSLE- 249 (498)
T ss_pred --cccccchhh----hHHhhchhhcccceecchHHHHHHHhcccchh-------------------------hhhhhHH-
Confidence 111111110 01112233333333333333444444322111 0011100
Q ss_pred ccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEE
Q 042075 353 ATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLREL 432 (1033)
Q Consensus 353 ~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 432 (1033)
.+..-..+.....+..|..-+.-.++|+.|+|++|+|+++-+.+|.++..+++|.|..|+|...-...|.++.+|+.|
T Consensus 250 --sl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL 327 (498)
T KOG4237|consen 250 --SLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTL 327 (498)
T ss_pred --hHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceee
Confidence 000000111112223333323333445555555555555555555555555555555555544444445555555555
Q ss_pred EccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEE--ecCCCccCCCCCccccCchhHHhhhhccCc
Q 042075 433 RLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTII--DLSNNNLTGTIPPQLLGLSSLLIVLELSRN 509 (1033)
Q Consensus 433 ~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L--~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N 509 (1033)
+|.+|+|+...|..|..+. |.+|+|-.|.+.-. . .|.+| .|..++-. ..|+ +.-+..++.+.++.+
T Consensus 328 ~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn-------C-~l~wl~~Wlr~~~~~-~~~~--Cq~p~~~~~~~~~dv 396 (498)
T KOG4237|consen 328 SLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN-------C-RLAWLGEWLRKKSVV-GNPR--CQSPGFVRQIPISDV 396 (498)
T ss_pred eecCCeeEEEecccccccceeeeeehccCcccCc-------c-chHHHHHHHhhCCCC-CCCC--CCCCchhccccchhc
Confidence 5555555544444444443 44444444443210 0 00000 01112211 1221 112222345555554
Q ss_pred ccc---CCcCCcccc---------ccccce-EEccccccccccCcccccccccceeecccccccCcccccccCcccCCcc
Q 042075 510 QLT---GPIPNEVGN---------LKNLEM-LNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVL 576 (1033)
Q Consensus 510 ~l~---~~~p~~~~~---------l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 576 (1033)
.+. -..|++.+. .+-+.. ..-|++.+. .+|.-+- ..-.+|++.+|.++ .+|.+ .+.+| .+
T Consensus 397 ~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~ 469 (498)
T KOG4237|consen 397 AFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LL 469 (498)
T ss_pred cccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hc
Confidence 432 112332221 122322 233444444 5555443 24578999999998 78887 77888 99
Q ss_pred ccccccccccCCcccccccccceeecCCC
Q 042075 577 DLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605 (1033)
Q Consensus 577 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 605 (1033)
|||+|+++-.--..|.++++|.+|-||+|
T Consensus 470 dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 470 DLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred ccccCceehhhcccccchhhhheeEEecC
Confidence 99999999777778889999999999887
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-24 Score=271.72 Aligned_cols=365 Identities=19% Similarity=0.286 Sum_probs=230.4
Q ss_pred CCeEEEEEcCCCCCCc-cc-ccccCCCCCCCEEEecCCC------ccccCCccccccc-cccEEecccCCCCCCCCcccc
Q 042075 83 HQRVTILDLKSLKLAG-YI-SAHVGNLSFLKVLDLHNNS------FHHEIPSEFDRLR-RLQVLALHNNSIGGEIPANIS 153 (1033)
Q Consensus 83 ~~~v~~l~l~~~~l~g-~~-~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~ 153 (1033)
+.+|..+.+.-..+.. .+ +.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..|
T Consensus 531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f- 608 (1153)
T PLN03210 531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF- 608 (1153)
T ss_pred cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-
Confidence 3456665554333321 12 2457888999999887653 3345777777764 5889999888887 778777
Q ss_pred CCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcc
Q 042075 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNL 233 (1033)
Q Consensus 154 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 233 (1033)
...+|++|+|++|++. .+|..+..+++|++|+|++|...+.+|. ++.+++|+.|+|++|..-..+|..++.+++|+.|
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L 686 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEE
Confidence 5788889999988887 6788888888888999888765556664 7788888888888877555788888888888888
Q ss_pred cccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccc
Q 042075 234 TMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313 (1033)
Q Consensus 234 ~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 313 (1033)
++++|..-+.+|..+ ++++|+.|++++|...+.+|. ...+|++|+|++|.++ .+|..+ .+++|+.|++.++..
T Consensus 687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~ 759 (1153)
T PLN03210 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS 759 (1153)
T ss_pred eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence 888875555677665 677788888877765545553 2346666777776665 344433 345555555544322
Q ss_pred cCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCc
Q 042075 314 TGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFG 393 (1033)
Q Consensus 314 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~ 393 (1033)
..... .+. .++......+++|+.|++++|...+
T Consensus 760 ~~l~~----------------------------------------------~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~ 792 (1153)
T PLN03210 760 EKLWE----------------------------------------------RVQ-PLTPLMTMLSPSLTRLFLSDIPSLV 792 (1153)
T ss_pred hhccc----------------------------------------------ccc-ccchhhhhccccchheeCCCCCCcc
Confidence 11000 000 0111111123567777777777666
Q ss_pred cCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCC
Q 042075 394 NIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQS 473 (1033)
Q Consensus 394 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l 473 (1033)
.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|+|++|.....+|.... .++.|+|++|.++ .+|.++..+
T Consensus 793 ~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~--nL~~L~Ls~n~i~-~iP~si~~l 868 (1153)
T PLN03210 793 ELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDIST--NISDLNLSRTGIE-EVPWWIEKF 868 (1153)
T ss_pred ccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccccc--ccCEeECCCCCCc-cChHHHhcC
Confidence 677777777777777777765444566554 567777777777654434443221 1445555555554 345555555
Q ss_pred CcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccc
Q 042075 474 ETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534 (1033)
Q Consensus 474 ~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (1033)
++|++|+|++| |+++ .+|..+..+++|+.|+++++.
T Consensus 869 ~~L~~L~L~~C------------------------~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 869 SNLSFLDMNGC------------------------NNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCEEECCCC------------------------CCcC-ccCcccccccCCCeeecCCCc
Confidence 55555555442 2333 345555666777777776653
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=218.51 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=189.2
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
...+|.+...|+.|+|++. |..+++|+++... ....++|..|.-.++.+.||||.++++.|..+ ....++.
T Consensus 194 l~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~is 266 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIIS 266 (448)
T ss_pred hhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEee
Confidence 3457889999999999998 4457788876432 33346799999999999999999999998544 4788999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe--ec
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG--DF 870 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~--Df 870 (1033)
.||+.|+|+..++. .....++..++.+++.+||+|++|||+. .|-|..--+.+..|++|++.+++|. |-
T Consensus 267 q~mp~gslynvlhe--------~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHE--------QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeccchHHHHHHhc--------CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 99999999999975 4556678889999999999999999997 4445556789999999999988874 32
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCC---cccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS---INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
-++.. .....-.+.||+||.++..+.+ .++|+|||++++||+.|+..||.....-+..
T Consensus 338 kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------- 398 (448)
T KOG0195|consen 338 KFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------- 398 (448)
T ss_pred eeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------
Confidence 22211 1112247899999998876543 6689999999999999999998632211100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
....-++.|...++.....+.++|.-|+..||.+||.++.|+-.|++++
T Consensus 399 ---------------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 ---------------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---------------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0111222333444555677999999999999999999999999998874
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=270.73 Aligned_cols=181 Identities=17% Similarity=0.248 Sum_probs=122.5
Q ss_pred CccccccccccEEecccCC------CCCCCCccccCCC-CCcEEEcccccccCCCCCCcccccccceeeecccccCCCCC
Q 042075 125 PSEFDRLRRLQVLALHNNS------IGGEIPANISSCS-NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP 197 (1033)
Q Consensus 125 p~~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 197 (1033)
+.+|..+++|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 4567778888888886653 3335666676664 5888888888876 677776 4678888888888877 566
Q ss_pred CCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcccccccc
Q 042075 198 PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277 (1033)
Q Consensus 198 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~ 277 (1033)
..+..+++|+.|+|++|...+.+|+ ++.+++|++|+|++|.....+|.++.++++|+.|++++|...+.+|..+ .++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~ 704 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLK 704 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCC
Confidence 6777788888888887654445664 7778888888888876666778778777778888777765444566543 456
Q ss_pred ccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
+|++|++++|...+.+|.. ..+|++|++++|.++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 6666666666544344432 234455555555544
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=215.81 Aligned_cols=170 Identities=22% Similarity=0.240 Sum_probs=127.3
Q ss_pred CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 798 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
|+|.++++. ....+++.++..++.|+++||+|||++ + ||+||+++.++.+|+ ||.++...
T Consensus 1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 688888852 245699999999999999999999998 5 999999999999999 99998654
Q ss_pred CCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccc
Q 042075 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDST 957 (1033)
Q Consensus 878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 957 (1033)
... ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+...........
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 125 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------- 125 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC--------
Confidence 322 13889999999999999999999999999999999999998533221111111111110000
Q ss_pred cCCCchhhhhccchhhhhhhhhhHHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 958 LLSDDEDLAVHGNQRQRQARINSKIECL--VAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 958 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
... + ....... .++.+++.+||+.+|++||++.|+++.+..+...
T Consensus 126 ----~~~------------~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 126 ----PRD------------R-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ----ccc------------c-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000 0 0011112 2589999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=269.42 Aligned_cols=202 Identities=18% Similarity=0.249 Sum_probs=138.8
Q ss_pred hcCC-CCceeEeeeeccccc--cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH
Q 042075 764 NIRH-RNLVKILTACSGVDY--QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH 840 (1033)
Q Consensus 764 ~l~h-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 840 (1033)
.++| +||.+++++|..... ......+.+|||+ +++|.++++. ....+++.+++.++.||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 3455 578888887632221 1223567888987 6699999953 2356899999999999999999999
Q ss_pred hCCCCCcEeccCCCCCeEecCC-------------------CcEEEeecccceecCCCCc--------------cccccc
Q 042075 841 HDCQPPIVHCDLKPSNVLLDEE-------------------MIAHVGDFGLATFLPLSHA--------------QTSSIF 887 (1033)
Q Consensus 841 ~~~~~~ivHrDlkp~NIll~~~-------------------~~~kL~DfG~a~~~~~~~~--------------~~~~~~ 887 (1033)
++ ||+||||||+|||++.. +.+|++|||+++....... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 99 99999999999999653 4556666666653211000 000111
Q ss_pred cccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhh
Q 042075 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAV 967 (1033)
Q Consensus 888 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 967 (1033)
..||+.|||||++.+..++.++|||||||++|||++|.+|+.... ...........+.
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~------------------- 232 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPP------------------- 232 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcCh-------------------
Confidence 347889999999999999999999999999999999988864110 0000000000000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 968 HGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..........+++.+||+++|.+||++.|+++.
T Consensus 233 ------------~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 233 ------------QILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred ------------hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 000112335678889999999999999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=249.11 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=117.6
Q ss_pred CCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCC
Q 042075 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484 (1033)
Q Consensus 405 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 484 (1033)
|+.|++++|+++ .+|. .+++|+.|+|++|+|++ +|.... .|..|++++|+|++ +|.. ..+|++|+|++|
T Consensus 284 L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~--~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N 352 (788)
T PRK15387 284 LCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALPS--ELCKLWAYNNQLTS-LPTL---PSGLQELSVSDN 352 (788)
T ss_pred cCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCcc--cccccccccCcccc-cccc---ccccceEecCCC
Confidence 444455555544 2232 12445555555555553 332211 14455566666653 4431 246777888888
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCccc
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIP 564 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (1033)
+|+ .+|... ..++.|++++|+|++ +|... .+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|
T Consensus 353 ~Ls-~LP~lp----~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP 418 (788)
T PRK15387 353 QLA-SLPTLP----SELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLP 418 (788)
T ss_pred ccC-CCCCCC----cccceehhhcccccc-Ccccc---cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCC
Confidence 877 466422 233667888888874 66533 46888889999888 466543 57888899999988 477
Q ss_pred ccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCC
Q 042075 565 SSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 565 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
... .+|+.|+|++|+|+ .+|..+.+++.|+.|+|++|+|+|.+|.
T Consensus 419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 543 46788999999998 7888888999999999999999988775
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=246.50 Aligned_cols=133 Identities=24% Similarity=0.347 Sum_probs=66.4
Q ss_pred CCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecc
Q 042075 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189 (1033)
Q Consensus 110 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 189 (1033)
-..|+|++|+|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 345666666665 4555554 25666666666665 34432 355566666666665 34432 24555556666
Q ss_pred cccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 190 NNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 190 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
|.++ .+|..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|+
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~ 335 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT 335 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCccc
Confidence 6555 333322 34555556666555 23331 2445555555555553 2321 123444445555544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=225.52 Aligned_cols=168 Identities=24% Similarity=0.137 Sum_probs=130.5
Q ss_pred HhhCCCCccceecccCceeEEEEEeCC-CCeEEEEEEeecc-----CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDE-GKTIVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
...++|++.+.||+|+||+||+|++.. +++.||||+.... .....+.+.+|++++++++|+|+++.+..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-----
Confidence 345789999999999999999999875 6788899986532 12234678999999999999999853322
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC-CCCCeEec
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL-KPSNVLLD 860 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~ 860 (1033)
. +..|+||||++|++|.... . .. ...++.|+++||+|||+. ||+|||| ||+||+++
T Consensus 90 ~---~~~~LVmE~~~G~~L~~~~-~---------~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 90 T---GKDGLVRGWTEGVPLHLAR-P---------HG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG 146 (365)
T ss_pred c---CCcEEEEEccCCCCHHHhC-c---------cc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence 1 2479999999999997321 0 00 146788999999999999 9999999 99999999
Q ss_pred CCCcEEEeecccceecCCCCcccc------ccccccccccccccccCCC
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTS------SIFAKGSIGYIAPEYGLGS 903 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 903 (1033)
.++.+||+|||+|+.+........ .....+++.|+|||.+...
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999999997754432111 1234588899999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=245.66 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=150.0
Q ss_pred cccCCChhhHHHHHHHHHhcccCCCCCCCC----CCCCCCCcceee----------------eEecCCCCCeEEEEEcCC
Q 042075 34 STVAGNETDRLALLEFKSKITHDPLGVFGS----WNESIHFCQWHG----------------VTCSRRQHQRVTILDLKS 93 (1033)
Q Consensus 34 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~----W~~~~~~c~w~g----------------v~C~~~~~~~v~~l~l~~ 93 (1033)
..+...++|.+.+++..+.+. -| +++++ |++.+++|-=.. |.|.. ..||.+..-+
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~-~p-~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~---~~vt~l~~~g 130 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLA-FP-AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG---KSVTYTRVTE 130 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhc-CC-chhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC---Cccccccccc
Confidence 355567889999999999995 34 55666 999999995433 77753 3466655444
Q ss_pred CCCCcccccccCCCCCCCEEEe----cCCCccccCC---ccc-----cccccccEEecccCCCCCCCCccccCCCCCcEE
Q 042075 94 LKLAGYISAHVGNLSFLKVLDL----HNNSFHHEIP---SEF-----DRLRRLQVLALHNNSIGGEIPANISSCSNLIRV 161 (1033)
Q Consensus 94 ~~l~g~~~~~~~~l~~L~~L~L----~~n~l~~~~p---~~~-----~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 161 (1033)
...+..-..+- +.-.+... ..+.-.+.-+ .++ +-..+.+.|+++++.++ .+|..+. ++|+.|
T Consensus 131 ~~~~~~~~~~~---~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L 204 (754)
T PRK15370 131 SEQASSASGSK---DAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTL 204 (754)
T ss_pred ccccccCCCCC---ChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEE
Confidence 22211111000 00000000 0010000000 001 11134667777777776 5666553 467777
Q ss_pred EcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccC
Q 042075 162 RLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 162 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
+|++|+|+ .+|..+. ++|++|++++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+
T Consensus 205 ~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 205 ILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS 275 (754)
T ss_pred EecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence 77777777 5555544 46777777777776 4555443 35777777777777 5565553 46777777777777
Q ss_pred CCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcC
Q 042075 242 GTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV 317 (1033)
Q Consensus 242 ~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 317 (1033)
.+|..+. ++|+.|++++|+|+ .+|..+. .+|++|++++|+++. +|..+. ++|+.|++++|.+++.+
T Consensus 276 -~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP 341 (754)
T PRK15370 276 -CLPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLP 341 (754)
T ss_pred -ccccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCC
Confidence 4566553 46777777777777 3554332 467888888888874 454432 57888888888877543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-22 Score=220.99 Aligned_cols=265 Identities=23% Similarity=0.226 Sum_probs=197.8
Q ss_pred CCCccceecccCceeEEEEEeCCCC-eEEEEEEeeccCchhHHHHHHHHHHHHhcCC----CCceeEeeeeccccccCCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGK-TIVAVKVFNLLHHGAFKSFIAECNTLKNIRH----RNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~ 786 (1033)
+|++.+.||+|+||.||+|.+..++ +.+|+|+...........+..|..++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999997664 6789998775433333377889999998863 58888888731 3566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC----
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---- 862 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---- 862 (1033)
+.++||+.+ |.+|.++... ...+.++..++.+|+.|++.+|+++|+. |++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 889999987 8899998743 2257899999999999999999999999 99999999999999854
Q ss_pred -CcEEEeecccce--ecCCCCcc----c-c-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 863 -MIAHVGDFGLAT--FLPLSHAQ----T-S-SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 863 -~~~kL~DfG~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
..+.+.|||+|+ .+...... . . ....+||..|+++.+..+.+.+++.|+||++.++.|++.|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998 33222111 1 1 1234599999999999999999999999999999999999999953321
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. ....+........... .....+.++.+++..+-..+..++|....+...+
T Consensus 243 ~~-~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 243 TD-LKSKFEKDPRKLLTDR---------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cc-hHHHHHHHhhhhcccc---------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 11 1111111110000000 0011234566777777778999999999999998
Q ss_pred HHHHHHh
Q 042075 1014 QSIKNIL 1020 (1033)
Q Consensus 1014 ~~i~~~~ 1020 (1033)
++.....
T Consensus 295 ~~~~~~~ 301 (322)
T KOG1164|consen 295 KDVFDSE 301 (322)
T ss_pred HHHHHhc
Confidence 8776553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=203.52 Aligned_cols=265 Identities=18% Similarity=0.204 Sum_probs=202.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
-.|++.++||+|+||+++.|+.--+++.||||.-.... ...++..|.+..+.+ ..++|..+|-+ -+.+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 47999999999999999999998899999999865432 346788899999988 57899998877 44555778
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-----c
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-----I 864 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-----~ 864 (1033)
+|+|.. |.+|+|++. ..+..++..++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .
T Consensus 101 LVidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence 999988 889999885 3456799999999999999999999999 999999999999997443 5
Q ss_pred EEEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 865 AHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
+.++|||+|+.+.++.+.. ......||.+||+-....+.+.+.+.|+-|+|-|+++.+-|..||+..... ..-.
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~ 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKE 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHH
Confidence 8999999999887655432 222234999999999999999999999999999999999999999754221 1111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
++.+ +-+..-.-.. ..-....++++..-+...-..+-.+-|..+-+...+..+.+.
T Consensus 247 kYeK---------IGe~Kr~T~i---------------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 247 KYEK---------IGETKRSTPI---------------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHH---------hccccccCCH---------------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1111 0000000000 001122455677777777778888889998888887777654
Q ss_pred h
Q 042075 1020 L 1020 (1033)
Q Consensus 1020 ~ 1020 (1033)
.
T Consensus 303 ~ 303 (449)
T KOG1165|consen 303 L 303 (449)
T ss_pred c
Confidence 4
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=195.76 Aligned_cols=203 Identities=23% Similarity=0.306 Sum_probs=167.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC-CCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~ 787 (1033)
....|.++++||.|+||.+|.|....+|+.||||+-..... ...+..|.++.+.+++ ..|..+..+ ..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 34679999999999999999999999999999999764322 3567789999999865 556666655 445567
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
-.+||+.. |.+|++.+.. ....++..+++-++-|++.-++|+|.+ +++||||||+|+|..- ...
T Consensus 86 nvlVMdLL-GPsLEdLfnf---------C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNF---------CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred ceeeeecc-CccHHHHHHH---------HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence 88999988 8899999864 345689999999999999999999999 9999999999999963 346
Q ss_pred EEEeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 865 AHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
+.++|||+|+.+.+..+. .....-.||..|.+-....+.+.+.+.|+-|+|.++.+...|..||+..
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 899999999987544332 2222334999999988888888899999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=238.01 Aligned_cols=255 Identities=20% Similarity=0.233 Sum_probs=188.0
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeec----c-Cch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNL----L-HHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~-~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..+++|.|++|.|+.+......+.++.|.++. . ... ....+..|+.+-..++|||++..+..+.+. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence 46789999999888888776666666665431 1 111 112266777788888999998887764332 233
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
.-+|||+++ +|..++. ....++..++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+
T Consensus 397 ~~~mE~~~~-Dlf~~~~----------~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVM----------SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhhhhcccH-HHHHHHh----------cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEe
Confidence 344999999 9999983 334688889999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcc--ccccccccccccccccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 869 DFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|||.+.....+... ......+|+..|+|||++.+.+|++. .||||.|+++..|.+|+.||......+..+. ...
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~ 539 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNN 539 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhc
Confidence 99999876544443 44445669999999999999999866 7999999999999999999975544333220 000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+. ..... ........+.+...+|.+|++.||.+|.|+++|++.
T Consensus 540 ~~~~~------~~~~~---------------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 540 YSDQR------NIFEG---------------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccc------ccccC---------------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000 00000 001122455678899999999999999999999874
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=233.59 Aligned_cols=217 Identities=23% Similarity=0.439 Sum_probs=154.8
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCc
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA 150 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 150 (1033)
+.|.-..|-.. .++.+++.+++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 168 a~~r~~~Cl~~---~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~ 237 (754)
T PRK15370 168 AVQRMRDCLKN---NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPA 237 (754)
T ss_pred HHHHHHhhccc---CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCCh
Confidence 34555567543 46788998888884 565553 47889999999998 5776654 58999999999998 6776
Q ss_pred cccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC
Q 042075 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL 230 (1033)
Q Consensus 151 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 230 (1033)
.+. .+|+.|+|++|.+. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|
T Consensus 238 ~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL 306 (754)
T PRK15370 238 TLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGI 306 (754)
T ss_pred hhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhH
Confidence 654 47899999999988 7777765 57899999999988 5676554 478999999999884 565443 478
Q ss_pred CcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccccc
Q 042075 231 VNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNS 310 (1033)
Q Consensus 231 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 310 (1033)
+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..+ .++|+.|+|++|+|+ .+|..+. ++|+.|++++
T Consensus 307 ~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 307 THLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSR 376 (754)
T ss_pred HHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCC
Confidence 88888888888 4555443 577778888887773 55443 256777777777776 3554442 4666777777
Q ss_pred ccccCcCc
Q 042075 311 NKLTGEVP 318 (1033)
Q Consensus 311 N~l~~~~~ 318 (1033)
|+|+..++
T Consensus 377 N~Lt~LP~ 384 (754)
T PRK15370 377 NALTNLPE 384 (754)
T ss_pred CcCCCCCH
Confidence 76664443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-21 Score=194.23 Aligned_cols=176 Identities=13% Similarity=0.110 Sum_probs=134.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHH---H------HHHHHHHHHhcCCCCceeEeeeecc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK---S------FIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
...+|++.+++|.|+||.||++.. ++..+|+|+++........ . +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999766 3567999999754332222 2 6799999999999999999888543
Q ss_pred ccc---cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCC
Q 042075 780 VDY---QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSN 856 (1033)
Q Consensus 780 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (1033)
... ...+..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 221 12346899999999999988741 111 2456999999999999 99999999999
Q ss_pred eEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHH
Q 042075 857 VLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELV 922 (1033)
Q Consensus 857 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ell 922 (1033)
|++++++ ++++|||............ .+.....+..++|+||||+++.-..
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999988 9999999887543222111 1334455778999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-19 Score=202.66 Aligned_cols=260 Identities=29% Similarity=0.398 Sum_probs=192.9
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch---hHHHHHHHHHHHHhcCCC-CceeEeeeeccccccCCCce
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG---AFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~ 788 (1033)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 678889999999999999997 77899998754332 367889999999999888 799999985 333447
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL 867 (1033)
++++||+.++++.+++..... . ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGR------K-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhccc------c-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence 999999999999977743110 0 3688999999999999999999999 999999999999999888 7999
Q ss_pred eecccceecCCCCccc----cccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccC--CccH
Q 042075 868 GDFGLATFLPLSHAQT----SSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEG--DMNL 938 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~--~~~~ 938 (1033)
+|||.++......... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 9999998654433221 2234559999999999887 57889999999999999999999996533221 0011
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.......... .......... .......+.+++..|+..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~----~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP----SLASPLSPSN------------------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc----ccccccCccc------------------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111100 0000000000 01123457889999999999999998887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=221.13 Aligned_cols=251 Identities=17% Similarity=0.187 Sum_probs=178.1
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHH--HHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNT--LKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+|...+.+|++.|=.|.+|++++ |. |+||++-+.. .-..+.+.++++- ...++|||++++.-+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 56778899999999999999984 44 8999986544 2223344443333 444589999998766 4455567
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+|-+|+.+ +|+|.+ ..+.-+...+.+-|+.|++.|+..+|.. ||+|||||.+|||++.-.-+.|+
T Consensus 97 ylvRqyvkh-nLyDRl----------STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRL----------STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HHHHHHHhh-hhhhhh----------ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhh
Confidence 888899854 999998 3556678889999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccc-----cccccccccccccccccCCC----------C-CCcccchHHHHHHHHHHHh-CCCCCCcc
Q 042075 869 DFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGS----------E-VSINGDVYSYGILLLELVT-RKKPTDIM 931 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlG~vl~ellt-g~~p~~~~ 931 (1033)
||..-+..--+.... -....+.-.+|.|||.+... . .+++.||||+|||++|+++ |++||+.
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L- 241 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL- 241 (1431)
T ss_pred cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-
Confidence 998776542211111 11112244579999975431 2 5788999999999999998 7888852
Q ss_pred ccCCccHHHHHhhhCCc-chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 932 FEGDMNLHNFAKTALPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 932 ~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
.+........ ...+..-..+ ....+.+++..|++.||++|.++++.+
T Consensus 242 -------SQL~aYr~~~~~~~e~~Le~I-------------------------ed~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 242 -------SQLLAYRSGNADDPEQLLEKI-------------------------EDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred -------HHHHhHhccCccCHHHHHHhC-------------------------cCccHHHHHHHHHccCchhccCHHHHH
Confidence 2221111110 0000000000 012478999999999999999999999
Q ss_pred HHHHHH
Q 042075 1011 HQLQSI 1016 (1033)
Q Consensus 1011 ~~L~~i 1016 (1033)
+.-..+
T Consensus 290 ~~yrG~ 295 (1431)
T KOG1240|consen 290 QKYRGL 295 (1431)
T ss_pred Hhhhcc
Confidence 875443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=187.77 Aligned_cols=140 Identities=16% Similarity=0.105 Sum_probs=108.1
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCch--h-------H-----------------HHHHHHHHHHHhcCCCC
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG--A-------F-----------------KSFIAECNTLKNIRHRN 769 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 769 (1033)
.+.||+|++|.||+|.+. +|+.||||+++..... . . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999753211 0 0 12235999999998877
Q ss_pred ceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCcE
Q 042075 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYL-HHDCQPPIV 848 (1033)
Q Consensus 770 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iv 848 (1033)
+.....+. . ...++||||++++++..... ....++..+...++.|++.+|+|+ |+. ||+
T Consensus 81 v~~p~~~~-----~--~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 81 IPCPEPIL-----L--KSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred CCCCcEEE-----e--cCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 64333221 1 12389999999877665431 224578899999999999999999 687 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
||||||+||+++ ++.++|+|||+|....
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 999999999998 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=189.58 Aligned_cols=200 Identities=22% Similarity=0.247 Sum_probs=140.5
Q ss_pred CCCCceeEeeeeccc----------------------cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHH
Q 042075 766 RHRNLVKILTACSGV----------------------DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823 (1033)
Q Consensus 766 ~h~niv~l~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 823 (1033)
+|||||++.++|.+. .+..+...|+||..++. +|.+|+. ....+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence 599999999886431 12234467899998854 9999994 2446677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--CCC--cEEEeecccceecCCCC----ccccccccccccccc
Q 042075 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEM--IAHVGDFGLATFLPLSH----AQTSSIFAKGSIGYI 895 (1033)
Q Consensus 824 ~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~kL~DfG~a~~~~~~~----~~~~~~~~~gt~~y~ 895 (1033)
...-+..|+++|+.|||.+ ||.|||+|++||++. +|+ ...|+|||++--.+... .........|.-.-|
T Consensus 342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 7888999999999999999 999999999999994 555 46889999875332211 111111223777889
Q ss_pred cccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCccccCCccHH--HHHhhhCCcchhhhcccccCCCchhhhh
Q 042075 896 APEYGLGSE------VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH--NFAKTALPDHVVDIVDSTLLSDDEDLAV 967 (1033)
Q Consensus 896 aPE~~~~~~------~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 967 (1033)
|||+....+ -..|+|.|+.|.+.||+++...||.. .+++.+. .+.+.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~----------------------- 473 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQES----------------------- 473 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhh-----------------------
Confidence 999865432 23679999999999999999999863 2221111 11010
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 968 HGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.-+..+..+++.+.+++...++.||.+|++..-....|
T Consensus 474 --------qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 474 --------QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred --------hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11112334667789999999999999999876554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.7e-20 Score=192.61 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=152.3
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcC----------CCCceeEeeeec
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIR----------HRNLVKILTACS 778 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~ 778 (1033)
.+...+.||.|+++.||.+++.++++.+|||++.... ....+++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455689999999999999999999999999986332 223456666664444432 212222222211
Q ss_pred ccc----c---cCCC-----ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042075 779 GVD----Y---QGND-----FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846 (1033)
Q Consensus 779 ~~~----~---~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (1033)
... . .+.. ..+++|+-+ .+||.+++....... .....+....++.+..|+++.+++||+. |
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 000 0 0001 236788877 568888864211111 1134456667778889999999999999 9
Q ss_pred cEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC--------CCCCcccchHHHHHHH
Q 042075 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--------SEVSINGDVYSYGILL 918 (1033)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~vl 918 (1033)
+||+||||+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999999988764332111 225678999997533 2578999999999999
Q ss_pred HHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCC
Q 042075 919 LELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSME 998 (1033)
Q Consensus 919 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 998 (1033)
|.|++|+.||+.......... . +....+.++.+.+++..+|++
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~-------------~------------------------f~~C~~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW-------------D------------------------FSRCRDMPEPVQFLIRGLLQR 283 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG-------------G------------------------GTTSS---HHHHHHHHHHT-S
T ss_pred HHHHHccCCCCCCCccccccc-------------c------------------------chhcCCcCHHHHHHHHHHccC
Confidence 999999999974422211100 0 000113567799999999999
Q ss_pred CCCCC
Q 042075 999 SPEDR 1003 (1033)
Q Consensus 999 dP~~R 1003 (1033)
+|++|
T Consensus 284 ~~~~R 288 (288)
T PF14531_consen 284 NPEDR 288 (288)
T ss_dssp SGGGS
T ss_pred CcccC
Confidence 99998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=180.66 Aligned_cols=141 Identities=19% Similarity=0.134 Sum_probs=110.4
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCch--------------------------hHHHHHHHHHHHHhcCCCC
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG--------------------------AFKSFIAECNTLKNIRHRN 769 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 769 (1033)
.+.||+|++|.||+|++. +|+.||||+++..... ....+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998753211 0122467899999999998
Q ss_pred ceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcE
Q 042075 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIV 848 (1033)
Q Consensus 770 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iv 848 (1033)
+.....+.. . ..++||||++|+++..... ....++..+...++.|++.++.++|+ . ||+
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l----------~~~~~~~~~~~~i~~~l~~~l~~lH~~~---giv 140 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRL----------KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLV 140 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhh----------hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEe
Confidence 754443311 1 2489999999875543321 12346778899999999999999999 8 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecCC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~~ 878 (1033)
||||||+||+++ ++.++|+|||+|.....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999998 78999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=175.43 Aligned_cols=187 Identities=17% Similarity=0.059 Sum_probs=138.6
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeeccCc----hhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCce
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH----GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|+++. |+++++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4568999999999998776 467788776653322 11235789999999994 5889999876 146
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC-CCCCeEecCCCcEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL-KPSNVLLDEEMIAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kL 867 (1033)
+++|||+.|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||++++++.++|
T Consensus 74 ~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred EEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEE
Confidence 899999999998764410 1134778999999999999 9999999 799999999999999
Q ss_pred eecccceecCCCCcc----c-------cccccccccccccccccCCC-CCC-cccchHHHHHHHHHHHhCCCCCCcc
Q 042075 868 GDFGLATFLPLSHAQ----T-------SSIFAKGSIGYIAPEYGLGS-EVS-INGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
+|||+|......... . .......++.|++|+...-. ..+ ...+.++-|+-+|.++||+.++...
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999999865433311 0 01112257777777753221 223 5679999999999999999986543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-20 Score=174.49 Aligned_cols=163 Identities=34% Similarity=0.610 Sum_probs=121.2
Q ss_pred CCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEE
Q 042075 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTII 479 (1033)
Q Consensus 401 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 479 (1033)
++.+...|.||+|+++ .+|+.++.+.+|+.|++++|+++ .+|..++.+. |+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3445555566666665 45555666666666666666665 5556666654 666666666665 788888888899999
Q ss_pred ecCCCccCC-CCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeeccccc
Q 042075 480 DLSNNNLTG-TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF 558 (1033)
Q Consensus 480 ~Ls~N~l~~-~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 558 (1033)
||++|++.. .+|..|+.+..+ +.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|.+++.+.+|++|++++|+
T Consensus 108 dltynnl~e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hccccccccccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 999888864 578888888877 88889999887 78888888888888888888887 788888888888888888888
Q ss_pred ccCcccccccCc
Q 042075 559 LQGPIPSSLSSL 570 (1033)
Q Consensus 559 l~~~~p~~~~~l 570 (1033)
++ .+|.+++++
T Consensus 185 l~-vlppel~~l 195 (264)
T KOG0617|consen 185 LT-VLPPELANL 195 (264)
T ss_pred ee-ecChhhhhh
Confidence 88 677666543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-19 Score=209.55 Aligned_cols=201 Identities=19% Similarity=0.192 Sum_probs=158.4
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC---CCCceeEeeeecccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVD 781 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 781 (1033)
+++...+.|.|.+.||+|+||+||+|...+ |+.||+|+-+....- +|.--.+++.+++ -+-|.++..+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a----- 762 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA----- 762 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH-----
Confidence 444556788999999999999999999986 999999997754432 1222233344444 1233333333
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD- 860 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~- 860 (1033)
+...+.-++|+||.+.|+|-+++. ..+.+++.-++.++.|+++.+++||.. +||||||||+|+++.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRR 829 (974)
T ss_pred HccCCcceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeec
Confidence 222335689999999999999994 556789999999999999999999999 999999999999994
Q ss_pred ------CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 861 ------EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 861 ------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
+..-++|+|||.+..+..-.........++|-.+-.+|+..++.+++.+|.|.++.+++-|+.|++-
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2336899999999877544444555566789999999999999999999999999999999999863
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=196.07 Aligned_cols=220 Identities=24% Similarity=0.337 Sum_probs=162.0
Q ss_pred HHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh
Q 042075 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH 841 (1033)
Q Consensus 762 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 841 (1033)
|+.+.|.|+.+++|.+... ...++|.+|+..|+|.|.+.. ....+++.....+.++|++||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 3567899999999997543 578999999999999999953 45678999999999999999999998
Q ss_pred CCCCCc-EeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCC-------CCcccchHH
Q 042075 842 DCQPPI-VHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-------VSINGDVYS 913 (1033)
Q Consensus 842 ~~~~~i-vHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwS 913 (1033)
. .| .|+.+++.|.++|....+|++|||+.................-..-|.|||.+.+.. .+.+.||||
T Consensus 67 s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 67 S---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred C---cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 7 44 999999999999999999999999988764311111111112456799999987641 467799999
Q ss_pred HHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHh
Q 042075 914 YGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGV 993 (1033)
Q Consensus 914 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 993 (1033)
||++++|+++++.||+........ .+.+..... .......+.+ ....+..+++..++.
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i--------------------~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSI--------------------ELLNELPPELLLLVA 201 (484)
T ss_pred HHHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCcch--------------------hhhhhcchHHHHHHH
Confidence 999999999999999864333322 111111000 0000000000 000134457899999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 994 ACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 994 ~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
+||..+|++||++++|...++.+....
T Consensus 202 ~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 202 RCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred HhcccChhhCccHHHHHhhhhhhcccc
Confidence 999999999999999999998887654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-20 Score=170.67 Aligned_cols=134 Identities=33% Similarity=0.549 Sum_probs=77.8
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 183 (1033)
+.++++.+.|.||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++++++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445555666666666666 45556666666666666666665 56666666666666666666665 5566666666666
Q ss_pred eeeecccccCC-CCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccC
Q 042075 184 YFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 184 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
+|||.+|++.. .+|..|..++.|+-|+|++|.++ .+|..++++++|+.|.+..|.+-
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence 66666666542 34555555555555555555555 44445555555555555555444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=169.39 Aligned_cols=139 Identities=19% Similarity=0.219 Sum_probs=105.7
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-----CCCCceeEeeeeccccccCCCce
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-----RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.-.+.||+|+||.||. +..+... +||+.........+.+.+|+++++.+ .||||+++++++.+.. +.+..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 4457899999999995 5555555 69988765444567899999999999 5799999999964321 12343
Q ss_pred e-EEEEc--ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHH-HHHHhCCCCCcEeccCCCCCeEecC---
Q 042075 789 A-LVFEF--MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL-SYLHHDCQPPIVHCDLKPSNVLLDE--- 861 (1033)
Q Consensus 789 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivHrDlkp~NIll~~--- 861 (1033)
+ +|+|| +++|+|.++++. ..+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCC
Confidence 3 78999 557999999943 124443 35678888777 999999 9999999999999974
Q ss_pred -CCcEEEeecccc
Q 042075 862 -EMIAHVGDFGLA 873 (1033)
Q Consensus 862 -~~~~kL~DfG~a 873 (1033)
++.++|+||+.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 337999995444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=195.04 Aligned_cols=226 Identities=24% Similarity=0.234 Sum_probs=173.4
Q ss_pred eecccCceeEEEEEe---CCCCeEEEEEEeeccCch--hHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCceeEE
Q 042075 718 LIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHG--AFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
++|+|.||.|++++- .+.+..+|+|+.++.... .......|..++...+ ||.++++... ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 378999999987654 335677899988643221 1124556788888886 9999999877 6667789999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
++|..+|++...+. ....+++.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||
T Consensus 76 ld~~rgg~lft~l~----------~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLS----------KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhccc----------cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCch
Confidence 99999999999884 344567777778888999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchh
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1033)
.++..-..... +||..|||||++. ....++|.||||++.+||+||..||.. ......
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I---------- 199 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI---------- 199 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH----------
Confidence 99865333222 5899999999987 567889999999999999999999853 000000
Q ss_pred hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 952 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
.+.....+.+......+++..+...+|..|.-.
T Consensus 200 ----------------------l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 200 ----------------------LKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----------------------hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 011122233455567778888888888888754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-20 Score=204.74 Aligned_cols=105 Identities=26% Similarity=0.283 Sum_probs=50.6
Q ss_pred EEcCCCCCCc-ccccccCCCCCCCEEEecCCCcccc----CCccccccccccEEecccCCCCC------CCCccccCCCC
Q 042075 89 LDLKSLKLAG-YISAHVGNLSFLKVLDLHNNSFHHE----IPSEFDRLRRLQVLALHNNSIGG------EIPANISSCSN 157 (1033)
Q Consensus 89 l~l~~~~l~g-~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~~~~l~~ 157 (1033)
|+|..+.+++ .....+..++.|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 4555555552 2333344455566666666665332 34444455556666666655541 12233444555
Q ss_pred CcEEEcccccccCCCCCCcccccc---cceeeecccccC
Q 042075 158 LIRVRLSSNELVGKIPSELGSLSK---IEYFSVSYNNLT 193 (1033)
Q Consensus 158 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~ 193 (1033)
|++|++++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 555555555554433333333333 555555554444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=171.61 Aligned_cols=144 Identities=18% Similarity=0.133 Sum_probs=112.1
Q ss_pred hCCCCccceecccCceeEEEEE-eCCCCeEEEEEEeeccCch------------------------hHHHHHHHHHHHHh
Q 042075 710 TDGFTSANLIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLHHG------------------------AFKSFIAECNTLKN 764 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 764 (1033)
...|.+.+.||+|++|.||+|. +..+|+.||+|+++..... ....+..|+..+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999998 5568999999998743210 11235689999999
Q ss_pred cCCC--CceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC
Q 042075 765 IRHR--NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD 842 (1033)
Q Consensus 765 l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 842 (1033)
+.+. .+.+++++ ...++||||++++++..... ........+...++.|++.++++||+.
T Consensus 107 L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 107 LYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred HHhcCCCCCeeeEe---------cCceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 9753 34444433 13479999999988876542 122345566789999999999999999
Q ss_pred CCCC-cEeccCCCCCeEecCCCcEEEeecccceec
Q 042075 843 CQPP-IVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876 (1033)
Q Consensus 843 ~~~~-ivHrDlkp~NIll~~~~~~kL~DfG~a~~~ 876 (1033)
| |+||||||+||+++ ++.++|+|||.|...
T Consensus 168 ---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 ---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-18 Score=186.07 Aligned_cols=125 Identities=30% Similarity=0.494 Sum_probs=107.0
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
.+.|+.|+++...+|.+|+... .....-++.....++.|++.|++| + +.+|||+||.||+...+..+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-------~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-------RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-------CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence 3678999999999999999642 233456788899999999999999 6 99999999999999999999
Q ss_pred EEeecccceecCCCC----ccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 866 HVGDFGLATFLPLSH----AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
||.|||+........ .........||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999999998765544 1222333459999999999999999999999999999999998
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-19 Score=200.61 Aligned_cols=208 Identities=26% Similarity=0.334 Sum_probs=127.0
Q ss_pred CcccEEEccCCCCCccCCccccCCCC---CCEEEcccCcccc----cCChhhhcC-CCCcEEEcccccccccc----Ccc
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVK---LLRLEMWNNRLSG----TIPPAIGEL-QNLRELRLQENRFLGNI----PPS 446 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~----p~~ 446 (1033)
++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++.. +..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 45666666666665555555555554 8888888887763 233445556 77788888888777422 223
Q ss_pred cccce-eceeeccccccCCC----CCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCcccc
Q 042075 447 IGNLK-LFNLQLSYNFLQGS----IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN 521 (1033)
Q Consensus 447 ~~~l~-L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~ 521 (1033)
+..+. |++|++++|.+++. ++..+...++|++|++++|.+++.-. +.++..+..
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~~~~ 219 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA---------------------SALAETLAS 219 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH---------------------HHHHHHhcc
Confidence 33333 66666666666531 22233444566666666665542100 012233456
Q ss_pred ccccceEEccccccccccCccccc-----ccccceeeccccccc----CcccccccCcccCCcccccccccccc----CC
Q 042075 522 LKNLEMLNVFENKLRGEIPRTLGS-----CIKLELLQMQGNFLQ----GPIPSSLSSLRGLSVLDLSQNNLSGK----IP 588 (1033)
Q Consensus 522 l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 588 (1033)
+++|+.|++++|.+++.....+.. .+.|++|++++|.++ ..+...+..+++|+.+|+++|+++.. +.
T Consensus 220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~ 299 (319)
T cd00116 220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA 299 (319)
T ss_pred cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHH
Confidence 678888888888887533333322 368888888888886 23445566678888888888888854 44
Q ss_pred cccccc-cccceeecCCCcC
Q 042075 589 EFLVGF-QLLEYLNLSNNDF 607 (1033)
Q Consensus 589 ~~~~~l-~~L~~L~ls~N~l 607 (1033)
..+... +.|+.+++.+|+|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 300 ESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHhhcCCchhhcccCCCCC
Confidence 455555 6788888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-17 Score=193.59 Aligned_cols=156 Identities=27% Similarity=0.443 Sum_probs=117.7
Q ss_pred ccccCCChhhHHHHHHHHHhcccCCCCCCCCCCCCCCCc----ceeeeEecCCC---CCeEEEEEcCCCCCCcccccccC
Q 042075 33 ASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFC----QWHGVTCSRRQ---HQRVTILDLKSLKLAGYISAHVG 105 (1033)
Q Consensus 33 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~~~c----~w~gv~C~~~~---~~~v~~l~l~~~~l~g~~~~~~~ 105 (1033)
.....+.++|.+||++||+++. ++.. .+|+++ +|| .|.||+|+... ..+|+.|+|++++++|.+|+.++
T Consensus 364 ~~~~~t~~~~~~aL~~~k~~~~-~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~ 439 (623)
T PLN03150 364 TAESKTLLEEVSALQTLKSSLG-LPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDIS 439 (623)
T ss_pred ccccccCchHHHHHHHHHHhcC-Cccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHh
Confidence 3445667889999999999994 5432 489753 342 79999996321 12588888888888888888888
Q ss_pred CCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccc-cccce
Q 042075 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSL-SKIEY 184 (1033)
Q Consensus 106 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~ 184 (1033)
.|++|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~ 519 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence 88888888888888888888888888888888888888888888888888888888888888888887777653 35556
Q ss_pred eeeccccc
Q 042075 185 FSVSYNNL 192 (1033)
Q Consensus 185 L~Ls~N~l 192 (1033)
+++++|..
T Consensus 520 l~~~~N~~ 527 (623)
T PLN03150 520 FNFTDNAG 527 (623)
T ss_pred EEecCCcc
Confidence 66666654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=162.06 Aligned_cols=134 Identities=20% Similarity=0.255 Sum_probs=108.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+.||+|++|.||+|.+ .+..|++|+...... ....++.+|++++..+.|+++.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 5799999999999988 466799998653221 11245788999999999998876665532 23467
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++|++|.+++.. . .. ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~----------~---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----------N---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----------c---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 899999999999999842 1 11 7889999999999999999 999999999999999 7889999
Q ss_pred eccccee
Q 042075 869 DFGLATF 875 (1033)
Q Consensus 869 DfG~a~~ 875 (1033)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-16 Score=159.49 Aligned_cols=145 Identities=19% Similarity=0.144 Sum_probs=112.3
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch----------------------hHHHHHHHHHH
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG----------------------AFKSFIAECNT 761 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~ 761 (1033)
+++......|.+.+.||+|+||.||+|... +++.||||+++..... ....+..|+.+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 344444445888999999999999999986 7899999987642210 11236778999
Q ss_pred HHhcCCCC--ceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHH
Q 042075 762 LKNIRHRN--LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYL 839 (1033)
Q Consensus 762 l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L 839 (1033)
+.++.|++ +++.++. ...++||||++|++|.+.... .....++.+++.++.++
T Consensus 87 l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~l 141 (198)
T cd05144 87 LKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKA 141 (198)
T ss_pred HHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHH
Confidence 99997774 4444432 245899999999998775420 23457889999999999
Q ss_pred HhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 840 HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 840 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
|+. ||+||||||+||++++++.++|+|||.+....
T Consensus 142 h~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 142 YKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 998 99999999999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-17 Score=188.73 Aligned_cols=167 Identities=28% Similarity=0.356 Sum_probs=123.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
....+|..++.|..|+||.||.++++.+.+.+|+|+=+. . .|++ ||..+.+ .
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilR-----nilt~a~-----------n 131 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILR-----NILTFAG-----------N 131 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhh-----ccccccC-----------C
Confidence 345689999999999999999999998999999965221 1 0111 2222221 2
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.+.| |+-...++. .+.++. +++.+++|+|+. ||+|||+||+|.+|+.-|++|+
T Consensus 132 pfvv------gDc~tllk~----------~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKl 184 (1205)
T KOG0606|consen 132 PFVV------GDCATLLKN----------IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKL 184 (1205)
T ss_pred ccee------chhhhhccc----------CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccc
Confidence 2333 444455532 122222 237899999999 9999999999999999999999
Q ss_pred eecccceecCCCC-------------ccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 868 GDFGLATFLPLSH-------------AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 868 ~DfG~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
+|||+++..-... .+......+||+.|+|||++..+.|...+|+|++|+|+||.+.|+.||.
T Consensus 185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 9999987542211 1112233469999999999999999999999999999999999999985
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-15 Score=179.10 Aligned_cols=146 Identities=21% Similarity=0.248 Sum_probs=113.5
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEe--eccCc------hhHHHHHHHHHHHHhcCCCCcee
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF--NLLHH------GAFKSFIAECNTLKNIRHRNLVK 772 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~E~~~l~~l~h~niv~ 772 (1033)
.++.........|...+.||+|+||+||+|.+... .+++|+. +.... ...+++.+|++++++++|++++.
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 34444444556667789999999999999998643 3444432 11111 12356889999999999999888
Q ss_pred EeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 773 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
...++. .....++||||+++++|.+++. ....++.|+++++.|||+. +|+|||+
T Consensus 401 p~~~~~-----~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDl 454 (535)
T PRK09605 401 PVIYDV-----DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDL 454 (535)
T ss_pred eEEEEE-----eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCC
Confidence 766642 2335689999999999999883 3467999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeeccccee
Q 042075 853 KPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 853 kp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
||+||++ +++.++|+|||+++.
T Consensus 455 kp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE-ECCcEEEEeCccccc
Confidence 9999999 677999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=157.53 Aligned_cols=130 Identities=21% Similarity=0.253 Sum_probs=102.0
Q ss_pred eecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.||+|++|.||+|.+ ++..|++|+...... ....++.+|+++++.++|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 389999999999996 467899998643211 11356778999999998876544433321 233568
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||++|++|.+++.. ... .++.|++.++.++|+. |++|||++|+||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~----------~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----------GND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhh----------cHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 99999999999998742 100 7899999999999999 999999999999999 78999999
Q ss_pred ccccee
Q 042075 870 FGLATF 875 (1033)
Q Consensus 870 fG~a~~ 875 (1033)
||.+..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.1e-16 Score=184.38 Aligned_cols=257 Identities=23% Similarity=0.232 Sum_probs=192.7
Q ss_pred hCCCCccceecccCceeEEEEEeCC-CCeEEEEEEeeccC--chhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-GKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 785 (1033)
...|.+.+.||+|+|+.|-.+.... ....+|+|.+.... .........|..+-+.+. |+|++++++. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 4567888899999999999888743 34556777665332 233345556888878886 9999999998 5566
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCcEeccCCCCCeEecCCC-
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEM- 863 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivHrDlkp~NIll~~~~- 863 (1033)
...++++||..|+++.+-+.. ......+......+..|+..++.|+| .. ++.|||+||+|.+++..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~ 162 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGS 162 (601)
T ss_pred cccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCC
Confidence 688999999999999888721 12224556667789999999999999 77 999999999999999999
Q ss_pred cEEEeecccceecCC-CCcccccccccc-ccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 864 IAHVGDFGLATFLPL-SHAQTSSIFAKG-SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
..+++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+.....+..+..
T Consensus 163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~ 242 (601)
T KOG0590|consen 163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS 242 (601)
T ss_pred cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee
Confidence 999999999998766 444444445568 9999999998884 4567899999999999999999999866555544444
Q ss_pred HHhhhCC--cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALP--DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
|...... ...+. .......++..+++..+|..|.+.+++...
T Consensus 243 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWN------------------------------SISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ecccccccccCccc------------------------------cCChhhhhcccccccCCchhcccccccccc
Confidence 4332211 00000 112336778888888999999998877543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=141.55 Aligned_cols=135 Identities=22% Similarity=0.266 Sum_probs=111.0
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC--CCceeEeeeeccccccCCCceeEEE
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.+.||+|.++.||++...+ ..+++|..+.... ...+.+|+.+++.++| .++++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 45789999999999999863 6799999865433 4678899999999976 5888888873 3446789999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||++++.+..+ +......++.+++++++++|....++++|+|++|+||++++++.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988666543 4456678899999999999986445799999999999999989999999998
Q ss_pred cee
Q 042075 873 ATF 875 (1033)
Q Consensus 873 a~~ 875 (1033)
++.
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=146.60 Aligned_cols=136 Identities=22% Similarity=0.213 Sum_probs=97.8
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCch--hHHH----------------------HHHHHHHHHhcCCC--C
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG--AFKS----------------------FIAECNTLKNIRHR--N 769 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--n 769 (1033)
.+.||+|+||+||+|.+. +++.||||+++..... .... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 7899999998743211 1111 13556666666433 2
Q ss_pred ceeEeeeeccccccCCCceeEEEEcccCCchhhh-cccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCc
Q 042075 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW-LHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPI 847 (1033)
Q Consensus 770 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i 847 (1033)
+.+.+++ ...++||||++++++... +.. . ... .+...++.+++.++.++|+ . +|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~---------~--~~~-~~~~~~~~~~~~~l~~lh~~~---~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKD---------V--RLL-EDPEELYDQILELMRKLYREA---GL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhh---------h--hhc-ccHHHHHHHHHHHHHHHhhcc---Cc
Confidence 4444432 135899999998654321 110 0 001 5678899999999999999 7 99
Q ss_pred EeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 848 VHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 848 vHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
+||||||+||+++ ++.++++|||.+....
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 9999999999999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.1e-15 Score=175.89 Aligned_cols=113 Identities=35% Similarity=0.539 Sum_probs=96.2
Q ss_pred ccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecC
Q 042075 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLS 603 (1033)
Q Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 603 (1033)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|+.+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCc--ccccccccccccccccccCCcc
Q 042075 604 NNDFEGMVPTE--GVFRNASITSVLGNLKLCGGTH 636 (1033)
Q Consensus 604 ~N~l~g~~p~~--~~~~~~~~~~~~~n~~lcg~~~ 636 (1033)
+|+|+|.+|.. ..+.......+.+|+.+||.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 99999999874 1222334567889999999764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=146.52 Aligned_cols=139 Identities=17% Similarity=0.128 Sum_probs=104.3
Q ss_pred cceec-ccCceeEEEEEeCCCCeEEEEEEeeccC-------------chhHHHHHHHHHHHHhcCCCCc--eeEeeeecc
Q 042075 716 ANLIG-AGSFGSVYKGILDEGKTIVAVKVFNLLH-------------HGAFKSFIAECNTLKNIRHRNL--VKILTACSG 779 (1033)
Q Consensus 716 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~ 779 (1033)
...|| .|+.|+||.+... +..+|||.++... .....++.+|++++.++.|++| ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8999999999885 6778999885311 1223567889999999988774 666665322
Q ss_pred ccccCCCceeEEEEcccC-CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 780 VDYQGNDFKALVFEFMHN-RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
.. ......++||||++| .+|.+++.. ..++.. .+.|++.++.+||+. ||+||||||+|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NIL 174 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-----------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNIL 174 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEE
Confidence 11 111123599999997 699988742 123332 357899999999999 9999999999999
Q ss_pred ecCCCcEEEeeccccee
Q 042075 859 LDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~ 875 (1033)
++.++.++|+|||.+..
T Consensus 175 v~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 175 LDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EcCCCCEEEEECCCccc
Confidence 99988999999998875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.8e-16 Score=167.56 Aligned_cols=176 Identities=33% Similarity=0.463 Sum_probs=110.9
Q ss_pred cEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccc
Q 042075 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNF 461 (1033)
Q Consensus 382 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~ 461 (1033)
...+|+.|++. .+|..+..+..|+.+.|..|.+. .+|..++.+..|+.|||+.|+++ ..|..++.+.|+.|-+++|+
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNk 154 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNK 154 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCc
Confidence 44566666665 55666666666666666666666 56666666767777777777666 66666666666666666666
Q ss_pred cCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCc
Q 042075 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541 (1033)
Q Consensus 462 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (1033)
++ .+|..++.+..|..||.+.|.+. .+|+.++++.++ +.|.+..|++. .+|.+++.|+ |..||+|.|+++ .+|-
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPV 228 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecch
Confidence 66 56666666666666666666666 566666666665 56666666665 4555555443 556666666665 5666
Q ss_pred ccccccccceeecccccccCcccccc
Q 042075 542 TLGSCIKLELLQMQGNFLQGPIPSSL 567 (1033)
Q Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~~ 567 (1033)
.|.+|+.|++|-|.+|.|+ ..|..+
T Consensus 229 ~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred hhhhhhhheeeeeccCCCC-CChHHH
Confidence 6666666666666666665 444444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-15 Score=165.59 Aligned_cols=181 Identities=31% Similarity=0.474 Sum_probs=110.7
Q ss_pred CCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEE
Q 042075 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTII 479 (1033)
Q Consensus 401 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 479 (1033)
.+..-...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..++++. |++|||+.|+++ ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444456677777776 66777777777777777777766 6666666665 666666666666 5555555554 6666
Q ss_pred ecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccc
Q 042075 480 DLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFL 559 (1033)
Q Consensus 480 ~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 559 (1033)
-+++|+++ .+|..+.....+ ..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|++++. -.|..||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCce
Confidence 66666665 566666533333 55666666665 45556666666666666666665 45555553 3455666666666
Q ss_pred cCcccccccCcccCCccccccccccccCCcccc
Q 042075 560 QGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLV 592 (1033)
Q Consensus 560 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 592 (1033)
+ .||-.|.+|+.|++|-|.+|.|. ..|..++
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 5 56666666666666666666665 4454444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-13 Score=138.37 Aligned_cols=162 Identities=23% Similarity=0.380 Sum_probs=124.5
Q ss_pred HHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHH
Q 042075 759 CNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838 (1033)
Q Consensus 759 ~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 838 (1033)
..-+-++.|.|+|+++.|+.+..+.+..+..++.|||..|++.++|++.+ .....+......+|+.||..||.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhh
Confidence 34455667999999999988887777788899999999999999997532 345668888889999999999999
Q ss_pred HHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC--CCCccccccccccccccccccccCCCCCCcccchHHHHH
Q 042075 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP--LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGI 916 (1033)
Q Consensus 839 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 916 (1033)
||+. .|.|+|+++..+-|++..+|-+|+.--.-..... ............+-++|.|||.-.....+.++|||+||+
T Consensus 192 Lhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 9985 8999999999999999999988874211110000 000011111123678999999866667788999999999
Q ss_pred HHHHHHhCCCC
Q 042075 917 LLLELVTRKKP 927 (1033)
Q Consensus 917 vl~elltg~~p 927 (1033)
...||..+..-
T Consensus 271 cAlemailEiq 281 (458)
T KOG1266|consen 271 CALEMAILEIQ 281 (458)
T ss_pred HHHHHHHheec
Confidence 99999988653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=155.77 Aligned_cols=198 Identities=28% Similarity=0.454 Sum_probs=121.7
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCC-CCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCS-NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666542 2233445566666667666666 6666666664 6667777777666 55566666667777777777
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCc
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 270 (1033)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.++.++..+.+++|++... +.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence 666 44544445666666777777766 55555555555667777666543 4556666666666666666666521 21
Q ss_pred cccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc
Q 042075 271 DIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY 319 (1033)
Q Consensus 271 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 319 (1033)
....+.++++|++++|+++.. +. +..+.+++.|++++|.++..++.
T Consensus 250 -~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 -SIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -hhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence 222455677777777777633 33 66777777777777777665553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=147.90 Aligned_cols=142 Identities=20% Similarity=0.229 Sum_probs=100.0
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhH----------------------------------------HHH
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF----------------------------------------KSF 755 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 755 (1033)
.+.||.|++|.||+|+.+ +|+.||||+.+....... -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999987 689999999864311100 024
Q ss_pred HHHHHHHHhcC----CCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHH
Q 042075 756 IAECNTLKNIR----HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831 (1033)
Q Consensus 756 ~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 831 (1033)
.+|+..+.+++ |.+-+.+-.++ .+.....++||||++|++|.++... ..... ...+++.+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~----~~~~~~~vLvmE~i~G~~L~~~~~~---------~~~~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVY----WDRTSERVLTMEWIDGIPLSDIAAL---------DEAGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEe----hhhcCCceEEEEeECCcccccHHHH---------HhcCC---CHHHHHHH
Confidence 45666665552 33333333332 1223356899999999999987632 00111 23456777
Q ss_pred HHH-HHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 832 VAC-ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 832 i~~-~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
++. .+..+|.. |++|+|++|.||+++++++++++|||++..+.
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 766 47888988 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.7e-13 Score=153.80 Aligned_cols=198 Identities=36% Similarity=0.504 Sum_probs=132.5
Q ss_pred EEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccc--eeceeeccccccCCCCCCccCCCCcccEEecCCC
Q 042075 407 RLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL--KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484 (1033)
Q Consensus 407 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 484 (1033)
.+++..|++. .....+..++.++.|++.+|.++ .+|...... .|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 22334444556666666666665 455555554 3666666666666 45556667777777777777
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCccc
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIP 564 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (1033)
+++ .+|........+ ..|++++|+++ .+|.....+..|++|++++|++. .++..+.++.++..|.+++|++. .+|
T Consensus 174 ~l~-~l~~~~~~~~~L-~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNL-NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhh-hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 777 566544444444 67777777777 56666555666777788777544 56667777778888888888877 457
Q ss_pred ccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc
Q 042075 565 SSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 565 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
..++.++.|+.|++++|+++ .++. +..+.+|+.|++++|.++..+|..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 77788888888888888887 4444 777788888888888888776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=146.51 Aligned_cols=198 Identities=26% Similarity=0.287 Sum_probs=156.0
Q ss_pred CCCccceecc--cCceeEEEEEe--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC
Q 042075 712 GFTSANLIGA--GSFGSVYKGIL--DEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 712 ~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 784 (1033)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .....+-.+|+...+++ .|++.++.+.. +++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4667789999 99999999998 7788999999854222 22233445677777777 59999997666 677
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHH----HHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC----ALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
.+..++-+|++ +.++.++.+. ....++......+..+... |+.++|+. +++|-|+||.||+..
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~---------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT---------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc---------ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc
Confidence 77889999988 5788888753 3344677777888888888 99999999 999999999999999
Q ss_pred CC-CcEEEeecccceecCCCCccccc---cccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 861 EE-MIAHVGDFGLATFLPLSHAQTSS---IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 861 ~~-~~~kL~DfG~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
.+ ...+++|||+...+......... ....|...|++||... .-++..+||||+|.++.+..++..++
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 99 88999999999888665532211 1224778899999854 46789999999999999999987764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.9e-11 Score=135.99 Aligned_cols=170 Identities=23% Similarity=0.201 Sum_probs=129.6
Q ss_pred EEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCC
Q 042075 729 KGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 808 (1033)
Q Consensus 729 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 808 (1033)
.|..+.++.+|.|..++.......+...+.++.++.++||+|+++++. ++.++..|+|+|.+. .|..++++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH--
Confidence 466677888999999886655445667788899999999999999998 666778999999884 67777743
Q ss_pred CCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcccccccc
Q 042075 809 REDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888 (1033)
Q Consensus 809 ~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 888 (1033)
++.....-.+.||+.||.|||+.| +++|++|.-+.|+|++.|..||++|..+.....-.. .....
T Consensus 101 -----------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 101 -----------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred -----------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 235556667899999999999765 899999999999999999999999998865432221 00111
Q ss_pred ccccccccccccCCCCCCcccchHHHHHHHHHHHhC
Q 042075 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924 (1033)
Q Consensus 889 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg 924 (1033)
.--..|..|+.+.... -..|.|.|||++||++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1223466666543322 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.9e-11 Score=140.30 Aligned_cols=149 Identities=17% Similarity=0.158 Sum_probs=96.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch----------------------------------hHH---
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG----------------------------------AFK--- 753 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~--- 753 (1033)
..|+. +.||.|++|.||+|+.+++|+.||||+.++.-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999999977999999998743110 011
Q ss_pred ---HHHHHHHHHHhcC----CCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHH
Q 042075 754 ---SFIAECNTLKNIR----HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826 (1033)
Q Consensus 754 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~ 826 (1033)
++.+|+..+.+++ +...+.+-.++ ++.....++||||++|+++.++-.-.. .......+....+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~~la~~~v~ 270 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRA----AGTDMKLLAERGVE 270 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHh----cCCCHHHHHHHHHH
Confidence 2344555555442 33333333332 222345789999999999987531100 00011123333333
Q ss_pred HHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC----cEEEeecccceecCC
Q 042075 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM----IAHVGDFGLATFLPL 878 (1033)
Q Consensus 827 ~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DfG~a~~~~~ 878 (1033)
.++.|+ +.. |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 271 ~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344444 345 999999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=116.29 Aligned_cols=138 Identities=20% Similarity=0.149 Sum_probs=99.5
Q ss_pred cceecccCceeEEEEEeCC------CCeEEEEEEeeccC------------c----------hhHHHH----HHHHHHHH
Q 042075 716 ANLIGAGSFGSVYKGILDE------GKTIVAVKVFNLLH------------H----------GAFKSF----IAECNTLK 763 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 763 (1033)
...||.|--+.||.|...+ .+..+|||+++... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998753 35789999986210 0 011222 38999999
Q ss_pred hcC--CCCceeEeeeeccccccCCCceeEEEEcccCCchhh-hcccCCCCccccccccccCHHHHHHHHHHHHHHHHHH-
Q 042075 764 NIR--HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEE-WLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYL- 839 (1033)
Q Consensus 764 ~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L- 839 (1033)
++. .-++.+.+++ ...++||||+.+..+.. .++ ...++..+...+..+++.+|..+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence 984 3466666654 14689999997643322 121 12244456677889999999999
Q ss_pred HhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 840 HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 840 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
|+. ||||||+++.||+++ ++.+.++|||.|....
T Consensus 142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 777 999999999999997 4679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.8e-12 Score=129.84 Aligned_cols=137 Identities=27% Similarity=0.278 Sum_probs=102.9
Q ss_pred cCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCccccccccc
Q 042075 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKL 549 (1033)
Q Consensus 470 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 549 (1033)
+...+.|++||||+|.|+ .+..++.-.+.. +.|++|+|.|+ .+ ..+..|.+|+.||||+|.++ .+-.+-..+-+.
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccce-eEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 334456777777777776 555555444444 77777777777 33 33778889999999999998 666676778888
Q ss_pred ceeecccccccCcccccccCcccCCccccccccccccC-CcccccccccceeecCCCcCcccCCC
Q 042075 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI-PEFLVGFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 550 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
+.|.|++|.|.. -+.++.|-+|..||+++|+|...- -..++++|-|+.+.|.+|++++.+--
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 999999999873 356788889999999999987422 24678899999999999999976543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-10 Score=117.12 Aligned_cols=131 Identities=18% Similarity=0.116 Sum_probs=95.6
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCc-eeEeeeeccccccCCCceeEEEEc
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
++.++.|.++.||+++.. ++.|++|+...... ....+.+|+.+++.+.+.++ .+++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 467899999999999875 67899999764332 12346789999999865444 4455431 1234799999
Q ss_pred ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 795 MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC--QPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 795 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
++|.++.+.- .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.
T Consensus 73 i~G~~l~~~~------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9998775431 011245678999999999982 12359999999999998 66899999998
Q ss_pred cee
Q 042075 873 ATF 875 (1033)
Q Consensus 873 a~~ 875 (1033)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.5e-11 Score=134.03 Aligned_cols=252 Identities=19% Similarity=0.158 Sum_probs=175.2
Q ss_pred HhhCCCCccceecccCceeEEEEEeC-CCCeEEEEEEeeccCchhHHH--HHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILD-EGKTIVAVKVFNLLHHGAFKS--FIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
....+|..+..||.|.|+.|++...+ .++..|++|...........+ -..|+.+...+ .|.+++..+.. +.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc
Confidence 34557888999999999999998866 678889999876433322222 23566665555 58888887766 44
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE- 862 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~- 862 (1033)
.....|+--||+++++...... ....++...++++..|++.++.++|+. .++|+|+||+||++..+
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG 403 (524)
T ss_pred ccccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence 4556779999999998887662 344567778899999999999999998 99999999999999876
Q ss_pred CcEEEeecccceecCCCCcccccccccccccc-ccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY-IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+..++.|||.++.+....... ...+..| .+|+......+-.+.|+||||..+.|..++...-+.. . . +
T Consensus 404 ~~~~~~~~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~-~---~ 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---V-Q---S 472 (524)
T ss_pred hhhhccccccccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCccc---c-c---c
Confidence 788999999987532221111 1133444 3566666677889999999999999999987642210 0 0 0
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
..+.... .........++..+...+...++..||.+.+.....+-.+
T Consensus 473 ---------~~i~~~~--------------------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ---------LTIRSGD--------------------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---------eeeeccc--------------------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000000 0000111244677778888999999999888776655443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-11 Score=140.94 Aligned_cols=196 Identities=25% Similarity=0.342 Sum_probs=96.9
Q ss_pred CCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccccee
Q 042075 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 106 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 185 (1033)
.+..+..+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 3455555556666665 23334555666666666666665 3333355566666666666666532 234445556666
Q ss_pred eecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCC-ccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccc
Q 042075 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264 (1033)
Q Consensus 186 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l 264 (1033)
++++|.|+ .++ .+..+.+|+.+++++|++....+ . ...+.+|+.+++++|.+... ..+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccc
Confidence 66666665 222 24445666666666666653333 1 34555666666666665521 2222333333445555554
Q ss_pred cCccCcccccccc--ccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 265 QGVIPLDIGFTLQ--NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 265 ~~~~p~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
+..-+.. .+. +|+.+++++|.+. ..+..+..+.++..|++.+|++.
T Consensus 221 ~~~~~l~---~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 221 SKLEGLN---ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred eeccCcc---cchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 4222111 111 1445555555544 22233444444444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-11 Score=131.23 Aligned_cols=226 Identities=20% Similarity=0.189 Sum_probs=146.1
Q ss_pred EEEecCCCcccc----CCccccccccccEEecccCCCCCCCC--ccccCCCCCcEEEcccccccCCCC--CCcccccccc
Q 042075 112 VLDLHNNSFHHE----IPSEFDRLRRLQVLALHNNSIGGEIP--ANISSCSNLIRVRLSSNELVGKIP--SELGSLSKIE 183 (1033)
Q Consensus 112 ~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~ 183 (1033)
.+.+++-++++. +-..=.++.+|+...|.+.... ..+ .....|++++.||||+|-+....| .-...|++|+
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le 175 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE 175 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence 344555444432 2222246788888888888875 444 356678889999999988873222 2345788899
Q ss_pred eeeecccccCCCCCCCC-CCCCCCcEEEcccCcCCCcC-CccccccCCCCcccccccccCCCCcccccCCCceeEEeccC
Q 042075 184 YFSVSYNNLTGSIPPSF-GNLSSISFLFLSRNNLDGSI-PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGI 261 (1033)
Q Consensus 184 ~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~ 261 (1033)
.|+|+.|++........ ..++.|+.|.|+.+.|+... ......+++|+.|+|..|..-+....+...+..|+.|||++
T Consensus 176 ~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~ 255 (505)
T KOG3207|consen 176 NLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN 255 (505)
T ss_pred hcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence 99999998874433222 25677888889888887322 22344578888888888853333334445566788888888
Q ss_pred ccccCccCccccccccccceeeecccccCCC-CCcc-----CcCCCCccccccccccccCc--Ccchhhhccccceeeec
Q 042075 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA-IPPA-----ISNASNLEVFQVNSNKLTGE--VPYLEKLQRLSHFVITR 333 (1033)
Q Consensus 262 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~l~~ 333 (1033)
|++...-.......++.|+.|+++.+.++.. .|+. ....++|++|+++.|++... ...+..+.+|++|.+..
T Consensus 256 N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 256 NNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred CcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 8876333223334577788888888877642 2332 34567788888888887543 33466667777777777
Q ss_pred CcCCC
Q 042075 334 NSLGS 338 (1033)
Q Consensus 334 N~l~~ 338 (1033)
|.+..
T Consensus 336 n~ln~ 340 (505)
T KOG3207|consen 336 NYLNK 340 (505)
T ss_pred ccccc
Confidence 76654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-11 Score=124.07 Aligned_cols=184 Identities=24% Similarity=0.295 Sum_probs=100.8
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCC---CCCc--------------------cccCCCCCcE
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG---EIPA--------------------NISSCSNLIR 160 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~---~~p~--------------------~~~~l~~L~~ 160 (1033)
+.-+.+|..+.+|.+.-.. |-.-...=+.|+++...+..++. .+|. .+..-+.|++
T Consensus 210 l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Lte 288 (490)
T KOG1259|consen 210 LNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQELTE 288 (490)
T ss_pred hHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHhhhhh
Confidence 3445666667666654331 11111222456677666655441 1111 1112234555
Q ss_pred EEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCccccccccc
Q 042075 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240 (1033)
Q Consensus 161 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 240 (1033)
||||+|.|+ .+..++.-+++++.|++|+|.|. .+.. +..|++|+.||||+|.++ .+.++-.+|.+++.|.|++|.|
T Consensus 289 lDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~i 364 (490)
T KOG1259|consen 289 LDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKI 364 (490)
T ss_pred ccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhH
Confidence 666666555 45555555556666666666555 2222 555555666666666555 3444444555555555555555
Q ss_pred CCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCC-CCccCcCCCCccccccccccccCcCcc
Q 042075 241 SGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA-IPPAISNASNLEVFQVNSNKLTGEVPY 319 (1033)
Q Consensus 241 ~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 319 (1033)
... +.+. .+-+|.+||+++|+|... --..+++++-|+.+.|.+|.+.+.+.+
T Consensus 365 E~L--SGL~-------------------------KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 365 ETL--SGLR-------------------------KLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hhh--hhhH-------------------------hhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 411 2222 344556666666666522 234688999999999999999988776
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.4e-11 Score=117.89 Aligned_cols=16 Identities=25% Similarity=0.268 Sum_probs=4.8
Q ss_pred ccCCCCcccccccccC
Q 042075 226 WLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 226 ~l~~L~~L~L~~N~l~ 241 (1033)
.+++|+.|+|.+|+++
T Consensus 111 ~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 111 SLPKLRVLSLEGNPVC 126 (175)
T ss_dssp G-TT--EEE-TT-GGG
T ss_pred cCCCcceeeccCCccc
Confidence 3444444444444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-11 Score=139.06 Aligned_cols=252 Identities=24% Similarity=0.262 Sum_probs=172.7
Q ss_pred cccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcE
Q 042075 129 DRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISF 208 (1033)
Q Consensus 129 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 208 (1033)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 45677788888888887 44455778888899999999888 454447788889999999998885543 566777888
Q ss_pred EEcccCcCCCcCCccccccCCCCcccccccccCCCCc-ccccCCCceeEEeccCccccCccCccccccccccceeeeccc
Q 042075 209 LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP-SSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRN 287 (1033)
Q Consensus 209 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N 287 (1033)
|++++|.|+. ...|..+++|+.+++++|+++..-+ . +..+.+++.++++.|.+...-... .+..+..+++..|
T Consensus 145 L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~---~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLD---LLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchH---HHHHHHHhhcccc
Confidence 9999998872 3346668888889999998885444 2 567788888888888887332222 3455666688888
Q ss_pred ccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccC
Q 042075 288 QLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367 (1033)
Q Consensus 288 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~ 367 (1033)
.++..-+-.......|+.+++++|++......+..+..+..+++..|.+.... .+.....+..+....|.+.
T Consensus 219 ~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~--------~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 219 KISKLEGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE--------GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cceeccCcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc--------cccccchHHHhccCcchhc
Confidence 88743222211111388888899888866566777888888888888876533 2344455555666666655
Q ss_pred CC---CccccccccCcccEEEccCCCCCccCCcc
Q 042075 368 GL---LPACISNFSTTLEVLLLDSNKIFGNIPAA 398 (1033)
Q Consensus 368 ~~---ip~~~~~~~~~L~~L~L~~N~i~~~~p~~ 398 (1033)
.. .......-.+.++...+..|.+....+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 291 LSEAISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred chhhhhccccccccccccccccccCccccccccc
Confidence 21 22221222357788888888887655433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=114.78 Aligned_cols=126 Identities=23% Similarity=0.324 Sum_probs=38.6
Q ss_pred ccccccceeeecccccCCCCCCCCC-CCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCcee
Q 042075 177 GSLSKIEYFSVSYNNLTGSIPPSFG-NLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 255 (1033)
Q Consensus 177 ~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1033)
.+..++++|+|.+|+|+ .+. .++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+|+. ++..+.
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~------ 84 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLD------ 84 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHH------
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchH------
Confidence 34446677777777776 333 344 46677777777777763 32 35566666666666666663 222221
Q ss_pred EEeccCccccCccCccccccccccceeeecccccCCCC-CccCcCCCCccccccccccccCcCcc----hhhhcccccee
Q 042075 256 VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAI-PPAISNASNLEVFQVNSNKLTGEVPY----LEKLQRLSHFV 330 (1033)
Q Consensus 256 ~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~----l~~l~~L~~L~ 330 (1033)
..+++|++|+|++|+|.... -..+..+++|+.|+|.+|+++....+ +..+++|+.||
T Consensus 85 ------------------~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 85 ------------------KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp ------------------HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred ------------------HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 12444555555555554211 23456677788888888888765433 45666666655
Q ss_pred e
Q 042075 331 I 331 (1033)
Q Consensus 331 l 331 (1033)
-
T Consensus 147 ~ 147 (175)
T PF14580_consen 147 G 147 (175)
T ss_dssp T
T ss_pred C
Confidence 3
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.5e-11 Score=128.71 Aligned_cols=213 Identities=19% Similarity=0.141 Sum_probs=114.0
Q ss_pred CCCCCcEEEcccccccCCCC--CCcccccccceeeecccccCCCCC--CCCCCCCCCcEEEcccCcCCCcCCc-cccccC
Q 042075 154 SCSNLIRVRLSSNELVGKIP--SELGSLSKIEYFSVSYNNLTGSIP--PSFGNLSSISFLFLSRNNLDGSIPD-TFGWLK 228 (1033)
Q Consensus 154 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~ 228 (1033)
++++|+...|.+.... ..+ .....+++++.||||.|-+...-| .....|++|+.|+|+.|++.-.... .-..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 5566666666666554 222 244556666666666665553222 1233556666666666665421111 111344
Q ss_pred CCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccc
Q 042075 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV 308 (1033)
Q Consensus 229 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 308 (1033)
+|+.|.|+.|.|+ -.--..+....++|+.|+|..|...+........+..|+.|||
T Consensus 198 ~lK~L~l~~CGls------------------------~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 198 HLKQLVLNSCGLS------------------------WKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred hhheEEeccCCCC------------------------HHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 4555555555444 1111112224566777777776533333344455667777777
Q ss_pred ccccccCcC--cchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEc
Q 042075 309 NSNKLTGEV--PYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLL 386 (1033)
Q Consensus 309 s~N~l~~~~--~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L 386 (1033)
++|++-... +..+.++.|..|.++.+.+.++...+....+..... ++|++|++
T Consensus 254 s~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f-------------------------~kL~~L~i 308 (505)
T KOG3207|consen 254 SNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF-------------------------PKLEYLNI 308 (505)
T ss_pred cCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccc-------------------------ccceeeec
Confidence 777776554 456777777778887777777666555444433333 35555555
Q ss_pred cCCCCCcc-CCccccCCCCCCEEEcccCccc
Q 042075 387 DSNKIFGN-IPAAFGKFVKLLRLEMWNNRLS 416 (1033)
Q Consensus 387 ~~N~i~~~-~p~~~~~l~~L~~L~L~~N~l~ 416 (1033)
+.|+|..- .-..+..+.+|+.|....|.+.
T Consensus 309 ~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 309 SENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccCccccccccchhhccchhhhhhccccccc
Confidence 55555311 1123344556666666677775
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.7e-10 Score=84.38 Aligned_cols=40 Identities=53% Similarity=1.028 Sum_probs=31.5
Q ss_pred hhhHHHHHHHHHhcccCCCCCCCCCCCC--CCCcceeeeEec
Q 042075 40 ETDRLALLEFKSKITHDPLGVFGSWNES--IHFCQWHGVTCS 79 (1033)
Q Consensus 40 ~~~~~aLl~~k~~~~~~~~~~~~~W~~~--~~~c~w~gv~C~ 79 (1033)
++|++||++||+++..+|.+.+++|+.. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999977788899999986 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.8e-09 Score=111.54 Aligned_cols=145 Identities=21% Similarity=0.220 Sum_probs=107.3
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCC--CCceeEeeeeccccccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 793 (1033)
+.|+.|..+.||+++.. +|+.+++|+...... .....+..|+++++.+.+ ..+.+++.++.... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 57899999999999886 357899998764322 134578899999999965 34577777643211 1235689999
Q ss_pred cccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 042075 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC------------------------------ 843 (1033)
Q Consensus 794 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------ 843 (1033)
|++|.++.+.+. ...++..+...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 81 RVDGRVLRDRLL-----------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred EeCCEecCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 999988877652 023566677778888888888887420
Q ss_pred -----------------------CCCcEeccCCCCCeEecC--CCcEEEeeccccee
Q 042075 844 -----------------------QPPIVHCDLKPSNVLLDE--EMIAHVGDFGLATF 875 (1033)
Q Consensus 844 -----------------------~~~ivHrDlkp~NIll~~--~~~~kL~DfG~a~~ 875 (1033)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.3e-09 Score=101.56 Aligned_cols=129 Identities=26% Similarity=0.280 Sum_probs=94.9
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccC--ch------hHHHHHHHHHHHHhcCCC--CceeEeeeeccccccCCC
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HG------AFKSFIAECNTLKNIRHR--NLVKILTACSGVDYQGND 786 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~ 786 (1033)
..+++|+-+.+|.+.+. |..+++|.=.+.. .. ...+-.+|++++.+++-- ++..++++ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 46889999999999885 4457777532111 11 124567899999988533 34444444 233
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
...++|||++|..|.+++.. . ...++..+-.-+.-||.. ||||+|+.++||++..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~----------~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEE----------A-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHh----------c-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence 56799999999999999843 1 245777788888899999 999999999999997664 99
Q ss_pred Eeeccccee
Q 042075 867 VGDFGLATF 875 (1033)
Q Consensus 867 L~DfG~a~~ 875 (1033)
++|||++..
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.9e-08 Score=105.24 Aligned_cols=276 Identities=14% Similarity=0.105 Sum_probs=169.3
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecc--ccccCCCceeE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG--VDYQGNDFKAL 790 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~~~~~l 790 (1033)
...+.||+|+-+.+|-.-.- ...+.|++.........+ .+..|... .||-+-.-+.+=.. .+........+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999965433 224678887544332222 23334444 56643331211000 01122223667
Q ss_pred EEEcccCC-chhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 791 VFEFMHNR-SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 791 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
.|+.+++. ....+....++. .......|.-.++.++.+|.+.+.||.. |.+-+|+.++|+|+++++.+.|+|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 88887664 334444332222 3445678999999999999999999999 999999999999999999999998
Q ss_pred cccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhC-CCCCCccccCC---ccHH-
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTR-KKPTDIMFEGD---MNLH- 939 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg-~~p~~~~~~~~---~~~~- 939 (1033)
-..-..... .......+|...|.+||... +...+...|-|.+|+++++++.| +.||....... ..++
T Consensus 161 sDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 654443322 22223345899999999643 44567889999999999999886 99987542211 1111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMES--PEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~L~~i~ 1017 (1033)
......+.. .. + ...-.....+.....-.++++..+..+|.... +.-|||++..+..|.++.
T Consensus 238 ~Ia~g~f~y------------a~-~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 238 DIAHGRFAY------------AS-D---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hhhcceeee------------ch-h---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 111100000 00 0 00000000111111234567888888998653 568999999999999988
Q ss_pred HHhh
Q 042075 1018 NILL 1021 (1033)
Q Consensus 1018 ~~~~ 1021 (1033)
+.+.
T Consensus 302 ~~L~ 305 (637)
T COG4248 302 QQLK 305 (637)
T ss_pred Hhhh
Confidence 7654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.9e-08 Score=110.66 Aligned_cols=182 Identities=15% Similarity=0.114 Sum_probs=137.6
Q ss_pred CceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcccC-Cchh
Q 042075 723 SFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN-RSLE 801 (1033)
Q Consensus 723 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 801 (1033)
...+.|++....+|..|++|+++............-+++++++.|+|+|++.+++.... .++...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence 34678999999999999999995433333334456688999999999999999876443 344568999999986 5787
Q ss_pred hhcccCCCCc-----cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceec
Q 042075 802 EWLHPITRED-----ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876 (1033)
Q Consensus 802 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~ 876 (1033)
++-....... .....+...++...+.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654322222 2234556788899999999999999999999 9999999999999999989999888877655
Q ss_pred CCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 877 PLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 877 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
..+... | +. --.+-|.=.||.++..+.||..-
T Consensus 444 ~~d~~~--------------~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE--------------P--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc--------------c--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 443311 0 11 12356999999999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3e-10 Score=134.13 Aligned_cols=206 Identities=23% Similarity=0.273 Sum_probs=144.5
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
...+++.+.+-+-+|.++.++.++-..++...+.|+..... ....+....+-.+.-..++|-++..... +..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 35567888889999999999999887777666666543211 1111222222222222234555444322 334
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++|++|+.+++|..-++... ..+..-.......+..+.+|||+. .+.|||++|.|++...++.
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence 557789999999999999986532 233333445666788999999998 7999999999999999999
Q ss_pred EEEeecccceecCCC-------------------------Ccc----ccccccccccccccccccCCCCCCcccchHHHH
Q 042075 865 AHVGDFGLATFLPLS-------------------------HAQ----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYG 915 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 915 (1033)
.++.|||.......- ... .......+|+.|.+||...+......+|.|+.|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 999999843322100 000 112234489999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcc
Q 042075 916 ILLLELVTRKKPTDIM 931 (1033)
Q Consensus 916 ~vl~elltg~~p~~~~ 931 (1033)
++++|.++|.+||...
T Consensus 1023 ~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhhcCCCCCCCc
Confidence 9999999999998643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-08 Score=98.00 Aligned_cols=143 Identities=19% Similarity=0.191 Sum_probs=98.8
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEee-ccC-------chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFN-LLH-------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
....+-+|+-+.|+++.+. |+.++||.-. +.. .-..++..+|++.+.++.--.|....-++ .+..
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----IDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----EecC
Confidence 5678999999999999986 7777787432 111 11235677899999988532222211121 1122
Q ss_pred ceeEEEEcccC-CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC--
Q 042075 787 FKALVFEFMHN-RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-- 863 (1033)
Q Consensus 787 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-- 863 (1033)
.-.++|||++| .++.+++... ............++.+|-+.+.-||.. +|+|+||..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~--------~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILST--------MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHH--------ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc
Confidence 45699999976 4788888541 111122222367888999999999999 999999999999997655
Q ss_pred -cEEEeeccccee
Q 042075 864 -IAHVGDFGLATF 875 (1033)
Q Consensus 864 -~~kL~DfG~a~~ 875 (1033)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 468999999863
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.6e-11 Score=122.28 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=121.5
Q ss_pred eEEEEEcCCCCCCc----ccccccCCCCCCCEEEecCC---CccccCCccc-------cccccccEEecccCCCCCCCCc
Q 042075 85 RVTILDLKSLKLAG----YISAHVGNLSFLKVLDLHNN---SFHHEIPSEF-------DRLRRLQVLALHNNSIGGEIPA 150 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls~n~l~~~~p~ 150 (1033)
.++.|+|++|.+.- .+.+.+.+.++|+.-++|+- ++...+|+.+ -.+++|++||||+|.|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 57788888887753 24455667778888888762 2233455543 3445788888888877643333
Q ss_pred c----ccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCc----CCc
Q 042075 151 N----ISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS----IPD 222 (1033)
Q Consensus 151 ~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 222 (1033)
. +.++..|++|.|.+|.+.-.--..++. -|..|. .|+. .+.-+.|+++..++|++..- +..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHHHH
Confidence 3 356777888888877764111111110 111111 1111 11123355555555554411 112
Q ss_pred cccccCCCCcccccccccCCC----CcccccCCCceeEEeccCccccCccCcc---ccccccccceeeecccccCCCCCc
Q 042075 223 TFGWLKNLVNLTMAQNRLSGT----IPSSIFNISSITVFDAGINQIQGVIPLD---IGFTLQNLQFFSVGRNQLTGAIPP 295 (1033)
Q Consensus 223 ~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~~~~p~~---~~~~l~~L~~L~L~~N~l~~~~p~ 295 (1033)
.|...+.|+.+.+.+|.|... +...+..+++|++|||..|-|+..-... ....+++|+.|+++++.+......
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~ 259 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI 259 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence 333444555555555544311 2233445555555555555554221111 112344566666666665533222
Q ss_pred cC-----cCCCCccccccccccccCcC-----cchhhhccccceeeecCcCC
Q 042075 296 AI-----SNASNLEVFQVNSNKLTGEV-----PYLEKLQRLSHFVITRNSLG 337 (1033)
Q Consensus 296 ~~-----~~l~~L~~L~Ls~N~l~~~~-----~~l~~l~~L~~L~l~~N~l~ 337 (1033)
.+ ...++|++|.+.+|.++... -.+...+.|..|+++.|.++
T Consensus 260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 22 12456666666666665421 12344666777777777664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-08 Score=100.33 Aligned_cols=126 Identities=22% Similarity=0.215 Sum_probs=83.4
Q ss_pred eEEEEEeCCCCeEEEEEEeeccC--------------c------------hhHHHHHHHHHHHHhcCCC--CceeEeeee
Q 042075 726 SVYKGILDEGKTIVAVKVFNLLH--------------H------------GAFKSFIAECNTLKNIRHR--NLVKILTAC 777 (1033)
Q Consensus 726 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~ 777 (1033)
.||.|... ++..||||+.+... . .......+|++.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999986 67899999986210 0 0123567899999999654 567777651
Q ss_pred ccccccCCCceeEEEEccc--CCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCcEeccCCC
Q 042075 778 SGVDYQGNDFKALVFEFMH--NRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYL-HHDCQPPIVHCDLKP 854 (1033)
Q Consensus 778 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHrDlkp 854 (1033)
..++||||++ |..+..+... .++..+...++.+++..+..+ |.. ||+|+|+.+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~------------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~ 135 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV------------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE 135 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC------------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred ---------CCEEEEEecCCCccchhhHHhc------------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence 3579999998 6555544321 111334567788888866664 677 999999999
Q ss_pred CCeEecCCCcEEEeecccceecC
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
.||+++++ .+.++|||.+....
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETT
T ss_pred hhEEeecc-eEEEEecCcceecC
Confidence 99999887 89999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.8e-10 Score=120.33 Aligned_cols=252 Identities=19% Similarity=0.228 Sum_probs=169.5
Q ss_pred ccccCCCCCCCEEEecCCCcccc----CCccccccccccEEecccCCCCC----CCCcc-------ccCCCCCcEEEccc
Q 042075 101 SAHVGNLSFLKVLDLHNNSFHHE----IPSEFDRLRRLQVLALHNNSIGG----EIPAN-------ISSCSNLIRVRLSS 165 (1033)
Q Consensus 101 ~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~-------~~~l~~L~~L~Ls~ 165 (1033)
-+.+.....++.|+||+|.|... +-..+.+.++|+.-++|+- ++| .+|.. +...++|++||||.
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 34566778889999999988643 5556677788888888763 333 34443 33556788888888
Q ss_pred ccccCCCCCC----cccccccceeeecccccCCCCC-CCCCCCCCCcEEEcccCcCCCcCCccccccCCCCccccccccc
Q 042075 166 NELVGKIPSE----LGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240 (1033)
Q Consensus 166 N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 240 (1033)
|.|.-.-+.. +.++..|++|.|.+|.+. ..- ..++ ..|..|. .|+. .+.-++|+.+..++|++
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRL 169 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeecccc
Confidence 8776444433 345667777777777665 111 1111 1233333 2222 23456899999999999
Q ss_pred CCC----CcccccCCCceeEEeccCccccCc---cCccccccccccceeeecccccCCC----CCccCcCCCCccccccc
Q 042075 241 SGT----IPSSIFNISSITVFDAGINQIQGV---IPLDIGFTLQNLQFFSVGRNQLTGA----IPPAISNASNLEVFQVN 309 (1033)
Q Consensus 241 ~~~----~p~~l~~l~~L~~L~ls~N~l~~~---~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls 309 (1033)
... +...+...+.|+.+.++.|.|... .-...+...++|+.|||.+|.++.. +...++.+++|+.|+++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 743 233456778999999999998622 1122345689999999999999833 34567788999999999
Q ss_pred cccccCcCc-----c-hhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccC
Q 042075 310 SNKLTGEVP-----Y-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367 (1033)
Q Consensus 310 ~N~l~~~~~-----~-l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~ 367 (1033)
++.+...-. . -...++|+.+.+..|.|+......+. ......+.|..|+++.|.+.
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la--~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALA--ACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHH--HHHhcchhhHHhcCCccccc
Confidence 999975432 1 23468899999999998864332221 22345778999999999995
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-09 Score=131.52 Aligned_cols=133 Identities=26% Similarity=0.366 Sum_probs=101.1
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCC--CCCCCCccccCCCCCcEEEcccccccCCCCCCcccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS--IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSK 181 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 181 (1033)
..+....+...+-+|.+. .++....+ ++|+.|-+..|. +.-..+..|..++.|++||||+|.=-+.+|..++.|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 334467788888888876 44444433 378888888886 44333445777888999999988766788888888889
Q ss_pred cceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccc
Q 042075 182 IEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNR 239 (1033)
Q Consensus 182 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 239 (1033)
|++|+|++..++ .+|..+++|..|.+|++..+.-...+|.....+.+|++|.+..-.
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 999999888888 888888888888888888887655667777778888888886554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=101.54 Aligned_cols=146 Identities=14% Similarity=0.031 Sum_probs=99.7
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCch-hH----------HHHHHHHHHHHhcCCCC--ceeEeeeecccccc
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AF----------KSFIAECNTLKNIRHRN--LVKILTACSGVDYQ 783 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~ 783 (1033)
+.+-+-....|+++.. +|+.|.||........ .. ..+.+|...+.++...+ +++.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4555555555777766 4778999977432211 01 14778999888884322 33334443211111
Q ss_pred CCCceeEEEEcccCC-chhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-
Q 042075 784 GNDFKALVFEFMHNR-SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE- 861 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~- 861 (1033)
.....++|||++++. +|.+++... .....+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLP 174 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecc
Confidence 123568999999886 899988421 123345667778999999999999999 9999999999999975
Q ss_pred ------CCcEEEeeccccee
Q 042075 862 ------EMIAHVGDFGLATF 875 (1033)
Q Consensus 862 ------~~~~kL~DfG~a~~ 875 (1033)
+..+.++||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.4e-09 Score=84.30 Aligned_cols=58 Identities=38% Similarity=0.549 Sum_probs=25.1
Q ss_pred CcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCc
Q 042075 158 LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215 (1033)
Q Consensus 158 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 215 (1033)
|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443223344444444444444444443334444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.1e-09 Score=84.88 Aligned_cols=61 Identities=41% Similarity=0.536 Sum_probs=47.0
Q ss_pred cccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCccccccccc
Q 042075 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240 (1033)
Q Consensus 180 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 240 (1033)
++|++|++++|+++...+..|.++++|++|++++|+++...|++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888866666777888888888888888777777777788788777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-08 Score=98.96 Aligned_cols=136 Identities=23% Similarity=0.153 Sum_probs=99.0
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc----------------------hhHHHHHHHHHHHHhcCCC-
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH----------------------GAFKSFIAECNTLKNIRHR- 768 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 768 (1033)
=+.+..+||.|--+.||.|.+. .|.++|||.-+.... ......++|.++|+++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999997 688999997541100 1123467899999999544
Q ss_pred -CceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042075 769 -NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPI 847 (1033)
Q Consensus 769 -niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 847 (1033)
.|.+.+++ +..++||||++|-.|...- ++....-.++..|++-+..+-.. ||
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---Gi 223 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GI 223 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Cc
Confidence 67776655 3568999999886655432 12233344555555555555566 99
Q ss_pred EeccCCCCCeEecCCCcEEEeeccccee
Q 042075 848 VHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 848 vHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
||+|+.+-||++++||.+.++||--+..
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCccccc
Confidence 9999999999999999999999976653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-08 Score=124.35 Aligned_cols=127 Identities=30% Similarity=0.382 Sum_probs=99.8
Q ss_pred CCCCEEEecCCC--ccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccccee
Q 042075 108 SFLKVLDLHNNS--FHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 108 ~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 185 (1033)
+.|++|-+..|. +....+..|..++.|++||||+|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|.+|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 369999999996 55333445778999999999998766799999999999999999999998 899999999999999
Q ss_pred eecccccCCCCCCCCCCCCCCcEEEcccCcCC--CcCCccccccCCCCcccc
Q 042075 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD--GSIPDTFGWLKNLVNLTM 235 (1033)
Q Consensus 186 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L 235 (1033)
++.++.-...+|.....|++|++|.+..-... ...-..+..|.+|+.+..
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 99999877677777778999999998876522 222223344444444444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-09 Score=98.86 Aligned_cols=133 Identities=26% Similarity=0.319 Sum_probs=68.7
Q ss_pred eceeeccccccCCCCCCcc---CCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceE
Q 042075 452 LFNLQLSYNFLQGSIPSSL---GQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528 (1033)
Q Consensus 452 L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L 528 (1033)
+..++|+++++. .+++.. .....|+..+|++|.+. .+|+.+....+.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344555555543 233332 23334555677777776 566655544434456666666666 455556666666666
Q ss_pred EccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCc
Q 042075 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 589 (1033)
Q Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 589 (1033)
+++.|.|. ..|..|..|.+|..|+..+|.+. .+|..+-.-......++.++.+.+.-|.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 66666665 45555555555555555555555 4444332222233334444444444433
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.9e-10 Score=124.05 Aligned_cols=129 Identities=31% Similarity=0.359 Sum_probs=95.3
Q ss_pred cccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCc-ccccccccceee
Q 042075 475 TLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQ 553 (1033)
Q Consensus 475 ~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 553 (1033)
.|...+.++|++. .+..++.-+..+ +.|||++|+++.. +.+..++.|+.|||+.|.|. .+|. ...++. |+.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~al-e~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPAL-ESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHh-hhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 4666777777776 444444333333 8888888888743 26778889999999999998 5554 444555 99999
Q ss_pred cccccccCcccccccCcccCCccccccccccccCC-cccccccccceeecCCCcCcccC
Q 042075 554 MQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-EFLVGFQLLEYLNLSNNDFEGMV 611 (1033)
Q Consensus 554 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~ 611 (1033)
+++|.++.. ..+.+|++|+.||||+|-|++.-- ..+..+..|+.|+|.+|++.+.+
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999832 467889999999999999886432 34567788999999999998654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.6e-09 Score=97.88 Aligned_cols=87 Identities=18% Similarity=0.343 Sum_probs=45.5
Q ss_pred ccceEEccccccccccCccccc-ccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeec
Q 042075 524 NLEMLNVFENKLRGEIPRTLGS-CIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNL 602 (1033)
Q Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 602 (1033)
.|+..+|++|.|. ..|+.|.. .+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|+.+..+.+|..|+.
T Consensus 54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 3444555555555 33333332 235555555555555 45555555555555555555555 44555555555555555
Q ss_pred CCCcCcccCCCc
Q 042075 603 SNNDFEGMVPTE 614 (1033)
Q Consensus 603 s~N~l~g~~p~~ 614 (1033)
.+|.+. +||..
T Consensus 131 ~~na~~-eid~d 141 (177)
T KOG4579|consen 131 PENARA-EIDVD 141 (177)
T ss_pred CCCccc-cCcHH
Confidence 555544 34433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=89.37 Aligned_cols=157 Identities=20% Similarity=0.190 Sum_probs=107.9
Q ss_pred CCCCCCHHHHHHhhCCCCcccee---cccCceeEEEEEeCCCCeEEEEEEeeccCchh----------------------
Q 042075 697 SFPNISYQNLYNATDGFTSANLI---GAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA---------------------- 751 (1033)
Q Consensus 697 ~~~~~~~~~l~~~~~~y~~~~~l---g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------------------- 751 (1033)
.+...++..+....++..+.... +.|--+.||+|... ++..||||+++......
T Consensus 31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~ 109 (268)
T COG1718 31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRK 109 (268)
T ss_pred hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHH
Confidence 35566777777777777766654 45666789999874 68899999987321100
Q ss_pred --HHHHHHHHHHHHhc--CCCCceeEeeeeccccccCCCceeEEEEcccCCc-hhhhcccCCCCccccccccccCHHHHH
Q 042075 752 --FKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS-LEEWLHPITREDETEEAPRSLNLLQRL 826 (1033)
Q Consensus 752 --~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~l~~~~~~ 826 (1033)
..-..+|+.-|+++ .+-.+.+.+++. ...+||||+.... -.-.| ....+...+..
T Consensus 110 lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~ 169 (268)
T COG1718 110 LVFAWARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAE 169 (268)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCc-----------ccCCcCchhHH
Confidence 11245678888877 344555555552 4579999995431 11111 12223333677
Q ss_pred HHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 827 ~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
.+..++++.+.-|-..+ ++||+||..=|||+. ++.+.|+|||-|....
T Consensus 170 ~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 170 GLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 78889999999888732 999999999999998 8899999999987654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.8e-09 Score=118.01 Aligned_cols=127 Identities=20% Similarity=0.232 Sum_probs=63.9
Q ss_pred CcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeec
Q 042075 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285 (1033)
Q Consensus 206 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~ 285 (1033)
|...+.+.|++. ....++.-++.|+.|+|++|+++..- .+..++.|++|||+.|.+. .+|.--..+ .+|+.|.++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~g-c~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVG-CKLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhh-hhheeeeec
Confidence 334444444444 33334444444444444444444221 3444444444444444444 333211111 236666666
Q ss_pred ccccCCCCCccCcCCCCccccccccccccCc--CcchhhhccccceeeecCcCCCC
Q 042075 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGE--VPYLEKLQRLSHFVITRNSLGSG 339 (1033)
Q Consensus 286 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~l~~N~l~~~ 339 (1033)
+|.++.. ..+.+|.+|+-||+++|-|.+. ...++.+..|+.|.|.+|.+-..
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 6666522 2355666677777777766653 33466667777777777766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=89.95 Aligned_cols=110 Identities=23% Similarity=0.218 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHhcCC--CCceeEeeeeccccccCCCceeEEEEcccCC-chhhhcccCCCCccccccccccCHHHHHHHH
Q 042075 753 KSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVFEFMHNR-SLEEWLHPITREDETEEAPRSLNLLQRLDIG 829 (1033)
Q Consensus 753 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 829 (1033)
.+..+|...+.++.. =.+++.+++..... ......++|+|++++. +|.+++.. ....+......++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----------~~~~~~~~~~~ll 124 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----------WEQLDPSQRRELL 124 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----------hcccchhhHHHHH
Confidence 467788888877732 23445555533221 1113458999999884 89998842 1125666778899
Q ss_pred HHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC---cEEEeecccceec
Q 042075 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM---IAHVGDFGLATFL 876 (1033)
Q Consensus 830 ~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DfG~a~~~ 876 (1033)
.++++.++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 125 ~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 125 RALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.8e-06 Score=85.68 Aligned_cols=159 Identities=16% Similarity=0.083 Sum_probs=109.6
Q ss_pred HHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc------CchhHHHHHHHHHHHHhcCC--CCceeEe
Q 042075 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL------HHGAFKSFIAECNTLKNIRH--RNLVKIL 774 (1033)
Q Consensus 703 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~l~ 774 (1033)
++.++.....+-..=--|+||.+.|++.... |+.+-+|.-... .+.....|.+|...++++.. -.+.+..
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 4444444433333333567999999998875 446788875411 12345789999999999842 2255554
Q ss_pred eeeccccccCCCceeEEEEcccC-CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 775 TACSGVDYQGNDFKALVFEFMHN-RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
++...........+||+|-+++ -+|.+++.. ....+.+...+..+..++++.+.-||+. |+.|+|+.
T Consensus 88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~--------~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly 155 (216)
T PRK09902 88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQ--------HAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCY 155 (216)
T ss_pred -eeeeeccCCceEEEEEEEeCCCCccHHHHHhc--------CCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 3221111223346799997754 589888843 1223567777889999999999999999 99999999
Q ss_pred CCCeEecCCCc--EEEeeccccee
Q 042075 854 PSNVLLDEEMI--AHVGDFGLATF 875 (1033)
Q Consensus 854 p~NIll~~~~~--~kL~DfG~a~~ 875 (1033)
+.||+++.++. ++++||.-++.
T Consensus 156 ~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 156 VRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HhheeecCCCCeeEEEEEhhccch
Confidence 99999986666 99999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1033 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-39 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-19 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-38 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-19 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 1e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-06 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 9e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 8e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 497 bits (1282), Expect = e-163
Identities = 164/573 (28%), Positives = 258/573 (45%), Gaps = 22/573 (3%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
LD+ S + I +G+ S L+ LD+ N + L++L + +N G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
IP +L + L+ N+ G+IP L G+ + +S N+ G++PP FG+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 206 ISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS-SITVFDAGINQ 263
+ L LS NN G +P DT ++ L L ++ N SG +P S+ N+S S+ D N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 264 IQGVIPLDIG-FTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-YLE 321
G I ++ LQ + N TG IPP +SN S L ++ N L+G +P L
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTL 381
L +L + N L GE L L+ ++ N+ G +P+ +SN T L
Sbjct: 440 SLSKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSN-CTNL 492
Query: 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLG 441
+ L +N++ G IP G+ L L++ NN SG IP +G+ ++L L L N F G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN--NLTGTIPPQLLGLSS 499
IP ++ +++ NF+ G + + N G QL LS+
Sbjct: 553 TIPAAMFKQSG---KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609
Query: 500 LLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFL 559
++ G N ++ L++ N L G IP+ +GS L +L + N +
Sbjct: 610 R-NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 560 QGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
G IP + LRGL++LDLS N L G+IP+ + +L ++LSNN+ G +P G F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 620 ASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKR 652
L N LCG R + H +
Sbjct: 729 FPPAKFLNNPGLCGYPLP-RCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-154
Identities = 171/598 (28%), Positives = 257/598 (42%), Gaps = 56/598 (9%)
Query: 31 VTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILD 90
AS + L+ FK + + W+ + + C + GVTC +VT +D
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDK--NLLPDWSSNKNPCTFDGVTCR---DDKVTSID 56
Query: 91 LKSLKLA---GYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE 147
L S L +S+ + +L+ L+ L L N+ + + F L L L NS+ G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 148 IPA--NISSCSNLIRVRLSSNELVGKIP-SELGSLSKIEYFSVSYNNLTGSIPPSF---G 201
+ ++ SCS L + +SSN L S L+ +E +S N+++G+ +
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 202 NLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGI 261
+ L +S N + G + NL L ++ N S IP + + S++ D
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG 232
Query: 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLE 321
N++ G I T L+ ++ NQ G IPP +L+ + NK TGE+P
Sbjct: 233 NKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIP--- 286
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTL 381
+ L L ++ N+F G +P + S L
Sbjct: 287 ------------DFLSG-------------ACDTLTGLDLSGNHFYGAVPPFFGSCS-LL 320
Query: 382 EVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAIGEL-QNLRELRLQENRF 439
E L L SN G +P K L L++ N SG +P ++ L +L L L N F
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 440 LGNIPPSIGNLKLFNLQ---LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLG 496
G I P++ LQ L N G IP +L L + LS N L+GTIP L
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 497 LSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG 556
LS L L+L N L G IP E+ +K LE L + N L GEIP L +C L + +
Sbjct: 441 LSK-LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 557 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614
N L G IP + L L++L LS N+ SG IP L + L +L+L+ N F G +P
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-25
Identities = 37/125 (29%), Positives = 55/125 (44%), Gaps = 2/125 (1%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
++ S G+ S N + LD+ N IP E + L +L L +N I
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS--FGNL 203
G IP + L + LSSN+L G+IP + +L+ + +S NNL+G IP F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 204 SSISF 208
F
Sbjct: 730 PPAKF 734
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-13
Identities = 32/91 (35%), Positives = 50/91 (54%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
+ LD+ L+GYI +G++ +L +L+L +N IP E LR L +L L +N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPS 174
+ G IP +S+ + L + LS+N L G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 1e-93
Identities = 88/309 (28%), Positives = 132/309 (42%), Gaps = 15/309 (4%)
Query: 344 LNFLCSLTNATRLK-W---FHININNFGGLLPACISNFSTTLEVLLLDSNKIFG--NIPA 397
L L N T L W + G+L + + + L L + IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 398 AFGKFVKLLRLEMWN-NRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNL 455
+ L L + N L G IPPAI +L L L + G IP + +K L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
SYN L G++P S+ L I N ++G IP S L + +SRN+LTG I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
P NL NL +++ N L G+ GS + + + N L + + + L+
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNG 248
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGT 635
LDL N + G +P+ L + L LN+S N+ G +P G + +++ N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 636 HEFRLPTCS 644
LP C+
Sbjct: 309 ----LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 2e-76
Identities = 79/309 (25%), Positives = 138/309 (44%), Gaps = 36/309 (11%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQ--WHGVTCSRRQH-QRVTILDLKSLK 95
N D+ ALL+ K + + SW + C W GV C RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 96 LAG--YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS 153
L I + + NL +L L + N++ G IP I+
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGI-----------------------NNLVGPIPPAIA 98
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR 213
+ L + ++ + G IP L + + SYN L+G++PPS +L ++ +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 214 NNLDGSIPDTFGWLKNLVN-LTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDI 272
N + G+IPD++G L +T+++NRL+G IP + N+ ++ D N ++G +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
Query: 273 GFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVI 331
G + +N Q + +N L + + + NL + +N++ G +P L +L+ L +
Sbjct: 218 G-SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 332 TRNSLGSGE 340
+ N+L GE
Sbjct: 276 SFNNL-CGE 283
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-60
Identities = 80/408 (19%), Positives = 137/408 (33%), Gaps = 116/408 (28%)
Query: 147 EIPANISSCSNL----IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS--IPPSF 200
+I ++ + + L + +G + ++ +S NL IP S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 201 GNLSSISFLFLS-RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDA 259
NL ++FL++ NNL G IP L L L + +SG IP +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ--------- 123
Query: 260 GINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY 319
++ L N L+G +PP+IS+ NL + N+++G
Sbjct: 124 ----------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA--- 164
Query: 320 LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFST 379
+P +FS
Sbjct: 165 --------------------------------------------------IPDSYGSFSK 174
Query: 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF 439
+ + N++ G IP F L +++ N L G G +N +++ L +N
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 440 LGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
++ +G K L L L N + G++P L Q + L +++S NNL G IP
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------- 285
Query: 499 SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSC 546
+ GNL+ ++ NK P L +C
Sbjct: 286 -------------------QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-58
Identities = 80/307 (26%), Positives = 126/307 (41%), Gaps = 36/307 (11%)
Query: 141 NNSIGGEIPANISSCSNLIRVRLSSNELVG--KIPSELGSLSKIEYFSVS-YNNLTGSIP 197
N + G + + + + LS L IPS L +L + + + NNL G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 198 PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVF 257
P+ L+ + +L+++ N+ G+IPD +K LV L + N LSGT+P SI ++ ++
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 258 DAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV 317
N+I G IP G + ++ RN+LTG IPP +N NL ++ N L G+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 318 PYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNF 377
+ + H+ N+ L +
Sbjct: 214 SV-----------------------------LFGSDKNTQKIHLAKNSLAFDLGK-VGL- 242
Query: 378 STTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQEN 437
S L L L +N+I+G +P + L L + N L G I P G LQ N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
Query: 438 RFLGNIP 444
+ L P
Sbjct: 302 KCLCGSP 308
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 2e-91
Identities = 102/623 (16%), Positives = 185/623 (29%), Gaps = 102/623 (16%)
Query: 29 LGVTASTVAGNETDRLALLEFKSKITHDPLGVFG-------SWNESIHFCQWH---GVTC 78
+ + S A D LAL E + G +WN + W GV+
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77
Query: 79 SRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH----EIPSEFDRLRRL 134
+ RVT L L+ +G + +G L+ L+VL L ++ P
Sbjct: 78 NSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 135 QVLALHNNSIGGEIPANIS--SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNL 192
+ S+LI+ ++S+ I K NN+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 193 TGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS 252
T + + L+ + ++ + +N + T N
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDN-- 247
Query: 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK 312
L++L V +P + +++ V N+
Sbjct: 248 -----------------------LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284
Query: 313 LTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGL-LP 371
G D L +++ +I NN +
Sbjct: 285 GIS---------------------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 372 ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRE 431
+ L +L N++ G +PA FG +KL L + N+++ G + +
Sbjct: 324 TSLQKM-KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVEN 381
Query: 432 LRLQENRFLGNIPPSIGNLKLFNLQ---LSYNFLQG-------SIPSSLGQSETLTIIDL 481
L N+ L IP + + SYN + + + + ++ I+L
Sbjct: 382 LSFAHNK-LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 482 SNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-------PIPNEVGNLKNLEMLNVFENK 534
SNN ++ P +L S L + L N LT N L +++ NK
Sbjct: 441 SNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 535 LRGEIPRTL--GSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVL------DLSQNNLSGK 586
L + + L + + N P+ + L D N +
Sbjct: 500 LTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 587 IPEFLVGFQLLEYLNLSNNDFEG 609
PE + L L + +ND
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-77
Identities = 66/501 (13%), Positives = 151/501 (30%), Gaps = 48/501 (9%)
Query: 79 SRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLA 138
R + + S I + +N+ + RL +L+
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFY 212
Query: 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP 198
+ N+ E N + + +L + V +P
Sbjct: 213 MGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 199 SFGNLSSISFLFLSRNNL--------DGSIPDTFGWLKNLVNLTMAQNRL-SGTIPSSIF 249
L + + ++ N D + + + + N L + + +S+
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN 309
+ + + + NQ++G +P G + L ++ NQ+T +E
Sbjct: 328 KMKKLGMLECLYNQLEGKLP-AFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385
Query: 310 SNKLTG--EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFL-CSLTNATRLKWFHININNF 366
NKL + + + +S + N +GS + ++ + L + + +++ N
Sbjct: 386 HNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445
Query: 367 GGLLPACISNFSTTLEVLLLDSNKI-------FGNIPAAFGKFVKLLRLEMWNNRLSGTI 419
S + L + L N + + F L +++ N+L+ +
Sbjct: 446 SKFPKELFST-GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-L 503
Query: 420 PPAI--GELQNLRELRLQENRFLGNIPPSIGNLK-------LFNLQLSYNFLQGSIPSSL 470
L L + L N P N N P +
Sbjct: 504 SDDFRATTLPYLVGIDLSYNS-FSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI 562
Query: 471 GQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNV 530
+LT + + +N++ + ++ + VL++ N + V M +
Sbjct: 563 TLCPSLTQLQIGSNDIR-KVNEKIT---PNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 531 FENKLRGEIPRTLGSCIKLEL 551
F +K + + C L++
Sbjct: 619 FYDK-----TQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-73
Identities = 70/527 (13%), Positives = 155/527 (29%), Gaps = 61/527 (11%)
Query: 88 ILDLKSLKLAGYISAHVGNLSFLKV--LDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+ + F + ++++ I + + +N+I
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+ + + L + + ++ V + E EY + + NL
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKD 250
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL--------SGTIPSSIFNISSITVF 257
++ + + +P L + + +A NR + I +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 258 DAGINQIQGV-IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGE 316
G N ++ + + ++ L NQL G PA + L + N++T
Sbjct: 311 YIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEI 368
Query: 317 VPYL-EKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACIS 375
+++ + N L + + + + + + N G +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKY-----IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 376 NFS------TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSG-------TIPPA 422
+ + L +N+I F L + + N L+
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 423 IGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQ---LSYNFLQGSIPSSLGQSETLTII 479
L + L+ N+ L + L L LSYN P+ S TL
Sbjct: 484 FKNTYLLTSIDLRFNK-LTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541
Query: 480 DLSN------NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
+ N N P + SL L++ N + + ++ N+ +L++ +N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSL-TQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 534 KLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
+ I+ + + + Q +RG LD+ +
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDKTQ--------DIRGCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-64
Identities = 69/479 (14%), Positives = 138/479 (28%), Gaps = 86/479 (17%)
Query: 175 ELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG----SIPDTFGWLKNL 230
L S ++ S+ +G +P + G L+ + L L + P +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 231 VNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT 290
+ T +L + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPRED-----------------------FSDLIKDCINSDPQQ 172
Query: 291 GAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSL 350
+I + SN +T V ++
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITF-VSK-----------------------------AV 202
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEM 410
T+L+ F++ + F E + + + + L +E+
Sbjct: 203 MRLTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 411 WNNRLSGTIPPAIGELQNLRELRLQENRFL--------GNIPPSIGNLK-LFNLQLSYNF 461
+N +P + L ++ + + NR + + + + + YN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 462 LQ-GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG 520
L+ + +SL + + L +++ N L G P L L L+ NQ+T N G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIK-LASLNLAYNQITEIPANFCG 374
Query: 521 NLKNLEMLNVFENKLRGEIPRTL--GSCIKLELLQMQGNFLQG-------PIPSSLSSLR 571
+ +E L+ NKL+ IP S + + N + P+ +
Sbjct: 375 FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 572 GLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLK 630
+S ++LS N +S E L +NL N + N + + L
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN-TYLLT 491
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-17
Identities = 30/172 (17%), Positives = 55/172 (31%), Gaps = 23/172 (13%)
Query: 52 KITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAH-VGNLSFL 110
+T P NE+ +T +DL+ KL L +L
Sbjct: 468 MLTEIPKNSLKDENENFKNTY------------LLTSIDLRFNKLTKLSDDFRATTLPYL 515
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHN------NSIGGEIPANISSCSNLIRVRLS 164
+DL NSF + P++ L+ + N N E P I+ C +L ++++
Sbjct: 516 VGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL 216
SN++ + ++ I + N L +
Sbjct: 575 SNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 3e-88
Identities = 106/519 (20%), Positives = 183/519 (35%), Gaps = 25/519 (4%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
K LDL N H F LQVL L I S S+L + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLK 228
LS ++ NL G+L ++ L ++ N + +P+ F L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 229 NLVNLTMAQNRLSGTIPSSIFNISSITVF----DAGINQIQGVIPLDIGFTLQNLQFFSV 284
NL +L ++ N++ + + + + + D +N + + P F L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG--AFKEIRLHKLTL 207
Query: 285 GRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPYLE----KLQRLSHFVITRNSLGSG 339
N + + I + LEV ++ + E + L+ L + I L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 340 EHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF 399
++ + + T + F + + +++ + L L + K FG P
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLELVNCK-FGQFPTLK 323
Query: 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR--FLGNIPPSIGNL-KLFNLQ 456
K +K L G + +L +L L L N F G S L L
Sbjct: 324 LKSLKRLTF----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 457 LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIP 516
LS+N + + S+ E L +D ++NL + LI L++S
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 517 NEVGNLKNLEMLNVFENKLRGEI-PRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
L +LE+L + N + P L L + L+ P++ +SL L V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614
L++S NN L+ L+ S N E
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 7e-83
Identities = 102/560 (18%), Positives = 189/560 (33%), Gaps = 38/560 (6%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
+LDL ++ +LS L L L N F L LQ L ++
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 147 EIPANISSCSNLIRVRLSSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
I L + ++ N + K+P +L+ +E+ +S N + L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 206 ISF----LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAG 260
+ L LS N ++ P F + L LT+ N S + + ++ + V
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 261 INQIQGVIPLD--IGFTLQNLQFFSVGRNQLT------GAIPPAISNASNLEVFQVNSNK 312
+ + + L+ L+ L ++ +L I + +N+ F + S
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 313 LTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPA 372
+ V H + G L SL T N + L
Sbjct: 294 IER-VKDFSYNFGWQHLELVNCKFG---QFPTLKLKSLKRLTFTSNKGGNAFSEVDL--- 346
Query: 373 CISNFSTTLEVLLLDSNKI--FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLR 430
+LE L L N + G + L L++ N + T+ L+ L
Sbjct: 347 ------PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 431 ELRLQENRFLGNIPPSI-GNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L Q + S+ +L+ L L +S+ + + +L ++ ++ N+
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
P + L L+LS+ QL P +L +L++LN+ N
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 549 LELLQMQGNFLQGPIPSSLSSL-RGLSVLDLSQNNLSGKIP--EFLVGFQLLEYLNLSNN 605
L++L N + L L+ L+L+QN+ + FL + L +
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579
Query: 606 DFEGMVPTEGVFRNASITSV 625
E P++ + + S+
Sbjct: 580 RMECATPSD--KQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-71
Identities = 98/496 (19%), Positives = 165/496 (33%), Gaps = 41/496 (8%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI 206
+IP N+ + + LS N L S +++ +S + ++ +LS +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 207 SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266
S L L+ N + F L +L L + L+ I ++ ++ + N IQ
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 267 VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN----SNKLTGEVPYLEK 322
+ L NL+ + N++ + + + ++ N + P K
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS--TT 380
RL + N + + L + N G L S
Sbjct: 199 EIRLHKLTLRNNFDSLNVMK--TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 381 LEVLLLDSNKI---FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQEN 437
L + + +I F + + + + + L L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNC 314
Query: 438 RF-------------------LGNIPPSIGNL-KLFNLQLSYNFLQ--GSIPSSLGQSET 475
+F G S +L L L LS N L G S + +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENK 534
L +DLS N + T+ LGL L L+ + L V +L+NL L++
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 535 LRGEIPRTLGSCIKLELLQMQGNFLQGPI-PSSLSSLRGLSVLDLSQNNLSGKIPEFLVG 593
R LE+L+M GN Q P + LR L+ LDLSQ L P
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 594 FQLLEYLNLSNNDFEG 609
L+ LN+S+N+F
Sbjct: 493 LSSLQVLNMSHNNFFS 508
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-62
Identities = 96/514 (18%), Positives = 179/514 (34%), Gaps = 39/514 (7%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH-EIPSEFDRLRRLQVLALHNNSIG 145
L LA + +G+L LK L++ +N ++P F L L+ L L +N I
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 146 GEIPANISSCSNL----IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SF 200
++ + + + LS N + P + + ++ N + ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCI 221
Query: 201 GNLSSISFLFLSRNNLDGSI---PDTFGWLKNLVNLTMAQNRLS------GTIPSSIFNI 251
L+ + L L+ L NLT+ + RL+ I +
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
++++ F I+ V F Q+L+ + + + + L
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLE---LVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 312 KLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371
EV L L+ L ++RN L + T LK+ ++ N +
Sbjct: 339 NAFSEVD-LPSLEFLD---LSRNGLSFKGCCSQSDF----GTTSLKYLDLSFNGVITMSS 390
Query: 372 ACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLR 430
+ LE L + + F L+ L++ + L +L
Sbjct: 391 NFLG--LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 431 ELRLQENRFLGNIPPSI-GNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L++ N F N P I L L L LS L+ P++ +L ++++S+NN
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNL-KNLEMLNVFENKLRGEIPRT--LGS 545
L+SL VL+ S N + E+ + +L LN+ +N L
Sbjct: 509 LDTFPYKCLNSL-QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 546 CIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLS 579
L ++ ++ PS +G+ VL L+
Sbjct: 568 IKDQRQLLVEVERMECATPSDK---QGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-12
Identities = 27/128 (21%), Positives = 48/128 (37%), Gaps = 3/128 (2%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
+ +T LDL +L +LS L+VL++ +N+F + L LQVL N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 144 IGGEIPANISSC-SNLIRVRLSSNELVGKIPSE--LGSLSKIEYFSVSYNNLTGSIPPSF 200
I + S+L + L+ N+ + L + V + + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 201 GNLSSISF 208
+ +S
Sbjct: 590 QGMPVLSL 597
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 9e-88
Identities = 113/562 (20%), Positives = 196/562 (34%), Gaps = 30/562 (5%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+T+L+L +L +A+ S L LD+ N+ P +L L+VL L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+ C+NL + L SN + + + +S+N L+ + + L +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKN--LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263
+ L LS N + + N L L ++ N++ P I + Q
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 264 IQGVIPLDIGFTLQN--LQFFSVGRNQLTGAIPPAISN--ASNLEVFQVNSNKLTGEVPY 319
+ + + L N ++ S+ +QL+ +NL + ++ N L
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 320 -LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTN---ATRLKWFHININNFGGLLPACIS 375
L +L +F + N++ L+ L ++ I++ + +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 376 NFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIG----ELQNLRE 431
LE L ++ N I G F + L L + N+ S L
Sbjct: 327 WL-KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 432 LRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIP-SSLGQSETLTIIDLSNNNLTGT 489
L L +N+ + L L L L N + + E + I LS N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 490 IPPQLLGLSSLLIVLELSRNQLTG--PIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCI 547
+ S L L L R L P+ L+NL +L++ N + L
Sbjct: 446 TRNSFALVPS-LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 548 KLELLQMQGNFLQ--------GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEY 599
KLE+L +Q N L G L L L +L+L N E L+
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 600 LNLSNNDFEGMVPTEGVFRNAS 621
++L N+ + VF N
Sbjct: 565 IDLGLNNLNTLPA--SVFNNQV 584
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 5e-83
Identities = 122/563 (21%), Positives = 201/563 (35%), Gaps = 59/563 (10%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
T L L S + + L LDL +N +L LQ L L NN I
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 147 EIPANISSCSN--LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG--- 201
+ +N L ++ LSSN++ P ++ ++ ++ L S+
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 202 NLSSISFLFLSRNNLDGSIPDTFGWLK--NLVNLTMAQNRLSGTIPSSIFNISSITVFDA 259
+SI L LS + L + TF LK NL L ++ N L+ S + + F
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 260 GINQIQGVIPLDIGFTLQNLQFFSVGRN---------QLTGAIPPAISNASNLEVFQVNS 310
N IQ + + L N+++ ++ R+ L + LE +
Sbjct: 280 EYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 311 NKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGL 369
N + G L L + ++ + + F L
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNS--------------------FTSLRTLTNETFVSL 378
Query: 370 LPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQN 428
+ L +L L NKI AF L L++ N + + L+N
Sbjct: 379 -------AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 429 LRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQG--SIPSSLGQSETLTIIDLSNNN 485
+ E+ L N++L S + L L L L+ S PS LTI+DLSNNN
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 486 LTGTIPPQLLGLSSLLIVLELSRNQLT--------GPIPNEVGNLKNLEMLNVFENKLRG 537
+ L GL L +L+L N L G + L +L +LN+ N
Sbjct: 492 IANINDDMLEGLEKLE-ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-FLVGFQL 596
+L+++ + N L S ++ L L+L +N ++ + F F+
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 597 LEYLNLSNNDFEGMVPTEGVFRN 619
L L++ N F+ + F N
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 2e-79
Identities = 90/524 (17%), Positives = 183/524 (34%), Gaps = 68/524 (12%)
Query: 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSN 166
+ + VL+L +N + F R +L L + N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSL------------------------DVGFN 59
Query: 167 ELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGW 226
+ P L ++ ++ +N L+ +F ++++ L L N++ + F
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 227 LKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIG-FTLQNLQFFSVG 285
KNL+ L ++ N LS T + + ++ N+IQ + ++ F +L+ +
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
NQ+ P L +N+ +L +
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT--------------------------E 213
Query: 346 FLCSLTNATRLKWFHININNFGGLLPACISNFS-TTLEVLLLDSNKIFGNIPAAFGKFVK 404
LC T ++ ++ + T L +L L N + +F +
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNI---------PPSIGNLK-LFN 454
L + N + ++ L N+R L L+ + +I S LK L +
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP--QLLGLS-SLLIVLELSRNQL 511
L + N + G + L + LSN+ + + L+ S L +L L++N++
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 512 TGPIPNEVGNLKNLEMLNVFENKLRGEIP-RTLGSCIKLELLQMQGNFLQGPIPSSLSSL 570
+ + L +LE+L++ N++ E+ + + + + N +S + +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 571 RGLSVLDLSQNNLSG--KIPEFLVGFQLLEYLNLSNNDFEGMVP 612
L L L + L P + L L+LSNN+ +
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-46
Identities = 77/423 (18%), Positives = 147/423 (34%), Gaps = 30/423 (7%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN---- 142
T+LDL L + L L+ L N+ H L ++ L L +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 143 -----SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP 197
S+ + L + + N++ G + L ++Y S+S + +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 198 PS--FGNL--SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NIS 252
+ F +L S + L L++N + D F WL +L L + N + + + +
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG--AIPPAISNASNLEVFQVNS 310
+I N+ + + +LQ + R L + P NL + +++
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 311 NKLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLC--SLTNATRLKWFHININNFG 367
N + LE L++L + N+L L + L ++ N F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 368 GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE-L 426
+ + L+++ L N + + F V L L + N ++ G
Sbjct: 550 EIPVEVFKDL-FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608
Query: 427 QNLRELRLQENRFLGNIPPSIGNLKLFNLQ------LSYNFLQGSIPSSLGQSETLTIID 480
+NL EL ++ N F + N LS ++L + P G + + D
Sbjct: 609 RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP--VRLFD 666
Query: 481 LSN 483
S+
Sbjct: 667 TSS 669
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-33
Identities = 51/270 (18%), Positives = 86/270 (31%), Gaps = 13/270 (4%)
Query: 68 IHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIP-S 126
T H + IL+L K++ S L L+VLDL N E+
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 127 EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL--VGKIPSELGSLSKIEY 184
E+ L + + L N + + +L R+ L L V PS L +
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL--------DGSIPDTFGWLKNLVNLTMA 236
+S NN+ L + L L NNL G L +L L +
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 237 QNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPA 296
N ++ + + D G+N + + + +L+ ++ +N +T
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA-SVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 297 ISNA-SNLEVFQVNSNKLTGEVPYLEKLQR 325
A NL + N +
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 26/130 (20%), Positives = 44/130 (33%), Gaps = 5/130 (3%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
+ IL+L+S +L LK++DL N+ + S F+ L+ L L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 144 IGGEIPANIS-SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI----PP 198
I + NL + + N S ++ I + L+ PP
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 199 SFGNLSSISF 208
+ F
Sbjct: 656 HYHGFPVRLF 665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-80
Identities = 108/662 (16%), Positives = 198/662 (29%), Gaps = 103/662 (15%)
Query: 29 LGVTASTVAGNETDRLALLEFKSKI----------THDPLGVFGSWNESIHFCQWHGVTC 78
+ + A D AL + T + +WN + W
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPG 316
Query: 79 -SRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVL 137
+ RVT L L G + +G L+ LKVL +S D +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 138 ALHNNSIGGEIPANISS------CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191
+ I S+L++ ++ N + I + K N
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNI 251
+T I + L+ + ++ + + + + S N+
Sbjct: 437 IT-FISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNL 490
Query: 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG---------AIPPAISNASN 302
+T + +P + L LQ ++ N+ +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 303 LEVFQVNSNKLTG--EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFH 360
+++F + N L L+K+ +L N +
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH---------------------- 587
Query: 361 ININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR-LEMWNNRLSGTI 419
+ FG L L LD N+I IP F F + L +N+L I
Sbjct: 588 --LEAFGTN---------VKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YI 634
Query: 420 PPA--IGELQNLRELRLQENRFLG---NIPPSIGNLKLFNLQ---LSYNFLQGSIPSSLG 471
P + + + N+ NI S+ + K N LSYN +Q
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 472 QSETLTIIDLSNNNLT-------GTIPPQLLGLSSLLIVLELSRNQLTGPIPNE--VGNL 522
++ I LSNN +T L ++L N+LT + ++ L
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL-TTIDLRFNKLTS-LSDDFRATTL 752
Query: 523 KNLEMLNVFENKLRGEIPRTLGSCIKLELLQ------MQGNFLQGPIPSSLSSLRGLSVL 576
L ++V N P + +L+ +GN + P+ +++ L L
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 577 DLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVL---GNLKLCG 633
+ N++ K+ E L L L++++N + T + VL + G
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
Query: 634 GT 635
Sbjct: 869 CD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-61
Identities = 77/556 (13%), Positives = 188/556 (33%), Gaps = 66/556 (11%)
Query: 82 QHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHN 141
+ + + ++ + A YI + + + LD N ++ +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK-EL 308
Query: 142 NSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG 201
+ G + ++ + + + L+ G++P +G L++++ S ++ T S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 202 NLSSISFLFLSRNNLDGSIPDTFG-WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAG 260
+ ++ + F + + L + Q+ ++
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN------------------R 410
Query: 261 INQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYL 320
+++ I D +L++ Q ++ N++T I AI + L++ ++ T + +
Sbjct: 411 NPEMKP-IKKDSRISLKDTQIGNLT-NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 321 EKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTT 380
+ S + + S +N L + LP + +
Sbjct: 468 DWEDANSDYAKQYENEEL----------SWSNLKDLTDVELYNCPNMTQLPDFLYDL-PE 516
Query: 381 LEVLLLDSNKI---------FGNIPAAFGKFVKLLRLEMWNNRLSG-TIPPAIGELQNLR 430
L+ L + N+ + + K+ M N L ++ ++ L
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG 576
Query: 431 ELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQ-SETLTIIDLSNNNLTG 488
L N+ + G KL +L+L YN ++ IP ++ + + S+N L
Sbjct: 577 LLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK- 632
Query: 489 TIPPQLLGLSSL--LIVLELSRNQLTGPIPN-----EVGNLKNLEMLNVFENKLRGEIPR 541
IP + S+ + ++ S N++ N + N + + N+++
Sbjct: 633 YIPN-IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691
Query: 542 TLGSCIKLELLQMQGNFLQ-------GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVG- 593
+ + + + N + P + + L+ +DL N L+ +F
Sbjct: 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATT 751
Query: 594 FQLLEYLNLSNNDFEG 609
L +++S N F
Sbjct: 752 LPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 4e-14
Identities = 21/134 (15%), Positives = 48/134 (35%), Gaps = 10/134 (7%)
Query: 101 SAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLAL------HNNSIGGEIPANISS 154
L +L +D+ N F P++ +L+ + N I + P I++
Sbjct: 746 DFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 155 CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214
C +LI++++ SN++ K+ +L ++ ++ N S L +
Sbjct: 805 CPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
Query: 215 NLDGSIPDTFGWLK 228
++
Sbjct: 862 KTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 28/268 (10%), Positives = 76/268 (28%), Gaps = 19/268 (7%)
Query: 424 GELQNLRELRLQENRFLGNIPPSIG-NLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLS 482
L+ +++ N K ++ ++ +P+ Q T
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTY--- 224
Query: 483 NNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV----GNLKNLEMLNVFENKLRGE 538
+ + + + + ++ +P ++ +K+ + L L G+
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 539 IPRTLGSCIKLELLQMQGNFLQGP------IPSSLSSLRGLSVLDLSQNNLSGKIPEFLV 592
R I + + NF + L + ++ L L+ G++P+ +
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 593 GFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKR 652
L+ L+ + + K H ++ ++
Sbjct: 345 QLTELKVLSFGTHSETV--SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 653 LT---LALKLALAIISGLIGLSLALSFL 677
L + + I +SL + +
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQI 430
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 4e-77
Identities = 103/321 (32%), Positives = 161/321 (50%), Gaps = 40/321 (12%)
Query: 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECN 760
S + L A+D F++ N++G G FG VYKG L +G T+VAVK G F E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQFQTEVE 79
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
+ HRNL+++ C + + LV+ +M N S+ L E E+ L
Sbjct: 80 MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERPESQPPL 128
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP--L 878
+ +R I + A L+YLH C P I+H D+K +N+LLDEE A VGDFGLA +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF---EGD 935
+H T+ +G+IG+IAPEY + S DV+ YG++LLEL+T ++ D+ + D
Sbjct: 189 THVTTA---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 936 MNLHNFAKTALPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVA 994
+ L ++ K L + + +VD L + +D E + + ++ +
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKD------------------EEVEQLIQVALL 287
Query: 995 CSMESPEDRMDMTNVVHQLQS 1015
C+ SP +R M+ VV L+
Sbjct: 288 CTQSSPMERPKMSEVVRMLEG 308
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 3e-73
Identities = 88/516 (17%), Positives = 170/516 (32%), Gaps = 40/516 (7%)
Query: 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSN 166
+ + L+ N + F RL L L L I S L + L++N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 167 ELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGW 226
L+ + L +++ ++ N ++ L+L N++
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 227 LKNLVNLTMAQNRLSGTIPSSIFNISSITV--FDAGINQIQGVIPLDIGFTLQNLQFFSV 284
+ L L N + + ++ T + N I G+ P F Q +
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG--AFDSAVFQSLNF 209
Query: 285 GRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDL 344
G Q I + N++ +Q L
Sbjct: 210 GGTQNLLVIFKGLKNST---------------------IQSLWLGTFEDMDDEDISPAVF 248
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK 404
LC ++ ++ ++ + F + F + L+ L L + + +P+
Sbjct: 249 EGLCEMS----VESINLQKHYFFNISSNTFHCF-SGLQELDLTATHL-SELPSGLVGLST 302
Query: 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP-SIGNL-KLFNLQLSYNFL 462
L +L + N+ + +L L ++ N + + NL L L LS++ +
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362
Query: 463 QGS--IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV- 519
+ S L L ++LS N L +L+L+ +L
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRLKVKDAQSPF 421
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPI---PSSLSSLRGLSVL 576
NL L++LN+ + L + L+ L +QGN +SL +L L +L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 577 DLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVP 612
LS +LS +++ +++LS+N
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-72
Identities = 104/571 (18%), Positives = 183/571 (32%), Gaps = 53/571 (9%)
Query: 63 SWNESIHFCQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLD 114
S + I C + L+ L + L L LD
Sbjct: 4 SDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 115 LHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPS 174
L + F RL L L N + +S L + +
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123
Query: 175 ELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLT 234
L + +E + N+++ P + L N + + L+ NL+
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183
Query: 235 --MAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGF-TLQNLQFFSVGRNQLTG 291
+ N ++ I F+ + + G Q VI + T+Q+L +
Sbjct: 184 LNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242
Query: 292 AIPPAISN--ASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
P ++E + + +
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSN-----------------------------T 273
Query: 350 LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE 409
+ L+ + + L P+ + ST L+ L+L +NK + F L L
Sbjct: 274 FHCFSGLQELDLTATHLSEL-PSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 410 MWNNRLSGTIPP-AIGELQNLRELRLQENR--FLGNIPPSIGNL-KLFNLQLSYNFLQGS 465
+ N + + L+NLREL L + + NL L +L LSYN
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNL 525
+ + L ++DL+ L LL VL LS + L L L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 526 EMLNVFENKLRGEI---PRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNN 582
+ LN+ N +L + +LE+L + L + +SL+ ++ +DLS N
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 583 LSGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613
L+ E L + + YLNL++N ++P+
Sbjct: 512 LTSSSIEALSHLKGI-YLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 6e-68
Identities = 90/510 (17%), Positives = 155/510 (30%), Gaps = 19/510 (3%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
T LDL ++ + L L L N + + L+ L I
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI 206
+ + L + L SN + + K++ N + +L
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 207 SFLFL--SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFN--ISSITVFDAGIN 262
+ L L + N++ I +L + I + N I S+ +
Sbjct: 180 TNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 263 QIQGVIPLDI-GFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLE 321
+ + P G +++ ++ ++ S L+ + + L+ L
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV 298
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTL 381
L L V++ N + S +N L I N L L
Sbjct: 299 GLSTLKKLVLSANKFENLCQI------SASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 382 EVLLLDSNKI--FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF 439
L L + I L L + N A E L L L R
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 440 LGNIPPSI-GNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGL 497
S NL L L LS++ L S L ++L N+ + L
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 498 SSL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQ 555
+L L +L LS L+ + +LK + +++ N+L L + L +
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLA 531
Query: 556 GNFLQGPIPSSLSSLRGLSVLDLSQNNLSG 585
N + +PS L L ++L QN L
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-57
Identities = 87/512 (16%), Positives = 179/512 (34%), Gaps = 36/512 (7%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
L ++ + N L+ L L +N + +L+VL NN+I
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 147 EIPANISSCSNL--IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP--SFGN 202
++SS + + L+ N++ I + + + I
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLK--NLVNLTMAQNRLSGTIPSSIFNISSITVFDAG 260
+ S+ + + P F L ++ ++ + ++ ++ S + D
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 261 INQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-- 318
+ +P + L L+ + N+ + SN +L + N E+
Sbjct: 287 ATHLSE-LPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
Query: 319 ---YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACIS 375
LE L+ L ++ + + + + +L N + L+ +++ N L
Sbjct: 345 CLENLENLRELD---LSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 376 NFSTTLEVLLLDSNKIFGNIP-AAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRL 434
LE+L L ++ + F L L + ++ L + L L+ L L
Sbjct: 398 EC-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 435 QENRFLGNIPPSIGNLK----LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTI 490
Q N F +L+ L L LS+ L + + + +DLS+N LT +
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 491 PPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLE 550
L L + L L+ N ++ +P+ + L +N+ +N L T + LE
Sbjct: 517 IEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLE 570
Query: 551 LLQMQGNFLQGPIP---SSLSSLRGLSVLDLS 579
+ L+ + LRG+ + D++
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-47
Identities = 71/463 (15%), Positives = 143/463 (30%), Gaps = 45/463 (9%)
Query: 82 QHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE--FDRLRRLQVLAL 139
Q L+L +AG I + + + L+ I ++ L +
Sbjct: 177 QQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 140 HNNSIGGEIPANISSCS--NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP 197
+ PA ++ + L + + S ++ ++ +L+ +P
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294
Query: 198 PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITV 256
LS++ L LS N + + +L +L++ N + + N+ ++
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 257 FDAGINQIQGVIPLDIGFT-LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTG 315
D + I+ ++ L +LQ ++ N+ A LE+ + +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 316 EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACIS 375
+ + +L LK +++ +
Sbjct: 415 KDAQ-------------------------SPFQNLHL---LKVLNLSHSLLDISSEQLFD 446
Query: 376 NFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE---MWNNRLSGTIPPAIGELQNLREL 432
L+ L L N L RLE + LS A L+ + +
Sbjct: 447 GLPA-LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505
Query: 433 RLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP 492
L NR + ++ +LK L L+ N + +PS L I+L N L T
Sbjct: 506 DLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-- 563
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L + + +L N L + + + L
Sbjct: 564 ---SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-68
Identities = 88/520 (16%), Positives = 159/520 (30%), Gaps = 26/520 (5%)
Query: 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167
S K +DL N F LQ L L I +L + L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGW 226
+ P L+ +E L G L ++ L ++ N + +P F
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 227 LKNLVNLTMAQNRLSGTIPSSIFNISSITVF----DAGINQIQGVIPLDIGFTLQNLQFF 282
L NLV++ ++ N + + + + D +N I + F L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--FQGIKLHEL 209
Query: 283 SVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTG----EVPYLEKLQRLSHFVITRNSLG 337
++ N + I + N + L V ++ + E+ ++ L I L
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 338 SGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA 397
+ + + + + L + L + ++ P
Sbjct: 270 YTNDFSDDIV-KFHCLANVSAMSLAGVSIKYLEDVP---KHFKWQSLSIIRCQL-KQFP- 323
Query: 398 AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQ- 456
L L + N+ S I L +L L L N + S +L +L+
Sbjct: 324 -TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 457 --LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514
LS+N + ++ E L +D ++ L L+ L++S
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 515 IPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGL 573
L +L L + N + + L L + L+ +L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 574 SVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613
+L++S NNL L L+ S N E
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 7e-68
Identities = 115/573 (20%), Positives = 196/573 (34%), Gaps = 44/573 (7%)
Query: 62 GSWNESIHFCQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVL 113
GS N I C ++ +V +DL L S N S L+ L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 114 DLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIP 173
DL + L L L L N I P + S ++L + +L
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES 121
Query: 174 SELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL-- 230
+G L ++ +V++N + +P F NL+++ + LS N + + +L+
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
Query: 231 --VNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ 288
++L M+ N + I F + N I L L + +
Sbjct: 182 VNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 289 LTGAIPPAISNASNLE--------VFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSG 339
I S +E F++ + L +S + S
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS---- 296
Query: 340 EHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF 399
+ +L + + + I + L+ L L NK +I
Sbjct: 297 ----IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKG--SISFKK 346
Query: 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQ--NLRELRLQENRFLGNIPPSIGNL-KLFNLQ 456
L L++ N LS + + +L +LR L L N + + L +L +L
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG-AIIMSANFMGLEELQHLD 405
Query: 457 LSYNFLQGSIP-SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
++ L+ S+ E L +D+S N LGL+S L L+++ N
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS-LNTLKMAGNSFKDNT 464
Query: 516 PNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLS 574
+ V N NL L++ + +L + +L+LL M N L S + L LS
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 575 VLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
LD S N + + L + NL+NN
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-57
Identities = 93/548 (16%), Positives = 168/548 (30%), Gaps = 57/548 (10%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
LDL ++ L L L L N P F L L+ L +
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 147 EIPANISSCSNLIRVRLSSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
I L ++ ++ N + K+P+ +L+ + + +SYN + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 206 ISF----LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAG 260
L +S N +D F + L LT+ N S I + N++ + V
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 261 INQIQG-----VIPLDIGFTLQNLQF--FSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313
+ + + + I L ++ F + +N+ + +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 314 TGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSL-------------TNATRLKWFH 360
+ + K + I R L DL FL SL L +
Sbjct: 298 K-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLD 356
Query: 361 ININNFGGLLPACISNFSTT-LEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTI 419
++ N S+ T L L L N + A F +L L+ ++ L
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT 415
Query: 420 PP-AIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSS-LGQSETL 476
A L+ L L + + L L L+++ N + + S+ + L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
Query: 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536
T +DLS L I + L +L +S N L + L +L L+ N++
Sbjct: 476 TFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 537 GEIPRTLGSCIKLELLQMQGN-----------------------FLQGPIPSSLSSLRGL 573
L + N ++ ++ +
Sbjct: 535 TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTS 594
Query: 574 SVLDLSQN 581
VLD + +
Sbjct: 595 LVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-55
Identities = 84/494 (17%), Positives = 165/494 (33%), Gaps = 23/494 (4%)
Query: 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS 195
+ + ++P +I S + + LS N L + S++++ +S +
Sbjct: 15 TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 196 IPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 255
++ L +S L L+ N + P +F L +L NL + +L+ I + ++
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 256 VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV----NSN 311
+ N I L NL + N + + + + N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 312 KLTGEVPYLEKLQRLSHFVITRNSLGSGEHRD-LNFLCSLTNATRLKWFHININNFGGLL 370
+ + +L + N S + L L L + + N
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 371 PACISNF-STTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNL 429
P+ + T++ L F + F + + + + + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309
Query: 430 RELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGT 489
+ L + + + LK +L L+ N +GSI +L+ +DLS N L+ +
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLK--SLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFS 365
Query: 490 IP--PQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSC 546
LG +SL L+LS N + L+ L+ L+ + L+ S
Sbjct: 366 GCCSYSDLGTNSLR-HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 547 IKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-EFLVGFQLLEYLNLSNN 605
KL L + + L L+ L ++ N+ L +L+LS
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 606 DFEGMVPTEGVFRN 619
E + + GVF
Sbjct: 484 QLEQI--SWGVFDT 495
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-68
Identities = 95/334 (28%), Positives = 149/334 (44%), Gaps = 43/334 (12%)
Query: 690 NPSSPINSFPN--ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL 747
SS + F + + +L AT+ F LIG G FG VYKG+L +G VA+K
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPE 74
Query: 748 HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI 807
+ F E TL RH +LV ++ C + L++++M N +L+ L+
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY-- 127
Query: 808 TREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867
++ S++ QRL+I I A L YLH I+H D+K N+LLDE + +
Sbjct: 128 ----GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 868 GDFGLATFLPL---SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
DFG++ +H T KG++GYI PEY + ++ DVYS+G++L E++
Sbjct: 181 TDFGISKKGTELDQTHLSTV---VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 925 KKPTDIMF-EGDMNLHNFAKTALPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 982
+ +NL +A + + + IVD L +I
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----------------ADKIRP-- 279
Query: 983 ECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
E L V C S EDR M +V+ +L+
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-62
Identities = 90/347 (25%), Positives = 139/347 (40%), Gaps = 60/347 (17%)
Query: 687 ENQNPSSPINSFPNISYQNLYNATDGF------TSANLIGAGSFGSVYKGILDEGKTIVA 740
EN++ F + S+ L N T+ F N +G G FG VYKG ++ T VA
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 741 VKVFNLLHHGAFKS------FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 794
VK L + F E + +H NLV++L S G+D LV+ +
Sbjct: 59 VKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVY 111
Query: 795 MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854
M N SL + L P L+ R I A +++LH + +H D+K
Sbjct: 112 MPNGSLLDRLS-----CLDGTPP--LSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161
Query: 855 SNVLLDEEMIAHVGDFGLATFLPL---SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDV 911
+N+LLDE A + DFGLA + + G+ Y+APE G E++ D+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSR---IVGTTAYMAPEALRG-EITPKSDI 217
Query: 912 YSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD--HVVDIVDSTLLSDDEDLAVHG 969
YS+G++LLE++T D E L + + + + D +D +
Sbjct: 218 YSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKM----------N 266
Query: 970 NQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
+ AM + C E R D+ V LQ +
Sbjct: 267 DADSTSVE---------AMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-60
Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 39/334 (11%)
Query: 696 NSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSF 755
+S ++ +NLY + + G FG V+K L VAVK+F + +++
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQ-N 65
Query: 756 IAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEE 815
E +L ++H N+++ + A D L+ F SL ++L
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA--------- 115
Query: 816 APRSLNLLQRLDIGIDVACALSYLHHD-------CQPPIVHCDLKPSNVLLDEEMIAHVG 868
++ + I +A L+YLH D +P I H D+K NVLL + A +
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSING------DVYSYGILLLELV 922
DFGLA + + G+ Y+APE L ++ D+Y+ G++L EL
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 923 TRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 982
+R D + M LP + L D +++ VH +R K
Sbjct: 233 SRCTAADGPVDEYM---------LPFEEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKH 282
Query: 983 ECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
+ + C E R+ V ++ +
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-56
Identities = 98/512 (19%), Positives = 177/512 (34%), Gaps = 25/512 (4%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
K LDL N H F LQVL L I S S+L + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL-DGSIPDTFGWLK 228
LS ++ NL G+L ++ L ++ N + +P+ F L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGI----NQIQGVIPLDIGFTLQNLQFFSV 284
NL +L ++ N++ + + + + + + + N + I F L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA-FKEIRLHKLTL 207
Query: 285 GRNQLTGAIPP-AISNASNLEVFQVNSNKLTG----EVPYLEKLQRLSHFVITRNSLGSG 339
N + + I + LEV ++ + E L+ L + I L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 340 EHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF 399
++ + + T + F + + + LE++ +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF------PT 321
Query: 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR--FLGNIPPSIGNL-KLFNLQ 456
K L RL +N+ + +L +L L L N F G S L L
Sbjct: 322 LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 457 LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIP 516
LS+N + ++ S+ E L +D ++NL + LI L++S
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 517 NEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
L +LE+L + N + L L + L+ P++ +SL L V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
L+++ N L L+ + L N +
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-48
Identities = 106/509 (20%), Positives = 184/509 (36%), Gaps = 49/509 (9%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI 206
+IP N+ + + LS N L S +++ +S + ++ +LS +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 207 SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266
S L L+ N + F L +L L + L+ I ++ ++ + N IQ
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 267 VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV------------------ 308
+ L NL+ + N++ + + + +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 309 ---------NSNKLTGEVP-----YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNAT 354
+N + V L L+ + + G+ E D + L L N T
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 355 RLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNR 414
++ F + ++ + N T + L S I ++ LE+ N +
Sbjct: 259 -IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCK 315
Query: 415 LSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQ--GSIPSSLGQ 472
P +L++L+ L N+ GN + L L LS N L G S
Sbjct: 316 FGQ-FPT--LKLKSLKRLTFTSNK-GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVF 531
+ +L +DLS N + T+ LGL L L+ + L V +L+NL L++
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 532 ENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPS-SLSSLRGLSVLDLSQNNLSGKIPEF 590
R LE+L+M GN Q + LR L+ LDLSQ L P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 591 LVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
L+ LN+++N + VP +G+F
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVP-DGIFDR 516
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 77/441 (17%), Positives = 138/441 (31%), Gaps = 44/441 (9%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH-EIPSEFDRLRRLQVLALHNNSIG 145
L LA + +G+L LK L++ +N ++P F L L+ L L +N I
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 146 GEIPANISSCSNL----IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SF 200
++ + + + LS N + I ++ ++ N + ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 201 GNLSSISFL------FLSRNNLDGSIPDTFGWLKNLV--NLTMAQNRLSGTIPSSIF-NI 251
L+ + F + NL+ L NL +A +F +
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
++++ F I+ V F Q+L+ + Q +L+ SN
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSN 335
Query: 312 KLTGEVP--YLEKLQRL--SHFVITRNSLGSGEHRDLNFLCSL--------------TNA 353
K L L+ L S ++ S L L
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGL 395
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
+L+ +N + + L L + F L L+M N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 414 RLSGTIPPAI-GELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSL 470
P I EL+NL L L + + L + P+ L L ++ N L+
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 471 GQSETLTIIDLSNNNLTGTIP 491
+ +L I L N + P
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 8/224 (3%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG--GEIPANISSCSNLIRVRL 163
L LK L +N + L L+ L L N + G + ++L + L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD 222
S N ++ + S L ++E+ ++NL S F +L ++ +L +S + +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 223 TFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQF 281
F L +L L MA N IF + ++T D Q++ + +L +LQ
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQV 498
Query: 282 FSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
++ NQL ++L+ +++N P ++ L R
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-15
Identities = 27/129 (20%), Positives = 47/129 (36%), Gaps = 4/129 (3%)
Query: 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536
N IP L L+LS N L + L++L++ +++
Sbjct: 10 ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 537 GEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQL 596
S L L + GN +Q + S L L L + NL+ + +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 597 LEYLNLSNN 605
L+ LN+++N
Sbjct: 126 LKELNVAHN 134
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-14
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 6/165 (3%)
Query: 91 LKSLKLAG----YISAHVGNLSFLKVLDLHNNSFHHEIP-SEFDRLRRLQVLALHNNSIG 145
LK L L+ +S++ L L+ LD +++ S F LR L L + +
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPSFGNLS 204
+ S+L ++++ N + L + + +S L P +F +LS
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 205 SISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF 249
S+ L ++ N L F L +L + + N + P +
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-53
Identities = 75/342 (21%), Positives = 124/342 (36%), Gaps = 46/342 (13%)
Query: 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECN 760
+ D LIG G +G+VYKG LDE VAVKVF+ + ++FI E N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFAN---RQNFINEKN 57
Query: 761 --TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPR 818
+ + H N+ + + V G LV E+ N SL ++L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------H 106
Query: 819 SLNLLQRLDIGIDVACALSYLHHD------CQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872
+ + + + V L+YLH + +P I H DL NVL+ + + DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 873 ATFL------PLSHAQTSSIFAKGSIGYIAPEY-------GLGSEVSINGDVYSYGILLL 919
+ L ++I G+I Y+APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 920 ELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQR-QARI 978
E+ R TD+ + + + T D + L QR +
Sbjct: 227 EIFMRC--TDLFPGESVPEYQ-----MAFQTEVGNHPT-FEDMQVLVSREKQRPKFPEAW 278
Query: 979 NSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020
+ ++ C + E R+ ++ + I
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-53
Identities = 102/507 (20%), Positives = 186/507 (36%), Gaps = 67/507 (13%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
L+ L + + L ++ L I + + +NL ++ S+
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
N+L P L +L+K+ ++ N + P NL++++ L L N + + D
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI--TDIDPLK 131
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L NL L ++ N +S S++ ++S+ G NQ+ + PL L L+ +
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLA---NLTTLERLDIS 185
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
N+++ ++ +NLE +N+++ + L L L + N L +D+
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL-----KDIG 237
Query: 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKL 405
L SLTN L L L +N+I P KL
Sbjct: 238 TLASLTN----------------------------LTDLDLANNQISNLAP--LSGLTKL 267
Query: 406 LRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGS 465
L++ N++S P + L L L L EN+ L +I P L L L +N +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQ-LEDISPISNLKNLTYLTLYFNNISDI 324
Query: 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNL 525
P + L + NN ++ L L+++ L NQ++ P + NL +
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNI-NWLSAGHNQISDLTP--LANLTRI 377
Query: 526 EMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSG 585
L + + + ++ L P+++S + D++ N S
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS- 434
Query: 586 KIPEFLVGFQLLEYLNLSNNDFEGMVP 612
E F + F G V
Sbjct: 435 YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-47
Identities = 98/486 (20%), Positives = 176/486 (36%), Gaps = 69/486 (14%)
Query: 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP 198
+ I ++ + ++ L + + L ++ +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SID 62
Query: 199 SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFD 258
L++++ + S N L P L LV++ M N+++ P + N++++T
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118
Query: 259 AGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP 318
NQI + PL L NL + N ++ A+S ++L+ N++T P
Sbjct: 119 LFNNQITDIDPLK---NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP 172
Query: 319 YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS 378
L L L I+ N + D++ L LTN
Sbjct: 173 -LANLTTLERLDISSNKV-----SDISVLAKLTN-------------------------- 200
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
LE L+ +N+I P G L L + N+L + L NL +L L N+
Sbjct: 201 --LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 254
Query: 439 FLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
+ N+ P G KL L+L N + P L LT ++L+ N L P + L
Sbjct: 255 -ISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309
Query: 499 SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF 558
+L L L N ++ P V +L L+ L + NK+ +L + + L N
Sbjct: 310 NL-TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364
Query: 559 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFR 618
+ P L++L ++ L L+ + + + N N ++ +
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNY---KANVSIPNTVKNVTGALIAPATISD 419
Query: 619 NASITS 624
S T
Sbjct: 420 GGSYTE 425
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-41
Identities = 86/450 (19%), Positives = 173/450 (38%), Gaps = 55/450 (12%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
VT L L + I V L+ L ++ NN P L +L + ++NN I
Sbjct: 48 VTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
P +++ +NL + L +N++ L +L+ + +S N ++ + L+S
Sbjct: 104 DITP--LANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTS 157
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
+ L N + P L L L ++ N++S S + ++++ A NQI
Sbjct: 158 LQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 212
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
+ PL L NL S+ NQL +++ +NL + +N+++ + L L +
Sbjct: 213 DITPLG---ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTK 266
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC------------ 373
L+ + N + +++ L LT L +N N + P
Sbjct: 267 LTELKLGANQI-----SNISPLAGLTA---LTNLELNENQLEDISPISNLKNLTYLTLYF 318
Query: 374 -----ISNFS--TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGEL 426
IS S T L+ L +NK+ + ++ + L +N++S P + L
Sbjct: 319 NNISDISPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANL 374
Query: 427 QNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNL 486
+ +L L + + N+ + N + P+++ + T D++ N
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLP 433
Query: 487 TGTIPPQLLGLSSLLIVLELSRNQLTGPIP 516
+ ++ S + + +G +
Sbjct: 434 --SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-16
Identities = 35/177 (19%), Positives = 65/177 (36%), Gaps = 13/177 (7%)
Query: 429 LRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L + ++ + I + L + ++ + +T + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-- 58
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
+ L++ L + S NQLT P + NL L + + N++ P L +
Sbjct: 59 KSIDGVEYLNN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
L L + N + P L +L L+ L+LS N +S L G L+ L+ N
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-09
Identities = 25/162 (15%), Positives = 56/162 (34%), Gaps = 9/162 (5%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
T L L ++ V +L+ L+ L +NN S L + L+ +N I
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD 367
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI 206
P +++ + + ++ L+ P + I + P + + S
Sbjct: 368 LTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSY 423
Query: 207 SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSI 248
+ ++ N + ++ + V + SGT+ +
Sbjct: 424 TEPDITWNLPSYTNEVSYTF-SQPVTIGKGTTTFSGTVTQPL 464
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-52
Identities = 87/357 (24%), Positives = 143/357 (40%), Gaps = 56/357 (15%)
Query: 681 LVRKRKENQNPSSPINSFPNISYQNLYNATD------GFTSANLIGAGSFGSVYKGILDE 734
+ + I + N+ +Q + D IGAGSFG+V++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 735 GKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792
+ VAVK+ H F+ E +K +RH N+V + A + Q + ++V
Sbjct: 61 --SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVT 113
Query: 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852
E++ SL LH A L+ +RL + DVA ++YLH+ PPIVH +L
Sbjct: 114 EYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165
Query: 853 KPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVY 912
K N+L+D++ V DFGL+ + + S A G+ ++APE + DVY
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 913 SYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQR 972
S+G++L EL T ++P + +N P VV V +R
Sbjct: 224 SFGVILWELATLQQP----WGN-LN---------PAQVVAAV------------GFKCKR 257
Query: 973 QRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRIVSNM 1029
I +A I C P R ++ L+ + + S++
Sbjct: 258 ---LEIPR--NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 75/303 (24%), Positives = 128/303 (42%), Gaps = 53/303 (17%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG+GSFG+VYKG VAVK+ N+ ++F E L+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ A+V ++ SL LH + + + +DI A +
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGM 133
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YLH I+H DLK +N+ L E+ +GDFGLAT GSI ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 897 PE---YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953
PE + S DVY++GI+L EL+T + P + ++N D ++++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSN---INN------RDQIIEM 237
Query: 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013
V G+ +++ S C M R+ C + ++R ++ ++
Sbjct: 238 V------------GRGSLSPDLSKVRS--NCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
Query: 1014 QSI 1016
+ +
Sbjct: 284 EEL 286
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 8e-50
Identities = 96/520 (18%), Positives = 181/520 (34%), Gaps = 41/520 (7%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
+ D +S S G + +K LDL N + + LQVL L ++ I
Sbjct: 8 GVCDGRSRSFT---SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-N 63
Query: 147 EIPANI-SSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLS 204
I + S +L + LS N L S G LS ++Y ++ N + F NL+
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 205 SISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263
++ L + I F L +L L + L S+ +I I +++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK----------- 312
+ L ++++ + L + + + +
Sbjct: 184 SA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 313 LTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTN--ATRLKWFHININNFGGLL 370
L + Y+ +L + T N LG + + + L ++ HI L
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 371 PACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP---AIGEL 426
S ++ + ++++K+F +P L L++ N + G
Sbjct: 303 STVYSLL-EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 427 QNLRELRLQENRF--LGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
+L+ L L +N + + L L +L +S N +P S E + ++LS+
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419
Query: 484 NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTL 543
+ + + L VL++S N L L L+ L + NKL+ +P
Sbjct: 420 TGIR-VVKTCIP---QTLEVLDVSNNNLDS-FSL---FLPRLQELYISRNKLK-TLPDA- 469
Query: 544 GSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
L ++++ N L+ L L + L N
Sbjct: 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 84/463 (18%), Positives = 170/463 (36%), Gaps = 29/463 (6%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR 213
SC S IPS L + ++ +S+N +T +++ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDI 272
+ ++ D F L +L +L ++ N LS ++ SS F +SS+ + N Q + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 273 GFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTG-EVPYLEKLQRLSHFV 330
L NLQ +G + I + ++L ++ + L + L+ ++ + H
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 331 ITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK 390
+ + + L S+ L+ N+ F + + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRY---LELRDTNLARF----QFSPLPVDEVSSPMKKLAFR 231
Query: 391 IFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450
+F + +KLLR + + + L L + E+ + + + +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCT----LNGLGDFNPSESDVVSEL-GKVETV 286
Query: 451 KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQ 510
+ L + +L + + E + I + N+ + +P L L+LS N
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENL 345
Query: 511 LT---GPIPNEVGNLKNLEMLNVFENKLR--GEIPRTLGSCIKLELLQMQGNFLQGPIPS 565
+ G +L+ L + +N LR + L + L L + N P+P
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404
Query: 566 SLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608
S + L+LS + + + Q LE L++SNN+ +
Sbjct: 405 SCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-14
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 14/168 (8%)
Query: 101 SAHVGNLSFLKVLDLHNNSFHH--EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNL 158
SA G L+ L L N + L+ L L + N+ +P + +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 159 IRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218
+ LSS + + + + +E VS NNL S L + L++SRN L
Sbjct: 413 RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKT 465
Query: 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQ 265
+ L+ + +++N+L ++P IF ++S+ N
Sbjct: 466 LPDASL--FPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 78/307 (25%), Positives = 115/307 (37%), Gaps = 58/307 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G+FG V K VA+K K+FI E L + H N+VK+ AC
Sbjct: 16 VGRGAFGVVCKAKWR--AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
N LV E+ SL LH E + + + ++Y
Sbjct: 72 ------NPV-CLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP 897
LH ++H DLKP N+LL + + DFG A + QT KGS ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAP 172
Query: 898 EYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDST 957
E GS S DV+S+GI+L E++TR+KP F+ + I+
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDE-----------IGGPAFRIMW-- 215
Query: 958 LLSDDEDLAVHGNQRQRQARINSKI--ECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015
AVH R + + + C + P R M +V +
Sbjct: 216 --------AVHNGTR-------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 1016 IKNILLG 1022
+ G
Sbjct: 261 LMRYFPG 267
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-48
Identities = 100/518 (19%), Positives = 189/518 (36%), Gaps = 39/518 (7%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L+ + L L N S F L +LQ+L L + I + NL + L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS--FGNLSSISFLFLSRNNLDG-SIP 221
S+++ P L + + + L+ ++ F NL +++ L LS+N + +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 222 DTFGWLKNLVNLTMAQNRLSGTIPSSIFN---ISSITVFDAGINQIQGVIPLDIGFTLQN 278
+FG L +L ++ + N++ + +++ F N + + +D G +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 279 LQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTG-EVPYLEKLQRLSHFVITRNSLG 337
+ + ++G N +++ SN ++ + L + +++
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 338 SGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA 397
+ L + ++ ++ L L+VL L NKI
Sbjct: 254 DPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADE 308
Query: 398 AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQ 456
AF L L + N L L + + LQ+N + L KL L
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 457 LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-PI 515
L N L +++ ++ I LS N L L ++ ++ LS N+L I
Sbjct: 369 LRDNAL-----TTIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDI 418
Query: 516 PNEVGNLKNLEMLNVFENKLRG-EIPRTLGSCIKLELLQMQGNFLQGPIPSSL-----SS 569
+ + +L++L + +N+ +T LE L + N LQ + L
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 570 LRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
L L VL L+ N L+ P L L+L++N
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-35
Identities = 113/635 (17%), Positives = 210/635 (33%), Gaps = 77/635 (12%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+L+L S I NL L++LDL ++ + P F L L L L+ +
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 146 GEI--PANISSCSNLIRVRLSSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGN 202
+ + L R+ LS N++ + G L+ ++ S N +
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 203 LS--SISFLFLSRNNLDGSIPDTFGWLKNLVNLT------------------MAQNRLSG 242
L ++SF L+ N+L + +G N N +S
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230
Query: 243 TIPSSIFNISSITVFDAGINQIQGVIPLDI--GFTLQNLQFFSVGRNQLTGAIPPAISNA 300
+ S+ I G + I+ + G +++ + +
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289
Query: 301 SNLEVFQVNSNKLTG-EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWF 359
+L+V + NK+ L L ++ N LG + L ++ +
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL------PKVAYI 343
Query: 360 HININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTI 419
+ N+ ++ F L+ L L N + + + + N+L T+
Sbjct: 344 DLQKNHIA-IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TL 396
Query: 420 PPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQ---LSYNFLQG-SIPSSLGQSET 475
P + L ENR L N+ L++ +LQ L+ N S + ++ +
Sbjct: 397 PK---INLTANLIHLSENR-LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 476 LTIIDLSNNNLTG----TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVF 531
L + L N L + + S L VL L+ N L P +L L L++
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512
Query: 532 ENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-EF 590
N+L L + LE+L + N L P P SL VLD++ N +
Sbjct: 513 SNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELST 567
Query: 591 LVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKH 650
+ + + ++ + F S+ S C
Sbjct: 568 FINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFS-------------LSTEGCD-----E 609
Query: 651 KRLTLALKLALAIISGLIGLSLALSFLIICLVRKR 685
+ + +LK +L I+ + ++ L + R
Sbjct: 610 EEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-33
Identities = 76/426 (17%), Positives = 142/426 (33%), Gaps = 67/426 (15%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
+ NLT +P L++ L LS N + +F +L+ L L + TI
Sbjct: 12 RFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
F L NL+ +G +++ P A +L +
Sbjct: 68 AFR------------------------NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103
Query: 308 VNSNKLTGEVP---YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININ 364
+ L+ V Y L+ L+ +++N + S L S LK + N
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS-----LYLHPSFGKLNSLKSIDFSSN 158
Query: 365 NFGGLLPACISNFS-TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI 423
+ + TL L +N ++ + +GK + R
Sbjct: 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN--------------- 203
Query: 424 GELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
L L + N + +I N + S SL + +
Sbjct: 204 ---MVLEILDVSGNGWTVDIT-----------GNFSNAISKSQAFSLILAHHIMGAGFGF 249
Query: 484 NNLTGTIPPQLLGLSSL-LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRT 542
+N+ GL+ + L+LS + LK+L++LN+ NK+
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA 309
Query: 543 LGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNL 602
L++L + N L S+ L ++ +DL +N+++ + + L+ L+L
Sbjct: 310 FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369
Query: 603 SNNDFE 608
+N
Sbjct: 370 RDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-29
Identities = 80/441 (18%), Positives = 146/441 (33%), Gaps = 71/441 (16%)
Query: 82 QHQRVTILDLKSLKLAGYISAHVGNLS------FLKVLDLHNNSFHHEIPSEF------- 128
Q + ++ L + L +S G L++LD+ N + +I F
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 129 -----DRLRRLQVLALHNNSIGGEIPANI---SSCSNLIRVRLSSNELVGKIPSELGSLS 180
+ ++I + N + S++ + LS + +L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 181 KIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240
++ +++YN + +F L ++ L LS N L F L + + + +N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 241 SGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNA 300
+ I F L+ LQ + N LT I
Sbjct: 351 A-IIQDQTFK------------------------FLEKLQTLDLRDNALT-----TIHFI 380
Query: 301 SNLEVFQVNSNKLTGEVPYLEKLQ-RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWF 359
++ ++ NKL L K+ + ++ N L +L+ L L L+
Sbjct: 381 PSIPDIFLSGNKLV----TLPKINLTANLIHLSENRL-----ENLDILYFLLRVPHLQIL 431
Query: 360 HININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI-----PAAFGKFVKLLRLEMWNNR 414
+N N F + + +LE L L N + F L L + +N
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 415 LSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSE 474
L+ P L LR L L NR L + + L L +S N L P
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNR-LTVLSHNDLPANLEILDISRNQLLAPNPDVF---V 547
Query: 475 TLTIIDLSNNNLTGTIPPQLL 495
+L+++D+++N
Sbjct: 548 SLSVLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-23
Identities = 57/290 (19%), Positives = 102/290 (35%), Gaps = 23/290 (7%)
Query: 349 SLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRL 408
S +L+ + + L +L L S+KI+ P AF L L
Sbjct: 43 SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102
Query: 409 EMWNNRLSGTIPP--AIGELQNLRELRLQENRFLG-NIPPSIGNL-KLFNLQLSYNFLQG 464
++ LS + L+ L L L +N+ + PS G L L ++ S N +
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162
Query: 465 SIPSSLG--QSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNL 522
L Q +TL+ L+ N+L + + + L ++G N
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NG 215
Query: 523 KNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV--LDLSQ 580
+++ F N + +L + + ++ P ++ + L SV LDLS
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 581 NNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLK 630
+ + L+ LNL+ N + + F L NL+
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKI--ADEAFYG------LDNLQ 317
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 29/142 (20%), Positives = 44/142 (30%), Gaps = 28/142 (19%)
Query: 478 IIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG 537
I NLT +P L + L LS N + + L+ L++L +
Sbjct: 8 IAFYRFCNLT-QVPQVL----NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLL 597
I + +L L +LDL + + P+ G L
Sbjct: 63 TID-----------------------KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHL 99
Query: 598 EYLNLSNNDFEGMVPTEGVFRN 619
L L V +G FRN
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRN 121
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-48
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 32/217 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+ G ++KG + VKV + + F EC L+ H N++ +L A
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C L+ +M SL LH E ++ Q + +D+A +
Sbjct: 76 CQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMARGM 124
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
++LH +P I L +V++DE+M A + + S + + ++A
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSPGRM---YAPAWVA 176
Query: 897 PE------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
PE + D++S+ +LL ELVTR+ P
Sbjct: 177 PEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-48
Identities = 73/310 (23%), Positives = 118/310 (38%), Gaps = 65/310 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKIL 774
IG G FG VY+ VAVK ++ E ++H N++ +
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C + + LV EF L L + + ++ + +A
Sbjct: 73 GVCL----KEPNL-CLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIAR 116
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH--------VGDFGLATFLPLSHAQTSSI 886
++YLH + PI+H DLK SN+L+ +++ + DFGLA +T+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKM 172
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946
A G+ ++APE S S DV+SYG+LL EL+T + P F G + A
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG---IDGLA---- 221
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
V V + ++ C A++ C P R
Sbjct: 222 ---VAYGV--------------AMNKLALPIPST---CPEPFAKLMEDCWNPDPHSRPSF 261
Query: 1007 TNVVHQLQSI 1016
TN++ QL +I
Sbjct: 262 TNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-47
Identities = 62/315 (19%), Positives = 111/315 (35%), Gaps = 66/315 (20%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 774
LIG G FG VY G VA+++ ++ + K+F E + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
AC A++ R+L + +A L++ + I ++
Sbjct: 96 GACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVK 141
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF---LPLSHAQTSSIFAKGS 891
+ YLH I+H DLK NV D + DFGL + L + G
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 892 IGYIAPE---------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942
+ ++APE S + DV++ G + EL R+ P F+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP----- 247
Query: 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002
+ ++ + + ++I ++ I + C E+
Sbjct: 248 ----AEAII-------------WQMGTGMKPNLSQIG----MGKEISDILLFCWAFEQEE 286
Query: 1003 RMDMTNVVHQLQSIK 1017
R T ++ L+ +
Sbjct: 287 RPTFTKLMDMLEKLP 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-47
Identities = 68/341 (19%), Positives = 124/341 (36%), Gaps = 72/341 (21%)
Query: 690 NPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF----- 744
P + P ++ + IG G FG V+KG L + K++VA+K
Sbjct: 5 GSEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 745 --NLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEE 802
F+ F E + N+ H N+VK+ + +V EF+ L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYH 110
Query: 803 WLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE- 861
L + + +L + +D+A + Y+ + PPIVH DL+ N+ L
Sbjct: 111 RLL---------DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSL 160
Query: 862 ----EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE--YGLGSEVSINGDVYSYG 915
+ A V DFGL+ H+ + G+ ++APE + D YS+
Sbjct: 161 DENAPVCAKVADFGLSQQ--SVHSVSG---LLGNFQWMAPETIGAEEESYTEKADTYSFA 215
Query: 916 ILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ 975
++L ++T + P F+ +++ K + + R
Sbjct: 216 MILYTILTGEGP----FDE----YSYGKIKFINMI----------------REEGLR--- 248
Query: 976 ARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
I +C + + C P+ R + +V +L +
Sbjct: 249 PTIPE--DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-46
Identities = 96/520 (18%), Positives = 177/520 (34%), Gaps = 84/520 (16%)
Query: 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISS---- 154
+I+ + +FL+ H+++ E+P E + ++ + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 155 ---------CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+ L++ L +P L E S N+LT +P +L S
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKS 115
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
+ + L P L L ++ N+L +P + N S + + D N ++
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
+ L +L+F + G NQL P + N L ++N L L+
Sbjct: 167 KLPDL-----PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLES 219
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLL 385
+ V N L +L L +L L + + N LP + LE L
Sbjct: 220 I---VAGNNIL-----EELPELQNLPF---LTTIYADNNLLKT-LPDLPPS----LEALN 263
Query: 386 LDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP 445
+ N + ++P L E + LS P NL L N + ++
Sbjct: 264 VRDNYL-TDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNE-IRSLCD 314
Query: 446 SIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLE 505
+L+ L +S N L +P+ + L + S N+L +P L L
Sbjct: 315 LPPSLE--ELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQ----LH 363
Query: 506 LSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPS 565
+ N L P+ ++++L M + E+P + +L + + N L+ P
Sbjct: 364 VEYNPLRE-FPDIPESVEDLRMNS-----HLAEVPELPQNLKQLHV---ETNPLRE-FPD 413
Query: 566 SLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
S+ L ++ + LE ++
Sbjct: 414 IPESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-38
Identities = 79/476 (16%), Positives = 145/476 (30%), Gaps = 89/476 (18%)
Query: 100 ISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLR-------------RLQVLALHNNSIGG 146
+ N+ + + P R + L L+N +
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP--------- 197
+P +L + S N L ++P SL + + + L+ P
Sbjct: 85 SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140
Query: 198 ------PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNI 251
P N S + + + N+L +PD +L + N+L + N+
Sbjct: 141 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQL--EELPELQNL 194
Query: 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
+T A N ++ + L +L+ G N L P + N L ++N
Sbjct: 195 PFLTAIYADNNSLKKLPDL-----PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNN 247
Query: 312 KLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371
L +P + L + N L + T L + L P
Sbjct: 248 LLK-TLP--DLPPSLEALNVRDNYLTD-------LPELPQSLTFLDVSENIFSGLSELPP 297
Query: 372 ------------ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTI 419
+ + +LE L + +NK+ +PA + L RL N L+ +
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLA-EV 352
Query: 420 PPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTII 479
P QNL++L ++ N L P +++ L N +P L +
Sbjct: 353 PE---LPQNLKQLHVEYNP-LREFPDIPESVE----DLRMNSHLAEVPELPQN---LKQL 401
Query: 480 DLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
+ N L P + L ++ ++ P LE +
Sbjct: 402 HVETNPLR-EFPDIPESVEDL----RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-34
Identities = 78/432 (18%), Positives = 139/432 (32%), Gaps = 80/432 (18%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
L+L+N +P L+ L NS+ E+P S +L+ + L
Sbjct: 73 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL- 126
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229
+P L L VS N L +P N S + + + N+L +PD +
Sbjct: 127 SDLPPLLEYLG------VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPD---LPPS 174
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
L + N+L + N+ +T A N ++ + L +L+ G N L
Sbjct: 175 LEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLKKLPDL-----PLSLESIVAGNNIL 227
Query: 290 TGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
P + N L ++N L +P + L + N L
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLP--DLPPSLEALNVRDNYLTD-------LPEL 275
Query: 350 LTNATRLKWFHININNFGGLLP------------ACISNFSTTLEVLLLDSNKIFGNIPA 397
+ T L + L P + + +LE L + +NK+ +PA
Sbjct: 276 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPA 334
Query: 398 AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL------- 450
+ L RL N L+ +P QNL++L ++ N L P ++
Sbjct: 335 LPPR---LERLIASFNHLA-EVPE---LPQNLKQLHVEYNP-LREFPDIPESVEDLRMNS 386
Query: 451 ----------KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL 500
L L + N L+ P + + +++ + +
Sbjct: 387 HLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVV-DPYEFAHETTDK 441
Query: 501 LIVLELSRNQLT 512
L +
Sbjct: 442 LEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 34/204 (16%)
Query: 419 IPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQ----- 472
I P L+E + L +P N+K +++ + + P G+
Sbjct: 3 INPRNVSNTFLQEPLRHSSN-LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 473 --------SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKN 524
++L+N L+ ++P L SL+ S N LT +P +LK+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV----ASCNSLT-ELPELPQSLKS 115
Query: 525 LEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
L + N L P LE L + N L+ +P L + L ++D+ N+L
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166
Query: 585 GKIPEFLVGFQLLEYLNLSNNDFE 608
K+P+ LE++ NN E
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE 186
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 63/315 (20%), Positives = 118/315 (37%), Gaps = 43/315 (13%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKIL 774
+G G +G V++G VAVK+F+ KS+ E +RH N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQG--ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ + L+ + SL ++L +L+ + L I + +A
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIAS 116
Query: 835 ALSYLHHD-----CQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP--LSHAQTSSIF 887
L++LH + +P I H DLK N+L+ + + D GLA + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 888 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
G+ Y+APE + D++++G++L E+ R I+ +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-------- 228
Query: 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001
P + V D + D + QR L ++A++ C ++P
Sbjct: 229 --YKPPFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 1002 DRMDMTNVVHQLQSI 1016
R+ + L I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 70/317 (22%), Positives = 112/317 (35%), Gaps = 43/317 (13%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G +G V+ G VAVKVF ++ E +RH N++ + A
Sbjct: 43 KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAA 99
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
L+ ++ N SL ++L +L+ L + L
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGL 147
Query: 837 SYLH-----HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+LH +P I H DLK N+L+ + + D GLA S I
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI-SDTNEVDIPPNTR 206
Query: 892 IG---YIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
+G Y+ PE L ++ N D+YS+G++L E+ R I+ E + H+
Sbjct: 207 VGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001
+P D ++ R S ECL M ++ C +P
Sbjct: 266 ----VPSDPS-------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 1002 DRMDMTNVVHQLQSIKN 1018
R+ V L +
Sbjct: 315 SRLTALRVKKTLAKMSE 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 64/320 (20%), Positives = 109/320 (34%), Gaps = 59/320 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
+G G FG K E ++ +K ++F+ E ++ + H N++K +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL- 76
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
Y+ + E++ +L + QR+ D+A ++Y
Sbjct: 77 ---YKDKRL-NFITEYIKGGTLRGIIK---------SMDSQYPWSQRVSFAKDIASGMAY 123
Query: 839 LHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK--------- 889
LH I+H DL N L+ E V DFGLA + Q + +
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 890 ---GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946
G+ ++APE G DV+S+GI+L E++ R +F
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY---LPRTMDFG---- 233
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
L V G + C + I V C PE R
Sbjct: 234 ------------------LNVRGFLDRYCPP-----NCPPSFFPITVRCCDLDPEKRPSF 270
Query: 1007 TNVVHQLQSIKNILLGQRIV 1026
+ H L++++ L G +
Sbjct: 271 VKLEHWLETLRMHLAGHLPL 290
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 63/317 (19%), Positives = 118/317 (37%), Gaps = 45/317 (14%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKIL 774
IG G FG V++G VAVK+F+ +S+ E +RH N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWRG--EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
A + + LV ++ + SL ++L+ ++ + + + + A
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTAS 150
Query: 835 ALSYLHHD-----CQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP--LSHAQTSSIF 887
L++LH + +P I H DLK N+L+ + + D GLA +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 888 AKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940
G+ Y+APE L +++ D+Y+ G++ E+ R I +
Sbjct: 211 RVGTKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED------- 262
Query: 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP 1000
LP + + D + + + + R E L MA+I C +
Sbjct: 263 ---YQLPYYDLVPSDPS-VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
Query: 1001 EDRMDMTNVVHQLQSIK 1017
R+ + L +
Sbjct: 319 AARLTALRIKKTLSQLS 335
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 77/428 (17%), Positives = 148/428 (34%), Gaps = 84/428 (19%)
Query: 134 LQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT 193
LA I P + + IR L + + L I V+ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 194 GSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253
SI L+++ +L L+ N + P L L NL + N++ T S++ N+++
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 254 ITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313
+ + I + PL L + ++G N +SN + L V +K+
Sbjct: 112 LRELYLNEDNISDISPLA---NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 314 TGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC 373
++ L
Sbjct: 168 K-----------------------------------------------DVTPIANL---- 176
Query: 374 ISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELR 433
T L L L+ N+I +I L + N+++ P + + L L+
Sbjct: 177 -----TDLYSLSLNYNQI-EDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 434 LQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP 492
+ N+ + ++ P + NL +L L++ N + +++ L ++++ +N ++
Sbjct: 228 IGNNK-ITDLSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--IS 281
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELL 552
L LS L L L+ NQL +G L NL L + +N + P L S K++
Sbjct: 282 VLNNLSQL-NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338
Query: 553 QMQGNFLQ 560
++
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-42
Identities = 76/383 (19%), Positives = 145/383 (37%), Gaps = 57/383 (14%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
+L+ L S + + L + L + + I I +NL + L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNG 75
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
N++ P L +L K+ + N +T + NL+++ L+L+ +N+ P
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LA 129
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L + +L + N + S + N++ + ++++ V P+ L +L S+
Sbjct: 130 NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIA---NLTDLYSLSLN 185
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
NQ+ P +++ ++L F N++T + + + RL+ I N + DL+
Sbjct: 186 YNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI-----TDLS 237
Query: 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKL 405
L +L+ L L + +N+I +I A KL
Sbjct: 238 PLANLSQ----------------------------LTWLEIGTNQI-SDIN-AVKDLTKL 267
Query: 406 LRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQG 464
L + +N++S + L L L L N+ IG L L L LS N +
Sbjct: 268 KMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 465 SIPSSLGQSETLTIIDLSNNNLT 487
P L + D +N +
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 69/398 (17%), Positives = 145/398 (36%), Gaps = 59/398 (14%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
+ I P +L+ L + ++ + L+++ L +A ++
Sbjct: 7 TLPAPINQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQG 61
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
I ++++ + NQI + PL L L +G N++T A+ N +NL
Sbjct: 62 IEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 308 VNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367
+N + ++ + L L ++ + N S +++
Sbjct: 117 LNEDNISD-ISPLANLTKMYSLNLGANHNLS-----------------------DLSPLS 152
Query: 368 GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQ 427
+ T L L + +K+ ++ L L + N++ + L
Sbjct: 153 NM---------TGLNYLTVTESKV-KDVTP-IANLTDLYSLSLNYNQIED--ISPLASLT 199
Query: 428 NLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNL 486
+L N+ + +I P + N+ L +L++ N + P L LT +++ N +
Sbjct: 200 SLHYFTAYVNQ-ITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 487 TGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSC 546
+ + L+ L +L + NQ++ + NL L L + N+L E +G
Sbjct: 256 SD--INAVKDLTKL-KMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 547 IKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
L L + N + P L+SL + D + +
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 82/377 (21%), Positives = 153/377 (40%), Gaps = 36/377 (9%)
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
L ++ P + +++ + V+ + L+++ V ++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56
Query: 290 TGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
I +NLE +N N++T + L L +L++ I N + D++ L +
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI-----TDISALQN 108
Query: 350 LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE 409
LTN L+ ++N +N + P ++N T + L L +N ++ L L
Sbjct: 109 LTN---LRELYLNEDNISDISP--LANL-TKMYSLNLGANHNLSDLSP-LSNMTGLNYLT 161
Query: 410 MWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPS 468
+ +++ I L +L L L N+ + +I P + +L L N + P
Sbjct: 162 VTESKVKD--VTPIANLTDLYSLSLNYNQ-IEDISP-LASLTSLHYFTAYVNQITDITP- 216
Query: 469 SLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528
+ L + + NN +T P L LS L LE+ NQ++ N V +L L+ML
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSP--LANLSQL-TWLEIGTNQISDI--NAVKDLTKLKML 270
Query: 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP 588
NV N++ L + +L L + N L + L L+ L LSQN+++ P
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 589 EFLVGFQLLEYLNLSNN 605
L ++ + +N
Sbjct: 329 --LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 64/353 (18%), Positives = 140/353 (39%), Gaps = 54/353 (15%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+T L + K+A I + L+ L+ L+L+ N P L +L L + N I
Sbjct: 46 ITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI- 100
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+ + + +NL + L+ + + S L +L+K+ ++ N+ S N++
Sbjct: 101 -TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTG 156
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
+++L ++ + + P L +L +L++ N++ P + +++S+ F A +NQI
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
+ P+ + L +G N++T P ++N S L ++ +N+++ + ++ L +
Sbjct: 213 DITPVA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLTK 266
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLL 385
L + N + I+ L + L L
Sbjct: 267 LKMLNVGSNQISD------------------------ISVLNNL---------SQLNSLF 293
Query: 386 LDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
L++N++ G L L + N ++ P + L +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-34
Identities = 70/340 (20%), Positives = 129/340 (37%), Gaps = 36/340 (10%)
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L NQ+ ++ + + +T V E+L+ ++ V+
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEK 55
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+ + + LTN L++ ++N N + P +SN L L + +NKI
Sbjct: 56 V-----ASIQGIEYLTN---LEYLNLNGNQITDISP--LSNL-VKLTNLYIGTNKI--TD 102
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFN 454
+A L L + + +S + L + L L N L ++ P + N+ L
Sbjct: 103 ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNY 159
Query: 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514
L ++ + ++ P + L + L+ N + P L L+SL NQ+T
Sbjct: 160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL-HYFTAYVNQITDI 214
Query: 515 IPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLS 574
P V N+ L L + NK+ P L + +L L++ N + +++ L L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLK 268
Query: 575 VLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614
+L++ N +S L L L L+NN
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 48/232 (20%), Positives = 96/232 (41%), Gaps = 15/232 (6%)
Query: 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164
NL+ + L+L N S + L L + + + P I++ ++L + L+
Sbjct: 129 ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN 185
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTF 224
N++ S L SL+ + YF+ N +T P N++ ++ L + N + P
Sbjct: 186 YNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239
Query: 225 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSV 284
L L L + N++S +++ +++ + + + G NQI + L+ L L +
Sbjct: 240 ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLN---NLSQLNSLFL 294
Query: 285 GRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSL 336
NQL I +NL ++ N +T + L L ++ +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-18
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164
+L+ L + N P + RL L + NN I P +++ S L + +
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG 251
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTF 224
+N++ + + L+K++ +V N ++ NLS ++ LFL+ N L +
Sbjct: 252 TNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 225 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
G L NL L ++QN ++ P + ++S + D I+
Sbjct: 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 53/328 (16%), Positives = 102/328 (31%), Gaps = 31/328 (9%)
Query: 291 GAIPPAISNASNLEVFQVN-SNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
G+ ++S E S L L + QR + R
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----------AWR 51
Query: 350 LTNATRLKWFHININNFGGLLPACISNF-STTLEVLLLDSNKIFGNIPAAFGKFVKLLRL 408
N+ + + + L L S + P + L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHM 109
Query: 409 EMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIP 467
+ L +P + + L L L N L +P SI +L L L + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLRELSIRACPELTELP 167
Query: 468 SSLGQSET---------LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNE 518
L ++ L + L + ++P + L +L L++ + L+ +
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPA 224
Query: 519 VGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG-NFLQGPIPSSLSSLRGLSVLD 577
+ +L LE L++ P G L+ L ++ + L +P + L L LD
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLD 283
Query: 578 LSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
L ++P + + + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 55/348 (15%), Positives = 104/348 (29%), Gaps = 36/348 (10%)
Query: 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLF 210
+ S + + + L + + + N ++
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 211 LSRNNLDGSIPDTFGWLK--NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268
+ L + D V L + L P F +S + + +
Sbjct: 63 RTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSH 328
P + L+ ++ RN L A+P +I++ + L + + E+P
Sbjct: 120 PDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP---------- 167
Query: 329 FVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDS 388
L S + L+ + L PA I+N L+ L + +
Sbjct: 168 -----EPLAS-----TDASGEHQGLVNLQSLRLEWTGIRSL-PASIANL-QNLKSLKIRN 215
Query: 389 NKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIG 448
+ + + A KL L++ PP G L+ L L++ L +P I
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 449 NLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL 495
L L L L +PS + Q II + +L +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 57/380 (15%), Positives = 114/380 (30%), Gaps = 60/380 (15%)
Query: 194 GSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253
GS + S L+ + D + N + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 254 ITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313
+ ++ L T + L P S+L+ +++ L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 314 TGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPA 372
E+P +++ L + RN L + LPA
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRA-------------------------------LPA 144
Query: 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLREL 432
I++ L L + + +P L NL+ L
Sbjct: 145 SIASL-NRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSL 188
Query: 433 RLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIP 491
RL+ + ++P SI NL+ L +L++ + L ++ ++ L +DL P
Sbjct: 189 RLEWTG-IRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 492 PQLLGLSSLLIVLELS-RNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLE 550
P G + L L L + L +P ++ L LE L++ +P +
Sbjct: 247 PIFGGRAPL-KRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 551 LLQMQGNFLQGPIPSSLSSL 570
++ + + +
Sbjct: 305 IILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 33/170 (19%), Positives = 64/170 (37%), Gaps = 11/170 (6%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEF---------DRLRRLQVLALHNNSIGGEIPANISS 154
+ +L+ L+ L + E+P L LQ L L I +PA+I++
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 155 CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214
NL +++ ++ L + + L K+E + + PP FG + + L L
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 215 NLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264
+ ++P L L L + +PS I + + + +
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 21/142 (14%), Positives = 46/142 (32%), Gaps = 2/142 (1%)
Query: 100 ISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLI 159
S L L+ L L +P+ L+ L+ L + N+ + + I L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 160 RVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS 219
+ L + P G + ++ + + ++P L+ + L L
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 220 IPDTFGWLKNLVNLTMAQNRLS 241
+P L + + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 4/125 (3%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163
+ NL LK L + N+ + L +L+ L L + P + L R+ L
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN---NLDGSI 220
+ +P ++ L+++E + +P L + + + + LD
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
Query: 221 PDTFG 225
P
Sbjct: 321 PVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 22/147 (14%), Positives = 39/147 (26%), Gaps = 10/147 (6%)
Query: 464 GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLK 523
GS S + + L + +R N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYN-ADRNRWHS----AWRQANSN 56
Query: 524 NLEMLNVFENKLRGEIPRTLGSC--IKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581
N ++ L+ L L+++ L P L L + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAA 114
Query: 582 NLSGKIPEFLVGFQLLEYLNLSNNDFE 608
L ++P+ + F LE L L+ N
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-39
Identities = 97/497 (19%), Positives = 185/497 (37%), Gaps = 38/497 (7%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V S+ V TIL++ ++ ++ + +LS L++L + +N + S
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 128 FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL-VGKIPSELGSLSKIEYFS 186
F + L+ L L +N + +I + NL + LS N I E G++S++++
Sbjct: 65 FKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPS 246
+S +L S +L+ L + L++ ++ +
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFH 179
Query: 247 SIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVF 306
I ++S TV + ++ I+ V+ + ++ +L+ L
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS---------NLTLNNI 230
Query: 307 QVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNF 366
+ N + L + +F I+ L F S T+ L + + F
Sbjct: 231 ETTWNSFI-RILQLVWHTTVWYFSISNVKLQGQLDFRD-FDYSGTSLKALSIHQVVSDVF 288
Query: 367 GGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGEL 426
G + I + + + + K L L+ NN L+ T+ G L
Sbjct: 289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 427 QNLRELRLQENRFLGNIPPSIGNL----KLFNLQLSYNFLQGSIPSSLGQS-ETLTIIDL 481
L L LQ N+ L + L L +S N + ++L +++
Sbjct: 348 TELETLILQMNQ-LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 482 SNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541
S+N LT TI L + VL+L N++ IP +V L+ L+ LNV N+L+ +P
Sbjct: 407 SSNILTDTIFRCLP---PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPD 461
Query: 542 -TLGSCIKLELLQMQGN 557
L+ + + N
Sbjct: 462 GIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 81/476 (17%), Positives = 158/476 (33%), Gaps = 55/476 (11%)
Query: 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220
V S N L+ +P +L K ++S N ++ +LS + L +S N +
Sbjct: 5 VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT-LQNL 279
F + + L L ++ N+L I ++ D N +P+ F + L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 280 QFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSG 339
+F + L + I++ + +V V + E + L F +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK----EDPEGLQDFNTESLHIVFP 173
Query: 340 EHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF 399
+++ +F+ ++ T NI L + F +I A
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCV-----------------LEDNKCSYFLSILAKL 216
Query: 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSY 459
KL L + N + I +L ++ + N++L
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWH---------------TTVWYFSISNVKLQG 261
Query: 460 NFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV 519
S + L+I + ++ S++ I + +
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI-KNFTVSGTRMVHMLCP 320
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ--GPIPSSLSSLRGLSVLD 577
+ L+ N L + G +LE L +Q N L+ I + ++ L LD
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 578 LSQNNL-SGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLC 632
+SQN++ + + L LN+S+N T+ +FR + + L L
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL-----TDTIFR--CLPPRIKVLDLH 429
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 62/377 (16%), Positives = 135/377 (35%), Gaps = 38/377 (10%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
L L + L + +L+ KVL + ++ + + + L+ +LH
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTN 175
Query: 147 EIPANISSCSNLIRVRLSSNELVG-----------KIPSELGSLSKIEYFSVSYNNLTGS 195
+ I S L + + I ++L + K+ +++ T +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 196 IPPSFGNL---SSISFLFLSRNNLDG-----SIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
L +++ + +S L G + LK L + + S
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSY 294
Query: 248 IFNI-SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVF 306
I+ I S++ + + ++ + ++ + + N LT + + + LE
Sbjct: 295 IYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 307 QVNSNKLT---GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHINI 363
+ N+L +++ L I++NS+ E + + L +++
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG-----DCSWTKSLLSLNMSS 408
Query: 364 NNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-A 422
N + C ++VL L SNKI +IP K L L + +N+L ++P
Sbjct: 409 NILTDTIFRC---LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 423 IGELQNLRELRLQENRF 439
L +L+++ L N +
Sbjct: 464 FDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 49/341 (14%), Positives = 106/341 (31%), Gaps = 14/341 (4%)
Query: 21 SLHLVPEFLGVTASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSR 80
L++ L + + + + L +S P + + + S
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 81 RQHQRVTILDLKSLKLAGYISAHVGNLSF-LKVLDLHNNSFHHEIPSEFDRLRRLQVLAL 139
+ L + + + + L ++ NSF + + ++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSI 254
Query: 140 HNNSIGGEIPANISSCSN-----LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG 194
N + G++ S L ++ S+ S + + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 195 SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP--SSIF-NI 251
+S L S N L ++ + G L L L + N+L + + + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373
Query: 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
S+ D N + ++L ++ N LT I + ++V ++SN
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431
Query: 312 KLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTN 352
K+ + KL+ L + N L S + L SL
Sbjct: 432 KIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQK 472
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 26/114 (22%), Positives = 51/114 (44%), Gaps = 6/114 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164
+ L+ LD+ NS ++ + L L + +N + I + + + L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLH 429
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
SN++ IP ++ L ++ +V+ N L S+P F L+S+ ++L N D
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-38
Identities = 75/506 (14%), Positives = 154/506 (30%), Gaps = 55/506 (10%)
Query: 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164
N + K+ + ++S + S ++ L L N + A+++ + L + LS
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTF 224
SN L +L SLS + ++ N + SI L + NN+ +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--C 116
Query: 225 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSV 284
+ N+ +A N+++ S + D +N+I V ++ + L+ ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 285 GRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDL 344
N + + + + L+ ++SNKL P + ++ + N L
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL------ 228
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI-FGNIPAAFGKFV 403
+ + LE L N G + F K
Sbjct: 229 -------------------------IEKALRFS-QNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 404 KLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFL 462
++ + + E P L L + +
Sbjct: 263 RVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 463 QGS----IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNE 518
QGS + ID T+ Q+ I LE + L + N
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 519 VGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGN-FLQGPIPSSLSSLRGLSVLD 577
L+ + + + E+ L+LL+ + + + + D
Sbjct: 380 RRAHAELD-GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWD 438
Query: 578 LSQNNLSGKIPEFLVGFQLLEYLNLS 603
+ Q+ + E +L +L+
Sbjct: 439 MYQHKETQLAEENARLKKLNGEADLA 464
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 65/460 (14%), Positives = 140/460 (30%), Gaps = 31/460 (6%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
R I + L +++ + +K LDL N ++ +L++L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203
+ E + S S L + L++N + EL IE + NN++ + S
Sbjct: 70 L-YETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 204 SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGIN 262
++L+ N + G + L + N + + + + ++ + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 263 QIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEK 322
I + L+ + N+L + P +A+ + + +NKL L
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLE 382
Q L HF + N G RD + R++ L T
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVKK---LTGQNEEECTVPT 287
Query: 383 VLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSG----TIPPAIGELQNLRELRLQENR 438
+ + + + L R E G + RE+ + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 439 FLGNIPPSIGNLK--LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLG 496
+ + K L+ L + + L +
Sbjct: 348 -YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEE 405
Query: 497 LSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536
S L ++ + + + + + +++++K
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 54/424 (12%), Positives = 121/424 (28%), Gaps = 53/424 (12%)
Query: 195 SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
+I N + ++ ++L ++ N+ L ++ N LS + + + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314
+ + N + + L+ +L L+ + N + + ++E +N ++
Sbjct: 61 ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 315 GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACI 374
V + Q + + N + + + G
Sbjct: 113 -RVS-CSRGQGKKNIYLANNKITM----------------------LRDLDEGCR----- 143
Query: 375 SNFSTTLEVLLLDSNKIFG-NIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELR 433
+ ++ L L N+I N L L + N + + + L+ L
Sbjct: 144 ----SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197
Query: 434 LQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP 492
L N+ L + P + + + L N L I +L S+ L DL N
Sbjct: 198 LSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELL 552
S V +++ + + + I L+
Sbjct: 256 DF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 553 QMQGNFLQG----PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608
+ QG + + +D + I + + Q L +
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
Query: 609 GMVP 612
V
Sbjct: 374 EQVS 377
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-34
Identities = 83/468 (17%), Positives = 170/468 (36%), Gaps = 34/468 (7%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
K L L NS + L L+VL L +N I + ++ +L + +S N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPPS--FGNLSSISFLFLSRNNLDGSIPDTFGW 226
I ++ + + +S+N+ +P FGNL+ ++FL LS
Sbjct: 113 Q-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 227 LK-NLVNLTMAQNRLSGTIPSSIFNI-SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSV 284
L + + L + + G S+ +++ N + V L +LQ ++
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 285 GRNQLTGAIPPAI-------SNASNLEVFQVNSN-KLTGEVPYLEKLQRLSHFVITRNSL 336
N N+ + + + K + ++ + + + I ++
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 337 -GSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+ + + + + ++ + F + + + + +L +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLF---SKEALYSVFAEMNIKMLSISDTPFIH 345
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL----K 451
L N + ++ L+ L+ L LQ N L N
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG-LKNFFKVALMTKNMSS 404
Query: 452 LFNLQLSYNFLQGSIPSSLGQ-SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQ 510
L L +S N L +E++ +++LS+N LTG++ L + VL+L N+
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR---CLPPKVKVLDLHNNR 461
Query: 511 LTGPIPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGN 557
+ IP +V +L+ L+ LNV N+L+ +P L+ + + N
Sbjct: 462 IMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 87/462 (18%), Positives = 155/462 (33%), Gaps = 32/462 (6%)
Query: 153 SSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFL 211
S V S+ L +P +L + + S+S N+++ + LS + L L
Sbjct: 28 FSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRL 83
Query: 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271
S N + F + ++L L ++ NRL I +S+ D N V+P+
Sbjct: 84 SHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPM--ASLRHLDLSFNDFD-VLPVC 139
Query: 272 IGFT-LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFV 330
F L L F + + + +L ++ + E LQ +
Sbjct: 140 KEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT-T 197
Query: 331 ITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK 390
+ + S+ L+ +I +N+ + F + L N
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN---CQRLMTFLSELTRGPTLLNV 254
Query: 391 IFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450
+I + VKL + W + L N+ L + E S L
Sbjct: 255 TLQHIETTWKCSVKLFQF-FWPRPVE--------YL-NIYNLTITERIDREEFTYSETAL 304
Query: 451 K-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRN 509
K L + S + + I LS ++ SS L ++N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF-LNFTQN 363
Query: 510 QLTGPIPNEVGNLKNLEMLNVFENKLR--GEIPRTLGSCIKLELLQMQGNFLQ-GPIPSS 566
T + LK L+ L + N L+ ++ + LE L + N L +
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423
Query: 567 LSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608
+ + VL+LS N L+G + L ++ L+L NN
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 67/460 (14%), Positives = 150/460 (32%), Gaps = 44/460 (9%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN--- 142
+L L ++ + HV L+ LD+ +N + I + L+ L L N
Sbjct: 79 RVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFD 134
Query: 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGN 202
+ + + + L + LS+ + + L +
Sbjct: 135 VLP--VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGIN 262
+ + + L L + + L +L ++ +L+ + S +
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 263 QIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEK 322
TLQ+++ +L +E + + +T + +
Sbjct: 253 N----------VTLQHIETTWKCSVKL-----FQFFWPRPVEYLNIYNLTITERIDR--E 295
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSL--TNATRLKWFHININNFGGLLPACISNFSTT 380
S + + +++ F + + ++I++ + C + ++
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP-SS 354
Query: 381 LEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFL 440
L N ++ +L L + N L +N+ L + L
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVS-L 412
Query: 441 GNIPPSI------GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQL 494
++ + L LS N L GS+ L + ++DL NN + +IP +
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDV 469
Query: 495 LGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFEN 533
L +L L ++ NQL +P+ V L +L+ + + +N
Sbjct: 470 THLQALQ-ELNVASNQLKS-VPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 9e-16
Identities = 41/240 (17%), Positives = 90/240 (37%), Gaps = 16/240 (6%)
Query: 82 QHQRVTILDLKSLKLAG-----YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQV 136
+ V L++ +L + + L L + + N F + + + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 137 LALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI 196
L + S S+ + + N + +L +++ + N L +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 197 PPSFGNLSSISFLFLSRNNLD----GSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS 252
++S L +L+ + T W ++++ L ++ N L+G++ +
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P 450
Query: 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSN 311
+ V D N+I IP D+ LQ LQ +V NQL ++P ++L+ ++ N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDV-THLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 64/472 (13%), Positives = 135/472 (28%), Gaps = 81/472 (17%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
S NLT +P L LS+N++ +L L L ++ NR+ ++
Sbjct: 39 SNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFH 94
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
+F Q+L++ V N+L I ++L
Sbjct: 95 VFL------------------------FNQDLEYLDVSHNRLQ-NISC--CPMASLRHLD 127
Query: 308 VNSNKLT--GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININN 365
++ N L +L+ ++ + + L L +
Sbjct: 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDL-----VSYH 182
Query: 366 FGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE 425
G + +TT+ L+ N +F L L++ N +L+
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMSVNALGHLQLSNIKLN--------- 231
Query: 426 LQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNN 485
+ RL P++ N+ L +++ ++ + +++ N
Sbjct: 232 --DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLNIYNLT 287
Query: 486 LTGTIPPQLLGLSSL----LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541
+T I + S L++ + + + + +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT------ 341
Query: 542 TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLN 601
F+ P S SS L+ +QN + + + + L+ L
Sbjct: 342 ---------------PFIHMVCPPSPSSFT---FLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 602 LSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCSPKKSKHKRL 653
L N + + +N S L +H + + L
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 35/183 (19%), Positives = 69/183 (37%), Gaps = 24/183 (13%)
Query: 52 KITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLK 111
T + + + R LK+ ++ N+S L+
Sbjct: 364 VFTDSVFQGCSTLK------RLQTLILQRNG--------LKNFFK---VALMTKNMSSLE 406
Query: 112 VLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVG 170
LD+ NS + + VL L +N + G + + + + L +N +
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI-M 463
Query: 171 KIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229
IP ++ L ++ +V+ N L S+P F L+S+ +++L N D + P +L
Sbjct: 464 SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG-IRYLSE 521
Query: 230 LVN 232
+N
Sbjct: 522 WIN 524
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 16/278 (5%)
Query: 352 NATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMW 411
N R K + ++ L + + ++ L L N + A F KL L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 412 NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLG 471
+N L + L LR L L N + + + L + N + + S G
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNY-VQELLVGP---SIETLHAANNNIS-RVSCSRG 119
Query: 472 QSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-PIPNEVGNLKNLEMLNV 530
Q I L+NN +T + G S + L+L N++ + LE LN+
Sbjct: 120 QG--KKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 531 FENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF 590
N + ++ + KL+ L + N L + S G++ + L N L I +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 591 LVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGN 628
L Q LE+ +L N F + +N + +V
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/387 (14%), Positives = 109/387 (28%), Gaps = 71/387 (18%)
Query: 195 SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
+I N + ++ ++L ++ N+ L ++ N LS I ++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA---- 55
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314
L+ ++ N L + + S L +N+N +
Sbjct: 56 --------------------PFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
Query: 315 GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACI 374
E+ ++ L N++ ++ + G
Sbjct: 94 -ELLVGPSIETLH---AANNNISR----------------------VSCSRGQG------ 121
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPA-IGELQNLRELR 433
+ + L +NKI G ++ L++ N + L L
Sbjct: 122 ------KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 434 LQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ 493
LQ N + ++ + KL L LS N L + + +T I L NN L I
Sbjct: 176 LQYNF-IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 494 LLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQ 553
L + L +L N KN + V + ++ + C L
Sbjct: 233 LRFSQN-LEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 554 MQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
+ L L
Sbjct: 291 YGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 58/327 (17%), Positives = 112/327 (34%), Gaps = 26/327 (7%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
R I + L +++ + +K LDL N ++ +L++L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203
+ E + S S L + L++N + EL IE + NN++ + S
Sbjct: 70 L-YETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 204 SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSG-TIPSSIFNISSITVFDAGIN 262
++L+ N + G + L + N + + ++ + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 263 QIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEK 322
I + + L+ + N+L + P +A+ + + +NKL L
Sbjct: 180 FIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLE 382
Q L HF + N G RD + R++ L + T+
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVK---KLT-GQNEEECTVP 286
Query: 383 VLLLDSNKIFGNIPAAFGKFVKLLRLE 409
L ++PA F +L+ L
Sbjct: 287 TLGHYGAYCCEDLPAPFAD--RLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 55/388 (14%), Positives = 118/388 (30%), Gaps = 74/388 (19%)
Query: 124 IPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183
I R ++ + ++S+ + + S N+ + LS N L ++L +K+E
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 184 YFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243
++S N L +LS++ L L+ N + ++ L A N +S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 244 IPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNL 303
+ S Q + + N++T S +
Sbjct: 114 VSCSRG---------------------------QGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 304 EVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHINI 363
+ + N++ +NF ++ L+ ++
Sbjct: 147 QYLDLKLNEID----------------------------TVNFAELAASSDTLEHLNLQY 178
Query: 364 NNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI 423
N + + L+ L L SNK+ + F + + + NN+L I A+
Sbjct: 179 NFIYD-VKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 424 GELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
QNL L+ N F + ++ ++ + + T+ +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTL-GHY 291
Query: 484 NNLTGTIPPQLLGLSSLLIVLELSRNQL 511
P ++ L +
Sbjct: 292 GAYCCEDLPAPFADR----LIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 48/362 (13%), Positives = 101/362 (27%), Gaps = 71/362 (19%)
Query: 172 IPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLV 231
I + ++ + V+ ++L ++ + ++ L LS N L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 232 NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291
L ++ N L ++ S L L+ + N +
Sbjct: 62 LLNLSSNVL-----YETLDLES----------------------LSTLRTLDLNNNYVQ- 93
Query: 292 AIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLT 351
+ ++E +N ++ V + Q + + N +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVS-CSRGQGKKNIYLANNKITM------------- 134
Query: 352 NATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFG-NIPAAFGKFVKLLRLEM 410
+ + G + ++ L L N+I N L L +
Sbjct: 135 ---------LRDLDEGCR---------SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 411 WNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSS 469
N + + + L+ L L N+ L + P + + + L N L I +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLN 529
L S+ L DL N + + + + E + L
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 530 VF 531
+
Sbjct: 293 AY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 34/178 (19%), Positives = 70/178 (39%), Gaps = 13/178 (7%)
Query: 443 IPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
I N + +++ + L+ ++ S + + +DLS N L+ I L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561
+L LS N L + + +L L L++ N ++ L +E L N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 562 PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
+ S +G + L+ N ++ ++YL+L N+ + V + +
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKI 773
+G G FGSV +G L D VAVK L + + F++E +K+ H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
L C + QG ++ FM L +L E P+ + L L +D+A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 834 CALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ YL + +H DL N +L ++M V DFGL+ + + + +G
Sbjct: 158 LGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKI-----YSGDYYRQGR 207
Query: 892 IGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 924
I + A E + + S DV+++G+ + E+ TR
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKS---DVWAFGVTMWEIATR 245
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 68/368 (18%), Positives = 132/368 (35%), Gaps = 31/368 (8%)
Query: 148 IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSI 206
I +N+ V + E +L+ + + + + +P + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 207 SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQ 265
L L+ ++ F + + L M N + +P +F N+ +TV N +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
+P I L S+ N L ++L+ Q++SN+LT V L +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-LSLIPS 187
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLL 385
L H ++ N L +L ++ + N+ + + L +L
Sbjct: 188 LFHANVSYNLLS-----------TLAIPIAVEELDASHNSINVVRG----PVNVELTILK 232
Query: 386 LDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP 445
L N + A + L+ +++ N L + ++Q L L + NR L +
Sbjct: 233 LQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALNL 289
Query: 446 SIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVL 504
+ L L LS+N L + + Q + L + L +N++ T+ L L
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH---HTLKNL 344
Query: 505 ELSRNQLT 512
LS N
Sbjct: 345 TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 65/360 (18%), Positives = 133/360 (36%), Gaps = 52/360 (14%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L+ K++ N++ + D R++++L L++ I EI + + ++ +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMG 101
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPDT 223
N + P ++ + + N+L+ S+P F N ++ L +S NNL+ DT
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 224 FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
F +L NL ++ NRL+ + S+ S+ + N + + ++
Sbjct: 161 FQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLSTLAI------PIAVEELD 211
Query: 284 VGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRD 343
N + + ++ L + ++ N LT + +L L ++ N L
Sbjct: 212 ASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE------ 261
Query: 344 LNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV 403
I + F + LE L + +N++ +
Sbjct: 262 ----------------KIMYHPFVKM---------QRLERLYISNNRL-VALNLYGQPIP 295
Query: 404 KLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQ 463
L L++ +N L + + L L L N + + S + L NL LS+N
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKLST-HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 76/474 (16%), Positives = 144/474 (30%), Gaps = 102/474 (21%)
Query: 172 IPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLV 231
I S L + L++ + + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 232 NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291
L + ++ I + F +Q +G N +
Sbjct: 73 LLNLNDLQIE-EIDTYAFA------------------------YAHTIQKLYMGFNAIR- 106
Query: 292 AIPPAI-SNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSL 350
+PP + N L V + N L+
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS------------------------------------ 130
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLE 409
+ F L L + +N + I F L L+
Sbjct: 131 ---------SLPRGIFHNT---------PKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQ 171
Query: 410 MWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSS 469
+ +NRL+ + + +L + N L + I + L S+N + +
Sbjct: 172 LSSNRLT-HVDL--SLIPSLFHANVSYNL-LSTLAIPI---AVEELDASHNSIN-VVRGP 223
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLN 529
+ LTI+ L +NNLT LL L + ++LS N+L + + ++ LE L
Sbjct: 224 VNVE--LTILKLQHNNLTD--TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 530 VFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 589
+ N+L + L++L + N L + + L L L N++ +
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK- 334
Query: 590 FLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTC 643
L L+ L LS+ND++ +FRN + +V + C ++ C
Sbjct: 335 -LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 23/155 (14%), Positives = 49/155 (31%), Gaps = 27/155 (17%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKN 524
I S+L + + + + L++ I + + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKI-VTFKNSTMRKLPAALLDSFRQ 70
Query: 525 LEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
+E+LN+ + ++ EI + + + L + N +
Sbjct: 71 VELLNLNDLQIE-EID-----------------------TYAFAYAHTIQKLYMGFNAIR 106
Query: 585 GKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
P LL L L ND +P G+F N
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLP-RGIFHN 139
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 6e-33
Identities = 79/428 (18%), Positives = 133/428 (31%), Gaps = 100/428 (23%)
Query: 179 LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQN 238
+ +V + LT ++P I+ L + NNL S+P L L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91
Query: 239 RLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAIS 298
+L+ ++P + +++F + + + L + NQLT ++P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SLPVLPP 141
Query: 299 NASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKW 358
L V L L KL + N L S
Sbjct: 142 GLQELSVSDNQLASLPALPSELCKLWAYN------NQLTS-------------------- 175
Query: 359 FHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGT 418
LP S L+ L + N++ +
Sbjct: 176 -----------LPMLPSG----LQELSVSDNQL-------------------------AS 195
Query: 419 IPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTI 478
+P EL L + L ++P LK L +S N L S+P + L
Sbjct: 196 LPTLPSELYKLWAYNNR----LTSLPALPSGLK--ELIVSGNRLT-SLPVLPSE---LKE 245
Query: 479 IDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE 538
+ +S N LT ++P GL SL + RNQLT +P + +L + +N+ N L E
Sbjct: 246 LMVSGNRLT-SLPMLPSGLLSL----SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-E 298
Query: 539 IPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLE 598
I +S L + + + E +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHM 358
Query: 599 YLNLSNND 606
+ N D
Sbjct: 359 FGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 74/339 (21%), Positives = 126/339 (37%), Gaps = 50/339 (14%)
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
+VG + LT +P + ++ + N LT +L+ L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTSLPALPPELRTLE---VSGNQ 92
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
L S L F + + LPA S L L + N++ ++
Sbjct: 93 LTS-------LPVLPPGLLELSIFSNPLTH----LPALPSG----LCKLWIFGNQL-TSL 136
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNL 455
P L L + +N+L+ ++P L +L N+ L ++P L+ L
Sbjct: 137 PVLPPG---LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQ-LTSLPMLPSGLQ--EL 186
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
+S N L S+P+ + L + NN LT ++P GL L +S N+LT +
Sbjct: 187 SVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL----IVSGNRLTS-L 236
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
P LK L V N+L +P + L + N L +P SL L +
Sbjct: 237 PVLPSELKEL---MVSGNRLT-SLPMLPSGLLSLSV---YRNQLTR-LPESLIHLSSETT 288
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614
++L N LS + + L + F+ +
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASA 327
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 68/401 (16%), Positives = 137/401 (34%), Gaps = 80/401 (19%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
VL++ + +P + L + +N++ +PA L +S N+L
Sbjct: 42 NAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNL-TSLPALPPELRTL---EVSGNQLT 94
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229
+P L ++ FS +L S + L++ N L S+P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLPVLPP---G 142
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
L L+++ N+L+ ++P+ + + ++ NQ+ +P+ LQ SV NQL
Sbjct: 143 LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPS----GLQELSVSDNQL 193
Query: 290 TGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
++P S L + N+LT L+ L ++ N L S
Sbjct: 194 A-SLPTLPSELYKLWAYN---NRLTSLPALPSGLKELI---VSGNRLTS----------- 235
Query: 350 LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE 409
LP S L+ L++ N++ ++P LL L
Sbjct: 236 --------------------LPVLPSE----LKELMVSGNRL-TSLPMLPS---GLLSLS 267
Query: 410 MWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSS 469
++ N+L+ +P ++ L + + L+ N L + + + I
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNP-LSERTLQALR----EITSAPGYSGPIIRFD 321
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQ 510
+ + + + P G + + +
Sbjct: 322 MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 75/405 (18%), Positives = 135/405 (33%), Gaps = 82/405 (20%)
Query: 130 RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189
VL + + + +P + +++ + + N L +P+ L +E VS
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSG 90
Query: 190 NNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF 249
N LT S+P L +S +L L L + N+L+ ++P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPP 141
Query: 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN 309
+ ++V D NQ+ +P L L NQLT ++P S L+ V+
Sbjct: 142 GLQELSVSD---NQLA-SLPALPS-ELCKLW---AYNNQLT-SLPMLP---SGLQELSVS 189
Query: 310 SNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGL 369
N+L +L +L N L S
Sbjct: 190 DNQLASLPTLPSELYKLW---AYNNRLTS------------------------------- 215
Query: 370 LPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNL 429
LPA S L+ L++ N++ ++P +L L + NRL+ ++P L
Sbjct: 216 LPALPSG----LKELIVSGNRL-TSLPVLPS---ELKELMVSGNRLT-SLPMLPS---GL 263
Query: 430 RELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L + N+ L +P S+ +L + L N L + +T + +
Sbjct: 264 LSLSVYRNQ-LTRLPESLIHLSSETTVNLEGNPLS-ERTLQALRE--ITSAPGYSGPII- 318
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
L L+ +P G + ++F
Sbjct: 319 RFDMAGASAPRETRALHLAAADWL--VPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-23
Identities = 67/377 (17%), Positives = 120/377 (31%), Gaps = 55/377 (14%)
Query: 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS 143
+T L + L + A L + L++ N +P L L + +
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 144 IGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203
+ S L ++ + N+L +P L + SVS N L S+P L
Sbjct: 116 LPALP-------SGLCKLWIFGNQL-TSLPVLPPGL---QELSVSDNQLA-SLPALPSEL 163
Query: 204 SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263
L+ N L S+P L L+++ N+L+ ++P+ + + ++ +
Sbjct: 164 CK---LWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS 215
Query: 264 IQGVIP----LDIGF--------TLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
+ + L + L+ V N+LT ++P S L V N
Sbjct: 216 LPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRN 271
Query: 312 KLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNA----TRLKWFHININNF 366
+LT +P L L + + N L + L + S R +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 367 GGLLPACISNFSTTLEVLLLDSNKI---FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPA- 422
L +++ FG A + L RL N + A
Sbjct: 331 TRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQ 390
Query: 423 ----IGELQNLRELRLQ 435
+ +L LR
Sbjct: 391 ISSWLAQLAEDEALRAN 407
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGAF-----KSFIAECNTLKNIRHRNL 770
+G G FGSV + L D VAVK+ L + F+ E +K H ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKM---LKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 771 VKILTACSGVDYQGNDFKAL-VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
K++ +G + + FM + L +L E P +L L +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVRFM 143
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+D+AC + YL + +H DL N +L E+M V DFGL+ + + +
Sbjct: 144 VDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKI-----YSGDYY 193
Query: 888 AKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 924
+G + A E L + S DV+++G+ + E++TR
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHS---DVWAFGVTMWEIMTR 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-32
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 774
+ +G G +G VY+G+ + VAVK L + F+ E +K I+H NLV++L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C+ + F ++ EFM +L ++L RE + ++ + L + ++
Sbjct: 283 GVCT----REPPFY-IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYMATQISS 329
Query: 835 ALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
A+ YL + +H +L N L+ E + V DFGL+ + T+ AK I
Sbjct: 330 AMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 384
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ APE ++ SI DV+++G+LL E+ T
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 768
+ +GAG FG V+ + T VAVK + G+ ++F+AE N +K ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHD 243
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
LVK+ + + ++ EFM SL ++L + DE L + +D
Sbjct: 244 KLVKLHAVVTK------EPIYIITEFMAKGSLLDFL----KSDE----GSKQPLPKLIDF 289
Query: 829 GIDVACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+A ++++ + +H DL+ +N+L+ ++ + DFGLA + + T+
Sbjct: 290 SAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 344
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
AK I + APE +I DV+S+GILL+E+VT
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 86/506 (16%), Positives = 176/506 (34%), Gaps = 73/506 (14%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L+ K++ N++ + D R++++L L++ I EI + + ++ +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMG 107
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPDT 223
N + P ++ + + N+L+ S+P F N ++ L +S NNL+ DT
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 224 FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
F +L NL ++ NRL+ + S+ S+ + N + + ++
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLSTLAI------PIAVEELD 217
Query: 284 VGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRD 343
N + + ++ L + ++ N LT + +L L ++ N L
Sbjct: 218 ASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE------ 267
Query: 344 LNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV 403
I + F + LE L + +N++ +
Sbjct: 268 ----------------KIMYHPFVKM---------QRLERLYISNNRL-VALNLYGQPIP 301
Query: 404 KLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQ 463
L L++ +N L + + L L L N + + S + L NL LS+N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKLST-HHTLKNLTLSHNDWD 358
Query: 464 GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLK 523
+ S + + + + I QL P L+
Sbjct: 359 CN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCC----------KESDKPYLDRLLQ 406
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
+ + +V E ++ R G C + + + L+G L+ N L
Sbjct: 407 YIALTSVVE-----KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461
Query: 584 SGKI----PEFLVGFQLLEYLNLSNN 605
++ E + QLL+ L+ +
Sbjct: 462 RAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-31
Identities = 80/476 (16%), Positives = 157/476 (32%), Gaps = 45/476 (9%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSS 205
I +N+ V + E +L+ + + + + +P + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQI 264
+ L L+ ++ F + + L M N + +P +F N+ +TV N +
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 265 QGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQ 324
+P I L S+ N L ++L+ Q++SN+LT V L +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-LSLIP 192
Query: 325 RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVL 384
L H ++ N L +L ++ + N+ + L +L
Sbjct: 193 SLFHANVSYNLLS-----------TLAIPIAVEELDASHNSINVVRGPVNVE----LTIL 237
Query: 385 LLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNI 443
L N + A + L+ +++ N L I ++Q L L + NR L +
Sbjct: 238 KLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNR-LVAL 293
Query: 444 PPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLI 502
+ L L LS+N L + + Q + L + L +N++ T+ L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH---HTLK 348
Query: 503 VLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCI----------KLELL 552
L LS N + +N+ V + +I L + L
Sbjct: 349 NLTLSHNDWDC--NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 553 QMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608
+ + + + ++ Q+ + V Q E L N+
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELR 462
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 75/406 (18%), Positives = 139/406 (34%), Gaps = 62/406 (15%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG-----WLKNLVNLTMAQNRLSG 242
YN + + ++D D + L N +T + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64
Query: 243 TIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNA 300
+P+++ + + + + QI+ I +Q +G N + +PP N
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 122
Query: 301 SNLEVFQVNSNKLTGEVPY--LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKW 358
L V + N L+ +P +L+ ++ N+L
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-------------------- 161
Query: 359 FHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGT 418
I + F T+L+ L L SN++ ++ L + N LS
Sbjct: 162 --IEDDTFQAT---------TSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-- 205
Query: 419 IPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTI 478
+ + EL N + + + N++L L+L +N L + + L L
Sbjct: 206 ---TLAIPIAVEELDASHNS-INVVRGPV-NVELTILKLQHNNL--TDTAWLLNYPGLVE 258
Query: 479 IDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE 538
+DLS N L I L L +S N+L + + L++L++ N L
Sbjct: 259 VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 539 IPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
+ R +LE L + N + + LS+ L L LS N+
Sbjct: 316 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 21/128 (16%), Positives = 39/128 (30%), Gaps = 5/128 (3%)
Query: 483 NNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-----PIPNEVGNLKNLEMLNVFENKLRG 537
N+ P S+L + E L N +++ + +R
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLL 597
L S ++ELL + ++ + + + L + N + P LL
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125
Query: 598 EYLNLSNN 605
L L N
Sbjct: 126 TVLVLERN 133
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+G G +G VY+G+ + VAVK L + F+ E +K I+H NLV++L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C+ Y ++ EFM +L ++L RE + ++ + L + ++
Sbjct: 78 CTREPPFY-------IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYMATQISS 122
Query: 835 ALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
A+ YL + +H DL N L+ E + V DFGL+ + T+ AK I
Sbjct: 123 AMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 177
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTR 924
+ APE ++ SI DV+++G+LL E+ T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS--FIAECNTLKNIRHR 768
+ +G G FG V+ G G T VA+K L G F+ E +K +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
LV++ S + +V E+M SL ++L + + + L L Q +D+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDM 285
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
+A ++Y+ VH DL+ +N+L+ E ++ V DFGLA + + T+ A
Sbjct: 286 AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGA 341
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K I + APE L +I DV+S+GILL EL T
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTAC 777
IG G FG V G VAVK + + A ++F+AE + + +RH NLV++L
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
+ +V E+M SL ++L L L +DV A+
Sbjct: 256 V----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAME 303
Query: 838 YL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL ++ VH DL NVL+ E+ +A V DFGL A ++ K + + A
Sbjct: 304 YLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTA 354
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVT 923
PE + S DV+S+GILL E+ +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 85/433 (19%), Positives = 160/433 (36%), Gaps = 68/433 (15%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
+ +DL NS + F RL+ LQ L + + G I N S+LI ++L N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 169 VGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP--SFGNLSSISFLFLSRNNLDGSIPDT-F 224
+ ++ + L+ +E +++ NL G++ F L+S+ L L NN+ P + F
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 225 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSV 284
++ L + N++ +I F L ++ +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHF--------------TLLRLSSITLQDM 195
Query: 285 GRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDL 344
L +++ ++ N E ++ I L
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILS------- 247
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFV 403
N ++ + + F GL ++ ++ L +KIF + F F
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGL-------EASGVKTCDLSKSKIF-ALLKSVFSHFT 299
Query: 404 KLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFL 462
L +L + N ++ I A L +L +L L +N LG+I + F
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF-LGSIDSRM-----F--------- 343
Query: 463 QGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-G 520
+L + L ++DLS N++ + Q GL +L L L NQL +P+ +
Sbjct: 344 -----ENLDK---LEVLDLSYNHIR-ALGDQSFLGLPNLK-ELALDTNQLKS-VPDGIFD 392
Query: 521 NLKNLEMLNVFEN 533
L +L+ + + N
Sbjct: 393 RLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 71/433 (16%), Positives = 145/433 (33%), Gaps = 64/433 (14%)
Query: 182 IEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNR 239
+ Y +S N++ + SF L + FL + + I +TF L +L+ L + N+
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 240 LSGTIPSSIF-NISSITVFDAGINQIQG-VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI 297
+ + F ++++ V + G V+ + L +L+ + N + I PA
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPA- 147
Query: 298 SNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLK 357
F ++R +T N + S DL
Sbjct: 148 ------SFFL--------------NMRRFHVLDLTFNKVKSICEEDLLNFQGK----HFT 183
Query: 358 WFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSG 417
++ ++ + K + L++ N
Sbjct: 184 LLRLSSITL-----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 418 TIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNL-QLSYNFLQGSIPSSLGQSETL 476
++ + +++ N+ S G+ + ++ L+ S +
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS---------GV 277
Query: 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKL 535
DLS + + + + + L L L++N++ I + L +L LN+ +N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-FLVGF 594
R + KLE+L + N ++ S L L L L N L +P+
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394
Query: 595 QLLEYLNLSNNDF 607
L+ + L N +
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 69/373 (18%), Positives = 126/373 (33%), Gaps = 70/373 (18%)
Query: 91 LKSLKLAG----YISAHV-GNLSFLKVLDLHNNSFH-HEIPSE-FDRLRRLQVLALHNNS 143
L LKL + L+ L+VL L + + F L L++L L +N+
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 144 IGGEIPANI-SSCSNLIRVRLSSNEL----------VGKIPSELGSLSKIEYFSVSYNNL 192
I PA+ + + L+ N++ L LS I ++ L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 193 TGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS 252
+ +SI+ L LS N S+ F + S + SS
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF---- 256
Query: 253 SITVFDAGINQIQGVIPL-DIGFTLQNLQFFSVGRNQLTGAIPPAI-SNASNLEVFQVNS 310
G + G ++ + ++++ A+ ++ S+ ++LE +
Sbjct: 257 -------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308
Query: 311 NKLTGEVPY--LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGG 368
N++ ++ L L +++N LGS I+ F
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFLGS----------------------IDSRMFEN 345
Query: 369 LLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-AIGEL 426
L LEVL L N I + +F L L + N+L ++P L
Sbjct: 346 L---------DKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394
Query: 427 QNLRELRLQENRF 439
+L+++ L N +
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 43/258 (16%), Positives = 85/258 (32%), Gaps = 44/258 (17%)
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQEN 437
+ + L N I +F + L L++ I L +L L+L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 438 RFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGT-IPPQLL- 495
+ + F + L L ++ L+ NL G +
Sbjct: 90 Q-FLQLETGA-------------F------NGLAN---LEVLTLTQCNLDGAVLSGNFFK 126
Query: 496 GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQM 554
L+SL +L L N + P N++ +L++ NK++ L + +
Sbjct: 127 PLTSL-EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 555 QGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614
L +++ D+++ L + + L+LS N F+ +
Sbjct: 186 --------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA-- 229
Query: 615 GVFRNASITSVLGNLKLC 632
F +A + + +L L
Sbjct: 230 KRFFDAIAGTKIQSLILS 247
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 12/175 (6%)
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
+P + + LS N + +S + + L + + I S L
Sbjct: 27 ELPAHVNYV-----DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 502 IVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEI--PRTLGSCIKLELLQMQGNF 558
I+L+L NQ + L NLE+L + + L G + LE+L ++ N
Sbjct: 82 IILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 559 LQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPEFLVGFQL--LEYLNLSNNDFEGM 610
++ P+S ++R VLDL+ N + E L+ FQ L LS+ + M
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 24/222 (10%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRL---RRLQVLALHNNS 143
T+ D+ L + + + LDL N F + F ++Q L L N+
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 144 I-GGEIPANISSC-----------SNLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYN 190
G S + LS +++ + + + +E +++ N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQN 309
Query: 191 NLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQNRLSGTIPSSI 248
+ I +F L+ + L LS+N L GSI F L L L ++ N + +
Sbjct: 310 EIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQS 366
Query: 249 F-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
F + ++ NQ++ +P I L +LQ + N
Sbjct: 367 FLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 8/145 (5%)
Query: 77 TCSRRQHQRVTILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQ 135
T + V DL K+ + V + + L+ L L N + + F L L
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL 326
Query: 136 VLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYNNLT 193
L L N + G I + + + L + LS N + + + L ++ ++ N L
Sbjct: 327 KLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK 384
Query: 194 GSIPPS-FGNLSSISFLFLSRNNLD 217
S+P F L+S+ ++L N D
Sbjct: 385 -SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 54/216 (25%), Positives = 81/216 (37%), Gaps = 38/216 (17%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLVKIL 774
IG G+FG V+ G L T+VAVK F+ E LK H N+V+++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 775 TACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
C+ Y +V E + +L L + L + D
Sbjct: 179 GVCTQKQPIY-------IVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDA 222
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A + YL +H DL N L+ E+ + + DFG++ A G +
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-----ADGVYAASGGL 274
Query: 893 GYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ APE S DV+S+GILL E +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ G G T VAVK L G+ +F+AE N +K ++H+ LV++
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + ++ E+M N SL ++L + L + + LD+ +A +
Sbjct: 77 VTQ------EPIYIITEYMENGSLVDFL----KTPS----GIKLTINKLLDMAAQIAEGM 122
Query: 837 SYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+++ + +H DL+ +N+L+ + + + DFGLA + + T+ AK I +
Sbjct: 123 AFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT 177
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVT 923
APE +I DV+S+GILL E+VT
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKS--FIAECNTLKNIRHR 768
+ +G G FG V+ G + G T VA+K L G F+ E +K +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
LV++ S + +V E+M SL ++L + + + L L Q +D+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDM 368
Query: 829 GIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+A ++Y+ + VH DL+ +N+L+ E ++ V DFGLA + + T+
Sbjct: 369 AAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQG 423
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
AK I + APE L +I DV+S+GILL EL T
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/219 (26%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 719 IGAGSFGSVYKGIL--DEGKTI-VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G GSFG V +G GKT+ VAVK L A FI E N + ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ + +V E SL + L + L + V
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQV 130
Query: 833 ACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
A + YL +H DL N+LL + +GDFGL LP + K
Sbjct: 131 AEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ APE S D + +G+ L E+ T ++P
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILTA 776
IG+G FG V+ G K VA+K + GA + FI E + + H LV++
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C LV EFM + L ++L R L + +DV
Sbjct: 72 CLEQAPIC-------LVTEFMEHGCLSDYL----RTQR-----GLFAAETLLGMCLDVCE 115
Query: 835 ALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
++YL ++H DL N L+ E + V DFG+ F+ L TSS K +
Sbjct: 116 GMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPV 169
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ +PE S S DV+S+G+L+ E+ +
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKI 773
+G+G FG+V+KG+ + K V +KV +F++ + ++ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
L C G Q LV +++ SL + + R+ +L L+ G+ +A
Sbjct: 81 LGLCPGSSLQ------LVTQYLPLGSLLDHV----RQHR-----GALGPQLLLNWGVQIA 125
Query: 834 CALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ YL H +VH +L NVLL V DFG+A LP Q AK
Sbjct: 126 KGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 927
I ++A E + + DV+SYG+ + EL+T +P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 770
+G+G+FG+VYKG+ ++ K VA+K L K + E + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
++L C Q L+ + M L +++ E ++ L+ +
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCV 124
Query: 831 DVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
+A ++YL +VH DL NVL+ + DFGLA L + +
Sbjct: 125 QIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 889 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
K I ++A E + + + S DV+SYG+ + EL+T KP
Sbjct: 180 KVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 44/225 (19%)
Query: 717 NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+IG G FG VY G + + A+K L ++F+ E ++ + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS---LSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++ ++ ++ +M + L +++ R + R+ + + G
Sbjct: 84 VLALIGIML----PPEGLPHVLLPYMCHGDLLQFI----RSPQ-----RNPTVKDLISFG 130
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ VA + YL VH DL N +LDE V DFGLA + +
Sbjct: 131 LQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSV 182
Query: 888 AKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 924
+ + A E + S DV+S+G+LL EL+TR
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKS---DVWSFGVLLWELLTR 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-29
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 718 LIGAGSFGSVYKG---ILDEGKTIVAVKVFNLLHHG---AFKSFIAECNTLKNIRHRNLV 771
I G G +Y ++ G+ V +K L+H G A +AE L + H ++V
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRP-VVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+I D G+ +V E++ +SL+ + L + + + ++
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLE 190
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ ALSYLH +V+ DLKP N++L EE + + D G + ++ G+
Sbjct: 191 ILPALSYLH---SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS----RINSFGYLY--GT 240
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
G+ APE ++ D+Y+ G L L G
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 774
IG GSF +VYKG+ + VA + F E LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ LV E M + +L+ +L + + + + +
Sbjct: 92 DSWESTVKGKKCI-VLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILK 140
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
L +LH PPI+H DLK N+ + +GD GLAT S A+ G+
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 195
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
++APE + + DVY++G+ +LE+ T + P
Sbjct: 196 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 718 LIGAGSFGSVYKG---ILDEGKTIVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLV 771
+G G +VY IL+ VA+K F E + + H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTILNI---KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 772 KILTACSGVDY-QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
++ D + +D LV E++ +L E++ P L++ ++
Sbjct: 75 SMI------DVDEEDDCYYLVMEYIEGPTLSEYIE--------SHGP--LSVDTAINFTN 118
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH-AQTSSIFAK 889
+ + + H IVH D+KP N+L+D + DFG+A L + QT+ +
Sbjct: 119 QILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-- 173
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G++ Y +PE G D+YS GI+L E++ + P F G+
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILTA 776
+G G FG V G G+ VA+K+ + G+ FI E + N+ H LV++
Sbjct: 32 LGTGQFGVVKYGKW-RGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C+ + ++ E+M N L +L RE Q L++ DV
Sbjct: 88 CTKQRPIF-------IITEYMANGCLLNYL----REMR-----HRFQTQQLLEMCKDVCE 131
Query: 835 ALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A+ YL +H DL N L++++ + V DFGL+ ++ L TSS+ +K +
Sbjct: 132 AMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 185
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ PE + S+ S D++++G+L+ E+ +
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILT 775
IG G FG V G VAVK + + A ++F+AE + + +RH NLV++L
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
+ +V E+M SL ++L R L L +DV A
Sbjct: 82 VIV----EEKGGLYIVTEYMAKGSLVDYL----RSRG----RSVLGGDCLLKFSLDVCEA 129
Query: 836 LSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
+ YL ++ VH DL NVL+ E+ +A V DFGL A ++ K + +
Sbjct: 130 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 180
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVT 923
APE + S DV+S+GILL E+ +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRNLV 771
+G G+FGSV D +VAVK L H + F E LK+++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K C G L+ E++ SL ++L ++ + ++ ++ L
Sbjct: 75 KYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL----QKHKER-----IDHIKLLQYTSQ 122
Query: 832 VACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
+ + YL +H DL N+L++ E +GDFGL LP +
Sbjct: 123 ICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
I + APE S+ S+ DV+S+G++L EL T
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 69/326 (21%), Positives = 119/326 (36%), Gaps = 17/326 (5%)
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTG-EVPYLEKLQRLSHFVITRNSLGSGEHRDL 344
R + A+P I + + + N++ L + N + + E
Sbjct: 20 RKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-- 74
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK 404
+ N L+ + N + + S L L + NKI + F
Sbjct: 75 ----AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKIVILLDYMFQDLYN 129
Query: 405 LLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNF 461
L LE+ +N L I A L +L +L L++ L +IP L L+L +
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLN 187
Query: 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN 521
+ S + L ++++S+ T+ P L +L L ++ LT V +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLTAVPYLAVRH 246
Query: 522 LKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581
L L LN+ N + L ++L+ +Q+ G L P + L L VL++S N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 582 NLSGKIPEFLVGFQLLEYLNLSNNDF 607
L+ LE L L +N
Sbjct: 307 QLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 73/401 (18%), Positives = 127/401 (31%), Gaps = 90/401 (22%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
++P + L L +N + D F +L L + +N +S +
Sbjct: 19 HRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPG 74
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI-SNASNLEVF 306
FN L NL+ + N+L IP + + SNL
Sbjct: 75 AFN------------------------NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKL 109
Query: 307 QVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNF 366
++ NK+ + F
Sbjct: 110 DISENKIV---------------------------------------------ILLDYMF 124
Query: 367 GGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGE 425
L L+ L + N + AF L +L + L+ +IP A+
Sbjct: 125 QDL---------YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH 174
Query: 426 LQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
L L LRL+ + I +L L++S+ ++ + LT + +++
Sbjct: 175 LHGLIVLRLRHLN-INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 484 NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTL 543
NLT +P + L L LS N ++ + + L L+ + + +L P
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 544 GSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
L +L + GN L S S+ L L L N L+
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 62/252 (24%), Positives = 102/252 (40%), Gaps = 16/252 (6%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
T +L L N+I F F L LE+ N +S + P A L NLR L
Sbjct: 28 EGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLG 86
Query: 434 LQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSLGQS-ETLTIIDLSNNNLTGTI 490
L+ NR L IP + G L L +S N + + + Q L +++ +N+L I
Sbjct: 87 LRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YI 143
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
+ GL+SL L L + LT IP E +L L +L + + + +
Sbjct: 144 SHRAFSGLNSLE-QLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF-LVGFQLLEYLNLSNNDF 607
L++L++ + + L+ L ++ NL+ +P + L +LNLS N
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 608 EGMVPTEGVFRN 619
+ +
Sbjct: 261 S-TIE-GSMLHE 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-22
Identities = 54/254 (21%), Positives = 95/254 (37%), Gaps = 14/254 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRL 163
NL L+ L L +N IP F L L L + N I + + NL + +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135
Query: 164 SSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIP 221
N+LV I L+ +E ++ NLT SIP + +L + L L N++
Sbjct: 136 GDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 222 DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQF 281
+F L L L ++ T+ + ++T + +P L L+F
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
Query: 282 FSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPY--LEKLQRLSHFVITRNSLGS 338
++ N ++ I + L+ Q+ +L V L L ++ N L +
Sbjct: 253 LNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTT 310
Query: 339 GEHRDLNFLCSLTN 352
E + + +L
Sbjct: 311 LEESVFHSVGNLET 324
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 61/289 (21%), Positives = 100/289 (34%), Gaps = 32/289 (11%)
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK 404
++ + + N N LL C+ L L+ + ++P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLI---NQFSELQLNRLNL-SSLPDNLPP--Q 81
Query: 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQG 464
+ LE+ N L ++P +L L +NR L +P +LK +L + N L
Sbjct: 82 ITVLEITQNALI-SLPELPA---SLEYLDACDNR-LSTLPELPASLK--HLDVDNNQLT- 133
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKN 524
+P L I+ NN LT +P L L + NQLT +P ++
Sbjct: 134 MLPELPAL---LEYINADNNQLT-MLPELPTSLEVL----SVRNNQLTF-LPEL---PES 181
Query: 525 LEMLNVFENKLRGEIPRTLGSCIKLE----LLQMQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
LE L+V N L +P E + + N + IP ++ SL + L
Sbjct: 182 LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILED 239
Query: 581 NNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNL 629
N LS +I E L + F + +V
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 55/400 (13%), Positives = 111/400 (27%), Gaps = 61/400 (15%)
Query: 100 ISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLI 159
+ + + N + + + L L+ ++ +P N+ +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNL--PPQIT 83
Query: 160 RVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS 219
+ ++ N L+ +P SL EY N L+ ++P +L L + N L
Sbjct: 84 VLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELPASLKH---LDVDNNQLT-M 134
Query: 220 IPDTFGWLKNLVNLTMAQNRLSGTIPSSIFN-----------------ISSITVFDAGIN 262
+P+ L + N+L+ +P + S+ D N
Sbjct: 135 LPELPA---LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTN 190
Query: 263 QIQGVIPLDIGFTLQNLQ----FFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP 318
++ +P + + FF N++T IP I + + N L+ +
Sbjct: 191 LLES-LPAVPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 319 YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS 378
Q T G + N F + +S
Sbjct: 248 ESLSQQ-------TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
E + F V + +++ + +L ELR Q
Sbjct: 301 HAFE--HEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFA 354
Query: 439 FLGNIPPSIGNLKLFNL------QLSYNFLQGSIPSSLGQ 472
+ S + L + +G + G
Sbjct: 355 VAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGA 394
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 21/163 (12%)
Query: 446 SIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN---NNLTGTIPPQLLGLSSLLI 502
I N + YN + G+ + L N + L+ +
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI---NQFS 62
Query: 503 VLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
L+L+R L+ +P+ + + +L + +N L +P S LE L N L
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLST- 114
Query: 563 IPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+P +SL+ LD+ N L+ +PE LLEY+N NN
Sbjct: 115 LPELPASLKH---LDVDNNQLT-MLPELP---ALLEYINADNN 150
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 31/163 (19%), Positives = 55/163 (33%), Gaps = 21/163 (12%)
Query: 87 TILDLKSLKLAG----YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142
LK L + + L + ++ NN +P L+VL++ NN
Sbjct: 118 LPASLKHLDVDNNQLTMLPELPALL---EYINADNNQLT-MLPEL---PTSLEVLSVRNN 170
Query: 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE----YFSVSYNNLTGSIPP 198
+ +P S L +S+N L +P+ E +F N +T IP
Sbjct: 171 QLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPE 224
Query: 199 SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241
+ +L + L N L I ++ + + S
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 69/307 (22%), Positives = 109/307 (35%), Gaps = 55/307 (17%)
Query: 646 KKSKHKRLTLALKLALAIISGLIGLSLALSFLIICLVRKRKENQNPSSPINSFPNISYQN 705
+ + A L GL G+ + EN ++S N
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 706 --LYNATDGF---------TSANLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA 751
L A +IG G FG VY G L D K AVK L+
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRIT 129
Query: 752 ----FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI 807
F+ E +K+ H N++ +L C +G+ +V +M + L ++
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI--- 182
Query: 808 TREDETEEAPRSLNLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIA 865
R + + + + G+ VA + +L VH DL N +LDE+
Sbjct: 183 -RNET-----HNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTV 231
Query: 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGIL 917
V DFGLA + + + + + A E + S DV+S+G+L
Sbjct: 232 KVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVL 285
Query: 918 LLELVTR 924
L EL+TR
Sbjct: 286 LWELMTR 292
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILTA 776
+G+G FG V G G+ VAVK+ + G+ F E T+ + H LVK
Sbjct: 16 LGSGQFGVVKLGKWK-GQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 777 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
CS Y +V E++ N L +L + L Q L++ DV
Sbjct: 72 CSKEYPIY-------IVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDVCE 115
Query: 835 ALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
+++L H +H DL N L+D ++ V DFG+ ++ L SS+ K +
Sbjct: 116 GMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPV 169
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ APE + S DV+++GIL+ E+ + K P
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G GSFG VY+G+ DE +T VA+K ++ A F+ E + +K +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V++L S QG ++ E M L+ +L + +L + + +
Sbjct: 90 VVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
++A ++YL+ VH DL N ++ E+ +GDFG+ + + + K
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRK 196
Query: 890 GSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 924
G G + +PE G+ + S DV+S+G++L E+ T
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIATL 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 770
+G G FG V D VAVK L + E L+N+ H N+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
VK C+ G + L+ EF+ + SL+E+L +++ +NL Q+L +
Sbjct: 86 VKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL----PKNK-----NKINLKQQLKYAV 133
Query: 831 DVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFA 888
+ + YL VH DL NVL++ E +GDFGL + T
Sbjct: 134 QICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 889 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 923
+ + APE S DV+S+G+ L EL+T
Sbjct: 190 DSPVFWYAPECLMQSKFYIAS---DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRNLV 771
+G G+FGSV D +VAVK L H + F E LK+++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K C + L+ E++ SL ++L ++ + ++ ++ L
Sbjct: 106 KYKGVCYSAGRRN---LKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQYTSQ 153
Query: 832 VACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
+ + YL +H DL N+L++ E +GDFGL LP +
Sbjct: 154 ICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
I + APE S+ S+ DV+S+G++L EL T
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 718 LIGAGSFGSVYKG---ILDEGKTIVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLV 771
++G G V+ VAVKV +L +F F E + H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR---DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 772 KILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ +G +V E++ +L + +H E P + + +++
Sbjct: 76 AVYD--TGEAETPAGPLPYIVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIA 123
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA---QTSSIF 887
D AL++ H Q I+H D+KP+N+++ V DFG+A + S QT+++
Sbjct: 124 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ Y++PE G V DVYS G +L E++T + P F GD
Sbjct: 181 --GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 719 IGAGSFGSVYKGIL--DEGKTIVAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G+G+FG+V KG + VAVK+ +AE N ++ + + +V+++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
C + LV E L ++L +++ R + +++ V+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYL----QQN------RHVKDKNIIELVHQVSM 128
Query: 835 ALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL-SHAQTSSIFAKGS 891
+ YL + VH DL NVLL + A + DFGL+ L + + K
Sbjct: 129 GMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 892 IGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ + APE Y + S DV+S+G+L+ E + +KP
Sbjct: 184 VKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 39/222 (17%)
Query: 719 IGAGSFGSVYKGIL--DEGKTIVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLVK 772
+G G+FGSV +G+ + + VA+KV L G K+ + E + + + +V+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
++ C LV E L ++L + + ++ V
Sbjct: 75 LIGVCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQV 119
Query: 833 ACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
+ + YL + VH DL NVLL A + DFGL+ L + T+ K
Sbjct: 120 SMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 890 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ + APE + S S DV+SYG+ + E ++ +KP
Sbjct: 175 WPLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRNLV 771
+G G+FGSV D +VAVK L H + F E LK + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K G G LV E++ + L ++L + L+ + L
Sbjct: 88 KYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL----QRHR-----ARLDASRLLLYSSQ 135
Query: 832 VACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH-AQTSSIFAK 889
+ + YL C VH DL N+L++ E + DFGLA LPL +
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
I + APE + S DV+S+G++L EL T
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 771
IG+G G V G L + VA+K L G + F++E + + H N++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 772 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++ + +V E+M N SL+ +L R + ++Q + +
Sbjct: 114 RLEGVVTRGRLAM-------IVTEYMENGSLDTFL----RTHD-----GQFTIMQLVGML 157
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL-SHAQTSSI 886
V + YL VH DL NVL+D ++ V DFGL+ L A ++
Sbjct: 158 RGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 887 FAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
K I + APE + S S DV+S+G+++ E++ ++P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG V+ + K +VAVK A K F E L N++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSLNLLQRLD 827
C G+ +VFE+M + L ++L I + + +A L L Q L
Sbjct: 83 YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 828 IGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
I +A + YL H VH DL N L+ ++ +GDFG++ + ++
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV-----YSTD 187
Query: 886 IFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ G + PE Y + DV+S+G++L E+ T
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 771
IG G FG V++GI + VA+K + + F+ E T++ H ++V
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K++ + ++ E L +L + + SL+L +
Sbjct: 80 KLIGVITENPVW------IIMELCTLGELRSFL----QVRK-----YSLDLASLILYAYQ 124
Query: 832 VACALSYL-HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
++ AL+YL VH D+ NVL+ +GDFGL+ ++ + K
Sbjct: 125 LSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKL 179
Query: 891 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
I ++APE + + S DV+ +G+ + E++ KP
Sbjct: 180 PIKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 717 NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+IG G FG VY G L D K AVK L+ F+ E +K+ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++ +L C +G+ +V +M + L ++ + + + G
Sbjct: 88 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFG 134
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ VA + YL VH DL N +LDE+ V DFGLA + +
Sbjct: 135 LQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM-----YDKEYY 184
Query: 888 AKGS-------IGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR 924
+ + + ++A E + S DV+S+G+LL EL+TR
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTR 228
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 770
+G+G+FG+VYKG+ ++ K VA+K L K + E + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
++L C Q L+ + M L +++ E ++ L+ +
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCV 124
Query: 831 DVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
+A ++YL +VH DL NVL+ + DFGLA L + +
Sbjct: 125 QIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 889 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
K I ++A E + + + S DV+SYG+ + EL+T KP
Sbjct: 180 KVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 771
+G G FG VY+G+ K VAVK + F++E +KN+ H ++V
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K++ + ++ E L +L ++ SL +L + +
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYL----ERNK-----NSLKVLTLVLYSLQ 121
Query: 832 VACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
+ A++YL + VH D+ N+L+ +GDFGL+ ++ + +
Sbjct: 122 ICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTR 175
Query: 890 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
I +++PE + + S DV+ + + + E+++ K+P
Sbjct: 176 LPIKWMSPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 68/280 (24%), Positives = 105/280 (37%), Gaps = 26/280 (9%)
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEM 410
+ T L + N+ L L L+L +NKI AF KL +L +
Sbjct: 54 PDTTLL---DLQNNDISELRKDDFKGL-QHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 411 WNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQ-GSIP 467
N L IPP + +L ELR+ +NR + +P + G + +++ N L+
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNR-IRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 468 SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLE 526
L + +S LT IP L L L L N++ I E L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLY 220
Query: 527 MLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGK 586
L + N++R +L L L + N L +P+ L L+ L V+ L NN++ K
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-K 278
Query: 587 IPE-------FLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
+ F V ++L NN FR
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 66/261 (25%), Positives = 103/261 (39%), Gaps = 18/261 (6%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
S +L L +N I F L L + NN++S I A L+ L++L
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 434 LQENRFLGNIPPSI-GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGT-IP 491
+ +N L IPP++ +L L++ N ++ + I++ N L +
Sbjct: 109 ISKNH-LVEIPPNLPSSLV--ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 492 PQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKL 549
P GL L L +S +LTG IP + L L++ NK++ I L KL
Sbjct: 166 PGAFDGLK--LNYLRISEAKLTG-IPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEG 609
L + N ++ SLS L L L L N LS ++P L +LL+ + L N+
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 610 MVPTEGVFRNASITSVLGNLK 630
V F
Sbjct: 278 KVG-VNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 74/361 (20%), Positives = 131/361 (36%), Gaps = 77/361 (21%)
Query: 70 FCQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSF 120
C V CS + V T+LDL++ ++ + L L L L NN
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 121 HHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLS 180
F LR+LQ L + N + EIP N+ S+L+ +R+ N +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIR----------- 136
Query: 181 KIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSI--PDTFGWLKNLVNLTMAQ 237
+P F L +++ + + N L+ S P F L L L +++
Sbjct: 137 --------------KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE 181
Query: 238 NRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-A 296
+L+ IP + ++ N+IQ I L+ L +G NQ+ I +
Sbjct: 182 AKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGS 236
Query: 297 ISNASNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATR 355
+S L +++NKL+ VP L L+ L + N++
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK----------------- 278
Query: 356 LKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI-FGNI-PAAFGKFVKLLRLEMWNN 413
+ +N+F + + L +N + + + PA F L ++ N
Sbjct: 279 -----VGVNDFCPVGF---GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
Query: 414 R 414
+
Sbjct: 331 K 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 61/396 (15%), Positives = 109/396 (27%), Gaps = 107/396 (27%)
Query: 153 SSCS-NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLF 210
C +L V+ S L +P E+ + N+++ + F L + L
Sbjct: 29 FGCHCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALV 84
Query: 211 LSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270
L N + F L+ L L +++N L IP ++
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--------------------- 122
Query: 271 DIGFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHF 329
+L + N++ +P S N+ ++ N L
Sbjct: 123 ------SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSG------------ 163
Query: 330 VITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSN 389
F GL L L +
Sbjct: 164 -------------------------------FEPGAFDGL----------KLNYLRISEA 182
Query: 390 KIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSI- 447
K+ IP L L + +N++ I + L L L N+ + I
Sbjct: 183 KL-TGIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ-IRMIENGSL 237
Query: 448 GNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP------QLLGLSSL 500
L L L L N L +P+ L + L ++ L NN+T + +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295
Query: 501 LIVLELSRNQLT-GPIPNEV-GNLKNLEMLNVFENK 534
+ L N + + + + + K
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 54/238 (22%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G G FG V K G T VAVK +L A + ++E N LK + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------------HPITREDETEE 815
++K+ ACS Q L+ E+ SL +L
Sbjct: 88 VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 816 APRSLNLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
R+L + + ++ + YL +VH DL N+L+ E + DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 874 TFLPLSHAQTSSIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ + K S G I A E + + DV+S+G+LL E+VT
Sbjct: 198 RDV-----YEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVT 247
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 34/225 (15%)
Query: 718 LIGAGSFGSVYKG---ILDEGKTIVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLV 771
L+G G G VY+ + + IVA+K+ L F++ E T ++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRER---IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
I G G + + ++ L L + P L + + I
Sbjct: 98 PIHD--FGEI-DGQLY--VDMRLINGVDLAAMLR--------RQGP--LAPPRAVAIVRQ 142
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-QTSSIFAKG 890
+ AL H H D+KP N+L+ + A++ DFG+A+ Q + G
Sbjct: 143 IGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--G 197
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
++ Y+APE S + D+Y+ +L E +T P ++GD
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 57/257 (22%), Positives = 89/257 (34%), Gaps = 50/257 (19%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
F LIG+G FG V+K +K + E L + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVH 68
Query: 773 ILTACSGVDYQGNDFKA-----------LVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
G DY + EF +LE+W+ E +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV------ 122
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
L++ + + Y+H +++ DLKPSN+ L + +GDFGL T L
Sbjct: 123 --LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----- 172
Query: 882 QTSSIFAKGSIG---YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932
+ S G Y++PE YG D+Y+ G++L EL+ F
Sbjct: 173 -KNDGKRTRSKGTLRYMSPEQISSQDYGKEV------DLYALGLILAELLHVCDT---AF 222
Query: 933 EGDMNLHNFAKTALPDH 949
E + + D
Sbjct: 223 ETSKFFTDLRDGIISDI 239
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 46/230 (20%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G FG VYKG L E VA+K L A + F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------PITREDETEEAPRSLNLL 823
+V +L + + +++F + + L E+L + D+ +L
Sbjct: 74 VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 824 QRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
+ + +A + YL HH +VH DL NVL+ +++ + D GL +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV----- 178
Query: 882 QTSSIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ + + APE YG S S D++SYG++L E+ +
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G+FG V+ ++ K +VAVK A + F E L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWL-----HPITREDETEEAPRSLNLLQRLDI 828
C+ +G +VFE+M + L +L + AP L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 829 GIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
VA + YL H VH DL N L+ + ++ +GDFG++ + ++
Sbjct: 164 ASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STDY 213
Query: 887 FAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ G + PE Y + S DV+S+G++L E+ T
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTES---DVWSFGVVLWEIFT 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 717 NLIGAGSFGSVYKGIL-----DEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRN 769
+GAG+FG V + ++ VAVK+ H ++ ++E + ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL----HPITREDETEEAPRSLNLLQR 825
+V +L AC+ G ++ E+ L +L + + A + +
Sbjct: 112 IVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 826 LDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
L VA +++L + +H D+ NVLL +A +GDFGLA +
Sbjct: 167 LHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDI-----MN 216
Query: 884 SSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
S + + APE ++ DV+SYGILL E+ +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 40/228 (17%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-RHR 768
+G G+FG V + VAVK +L GA ++ ++E L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSLNL 822
N+V +L AC+ + ++ EF +L +L + + L L
Sbjct: 92 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 823 LQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ VA + +L +H DL N+LL E+ + + DFGLA +
Sbjct: 148 EHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI---- 198
Query: 881 AQTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ + + APE +I DV+S+G+LL E+ +
Sbjct: 199 -YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 719 IGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 771
+GAG FG V G L + + VA+K L G + F+ E + + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 772 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++ + +V E+M N SL+ +L R+ + ++Q + +
Sbjct: 110 RLEGVVTKSKPVM-------IVTEYMENGSLDSFL----RKHD-----AQFTVIQLVGML 153
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP-LSHAQTSSI 886
+A + YL VH DL N+L++ ++ V DFGL L A ++
Sbjct: 154 RGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 927
K I + +PE + + DV+SYGI+L E+++ ++P
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 33/225 (14%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNI-RHRNLV 771
+GAG+FG V + + VAVK+ H ++ ++E L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------HPITREDETEEAPRSLNLL 823
+L AC+ G ++ E+ L +L T E+ +L+L
Sbjct: 91 NLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
L VA +++L +H DL N+LL I + DFGLA + +
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI-----KN 197
Query: 884 SSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
S + + APE + DV+SYGI L EL +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 717 NLIGAGSFGSVYKGIL--DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-RHRN 769
++IG G+FG V K + D + A+K + A + F E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSLNLL 823
++ +L AC Y L E+ + +L ++L +L+
Sbjct: 88 IINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 824 QRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
Q L DVA + YL +H DL N+L+ E +A + DFGL +
Sbjct: 143 QLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGL--------S 189
Query: 882 QTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ ++ K ++G + A E S + N DV+SYG+LL E+V+
Sbjct: 190 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 719 IGAGSFGSVYKGIL--DEGKTIVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLVK 772
+G G+FGSV +G+ + + VA+KV L G K+ + E + + + +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
++ C LV E L ++L + + ++ V
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQV 445
Query: 833 ACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAK 889
+ + YL + VH +L NVLL A + DFGL+ L + T+ K
Sbjct: 446 SMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ + APE + S DV+SYG+ + E ++ +KP
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 770
IGAG FG VYKG+L + + VA+K L G F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 771 VKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
+++ S ++ E+M N +L+++L RE + ++LQ + +
Sbjct: 109 IRLEGVISKYKPMM-------IITEYMENGALDKFL----REKD-----GEFSVLQLVGM 152
Query: 829 GIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP-LSHAQTSS 885
+A + YL + VH DL N+L++ ++ V DFGL+ L A ++
Sbjct: 153 LRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 886 IFAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
K I + APE Y + + DV+S+GI++ E++T ++P
Sbjct: 208 SGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 37/218 (16%)
Query: 719 IGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 770
+G G FG V D +VAVK L A + E + L+ + H ++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+K C LV E++ SL ++L S+ L Q L
Sbjct: 96 IKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQ 141
Query: 831 DVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH----AQTSS 885
+ ++YLH +H DL NVLLD + + +GDFGLA +P H +
Sbjct: 142 QICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED- 196
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
+ + APE + DV+S+G+ L EL+T
Sbjct: 197 --GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G G+FG VY+G + D VAVK L F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V+ + Q ++ E M L+ +L P SL +L L +
Sbjct: 95 IVRCIGVSL----QSLPR-FILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVA 146
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLD---EEMIAHVGDFGLATFLPLSHAQTS 884
D+AC YL +H +H D+ N LL +A +GDFG+A + +
Sbjct: 147 RDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRA 196
Query: 885 SIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
S + KG + PE G+ + D +S+G+LL E+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 69/454 (15%), Positives = 145/454 (31%), Gaps = 72/454 (15%)
Query: 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215
N ++ E+ L+ + +++T + L+ ++ L + NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
+ ++ NL L N+L+ + + ++ +T + N++ LD+
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS-Q 125
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L + + RN LT I +S+ + L + NK + +L+ + N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNK 181
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+ ++++ L L D+N I +
Sbjct: 182 ITE----------------------LDVSQN------------KLLNRLNCDTNNIT-KL 206
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNL 455
+ ++L L+ +N+L+ I + L L N L + S KL L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNP-LTELDVS-TLSKLTTL 259
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
L I L + L + + ++ L +L+ +T
Sbjct: 260 HCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD---VTHNTQLYLLDCQAAGIT--- 310
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSV 575
++ L L + +L E+ + KL+ L +Q S+ + L+
Sbjct: 311 ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNN 365
Query: 576 LDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEG 609
++ E L L ++ D G
Sbjct: 366 NFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 86/428 (20%), Positives = 159/428 (37%), Gaps = 58/428 (13%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163
L+ L LD HN+S + ++L L L +N+I + +S +NL +
Sbjct: 38 EEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDT 223
SN+L + + L+K+ Y + N LT + +++L +RN L I
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID-- 143
Query: 224 FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
L L N+ + + + +T D N+I LD+ + L +
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVS-QNKLLNRLN 197
Query: 284 VGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRD 343
N +T + ++ L +SNKLT E+ + L +L++F + N L +
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID-VTPLTQLTYFDCSVNPLTELDVST 252
Query: 344 LNFL----CS--------LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI 391
L+ L C LT+ T+L +F + +++ T L +L + I
Sbjct: 253 LSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRK--IKELDVTHN-TQLYLLDCQAAGI 309
Query: 392 FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451
+ + KL+ L + N L+ + + L+ L + +
Sbjct: 310 -TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH-IQDFSSVGKIPA 362
Query: 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQL 511
L N + Q+ T+ L+NN+LT + P LL + +E +
Sbjct: 363 LNNNFEAEG-----------QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411
Query: 512 TGPIPNEV 519
N +
Sbjct: 412 YDQATNTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 84/511 (16%), Positives = 156/511 (30%), Gaps = 85/511 (16%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
++L L L HN+SI ++ I + L ++ +SN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNNIT 77
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229
+ L + + Y + N LT ++ L+ +++L N L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
L L A+N L+ I S + + +T D +N+ + + L N++
Sbjct: 129 LTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKI 182
Query: 290 TGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
T + +S L ++N +T ++ L + +L+ + N L
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT-KLD-LNQNIQLTFLDCSSNKLTE----------- 226
Query: 350 LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE 409
I++ T L N + + KL L
Sbjct: 227 -----------IDVTPL------------TQLTYFDCSVNPL-TELD--VSTLSKLTTLH 260
Query: 410 MWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSS 469
L I + L + + R + + + N +L+ L + +
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT-HNTQLYLLDCQAAGIT-ELD-- 313
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLN 529
L Q+ L + L+N LT + + L L + VG + L
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELDVSHN---TKLKSLSCVNAHIQD-FS-SVGKIPALNNNF 367
Query: 530 VFENKLRGEIPRTLGS-----CIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
E + TL + + +LL GN + I + + ++ NLS
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLS 425
Query: 585 GKIPEFLVGFQLLEYLNLSNNDFEGMVPTEG 615
P F N G V T
Sbjct: 426 TDNPAVTYTF------TSENGAIVGTVTTPF 450
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 72/432 (16%), Positives = 134/432 (31%), Gaps = 53/432 (12%)
Query: 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIG 273
+ + PD N + A + T S ++++T D + I + ++
Sbjct: 9 QSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE-- 61
Query: 274 FTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITR 333
L L N +T + +S +NL +SNKLT + + L +L++
Sbjct: 62 -KLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDT 115
Query: 334 NSLGSGEHRDLNFLCSL------------TNATRLKWFHININNFGGLLPACISNFSTTL 381
N L + L L ++ T+L ++N L ++ T L
Sbjct: 116 NKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQ-TQL 172
Query: 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLG 441
L NKI + + L RL N ++ + + + L L N+ L
Sbjct: 173 TTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK-LT 225
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
I + +L S N L + S LT + +L + L+
Sbjct: 226 EIDVT-PLTQLTYFDCSVNPLT-ELDVSTLSK--LTTLHCIQTDLLE------IDLTHNT 275
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561
++ +V + L +L+ + E+ L KL L + L
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE 332
Query: 562 PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNAS 621
+ +S L L ++ + L + M + +
Sbjct: 333 -LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLT 387
Query: 622 ITSVLGNLKLCG 633
I L G
Sbjct: 388 IAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 50/279 (17%), Positives = 96/279 (34%), Gaps = 28/279 (10%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
T LD K + V + L LD N + + + L L N+I
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT- 204
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI 206
++ ++ L + SSN+L ++ L+++ YF S N LT + S LS +
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKL 256
Query: 207 SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266
+ L + +L I L+ R + + + + + + D I
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT- 310
Query: 267 VIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRL 326
LD+ L + + +LT + +S+ + L+ + + + + K+ L
Sbjct: 311 --ELDLSQ-NPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPAL 363
Query: 327 SHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININN 365
++ + L SLT A N
Sbjct: 364 NNNFEAEGQTITMPKETLT-NNSLTIAVSPDLLDQFGNP 401
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 43/230 (18%)
Query: 719 IGAGSFGSVYKGIL-------DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 766
+G G+FG V + VAVK+ L A ++E +K I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSL 820
H+N++ +L AC+ Q ++ E+ +L E+L D +
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 821 NLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
+ +A + YL +H DL NVL+ E + + DFGLA +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI-- 207
Query: 879 SHAQTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ K + G + APE + DV+S+G+L+ E+ T
Sbjct: 208 ---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 46/230 (20%), Positives = 92/230 (40%), Gaps = 48/230 (20%)
Query: 719 IGAGSFGSVYKGIL-------DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 771
+G G+F ++KG+ +T V +KV + H +SF + + + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 772 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
C D LV EF+ SL+ +L + +N+L +L++
Sbjct: 76 LNYGVCVCGDENI-------LVQEFVKFGSLDTYLK---------KNKNCINILWKLEVA 119
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLD--------EEMIAHVGDFGLATFLPLS 879
+A A+ +L + ++H ++ N+LL + D G++ +
Sbjct: 120 KQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--- 171
Query: 880 HAQTSSIFAKGSIGYIAPE-YGLGSEVSINGDVYSYGILLLELVTR-KKP 927
+ I ++ PE +++ D +S+G L E+ + KP
Sbjct: 172 ---LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 57/235 (24%), Positives = 88/235 (37%), Gaps = 48/235 (20%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-RHR 768
+G+G+FG V VAVK +L A ++ ++E + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL-------------HPITREDETEE 815
N+V +L AC+ L+FE+ L +L + + E EE
Sbjct: 110 NIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 816 APRSLNLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
L L VA + +L VH DL NVL+ + + DFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 874 TFLPLSHAQTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ + S + + APE +I DV+SYGILL E+ +
Sbjct: 220 RDI-----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 20/213 (9%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
++G G++G VY G + +A+K + E K+++H+N+V+ L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
G + K + E + SL L + E Q L+ L
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLK 136
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YLH + IVH D+K NVL++ + + DFG + L + T + G++ Y+A
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 191
Query: 897 PEYGLGSEVSING--DVYSYGILLLELVTRKKP 927
PE D++S G ++E+ T K P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 57/261 (21%), Positives = 101/261 (38%), Gaps = 17/261 (6%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
+ +L L +NKI F L L + NN++S I P A L L L
Sbjct: 48 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY 106
Query: 434 LQENRFLGNIPPSI-GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT-GTIP 491
L +N+ L +P + L+ L++ N + S + +++L N L I
Sbjct: 107 LSKNQ-LKELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 492 PQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIP-RTLGSCIKL 549
G+ L + ++ +T IP G +L L++ NK+ ++ +L L
Sbjct: 164 NGAFQGMKK-LSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNL 218
Query: 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEG 609
L + N + SL++ L L L+ N L K+P L + ++ + L NN+
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
Query: 610 MVPTEGVFRNASITSVLGNLK 630
+ F + +
Sbjct: 278 I--GSNDFCPPGYNTKKASYS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 45/289 (15%)
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEM 410
+ L + N + N L L+L +NKI P AF VKL RL +
Sbjct: 52 PDTALL---DLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYL 107
Query: 411 WNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSI-- 466
N+L +P + L+ELR+ EN + + S+ G ++ ++L N L+ S
Sbjct: 108 SKNQLK-ELPE--KMPKTLQELRVHENE-ITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 467 PSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSL--------------------LIVLE 505
+ + L+ I +++ N+T TIP L L+ L L L
Sbjct: 164 NGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 506 LSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG--- 561
LS N ++ + N N +L L++ NKL ++P L ++++ + N +
Sbjct: 223 LSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 562 ---PIPSSLSSLRGLSVLDLSQNNLS-GKIPEFL-VGFQLLEYLNLSNN 605
P + S + L N + +I + + L N
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 65/343 (18%), Positives = 116/343 (33%), Gaps = 80/343 (23%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
+LDL NN +F L+ L L L NN I +I + L R+ LS N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSI--PDTFG 225
++P ++ ++ V N +T + F L+ + + L N L S F
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
+K L + +A ++ TIP + S+T N+I + L NL +
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 286 RNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDL 344
N ++ A+ +++N +L +N+NKL +VP
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVP-------------------------- 256
Query: 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI-------FGNIPA 397
++V+ L +N I F P
Sbjct: 257 -------------------GGLADH---------KYIQVVYLHNNNISAIGSNDFCP-PG 287
Query: 398 AFGKFVKLLRLEMWNNRLSGT-IPP-AIGELQNLRELRLQENR 438
K + +++N + I P + ++L +
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 55/285 (19%), Positives = 113/285 (39%), Gaps = 29/285 (10%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH 122
C V CS ++V +LDL++ K+ NL L L L NN
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 123 EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSE-LGSLSK 181
P F L +L+ L L N + E+P + L +R+ NE+ K+ L++
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 182 IEYFSVSYNNLT-GSIPP-SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNR 239
+ + N L I +F + +S++ ++ N+ +IP G +L L + N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203
Query: 240 LSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAIS 298
++ + ++ ++++ N I + +L+ + N+L +P ++
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 299 NASNLEVFQVNSNKLT-------GEVPYLEKLQRLSHFVITRNSL 336
+ ++V +++N ++ Y K S + N +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 34/145 (23%), Positives = 61/145 (42%), Gaps = 9/145 (6%)
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L ++ S+ L +P L +L+L N++T + NLKNL L + NK+
Sbjct: 33 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF-LVGF 594
P +KLE L + N L+ +P + + L L + +N ++ K+ + G
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 595 QLLEYLNLSNNDFEGMVPTEGVFRN 619
+ + L N + G F+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQG 169
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 35/251 (13%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRN 769
F +G G FG V++ A+K L + + + E L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 770 LVKILTACSGVDYQGNDFKA-------LVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
+V+ A + + + + +L++W++ +E E +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS------ 118
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL------ 876
L I + +A A+ +LH ++H DLKPSN+ + + VGDFGL T +
Sbjct: 119 -VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 877 -PLSHAQTSSIFAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932
+ + G +G Y++PE G+ S D++S G++L EL+ F
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------F 227
Query: 933 EGDMNLHNFAK 943
M
Sbjct: 228 STQMERVRTLT 238
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 719 IGAGSFGSVYKGIL-------DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 766
+G G+FG V T VAVK +L A I+E +K I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSL 820
H+N++ +L AC+ Q ++ E+ +L E+L + + L
Sbjct: 134 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 821 NLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
+ + VA + YL +H DL NVL+ E+ + + DFGLA +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDI-- 241
Query: 879 SHAQTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ K + G + APE + DV+S+G+LL E+ T
Sbjct: 242 ---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 60/253 (23%), Positives = 95/253 (37%), Gaps = 35/253 (13%)
Query: 683 RKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK 742
R+ S + S + F + +G GS+G V+K E + AVK
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 743 VFNLLHHGAF--KSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS 799
G +AE + + + +H V++ A ++ L E S
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELC-GPS 142
Query: 800 LEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
L++ E SL Q D AL++LH +VH D+KP+N+ L
Sbjct: 143 LQQHC---------EAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFL 190
Query: 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE-----YGLGSEVSINGDVYSY 914
+GDFGL L A + +G Y+APE YG + DV+S
Sbjct: 191 GPRGRCKLGDFGLLVE--LGTAGAGEVQ-EGDPRYMAPELLQGSYGTAA------DVFSL 241
Query: 915 GILLLELVTRKKP 927
G+ +LE+ +
Sbjct: 242 GLTILEVACNMEL 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 35/237 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 768
+ + IG GS+G K I+ K + + + ++E N L+ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRL 826
N+V+ +D +V E+ L + T+E + EE L
Sbjct: 66 NIVRYYD--RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEE--------FVL 114
Query: 827 DIGIDVACALSYLH--HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
+ + AL H D ++H DLKP+NV LD + +GDFGLA L +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 885 SIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ G+ Y++PE Y S D++S G LL EL P F
Sbjct: 175 TF--VGTPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 57/236 (24%), Positives = 85/236 (36%), Gaps = 11/236 (4%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
+ L L N I F L L++ N + I A L +L L
Sbjct: 71 QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 434 LQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSLGQS-ETLTIIDLSNNNLTGTI 490
L +N L IP KL L L N ++ SIPS +L +DL I
Sbjct: 130 LFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYI 187
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKL 549
GL +L L L + +P + L LE L + N P + L
Sbjct: 188 SEGAFEGLFNL-KYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+ L + + + ++ L L L+L+ NNLS + + L L+L +N
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 59/235 (25%), Positives = 86/235 (36%), Gaps = 12/235 (5%)
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWN 412
+ ++ ++ NN + + LEVL L N I I AF L LE+++
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132
Query: 413 NRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLS-YNFLQGSIPS 468
N L+ IP A L LREL L+ N + +IP L L L L+
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNP-IESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 469 SLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528
+ L ++L N+ P L L L LE+S N P L +L+ L
Sbjct: 191 AFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLE-ELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
V +++ L L + N L + LR L L L N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 91 LKSLKLAG----YISAHV-GNLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSI 144
L+ L+L I L+ L L+L +N IPS F+ L +L+ L L NN I
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPI 159
Query: 145 GGEIPANI-SSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPSFGN 202
IP+ + +L+R+ L + + I L ++Y ++ N+ +P +
Sbjct: 160 E-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTP 216
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGI 261
L + L +S N+ P +F L +L L + +++S I + F ++S+ +
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAH 275
Query: 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
N + +P D+ L+ L + N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 56/279 (20%), Positives = 90/279 (32%), Gaps = 49/279 (17%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
+ L+L N+ F L L+VL L NSI +I + ++L + L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 169 VGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIP-DTFG 225
IPS LSK+ + N + SIP +F + S+ L L I F
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L NL L + NI + L L+ +
Sbjct: 194 GLFNLKYLNLGMC-----------NIKDMPNLTP----------------LVGLEELEMS 226
Query: 286 RNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPY--LEKLQRLSHFVITRNSLGSGEHR 342
N I P + S+L+ V +++++ + + L L + N+L S H
Sbjct: 227 GNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 343 DLNFLCSLTNAT----------RLKWFHININNFGGLLP 371
L L + W + +
Sbjct: 285 LFTPLRYLVELHLHHNPWNCDCDILWLAWWLREYIPTNS 323
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 45/196 (22%), Positives = 66/196 (33%), Gaps = 14/196 (7%)
Query: 428 NLRELRLQENRFLGNIPPSI-GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNL 486
++ L +P I N + L L N +Q + L ++ L N++
Sbjct: 55 QFSKVVCTRRG-LSEVPQGIPSNTRY--LNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 487 TGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLG 544
I GL+SL LEL N LT IP+ L L L + N +
Sbjct: 112 R-QIEVGAFNGLASL-NTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 545 SCIKLELLQMQG-NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLS 603
L L + L+ + L L L+L N+ +P LE L +S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMS 226
Query: 604 NNDFEGMVPTEGVFRN 619
N F G F
Sbjct: 227 GNHFP--EIRPGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 14/136 (10%)
Query: 91 LKSLKLAGY-----ISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSI 144
L L L IS L LK L+L + +P+ L L+ L + N
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHF 230
Query: 145 GGEIPAN-ISSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPS-FG 201
EI S+L ++ + ++++ I L+ + ++++NNL+ S+P F
Sbjct: 231 P-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
Query: 202 NLSSISFLFLSRNNLD 217
L + L L N +
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
+G G+FG VY+G + D VAVK L F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V+ + Q ++ E M L+ +L P SL +L L +
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVA 187
Query: 830 IDVACALSYL--HHDCQPPIVHCDLKPSNVLLD---EEMIAHVGDFGLATFLPLSHAQTS 884
D+AC YL +H +H D+ N LL +A +GDFG+A + +
Sbjct: 188 RDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRA 237
Query: 885 SIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ KG + PE G+ + + D +S+G+LL E+ +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 281
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 43/230 (18%)
Query: 719 IGAGSFGSVYKGIL-------DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 766
+G G FG V + VAVK+ L A ++E +K I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETEEAPRSL 820
H+N++ +L AC+ Q ++ E+ +L E+L D +
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 821 NLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
+ +A + YL +H DL NVL+ E + + DFGLA +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI-- 253
Query: 879 SHAQTSSIFAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 923
+ K + G + APE + DV+S+G+L+ E+ T
Sbjct: 254 ---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/238 (22%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
F ++G G+FG V K A+K + ++E L ++ H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 773 ILTACSGVDYQGNDFKA--------LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQ 824
A A + E+ N +L + +H + +E
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-------- 118
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-------- 876
+ + ALSY+H I+H DLKP N+ +DE +GDFGLA +
Sbjct: 119 -WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 877 -PLSHAQTSSIFAKGSIG---YIAPE-------YGLGSEVSINGDVYSYGILLLELVT 923
+ SS +IG Y+A E Y ++ D+YS GI+ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIY 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 11/236 (4%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
ST +L L N+I +F L L++ N + TI A L NL L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118
Query: 434 LQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSL-GQSETLTIIDLSNNNLTGTI 490
L +NR L IP KL L L N ++ SIPS + +L +DL I
Sbjct: 119 LFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKL 549
GLS+L L L+ L IP + L L+ L++ N L P + + L
Sbjct: 177 SEGAFEGLSNLR-YLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+ L M + +Q ++ +L+ L ++L+ NNL+ + LE ++L +N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 12/225 (5%)
Query: 364 NNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP- 421
N + + LE+L L N I I AF L LE+++NRL+ TIP
Sbjct: 74 NQIQIIKVNSFKHL-RHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNG 130
Query: 422 AIGELQNLRELRLQENRFLGNIPPSI-GNL-KLFNLQLS-YNFLQGSIPSSLGQSETLTI 478
A L L+EL L+ N + +IP + L L L L + L
Sbjct: 131 AFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY 189
Query: 479 IDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE 538
++L+ NL IP L L L L+LS N L+ P L +L+ L + +++++
Sbjct: 190 LNLAMCNLR-EIPN-LTPLIKLD-ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246
Query: 539 IPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
+ L + + N L + L L + L N
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 91 LKSLKLAG----YISAHV-GNLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSI 144
L+ L+L+ I L+ L L+L +N IP+ F L +L+ L L NN I
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 145 GGEIPANI-SSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPSFGN 202
IP+ + +L R+ L + + I LS + Y +++ NL IP +
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTP 205
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGI 261
L + L LS N+L P +F L +L L M Q+++ I + F N+ S+ +
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264
Query: 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
N + ++P D+ L +L+ + N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 48/226 (21%), Positives = 79/226 (34%), Gaps = 40/226 (17%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
++L+LH N + F LR L++L L N I I + +NL + L N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 169 VGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIP-DTFG 225
IP+ LSK++ + N + SIP +F + S+ L L I F
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L NL L +A N+ I L L +
Sbjct: 183 GLSNLRYLNLAMC-----------NLREIPNLT----------------PLIKLDELDLS 215
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-----YLEKLQRL 326
N L+ P + +L+ + +++ + L+ L +
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEI 260
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 54/197 (27%), Positives = 78/197 (39%), Gaps = 16/197 (8%)
Query: 428 NLRELRLQENRFLGNIPPSI-GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNL 486
++ L +P I N +L L L N +Q +S L I+ LS N++
Sbjct: 44 QFSKVICVRKN-LREVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 487 TGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIP-RTL 543
TI GL++L LEL N+LT IPN L L+ L + N + IP
Sbjct: 101 R-TIEIGAFNGLANLNT-LELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 544 GSCIKLELLQMQG-NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNL 602
L L + L + L L L+L+ NL +IP L+ L+L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLT-PLIKLDELDL 214
Query: 603 SNNDFEGMVPTEGVFRN 619
S N + P G F+
Sbjct: 215 SGNHLSAIRP--GSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 33/138 (23%), Positives = 57/138 (41%), Gaps = 9/138 (6%)
Query: 84 QRVTILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142
+ LDL LK YIS LS L+ L+L + IP+ L +L L L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGN 217
Query: 143 SIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPS- 199
+ I +L ++ + +++ I +L + ++++NNLT +P
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 200 FGNLSSISFLFLSRNNLD 217
F L + + L N +
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 12/241 (4%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLS--GTIPPAIGELQNLREL 432
+ ++ L L+SNK+ F K +L +L + +N LS G + +L+ L
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83
Query: 433 RLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQS-ETLTIIDLSNNNLTGTI 490
L N + + + L +L +L ++ L+ S+ S L +D+S+ +
Sbjct: 84 DLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VA 141
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
+ GLSSL VL+++ N ++ L+NL L++ + +L P S
Sbjct: 142 FNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE--FLVGFQLLEYLNLSNND 606
L++L M N L L VLD S N++ + L +LNL+ ND
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQND 259
Query: 607 F 607
F
Sbjct: 260 F 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 15/239 (6%)
Query: 388 SNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI 447
++K ++P L LE +N+L +L L +L L N S
Sbjct: 15 NSKGLTSVPTGIPSSATRLELE--SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 448 GNLKLFNLQ---LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ--LLGLSSLLI 502
+ +L+ LS+N + ++ S+ E L +D ++NL + L L +L I
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL-I 129
Query: 503 VLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGNFLQ 560
L++S N + L +LE+L + N + L L + L+
Sbjct: 130 YLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 561 GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
P++ +SL L VL++S NN L+ L+ S N + ++
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK-KQELQH 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 54/260 (20%), Positives = 93/260 (35%), Gaps = 23/260 (8%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNN--SF 120
C + C+ + V T L+L+S KL L+ L L L +N SF
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 121 HHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSE--LGS 178
L+ L L N + + +N L + + L ++ S
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124
Query: 179 LSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSI-PDTFGWLKNLVNLTMA 236
L + Y +S+ + F LSS+ L ++ N+ + PD F L+NL L ++
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 237 QNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP 295
Q +L + + F ++SS+ V + N + L +LQ N +
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 296 AI--SNASNLEVFQVNSNKL 313
S+L + N
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 48/251 (19%), Positives = 93/251 (37%), Gaps = 17/251 (6%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT--GSIPPSFGNLS 204
+P I S + R+ L SN+L L+++ S+S N L+ G S +
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 205 SISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQ 263
S+ +L LS N + ++ F L+ L +L + L S+F ++ ++ D
Sbjct: 79 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPY--L 320
+ V I L +L+ + N P + NL ++ +L ++
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 321 EKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTT 380
L L ++ N+ S + L+ ++N+ + +F ++
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTF------PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 381 LEVLLLDSNKI 391
L L L N
Sbjct: 250 LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 55/308 (17%), Positives = 91/308 (29%), Gaps = 71/308 (23%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS-GTIPS 246
+ LT S+P SS + L L N L F L L L+++ N LS S
Sbjct: 15 NSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 247 SIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVF 306
F +L++ + N + + LE
Sbjct: 72 QSD------------------------FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106
Query: 307 QVNSNKLT--GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININ 364
+ L E L+ L + I+
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV----------------------AFNG 144
Query: 365 NFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-A 422
F GL ++LEVL + N N F + L L++ +L + P A
Sbjct: 145 IFNGL---------SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 423 IGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSLGQS--ETLTI 478
L +L+ L + N ++ L L S N + + Q +L
Sbjct: 195 FNSLSSLQVLNMSHNN-FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF 252
Query: 479 IDLSNNNL 486
++L+ N+
Sbjct: 253 LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 34/140 (24%), Positives = 60/140 (42%), Gaps = 6/140 (4%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
+L L LD+ + F+ L L+VL + NS +I + NL + LS
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 165 SNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD 222
+L ++ SLS ++ ++S+NN S+ + L+S+ L S N++ S
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 223 TFGWL-KNLVNLTMAQNRLS 241
+L L + QN +
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 22/135 (16%), Positives = 43/135 (31%), Gaps = 30/135 (22%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSI 144
+L + + L L LDL + F+ L LQVL + +N+
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNF 211
Query: 145 GGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNL 203
+ L+ ++ S N++ + +
Sbjct: 212 -FSLDTFP-----------------------YKCLNSLQVLDYSLNHIM-TSKKQELQHF 246
Query: 204 -SSISFLFLSRNNLD 217
SS++FL L++N+
Sbjct: 247 PSSLAFLNLTQNDFA 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 63/338 (18%), Positives = 119/338 (35%), Gaps = 79/338 (23%)
Query: 642 TCSPKKSKHKRLTLALKLA-----LAIISGLIGLSLALSFLIICL------------VRK 684
S + K ++ L LK+A L + + + ++ ++ LI +R
Sbjct: 273 QYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRP 332
Query: 685 RKENQNPSSPINSFPNISYQNLYNATDGFTSAN--------------------------- 717
+KE + I N Q + + T + +
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 718 ----LIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIR 766
IG G FG V++GI + VA+K + + F+ E T++
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCTSDSVREKFLQEALTMRQFD 449
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H ++VK++ + ++ E L +L SL+L +
Sbjct: 450 HPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ---------VRKFSLDLASLI 494
Query: 827 DIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
++ AL+YL VH D+ NVL+ +GDFGL+ ++ +
Sbjct: 495 LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKA 549
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923
K I ++APE + DV+ +G+ + E++
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 54/238 (22%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 769
IG G+FG V++ E T+VAVK+ L A F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDNPN 111
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------------HPITREDETEE 815
+VK+L C+ G L+FE+M L E+L TR +
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 816 APRSLNLLQRLDIGIDVACALSYL--HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA 873
P L+ ++L I VA ++YL VH DL N L+ E M+ + DFGL+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 874 TFLPLSHAQTSSIFAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 923
+ ++ + I PE Y + S DV++YG++L E+ +
Sbjct: 222 RNI-----YSADYYKADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGVVLWEIFS 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 28/262 (10%)
Query: 683 RKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK 742
+ + P + YN F IG G F VY+ VA+K
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63
Query: 743 VFNLLHHGAFK---SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS 799
+ K I E + LK + H N++K + + ++ +V E
Sbjct: 64 KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGD 118
Query: 800 LEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857
L + ++ E + + AL ++H ++H D+KP+NV
Sbjct: 119 LSRMIKHFKKQKRLIPER--------TVWKYFVQLCSALEHMH---SRRVMHRDIKPANV 167
Query: 858 LLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGIL 917
+ + +GD GL F S+ G+ Y++PE + + D++S G L
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 918 LLELVTRKKPTDIMFEGD-MNL 938
L E+ + P F GD MNL
Sbjct: 226 LYEMAALQSP----FYGDKMNL 243
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 58/261 (22%), Positives = 102/261 (39%), Gaps = 44/261 (16%)
Query: 686 KENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
+ + S N+ +Q++ ++ IG+G V++ L+E K I A+K N
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61
Query: 746 L--LHHGAFKSFIAECNTLKNIRHRNL--VKILTACSGVDYQGNDFKALVFEFMHNRSLE 801
L + S+ E L ++ + +++ + +V E N L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY----DYEITDQYIY-MVMEC-GNIDLN 115
Query: 802 EWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLD 860
WL D E ++ A+ +H H IVH DLKP+N L+
Sbjct: 116 SWLKKKKSIDPWERK----------SYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 161
Query: 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAK---GSIGYIAPE-----------YGLGSEVS 906
+ M+ + DFG+A + T+S+ G++ Y+ PE S++S
Sbjct: 162 DGML-KLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 217
Query: 907 INGDVYSYGILLLELVTRKKP 927
DV+S G +L + K P
Sbjct: 218 PKSDVWSLGCILYYMTYGKTP 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/324 (17%), Positives = 106/324 (32%), Gaps = 62/324 (19%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G F V A+K + E + + H N+++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACA 835
++ L+ F +L + + + TE+ Q L + + +
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNFLTED--------QILWLLLGICRG 146
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA------- 888
L +H H DLKP+N+LL +E + D G + +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 889 KGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942
+ +I Y APE + + E + DV+S G +L ++ + P ++
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV------- 249
Query: 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ-ARINSKIECLVAMARIGVACSMESPE 1001
D LAV Q R +S + L+ P
Sbjct: 250 --------------FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNS------MMTVDPH 289
Query: 1002 DRMDMTNVVHQLQSIKNILLGQRI 1025
R + ++ QL++++ GQ
Sbjct: 290 QRPHIPLLLSQLEALQPPAPGQHT 313
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/234 (25%), Positives = 91/234 (38%), Gaps = 29/234 (12%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
+ + L N+I A+F L L + +N L+ I A L L +L
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLD 86
Query: 434 LQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ 493
L +N L ++ P+ F LG+ L + L L + P
Sbjct: 87 LSDNAQLRSVDPAT-------------F------HGLGR---LHTLHLDRCGLQ-ELGPG 123
Query: 494 LL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
L GL++L L L N L +P++ +L NL L + N++ R L+
Sbjct: 124 LFRGLAALQY-LYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 552 LQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
L + N + P + L L L L NNLS E L + L+YL L++N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 44/226 (19%), Positives = 88/226 (38%), Gaps = 16/226 (7%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
+C ++ Q V + L +++ +A L +L LH+N +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 128 FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYF 185
F L L+ L L +N+ + L + L L ++ L+ ++Y
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 186 SVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244
+ N L ++P +F +L +++ LFL N + F L +L L + QNR++ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HV 192
Query: 245 PSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
F ++ + N + +P + L+ LQ+ + N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 46/249 (18%), Positives = 82/249 (32%), Gaps = 42/249 (16%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLS 327
+P+ I Q + + N+++ + NL + ++SN L
Sbjct: 26 VPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLA------------- 69
Query: 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLD 387
+ + + T L+ ++ N + + L L LD
Sbjct: 70 -------RIDAA---------AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 388 SNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPP 445
+ + F L L + +N L +P +L NL L L NR + ++P
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR-ISSVPE 170
Query: 446 SI--GNLKLFNLQLSYNFLQGSIPSSLGQS-ETLTIIDLSNNNLTGTIPPQLLGLSSLLI 502
G L L L N + + + L + L NNL+ +P + L L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQ 228
Query: 503 VLELSRNQL 511
L L+ N
Sbjct: 229 YLRLNDNPW 237
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 55/253 (21%), Positives = 99/253 (39%), Gaps = 40/253 (15%)
Query: 691 PSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG 750
S N+ +Q++ + + IG GSFG E +K N+
Sbjct: 8 SSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 751 A--FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 808
+ + E L N++H N+V+ + ++ N +V ++ L + ++
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 809 REDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868
E+ Q LD + + AL ++H I+H D+K N+ L ++ +G
Sbjct: 119 GVLFQED--------QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG 167
Query: 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELV 922
DFG+A L + + G+ Y++PE Y S D+++ G +L EL
Sbjct: 168 DFGIARVLNSTVELARAC--IGTPYYLSPEICENKPYNNKS------DIWALGCVLYELC 219
Query: 923 TRKKPTDIMFEGD 935
T K FE
Sbjct: 220 TLKHA----FEAG 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRN 769
D F + +GAG+ G V+K ++A K+ +L A ++ I E L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V G Y + + E M SL++ L R E +
Sbjct: 93 IVG----FYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGK----------VS 137
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
I V L+YL + I+H D+KPSN+L++ + DFG++ L S A + F
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FV- 191
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y++PE G+ S+ D++S G+ L+E+ + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 26/255 (10%), Positives = 56/255 (21%), Gaps = 30/255 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+ G V+ E A+KVF + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 775 TAC-------SGVDYQGNDFKALVFEFMHNRSLEEWL----------HPITREDETEEAP 817
+ F L L + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 818 RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
+L + + + L +VH P N+ + + +GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPTDIMFEGD 935
+ + Y E+ S + + + G+ + + P ++ G
Sbjct: 243 -KVGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 936 MNLHNFAKTALPDHV 950
+P
Sbjct: 301 KGSWKRPSLRVPGTD 315
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/237 (22%), Positives = 87/237 (36%), Gaps = 28/237 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTA 776
++ G F VY+ A+K ++ I E +K + H N+V+ +A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 777 CSGV--DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
S + + L+ + L E+L + L I
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD-------TVLKIFYQTCR 147
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK----- 889
A+ ++H +PPI+H DLK N+LL + + DFG AT + + S +
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 890 -----GSIGYIAPE-YGLGSEVSIN--GDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
+ Y PE L S I D+++ G +L L R+ P FE L
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 48/219 (21%), Positives = 78/219 (35%), Gaps = 27/219 (12%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
T +G GSFG V++ + AVK L + E + +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVP 114
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ G +G + E + SL + + + E L+
Sbjct: 115 LY----GAVREGPWVN-IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------- 161
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIFA--- 888
L YLH I+H D+K NVLL + A + DFG A L S +
Sbjct: 162 --GLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE +G D++S ++L ++ P
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 51/250 (20%), Positives = 96/250 (38%), Gaps = 33/250 (13%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNIR 766
+ + ++++G G+ +V++G + + A+KVFN + + E LK +
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H+N+VK+ + K L+ EF SL L + E L +L+
Sbjct: 66 HKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR-- 119
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATFLPLSHAQ 882
DV +++L + IVH ++KP N++ D + + + DFG A L
Sbjct: 120 ----DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVSING--------DVYSYGILLLELVTRKKPTDIMFEG 934
S G+ Y+ P+ + + + D++S G+ T P F
Sbjct: 173 VSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRP 225
Query: 935 DMNLHNFAKT 944
+
Sbjct: 226 FEGPRRNKEV 235
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 50/273 (18%), Positives = 95/273 (34%), Gaps = 31/273 (11%)
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLE 409
L ++ N + + + L+ L+L SN I I +F L L+
Sbjct: 52 EAVKSL---DLSNNRITYISNSDLQRC-VNLQALVLTSNGI-NTIEEDSFSSLGSLEHLD 106
Query: 410 MWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSI---GNLKLFNLQLSYNFLQGS 465
+ N LS + L +L L L N + + KL L++
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNP-YKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 466 IP----SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN 521
I + L L +++ ++L + P+ L + L L Q + V
Sbjct: 165 IQRKDFAGLTF---LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 522 LKNLEMLNVFENKLRG----EIP----RTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGL 573
++E L + + L E+ +L +++ L + L+ + GL
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 574 SVLDLSQNNLSGKIPEFLV-GFQLLEYLNLSNN 605
L+ S+N L +P+ + L+ + L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 17/294 (5%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLS 212
SC + SS L IPS L ++ +S N +T I S ++ L L+
Sbjct: 29 SCDRNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLT 84
Query: 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLD 271
N ++ D+F L +L +L ++ N LS + SS F +SS+T + N + +
Sbjct: 85 SNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVPY--LEKLQRLSH 328
+ L LQ VG I + + LE +++++ L L+ +Q +SH
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH 202
Query: 329 FVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS--TTLEVLLL 386
++ ++ S+ L+ ++ +F L ++ T + +
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVEC-LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 387 DSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRF 439
+F + + LL LE N+L ++P L +L+++ L N +
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 59/307 (19%), Positives = 111/307 (36%), Gaps = 50/307 (16%)
Query: 243 TIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNAS 301
+IPS + ++ D N+I I NLQ + N + I + S+
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 302 NLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHI 361
+LE ++ N L+ +L S + L + ++
Sbjct: 101 SLEHLDLSYNYLS--------------------NLSSS---------WFKPLSSLTFLNL 131
Query: 362 NINNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIP 420
N + L + + T L++L + + F I F L LE+ + L P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 421 PAIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQG----SIPS----SL 470
++ +QN+ L L + + + L+L L + + SL
Sbjct: 192 KSLKSIQNVSHLILHMKQ-HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250
Query: 471 GQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLN 529
+ T + +++ +L + L +S LL LE SRNQL +P+ + L +L+ +
Sbjct: 251 IKKFTFRNVKITDESLF-QVMKLLNQISGLL-ELEFSRNQLKS-VPDGIFDRLTSLQKIW 307
Query: 530 VFENKLR 536
+ N
Sbjct: 308 LHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 44/276 (15%), Positives = 90/276 (32%), Gaps = 28/276 (10%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPS 126
S + LDL + ++ YIS L+ L L +N +
Sbjct: 36 CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEED 94
Query: 127 EFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEY 184
F L L+ L L N + + ++ S+L + L N + L L+K++
Sbjct: 95 SFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153
Query: 185 FSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243
V + I F L+ + L + ++L P + ++N+ +L + +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-L 212
Query: 244 IPSSIF-NISSITVFDAGINQIQGV-------IPLDIGFTLQNLQFFSVGRNQLTGAIPP 295
+ SS+ + + + + + L +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 296 AISNASNLEVFQVNSNKLT----GEVPYLEKLQRLS 327
++ S L + + N+L G L LQ++
Sbjct: 272 LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 44/239 (18%), Positives = 87/239 (36%), Gaps = 26/239 (10%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
S + ++ L L +N+I + + V L L + +N ++ TI + L +L L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106
Query: 434 LQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPSSL-GQSETLTIIDLSNNNLTGTI 490
L N L N+ S L L L N + +SL L I+ + N + I
Sbjct: 107 LSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
+ GL+ L LE+ + L + +++N+ L + + + +
Sbjct: 166 QRKDFAGLTFL-EELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
+E L+++ L S LS+ S++ + +++
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFT----------------FRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 22/234 (9%)
Query: 412 NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIP-- 467
+ L+ +IP + + ++ L L NR + I S + L L L+ N + +I
Sbjct: 40 SGSLN-SIPSGL--TEAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGIN-TIEED 94
Query: 468 --SSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLK 523
SSLG L +DLS N L+ + LSSL L L N + +L
Sbjct: 95 SFSSLGS---LEHLDLSYNYLS-NLSSSWFKPLSSLTF-LNLLGNPYKTLGETSLFSHLT 149
Query: 524 NLEMLNVFENKLRGEIP-RTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNN 582
L++L V +I + LE L++ + LQ P SL S++ +S L L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 583 LSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE---GVFRNASITSVLGNLKLCG 633
+ F+ +E L L + D + +E G + N+K+
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 28/143 (19%), Positives = 52/143 (36%), Gaps = 13/143 (9%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L+FL+ L++ + P ++ + L LH + S++ + L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECLELR 230
Query: 165 SNELVGKIPSELGS--------LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL 216
+L SEL + ++ +L + +S + L SRN L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 217 DGSIPD-TFGWLKNLVNLTMAQN 238
S+PD F L +L + + N
Sbjct: 290 K-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 11/121 (9%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISS--------CSN 157
++ + L LH + D ++ L L + + + +S+
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 158 LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNL 216
V+++ L ++ L +S + S N L S+P F L+S+ ++L N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
Query: 217 D 217
D
Sbjct: 314 D 314
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 44/230 (19%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL--VK 772
IG+G V++ L+E K I A+K NL + S+ E L ++ + ++
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ + +V E N L WL +S++ +R ++
Sbjct: 74 LY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNM 117
Query: 833 ACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-- 889
A+ +H H IVH DLKP+N L+ + M+ + DFG+A + T+S+
Sbjct: 118 LEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQ---PDTTSVVKDSQ 169
Query: 890 -GSIGYIAPE-----------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
G++ Y+ PE S++S DV+S G +L + K P
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 44/230 (19%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL--VK 772
IG+G V++ L+E K I A+K NL + S+ E L ++ + ++
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ + +V E N L WL +S++ +R ++
Sbjct: 121 LY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNM 164
Query: 833 ACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-- 889
A+ +H H IVH DLKP+N L+ + M+ + DFG+A + T+S+
Sbjct: 165 LEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQ---PDTTSVVKDSQ 216
Query: 890 -GSIGYIAPE-----------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
G++ Y+ PE S++S DV+S G +L + K P
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G F ++ + K + A K+ LL + E + +++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
++ NDF +V E RSL E E E L+++
Sbjct: 82 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQI------VL 126
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK---GS 891
YLH + ++H DLK N+ L+E++ +GDFGLAT + + K G+
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGT 178
Query: 892 IGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
YIAPE G EV DV+S G ++ L+ K P FE
Sbjct: 179 PNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 218
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 3e-22
Identities = 37/281 (13%), Positives = 79/281 (28%), Gaps = 51/281 (18%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA------FKSFIAECNTLKNIRH---- 767
++G + + E V V K + L+ I++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 768 ---------RNLVKILTACSGVD--------YQGNDFKALVFEFMHNRSLEEWLHPITRE 810
+LVK + + + F + ++ E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 811 DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870
++ RL + + V L+ LHH +VH L+P +++LD+ + F
Sbjct: 205 HKSLVHHA------RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-----VSINGDVYSYGILLLELVTRK 925
+ A + A + ++ D ++ G+ + +
Sbjct: 256 EHLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 926 KPTDIMFEGDMNLHNFAKT-----ALPDHVVDIVDSTLLSD 961
P D L +P V +++ L
Sbjct: 315 LP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-22
Identities = 60/249 (24%), Positives = 97/249 (38%), Gaps = 22/249 (8%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKIL-TA 776
+G G FG V + I + VA+K L + + E +K + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
ND L E+ L ++L+ +E LL D++ AL
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLS------DISSAL 134
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLD---EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
YLH + I+H DLKP N++L + +I + D G A L T + G++
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQ 188
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953
Y+APE + ++ D +S+G L E +T +P F + + I
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREKSNEHI 244
Query: 954 VDSTLLSDD 962
V L+
Sbjct: 245 VVYDDLTGA 253
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G F ++ + K + A K+ LL + E + +++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
++ NDF +V E RSL E E E L+++
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQI------VL 152
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK---GS 891
YLH + ++H DLK N+ L+E++ +GDFGLAT + + K G+
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGT 204
Query: 892 IGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
YIAPE G EV DV+S G ++ L+ K P FE
Sbjct: 205 PNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 244
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 8e-22
Identities = 46/238 (19%), Positives = 79/238 (33%), Gaps = 14/238 (5%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLREL 432
S+ L K+ I AF F L ++E+ N + I L L E+
Sbjct: 26 SDLPRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84
Query: 433 RLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPS-SLGQSETLTIIDLSNNNLTGT 489
R+++ L I P L L +S ++ +P S ++D+ +N T
Sbjct: 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 490 IPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCI 547
I GLS ++L L++N + I N + E+ N L
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 548 KLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+L + + L +L+ L K+P L +L+
Sbjct: 203 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL-EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 43/233 (18%), Positives = 82/233 (35%), Gaps = 14/233 (6%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
L F L+ + + N + I A++ S+ L +R+
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 169 VGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD-TFG 225
+ I E +L ++Y +S + +P + L + N +I +F
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 226 WL-KNLVNLTMAQNRLSGTIPSSIFN-ISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
L V L + +N + I +S FN + + N ++ +P D+
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 284 VGRNQLTGAIPPAI-SNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
+ R ++ ++P N L + K ++P LEKL L +T S
Sbjct: 209 ISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 38/225 (16%), Positives = 71/225 (31%), Gaps = 12/225 (5%)
Query: 388 SNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPS 446
IP+ + L +L I A +L ++ + +N L I
Sbjct: 17 QESKVTEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 447 I--GNLKLFNLQLS-YNFLQGSIPSSLGQS-ETLTIIDLSNNNLTGTIPPQLLGLSSLLI 502
+ KL +++ N L I Q+ L + +SN + +P S +
Sbjct: 74 VFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV 131
Query: 503 VLELSRNQLTGPIPNEV--GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ 560
+L++ N I G +L + +N ++ EL N L+
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
Query: 561 GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
G +LD+S+ + L + L + N
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 45/281 (16%), Positives = 90/281 (32%), Gaps = 41/281 (14%)
Query: 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244
F + +T IP + L L F +L + ++QN + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 245 PSSIF-NISSITVFD-AGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNAS 301
+ +F N+ + N + I + L NLQ+ + + +P ++
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128
Query: 302 NLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHI 361
+ + N + + N L+ +
Sbjct: 129 QKVLLDIQDNI---------NIHTIER----------------NSFVGLSF--ESVILWL 161
Query: 362 NINNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIP 420
N N + N + E+ L D+N + +P F + L++ R+ ++P
Sbjct: 162 NKNGIQEI-HNSAFNGTQLDELNLSDNNNL-EELPNDVFHGASGPVILDISRTRIH-SLP 218
Query: 421 PAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNF 461
L+NL++LR + L +P + L L+Y
Sbjct: 219 SYG--LENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 29/176 (16%), Positives = 53/176 (30%), Gaps = 10/176 (5%)
Query: 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514
+ + IPS L + L I L +E+S+N +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 515 IPNEV-GNLKNLEMLNVFE-NKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRG 572
I +V NL L + + + N L P + L+ L + ++
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129
Query: 573 LSVLDLSQNNLSGKIPE--FLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVL 626
+LD+ N I F+ L L+ N + + F + +
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH-NSAFNGTQLDELN 183
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 28/139 (20%), Positives = 54/139 (38%), Gaps = 8/139 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANISS--CSNLIRVR 162
NL L+ L + N H +P + +L + +N I N + +
Sbjct: 102 NLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160
Query: 163 LSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIP 221
L+ N + +I + + ++++ ++S NN +P F S L +SR + S+P
Sbjct: 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 218
Query: 222 D-TFGWLKNLVNLTMAQNR 239
LK L + +
Sbjct: 219 SYGLENLKKLRARSTYNLK 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 47/242 (19%), Positives = 96/242 (39%), Gaps = 40/242 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN-----------------LLHHGAFKSFIAECNT 761
+ G F + + A+K + + + F E
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
+ +I++ + G+ D +++E+M N S+ ++ D+ +
Sbjct: 97 ITDIKNEYCLTCE----GI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
+++ I V + SY+H+ + I H D+KPSN+L+D+ + DFG + ++
Sbjct: 152 VIKC--IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSING---DVYSYGILLLELVTRKKPTDIMFEGDMNL 938
+ S +G+ ++ PE+ +E S NG D++S GI L + P F ++L
Sbjct: 208 KGS----RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISL 258
Query: 939 HN 940
Sbjct: 259 VE 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 50/233 (21%), Positives = 92/233 (39%), Gaps = 48/233 (20%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA----ECNTLKNI-RH 767
F +++G G+ G++ + + + VAVK + E L+ H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+++ C+ + F+ + E +L+E+ + ++D + LLQ
Sbjct: 78 PNVIRYF--CT---EKDRQFQYIAIELCAA-TLQEY---VEQKDFAHLGLEPITLLQ--- 125
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-----EMIAHVGDFGLATFL-PLSHA 881
L++LH IVH DLKP N+L+ ++ A + DFGL L H+
Sbjct: 126 ---QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 882 QTSSIFAKGSIGYIAPEY-------GLGSEVSINGDVYSYGILLLELVTRKKP 927
+ G+ G+IAPE V D++S G + +++
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTV----DIFSAGCVFYYVISEGSH 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G G FG+VY + K I+A+KV L G E ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ L+ E+ ++ L +++ DE R+ + L A
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITEL------A 119
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
ALSY H ++H D+KP N+LL + DFG + P S G++
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 172
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
Y+ PE G D++S G+L E + K P FE +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 44/230 (19%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
L+G GSF VY+ VA+K+ + + G + E ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 775 TACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITRE-DETEEAPRSLNLLQRLDIGIDV 832
+Y + LV E HN + +L + E + + + ++
Sbjct: 78 ------NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE----NEARHFMHQI------ 121
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK--- 889
+ YLH I+H DL SN+LL M + DFGLAT +
Sbjct: 122 ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT-----QLKMPHEKHYTLC 173
Query: 890 GSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ YI+PE G E DV+S G + L+ + P F+ D
Sbjct: 174 GTPNYISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP----FDTD 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-21
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 33/240 (13%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
++G G+ +V++G + + A+KVFN + + E LK + H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ K L+ EF SL L + E L +L+ DV +
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR------DVVGGM 125
Query: 837 SYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
++L + IVH ++KP N++ D + + + DFG A L S G+
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTE 179
Query: 893 GYIAPEYGLGSEVSING--------DVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944
Y+ P+ + + + D++S G+ T P F +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEV 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 9e-21
Identities = 40/290 (13%), Positives = 83/290 (28%), Gaps = 68/290 (23%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVF----------------------------NLLHH 749
++G + + E V V N
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 750 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE--EWLHPI 807
FI + +K+ + + +++ + + + F ++ M + E L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIR-VRLDERDMWVLSRF--FLYPRMQSNLQTFGEVLLSH 196
Query: 808 TREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867
+ ++ RL + + V L+ LHH +VH L+P +++LD+ +
Sbjct: 197 SSTHKSLV------HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 247
Query: 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSING-----------DVYSYGI 916
F + SS S G+ PE D ++ G+
Sbjct: 248 TGFEHL--VRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 917 LLLELVTRKKPTDIMFEGDMNLHNFAK-----TALPDHVVDIVDSTLLSD 961
++ + P D L +P V +++ L
Sbjct: 302 VIYWIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 347
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T IG G+ G+VY + VA++ NL + I E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
L + Y D +V E++ SL + + T DE + A LQ
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ-------- 127
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS- 891
AL +LH + ++H D+K N+LL + + DFG AQ + +K S
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC-------AQITPEQSKRST 175
Query: 892 -IG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+G ++APE D++S GI+ +E++ + P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 51/271 (18%), Positives = 89/271 (32%), Gaps = 59/271 (21%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV 771
F +G G FG V++ A+K L + A + + E L + H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR------ 825
+ A + + + P + + + R +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 826 ---------------------------------------LDIGIDVACALSYLHHDCQPP 846
L I I +A A+ +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-------GSIG---YIA 896
++H DLKPSN+ + + VGDFGL T + + + + G +G Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
PE G+ S D++S G++L EL+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 43/240 (17%), Positives = 88/240 (36%), Gaps = 37/240 (15%)
Query: 374 ISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRE 431
I + + + L L + IP+ AF + R+ + + + + L +
Sbjct: 26 IPSLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 432 LRLQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIP--SSLGQSETLTIIDLSNNNLT 487
+ ++ R L I P L L + L+ P + + ++ I+++++N
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
Query: 488 GTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSC 546
+IP GL + + L+L N T + N L+ + + +NK I
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVID------ 196
Query: 547 IKLELLQMQGNFLQGPIPSSLSSLR-GLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+ + G S+LD+SQ +++ +P G + L+ L N
Sbjct: 197 -----------------KDAFGGVYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/224 (16%), Positives = 72/224 (32%), Gaps = 20/224 (8%)
Query: 76 VTCSRRQHQRV-------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSE 127
+ + QR+ L L L I +H NL + + + + ++ S
Sbjct: 16 FRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESH 74
Query: 128 -FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSE--LGSLSKIE 183
F L ++ + + N I + L + + + L P + S
Sbjct: 75 SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFF 133
Query: 184 YFSVSYNNLTGSIPP-SFGNLSSISF-LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241
++ N SIP +F L + + L L N S+ L + + +N+
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYL 192
Query: 242 GTIPSSIFN--ISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
I F S ++ D + +P L+ L +
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 31/196 (15%), Positives = 66/196 (33%), Gaps = 12/196 (6%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
+ L L F L + + + + ++ ++ + S + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 169 VGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP--SFGNLSSISFLFLSRNNLDGSIP-DTF 224
+ I + L L +++ + L P + L ++ N SIP + F
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 225 GWLKN-LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT--LQNLQF 281
L N + L + N + ++ FN + + N+ VI D F
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA-FGGVYSGPSL 209
Query: 282 FSVGRNQLTGAIPPAI 297
V + +T A+P
Sbjct: 210 LDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 32/168 (19%), Positives = 57/168 (33%), Gaps = 13/168 (7%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNL 522
IPS + + L +L TIP L ++ + +S + + + NL
Sbjct: 25 RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISR-IYVSIDVTLQQLESHSFYNL 79
Query: 523 KNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGNFLQG-PIPSSLSSLRGLSVLDLSQ 580
+ + + + I L L+ L + L+ P + + S +L+++
Sbjct: 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITD 139
Query: 581 NNLSGKIPE--FLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVL 626
N IP F L L NN F V F + +V
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ-GYAFNGTKLDAVY 185
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 41/233 (17%), Positives = 78/233 (33%), Gaps = 39/233 (16%)
Query: 278 NLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLTGEVP--YLEKLQRLSHFVITRN 334
+ Q + L IP A SN N+ V+ + ++ L +++H I
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 335 SLGSGEHRDLNFLCS--LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIF 392
R+L ++ L LK+ I + +L + N
Sbjct: 91 -------RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYM 143
Query: 393 GNIPA-AFGKFVKLLR-LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450
+IP AF L+++NN + ++ L + L +N++L I
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA--- 199
Query: 451 KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLI 502
F G +++D+S ++T +P + L L L+
Sbjct: 200 --FG----------------GVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 48/238 (20%), Positives = 91/238 (38%), Gaps = 39/238 (16%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTL-KNIRHRNLV 771
S ++G GS G+V +G+ VAVK + + E L ++ H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLI---DFCDIALMEIKLLTESDDHPNVI 72
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+ CS + F + E N +L++ + ++ ++E + + +
Sbjct: 73 RYY--CS---ETTDRFLYIALELC-NLNLQDL---VESKNVSDENLKLQKEYNPISLLRQ 123
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG-------------DFGLATFLPL 878
+A +++LH I+H DLKP N+L+ DFGL L
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 879 SHAQTSSIF--AKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKP 927
+ + G+ G+ APE S D++S G + ++++ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECN-TLKNIRHRNLVKILTA 776
+G G++G V K I+AVK + K + + + +++ + V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-EEAPRSLNLLQRLDIGIDVACA 835
G ++ D + E M + SL+++ + + +T E ++L + I + + A
Sbjct: 71 FYGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPE-----DILGK--IAVSIVKA 121
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
L +LH ++H D+KPSNVL++ + DFG++ +L A+ G Y+
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYM 176
Query: 896 APE----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
APE S+ D++S GI ++EL + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 27/216 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTL-KNIRHRNLVKILTA 776
+G+G+ G V+K + ++AVK + K + + + + K+ +V+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C G D + E M + + E ++ +++ AL
Sbjct: 89 CFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK----------AL 137
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL ++H D+KPSN+LLDE + DFG++ L A+ S G Y+A
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMA 192
Query: 897 PE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
PE + I DV+S GI L+EL T + P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
S IG GS G V VAVK+ +L + E +++ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ + Y + ++ EF+ +L + + R +E + A +LQ
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQ-------- 152
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK--- 889
AL+YLH ++H D+K ++LL + + DFG AQ S K
Sbjct: 153 --ALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKS 200
Query: 890 --GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE S + D++S GI+++E+V + P
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G FG+VY + K I+A+KV L G E ++RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ L+ EF L + L R DE RS ++ L A
Sbjct: 81 NY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEEL------AD 125
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL Y H ++H D+KP N+L+ + + DFG + P +T G++ Y
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDY 178
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ PE G D++ G+L E + P F+
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 7e-20
Identities = 45/292 (15%), Positives = 85/292 (29%), Gaps = 36/292 (12%)
Query: 717 NLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 771
+L+G G+F VY+ + K +KV + F LK +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
K +A + + LV E +L ++ E + + + +
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-----KVMPQGLVISFAMR 180
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG-----------DFGLATFLPLSH 880
+ + +H I+H D+KP N +L + D G + + L
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH- 939
T + G+ E + D + + ++ G+
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 940 NFAKTALPDHVVDIVDSTLLSDDE------DLAVHGNQRQRQARINSKIECL 985
F + D + L D DL ++ Q +KI L
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNT-LKNIRHRNLVKILTA 776
IG G++GSV K + I+AVK + K + + + +++ +V+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
G ++ D + E M + S +++ + + +L + I + AL
Sbjct: 86 FYGALFREGDCW-ICMELM-STSFDKFYKYVYS---VLDDVIPEEILGK--ITLATVKAL 138
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
++L + + I+H D+KPSN+LLD + DFG++ L S A+T G Y+A
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 193
Query: 897 PE----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
PE + DV+S GI L EL T + P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 54/271 (19%), Positives = 91/271 (33%), Gaps = 22/271 (8%)
Query: 356 LKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV---KLLRLEMWN 412
L++ ++ L S +L+ L + + +I I + + L L + N
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 413 NRLSGTIPPAIGELQ--NLRELRLQENRFLG--NIPPSIGNLKLFNLQ---LSYNFLQGS 465
++GT PP + E +L L L+ + + L+ ++
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQ---LLGLSSLLIVLELSRNQLT---GPIPNEV 519
+ L+ +DLS+N G L VL L + G
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGS-CIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDL 578
L+ L++ N LR +L L + L+ +P L + LSVLDL
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDL 281
Query: 579 SQNNLSGKIPEFLVGFQLLEYLNLSNNDFEG 609
S N L P + L+L N F
Sbjct: 282 SYNRLDR-NPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 48/282 (17%), Positives = 87/282 (30%), Gaps = 27/282 (9%)
Query: 298 SNASNLEVFQVNSNKLTGEVPYLEKLQ--RLSHFVITRNSLGSGEHRDLNFLCSLTNATR 355
+LE + + + ++ L + + S R L + +
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPS---RILFGALRVLGISG 96
Query: 356 LKWFHININNFGGLLPACISNFS-TTLEVLLLDSNKI--FGNIPAAFGKFVK--LLRLEM 410
L+ + G P + + L +L L + A +++K L L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 411 WNNRLSGTIPPAIGELQNLRELRLQENRFLGNIP----------PSIGNLKLFNLQLSYN 460
+ L L L +N LG P++ L L N +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--E 214
Query: 461 FLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG 520
G + L +DLS+N+L S L L LS L +P +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL- 272
Query: 521 NLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
L +L++ N+L P ++ L ++GN
Sbjct: 273 -PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 37/272 (13%), Positives = 74/272 (27%), Gaps = 44/272 (16%)
Query: 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS---SCSNLIRV 161
G S +L + ++ + L+ L + I I S L +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 162 RLSSNELVGKIPSELGSLS------------------------------KIEYFSVSYNN 191
L + E+ G P L + ++ S++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDT----FGWLKNLVNLTMAQNR---LSGTI 244
++S L LS N G L L + SG
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 245 PSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLE 304
+ + D N ++ L ++ L +P + + L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLS 277
Query: 305 VFQVNSNKLTGEVPYLEKLQRLSHFVITRNSL 336
V ++ N+L P ++L ++ + + N
Sbjct: 278 VLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 33/248 (13%), Positives = 66/248 (26%), Gaps = 23/248 (9%)
Query: 85 RVTILDLKSLKLAGYISAH---VGNLSFLKVLDLHNNSFHHEIPSEFDRL--RRLQVLAL 139
+ L +++ ++ I V +S L+ L L N P L +L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 140 HNNSIGGE--IPANISSCS--NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS 195
N S A + L + ++ + ++ + +S N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 196 IPPS----FGNLSSISFLFLSRNN---LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSI 248
++ L L G L L ++ N L +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 249 FNI-SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
+ S + + ++ V L + N+L P+ +
Sbjct: 249 CDWPSQLNSLNLSFTGLKQVPK----GLPAKLSVLDLSYNRLDRN--PSPDELPQVGNLS 302
Query: 308 VNSNKLTG 315
+ N
Sbjct: 303 LKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 46/257 (17%), Positives = 79/257 (30%), Gaps = 35/257 (13%)
Query: 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR-----LEMWNNRLSGTIPPAIGELQ 427
C NFS D + F + AA + R L+ + I +
Sbjct: 13 CSCNFSDPKP----DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL 68
Query: 428 NLRELRLQENRFLGNIPPSI----GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
+L+ L ++ R I G L L L + G+ P L ++ + L+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 484 NNLTGTIPPQLLG-----LSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE 538
N++ L L L VL +++ +V L L++ +N GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 539 IPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLE 598
C P +L+ L++ + SG L+
Sbjct: 189 RGLISALC-----------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 599 YLNLSNNDFEGMVPTEG 615
L+LS+N
Sbjct: 232 GLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 36/218 (16%), Positives = 70/218 (32%), Gaps = 28/218 (12%)
Query: 80 RRQHQRVTILDLKSLKLAGYIS--AHVGNLSF--LKVLDLHNNSFHHEIPSEFDRLRRLQ 135
+ IL+L+++ A + A + LKVL + + + L
Sbjct: 117 EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176
Query: 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS 195
L L +N GE + C P + +L + + +G
Sbjct: 177 TLDLSDNPELGERGLISALC-----------------PLKFPTLQVLALRNAGMETPSGV 219
Query: 196 IPPSFGNLSSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
+ L LS N+L + + W L +L ++ L +P + + +
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKL 276
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292
+V D N++ D L + S+ N +
Sbjct: 277 SVLDLSYNRLDRNPSPD---ELPQVGNLSLKGNPFLDS 311
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 47/266 (17%), Positives = 94/266 (35%), Gaps = 61/266 (22%)
Query: 713 FTSANLIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLHHGAF--KSFIAECNTLKNI-RHR 768
F IG+G FGSV+K + +G I A+K G+ ++ + E + +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
++V+ +A + +D + E+ + SL + + R + +LL
Sbjct: 72 HVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL----- 121
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------------------MIAHVGD 869
+ V L Y+H +VH D+KPSN+ + ++ +GD
Sbjct: 122 -LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPE-------YGLGSEVSINGDVYSYGILLLELV 922
G T + + G ++A E + + D+++ + ++
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKA------DIFALALTVVCAA 225
Query: 923 TRKKPTDIMFEGDMNLHNFAKTALPD 948
+ H + LP
Sbjct: 226 GAEPL----PRNGDQWHEIRQGRLPR 247
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 64/251 (25%), Positives = 96/251 (38%), Gaps = 37/251 (14%)
Query: 692 SSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA 751
SP S I L + F L+G G++G VYKG + + A+KV + +
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDE 63
Query: 752 FKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITR 809
+ E N LK HRN+ A + G D + LV EF S+ + +
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 810 EDETEEAPRSLNLLQRLDIGI---DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866
EE I ++ LS+LH ++H D+K NVLL E
Sbjct: 124 NTLKEEW-----------IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 867 VGDFGLATFLPLSHAQTSSIFAK--GSIG---YIAPEYGLGSEVSING-----DVYSYGI 916
+ DFG++ AQ + IG ++APE E D++S GI
Sbjct: 170 LVDFGVS-------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 917 LLLELVTRKKP 927
+E+ P
Sbjct: 223 TAIEMAEGAPP 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 48/257 (18%)
Query: 682 VRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAV 741
+RK +E ++ ++ PN ++ + +G G+FG VYK E + A
Sbjct: 2 MRKSREYEHVRRDLD--PNEVWEIV----------GELGDGAFGKVYKAKNKETGALAAA 49
Query: 742 KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 801
KV + +I E L H +VK+L A Y + ++ EF +++
Sbjct: 50 KVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAVD 104
Query: 802 EWLHPITRE-DETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860
+ + R E + +L+ AL++LH I+H DLK NVL+
Sbjct: 105 AIMLELDRGLTEPQIQVVCRQMLE----------ALNFLHSK---RIIHRDLKAGNVLMT 151
Query: 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGS--IG---YIAPEYGLGSEVSING-----D 910
E + DFG++ A+ K IG ++APE + + D
Sbjct: 152 LEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 204
Query: 911 VYSYGILLLELVTRKKP 927
++S GI L+E+ + P
Sbjct: 205 IWSLGITLIEMAQIEPP 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 28/241 (11%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAF-KSFIAECN 760
+ + + + IG+G+ G V + VA+K + + K E
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPR 818
+K + H+N++ +L + +F+ +V E M + L + + + E
Sbjct: 77 LMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMS 130
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
L L Q L C + +LH I+H DLKPSN+++ + + DFGLA
Sbjct: 131 YL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
S T + + Y APE LG N D++S G ++ E++ ++F G ++
Sbjct: 180 SFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHI 232
Query: 939 H 939
Sbjct: 233 D 233
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-18
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 39/224 (17%)
Query: 720 GAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
G +V V V+ NL + E + K H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT- 94
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI---DVAC 834
+ ++ +V FM S ++ + + E A I V
Sbjct: 95 ----FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----------IAYILQGVLK 139
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL--PLSHAQTSSIFAKGSI 892
AL Y+HH VH +K S++L+ + ++ + + F K S+
Sbjct: 140 ALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 893 G---YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
+++PE G ++ D+YS GI EL P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 10/186 (5%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRL 434
+ +L L N ++ A + +L +L + L T G L L L L
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDL 84
Query: 435 QENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSET-LTIIDLSNNNLTGTIPP 492
N+ L ++P L L L +S+N L S+P + L + L N L T+PP
Sbjct: 85 SHNQ-LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP 141
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
LL + L L L+ N LT +P + L+NL+ L + EN L IP+ L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199
Query: 552 LQMQGN 557
+ GN
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 40/181 (22%), Positives = 70/181 (38%), Gaps = 11/181 (6%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
+L L N + + RL L L + ++ + + L + LS N+L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIP-DTFGWL 227
+P +L + VS+N LT S+P L + L+L N L ++P
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 228 KNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGR 286
L L++A N L+ +P+ + + ++ N + IP F L F +
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGF-FGSHLLPFAFLHG 204
Query: 287 N 287
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 44/191 (23%), Positives = 70/191 (36%), Gaps = 18/191 (9%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V C +R + TIL L L + A + + L L+L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQV 72
Query: 128 FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYFS 186
L L L L +N + +P + L + +S N L +P L +++
Sbjct: 73 DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 187 VSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQNRLSGTI 244
+ N L ++PP + L L+ NNL +P L+NL L + +N L TI
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 245 PSSIFNISSIT 255
P F +
Sbjct: 188 PKGFFGSHLLP 198
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 426 LQNLRELRLQENRFLGNIPPSI-GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484
+ + E+ + L +PP + + L LS N L ++L LT ++L
Sbjct: 9 VASHLEVNCDKRN-LTALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLG 544
LT + L L L+LS NQL +P L L +L+V N+L L
Sbjct: 66 ELT-KLQV-DGTLPVL-GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 545 SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFL-VGFQLLEYLNLS 603
+L+ L ++GN L+ P L+ L L L+ NNL+ ++P L G + L+ L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 604 NNDFEGMVPTEGVFRNASITSV 625
N +P +G F + +
Sbjct: 181 ENSLY-TIP-KGFFGSHLLPFA 200
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 46/221 (20%), Positives = 70/221 (31%), Gaps = 44/221 (19%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLS 327
+P D+ L N L + + L ++ +LT ++ L L
Sbjct: 25 LPPDLPKDTTILHL---SENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLG 80
Query: 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLD 387
++ N L S LP L VL +
Sbjct: 81 TLDLSHNQLQS-------------------------------LPLLGQTL-PALTVLDVS 108
Query: 388 SNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELRLQENRFLGNIPP 445
N++ ++P A +L L + N L T+PP + L +L L N L +P
Sbjct: 109 FNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN-LTELPA 165
Query: 446 SI-GNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484
+ L L L L N L +IP S L L N
Sbjct: 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 768
+ IG G++G+V+K E IVA+K L G S + E LK ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N+V++ V + LVFEF L+++ + + E +S L Q L
Sbjct: 62 NIVRLH----DVLHSDKKL-TLVFEFCDQ-DLKKYFDSCNGDLDPEIV-KSF-LFQLL-- 111
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIF 887
L + H ++H DLKP N+L++ + +FGLA F ++ +
Sbjct: 112 -----KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 888 AKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ Y P+ G+++ S + D++S G + EL +P +F G+
Sbjct: 164 T---LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 29/232 (12%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-FKSFIAECNTLKNIR 766
D + +IG+G+ V K VA+K NL + E +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H N+V T+ + D LV + + S+ + + I + E + L
Sbjct: 72 HPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDES 121
Query: 827 DIGI---DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
I +V L YLH + Q +H D+K N+LL E+ + DFG++ FL T
Sbjct: 122 TIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 884 SSIFAKGSIG---YIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ K +G ++APE G + D++S+GI +EL T P
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 39/245 (15%)
Query: 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNT 761
S+ + D + +G G + V++ I V VK+ + K E
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 83
Query: 762 LKNIR-HRNLVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRS 819
L+N+R N++ + + ALVFE ++N ++ +T D R
Sbjct: 84 LENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-----IRF 134
Query: 820 LNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLD-EEMIAHVGDFGLATFLP 877
+ + L AL Y H I+H D+KP NV++D E + D+GLA F
Sbjct: 135 Y-MYEIL-------KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEG 934
+ S + PE + + S+ D++S G +L ++ RK+P F G
Sbjct: 183 PGQEYNVRV---ASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHG 234
Query: 935 DMNLH 939
N
Sbjct: 235 HDNYD 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-18
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 43/216 (19%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G G+F V + + A + N L + E + ++H N+V++ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
L+F+ + L E + + RE +E + Q L+ A+
Sbjct: 79 -----ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHC-IQQILE-------AV 123
Query: 837 SYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
+ H +VH +LKP N+LL + + DFGLA + G+
Sbjct: 124 LHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTP 177
Query: 893 GYIAPE------YGLGSEVSINGDVYSYG----ILL 918
GY++PE YG V D+++ G ILL
Sbjct: 178 GYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR 766
+ + FT IG GSFG V+KGI + + +VA+K+ +L + E L
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
+ K + Y + ++ E++ S + L P DET+ A +L+
Sbjct: 79 SPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILK-- 130
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
L YLH + +H D+K +NVLL E + DFG+A Q +
Sbjct: 131 --------GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDT 172
Query: 887 FAKGS--IG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
K + +G ++APE S D++S GI +EL + P
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 58/224 (25%), Positives = 86/224 (38%), Gaps = 39/224 (17%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR 766
N F ++G+G+F V+ + A+K S E LK I+
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H N+V + Y+ LV + + L + + + R TE+ + + Q L
Sbjct: 65 HENIVTLEDI-----YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLV-IQQVL 116
Query: 827 DIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQ 882
A+ YLH + IVH DLKP N+L +E + DFGL+
Sbjct: 117 S-------AVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 883 TSSIFAKGSIGYIAPE----YGLGSEVSINGDVYSYG----ILL 918
T A G+ GY+APE V D +S G ILL
Sbjct: 166 T----ACGTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 48/239 (20%), Positives = 85/239 (35%), Gaps = 32/239 (13%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELR 433
N + + L L N + +F F +L L++ + TI A L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 434 LQENRFLGNIPPSI-GNL-KLFNLQLSYNFLQGSIPSSL-GQSETLTIIDLSNNNLTGTI 490
L N + ++ L L L L S+ + G +TL +++++N +
Sbjct: 83 LTGNP-IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 491 PPQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
P+ L++L L+LS N++ I L + +LN+
Sbjct: 141 LPEYFSNLTNLE-HLDLSSNKIQS-IYCTDLRVLHQMPLLNL------------------ 180
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
L + N + P + +R L L L N L L+ + L N +
Sbjct: 181 --SLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 47/235 (20%), Positives = 85/235 (36%), Gaps = 25/235 (10%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFH 121
C ++ LDL L ++ ++ + L+VLDL
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 122 HEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSL 179
+ L L L L N I + S S+L ++ L + + G L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHL 123
Query: 180 SKIEYFSVSYNNLTGSIPPS--FGNLSSISFLFLSRNNLDGSIP-DTFGWLKNL----VN 232
++ +V++N + S F NL+++ L LS N + SI L + ++
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLS 181
Query: 233 LTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRN 287
L ++ N ++ I F + NQ++ +P I L +LQ + N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 46/251 (18%), Positives = 85/251 (33%), Gaps = 47/251 (18%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTG-EVPYLEKLQRL 326
IP ++ F+ +NL N L + + L+V ++ ++ E + L L
Sbjct: 22 IPDNLPFSTKNLDL---SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 327 SHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLL 386
S ++T N + S L + ++L+ L+
Sbjct: 79 STLILTGNPIQS-------------------------------LALGAFSGLSSLQKLVA 107
Query: 387 DSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELRLQENRFLGNIP 444
+ ++ G L L + +N + P L NL L L N+ + +I
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIY 165
Query: 445 PSI----GNLKLFN--LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
+ + L N L LS N + I + L + L N L ++P +
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRL 223
Query: 499 SLLIVLELSRN 509
+ L + L N
Sbjct: 224 TSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 26/138 (18%), Positives = 45/138 (32%), Gaps = 34/138 (24%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQV----LALH 140
L++ + + NL+ L+ LDL +N I L ++ + L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLS 185
Query: 141 NNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-S 199
N + I L + L +N+L S+P
Sbjct: 186 LNPM-NFIQPGAFKEIRLKELALDTNQLK-------------------------SVPDGI 219
Query: 200 FGNLSSISFLFLSRNNLD 217
F L+S+ ++L N D
Sbjct: 220 FDRLTSLQKIWLHTNPWD 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 27/235 (11%)
Query: 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSF----IAECNTLK 763
AT + IG G++G+VYK VA+K + + G + E L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 764 NIR---HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
+ H N+V+++ C+ LVFE + + L +L E + L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 125
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ Q L L +LH +C IVH DLKP N+L+ + DFGLA
Sbjct: 126 -MRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
A T + + Y APE L S + D++S G + E+ R KP +F G+
Sbjct: 175 ALTPVVVT---LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFCGN 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-18
Identities = 52/259 (20%), Positives = 89/259 (34%), Gaps = 41/259 (15%)
Query: 683 RKRKENQNPSSPINSFPNISYQNLYNATDGFTSA----NLIGAGSFGSVYKGILDEGKTI 738
+ + + + +G+G++G V
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 739 VAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH 796
A+K+ + + + E LK + H N++K+ ++ LV E
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYK 119
Query: 797 NRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSN 856
L + + I R E I V ++YLH IVH DLKP N
Sbjct: 120 GGELFDEI--IHRMKFNEVDAA--------VIIKQVLSGVTYLHKHN---IVHRDLKPEN 166
Query: 857 VLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE-----YGLGSEVSIN 908
+LL +++ + + DFGL+ + G+ YIAPE Y +
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVLRKKY--DEKC--- 218
Query: 909 GDVYSYGILLLELVTRKKP 927
DV+S G++L L+ P
Sbjct: 219 -DVWSIGVILFILLAGYPP 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRH 767
+D + +G G+F V + + A K+ N L F+ E + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N+V++ + Q F LVF+ + L E + + RE +E + Q L+
Sbjct: 65 PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC-IQQILE 116
Query: 828 IGIDVACALSYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQT 883
+++Y H + IVH +LKP N+LL + + DFGLA + S A
Sbjct: 117 -------SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 884 SSIFAKGSIGYIAPE------YGLGSEVSINGDVYSYG----ILL 918
G+ GY++PE Y V D+++ G ILL
Sbjct: 166 GFA---GTPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 50/239 (20%)
Query: 719 IGAGSFGSVYKGILDEGKT--IVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G G++G VYK +GK A+K G S E L+ ++H N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 777 CSGVDYQGNDFKALVFEFM-HNRSLEEWLHPITREDETEEAPRSLN-------LLQRLDI 828
+ L+F++ H+ L + R + + P L L Q LD
Sbjct: 87 FLS---HADRKVWLLFDYAEHD--LWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILD- 139
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH----VGDFGLATFL-----PLS 879
+ YLH + ++H DLKP+N+L+ E + D G A PL+
Sbjct: 140 ------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 880 HAQTSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ + Y APE LG+ +I D+++ G + EL+T +P +F
Sbjct: 191 DLDPVVV----TFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTS-EP---IFHCR 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 27/232 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKT--IVAVKVFNLLH--HGAFKSFIAECNTLKNIR 766
+ IG G++G V+K D VA+K + G S I E L+++
Sbjct: 11 QQYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 767 ---HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
H N+V++ C+ LVFE + + L +L + E + + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDM-MF 127
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
Q L L +LH +VH DLKP N+L+ + DFGLA A T
Sbjct: 128 QLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
S + + Y APE L S + D++S G + E+ R KP +F G
Sbjct: 178 SVVVT---LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 40/247 (16%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAF-KSFIAECN 760
+ + + + IG+G+ G V VA+K + + K E
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPR 818
+K + H+N++ +L + +F+ LV E M + L + + + E
Sbjct: 114 LMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS 167
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
L L Q L C + +LH I+H DLKPSN+++ + + DFGLA
Sbjct: 168 YL-LYQML-------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 879 SHAQTSSIFAKGSIGYI------APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932
S T Y+ APE LG N D++S G ++ E+V K I+F
Sbjct: 217 SFMMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILF 263
Query: 933 EGDMNLH 939
G +
Sbjct: 264 PGRDYID 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 55/252 (21%), Positives = 97/252 (38%), Gaps = 50/252 (19%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFKS-FIAECNTLKN 764
D F + G G+FG+V G VA+K V F++ + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAV 75
Query: 765 IRHRNLVKILTA-CSGVDYQGND-FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
+ H N+V++ + + + D + +V E++ + LH R + L
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPIL 130
Query: 823 L-----QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLATFL 876
+ Q + ++ LH + H D+KP NVL++E + DFG A L
Sbjct: 131 IKVFLFQLI-------RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 877 PLSHAQTSSIFAKGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVTRKKP 927
S + YI APE G++ ++ D++S G + E++ +P
Sbjct: 183 SPSEPNVA---------YICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLG-EP 230
Query: 928 TDIMFEGDMNLH 939
+F GD +
Sbjct: 231 ---IFRGDNSAG 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 40/214 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G G+F V + + A K+ N L F+ E + ++H N+V++ +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
Q F LVF+ + L E + + RE +E + Q L+ ++
Sbjct: 97 -----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC-IQQILE-------SI 141
Query: 837 SYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
+Y H + IVH +LKP N+LL + + DFGLA + S A G+
Sbjct: 142 AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTP 194
Query: 893 GYIAPE----YGLGSEVSINGDVYSYG----ILL 918
GY++PE V D+++ G ILL
Sbjct: 195 GYLSPEVLKKDPYSKPV----DIWACGVILYILL 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 36/254 (14%)
Query: 686 KENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
+ + SS + + + +G G++G VYK D IVA+K
Sbjct: 2 HHHHHHSSGRENLYFQGLM------EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIR 54
Query: 746 LLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 803
L G + I E + LK + H N+V ++ LVFEFM L++
Sbjct: 55 LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCLTLVFEFMEK-DLKKV 108
Query: 804 LHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863
L + + + L Q L +++ H I+H DLKP N+L++ +
Sbjct: 109 LD-ENKTGLQDSQIKIY-LYQLL-------RGVAHCHQHR---ILHRDLKPQNLLINSDG 156
Query: 864 IAHVGDFGLA-TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLEL 921
+ DFGLA F + T + + Y AP+ +GS+ S + D++S G + E+
Sbjct: 157 ALKLADFGLARAFGIPVRSYTHEVVT---LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213
Query: 922 VTRKKPTDIMFEGD 935
+T KP +F G
Sbjct: 214 ITG-KP---LFPGV 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 29/234 (12%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR 766
+++ F +G G++ +VYKG+ VA+K L G + I E + +K ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHN---RSLEEWLHPITREDETEEAPRSLNLL 823
H N+V++ + LVFEFM N + ++ T +
Sbjct: 62 HENIVRLYDVIHT---ENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF-QW 115
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQ 882
Q L L++ H + I+H DLKP N+L+++ +GDFGLA F +
Sbjct: 116 QLL-------QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 883 TSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+S + + Y AP+ +GS S + D++S G +L E++T KP +F G
Sbjct: 166 SSEVVT---LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---LFPGT 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 52/283 (18%), Positives = 108/283 (38%), Gaps = 31/283 (10%)
Query: 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN 309
+++ AG + + + L + S +T + +NL ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 310 SNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGL 369
N++T ++ L+ L +++ ++ N L ++++ + L + L I +
Sbjct: 72 DNQIT-DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQITD---- 121
Query: 370 LPACISNFS--TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQ 427
++ + + L+VL LD N+I NI L L + N ++S + P + L
Sbjct: 122 ----VTPLAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLS 173
Query: 428 NLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT 487
L L+ +N+ + +I P L + L N + S S L + L I+ L+N +T
Sbjct: 174 KLTTLKADDNK-ISDISPLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTIT 230
Query: 488 GTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNV 530
L +V S + P + + N+
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 28/293 (9%)
Query: 342 RDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGK 401
+ +L NA ++ N+ + ++ + L + I
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTDTVTQ-----ADL-DGITTLSAFGTGV-TTIEG-VQY 61
Query: 402 FVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNF 461
L+ LE+ +N+++ + P + L + EL L N L N+ G + L L+
Sbjct: 62 LNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNP-LKNVSAIAGLQSIKTLDLTSTQ 118
Query: 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGN 521
+ P L L ++ L N +T I P L GL++L L + Q++ P + N
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNL-QYLSIGNAQVSDLTP--LAN 171
Query: 522 LKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581
L L L +NK+ P L S L + ++ N + S L++ L ++ L+
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQ 227
Query: 582 NLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE----GVFRNASITSVLGNLK 630
++ + + + + + P G + + ++T L +
Sbjct: 228 TITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 48/237 (20%), Positives = 95/237 (40%), Gaps = 19/237 (8%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+ + ++ +L + L L L L L +N I
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI- 75
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
++ + + + + + LS N L K S + L I+ ++ +T + P LS+
Sbjct: 76 TDLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSN 130
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
+ L+L N + +I L NL L++ ++S + + N+S +T A N+I
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS 186
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEK 322
+ PL +L NL + NQ++ P ++N SNL + + + +T + +
Sbjct: 187 DISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 42/211 (19%), Positives = 81/211 (38%), Gaps = 15/211 (7%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163
V L+ L L+L +N + L ++ L L N + + + I+ ++ + L
Sbjct: 59 VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDL 114
Query: 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDT 223
+S ++ P L LS ++ + N +T +I P L+++ +L + + P
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP-- 168
Query: 224 FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFS 283
L L L N++S S + ++ ++ NQI V PL NL +
Sbjct: 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLA---NTSNLFIVT 223
Query: 284 VGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314
+ +T +N V + S
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 45/220 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---------LLHHGAFKSFIAECNTLKNI-RHR 768
+G G V + I AVK+ + ++ + E + L+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N++++ Y+ N F LVF+ M L ++L + +E+ R + + L+
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKI-MRALLE- 135
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
+ LH IVH DLKP N+LLD++M + DFG + L
Sbjct: 136 ------VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-- 184
Query: 889 KGSIGYIAPE----------YGLGSEVSINGDVYSYGILL 918
G+ Y+APE G G EV D++S G+++
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
F +G GS+GSVYK I E IVA+K + + I E + ++ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE-DETEEAPRSLNLLQRLDIGID 831
+ Y N +V E+ S+ + + + E E A + L+
Sbjct: 89 YYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK------- 136
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
L YLH +H D+K N+LL+ E A + DFG+A Q + AK +
Sbjct: 137 ---GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRN 183
Query: 892 --IG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
IG ++APE + D++S GI +E+ K P
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 6e-17
Identities = 47/276 (17%), Positives = 105/276 (38%), Gaps = 26/276 (9%)
Query: 309 NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGG 368
S + ++ + + + S+ D L + ++ + +I + G
Sbjct: 7 VSTPIK-QIFPDDAFAETIKDNLKKKSV-----TDAVTQNELNSIDQIIANNSDIKSVQG 60
Query: 369 LLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQN 428
+ + L L+ NK+ +I L L + N++ + + +L+
Sbjct: 61 I-----QYL-PNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 429 LRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L+ L L+ N + +I + +L +L L N + + + L + L + L +N ++
Sbjct: 111 LKSLSLEHNG-ISDINGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS- 166
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIK 548
I P L GL+ L L LS+N ++ + LKNL++L +F + + + +
Sbjct: 167 DIVP-LAGLTKL-QNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
++ L P +S ++ +
Sbjct: 223 PNTVKNTDGSLVTPEI--ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 1e-15
Identities = 54/329 (16%), Positives = 112/329 (34%), Gaps = 51/329 (15%)
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
+ + P + + + + + L ++ + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI 55
Query: 290 TGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCS 349
++ I N+ +N NKLT ++ L L+ L + N + +DL+ L
Sbjct: 56 K-SVQG-IQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKI-----KDLSSLKD 107
Query: 350 LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLE 409
L L+ L L+ N I +I +L L
Sbjct: 108 LKK----------------------------LKSLSLEHNGI-SDIN-GLVHLPQLESLY 137
Query: 410 MWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSS 469
+ NN+++ I + L L L L++N+ + +I P G KL NL LS N + S +
Sbjct: 138 LGNNKIT-DITV-LSRLTKLDTLSLEDNQ-ISDIVPLAGLTKLQNLYLSKNHI--SDLRA 192
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLN 529
L + L +++L + + S+L++ + + P + + + E N
Sbjct: 193 LAGLKNLDVLELFSQECLN---KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249
Query: 530 VFENKLRGEIPRTLGSCIKLELLQMQGNF 558
V + + + + + + F
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKAKARF 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 4e-15
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 40/225 (17%)
Query: 381 LEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFL 440
+ + S I I F + ++ + ++ + EL ++ ++ + +
Sbjct: 1 MGETITVSTPI-KQIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-I 55
Query: 441 GNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL 500
++ I L +T + L+ N LT I P L L +L
Sbjct: 56 KSVQG-IQYLP-----------------------NVTKLFLNGNKLT-DIKP-LTNLKNL 89
Query: 501 LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ 560
L L N++ + + + +LK L+ L++ N + +I L +LE L + N +
Sbjct: 90 -GWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT 144
Query: 561 GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
+ LS L L L L N +S I L G L+ L LS N
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 9e-15
Identities = 44/264 (16%), Positives = 104/264 (39%), Gaps = 25/264 (9%)
Query: 174 SELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNL 233
+ ++ ++ ++T ++ L+SI + + +++ S+ +L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 234 TMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAI 293
+ N+L+ + N+ ++ N+I+ + L L+ L+ S+ N ++ I
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSSLK---DLKKLKSLSLEHNGIS-DI 124
Query: 294 PPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNA 353
+ + LE + +NK+T ++ L +L +L + N + D+ L LT
Sbjct: 125 NG-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQI-----SDIVPLAGLTKL 177
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
L +I++ L + L+VL L S + V ++ +
Sbjct: 178 QNLYLSKNHISDLRAL-----AGL-KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 414 RLSGTIPPAIGELQNLRELRLQEN 437
L P I + + + ++ +
Sbjct: 232 SL--VTPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 6e-14
Identities = 43/291 (14%), Positives = 95/291 (32%), Gaps = 18/291 (6%)
Query: 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
+LK + ++ L+ + + +N+ + L + L L+ N +
Sbjct: 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKL- 77
Query: 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+I +++ NL + L N++ + S L L K++ S+ +N ++ I +L
Sbjct: 78 TDIK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
+ L+L N + + L L L++ N++S I + ++ + N I
Sbjct: 133 LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS 188
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
+ L L+NL + + SN + L +
Sbjct: 189 DLRALA---GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGD 244
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISN 376
+ + F +T FH + + +
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYD 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 56/295 (18%), Positives = 92/295 (31%), Gaps = 64/295 (21%)
Query: 686 KENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
+ + F S L + IG GS+G V I ++ + I A+K+ N
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 746 -----LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH---- 796
++ + E +K + H N+ ++ Y+ + LV E H
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHL 115
Query: 797 -----NRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC----------------- 834
+ +T+ P + ++ I
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 835 ----ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFA 888
AL YLH I H D+KP N L + DFGL+ +
Sbjct: 176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 889 K--GSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ ++APE G + D +S G+LL L+ P F G
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGVLLHLLLMGAVP----FPGV 279
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 28/228 (12%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRN 769
+ + + +G G++ +VYKG +VA+K L H GA + I E + LK+++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V + + + LVFE++ + L+++L + L Q L
Sbjct: 62 IVTLH----DIIHTEKSL-TLVFEYLD-KDLKQYLDDCGNIINMHNV-KLF-LFQLLR-- 111
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIFA 888
L+Y H ++H DLKP N+L++E + DFGLA + + +
Sbjct: 112 -----GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 889 KGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ Y P+ LGS S D++ G + E+ T +P +F G
Sbjct: 164 ---LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G GSFG V K + AVKV N + + + E LK + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + +V E L + + I R+ +E I V +
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAA--------RIIKQVFSGI 134
Query: 837 SYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
+Y+H + IVH DLKP N+LL +++ + DFGL+T + I G+
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188
Query: 894 YIAPE-----YGLGSEVSINGDVYSYG----ILL 918
YIAPE Y + DV+S G ILL
Sbjct: 189 YIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 39/212 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG GS+G V + + A K F E +K++ H N++++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
++ N LV E L E + + + E + + L A++Y
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARI-MKDVLS-------AVAY 121
Query: 839 LHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
H + + H DLKP N L + + DFGLA + + G+ Y+
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYV 175
Query: 896 APE-----YGLGSEVSINGDVYSYG----ILL 918
+P+ YG E D +S G +LL
Sbjct: 176 SPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-16
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 768
+ + IG G++G VYK + A+K L G + I E + LK ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N+VK+ V + LVFE + L++ L + +S LLQ L
Sbjct: 61 NIVKLY----DVIHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSF-LLQLL-- 110
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIF 887
++Y H ++H DLKP N+L++ E + DFGLA F T I
Sbjct: 111 -----NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 888 AKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ Y AP+ +GS+ S D++S G + E+V P +F G
Sbjct: 163 T---LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
+G GSFG V AVKV + + +S + E LK + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACA 835
++ + LV E L + + I+R+ +E I V
Sbjct: 94 F-----FEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA--------RIIRQVLSG 138
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
++Y+H + IVH DLKP N+LL ++ + DFGL+T S I G+
Sbjct: 139 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTA 192
Query: 893 GYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
YIAPE Y + DV+S G++L L++ P F G
Sbjct: 193 YYIAPEVLHGTY--DEKC----DVWSTGVILYILLSGCPP----FNGA 230
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 44/218 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--------LLHHGAFKSFIAECNTLKNIRHRNL 770
+G+G+ G V + VA+K+ + + E LK + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+KI + D+ +V E M L + + + + E + Q
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELFDKV--VGNKRLKEATCKLY-FYQ------ 122
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ A+ YLH + I+H DLKP NVLL +E+ + + DFG + L + +
Sbjct: 123 -MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 177
Query: 888 AKGSIGYIAPE-------YGLGSEVSINGDVYSYGILL 918
G+ Y+APE G V D +S G++L
Sbjct: 178 --GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 54/245 (22%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLV 771
+T +IG GSFG VY+ L + +VA+K V FK+ E ++ + H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 110
Query: 772 KILTA-CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL-----QR 825
++ S + + + LV +++ E ++ + R + + + Q
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 826 LDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLATFLPLSHAQT 883
+L+Y+H I H D+KP N+LLD + + + DFG A L
Sbjct: 166 F-------RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 884 SSIFAKGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEG 934
S YI APE G+ SI DV+S G +L EL+ +P +F G
Sbjct: 215 S---------YICSRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLG-QP---IFPG 259
Query: 935 DMNLH 939
D +
Sbjct: 260 DSGVD 264
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/236 (21%), Positives = 90/236 (38%), Gaps = 41/236 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVF-NLLHHGAFKSFIAECNTLKNIR--------HR 768
+G G F +V+ T VA+K+ + ++ E L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 769 NLVKILTACSGVDYQGNDFK--ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
IL +++G + +VFE + +L + + E L +++
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIK------KYEHRGIPLIYVKQ- 135
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH------VGDFGLATFLPLSH 880
I + L Y+H C I+H D+KP NVL++ + D G A + +
Sbjct: 136 -ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 881 AQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ + Y +PE LG+ D++S L+ EL+T D +FE D
Sbjct: 193 TNSIQTRE------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 11/177 (6%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNEL 168
K LDL +N F RL +L++L L++N + +PA I NL + ++ N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 169 VGKIPSEL-GSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD-TFG 225
+P + L + + N L S+PP F +L+ +++L L N L S+P F
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQF 281
L +L L + N+L +P F ++ + NQ++ +P +L+ L+
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFH 121
+ V CS ++ + LDL+S KL+ + + L+ L++L L++N
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL- 73
Query: 122 HEIPSE-FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GS 178
+P+ F L+ L+ L + +N + +P + NL +RL N+L +P + S
Sbjct: 74 QTLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131
Query: 179 LSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMA 236
L+K+ Y S+ YN L S+P F L+S+ L L N L +P+ F L L L +
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLD 189
Query: 237 QNRLSGTIPSSIFN 250
N+L +P F+
Sbjct: 190 NNQLK-RVPEGAFD 202
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 55/163 (33%), Positives = 80/163 (49%), Gaps = 16/163 (9%)
Query: 379 TTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELRLQE 436
T L +L L+ NK+ +PA F + L L + +N+L +P + +L NL ELRL
Sbjct: 61 TKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDR 118
Query: 437 NRFLGNIPPSI-GNL-KLFNLQLSYNFLQGSIPS----SLGQSETLTIIDLSNNNLTGTI 490
N+ L ++PP + +L KL L L YN LQ S+P L L + L NN L +
Sbjct: 119 NQ-LKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS---LKELRLYNNQLK-RV 172
Query: 491 PPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
P + L L+L NQL +L+ L+ML + EN
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 50/188 (26%), Positives = 95/188 (50%), Gaps = 17/188 (9%)
Query: 148 IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS-FGNLSSI 206
IP+NI + + ++ L SN+L L+K+ ++ N L ++P F L ++
Sbjct: 31 IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 207 SFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQI 264
L+++ N L ++P F L NL L + +N+L ++P +F +++ +T G N++
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 265 QGVIPLDIGFT-LQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNKLT----GEVP 318
Q +P + F L +L+ + NQL +P A + L+ ++++N+L G
Sbjct: 146 Q-SLPKGV-FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 319 YLEKLQRL 326
LEKL+ L
Sbjct: 203 SLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 60/234 (25%), Positives = 91/234 (38%), Gaps = 54/234 (23%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELR 433
SN + L L SNK+ AF + KL L + +N+L T+P I EL+NL L
Sbjct: 33 SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLW 91
Query: 434 LQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ 493
+ +N+ L +P + F+ QL L + L N L ++PP+
Sbjct: 92 VTDNK-LQALPIGV-----FD-QLV----------------NLAELRLDRNQLK-SLPPR 127
Query: 494 LL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
+ L+ L L L N+L +P V L +L+ L ++ N+L+ +P
Sbjct: 128 VFDSLTKL-TYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPE---------- 174
Query: 552 LQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
G F L L L L N L + L+ L L N
Sbjct: 175 ----GAF---------DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 10/157 (6%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSI 144
+L L KL + A + L L+ L + +N +P FD+L L L L N +
Sbjct: 64 RLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK-LQALPIGVFDQLVNLAELRLDRNQL 121
Query: 145 GGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPPS-FG 201
+P + S + L + L NEL +P + L+ ++ + N L +P F
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFD 178
Query: 202 NLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQN 238
L+ + L L N L F L+ L L + +N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 70/304 (23%), Positives = 112/304 (36%), Gaps = 96/304 (31%)
Query: 141 NNSIGGEIPANISSCSN-LIRVRLSSNELV---GKIPSELGSLSKIEYFSVSYNNLTGSI 196
N ++ + + SC+N V SS +L IP++ L + N L+ S+
Sbjct: 1 NEALC-KKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLD------LQSNKLS-SL 52
Query: 197 PPS-FGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
P F L+ + L+L+ N L ++P F LKNL L + N+L +P +F+
Sbjct: 53 PSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFD---- 106
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI-SNASNLEVFQVNSNKL 313
L NL + RNQL ++PP + + + L + N+L
Sbjct: 107 --------------------QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 314 TGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC 373
Q L V F L
Sbjct: 146 ----------QSLPKGV-----------------------------------FDKL---- 156
Query: 374 ISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELR 433
T+L+ L L +N++ AF K +L L++ NN+L A L+ L+ L+
Sbjct: 157 -----TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211
Query: 434 LQEN 437
LQEN
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 6/115 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L L L L N P FD L +L L+L N + +P + ++L +RL
Sbjct: 107 QLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLY 165
Query: 165 SNELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
+N+L ++P L++++ + N L +P +F +L + L L N D
Sbjct: 166 NNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFE 532
+ +D S+ LT IP + + L+L N+L+ L L +L + +
Sbjct: 15 NNNKNSVDCSSKKLT-AIPS---NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLND 70
Query: 533 NKLRGEIPRTL-GSCIKLELLQMQGNFLQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPE- 589
NKL+ +P + LE L + N LQ +P + L L+ L L +N L +P
Sbjct: 71 NKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
Query: 590 -FLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLK 630
F L YL+L N+ + +P +GVF L +LK
Sbjct: 128 VF-DSLTKLTYLSLGYNELQ-SLP-KGVFDK------LTSLK 160
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 62/258 (24%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIA----------------- 757
IG GS+G V + T A+KV + L+ F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 758 ------ECNTLKNIRHRNLVK----ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI 807
E LK + H N+VK + Y +VFE ++ + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPV---MEVP 129
Query: 808 TREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867
T + +E+ R Q D+ + YLH+ I+H D+KPSN+L+ E+ +
Sbjct: 130 TLKPLSEDQAR--FYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKI 178
Query: 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSING---DVYSYGILLLELVTR 924
DFG++ S A S+ G+ ++APE + +G DV++ G+ L V
Sbjct: 179 ADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 925 KKPTDIMFEGD--MNLHN 940
+ P F + M LH+
Sbjct: 237 QCP----FMDERIMCLHS 250
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 44/218 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKV-----FNLLHHGAFKSFIAECNTLKNIRHRNLVKI 773
IG G F V + I E AVK+ F + + E + ++H ++V++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-----TEEAPRSLNLLQRLDI 828
L Y + +VFEFM + I + + +E + Q L+
Sbjct: 92 LET-----YSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHY-MRQILE- 141
Query: 829 GIDVACALSYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTS 884
AL Y H ++ I+H D+KP VLL + +G FG+A L S
Sbjct: 142 ------ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 885 SIFAKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 918
G+ ++APE G V DV+ G++L
Sbjct: 192 GRV--GTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 46/229 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G+F V VA+K+ + L+ + + E +K + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 777 CSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
++ + + L+ E+ + ++L R E +EA +++
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS---KFRQI------V 124
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT-FLPLSHAQTSSIFAKGSI 892
A+ Y H IVH DLK N+LLD +M + DFG + F G+
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAP 177
Query: 893 GYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
Y APE Y G EV DV+S G++L LV+ P F+G
Sbjct: 178 PYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 27/224 (12%), Positives = 54/224 (24%), Gaps = 62/224 (27%)
Query: 718 LIGAGSFGSVYKG---ILDEGKTIVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLV 771
G ++ LD VA+ + ++ L I +
Sbjct: 38 FHGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
++L V + +V E++ SL+E +T +P +
Sbjct: 95 RVLDV---VHTRAGGL--VVAEWIRGGSLQEVA-------DTSPSPV-----GAIRAMQS 137
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+A A H + PS V + + +
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ + D+ G L L+ + P
Sbjct: 175 --TMPD-------ANPQDDIRGIGASLYALLVNRWP----LPEA 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 768
D + +G G++G VYK I VA+K L H G + I E + LK ++HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N++++ + V + + L+FE+ L++++ +S L Q ++
Sbjct: 94 NIIELKS----VIHHNHRL-HLIFEYAE-NDLKKYMDKNPDVSMRVI--KSF-LYQLIN- 143
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG-----DFGLA-TFLPLSHAQ 882
+++ H +H DLKP N+LL + DFGLA F
Sbjct: 144 ------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 883 TSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
T I + Y PE LGS S + D++S + E++ + P +F GD
Sbjct: 195 THEIIT---LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 45/234 (19%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIA-ECNTLKNIRHRNLVKI 773
L+G GS+G V + + E AVK+ L ++ + E L+ +RH+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 774 LTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ V Y K +V E+ ++E L + + +L
Sbjct: 72 VD----VLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAH--GYFCQL------ 118
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA----QTSSIFA 888
L YLH IVH D+KP N+LL + G+A L A +TS
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172
Query: 889 KGSIGYIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
GS + PE + G +V D++S G+ L + T P FEGD
Sbjct: 173 -GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD 216
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 23/181 (12%), Positives = 59/181 (32%), Gaps = 13/181 (7%)
Query: 428 NLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNL 486
+ + + L + L+ + + + + + + + ++N +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 487 TGTIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLG 544
T +S L L L + +T + L +L +L++ + I +
Sbjct: 79 TN-----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 545 SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604
+ K+ + + N I L +L L L++ + + + F L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190
Query: 605 N 605
Sbjct: 191 Q 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 13/163 (7%)
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
+L + L + + ++ + L + N + P I L NL LR+
Sbjct: 44 NSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 439 FLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGL 497
+ P++ L L L +S++ SI + + + IDLS N I P L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP----L 155
Query: 498 SSL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE 538
+L L L + + + + + L L F + G+
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 32/207 (15%), Positives = 78/207 (37%), Gaps = 14/207 (6%)
Query: 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF 439
E L +++ NIP + F L + + + ++ +L + L
Sbjct: 2 AAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN- 55
Query: 440 LGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
+ ++ I + +L ++ + + + L + + ++T P L GL+
Sbjct: 56 VTDLTG-IEYAHNIKDLTINNI--HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT 112
Query: 499 SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF 558
SL +L++S + I ++ L + +++ N +I L + +L+ L +Q +
Sbjct: 113 SL-TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170
Query: 559 LQGPIPSSLSSLRGLSVLDLSQNNLSG 585
+ + L+ L + G
Sbjct: 171 VHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 24/186 (12%), Positives = 65/186 (34%), Gaps = 11/186 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
L +S + ++ + L + L N ++ ++ I N+ + +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINN 75
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
+ + LS +E + ++T P+ L+S++ L +S + D SI
Sbjct: 76 IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L + ++ ++ N I + + + + + + ++ L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE---DFPKLNQLYAF 189
Query: 286 RNQLTG 291
+ G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 24/172 (13%), Positives = 58/172 (33%), Gaps = 17/172 (9%)
Query: 319 YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS 378
++ L++ + ++ DL + N L +I+ N + S
Sbjct: 39 TEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTINNIHATN--------YNPIS 85
Query: 379 --TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQE 436
+ LE L + + + L L++ ++ +I I L + + L
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 437 NRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
N + +I P +L +L + ++ + + L + + + G
Sbjct: 146 NGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 21/181 (11%), Positives = 59/181 (32%), Gaps = 13/181 (7%)
Query: 189 YNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSI 248
+ + + ++S++++ L+ N+ + N+ +LT+ + + I
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPI 84
Query: 249 FNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV 308
+S++ + ++ L +L + + +I I+ + +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 309 NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGG 368
+ N ++ L+ L L I + + D + L + GG
Sbjct: 144 SYNGAITDIMPLKTLPELKSLNIQFDGV-----HDYRGIEDFPK---LNQLYAFSQTIGG 195
Query: 369 L 369
Sbjct: 196 K 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 33/228 (14%), Positives = 72/228 (31%), Gaps = 43/228 (18%)
Query: 211 LSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270
L + + +IPD+ K +N + Q+ + + ++S+T + + +
Sbjct: 8 LKASQDNVNIPDST--FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGI 62
Query: 271 DIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFV 330
+ N++ ++ T P IS SNLE ++ +T +
Sbjct: 63 E---YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSD-------------- 103
Query: 331 ITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK 390
+ L LT+ L I+ + + I+ + + L N
Sbjct: 104 ------------KIPNLSGLTS---LTLLDISHSAHDDSILTKINTL-PKVNSIDLSYNG 147
Query: 391 IFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
+I +L L + + + I + L +L
Sbjct: 148 AITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 41/236 (17%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRH 767
+ + ++G GSFG V K + AVKV N + + + E LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N++K+ + + +V E L + + I R+ +E
Sbjct: 81 PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAA--------R 125
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTS 884
I V ++Y+H IVH DLKP N+LL +++ + DFGL+T +
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 885 SIFAKGSIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
I G+ YIAPE Y + DV+S G++L L++ P F G
Sbjct: 183 RI---GTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGK 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 43/248 (17%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAF-KSFIAECN 760
+ + + S +G+G++GSV I VA+K + F K E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL 75
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPR 818
LK+++H N++ +L + +F LV FM + L I +EE +
Sbjct: 76 LLKHMQHENVIGLLDVFT-PASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ 129
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
L + Q L L Y+H +VH DLKP N+ ++E+ + DFGLA
Sbjct: 130 YL-VYQML-------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HA 176
Query: 879 SHAQTSSIFAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIM 931
T GY+ APE L + D++S G ++ E++T K +
Sbjct: 177 DAEMT---------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TL 223
Query: 932 FEGDMNLH 939
F+G L
Sbjct: 224 FKGKDYLD 231
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 44/218 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--------LLHHGAFKSFIAECNTLKNIRHRNL 770
+G+G+ G V + VA+++ + + E LK + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+KI DY +V E M L + + + + E + Q
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELFDKV--VGNKRLKEATCKLY-FYQ------ 247
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ A+ YLH + I+H DLKP NVLL +E+ + + DFG + L + +
Sbjct: 248 -MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC- 302
Query: 888 AKGSIGYIAPE-------YGLGSEVSINGDVYSYGILL 918
G+ Y+APE G V D +S G++L
Sbjct: 303 --GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-16
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 39/232 (16%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSF----IAECNTLKNIR 766
+ IG G+FG V+K + VA+K + + F + E L+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKILQLLK 74
Query: 767 HRNLVKILTACSGVDYQGNDFKA---LVFEFM-HNRSLEEWL-HPITREDETEEAPRSLN 821
H N+V ++ C N K LVF+F H+ L L + + + +E + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSEI--KRV- 129
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF--LPLS 879
+ L+ L Y+H + I+H D+K +NVL+ + + + DFGLA L +
Sbjct: 130 MQMLLN-------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 880 HAQ---TSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 925
T+ + + Y PE LG I D++ G ++ E+ TR
Sbjct: 180 SQPNRYTNRVVT---LWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRS 226
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH 767
+ D + +G+G+FG V++ + + K N + + E + + + H
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQR 825
L+ + A ++ L+ EF+ S E I ED +E + + Q
Sbjct: 108 PKLINLHDA-----FEDKYEMVLILEFL---SGGELFDRIAAEDYKMSEAEVINY-MRQA 158
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQT 883
+ L ++H + IVH D+KP N++ + + + V DFGLAT L
Sbjct: 159 CE-------GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
+ + + APE V D+++ G+L
Sbjct: 209 VTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/253 (20%), Positives = 79/253 (31%), Gaps = 83/253 (32%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIA---ECNTLKNIR----H 767
L+G G FG+V+ G + VA+KV +L + E L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 768 RNLVKIL--------------TACSGVDYQGNDFKALVFEF-MHNRSLEEWLHPITREDE 812
++++L D +F++ L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQD---------LFDYITEKGPLGE---------- 138
Query: 813 TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM----IAHVG 868
+ R Q V A+ + H +VH D+K N+L+D +
Sbjct: 139 -GPS-RCF-FGQ-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI--- 182
Query: 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELV 922
DFG L G+ Y PE Y V+S GILL ++V
Sbjct: 183 DFGSGALLHDEPYTDFD----GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMV 233
Query: 923 TRKKPTDIMFEGD 935
P FE D
Sbjct: 234 CGDIP----FERD 242
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 39/216 (18%), Positives = 81/216 (37%), Gaps = 17/216 (7%)
Query: 110 LKVLDLHNNSFHHEIPSE--FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSN 166
+LDL +N+ + +E RL L L L +N + I + NL + LSSN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 167 ELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPDTF 224
L + L +E + N++ + +F +++ + L+LS+N + +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156
Query: 225 GWLKNLVNLT---MAQNRLSGTIPSSIFNISSITVFDAGI--NQIQ---GVIPLDIGFTL 276
L L ++ N+L + + + + + N ++ + L +
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQY 216
Query: 277 QNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK 312
+ L + L + N +L+ F + K
Sbjct: 217 RQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYK 252
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 13/148 (8%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQ--LLGLSSLLIVLELSRNQLTGPIPNEV-GN 521
++P SL ++DLS+NNL+ + + L++L L LS N L I +E
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNL-HSLLLSHNHLNF-ISSEAFVP 86
Query: 522 LKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581
+ NL L++ N L LE+L + N + ++ + L L LSQN
Sbjct: 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 582 NLSGKIPE--FLVGFQL--LEYLNLSNN 605
+S + P G +L L L+LS+N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSN 173
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 22/175 (12%)
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPS--SLGQSETLTIIDLSNNNLTGTIPPQLL-GLS 498
++P L LS+N L + + + + L + LS+N+L I + +
Sbjct: 36 SLPSYT-----ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 499 SLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQG 556
+L L+LS N L + + +L+ LE+L ++ N + + R +L+ L +
Sbjct: 89 NL-RYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 557 NFLQGPIP----SSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLL--EYLNLSNN 605
N + P + L L +LDLS N L L L L NN
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 32/120 (26%), Positives = 51/120 (42%), Gaps = 11/120 (9%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRL 163
+ L+ LDL +N H + F L+ L+VL L+NN I + N + L ++ L
Sbjct: 86 PVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYL 143
Query: 164 SSNELVGKIPSE----LGSLSKIEYFSVSYNNLTGSIPPSFGNLSSIS--FLFLSRNNLD 217
S N++ + P E L K+ +S N L L + L+L N L+
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 39/189 (20%), Positives = 68/189 (35%), Gaps = 30/189 (15%)
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-----YLEKLQRLSHFVITRNSLGSGE 340
+ QL +P ++ S + ++ N L+ L L L ++ N L
Sbjct: 27 KQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLL---LSHNHLNFIS 80
Query: 341 HRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AF 399
+ L++ ++ N+ L + + LEVLLL +N I + AF
Sbjct: 81 SE------AFVPVPNLRYLDLSSNHLHTL-DEFLFSDLQALEVLLLYNNHI-VVVDRNAF 132
Query: 400 GKFVKLLRLEMWNNRLSGTIPP----AIGELQNLRELRLQENRFLGNIPP----SIGNLK 451
+L +L + N++S P +L L L L N+ L +P +
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK-LKKLPLTDLQKLPAWV 190
Query: 452 LFNLQLSYN 460
L L N
Sbjct: 191 KNGLYLHNN 199
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 60/235 (25%), Positives = 91/235 (38%), Gaps = 58/235 (24%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRN 769
F+ IG GSFG+VY +VA+K + + ++ I E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 770 LVKILTACSGVDYQGNDFKALVFEFM----------HNRSL-EEWLHPITREDETEEAPR 818
++ Y LV E+ H + L E + +T
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG-------- 162
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
LQ L+YLH ++H D+K N+LL E + +GDFG A
Sbjct: 163 ---ALQ----------GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 879 SHAQTSSIFAKGSIG---YIAPEYGLGSEVSING---DVYSYGILLLELVTRKKP 927
+ + A +G ++APE L + DV+S GI +EL RK P
Sbjct: 202 --SIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-15
Identities = 59/278 (21%), Positives = 100/278 (35%), Gaps = 59/278 (21%)
Query: 686 KENQNPSSPINSFPNISYQ-------NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTI 738
+ + F I+ + + +G+G++G V G +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 739 VAVKV-------------FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785
A+KV N + E + LK++ H N++K+ ++
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDK 118
Query: 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQP 845
+ LV EF L E + I R E +I + + YLH
Sbjct: 119 KYFYLVTEFYEGGELFEQI--INRHKFDECDAA--------NIMKQILSGICYLHKHN-- 166
Query: 846 PIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE---- 898
IVH D+KP N+LL + + + DFGL++F + + G+ YIAPE
Sbjct: 167 -IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVLKK 222
Query: 899 -YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
Y + DV+S G+++ L+ P F G
Sbjct: 223 KY--NEKC----DVWSCGVIMYILLCGYPP----FGGQ 250
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFK-----SFIAECNTLKNI 765
+ + +G G F +VYK IVA+K L H K + + E L+ +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
H N++ +L ++ +LVF+FM LE + T ++ +L
Sbjct: 70 SHPNIIGLL----DAFGHKSNI-SLVFDFME-TDLEVIIKD-NSLVLTPSHIKAY-MLMT 121
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTS 884
L L YLH I+H DLKP+N+LLDE + + DFGLA +F + A T
Sbjct: 122 LQ-------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
Query: 885 SIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 925
+ Y APE G+ V + D+++ G +L EL+ R
Sbjct: 172 QVVT---RWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 768
+ + + L+G GS+G V K + IVA+K F K + E LK +RH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN------- 821
NLV +L C + LVFEF+ ++ + L E P L+
Sbjct: 85 NLVNLLEVC-----KKKKRWYLVFEFVD-HTILDDL---------ELFPNGLDYQVVQKY 129
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSH 880
L Q ++ + + H I+H D+KP N+L+ + + + DFG A T
Sbjct: 130 LFQIIN-------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEV---SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+ Y APE +G ++ DV++ G L+ E+ +P +F GD
Sbjct: 180 VYDDEVAT---RWYRAPELLVGDVKYGKAV--DVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 48/259 (18%)
Query: 683 RKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK 742
K EN S + + ++IG G V + + AVK
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125
Query: 743 VFNL--------LHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFE 793
+ + ++ E + L+ + H +++ ++ + Y+ + F LVF+
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSFMFLVFD 180
Query: 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853
M L ++L + +E+ RS+ + L+ A+S+LH + IVH DLK
Sbjct: 181 LMRKGELFDYL--TEKVALSEKETRSI-MRSLLE-------AVSFLHANN---IVHRDLK 227
Query: 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE----------YGLGS 903
P N+LLD+ M + DFG + L G+ GY+APE G G
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLAPEILKCSMDETHPGYGK 284
Query: 904 EVSINGDVYSYG----ILL 918
EV D+++ G LL
Sbjct: 285 EV----DLWACGVILFTLL 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 41/226 (18%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIA-----ECNTLKNIRHRNL 770
+G+G+FG V+ + E V VK +L + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+K+L ++ F LV E H L+ + E + Q
Sbjct: 92 IKVLDI-----FENQGFFQLVMEK-HGSGLDLFAFIDRHPRLDEPLASYI-FRQ------ 138
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA-QTSSIFAK 889
+ A+ YL I+H D+K N+++ E+ + DFG A +L T
Sbjct: 139 -LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190
Query: 890 GSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
G+I Y APE Y G E+ +++S G+ L LV + P
Sbjct: 191 GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPFC 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 47/234 (20%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIA---ECNTLKNIRHR--N 769
L+G+G FGSVY GI VA+K + G + E LK +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNR-SLEEWLHPITREDETEEAPRSLNLLQRLDI 828
++++L ++ D L+ E L +++ E E A RS Q
Sbjct: 110 VIRLLDW-----FERPDSFVLILERPEPVQDLFDFITERGALQE-ELA-RSF-FWQ---- 157
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIF 887
V A+ + H+ ++H D+K N+L+D + DFG L +
Sbjct: 158 ---VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-- 209
Query: 888 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G+ Y PE Y G V+S GILL ++V P FE D
Sbjct: 210 --GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 70/268 (26%)
Query: 719 IGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHHGA----FKSFIAECNTLKNI-RHR 768
+G G+FG V + VAVK +L GA ++ ++E L +I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH--------PITREDETEEAPRSL 820
N+V +L AC+ + ++ EF +L +L T+ + +
Sbjct: 87 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 821 NLL-----QRLDIGIDVACALSYLHHDCQPP----------------------------- 846
+ +RLD + S + +
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 202
Query: 847 -----------IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+H DL N+LL E+ + + DFGLA + A+ + ++
Sbjct: 203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVT 923
APE +I DV+S+G+LL E+ +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 33/245 (13%)
Query: 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-KSFIAECNTLKNI 765
YN + F +L+G G++G V IVA+K F + E LK+
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
+H N++ I ++ + ++ E M + LH + + + Q
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSS 885
L A+ LH ++H DLKPSN+L++ V DFGLA + S A S
Sbjct: 122 L-------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 886 IFAKGSI--GYI------APEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEG 934
+ S ++ APE L S ++ DV+S G +L EL R+ +F G
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM--DVWSCGCILAELFLRR----PIFPG 225
Query: 935 DMNLH 939
H
Sbjct: 226 RDYRH 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 40/247 (16%)
Query: 684 KRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV 743
++ + I N +D F + +G G+ VY+ + A+KV
Sbjct: 26 VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85
Query: 744 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 803
K E L + H N++K+ ++ +LV E + L +
Sbjct: 86 LK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFDR 138
Query: 804 LHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLL--- 859
+ + + +E + Q L+ A++YLH + IVH DLKP N+L
Sbjct: 139 I--VEKGYYSERDAADA-VKQILE-------AVAYLHENG----IVHRDLKPENLLYATP 184
Query: 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE----YGLGSEVSINGDVYSYG 915
+ + DFGL+ + + G+ GY APE G EV D++S G
Sbjct: 185 APDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEILRGCAYGPEV----DMWSVG 237
Query: 916 ----ILL 918
ILL
Sbjct: 238 IITYILL 244
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 5e-15
Identities = 51/244 (20%), Positives = 87/244 (35%), Gaps = 32/244 (13%)
Query: 682 VRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAV 741
V +N +P + D + +G G+FG V++ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 742 KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 801
K H ++ E T+ +RH LV + A ++ ++ +++EFM L
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELF 242
Query: 802 EWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
E + E +E+ + Q L ++H + VH DLKP N++
Sbjct: 243 EK---VADEHNKMSEDEAVEY-MRQVCK-------GLCHMH---ENNYVHLDLKPENIMF 288
Query: 860 DEE-----MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSY 914
+ + DFGL L G+ + APE G V D++S
Sbjct: 289 TTKRSNELKLI---DFGLTAHLD-PKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 915 GILL 918
G+L
Sbjct: 343 GVLS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 32/215 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+ ++G G FG V+K +A K+ + E + + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGI 830
+ A ++ + LV E++ L + I E TE + Q +
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDR---IIDESYNLTELDTILF-MKQICE--- 198
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ ++H Q I+H DLKP N+L D + I + DFGLA +
Sbjct: 199 ----GIRHMH---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNF- 249
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYG----ILL 918
G+ ++APE VS D++S G +LL
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 32/209 (15%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G+G+FG V+ +K N + AE LK++ H N++KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACA 835
++ +V E L E + + +E ++ + A
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA--------ELMKQMMNA 136
Query: 836 LSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
L+Y H +VH DLKP N+L + DFGLA T++ G+
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTA 190
Query: 893 GYIAPE---YGLGSEVSINGDVYSYGILL 918
Y+APE + + D++S G+++
Sbjct: 191 LYMAPEVFKRDVTFKC----DIWSAGVVM 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 66/231 (28%), Positives = 95/231 (41%), Gaps = 47/231 (20%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G+FG V G VAVK+ N + E LK RH +++K+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 775 TACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
YQ +V E++ L +++ R +E E + L Q++
Sbjct: 77 -------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME----ARRLFQQI----- 120
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLPLSHAQTSSIFAKG 890
A+ Y H +VH DLKP NVLLD M A + DFGL +TS G
Sbjct: 121 -LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 172
Query: 891 SIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
S Y APE Y G EV D++S G++L L+ P F+ +
Sbjct: 173 SPNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDE 214
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 54/230 (23%), Positives = 89/230 (38%), Gaps = 47/230 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG GS+G V+K + IVA+K F K + E LK ++H NLV +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN-------LLQRLDIG 829
V + LVFE+ ++ L + R + Q L
Sbjct: 69 --EVFRRKRRL-HLVFEYCD-HTVLHEL---------DRYQRGVPEHLVKSITWQTLQ-- 113
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLA-TFLPLSHAQTSSIFA 888
A+++ H +H D+KP N+L+ + + + DFG A S +
Sbjct: 114 -----AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
Query: 889 KGSIGYIAPEYGLGSEV---SINGDVYSYGILLLELVTRKKPTDIMFEGD 935
Y +PE +G + DV++ G + EL++ P ++ G
Sbjct: 166 ---RWYRSPELLVGDTQYGPPV--DVWAIGCVFAELLSG-VP---LWPGK 206
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 62/284 (21%), Positives = 109/284 (38%), Gaps = 51/284 (17%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAF-KSFIAECN 760
+ + + +G+G++G+V + VA+K ++ F K E
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPR 818
LK++RH N++ +L + D +DF LV FM L + + ++ E
Sbjct: 77 LLKHMRHENVIGLLDVFT-PDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRI 130
Query: 819 SLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878
+ Q L L Y+H I+H DLKP N+ ++E+ + DFGLA
Sbjct: 131 QFLVYQML-------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QA 178
Query: 879 SHAQTSSIFAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIM 931
T GY+ APE L + D++S G ++ E++T K +
Sbjct: 179 DSEMT---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TL 225
Query: 932 FEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ 975
F+G +L + I+ T E + + +
Sbjct: 226 FKGSDHLDQLKE---------IMKVTGTPPAEFVQRLQSDEAKN 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 54/259 (20%), Positives = 93/259 (35%), Gaps = 48/259 (18%)
Query: 682 VRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAV 741
+RK K N S N A D + +IG G+FG V + + A+
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 742 KVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 798
K+ + ++ F E + + +V++ A +Q + + +V E+M
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGG 154
Query: 799 SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA--------CALSYLHHDCQPPIVHC 850
L +NL+ D+ A AL +H +H
Sbjct: 155 DL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHR 192
Query: 851 DLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYIAPE--YGLGSEVS 906
D+KP N+LLD+ H+ DFG + G+ YI+PE G +
Sbjct: 193 DVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 249
Query: 907 INGDV--YSYGILLLELVT 923
+ +S G+ L E++
Sbjct: 250 YGRECDWWSVGVFLYEMLV 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 58/286 (20%), Positives = 96/286 (33%), Gaps = 63/286 (22%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
D F +IG G+F V + + + A+K+ N +L G F E + L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
R + ++ A +Q ++ LV E+ L L LL +
Sbjct: 121 RWITQLHFA-----FQDENYLYLVMEYYVGGDL-------------------LTLLSKFG 156
Query: 828 IGID----------VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATF 875
I + A+ +H + VH D+KP N+LLD H+ DFG
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLK 211
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVY-------SYGILLLELVTRKKP- 927
L S + G+ Y++PE Y + G+ E+ + P
Sbjct: 212 LRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 928 ----TDIMFEGDMNLHN-----FAKTALPDHVVDIVDSTLLSDDED 964
T + ++ +P+ D + LL E
Sbjct: 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPET 315
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 27/230 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
D F ++G G FG V+ + + A K N L ++ + E L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
R +V L ++ LV M+ + ++ + ++ + PR+
Sbjct: 245 RFIVS-LAYA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-----IFY 294
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSS 885
+ L +LH Q I++ DLKP NVLLD++ +V D GLA L +T
Sbjct: 295 TA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKG 348
Query: 886 IFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+A G+ G++APE LG E + D ++ G+ L E++ + P F
Sbjct: 349 -YA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 769
F ++G G FG V + + A K + + E L+ + R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+V L Y+ D LV M+ L+ ++ + + E R+
Sbjct: 246 VVS-LAYA----YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE--ARA-----VFYAA 293
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIF 887
++ C L LH + IV+ DLKP N+LLD+ H+ D GLA +P QT
Sbjct: 294 -EICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVP--EGQTIKGR 345
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
G++GY+APE + + D ++ G LL E++ + P F+
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 56/231 (24%), Positives = 90/231 (38%), Gaps = 40/231 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTA 776
+G G++G V + + VAVK+ ++ I E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
G +GN L E+ L + + P E + + +L +
Sbjct: 72 --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQL------MAGV 118
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK---GSIG 893
YLH I H D+KP N+LLDE + DFGLAT + G++
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERLLNKMCGTLP 172
Query: 894 YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
Y+APE + V DV+S GI+L ++ + P ++ +
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 26/259 (10%)
Query: 686 KENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
+ + ++ + P + +++ +T+ + IG G++G V + K VA+K +
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 746 LLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL 804
H + + + E L RH N++ I + +V + M E L
Sbjct: 62 PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL 116
Query: 805 HPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864
+ + + L Q L L Y+H ++H DLKPSN+LL+
Sbjct: 117 YKLLKTQHLSNDHICYFLYQIL-------RGLKYIH---SANVLHRDLKPSNLLLNTTCD 166
Query: 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIG---YIAPEYGLGS-EVSINGDVYSYGILLLE 920
+ DFGLA + F + Y APE L S + + D++S G +L E
Sbjct: 167 LKICDFGLAR--VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 921 LVTRKKPTDIMFEGDMNLH 939
+++ + +F G L
Sbjct: 225 MLSNR----PIFPGKHYLD 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-KSFIAECNTLKNIRHR------NL 770
+IG GSFG V K + VA+K+ + + F + E L+++R + N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM--VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ +L ++ + + FE + +L E + + + SL L+++
Sbjct: 162 IHMLEN---FTFRNHIC--MTFELLSM-NLYELIK------KNKFQGFSLPLVRK--FAH 207
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH--VGDFGLATFLPLSHAQT-SSIF 887
+ L LH + I+HCDLKP N+LL ++ + V DFG + + S F
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
Y APE LG+ + D++S G +L EL+T + G+ A
Sbjct: 265 ------YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLAC 310
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 50/276 (18%), Positives = 108/276 (39%), Gaps = 31/276 (11%)
Query: 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLE 321
I+ + D ++ + +T A+ + ++++ N++ + V ++
Sbjct: 12 TPIKQIFSDD---AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQ 65
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS--T 379
L ++ + N L D+ L +L N L + + +S+
Sbjct: 66 YLPNVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVKD--------LSSLKDLK 112
Query: 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF 439
L+ L L+ N I +I +L L + NN+++ I + L L L L++N+
Sbjct: 113 KLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQ- 167
Query: 440 LGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSS 499
+ +I P G KL NL LS N + + +L + L +++L + + S+
Sbjct: 168 ISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLN---KPINHQSN 222
Query: 500 LLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L++ + + P + + + E NV +
Sbjct: 223 LVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLP 258
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 46/229 (20%), Positives = 90/229 (39%), Gaps = 20/229 (8%)
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR 438
L + + + + ++ N+ + ++ I L N+ +L L N+
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK 79
Query: 439 FLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498
L +I P L L L N ++ + SSL + L + L +N ++ + GL
Sbjct: 80 -LTDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-----DINGLV 131
Query: 499 SL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG 556
L L L L N++T + L L+ L++ +N++ +P L KL+ L +
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 557 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605
N + +L+ L+ L VL+L K + + ++
Sbjct: 188 NHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 47/253 (18%), Positives = 96/253 (37%), Gaps = 24/253 (9%)
Query: 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP 198
I +I + + + I+ L + L+ I+ + +++ S+
Sbjct: 9 TVPTPIK-QIF-SDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG 63
Query: 199 SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFD 258
L +++ LFL+ N L I LKNL L + +N++ + SS+ ++ +
Sbjct: 64 -IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118
Query: 259 AGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP 318
N I + L L L+ +G N++T +S + L+ + N+++ ++
Sbjct: 119 LEHNGISDINGLV---HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIV 172
Query: 319 YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS 378
L L +L + +++N + DL L L N L + SN
Sbjct: 173 PLAGLTKLQNLYLSKNHI-----SDLRALAGLKN---LDVLELFSQECLNKPINHQSNLV 224
Query: 379 TTLEVLLLDSNKI 391
V D + +
Sbjct: 225 VPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 43/280 (15%), Positives = 103/280 (36%), Gaps = 30/280 (10%)
Query: 309 NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGG 368
+ ++ + + + S+ D L + ++ + +I + G
Sbjct: 10 VPTPIK-QIFSDDAFAETIKDNLKKKSV-----TDAVTQNELNSIDQIIANNSDIKSVQG 63
Query: 369 LLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQN 428
+ + L L+ NK+ +I L L + N++ + + +L+
Sbjct: 64 I-----QYL-PNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKK 113
Query: 429 LRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L+ L L+ N + +I + +L +L L N + + + L + L + L +N ++
Sbjct: 114 LKSLSLEHNG-ISDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS- 169
Query: 489 TIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSC 546
++ L+ L L L LS+N ++ + LKNL++L +F + + +
Sbjct: 170 ----DIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 547 IKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGK 586
+ ++ L P +S ++ +
Sbjct: 224 VVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 37/218 (16%), Positives = 85/218 (38%), Gaps = 17/218 (7%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
+ +L S + + L + + +N+ I + I N+ ++ L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
N+L I L +L + + + N + + +L + L L N + S +
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI--SDINGLV 131
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L L +L + N++ T + + ++ + NQI ++PL L LQ +
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLS 186
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKL 323
+N ++ + ++ NL+V ++ S + + +
Sbjct: 187 KNHISD-LRA-LAGLKNLDVLELFSQECLNKPINHQSN 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 35/177 (19%), Positives = 69/177 (38%), Gaps = 10/177 (5%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163
+ NL L L L N ++ S L++L+ L+L +N I +I + L + L
Sbjct: 86 LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI-SDIN-GLVHLPQLESLYL 141
Query: 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDT 223
+N++ + L L+K++ S+ N ++ I P L+ + L+LS+N++ +
Sbjct: 142 GNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA- 195
Query: 224 FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQ 280
LKNL L + + N+ + + +
Sbjct: 196 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 37/166 (22%), Positives = 59/166 (35%), Gaps = 16/166 (9%)
Query: 91 LKSLKLAG-YIS--AHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE 147
LKSL L IS + +L L+ L L NN + RL +L L+L +N I
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--S 169
Query: 148 IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSIS 207
++ + L + LS N + L L ++ + NL +
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 208 FLFLSRNNLDGSI--PDTFGWLKNLVNLTMAQNRLSGT-IPSSIFN 250
+ N DGS+ P+ + + + T S IF
Sbjct: 228 TV----KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 61/256 (23%), Positives = 108/256 (42%), Gaps = 59/256 (23%)
Query: 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLK 763
+ +T+ +IG GSFG V++ L E VA+K +L FK+ E ++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK--KVLQDKRFKN--RELQIMR 87
Query: 764 NIRHRNLVKILTA-CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
++H N+V + S D + F LV E++ E ++ +R + + L
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLL 142
Query: 823 LQ-------RLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEM-IAHVGDFGLA 873
++ R +L+Y+H I H D+KP N+LLD + + DFG A
Sbjct: 143 IKLYMYQLLR---------SLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
Query: 874 -TFLPLSHAQTSSIFAKGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVT 923
+ + ++ YI APE G+ +I D++S G ++ EL+
Sbjct: 190 KILIAG----------EPNVSYICSRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQ 237
Query: 924 RKKPTDIMFEGDMNLH 939
+P +F G+ +
Sbjct: 238 G-QP---LFPGESGID 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 42/211 (19%)
Query: 709 ATDGFTS---------ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAEC 759
+TD F+ +++G G+ V I AVK+ E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 760 NTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE---DETEE 815
L + HRN+++++ ++ D LVFE M S+ L I + +E E
Sbjct: 62 EMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEA 113
Query: 816 APRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGL 872
+ + DVA AL +LH I H DLKP N+L ++ + DF L
Sbjct: 114 S----------VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160
Query: 873 ATFLPLSHAQTSSIFAK-----GSIGYIAPE 898
+ + L+ + + GS Y+APE
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 64/312 (20%), Positives = 110/312 (35%), Gaps = 62/312 (19%)
Query: 682 VRKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAV 741
+R+ K F + Q + D F +IG G+FG V L + A+
Sbjct: 46 LRREKNILEYLEWAKPFTSKVKQMRLHRED-FEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 742 KVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 798
K+ N +L F E + L N + + + A +Q ++ LV ++
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA-----FQDDNNLYLVMDYYVGG 159
Query: 799 SLEEWLHPITREDETEEAPRSLNLLQRLDIGID----------VACALSYLHHDCQPPIV 848
L L LL + + + + A+ +H Q V
Sbjct: 160 DL-------------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197
Query: 849 HCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS 906
H D+KP N+L+D H+ DFG L SS+ G+ YI+PE E
Sbjct: 198 HRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGG 254
Query: 907 ING-----DVYSYGILLLELVTRKKP-----TDIMFEGDMNLHNFAK-----TALPDHVV 951
D +S G+ + E++ + P + MN + T + ++
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 952 DIVDSTLLSDDE 963
D++ L+ E
Sbjct: 315 DLIRR-LICSRE 325
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 56/231 (24%), Positives = 90/231 (38%), Gaps = 40/231 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTA 776
+G G++G V + + VAVK+ ++ I E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
G +GN L E+ L + + P E + + +L +
Sbjct: 72 --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQL------MAGV 118
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK---GSIG 893
YLH I H D+KP N+LLDE + DFGLAT + G++
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERLLNKMCGTLP 172
Query: 894 YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
Y+APE + V DV+S GI+L ++ + P ++ +
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 58/266 (21%), Positives = 106/266 (39%), Gaps = 43/266 (16%)
Query: 686 KENQNPSSPINSFPNIS-YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-V 743
+ + S +F + ++ + + + + +G+G++GSV + VAVK +
Sbjct: 3 HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 62
Query: 744 FNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSL 800
K E LK+++H N++ +L + +F LV M
Sbjct: 63 SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLM----- 116
Query: 801 EEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860
L+ I + + + + Q L L Y+H I+H DLKPSN+ ++
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQIL-------RGLKYIH---SADIIHRDLKPSNLAVN 166
Query: 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI------APEYGLGS-EVSINGDVYS 913
E+ + DFGLA + T GY+ APE L + D++S
Sbjct: 167 EDCELKILDFGLAR--HTADEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWS 215
Query: 914 YGILLLELVTRKKPTDIMFEGDMNLH 939
G ++ EL+T + +F G ++
Sbjct: 216 VGCIMAELLTGR----TLFPGTDHID 237
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 8e-14
Identities = 52/302 (17%), Positives = 99/302 (32%), Gaps = 14/302 (4%)
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
+ + P + + + V+ L+ E + R SH + S +
Sbjct: 256 CLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQ 315
Query: 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKL 405
+ + S L L K + + +L
Sbjct: 316 HTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKEL 374
Query: 406 LRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGS 465
LE N TI + L L +E + ++ ++ L +
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYE--KETLQYFSTLKAVDPMRAAYLDDLRSKFLLE 432
Query: 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLK 523
+ + ++ L++ +LT L L L + L+LS N+L +P + L+
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLT-----VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALR 486
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG-PIPSSLSSLRGLSVLDLSQNN 582
LE+L +N L + + + +L+ L + N LQ L S L +L+L N+
Sbjct: 487 CLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
Query: 583 LS 584
L
Sbjct: 545 LC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 5e-12
Identities = 42/235 (17%), Positives = 76/235 (32%), Gaps = 21/235 (8%)
Query: 294 PPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNA 353
+ L +++ K T LE + L L + +
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENK------WCLLTIILLMRAL 395
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
L + + F L + ++ +K ++ + L + +
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDL----RSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 414 RLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSLGQ 472
L T+ + +L + L L NR L +PP++ L L LQ S N L+ ++ +
Sbjct: 452 DL--TVLCHLEQLLLVTHLDLSHNR-LRALPPALAALRCLEVLQASDNALE-NVDG-VAN 506
Query: 473 SETLTIIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLKNL 525
L + L NN L + L S L++L L N L L +
Sbjct: 507 LPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 4e-10
Identities = 42/314 (13%), Positives = 92/314 (29%), Gaps = 34/314 (10%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAG 98
E + + +E+ +W R + V + DL + L
Sbjct: 253 EEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTP-DGRNRPSHVWLCDLPAASLND 311
Query: 99 YISAHVGNLSFLKVLDLHN----NSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISS 154
+ H + + + +L L + + + S
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELES 370
Query: 155 CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG-------------------- 194
C L + + + I + +L + Y + +
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL 430
Query: 195 -SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253
+ + L L+ +L ++ L + +L ++ NRL +P ++ +
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487
Query: 254 ITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG-AIPPAISNASNLEVFQVNSNK 312
+ V A N ++ V + L LQ + N+L A + + L + + N
Sbjct: 488 LEVLQASDNALENVDGVA---NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
Query: 313 LTGEVPYLEKLQRL 326
L E E+L +
Sbjct: 545 LCQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 7e-09
Identities = 42/206 (20%), Positives = 69/206 (33%), Gaps = 12/206 (5%)
Query: 402 FVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNF 461
L + + T + +E L ++R S + +LF +LS
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSR--NQLTGPIPNEV 519
+ S L + L ++ N TI + L LL E + + L P
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP--- 416
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLS 579
L+ +K E + +L + L + L L ++ LDLS
Sbjct: 417 ---MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLS 471
Query: 580 QNNLSGKIPEFLVGFQLLEYLNLSNN 605
N L +P L + LE L S+N
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDN 496
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 50/226 (22%), Positives = 84/226 (37%), Gaps = 45/226 (19%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN------LLHHGAFKSFIAECNTLK 763
D + +G+G F V K A K + E + L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+ H N++ + Y+ L+ E + L ++L +E +EE S +
Sbjct: 71 QVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF-IK 122
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------MIAHVGDFGLATFL 876
Q LD ++YLH I H DLKP N++L ++ + DFGLA +
Sbjct: 123 QILD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI---DFGLAHEI 169
Query: 877 PLSHAQTSSIFAKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 918
+ G+ ++APE LG E D++S G++
Sbjct: 170 EDGVEFKNIF---GTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 55/260 (21%), Positives = 91/260 (35%), Gaps = 55/260 (21%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGA----FKSFIA 757
L+ +T I +GS+G+V G+ D VA+K VFN + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 758 ------ECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITR 809
E L + H N++ + V ++ LV E M L +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIF--VHFEEPAMHKLYLVTELM-----RTDLAQVIH 125
Query: 810 EDE---TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866
+ + + + + L L LH + +VH DL P N+LL +
Sbjct: 126 DQRIVISPQHIQYF-MYHIL-------LGLHVLH---EAGVVHRDLHPGNILLADNNDIT 174
Query: 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLL 919
+ DF LA +T Y+ APE + + D++S G ++
Sbjct: 175 ICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 920 ELVTRKKPTDIMFEGDMNLH 939
E+ RK +F G +
Sbjct: 226 EMFNRK----ALFRGSTFYN 241
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/270 (21%), Positives = 97/270 (35%), Gaps = 61/270 (22%)
Query: 689 QNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH 748
+ + + D F ++G GSF +V A+K+
Sbjct: 9 RPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILE--- 64
Query: 749 HGAFKSFI----------AECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 798
K I E + + + H VK+ +Q ++ + N
Sbjct: 65 ----KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNG 115
Query: 799 SLEEWLHPITREDETE------EAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCD 851
L +++ I DET E + AL YLH I+H D
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAE----------------IVSALEYLHGKG----IIHRD 155
Query: 852 LKPSNVLLDEEMIAHV--GDFGLA-TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSIN 908
LKP N+LL+E+M H+ DFG A P S ++ F G+ Y++PE +
Sbjct: 156 LKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSACKS 212
Query: 909 GDVYSYGILLLELVTRKKP-----TDIMFE 933
D+++ G ++ +LV P ++F+
Sbjct: 213 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 242
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G G+FG V G + VAVK+ N + E LK RH +++K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 775 TACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
YQ + +V E++ L +++ R DE E S L Q++
Sbjct: 82 -------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE----SRRLFQQI----- 125
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLPLSHAQTSSIFAKG 890
+ Y H +VH DLKP NVLLD M A + DFGL +TS G
Sbjct: 126 -LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 177
Query: 891 SIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
S Y APE Y G EV D++S G++L L+ P F+ D
Sbjct: 178 SPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 685 RKENQNPSSPINSFPNISY---QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAV 741
++E Q +S P S + + D + +LIG GS+G V + K +VA+
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 742 K-VFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS 799
K + + K + E L + H ++VK+L D + D +V E
Sbjct: 84 KKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---- 139
Query: 800 LEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSN 856
+ + R TE ++L L L + Y+H I+H DLKP+N
Sbjct: 140 -DSDFKKLFRTPVYLTELHIKTL-LYNLL-------VGVKYVHSAG----ILHRDLKPAN 186
Query: 857 VLLDEEMIAHVGDFGLA 873
L++++ V DFGLA
Sbjct: 187 CLVNQDCSVKVCDFGLA 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 31/217 (14%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH 767
+ + A +G G FG V++ + K K + E + L RH
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TEEAPRSLNLLQRL 826
RN++ + + ++ + ++FEF+ + E + T E E S + Q
Sbjct: 61 RNILHLHES-----FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSY-VHQVC 112
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-----MIAHVGDFGLATFLPLSHA 881
+ AL +LH I H D++P N++ I +FG A L
Sbjct: 113 E-------ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKII---EFGQARQLKPGDN 159
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
+ Y APE VS D++S G L+
Sbjct: 160 FRLLF---TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG GSFG V ++ K + A+K N + ++ E ++ + H LV +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ +Q + +V + + L L E +L I ++
Sbjct: 82 YS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE----ETV-----KLFIC-ELVM 126
Query: 835 ALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL YL I+H D+KP N+LLDE H+ DF +A LP T+ A G+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA-GTKP 179
Query: 894 YIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKP 927
Y+APE G V D +S G+ EL+ ++P
Sbjct: 180 YMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 49/215 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA----ECNTLKNIR-HRNLVKI 773
+G GSF K + + AVK+ + K A E LK H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT-REDETEEAPRSLNLLQRLDIGIDV 832
+ LV E ++ L I ++ +E I +
Sbjct: 72 HEV-----FHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS--------YIMRKL 115
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
A+S++H +VH DLKP N+L ++ + + DFG A P + +
Sbjct: 116 VSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-- 170
Query: 890 GSIGYIAPE------YGLGSEVSINGDVYSYGILL 918
++ Y APE Y D++S G++L
Sbjct: 171 FTLHYAAPELLNQNGYDE--SC----DLWSLGVIL 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 61/246 (24%), Positives = 90/246 (36%), Gaps = 61/246 (24%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA------ECNTLKNIRHRNLV 771
IG+G+FG K +VAVK + E +++RH N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79
Query: 772 K----ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+ ILT A++ E+ L E + R E E + Q+L
Sbjct: 80 RFKEVILT---------PTHLAIIMEYASGGELYERICNAGRFSEDE----ARFFFQQL- 125
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH--VGDFGL-ATFLPLSHAQTS 884
+SY H I H DLK N LLD + DFG + + S +++
Sbjct: 126 -----LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 885 SIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
G+ YIAPE Y G DV+S G+ L ++ P FE
Sbjct: 178 V----GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDPEEP 224
Query: 939 HNFAKT 944
++ KT
Sbjct: 225 RDYRKT 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 46/210 (21%), Positives = 80/210 (38%), Gaps = 31/210 (14%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G+G F V K A K + + E + L+ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ Y+ L+ E + L ++L +E +EE S + Q LD
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF-IKQILD----- 126
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
++YLH I H DLKP N++L + DFGLA + +
Sbjct: 127 --GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
G+ ++APE + + D++S G++
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 46/166 (27%), Positives = 67/166 (40%), Gaps = 14/166 (8%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELR 433
S E L L S + A F KL L + N+L T+ + +L L L
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 434 LQENRFLGNIPPSI--GNLKLFNLQLSYNFLQGSIPS----SLGQSETLTIIDLSNNNLT 487
L N+ L ++P + +L L L N L+ S+PS L + L + L+ N L
Sbjct: 90 LANNQ-LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ 144
Query: 488 GTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
+IP + L L LS NQL L L+ + +F N
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
+ LDL + + F L +L L L N + + A + + L + L++N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD-TFGW 226
+P + L++++ + N L S+P F L+ + L L+ N L SIP F
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDK 153
Query: 227 LKNLVNLTMAQNRLSGTIPSSIF-NISSIT 255
L NL L+++ N+L ++P F + +
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQ 182
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V C + V LDL+S LA A L+ L L+L N
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78
Query: 128 FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYF 185
FD L L L L NN + +P + + L ++ L N+L +PS + L+K++
Sbjct: 79 FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL 136
Query: 186 SVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQN 238
++ N L SIP F L+++ L LS N L S+P F L L +T+ N
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 87 TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIG 145
T L+L +L +SA V +L+ L L L NN FD L +L L L N +
Sbjct: 62 TWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK 120
Query: 146 GEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGN 202
+P+ + + L +RL++N+L IP+ L+ ++ S+S N L S+P +F
Sbjct: 121 -SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDR 177
Query: 203 LSSISFLFLSRNNLDGSIPDTFGWLKN 229
L + + L N D S + +L
Sbjct: 178 LGKLQTITLFGNQFDCSRCEIL-YLSQ 203
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 12/137 (8%)
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
T+L W +++ N L A + + T L L L +N++ F +L +L + N
Sbjct: 59 TKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117
Query: 414 RLSGTIPPAI-GELQNLRELRLQENRFLGNIPP----SIGNLKLFNLQLSYNFLQGSIPS 468
+L ++P + L L+ELRL N+ L +IP + NL+ L LS N LQ S+P
Sbjct: 118 QLK-SLPSGVFDRLTKLKELRLNTNQ-LQSIPAGAFDKLTNLQ--TLSLSTNQLQ-SVPH 172
Query: 469 SLGQSET-LTIIDLSNN 484
L I L N
Sbjct: 173 GAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 37/162 (22%), Positives = 56/162 (34%), Gaps = 20/162 (12%)
Query: 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFE 532
+E +D +L ++P G+ + L+L L L L LN+
Sbjct: 13 NEGKKEVDCQGKSLD-SVPS---GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDY 68
Query: 533 NKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE--F 590
N+L+ +L L + N L L L L L N L +P F
Sbjct: 69 NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF 127
Query: 591 --LVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLK 630
L L+ L L+ N + +P G F L NL+
Sbjct: 128 DRLTK---LKELRLNTNQLQS-IP-AGAFDK------LTNLQ 158
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 19/175 (10%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT----GEVPYLEKL 323
+P I + L + L + L ++ N+L G L +L
Sbjct: 29 VPSGIPADTEKLD---LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 324 QRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEV 383
L + N L S + LT +L ++ N LP+ + + T L+
Sbjct: 86 GTLG---LANNQLASLPLGVFD---HLTQLDKL---YLGGNQLKS-LPSGVFDRLTKLKE 135
Query: 384 LLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQEN 437
L L++N++ +IPA AF K L L + N+L A L L+ + L N
Sbjct: 136 LRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 62/240 (25%), Positives = 95/240 (39%), Gaps = 66/240 (27%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
+G GSFG V + + VA+K + L E + LK +RH +++K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 775 TACSGVDYQGNDFKA---LVFEF---------MHNRSLEEWLHPITREDETEEAPRSLNL 822
Y +V E+ + + + E +E R
Sbjct: 75 -------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----------DEGRR---F 113
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL-ATFLPLSHA 881
Q++ CA+ Y H IVH DLKP N+LLD+ + + DFGL +
Sbjct: 114 FQQI------ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164
Query: 882 QTSSIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+TS GS Y APE Y G EV DV+S GI+L ++ + P F+ +
Sbjct: 165 KTSC----GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDE 211
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 29/131 (22%), Positives = 58/131 (44%), Gaps = 6/131 (4%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
+ L N+ P F ++L+ + L NN I E+ + +L + L N++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPDTFGWL 227
++P L L ++ ++ N + + +F +L +++ L L N L TF L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 228 KNLVNLTMAQN 238
+ + + +AQN
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 5/142 (3%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLK 523
IP++L ET+T I L N + IPP L ++LS NQ++ + + L+
Sbjct: 25 EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLR 80
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
+L L ++ NK+ L+LL + N + + L L++L L N L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 584 SGKIPEFLVGFQLLEYLNLSNN 605
+ ++ ++L+ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 16/159 (10%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFH 121
C + V C + + T + L+ + I L+ +DL NN
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS 69
Query: 122 HEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSL 179
P F LR L L L+ N I E+P ++ +L + L++N++ + + L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 180 SKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
+ S+ N L +I +F L +I + L++N
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 9/160 (5%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLS 212
+CSN I V L +IP+ L I + N + IPP +F + + LS
Sbjct: 10 TCSNNI-VDCRGKGLT-EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLS 64
Query: 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITVFDAGINQIQGVIPLD 271
N + PD F L++L +L + N+++ +P S+F + S+ + N+I + +D
Sbjct: 65 NNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVD 122
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
L NL S+ N+L S ++ + N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 36/167 (21%)
Query: 394 NIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPSIGNLKL 452
N+P + +RLE N + IPP A + LR + L N+ + + P
Sbjct: 29 NLPET----ITEIRLE--QNTIK-VIPPGAFSPYKKLRRIDLSNNQ-ISELAPDA----- 75
Query: 453 FNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLIVLELSRNQL 511
F L L + L N +T +P L GL SL + L L+ N++
Sbjct: 76 --------FQG------LRS---LNSLVLYGNKIT-ELPKSLFEGLFSLQL-LLLNANKI 116
Query: 512 TGPIPNEV-GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGN 557
+ + +L NL +L++++NKL+ T ++ + + N
Sbjct: 117 NC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 50/241 (20%), Positives = 96/241 (39%), Gaps = 35/241 (14%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+ +G G G V+ + ++ VA+K L + K + E ++ + H N+VK
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 773 IL-------TACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+ + + + + +V E+M E L + + E L +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMY 127
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDFGLATFLPLSHAQ 882
Q L L Y+H ++H DLKP+N+ ++ E+++ +GDFGLA +
Sbjct: 128 QLL-------RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR--IMDPHY 175
Query: 883 TSSIFAKGSIG---YIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
+ + Y +P L + D+++ G + E++T K +F G L
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHEL 231
Query: 939 H 939
Sbjct: 232 E 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 26/194 (13%)
Query: 686 KENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VF 744
+ + S N + + D + +LIG GS+G VY + VA+K V
Sbjct: 3 HHHHHSSGRENLYF--QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 745 NLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLE 801
+ K + E L ++ ++++ D F +V E +
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIA-----D 113
Query: 802 EWLHPI--TREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
L + T TEE +++ L L +++H + I+H DLKP+N LL
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTI-LYNLL-------LGENFIH---ESGIIHRDLKPANCLL 162
Query: 860 DEEMIAHVGDFGLA 873
+++ V DFGLA
Sbjct: 163 NQDCSVKVCDFGLA 176
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 56/276 (20%), Positives = 101/276 (36%), Gaps = 74/276 (26%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFKSFIAECNTLKNIR 766
++ ++ +G GSFG V + E A+K V +K E + +K +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK--NRELDIMKVLD 58
Query: 767 HRNLVKIL-------------------------------TACSGVDYQGNDFKA--LVFE 793
H N++K++ V + K ++ E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 794 FMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853
++ + LH + + +NL+ + A+ ++H I H D+K
Sbjct: 119 YV-----PDTLHKVLKSFIRSGRSIPMNLISIYIYQL--FRAVGFIH---SLGICHRDIK 168
Query: 854 PSNVLLDEEM-IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI------APEYGLGSE-- 904
P N+L++ + + DFG A L S + YI APE LG+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEY 219
Query: 905 -VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
SI D++S G + EL+ KP +F G+ ++
Sbjct: 220 TPSI--DLWSIGCVFGELILG-KP---LFSGETSID 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-13
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
L+G G+FG V A+K+ ++ + E L+N RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-L 213
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+Q +D V E+ + L ++RE E R+ R ++
Sbjct: 214 KYS----FQTHDRLCFVMEYANGGEL---FFHLSRERVFSE-DRA-----RFYGA-EIVS 259
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
AL YLH + +V+ DLK N++LD++ + DFGL + T F G+ Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEY 315
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFE 933
+APE ++ D + G+++ E++ + P + +FE
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 49/221 (22%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G+G F V K A K + + E N L+ IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ ++ L+ E + L ++L +E TE+ L Q LD
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQF-LKQILD----- 119
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------MIAHVGDFGLATFLPLSHAQTSS 885
+ YLH I H DLKP N++L ++ + DFG+A + + +
Sbjct: 120 --GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLI---DFGIAHKIEAGNEFKNI 171
Query: 886 IFAKGSIGYIAPE----YGLGSEVSINGDVYSYG----ILL 918
G+ ++APE LG E D++S G ILL
Sbjct: 172 F---GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILL 205
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 78/465 (16%), Positives = 146/465 (31%), Gaps = 91/465 (19%)
Query: 110 LKVLDLHNNSFHHE-IPSEFDRLRRLQVLALHNNSIGGE----IPANISSCSNLIRVRLS 164
++ LD+ L++ QV+ L + + I + + L + L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 165 SNEL----VGKIPSELGSLS-KIEYFSVSYNNLT----GSIPPSFGNLSSISFLFLSRNN 215
SNEL V + L + S KI+ S+ LT G + + L ++ L LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
L + G L+ L + + + +
Sbjct: 125 LGDA-----G-LQLLCEGLLDPQ-------------CRLEKLQLEYCSLSAASCEPLASV 165
Query: 276 L---QNLQFFSVGRNQLTG----AIPPAI-SNASNLEVFQVNSNKLTGE-----VPYLEK 322
L + + +V N + + + + LE ++ S +T + +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 323 LQRLSHFVITRNSLGSGEHRDLNFLCS--LTNATRLKWFHININNFG-----GLLPACIS 375
L + N LG + LC L ++RL+ I L +
Sbjct: 226 KASLRELALGSNKLGD---VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 376 NFSTTLEVLLLDSNKIFGNIPAAFGKFVK-----LLRLEMWNNRLSGT----IPPAIGEL 426
+L+ L L N++ + + L L + + + + +
Sbjct: 283 K--ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 427 QNLRELRLQENRF-----------LGNIPPSIGNLKLFNLQLSYNFLQ----GSIPSSLG 471
+ L EL++ NR LG L L L+ + S+ ++L
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQ-----PGSVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 472 QSETLTIIDLSNNNLTGT----IPPQLLGLSSLLIVLELSRNQLT 512
+ +L +DLSNN L + + LL L L +
Sbjct: 396 ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 77/451 (17%), Positives = 140/451 (31%), Gaps = 88/451 (19%)
Query: 204 SSISFLFLSRNNL-DGSIPDTFGWLKNLVNLTMAQNRLSGT----IPSSIFNISSITVFD 258
I L + L D + L+ + + L+ I S++ ++ +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 259 AGINQIQ--GVIPLDIGFTLQN--LQFFSVGRNQLT----GAIPPAISNASNLEVFQVNS 310
N++ GV + G + +Q S+ LT G + + L+ ++
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 311 NKLTGE-VPYL-EKLQ----RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININ 364
N L + L E L RL + SL + L + L K ++ N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNN 180
Query: 365 NFGG----LLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIP 420
+ +L + + LE L L+S + + +
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGV-TSDNCRD-------------------LC 220
Query: 421 PAIGELQNLRELRLQENRFLGNI-------PPSIGNLKLFNLQLSYNFLQ----GSIPSS 469
+ +LREL L N+ LG++ + +L L + + G +
Sbjct: 221 GIVASKASLRELALGSNK-LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 470 LGQSETLTIIDLSNNNLTGT----IPPQLLGLSSLLIVLELSRNQLTG----PIPNEVGN 521
L E+L + L+ N L + LL L L + T + +
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 522 LKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581
+ L L + N+L R L + L VL L+
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLG-------------------QPGSVLRVLWLADC 380
Query: 582 NLSGK----IPEFLVGFQLLEYLNLSNNDFE 608
++S + L+ L L+LSNN
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 59/362 (16%), Positives = 116/362 (32%), Gaps = 53/362 (14%)
Query: 80 RRQHQRVTILDLKSLKL----AGYISAHVGNLSFLKVLDLHNNSFHHE-IPSEFDRLR-- 132
+ ++ L L++ L G +S+ + L L+ L L +N + + L
Sbjct: 81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140
Query: 133 --RLQVLALHNNSIGGEIPANISS----CSNLIRVRLSSNEL----VGKIPSELG-SLSK 181
RL+ L L S+ ++S + + +S+N++ V + L S +
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 182 IEYFSVSYNNLT----GSIPPSFGNLSSISFLFLSRNNL--DGSIPDTFGWLK---NLVN 232
+E + +T + + +S+ L L N L G G L L
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 233 LTMAQNRLS----GTIPSSIFNISSITVFDAGINQIQ--GVIPLDIGFTLQN--LQFFSV 284
L + + ++ G + + S+ N++ G L L+ V
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 285 GRNQLTG----AIPPAISNASNLEVFQVNSNKLTGE-VPYL--------EKLQRLSHFVI 331
T ++ L Q+++N+L V L L+ L +
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW---L 377
Query: 332 TRNSLGSGEHRDL-NFLCSLTNATRLKWFHININNFGG-LLPACISNFSTTLEVLLLDSN 389
+ L L + + L + + + G L + LE L+L
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 390 KI 391
Sbjct: 438 YW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 35/153 (22%), Positives = 55/153 (35%), Gaps = 18/153 (11%)
Query: 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLT----GPIPNEVGNLKNLEML 528
S + +D+ L+ +LL L V+ L LT I + + L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 529 NVFENKLRGEIPRTLGSCIK-----LELLQMQGNFLQ----GPIPSSLSSLRGLSVLDLS 579
N+ N+L + ++ ++ L +Q L G + S+L +L L L LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 580 QNNLSGKIPEFLVGFQL-----LEYLNLSNNDF 607
N L + L L LE L L
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 43/211 (20%), Positives = 74/211 (35%), Gaps = 35/211 (16%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHR-NLVKILT 775
+G G F V + I A K + E L+ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TEEAPRSLNLLQRLDIGIDVA 833
Y+ L+ E+ + + E +E L + Q L+
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRL-IKQILE------ 142
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEE------MIAHVGDFGLATFLPLSHAQTSSIF 887
+ YLH Q IVH DLKP N+LL I DFG++ + + +
Sbjct: 143 -GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIM- 194
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
G+ Y+APE ++ D+++ GI+
Sbjct: 195 --GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 45/228 (19%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN------LLHHGAFKSFIAECNT 761
N D + + +G+G F V K A K + + E +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
LK I+H N++ + Y+ L+ E + L ++L +E TEE
Sbjct: 68 LKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFL--AEKESLTEEEATEF- 119
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------MIAHVGDFGLAT 874
L Q L+ + YLH I H DLKP N++L + I DFGLA
Sbjct: 120 LKQILN-------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII---DFGLAH 166
Query: 875 FLPLSHAQTSSIFAKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 918
+ + + G+ ++APE LG E D++S G++
Sbjct: 167 KIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 207
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 63/257 (24%), Positives = 107/257 (41%), Gaps = 59/257 (22%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVK-VFNLLHHGAFKSFIAECNTLKNIR----- 766
+ +G G++G V+K I +VAVK +F+ AF++ T + I
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTDAQRTFREIMILTEL 65
Query: 767 --HRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
H N+V +L + ++ + LVF++M E LH + R + E + +
Sbjct: 66 SGHENIVNLLNV-----LRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVV 115
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
Q + + YLH ++H D+KPSN+LL+ E V DFGL+
Sbjct: 116 YQLI-------KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 883 TSSIFAKGSIG-------------------YIAPEYGLGS-EVSINGDVYSYGILLLELV 922
T++I + Y APE LGS + + D++S G +L E++
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 923 TRKKPTDIMFEGDMNLH 939
K +F G ++
Sbjct: 226 CGK----PIFPGSSTMN 238
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 53/226 (23%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIA---ECNTL-KNI 765
TDG+ IG GS+ + I AVK+ + KS E L +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYG 73
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR 825
+H N++ + Y + +V E M L + + + ++ +E
Sbjct: 74 QHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREAS------- 119
Query: 826 LDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------MIAHVGDFGLATFLPL 878
+ + + YLH +VH DLKPSN+L +E I DFG A L
Sbjct: 120 -AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRIC---DFGFAKQLRA 172
Query: 879 SHAQTSSIFAKGSIGYIAPE------YGLGSEVSINGDVYSYGILL 918
+ + + ++APE Y D++S G+LL
Sbjct: 173 ENGLLMTPC--YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 30/159 (18%), Positives = 62/159 (38%), Gaps = 15/159 (9%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAG-YISAHVGNLSFLKVLDLHNNSFH 121
C+ V CS ++ ++ L L + + + L L+ ++ NN
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 122 HEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSL 179
F+ + + L +N + + + +L + L SN + + ++ L
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128
Query: 180 SKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
S + S+ N +T ++ P +F L S+S L L N +
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 33/164 (20%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIP--AAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRE 431
+ L L++N+ + F K +L ++ NN+++ I A + E
Sbjct: 28 EHIPQYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNE 85
Query: 432 LRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIP 491
+ L NR L N+ + F L L + L +N +T +
Sbjct: 86 ILLTSNR-LENVQHKM-----F--------------KGLES---LKTLMLRSNRIT-CVG 121
Query: 492 PQLL-GLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFEN 533
GLSS+ + L L NQ+T + L +L LN+ N
Sbjct: 122 NDSFIGLSSVRL-LSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 27/142 (19%), Positives = 48/142 (33%), Gaps = 4/142 (2%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLK 523
IP + + + L+NN T + L + S N++T I
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGAS 81
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
+ + + N+L + L+ L ++ N + S L + +L L N +
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 584 SGKIPEFLVGFQLLEYLNLSNN 605
+ P L LNL N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 8/128 (6%)
Query: 188 SYNNLTGSIPPS--FGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245
+ N T + + F L + + S N + F + + + NRL +
Sbjct: 40 NNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQ 97
Query: 246 SSIF-NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNASNL 303
+F + S+ N+I + D L +++ S+ NQ+T + P A +L
Sbjct: 98 HKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSL 155
Query: 304 EVFQVNSN 311
+ +N
Sbjct: 156 STLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 30/142 (21%), Positives = 54/142 (38%), Gaps = 18/142 (12%)
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLE 409
L +N N F L I L + +NKI +I AF + +
Sbjct: 32 QYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEIL 87
Query: 410 MWNNRLSGTIPPAI-GELQNLRELRLQENRFLGNIPPSI-GNL-KLFNLQLSYNFLQGSI 466
+ +NRL + + L++L+ L L+ NR + + L + L L N + ++
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144
Query: 467 P----SSLGQSETLTIIDLSNN 484
+L L+ ++L N
Sbjct: 145 APGAFDTLHS---LSTLNLLAN 163
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 51/248 (20%), Positives = 88/248 (35%), Gaps = 48/248 (19%)
Query: 687 ENQNPSSPINSFPNISYQNLYNATDGFT-SANLIGAGSFGSVYKGILDEGKTIVAVKVFN 745
+ + SS + Y TD + S ++G G G V + A+K+
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63
Query: 746 LLHHGAFKSFIA--ECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH-----N 797
S A E + + ++V IL + + ++ E M +
Sbjct: 64 -------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGELFS 115
Query: 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857
R E T E E A +I D+ A+ +LH I H D+KP N+
Sbjct: 116 RIQERGDQAFT---EREAA----------EIMRDIGTAIQFLHSHN---IAHRDVKPENL 159
Query: 858 LL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE----YGLGSEVSINGD 910
L +++ + + DFG A + QT + Y+APE D
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPEVLGPEKYDKSC----D 211
Query: 911 VYSYGILL 918
++S G+++
Sbjct: 212 MWSLGVIM 219
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR----- 768
+LIG GSFG V K + VA+K+ + A E L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115
Query: 769 -NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+V + ++ + LVFE + +L + L T SLNL ++
Sbjct: 116 YYIVHLKRH---FMFRNHLC--LVFEMLS-YNLYDLL------RNTNFRGVSLNLTRK-- 161
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH--VGDFGLATFLPLSHAQ-TS 884
+ AL +L + I+HCDLKP N+LL + + DFG + L Q
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939
S F Y +PE LG + D++S G +L+E+ T + +F G +
Sbjct: 221 SRF------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANEVD 265
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 56/252 (22%), Positives = 90/252 (35%), Gaps = 61/252 (24%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR----- 768
+G G+FG V + + GK+ VA+K+ A E N LK I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKENK 81
Query: 769 -NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
V + ++ G+ + FE + ++ E+L E P L ++
Sbjct: 82 FLCVLMSDW---FNFHGHMC--IAFELLG-KNTFEFL------KENNFQPYPLPHVRH-- 127
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG------------------- 868
+ + AL +LH + Q + H DLKP N+L +
Sbjct: 128 MAYQLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 869 DFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
DFG ATF H ++ Y PE L + DV+S G +L E
Sbjct: 185 DFGSATFDHEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR---- 234
Query: 928 TDIMFEGDMNLH 939
+F+ N
Sbjct: 235 GFTLFQTHENRE 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 23/228 (10%)
Query: 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYN 460
++ + ++ + EL ++ + + ++ L L LS+N
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSN-IQSLAGMQFFTNLKELHLSHN 73
Query: 461 FLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL-LIVLELSRNQLTGPIPNEV 519
Q S S L L + ++ N L L G+ S L L L N+L +
Sbjct: 74 --QISDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS--L 124
Query: 520 GNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLS 579
+LKNLE+L++ NKL+ I LG KLE+L + GN + L+ L+ ++ +DL+
Sbjct: 125 IHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLT 180
Query: 580 QNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE----GVFRNASIT 623
+ ++ + + + D + P G + + +
Sbjct: 181 GQKCVNEPVKYQPELYIT--NTVKDPDGRWISPYYISNGGSYVDGCVL 226
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 38/200 (19%), Positives = 80/200 (40%), Gaps = 21/200 (10%)
Query: 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP 198
I ++ +N ++ L + LS ++ F+ +N+ S+
Sbjct: 4 QRPTPIN-QV-FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG 58
Query: 199 SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNIS--SITV 256
+++ L LS N + S L L L++ +NRL ++ I ++
Sbjct: 59 -MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSR 110
Query: 257 FDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGE 316
N+++ L L+NL+ S+ N+L +I + S LEV ++ N++T
Sbjct: 111 LFLDNNELRDTDSLI---HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-N 164
Query: 317 VPYLEKLQRLSHFVITRNSL 336
L +L++++ +T
Sbjct: 165 TGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 44/185 (23%), Positives = 78/185 (42%), Gaps = 16/185 (8%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
L+ +L S + L +Q N++I + A + +NL + LS
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSH 72
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
N++ + S L L+K+E SV+ N L ++ + +S LFL N L D+
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNEL--RDTDSLI 125
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
LKNL L++ N+L +I + +S + V D N+I L L+ + + +
Sbjct: 126 HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLT---RLKKVNWIDLT 180
Query: 286 RNQLT 290
+
Sbjct: 181 GQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 41/197 (20%), Positives = 76/197 (38%), Gaps = 23/197 (11%)
Query: 412 NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYNFLQGSIPSSL 470
++ P L N + L + + ++ L + N + +Q S+ + +
Sbjct: 6 PTPINQVFP--DPGLANAVKQNLGKQS-VTDLVS-QKELSGVQNFNGDNSNIQ-SL-AGM 59
Query: 471 GQSETLTIIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLKNLEML 528
L + LS+N ++ L L L L L ++RN+L L L
Sbjct: 60 QFFTNLKELHLSHNQIS-----DLSPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRL 111
Query: 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP 588
+ N+LR +L LE+L ++ N L+ L L L VLDL N ++
Sbjct: 112 FLDNNELRD--TDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT-- 165
Query: 589 EFLVGFQLLEYLNLSNN 605
L + + +++L+
Sbjct: 166 GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 46/274 (16%), Positives = 87/274 (31%), Gaps = 50/274 (18%)
Query: 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLE 321
I V P L N ++G+ +T + S ++ F +++ + + ++
Sbjct: 7 TPINQVFPDP---GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQ 60
Query: 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTL 381
L ++ N + DL+ L LT L + N G+ S L
Sbjct: 61 FFTNLKELHLSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNGIP-------SACL 108
Query: 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLG 441
L LD+N++ ++ L+NL L ++ N+ L
Sbjct: 109 SRLFLDNNEL--------------------------RDTDSLIHLKNLEILSIRNNK-LK 141
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
+I KL L L N + + L + + + IDL+ L
Sbjct: 142 SIVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITN 199
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
V + ++ P + N + V
Sbjct: 200 TVKDPDGRWIS---PYYISNGGSYVDGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 15/140 (10%)
Query: 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS--SCSNLIRV 161
+ + LK L L +N ++ S L +L+ L+++ N + N++ + L R+
Sbjct: 59 MQFFTNLKELHLSHNQI-SDL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRL 111
Query: 162 RLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIP 221
L +NEL + L L +E S+ N L SI G LS + L L N + +
Sbjct: 112 FLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTG 166
Query: 222 DTFGWLKNLVNLTMAQNRLS 241
LK + + + +
Sbjct: 167 G-LTRLKKVNWIDLTGQKCV 185
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 37/226 (16%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL---KNIR 766
F+ +IG G FG VY + + A+K + + + E L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
+V ++ + D + + + M+ L L E R
Sbjct: 251 CPFIVC-MSYA----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADM-----RF 296
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTS 884
++ L ++H +V+ DLKP+N+LLDE HV D GLA
Sbjct: 297 YAA-EIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHA- 349
Query: 885 SIFAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ GY+APE G+ + S D +S G +L +L+ P
Sbjct: 350 --SV-GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 32/226 (14%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVKIL 774
L+G G+FG V A+K+ ++ + E L+N RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA-L 70
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+Q +D V E+ + L ++RE E R+ R ++
Sbjct: 71 KYA----FQTHDRLCFVMEYANGGEL---FFHLSRERVFTE-ERA-----RFYGA-EIVS 116
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSI 892
AL YLH +V+ D+K N++LD++ H+ DFGL +S T F G+
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK-EGISDGATMKTFC-GTP 169
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFE 933
Y+APE ++ D + G+++ E++ + P + +FE
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 1e-10
Identities = 88/679 (12%), Positives = 197/679 (29%), Gaps = 203/679 (29%)
Query: 179 LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD-GSIPDTFGWLKNLV------ 231
+ +Y Y ++ +F +N D + D K+++
Sbjct: 11 TGEHQY---QYKDILSVFEDAF------------VDNFDCKDVQDM---PKSILSKEEID 52
Query: 232 NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ----GVIPLDIGFTLQNLQFFSVGRN 287
++ M+++ +SGT+ +F T+ +Q V+ ++ F + ++
Sbjct: 53 HIIMSKDAVSGTL--RLF----WTLLSKQEEMVQKFVEEVLRINYKFLMSPIK------- 99
Query: 288 QLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQ--RLSHFVITRNSL--------- 336
T P++ ++ ++L + K RL ++ R +L
Sbjct: 100 --TEQRQPSM----MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 337 ------GSGEH-------RDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEV 383
GSG+ C + ++ W ++ N + + ++
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDF--KIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 384 LLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRF---- 439
+ NI LR+ L R L L+ +
Sbjct: 212 NWTSRSDHSSNIK---------LRIHSIQAEL--------------RRL-LKSKPYENCL 247
Query: 440 --LGNI-PPSIGNLKLFNLQ---L-------SYNFLQGS---------IPSSLGQSETLT 477
L N+ FNL L +FL + +L E +
Sbjct: 248 LVLLNVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 478 IIDLSNNNLTGTIPPQLLGLSSLLIVL--ELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
++ + +P ++L + + + E R + + N + +N +KL
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR--------DGLATWDNWKHVNC--DKL 355
Query: 536 RGEIPRTLGSCIK-LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGF 594
+ S + LE + + F + LSV S + IP
Sbjct: 356 T----TIIESSLNVLEPAEYRKMFDR------------LSVFPPSAH-----IPT----- 389
Query: 595 QLLEYL--NLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHE-----FRL-PTCSPK 646
LL + ++ +D +V S L + T L +
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNK---LHKYS----LVEKQPKESTISIPSIYLELKVKLENE 442
Query: 647 KSKHKRLTLALKLALAIISGLIGLSLA----LSFLIICLVRKRKENQNPSSPINSFPNIS 702
+ H+ + + S + S + L +N + F +
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL-----KNIEHPERMTLFRMV- 496
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF-------KSF 755
+ + F + + + IL+ + + K + + + F
Sbjct: 497 FLDF-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 756 IAECNT-LKNIRHRNLVKI 773
+ + L ++ +L++I
Sbjct: 552 LPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 6e-09
Identities = 93/589 (15%), Positives = 168/589 (28%), Gaps = 154/589 (26%)
Query: 518 EVG--NLKNLEMLNVFENKLRG-----EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSL 570
E G + ++L+VFE+ ++ S + E + + + S +L
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID---HIIMSKDAVS-GTL 65
Query: 571 RGLSVLDLSQNNLSGKIPEFLV-------GFQLLEYLNLSNNDFEGMVPTEGVFRNASIT 623
R L Q + + +F+ F L+ + M R+
Sbjct: 66 RLFWTLLSKQEEM---VQKFVEEVLRINYKF-LMSPIKTEQRQPSMMTRMYIEQRD---- 117
Query: 624 SVLGNLKLCGGTHEFRLPTCSPKKSKHKRLTLAL-KLALA---IISGLIGL---SLALSF 676
+L F + + +L AL +L A +I G++G +AL
Sbjct: 118 ------RLYNDNQVFA-KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 677 LIICLVRKRKENQ-------NPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYK 729
+ V+ + + + N +SP + Q L D N S K
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEML--QKLLYQIDP----NWTSRSDHSSNIK 224
Query: 730 GILDEGKT----IVAVKVFN--LL------HHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+ + ++ K + LL + A+ +F C L R + + L+A
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 778 SGVDYQGNDFKALVFEFMHNRSLE---EWLHPITREDETEEA----PRSLNLLQRLDIGI 830
+ + + ++L +D E PR L+++
Sbjct: 285 TTTHISLDHHSM---TLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSIIAESI--R 338
Query: 831 DVACALSYLHHDCQPPIVHCD-----LKPS-NVLLDEEMIAHVGDFGLATF-----LPLS 879
D H V+CD ++ S NVL E + F +P
Sbjct: 339 DGLATWDNWKH------VNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAHIP-- 388
Query: 880 HAQTSSIFAKGSIGY----IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
S+ I + + S V + I + L + K E +
Sbjct: 389 -TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL-----ENE 442
Query: 936 MNLH-------NFAKTALPDHVVDIVDSTLLSDDED------LAVHGNQRQRQAR----- 977
LH N KT D L+ D + H + R
Sbjct: 443 YALHRSIVDHYNIPKTFDSDD--------LIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 978 --------INSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018
+ KI A + + N + QL+ K
Sbjct: 495 MVFLDFRFLEQKIR------HDSTAWNASGS-----ILNTLQQLKFYKP 532
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 5e-08
Identities = 85/518 (16%), Positives = 162/518 (31%), Gaps = 149/518 (28%)
Query: 43 RLALLEFKSK---ITHDPLGVFG-SW--NESIHFCQWHGVTCSRRQHQRVTILDLKSLKL 96
R ALLE + + LG G +W + C + V C + ++ L+LK+
Sbjct: 141 RQALLELRPAKNVLIDGVLG-SGKTWVALDV---CLSYKVQC--KMDFKIFWLNLKNCNS 194
Query: 97 AGYISAHVGNLSFLKVLDLHNNSFH-----HEIPSEFDRLRRLQVLALHNNSIGGEIPAN 151
+ + L + + + S H I S LRRL + N + + N
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLN 252
Query: 152 ISS----------CSNLIRVRLSS--NELVGKIPSEL------GSLSKIE---YFSVSYN 190
+ + C L+ R + L + + +L+ E +
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 191 NLTGSIPPSFGNLSSISFLFLS------RNNLDGSIPDTF-GWLKNLVNLTMAQNRLSGT 243
+P + + + LS R+ T+ W VN ++L+
Sbjct: 313 CRPQDLPRE---VLTTNPRRLSIIAESIRDG-----LATWDNWKH--VNC----DKLTTI 358
Query: 244 IPSSIFNIS---------SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIP 294
I SS+ + ++VF + IP L + + +
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAH-----IPTI---LLSLIW------FDVIKSDV 404
Query: 295 PAISNA-SNLEVFQVNSNKLTGEVP--YLEKLQRLSHFVITRNSLGSGEHRDL----NFL 347
+ N + + + T +P YLE +L + +L HR + N
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLEN----EYAL----HRSIVDHYNIP 456
Query: 348 CSLTNATRLK------WF-HININNFGG--LLPACISNFSTTLEVLLLDSNKIFGNIPAA 398
+ + + ++ HI G L T ++ LD F
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHI------GHHLKNIEHPERMTLFRMVFLD----F------ 500
Query: 399 FGKFV--KLLRLEMWNNRLSGTIPPAIGELQN-LRELRLQENRFLGNIPPS---IGNLKL 452
+F+ K+ R T A G + N L++L+ + N P + +
Sbjct: 501 --RFLEQKI--------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL- 549
Query: 453 FNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTI 490
+FL I +L S+ ++ ++ I
Sbjct: 550 -------DFLP-KIEENLICSKYTDLLRIALMAEDEAI 579
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 64/243 (26%)
Query: 718 LIGAGSFGSVY---KGILDEGKTIVAVKVFNLLHHGAFKSFI---------AECNTLKNI 765
++G GSFG V+ K + + + A+KV K+ + E + L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83
Query: 766 RHRNLVKILTACSGVDYQGNDFKALVFE-------FMHNRSLEEWLHPITREDETEEAPR 818
H +VK L +Q L+ + F +++E E
Sbjct: 84 NHPFIVK-LHYA----FQTEGKLYLILDFLRGGDLFTR----------LSKEVMFTE-ED 127
Query: 819 SLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATF 875
+ + ++A AL +LH I++ DLKP N+LLDEE H+ DFGL+
Sbjct: 128 V-----KFYLA-ELALALDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSK- 174
Query: 876 LPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDI 930
+ H + + F G++ Y+APE + + D +S+G+L+ E++T P
Sbjct: 175 ESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 931 MFE 933
Sbjct: 234 TMT 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 34/260 (13%)
Query: 685 RKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF 744
+ + ++ I+ F N ++ TD F ++G GSFG V + AVK+
Sbjct: 316 KAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL 374
Query: 745 ---NLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSL 800
++ + + E L + L + L +C +Q D V E+++ L
Sbjct: 375 KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ-LHSC----FQTMDRLYFVMEYVNGGDL 429
Query: 801 EEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860
+ + +E P ++ ++A L +L I++ DLK NV+LD
Sbjct: 430 MYHIQ---QVGRFKE-PHAV------FYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLD 476
Query: 861 EEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
E H+ DFG+ + T+ F G+ YIAPE + D +++G+LL
Sbjct: 477 SE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 919 LELVTRKKP-----TDIMFE 933
E++ + P D +F+
Sbjct: 533 YEMLAGQAPFEGEDEDELFQ 552
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 49/253 (19%), Positives = 86/253 (33%), Gaps = 52/253 (20%)
Query: 683 RKRKENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVK 742
Q P + S I + + D ++ ++G G G V + + A+K
Sbjct: 36 PPPPPQQFPQFHVKSGLQIKKNAIID--DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK 93
Query: 743 VFNLLHHGAFKSFIA--ECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMH--- 796
+ A E + ++V+I+ Y G +V E +
Sbjct: 94 MLQ-------DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGE 145
Query: 797 --NRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854
+R + T E E + +I + A+ YLH I H D+KP
Sbjct: 146 LFSRIQDRGDQAFT---EREAS----------EIMKSIGEAIQYLH---SINIAHRDVKP 189
Query: 855 SNVLL---DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPE------YGLGSEV 905
N+L I + DFG A ++ T+ + Y+APE Y
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKYDK--SC 244
Query: 906 SINGDVYSYGILL 918
D++S G+++
Sbjct: 245 ----DMWSLGVIM 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 63/262 (24%), Positives = 95/262 (36%), Gaps = 69/262 (26%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR-----N 769
+G G+FG V + K AVKV A E + LK I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+VK Y + L+FE + SL E + + ++
Sbjct: 98 IVKYHGK---FMYYDHMC--LIFEPLG-PSLYEII------TRNNYNGFHIEDIKL--YC 143
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG--------------------- 868
I++ AL+YL + H DLKP N+LLD+
Sbjct: 144 IEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 869 ----DFGLATFLPLSHAQT-SSIFAKGSIGYIAPE--YGLGSEVSINGDVYSYGILLLEL 921
DFG ATF H ++ Y APE LG +VS D++S+G +L EL
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSS--DMWSFGCVLAEL 252
Query: 922 VTRKKPTDIMFEGDMNLHNFAK 943
T ++F ++ + A
Sbjct: 253 YT----GSLLFRTHEHMEHLAM 270
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 29/120 (24%)
Query: 832 VACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFA 888
+ AL +LH I++ D+K N+LLD HV DFGL+ + + F
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC 221
Query: 889 KGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVT---------RKKPTDIMFE 933
G+I Y+AP+ G V D +S G+L+ EL+T K +
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 66/245 (26%)
Query: 718 LIGAGSFGSVY---KGILDEGKTIVAVKVFNLLHHGAFKSFI-----------AECNTLK 763
++G G +G V+ K I A+KV K+ I AE N L+
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFE-------FMHNRSLEEWLHPITREDETEEA 816
++H +V L +Q L+ E FM + RE E
Sbjct: 77 EVKHPFIVD-LIYA----FQTGGKLYLILEYLSGGELFMQ----------LEREGIFME- 120
Query: 817 PRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLA 873
+ + +++ AL +LH I++ DLKP N++L+ + HV DFGL
Sbjct: 121 DTA-----CFYLA-EISMALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLC 168
Query: 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----T 928
+ + F G+I Y+APE + S + D +S G L+ +++T P
Sbjct: 169 K-ESIHDGTVTHTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226
Query: 929 DIMFE 933
+
Sbjct: 227 KKTID 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 48/246 (19%)
Query: 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI------- 756
QN F +G GSFG V E A+K+ + K +
Sbjct: 35 QNTAQLDQ-FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIE 86
Query: 757 ---AECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 813
E L+ + LVK+ + ++ N +V E++ + L I R E
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE- 140
Query: 814 EEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872
P + R + YLH D +++ DLKP N+L+D++ V DFG
Sbjct: 141 ---PHA-----RFYAA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 873 ATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP----- 927
A + +T ++ G+ +APE L + D ++ G+L+ E+ P
Sbjct: 188 AKRVK---GRTWTLC--GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 928 TDIMFE 933
++E
Sbjct: 243 PIQIYE 248
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 6e-10
Identities = 35/207 (16%), Positives = 59/207 (28%), Gaps = 57/207 (27%)
Query: 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV--------FNLLHHGAFKSFIAECN 760
T+ IG G FG V++ I D T VA+K+ N H F+ + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 761 TLKNI---------RHRNLVKILTAC-------------------------SGVDYQGND 786
K + R + + + D+ +D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846
+V EF E + + +L I + +L+ +
Sbjct: 136 QLFIVLEFEFGGIDLEQMR-----------TKLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 847 IVHCDLKPSNVLLDEEMIAHVGDFGLA 873
H DL NVLL + + +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-10
Identities = 75/262 (28%), Positives = 107/262 (40%), Gaps = 38/262 (14%)
Query: 687 ENQNPSSPINSFPNISYQNLYNAT---DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKV 743
N NP+ P I+ N F +IG GSFG V + AVKV
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 744 F---NLLHHGAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRS 799
+L K ++E N L KN++H LV L +Q D V ++++
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFS----FQTADKLYFVLDYINGGE 125
Query: 800 LEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVL 858
L L E PR+ R ++A AL YLH + IV+ DLKP N+L
Sbjct: 126 LFYHLQRERCFLE----PRA-----RFYAA-EIASALGYLHSLN----IVYRDLKPENIL 171
Query: 859 LDEEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGI 916
LD + H+ DFGL + H T+S F G+ Y+APE D + G
Sbjct: 172 LDSQ--GHIVLTDFGLCK-ENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 917 LLLELVTRKKP-----TDIMFE 933
+L E++ P T M++
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYD 249
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 52/257 (20%), Positives = 92/257 (35%), Gaps = 71/257 (27%)
Query: 718 LIGAGSFGSVYKGI-LDEGKTIVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR----- 768
+G G+FG V + I G VAVK+ + A E L+++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNST 76
Query: 769 -NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
V++L ++ G+ +VFE + S +++ E P L+ +++
Sbjct: 77 FRCVQMLEW---FEHHGHIC--IVFELLG-LSTYDFI------KENGFLPFRLDHIRK-- 122
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG------------------- 868
+ + ++++LH + + H DLKP N+L +
Sbjct: 123 MAYQICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 869 DFGLATFLPLSHAQTSSI----FAKGSIGYIAPE--YGLGSEVSINGDVYSYGILLLELV 922
DFG AT+ S++ Y APE LG DV+S G +L+E
Sbjct: 180 DFGSATY---DDEHHSTLVSTRH------YRAPEVILALGWSQPC--DVWSIGCILIEYY 228
Query: 923 TRKKPTDIMFEGDMNLH 939
+F +
Sbjct: 229 L----GFTVFPTHDSKE 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 9e-10
Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 47/257 (18%)
Query: 692 SSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF---NLLH 748
++ ++ F N ++ TD F ++G GSFG V + AVK+ ++
Sbjct: 2 TNTVSKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 749 HGAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVFE-------FMHNRSL 800
+ + E L + L + L +C +Q D V E H
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQ-LHSC----FQTMDRLYFVMEYVNGGDLMYH---- 111
Query: 801 EEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860
I + +E P + ++A L +L I++ DLK NV+LD
Sbjct: 112 ------IQQVGRFKE-PHA-----VFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLD 155
Query: 861 EEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILL 918
E H+ DFG+ + T+ F G+ YIAPE + D +++G+LL
Sbjct: 156 SE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 919 LELVTRKKPTDIMFEGD 935
E++ + P FEG+
Sbjct: 212 YEMLAGQAP----FEGE 224
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 10/122 (8%)
Query: 370 LPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQN 428
+ + T ++L L N+I P F + L L + +N+L +P + L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 429 LRELRLQENRFLGNIPP----SIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484
L L L N+ L +P + +LK L + N L +P + + LT + L N
Sbjct: 90 LTVLDLGTNQ-LTVLPSAVFDRLVHLKE--LFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 485 NL 486
L
Sbjct: 146 QL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
++L LH+N P FD L L+ L L +N + G +P + S + L + L +N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPD-TFGWL 227
+PS + L ++ + N LT +P L+ ++ L L +N L SIP F L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158
Query: 228 KNLVNLTMAQN 238
+L + + N
Sbjct: 159 SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 13/157 (8%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V C ++H V IL L ++ +L LK L L +N
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83
Query: 128 FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186
FD L +L VL L N + +P+ + +L + + N+L ++P + L+ + + +
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLA 141
Query: 187 VSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD 222
+ N L SIP +F LSS++ +L N D D
Sbjct: 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCECRD 177
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 31/162 (19%)
Query: 195 SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 254
S+P G ++ L+L N + P F L NL L + N+L +P +F+
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD---- 85
Query: 255 TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI-SNASNLEVFQVNSNKL 313
+L L +G NQLT +P A+ +L+ + NKL
Sbjct: 86 --------------------SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL 124
Query: 314 TGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNAT 354
T E+P +E+L L+H + +N L S H + L SLT+A
Sbjct: 125 T-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAY 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 34/251 (13%)
Query: 694 PINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVF---NLLHHG 750
P + S Q D F ++G GSFG V+ + A+K +L
Sbjct: 1 PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 751 AFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 809
+ + E L H L + +Q + V E+++ L +
Sbjct: 60 DVECTMVEKRVLSLAWEHPFLTH-MFCT----FQTKENLFFVMEYLNGGDLMYHIQ---S 111
Query: 810 EDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV-- 867
+ + R+ ++ L +LH IV+ DLK N+LLD++ H+
Sbjct: 112 CHKFDL-SRA-----TFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKI 159
Query: 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
DFG+ + ++ F G+ YIAPE LG + + + D +S+G+LL E++ + P
Sbjct: 160 ADFGMCK-ENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 928 -----TDIMFE 933
+ +F
Sbjct: 218 FHGQDEEELFH 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAK 889
++ AL+YLH + I++ DLK NVLLD E H+ D+G+ L T+S F
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC- 214
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ YIAPE G + + D ++ G+L+ E++ + P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAK 889
++ AL+YLH + I++ DLK NVLLD E H+ D+G+ L T+S F
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC- 171
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ YIAPE G + + D ++ G+L+ E++ + P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELRLQEN 437
+ L L NK+ +I A + L L + N+L ++P + +L NL+EL L EN
Sbjct: 63 PNVRYLALGGNKL-HDISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 438 RFLGNIPPSIGNL--KLFNLQLSYNFLQGSIPS----SLGQSETLTIIDLSNNNLTGTIP 491
+ L ++P + + L L L++N LQ S+P L LT +DLS N L ++P
Sbjct: 120 Q-LQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN---LTELDLSYNQLQ-SLP 173
Query: 492 PQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFEN 533
+ + L L L +NQL +P+ V L +L+ + + +N
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSS 165
L ++ L L N H +I + L L L L N + +P + +NL + L
Sbjct: 62 LPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVE 118
Query: 166 NELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD- 222
N+L +P + L+ + Y ++++N L S+P F L++++ L LS N L S+P+
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEG 175
Query: 223 TFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSIT 255
F L L +L + QN+L ++P +F ++S+
Sbjct: 176 VFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQ 208
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLS 164
L+ L L L N FD+L L+ L L N + +P + +NL + L+
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLA 141
Query: 165 SNELVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPPS-FGNLSSISFLFLSRNNLDGSIPD 222
N+L +P + L+ + +SYN L S+P F L+ + L L +N L S+PD
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPD 198
Query: 223 -TFGWLKNLVNLTMAQN 238
F L +L + + N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 18/203 (8%)
Query: 243 TIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASN 302
P F + + + + + L ++ + + I N
Sbjct: 12 IFPDDAF--AETIKANLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS--VQGIQYLPN 64
Query: 303 LEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHIN 362
+ + NKL ++ L++L L++ ++T N L S + + L T LK +
Sbjct: 65 VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKL------TNLKELVLV 117
Query: 363 INNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPA 422
N L P + + T L L L N++ F K L L++ N+L ++P
Sbjct: 118 ENQLQSL-PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEG 175
Query: 423 I-GELQNLRELRLQENRFLGNIP 444
+ +L L++LRL +N+ L ++P
Sbjct: 176 VFDKLTQLKDLRLYQNQ-LKSVP 197
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAK 889
+ AL +LH I++ DLK NVLLD E H DFG+ + + T++ F
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK-EGICNGVTTATFC- 185
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFE 933
G+ YIAPE D ++ G+LL E++ P D +FE
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 32/174 (18%), Positives = 60/174 (34%), Gaps = 32/174 (18%)
Query: 718 LIGAGSFGSVYKGILDEG-----KTIVAVKV-----------FNLLHHGAFKSFIAECNT 761
IG G FG +Y ++ VKV A I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
+ +++ + K D G ++ ++ + L++ E + +
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF-GSDLQKIY---------EANAKRFS 150
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEMIAHVGDFGLA 873
L + + + L Y+H VH D+K SN+LL+ ++ D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 57/244 (23%), Positives = 90/244 (36%), Gaps = 61/244 (25%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFI----------AECNTL 762
F +G GSFG V+ A+KV K + E L
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTNDERLML 60
Query: 763 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
+ H ++++ +Q ++ +++ L L R P +
Sbjct: 61 SIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVA--- 108
Query: 823 LQRLDIGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEE---MIAHVGDFGLATFLPL 878
+ +V AL YLH D I++ DLKP N+LLD+ I DFG A ++P
Sbjct: 109 --KFYAA-EVCLALEYLHSKD----IIYRDLKPENILLDKNGHIKIT---DFGFAKYVP- 157
Query: 879 SHAQTSSIFAKGSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP-----TD 929
T + G+ YIAPE + D +S+GIL+ E++ P T
Sbjct: 158 --DVTYT-LC-GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTPFYDSNTM 209
Query: 930 IMFE 933
+E
Sbjct: 210 KTYE 213
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 35/166 (21%), Positives = 68/166 (40%), Gaps = 28/166 (16%)
Query: 370 LPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQN 428
+ + L L++N + F + L +L + N+L ++P + +L +
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 429 LRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488
L L L N+ L ++P + F+ L Q L + L+ N L
Sbjct: 78 LTYLNLSTNQ-LQSLPNGV-----FD--------------KLTQ---LKELALNTNQLQ- 113
Query: 489 TIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFEN 533
++P + + L L L +NQL +P+ V L +L+ + + +N
Sbjct: 114 SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
LDL NS FD L L L L N + +P + + ++L + LS+N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD-TFGW 226
+P+ + L++++ +++ N L S+P F L+ + L L +N L S+PD F
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 227 LKNLVNLTMAQN 238
L +L + + N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 14/158 (8%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V C + V T LDL++ L + L+ L L L N
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV 71
Query: 128 FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELVGKIPSEL-GSLSKIEYF 185
F++L L L L N + +P + + L + L++N+L +P + L++++
Sbjct: 72 FNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDL 129
Query: 186 SVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD 222
+ N L S+P F L+S+ +++L N D + P
Sbjct: 130 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 36/159 (22%), Positives = 69/159 (43%), Gaps = 7/159 (4%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR 213
SCS V S +P+ G ++ Y + N+L F L+S++ L+L
Sbjct: 6 SCSG-TTVECYSQGRTS-VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGG 61
Query: 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFN-ISSITVFDAGINQIQGVIPLDI 272
N L F L +L L ++ N+L ++P+ +F+ ++ + NQ+Q +P +
Sbjct: 62 NKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGV 119
Query: 273 GFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311
L L+ + +NQL ++L+ ++ N
Sbjct: 120 FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 32/163 (19%), Positives = 55/163 (33%), Gaps = 36/163 (22%)
Query: 446 SIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL--LIV 503
+ L ++ + ++L + + LS NN+ ++ LS + L +
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRI 74
Query: 504 LELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPI 563
L L RN + I N LE L + N++ L
Sbjct: 75 LSLGRNLIKK-IENLDAVADTLEELWISYNQIA-----------SLS------------- 109
Query: 564 PSSLSSLRGLSVLDLSQNNLSG-KIPEFLVGFQLLEYLNLSNN 605
+ L L VL +S N ++ + L LE L L+ N
Sbjct: 110 --GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 19/140 (13%)
Query: 403 VKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL----KLFNLQLS 458
+ + L + + + L+ + L L N I +L L L L
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLG 78
Query: 459 YNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQLTGPIP 516
N ++ I + ++TL + +S N + L G+ L L VL +S N++T
Sbjct: 79 RNLIK-KIENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 517 -NEVGNLKNLEMLNVFENKL 535
+++ L LE L + N L
Sbjct: 133 IDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 32/134 (23%), Positives = 60/134 (44%), Gaps = 7/134 (5%)
Query: 110 LKVLDLHNNSFH-HEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL 168
+ ++LH ++ + L+ + LAL N+I +I +++S NL + L N +
Sbjct: 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL-DGSIPDTFGWL 227
KI + +E +SYN + S+ L ++ L++S N + + D L
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 228 KNLVNLTMAQNRLS 241
L +L +A N L
Sbjct: 140 DKLEDLLLAGNPLY 153
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 26/175 (14%), Positives = 57/175 (32%), Gaps = 36/175 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTI--------VAVKV----------FNLLHHGAFKSFIAECN 760
+ G +Y+ T ++K+ N A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 761 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
L + + + GV + ++ LV + RSL+ L + L
Sbjct: 110 KLYSTPLLAIPTCM--GFGV--HQDKYRFLVLPSL-GRSLQSALDVSPK--------HVL 156
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL--DEEMIAHVGDFGLA 873
+ L + + AL +LH + VH ++ N+ + +++ + +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 32/172 (18%), Positives = 58/172 (33%), Gaps = 31/172 (18%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKV--------------FNLLHHGAFKSFIAECNTLK 763
IG+G FG +Y A V A K I + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+ + + +++G ++ +V E L++ +
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVME-RLGIDLQKIS----------GQNGTFKKS 151
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEMIAHVGDFGLA 873
L +GI + L Y+H + VH D+K +N+LL ++ D+GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 30/112 (26%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSS 205
+P I ++ + L N+ +P EL + + +S N ++ ++ SF N++
Sbjct: 24 VLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 206 ISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSIT 255
+ L LS N L IP TF LK+L L++ N +S +P F ++S+++
Sbjct: 80 LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 7/110 (6%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
L L N F +P E + L ++ L NN I + S+ + L+ + LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
IP L + S+ N+++ +P +F +LS++S L + N L
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 442 NIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
IP + L L Q + +P L + LT+IDLSNN ++ T+ Q + L
Sbjct: 28 GIPRDVTELYLDGNQFT------LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 502 IVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRGEIPR 541
+ L LS N+L IP LK+L +L++ N + +P
Sbjct: 81 LTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 13/105 (12%), Positives = 30/105 (28%), Gaps = 3/105 (2%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLS 212
+R + + + L + + + L + L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVF 257
++ L PD F + L L ++ N L ++ S+
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 23/103 (22%), Positives = 45/103 (43%), Gaps = 4/103 (3%)
Query: 412 NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP-SIGNL-KLFNLQLSYNFLQGSIPSS 469
+ + +NL EL ++ + L ++ + L +L NL + + L+ P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 470 LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLT 512
+ L+ ++LS N L ++ + + S L L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 9e-08
Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 4/96 (4%)
Query: 147 EIPANISSCSNLIRVRLSSNELVGKIPSE-LGSLSKIEYFSVSYNNLTGSIPP-SFGNLS 204
+ ++ NL + + + + + + L L ++ ++ + L + P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 205 SISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240
+S L LS N L+ T L +L L ++ N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 3/87 (3%)
Query: 379 TTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQE 436
L L +++ + ++ +L L + + L + P A L L L
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF 89
Query: 437 NRFLGNIPPSIGNLKLFNLQLSYNFLQ 463
N ++ L L L LS N L
Sbjct: 90 NALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQ-LLGLSSLLIVLELSRNQLTGPIPNEVGNLK 523
L +E LT + + N + + L GL L L + ++ L P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-LRNLTIVKSGLRFVAPDAFHFTP 80
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ 560
L LN+ N L + + L+ L + GN L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 22/103 (21%), Positives = 38/103 (36%), Gaps = 5/103 (4%)
Query: 388 SNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNIPPS 446
+ + L L + N + + + L LR L + ++ L + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPD 74
Query: 447 I--GNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT 487
+L L LS+N L+ S+ Q +L + LS N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 19/112 (16%), Positives = 39/112 (34%), Gaps = 15/112 (13%)
Query: 71 CQW-HGVTCSRRQH----------QRVTILDLKSLKLAGYISAHV-GNLSFLKVLDLHNN 118
G+ C+R + +T L +++ + ++ L L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 119 SFHHEIPSE-FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
+ + F RL L L N++ + +L + LS N L
Sbjct: 67 GLRF-VAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 4/108 (3%)
Query: 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKL 535
+ + + + L G +L L + Q + L L L + ++ L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
R P +L L + N L+ ++ L L L LS N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 60/293 (20%), Positives = 102/293 (34%), Gaps = 80/293 (27%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-----HRNLVKI 773
+G G F +V+ +GK VA+KV H ++ + E LK++R N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 774 LTACSGVDYQGNDFK--ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+ G + +VFE + L +W+ ++ L +++ I
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLG-HHLLKWII------KSNYQGLPLPCVKK--IIQQ 154
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLL-------------------------------- 859
V L YLH C+ I+H D+KP N+LL
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 860 -----------------DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG 902
E++ + D G A + + T I + Y + E +G
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDI---QTRQYRSLEVLIG 267
Query: 903 SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955
S + D++S + EL T D +FE T DH+ I++
Sbjct: 268 SGYNTPADIWSTACMAFELATG----DYLFEPHSGEEY---TRDEDHIALIIE 313
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 44/169 (26%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 772
IG+GSFG +Y G VA+K+ EC +H L K
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--------------EC---VKTKHPQLHIESKIYK 59
Query: 773 ILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
++ G + + G D+ +V E + SLE+ R +L L
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMVME-LLGPSLEDLF---------NFCSRKFSLKTVLL 109
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLA 873
+ + + Y+H +H D+KP N L+ + + ++ DFGLA
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 34/165 (20%), Positives = 56/165 (33%), Gaps = 33/165 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTAC 777
+G G G V + + A+K+ E + ++V+I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 778 SGVDYQGNDFKALVFEFMH-----NRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
Y G +V E + +R + T E E + +I +
Sbjct: 81 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREAS----------EIMKSI 126
Query: 833 ACALSYLH-HDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLA 873
A+ YLH + I H D+KP N+L I + DFG A
Sbjct: 127 GEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 39/166 (23%), Positives = 63/166 (37%), Gaps = 34/166 (20%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG G+FG + G VA+K + + L K L +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK---------LEPMKSRAPQLH--LEYRFYKQLGSGD 65
Query: 779 G---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
G V Y G + A+V E + SLE+ + R+ +L L I I +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLE-LLGPSLEDLF---------DLCDRTFSLKTVLMIAIQLI 115
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLL-----DEEMIAHVGDFGLAT 874
+ Y+H +++ D+KP N L+ + + H+ DF LA
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 54/342 (15%), Positives = 102/342 (29%), Gaps = 76/342 (22%)
Query: 320 LEKLQRLSHFVITRNSLGSGEHRDL-NFLCSLTNATRLKWFHININNFGGLLPACISNFS 378
L + + V++ N++G+ R L + S + ++ I +P +
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 379 ------TTLEVLLLDSNKIFGNIPAAFGKFVK----LLRLEMWNNRLS------------ 416
L + L N F+ L L + NN L
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 417 -GTIPPAIGELQNLRELRLQENRF-------LGNIPPSIGNLKLFNLQLSYNFL-----Q 463
+ LR + NR S L +++ N + +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH--TVKMVQNGIRPEGIE 205
Query: 464 GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLK 523
+ L + L ++DL +N T G S+L I L+ +
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHL------GSSALAIALK---------------SWP 244
Query: 524 NLEMLNVFENKLRGE----IPRTLGSC--IKLELLQMQGNFLQGP----IPSSL-SSLRG 572
NL L + + L + I L+ L++Q N ++ + + + +
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304
Query: 573 LSVLDLSQNNLS------GKIPEFLVGFQLLEYLNLSNNDFE 608
L L+L+ N S +I E E L + +
Sbjct: 305 LLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 40/311 (12%), Positives = 87/311 (27%), Gaps = 54/311 (17%)
Query: 134 LQVLALHNNSIGGE----IPANISSCSNLIRVRLSSNEL----VGKIPSELGSLSKIEYF 185
++ +L ++I E + A + ++ + LS N + + + S +E
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 186 SVSYNNL----------TGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWL----KNLV 231
S + + + + LS N + + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 232 NLTMAQNRLS-------------GTIPSSIFNISSITVFDAGINQIQ--GVIPLDIGF-T 275
+L + N L + N + G N+++ + F +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 276 LQNLQFFSVGRNQLT-----GAIPPAISNASNLEVFQVNSNKLTGE-----VPYLEKLQR 325
+ L + +N + + ++ L+V + N T L+
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 326 LSHFVITRNSLGSGEHRDL-NFLCSLTNATRLKWFHININNFGG----LLPACISNFSTT 380
L + L + + + L N L+ + N L I
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPD 304
Query: 381 LEVLLLDSNKI 391
L L L+ N+
Sbjct: 305 LLFLELNGNRF 315
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 28/112 (25%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 111 KVLDLHNNSFHHEIPSE--FDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNE 167
L L++N I S+ F RL L L L N + I N S++ ++L N+
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89
Query: 168 LVGKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLD 217
+ +I +++ L +++ ++ N ++ + P SF +L+S++ L L+ N +
Sbjct: 90 I-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 148 IPANI-SSCSNLIRVRLSSNELVGKIPSE--LGSLSKIEYFSVSYNNLTGSIPPS-FGNL 203
IP +I + L L+ NEL +I S+ G L + + N LT I P+ F
Sbjct: 23 IPRDIPLHTTEL---LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77
Query: 204 SSISFLFLSRNNLDGSIPD-TFGWLKNLVNLTMAQNRLSGTIPSSIF-NISSIT 255
S I L L N + I + F L L L + N++S + F +++S+T
Sbjct: 78 SHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLT 129
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 37/172 (21%), Positives = 60/172 (34%), Gaps = 46/172 (26%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 772
IG GSFG +++G VA+K E + L K
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--------------EP---RRSDAPQLRDEYRTYK 60
Query: 773 ILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+L C+G V Y G LV + + SLE+ L + R ++
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVID-LLGPSLEDLL---------DLCGRKFSVKTVAM 110
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-----IAHVGDFGLAT 874
+ + +H +V+ D+KP N L+ + +V DFG+
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 7/114 (6%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELR 433
+ ++ L L+SNK+ F K +L +L + N++ ++P + +L L L
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82
Query: 434 LQENRFLGNIPPSI-GNL-KLFNLQLSYNFLQGSIPSSLGQSET-LTIIDLSNN 484
L EN+ L ++P + L +L L L N L+ S+P + T L I L N
Sbjct: 83 LHENK-LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
L+L +N FD+L +L L+L N I +P + + L + L N+L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL- 88
Query: 170 GKIPSEL-GSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLSRNNLDGSIPD 222
+P+ + L++++ ++ N L S+P F L+S+ ++L N D S P
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 23/165 (13%), Positives = 56/165 (33%), Gaps = 18/165 (10%)
Query: 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQ------LS 458
+ L + + + NL+ L + ++ I L NL+
Sbjct: 171 MPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230
Query: 459 YNFLQGSIPSSL------GQSETLTIIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQ 510
++ + + L + + + + L L L +++S
Sbjct: 231 EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290
Query: 511 LTG----PIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
LT + + V +K+L+ +N+ N L E+ + L + +++
Sbjct: 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 30/188 (15%), Positives = 58/188 (30%), Gaps = 35/188 (18%)
Query: 417 GTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQS--- 473
+ P + + L L+++ L NLK +L++ L S+ + S
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK--SLEIISGGLPDSVVEDILGSDLP 219
Query: 474 --ETLTIIDLSNNNLTGTIPPQLLGLSSL-----LIVLELSRNQLTGPIPN---EVGNLK 523
E L + + L S L L + + + E L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNL 583
LE +++ L E R L + ++ L +++ N L
Sbjct: 280 QLETMDISAGVLTDEGARLL--------------------LDHVDKIKHLKFINMKYNYL 319
Query: 584 SGKIPEFL 591
S ++ + L
Sbjct: 320 SDEMKKEL 327
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 23/131 (17%), Positives = 51/131 (38%), Gaps = 11/131 (8%)
Query: 478 IIDLSNNNLTGTIPPQLLGLSSL--LIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
++ L+ + Q ++ L+L ++ I N L + ++ +N++
Sbjct: 1 MVKLTAELIE-----QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 54
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSG-KIPEFLVGF 594
R ++ +L+ L + N + +L L+ L L+ N+L + L
Sbjct: 55 R-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112
Query: 595 QLLEYLNLSNN 605
+ L YL + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 23/114 (20%), Positives = 44/114 (38%), Gaps = 4/114 (3%)
Query: 126 SEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185
+++ R + L L I I ++ + S NE+ K+ L +++
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLKNLVNLTMAQN 238
V+ N + L ++ L L+ N+L D LK+L L + +N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 23/130 (17%), Positives = 49/130 (37%), Gaps = 5/130 (3%)
Query: 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220
V+L++ L+ + + + + + + I L + S N + +
Sbjct: 2 VKLTAE-LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQ 280
D F L+ L L + NR+ + +T N + + LD +L++L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 281 FFSVGRNQLT 290
+ + RN +T
Sbjct: 117 YLCILRNPVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 4/104 (3%)
Query: 504 LELSRNQLT-GPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
L L ++ G + + LE L+ L I L KL+ L++ N + G
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGG 79
Query: 563 IPSSLSSLRGLSVLDLSQNNLSG-KIPEFLVGFQLLEYLNLSNN 605
+ L+ L+LS N + E L + L+ L+L N
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 12/117 (10%)
Query: 444 PPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL--L 501
P + L L N + + +G + + E L + N LT + L L L
Sbjct: 16 PSDVKELVLDNSRSN----EGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKL 66
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG-EIPRTLGSCIKLELLQMQGN 557
LELS N+++G + NL LN+ NK++ L L+ L +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 4/88 (4%)
Query: 521 NLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
++K L + N N+ G++ +LE L L ++L L L L+LS
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSD 73
Query: 581 NNLSGKIPEFLVGFQLLEYLNLSNNDFE 608
N +SG + L +LNLS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 23/111 (20%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 106 NLSFLKVLDLHNNSFHH-EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164
S +K L L N+ + ++ D L+ L+ N + I AN+ + L ++ LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRN 214
N + G + + + ++S N + S L ++ L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 44/170 (25%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 772
IG+GSFG +Y G + VA+K+ E +H L+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--------------EN---VKTKHPQLLYESKIYR 57
Query: 773 ILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
IL +G V + G D+ LV + + SLE+ R L+L L
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMD-LLGPSLEDLF---------NFCSRKLSLKTVLM 107
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAHVGDFGLAT 874
+ + + ++H +H D+KP N L+ ++ DFGLA
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 4/105 (3%)
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG 561
+VL+ ++ G I NLE L++ L + L KL+ L++ N + G
Sbjct: 29 LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFG 85
Query: 562 PIPSSLSSLRGLSVLDLSQNNLSG-KIPEFLVGFQLLEYLNLSNN 605
+ L L+ L+LS N L E L + L+ L+L N
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 30/118 (25%), Positives = 45/118 (38%), Gaps = 14/118 (11%)
Query: 444 PPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSL--L 501
P ++ L L N + + G I + L + L N L + L L L
Sbjct: 23 PAAVRELVLDNCKSN----DGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKL 73
Query: 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR--GEIPRTLGSCIKLELLQMQGN 557
LELS N++ G + L NL LN+ NKL+ + L L+ L +
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 521 NLKNLEMLNVFENKLR-GEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLS 579
+ L + K G+I + LE L + L S+L L L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 580 QNNLSGKIPEFLVGFQLLEYLNLSNN 605
+N + G + L +LNLS N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 40/281 (14%), Positives = 90/281 (32%), Gaps = 47/281 (16%)
Query: 350 LTNATRLKWFHININNFGG----LLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK- 404
+ + +++NN L +N ++ L L N + + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 405 ----LLRLEMWNNRLSGTIPPAIGEL-----QNLRELRLQENRF-------LGNIPPSIG 448
+ L + N LS + + + L L N F ++
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL- 136
Query: 449 NLKLFNLQLSYNFLQGSIPSSLGQS-----ETLTIIDLSNNNLTGT----IPPQLLGLSS 499
+ +L L N L L Q + ++L NNL + L + +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 500 LLIVLELSRNQLTGPIPNEVG-----NLKNLEMLNVFENKLRGE----IPRTLGSCIKLE 550
+ L+LS N L E+ ++ LN+ N L G + S L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 551 LLQMQGNFLQGP-------IPSSLSSLRGLSVLDLSQNNLS 584
+ + + ++ + ++ +++ + ++D + +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 54/313 (17%), Positives = 92/313 (29%), Gaps = 35/313 (11%)
Query: 341 HRDLNFLCSLT-----NATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+D N SL R + I N + PA + + + L F +
Sbjct: 24 DKDRN-SVSLVCKSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADF 82
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQE----NRFLGNIPPSIGNLK 451
L + W + I L E+RL+ + L I S N K
Sbjct: 83 N---------LVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133
Query: 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLE-LSRNQ 510
+ L F + + L +DL +++ L L L+ +
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193
Query: 511 LTGPIPNE-----VGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG------NFL 559
L + V NL+ L + ++ L +LE L G +
Sbjct: 194 LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV 253
Query: 560 QGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRN 619
+ +LS + L L + + +P L LNLS V + + +
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT----VQSYDLVKL 309
Query: 620 ASITSVLGNLKLC 632
L L +
Sbjct: 310 LCQCPKLQRLWVL 322
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 36/337 (10%), Positives = 88/337 (26%), Gaps = 59/337 (17%)
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
+ +L + + L+ + + E L L + +
Sbjct: 35 KKKLGKLGRQVLPPSELLDHLF-FHYEFQNQRFSAEVLSSLRQLNLAGVRMTP---VKCT 90
Query: 346 FLCS--LTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV 403
+ + + L ++ + L L N + +
Sbjct: 91 VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150
Query: 404 K-----LLRLEMWNNRLSGT----IPPAIGELQNLRELRLQENRFLGNIPPSIG------ 448
+ L + NN L+ + + ++ L L +G
Sbjct: 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTG--------LGDEGLEL 202
Query: 449 -------NLKLFNLQLSYNFLQGS----IPSSLGQSETLTIIDLSNNNLTGT------IP 491
N +L L ++YN + + + + +L ++ L N L+
Sbjct: 203 LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262
Query: 492 PQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
+ ++V ++ E ++ E+ + R + R L +L L
Sbjct: 263 GGAAEGGARVVVSLTEGTAVS-----EYWSVILSEVQRNLNSWDRARVQRHL----ELLL 313
Query: 552 LQMQGNFLQ--GP--IPSSLSSLRGLSVLDLSQNNLS 584
++ + P L + L +
Sbjct: 314 RDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1033 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.52 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.1 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.75 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.63 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.4 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.45 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.15 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.12 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.62 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.84 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.31 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 81.67 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.49 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-84 Score=809.52 Aligned_cols=595 Identities=31% Similarity=0.471 Sum_probs=458.0
Q ss_pred ccccCCChhhHHHHHHHHHhcccCCCCCCCCCCCCCCCcceeeeEecCCCCCeEEEEEcCCCCCCcc---cc--------
Q 042075 33 ASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGY---IS-------- 101 (1033)
Q Consensus 33 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~---~~-------- 101 (1033)
++++++.++|++||++||+++. ||. .+++|+.++|||+|.||+|+ .+||+.|||++++++|. ++
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred CccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 3455567899999999999996 887 89999988899999999998 36999999999999987 54
Q ss_pred ---------------cccCCCCCCCEEEecCCCccccCCc--cccccccccEEecccCCCCCCCCccc-cCCCCCcEEEc
Q 042075 102 ---------------AHVGNLSFLKVLDLHNNSFHHEIPS--EFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRL 163 (1033)
Q Consensus 102 ---------------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L 163 (1033)
+.++++++|++|||++|.++|.+|. .|+++++|++|+|++|.+++.+|..+ .++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 4677888999999999999988888 89999999999999999988888766 67777777777
Q ss_pred ccccccCCCCCC---c----------------------ccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC
Q 042075 164 SSNELVGKIPSE---L----------------------GSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218 (1033)
Q Consensus 164 s~N~l~~~~p~~---~----------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 218 (1033)
++|++++..|.. + ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~ 237 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG 237 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence 777777655544 3 3455555566666666655555 6666666666666666666
Q ss_pred cCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCc
Q 042075 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAIS 298 (1033)
Q Consensus 219 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 298 (1033)
.+|..|+.+++|++|+|++|++++.+|.. .+++|++|++++|.+++.+|..++..+++|++|+|++|++++.+|..+.
T Consensus 238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~ 315 (768)
T 3rgz_A 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315 (768)
T ss_dssp CHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred cccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence 66666666666666666666666655554 5666666666677776677777665568888888888888888888888
Q ss_pred CCCCccccccccccccCcCcc--hhhhccccceeeecCcCCCCCCccchhhc-c------------------ccc--ccC
Q 042075 299 NASNLEVFQVNSNKLTGEVPY--LEKLQRLSHFVITRNSLGSGEHRDLNFLC-S------------------LTN--ATR 355 (1033)
Q Consensus 299 ~l~~L~~L~Ls~N~l~~~~~~--l~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~------------------l~~--~~~ 355 (1033)
++++|++|++++|++++.+|. +.++++|++|++++|.+.......+..+. . +.. +++
T Consensus 316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 395 (768)
T 3rgz_A 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395 (768)
T ss_dssp GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence 888888888888888866553 77788888888888877532222221111 0 111 445
Q ss_pred cceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEcc
Q 042075 356 LKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQ 435 (1033)
Q Consensus 356 L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 435 (1033)
|+.++++.|.+.+.+|..+.++ ++|+.|++++|++++.+|..|+++++|++|++++|++++.+|..+..+++|++|+|+
T Consensus 396 L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 396 LQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred ccEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 6666666666666666666554 567777777777776777777777777777777777777777777777777777777
Q ss_pred ccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCC
Q 042075 436 ENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514 (1033)
Q Consensus 436 ~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~ 514 (1033)
+|++++.+|..+..++ |++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..+..+.++ +.|++++|.++|.
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ 553 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGT 553 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESB
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCc
Confidence 7777777777777665 7777777777777777777777777777777777776777766666666 6677777776665
Q ss_pred cCC----------------------------------------------------------------------ccccccc
Q 042075 515 IPN----------------------------------------------------------------------EVGNLKN 524 (1033)
Q Consensus 515 ~p~----------------------------------------------------------------------~~~~l~~ 524 (1033)
+|. .++.+++
T Consensus 554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 554 4455678
Q ss_pred cceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCC
Q 042075 525 LEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604 (1033)
Q Consensus 525 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 604 (1033)
|+.|||++|+++|.+|.+|+++++|+.|+|++|+++|.+|..++++++|+.||||+|+++|.+|..+..+++|++|||++
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcccCCCcccccccccccccccccccCCccc
Q 042075 605 NDFEGMVPTEGVFRNASITSVLGNLKLCGGTHE 637 (1033)
Q Consensus 605 N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~ 637 (1033)
|+|+|.||..++|.++...+|.||+++||.|+.
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 746 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCCCc
Confidence 999999999999999999999999999999875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-65 Score=635.58 Aligned_cols=515 Identities=30% Similarity=0.487 Sum_probs=401.8
Q ss_pred eEEEEEcCCCCCCccccccc-CCCCCCCEEEecCCCccccCCcc---cc----------------------ccccccEEe
Q 042075 85 RVTILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHHEIPSE---FD----------------------RLRRLQVLA 138 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~~~-~~l~~L~~L~L~~n~l~~~~p~~---~~----------------------~l~~L~~L~ 138 (1033)
+.+.|+|+++.+++.++..+ +++++|++|+|++|++++..|.. +. .+++|++|+
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~ 206 (768)
T 3rgz_A 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD 206 (768)
T ss_dssp TCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEE
T ss_pred CCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEE
Confidence 46677777777777666654 66677777777777766655544 34 455555555
Q ss_pred cccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC
Q 042075 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218 (1033)
Q Consensus 139 Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 218 (1033)
|++|.+++.+|. ++++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|.. .+++|++|+|++|++++
T Consensus 207 Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~ 283 (768)
T 3rgz_A 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283 (768)
T ss_dssp CCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEE
T ss_pred CcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCC
Confidence 555555555554 666666666666666666666666666666666666666666555543 55666666666666666
Q ss_pred cCCcccccc-CCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccC
Q 042075 219 SIPDTFGWL-KNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI 297 (1033)
Q Consensus 219 ~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 297 (1033)
.+|..+..+ ++|++|+|++|++++.+|..+.++++|++|++++|.+++.+|...+..+++|++|+|++|++++.+|..+
T Consensus 284 ~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l 363 (768)
T 3rgz_A 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363 (768)
T ss_dssp SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH
T ss_pred ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH
Confidence 666666554 6677777777777766677777777777777777777666666655566777777777777776677766
Q ss_pred cCCC-CccccccccccccCcCc-chhh--hccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccc
Q 042075 298 SNAS-NLEVFQVNSNKLTGEVP-YLEK--LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC 373 (1033)
Q Consensus 298 ~~l~-~L~~L~Ls~N~l~~~~~-~l~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~ 373 (1033)
..++ +|++|++++|++++..| .+.. +++|++|++++|.+.... ...+.++++|+.|+++.|.+.+.+|..
T Consensus 364 ~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 437 (768)
T 3rgz_A 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------PPTLSNCSELVSLHLSFNYLSGTIPSS 437 (768)
T ss_dssp HHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------CGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred HhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------CHHHhcCCCCCEEECcCCcccCcccHH
Confidence 6665 67777777777766443 3333 566777777777665321 234678899999999999999999999
Q ss_pred cccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-e
Q 042075 374 ISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-L 452 (1033)
Q Consensus 374 ~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L 452 (1033)
+..+ ++|+.|++++|.+++.+|..+..+++|++|++++|++++.+|.++..+++|++|+|++|++++.+|.+++.++ |
T Consensus 438 l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 516 (768)
T 3rgz_A 438 LGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516 (768)
T ss_dssp GGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred HhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCC
Confidence 8876 6999999999999999999999999999999999999999999999999999999999999999999999998 9
Q ss_pred ceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCch----------------------------------
Q 042075 453 FNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS---------------------------------- 498 (1033)
Q Consensus 453 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~---------------------------------- 498 (1033)
++|+|++|+++|.+|..++.+++|++|++++|+++|.+|..++...
T Consensus 517 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (768)
T 3rgz_A 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596 (768)
T ss_dssp CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEEC
T ss_pred CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999998765421
Q ss_pred -----------------------------------hHHhhhhccCccccCCcCCccccccccceEEccccccccccCccc
Q 042075 499 -----------------------------------SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTL 543 (1033)
Q Consensus 499 -----------------------------------~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (1033)
..++.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+|.+|
T Consensus 597 ~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l 676 (768)
T 3rgz_A 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676 (768)
T ss_dssp TTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred ccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHH
Confidence 123789999999999999999999999999999999999999999
Q ss_pred ccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCc-Cccc
Q 042075 544 GSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNND-FEGM 610 (1033)
Q Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~ 610 (1033)
+++++|+.|||++|+++|.+|..++++++|++||||+|+|+|.||.. ..+..+....+.+|+ |.|.
T Consensus 677 ~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999999999999999999999999999975 345556666777886 6663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=576.70 Aligned_cols=562 Identities=21% Similarity=0.222 Sum_probs=469.2
Q ss_pred cceeeeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccC
Q 042075 71 CQWHGVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142 (1033)
Q Consensus 71 c~w~gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 142 (1033)
|.++.|.|.... ..+++.|+|+++++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 456667776421 347899999999999887788999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCc
Q 042075 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPD 222 (1033)
Q Consensus 143 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 222 (1033)
.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99965556799999999999999999977778999999999999999999999999999999999999999999988887
Q ss_pred ccc--ccCCCCcccccccccCCCCcccccCCC---------------------------ceeEEeccCccccCccCcccc
Q 042075 223 TFG--WLKNLVNLTMAQNRLSGTIPSSIFNIS---------------------------SITVFDAGINQIQGVIPLDIG 273 (1033)
Q Consensus 223 ~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~---------------------------~L~~L~ls~N~l~~~~p~~~~ 273 (1033)
.|. .+++|++|++++|++++..|..+..+. +|+.|++++|.+++..|..+.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 765 458999999999999988888776654 466777777777766665443
Q ss_pred cccc--ccceeeecccccCCCCCccCcCCCCccccccccccccCcCc-chhhhccccceeeecCcCCCC-CCccchhh--
Q 042075 274 FTLQ--NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVITRNSLGSG-EHRDLNFL-- 347 (1033)
Q Consensus 274 ~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~l~~N~l~~~-~~~~~~~l-- 347 (1033)
.+. +|++|+|++|++++..|..+..+++|++|++++|++++.+| .+..+++|+.|++++|..... ....+..+
T Consensus 244 -~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 244 -GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp -GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred -ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 444 49999999999988888888889999999999999888766 578888899998887654321 00011111
Q ss_pred cccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCc--cCCccccCC--CCCCEEEcccCcccccCChhh
Q 042075 348 CSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFG--NIPAAFGKF--VKLLRLEMWNNRLSGTIPPAI 423 (1033)
Q Consensus 348 ~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~ 423 (1033)
..+..+++|+.++++.|.+.+..|..+..+ ++|+.|++++|.+.. ..+..|..+ ++|+.|++++|++++..|.+|
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~ 401 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence 145678899999999999998777766655 789999999997543 333445444 589999999999999999999
Q ss_pred hcCCCCcEEEccccccccccC-cccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccC--CCCCccccCchh
Q 042075 424 GELQNLRELRLQENRFLGNIP-PSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT--GTIPPQLLGLSS 499 (1033)
Q Consensus 424 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~~~~ 499 (1033)
..+++|+.|+|++|++++.+| ..+..++ |++|++++|.+.+..+..|..+++|+.|++++|+++ +.+|..+..+.+
T Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~ 481 (680)
T 1ziw_A 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481 (680)
T ss_dssp TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence 999999999999999988776 6788887 999999999999889999999999999999999986 578888888888
Q ss_pred HHhhhhccCccccCCcCCccccccccceEEccccccccccC--------cccccccccceeecccccccCcccccccCcc
Q 042075 500 LLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIP--------RTLGSCIKLELLQMQGNFLQGPIPSSLSSLR 571 (1033)
Q Consensus 500 ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 571 (1033)
+ +.|++++|++++..|..|..+++|+.|+|++|++++..+ ..|.++++|++|+|++|+++...+..|..++
T Consensus 482 L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 560 (680)
T 1ziw_A 482 L-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560 (680)
T ss_dssp C-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred C-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence 7 999999999998878889999999999999999986422 2478899999999999999954445789999
Q ss_pred cCCccccccccccccCCcccccccccceeecCCCcCcccCCCcc--cccccccccccccccccCCc
Q 042075 572 GLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEG--VFRNASITSVLGNLKLCGGT 635 (1033)
Q Consensus 572 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~~~n~~lcg~~ 635 (1033)
+|+.|||++|+|++..+..|..+++|+.|+|++|+|++.+|..- .+..+....+.+|+..|+..
T Consensus 561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999997777778899999999999999998777532 46677777889999998765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-61 Score=586.45 Aligned_cols=504 Identities=20% Similarity=0.270 Sum_probs=355.5
Q ss_pred ccccCCChhhHHHHHHHHHhcccCCCCCC-------CCCCCCCCCcce---eeeEecCCCCCeEEEEEcCCCCCCccccc
Q 042075 33 ASTVAGNETDRLALLEFKSKITHDPLGVF-------GSWNESIHFCQW---HGVTCSRRQHQRVTILDLKSLKLAGYISA 102 (1033)
Q Consensus 33 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~-------~~W~~~~~~c~w---~gv~C~~~~~~~v~~l~l~~~~l~g~~~~ 102 (1033)
.+..+....|++||.+||+++.++.+... .+|+.+++||.| .||+|+.. +||+.|+|++++++|.+|+
T Consensus 22 ~~~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~ 99 (636)
T 4eco_A 22 LSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPD 99 (636)
T ss_dssp CCCCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT--CCEEEEECTTSCCEEEECG
T ss_pred chhhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC--CCEEEEEecCcccCCcCCh
Confidence 34445556899999999999965555433 389988999999 99999865 6999999999999999999
Q ss_pred ccCCCCCCCEEEecCCCc------cc------cCCccccccccccEEecccCCCCCCCCccccC-CCCCcEEEccccccc
Q 042075 103 HVGNLSFLKVLDLHNNSF------HH------EIPSEFDRLRRLQVLALHNNSIGGEIPANISS-CSNLIRVRLSSNELV 169 (1033)
Q Consensus 103 ~~~~l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~ 169 (1033)
++++|++|++|+|++|.+ .| .+|... +.+|+ +++++|.+.+.+|..+.. +.++..+++....+.
T Consensus 100 ~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~ 176 (636)
T 4eco_A 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176 (636)
T ss_dssp GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCC
T ss_pred HHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccc
Confidence 999999999999999987 34 566555 67788 999999999888887763 233444444432222
Q ss_pred CCCCCCcccccccceeee--cccccCCCCCCCCCCCCCCcEEEcccCcCCCc-----------------CCcccc--ccC
Q 042075 170 GKIPSELGSLSKIEYFSV--SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS-----------------IPDTFG--WLK 228 (1033)
Q Consensus 170 ~~~p~~~~~l~~L~~L~L--s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~ 228 (1033)
. .....++.+.+ .+|+++| +|..|+++++|++|+|++|++++. +|+.++ +++
T Consensus 177 ~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~ 249 (636)
T 4eco_A 177 K------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLK 249 (636)
T ss_dssp C------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred c------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccC
Confidence 1 11112222222 2455665 555566666666666666666653 666666 666
Q ss_pred CCCcccccccccCCCCcccccCCCceeEEeccCcc-ccC-ccCccccc-----cccccceeeecccccCCCCCc--cCcC
Q 042075 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ-IQG-VIPLDIGF-----TLQNLQFFSVGRNQLTGAIPP--AISN 299 (1033)
Q Consensus 229 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~-l~~-~~p~~~~~-----~l~~L~~L~L~~N~l~~~~p~--~~~~ 299 (1033)
+|++|+|++|++.+.+|..+.++++|++|++++|+ +++ .+|..++. .+++|++|+|++|+++ .+|. .+.+
T Consensus 250 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~ 328 (636)
T 4eco_A 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQK 328 (636)
T ss_dssp TCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTT
T ss_pred CCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhcc
Confidence 66666666666666666666666666666666665 665 56655442 2377777777777777 6777 7778
Q ss_pred CCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccC
Q 042075 300 ASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFST 379 (1033)
Q Consensus 300 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~ 379 (1033)
+++|++|++++|+++|.+|.+..++
T Consensus 329 l~~L~~L~L~~N~l~g~ip~~~~l~------------------------------------------------------- 353 (636)
T 4eco_A 329 MKKLGMLECLYNQLEGKLPAFGSEI------------------------------------------------------- 353 (636)
T ss_dssp CTTCCEEECCSCCCEEECCCCEEEE-------------------------------------------------------
T ss_pred CCCCCEEeCcCCcCccchhhhCCCC-------------------------------------------------------
Confidence 8888888888887776554433333
Q ss_pred cccEEEccCCCCCccCCccccCCCC-CCEEEcccCcccccCChhhhcCC--CCcEEEccccccccccCcccc-------c
Q 042075 380 TLEVLLLDSNKIFGNIPAAFGKFVK-LLRLEMWNNRLSGTIPPAIGELQ--NLRELRLQENRFLGNIPPSIG-------N 449 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~ 449 (1033)
+|+.|++++|+++ .+|..+.++++ |++|++++|+++ .+|..+..++ +|+.|+|++|++++.+|..+. .
T Consensus 354 ~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~ 431 (636)
T 4eco_A 354 KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431 (636)
T ss_dssp EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCC
T ss_pred CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccccccc
Confidence 3444444445444 45555666666 666666666666 5565555543 666667777766666666665 4
Q ss_pred ce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchh-------HHhhhhccCccccCCcCCccc-
Q 042075 450 LK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSS-------LLIVLELSRNQLTGPIPNEVG- 520 (1033)
Q Consensus 450 l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-------ll~~L~ls~N~l~~~~p~~~~- 520 (1033)
+. |++|+|++|.+++..+..+..+++|++|+|++|+++ .+|..++.... .|+.|+|++|+|+ .+|..+.
T Consensus 432 ~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 509 (636)
T 4eco_A 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRA 509 (636)
T ss_dssp CCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGST
T ss_pred CCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhh
Confidence 44 777777777777433344556778888888888887 77776655431 3378888888888 6777776
Q ss_pred -cccccceEEccccccccccCcccccccccceeec------ccccccCcccccccCcccCCccccccccccccCCccccc
Q 042075 521 -NLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQM------QGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVG 593 (1033)
Q Consensus 521 -~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 593 (1033)
.+++|+.|+|++|++++ +|..++++++|++|+| ++|++.+.+|.+++.+++|+.|+|++|+| +.+|..+.
T Consensus 510 ~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~- 586 (636)
T 4eco_A 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT- 586 (636)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-
T ss_pred ccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-
Confidence 88888888888888886 8888888888888888 56888899999999999999999999999 68888876
Q ss_pred ccccceeecCCCcCcccCC
Q 042075 594 FQLLEYLNLSNNDFEGMVP 612 (1033)
Q Consensus 594 l~~L~~L~ls~N~l~g~~p 612 (1033)
++|+.|+|++|++...-+
T Consensus 587 -~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 587 -PNISVLDIKDNPNISIDL 604 (636)
T ss_dssp -TTCCEEECCSCTTCEEEC
T ss_pred -CcCCEEECcCCCCccccH
Confidence 799999999998875443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=558.77 Aligned_cols=528 Identities=18% Similarity=0.180 Sum_probs=401.6
Q ss_pred eeeeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCC
Q 042075 73 WHGVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSI 144 (1033)
Q Consensus 73 w~gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 144 (1033)
+..|.|.... ...++.|||+++++++..+..|+++++|++|+|++|++++..|.+|+++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 4568887532 24678888888888887777888888888888888888888888888888888888888888
Q ss_pred CCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccc
Q 042075 145 GGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTF 224 (1033)
Q Consensus 145 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 224 (1033)
++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++..++.+..+++|++|+|++|++++..|..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 88888888888888888888888887667788888888888888888887544445558888888888888888778888
Q ss_pred cccCCCC--cccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccC-----CCCCccC
Q 042075 225 GWLKNLV--NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT-----GAIPPAI 297 (1033)
Q Consensus 225 ~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~ 297 (1033)
+.+++|+ .|++++|++++..|..+ ...+|+.|++++|... +. .+..+.++....+..+.+. ...+..+
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~-~~~~L~~L~l~~~~~~---~~-~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFGGTQNL---LV-IFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTT-TTCEEEEEECTTCSCH---HH-HHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHh-hhccccccccCCchhH---HH-HhhhccccchhheechhhccccccccChhHh
Confidence 8888888 78888888887666554 4468888888877511 11 0111221111111111111 1111222
Q ss_pred cCCC--CccccccccccccCcCcc-hhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCcccc
Q 042075 298 SNAS--NLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACI 374 (1033)
Q Consensus 298 ~~l~--~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~ 374 (1033)
..+. +|+.|++++|++++.++. +..+++|++|++++|.++..+. .+.++++|+.|+++.|.+.+..|..+
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~n~l~~~~~~~~ 321 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS-------GLVGLSTLKKLVLSANKFENLCQISA 321 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS-------SCCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh-------hhcccccCCEEECccCCcCcCchhhh
Confidence 2222 455555555555554443 4555555555555555543321 23455566666666666666666555
Q ss_pred ccccCcccEEEccCCCCCccCCc-cccCCCCCCEEEcccCcccccC--ChhhhcCCCCcEEEccccccccccCcccccce
Q 042075 375 SNFSTTLEVLLLDSNKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTI--PPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451 (1033)
Q Consensus 375 ~~~~~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 451 (1033)
..+ ++|+.|++++|.+.+.+|. .+.++++|++|++++|++++.. |..+..+++|++|++++|++.+..|..+..++
T Consensus 322 ~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 322 SNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp GGC-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred hcc-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 554 6788888888888765554 4888888888888888888665 77788888888888888888888888888876
Q ss_pred -eceeeccccccCCCCCCc-cCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccC---CcCCccccccccc
Q 042075 452 -LFNLQLSYNFLQGSIPSS-LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG---PIPNEVGNLKNLE 526 (1033)
Q Consensus 452 -L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~---~~p~~~~~l~~L~ 526 (1033)
|++|++++|.+.+..|.. +..+++|++|++++|++++..|..+..+.++ +.|++++|++++ ..+..+..+++|+
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC-CEEECCCCCCCccccccchhhccCCCcc
Confidence 888888888888776544 8888888899999888887777777777776 888899988876 2346789999999
Q ss_pred eEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCc
Q 042075 527 MLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNND 606 (1033)
Q Consensus 527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 606 (1033)
.|++++|++++..|..|+++++|++|+|++|++++.+|..+.+++.| .|+|++|++++.+|..+..+++|++|++++|+
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 99999999999889999999999999999999999999999999999 99999999999999999999999999999999
Q ss_pred CcccCCCcc
Q 042075 607 FEGMVPTEG 615 (1033)
Q Consensus 607 l~g~~p~~~ 615 (1033)
+++..+...
T Consensus 559 ~~c~c~~~~ 567 (606)
T 3t6q_A 559 LDCTCSNIY 567 (606)
T ss_dssp EECSGGGHH
T ss_pred ccccCCcHH
Confidence 999887543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=553.22 Aligned_cols=534 Identities=21% Similarity=0.205 Sum_probs=439.4
Q ss_pred CCccee----eeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccE
Q 042075 69 HFCQWH----GVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQV 136 (1033)
Q Consensus 69 ~~c~w~----gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 136 (1033)
++|.|. .|.|.... ..+++.|+|+++++++..+..|.++++|++|+|++|++++..|.+|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 456663 57776421 246778888888888777778888888888888888888777778888888888
Q ss_pred EecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCC-CCCCCCCCCCCCcEEEcccCc
Q 042075 137 LALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNN 215 (1033)
Q Consensus 137 L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 215 (1033)
|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++ .+|..|+++++|++|+|++|+
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 8888888887778888888888888888888886666778888888888888888875 467788888888888888888
Q ss_pred CCCcCCccccccCCCC----cccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCC
Q 042075 216 LDGSIPDTFGWLKNLV----NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291 (1033)
Q Consensus 216 l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~ 291 (1033)
+++..|..|+.+++|+ +|++++|++++..+.. +...+|+.|++++|.+.+......+..+++|+.+++..+.+.+
T Consensus 165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~-~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 243 (606)
T 3vq2_A 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA-FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243 (606)
T ss_dssp CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTT-TTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred ceecChhhhhhhhccccccceeeccCCCcceeCccc-ccCceeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence 8877777787777665 6888888888544444 4444788888888887654444455577778877776655542
Q ss_pred C------CCccCcCCC--Ccccccc-ccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeec
Q 042075 292 A------IPPAISNAS--NLEVFQV-NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHIN 362 (1033)
Q Consensus 292 ~------~p~~~~~l~--~L~~L~L-s~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~ 362 (1033)
. .+..+..+. +++.+++ ..|.+++..|.+..+++|+.|++++|.+...+ .+..+++|+.++++
T Consensus 244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~ 315 (606)
T 3vq2_A 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSII 315 (606)
T ss_dssp SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEE
T ss_pred CCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhh--------hccccccCCEEEcc
Confidence 1 112222222 3555666 67888888888999999999999999987643 46778899999999
Q ss_pred ccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCccccc--CChhhhcCCCCcEEEccccccc
Q 042075 363 INNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGT--IPPAIGELQNLRELRLQENRFL 440 (1033)
Q Consensus 363 ~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~ 440 (1033)
.|.+ +.+|. + ..++|+.|++++|...+.. .+..+++|++|++++|++++. .|..+..+++|++|+|++|.++
T Consensus 316 ~n~l-~~lp~-~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 389 (606)
T 3vq2_A 316 RCQL-KQFPT-L--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389 (606)
T ss_dssp SCCC-SSCCC-C--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE
T ss_pred cccC-ccccc-C--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc
Confidence 9999 78884 3 4479999999999766544 778999999999999999976 4899999999999999999998
Q ss_pred cccCcccccce-eceeeccccccCCCCC-CccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccC-CcCC
Q 042075 441 GNIPPSIGNLK-LFNLQLSYNFLQGSIP-SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-PIPN 517 (1033)
Q Consensus 441 ~~~p~~~~~l~-L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~-~~p~ 517 (1033)
+ +|..+..++ |++|++++|.+.+..| ..+..+++|++|++++|++++.+|..+..+.++ +.|++++|++++ .+|.
T Consensus 390 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~ 467 (606)
T 3vq2_A 390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSN 467 (606)
T ss_dssp E-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECS
T ss_pred c-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC-CEEECCCCcCCCcchHH
Confidence 4 778888887 9999999999999888 789999999999999999998888888888887 999999999998 4799
Q ss_pred ccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCccccccc-c
Q 042075 518 EVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQ-L 596 (1033)
Q Consensus 518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~ 596 (1033)
.++.+++|+.|+|++|++++..|..|+++++|++|+|++|++++.+|..+..+++|+.|||++|+|+ .+|..+..++ +
T Consensus 468 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~ 546 (606)
T 3vq2_A 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKS 546 (606)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTT
T ss_pred hhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999 7888899997 5
Q ss_pred cceeecCCCcCcccCCCccccccc
Q 042075 597 LEYLNLSNNDFEGMVPTEGVFRNA 620 (1033)
Q Consensus 597 L~~L~ls~N~l~g~~p~~~~~~~~ 620 (1033)
|++|++++|++.+..+..+...+.
T Consensus 547 L~~l~l~~N~~~c~c~~~~~~~~l 570 (606)
T 3vq2_A 547 LAFFNLTNNSVACICEHQKFLQWV 570 (606)
T ss_dssp CCEEECCSCCCCCSSTTHHHHTTT
T ss_pred CcEEEccCCCcccCCccHHHHHHH
Confidence 999999999999988875444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=569.70 Aligned_cols=486 Identities=19% Similarity=0.212 Sum_probs=292.0
Q ss_pred cccccCCChhhHHHHHHHHHhcccCCCCCCCCCCCCC-----CC--cce------------eeeEecCCCCCeEEEEEcC
Q 042075 32 TASTVAGNETDRLALLEFKSKITHDPLGVFGSWNESI-----HF--CQW------------HGVTCSRRQHQRVTILDLK 92 (1033)
Q Consensus 32 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~-----~~--c~w------------~gv~C~~~~~~~v~~l~l~ 92 (1033)
..+.+++..+|++||++||+++. +| +|+.+. +| |.| .||+|+. .+||+.|+|+
T Consensus 260 ~~~~~~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls 331 (876)
T 4ecn_A 260 QLKETAEYIKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLA 331 (876)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECT
T ss_pred eccccccchHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECc
Confidence 34556677899999999999994 65 786543 55 999 9999986 4799999999
Q ss_pred CCCCCcccccccCCCCCCCEEEe-cCCCccccCCccccc-----------------------------------------
Q 042075 93 SLKLAGYISAHVGNLSFLKVLDL-HNNSFHHEIPSEFDR----------------------------------------- 130 (1033)
Q Consensus 93 ~~~l~g~~~~~~~~l~~L~~L~L-~~n~l~~~~p~~~~~----------------------------------------- 130 (1033)
+++++|.+|+++++|++|++|+| ++|.++|..|-....
T Consensus 332 ~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~ 411 (876)
T 4ecn_A 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411 (876)
T ss_dssp TTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred cCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence 99999999999999999999999 899998875432111
Q ss_pred ----------cccccEEeccc--CCCCCCCCccccCCCCCcEEEcccccccC-----------------CCCCCcc--cc
Q 042075 131 ----------LRRLQVLALHN--NSIGGEIPANISSCSNLIRVRLSSNELVG-----------------KIPSELG--SL 179 (1033)
Q Consensus 131 ----------l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l 179 (1033)
...++.+.++. |+++| +|..|+++++|++|+|++|+|+| .+|..++ ++
T Consensus 412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L 490 (876)
T 4ecn_A 412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL 490 (876)
T ss_dssp TTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred ccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccC
Confidence 11222222222 55555 56666666666666666666665 2555544 55
Q ss_pred cccceeeecccccCCCCCCCCCCCCCCcEEEcccCc-CCC-cCCccccccC-------CCCcccccccccCCCCcc--cc
Q 042075 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN-LDG-SIPDTFGWLK-------NLVNLTMAQNRLSGTIPS--SI 248 (1033)
Q Consensus 180 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l 248 (1033)
++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..|+.++ +|++|+|++|+++ .+|. .+
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 555555555555555555555555555555555555 554 4555444443 5555555555555 4554 55
Q ss_pred cCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCC-ccccccccccccCcCcchhhhcccc
Q 042075 249 FNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASN-LEVFQVNSNKLTGEVPYLEKLQRLS 327 (1033)
Q Consensus 249 ~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~l~~l~~L~ 327 (1033)
.++++|+.|+|++|+++ .+| .+..+++|++|+|++|+++ .+|..+..+++ |+.|+|++|+++..
T Consensus 570 ~~L~~L~~L~Ls~N~l~-~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l----------- 634 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR-HLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI----------- 634 (876)
T ss_dssp TTCTTCCEEECTTSCCC-BCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC-----------
T ss_pred hcCCCCCEEECCCCCcc-cch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcC-----------
Confidence 55555555555555555 444 2334455555555555555 44444555544 55555555544422
Q ss_pred ceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCcccccccc-CcccEEEccCCCCCccCCcc---cc--C
Q 042075 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFS-TTLEVLLLDSNKIFGNIPAA---FG--K 401 (1033)
Q Consensus 328 ~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~-~~L~~L~L~~N~i~~~~p~~---~~--~ 401 (1033)
|..+.... ++|+.|++++|++++.+|.. +. .
T Consensus 635 -------------------------------------------p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~ 671 (876)
T 4ecn_A 635 -------------------------------------------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671 (876)
T ss_dssp -------------------------------------------CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCC
T ss_pred -------------------------------------------chhhhccccCCCCEEECcCCcCCCccccchhhhcccc
Confidence 21111111 23666777777776655432 22 2
Q ss_pred CCCCCEEEcccCcccccCChh-hhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEe
Q 042075 402 FVKLLRLEMWNNRLSGTIPPA-IGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIID 480 (1033)
Q Consensus 402 l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 480 (1033)
+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++ .+|..+... .+..+.++++|++|+
T Consensus 672 ~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~---------------~~~~l~nl~~L~~L~ 734 (876)
T 4ecn_A 672 GINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKP---------------KDGNYKNTYLLTTID 734 (876)
T ss_dssp CCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSC---------------TTSCCTTGGGCCEEE
T ss_pred CCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhcc---------------ccccccccCCccEEE
Confidence 347777888888877 44544 446777888888887777 555443221 011123344666666
Q ss_pred cCCCccCCCCCcccc--CchhHHhhhhccCccccCCcCCccccccccceEEccc------cccccccCccccccccccee
Q 042075 481 LSNNNLTGTIPPQLL--GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFE------NKLRGEIPRTLGSCIKLELL 552 (1033)
Q Consensus 481 Ls~N~l~~~~p~~~~--~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L 552 (1033)
|++|+|+ .+|..++ .+.++ +.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|.++++|+.|
T Consensus 735 Ls~N~L~-~lp~~l~~~~l~~L-~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L 811 (876)
T 4ecn_A 735 LRFNKLT-SLSDDFRATTLPYL-SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811 (876)
T ss_dssp CCSSCCC-CCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred CCCCCCc-cchHHhhhccCCCc-CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEE
Confidence 6666666 5666554 44444 566666666664 566666666666666655 55666666666666666666
Q ss_pred ecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCc
Q 042075 553 QMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 553 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus 812 ~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 812 QIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp ECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 6666666 45666554 46666666666666555555555555555555555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=558.42 Aligned_cols=522 Identities=23% Similarity=0.250 Sum_probs=458.1
Q ss_pred CeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEc
Q 042075 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 163 (1033)
.+++.|+|+++.+++..+..++++++|++|+|++|++++..+..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 36889999999999988889999999999999999999655567999999999999999999877789999999999999
Q ss_pred ccccccCCCCCCcccccccceeeecccccCCCCCCCCC--CCCCCcEEEcccCcCCCcCCcccccc--------------
Q 042075 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG--NLSSISFLFLSRNNLDGSIPDTFGWL-------------- 227 (1033)
Q Consensus 164 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l-------------- 227 (1033)
++|.+++..|..++++++|++|++++|++++..+..+. .+++|++|++++|++++..|..|..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999977776554 56899999999999999888877755
Q ss_pred -------------CCCCcccccccccCCCCcccccCCCc--eeEEeccCccccCccCccccccccccceeeecccccCCC
Q 042075 228 -------------KNLVNLTMAQNRLSGTIPSSIFNISS--ITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292 (1033)
Q Consensus 228 -------------~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 292 (1033)
++|++|++++|++++..|..+.+++. |+.|++++|.+++..|. .+..+++|++|+|++|++++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND-SFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcc-cccCcccccEeeCCCCccCcc
Confidence 46788889999999888999988865 99999999999966554 445799999999999999999
Q ss_pred CCccCcCCCCccccccccccccCc-----Cc-----chhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeec
Q 042075 293 IPPAISNASNLEVFQVNSNKLTGE-----VP-----YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHIN 362 (1033)
Q Consensus 293 ~p~~~~~l~~L~~L~Ls~N~l~~~-----~~-----~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~ 362 (1033)
.|..+..+++|++|++++|...+. .| .+..+++|++|++++|.+...... .+.++++|+.++++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECC
Confidence 999999999999999999876642 22 467889999999999999875443 35678899999999
Q ss_pred ccccCCC-Cccccc-cc-cCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCC-hhhhcCCCCcEEEccccc
Q 042075 363 INNFGGL-LPACIS-NF-STTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIP-PAIGELQNLRELRLQENR 438 (1033)
Q Consensus 363 ~n~l~~~-ip~~~~-~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 438 (1033)
.|.+... ++...+ .. .++|+.|++++|++++..|.+|..+++|++|++++|++++.+| ..|..+++|++|+|++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 9986543 232222 11 1589999999999999999999999999999999999987666 789999999999999999
Q ss_pred cccccCcccccce-eceeeccccccC--CCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCc
Q 042075 439 FLGNIPPSIGNLK-LFNLQLSYNFLQ--GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515 (1033)
Q Consensus 439 l~~~~p~~~~~l~-L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~ 515 (1033)
+.+..+..|..++ |+.|++++|.+. +.+|..|..+++|++|+|++|++++..|..+.++.++ +.|++++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccc
Confidence 9999999999987 999999999997 6789999999999999999999996555567777777 99999999998642
Q ss_pred C--------CccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccC
Q 042075 516 P--------NEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI 587 (1033)
Q Consensus 516 p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 587 (1033)
+ ..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 23789999999999999999544557999999999999999999777777899999999999999999988
Q ss_pred Ccccc-cccccceeecCCCcCcccCCC
Q 042075 588 PEFLV-GFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 588 p~~~~-~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
|..+. .+++|+.|++++|++.+..+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 88887 899999999999999998875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=560.76 Aligned_cols=520 Identities=19% Similarity=0.199 Sum_probs=441.7
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccC-CccccccccccEEecccCCCCCCCC
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEI-PSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
|.|..|.+ . ..+++.|||+++.+++..+..|.++++|++|+|++|.+.+.+ |.+|.++++|++|+|++|.+++..|
T Consensus 14 ~~L~~vP~--l-p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--V-LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS--S-CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC--C-CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 56777776 2 457999999999999988899999999999999999777776 7889999999999999999998889
Q ss_pred ccccCCCCCcEEEcccccccCCCCCC--cccccccceeeecccccCCCCC-CCCCCCCCCcEEEcccCcCCCcCCccccc
Q 042075 150 ANISSCSNLIRVRLSSNELVGKIPSE--LGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRNNLDGSIPDTFGW 226 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 226 (1033)
..|+++++|++|+|++|.+++.+|.. |.++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..|..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999999877765 9999999999999999997765 57999999999999999999999999998
Q ss_pred c--CCCCcccccccccCCCCcccccCCCc------eeEEeccCccccCccCccccccc--cccceeeecc---------c
Q 042075 227 L--KNLVNLTMAQNRLSGTIPSSIFNISS------ITVFDAGINQIQGVIPLDIGFTL--QNLQFFSVGR---------N 287 (1033)
Q Consensus 227 l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~ls~N~l~~~~p~~~~~~l--~~L~~L~L~~---------N 287 (1033)
+ ++|+.|+|++|.+++..|..+..+.+ |+.|++++|.+++.+|..+...+ .+++.|.++. |
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 8 89999999999999999888877765 99999999999988887765432 5677777763 3
Q ss_pred ccCCCCCccCcCC--CCccccccccccccCcCc-chhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeeccc
Q 042075 288 QLTGAIPPAISNA--SNLEVFQVNSNKLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININ 364 (1033)
Q Consensus 288 ~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n 364 (1033)
.+.+..+..+..+ ++|+.|++++|.+++..+ .+..+++|+.|++++|.+...... .+..+++|+.|+++.|
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~Ls~N 324 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNLSYN 324 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT------TTTTCSSCCEEEEESC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH------HhcCCCCCCEEECCCC
Confidence 4444444555554 689999999999988765 478899999999999998764432 3567788999999999
Q ss_pred ccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccC
Q 042075 365 NFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIP 444 (1033)
Q Consensus 365 ~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 444 (1033)
.+.+..|..+..+ ++|+.|++++|+|++..+..|.++++|++|+|++|.+++. + .+++|+.|++++|+++ .+|
T Consensus 325 ~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 325 LLGELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCSCCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCC
T ss_pred CCCccCHHHhcCC-CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-ccc
Confidence 9988888777766 6899999999999998899999999999999999999843 3 2889999999999998 556
Q ss_pred cccccceeceeeccccccCCCC-CCccCCCCcccEEecCCCccCCCCCcc-ccCchhHHhhhhccCcccc-----CCcCC
Q 042075 445 PSIGNLKLFNLQLSYNFLQGSI-PSSLGQSETLTIIDLSNNNLTGTIPPQ-LLGLSSLLIVLELSRNQLT-----GPIPN 517 (1033)
Q Consensus 445 ~~~~~l~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~~ll~~L~ls~N~l~-----~~~p~ 517 (1033)
... ..++.|++++|++++.. +..+.++++|++|+|++|++++..+.. +..+.++ +.|++++|.++ +..|.
T Consensus 398 ~~~--~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L-~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 398 KIN--LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL-EQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CCC--TTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC-CBCEEESCCCSSSCCSCCCSS
T ss_pred ccc--cccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc-ccccCCCCccccccccccchh
Confidence 542 24889999999998643 234568999999999999998654443 3334444 99999999997 44556
Q ss_pred ccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCccccccccc
Q 042075 518 EVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLL 597 (1033)
Q Consensus 518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 597 (1033)
.|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+. +|
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L 549 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SL 549 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SC
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---Cc
Confidence 788999999999999999998899999999999999999999987777666 8999999999999999998764 78
Q ss_pred ceeecCCCcCcccCCCc
Q 042075 598 EYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 598 ~~L~ls~N~l~g~~p~~ 614 (1033)
+.|++++|++.+..+..
T Consensus 550 ~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 550 SVLDITHNKFICECELS 566 (844)
T ss_dssp CEEEEEEECCCCSSSCC
T ss_pred CEEEecCCCcccccccH
Confidence 89999999999988754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=541.15 Aligned_cols=530 Identities=20% Similarity=0.201 Sum_probs=457.9
Q ss_pred EEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 88 ILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 88 ~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
.++..+.+++ .+|..+.. .+++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5778888887 56766653 78999999999998889999999999999999999998889999999999999999999
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCccc
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 247 (1033)
+++..|..|+++++|++|++++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|++++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99888999999999999999999999877888999999999999999999755455556999999999999999888999
Q ss_pred ccCCCcee--EEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCc-----Cc-c
Q 042075 248 IFNISSIT--VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGE-----VP-Y 319 (1033)
Q Consensus 248 l~~l~~L~--~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~~-~ 319 (1033)
+..+++|+ .|++++|.+++..|..+ ...+|++|++++|. .++..+..+.++....+..+.+.+. .+ .
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~--~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~ 247 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAF--DSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTT--TTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHh--hhccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhH
Confidence 99999999 99999999997666543 35789999999987 2344455555544443333322211 11 1
Q ss_pred hhhhc--cccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCc
Q 042075 320 LEKLQ--RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPA 397 (1033)
Q Consensus 320 l~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~ 397 (1033)
+..+. +|+.|++++|.+...... .+.++++|+.++++.|.+. .+|..+..+ ++|++|++++|.+++..|.
T Consensus 248 ~~~l~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~ 319 (606)
T 3t6q_A 248 FEGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQI 319 (606)
T ss_dssp GGGGGGSEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGG
T ss_pred hchhhcCceeEEEeecCccCccCHH------HhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchh
Confidence 33333 799999999999876543 3567889999999999998 678877665 7999999999999999999
Q ss_pred cccCCCCCCEEEcccCcccccCCh-hhhcCCCCcEEEcccccccccc--Ccccccce-eceeeccccccCCCCCCccCCC
Q 042075 398 AFGKFVKLLRLEMWNNRLSGTIPP-AIGELQNLRELRLQENRFLGNI--PPSIGNLK-LFNLQLSYNFLQGSIPSSLGQS 473 (1033)
Q Consensus 398 ~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l 473 (1033)
.+.++++|++|++++|.+.+.+|. .+..+++|++|++++|++++.. |..+..++ |++|++++|.+.+..|..|..+
T Consensus 320 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 399 (606)
T 3t6q_A 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399 (606)
T ss_dssp CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence 999999999999999999876665 5999999999999999999776 78899987 9999999999999999999999
Q ss_pred CcccEEecCCCccCCCCCcc-ccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccc---cCccccccccc
Q 042075 474 ETLTIIDLSNNNLTGTIPPQ-LLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE---IPRTLGSCIKL 549 (1033)
Q Consensus 474 ~~L~~L~Ls~N~l~~~~p~~-~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L 549 (1033)
++|++|++++|++++..|.. +..+.++ +.|++++|.+++..|..+..+++|+.|++++|++++. .+..+..+++|
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 99999999999999777765 5666666 9999999999999999999999999999999999873 33679999999
Q ss_pred ceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc-cccccccccccccc
Q 042075 550 ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE-GVFRNASITSVLGN 628 (1033)
Q Consensus 550 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~n 628 (1033)
++|+|++|++++..|..|+.+++|+.|+|++|++++.+|+.+..++.| +|++++|++++.+|.. ..+..+....+.||
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 557 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC
Confidence 999999999999999999999999999999999999999999999999 9999999999888764 44566677788899
Q ss_pred ccccCCc
Q 042075 629 LKLCGGT 635 (1033)
Q Consensus 629 ~~lcg~~ 635 (1033)
+..|..+
T Consensus 558 ~~~c~c~ 564 (606)
T 3t6q_A 558 PLDCTCS 564 (606)
T ss_dssp CEECSGG
T ss_pred CccccCC
Confidence 8888644
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=530.11 Aligned_cols=527 Identities=18% Similarity=0.181 Sum_probs=450.0
Q ss_pred EEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 88 ILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 88 ~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
.++.++.+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5788998887 5666554 889999999999998888899999999999999999998889999999999999999999
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC-cCCccccccCCCCcccccccccCCCCcc
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLKNLVNLTMAQNRLSGTIPS 246 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 246 (1033)
+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 998889999999999999999999998888889999999999999999986 5799999999999999999999988888
Q ss_pred cccCCCcee----EEeccCccccCccCccccccccccceeeecccccC-CCCCccCcCCCCccccccccccccCcCc---
Q 042075 247 SIFNISSIT----VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT-GAIPPAISNASNLEVFQVNSNKLTGEVP--- 318 (1033)
Q Consensus 247 ~l~~l~~L~----~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--- 318 (1033)
.+..+++|+ .|++++|.++ .+|...+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+...
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 888777665 8999999998 4555555444 8999999999997 5677889999999999988776654211
Q ss_pred ----chhhhc--cccceee-ecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCC
Q 042075 319 ----YLEKLQ--RLSHFVI-TRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI 391 (1033)
Q Consensus 319 ----~l~~l~--~L~~L~l-~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i 391 (1033)
.+..+. .++.+.+ ..|.+.. .+..+..+++|+.++++.|.+.. +| .+..+ ++|+.|++++|.+
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~-------~~~~~~~l~~L~~L~l~~~~~~~-l~-~l~~~-~~L~~L~l~~n~l 319 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSD-------DIVKFHCLANVSAMSLAGVSIKY-LE-DVPKH-FKWQSLSIIRCQL 319 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCG-------GGGSCGGGTTCSEEEEESCCCCC-CC-CCCTT-CCCSEEEEESCCC
T ss_pred cChHHhhhhhhccHhheeccccccccc-------cccccccCCCCCEEEecCccchh-hh-hcccc-ccCCEEEcccccC
Confidence 112222 3444444 3444332 12236788999999999999865 55 44443 7999999999999
Q ss_pred CccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccc--cCcccccce-eceeeccccccCCCCCC
Q 042075 392 FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGN--IPPSIGNLK-LFNLQLSYNFLQGSIPS 468 (1033)
Q Consensus 392 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~-L~~L~Ls~N~l~~~~p~ 468 (1033)
+.+| .+ .+++|++|++++|+..+.. .+..+++|++|+|++|++++. +|..+..++ |++|++++|.+++ +|.
T Consensus 320 -~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~ 393 (606)
T 3vq2_A 320 -KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA 393 (606)
T ss_dssp -SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECC
T ss_pred -cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chh
Confidence 6777 55 9999999999999765544 678999999999999999976 488888887 9999999999985 678
Q ss_pred ccCCCCcccEEecCCCccCCCCC-ccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccccc-ccCcccccc
Q 042075 469 SLGQSETLTIIDLSNNNLTGTIP-PQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG-EIPRTLGSC 546 (1033)
Q Consensus 469 ~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l 546 (1033)
.+..+++|++|++++|++++..| ..+..+.++ +.|++++|.+++..|..+..+++|+.|++++|++++ .+|..|+.+
T Consensus 394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 472 (606)
T 3vq2_A 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472 (606)
T ss_dssp CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred hccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence 99999999999999999997777 566777777 999999999999999999999999999999999998 479999999
Q ss_pred cccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCccccc-ccccccc
Q 042075 547 IKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFR-NASITSV 625 (1033)
Q Consensus 547 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~-~~~~~~~ 625 (1033)
++|++|+|++|++++..|..++.+++|+.|+|++|++++.+|..+..+++|++|+|++|+|+..++.-..+. ++....+
T Consensus 473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l 552 (606)
T 3vq2_A 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEc
Confidence 999999999999999999999999999999999999999999999999999999999999995443323332 4666778
Q ss_pred cccccccCCcc
Q 042075 626 LGNLKLCGGTH 636 (1033)
Q Consensus 626 ~~n~~lcg~~~ 636 (1033)
.+|+..|+.+.
T Consensus 553 ~~N~~~c~c~~ 563 (606)
T 3vq2_A 553 TNNSVACICEH 563 (606)
T ss_dssp CSCCCCCSSTT
T ss_pred cCCCcccCCcc
Confidence 89998887654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=537.89 Aligned_cols=521 Identities=21% Similarity=0.233 Sum_probs=439.6
Q ss_pred EEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCC-CccccCCCCCcEEEccccc
Q 042075 89 LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEI-PANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 89 l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~ 167 (1033)
+|.++++++. +|. ..++|++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.
T Consensus 9 ~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 4555667774 454 4589999999999999999999999999999999999776677 7889999999999999999
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCC--CCCCCCCcEEEcccCcCCCcCC-ccccccCCCCcccccccccCCCC
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPS--FGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTI 244 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 244 (1033)
+++..|..|+++++|++|+|++|++++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 99888999999999999999999999877665 9999999999999999997765 58999999999999999999999
Q ss_pred cccccCC--CceeEEeccCccccCccCccccc-----cccccceeeecccccCCCCCccCcCC---CCccccccccccc-
Q 042075 245 PSSIFNI--SSITVFDAGINQIQGVIPLDIGF-----TLQNLQFFSVGRNQLTGAIPPAISNA---SNLEVFQVNSNKL- 313 (1033)
Q Consensus 245 p~~l~~l--~~L~~L~ls~N~l~~~~p~~~~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l- 313 (1033)
|..+..+ ++|+.|+++.|.+.+..|..+.. ....|++|++++|.+++..|..+... .+++.|.++.+.+
T Consensus 165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~ 244 (844)
T 3j0a_A 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244 (844)
T ss_dssp SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB
T ss_pred HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc
Confidence 9999888 89999999999999888876542 11249999999999998888877653 5677777764333
Q ss_pred --------cCcCc-chhh--hccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCccc
Q 042075 314 --------TGEVP-YLEK--LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLE 382 (1033)
Q Consensus 314 --------~~~~~-~l~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~ 382 (1033)
.+..+ .+.. .++|+.|++++|.+...... .+.++++|+.|+++.|.+.+..|..+..+ ++|+
T Consensus 245 ~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~ 317 (844)
T 3j0a_A 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR------VFETLKDLKVLNLAYNKINKIADEAFYGL-DNLQ 317 (844)
T ss_dssp CSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC------CSSSCCCCCEEEEESCCCCEECTTTTTTC-SSCC
T ss_pred ccccccccCCCChhhhhccccCCccEEECCCCcccccChh------hhhcCCCCCEEECCCCcCCCCChHHhcCC-CCCC
Confidence 22211 1333 36899999999998764332 45678899999999999998888777665 6999
Q ss_pred EEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccc
Q 042075 383 VLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNF 461 (1033)
Q Consensus 383 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~ 461 (1033)
.|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|.+++ ++. ++ |+.|++++|+
T Consensus 318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~----~~~L~~L~l~~N~ 392 (844)
T 3j0a_A 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHF----IPSIPDIFLSGNK 392 (844)
T ss_dssp EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSS----CCSCSEEEEESCC
T ss_pred EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccC----CCCcchhccCCCC
Confidence 99999999999999999999999999999999998888889999999999999999984 332 44 8999999999
Q ss_pred cCCCCCCccCCCCcccEEecCCCccCCCCCc--cccCchhHHhhhhccCccccCCcCC-ccccccccceEEccccccc--
Q 042075 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPP--QLLGLSSLLIVLELSRNQLTGPIPN-EVGNLKNLEMLNVFENKLR-- 536 (1033)
Q Consensus 462 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~~~~ll~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-- 536 (1033)
++ .+|.. ..+++.|++++|++++ ++. .+..+.++ +.|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus 393 l~-~l~~~---~~~l~~L~ls~N~l~~-l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 393 LV-TLPKI---NLTANLIHLSENRLEN-LDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466 (844)
T ss_dssp CC-CCCCC---CTTCCEEECCSCCCCS-STTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSS
T ss_pred cc-ccccc---ccccceeecccCcccc-CchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCccccc
Confidence 98 55554 4678999999999984 332 23456666 9999999999965443 4667899999999999997
Q ss_pred ---cccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCC
Q 042075 537 ---GEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 537 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
+..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|+|++|+|+|.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 45567799999999999999999999999999999999999999999987777776 8999999999999999986
Q ss_pred cccccccccccccccccccCCc
Q 042075 614 EGVFRNASITSVLGNLKLCGGT 635 (1033)
Q Consensus 614 ~~~~~~~~~~~~~~n~~lcg~~ 635 (1033)
. +..+....+.+|+..|+.+
T Consensus 545 ~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 545 V--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp C--CSSCCEEEEEEECCCCSSS
T ss_pred H--hCCcCEEEecCCCcccccc
Confidence 4 5677777888999888544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=504.59 Aligned_cols=492 Identities=21% Similarity=0.235 Sum_probs=380.2
Q ss_pred CcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCC
Q 042075 70 FCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 70 ~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
.|.|.|| |+.. +++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus 3 ~C~~~~~-c~~~-----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGR-----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp EECTTSE-EECT-----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred cCCCCce-EECC-----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 5999999 8643 34555 5666554 789999999999998889999999999999999999998888
Q ss_pred ccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCC-CCCCCCCCCCCCcEEEcccCcCCCcC-Ccccccc
Q 042075 150 ANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSI-PDTFGWL 227 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l 227 (1033)
..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..|+++++|++|++++|++.+.+ +..|+.+
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 999999999999999999998777789999999999999999997 45778999999999999999944444 4789999
Q ss_pred CCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCC--C-ccCcCCCCcc
Q 042075 228 KNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAI--P-PAISNASNLE 304 (1033)
Q Consensus 228 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~ 304 (1033)
++|++|++++|++++..|..+.++++|+.|+++.|.+. .+|..++..+++|++|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999999999999999999999999986 666666667899999999999999753 2 2345678899
Q ss_pred ccccccccccCcCc-----chhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccC
Q 042075 305 VFQVNSNKLTGEVP-----YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFST 379 (1033)
Q Consensus 305 ~L~Ls~N~l~~~~~-----~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~ 379 (1033)
.|++++|++++..+ .+..+.+|+.+++++|.+.............+..+ +
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l-------------------------~ 281 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL-------------------------G 281 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCC-------------------------T
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhh-------------------------c
Confidence 99999999986533 24566778888888877654321111111112223 3
Q ss_pred cccEEEccCCCCCcc-----CCccccCCCCCCEEEcccCcccccCChhh-hcCCCCcEEEccccccccccCc---ccccc
Q 042075 380 TLEVLLLDSNKIFGN-----IPAAFGKFVKLLRLEMWNNRLSGTIPPAI-GELQNLRELRLQENRFLGNIPP---SIGNL 450 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l 450 (1033)
+|+.|.+.++.+... ++..+....+|++|++++|++. .+|..+ ..+++|++|+|++|++++.+|. .++.+
T Consensus 282 ~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l 360 (549)
T 2z81_A 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360 (549)
T ss_dssp TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSS
T ss_pred ccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhcc
Confidence 455555555554321 1222334456777777777776 455554 4677777777777777765532 35555
Q ss_pred e-eceeeccccccCCCCC--CccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccce
Q 042075 451 K-LFNLQLSYNFLQGSIP--SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEM 527 (1033)
Q Consensus 451 ~-L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~ 527 (1033)
+ |++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+.++ +.|++++|+++ .+|..+. ++|+.
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~~--~~L~~ 435 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCIP--QTLEV 435 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTSC--TTCSE
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchhc--CCceE
Confidence 5 7777777777765432 44677777777777777777 677766666665 77777777777 3454442 58999
Q ss_pred EEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcC
Q 042075 528 LNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607 (1033)
Q Consensus 528 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 607 (1033)
|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|||++|+|++.+|..+..+++|+.|++++|++
T Consensus 436 L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 436 LDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509 (549)
T ss_dssp EECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred EECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence 999999998643 57889999999999998 7776 57899999999999999998888999999999999999999
Q ss_pred cccCCCc
Q 042075 608 EGMVPTE 614 (1033)
Q Consensus 608 ~g~~p~~ 614 (1033)
+|.+|..
T Consensus 510 ~~~~~~~ 516 (549)
T 2z81_A 510 DCSCPRI 516 (549)
T ss_dssp CCCHHHH
T ss_pred cCCCccH
Confidence 9988853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=498.08 Aligned_cols=511 Identities=20% Similarity=0.203 Sum_probs=333.3
Q ss_pred CeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEc
Q 042075 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 163 (1033)
.+++.|||+++++++..+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 35777888888887766667788888888888888887766777888888888888888887666677888888888888
Q ss_pred ccccccCCCCCCcccccccceeeecccccCC-CCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC----Cccccccc
Q 042075 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL----VNLTMAQN 238 (1033)
Q Consensus 164 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N 238 (1033)
++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 8888875555567788888888888888776 357778888888888888888877777777777777 77788888
Q ss_pred ccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccC------CCCCccCcCCCC--cccccccc
Q 042075 239 RLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT------GAIPPAISNASN--LEVFQVNS 310 (1033)
Q Consensus 239 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~------~~~p~~~~~l~~--L~~L~Ls~ 310 (1033)
++++..|..+..+ +|+.|++++|......-......+.+++.+.+..+.+. ......+..+.+ ++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 8876666665554 78888887774432211112223444444333322211 111122222222 44555555
Q ss_pred c-cccCcCc-chhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccC
Q 042075 311 N-KLTGEVP-YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDS 388 (1033)
Q Consensus 311 N-~l~~~~~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~ 388 (1033)
| .+.+..+ .+..+++|+.|++++|.+...+.. +..+ +|+.++++.|.+. .+|.. ..++|+.|++++
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~-------~~~~-~L~~L~l~~n~~~-~l~~~---~l~~L~~L~l~~ 334 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF-------SYNF-GWQHLELVNCKFG-QFPTL---KLKSLKRLTFTS 334 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSCCBC-------CSCC-CCSEEEEESCBCS-SCCBC---BCSSCCEEEEES
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhhhhh-------hccC-CccEEeeccCccc-ccCcc---cccccCEEeCcC
Confidence 5 4554443 366677777777777665532111 1122 3333333333333 22221 113444555555
Q ss_pred CCCCccCCccccCCCCCCEEEcccCcccccC--ChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCC
Q 042075 389 NKIFGNIPAAFGKFVKLLRLEMWNNRLSGTI--PPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSI 466 (1033)
Q Consensus 389 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~ 466 (1033)
|.+.+..+. ..+++|++|++++|++++.. |..+..+++|++|++++|++ .+..
T Consensus 335 n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l-----------------------~~~~ 389 (570)
T 2z63_A 335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-----------------------ITMS 389 (570)
T ss_dssp CBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSE-----------------------EEEE
T ss_pred Ccccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcc-----------------------cccc
Confidence 544443333 44445555555555544332 44444455555555555544 4322
Q ss_pred CCccCCCCcccEEecCCCccCCCCCc-cccCchhHHhhhhccCccccCCcCCccccccccceEEccccccc-cccCcccc
Q 042075 467 PSSLGQSETLTIIDLSNNNLTGTIPP-QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR-GEIPRTLG 544 (1033)
Q Consensus 467 p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~ 544 (1033)
+. +..+++|++|++++|++++..|. .+..+.++ +.|++++|.+++..|..+..+++|+.|++++|+++ +.+|..+.
T Consensus 390 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~ 467 (570)
T 2z63_A 390 SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467 (570)
T ss_dssp EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred cc-ccccCCCCEEEccCCccccccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence 22 55556666666666666544442 33344444 66666666666677778888999999999999997 67899999
Q ss_pred cccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccc-ccccc-
Q 042075 545 SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVF-RNASI- 622 (1033)
Q Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~~~~- 622 (1033)
.+++|++|+|++|++++..|.++..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|....+ .|+..
T Consensus 468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~ 547 (570)
T 2z63_A 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547 (570)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHT
T ss_pred cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhc
Confidence 9999999999999999888999999999999999999999988888999999999999999999999976544 34332
Q ss_pred -ccccccccccCCc
Q 042075 623 -TSVLGNLKLCGGT 635 (1033)
Q Consensus 623 -~~~~~n~~lcg~~ 635 (1033)
..+.+.+ .|..|
T Consensus 548 ~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 548 SQKEQGSA-KCSGS 560 (570)
T ss_dssp GGGEESCC-BBTTT
T ss_pred cccCCCch-hhCCC
Confidence 2233443 56544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=446.12 Aligned_cols=264 Identities=29% Similarity=0.455 Sum_probs=204.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+++++.++||+|+||+||+|+++. .||||+++.. .....++|.+|++++++++|||||+++++|. ++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCe
Confidence 4578889999999999999999763 4999998743 2344578999999999999999999999863 235
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++|||||++|+|.++++. ....+++.++..|+.|||+||+|||++ +||||||||+|||+++++++||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEE
Confidence 7999999999999999953 345699999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||+|+...............||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .+......
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~ 252 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGR 252 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhc
Confidence 99999987654433333334569999999999864 468999999999999999999999996322111 11111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
... .+... ..+..+++++.+++.+||+.||++||||+||++.|+.++...+
T Consensus 253 ~~~-------~p~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 253 GYA-------SPDLS-------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCC-------CCCST-------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCC-------CCCcc-------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 100 00000 0111345678999999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=455.07 Aligned_cols=269 Identities=24% Similarity=0.386 Sum_probs=207.0
Q ss_pred CCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|.+.++||+|+||+||+|+++ .+++.||||+++.......++|.+|++++++++|||||+++++|. .+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 35677899999999999999875 357899999998776667788999999999999999999999964 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcc-----ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDE-----TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
+..++|||||++|+|.++++....... .......++|.+++.|+.|||+||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 578999999999999999975432211 112345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
+++++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999987654443333334569999999999999999999999999999999999 89998632111 011
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
..+... .+.+.+..+++++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 271 ~~i~~g------------------------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQG------------------------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHT------------------------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcC------------------------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111000 01111223456799999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=452.70 Aligned_cols=270 Identities=24% Similarity=0.391 Sum_probs=213.8
Q ss_pred CCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++|+|. ++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 46788899999999999999875 357889999998776667788999999999999999999999964 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCc---cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITRED---ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
+..++|||||++|+|.++++...... ........+++.++++|+.|||+||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 57899999999999999996532100 0112346799999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 941 (1033)
+++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~ 239 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEV 239 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 9999999999987654443333333458999999999999999999999999999999999 8999863211 111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.... ... .+.+.+..+++++.+++.+||+.||++||||+||.+.|+++.+..
T Consensus 240 ~~~i--------~~~-------------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECI--------TQG-------------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHH--------HHT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHH--------HcC-------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1100 000 001112234567999999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=443.48 Aligned_cols=265 Identities=21% Similarity=0.304 Sum_probs=208.8
Q ss_pred CCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 712 GFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++++.++||+|+||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|. .+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence 4567889999999999999974 357889999997543 334578999999999999999999999964 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
+..++|||||++|+|.++++....... .......+++.++++|+.|||+||+|||++ +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 578999999999999999964322111 112345799999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNL 938 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 938 (1033)
++++++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDV 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987654433333334569999999999999999999999999999999999 8999863211 111
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
...+... .+.+.+.++++++.++|.+||+.||++||||+||+++|+++
T Consensus 257 ~~~i~~~------------------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNR------------------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcC------------------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111100 00111223567799999999999999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=480.19 Aligned_cols=505 Identities=22% Similarity=0.231 Sum_probs=407.6
Q ss_pred CCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCC
Q 042075 95 KLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPS 174 (1033)
Q Consensus 95 ~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 174 (1033)
+++ .+|..+. +.+++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|.
T Consensus 18 ~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (570)
T 2z63_A 18 NFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94 (570)
T ss_dssp CCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred Ccc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHh
Confidence 444 3555443 5789999999999988888999999999999999999987788899999999999999999977788
Q ss_pred CcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC-cCCccccccCCCCcccccccccCCCCcccccCCCc
Q 042075 175 ELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253 (1033)
Q Consensus 175 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 253 (1033)
.|.++++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..+..+++
T Consensus 95 ~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 174 (570)
T 2z63_A 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174 (570)
T ss_dssp TTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHT
T ss_pred hhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhc
Confidence 99999999999999999997666679999999999999999987 46899999999999999999999887888887777
Q ss_pred e----eEEeccCccccCccCccccccccccceeeecccccCC-CCCccCcCCCCccccccccccccCcCcchhhhccccc
Q 042075 254 I----TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG-AIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSH 328 (1033)
Q Consensus 254 L----~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~ 328 (1033)
| +.|++++|.+++..|. .+.. .+|++|++++|.... .++..+..+++++.+.+..+.+....
T Consensus 175 L~~~~~~L~l~~n~l~~~~~~-~~~~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~----------- 241 (570)
T 2z63_A 175 MPLLNLSLDLSLNPMNFIQPG-AFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG----------- 241 (570)
T ss_dssp CTTCCCEEECTTCCCCEECTT-TTTT-CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCS-----------
T ss_pred cchhhhhcccCCCCceecCHH-Hhcc-CcceeEecccccccccchhhhhcCccccceeeeccccccCch-----------
Confidence 7 7888888888755443 3322 368888887775432 23445555666665555443332110
Q ss_pred eeeecCcCCCCCCccchhhcccccccCcceeeeccc-ccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCE
Q 042075 329 FVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININ-NFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR 407 (1033)
Q Consensus 329 L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n-~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~ 407 (1033)
.+.......+ ..+.++ .++.++++.+ .+.+.+|..+..+ ++|+.|++++|.++ .+|..+..+ +|++
T Consensus 242 ------~l~~~~~~~~---~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~ 308 (570)
T 2z63_A 242 ------NLEKFDKSAL---EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQH 308 (570)
T ss_dssp ------SCEECCTTTT---GGGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSE
T ss_pred ------hhhhcchhhh---cccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccE
Confidence 0000011111 112222 2456666666 6667777776655 78999999999998 578888888 9999
Q ss_pred EEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCC--CCccCCCCcccEEecCCC
Q 042075 408 LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSI--PSSLGQSETLTIIDLSNN 484 (1033)
Q Consensus 408 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N 484 (1033)
|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..++ |++|++++|.+++.. |..+..+++|++|++++|
T Consensus 309 L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n 383 (570)
T 2z63_A 309 LELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383 (570)
T ss_dssp EEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSC
T ss_pred EeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCC
Confidence 999999998 5665 5789999999999999877665 5565 999999999998654 778899999999999999
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccCCcC-CccccccccceEEccccccccccCcccccccccceeeccccccc-Cc
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTGPIP-NEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ-GP 562 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ 562 (1033)
+++ .+|..+..+.++ +.|++++|.+++..| ..+..+++|+.|++++|++++..|..|.++++|++|+|++|+++ +.
T Consensus 384 ~l~-~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 461 (570)
T 2z63_A 384 GVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461 (570)
T ss_dssp SEE-EEEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred ccc-cccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCcccc
Confidence 998 456667777777 999999999998766 57899999999999999999999999999999999999999998 68
Q ss_pred ccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc-ccccccccccccccccccCCc
Q 042075 563 IPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE-GVFRNASITSVLGNLKLCGGT 635 (1033)
Q Consensus 563 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lcg~~ 635 (1033)
+|..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++.+|.. ..+..+....+.+|+..|..+
T Consensus 462 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred chhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 9999999999999999999999999999999999999999999999987753 455666777778887776544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=481.61 Aligned_cols=457 Identities=19% Similarity=0.249 Sum_probs=340.7
Q ss_pred EEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 88 ILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 88 ~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
.+|+++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5788888887 4666665 788888888888887777788888888888888888887778888888888888888888
Q ss_pred ccCCCCCCcccccccceeeecccccCC-CCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC--Cccccccccc--CC
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL--VNLTMAQNRL--SG 242 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~ 242 (1033)
++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..|..+++| ++|++++|++ ++
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 87 56665 77888888888888876 467778888888888888888875 456677777 8888888888 77
Q ss_pred CCcccccCCC-ceeEEeccCccccCccCccccccccccceeeecccc-------cCCCCCccCcCCCCcccccccccccc
Q 042075 243 TIPSSIFNIS-SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ-------LTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 243 ~~p~~l~~l~-~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
..|..+..+. +...+++++|.+.+.++...+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 7777777665 344566667776666666555556666666666665 443333 4455555555555555544
Q ss_pred CcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCcc
Q 042075 315 GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN 394 (1033)
Q Consensus 315 ~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~ 394 (1033)
+.... +..+ .. ..++|+.|++++|+++|.
T Consensus 234 ~~~~~------------------------------------------------~~~~-~~--~~~~L~~L~l~~n~l~~~ 262 (520)
T 2z7x_B 234 WNSFI------------------------------------------------RILQ-LV--WHTTVWYFSISNVKLQGQ 262 (520)
T ss_dssp HHHHH------------------------------------------------HHHH-HH--HTSSCSEEEEEEEEEESC
T ss_pred HHHHH------------------------------------------------HHHH-Hh--hhCcccEEEeecccccCc
Confidence 32100 0000 00 013566666666666666
Q ss_pred CCccc-----cCCCCCCEEEcccCcccccCC-hhhhcC---CCCcEEEccccccccccCcccccce-eceeeccccccCC
Q 042075 395 IPAAF-----GKFVKLLRLEMWNNRLSGTIP-PAIGEL---QNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQG 464 (1033)
Q Consensus 395 ~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~ 464 (1033)
+|..+ .++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..++ |++|++++|.+++
T Consensus 263 ~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~ 338 (520)
T 2z7x_B 263 LDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTD 338 (520)
T ss_dssp CCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCT
T ss_pred cccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccCh
Confidence 66666 7788888888888888 445 556555 67888888888876422 114555 8888888888888
Q ss_pred CCCCccCCCCcccEEecCCCccCC--CCCccccCchhHHhhhhccCccccCCcCC-ccccccccceEEccccccccccCc
Q 042075 465 SIPSSLGQSETLTIIDLSNNNLTG--TIPPQLLGLSSLLIVLELSRNQLTGPIPN-EVGNLKNLEMLNVFENKLRGEIPR 541 (1033)
Q Consensus 465 ~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~ll~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (1033)
.+|..++.+++|++|+|++|++++ .+|..+..+.++ +.|++++|++++.+|. .+..+++|+.|++++|++++.+|.
T Consensus 339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 417 (520)
T 2z7x_B 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417 (520)
T ss_dssp TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGG
T ss_pred hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhh
Confidence 888888888888888888888885 455667777776 8888888888875665 488899999999999999988888
Q ss_pred ccccccccceeecccccccCcccccccCcccCCccccccccccccCCcc-cccccccceeecCCCcCcccCCCc
Q 042075 542 TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF-LVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
.+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|++++|+++|.++..
T Consensus 418 ~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 487 (520)
T 2z7x_B 418 CLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 487 (520)
T ss_dssp SCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred hhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCch
Confidence 775 79999999999999 89998889999999999999999 56665 889999999999999999987743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=481.25 Aligned_cols=539 Identities=21% Similarity=0.207 Sum_probs=391.4
Q ss_pred CCCCCCCCCC----CCccee----eeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccc
Q 042075 59 GVFGSWNESI----HFCQWH----GVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH 122 (1033)
Q Consensus 59 ~~~~~W~~~~----~~c~w~----gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~ 122 (1033)
..+++|+.+. ++|.|. .|.|...+ +..++.|||++|++++..+.+|.++++|++|||++|+|++
T Consensus 11 ~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~ 90 (635)
T 4g8a_A 11 DKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 90 (635)
T ss_dssp --------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred chhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC
Confidence 3455555321 345543 46786432 2346677777777776555667777777777777777776
Q ss_pred cCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCC-CCCCCC
Q 042075 123 EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS-IPPSFG 201 (1033)
Q Consensus 123 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~ 201 (1033)
..|.+|.+|++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++. +|..++
T Consensus 91 i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~ 170 (635)
T 4g8a_A 91 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 170 (635)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhc
Confidence 6666677777777777777777755555677777777777777777755556677777777777777777643 456666
Q ss_pred CCCCCcEEEcccCcCCCcCCccccccCCCC----cccccccccCCCCcccccCCCceeEEeccCccccCccCcccccccc
Q 042075 202 NLSSISFLFLSRNNLDGSIPDTFGWLKNLV----NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277 (1033)
Q Consensus 202 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~ 277 (1033)
++++|++|+|++|+|++..|..|..+.+++ .++++.|+++.. +........+..++++.|.....++...+..+.
T Consensus 171 ~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i-~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~ 249 (635)
T 4g8a_A 171 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 249 (635)
T ss_dssp GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEE-CTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTT
T ss_pred cchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccccc-CcccccchhhhhhhhhcccccccccchhhcCCc
Confidence 777777777777777766676666665544 456667777633 333444455666777777655444444455566
Q ss_pred ccceeeeccccc------CCCCCccCcCCCCcccccccccccc----CcCcchhhhccccceeeecCcCCCCCCccchhh
Q 042075 278 NLQFFSVGRNQL------TGAIPPAISNASNLEVFQVNSNKLT----GEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFL 347 (1033)
Q Consensus 278 ~L~~L~L~~N~l------~~~~p~~~~~l~~L~~L~Ls~N~l~----~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 347 (1033)
.++...+..+.. .......+..+..+...++..+... +....+..+.+++.+.+.+|.+...
T Consensus 250 ~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~-------- 321 (635)
T 4g8a_A 250 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV-------- 321 (635)
T ss_dssp TCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--------
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--------
Confidence 666555544332 2233344555555555555544432 2333456677788888888766532
Q ss_pred cccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCccc--ccCChhhhc
Q 042075 348 CSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLS--GTIPPAIGE 425 (1033)
Q Consensus 348 ~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~ 425 (1033)
..+.....|+.+++..|.+.+..+..+ ..|+.+++.+|.+... .....+++|+.|++++|.+. +..+..+..
T Consensus 322 ~~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 322 KDFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp GGGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccchhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhh
Confidence 234556678889999988877654432 5789999999988643 34567899999999999985 456788889
Q ss_pred CCCCcEEEccccccccccCcccccce-eceeeccccccCCCCC-CccCCCCcccEEecCCCccCCCCCccccCchhHHhh
Q 042075 426 LQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIP-SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIV 503 (1033)
Q Consensus 426 l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~ 503 (1033)
+.+|+.|+++.|.+.+ .+..+..+. |+.+++++|+.....+ ..|..+++++.+++++|++.+..|..+..+..+ +.
T Consensus 396 ~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~ 473 (635)
T 4g8a_A 396 TISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EV 473 (635)
T ss_dssp CSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CE
T ss_pred hhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhh-hh
Confidence 9999999999999884 555666676 9999999888776654 568899999999999999997777777777766 99
Q ss_pred hhccCccc-cCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCcccccccc
Q 042075 504 LELSRNQL-TGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNN 582 (1033)
Q Consensus 504 L~ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 582 (1033)
|++++|.+ .+..|..|..+++|++|||++|+|++..|.+|+++++|++|+|++|+|++..|..|..+++|+.|||++|+
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 553 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 553 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence 99999975 45678899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccc-cccceeecCCCcCcccCCCc
Q 042075 583 LSGKIPEFLVGF-QLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 583 l~~~~p~~~~~l-~~L~~L~ls~N~l~g~~p~~ 614 (1033)
|++.+|..+..+ ++|++|+|++|+|++...-.
T Consensus 554 l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 554 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp CCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred CCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence 999999999988 68999999999999977643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=443.18 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=207.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+.|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++ ..++..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 4689999999999999999999999999999999866555567789999999999999999999994 45568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|||||+||+|.++++. ..+++.++..++.||+.||+|||++ +||||||||+|||+++++.+||+||
T Consensus 149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence 9999999999999842 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+|+.+....... ...+||+.|||||++.+..|+.++||||+||++|||++|++||.... ............+...
T Consensus 215 Gla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~ 290 (346)
T 4fih_A 215 GFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL 290 (346)
T ss_dssp TTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCC
T ss_pred cCceecCCCCCcc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC
Confidence 9999875443322 23469999999999999999999999999999999999999986321 1111111111111000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+++++.+++.+||+.||++|||++|+++.
T Consensus 291 ----------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 ----------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ----------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011234568999999999999999999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=480.52 Aligned_cols=479 Identities=18% Similarity=0.201 Sum_probs=394.5
Q ss_pred cceeeeEecCCC-CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCC
Q 042075 71 CQWHGVTCSRRQ-HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 71 c~w~gv~C~~~~-~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
|++.+++.-+.. ..+++.|+|+++++++..+..++++++|++|+|++|++++..|..|+.+++|++|+|++|.+++..|
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 445555443221 2478999999999998888899999999999999999999888999999999999999999998777
Q ss_pred ccccCCCCCcEEEcccccccC-CCCCCcccccccceeeecccccCCCCC-CCCCCCCCCcEEEcccCcCCCcCCcccccc
Q 042075 150 ANISSCSNLIRVRLSSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRNNLDGSIPDTFGWL 227 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 227 (1033)
..|+++++|++|+|++|.+++ .+|..++++++|++|++++|++.+.+| ..|.++++|++|++++|++++..|..|+.+
T Consensus 92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 171 (549)
T 2z81_A 92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171 (549)
T ss_dssp HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence 789999999999999999986 467899999999999999999555555 689999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCcccc-cCCCceeEEeccCccccCcc--CccccccccccceeeecccccCCCCC----ccCcCC
Q 042075 228 KNLVNLTMAQNRLSGTIPSSI-FNISSITVFDAGINQIQGVI--PLDIGFTLQNLQFFSVGRNQLTGAIP----PAISNA 300 (1033)
Q Consensus 228 ~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~ls~N~l~~~~--p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l 300 (1033)
++|++|++++|.+. .+|..+ ..+++|+.|++++|++++.. |..+...+.+|++|++++|.+++..+ ..+..+
T Consensus 172 ~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~ 250 (549)
T 2z81_A 172 RDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250 (549)
T ss_dssp SEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGC
T ss_pred ccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhh
Confidence 99999999999987 455544 57899999999999998743 34444568899999999999986544 345678
Q ss_pred CCccccccccccccCcC-------cchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccc
Q 042075 301 SNLEVFQVNSNKLTGEV-------PYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPAC 373 (1033)
Q Consensus 301 ~~L~~L~Ls~N~l~~~~-------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~ 373 (1033)
++|+.+++++|.+.+.. +.+..+.+|+.|.+.++.+..... .. .++ .
T Consensus 251 ~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--------~~-----------------~l~-~ 304 (549)
T 2z81_A 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--------FY-----------------DLS-T 304 (549)
T ss_dssp TTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--------SC-----------------CCC-H
T ss_pred ccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--------cc-----------------cch-h
Confidence 89999999999998753 234667788888888887653210 00 011 1
Q ss_pred cccccCcccEEEccCCCCCccCCccc-cCCCCCCEEEcccCcccccCCh---hhhcCCCCcEEEccccccccccC--ccc
Q 042075 374 ISNFSTTLEVLLLDSNKIFGNIPAAF-GKFVKLLRLEMWNNRLSGTIPP---AIGELQNLRELRLQENRFLGNIP--PSI 447 (1033)
Q Consensus 374 ~~~~~~~L~~L~L~~N~i~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p--~~~ 447 (1033)
+....++|+.|++++|+++ .+|..+ .++++|++|++++|++++.+|. .++.+++|++|+|++|++++..+ ..+
T Consensus 305 ~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 383 (549)
T 2z81_A 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383 (549)
T ss_dssp HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence 1122357888888888887 455555 6788999999999999876653 37788899999999999886433 457
Q ss_pred ccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccc
Q 042075 448 GNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLE 526 (1033)
Q Consensus 448 ~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~ 526 (1033)
..++ |++|+|++|+++ .+|..+..+++|++|++++|+++ .+|..+. .+ |+.|++++|+|++.+ ..+++|+
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~-L~~L~Ls~N~l~~~~----~~l~~L~ 454 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QT-LEVLDVSNNNLDSFS----LFLPRLQ 454 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TT-CSEEECCSSCCSCCC----CCCTTCC
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CC-ceEEECCCCChhhhc----ccCChhc
Confidence 7776 899999999998 68888899999999999999998 5665543 23 489999999999643 5789999
Q ss_pred eEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCC
Q 042075 527 MLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP 588 (1033)
Q Consensus 527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 588 (1033)
+|+|++|+|+ .+|. .+.+++|++|+|++|++++.+|..+..+++|+.|+|++|++++..|
T Consensus 455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999999999 7776 5789999999999999999999999999999999999999998777
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=442.85 Aligned_cols=253 Identities=20% Similarity=0.289 Sum_probs=200.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++ .+++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 46899999999999999999999999999999999753 334457899999999999999999999994 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+|||||+||+|.++++. .....+++.+++.|+.||+.||+|||++ |||||||||+|||+++++.+||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--------~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEE
T ss_pred EEEEEeCCCCCcHHHHHHH--------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEE
Confidence 9999999999999999953 2345678999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..........
T Consensus 167 ~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~ 239 (350)
T 4b9d_A 167 GDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIIS 239 (350)
T ss_dssp CSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH
T ss_pred cccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHc
Confidence 99999987643221 1223459999999999999999999999999999999999999996321 1111111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .... +..+++++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~--------~~~~-------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 GS--------FPPV-------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TC--------CCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC--------CCCC-------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000 01124568999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=435.61 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=207.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++|||||+++++ +++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence 5799999999999999999999999999999999743 23345778999999999999999999999 556678
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||++||+|.++++ ..+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||
T Consensus 107 ~yivmEy~~gG~L~~~i~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence 999999999999999994 345699999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..........
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~ 248 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIK 248 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHc
Confidence 99999998765444443444569999999999999999999999999999999999999996321 1111111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. . ..+...++++.+++.+||+.||++|||++|++.
T Consensus 249 ~~--------~--------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 249 LE--------Y--------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp TC--------C--------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CC--------C--------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 00 0 000112345889999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=444.12 Aligned_cols=275 Identities=23% Similarity=0.302 Sum_probs=216.7
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCC-CCceeEeeeeccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRH-RNLVKILTACSGV 780 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 780 (1033)
...++|++.+.||+|+||+||+|++... ++.||||+++... ....+++.+|++++++++| ||||+++|+|.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~-- 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-- 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE--
Confidence 3457899999999999999999998643 4789999997543 3345779999999999965 89999999973
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..++..++|||||++|+|.++++...... ........+++.+++.++.|||+||+|||++ +||||||||
T Consensus 139 --~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~ 213 (353)
T 4ase_A 139 --KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213 (353)
T ss_dssp --CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence 33456899999999999999996532211 0011245689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997765544444444568999999999999999999999999999999998 8999864321
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.+ .+........ ++..+..+++++.++|.+||+.||++|||++||+++|
T Consensus 294 ~~-~~~~~i~~g~------------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 294 DE-EFCRRLKEGT------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp SH-HHHHHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH-HHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 11 1111111110 1111223456789999999999999999999999999
Q ss_pred HHHHHHh
Q 042075 1014 QSIKNIL 1020 (1033)
Q Consensus 1014 ~~i~~~~ 1020 (1033)
+++.+.-
T Consensus 343 ~~llq~~ 349 (353)
T 4ase_A 343 GNLLQAN 349 (353)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 9987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=435.99 Aligned_cols=258 Identities=21% Similarity=0.223 Sum_probs=206.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.+.|++.++||+|+||+||+|+++.+++.||||+++.... ..+|+.++++++|||||++++++ .+++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 4568888999999999999999999999999999975432 24799999999999999999995 4556899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~ 868 (1033)
+|||||+||+|.++++ ....+++.++..++.||+.||+|||++ +||||||||+|||++.++ ++||+
T Consensus 127 ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIK----------QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence 9999999999999995 335699999999999999999999999 999999999999999987 69999
Q ss_pred ecccceecCCCCcc---ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 869 DFGLATFLPLSHAQ---TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|||+|+........ ......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ .+.......
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~ 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC
Confidence 99999987543321 12223469999999999999999999999999999999999999996432221 111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
. ... ..+..+++++.+++.+||+.||++|||+.|+++.|.......
T Consensus 273 ~--~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 273 P--PIR---------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp C--GGG---------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred C--Cch---------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0 000 011124566899999999999999999999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=426.56 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=197.6
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
++.++||+|+||+||+|++..+++.||+|++... .....+++.+|++++++++|||||+++++|.+.. ..++..|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 5677899999999999999999999999998743 3344577999999999999999999999874321 234568999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~Df 870 (1033)
||||+||+|.++++ ....+++.++..|+.||+.||+|||++ .++||||||||+|||++ +++.+||+||
T Consensus 108 mEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 108 TELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence 99999999999995 345689999999999999999999998 22399999999999998 4789999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ..............
T Consensus 177 Gla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 177 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVK 247 (290)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCC
T ss_pred cCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCCC
Confidence 9998643322 123459999999999865 69999999999999999999999985321 11111111111000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... .+..+++++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00112345889999999999999999999876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=486.73 Aligned_cols=450 Identities=18% Similarity=0.233 Sum_probs=381.7
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCC------CC------CCCccccCCCCCcEEEcccccccCCCCCC
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSI------GG------EIPANISSCSNLIRVRLSSNELVGKIPSE 175 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 175 (1033)
.+++.|+|++|+++|.+|++|++|++|++|+|++|.+ .| .+|... +.+|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4688999999999999999999999999999999976 33 444444 56777 888999888888877
Q ss_pred ccc-ccccceeeecccccCCCCCCCCCCCCCCcEEEcc--cCcCCCcCCccccccCCCCcccccccccCCC---------
Q 042075 176 LGS-LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLS--RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT--------- 243 (1033)
Q Consensus 176 ~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------- 243 (1033)
+.. +.++..+++....+.. .....++.+.+. +|+++| +|.+|+++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 763 4456666665544431 122334444444 689998 999999999999999999999986
Q ss_pred --------Cccccc--CCCceeEEeccCccccCccCccccccccccceeeecccc-cCC-CCCccCcCC------CCccc
Q 042075 244 --------IPSSIF--NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ-LTG-AIPPAISNA------SNLEV 305 (1033)
Q Consensus 244 --------~p~~l~--~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~ 305 (1033)
+|..+. ++++|++|++++|.+.+.+|..+. .+++|++|+|++|+ ++| .+|..++.+ ++|++
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~ 309 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence 999999 999999999999999999997655 79999999999999 998 899988887 89999
Q ss_pred cccccccccCcCc--chhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccE
Q 042075 306 FQVNSNKLTGEVP--YLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEV 383 (1033)
Q Consensus 306 L~Ls~N~l~~~~~--~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~ 383 (1033)
|++++|+++..++ .+..+ ++|+.
T Consensus 310 L~L~~n~l~~ip~~~~l~~l-------------------------------------------------------~~L~~ 334 (636)
T 4eco_A 310 IYIGYNNLKTFPVETSLQKM-------------------------------------------------------KKLGM 334 (636)
T ss_dssp EECCSSCCSSCCCHHHHTTC-------------------------------------------------------TTCCE
T ss_pred EECCCCcCCccCchhhhccC-------------------------------------------------------CCCCE
Confidence 9999999884333 23222 46788
Q ss_pred EEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCC-CcEEEccccccccccCcccccce---eceeeccc
Q 042075 384 LLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQN-LRELRLQENRFLGNIPPSIGNLK---LFNLQLSY 459 (1033)
Q Consensus 384 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~---L~~L~Ls~ 459 (1033)
|++++|+++|.+| .|.++++|++|++++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..+. |++|++++
T Consensus 335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp EECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred EeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 8888888988888 9999999999999999999 88999999999 999999999999 8899888763 99999999
Q ss_pred cccCCCCCCccC-------CCCcccEEecCCCccCCCCCccccC-chhHHhhhhccCccccCCcCCcccc-c-------c
Q 042075 460 NFLQGSIPSSLG-------QSETLTIIDLSNNNLTGTIPPQLLG-LSSLLIVLELSRNQLTGPIPNEVGN-L-------K 523 (1033)
Q Consensus 460 N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~-~~~ll~~L~ls~N~l~~~~p~~~~~-l-------~ 523 (1033)
|.+++.+|..|. .+++|++|+|++|+++ .+|..++. +..+ +.|+|++|+++ .+|..+.. + +
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~ 488 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPL-SSINLMGNMLT-EIPKNSLKDENENFKNTY 488 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCC-SEEECCSSCCS-BCCSSSSEETTEECTTGG
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCC-CEEECCCCCCC-CcCHHHhccccccccccC
Confidence 999999999998 8889999999999999 78887665 5555 99999999999 66665433 2 3
Q ss_pred ccceEEccccccccccCcccc--cccccceeecccccccCcccccccCcccCCcccc------ccccccccCCccccccc
Q 042075 524 NLEMLNVFENKLRGEIPRTLG--SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDL------SQNNLSGKIPEFLVGFQ 595 (1033)
Q Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~ 595 (1033)
+|+.|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+.++++|+.|+| ++|++.+.+|..+..++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 9999999999999 7898887 99999999999999997 9999999999999999 56889999999999999
Q ss_pred ccceeecCCCcCcccCCCcccccccccccccccccccC
Q 042075 596 LLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCG 633 (1033)
Q Consensus 596 ~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg 633 (1033)
+|++|+|++|++ +.+|.. .+..+....+.+|+..|-
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEE
T ss_pred CCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccc
Confidence 999999999999 788875 335666667778876653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=441.49 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=207.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+.|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.+|++++|||||++++++ ..++..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence 5699999999999999999999999999999999866656667789999999999999999999995 45568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
|||||+||+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 226 VmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence 9999999999999842 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+|+.+....... ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ............+..
T Consensus 292 Gla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~- 366 (423)
T 4fie_A 292 GFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR- 366 (423)
T ss_dssp TTCEECCSSCCCB--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCC-
T ss_pred ccceECCCCCccc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC-
Confidence 9999775443322 23459999999999999999999999999999999999999985321 111111111111110
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+. ....+++++.+++.+||+.||++|||++|+++.
T Consensus 367 -------~~--------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 -------LK--------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -------CS--------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------Cc--------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 001124568999999999999999999999874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=486.23 Aligned_cols=439 Identities=20% Similarity=0.284 Sum_probs=333.9
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEec-ccCCCCCCCCccccCC----CCCc--EEEc----------cccccc-
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLAL-HNNSIGGEIPANISSC----SNLI--RVRL----------SSNELV- 169 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~l----~~L~--~L~L----------s~N~l~- 169 (1033)
.+++.|+|++|++.|.+|++|++|++|++|+| ++|.++|..|...... ..++ .+.. ....+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56889999999999999999999999999999 9998888755332111 0000 0000 000000
Q ss_pred ----------CCCCCCcccccccceeeecc--cccCCCCCCCCCCCCCCcEEEcccCcCCC-----------------cC
Q 042075 170 ----------GKIPSELGSLSKIEYFSVSY--NNLTGSIPPSFGNLSSISFLFLSRNNLDG-----------------SI 220 (1033)
Q Consensus 170 ----------~~~p~~~~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~ 220 (1033)
...+........++.+.++. |++++ +|..|+++++|++|+|++|+|++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 00111112223344444443 66776 66677777777777777777776 37
Q ss_pred Ccccc--ccCCCCcccccccccCCCCcccccCCCceeEEeccCcc-ccC-ccCcccc------ccccccceeeecccccC
Q 042075 221 PDTFG--WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ-IQG-VIPLDIG------FTLQNLQFFSVGRNQLT 290 (1033)
Q Consensus 221 p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~-l~~-~~p~~~~------~~l~~L~~L~L~~N~l~ 290 (1033)
|+.++ ++++|++|+|++|++.+.+|..+.++++|+.|+|++|+ +++ .+|..+. ..+++|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 77766 88888888888888888888888888888888888887 777 6776543 23458999999999999
Q ss_pred CCCCc--cCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCC
Q 042075 291 GAIPP--AISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGG 368 (1033)
Q Consensus 291 ~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~ 368 (1033)
.+|. .+.++++|+.|+|++|+++ .+|.+..+
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L--------------------------------------------- 594 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTN--------------------------------------------- 594 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTT---------------------------------------------
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCC---------------------------------------------
Confidence 7888 8999999999999999887 33333322
Q ss_pred CCccccccccCcccEEEccCCCCCccCCccccCCCC-CCEEEcccCcccccCChhhhcCCC--CcEEEccccccccccCc
Q 042075 369 LLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK-LLRLEMWNNRLSGTIPPAIGELQN--LRELRLQENRFLGNIPP 445 (1033)
Q Consensus 369 ~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~ 445 (1033)
++|+.|+|++|+++ .+|..+.++++ |++|+|++|+++ .+|..+..++. |+.|+|++|++++.+|.
T Consensus 595 ----------~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~ 662 (876)
T 4ecn_A 595 ----------VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662 (876)
T ss_dssp ----------SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred ----------CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc
Confidence 45666777777776 66777888887 888888888888 67777776654 88888888888876664
Q ss_pred cc---ccc---eeceeeccccccCCCCCCc-cCCCCcccEEecCCCccCCCCCccccCchh-------HHhhhhccCccc
Q 042075 446 SI---GNL---KLFNLQLSYNFLQGSIPSS-LGQSETLTIIDLSNNNLTGTIPPQLLGLSS-------LLIVLELSRNQL 511 (1033)
Q Consensus 446 ~~---~~l---~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-------ll~~L~ls~N~l 511 (1033)
.. ..+ .|+.|+|++|.++ .+|.. +..+++|+.|+|++|+|+ .+|..++.... .|+.|+|++|+|
T Consensus 663 l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L 740 (876)
T 4ecn_A 663 ISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740 (876)
T ss_dssp CSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCC
T ss_pred chhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCC
Confidence 33 222 3889999999998 45554 458899999999999999 88888776541 349999999999
Q ss_pred cCCcCCccc--cccccceEEccccccccccCcccccccccceeeccc------ccccCcccccccCcccCCccccccccc
Q 042075 512 TGPIPNEVG--NLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG------NFLQGPIPSSLSSLRGLSVLDLSQNNL 583 (1033)
Q Consensus 512 ~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l 583 (1033)
+ .+|..+. .+++|+.|+|++|+|++ +|..++++++|+.|+|++ |++.+.+|..+.++++|+.|+|++|+|
T Consensus 741 ~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 741 T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp C-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred c-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 9 7898887 99999999999999997 899999999999999976 889999999999999999999999999
Q ss_pred cccCCcccccccccceeecCCCcCcccCCC
Q 042075 584 SGKIPEFLVGFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 584 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
+.+|..+. ++|+.|+|++|++....+.
T Consensus 819 -~~Ip~~l~--~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 819 -RKVDEKLT--PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp -CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred -CccCHhhc--CCCCEEECCCCCCCccChH
Confidence 69999876 6999999999999865543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=427.95 Aligned_cols=281 Identities=22% Similarity=0.289 Sum_probs=203.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|.+.++||+|+||+||+|+++ |+.||||+++..... ...+..|+..+.+++|||||+++++|.+.. ......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 45788899999999999999984 889999999754322 123345666667889999999999985432 11235799
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEeccCCCCCeEecCCCcE
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD-----CQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
|||||++|+|.++++. ..+++.++.+++.|+++||+|||++ +.++||||||||+|||+++++++
T Consensus 79 V~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 9999999999999953 3589999999999999999999976 25689999999999999999999
Q ss_pred EEeecccceecCCCCcc--ccccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 866 HVGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
||+|||+|+........ .......||+.|||||++.+. .++.++|||||||++|||+||++||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999876543322 122234599999999998764 4778999999999999999999887543222221
Q ss_pred HHHHHhhhCC-cchhh-hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 938 LHNFAKTALP-DHVVD-IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 938 ~~~~~~~~~~-~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
+......... +.... +.+....+.. .......++++.+.+++.+||+.||++||||.||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~-------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCC-------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCC-------------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1111000000 00000 0011110000 0001123466789999999999999999999999999999
Q ss_pred HHHH
Q 042075 1016 IKNI 1019 (1033)
Q Consensus 1016 i~~~ 1019 (1033)
+.+.
T Consensus 295 l~~~ 298 (303)
T 3hmm_A 295 LSQQ 298 (303)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 8753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=417.31 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=189.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||+++++ +..++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECC
Confidence 368999999999999999999999999999999997432 2335678999999999999999999999 45566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+ +|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIV----------QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEEECC-CEEHHHHHH----------HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEEeCC-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 899999999 689999984 345699999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+|+......... ..+||+.|||||++.+..| +.++||||+||++|||+||+.||+.. ......+..
T Consensus 153 l~DFGla~~~~~~~~~~---~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i 224 (275)
T 3hyh_A 153 IADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNI 224 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred EeecCCCeecCCCCccC---CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHH
Confidence 99999998764433222 2459999999999998876 58999999999999999999999632 111111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .. . .+...++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~--------~~-~-------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 SNG--------VY-T-------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHT--------CC-C-------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HcC--------CC-C-------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 00 0 001123558899999999999999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=459.06 Aligned_cols=451 Identities=21% Similarity=0.224 Sum_probs=364.7
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999999 6888776 89999999999999877789999999999999999999888999999999999999999
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCC-cCCccccccCCCCcccccccccCCCCcccccCCCce--eEEeccCccc--c
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI--TVFDAGINQI--Q 265 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~ls~N~l--~ 265 (1033)
+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++ ..+..+++| +.|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 56665 79999999999999997 478999999999999999999986 455666666 8888888888 6
Q ss_pred CccCccccccccccceeeecccccCCCCCc-cCcCCCCcccccccccc-------ccCcCcchhhhccccceeeecCcCC
Q 042075 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPP-AISNASNLEVFQVNSNK-------LTGEVPYLEKLQRLSHFVITRNSLG 337 (1033)
Q Consensus 266 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~~~~~~l~~l~~L~~L~l~~N~l~ 337 (1033)
+..|..+..--.+...+++++|++.+.++. .+.++++|+.|++++|. +.+.++.+..++
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~------------- 220 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP------------- 220 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCT-------------
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhcccc-------------
Confidence 666654432111344567777777765554 56677788888888776 443333333333
Q ss_pred CCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCcccc---CCCCCCEEEcccCc
Q 042075 338 SGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFG---KFVKLLRLEMWNNR 414 (1033)
Q Consensus 338 ~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~---~l~~L~~L~L~~N~ 414 (1033)
+|+.|++++|.+++..+..+. ..++|++|++++|+
T Consensus 221 ------------------------------------------~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 258 (520)
T 2z7x_B 221 ------------------------------------------KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258 (520)
T ss_dssp ------------------------------------------TCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEE
T ss_pred ------------------------------------------chhhccccccccCHHHHHHHHHHhhhCcccEEEeeccc
Confidence 344444444444432222111 24689999999999
Q ss_pred ccccCChhh-----hcCCCCcEEEccccccccccC-cccccc----eeceeeccccccCCCCCCccCCCCcccEEecCCC
Q 042075 415 LSGTIPPAI-----GELQNLRELRLQENRFLGNIP-PSIGNL----KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484 (1033)
Q Consensus 415 l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l----~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 484 (1033)
++|.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .++.|++++|.+.+.. .+..+++|++|++++|
T Consensus 259 l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNN 334 (520)
T ss_dssp EESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSS
T ss_pred ccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECC
Confidence 999999998 9999999999999999 566 455443 4999999999987432 1268899999999999
Q ss_pred ccCCCCCccccCchhHHhhhhccCccccC--CcCCccccccccceEEccccccccccCc-ccccccccceeecccccccC
Q 042075 485 NLTGTIPPQLLGLSSLLIVLELSRNQLTG--PIPNEVGNLKNLEMLNVFENKLRGEIPR-TLGSCIKLELLQMQGNFLQG 561 (1033)
Q Consensus 485 ~l~~~~p~~~~~~~~ll~~L~ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 561 (1033)
++++.+|..+..+.++ +.|++++|++++ .+|..++.+++|+.|++++|++++.+|. .+..+++|++|++++|++++
T Consensus 335 ~l~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 335 LLTDTVFENCGHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp CCCTTTTTTCCCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred ccChhhhhhhccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 9998899999888887 999999999997 5667899999999999999999986776 48899999999999999998
Q ss_pred cccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc--ccccccccccccccccccCC
Q 042075 562 PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE--GVFRNASITSVLGNLKLCGG 634 (1033)
Q Consensus 562 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~--~~~~~~~~~~~~~n~~lcg~ 634 (1033)
.+|..+. ++|+.|||++|+|+ .+|..+..+++|++|+|++|+|++ +|.. ..+..+....+.+|+..|..
T Consensus 414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccC
Confidence 8888775 79999999999999 889988899999999999999995 5543 34556666777888877753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=419.28 Aligned_cols=243 Identities=23% Similarity=0.242 Sum_probs=189.7
Q ss_pred CCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.+.||+|+||+||+|++. .+++.||||+++... .....++.+|++++++++|||||++++++ +++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999873 467899999997432 22335688999999999999999999994 456
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..|+||||++||+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence 68999999999999999994 345699999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.....
T Consensus 166 Kl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i 238 (304)
T 3ubd_A 166 KLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMTMI 238 (304)
T ss_dssp EEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred EecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHHHH
Confidence 99999999865433222 223459999999999999999999999999999999999999996321 11111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
... .. ..+..+++++.+++.+||+.||++|||+
T Consensus 239 ~~~--------~~--------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 239 LKA--------KL--------------------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHC--------CC--------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HcC--------CC--------------------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 000 00 0011134568999999999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=455.43 Aligned_cols=460 Identities=19% Similarity=0.210 Sum_probs=349.0
Q ss_pred EEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccc
Q 042075 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSN 166 (1033)
Q Consensus 87 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 166 (1033)
..+|++++++++ +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 578889999985 776554 78999999999999877789999999999999999999888899999999999999999
Q ss_pred cccCCCCCCcccccccceeeecccccCC-CCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC--Cccccccccc--C
Q 042075 167 ELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL--VNLTMAQNRL--S 241 (1033)
Q Consensus 167 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~ 241 (1033)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..|..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeeccccccc
Confidence 998 67776 78999999999999987 346789999999999999999885 345666666 9999999999 8
Q ss_pred CCCcccccCCC-ceeEEeccCccccCccCccccccccccceeeeccccc-----CCCCCccCcCCCCccccccccccccC
Q 042075 242 GTIPSSIFNIS-SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL-----TGAIPPAISNASNLEVFQVNSNKLTG 315 (1033)
Q Consensus 242 ~~~p~~l~~l~-~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l-----~~~~p~~~~~l~~L~~L~Ls~N~l~~ 315 (1033)
+..|..+..+. ....++++.|.+.+.++...+..+++|+.|++++|+. .+ .+..+..+++|+.|+++++.+++
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 88888887765 2235577788777777766666677777777777642 11 11223444444444444444432
Q ss_pred cCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccC
Q 042075 316 EVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395 (1033)
Q Consensus 316 ~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~ 395 (1033)
.. +.+ ++.... .++|++|++++|.++|.+
T Consensus 264 ~~------------------------------------------------~~~-~~~~~~--~~~L~~L~l~~n~l~~~i 292 (562)
T 3a79_B 264 KC------------------------------------------------SVK-LFQFFW--PRPVEYLNIYNLTITERI 292 (562)
T ss_dssp HH------------------------------------------------HHH-HHHHHT--TSSEEEEEEEEEEECSCC
T ss_pred HH------------------------------------------------HHH-HHHhhh--cccccEEEEeccEeeccc
Confidence 10 000 000010 135667777777777666
Q ss_pred Cccc-----cCCCCCCEEEcccCcccccCC-hhhhcC---CCCcEEEccccccccccCcccccce-eceeeccccccCCC
Q 042075 396 PAAF-----GKFVKLLRLEMWNNRLSGTIP-PAIGEL---QNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGS 465 (1033)
Q Consensus 396 p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~ 465 (1033)
|..+ .+++.|+.++++.|.+ .+| ..+..+ .+|+.|++++|.+.... ....++ |++|++++|.+++.
T Consensus 293 p~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~ 368 (562)
T 3a79_B 293 DREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDS 368 (562)
T ss_dssp CCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTT
T ss_pred cchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccc
Confidence 6666 6677777777777777 344 333333 67888888888875322 114555 88888888888888
Q ss_pred CCCccCCCCcccEEecCCCccCC--CCCccccCchhHHhhhhccCccccCCcCC-ccccccccceEEccccccccccCcc
Q 042075 466 IPSSLGQSETLTIIDLSNNNLTG--TIPPQLLGLSSLLIVLELSRNQLTGPIPN-EVGNLKNLEMLNVFENKLRGEIPRT 542 (1033)
Q Consensus 466 ~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~ll~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~ 542 (1033)
+|..+.++++|++|+|++|++++ .+|..+..+.++ +.|++++|++++.+|. .+..+++|+.|+|++|++++.+|..
T Consensus 369 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 447 (562)
T 3a79_B 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447 (562)
T ss_dssp TTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSS
T ss_pred hhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhh
Confidence 88888888899999999998884 233456666666 8889999999875555 5888999999999999999888877
Q ss_pred cccccccceeecccccccCcccccccCcccCCccccccccccccCCcc-cccccccceeecCCCcCcccCCCccc
Q 042075 543 LGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF-LVGFQLLEYLNLSNNDFEGMVPTEGV 616 (1033)
Q Consensus 543 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~ 616 (1033)
+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|++++|+++|.+|..+.
T Consensus 448 l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 448 LP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp CC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred hc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 65 79999999999999 78888889999999999999999 56665 89999999999999999998875433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=415.53 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=190.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-------
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------- 782 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 782 (1033)
++|++.+.||+|+||+||+|+++.+++.||||+++... ....+++.+|++++++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999999999999999997543 3345678999999999999999999999754321
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
..+.+.|+||||+++|+|.++++... .....++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 12335799999999999999996421 223356677889999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccc----------cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 863 MIAHVGDFGLATFLPLSHAQT----------SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
+.+||+|||+|+......... .....+||+.|||||++.+..|+.++||||+||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999998765432211 1123459999999999999999999999999999999996 764211
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+ ....... +.+.. .++...+..+...+++.+||+.||++|||+.|+++
T Consensus 232 ~----~~~~~~~--------~~~~~-------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 E----RVRTLTD--------VRNLK-------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----HHHHHHH--------HHTTC-------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHHHHHH--------HhcCC-------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000000 00000 00111223445678999999999999999999987
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=456.87 Aligned_cols=530 Identities=20% Similarity=0.166 Sum_probs=421.3
Q ss_pred EEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccc
Q 042075 89 LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL 168 (1033)
Q Consensus 89 l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 168 (1033)
++=++.+++ .+|+.+- +.+++|||++|+|++..|.+|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|
T Consensus 36 ~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 36 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 455566776 4665442 4789999999999987778999999999999999999987788899999999999999999
Q ss_pred cCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC-cCCccccccCCCCcccccccccCCCCccc
Q 042075 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG-SIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 169 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 247 (1033)
++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|..++.+++|++|+|++|++++..|..
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 97777789999999999999999998878889999999999999999986 46888999999999999999999888888
Q ss_pred ccCCCce----eEEeccCccccCccCccccccccccceeeecccccCCC-CCccCcCCCCccccccccccccCc------
Q 042075 248 IFNISSI----TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA-IPPAISNASNLEVFQVNSNKLTGE------ 316 (1033)
Q Consensus 248 l~~l~~L----~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~------ 316 (1033)
+..+.++ ..++++.|.++. ++...+ ....++.+++.+|..... .+..+..+..++...+..+.....
T Consensus 193 l~~L~~l~~~~~~~~ls~n~l~~-i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~ 270 (635)
T 4g8a_A 193 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 270 (635)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCE-ECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred ccchhhhhhhhhhhhcccCcccc-cCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence 8766543 478999999984 444444 345678889988876532 334566777777776655443321
Q ss_pred -CcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccC
Q 042075 317 -VPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395 (1033)
Q Consensus 317 -~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~ 395 (1033)
...+..+..+....+..+........ ....+.....+..+.+..+.+....+. .....++.|++.+|.+.+..
T Consensus 271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~---~~~~~~~~~~l~~l~~~~~~~~~~~~~---~~~~~L~~L~l~~~~~~~~~ 344 (635)
T 4g8a_A 271 DKSALEGLCNLTIEEFRLAYLDYYLDG---IIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKFGQFP 344 (635)
T ss_dssp CTTTTGGGGGSEEEEEEEECCCSCEEE---CTTTTGGGTTCSEEEEESCEEEECGGG---GSCCCCSEEEEESCEESSCC
T ss_pred cccccccccchhhhhhhhhhhcccccc---hhhhhhhhccccccccccccccccccc---ccchhhhhhhcccccccCcC
Confidence 12345555566555555443321111 122344566777777777776654332 22357999999999998665
Q ss_pred CccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEcccccccc--ccCcccccce-eceeeccccccCCCCCCccCC
Q 042075 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLG--NIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQ 472 (1033)
Q Consensus 396 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~ 472 (1033)
+. .+..|+.++++.|.+... .....+++|+.|++++|.+.. ..+..+..+. ++.|+++.|.+.. .+..+..
T Consensus 345 ~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~ 418 (635)
T 4g8a_A 345 TL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLG 418 (635)
T ss_dssp CC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTT
T ss_pred cc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccc
Confidence 53 467789999999998743 345679999999999999864 3455555554 9999999999884 5667889
Q ss_pred CCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccc-ccccCcccccccccce
Q 042075 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL-RGEIPRTLGSCIKLEL 551 (1033)
Q Consensus 473 l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~ 551 (1033)
+++|+.+++++|+.....+...+.....++.++++.|.+++..|..+..+++|+.|+|++|++ .+.+|..|..+++|++
T Consensus 419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~ 498 (635)
T 4g8a_A 419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 498 (635)
T ss_dssp CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence 999999999999887666655444333448999999999999999999999999999999985 4567899999999999
Q ss_pred eecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcc-cc-cccccccccccc
Q 042075 552 LQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEG-VF-RNASITSVLGNL 629 (1033)
Q Consensus 552 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~-~~~~~~~~~~n~ 629 (1033)
|+|++|+|++.+|.+|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++.+|..- .+ ..+....+.+|+
T Consensus 499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np 578 (635)
T 4g8a_A 499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 578 (635)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence 9999999999999999999999999999999999999999999999999999999999988752 22 456677788999
Q ss_pred cccCCc
Q 042075 630 KLCGGT 635 (1033)
Q Consensus 630 ~lcg~~ 635 (1033)
.-|...
T Consensus 579 ~~C~C~ 584 (635)
T 4g8a_A 579 FACTCE 584 (635)
T ss_dssp BCCSGG
T ss_pred CcccCC
Confidence 988643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=448.80 Aligned_cols=441 Identities=18% Similarity=0.219 Sum_probs=311.8
Q ss_pred CeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEc
Q 042075 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 163 (1033)
.+++.|+|+++++++..+..++++++|++|+|++|++++..|..|..+++|++|||++|.|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 46899999999999888889999999999999999999988999999999999999999999 78877 8999999999
Q ss_pred ccccccC-CCCCCcccccccceeeecccccCCCCCCCCCCCCCC--cEEEcccCcC--CCcCCccccccC--CCCccccc
Q 042075 164 SSNELVG-KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSI--SFLFLSRNNL--DGSIPDTFGWLK--NLVNLTMA 236 (1033)
Q Consensus 164 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~L~ 236 (1033)
++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|+|++|++ ++..|..|..+. .| .++++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~ 204 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFH 204 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEEC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEec
Confidence 9999996 4568999999999999999999863 45666666 9999999999 889999998865 33 66889
Q ss_pred ccccCCCCcc-cccCCCceeEEeccCcc-----ccCccCccccccccccceeeecccccCCCC----CccCcCCCCcccc
Q 042075 237 QNRLSGTIPS-SIFNISSITVFDAGINQ-----IQGVIPLDIGFTLQNLQFFSVGRNQLTGAI----PPAISNASNLEVF 306 (1033)
Q Consensus 237 ~N~l~~~~p~-~l~~l~~L~~L~ls~N~-----l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L 306 (1033)
+|.+.+.++. .+.++++|+.+++++|. +.+.++ .+..+++|+.|+++++.+++.. +..+ ..++|++|
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~--~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L 281 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS--ELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYL 281 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHH--HHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHHH--HHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEE
Confidence 9999887665 55688999999999995 222222 2346788888888888776321 1111 22367777
Q ss_pred ccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCc-ccccccc--CcccE
Q 042075 307 QVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP-ACISNFS--TTLEV 383 (1033)
Q Consensus 307 ~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip-~~~~~~~--~~L~~ 383 (1033)
++++|+++|..|.-. + -....+++.|+.++++.+.+ .+| ..+.... .+|+.
T Consensus 282 ~l~~n~l~~~ip~~~----------------------~--~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 282 NIYNLTITERIDREE----------------------F--TYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EEEEEEECSCCCCCC----------------------C--CCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred EEeccEeeccccchh----------------------h--hcccccchheehhhccccee--ecChhhhhhhhccCcceE
Confidence 777777775544200 0 00124455555555555555 333 1111110 23555
Q ss_pred EEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccC
Q 042075 384 LLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQ 463 (1033)
Q Consensus 384 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~ 463 (1033)
|++++|.+.... ....+++|++|++++|++++.+|..+..+++|+.|+|++|++++..
T Consensus 336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-------------------- 393 (562)
T 3a79_B 336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF-------------------- 393 (562)
T ss_dssp EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT--------------------
T ss_pred EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc--------------------
Confidence 555555553211 1134455555555555555545555555555555555555554311
Q ss_pred CCCCCccCCCCcccEEecCCCccCCCCCcccc-CchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcc
Q 042075 464 GSIPSSLGQSETLTIIDLSNNNLTGTIPPQLL-GLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRT 542 (1033)
Q Consensus 464 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 542 (1033)
.+|..+.++++|++|++++|++++.+|...+ .+.++ +.|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..
T Consensus 394 -~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 394 -KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI-LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp -HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC-CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred -cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC-CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence 1234455666666666666666654555433 33333 6666666666665665554 68999999999998 78887
Q ss_pred cccccccceeecccccccCccccc-ccCcccCCccccccccccccCC
Q 042075 543 LGSCIKLELLQMQGNFLQGPIPSS-LSSLRGLSVLDLSQNNLSGKIP 588 (1033)
Q Consensus 543 ~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 588 (1033)
+..+++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..|
T Consensus 469 ~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred hcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 779999999999999999 56665 8999999999999999997655
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=418.74 Aligned_cols=287 Identities=21% Similarity=0.194 Sum_probs=205.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccc-cccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGV-DYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~ 786 (1033)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+++.+|+++|++++|||||++++++... .+...+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999999999999999997432 33456788999999999999999999987543 234556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+|||||+ |+|.+++. ....+++.++..++.||+.||+|||++ |||||||||+|||++.++.+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEE
Confidence 8899999995 68999994 345799999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc--cccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||+|+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...... ..+.....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~ 277 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMM 277 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 999999987643321 2222335699999999998875 5689999999999999999999999632111 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... +.....................+..-........+++.+++.+||+.||++|||++|+++.
T Consensus 278 ~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 278 VLGTPSP-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHCCCCG-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hcCCCCh-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111100 0000000000000000000000000000001124568899999999999999999999874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=405.43 Aligned_cols=295 Identities=28% Similarity=0.456 Sum_probs=278.8
Q ss_pred cCCChhhHHHHHHHHHhcccCCCCCCCCCCCCCCCcc--eeeeEecCCC-CCeEEEEEcCCCCCCc--ccccccCCCCCC
Q 042075 36 VAGNETDRLALLEFKSKITHDPLGVFGSWNESIHFCQ--WHGVTCSRRQ-HQRVTILDLKSLKLAG--YISAHVGNLSFL 110 (1033)
Q Consensus 36 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~~~c~--w~gv~C~~~~-~~~v~~l~l~~~~l~g--~~~~~~~~l~~L 110 (1033)
+.|.++|++||++||+++ .||. .+++|..+.+||. |.||+|+..+ .++|+.|+|++++++| .+|+.++++++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~-~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDL-GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHT-TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhc-CCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 369999999999999999 4775 7899988889998 9999998642 2689999999999999 899999999999
Q ss_pred CEEEecC-CCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecc
Q 042075 111 KVLDLHN-NSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189 (1033)
Q Consensus 111 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 189 (1033)
++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..|..+++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCC-CCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCcc
Q 042075 190 NNLTGSIPPSFGNLS-SISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268 (1033)
Q Consensus 190 N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 268 (1033)
|++++.+|..+.+++ +|++|+|++|++++.+|..|..++ |++|+|++|++++.+|..+..+++|+.|++++|.+++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 999999999999998 999999999999999999999998 999999999999999999999999999999999999877
Q ss_pred CccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCc
Q 042075 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335 (1033)
Q Consensus 269 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~ 335 (1033)
|. +..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|....+++|+.+++++|.
T Consensus 238 ~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 238 GK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred Cc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 76 456899999999999999999999999999999999999999999988899999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=407.33 Aligned_cols=200 Identities=24% Similarity=0.320 Sum_probs=169.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
...++|++.++||+|+||+||+|+++ .+++.||||++.... ...++.+|+++++++ +||||++++++ +.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC-----FR 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE-----EE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE-----EE
Confidence 34678999999999999999999874 467899999986543 335678999999998 79999999998 45
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE- 862 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~- 862 (1033)
.++..|+||||+++|+|.++++ .+++.++..++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCC
Confidence 5668999999999999999983 378999999999999999999999 99999999999999876
Q ss_pred CcEEEeecccceecCCCCcc--------------------------ccccccccccccccccccCCC-CCCcccchHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQ--------------------------TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYG 915 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG 915 (1033)
+.+||+|||+|+........ ......+||+.|||||++.+. .|+.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 79999999999865433211 011224599999999998875 489999999999
Q ss_pred HHHHHHHhCCCCCCc
Q 042075 916 ILLLELVTRKKPTDI 930 (1033)
Q Consensus 916 ~vl~elltg~~p~~~ 930 (1033)
|++|||++|+.||..
T Consensus 235 ~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 235 VIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHTCSSSSC
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999853
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=416.45 Aligned_cols=392 Identities=24% Similarity=0.311 Sum_probs=193.0
Q ss_pred ccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCC-------------cEEEccccc
Q 042075 101 SAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNL-------------IRVRLSSNE 167 (1033)
Q Consensus 101 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~Ls~N~ 167 (1033)
.|.-...++|++|++++|++ |.+|++|+++++|++|++++|.++|.+|..++++++| ++|++++|.
T Consensus 4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~ 82 (454)
T 1jl5_A 4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence 34444567888888888888 6888888888888888888888888888888887765 777777777
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCccc
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 247 (1033)
+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .
T Consensus 83 l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 83 LSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp CSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred ccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c
Confidence 764 4442 2567777777777775 5543 3567777777777774 3321 1567777777777775 56 4
Q ss_pred ccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhcccc
Q 042075 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLS 327 (1033)
Q Consensus 248 l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~ 327 (1033)
+.++++|++|++++|++++ +|.. ..+|++|++++|++++ +| .+.++++|++|++++|++++.+...
T Consensus 149 ~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~------- 214 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP------- 214 (454)
T ss_dssp CTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC-------
T ss_pred cCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc-------
Confidence 7777777777777777764 4432 2467777777777765 44 4666777777777776666432111
Q ss_pred ceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCE
Q 042075 328 HFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLR 407 (1033)
Q Consensus 328 ~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~ 407 (1033)
++|+.|++++|+++ .+| .++++++|++
T Consensus 215 ---------------------------------------------------~~L~~L~l~~n~l~-~lp-~~~~l~~L~~ 241 (454)
T 1jl5_A 215 ---------------------------------------------------LSLESIVAGNNILE-ELP-ELQNLPFLTT 241 (454)
T ss_dssp ---------------------------------------------------TTCCEEECCSSCCS-SCC-CCTTCTTCCE
T ss_pred ---------------------------------------------------CcccEEECcCCcCC-ccc-ccCCCCCCCE
Confidence 24455555555554 333 2555555555
Q ss_pred EEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCCccC
Q 042075 408 LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT 487 (1033)
Q Consensus 408 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 487 (1033)
|++++|++++ +|.. +++|+.|++++|++++ +|..+ -.|++|++++|.+++. |.. .++|++|++++|+++
T Consensus 242 L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~ 310 (454)
T 1jl5_A 242 IYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIR 310 (454)
T ss_dssp EECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCS
T ss_pred EECCCCcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCC
Confidence 5555555553 2321 2455555555555553 33322 1245555555555531 110 135555555555555
Q ss_pred CCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccC--cccc
Q 042075 488 GTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQG--PIPS 565 (1033)
Q Consensus 488 ~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~ 565 (1033)
+ ++ .....|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|++|++++|++++ .+|.
T Consensus 311 ~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~ 377 (454)
T 1jl5_A 311 S-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377 (454)
T ss_dssp E-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred c-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence 2 22 111122555555555553 4432 355666666666665 3444 34556666666666665 4555
Q ss_pred cccCcccCCccccccccccccCCcccccccccceeecCCCcCcc
Q 042075 566 SLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEG 609 (1033)
Q Consensus 566 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 609 (1033)
+++.+ +.|++.|.+|.. +++|++|++++|+++|
T Consensus 378 ~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 378 SVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLRE 410 (454)
T ss_dssp TCCEE--------ECCC---------------------------
T ss_pred HHHhh--------hhcccccccccc---cCcCCEEECCCCcCCc
Confidence 44432 234444444442 2445555555555554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=413.15 Aligned_cols=393 Identities=18% Similarity=0.205 Sum_probs=248.1
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCC-CCCcccccccceeeeccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKI-PSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N 190 (1033)
.++.++++++ .+|. +. ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4566666665 4554 22 56666666666666655666666666666666666665444 345666666666666666
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCcc--ccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCcc
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDT--FGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 268 (1033)
++++..|..|+++++|++|+|++|++++..|.. |+.+++|++|+|++|++++..
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~------------------------ 145 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ------------------------ 145 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCC------------------------
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccC------------------------
Confidence 666555666666666666666666665533332 555555555555555555443
Q ss_pred CccccccccccceeeecccccCCCCCccCcCC--CCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchh
Q 042075 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNA--SNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNF 346 (1033)
Q Consensus 269 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 346 (1033)
|..++..+++|++|++++|++++..|..+..+ .+|+.|++++|.+++..+....
T Consensus 146 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~------------------------ 201 (455)
T 3v47_A 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG------------------------ 201 (455)
T ss_dssp CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT------------------------
T ss_pred cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc------------------------
Confidence 43333345555555555555555555555544 4555566655555533221000
Q ss_pred hcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcC
Q 042075 347 LCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGEL 426 (1033)
Q Consensus 347 l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 426 (1033)
......+..+++|++|++++|++++..|..+..+
T Consensus 202 ----------------------------------------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~ 235 (455)
T 3v47_A 202 ----------------------------------------------WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235 (455)
T ss_dssp ----------------------------------------------HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH
T ss_pred ----------------------------------------------ccccccccccceeeeEecCCCcccccchhhhhcc
Confidence 0000112233445555555555554444444433
Q ss_pred ---CCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCC--CCcccEEecCCCccCCCCCccccCchhHH
Q 042075 427 ---QNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQ--SETLTIIDLSNNNLTGTIPPQLLGLSSLL 501 (1033)
Q Consensus 427 ---~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll 501 (1033)
++|+.|++++|.+.+.. +..+.+.+..+..+.. .++|++|++++|++++.+|..+..+.++
T Consensus 236 ~~~~~L~~L~l~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L- 301 (455)
T 3v47_A 236 IAGTKIQSLILSNSYNMGSS-------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL- 301 (455)
T ss_dssp TTTCCEEEEECTTCTTTSCC-------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTC-
T ss_pred ccccceeeEeeccccccccc-------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCC-
Confidence 55556666555544221 1111222222222222 2456666666666665556556555555
Q ss_pred hhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccc
Q 042075 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581 (1033)
Q Consensus 502 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 581 (1033)
+.|++++|++++..|..|+.+++|+.|+|++|++++..|..|+++++|++|+|++|++++..|.+|..+++|++|+|++|
T Consensus 302 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 381 (455)
T 3v47_A 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381 (455)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence 66677777777667778889999999999999999888899999999999999999999888999999999999999999
Q ss_pred cccccCCcccccccccceeecCCCcCcccCCCccc
Q 042075 582 NLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGV 616 (1033)
Q Consensus 582 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 616 (1033)
+|++..+..+..+++|++|++++|+++|.+|....
T Consensus 382 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 416 (455)
T 3v47_A 382 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 416 (455)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred ccccCCHhHhccCCcccEEEccCCCcccCCCcchH
Confidence 99987777889999999999999999999996433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=414.38 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=198.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHH---HHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSF---IAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.++||+|+||+||+|+++.+|+.||||++++.. ....... ..++.+++.++|||||+++++ ++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence 457999999999999999999999999999999997421 1112223 344667777899999999999 55
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
+++..|+||||++||+|.+++. ....+++..+..++.||+.||+|||++ |||||||||+|||++++|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~----------~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred ECCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 6678999999999999999994 345699999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
++||+|||+|+........ ..+||+.|||||++.+ ..|+.++||||+||++|||++|++||......+ .....
T Consensus 330 ~vKL~DFGlA~~~~~~~~~----t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID 403 (689)
T ss_dssp CEEECCCTTCEECSSCCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH
T ss_pred CEEecccceeeecCCCCCC----CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence 9999999999977544322 2459999999999965 579999999999999999999999996422111 11111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
....... . ..+...++++.+++.+||+.||++|++ ++||+++
T Consensus 404 ~~i~~~~--------~--------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 404 RMTLTMA--------V--------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHCC--------C--------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HhhcCCC--------C--------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1110000 0 001112456899999999999999998 6777653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=415.39 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=207.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++.......+.+.+|+++|++++|||||+++++ +..++..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 4689999999999999999999999999999999987666666788999999999999999999999 45667899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC--CcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE--MIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL 867 (1033)
+|||||+||+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~~---------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHTC---------TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999853 345689999999999999999999999 99999999999999854 79999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+.+....... ..+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..+.........
T Consensus 299 ~DFG~a~~~~~~~~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~~ 374 (573)
T 3uto_A 299 IDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWN 374 (573)
T ss_dssp CCCSSCEECCTTSEEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCC
T ss_pred eeccceeEccCCCcee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCCC
Confidence 9999999876543322 245999999999999999999999999999999999999998632111 001111100000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .. .....+++++.+++.+||+.||++|||+.|++++
T Consensus 375 --~----------~~----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 --M----------DD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --C----------CS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --C----------Cc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 0001123557899999999999999999999873
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=407.02 Aligned_cols=387 Identities=20% Similarity=0.271 Sum_probs=270.9
Q ss_pred CCcceee--eEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCC
Q 042075 69 HFCQWHG--VTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146 (1033)
Q Consensus 69 ~~c~w~g--v~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 146 (1033)
..|.|.+ |.|+.. +++ .+|. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+
T Consensus 6 ~~c~~~~~~~~c~~~-------------~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~ 68 (455)
T 3v47_A 6 SECSVIGYNAICINR-------------GLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68 (455)
T ss_dssp -CCEEETTEEECCSS-------------CCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC
T ss_pred ceeEEEccccCcCCC-------------Ccc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccc
Confidence 4577766 788654 232 3444 2 2789999999999998889999999999999999999986
Q ss_pred CC-CccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCC--CCCCCCCCcEEEcccCcCCCcCCcc
Q 042075 147 EI-PANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP--SFGNLSSISFLFLSRNNLDGSIPDT 223 (1033)
Q Consensus 147 ~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~ 223 (1033)
.+ |..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.+|. .|.++++|++|+|++|++++..|..
T Consensus 69 ~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 148 (455)
T 3v47_A 69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG
T ss_pred eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc
Confidence 66 56789999999999999999988899999999999999999999975544 4899999999999999999887876
Q ss_pred -ccccCCCCcccccccccCCCCcccccCC--CceeEEeccCccccCccCcccc-------ccccccceeeecccccCCCC
Q 042075 224 -FGWLKNLVNLTMAQNRLSGTIPSSIFNI--SSITVFDAGINQIQGVIPLDIG-------FTLQNLQFFSVGRNQLTGAI 293 (1033)
Q Consensus 224 -~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~ls~N~l~~~~p~~~~-------~~l~~L~~L~L~~N~l~~~~ 293 (1033)
|..+++|++|++++|++++..|..+..+ .+|+.|++++|.+.+..+..+. ..+++|++|++++|++++..
T Consensus 149 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~ 228 (455)
T 3v47_A 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228 (455)
T ss_dssp GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHH
T ss_pred ccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccc
Confidence 8899999999999999998888888776 6888899998888854443221 23456777777777776666
Q ss_pred CccCcCC---CCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCC
Q 042075 294 PPAISNA---SNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLL 370 (1033)
Q Consensus 294 p~~~~~l---~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~i 370 (1033)
|..+..+ ++|+.|++++|.+.+...... .+ .+..
T Consensus 229 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~-------------~~------------------------------~~~~ 265 (455)
T 3v47_A 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHT-------------NF------------------------------KDPD 265 (455)
T ss_dssp HHHHHHHTTTCCEEEEECTTCTTTSCCTTCC-------------SS------------------------------CCCC
T ss_pred hhhhhccccccceeeEeeccccccccccchh-------------hh------------------------------ccCc
Confidence 6555443 566666666665543211100 00 0000
Q ss_pred ccccccc-cCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCccccc
Q 042075 371 PACISNF-STTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGN 449 (1033)
Q Consensus 371 p~~~~~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 449 (1033)
+..+... .++|+.|++++|++++..|..|.++++|++|++++|++++..|..|..+++|++|+|++|++++..|..+..
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 0011100 135666777777776666666777777777777777776666666666677777777766666555555555
Q ss_pred ce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceE
Q 042075 450 LK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528 (1033)
Q Consensus 450 l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L 528 (1033)
++ |++|+|++|++++..|..|..+++|++|+|++|+++ +..+..+..+++|+.|
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L 400 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-------------------------SVPDGIFDRLTSLQKI 400 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-------------------------CCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCccc-------------------------cCCHhHhccCCcccEE
Confidence 54 555555555555555555555555555555555554 3333445666777778
Q ss_pred EccccccccccC
Q 042075 529 NVFENKLRGEIP 540 (1033)
Q Consensus 529 ~Ls~N~l~~~~p 540 (1033)
++++|++++..|
T Consensus 401 ~l~~N~l~~~~~ 412 (455)
T 3v47_A 401 WLHTNPWDCSCP 412 (455)
T ss_dssp ECCSSCBCCCTT
T ss_pred EccCCCcccCCC
Confidence 888887776665
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=382.34 Aligned_cols=286 Identities=31% Similarity=0.481 Sum_probs=226.7
Q ss_pred CCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccc
Q 042075 701 ISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780 (1033)
Q Consensus 701 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 780 (1033)
+++.++...+++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||++++++|
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 104 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--- 104 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 445566678899999999999999999999976 6889999998876666678899999999999999999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++..++||||+++|+|.+++.... .....+++.++..++.|++.||+|||++ +|+||||||+||+++
T Consensus 105 --~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 105 --DERNEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLD 173 (321)
T ss_dssp --CCTTCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEEC
T ss_pred --cCCCeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEEC
Confidence 44568899999999999999996421 1234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC-ccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-MNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~-~~~~ 939 (1033)
+++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 999999999999987543333222333458999999999988899999999999999999999999997543222 1222
Q ss_pred HHHhh-hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 940 NFAKT-ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 940 ~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
.+... .........+++... .....+++.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 254 EWAVESHNNGQLEQIVDPNLA------------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHTHHHHTTTCCCSSSSSSCT------------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhccccccHHHhcChhhc------------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 22111 111112222222211 11234567889999999999999999999999999998865
Q ss_pred H
Q 042075 1019 I 1019 (1033)
Q Consensus 1019 ~ 1019 (1033)
.
T Consensus 316 ~ 316 (321)
T 2qkw_B 316 L 316 (321)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=398.60 Aligned_cols=407 Identities=23% Similarity=0.274 Sum_probs=241.3
Q ss_pred CeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccc-------------cEEecccCCCCCCCCc
Q 042075 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRL-------------QVLALHNNSIGGEIPA 150 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p~ 150 (1033)
.+++.++++++++ |.+|+++++|++|++|++++|+++|.+|.+++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4688899999999 8999999999999999999999999999999998875 999999999995 565
Q ss_pred cccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC
Q 042075 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL 230 (1033)
Q Consensus 151 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 230 (1033)
. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+.+++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 3 3789999999999996 7764 3799999999999995 4432 2689999999999996 77 59999999
Q ss_pred CcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccccc
Q 042075 231 VNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNS 310 (1033)
Q Consensus 231 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 310 (1033)
++|++++|++++ +|..+ .+|++|++++|++++ +| . +..+++|++|++++|++++ +|... ++|++|++++
T Consensus 156 ~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~-~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~ 224 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-E-LQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGN 224 (454)
T ss_dssp CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-C-CTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCS
T ss_pred CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-c-ccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcC
Confidence 999999999995 66544 589999999999996 66 3 5689999999999999996 55443 5899999999
Q ss_pred ccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCC
Q 042075 311 NKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK 390 (1033)
Q Consensus 311 N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~ 390 (1033)
|+++. +|.+..+++|++|++++|.+... |. ..++|+.|++++|+
T Consensus 225 n~l~~-lp~~~~l~~L~~L~l~~N~l~~l-------------------------------~~----~~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 225 NILEE-LPELQNLPFLTTIYADNNLLKTL-------------------------------PD----LPPSLEALNVRDNY 268 (454)
T ss_dssp SCCSS-CCCCTTCTTCCEEECCSSCCSSC-------------------------------CS----CCTTCCEEECCSSC
T ss_pred CcCCc-ccccCCCCCCCEEECCCCcCCcc-------------------------------cc----cccccCEEECCCCc
Confidence 99984 44566666666665555554321 11 11345555555555
Q ss_pred CCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCcc
Q 042075 391 IFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSL 470 (1033)
Q Consensus 391 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~ 470 (1033)
+++ +|.. +++|++|++++|++++. |.. .++|+.|++++|+++ + ++..
T Consensus 269 l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~-----------------------~-i~~~- 315 (454)
T 1jl5_A 269 LTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIR-----------------------S-LCDL- 315 (454)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCS-----------------------E-ECCC-
T ss_pred ccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCC-----------------------c-ccCC-
Confidence 554 2222 24455555555555531 110 134555555555444 2 1110
Q ss_pred CCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccccc--ccCcccccccc
Q 042075 471 GQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG--EIPRTLGSCIK 548 (1033)
Q Consensus 471 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~ 548 (1033)
.++|++|++++|++++ +|..+ .++ +.|++++|+++ .+|. .+++|+.|++++|++++ .+|.+++.
T Consensus 316 --~~~L~~L~Ls~N~l~~-lp~~~---~~L-~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--- 381 (454)
T 1jl5_A 316 --PPSLEELNVSNNKLIE-LPALP---PRL-ERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--- 381 (454)
T ss_dssp --CTTCCEEECCSSCCSC-CCCCC---TTC-CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---
T ss_pred --cCcCCEEECCCCcccc-ccccC---CcC-CEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh---
Confidence 1366677777777763 55432 233 66777777777 3555 36788899999999987 67776654
Q ss_pred cceeecccccccCcccccccCcccCCccccccccccc--cCCcccccccccceeecCCCcCcccCCC
Q 042075 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSG--KIPEFLVGFQLLEYLNLSNNDFEGMVPT 613 (1033)
Q Consensus 549 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 613 (1033)
|+.|++.|.+|.. +++|+.||+++|++++ .+|.+ ++.|.+++|.+.+.+|.
T Consensus 382 -----L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 382 -----LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -----EECCC---------------------------------------------------------
T ss_pred -----hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 3457777788874 5789999999999987 66754 45667889999888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=381.19 Aligned_cols=290 Identities=34% Similarity=0.565 Sum_probs=230.1
Q ss_pred CCCCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEe
Q 042075 696 NSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKIL 774 (1033)
Q Consensus 696 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 774 (1033)
.....+++.++....++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 34567899999999999999999999999999999865 688999999875432 2234789999999999999999999
Q ss_pred eeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
++|. ..+..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+++.++|+||||||
T Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 94 GFCM-----TPTERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp EEEC-----CSSCCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred EEEe-----cCCceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 9953 4557899999999999999996421 2345689999999999999999999998778999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc--
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF-- 932 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~-- 932 (1033)
+||++++++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhEEECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 99999999999999999998765433322 223448999999999988899999999999999999999999996321
Q ss_pred -cCCccHHHHHhhhCCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 933 -EGDMNLHNFAKTALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 933 -~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
..+.....+........ .....+..... ....+.++.+.+++.+||+.||++|||++||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 303 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQG------------------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTT------------------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhcc------------------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence 22233333333333222 22222222211 12345677899999999999999999999999
Q ss_pred HHHHHH
Q 042075 1011 HQLQSI 1016 (1033)
Q Consensus 1011 ~~L~~i 1016 (1033)
++|++.
T Consensus 304 ~~L~~~ 309 (326)
T 3uim_A 304 RMLEGD 309 (326)
T ss_dssp HHHHTS
T ss_pred HHhcCc
Confidence 999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.70 Aligned_cols=266 Identities=23% Similarity=0.386 Sum_probs=215.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++. .++..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 457899999999999999999999999999999987666667788999999999999999999999954 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence 99999999999999953 345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcccc------------ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 870 FGLATFLPLSHAQTS------------SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
||+++.......... .....||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 999987644332211 11345999999999999999999999999999999999999998643221111
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
... ......+. ..+..+++++.+++.+||+.||++|||+.|+++.|++++
T Consensus 232 ~~~--------~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 232 FGL--------NVRGFLDR----------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SSB--------CHHHHHHH----------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hhh--------hhhccccc----------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00000000 001123455899999999999999999999999999998
Q ss_pred HHhhh
Q 042075 1018 NILLG 1022 (1033)
Q Consensus 1018 ~~~~~ 1022 (1033)
+...+
T Consensus 282 ~~~~~ 286 (310)
T 3s95_A 282 MHLAG 286 (310)
T ss_dssp HHHHH
T ss_pred HhccC
Confidence 87653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=371.96 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=206.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++. .++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence 468999999999999999999999899999999998666556678899999999999999999999953 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 99999999999999842 3588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||++.......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........+.
T Consensus 160 fg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~- 235 (297)
T 3fxz_A 160 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE- 235 (297)
T ss_dssp CTTCEECCSTTCCB--CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC-
T ss_pred CCCceecCCccccc--CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-
Confidence 99998765443322 22459999999999999999999999999999999999999985321110 000000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+...++.+.+++.+||+.||++|||++|+++.
T Consensus 236 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 ----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----------------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00011234568999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=376.74 Aligned_cols=285 Identities=23% Similarity=0.307 Sum_probs=212.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.++||+|+||+||+|++. ++.||||+++.... ......+|+.++++++||||+++++++.... ......
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceE
Confidence 4568999999999999999999986 78999999975432 3345667999999999999999999975432 113357
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC-------CCCCcEeccCCCCCeEecC
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD-------CQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivHrDlkp~NIll~~ 861 (1033)
++||||+++|+|.++++. ..+++.++..++.|++.||+|||+. +.++|+||||||+||++++
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred EEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 999999999999999942 3489999999999999999999975 2448999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 99999999999987765544333333569999999999876 3567789999999999999999999975432211
Q ss_pred -cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 937 -NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 937 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
.+...... . ....++.+..... ..+...........+++++.+++.+||+.||++|||++||++.|++
T Consensus 247 ~~~~~~~~~-~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 247 LPFEEEIGQ-H-PSLEDMQEVVVHK---------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CTTHHHHCS-S-CCHHHHHHHHTTS---------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhhhcc-C-Cchhhhhhhhhcc---------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11110000 0 0000000000000 0000000011122456779999999999999999999999999999
Q ss_pred HHHH
Q 042075 1016 IKNI 1019 (1033)
Q Consensus 1016 i~~~ 1019 (1033)
+++.
T Consensus 316 l~~~ 319 (322)
T 3soc_A 316 MQRL 319 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=364.19 Aligned_cols=284 Identities=30% Similarity=0.453 Sum_probs=224.6
Q ss_pred CCCCCCHHHHHHhhCCCCcc------ceecccCceeEEEEEeCCCCeEEEEEEeecc----CchhHHHHHHHHHHHHhcC
Q 042075 697 SFPNISYQNLYNATDGFTSA------NLIGAGSFGSVYKGILDEGKTIVAVKVFNLL----HHGAFKSFIAECNTLKNIR 766 (1033)
Q Consensus 697 ~~~~~~~~~l~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 766 (1033)
....+++.++..++++|... +.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999998877 8999999999999997 4788999998642 2334578899999999999
Q ss_pred CCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042075 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846 (1033)
Q Consensus 767 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (1033)
||||+++++++ ...+..++||||+++++|.+++... .....+++..+..++.|++.||+|||++ +
T Consensus 89 h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ 153 (307)
T 2nru_A 89 HENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQGAANGINFLHEN---H 153 (307)
T ss_dssp CTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 99999999995 4455789999999999999999531 2335689999999999999999999999 9
Q ss_pred cEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCC
Q 042075 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 926 (1033)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~ 926 (1033)
|+||||||+||++++++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654433322333458999999998765 58999999999999999999999
Q ss_pred CCCccccCCccHHHHHhhh--CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC
Q 042075 927 PTDIMFEGDMNLHNFAKTA--LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004 (1033)
Q Consensus 927 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1004 (1033)
||....... ....+.... ....+.+.+++.+.. .+...++++.+++.+||+.||++||
T Consensus 233 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 233 AVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMND-------------------ADSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp SBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSC-------------------CCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred CcccCcchH-HHHHHHHHhhhhhhhhhhhccccccc-------------------cchHHHHHHHHHHHHHcCCCcccCc
Confidence 997543222 111111111 111122333322211 1234567899999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 042075 1005 DMTNVVHQLQSIKN 1018 (1033)
Q Consensus 1005 t~~evl~~L~~i~~ 1018 (1033)
|++||++.|+++++
T Consensus 293 s~~~l~~~L~~l~~ 306 (307)
T 2nru_A 293 DIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=378.74 Aligned_cols=272 Identities=22% Similarity=0.352 Sum_probs=213.6
Q ss_pred hCCCCccceecccCceeEEEEEeC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-------EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 467899999999999999999874 346789999997543 33457799999999999 899999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..++..|+||||+++|+|.++++....... .......+++.++..++.||+.||+|||++ +|+||||||
T Consensus 157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 345578999999999999999965321100 011234689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999997655443333333447889999999999999999999999999999999 9999863211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
........... +...+..++.++.+++.+||+.||++|||+.|+++.|
T Consensus 312 --~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 --EELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp --GGHHHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111111000 0001112345689999999999999999999999999
Q ss_pred HHHHHHhh
Q 042075 1014 QSIKNILL 1021 (1033)
Q Consensus 1014 ~~i~~~~~ 1021 (1033)
+++.....
T Consensus 360 ~~il~~~~ 367 (370)
T 2psq_A 360 DRILTLTT 367 (370)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99977554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=386.30 Aligned_cols=361 Identities=20% Similarity=0.234 Sum_probs=244.2
Q ss_pred ccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccc
Q 042075 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGS 178 (1033)
Q Consensus 99 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 178 (1033)
..+..++++++|++|+|++|++++ +| .|+.+++|++|+|++|.+++ +| ++++++|++|+|++|++++. | +++
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCC
Confidence 334456666777777777777765 34 56777777777777777764 33 66677777777777777643 3 666
Q ss_pred ccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEe
Q 042075 179 LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFD 258 (1033)
Q Consensus 179 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 258 (1033)
+++|++|++++|++++ +| ++++++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..
T Consensus 105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~-------- 168 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTP-------- 168 (457)
T ss_dssp CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTT--------
T ss_pred CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--cccc--------
Confidence 7777777777777765 33 66666777777777776653 2 556666666666666444333 2334
Q ss_pred ccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCC
Q 042075 259 AGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGS 338 (1033)
Q Consensus 259 ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~ 338 (1033)
+++|++|++++|++++ +| +..+++|+.|++++|++++.. +..
T Consensus 169 -----------------l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~--l~~---------------- 210 (457)
T 3bz5_A 169 -----------------QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLD--LNQ---------------- 210 (457)
T ss_dssp -----------------CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCC--CTT----------------
T ss_pred -----------------CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeec--ccc----------------
Confidence 4455555555555554 23 555666666666666665320 111
Q ss_pred CCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCccccc
Q 042075 339 GEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGT 418 (1033)
Q Consensus 339 ~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~ 418 (1033)
.++|+.|++++|++++ +| ++.+++|++|++++|++++.
T Consensus 211 ---------------------------------------l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 211 ---------------------------------------NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp ---------------------------------------CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred ---------------------------------------CCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 1356666666666665 34 66777788888888888764
Q ss_pred CChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCch
Q 042075 419 IPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLS 498 (1033)
Q Consensus 419 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 498 (1033)
. +..+++|+.|++++|++ +.|++++|.+.+.+| ++.+++|+.|++++|++.+.+|... .
T Consensus 249 ~---~~~l~~L~~L~l~~n~L-------------~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~---~ 307 (457)
T 3bz5_A 249 D---VSTLSKLTTLHCIQTDL-------------LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA---A 307 (457)
T ss_dssp C---CTTCTTCCEEECTTCCC-------------SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT---C
T ss_pred C---HHHCCCCCEEeccCCCC-------------CEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC---C
Confidence 3 45567788888777654 467788888777776 4678889999999998887777432 2
Q ss_pred hHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCcccc
Q 042075 499 SLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDL 578 (1033)
Q Consensus 499 ~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 578 (1033)
.+ +.|++++ +++|+.|++++|+|++. + ++++++|+.|++++|+|++ ++.|..|++
T Consensus 308 ~L-~~L~l~~-------------~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l 362 (457)
T 3bz5_A 308 GI-TELDLSQ-------------NPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPA 362 (457)
T ss_dssp CC-SCCCCTT-------------CTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSG
T ss_pred cc-eEechhh-------------cccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccc
Confidence 22 4444444 36899999999999974 3 8999999999999999985 356778899
Q ss_pred ccccccccCCcccccccccceeecCCCcCcccCCCc
Q 042075 579 SQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 579 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
++|+++|. ..+..|..+++++|+|+|.||..
T Consensus 363 ~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 363 LNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp GGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 99999986 35677888999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.59 Aligned_cols=279 Identities=22% Similarity=0.361 Sum_probs=210.7
Q ss_pred hCCCCccceecccCceeEEEEE----eCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGI----LDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||+||+|+ ...+++.||||+++.......+.+.+|++++++++||||++++++|... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 4678999999999999999999 4567899999999876666678899999999999999999999986432 23
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeE
Confidence 457999999999999999953 334589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++|..||...... .......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~ 230 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 230 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcC
Confidence 99999999876543321 1122233778899999999899999999999999999999999998532110 0000000
Q ss_pred hCCcc-h-hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 945 ALPDH-V-VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 945 ~~~~~-~-~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
..... . .... .......+...+..+++++.+++.+||+.||++|||++|+++.|+++++...
T Consensus 231 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 231 DKQGQMIVFHLI---------------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp TCCTHHHHHHHH---------------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccccchhHHHHH---------------HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00000 0 0000 0000011111223456779999999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=386.71 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=211.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+++.+|++++++++||||++++++|. .++.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence 3457889999999999999999999889999999987543 233457889999999999999999999963 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---------EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEE
Confidence 8999999999999999953 334689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~ 332 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGG 332 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTC
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence 99999987544322222222235778999999988899999999999999999998 99998632111 1111111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+...+..+++++.+++.+||+.||++|||++++++.|+++++.
T Consensus 333 ------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 ------------------------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0011112346689999999999999999999999999999765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=370.40 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=200.4
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
...++|++.+.||+|+||+||+|++. ++.||||++.... ....+++.+|++++++++||||+++++++ ...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 34568899999999999999999884 7889999987543 33456789999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEecCCC
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~ 863 (1033)
+..++||||+++|+|.+++... .....+++.++..++.|++.||+|||++ + |+||||||+||++++++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKS-------GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHST-------THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTC
T ss_pred CceEEEEecCCCCcHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCC
Confidence 5789999999999999999531 1223589999999999999999999999 8 99999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......
T Consensus 177 ~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~ 252 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVG 252 (309)
T ss_dssp CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHH
T ss_pred cEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 9999999999864333211 222458999999999999999999999999999999999999986321110 000000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
.... +...+..+++++.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 253 ~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 FKCK-----------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HSCC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hcCC-----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0000 000011234568999999999999999999999999999876553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=369.69 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=212.2
Q ss_pred CCCCHHHHHHhhCC----------CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCC
Q 042075 699 PNISYQNLYNATDG----------FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHR 768 (1033)
Q Consensus 699 ~~~~~~~l~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 768 (1033)
+.++++++..+++. |+..+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888887764 67778999999999999999989999999999876666667899999999999999
Q ss_pred CceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042075 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848 (1033)
Q Consensus 769 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 848 (1033)
||+++++++. ..+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+
T Consensus 103 niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iv 163 (321)
T 2c30_A 103 NVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQ---GVI 163 (321)
T ss_dssp TBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 9999999954 34578999999999999999842 3589999999999999999999999 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
||||||+||+++.++.+||+|||++.......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765433222 2345999999999999999999999999999999999999998
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
...... ............ .. ......++++.+++.+||+.||++|||++|
T Consensus 242 ~~~~~~--~~~~~~~~~~~~--------~~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 242 FSDSPV--QAMKRLRDSPPP--------KL--------------------KNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp TTSCHH--HHHHHHHHSSCC--------CC--------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCHH--HHHHHHhcCCCC--------Cc--------------------CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 532110 000001100000 00 000112356889999999999999999999
Q ss_pred HHHH
Q 042075 1009 VVHQ 1012 (1033)
Q Consensus 1009 vl~~ 1012 (1033)
+++.
T Consensus 292 ll~h 295 (321)
T 2c30_A 292 LLDH 295 (321)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=371.53 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=203.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++ ..++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 4689999999999999999999999999999999874332 2346688999999999999999999995 445688
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence 99999999999999994 345689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++...............||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........+..+......
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 9999987643333332333559999999999988775 788999999999999999999997433222222222111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. .......++.+++.+||+.||++|||++|+++.
T Consensus 228 ~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LN------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ST------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 001123557899999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.26 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=204.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
...++|++.+.||+|+||.||+|++..+++.||||+++.. .....+++.+|++++++++||||+++++++ ...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 3456899999999999999999999889999999999753 334456788999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLV----------AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CEEEEEEECCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCE
Confidence 68999999999999999994 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||++......... ....||+.|+|||++.+..++ .++||||+||++|||++|+.||+... .......
T Consensus 154 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~ 225 (328)
T 3fe3_A 154 KIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRER 225 (328)
T ss_dssp EECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred EEeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence 99999999876543322 234599999999999888775 78999999999999999999986321 1111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... . ..+...++++.+++.+||+.||++|||++|+++.
T Consensus 226 i~~~~--------~--------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 VLRGK--------Y--------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHCC--------C--------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHhCC--------C--------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 0001123558899999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=364.77 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=205.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHh--cCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|++ +++.||||+++.. ....+.+|.+++.. ++||||+++++++.... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence 46899999999999999999998 4889999998643 23556667777766 79999999999865432 33456
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEeccCCCCCeEe
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH--------HDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivHrDlkp~NIll 859 (1033)
.++||||+++|+|.++++. ..+++.++..++.|++.||+||| +. +|+||||||+||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEE
T ss_pred eEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEE
Confidence 8999999999999999942 35899999999999999999999 77 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccc--cccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhC-------
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTR------- 924 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~vl~elltg------- 924 (1033)
+.++.+||+|||+|+......... ......||+.|+|||++.+. .+++++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999998764433221 11223599999999998876 556799999999999999999
Q ss_pred ---CCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCC
Q 042075 925 ---KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001 (1033)
Q Consensus 925 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 1001 (1033)
+.||......+................... ........+++++.+++.+||+.||+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI---------------------PNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC---------------------CGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCC---------------------ChhhccCccHHHHHHHHHHHhhcChh
Confidence 777754433333333322221111100000 00001224567899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 042075 1002 DRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 1002 ~RPt~~evl~~L~~i 1016 (1033)
+|||++||++.|+++
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=377.45 Aligned_cols=281 Identities=22% Similarity=0.288 Sum_probs=217.7
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEE-----eCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEe
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGI-----LDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKIL 774 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~ 774 (1033)
...+.....++|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 445555667899999999999999999999 45567999999997543 33456799999999999 899999999
Q ss_pred eeeccccccCCCceeEEEEcccCCchhhhcccCCCCcc------------------------------------------
Q 042075 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------------------ 812 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------ 812 (1033)
++|. ..+...++||||+++|+|.++++.......
T Consensus 93 ~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 93 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp EEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 9963 334458999999999999999975432100
Q ss_pred --------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCC
Q 042075 813 --------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPL 878 (1033)
Q Consensus 813 --------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~ 878 (1033)
.......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 000122389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcchhhhcccc
Q 042075 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDST 957 (1033)
Q Consensus 879 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 957 (1033)
...........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .............
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~-------- 316 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMR-------- 316 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCC--------
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCC--------
Confidence 443333334558899999999998999999999999999999998 999986432211 1111111100000
Q ss_pred cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 958 LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 958 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.+..+++++.+++.+||+.||++|||++|++++|+++.+..
T Consensus 317 ----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 ----------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00112356899999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=370.22 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=208.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|++..+ +..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 35788899999999999999999754 446999999754 334457799999999999999999999995 344
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence 578999999999999999953 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 866 HVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~ 268 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVE 268 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHH
Confidence 99999999877543221 12222336788999999998899999999999999999999 99998532111 1111000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 1022 (1033)
... +...+..+++++.+++.+||+.||++|||+.||++.|+++.+....
T Consensus 269 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 269 EGY------------------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred cCC------------------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 000 0001112345689999999999999999999999999999876544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=364.03 Aligned_cols=264 Identities=20% Similarity=0.346 Sum_probs=206.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+++.+|+.++++++||||+++++++ ..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 46899999999999999999999989999999998642 233457789999999999999999999994 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 8999999999999999994 334689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++......... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .... ....
T Consensus 152 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~-~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIA-IKHI 225 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH----HHHH-HHHH
T ss_pred EEeCCCccccccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHH-HHHh
Confidence 99999998654332221 2224489999999999999999999999999999999999999863211 1111 1000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHHh
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-DMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~ 1020 (1033)
....... .......+++.+.+++.+||+.||++|| +++++.+.|+++....
T Consensus 226 ~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 226 QDSVPNV-----------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp SSCCCCH-----------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred hccCCCc-----------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0000000 0000112346689999999999999999 8999999998875543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.90 Aligned_cols=253 Identities=18% Similarity=0.210 Sum_probs=203.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch------hHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
..++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----- 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----- 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence 346799999999999999999999999999999999754321 246789999999999999999999994
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
...+..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT----------TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCC
Confidence 45568999999999999999994 335689999999999999999999999 99999999999999877
Q ss_pred C----cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 863 M----IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 863 ~----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+ .+||+|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|..||.....
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----- 223 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----- 223 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----
T ss_pred CCCccCEEEEecCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 6 7999999999876553322 224499999999999999999999999999999999999999853211
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
........ .... .... ......++.+.+++.+||..||++|||+.|+++
T Consensus 224 ~~~~~~i~--------~~~~-~~~~---------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 QETLANIT--------AVSY-DFDE---------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHH--------TTCC-CCCH---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHH--------hcCC-CCCc---------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111000 0000 0000 000122456889999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.15 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=207.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++. +++.||+|+++.... ..+++.+|++++++++||||+++++++ ..++..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 457899999999999999999997 577899999975443 346789999999999999999999995 4455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence 99999999999999953 345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ............
T Consensus 150 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~ 226 (269)
T 4hcu_A 150 FGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL 226 (269)
T ss_dssp TTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC
T ss_pred ccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccC
Confidence 9999866443221 2222347788999999988899999999999999999999 99998632111 111100000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
. .+...++++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 227 ~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 Y------------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C------------------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 0011235589999999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.42 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=204.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|+++... .....+.+|+.++++++||||+++++++ ...+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence 468999999999999999999999999999999987543 3446788999999999999999999995 4455899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC--CCcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE--EMIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL 867 (1033)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEE
Confidence 99999999999999953 334689999999999999999999999 9999999999999987 789999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++......... ...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 146 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 221 (321)
T 1tki_A 146 IEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT 221 (321)
T ss_dssp CCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC
T ss_pred EECCCCeECCCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCC
Confidence 9999998875443222 234899999999999988999999999999999999999998632111 001111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... ......++++.+++.+||+.||++|||+.|+++.
T Consensus 222 ------------~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 ------------FDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ------------CCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------------CCh----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0011234568999999999999999999999885
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.44 Aligned_cols=286 Identities=20% Similarity=0.222 Sum_probs=213.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 357999999999999999999999899999999997533 2345678899999999999999999998642 234477
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe----cCCCc
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMI 864 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~ 864 (1033)
++||||+++++|.+++... .....+++.++..++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHh-------ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCce
Confidence 9999999999999999641 1223489999999999999999999999 99999999999999 77888
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccC--------CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL--------GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
+||+|||+++......... ...||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 9999999998775543322 234899999999875 57889999999999999999999999964332222
Q ss_pred cHHHHH--hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 937 NLHNFA--KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 937 ~~~~~~--~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...... ....+......+........ . ..................+.+++.+||+.||++|||++|+++...
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAENGPI-D-----WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECSTTCCE-E-----EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhhhcccCCcc-c-----cCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111111 11111111110000000000 0 000000111223456778999999999999999999999999988
Q ss_pred HHH
Q 042075 1015 SIK 1017 (1033)
Q Consensus 1015 ~i~ 1017 (1033)
+..
T Consensus 306 d~~ 308 (319)
T 4euu_A 306 DIL 308 (319)
T ss_dssp HHT
T ss_pred HHh
Confidence 654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=376.65 Aligned_cols=268 Identities=23% Similarity=0.378 Sum_probs=208.0
Q ss_pred hCCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.. ......++.+|+.++++++||||+++++++ .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~ 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 35789999999999999999994 446788999998643 334456788999999999999999999995 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.....++||||+++|+|.++++..... ......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCC---SSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccc---cCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 455789999999999999999653221 12335689999999999999999999999 999999999999999554
Q ss_pred ---cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 864 ---IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~ 296 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL 296 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 599999999975532222222223447899999999988899999999999999999998 9999863211 1111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
........ ...+..++.++.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 297 ~~i~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFVTSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11110000 000112345689999999999999999999999999998764
Q ss_pred h
Q 042075 1020 L 1020 (1033)
Q Consensus 1020 ~ 1020 (1033)
.
T Consensus 347 ~ 347 (367)
T 3l9p_A 347 P 347 (367)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.61 Aligned_cols=250 Identities=22% Similarity=0.258 Sum_probs=203.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. .......+.+|+.++++++||||+++++++ ...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 46799999999999999999999999999999999753 233456788999999999999999999994 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence 8999999999999999984 335689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .........
T Consensus 146 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~ 218 (337)
T 1o6l_A 146 ITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELIL 218 (337)
T ss_dssp ECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH
T ss_pred EeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHHHH
Confidence 9999999864332221 223459999999999999999999999999999999999999985321 111111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
... . . .+...++++.+++.+||+.||++|| +++|+++.
T Consensus 219 ~~~--------~-~-------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 MEE--------I-R-------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HCC--------C-C-------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cCC--------C-C-------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 000 0 0 0011235689999999999999999 89998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=355.02 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=208.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++. ++..||+|+++.... ..+++.+|++++++++||||+++++++ ..++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPI 78 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCce
Confidence 3468999999999999999999887 577899999975443 346789999999999999999999995 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 146 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRS---------HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVS 146 (268)
T ss_dssp EEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEEC
T ss_pred EEEEEccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEc
Confidence 999999999999999953 345689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.+.......... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||+..... ........
T Consensus 147 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~ 220 (268)
T 3sxs_A 147 DFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQ 220 (268)
T ss_dssp CTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHT
T ss_pred cCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHc
Confidence 999998765443322 222346788999999988899999999999999999999 99998632111 11100000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.. ... .+...++++.+++.+||+.||++|||+.|+++.|+++++..
T Consensus 221 ~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 221 GH--------RLY-------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TC--------CCC-------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CC--------CCC-------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 00 000 00012345899999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=374.58 Aligned_cols=262 Identities=23% Similarity=0.404 Sum_probs=198.0
Q ss_pred hCCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+++.+|+.++++++||||++++++| ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeC
Confidence 358999999999999999999986 457789999997543 34456799999999999999999999995 345
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.++++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCE
Confidence 578999999999999999953 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 866 HVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~ 261 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIK 261 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHH
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 999999998765432211 1112235778999999998899999999999999999998 9999853211 11111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.. .... +...+..++.++.+++.+||+.||++||++.||++.|+++.+..
T Consensus 262 ~i---------~~~~------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 262 AV---------DEGY------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HH---------HTTE------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HH---------HcCC------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00 0000 00011123466899999999999999999999999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=361.03 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=196.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------------------------hhHHHHHHHHHHHH
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------------------------GAFKSFIAECNTLK 763 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 763 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999864321 12356889999999
Q ss_pred hcCCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Q 042075 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC 843 (1033)
Q Consensus 764 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 843 (1033)
+++||||+++++++.+ ...+..++||||+++++|.+++. ...+++.++..++.||+.||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999999999999643 23557899999999999988762 24689999999999999999999999
Q ss_pred CCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCC---CCcccchHHHHHHHHH
Q 042075 844 QPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLE 920 (1033)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~vl~e 920 (1033)
+|+||||||+||+++.++.+||+|||+++......... ....||+.|+|||++.+.. ++.++|||||||++||
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 99999999999999999999999999998765433221 2245899999999987765 4788999999999999
Q ss_pred HHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCC
Q 042075 921 LVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESP 1000 (1033)
Q Consensus 921 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1000 (1033)
|++|+.||.... ........... .. ..+ .....++++.+++.+||+.||
T Consensus 233 l~~g~~pf~~~~-----~~~~~~~~~~~--------~~-~~~-----------------~~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 233 FVFGQCPFMDER-----IMCLHSKIKSQ--------AL-EFP-----------------DQPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp HHHSSCSSCCSS-----HHHHHHHHHHC--------CC-CCC-----------------SSSCCCHHHHHHHHHHTCSCT
T ss_pred HHHCCCCCCCcc-----HHHHHHHHhcc--------cC-CCC-----------------CccccCHHHHHHHHHHhhcCh
Confidence 999999985321 11111100000 00 000 000123568999999999999
Q ss_pred CCCCCHHHHHHH
Q 042075 1001 EDRMDMTNVVHQ 1012 (1033)
Q Consensus 1001 ~~RPt~~evl~~ 1012 (1033)
++|||+.|+++.
T Consensus 282 ~~R~s~~e~l~h 293 (298)
T 2zv2_A 282 ESRIVVPEIKLH 293 (298)
T ss_dssp TTSCCHHHHTTC
T ss_pred hhCCCHHHHhcC
Confidence 999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.94 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=203.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch------hHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35689999999999999999999999999999998753321 356789999999999999999999995 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..++||||+++++|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----------TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 4568999999999999999994 235689999999999999999999999 999999999999999887
Q ss_pred ----cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 864 ----IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 227 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA 227 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSCCC---CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH
T ss_pred CCCCCEEEEECCCCeECCCCCccc---cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHH
Confidence 89999999998775433222 234899999999999999999999999999999999999998532110 0000
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ ... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~-------------~~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 228 NVSAVNYE-------------FED---------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTCCC-------------CCH---------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCCC-------------cCc---------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 000 0011234568899999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=372.22 Aligned_cols=277 Identities=16% Similarity=0.202 Sum_probs=209.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCC-----CeEEEEEEeeccCchh-----------HHHHHHHHHHHHhcCCCCcee
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEG-----KTIVAVKVFNLLHHGA-----------FKSFIAECNTLKNIRHRNLVK 772 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 772 (1033)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999754 5789999987543211 122345566677788999999
Q ss_pred EeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 773 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
+++++.... ......++||||+ +++|.+++.. ....+++.++..++.||+.||+|||++ +|+||||
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDI 178 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecC
Confidence 999975432 2235689999999 9999999953 335699999999999999999999999 9999999
Q ss_pred CCCCeEec--CCCcEEEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC
Q 042075 853 KPSNVLLD--EEMIAHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925 (1033)
Q Consensus 853 kp~NIll~--~~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~ 925 (1033)
||+||+++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 88999999999998764332211 112234999999999999999999999999999999999999
Q ss_pred CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 926 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
.||...... ..+.............+++++.+.. ..+++++.+++..||+.||++||+
T Consensus 259 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 259 LPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp CTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CCccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCC
Confidence 999743221 1111112222222222222222110 122467899999999999999999
Q ss_pred HHHHHHHHHHHHHHhh
Q 042075 1006 MTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 1006 ~~evl~~L~~i~~~~~ 1021 (1033)
++++++.|+++.+...
T Consensus 317 ~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 317 YENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcC
Confidence 9999999999887653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=365.94 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=201.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeE----EEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTI----VAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||+||+|++..+++. ||+|.++.. .....+++.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35789999999999999999998776665 577777532 23445789999999999999999999999742
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
+..++|+||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCC
Confidence 247899999999999999953 345689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||+..... .......
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~ 233 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE 233 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHH
Confidence 99999999987755444333333457889999999999999999999999999999999 99998642211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.... ...+..++.++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 234 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 KGER------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCC------------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1100 000112345689999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.62 Aligned_cols=270 Identities=23% Similarity=0.368 Sum_probs=212.2
Q ss_pred hCCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|.+.+.||+|+||.||+|++ ..+++.||||+++... ....+.+.+|++++++++||||+++++++ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence 56899999999999999999998 3456899999997543 34457889999999999999999999995 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCcc--------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDE--------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVH 849 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (1033)
.++..++||||+++++|.+++........ .......+++.++..++.||++||+|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 45578999999999999999965322100 001234589999999999999999999999 9999
Q ss_pred ccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 042075 850 CDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPT 928 (1033)
Q Consensus 850 rDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~ 928 (1033)
|||||+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987755444333333457889999999988899999999999999999999 99998
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
...... ............ ..+..+++++.+++.+||+.||++|||+.|
T Consensus 254 ~~~~~~--~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 254 PGIPPE--RLFNLLKTGHRM------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp TTCCGG--GHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHH--HHHHHhhcCCcC------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 632211 111111110000 001123456899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042075 1009 VVHQLQSIKNI 1019 (1033)
Q Consensus 1009 vl~~L~~i~~~ 1019 (1033)
+++.|+++...
T Consensus 302 l~~~l~~~~~~ 312 (314)
T 2ivs_A 302 ISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=357.16 Aligned_cols=277 Identities=20% Similarity=0.267 Sum_probs=201.7
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 57999999999999999999999999999999997433 33347788999999999999999999995 345588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++ ++.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS---------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 66665532 345689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++......... ....||+.|+|||++.+.. ++.++||||+||++|||++|..||.........+.........
T Consensus 144 Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 144 NFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecccceecCCccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999998765332222 2234899999999988765 8999999999999999999988864322222222222211111
Q ss_pred cc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ........ ....... ................+++.+++.+||+.||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 222 PTEEQWPSMTKL--PDYKPYP---MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGGS--TTCCCCC---CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhhhhhccc--ccccccc---cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 10 00000000 0000000 0000000001111234568899999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=377.74 Aligned_cols=254 Identities=27% Similarity=0.369 Sum_probs=206.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||++++++|. ..++..+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCceE
Confidence 457889999999999999999986 7799999997543 4578999999999999999999999863 3344689
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. .....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 264 iv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEECCTTCBHHHHHHH--------HCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence 99999999999999964 2233478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++....... ...++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 333 fG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~-- 403 (450)
T 1k9a_A 333 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY-- 403 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTC--
T ss_pred CCCccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--
Confidence 999986533211 1237889999999999999999999999999999998 99998633211 1111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+...+..+++++.++|.+||+.||++|||+.|+++.|++++..
T Consensus 404 ----------------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 ----------------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0111123456799999999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.66 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=201.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchh-------HHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-------FKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 468999999999999999999999899999999986432211 1678999999999999999999998532
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEec
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLLD 860 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~ 860 (1033)
..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ + |+||||||+||+++
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 95 ----PPRMVMEFVPCGDLYHRLLD---------KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp ----TTEEEEECCTTCBHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEES
T ss_pred ----CCeEEEEecCCCCHHHHHhc---------ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEe
Confidence 23699999999999998853 345689999999999999999999999 8 99999999999998
Q ss_pred CCCc-----EEEeecccceecCCCCccccccccccccccccccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 861 EEMI-----AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL--GSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 861 ~~~~-----~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
.++. +||+|||+++..... .....||+.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 8776 999999999854332 12244899999999984 45678999999999999999999999964322
Q ss_pred CCccHHHHHhh-hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 934 GDMNLHNFAKT-ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 934 ~~~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........... .... ..+..+++++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 234 GKIKFINMIREEGLRP------------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CHHHHHHHHHHSCCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhccCCCC------------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 21111111110 0000 0011234568999999999999999999999999
Q ss_pred HHHH
Q 042075 1013 LQSI 1016 (1033)
Q Consensus 1013 L~~i 1016 (1033)
|+++
T Consensus 284 L~~l 287 (287)
T 4f0f_A 284 LSEL 287 (287)
T ss_dssp HHTC
T ss_pred HHhC
Confidence 9863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=366.89 Aligned_cols=254 Identities=18% Similarity=0.235 Sum_probs=205.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++ ...+..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 46899999999999999999999999999999999866555567889999999999999999999995 4456899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC--CCcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE--EMIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL 867 (1033)
+||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ ||+||||||+||+++. ++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 99999999999999953 334689999999999999999999999 9999999999999974 568999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......+.
T Consensus 193 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~ 268 (387)
T 1kob_A 193 IDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE 268 (387)
T ss_dssp CCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC
T ss_pred EecccceecCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence 9999999775443222 234899999999999999999999999999999999999998632110 011111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +.. .....++++.+++.+||+.||++|||+.|+++.
T Consensus 269 ~------~~~----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 F------DED----------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C------CSS----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C------Ccc----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 000 001124568999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.80 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=200.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++ ...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 468999999999999999999999899999999987432 22235788999999999999999999995 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+ +|+|.+++. ....+++.++..++.|++.||+|||+. ||+||||||+||++++++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIV----------EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEE
Confidence 789999999 789999884 335689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||++.......... ...||+.|+|||++.+..+ ++++||||+||++|||++|+.||+......
T Consensus 149 l~DFG~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------- 215 (336)
T 3h4j_B 149 IADFGLSNIMTDGNFLK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------- 215 (336)
T ss_dssp ECCSSCTBTTTTSBTTC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------
T ss_pred EEEeccceeccCCcccc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------
Confidence 99999998765443222 2349999999999988776 789999999999999999999996321110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....+....... +...++++.+++.+||+.||++|||++|+++.
T Consensus 216 ----~~~~i~~~~~~~-------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 216 ----LFKKVNSCVYVM-------------------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----CBCCCCSSCCCC-------------------CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----HHHHHHcCCCCC-------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000000000000 01123568899999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.50 Aligned_cols=257 Identities=21% Similarity=0.242 Sum_probs=202.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 357999999999999999999999999999999986421 12357789999999999999999999995 44
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++++|.+++... ......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKR------ADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred CCEEEEEEeCCCCCCHHHHHHHh------cccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence 56899999999999999888431 11234589999999999999999999999 9999999999999986554
Q ss_pred ---EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 865 ---AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 865 ---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+...
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i 244 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI 244 (351)
T ss_dssp TCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHH
T ss_pred CCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHH
Confidence 999999999877543322 122459999999999999999999999999999999999999986321 1011111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... .... .....++++.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~------------~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 IKGKYK------------MNPR----------------QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHTCCC------------CCHH----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCC------------CCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110000 0000 001234568999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.20 Aligned_cols=276 Identities=24% Similarity=0.366 Sum_probs=211.3
Q ss_pred HHhhCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccc
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 780 (1033)
....++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+.++++++||||++++++|
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--- 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--- 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence 345678999999999999999999996 345899999997543 33457789999999999999999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCcc--------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE--------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (1033)
..++..++||||+++|+|.++++....... .......+++.+++.++.||++||+|||++ +
T Consensus 120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 345578999999999999999965321100 001136799999999999999999999999 9
Q ss_pred cEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CC
Q 042075 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RK 925 (1033)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~ 925 (1033)
|+||||||+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999986644332222233458899999999988899999999999999999999 99
Q ss_pred CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 926 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
.||..... ........... ... .+..++.++.+++.+||+.||++|||
T Consensus 275 ~p~~~~~~-----~~~~~~~~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 275 QPYYGMAH-----EEVIYYVRDGN--------ILA-------------------CPENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp CTTTTSCH-----HHHHHHHHTTC--------CCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcCCCCCh-----HHHHHHHhCCC--------cCC-------------------CCCCCCHHHHHHHHHHcccCcccCCC
Confidence 99853211 11111100000 000 00123456899999999999999999
Q ss_pred HHHHHHHHHHHHHHhhh
Q 042075 1006 MTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 1006 ~~evl~~L~~i~~~~~~ 1022 (1033)
+.|+++.|+++.+...+
T Consensus 323 ~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 323 FCSIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHHHTTC----
T ss_pred HHHHHHHHHHHHhhhhh
Confidence 99999999998776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=368.74 Aligned_cols=275 Identities=23% Similarity=0.343 Sum_probs=215.5
Q ss_pred hCCCCccceecccCceeEEEEEeCC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++|.+.+.||+|+||+||+|++.. .++.||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---
Confidence 4689999999999999999999743 34689999997543 33457789999999999 999999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..++..++||||+++|+|.+++....... ........+++.++..++.||+.||+|||++ +|+||||||
T Consensus 145 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 145 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 44557899999999999999996532110 0011235699999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655443333333457899999999999999999999999999999999 9999853211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
............. ..+..+++++.+++.+||+.||++|||++||++.|
T Consensus 300 --~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 300 --EELFKLLKEGHRM------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp --HHHHHHHHTTCCC------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHHcCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111111100000 00112345689999999999999999999999999
Q ss_pred HHHHHHhhhch
Q 042075 1014 QSIKNILLGQR 1024 (1033)
Q Consensus 1014 ~~i~~~~~~~~ 1024 (1033)
+++......+.
T Consensus 348 ~~~~~~~~~~~ 358 (382)
T 3tt0_A 348 DRIVALTSNQE 358 (382)
T ss_dssp HHHHHHSCSCC
T ss_pred HHHHHHHhcCC
Confidence 99987765443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=363.85 Aligned_cols=264 Identities=19% Similarity=0.218 Sum_probs=208.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.... .+.+.+|+++++++ +||||+++++++ ..++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence 4689999999999999999999988999999999875432 34688999999999 999999999995 345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc----
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI---- 864 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---- 864 (1033)
++||||+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 9999999953 245799999999999999999999999 9999999999999998887
Q ss_pred -EEEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 865 -AHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 865 -~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~ 225 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL 225 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence 9999999998764433211 112345999999999999999999999999999999999999999643211 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhh-hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN-SKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
........... ...... ....++ ++.+++..||+.||++||++++|.+.|+++.
T Consensus 226 ~~~~~~i~~~~------------------------~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 226 KERYQKIGDTK------------------------RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHHHHHHH------------------------HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhhh------------------------ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 11111000000 000000 000123 7999999999999999999999999999887
Q ss_pred HHh
Q 042075 1018 NIL 1020 (1033)
Q Consensus 1018 ~~~ 1020 (1033)
+..
T Consensus 281 ~~~ 283 (330)
T 2izr_A 281 DRK 283 (330)
T ss_dssp HHT
T ss_pred HHc
Confidence 764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=365.43 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=202.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 467999999999999999999999999999999997532 33456788999999999999999999995 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC---Cc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---MI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~ 864 (1033)
.++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +.
T Consensus 103 ~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 899999999999999984 234689999999999999999999999 99999999999999865 45
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||++......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+......
T Consensus 170 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~ 245 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAG 245 (362)
T ss_dssp EEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred EEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC
Confidence 999999999876543322 2245999999999999999999999999999999999999998532110 001111000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... . .....+++++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~------------~----------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AYDYP------------S----------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCCC------------T----------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCC------------c----------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 0001124568999999999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=372.62 Aligned_cols=255 Identities=17% Similarity=0.175 Sum_probs=202.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 3567999999999999999999999999999999987543 23456789999999999999999999994 4566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec---CCC
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD---EEM 863 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~ 863 (1033)
..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++ +++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~----------~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIV----------AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp EEEEEECCCBCCBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred EEEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence 8999999999999999984 335689999999999999999999999 999999999999998 567
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+++......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 151 ~vkL~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~ 227 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKA 227 (444)
T ss_dssp CEEECCCSSCBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred cEEEccCceeEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh
Confidence 89999999998765433221 2245999999999999999999999999999999999999998532110 00111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... .+. ....++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~-----~~~-----------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 GAYDFP-----SPE-----------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TCCCCC-----TTT-----------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCC-----ccc-----------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 000 00123568899999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.36 Aligned_cols=286 Identities=22% Similarity=0.321 Sum_probs=191.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 468999999999999999999999899999999997543 23346788999999999999999999995 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||++ |+|.+++..... ......+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTV----GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHS----SSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecC-CCHHHHHHhccc----cccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 99999997 599999853211 11234689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh--
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA-- 945 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-- 945 (1033)
|||+++......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 151 Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~ 227 (317)
T 2pmi_A 151 DFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGT 227 (317)
T ss_dssp CCSSCEETTSCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCS
T ss_pred cCccceecCCCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 999998765332221 22348999999999876 46899999999999999999999999643211 1111111110
Q ss_pred CCcchhhhcccccCCCchhhhhc-cchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVH-GNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+.....+.... ......... ..................++.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCT-TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhh-hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0011110000000 000000000 00000000000111234568999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.38 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=206.0
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
...++|++.+.||+|+||+||+|.+. ++..||+|+++.... ..+++.+|++++++++||||+++++++ ..++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 93 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRP 93 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCC
Confidence 34568999999999999999999987 678899999975433 346789999999999999999999995 44567
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp EEEEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEE
Confidence 8999999999999999953 345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ..........
T Consensus 162 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~ 238 (283)
T 3gen_A 162 SDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGL 238 (283)
T ss_dssp CSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTC
T ss_pred cccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhccc
Confidence 99999986643322 12222347788999999998889999999999999999998 99998632111 1111011000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.. . .+...++.+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 239 ~~--------~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RL--------Y----------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CC--------C----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC--------C----------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00 0 0001234589999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=356.01 Aligned_cols=265 Identities=17% Similarity=0.168 Sum_probs=210.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+++++ +|+|++++++++ ..+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence 467999999999999999999998899999999986433 235678999999999 899999999984 445588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc----
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI---- 864 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---- 864 (1033)
++||||+ +++|.++++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 9999999953 234689999999999999999999999 9999999999999987775
Q ss_pred -EEEeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc-
Q 042075 865 -AHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN- 937 (1033)
Q Consensus 865 -~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~- 937 (1033)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 999999999876543321 1123345999999999999999999999999999999999999999643211100
Q ss_pred -HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 938 -LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 938 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+........... .......+++++.+++.+||+.||++|||+++|++.|+++
T Consensus 229 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 229 KYERIGEKKQSTP---------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHHHHHSC---------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhccCcc---------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 000000000000 0000112356799999999999999999999999999999
Q ss_pred HHHhh
Q 042075 1017 KNILL 1021 (1033)
Q Consensus 1017 ~~~~~ 1021 (1033)
.+...
T Consensus 282 ~~~~~ 286 (298)
T 1csn_A 282 LERLN 286 (298)
T ss_dssp HHHTT
T ss_pred HHhcC
Confidence 87654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=370.58 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=197.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.++||+|+||+||+|+++.+++.||+|+++... ....+.+.+|..+++++ +||||+++++++ ..+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence 467999999999999999999999999999999997532 23345678999999887 899999999994 455
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence 68999999999999999994 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc----HHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN----LHNF 941 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~----~~~~ 941 (1033)
||+|||+|+....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ....
T Consensus 193 kL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred EEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 9999999986332222 122345999999999999999999999999999999999999999643211100 0000
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
.... ... ....+...+.++.+++.+||+.||++||++
T Consensus 271 ~~~i--------~~~--------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQVI--------LEK--------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHH--------HHC--------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHH--------hcc--------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000 000 000111234568999999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=365.21 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 357999999999999999999999999999999987432 23456788999999999999999999995 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++|+|.++++ ....+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 8999999999999999994 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 156 L~DFG~a~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~ 230 (384)
T 4fr4_A 156 ITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVH 230 (384)
T ss_dssp ECCCTTCEECCTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHH
T ss_pred EeccceeeeccCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHH
Confidence 9999999876543322 23459999999999864 45899999999999999999999999632211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-MTNVVH 1011 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 1011 (1033)
... ..... .+...++++.+++.+||+.||++||+ ++++.+
T Consensus 231 ~~~---------~~~~~-------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TFE---------TTVVT-------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHH---------HCCCC-------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHh---------hcccC-------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 100 00000 01112456899999999999999998 666553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.26 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=204.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeE----EEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTI----VAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||+||+|++..+++. ||+|++.... ......+.+|+.++++++||||++++++|.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35789999999999999999999877765 7777765332 233456788999999999999999999863
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSC
T ss_pred CCccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCe
Confidence 3468899999999999999953 345688999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~ 231 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLE 231 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHH
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHH
Confidence 99999999998765544333344558889999999998899999999999999999999 99998642211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
...... .+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 232 ~~~~~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 232 KGERLA------------------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTCBCC------------------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCCCCC------------------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 100000 0001223478899999999999999999999999988643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.04 Aligned_cols=278 Identities=24% Similarity=0.377 Sum_probs=204.1
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCC---CCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
++....++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 333455688999999999999999998764 4568999998743 23445778999999999999999999999765
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
.........++||||+++|+|.+++...... .....+++.++..++.||++||+|||++ +|+||||||+||++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli 180 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCML 180 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEE
Confidence 4433334569999999999999998532211 2346799999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNL 938 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 938 (1033)
++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 258 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EM 258 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HH
Confidence 9999999999999987654433232333447889999999999999999999999999999999 88888532111 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
.......... ..+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 259 ~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLHGHRL------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHTTCCC------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111100000 0011234568999999999999999999999999999987
Q ss_pred Hhh
Q 042075 1019 ILL 1021 (1033)
Q Consensus 1019 ~~~ 1021 (1033)
..+
T Consensus 309 ~lp 311 (313)
T 3brb_A 309 SLP 311 (313)
T ss_dssp HC-
T ss_pred hcC
Confidence 654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=363.46 Aligned_cols=274 Identities=23% Similarity=0.382 Sum_probs=195.7
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCe---EEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKT---IVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
...++|++.+.||+|+||+||+|++..++. .||||+++.. .....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999876664 7999998753 34456789999999999999999999999654321
Q ss_pred cC-CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 783 QG-NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 783 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
.. ....++||||+++|+|.+++..... ......+++.++..++.|++.||+|||++ ||+||||||+||++++
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRI----GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhc----cccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 11 1123899999999999999953211 11233689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~ 940 (1033)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~ 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYN 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHH
Confidence 99999999999987655443333333447889999999999899999999999999999999 89998632211 1111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
....... ...+..+++++.+++.+||+.||++|||+.|+++.|+++....
T Consensus 251 ~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 YLIGGNR------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHTTCC------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhcCCC------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1000000 0001123456899999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=355.02 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=194.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||+||+|++.. .||||+++... ....+.+.+|++++++++||||+++++++ ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCC
Confidence 35689999999999999999998753 49999987433 34457789999999999999999999974 234
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT---------C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred ccEEEEEecCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 57999999999999999953 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||+++...............||+.|+|||++. +..++.++||||||+++|||++|+.||......+........
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 99999998654333222223345899999999986 567889999999999999999999999643221111111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.......... ...+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 ~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 GSLSPDLSKV---------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSCCCCTTSS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCcchhhc---------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111111000 0123466899999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.66 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=198.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.++||+|+||+||+|+++.+++.||||+++.. .....+.+.+|..+++.+ +||||+++++++ ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 357899999999999999999999999999999999743 223446688999999998 799999999994 45
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..|+||||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence 568999999999999999994 335689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+|+....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 163 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~ 235 (353)
T 3txo_A 163 CKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEA 235 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred EEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 99999999985433222 12234599999999999988999999999999999999999999863211 111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM------TNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 1011 (1033)
.. .... . .+....+++.+++.+||+.||++||++ +|+++
T Consensus 236 i~--------~~~~-~-------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 IL--------NDEV-V-------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HH--------HCCC-C-------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HH--------cCCC-C-------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00 0000 0 000123458899999999999999998 66665
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=366.31 Aligned_cols=276 Identities=22% Similarity=0.296 Sum_probs=208.2
Q ss_pred hhCCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
..++|++.+.||+|+||.||+|++ ..+++.||||+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 457899999999999999999997 346778999999743 233457889999999999 999999999995
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCc-------------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITRED-------------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 848 (1033)
...+..++||||+++|+|.+++....... ........+++.++..++.||+.||+|||++ ||+
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 34557899999999999999996532110 0001124589999999999999999999999 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKP 927 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p 927 (1033)
||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654433333333447889999999988899999999999999999998 9999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|...... ..+........... .+..+++++.+++.+||+.||++|||+.
T Consensus 275 ~~~~~~~-~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 275 YPGIPVD-ANFYKLIQNGFKMD------------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp STTCCCS-HHHHHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCCcH-HHHHHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 8643211 11111111111000 0111245689999999999999999999
Q ss_pred HHHHHHHHHHHHhhhc
Q 042075 1008 NVVHQLQSIKNILLGQ 1023 (1033)
Q Consensus 1008 evl~~L~~i~~~~~~~ 1023 (1033)
|+++.|+.+.+....+
T Consensus 324 ~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 324 NLTSFLGCQLADAEEA 339 (344)
T ss_dssp HHHHHHHHHC------
T ss_pred HHHHHHHHHHHHHHHH
Confidence 9999999987765543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.86 Aligned_cols=283 Identities=22% Similarity=0.277 Sum_probs=217.1
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhc-CCCCceeEe
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKIL 774 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 774 (1033)
.........++|++.+.||+|+||+||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445668999999999999999999985 34678999999975433 3456789999999999 799999999
Q ss_pred eeeccccccCCCceeEEEEcccCCchhhhcccCCCCccc------cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042075 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET------EEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIV 848 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 848 (1033)
+++. ..+...++||||+++|+|.+++......... ......+++.++..++.|++.||+|||++ +|+
T Consensus 98 ~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 9963 3344689999999999999999653221000 00123389999999999999999999999 999
Q ss_pred eccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 042075 849 HCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKP 927 (1033)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p 927 (1033)
||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654443333333457889999999988899999999999999999998 9999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|....... .+........... .+...++++.+++.+||+.||++|||+.
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 299 (316)
T 2xir_A 251 YPGVKIDE-EFCRRLKEGTRMR------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFS 299 (316)
T ss_dssp STTCCCSH-HHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcccchhH-HHHHHhccCccCC------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 86432111 1111111100000 0011235689999999999999999999
Q ss_pred HHHHHHHHHHHHhhh
Q 042075 1008 NVVHQLQSIKNILLG 1022 (1033)
Q Consensus 1008 evl~~L~~i~~~~~~ 1022 (1033)
|+++.|+++.+...+
T Consensus 300 ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 300 ELVEHLGNLLQANAQ 314 (316)
T ss_dssp HHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHhhhcc
Confidence 999999999876543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.15 Aligned_cols=354 Identities=18% Similarity=0.190 Sum_probs=278.0
Q ss_pred CeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEc
Q 042075 84 QRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRL 163 (1033)
Q Consensus 84 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 163 (1033)
.+++.|+++++++++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|.+++. | ++++++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 3688999999999975 4 79999999999999999997 45 99999999999999999964 4 899999999999
Q ss_pred ccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCC
Q 042075 164 SSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 164 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
++|++++ +| ++.+++|++|++++|++++. + ++++++|++|++++|+..+.+ .++.+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 9999996 55 89999999999999999974 3 889999999999999766566 48899999999999999996
Q ss_pred CcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhh
Q 042075 244 IPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKL 323 (1033)
Q Consensus 244 ~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l 323 (1033)
+| +..+++|+.|++++|++++. + +..+++|++|++++|++++ +| +..+++|++|++++|++++.+ .+.+
T Consensus 185 l~--l~~l~~L~~L~l~~N~l~~~-~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~--~~~l 253 (457)
T 3bz5_A 185 LD--VSQNKLLNRLNCDTNNITKL-D---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD--VSTL 253 (457)
T ss_dssp CC--CTTCTTCCEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--CTTC
T ss_pred ec--cccCCCCCEEECcCCcCCee-c---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC--HHHC
Confidence 55 88899999999999999864 3 4468899999999999987 55 788889999999999988754 3445
Q ss_pred ccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCC
Q 042075 324 QRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFV 403 (1033)
Q Consensus 324 ~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~ 403 (1033)
++|+.|+++.| +|+.|++++|.+.+.+| ++.++
T Consensus 254 ~~L~~L~l~~n---------------------------------------------~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 254 SKLTTLHCIQT---------------------------------------------DLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp TTCCEEECTTC---------------------------------------------CCSCCCCTTCTTCCEEE--CTTCT
T ss_pred CCCCEEeccCC---------------------------------------------CCCEEECCCCccCCccc--ccccc
Confidence 55555555443 24445566666655555 45667
Q ss_pred CCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCC
Q 042075 404 KLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483 (1033)
Q Consensus 404 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 483 (1033)
+|+.|++++|.+.+.+|. ..++|+.|++++|. .|++|+|++|++++. + ++++++|+.|++++
T Consensus 287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~~------------~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQNP------------KLVYLYLNNTELTEL-D--VSHNTKLKSLSCVN 348 (457)
T ss_dssp TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTCT------------TCCEEECTTCCCSCC-C--CTTCTTCSEEECCS
T ss_pred cCCEEECCCCcccceecc---CCCcceEechhhcc------------cCCEEECCCCccccc-c--cccCCcCcEEECCC
Confidence 777777777777666664 34556666666551 367778888888763 3 77888888888888
Q ss_pred CccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccc
Q 042075 484 NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLG 544 (1033)
Q Consensus 484 N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 544 (1033)
|++++ + ..+ ..|++++|.++|. +.+..|..+++++|+++|.+|..+.
T Consensus 349 N~l~~-l-------~~L-~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 349 AHIQD-F-------SSV-GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp SCCCB-C-------TTG-GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CCCCC-c-------ccc-ccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 88874 2 223 6677888888764 3556677778888888877776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=358.81 Aligned_cols=273 Identities=23% Similarity=0.321 Sum_probs=213.1
Q ss_pred hhCCCCccceecccCceeEEEEEe-----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
..++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 346899999999999999999985 45678999999975433 3457789999999999 999999999995
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCc--------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITRED--------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
..++..++||||+++|+|.+++....... ........+++.++..++.|++.||+|||++ +|+|||||
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 34557899999999999999996532110 0011234589999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMF 932 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~ 932 (1033)
|+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987765443333333447889999999988899999999999999999999 999986432
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... ............. .+...++++.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDS-KFYKMIKEGFRML------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSH-HHHHHHHHTCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chh-HHHHHhccCCCCC------------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 111 1111111111000 001124568999999999999999999999999
Q ss_pred HHHHHHHh
Q 042075 1013 LQSIKNIL 1020 (1033)
Q Consensus 1013 L~~i~~~~ 1020 (1033)
|+++....
T Consensus 302 L~~~~~~~ 309 (313)
T 1t46_A 302 IEKQISES 309 (313)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=366.22 Aligned_cols=289 Identities=24% Similarity=0.339 Sum_probs=205.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHH--HHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNT--LKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|+. +++.||||+++.... ..+..|.++ +..++||||+++++++..........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999987 579999999875432 334445444 44589999999998765554556667
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCcEeccCCCCCeEecC
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC------QPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivHrDlkp~NIll~~ 861 (1033)
.++||||+++|+|.++++. ...++..+..++.||+.||+|||+.+ .++|+||||||+||+++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 8999999999999999943 23488899999999999999999863 338999999999999999
Q ss_pred CCcEEEeecccceecCCCCc------cccccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 862 EMIAHVGDFGLATFLPLSHA------QTSSIFAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987653321 111223459999999999887 45678999999999999999998776
Q ss_pred CccccCCccHHHHHhhhCCc-c---hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC
Q 042075 929 DIMFEGDMNLHNFAKTALPD-H---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~-~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1004 (1033)
............+....... . ....+.... ..............+++++.+++.+||+.||++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----------QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----------CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccc-----------cCCCCCcccccccchHHHHHHHHHHHhcCChhhCc
Confidence 43221111000000000000 0 000000000 00000011111224567899999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhhchh
Q 042075 1005 DMTNVVHQLQSIKNILLGQRI 1025 (1033)
Q Consensus 1005 t~~evl~~L~~i~~~~~~~~~ 1025 (1033)
|++|+++.|+++...+....-
T Consensus 305 s~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 305 TAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp CHHHHHHHHHHHHHCCCC---
T ss_pred chHHHHHHHHHHHHHHHhccc
Confidence 999999999999987765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.53 Aligned_cols=280 Identities=24% Similarity=0.293 Sum_probs=213.1
Q ss_pred hCCCCccceecccCceeEEEEE----eCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGI----LDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|+ ...+++.||||+++.......+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 3579999999999999999999 456889999999987666667789999999999999999999998642 345
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCE
Confidence 578999999999999999953 234689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||.++........ .......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ...+...
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccc
Confidence 99999999877544322 12222348888999999998889999999999999999999999975321100 0000000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
..........+ ......+...+..+++++.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 245 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 245 RDVPALSRLLE---------------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --CCHHHHHHH---------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccccHHHHHH---------------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 00000000000 000011111222345679999999999999999999999999998865443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=355.57 Aligned_cols=283 Identities=24% Similarity=0.282 Sum_probs=202.9
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-----chhHHHHHHHHHHHHhcC---CCCceeEeeeeccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIR---HRNLVKILTACSGV 780 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 780 (1033)
..++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999998899999999987432 122346678888877774 99999999997654
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
........++||||+. ++|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||+++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK--------APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT--------CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 3333336799999996 599999964 2334489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
.++.+||+|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~ 230 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGK 230 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHH
T ss_pred CCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 9999999999999866443322 22348999999999999999999999999999999999999986432211 1111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
............+.. .......... . ...........+..+++.+++.+||+.||++|||+.|+++.
T Consensus 231 i~~~~~~~~~~~~~~-~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 231 IFDLIGLPPEDDWPR-DVSLPRGAFP---P-RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHCCCCTTTSCS-SCSSCGGGSC---C-CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCChhhccc-hhhccccccC---C-CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111000000000 0000000000 0 00000000111234678999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=356.20 Aligned_cols=279 Identities=21% Similarity=0.251 Sum_probs=201.1
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
...++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence 34578999999999999999999996 58999999987432 23346788999999999999999999994 455
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDE---------NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHT---------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEEcCCCC-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence 689999999974 88888753 335589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++......... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........
T Consensus 159 kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~ 235 (311)
T 3niz_A 159 KLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI 235 (311)
T ss_dssp EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred EEccCcCceecCCCcccc--cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 999999998765332222 22348999999999876 568999999999999999999999997443222 22222211
Q ss_pred hCCcchhhhcccccCCCchhhhh-ccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAV-HGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
........+.. ... ...... ..................+++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQ--VQE-LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGG--GTT-SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhh--hhc-cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110000000 000 000000 00000000000011123456889999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.22 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=197.9
Q ss_pred hhCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.+.||+|+||.||+|.+..+ +..||+|+.+... ....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 346899999999999999999998643 5679999987533 334567899999999999999999999852
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred cCccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCC
Confidence 2467899999999999999953 334689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~ 231 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE 231 (281)
T ss_dssp EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred EEECccccccccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHH
Confidence 9999999998765433221 122336789999999988899999999999999999997 99998643211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.... ...+..+++++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 232 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 232 NGER------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCC------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000 0001123456899999999999999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.32 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=197.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|..+++++ +||||+++++++ ...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 35789999999999999999999999999999999753 233456688999999988 899999999994 455
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 68999999999999999994 234689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc----cHHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM----NLHNF 941 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~----~~~~~ 941 (1033)
||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .....
T Consensus 150 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 227 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227 (345)
T ss_dssp EECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred EEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence 9999999986432221 12234599999999999999999999999999999999999999964221110 00000
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
... +.... ...+...+.++.+++.+||+.||++||++
T Consensus 228 ~~~--------i~~~~--------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 228 FQV--------ILEKQ--------------------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHH--------HHHCC--------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHH--------HHcCC--------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000 00000 00011234568999999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=362.57 Aligned_cols=253 Identities=21% Similarity=0.242 Sum_probs=188.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||++++++| ...+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence 4568999999999999999999999899999999997543 336688999999999999999999995 345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCcE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMIA 865 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~ 865 (1033)
++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE----------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHTT----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCE
Confidence 999999999999999942 34589999999999999999999999 9999999999999975 8899
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.......
T Consensus 191 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~ 267 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred EEccCccccccCccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence 99999999865433221 223489999999999999999999999999999999999999853221111111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ...+. ..+.+.++.+++.+||+.||++|||+.|+++.
T Consensus 268 ~~-----~~~~~-----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 YY-----FISPW-----------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CC-----CCTTT-----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cc-----cCCch-----------------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 01123568899999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=373.72 Aligned_cols=284 Identities=19% Similarity=0.162 Sum_probs=201.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 785 (1033)
..++|++.+.||+|+||+||+|++..+++.||||++... .....+++.+|+.++++++||||+++++++..... ...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 457899999999999999999999999999999999753 33445778899999999999999999999754321 334
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||+++ ++.+.+. ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CeEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCE
Confidence 567999999965 5666663 1388999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+|+........ ....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..+.......
T Consensus 204 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~l 279 (464)
T 3ttj_A 204 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL 279 (464)
T ss_dssp EECCCCCC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred EEEEEEeeeecCCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence 99999999876443222 2245899999999999999999999999999999999999998632111 1111111110
Q ss_pred CC----------cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LP----------DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
-. ......++..............................+++.+++.+||+.||++|||++|+++.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00111111100000000000000000000011122335678999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.56 Aligned_cols=268 Identities=24% Similarity=0.371 Sum_probs=208.5
Q ss_pred CCCccceecccCceeEEEEEeCCCC---eEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGK---TIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.|.+.++||+|+||+||+|++..++ ..||+|+++... ....+.+.+|+.++++++||||+++++++. ..+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCC
Confidence 4556789999999999999975443 379999987533 344578899999999999999999999963 23345
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+.+|+|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||++++++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEe
Confidence 5899999999999999953 345688999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCc--cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 868 GDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++|..|+...... ..........
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcC
Confidence 99999986543321 11222344789999999999999999999999999999999966654321111 1111111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhchh
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRI 1025 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 1025 (1033)
... ..+..+++++.+++.+||+.||++|||++|+++.|+++.+...+..+
T Consensus 245 ~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 245 RRL------------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp CCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred CCC------------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 000 00111235689999999999999999999999999999988876654
Q ss_pred h
Q 042075 1026 V 1026 (1033)
Q Consensus 1026 ~ 1026 (1033)
.
T Consensus 295 ~ 295 (298)
T 3pls_A 295 V 295 (298)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.41 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=201.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.+++.++||||+++++++ ...+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 457999999999999999999999999999999997532 23346788999999999999999999994 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence 89999999999999999952 34689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 147 L~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i- 215 (318)
T 1fot_A 147 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKI- 215 (318)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH-
T ss_pred EeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH-
Confidence 99999998754321 224599999999999999999999999999999999999999853211 1111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
...... . +....+++.+++.+||+.||++|| +++|+++.
T Consensus 216 -------~~~~~~-~-------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 216 -------LNAELR-F-------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -------HHCCCC-C-------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------HhCCCC-C-------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 000000 0 001234588999999999999999 88888753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=359.54 Aligned_cols=275 Identities=21% Similarity=0.345 Sum_probs=211.4
Q ss_pred hCCCCccceecccCceeEEEEEeC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-------EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE---
Confidence 468999999999999999999975 356789999997543 34457789999999999 899999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..++..++||||+++|+|.+++........ .......+++.++..++.||+.||+|||++ +|+||||||
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 111 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp --CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred --ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 345578999999999999999965321100 001234589999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999987765443333333447889999999988889999999999999999999 9999853211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
............ ...+..++.++.+++.+||+.||++|||+.|+++.|
T Consensus 266 --~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 266 --EELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp --HHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 011111110000 000112345689999999999999999999999999
Q ss_pred HHHHHHhhhch
Q 042075 1014 QSIKNILLGQR 1024 (1033)
Q Consensus 1014 ~~i~~~~~~~~ 1024 (1033)
+++........
T Consensus 314 ~~l~~~~~~~~ 324 (334)
T 2pvf_A 314 DRILTLTTNEE 324 (334)
T ss_dssp HHHHHHHC---
T ss_pred HHHHhccccCc
Confidence 99988765444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=349.00 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=204.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 457999999999999999999999899999999987433 334578899999999999999999999953 44578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEe
Confidence 99999999999999984 334689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.+................||+.|+|||++.+..+ +.++||||||+++|||++|+.||.........+..+......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc
Confidence 9999987643332222233458999999999988765 788999999999999999999997433222222222111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ......++.+.+++.+||+.||++|||++|+++
T Consensus 228 ~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L------------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------------------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 000112355889999999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=373.69 Aligned_cols=260 Identities=18% Similarity=0.225 Sum_probs=204.7
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 780 (1033)
.++....++|++.++||+|+||+||+|+++.+++.||+|+++... ....+.+.+|+.+++.++||||++++++|
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--- 138 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 138 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 344456789999999999999999999999999999999987421 12234578999999999999999999995
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++..|+||||++||+|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++
T Consensus 139 --~~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~ 202 (410)
T 3v8s_A 139 --QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD 202 (410)
T ss_dssp --ECSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred --EECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeEC
Confidence 455689999999999999999842 3588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
.++.+||+|||+|+......... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 203 ~~g~ikL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---- 277 (410)
T 3v8s_A 203 KSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---- 277 (410)
T ss_dssp TTSCEEECCCTTCEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS----
T ss_pred CCCCEEEeccceeEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC----
Confidence 99999999999998765443221 22345999999999987655 8899999999999999999999986321
Q ss_pred cHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042075 937 NLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED--RMDMTNVVHQ 1012 (1033)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1012 (1033)
............. . ...+.....++++.+++.+||+.+|++ ||+++||+++
T Consensus 278 -~~~~~~~i~~~~~-~-----------------------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 278 -LVGTYSKIMNHKN-S-----------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHHHHHHTHHH-H-----------------------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -hhhHHHHHHhccc-c-----------------------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111111000000 0 000000012356899999999999998 9999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.05 Aligned_cols=264 Identities=24% Similarity=0.367 Sum_probs=214.3
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
-..++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+.+|++++++++||||+++++++ ..++.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCC
Confidence 35678999999999999999999999889999999987543 3457889999999999999999999995 44557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp EEEEEECCTTEEHHHHHHH--------CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHh--------cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEE
Confidence 8999999999999999954 2345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+......... ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||...... ..........
T Consensus 153 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~ 229 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY 229 (288)
T ss_dssp CCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC
T ss_pred ccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccC
Confidence 999999876543322 2222347889999999988899999999999999999999 99998632111 1111111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
.. ..+..+++++.+++.+||+.||++|||++|+++.|+++.....
T Consensus 230 ~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 230 RM------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0011234568999999999999999999999999999876553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=353.32 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=206.3
Q ss_pred CCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.+|++.+.||+|+||+||+|++..+ ...||+|.++... ....+.+.+|+.++++++||||++++++| ...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----CCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE----EcCCC
Confidence 4688899999999999999997533 3468999987533 34457789999999999999999999986 34456
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred ceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEE
Confidence 78999999999999999953 345688999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 867 VGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
|+|||.++........ .......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||..... . .......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~-~~~~~~~ 246 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-F-DITVYLL 246 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-T-THHHHHH
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-H-HHHHHHh
Confidence 9999999876443221 11222347889999999998899999999999999999999 5555542211 1 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQ 1023 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 1023 (1033)
..... ..+..+++++.+++.+||+.||++|||++|+++.|+++.....++
T Consensus 247 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 QGRRL------------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred cCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00000 000112356899999999999999999999999999998877654
Q ss_pred h
Q 042075 1024 R 1024 (1033)
Q Consensus 1024 ~ 1024 (1033)
.
T Consensus 297 ~ 297 (298)
T 3f66_A 297 H 297 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=362.66 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=200.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
...++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+..|..+++.+ +||||+++++++ .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence 45678999999999999999999999999999999997532 23446678899999987 999999999994 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..|+||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCC
Confidence 5568999999999999999994 234689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....
T Consensus 156 ~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~ 228 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH 228 (345)
T ss_dssp CEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred CEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Confidence 9999999999864332222 2234599999999999999999999999999999999999999863211 11111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT-NVV 1010 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 1010 (1033)
...... ... +...++++.+++.+||+.||++||++. |++
T Consensus 229 ~i~~~~------~~~----------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 229 SIRMDN------PFY----------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHCC------CCC----------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHhCC------CCC----------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 100000 000 001235588999999999999999997 664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=354.36 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=199.4
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||+||+|++. ++.||||+++.. ...+.+.+|++++++++||||+++++++. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence 57889999999999999999985 688999998643 34578899999999999999999999853 24789
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc-EEEee
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI-AHVGD 869 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-~kL~D 869 (1033)
||||+++|+|.++++.. .....+++.+++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|
T Consensus 77 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA-------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp EEECCTTCBHHHHHHCS-------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred EEEcCCCCCHHHHHhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 99999999999999641 12235788999999999999999999932239999999999999998886 79999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||+...................
T Consensus 150 fg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 223 (307)
T 2eva_A 150 FGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP- 223 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-
T ss_pred ccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-
Confidence 99997653321 123489999999999999999999999999999999999999864321111110000000000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 1022 (1033)
.....+++.+.+++.+||+.||++|||++|+++.|+.+.+...+
T Consensus 224 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 -----------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp -----------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred -----------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00112245689999999999999999999999999999876643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=378.55 Aligned_cols=202 Identities=26% Similarity=0.351 Sum_probs=161.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||+||+|++..+++.||||++... .....+++.+|++++++++||||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 347899999999999999999999999999999998643 233457789999999999999999999998655545567
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+ +++|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp CEEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEe
Confidence 899999998 579999984 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc-------------------------cccccccccccccccccc-CCCCCCcccchHHHHHHHHH
Q 042075 867 VGDFGLATFLPLSHAQ-------------------------TSSIFAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLE 920 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~vl~e 920 (1033)
|+|||+|+........ ......+||+.|+|||++ .+..++.++|||||||++||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 9999999876432211 112234589999999976 55679999999999999999
Q ss_pred HHhC
Q 042075 921 LVTR 924 (1033)
Q Consensus 921 lltg 924 (1033)
|++|
T Consensus 277 lltg 280 (458)
T 3rp9_A 277 LLNM 280 (458)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9994
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.85 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=191.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc----hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 468999999999999999999985 78899999864322 2346788999999999999999999995 345
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC----
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---- 861 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---- 861 (1033)
+..++||||+++++|.+++. ...+++.++..++.|++.||+|||++...+|+||||||+||++++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 57899999999999999984 246899999999999999999999991112999999999999986
Q ss_pred ----CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 862 ----EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 862 ----~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
++.+||+|||.++........ ...||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 220 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--- 220 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---
T ss_pred ccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 678999999999865433222 234899999999998888999999999999999999999998632111
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
..... ....... ...+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 221 -~~~~~-~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 -AVAYG-VAMNKLA--------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -HHHHH-HHTSCCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -HHHHh-hhcCCCC--------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000 0000000 000112345689999999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.93 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=200.3
Q ss_pred CCCccceecccCceeEEEEEeCCC---CeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.|++.+.||+|+||+||+|++..+ +..||||.++.. .....+++.+|+.++++++||||++++++| ...++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~----~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE----CCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE----EcCCCC
Confidence 356778999999999999997532 346899998643 334567899999999999999999999986 334457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.++++. ....+++.++..++.||++||+|||++ +|+||||||+||++++++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence 8999999999999999953 334578999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...... ........
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~ 311 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ 311 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHc
Confidence 999999865433211 11122347889999999999999999999999999999999 67777532211 11111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhch
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQR 1024 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 1024 (1033)
... ...+..++.++.+++.+||+.||++|||++|+++.|+++...+.++.
T Consensus 312 ~~~------------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 GRR------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp TCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 000 00011234568999999999999999999999999999998877665
Q ss_pred h
Q 042075 1025 I 1025 (1033)
Q Consensus 1025 ~ 1025 (1033)
.
T Consensus 362 ~ 362 (373)
T 3c1x_A 362 Y 362 (373)
T ss_dssp B
T ss_pred e
Confidence 3
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.59 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=200.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------ 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 782 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||++++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999999899999999997533 3355789999999999999999999998743221
Q ss_pred ----------------------------------------------cCCCceeEEEEcccCCchhhhcccCCCCcccccc
Q 042075 783 ----------------------------------------------QGNDFKALVFEFMHNRSLEEWLHPITREDETEEA 816 (1033)
Q Consensus 783 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 816 (1033)
..+...++||||+++++|.++++.. ..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~ 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-------CS 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-------CS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-------cC
Confidence 1122479999999999999999642 12
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcc----------cccc
Q 042075 817 PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ----------TSSI 886 (1033)
Q Consensus 817 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~----------~~~~ 886 (1033)
....++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 34457778899999999999999999 9999999999999999999999999999887554221 1122
Q ss_pred ccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhh
Q 042075 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLA 966 (1033)
Q Consensus 887 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 966 (1033)
...||+.|+|||++.+..++.++||||+||++|||++|..|+... ........ ..
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~--------~~---------- 289 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVR--------NL---------- 289 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHH--------TT----------
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhh--------cc----------
Confidence 345999999999999999999999999999999999987764210 00000000 00
Q ss_pred hccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 967 VHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 967 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..........+++.+++.+||+.||++|||++|+++.
T Consensus 290 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 290 ---------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp ---------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ---------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 0001112334567899999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=360.80 Aligned_cols=275 Identities=19% Similarity=0.209 Sum_probs=213.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 467999999999999999999998899999999987666666788999999999999999999999975321 2344789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+++.... .....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999995311 1346689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccc-------cccccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 870 FGLATFLPLSHAQT-------SSIFAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 870 fG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
||.+.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||+..........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987653221110 011233799999999987654 78999999999999999999999864322222221
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
........ .+.....+.++.+++.+||+.||++|||++|+++.|+.++..
T Consensus 258 ~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 258 LAVQNQLS------------------------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHCC--------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHhhccCC------------------------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11111000 000011235689999999999999999999999999998776
Q ss_pred hhhch
Q 042075 1020 LLGQR 1024 (1033)
Q Consensus 1020 ~~~~~ 1024 (1033)
.+++.
T Consensus 308 ~~~~~ 312 (317)
T 2buj_A 308 APGQH 312 (317)
T ss_dssp CCC--
T ss_pred CCCCC
Confidence 65544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.56 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=201.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC-------eEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK-------TIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||+||+|++..++ +.||+|+++.......+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 357899999999999999999987665 579999998766666788999999999999999999999953
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
.++..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE 149 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred -eCCCCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence 45578999999999999999953 334589999999999999999999999 99999999999999988
Q ss_pred Cc--------EEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 863 MI--------AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 863 ~~--------~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
+. +||+|||.+...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 86 999999998754321 11237899999999887 6789999999999999999996555432111
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
... ....... ..... ...++++.+++.+||+.||++|||++|+++.|
T Consensus 224 ~~~-~~~~~~~--~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 224 SQR-KLQFYED--RHQLP------------------------------APKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHH-HHHHHHT--TCCCC------------------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHH-HHHHhhc--cCCCC------------------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 110 0000000 00000 00123478999999999999999999999999
Q ss_pred HHHHHHh
Q 042075 1014 QSIKNIL 1020 (1033)
Q Consensus 1014 ~~i~~~~ 1020 (1033)
+++....
T Consensus 271 ~~l~~p~ 277 (289)
T 4fvq_A 271 NSLFTPD 277 (289)
T ss_dssp HTCC---
T ss_pred HHhcCCC
Confidence 9886543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=369.35 Aligned_cols=283 Identities=18% Similarity=0.198 Sum_probs=204.6
Q ss_pred hhCCCCccceeccc--CceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAG--SFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.++||+| +||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++. .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence 35689999999999 99999999999999999999997543 344567889999999999999999999953 4
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++|+|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICT--------HFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK 166 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH--------TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred CCEEEEEEEccCCCCHHHHHhh--------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 5589999999999999999954 2235589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCc-----cccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 865 AHVGDFGLATFLPLSHA-----QTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+||+|||.+........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~- 245 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM- 245 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 99999999875422211 111122358999999999987 6799999999999999999999999964322211
Q ss_pred HHHHHhhhCCcchhhhcccccCCC----------------chhhhhc--cchhhhhhhhhhHHHHHHHHHHHHhhccCCC
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSD----------------DEDLAVH--GNQRQRQARINSKIECLVAMARIGVACSMES 999 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~----------------~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 999 (1033)
.........+ ...+...... ....... .................+++.+++.+||+.|
T Consensus 246 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 246 LLEKLNGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp HHHC------------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHHhcCCCC----ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 1111111100 0000000000 0000000 0000000011122334567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042075 1000 PEDRMDMTNVVHQ 1012 (1033)
Q Consensus 1000 P~~RPt~~evl~~ 1012 (1033)
|++|||++|+++.
T Consensus 322 P~~Rpta~ell~h 334 (389)
T 3gni_B 322 PDARPSASTLLNH 334 (389)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccCCCHHHHhcC
Confidence 9999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=382.43 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=210.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 4567889999999999999999997 57889999998543 34578999999999999999999999863 3468
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.++++. .....+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EEEECCCTTCBHHHHHHS--------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEEC
T ss_pred EEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEe
Confidence 999999999999999953 2234688999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++....... .......+|..|+|||++....++.++|||||||++|||++ |+.||...... .........
T Consensus 327 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~-- 401 (454)
T 1qcf_A 327 DFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERG-- 401 (454)
T ss_dssp STTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHT--
T ss_pred eCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC--
Confidence 9999987643221 11222336789999999988899999999999999999999 99998632111 111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQ 1023 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 1023 (1033)
.+.+.+..+++++.+++.+||+.||++|||+++|++.|+++......+
T Consensus 402 ----------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 402 ----------------------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp ----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 001111234567999999999999999999999999999886654433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=358.28 Aligned_cols=275 Identities=26% Similarity=0.356 Sum_probs=207.4
Q ss_pred CCCCccceecccCceeEEEEE----eCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGI----LDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 458899999999999999999 45689999999987433 3345788999999999999999999999653 223
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCE
Confidence 568999999999999999953 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||++......... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..+...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~ 239 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKM 239 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhc
Confidence 99999999877554322 22223448889999999998899999999999999999999999864221 111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
..+....... .. .........+...+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 240 ~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 240 IGPTHGQMTV--------TR---LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HCSCCGGGHH--------HH---HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcccccCH--------HH---HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000000 00 00000000111112234567999999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=370.77 Aligned_cols=264 Identities=19% Similarity=0.185 Sum_probs=206.3
Q ss_pred HHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 703 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
+.++....++|++.++||+|+||+||+|+++.+++.||||+++... ......+.+|..+++.++||||++++++|
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-- 143 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-- 143 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE--
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence 3444456789999999999999999999999999999999997422 12234488999999999999999999995
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
..++..|+||||+++|+|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 144 ---~~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl 208 (437)
T 4aw2_A 144 ---QDDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILM 208 (437)
T ss_dssp ---ECSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ---eeCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeE
Confidence 455689999999999999999953 245689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
+.++.+||+|||+|+......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cCCCCEEEcchhhhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 999999999999998765443322 22245999999999986 567999999999999999999999999632111
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED--RMDMTNVVHQ 1012 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1012 (1033)
..+....... . ...-+. . ....++++.+++.+||..+|++ ||+++|+++.
T Consensus 288 -~~~~~i~~~~----~-~~~~p~---~-------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 -ETYGKIMNHK----E-RFQFPT---Q-------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHHHHHHTHH----H-HCCCCS---S-------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -HHHHhhhhcc----c-cccCCc---c-------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111111000 0 000000 0 0012355889999999998888 9999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=381.44 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=209.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ..+++.+|+.++++++||||++++++|. ..+..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence 4578899999999999999999998899999999975433 4578999999999999999999999963 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. .....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 293 lv~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEccCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence 99999999999999964 2335689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 362 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-- 436 (495)
T 1opk_A 362 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY-- 436 (495)
T ss_dssp TTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC--
T ss_pred cccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--
Confidence 999987644322 22222346789999999998899999999999999999999 99998632111 1111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
+...+..+++++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 437 ----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ----------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00111234567899999999999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=360.15 Aligned_cols=260 Identities=22% Similarity=0.348 Sum_probs=200.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEE----EEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIV----AVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||+||+|++..+++.| |+|.++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 467999999999999999999998777654 66666432 33455789999999999999999999999642
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
+..++|+||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCceEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 247899999999999999953 345689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~ 233 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE 233 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987654443333333447889999999999999999999999999999999 99998643211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.... ...+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 234 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 KGER------------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCC------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1100 000111245689999999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.34 Aligned_cols=267 Identities=19% Similarity=0.253 Sum_probs=207.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+...... .+++.+|++++++++|++++..+.++ ...++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEE----EEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeee----cCCCCce
Confidence 45789999999999999999999988999999998764332 24578899999999998888887775 3445678
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIA 865 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~ 865 (1033)
++||||+ +++|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||++ ++++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCE
T ss_pred EEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeE
Confidence 9999999 9999999853 234689999999999999999999999 99999999999999 788999
Q ss_pred EEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc--cH
Q 042075 866 HVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM--NL 938 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~--~~ 938 (1033)
||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 999999998765433211 12234589999999999999999999999999999999999999964322111 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
............ ......+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 228 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 228 ERISEKKMSTPI---------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhhcccccchh---------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 111110000000 00001224679999999999999999999999999999987
Q ss_pred Hhh
Q 042075 1019 ILL 1021 (1033)
Q Consensus 1019 ~~~ 1021 (1033)
...
T Consensus 281 ~~~ 283 (296)
T 4hgt_A 281 RQG 283 (296)
T ss_dssp HHT
T ss_pred HhC
Confidence 664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=369.92 Aligned_cols=146 Identities=21% Similarity=0.376 Sum_probs=78.1
Q ss_pred CCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceee
Q 042075 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 186 (1033)
+++++.|++++|.+. .+| .+..+++|++|+|++|.+++.. . ++++++|++|++++|.+++..| ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 455666666666665 244 2555666666666666665332 2 5666666666666666654333 56666666666
Q ss_pred ecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 187 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
+++|++++..+ +.++++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+..+ +.++++|+.|++++|.++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS 190 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence 66666654332 5556666666666666553 22 25555555555553 33332211 444444444444444443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=364.73 Aligned_cols=210 Identities=29% Similarity=0.339 Sum_probs=181.0
Q ss_pred CCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-----CCCcee
Q 042075 698 FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-----HRNLVK 772 (1033)
Q Consensus 698 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 772 (1033)
...+++.+.....++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++++. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44566666667788999999999999999999999989999999998743 233466788999999996 999999
Q ss_pred EeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 773 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
+++++. ..+..++||||+ +++|.+++.. .....+++.++..++.||+.||+|||++ ||+||||
T Consensus 101 ~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 163 (360)
T 3llt_A 101 YHGKFM-----YYDHMCLIFEPL-GPSLYEIITR--------NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDL 163 (360)
T ss_dssp EEEEEE-----ETTEEEEEECCC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred ccceee-----ECCeeEEEEcCC-CCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCC
Confidence 999954 345889999999 9999999954 2334589999999999999999999999 9999999
Q ss_pred CCCCeEecC-------------------------CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCc
Q 042075 853 KPSNVLLDE-------------------------EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI 907 (1033)
Q Consensus 853 kp~NIll~~-------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 907 (1033)
||+||+++. ++.+||+|||+|+....... ...||+.|+|||++.+..++.
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCC
Confidence 999999975 78999999999986543221 234899999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCc
Q 042075 908 NGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 908 ~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
++||||+||++|||++|+.||..
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999964
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=362.76 Aligned_cols=255 Identities=22% Similarity=0.238 Sum_probs=194.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||+||+|++..+++.||||+++.... ..+.+.+|+.++++++||||+++++++ ...+..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEE
Confidence 35689999999999999999999999999999999975432 236788999999999999999999995 345589
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc--EE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI--AH 866 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~k 866 (1033)
++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++. +|
T Consensus 92 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 92 AIIMEYASGGELYERIC----------NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp EEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred EEEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence 99999999999999984 334689999999999999999999999 9999999999999987765 99
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++........ ....||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .+.......
T Consensus 159 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~ 234 (361)
T 3uc3_A 159 ICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRI 234 (361)
T ss_dssp ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHH
T ss_pred EeecCccccccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHH
Confidence 9999999754322221 22349999999999988887655 899999999999999999996432221 122211111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .. +.....++++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~------~~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVKY------SI--------------------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTCC------CC--------------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCCC------CC--------------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11000 00 0000123568899999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=349.40 Aligned_cols=267 Identities=19% Similarity=0.253 Sum_probs=211.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++..+++.||||++..... .+++.+|+.++++++|++++..+.++ ...++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEE----EEETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccc----cCCCCce
Confidence 35789999999999999999999988999999999875432 35688999999999998887777765 2345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIA 865 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~ 865 (1033)
++||||+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++ ++++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred EEEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeE
Confidence 9999999 9999999953 334689999999999999999999999 99999999999999 488899
Q ss_pred EEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC--ccH
Q 042075 866 HVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD--MNL 938 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~--~~~ 938 (1033)
||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 999999998765443211 1223458999999999999999999999999999999999999997432111 111
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
............ ......+++++.+++.+||+.||++|||++++++.|+++..
T Consensus 228 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 228 ERISEKKMSTPI---------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhcccccCCch---------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 111110000000 00011234668999999999999999999999999999987
Q ss_pred Hhh
Q 042075 1019 ILL 1021 (1033)
Q Consensus 1019 ~~~ 1021 (1033)
...
T Consensus 281 ~~~ 283 (296)
T 3uzp_A 281 RQG 283 (296)
T ss_dssp HTT
T ss_pred hcC
Confidence 654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=368.61 Aligned_cols=288 Identities=19% Similarity=0.221 Sum_probs=214.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 357999999999999999999999999999999997533 2335678899999999999999999998642 223467
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe----cCCCc
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMI 864 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~ 864 (1033)
++||||+++|+|.++++.. .....+++.++..++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHhh-------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCcee
Confidence 9999999999999999641 1223489999999999999999999999 99999999999999 77788
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCC--------CCCCcccchHHHHHHHHHHHhCCCCCCccccCCc
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--------SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~ 936 (1033)
+||+|||+++......... ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 9999999998765433222 2448999999998764 5678899999999999999999999964332222
Q ss_pred cHHHHHhh--hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 937 NLHNFAKT--ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 937 ~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
....+... ..+......+........ + ..................+.+++.+||+.||++||+++|+++.++
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~-----~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAENGPI-D-----WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTTCCE-E-----EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhheeccCCCc-c-----cCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 22211111 111111100000000000 0 000000111122456778999999999999999999999999998
Q ss_pred HHHHH
Q 042075 1015 SIKNI 1019 (1033)
Q Consensus 1015 ~i~~~ 1019 (1033)
++.+.
T Consensus 306 ~il~~ 310 (396)
T 4eut_A 306 DILHR 310 (396)
T ss_dssp HHHTC
T ss_pred HHhhc
Confidence 88654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=371.86 Aligned_cols=207 Identities=24% Similarity=0.315 Sum_probs=172.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+++.+|++++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999999999999999999753 333457889999999999999999999997654444446
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||++ ++|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK----------TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCC-cCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEE
Confidence 7899999985 69999994 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc--------------------cccccccccccccccccc-CCCCCCcccchHHHHHHHHHHHhCC
Q 042075 867 VGDFGLATFLPLSHAQ--------------------TSSIFAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLELVTRK 925 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~vl~elltg~ 925 (1033)
|+|||+|+........ .......||+.|+|||++ ....++.++||||+||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999876543221 112335589999999985 5567999999999999999999976
Q ss_pred CCCC
Q 042075 926 KPTD 929 (1033)
Q Consensus 926 ~p~~ 929 (1033)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 6654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=361.96 Aligned_cols=278 Identities=22% Similarity=0.282 Sum_probs=213.6
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCC-----eEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeec
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGK-----TIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACS 778 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 778 (1033)
..-..++|++.+.||+|+||.||+|.+..++ +.||+|+++... ....+.+.+|+.+++++ +||||++++++|
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 119 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC- 119 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-
Confidence 3345678999999999999999999987655 479999997543 33457789999999999 899999999995
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCcc----ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE----TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
..++..++||||+++|+|.+++........ .......+++.++..++.|++.||+|||++ +|+||||||
T Consensus 120 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 120 ----THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp ----CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ----ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 445578999999999999999964211000 001134689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999986644333222233447889999999988899999999999999999999 9999864321
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
.. ............. .+..+++.+.+++.+||+.||++|||+.|+++.|
T Consensus 273 ~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 273 NS-KFYKLVKDGYQMA------------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp SH-HHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hH-HHHHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 11 1111111111000 0011235689999999999999999999999999
Q ss_pred HHHHHHhhh
Q 042075 1014 QSIKNILLG 1022 (1033)
Q Consensus 1014 ~~i~~~~~~ 1022 (1033)
+++......
T Consensus 322 ~~~~~~~~~ 330 (333)
T 2i1m_A 322 QEQAQEDRR 330 (333)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHhhhc
Confidence 998775543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.79 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=203.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 45799999999999999999999999999999999876555678899999999999999999999995 4455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAH 866 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 866 (1033)
+||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~ 149 (277)
T 3f3z_A 83 LVMELCTGGELFERVV----------HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLK 149 (277)
T ss_dssp EEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999984 345689999999999999999999999 99999999999999 7888999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||.+.......... ...||+.|+|||++.+. ++.++||||+|+++|||++|+.||......+ ..........
T Consensus 150 l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~ 224 (277)
T 3f3z_A 150 LIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTF 224 (277)
T ss_dssp ECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC
T ss_pred EEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC
Confidence 99999998765443322 23489999999998654 8999999999999999999999986321110 0111100000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .... .....++++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~-------------~~~~---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 T-------------FPEK---------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C-------------CCHH---------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C-------------CCch---------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 001234568999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.43 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=196.0
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEEEcc
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 795 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 795 (1033)
.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence 56899999999999999989999999999876656667899999999999999999999995 3455789999999
Q ss_pred cCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe--cCCCcEEEeecccc
Q 042075 796 HNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL--DEEMIAHVGDFGLA 873 (1033)
Q Consensus 796 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~~~kL~DfG~a 873 (1033)
++++|.+++.. ....+++.++..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 169 ~~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRIID---------ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999998852 345689999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhh
Q 042075 874 TFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953 (1033)
Q Consensus 874 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1033)
+......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......+..
T Consensus 237 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~----- 307 (373)
T 2x4f_A 237 RRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDL----- 307 (373)
T ss_dssp EECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCS-----
T ss_pred eecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC-----
Confidence 9775443322 234899999999999999999999999999999999999998632111 1111111111000
Q ss_pred cccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 954 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .....++++.+++.+||+.||++|||+.|+++.
T Consensus 308 -------~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 308 -------EDE----------------EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -------CSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------Chh----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 001124568999999999999999999999983
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=353.63 Aligned_cols=276 Identities=23% Similarity=0.337 Sum_probs=204.1
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc--CCCCceeEeeeeccccccC
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~ 784 (1033)
....++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 344578999999999999999999986 8899999986432 24455666666655 9999999999865331 12
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEeccCCCCCeEe
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC-----QPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivHrDlkp~NIll 859 (1033)
....++||||+++|+|.++++. ..+++.++..++.|++.||+|||+++ .++|+||||||+||++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 2578999999999999999942 35899999999999999999999752 3489999999999999
Q ss_pred cCCCcEEEeecccceecCCCCcccc--ccccccccccccccccCCCCCCcc------cchHHHHHHHHHHHhCC------
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTS--SIFAKGSIGYIAPEYGLGSEVSIN------GDVYSYGILLLELVTRK------ 925 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~vl~elltg~------ 925 (1033)
+.++.+||+|||+++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++|.
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 9999999999999987644332211 122459999999999988766665 99999999999999994
Q ss_pred ----CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCC
Q 042075 926 ----KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001 (1033)
Q Consensus 926 ----~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 1001 (1033)
.||.........+............. .. ........++++++.+++.+||+.||+
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLR--------PS-------------FPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCC--------CC-------------CCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccC--------cc-------------ccccchhhHHHHHHHHHHHHhhhhChh
Confidence 44433222222222221111100000 00 000011235678899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHh
Q 042075 1002 DRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 1002 ~RPt~~evl~~L~~i~~~~ 1020 (1033)
+|||+.||++.|+++.+..
T Consensus 315 ~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHhhc
Confidence 9999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=355.47 Aligned_cols=273 Identities=19% Similarity=0.208 Sum_probs=199.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----ID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eC
Confidence 3578999999999999999999999899999999987532 223477889999999999999999999953 45
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----------QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CeEEEEEEecCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 588999999999999999942 34689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||++.......... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .........
T Consensus 174 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 250 (309)
T 2h34_A 174 YLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA 250 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred EEecCccCcccccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence 999999998654432211 12234899999999999999999999999999999999999998632111 111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHHhhhch
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-DMTNVVHQLQSIKNILLGQR 1024 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~~~~~ 1024 (1033)
.+. .. .....+++++.+++.+||+.||++|| +++++++.|+++.+......
T Consensus 251 ~~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 251 IPR-PS---------------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp CCC-GG---------------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred CCC-cc---------------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 000 00 00112235689999999999999999 99999999998876665555
Q ss_pred hhcccc
Q 042075 1025 IVSNMQ 1030 (1033)
Q Consensus 1025 ~~~~~~ 1030 (1033)
..+.++
T Consensus 303 ~~~~~~ 308 (309)
T 2h34_A 303 ATDILR 308 (309)
T ss_dssp ------
T ss_pred hhhhhh
Confidence 444433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.67 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=197.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 468999999999999999999998899999999997542 233467889999999999999999999865332 1122
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.++++ ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEE
T ss_pred ccEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEE
Confidence 4599999999999999994 234689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~ 235 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVRED 235 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcCC
Confidence 9999999876443221 122224489999999999999999999999999999999999999863211110000 00000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV-HQLQSIK 1017 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl-~~L~~i~ 1017 (1033)
... . .......++++.+++.+||+.||++||++.+++ +.+.++.
T Consensus 236 ~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 PIP-P---------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCC-H---------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCC-c---------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 000 0 000012345689999999999999999655544 5565554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=348.58 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=202.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|++. ++.||||+++... ....+.+.+|+.++++++||||+++++++... ..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 457999999999999999999985 7889999997543 34456799999999999999999999996432 2357
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEecCCCcE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~ 865 (1033)
.++||||+++|+|.++++. .....+++.++..++.|++.||+|||++ + |+||||||+||++++++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHE--------GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp CEEEEECCTTCBHHHHHHS--------CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred eEeeecccCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence 8999999999999999964 2233689999999999999999999998 7 9999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCc---ccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSI---NGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
+|+|||++...... ...||+.|+|||++.+..++. ++|||||||++|||++|+.||......+ ......
T Consensus 153 ~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~ 224 (271)
T 3kmu_A 153 RISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-IGMKVA 224 (271)
T ss_dssp EEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-HHHHHH
T ss_pred eEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-HHHHHH
Confidence 99999887643221 134899999999988765554 7999999999999999999986321111 000110
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
....... .+..+++++.+++.+||+.||++|||++|+++.|+++++
T Consensus 225 ~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEGLRPT------------------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSCCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcCCCCC------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0000000 011234568999999999999999999999999998854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=359.84 Aligned_cols=276 Identities=22% Similarity=0.375 Sum_probs=213.3
Q ss_pred hCCCCccceecccCceeEEEEEe----CCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.......+.+.+|++++++++||||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 45689999999999999999994 55789999999987666667889999999999999999999998642 223
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred CceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcE
Confidence 468999999999999999953 234589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++|..||..... .+......
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~ 261 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGN 261 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCT
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhcc
Confidence 999999998775443221 11223477889999999888899999999999999999999998752210 00000000
Q ss_pred hCCcc-----hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 945 ALPDH-----VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 945 ~~~~~-----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
..... +.+.+.. ..+...+..+++++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKN------------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCTHHHHHHHHHHHHT------------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhc------------------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0000000 001111223456799999999999999999999999999999886
Q ss_pred hh
Q 042075 1020 LL 1021 (1033)
Q Consensus 1020 ~~ 1021 (1033)
..
T Consensus 324 l~ 325 (326)
T 2w1i_A 324 MA 325 (326)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.52 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=207.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|.+. +++.||+|+++.... ..+.+.+|++++++++||||+++++++ ..++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence 457899999999999999999997 678899999976443 236789999999999999999999995 3455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999953 334689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||.+........ .......++..|+|||++.+..++.++||||+|+++|||++ |+.||..... ..........
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~ 221 (267)
T 3t9t_A 148 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTG 221 (267)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTT
T ss_pred cccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcC
Confidence 999986543221 11222347889999999988889999999999999999999 8999863211 1111100000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
. ... .+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 222 ~-----~~~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 F-----RLY----------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp C-----CCC----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-----cCC----------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000 0001235589999999999999999999999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.83 Aligned_cols=272 Identities=23% Similarity=0.295 Sum_probs=199.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++. ..+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 3689999999999999999999998999999999864332 23467889999999999999999999953 4557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.++++ ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||
T Consensus 77 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp EEEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEE
Confidence 899999999999999884 335689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.+.......... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ... ......
T Consensus 144 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~-~~~~~~ 219 (311)
T 4agu_A 144 CDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLY-LIRKTL 219 (311)
T ss_dssp CCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH-HHHHHH
T ss_pred eeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHh
Confidence 9999998765433222 12348999999999876 678999999999999999999999996432211 111 111110
Q ss_pred Cc---chhhhcc------cccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PD---HVVDIVD------STLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~---~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ....... ......... ...... .....++++.+++.+||+.||++|||++|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPED------MEPLEL---KFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSS------CCCHHH---HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccCcCCCccc------cchhhh---hcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000 000000000 000000 011234568999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.57 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=204.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCC---CCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.+.||+|+||+||+|++.. ++..||+|+++.. .....+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------ 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence 35689999999999999999999753 3456999998754 3344578899999999999999999999853
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPEC 151 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTE
T ss_pred CCCCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCc
Confidence 2346899999999999999953 335589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||.+.......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~ 228 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE 228 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH
T ss_pred EEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh
Confidence 9999999998764433221 122347889999999988899999999999999999998 99998632211 1111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
..... ..+..+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 229 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 KGDRL------------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCC------------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 10000 000112356899999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.05 Aligned_cols=274 Identities=22% Similarity=0.275 Sum_probs=196.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|+||+||+|++ .+++.||+|+++.... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5799999999999999999999 4789999999864332 2346788999999999999999999995 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 99998853 335689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.........
T Consensus 143 Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 219 (288)
T 1ob3_A 143 DFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGT 219 (288)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred ECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCC
Confidence 99999865432221 122348999999999876 458999999999999999999999996432111 11111111100
Q ss_pred cc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. ........ ............ ... .......++++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 220 PNSKNWPNVTEL-PKYDPNFTVYEP-LPW---ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTTSTTGGGS-TTCCTTCCCCCC-CCG---GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhchhhhcc-cccccccccccC-ccH---HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000000 000000000000 000 0001123456889999999999999999999876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.86 Aligned_cols=247 Identities=19% Similarity=0.215 Sum_probs=201.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++ ..++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence 357999999999999999999999999999999997432 23456788999999999999999999994 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence 89999999999999999952 34689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 182 L~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~ 251 (350)
T 1rdq_E 182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIV 251 (350)
T ss_dssp ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH
T ss_pred EcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHH
Confidence 99999998764322 22358999999999999999999999999999999999999986321 111111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
.... . .+...+.++.+++.+||+.||++||+ ++|+++.
T Consensus 252 --------~~~~-~-------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 --------SGKV-R-------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------HCCC-C-------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------cCCC-C-------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0000 0 00112356899999999999999998 7777653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.92 Aligned_cols=271 Identities=24% Similarity=0.364 Sum_probs=209.5
Q ss_pred CCccceecccCceeEEEEEe----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 713 FTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
|++.+.||+|+||+||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.. .....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 48999999999999988764 3478999999997543 3445778999999999999999999999743 22457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 8999999999999999943 3489999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||.++........ .......+|..|+|||++.+..++.++||||+||++|||++|+.||....... ... ...
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~--~~~ 250 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LEL--IGI 250 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHH--HCS
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhh--hcc
Confidence 999999987554322 12223347888999999998899999999999999999999999985321110 000 000
Q ss_pred Ccc------hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 947 PDH------VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 947 ~~~------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
... ..+.++. ..+...+..+++++.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 251 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 251 AQGQMTVLRLTELLER------------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCHHHHHHHHHHHHHT------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHhc------------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 000 0000000 0111112234567999999999999999999999999999999887
Q ss_pred hhc
Q 042075 1021 LGQ 1023 (1033)
Q Consensus 1021 ~~~ 1023 (1033)
.++
T Consensus 313 ~~~ 315 (318)
T 3lxp_A 313 QGQ 315 (318)
T ss_dssp HC-
T ss_pred ccC
Confidence 654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=352.72 Aligned_cols=253 Identities=18% Similarity=0.215 Sum_probs=203.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch------hHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 45799999999999999999999989999999999753321 356789999999999999999999995 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----------TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCC
Confidence 4568999999999999999994 234688999999999999999999999 999999999999999887
Q ss_pred ----cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 864 ----IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~ 224 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q 224 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H
T ss_pred CCcCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----H
Confidence 7999999999876543322 223489999999999999999999999999999999999999853211 1
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ ... ..... .....++.+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~i~~--------~~~-~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 ETLANITS--------VSY-DFDEE---------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHT--------TCC-CCCHH---------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHh--------ccc-ccChh---------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 000 00000 001223568999999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.83 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=203.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 468999999999999999999999999999999997532 33457788999999999999999999995 44557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc---
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI--- 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--- 864 (1033)
.++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence 899999999999999884 335689999999999999999999999 9999999999999986654
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||.+.......... ...||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .........
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~ 222 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAG 222 (284)
T ss_dssp EEECCCTTCEECCSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred EEEeeceeeEEcccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhc
Confidence 9999999998765443322 234899999999999999999999999999999999999998532111 001111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+ .....++++.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~~-----~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 223 AYDYP-----SP-----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCCC-----TT-----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccCC-----ch-----------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 00 001123568999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.96 Aligned_cols=265 Identities=26% Similarity=0.403 Sum_probs=208.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence 3468899999999999999999987 677899999875432 3578899999999999999999999853 2357
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. .....+++.++..++.|++.||+|||++ ||+||||||+||++++++.+||+
T Consensus 83 ~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp EEEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEEC
Confidence 999999999999999953 1234689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.+.......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 152 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~ 228 (279)
T 1qpc_A 152 DFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR 228 (279)
T ss_dssp CCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC
T ss_pred CCcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccC
Confidence 999998765433221 222346789999999988889999999999999999999 99998632111 11111100000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhchh
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRI 1025 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 1025 (1033)
. ..+..+++++.+++.+||+.||++|||++++++.|+++.....++.-
T Consensus 229 --------~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 229 --------M----------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp --------C----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred --------C----------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 0 00012245689999999999999999999999999999887766543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.75 Aligned_cols=269 Identities=22% Similarity=0.298 Sum_probs=201.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|+.++++++||||+++++++. .+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----ED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence 345799999999999999999999889999999998742 2344577899999999999999999999954 34
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++... ......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHF------KKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 175 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEecCCCCCHHHHHHHh------cccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence 5789999999999999998531 12345689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||++.......... ....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .........
T Consensus 176 kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~ 250 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI 250 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHH
T ss_pred EEEeccceeeecCCCccc--cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHh
Confidence 999999998654332211 223489999999999999999999999999999999999999853211 111111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLG 1022 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 1022 (1033)
..... +... ....++++.+++.+||+.||++|||++||++.|+++++....
T Consensus 251 ~~~~~-----~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 251 EQCDY-----PPLP---------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HTTCS-----CCCC---------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred hcccC-----CCCc---------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 00000 0000 001235689999999999999999999999999999876643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.57 Aligned_cols=250 Identities=19% Similarity=0.232 Sum_probs=200.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+..|..+++.+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3568999999999999999999999889999999997532 23456788999999988 899999999984 45
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..|+||||++||+|.++++. ...+++.++..++.||+.||+|||++ ||+||||||+||+++.++.
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence 5689999999999999999942 34689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 160 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~ 232 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQS 232 (353)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred EEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHHHH
Confidence 99999999986432222 1223459999999999999999999999999999999999999986321 1111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1011 (1033)
.. .... . .+...++++.+++.+||+.||++||+ ++|+++
T Consensus 233 i~--------~~~~-~-------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 IM--------EHNV-A-------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HH--------HCCC-C-------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HH--------hCCC-C-------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 0000 0 00112356899999999999999996 466654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.24 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=164.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.+++++. ||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 457899999999999999999999999999999998542 3344567889999999996 9999999999642 234
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||++ ++|.++++. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCE
Confidence 47899999997 699998842 4688999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCc-------------------cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCC
Q 042075 866 HVGDFGLATFLPLSHA-------------------QTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRK 925 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~ 925 (1033)
||+|||+|+....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 9999999987533111 111223459999999999876 67899999999999999999999
Q ss_pred CCCCc
Q 042075 926 KPTDI 930 (1033)
Q Consensus 926 ~p~~~ 930 (1033)
+||..
T Consensus 229 ~pf~~ 233 (388)
T 3oz6_A 229 PIFPG 233 (388)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=363.54 Aligned_cols=292 Identities=18% Similarity=0.212 Sum_probs=209.4
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.+.....++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 334445678999999999999999999999999999999997533 3344778999999999999999999999865554
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
......++||||++ |+|.++++. ..+++.++..++.|++.||+|||++ ||+||||||+||+++.+
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~ 164 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT 164 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred cccceEEEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCC
Confidence 55567899999996 599998842 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCcccc-ccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTS-SIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+.+||+|||+++.......... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+..
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~ 243 (364)
T 3qyz_A 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNH 243 (364)
T ss_dssp CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHH
T ss_pred CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHH
Confidence 9999999999987654332211 123458999999998655 458999999999999999999999986432211 1111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
......... .+..................................++.+++.+||+.||++|||++|+++.
T Consensus 244 i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 244 ILGILGSPS-QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCC-HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111100 00000000000000000000000000000011234568999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=362.58 Aligned_cols=269 Identities=18% Similarity=0.232 Sum_probs=201.4
Q ss_pred hCCCCccceecccCceeEEEEEeCC---CCeEEEEEEeeccCch-----------hHHHHHHHHHHHHhcCCCCceeEee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLLHHG-----------AFKSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
.++|++.+.||+|+||+||+|++.. ++..||||+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999986 7888999998754321 1234667888999999999999999
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
++... +......++||||+ +++|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 97542 23356889999999 9999999953 33789999999999999999999999 9999999999
Q ss_pred CeEecCCC--cEEEeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 856 NVLLDEEM--IAHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 856 NIll~~~~--~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 9999999999876432211 1112345899999999999999999999999999999999999999
Q ss_pred CccccCCccHHHHHhhh---CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC
Q 042075 929 DIMFEGDMNLHNFAKTA---LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1005 (1033)
................. .+....... ....+++++.+++.+||+.||++|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWA-------------------------PSGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHS-------------------------CTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhc-------------------------cccccHHHHHHHHHHHhhcCcccCCC
Confidence 53222111111111100 000000000 00023457999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042075 1006 MTNVVHQLQSIKN 1018 (1033)
Q Consensus 1006 ~~evl~~L~~i~~ 1018 (1033)
+++|++.|+++..
T Consensus 316 ~~~l~~~L~~~~~ 328 (345)
T 2v62_A 316 YQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHCTTCC
T ss_pred HHHHHHHHhccCC
Confidence 9999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=360.07 Aligned_cols=277 Identities=20% Similarity=0.332 Sum_probs=212.9
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEee
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
..++.....++|++.+.||+|+||.||+|++. .+++.||||+++... .....++.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33444556788999999999999999999876 357889999987543 234467889999999999999999999
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
++ ..++..++||||+++|+|.++++..............+++.++..++.||+.||+|||++ ||+||||||+
T Consensus 96 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~ 167 (322)
T 1p4o_A 96 VV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR 167 (322)
T ss_dssp EE-----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGG
T ss_pred EE-----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccc
Confidence 95 445578999999999999999964211100011124578999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccC
Q 042075 856 NVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEG 934 (1033)
Q Consensus 856 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~ 934 (1033)
||++++++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 246 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN- 246 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-
Confidence 99999999999999999986543332222223347889999999988899999999999999999999 8899853211
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
........... ... .+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus 247 ----~~~~~~~~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 247 ----EQVLRFVMEGG--------LLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp ----HHHHHHHHTTC--------CCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred ----HHHHHHHHcCC--------cCC-------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111110000 000 00123456899999999999999999999999998
Q ss_pred HHHH
Q 042075 1015 SIKN 1018 (1033)
Q Consensus 1015 ~i~~ 1018 (1033)
++.+
T Consensus 296 ~~~~ 299 (322)
T 1p4o_A 296 EEME 299 (322)
T ss_dssp GGSC
T ss_pred Hhhc
Confidence 8744
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=368.89 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=202.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++ ...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 467999999999999999999999899999999997432 22346789999999999999999999995 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYIC----------KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTT----------SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 8999999999999999994 335689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++......... ...||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... ........
T Consensus 157 L~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i 228 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKI 228 (476)
T ss_dssp ECCCSSCEECCTTCCBC---CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHH
T ss_pred EEeccchhhcccccccc---ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHH
Confidence 99999998765433222 2359999999999988765 689999999999999999999986321 11111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. +... .. +....+++.+++.+||+.||++|||++|+++.
T Consensus 229 ~--------~~~~-~~-------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 229 C--------DGIF-YT-------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp H--------TTCC-CC-------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h--------cCCc-CC-------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0000 00 00123458899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=368.34 Aligned_cols=262 Identities=19% Similarity=0.212 Sum_probs=203.8
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 780 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 780 (1033)
.+.....++|++.++||+|+||+||+|+++.+++.||||+++... ....+.+.+|..++.+++||||+++++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--- 130 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF--- 130 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE---
Confidence 344455688999999999999999999999999999999997422 22335588999999999999999999994
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++..|+||||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++
T Consensus 131 --~~~~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld 196 (412)
T 2vd5_A 131 --QDENYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLD 196 (412)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred --eeCCEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeec
Confidence 455689999999999999999953 234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccC-------CCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-------GSEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
.++++||+|||+++......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 197 ~~g~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp TTSCEEECCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCCCEEEeechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 99999999999998765443221 22345999999999987 46789999999999999999999999863211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCC---CCHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDR---MDMTNVV 1010 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl 1010 (1033)
. ..+........ ...-+. .....++++.+++.+||. +|++| |+++|++
T Consensus 276 ~-~~~~~i~~~~~-----~~~~p~----------------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 276 A-ETYGKIVHYKE-----HLSLPL----------------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp H-HHHHHHHTHHH-----HCCCC--------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred H-HHHHHHHhccc-----CcCCCc----------------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 0 01111110000 000000 001234568999999999 99998 5888886
Q ss_pred HH
Q 042075 1011 HQ 1012 (1033)
Q Consensus 1011 ~~ 1012 (1033)
+.
T Consensus 327 ~H 328 (412)
T 2vd5_A 327 TH 328 (412)
T ss_dssp TS
T ss_pred cC
Confidence 54
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=368.25 Aligned_cols=167 Identities=23% Similarity=0.361 Sum_probs=100.2
Q ss_pred eEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcc
Q 042075 85 RVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 164 (1033)
+++.|++.+++++. ++ .+..+++|++|+|++|.+++..| +.++++|++|+|++|.+++..| ++++++|++|+|+
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 45566666666653 33 35666677777777776664333 6666777777777777664433 6667777777777
Q ss_pred cccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCC
Q 042075 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244 (1033)
Q Consensus 165 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 244 (1033)
+|.+++. |. +.++++|++|++++|++++. + .++++++|++|+++ |.+.+.. .++.+++|++|++++|++++.
T Consensus 121 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~- 192 (466)
T 1o6v_A 121 NNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI- 192 (466)
T ss_dssp SSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-
T ss_pred CCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-
Confidence 7766643 22 66667777777777766642 3 36666677777765 4444322 266666777777777766632
Q ss_pred cccccCCCceeEEeccCccccC
Q 042075 245 PSSIFNISSITVFDAGINQIQG 266 (1033)
Q Consensus 245 p~~l~~l~~L~~L~ls~N~l~~ 266 (1033)
..+..+++|+.|++++|.+++
T Consensus 193 -~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 193 -SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCC
T ss_pred -hhhccCCCCCEEEecCCcccc
Confidence 234555555555555555543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.65 Aligned_cols=245 Identities=24% Similarity=0.269 Sum_probs=192.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.++||+|+||+||+|++..+++.||||++.... .....+...|+..+.++ +||||++++++|. .++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 57999999999999999999999899999999986432 23334555666666665 9999999999953 4558
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+ +++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEA---------WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEEEECC-CCBHHHHHHH---------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEecc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 99999999 7799998853 345699999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++........ ....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ...........+
T Consensus 199 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~ 270 (311)
T 3p1a_A 199 GDFGLLVELGTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLP 270 (311)
T ss_dssp CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCC
T ss_pred ccceeeeecccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCC
Confidence 999999876543322 22348999999999876 7899999999999999999997765321 111111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ......++++.+++.+||+.||++|||++|+++
T Consensus 271 ~------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 P------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 001123466899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.42 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=199.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|++. ++.||||+++... ..+++.+|++++++++||||+++++++. ...+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence 468999999999999999999985 7899999987543 4577899999999999999999999863 3345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++++|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEee
Confidence 99999999999999953 2223488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||++........ ...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 161 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~- 232 (278)
T 1byg_A 161 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK- 232 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC-
T ss_pred cccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC-
Confidence 999986543221 1237889999999988899999999999999999998 99998632111 11111100000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
...+..+++++.+++.+||+.||++|||+.|+++.|++++...
T Consensus 233 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 -----------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0001123456899999999999999999999999999997653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=358.95 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=200.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 4689999999999999999999999999999999975421 1334677899999999999999999995
Q ss_pred ccCCCceeEEEEcccCC-chhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 782 YQGNDFKALVFEFMHNR-SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
...+..++||||+.+| +|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFID----------RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIA 164 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHH----------TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEc
Confidence 4556889999999777 9999994 334689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
+++.+||+|||+++......... ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------ 235 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------ 235 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred CCCcEEEeecccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence 99999999999998775543322 2348999999999988876 7899999999999999999999853111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ +...++++.+++.+||+.||++|||++|+++.
T Consensus 236 -------------~~~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------------TVEAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------------GTTTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------------HHhhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00123458999999999999999999999885
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.43 Aligned_cols=282 Identities=19% Similarity=0.192 Sum_probs=197.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 785 (1033)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|++++++++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 457899999999999999999999989999999998543 2334567889999999999999999999975432 1122
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||+ +++|.++++. ..+++..+..++.||++||+|||++ ||+||||||+||+++.++.+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence 4569999999 8899999842 4588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++...... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+......
T Consensus 168 kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 241 (367)
T 1cm8_A 168 KILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKV 241 (367)
T ss_dssp EECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred EEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 999999998754321 22358999999999877 679999999999999999999999986322110 11111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ....+.+......................-........+.+.+++.+||+.||++|||++|+++.
T Consensus 242 ~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 242 TG-TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HC-CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cC-CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 00000000000000000000000000000000011234668999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.60 Aligned_cols=271 Identities=20% Similarity=0.262 Sum_probs=203.3
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-----CchhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
++....++|++.+.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|++++++++||||+++++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-- 97 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-- 97 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--
Confidence 3455677899999999999999999999999999999998643 234557899999999999999999999995
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCcc------------------------------ccccccccCHHHHHHHH
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------TEEAPRSLNLLQRLDIG 829 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~ 829 (1033)
...+..++||||+++|+|.+++........ .......+++..+..++
T Consensus 98 ---~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 98 ---EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ---ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ---ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 445689999999999999999953111100 00113345678889999
Q ss_pred HHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC--cEEEeecccceecCCCCc--cccccccccccccccccccCC--C
Q 042075 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM--IAHVGDFGLATFLPLSHA--QTSSIFAKGSIGYIAPEYGLG--S 903 (1033)
Q Consensus 830 ~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~ 903 (1033)
.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 9999999999999 999999999999998776 899999999987533221 111223458999999999875 6
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHH
Q 042075 904 EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE 983 (1033)
Q Consensus 904 ~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1033)
.++.++|||||||++|||++|+.||......+ ........... ... .....
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~------------~~~----------------~~~~~ 302 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLC------------FEN----------------PNYNV 302 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC------------TTS----------------GGGGG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccc------------cCC----------------ccccc
Confidence 78999999999999999999999986322111 11111110000 000 00011
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 984 CLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 984 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.++++.+++.+||+.||++|||+.|+++.
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 24568999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=353.11 Aligned_cols=278 Identities=22% Similarity=0.321 Sum_probs=211.0
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHh--cCCCCceeEeeeecc
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACSG 779 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 779 (1033)
+...-....++|++.+.||+|+||.||+|++. ++.||||+++.. ..+.+.+|+++++. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34334455678999999999999999999984 899999998643 34667889999888 699999999999643
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecc
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH--------HDCQPPIVHCD 851 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivHrD 851 (1033)
.. ......++||||+++|+|.++++. ..+++.++..++.|++.||+||| +. +|+|||
T Consensus 108 ~~-~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~D 172 (342)
T 1b6c_B 108 DN-GTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRD 172 (342)
T ss_dssp CC-SSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSC
T ss_pred cC-CccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCC
Confidence 22 111378999999999999999942 35899999999999999999999 77 999999
Q ss_pred CCCCCeEecCCCcEEEeecccceecCCCCccc--cccccccccccccccccCCC------CCCcccchHHHHHHHHHHHh
Q 042075 852 LKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 852 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~vl~ellt 923 (1033)
|||+||++++++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999999999999999999998765433211 12234589999999998765 34478999999999999999
Q ss_pred C----------CCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHh
Q 042075 924 R----------KKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGV 993 (1033)
Q Consensus 924 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 993 (1033)
| +.||......+.....+.......... +... .+ ....++++.+.+++.
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~----------------~~-~~~~~~~~~l~~li~ 311 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR----PNIP----------------NR-WQSCEALRVMAKIMR 311 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC----CCCC----------------GG-GGTSHHHHHHHHHHH
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC----CCCc----------------cc-ccchhHHHHHHHHHH
Confidence 9 667654333332333222211111100 0000 00 012246678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 994 ACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 994 ~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
+||+.||++|||+.||++.|+++.+..
T Consensus 312 ~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 312 ECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999997654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=350.34 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=206.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------- 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 782 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457899999999999999999999899999999987543 346789999999999999999998754222
Q ss_pred ----cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 783 ----QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 783 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
......++||||+++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil 154 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEK--------RRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIF 154 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHH--------GGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEE
Confidence 124457999999999999999953 2335689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+++++.+||+|||++.......... ...||+.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 224 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------- 224 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred EcCCCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence 9999999999999998765443222 234899999999999999999999999999999999999886311
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
...... ..+.... ...+..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 225 ~~~~~~--------~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 SKFFTD--------LRDGIIS----------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHH--------HHTTCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHH--------hhccccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 001000 0000000 0113457899999999999999999999999999876
Q ss_pred Hhh
Q 042075 1019 ILL 1021 (1033)
Q Consensus 1019 ~~~ 1021 (1033)
...
T Consensus 275 ~~~ 277 (284)
T 2a19_B 275 SPE 277 (284)
T ss_dssp ---
T ss_pred CCC
Confidence 554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=346.63 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=199.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
+.|++.+.||+|+||.||+|.+..++..||+|+++.. .....+.+.+|+.++++++||||+++++++... .......
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 3478888999999999999999999999999998743 334457789999999999999999999987543 2345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEec-CCCcE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLLD-EEMIA 865 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~ 865 (1033)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. + |+||||||+||+++ +++.+
T Consensus 105 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred EEEEEecCCCCHHHHHH----------HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence 99999999999999994 235689999999999999999999998 7 99999999999998 78999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||++........ ....||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ........
T Consensus 172 kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~ 242 (290)
T 1t4h_A 172 KIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRV 242 (290)
T ss_dssp EECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHH
T ss_pred EEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHH
Confidence 9999999975443322 12348999999998764 589999999999999999999999863221 11111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ .+...++++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 243 TSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 10000000 000113458999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=357.31 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=178.8
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCceeEEEEc
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+++++. ||||+++++++ ..+...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence 47899999999999999999999999998743 3466789999999996 99999999995 455688999999
Q ss_pred ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC---cEEEeecc
Q 042075 795 MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM---IAHVGDFG 871 (1033)
Q Consensus 795 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DfG 871 (1033)
+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIK----------KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999995 335689999999999999999999999 999999999999998665 89999999
Q ss_pred cceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCC--ccHHHHHhhhCCcc
Q 042075 872 LATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD--MNLHNFAKTALPDH 949 (1033)
Q Consensus 872 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~ 949 (1033)
+++......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .............
T Consensus 155 ~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~- 231 (325)
T 3kn6_A 155 FARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG- 231 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-
T ss_pred cceecCCCCCcc--cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-
Confidence 998765433222 22348999999999999999999999999999999999999996432210 0111111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..... .......++++.+++.+||+.||++|||++|+++
T Consensus 232 -------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 232 -------DFSFE----------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -------CCCCC----------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -------CCCCC----------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00000 0011123567899999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=364.36 Aligned_cols=255 Identities=18% Similarity=0.226 Sum_probs=193.4
Q ss_pred hCCCCcc-ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSA-NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|.+. ++||+|+||+||+|.+..+++.||||+++.. ..+.+|++++.+. +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567776 6899999999999999999999999998632 4567888887554 899999999986432 233557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.|+||||+++|+|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHC--------C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHH--------hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence 8999999999999999953 2234689999999999999999999999 9999999999999997 789
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc--cHHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM--NLHNFA 942 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~--~~~~~~ 942 (1033)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 203 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 999999999876433222 224489999999999999999999999999999999999999964322111 011110
Q ss_pred h-hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 K-TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ...... .+ ....+++++.+++.+||+.||++|||+.|+++.
T Consensus 280 ~~~~~~~~-----~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 280 RMGQYEFP-----NP-----------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHTCCCCC-----TT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HcCcccCC-----Cc-----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 00 001234568999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=345.21 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=213.0
Q ss_pred hCCCCccc-eecccCceeEEEEEeC--CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSAN-LIGAGSFGSVYKGILD--EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++... ....+++.+|++++++++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence 34666666 9999999999999864 467889999997643 345578899999999999999999999962 2
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred CCcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCE
Confidence 358999999999999999953 345689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHh
Q 042075 866 HVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 943 (1033)
||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ........
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~ 227 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIE 227 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHH
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHh
Confidence 999999998775433221 1222346899999999988889999999999999999998 9999863221 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQ 1023 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 1023 (1033)
.... ...+..+++++.+++.+||+.||++||++.|+++.|+++......+
T Consensus 228 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 228 QGKR------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCc------------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1000 0001123456899999999999999999999999999999887766
Q ss_pred hhhcc
Q 042075 1024 RIVSN 1028 (1033)
Q Consensus 1024 ~~~~~ 1028 (1033)
.-...
T Consensus 278 ~~~~~ 282 (287)
T 1u59_A 278 VEGHH 282 (287)
T ss_dssp CSSCC
T ss_pred ccCCc
Confidence 54443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.53 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=182.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence 3467999999999999999999998899999999987432 22346789999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++.. ....+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCE
T ss_pred CeEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence 688999999999999999953 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||.+.......... ....||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ...
T Consensus 152 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~-- 222 (278)
T 3cok_A 152 KIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLN-- 222 (278)
T ss_dssp EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------
T ss_pred EEEeecceeeccCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHH--
Confidence 999999998765332221 22348999999999999899999999999999999999999986321110 000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..... ... .+...+.++.+++.+||+.||++|||++|+++
T Consensus 223 ------~~~~~----~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 ------KVVLA----DYE----------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -------CCSS----CCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------HHhhc----ccC----------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000 000 00012345889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=374.80 Aligned_cols=231 Identities=22% Similarity=0.150 Sum_probs=166.1
Q ss_pred EEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccc
Q 042075 383 VLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNF 461 (1033)
Q Consensus 383 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~ 461 (1033)
.|++++|.+++..+..|.++++|++|++++|++++..+..|..+++|+.|+|++|++.+..+..|..+. |++|++++|.
T Consensus 132 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT
T ss_pred EEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc
Confidence 333333444444556677888899999999999977777899999999999999988866555555554 5555555555
Q ss_pred cCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCc
Q 042075 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541 (1033)
Q Consensus 462 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (1033)
+.+.+|..+....+|++ |++++|++++..+..|..+++|+.|+|++|++++..+.
T Consensus 212 ~~~~~~~~~~~~~~L~~-------------------------L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 266 (477)
T 2id5_A 212 YLDTMTPNCLYGLNLTS-------------------------LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266 (477)
T ss_dssp TCCEECTTTTTTCCCSE-------------------------EEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccCcccccCccccE-------------------------EECcCCcccccCHHHhcCccccCeeECCCCcCCccChh
Confidence 54444444444444444 45555555433234566778888888888888877777
Q ss_pred ccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccc
Q 042075 542 TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNAS 621 (1033)
Q Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~ 621 (1033)
.|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+..+.+++..
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~ 346 (477)
T 2id5_A 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRW 346 (477)
T ss_dssp SCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTT
T ss_pred hccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhh
Confidence 88888888888888888888888888888888888888888887777778888888888888888888776554444444
Q ss_pred cccccccccccCCcccc
Q 042075 622 ITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 622 ~~~~~~n~~lcg~~~~~ 638 (1033)
...+.++...|+.|...
T Consensus 347 ~~~~~~~~~~C~~p~~~ 363 (477)
T 2id5_A 347 RLNFNRQQPTCATPEFV 363 (477)
T ss_dssp SSCCTTCCCBEEESGGG
T ss_pred ccccCccCceeCCchHH
Confidence 45566777778776554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.14 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=199.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
+.++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence 3568999999999999999999999999999999986432 22346788999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++. ....+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred CEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence 57899999999999999984 235689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||++........ ....||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ........
T Consensus 149 ~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~ 219 (279)
T 3fdn_A 149 KIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRI 219 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH
T ss_pred EEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHHHHH
Confidence 9999999865433221 22348999999999999999999999999999999999999986321 11111000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. . .... .+...++.+.+++.+||+.||++|||++|+++.
T Consensus 220 ~-----~-~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 S-----R-VEFT----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp H-----H-TCCC----------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred H-----h-CCCC----------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 0000 001123558899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.42 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=208.1
Q ss_pred HhhCCCCccc-eecccCceeEEEEEe--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 708 NATDGFTSAN-LIGAGSFGSVYKGIL--DEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 708 ~~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
...++|++.+ .||+|+||+||+|.+ ..+++.||||+++... ....+++.+|++++++++||||+++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 87 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC----- 87 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 3456788888 999999999999954 5567899999997542 23357899999999999999999999986
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
..+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCC
Confidence 23468999999999999999952 34589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~ 940 (1033)
+.+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~ 231 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTA 231 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Confidence 999999999998765443321 1222336789999999988889999999999999999999 9999863211 11111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
........ ..+..+++++.+++.+||+.||++||++.|+++.|+++-...
T Consensus 232 ~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 232 MLEKGERM------------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11100000 001123456899999999999999999999999999998766
Q ss_pred hhc
Q 042075 1021 LGQ 1023 (1033)
Q Consensus 1021 ~~~ 1023 (1033)
.+.
T Consensus 282 ~~~ 284 (291)
T 1xbb_A 282 VNE 284 (291)
T ss_dssp HHH
T ss_pred hhc
Confidence 543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=376.61 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=203.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+++.+|++++++++||||+++++++.+ +..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence 34578899999999999999999984 56799999975432 34789999999999999999999998632 468
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.++++. .....+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 322 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 322 (452)
T ss_dssp EEEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEehhhcCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEEC
Confidence 999999999999999953 2234589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .........
T Consensus 323 DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~-- 397 (452)
T 1fmk_A 323 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERG-- 397 (452)
T ss_dssp CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT--
T ss_pred CCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC--
Confidence 99999876433221 1222347889999999988899999999999999999999 99998632111 011000000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
.+.+.+..+++.+.+++.+||+.||++|||++++++.|+++.....
T Consensus 398 ----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 ----------------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp ----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0001112345678999999999999999999999999998865443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.24 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=192.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCC--CCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++++++| |||+++++++ ..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 467999999999999999999986 6889999998743 23345778999999999976 9999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||| +.+++|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHH----------HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred CEEEEEEe-CCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 58999999 55889999995 345689999999999999999999999 999999999999997 5789
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 9999999987654433322333459999999999754 67899999999999999999999998632211
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ..++....... +...+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ---~~~~~---------~~~~~~~~~~~------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ---ISKLH---------AIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHH---------HHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHH---------HHhcCCcccCC------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111 11111000000 00112458899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.92 Aligned_cols=278 Identities=21% Similarity=0.255 Sum_probs=204.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++... .+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 367999999999999999999999899999999987433 467889999999996 9999999999643 224578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL 867 (1033)
++||||+++++|.++++ .+++.++..++.|++.||+|||++ ||+||||||+||+++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999883 278889999999999999999999 999999999999999776 8999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+++......... ...||..|+|||++.+ ..++.++||||+||++|||++|+.||.................-
T Consensus 173 ~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 9999998765443322 2348999999999877 67899999999999999999999998533222222222111111
Q ss_pred CcchhhhcccccCCCchh---hhhccc--hhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDED---LAVHGN--QRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+.++......... ...... ..............++++.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111111110000000 000000 000000111112245678999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=350.69 Aligned_cols=270 Identities=23% Similarity=0.259 Sum_probs=198.1
Q ss_pred hCCCCcc-ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSA-NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+.|++. +.||+|+||+||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++ ..++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCE
Confidence 3578874 7899999999999999989999999999866555567899999999995 799999999995 34558
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc---
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI--- 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--- 864 (1033)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----------RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred EEEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence 9999999999999999952 34689999999999999999999999 9999999999999998775
Q ss_pred EEEeecccceecCCCCc-----cccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 865 AHVGDFGLATFLPLSHA-----QTSSIFAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
+||+|||++........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999976542211 111122348999999999865 56899999999999999999999999754322
Q ss_pred CccHHHHHhh-hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 935 DMNLHNFAKT-ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 935 ~~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+..+...... .......+.+.......+ .......++++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGKYEFP---------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccchhHHHHHHHHHhccCcccC---------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2111000000 000000000000000000 00001234668999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=352.30 Aligned_cols=263 Identities=23% Similarity=0.391 Sum_probs=201.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCC----CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG----KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
.++|++.+.||+|+||.||+|.+..+ +..||||+++... ......+.+|+.++++++||||+++++++ ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence 34677889999999999999998644 3469999997543 33456789999999999999999999995 44
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..++||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||++++++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCc
Confidence 5688999999999999999953 335689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~ 263 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAI 263 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH
Confidence 999999999876443221 11122336789999999998999999999999999999999 99998532110 011100
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
.... +...+..++.++.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 264 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 264 NDGF------------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HTTC------------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HCCC------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0000 000011234568999999999999999999999999999877554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=374.37 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=204.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.++||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++ ...+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence 457899999999999999999999999999999997432 23346688999999999999999999984 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||++||+|.+++.. .....+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~--------~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYH--------MGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHS--------SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 89999999999999999954 2234589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+|+......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 327 L~DFGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~ 402 (576)
T 2acx_A 327 ISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVK 402 (576)
T ss_dssp ECCCTTCEECCTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHH
T ss_pred EEecccceecccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhh
Confidence 99999998765443222 2359999999999999999999999999999999999999996432211 1111111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
..... .+...++++.+++.+||+.||++|| +++||++.
T Consensus 403 ---------~~~~~-------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 ---------EVPEE-------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---------HCCCC-------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---------ccccc-------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00000 0011235689999999999999999 77888764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=381.26 Aligned_cols=385 Identities=20% Similarity=0.226 Sum_probs=248.3
Q ss_pred CCCCCCCCCCCCCCCcc----eeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCcccccc
Q 042075 56 DPLGVFGSWNESIHFCQ----WHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRL 131 (1033)
Q Consensus 56 ~~~~~~~~W~~~~~~c~----w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 131 (1033)
+....+++|..+.+||. |.++.|+.. + +-..... .....-..+++++.|++++|.+.+..+..|..+
T Consensus 4 ~~~~~l~~~~~~~~C~~~~~~~~c~~~~~~----i---~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l 74 (597)
T 3oja_B 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVH----I---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74 (597)
T ss_dssp -------CCCSEECCCCC--CCSEEECSCE----E---CSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHC
T ss_pred cccccccCCCCCCcCcccCcCceeEecCce----e---ccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccC
Confidence 34456789998878874 777766521 1 1111111 111122346778888888888876555567778
Q ss_pred ccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEc
Q 042075 132 RRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211 (1033)
Q Consensus 132 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 211 (1033)
++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 88888888888888777778888888888888888888777777777888888888888877555555677777777777
Q ss_pred ccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCC
Q 042075 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291 (1033)
Q Consensus 212 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~ 291 (1033)
++|.+++..|..|+.+++|++|+|++|++++..
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----------------------------------------------- 187 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD----------------------------------------------- 187 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC-----------------------------------------------
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC-----------------------------------------------
Confidence 777777666666666666666666666555210
Q ss_pred CCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCc
Q 042075 292 AIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371 (1033)
Q Consensus 292 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip 371 (1033)
+..+++|+.|++++|.++
T Consensus 188 -----~~~l~~L~~L~l~~n~l~--------------------------------------------------------- 205 (597)
T 3oja_B 188 -----LSLIPSLFHANVSYNLLS--------------------------------------------------------- 205 (597)
T ss_dssp -----GGGCTTCSEEECCSSCCS---------------------------------------------------------
T ss_pred -----hhhhhhhhhhhcccCccc---------------------------------------------------------
Confidence 111122222222222222
Q ss_pred cccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce
Q 042075 372 ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451 (1033)
Q Consensus 372 ~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 451 (1033)
+ +...++|+.|++++|.++...+. + .++|+.|+|++|.++
T Consensus 206 ---------------------~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~----------- 245 (597)
T 3oja_B 206 ---------------------T-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLT----------- 245 (597)
T ss_dssp ---------------------E-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCC-----------
T ss_pred ---------------------c-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCC-----------
Confidence 1 01112344444444444322111 1 123444444444433
Q ss_pred eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcc
Q 042075 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVF 531 (1033)
Q Consensus 452 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (1033)
+ +..+..+++|++|+|++|+++ +..|..|+.+++|+.|+|+
T Consensus 246 ------------~--~~~l~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls 286 (597)
T 3oja_B 246 ------------D--TAWLLNYPGLVEVDLSYNELE-------------------------KIMYHPFVKMQRLERLYIS 286 (597)
T ss_dssp ------------C--CGGGGGCTTCSEEECCSSCCC-------------------------EEESGGGTTCSSCCEEECT
T ss_pred ------------C--ChhhccCCCCCEEECCCCccC-------------------------CCCHHHhcCccCCCEEECC
Confidence 2 133445556666666666554 4556677788889999999
Q ss_pred ccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccC
Q 042075 532 ENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMV 611 (1033)
Q Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 611 (1033)
+|++++ +|..+..+++|+.|+|++|+++ .+|..++.+++|+.|+|++|+|++. | +..+++|+.|+|++|+++|..
T Consensus 287 ~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp TSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 999985 6777888999999999999998 6888889999999999999999854 3 667889999999999999875
Q ss_pred CCcccccccccccccccccccCCccccCCCCC
Q 042075 612 PTEGVFRNASITSVLGNLKLCGGTHEFRLPTC 643 (1033)
Q Consensus 612 p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~ 643 (1033)
+. ..+..+....+.++...|+.+.......|
T Consensus 362 ~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~c 392 (597)
T 3oja_B 362 LR-ALFRNVARPAVDDADQHCKIDYQLEHGLC 392 (597)
T ss_dssp HH-HHTTTCCTTTBCCCCCCCCTTCEEETTEE
T ss_pred HH-HHHHHHhhhccccccccCCcchhccCCcc
Confidence 43 34566666778889999998665544444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=358.42 Aligned_cols=276 Identities=21% Similarity=0.295 Sum_probs=195.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch-hHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++ ..++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 5799999999999999999999989999999998743322 122455799999999999999999995 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||++ |+|.+++.. ....+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDD---------CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence 9999997 599998853 345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC-
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP- 947 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 947 (1033)
||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...........
T Consensus 144 fg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 220 (324)
T 3mtl_A 144 FGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTP 220 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred CcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 9999865433222 122348999999999876 568999999999999999999999996432111 11111111100
Q ss_pred --cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 --DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 --~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
......... ........................+++.+++.+||+.||++|||++|+++.
T Consensus 221 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 221 TEETWPGILSN-----EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CTTTSTTGGGC-----HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChHhchhhhcc-----hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 001110000 000000000000000011111234568999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=361.56 Aligned_cols=269 Identities=16% Similarity=0.153 Sum_probs=205.7
Q ss_pred hCCCCccceecccCceeEEEEEeCC--------CCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeE--------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE--------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI-------- 773 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------- 773 (1033)
.++|++.+.||+|+||.||+|++.. .++.||||+++.. +.+.+|++++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999986 3789999998743 457899999999999999984
Q ss_pred -------eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042075 774 -------LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846 (1033)
Q Consensus 774 -------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (1033)
++++ ...++..++||||+ +++|.+++.. .....+++.++..++.||+.||+|||++ +
T Consensus 116 ~~~i~~~~~~~----~~~~~~~~lv~e~~-~~~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ 179 (352)
T 2jii_A 116 LLAIPTCMGFG----VHQDKYRFLVLPSL-GRSLQSALDV--------SPKHVLSERSVLQVACRLLDALEFLHEN---E 179 (352)
T ss_dssp TCSCCCCCEEE----EETTTEEEEEEECC-CEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccCccchhhcc----ccCCcEEEEEecCC-CcCHHHHHHh--------CCcCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4443 22356789999999 9999999953 1246799999999999999999999999 9
Q ss_pred cEeccCCCCCeEecCCC--cEEEeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHH
Q 042075 847 IVHCDLKPSNVLLDEEM--IAHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLL 919 (1033)
Q Consensus 847 ivHrDlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ 919 (1033)
|+||||||+||+++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999998 99999999998764332111 112235899999999999999999999999999999
Q ss_pred HHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCC
Q 042075 920 ELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMES 999 (1033)
Q Consensus 920 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 999 (1033)
||++|+.||................. ........+.... ....++++.+++.+||+.|
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGH---------------------WIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSC---------------------EECCCHHHHHHHHHHHTCC
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhccc---------------------cCCCcHHHHHHHHHHHhCC
Confidence 99999999974332221121111110 0000000000000 0012356899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHhh
Q 042075 1000 PEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 1000 P~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
|++|||++|+++.|+++.+...
T Consensus 318 p~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 318 YEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhhCCCHHHHHHHHHHHHHhcC
Confidence 9999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=362.72 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=193.5
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--------chhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999999999999999987432 112235789999999999999999999852
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
.+..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred -----cCceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 234789999999999999984 345689999999999999999999999 99999999999999
Q ss_pred cCC---CcEEEeecccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 042075 860 DEE---MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFE 933 (1033)
Q Consensus 860 ~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~ 933 (1033)
+.+ +.+||+|||+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 754 45999999999876543222 22458999999999853 5688999999999999999999999964322
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ............... ....+.++++.+++.+||+.||++|||++|+++.
T Consensus 350 ~~-~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 350 QV-SLKDQITSGKYNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SC-CHHHHHHTTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hH-HHHHHHhcCCCCCCc---------------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 21 111111110000000 0011234568999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.84 Aligned_cols=250 Identities=22% Similarity=0.236 Sum_probs=190.5
Q ss_pred hCCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 467999999999999999999984 578999999997532 23345678899999999999999999995
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
..++..++||||+++++|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 44568999999999999999994 234688999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
+.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~ 234 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKIL 234 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred CcEEEEeCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 99999999999764332221 12245899999999999999999999999999999999999998632110 0011111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
.. .. ..+...++++.+++.+||+.||++|| ++.|+++.
T Consensus 235 ~~------------~~--------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 KC------------KL--------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HT------------CC--------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred hC------------CC--------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 00 00 00011235689999999999999999 67777663
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=354.52 Aligned_cols=268 Identities=23% Similarity=0.368 Sum_probs=203.3
Q ss_pred hCCCCccceecccCceeEEEEE-----eCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGI-----LDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|+ ...+++.||||+++.. ......++.+|+.++++++||||+++++++ .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----c
Confidence 4689999999999999999999 4456788999999743 334456789999999999999999999995 3
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC--
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-- 861 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-- 861 (1033)
..+..++||||+++++|.+++...... ......+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCC---SSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhccc---ccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence 455789999999999999999653221 12335689999999999999999999999 9999999999999984
Q ss_pred -CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 862 -EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 862 -~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
+..+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHH
Confidence 44699999999976543332222233447899999999988899999999999999999998 9999853211 1111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
......... ..+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 256 ~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 EFVTSGGRM------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111100000 00012345689999999999999999999999999998764
Q ss_pred h
Q 042075 1020 L 1020 (1033)
Q Consensus 1020 ~ 1020 (1033)
.
T Consensus 306 ~ 306 (327)
T 2yfx_A 306 P 306 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.45 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=196.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ...+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 357999999999999999999999899999999987543 33457889999999999999999999995 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIA 865 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~ 865 (1033)
++||||+++|+|.+++... ......+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSA------QARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCcHHHHHHhh------hhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence 9999999999999998531 12336689999999999999999999999 99999999999999 456789
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||++......... ....||+.|+|||++. ..++.++||||+||++|||++|+.||...... .........
T Consensus 167 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~ 240 (285)
T 3is5_A 167 KIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYK 240 (285)
T ss_dssp EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred EEEeeecceecCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccC
Confidence 99999999865443222 2234899999999875 56899999999999999999999998632111 111100000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.+. ..... ...++++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~---------~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPN---------YAVEC-------------------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC---------CCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Ccc---------ccccc-------------------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000 001345889999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=351.53 Aligned_cols=269 Identities=17% Similarity=0.208 Sum_probs=207.6
Q ss_pred CCCCCCCHHHHHHhhCCCCcc-ceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhc-CCCCce
Q 042075 696 NSFPNISYQNLYNATDGFTSA-NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLV 771 (1033)
Q Consensus 696 ~~~~~~~~~~l~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv 771 (1033)
..-+++.++....-.++|.+. +.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++++ .||||+
T Consensus 13 ~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp ---CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred ccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEE
Confidence 344566666666777788887 89999999999999999999999999987432 23357789999999999 569999
Q ss_pred eEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEecc
Q 042075 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCD 851 (1033)
Q Consensus 772 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 851 (1033)
++++++ ...+..++||||+++|+|.+++.. .....+++.++..++.|++.||+|||++ ||+|||
T Consensus 93 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~D 156 (327)
T 3lm5_A 93 NLHEVY-----ENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLD 156 (327)
T ss_dssp CEEEEE-----ECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred EEEEEE-----EeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCc
Confidence 999995 455689999999999999999853 2345689999999999999999999999 999999
Q ss_pred CCCCCeEecC---CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 852 LKPSNVLLDE---EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 852 lkp~NIll~~---~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
|||+||+++. ++.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (327)
T 3lm5_A 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233 (327)
T ss_dssp CCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChHHEEEecCCCCCcEEEeeCccccccCCccccc---cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999987 7899999999998765433222 234899999999999999999999999999999999999998
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
......+ .+......... ... .....+++.+.+++.+||+.||++|||++|
T Consensus 234 ~~~~~~~-~~~~i~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 234 VGEDNQE-TYLNISQVNVD-YSE---------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp CCSSHHH-HHHHHHHTCCC-CCT---------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCchH-HHHHHHhcccc-cCc---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 6321110 01111000000 000 000123456889999999999999999999
Q ss_pred HHHH
Q 042075 1009 VVHQ 1012 (1033)
Q Consensus 1009 vl~~ 1012 (1033)
+++.
T Consensus 285 ll~h 288 (327)
T 3lm5_A 285 CLSH 288 (327)
T ss_dssp HTTC
T ss_pred HhCC
Confidence 9864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.15 Aligned_cols=279 Identities=24% Similarity=0.319 Sum_probs=194.2
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
....++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence 3456789999999999999999999999999999999974332 2345678999999999999999999995 44
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe-----
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----- 859 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----- 859 (1033)
++..++||||++ |+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMD----------KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred CCEEEEEEecCC-CCHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence 558999999997 59999984 334589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
++++.+||+|||+++......... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~ 247 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QL 247 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred CccceEEECcCCCccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HH
Confidence 455569999999998764332221 223479999999998874 48999999999999999999999986432211 11
Q ss_pred HHHHhh-hCCcc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 939 HNFAKT-ALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 939 ~~~~~~-~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...... ..+.. ....... ......... .......+........+++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 248 FKIFEVLGLPDDTTWPGVTA-LPDWKQSFP---KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHCCCCTTTSTTGGG-STTCCTTCC---CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhhhhhhhh-hhhhhhhhh---hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111111 11111 0000000 000000000 000000000111123466899999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.65 Aligned_cols=283 Identities=19% Similarity=0.187 Sum_probs=188.9
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 784 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 784 (1033)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|++++++++||||+++++++.... ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3457899999999999999999999999999999998643 2334577889999999999999999999975431 223
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
....++||||+ +++|.++++. ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp CCCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred CCeEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCC
Confidence 35679999999 7899998842 4589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 171 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~ 244 (367)
T 2fst_X 171 LKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR 244 (367)
T ss_dssp EEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred EEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999999999865432 122358999999999877 67899999999999999999999998632211 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ......+.+......................-........+.+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 245 L-VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp H-HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1 1110001110000000000000000000000000011234568999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.92 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=198.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||.||+|+++.+++.||||+++.... ...+|++++.++ +||||+++++++ ..++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 35679999999999999999999999999999999975432 235688888888 799999999994 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC----C
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE----M 863 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~ 863 (1033)
.|+||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||++.++ +
T Consensus 91 ~~lv~E~~~gg~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKIL----------RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEEECCCCSCBHHHHHH----------TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcC
Confidence 999999999999999984 234689999999999999999999999 99999999999998533 3
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+++......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~ 233 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILA 233 (342)
T ss_dssp GEEECCCTTCEECBCTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHH
T ss_pred eEEEEECCCcccCcCCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHH
Confidence 59999999998764433221 224589999999999888899999999999999999999999963211 11111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... . .... .....++++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~i~~~~~-~-----~~~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 234 RIGSGKF-S-----LSGG------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHCCC-C-----CCST------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHccCCc-c-----cCcc------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1000000 0 0000 001124568999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=361.05 Aligned_cols=261 Identities=13% Similarity=0.084 Sum_probs=205.4
Q ss_pred HHhhCCCCccceecccCceeEEEEE-----eCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC---CCCceeEeeeec
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGI-----LDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACS 778 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 778 (1033)
....++|++.+.||+|+||+||+|. ...+++.||||+++... ..++..|++++++++ |+||+++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~- 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH- 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE-
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee-
Confidence 3456789999999999999999994 55678999999987543 356778888888886 99999999995
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
..++..++||||+++|+|.++++.... .....+++.++..|+.||+.||+|||++ +|+||||||+|||
T Consensus 137 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIl 204 (365)
T 3e7e_A 137 ----LFQNGSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFI 204 (365)
T ss_dssp ----ECSSCEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEE
T ss_pred ----ecCCCcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 345578999999999999999953211 1345699999999999999999999999 9999999999999
Q ss_pred ecC-----------CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 859 LDE-----------EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 859 l~~-----------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
++. ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 998 899999999999865433333333445699999999999999999999999999999999999999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCC-CCH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDR-MDM 1006 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~ 1006 (1033)
|.....+... +........ ..+.+.+++..|++.+|.+| |++
T Consensus 285 f~~~~~~~~~----------------~~~~~~~~~---------------------~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 285 KVKNEGGECK----------------PEGLFRRLP---------------------HLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp CEEEETTEEE----------------ECSCCTTCS---------------------SHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred cccCCCCcee----------------echhccccC---------------------cHHHHHHHHHHHcCCCCCCcchHH
Confidence 8532221100 000000000 12457889999999999999 578
Q ss_pred HHHHHHHHHHHHHh
Q 042075 1007 TNVVHQLQSIKNIL 1020 (1033)
Q Consensus 1007 ~evl~~L~~i~~~~ 1020 (1033)
+++.+.|+++.+..
T Consensus 328 ~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 328 DLLRQKLKKVFQQH 341 (365)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 88999998887654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.03 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=202.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc------hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 568999999999999999999998999999999875322 1357789999999999999999999995 34
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM- 863 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~- 863 (1033)
.+..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLA----------EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSS
T ss_pred CCeEEEEEeecCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCC
Confidence 557899999999999999994 235689999999999999999999999 999999999999998877
Q ss_pred ---cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 864 ---IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 864 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
.+||+|||.+......... ....|++.|+|||++.+..++.++||||||+++|||++|+.||..... . .
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-~ 218 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----Q-E 218 (283)
T ss_dssp SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----H-H
T ss_pred CCCceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----H-H
Confidence 8999999999876543322 223489999999999999999999999999999999999999863211 1 1
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
....... ... .... ......++.+.+++.+||+.||++|||+.|+++. ++.++.
T Consensus 219 ~~~~~~~--------~~~-~~~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 219 TLTNISA--------VNY-DFDE---------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHT--------TCC-CCCH---------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHhHh--------ccc-CCcc---------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1000000 000 0000 0011234568999999999999999999999984 555544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=361.86 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=191.8
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcC--CCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.+.||+|+||.||+|.+.. ++.||||+++.. .....+.+.+|+.++++++ ||||+++++++. .++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 459999999999999999999874 889999998743 2344578899999999996 599999999853 445
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||| +.+++|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 7999999 568899999953 34688899999999999999999999 999999999999995 57999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccccCC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~ 935 (1033)
|+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~- 273 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ- 273 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-
Confidence 999999987654433222233459999999999865 36899999999999999999999999632211
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... . .+++....... +...+.++.+++.+||+.||++|||+.|+++.
T Consensus 274 --~~~~-~--------~~~~~~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 --ISKL-H--------AIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHH-H--------HHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHH-H--------HHhCccccCCC------------------CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 1 11111100000 00012458899999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=356.61 Aligned_cols=247 Identities=26% Similarity=0.340 Sum_probs=197.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+.|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++||||+++++++. .++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence 45888999999999999999998899999999997432 233467889999999999999999999953 4458
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||++ |++.+++.. ....+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 899999997 688888742 345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||+++...... ...||+.|+|||++. +..++.++|||||||++|||++|+.||....... ........
T Consensus 196 ~DfG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~ 268 (348)
T 1u5q_A 196 GDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 268 (348)
T ss_dssp CCCTTCBSSSSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred eeccCceecCCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc
Confidence 9999998654321 234899999999874 5678999999999999999999999985321110 01111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. +... ....++.+.+++.+||+.||++|||++|+++.
T Consensus 269 ~~---------~~~~---------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ES---------PALQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC---------CCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---------CCCC---------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000 00123458899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.46 Aligned_cols=248 Identities=24% Similarity=0.258 Sum_probs=189.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHH-HHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|+++.+++.||||+++... ......+.+|..+ ++.++||||+++++++ ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 457999999999999999999999999999999997543 2233456677776 5678999999999994 455
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..|+||||++||+|.++++ ....+++..+..++.||+.||+|||++ ||+||||||+||+++.++++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 68999999999999999994 234688999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........
T Consensus 179 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i 251 (373)
T 2r5t_A 179 VLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNI 251 (373)
T ss_dssp EECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHH
T ss_pred EEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHH
Confidence 9999999986432221 1223459999999999999999999999999999999999999986321 11111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1010 (1033)
...... .+...+.++.+++.+||+.||++||++.+.+
T Consensus 252 --------~~~~~~--------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 252 --------LNKPLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --------HHSCCC--------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --------HhcccC--------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 000000 0001234588999999999999999986433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=353.43 Aligned_cols=269 Identities=22% Similarity=0.229 Sum_probs=196.8
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeecccc---
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD--- 781 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--- 781 (1033)
+.....+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3344568999999999999999999999899999999987666666678899999999995 999999999974221
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--cEeccCCCCCeEe
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP--IVHCDLKPSNVLL 859 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll 859 (1033)
.......++||||+. |+|.+++... .....+++.++..++.||+.||+|||++ + |+||||||+||++
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLL 171 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEE
Confidence 134456899999995 7999988531 2345699999999999999999999998 7 9999999999999
Q ss_pred cCCCcEEEeecccceecCCCCccc----------ccccccccccccccccc---CCCCCCcccchHHHHHHHHHHHhCCC
Q 042075 860 DEEMIAHVGDFGLATFLPLSHAQT----------SSIFAKGSIGYIAPEYG---LGSEVSINGDVYSYGILLLELVTRKK 926 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~vl~elltg~~ 926 (1033)
+.++.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998765432211 11123489999999998 56678999999999999999999999
Q ss_pred CCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 927 PTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 927 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
||...... .......... . .......+.+++.+||+.||++|||+
T Consensus 252 p~~~~~~~-----~~~~~~~~~~------------~------------------~~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 252 PFEDGAKL-----RIVNGKYSIP------------P------------------HDTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp CC-----------------CCCC------------T------------------TCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred CCcchhHH-----HhhcCcccCC------------c------------------ccccchHHHHHHHHHccCChhhCcCH
Confidence 98532110 0000000000 0 00012337889999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 042075 1007 TNVVHQLQSIKNIL 1020 (1033)
Q Consensus 1007 ~evl~~L~~i~~~~ 1020 (1033)
.|+++.|+++.+..
T Consensus 297 ~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 297 AEVVHQLQEIAAAR 310 (337)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcc
Confidence 99999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=371.02 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=192.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|+.++++++||||++++++|. ..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 46799999999999999999999999999999999743 2334466788999999999999999999953 445
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+ . ||+||||||+||+++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 7899999999999999984 34568999999999999999999998 7 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 289 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i 361 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI 361 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred EEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHH
Confidence 99999999864332221 2234599999999999999999999999999999999999999853211 1111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
.... . . .+...++++.+++.+||+.||++|| +++|+++.
T Consensus 362 ~~~~--------~-~-------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 362 LMEE--------I-R-------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHCC--------C-C-------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhCC--------C-C-------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0000 0 0 0011235689999999999999999 99999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.96 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=204.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.+.|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeE
Confidence 457999999999999999999999899999999997543 344578999999999999999999999954 34578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. ..+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence 999999999999999842 4589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+.......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..........+.
T Consensus 162 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~ 237 (303)
T 3a7i_A 162 DFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP 237 (303)
T ss_dssp CCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC
T ss_pred ecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC
Confidence 999998765433221 2245899999999999999999999999999999999999998632111 011111000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
... ...+..+.+++.+||+.||++|||+.|+++..-
T Consensus 238 --------~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 --------TLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --------CCC----------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --------CCc----------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 000 012345899999999999999999999998644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=346.26 Aligned_cols=252 Identities=21% Similarity=0.222 Sum_probs=199.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 45799999999999999999999989999999999865544556788999999999999999999995 4456889
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAH 866 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 866 (1033)
+||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++ ++++.+|
T Consensus 83 lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 83 LVMQLVSGGELFDRIL----------ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEcCCCccHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEE
Confidence 9999999999999984 234689999999999999999999999 99999999999999 7888999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||.+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 150 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~ 224 (304)
T 2jam_A 150 ITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYY 224 (304)
T ss_dssp BCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCC
T ss_pred EccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC
Confidence 99999997543321 11234899999999999999999999999999999999999998632111 00111111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ..+ .....++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~-----~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 EF-----ESP-----------------------FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CC-----CTT-----------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CC-----Ccc-----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 000 001123568999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=344.89 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=203.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++ ..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCC
Confidence 46799999999999999999999999999999998743 233456788999999999999999999995 4455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++. ....+++.++..++.|+++||+|||++ +|+||||||+||++++++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEE
Confidence 7899999999999999884 335689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||.+.......... ....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ........
T Consensus 156 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~ 228 (294)
T 2rku_A 156 IGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIK 228 (294)
T ss_dssp ECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH
T ss_pred EEeccCceecccCcccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHh
Confidence 99999998765332222 224489999999999998999999999999999999999999863211 11100000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... . . .+....+.+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~--------~-~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 229 KNE--------Y-S-------------------IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTC--------C-C-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hcc--------C-C-------------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0 0 000123458899999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.37 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=203.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++.+ ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999999899999999997532 3445778999999999999999999998642 23457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEeccCCCCCeEecCC
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP-----IVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~ 862 (1033)
.++||||+++++|.+++... ......+++.++..++.|++.||+|||+. + |+||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhh------cccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 89999999999999999531 11234589999999999999999999998 7 9999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
+.+||+|||.++......... ....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .......
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i 228 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI 228 (279)
T ss_dssp SCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred CCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH
Confidence 999999999998764332211 123489999999999998999999999999999999999999863211 1111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...... .+ +...+.++.+++.+||+.||++|||++|+++.+.
T Consensus 229 ~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 229 REGKFR--------RI----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHTCCC--------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hhcccc--------cC----------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 100000 00 0112356899999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.73 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=203.6
Q ss_pred HHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhc-CCCCceeE
Q 042075 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNI-RHRNLVKI 773 (1033)
Q Consensus 703 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l 773 (1033)
+.......++|++.+.||+|+||.||+|++..+|+.||||+++.... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 34444556789999999999999999999988899999999875331 1245678999999999 89999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
++++ ...+..++||||+++++|.+++. ....+++..+..++.||+.||+|||+. ||+|||||
T Consensus 166 ~~~~-----~~~~~~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlk 227 (365)
T 2y7j_A 166 IDSY-----ESSSFMFLVFDLMRKGELFDYLT----------EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLK 227 (365)
T ss_dssp EEEE-----EBSSEEEEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred EEEE-----eeCCEEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 9995 44568999999999999999994 235689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCC
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
|+||++++++.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 228 p~NIl~~~~~~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 228 PENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEECCCCCEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 99999999999999999999877544322 22458999999998753 3588999999999999999999999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|..... .......... ...... +.....+.++.+++.+||+.||++|||+.
T Consensus 305 f~~~~~--~~~~~~i~~~-----------~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 305 FWHRRQ--ILMLRMIMEG-----------QYQFSS----------------PEWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp SCCSSH--HHHHHHHHHT-----------CCCCCH----------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCH--HHHHHHHHhC-----------CCCCCC----------------cccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 853211 0000000000 000000 00011235689999999999999999999
Q ss_pred HHHH
Q 042075 1008 NVVH 1011 (1033)
Q Consensus 1008 evl~ 1011 (1033)
|+++
T Consensus 356 ell~ 359 (365)
T 2y7j_A 356 QALQ 359 (365)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=358.24 Aligned_cols=282 Identities=19% Similarity=0.168 Sum_probs=203.2
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-----------hhHHHHHHHHHHHHhcCCCCc
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-----------GAFKSFIAECNTLKNIRHRNL 770 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni 770 (1033)
...++....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34677788899999999999999999999987 489999999864221 123778999999999999999
Q ss_pred eeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 042075 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHC 850 (1033)
Q Consensus 771 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 850 (1033)
+++++++...........++||||++ |+|.+++.. ....+++.++..++.||+.||+|||++ +|+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~ 158 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---------QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHR 158 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEec
Confidence 99999975544344557899999997 688888853 345689999999999999999999999 99999
Q ss_pred cCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCC
Q 042075 851 DLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 851 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~ 929 (1033)
||||+||+++.++.+||+|||+++........ ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999854433222 22348999999999877 678999999999999999999999986
Q ss_pred ccccCCccHHHHHhhhCCcch-----------hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCC
Q 042075 930 IMFEGDMNLHNFAKTALPDHV-----------VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSME 998 (1033)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 998 (1033)
..... ............... .+.+........ ............+.+.+++.+||+.
T Consensus 236 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 236 GSTFY-NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-----------ARAWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp CSSHH-HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC-----------CCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred CCCHH-HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC-----------hhhHHhhCCCCCHHHHHHHHHHhcC
Confidence 43211 111111111111110 011100000000 0000011112346689999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042075 999 SPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 999 dP~~RPt~~evl~~ 1012 (1033)
||++|||++|+++.
T Consensus 304 dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 304 NPQRRISTEQALRH 317 (362)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHHcC
Confidence 99999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=353.45 Aligned_cols=286 Identities=21% Similarity=0.277 Sum_probs=202.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc---cC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 784 (1033)
.++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999999899999999986432 2234578899999999999999999999754321 11
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..++||||+++ +|.+.+.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccCC-CHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 4568999999975 77777742 334689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCcc--ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 999999999876533221 22223458999999999876 458999999999999999999999986432111 11111
Q ss_pred Hhh--hCCcchhhhccc-ccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKT--ALPDHVVDIVDS-TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~--~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... ..+.......+. ....... ...................+.+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSC---CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCChhhccccccchhhcccc---cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111 111111111100 0000000 0000000000000011123568899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=364.06 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=206.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||.||+|++..+++.||||+++.... ..++.+|+++++.++|++.+..+.++ ....+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence 4689999999999999999999988999999999875433 24578999999999875544444443 23455789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCCcEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEMIAH 866 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 866 (1033)
+||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||+ ++++.+|
T Consensus 80 lvme~~-g~sL~~ll~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNF---------CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEECC-CCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEE
Confidence 999999 9999999953 245699999999999999999999999 99999999999999 6889999
Q ss_pred EeecccceecCCCCccc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCc--cHH
Q 042075 867 VGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM--NLH 939 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~--~~~ 939 (1033)
|+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 99999998765443221 11234599999999999999999999999999999999999999974322110 011
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
........... ......+++++.+++..||+.||++||++++|++.|+++...
T Consensus 227 ~i~~~~~~~~~---------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 227 KISEKKVATSI---------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHSCH---------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhccccccH---------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11000000000 000112346799999999999999999999999999999765
Q ss_pred hh
Q 042075 1020 LL 1021 (1033)
Q Consensus 1020 ~~ 1021 (1033)
..
T Consensus 280 ~~ 281 (483)
T 3sv0_A 280 EG 281 (483)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.47 Aligned_cols=280 Identities=23% Similarity=0.302 Sum_probs=200.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++. ..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCC
Confidence 34689999999999999999999998999999999864332 23456789999999999999999999953 455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 98 ~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEE
Confidence 7899999999999998873 334689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.++......... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .........
T Consensus 165 l~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 241 (331)
T 4aaa_A 165 LCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCL 241 (331)
T ss_dssp ECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred EEeCCCceeecCCcccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHh
Confidence 99999998654432221 223489999999998775 78999999999999999999999986432211 111111100
Q ss_pred --CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 --LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 --~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..+.................. ..............+++++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 242 GNLIPRHQELFNKNPVFAGVRLP---EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CSCCHHHHHHHHHCGGGTTCCCC---CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCChhhhhHhhhccccccccCc---cccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000000000000 0000000000111245679999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.83 Aligned_cols=273 Identities=23% Similarity=0.291 Sum_probs=202.3
Q ss_pred CCCCCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeE
Q 042075 695 INSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKI 773 (1033)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 773 (1033)
..+...+++.++....++|++.+.||+|+||.||+|++..+++.||||+++.... ..+.+.+|+.+++++ +||||+++
T Consensus 8 ~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp --------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred CCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeee
Confidence 3445566667777788999999999999999999999988999999999875433 347788999999999 89999999
Q ss_pred eeeecccccc-CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccC
Q 042075 774 LTACSGVDYQ-GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDL 852 (1033)
Q Consensus 774 ~~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 852 (1033)
++++...... ..+..++||||+++++|.+++.. .....+++..+..++.||+.||+|||++ ||+||||
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dl 155 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDI 155 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCC
Confidence 9997542211 14578999999999999999953 2335689999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 853 KPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 853 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
||+||+++.++.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999865432211 12234899999999987 56789999999999999999999999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|....... .......... +... ....+..+.+++.+||+.||++|||++
T Consensus 234 ~~~~~~~~-~~~~~~~~~~---------~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 282 (326)
T 2x7f_A 234 LCDMHPMR-ALFLIPRNPA---------PRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPATE 282 (326)
T ss_dssp TTTSCHHH-HHHHHHHSCC---------CCCS---------------------CSCSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCcHHH-HHHHhhcCcc---------ccCC---------------------ccccCHHHHHHHHHHhccChhhCCCHH
Confidence 85321110 0000000000 0000 001235689999999999999999999
Q ss_pred HHHHH
Q 042075 1008 NVVHQ 1012 (1033)
Q Consensus 1008 evl~~ 1012 (1033)
|+++.
T Consensus 283 ~ll~h 287 (326)
T 2x7f_A 283 QLMKH 287 (326)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=351.55 Aligned_cols=267 Identities=23% Similarity=0.380 Sum_probs=204.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEE--EEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIV--AVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.+.||+|+||.||+|++..++..+ |+|+++.. .....+.+.+|+++++++ +||||+++++++ ...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeCC
Confidence 47899999999999999999998788765 99988743 233456789999999999 999999999995 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCcc------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDE------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++||||+++|+|.+++........ .......+++.++..++.||+.||+|||++ ||+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 88999999999999999964210000 001235689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 939 (1033)
.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~ 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H
T ss_pred CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----H
Confidence 99999999999997432211 1122337889999999988889999999999999999998 9999853211 1
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
....... .. . +...+..+++++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 249 ~~~~~~~-~~--------~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 249 ELYEKLP-QG--------Y------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHGG-GT--------C------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhh-cC--------C------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111100 00 0 0000112245689999999999999999999999999998765
Q ss_pred h
Q 042075 1020 L 1020 (1033)
Q Consensus 1020 ~ 1020 (1033)
.
T Consensus 302 ~ 302 (327)
T 1fvr_A 302 R 302 (327)
T ss_dssp S
T ss_pred h
Confidence 4
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.94 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=196.4
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+|.....||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence 4555669999999999999999899999999998766666688999999999999999999999953 44578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-CCcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-EMIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~Df 870 (1033)
|||+++++|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 98 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 98 MEQVPGGSLSALLRSK-------WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EECCSEEEHHHHHHHT-------TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCCCCHHHHHHhh-------ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence 9999999999999531 1234567888999999999999999999 9999999999999987 899999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|.+.......... ....||+.|+|||++.+.. ++.++||||||+++|||++|+.||..................
T Consensus 168 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 243 (295)
T 2clq_A 168 GTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-- 243 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC--
T ss_pred ccccccCCCCCcc--cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc--
Confidence 9998764432211 2234899999999987643 789999999999999999999998532111100000000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.+. .+...++++.+++.+||+.||++|||++|+++
T Consensus 244 ------~~~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 ------HPE----------------------IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------CCC----------------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------ccc----------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 01123456899999999999999999999976
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=368.54 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=203.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.++||+|+||.||+|+++.+++.||+|+++... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence 367899999999999999999999899999999997432 23346788999999999999999999984 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||++||+|.+++.... .....+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence 8999999999999999986421 1245689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 330 L~DFGla~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~ 406 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL 406 (543)
T ss_dssp ECCCTTCEECCTTCCCB--CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH
T ss_pred EeecceeeeccCCCccc--ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh
Confidence 99999998765443222 22359999999999999999999999999999999999999996432111 1111111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM-----TNVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1011 (1033)
.... ..+...++.+.+++.+||+.||++||++ +++++
T Consensus 407 --------~~~~--------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 --------EQAV--------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --------HCCC--------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --------hccc--------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0000 0001224568999999999999999975 55554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=351.27 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=204.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..++|.+.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++ ...
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence 346799999999999999999999999999999998743 234457788999999999999999999995 445
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++++|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred CeEEEEEecCCCCCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence 58899999999999999884 335689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.......
T Consensus 181 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 257 (335)
T 2owb_A 181 KIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNE 257 (335)
T ss_dssp EECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC
T ss_pred EEeeccCceecccCcccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCC
Confidence 999999998765332221 22448999999999999999999999999999999999999986321110 000000000
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .. +......+.+++.+||+.||++|||++|+++.
T Consensus 258 ~----------~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 Y----------SI----------------------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp C----------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----------CC----------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 00123458899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.66 Aligned_cols=282 Identities=19% Similarity=0.165 Sum_probs=196.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999989999999998753 2344567889999999999999999999975432 12334
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCC-CCHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 6899999996 57888873 2378899999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..... ..
T Consensus 168 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~-~~ 242 (371)
T 2xrw_A 168 ILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE-QL 242 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC--C
T ss_pred EEEeeccccccccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-Hh
Confidence 9999999865433221 22348999999999999999999999999999999999999986421110 1111111 00
Q ss_pred Ccc-----------hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDH-----------VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~-----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .....................................++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 000000000000000000000000000111123346789999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.11 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=201.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence 357999999999999999999999899999999986432 22346789999999999999999999995 4456
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK----------HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEE
Confidence 88999999999999999952 34689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||.+........ ....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 155 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~ 225 (284)
T 2vgo_A 155 IADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIV 225 (284)
T ss_dssp ECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH
T ss_pred EecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHh
Confidence 999999976543221 2234899999999999999999999999999999999999998632111 1111000
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... ... +...+.++.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~------~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 226 NVD------LKF----------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TTC------CCC----------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ccc------cCC----------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 000 000 01123558899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.32 Aligned_cols=281 Identities=23% Similarity=0.264 Sum_probs=196.9
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-----hhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
....++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---- 81 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 3446789999999999999999999998999999999874322 1235678999999999999999999995
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
...+..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 82 -~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 82 -GHKSNISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 147 (346)
T ss_dssp -CCTTCCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCCceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC
Confidence 445688999999975 89888853 334688889999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~ 224 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTR 224 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred CCCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 999999999999876433222 2224489999999998764 5899999999999999999999998632211 11111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
............+.+.....+.... ....... ........++++.+++.+||+.||++|||++|+++.
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTF---KSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCC---CCCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCChhhhhhhccCcccccc---cccCCCC-hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1111111100000000000000000 0000000 000011234678999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=358.91 Aligned_cols=291 Identities=19% Similarity=0.178 Sum_probs=203.2
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc----
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---- 782 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 782 (1033)
....++|++.+.||+|+||+||+|++..+++.||||++..... ...+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999998999999999864322 22479999999999999999999744221
Q ss_pred -----------------------------cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHH
Q 042075 783 -----------------------------QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833 (1033)
Q Consensus 783 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 833 (1033)
..+...++||||++ |+|.+.++.. ......+++..+..++.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF------IRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH------HhcCCCCCHHHHHHHHHHHH
Confidence 23445889999997 5888877431 12346789999999999999
Q ss_pred HHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccch
Q 042075 834 CALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDV 911 (1033)
Q Consensus 834 ~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv 911 (1033)
+||+|||++ ||+||||||+||+++ +++.+||+|||+|+......... ...+|+.|+|||++.+. .++.++||
T Consensus 152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhh
Confidence 999999999 999999999999998 68899999999998765443322 23489999999998775 58999999
Q ss_pred HHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHH
Q 042075 912 YSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARI 991 (1033)
Q Consensus 912 wSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 991 (1033)
||+||++|||++|+.||...... ..+.......-......+.... ..+..... ........+...+...++++.++
T Consensus 226 wslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMN--PHYTEVRF-PTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHC--TTC--CCC-CCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhC--cccccccC-CccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999998643211 1111221111111100000000 00000000 00000000011111244668999
Q ss_pred HhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 992 GVACSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 992 ~~~cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
+.+||+.||++|||+.|+++. +++++.
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999999999864 555544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.59 Aligned_cols=288 Identities=20% Similarity=0.176 Sum_probs=204.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++... .....++.+|++++++++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999999899999999997433 334567889999999999999999999976555555678
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||++ ++|.+++.. ..+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEE
Confidence 899999996 699998842 4589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccc--------cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH
Q 042075 868 GDFGLATFLPLSHAQT--------SSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~ 938 (1033)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~ 232 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QL 232 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH
Confidence 9999998765332211 1122358999999998654 678999999999999999999999986432111 11
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.......-.................+....................++++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111000000000000000000000000000000000000111345678999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=361.58 Aligned_cols=260 Identities=15% Similarity=0.131 Sum_probs=193.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeec---cCchhHHHHHHHHH---HHHhcCCCCceeEeeeecccc--
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECN---TLKNIRHRNLVKILTACSGVD-- 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~-- 781 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++. ......+.+.+|++ ++++++||||+++++.+....
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4678899999999999999999988899999999973 23345578899994 555558999999984432100
Q ss_pred ccCC------------C-----ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 042075 782 YQGN------------D-----FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQ 844 (1033)
Q Consensus 782 ~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 844 (1033)
+... + ..|+||||+ +|+|.+++...... ......+++..+..|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT---TTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc---ccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 1111 1 378999999 68999999642110 11224456688999999999999999999
Q ss_pred CCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCC-----------CCCcccchHH
Q 042075 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-----------EVSINGDVYS 913 (1033)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwS 913 (1033)
+|+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++||||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999999999999999999986432 1122347 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHh
Q 042075 914 YGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGV 993 (1033)
Q Consensus 914 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 993 (1033)
|||++|||++|+.||........ ...+.. .. ..+++++.+++.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-----------------------~~~~~~~~~li~ 341 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG-------------SEWIFR-SC-----------------------KNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC-------------SGGGGS-SC-----------------------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc-------------hhhhhh-hc-----------------------cCCCHHHHHHHH
Confidence 99999999999999853211110 000000 00 012356899999
Q ss_pred hccCCCCCCCCCHHHHHH--HHHHHHHH
Q 042075 994 ACSMESPEDRMDMTNVVH--QLQSIKNI 1019 (1033)
Q Consensus 994 ~cl~~dP~~RPt~~evl~--~L~~i~~~ 1019 (1033)
+||+.||++|||+.|+++ .++++++.
T Consensus 342 ~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999999999999999997 45555543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=368.80 Aligned_cols=252 Identities=23% Similarity=0.260 Sum_probs=199.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.++||+|+||+||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++ .....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCE
Confidence 45799999999999999999999989999999998642 223457789999999999999999999995 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec---CCCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD---EEMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~ 864 (1033)
.++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++ .++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp EEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCC
T ss_pred EEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 999999999999999884 335689999999999999999999999 999999999999995 5568
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ..+......
T Consensus 163 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~ 237 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETG 237 (486)
T ss_dssp EEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred EEEEECCcCeECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC
Confidence 999999999866543322 22359999999999876 5999999999999999999999998632111 001111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... +.....++++.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFDL----------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSCS----------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC----------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0001234568899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.26 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=195.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--------chhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc---
Confidence 467999999999999999999999999999999986432 112345789999999999999999999853
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
.+ ..++||||+++++|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 86 --~~-~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 86 --AE-DYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS 149 (322)
T ss_dssp --SS-SEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESS
T ss_pred --CC-ceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEec
Confidence 22 3799999999999999984 335689999999999999999999999 9999999999999987
Q ss_pred CCc---EEEeecccceecCCCCccccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccCC
Q 042075 862 EMI---AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935 (1033)
Q Consensus 862 ~~~---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~ 935 (1033)
++. +||+|||+++........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred CCCCCeEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 654 999999999876543221 1234899999999863 5678999999999999999999999996432221
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ............. . ......++++.+++.+||+.||++|||+.|+++
T Consensus 227 ~-~~~~~~~~~~~~~-----------~----------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 S-LKDQITSGKYNFI-----------P----------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-HHHHHHHTCCCCC-----------H----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHhCccccC-----------c----------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 1111111000000 0 001123456899999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=375.75 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCCccc-eecccCceeEEEEEeC--CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 712 GFTSAN-LIGAGSFGSVYKGILD--EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 712 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+++.+|++++++++||||++++++|.. +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 344444 7999999999999875 356779999997543 3356789999999999999999999999642 35
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL 477 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKI 477 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEeCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEE
Confidence 8999999999999999953 345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhh
Q 042075 868 GDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .........
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~ 555 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG 555 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTT
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999876433221 11122235689999999998899999999999999999998 99998642211 111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
. +...+..+++++.++|.+||+.||++||++.+|++.|+.+.....
T Consensus 556 ~------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 556 K------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp C------------------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred C------------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 0 001112345679999999999999999999999999999876654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=340.77 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=200.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC----chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 478999999999999999999999899999999997432 2345778999999999999999999998632 344
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||++++ +.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDS--------VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHH--------STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CeEEEEehhccCC-HHHHHHh--------CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcE
Confidence 5789999999876 7777743 2345689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
||+|||.+................||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ......
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~ 223 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFE 223 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHH
Confidence 999999998765433333333445899999999987644 4789999999999999999999986321 111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .... ..+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 224 ~i~--------~~~~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 224 NIG--------KGSY--------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHH--------HCCC--------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHh--------cCCC--------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000 0001123568899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=378.89 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=207.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++.. +..||||+++.... ..+++.+|++++++++||||++++++|.+ +..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence 45678899999999999999999974 57799999975432 34789999999999999999999998632 468
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.++++. .....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EEEECCCTTEEHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred eEeeehhcCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEc
Confidence 999999999999999953 2234589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 406 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~- 481 (535)
T 2h8h_A 406 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY- 481 (535)
T ss_dssp CTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTC-
T ss_pred ccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-
Confidence 9999986543211 11222346789999999988899999999999999999999 99998632111 0111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
+...+..+++++.++|.+||+.||++|||+++|++.|+++.....
T Consensus 482 -----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 -----------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 001111345668999999999999999999999999998755443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.84 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=194.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 468999999999999999999999899999999987432 23346788999999999999999999995 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence 88999999999999999942 34589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||.+......... ....+++.|+|||++.+..+ +.++||||||+++|||++|+.||+... ........
T Consensus 152 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~ 223 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKI 223 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred EeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHh
Confidence 9999999876543222 12348999999999988765 689999999999999999999986321 11111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ...... +...+.++.+++.+||+.||++|||++|+++.
T Consensus 224 ~---------~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 224 R---------GGVFYI-------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp H---------HCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---------cCcccC-------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 000000 00123458899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.20 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=196.2
Q ss_pred hCCCCccceecccCceeEEEEEeCC-CC--eEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-GK--TIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||+||+|++.. ++ ..||||+++.. .....+++.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4579999999999999999998643 23 36899998743 23455788999999999999999999998532
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
+ ..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 93 -~-~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 93 -P-PMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp -S-SCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred -C-CceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 2 37899999999999999953 335689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 941 (1033)
.+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~ 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQI 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHH
Confidence 99999999998775443221 1222347889999999988889999999999999999999 9999863211 111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
......... +...+..+++++.+++.+||+.||++|||+.++++.|+++.....
T Consensus 234 ~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 234 LHKIDKEGE--------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp HHHHHTSCC--------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHccCC--------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 111100000 000011234568999999999999999999999999998865443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.91 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=198.3
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ..+.+.+|+.++++++||||+++++++. ..+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 4568999999999999999999999899999999997543 3467899999999999999999999953 34578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL---------RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEe
Confidence 999999999999999852 345689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||.+......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 168 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~ 243 (314)
T 3com_A 168 DFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPP 243 (314)
T ss_dssp CCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC
T ss_pred ecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCc
Confidence 99999876443222 122348999999999999999999999999999999999999986321110 00000000000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. . ..+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~--------~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 244 T--------F--------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp C--------C--------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred c--------c--------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0 0011123568999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=347.12 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||.||+|++..+++.||+|++........+++.+|++++++++||||+++++++. .++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence 3468999999999999999999999899999999998666666788999999999999999999999953 44588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEE
Confidence 999999999999999853 345689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcccccccccccccccccccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYG-----LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
|||++....... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .......
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 236 (302)
T 2j7t_A 160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK 236 (302)
T ss_dssp CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc
Confidence 999875421111 111123489999999987 46678999999999999999999999986321110 0111110
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
...+. . ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~---------~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 SDPPT---------L--------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCCCC---------C--------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCcc---------c--------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 0 001122456899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=358.74 Aligned_cols=200 Identities=26% Similarity=0.347 Sum_probs=173.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|+.++++++||||+++++++. .++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence 35799999999999999999999999999999999754 3344577899999999999999999999953 45578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++++|.++++. ...+++..+..++.|++.||+|||+.+ ||+||||||+||+++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEE
Confidence 999999999999999952 346899999999999999999999831 89999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 175 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 175 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999987542211 1223489999999999999999999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.38 Aligned_cols=248 Identities=19% Similarity=0.274 Sum_probs=197.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ......++.+|+..+.++ +||||+++++++ ..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCC
Confidence 46799999999999999999999989999999998753 233456788999999999 999999999995 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC----
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---- 862 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---- 862 (1033)
..++||||+++++|.+++... ......+++.++..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISEN------YRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred eEEEEEEecCCCcHHHHHHhh------cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence 889999999999999999531 11225689999999999999999999999 99999999999999844
Q ss_pred ---------------CcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCC
Q 042075 863 ---------------MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKK 926 (1033)
Q Consensus 863 ---------------~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~ 926 (1033)
..+||+|||.+........ ..||+.|+|||++.+. .+++++|||||||++|||++|.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4799999999987654322 2389999999998775 56789999999999999999998
Q ss_pred CCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 042075 927 PTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006 (1033)
Q Consensus 927 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1006 (1033)
|+.. ............+ .. +..+++++.+++.+||+.||++|||+
T Consensus 230 ~~~~----~~~~~~~~~~~~~---------~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 230 LPRN----GDQWHEIRQGRLP---------RI----------------------PQVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp CCSS----SHHHHHHHTTCCC---------CC----------------------SSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcc----hhHHHHHHcCCCC---------CC----------------------CcccCHHHHHHHHHHhCCCcccCCCH
Confidence 7632 1111111111110 00 00123568999999999999999999
Q ss_pred HHHHHH
Q 042075 1007 TNVVHQ 1012 (1033)
Q Consensus 1007 ~evl~~ 1012 (1033)
.|+++.
T Consensus 275 ~~ll~h 280 (289)
T 1x8b_A 275 MALVKH 280 (289)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=367.49 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=199.4
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-------------hhHHHHHHHHHHHHhcCCCCceeEee
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-------------GAFKSFIAECNTLKNIRHRNLVKILT 775 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 775 (1033)
..++|++.++||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999874321 23467889999999999999999999
Q ss_pred eeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCC
Q 042075 776 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPS 855 (1033)
Q Consensus 776 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (1033)
+| ..+...++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQII----------NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPE 175 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHH
Confidence 95 45568999999999999999984 335689999999999999999999999 9999999999
Q ss_pred CeEecCCC---cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 856 NVLLDEEM---IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 856 NIll~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
||+++.++ .+||+|||+++......... ...||+.|+|||++. ..++.++||||+||++|+|++|+.||....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCCccc---cccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998776 69999999998775443222 234999999999976 469999999999999999999999986321
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ..+.......... .. ......++++.+++.+||+.||++|||++|+++.
T Consensus 252 ~~-~~~~~i~~~~~~~------------~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 252 DQ-DIIKKVEKGKYYF------------DF----------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH-HHHHHHHHCCCCC------------CH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHHHHHHcCCCCC------------Cc----------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 0011100000000 00 0001234568999999999999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=370.61 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=202.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.++||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++ ...+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 357999999999999999999999999999999986432 33457889999999999999999999995 4556
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---cCCC
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL---DEEM 863 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~ 863 (1033)
..++||||+.+|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++ +.++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEII----------SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEEEECCCCSCBHHHHHH----------TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence 8999999999999999984 335689999999999999999999999 99999999999999 5678
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||+++......... ...||+.|+|||++.+ .++.++||||+||++|||++|++||...... ..+.....
T Consensus 167 ~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~ 241 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEK 241 (484)
T ss_dssp CEEECCTTHHHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred cEEEEeeeeeEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHc
Confidence 99999999998765443322 2349999999999876 6999999999999999999999998632111 00111111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... +.....++++.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 GKYTFEL----------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCCCCS----------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCC----------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000000 0001234568999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=338.29 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=201.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---------chhHHHHHHHHHHHHhcC-CCCceeEeeeec
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---------HGAFKSFIAECNTLKNIR-HRNLVKILTACS 778 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 778 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 4578999999999999999999999999999999997543 122456789999999995 99999999995
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
..++..++||||+++++|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil 156 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL 156 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEE
Confidence 44568999999999999999994 235689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccceecCCCCccccccccccccccccccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 859 LDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL------GSEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 859 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
++.++.+||+|||.+.......... ...|++.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEecccchhhcCCCcccc---cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999999999998765433222 234899999999874 4568899999999999999999999985321
Q ss_pred cCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 933 EGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. .............. .. +.....+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~--~~~~~~~~~~~~~~-----------~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 Q--MLMLRMIMSGNYQF-----------GS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H--HHHHHHHHHTCCCC-----------CT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H--HHHHHHHhcCCccc-----------Cc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 01111000000000 00 000123456899999999999999999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=364.55 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=196.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||++++++| .....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 346999999999999999999999999999999987532 23357789999999999999999999995 44568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++. ++.
T Consensus 111 ~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEII----------HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence 899999999999999884 335689999999999999999999999 9999999999999975 456
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++........ ....||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ..+......
T Consensus 178 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~ 252 (494)
T 3lij_A 178 IKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKG 252 (494)
T ss_dssp EEECCCTTCEECBTTBCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred EEEEECCCCeECCCCccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC
Confidence 999999999876543322 2245999999999976 56999999999999999999999998632111 001111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+ .....++++.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~-----~~-----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYTFD-----SP-----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCCCC-----SG-----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCC-----ch-----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000 00 001123568899999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=352.50 Aligned_cols=281 Identities=20% Similarity=0.174 Sum_probs=198.4
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc-CC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ-GN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~~ 785 (1033)
..++|.+.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|+.++++++||||+++++++...... ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999999999999999999753 233457788999999999999999999997543211 11
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...++||||+. ++|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence 13499999996 68888873 2389999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+++...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+......
T Consensus 184 kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 257 (371)
T 4exu_A 184 KILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV 257 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred EEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 999999998654322 22348999999999887 689999999999999999999999996422111 11111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.-.. ..+.................................+++.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 258 TGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HCCC-CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCC-cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1000 000000000000000000000000000000111235678999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=375.32 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=197.7
Q ss_pred ceecccCceeEEEEEe--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGIL--DEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
+.||+|+||+||+|.+ ..+++.||||+++... ....+++.+|++++++++||||++++++|. .+..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 4799999999999965 4567899999997533 234578999999999999999999999863 23578999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.++++ ....+++.++..|+.||+.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHh----------hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 9999999999994 335689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcch
Q 042075 873 ATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 873 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..........
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~---- 589 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE---- 589 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC----
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC----
Confidence 9876543321 12222346789999999998899999999999999999998 99998632111 1111111100
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+...+..+++++.+++.+||+.||++|||+++|++.|+++-..
T Consensus 590 --------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 --------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0001112456789999999999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.69 Aligned_cols=257 Identities=20% Similarity=0.266 Sum_probs=186.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.++...++.++||||+++++++. .++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 35689999999999999999999998999999999975422 22233445555678889999999999953 455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||++ |+|.+++... ......+++.++..++.|++.||+|||+++ ||+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQV------IDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEE
T ss_pred CEEEEEehhc-cchHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEE
Confidence 7899999997 5888887431 123467999999999999999999999842 899999999999999999999
Q ss_pred EeecccceecCCCCcccccccccccccccccccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYG----LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
|+|||+++......... ...||+.|+|||++ .+..++.++||||+||++|||++|+.||+.............
T Consensus 151 l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 151 MCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred EeecCCccccccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 99999998764433222 23489999999996 556789999999999999999999999863221111111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....+.. . ....++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~------------~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 228 EEPSPQL------------P------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HSCCCCC------------C------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccCCCCc------------c------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1110000 0 00123568999999999999999999999883
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=356.90 Aligned_cols=199 Identities=26% Similarity=0.324 Sum_probs=170.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc------CCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 783 (1033)
..+|++.+.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+++++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----- 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----- 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence 467999999999999999999999999999999997532 3346677888888887 5779999999953
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
..+..++||||+. ++|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKK--------NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQG 237 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCC
Confidence 4458899999995 699999854 2334589999999999999999999999 999999999999999988
Q ss_pred c--EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 864 I--AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 864 ~--~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
. +||+|||+|+....... ...||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 99999999986543221 234899999999999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=357.35 Aligned_cols=266 Identities=9% Similarity=0.014 Sum_probs=184.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhc--CCCCceeEeeee-------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNI--RHRNLVKILTAC------- 777 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~~~~------- 777 (1033)
..+|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999998999999999986432 3346677886555555 699988865332
Q ss_pred ccccc------------cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHH------HHHHHHHHHHHHHH
Q 042075 778 SGVDY------------QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQR------LDIGIDVACALSYL 839 (1033)
Q Consensus 778 ~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~L 839 (1033)
..... ......++||||++ |+|.++++. ....+.+..+ ..++.||+.||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~---------~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFST---------LDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHH---------HHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHH---------hccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 11100 00134799999998 899999964 1233455555 77889999999999
Q ss_pred HhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC--CCCCcccchHHHHHH
Q 042075 840 HHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGIL 917 (1033)
Q Consensus 840 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~v 917 (1033)
|++ +|+||||||+|||++.++.+||+|||+|+....... ...+|+.|+|||++.+ ..++.++|||||||+
T Consensus 211 H~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 999 999999999999999999999999999987643221 2337799999999987 679999999999999
Q ss_pred HHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccC
Q 042075 918 LLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSM 997 (1033)
Q Consensus 918 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 997 (1033)
+|||++|+.||......... .+.... ........ ........+++.+.+++.+||+
T Consensus 283 l~elltg~~Pf~~~~~~~~~--~~~~~~----~~~~~~~~------------------~~~~~~~~~~~~~~~li~~~L~ 338 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKG--SWKRPS----LRVPGTDS------------------LAFGSCTPLPDFVKTLIGRFLN 338 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTT--CCCBCC----TTSCCCCS------------------CCCTTSSCCCHHHHHHHHHHTC
T ss_pred HHHHHhCCCCCCCcCccccc--chhhhh----hhhccccc------------------cchhhccCCCHHHHHHHHHHcC
Confidence 99999999999743221100 000000 00000000 0000001234568999999999
Q ss_pred CCCCCCCCHHHHHHH--HHHHH
Q 042075 998 ESPEDRMDMTNVVHQ--LQSIK 1017 (1033)
Q Consensus 998 ~dP~~RPt~~evl~~--L~~i~ 1017 (1033)
.||++|||+.|+++. ++++.
T Consensus 339 ~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 339 FDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp SSTTTCCCHHHHTTSHHHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999863 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=347.66 Aligned_cols=270 Identities=22% Similarity=0.310 Sum_probs=184.9
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++++++||||+++++++. ..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence 4578999999999999999999998889999999986432 234567889999999999999999999953 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++++|.+++....... ......+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 899999999999999985321110 11345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc---ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 868 GDFGLATFLPLSHAQ---TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
+|||.+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQ 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhc
Confidence 999999765433211 11122348999999999866 5689999999999999999999999864322111 100000
Q ss_pred hhCCcchh-hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVV-DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... ...+... ....++++.+++.+||+.||++|||+.|+++.
T Consensus 242 -~~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 -NDPPSLETGVQDKEM----------------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SSCCCTTC-----CC----------------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -cCCCccccccccchh----------------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000 0000000 00123468999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=349.79 Aligned_cols=292 Identities=18% Similarity=0.175 Sum_probs=195.5
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY- 782 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 782 (1033)
.......++|++.+.||+|+||+||+|++..+++.||||++.... ....+..+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677889999999999999999999999899999999886432 233566788888999999999999999754332
Q ss_pred -cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHH--hCCCCCcEeccCCCCCeEe
Q 042075 783 -QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLH--HDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 783 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivHrDlkp~NIll 859 (1033)
......++||||+++ +|.+.+... ......+++..+..++.|++.|++||| +. +|+||||||+||++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNY------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLV 164 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEE
Confidence 122247899999976 554444210 124456889999999999999999999 77 99999999999999
Q ss_pred cC-CCcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 860 DE-EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 860 ~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+. ++.+||+|||+++......... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~ 240 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQ 240 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred eCCCCcEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HH
Confidence 96 8999999999998765443322 23489999999998665 4899999999999999999999998643211 11
Q ss_pred HHHHHhhhCCc--chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 938 LHNFAKTALPD--HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 938 ~~~~~~~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+....+..... .....+++..... +........-............+++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDV--DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCG--GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhc--cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11221111111 1111111110000 0000000000000011111245679999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.02 Aligned_cols=285 Identities=18% Similarity=0.216 Sum_probs=198.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccc--------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 781 (1033)
.++|++.+.||+|+||.||+|++..+++.||+|++........+++.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999999899999999998766666788999999999999999999999864321
Q ss_pred -ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 782 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 782 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
.......++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 134467899999997 699999842 4588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEeecccceecCCCCcc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 861 -EEMIAHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 861 -~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
+++.+||+|||.++........ .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 5679999999999876432211 11122347899999998765 678999999999999999999999986432111 1
Q ss_pred HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 938 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ...+....+.................. .............++++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLIL-ESIPVVHEEDRQELLSVIPVYIRNDMT-EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHH-HHSCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHH-HhcCCCchhhhhhhhhcCccccccccc-CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111 111110000000000000000000000 00000000111245678999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=353.29 Aligned_cols=256 Identities=22% Similarity=0.268 Sum_probs=198.7
Q ss_pred hCCCCccceecccCceeEEEEEeC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHHhc-CCCCceeEeeeecccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD---EGKTIVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 781 (1033)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence 457999999999999999999984 478999999986432 23345677899999999 699999999985
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
..++..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCceEEEEeecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 345578999999999999999942 34689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
++.+||+|||+++......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHH
T ss_pred CCcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHH
Confidence 9999999999998764332222 223459999999999886 357899999999999999999999996432211 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQL 1013 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L 1013 (1033)
......... ....+.+.+..+.+++.+||+.||++|| +++|+++..
T Consensus 273 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EISRRILKS----------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHhcc----------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111110000 0000112235588999999999999999 899998753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=348.57 Aligned_cols=349 Identities=19% Similarity=0.209 Sum_probs=248.9
Q ss_pred CCCCCCCCCCcc-eeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEec
Q 042075 61 FGSWNESIHFCQ-WHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLAL 139 (1033)
Q Consensus 61 ~~~W~~~~~~c~-w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 139 (1033)
+++|....+||. |.+..|.... .+| ............-..+++++.|++++|.++...+..|..+++|++|+|
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~-~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYD-VHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76 (390)
T ss_dssp ----CCEECBCC------EEEES-CEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred cCCCCCccceehhhhhhccceee-eee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence 678988778885 4444443210 111 221222222223345789999999999998544455789999999999
Q ss_pred ccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCc
Q 042075 140 HNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS 219 (1033)
Q Consensus 140 s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 219 (1033)
++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|+|++|++++.
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 156 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence 99999977778999999999999999999988888899999999999999999965556679999999999999999988
Q ss_pred CCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcC
Q 042075 220 IPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISN 299 (1033)
Q Consensus 220 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 299 (1033)
.|+.|..+++|++|++++|++++. .+..+++|+.|++++|.+++. + ...+|++|++++|+++.. |.. .
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-~-----~~~~L~~L~l~~n~l~~~-~~~--~ 224 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-A-----IPIAVEELDASHNSINVV-RGP--V 224 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-E-----CCSSCSEEECCSSCCCEE-ECC--C
T ss_pred ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-C-----CCCcceEEECCCCeeeec-ccc--c
Confidence 888999999999999999999854 355667788888888877632 1 234677777777776643 222 1
Q ss_pred CCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccC
Q 042075 300 ASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFST 379 (1033)
Q Consensus 300 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~ 379 (1033)
.++|+.|++++|++++. +.+.. .+
T Consensus 225 ~~~L~~L~l~~n~l~~~-~~l~~-------------------------------------------------------l~ 248 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT-AWLLN-------------------------------------------------------YP 248 (390)
T ss_dssp CSSCCEEECCSSCCCCC-GGGGG-------------------------------------------------------CT
T ss_pred cccccEEECCCCCCccc-HHHcC-------------------------------------------------------CC
Confidence 34566666666655532 11111 14
Q ss_pred cccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeecc
Q 042075 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLS 458 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls 458 (1033)
+|+.|++++|.+++..|..|.++++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..++ |++|+|+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 326 (390)
T 3o6n_A 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326 (390)
T ss_dssp TCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECC
Confidence 56677777777777777777777788888888887774 4556667777888888888777 4566666665 7777777
Q ss_pred ccccCCCCCCccCCCCcccEEecCCCccCC
Q 042075 459 YNFLQGSIPSSLGQSETLTIIDLSNNNLTG 488 (1033)
Q Consensus 459 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 488 (1033)
+|.+++. | +..+++|+.|++++|.+++
T Consensus 327 ~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 327 HNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp SSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCcccee-C--chhhccCCEEEcCCCCccc
Confidence 7777643 3 5667788888888888763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=354.18 Aligned_cols=284 Identities=20% Similarity=0.249 Sum_probs=204.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC--------CCCceeEeeeecccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR--------HRNLVKILTACSGVD 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~ 781 (1033)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999989999999999743 334577889999999995 788999999864321
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
......++||||+ ++++.+++.. .....+++.++..++.||+.||+|||+++ ||+||||||+|||++.
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIK--------SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred -CCCceEEEEEecc-CccHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 2445789999999 5666666642 23356899999999999999999999853 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEeecccceecCCCCcccccccccccc
Q 042075 862 EM-------------------------------------------------IAHVGDFGLATFLPLSHAQTSSIFAKGSI 892 (1033)
Q Consensus 862 ~~-------------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~ 892 (1033)
++ .+||+|||.++...... ....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCC
Confidence 75 79999999998764322 2234899
Q ss_pred ccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc-----HHHHHhh--hCCcch-------hhhccccc
Q 042075 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN-----LHNFAKT--ALPDHV-------VDIVDSTL 958 (1033)
Q Consensus 893 ~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~-----~~~~~~~--~~~~~~-------~~~~d~~l 958 (1033)
.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..+... .+......
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999999999999999999999999999999999743322111 1111100 000000 00000000
Q ss_pred C-CCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 959 L-SDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 959 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. .....................+.+...++.+++.+||+.||++|||++|+++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 0000000000000111122234566788999999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=359.93 Aligned_cols=151 Identities=23% Similarity=0.168 Sum_probs=75.7
Q ss_pred ccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCC
Q 042075 386 LDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGS 465 (1033)
Q Consensus 386 L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~ 465 (1033)
+++|.+.+..+..|..+++|++|++++|.+.+.+|..+....+|+.|+|++|+++ +.
T Consensus 183 l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-----------------------~~ 239 (477)
T 2id5_A 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-----------------------AV 239 (477)
T ss_dssp EESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-----------------------SC
T ss_pred CCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-----------------------cc
Confidence 3333333344445556666777777776666555555555556666666666555 22
Q ss_pred CCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCccccc
Q 042075 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGS 545 (1033)
Q Consensus 466 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 545 (1033)
.+..|..+++|++|+|++|++++..+..+..+.++ +.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..
T Consensus 240 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 318 (477)
T 2id5_A 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL-QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318 (477)
T ss_dssp CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTC-CEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSC
T ss_pred CHHHhcCccccCeeECCCCcCCccChhhccccccC-CEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCC
Confidence 23345556666666666666553222222222222 33333333333333444445555555555555555444444555
Q ss_pred ccccceeeccccccc
Q 042075 546 CIKLELLQMQGNFLQ 560 (1033)
Q Consensus 546 l~~L~~L~Ls~N~l~ 560 (1033)
+++|++|+|++|+++
T Consensus 319 l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 319 VGNLETLILDSNPLA 333 (477)
T ss_dssp GGGCCEEECCSSCEE
T ss_pred CcccCEEEccCCCcc
Confidence 555555555555554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=373.91 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=202.1
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 784 (1033)
..++|++.++||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|++++++ ++.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 356899999999999999999999999999999999743 233456788899999988 79999999998 556
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..|+||||+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 6689999999999999999952 34689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.... .......
T Consensus 481 ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~~~~~~~ 553 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQS 553 (674)
T ss_dssp EEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred EEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----HHHHHHH
Confidence 999999999864333222 223459999999999999999999999999999999999999996321 1111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM-----TNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1011 (1033)
..... . .. +....+++.+++.+||+.||++||++ +||++
T Consensus 554 i~~~~--------~-~~-------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 554 IMEHN--------V-AY-------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSSC--------C-CC-------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHhCC--------C-CC-------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11100 0 00 01124568999999999999999997 55554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=344.13 Aligned_cols=278 Identities=20% Similarity=0.243 Sum_probs=202.0
Q ss_pred hCCCCccceecccCceeEEEEEe-CCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC------ceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGIL-DEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN------LVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|++++++++|++ ++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence 46899999999999999999998 5578999999987532 34567889999999987654 99999984
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE- 861 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~- 861 (1033)
...+..++||||+ +++|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKE--------NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS 154 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHh--------cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence 4455899999999 8899999953 2234688999999999999999999999 9999999999999987
Q ss_pred ------------------CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 862 ------------------EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 862 ------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
++.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 6689999999998754322 12348999999999999999999999999999999999
Q ss_pred CCCCCCccccCCccHHHHHhhh---CCcchhhhccc---------ccCCCchhhh-hccchhhhhhhhhhHHHHHHHHHH
Q 042075 924 RKKPTDIMFEGDMNLHNFAKTA---LPDHVVDIVDS---------TLLSDDEDLA-VHGNQRQRQARINSKIECLVAMAR 990 (1033)
Q Consensus 924 g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~---------~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 990 (1033)
|+.||...... ......... .+......... .......... .................+++++.+
T Consensus 230 g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 230 GFTVFPTHDSK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp SSCSCCCSCHH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 99999643211 111111111 11111000000 0000000000 000000000111122345678999
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 042075 991 IGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 991 l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
++.+||+.||++|||++|+++.
T Consensus 308 li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCcCcccccCHHHHhcC
Confidence 9999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.87 Aligned_cols=283 Identities=22% Similarity=0.287 Sum_probs=203.3
Q ss_pred HhhCCCCccceecccCceeEEEEEeC-CCCeEEEEEEeeccCc--hhHHHHHHHHHHHHhc---CCCCceeEeeeecccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILD-EGKTIVAVKVFNLLHH--GAFKSFIAECNTLKNI---RHRNLVKILTACSGVD 781 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~ 781 (1033)
.+.++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++++ +||||++++++|....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999994 6789999999874322 2234566788877776 8999999999975433
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
.......++||||++ |+|.+++.. .....+++.++..++.|++.||+|||++ ||+||||||+||+++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 155 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHH--------SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred cCCCceEEEEEecCC-CCHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcC
Confidence 335567899999997 699999854 2234589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 862 EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
++.+||+|||.++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i 231 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI 231 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH
Confidence 9999999999998654322 1222448999999999999999999999999999999999999986432111 11111
Q ss_pred HhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 942 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..........++... ........ ..... ..........++.+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 232 LDVIGLPGEEDWPRD-VALPRQAF--HSKSA--QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHCCCCGGGSCTT-CSSCGGGS--CCCCC--CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCcccCccc-cccchhhh--cccCc--chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111100000000000 00000000 00000 0000011123456899999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=355.94 Aligned_cols=278 Identities=20% Similarity=0.211 Sum_probs=197.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~ 789 (1033)
.+|++.+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||++++++|..... ....+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468899999999999999999998999999999864322 23479999999999999999998754321 2233467
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC-CcEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~ 868 (1033)
+||||+++ ++.+.+... ......+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 130 lv~e~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp EEEECCCE-EHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred eehhcccc-cHHHHHHHH------hhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEec
Confidence 99999975 676665321 12346789999999999999999999999 99999999999999965 578999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+++......... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....+..-.
T Consensus 200 DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~ 275 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGT 275 (420)
T ss_dssp CCTTCEECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCS
T ss_pred cchhhhhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 999998765433222 23489999999998765 7999999999999999999999998642211 111222211111
Q ss_pred cc---hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DH---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. +... ++...... ... .....+.. ......++++.+++.+||+.||++|||+.|+++.
T Consensus 276 p~~~~~~~~-~~~~~~~~--~p~-~~~~~~~~--~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 276 PTREQIREM-NPNYTEFK--FPQ-IKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCHHHHHHH-CSCCCCCC--CCC-CCCCCHHH--HSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhh-Chhhhhhc--cCc-cCCCCHHH--hcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 10 1110 11000000 000 00000000 0011234568999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=346.15 Aligned_cols=272 Identities=16% Similarity=0.204 Sum_probs=201.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchh-----------------HHHHHHHHHHHHhcCCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA-----------------FKSFIAECNTLKNIRHRNLVK 772 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 772 (1033)
.++|++.+.||+|+||.||+|++ +++.||||+++...... .+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 78999999987432111 178899999999999999999
Q ss_pred EeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecc
Q 042075 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCD 851 (1033)
Q Consensus 773 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrD 851 (1033)
+++++ ...+..++||||+++++|.+++...... .......+++..+..++.|++.||+|||+ . ||+|||
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~d 177 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVL--DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRD 177 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESS--CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCC
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhh--hhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecC
Confidence 99995 3455899999999999999994211000 00225679999999999999999999999 8 999999
Q ss_pred CCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCC-CCCc-ccchHHHHHHHHHHHhCCCCCC
Q 042075 852 LKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSI-NGDVYSYGILLLELVTRKKPTD 929 (1033)
Q Consensus 852 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~vl~elltg~~p~~ 929 (1033)
|||+||+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876443 12224489999999999887 6666 9999999999999999999986
Q ss_pred ccccCCccHHHHHhhhC--CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 930 IMFEGDMNLHNFAKTAL--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 930 ~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
................. +........+.. ...........+.++.+++.+||+.||++|||++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLT---------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC---------------C--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhcccc---------------ccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 43221111111111100 000000000000 0000001122346789999999999999999999
Q ss_pred HHHHH
Q 042075 1008 NVVHQ 1012 (1033)
Q Consensus 1008 evl~~ 1012 (1033)
|+++.
T Consensus 319 e~l~h 323 (348)
T 2pml_X 319 DALKH 323 (348)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.23 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=196.1
Q ss_pred CCCCCHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcC--CCCceeE
Q 042075 698 FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKI 773 (1033)
Q Consensus 698 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l 773 (1033)
...+.++.+....++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++++++ ||||+++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 344555556666788999999999999999999986 5889999998743 2344578899999999996 5999999
Q ss_pred eeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 774 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
++++ ..++..++||| +.+++|.+++.. ...+++.++..++.|+++||+|||++ +|+|||||
T Consensus 94 ~~~~-----~~~~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlk 154 (313)
T 3cek_A 94 YDYE-----ITDQYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLK 154 (313)
T ss_dssp EEEE-----ECSSEEEEEEC-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred EEEe-----ecCCEEEEEEe-cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCC
Confidence 9995 34557899999 568899999952 34689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHH
Q 042075 854 PSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELV 922 (1033)
Q Consensus 854 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~vl~ell 922 (1033)
|+||++++ +.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 155 p~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 233 (313)
T 3cek_A 155 PANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233 (313)
T ss_dssp GGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred cccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence 99999964 8999999999987654433222223458999999999865 46889999999999999999
Q ss_pred hCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC
Q 042075 923 TRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002 (1033)
Q Consensus 923 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1002 (1033)
+|+.||............ ..+....... +...++++.+++.+||+.||++
T Consensus 234 ~g~~pf~~~~~~~~~~~~------------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~ 283 (313)
T 3cek_A 234 YGKTPFQQIINQISKLHA------------IIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQ 283 (313)
T ss_dssp HSSCTTTTCCSHHHHHHH------------HHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTT
T ss_pred hCCCchhhHHHHHHHHHH------------HHhcccccCC------------------cccchHHHHHHHHHHccCCccc
Confidence 999998633211111111 1111000000 0011345889999999999999
Q ss_pred CCCHHHHHHH
Q 042075 1003 RMDMTNVVHQ 1012 (1033)
Q Consensus 1003 RPt~~evl~~ 1012 (1033)
|||++|+++.
T Consensus 284 Rps~~ell~h 293 (313)
T 3cek_A 284 RISIPELLAH 293 (313)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=345.76 Aligned_cols=280 Identities=20% Similarity=0.181 Sum_probs=197.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 786 (1033)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+++.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999899999999986432 3335678899999999999999999999653221 1112
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||++ ||+||||||+||++++++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 4599999996 68888773 2389999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|||+++...... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.......
T Consensus 167 l~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 240 (353)
T 3coi_A 167 ILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 240 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH
T ss_pred EeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 99999998653321 22348999999999877 678999999999999999999999986422111 111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.....+.....................+..-.......++++.+++.+||+.||++|||++|+++.
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 241 -GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp -CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000000000000000000000000000111235678999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=351.86 Aligned_cols=279 Identities=20% Similarity=0.221 Sum_probs=194.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~ 788 (1033)
..+|++.++||+|+||+||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++..... ......
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3479999999999999999999986655 88887754322 12369999999999999999999754332 233347
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEE
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHV 867 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL 867 (1033)
++||||++++.+...... ......+++..+..++.||++||+|||++ ||+||||||+||+++ .++.+||
T Consensus 114 ~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHY-------AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp EEEEECCSEEHHHHHHHH-------HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEeeccCccHHHHHHHH-------HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEE
Confidence 899999977544333211 12345689999999999999999999999 999999999999999 7999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
+|||+|+......... ...||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+....+..-
T Consensus 184 ~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g 259 (394)
T 4e7w_A 184 IDFGSAKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLG 259 (394)
T ss_dssp CCCTTCEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred eeCCCcccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 9999998765443322 23489999999998765 5899999999999999999999998643211 11111111111
Q ss_pred Ccc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... .....++...... . ................++++.+++.+||+.||++|||+.|+++.
T Consensus 260 ~p~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHK--F---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCHHHHHHHCGGGSSSC--C---CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhc--c---ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 110 0000000000000 0 00000000000111234678999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=335.26 Aligned_cols=253 Identities=24% Similarity=0.257 Sum_probs=199.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCC
Confidence 3468999999999999999999999899999999987432 23457889999999999999999999995 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC---C
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE---M 863 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~ 863 (1033)
..++||||+++++|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +
T Consensus 95 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred eEEEEEEccCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcc
Confidence 7899999999999999884 234689999999999999999999999 99999999999999754 4
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
.+||+|||++.......... ...+|+.|+|||++.+ .++.++||||||+++|||++|+.||......+ .......
T Consensus 162 ~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~ 236 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET 236 (287)
T ss_dssp CEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHc
Confidence 79999999998664433222 2238999999999875 48999999999999999999999986321110 0000000
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... . +.....++++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~------------~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GKYAFD------------L----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCCCC------------S----------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCC------------c----------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000000 0 0001224568999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.28 Aligned_cols=204 Identities=26% Similarity=0.315 Sum_probs=170.7
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CC-----CceeEeeeecc
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HR-----NLVKILTACSG 779 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 779 (1033)
.....++|++.+.||+|+||+||+|++..+++.||||+++.. .....++..|+.+++.++ |+ +|+++++++.
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~- 126 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM- 126 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-
Confidence 334567999999999999999999999999999999999743 233467788999998884 55 4899998853
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
..+..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||++ ..||+||||||+||++
T Consensus 127 ----~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 127 ----FRNHLCLVFEMLS-YNLYDLLRN--------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL 192 (382)
T ss_dssp ----ETTEEEEEEECCC-CBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred ----cCCceEEEEecCC-CCHHHHHhh--------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence 4458899999995 599999954 2234589999999999999999999952 2399999999999999
Q ss_pred c--CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 860 D--EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 860 ~--~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
+ .++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5 47789999999998764322 123489999999999999999999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=337.64 Aligned_cols=259 Identities=23% Similarity=0.298 Sum_probs=193.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeecccc--------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 781 (1033)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45799999999999999999999889999999998643 334577899999999999999999999875321
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
....+..++||||+++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE 151 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---------cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC
Confidence 1234578999999999999999953 335678899999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCc------------cccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCC
Q 042075 862 EMIAHVGDFGLATFLPLSHA------------QTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
++.+||+|||.++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986543211 1111224489999999998764 68999999999999999998 54
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
...... ........... ...... .....++.+.+++.+||+.||++|||+.|
T Consensus 229 ~~~~~~----~~~~~~~~~~~------~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 229 STGMER----VNILKKLRSVS------IEFPPD------------------FDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp SSHHHH----HHHHHHHHSTT------CCCCTT------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCchhH----HHHHHhccccc------cccCcc------------------ccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 321111 11111000000 000000 00122355889999999999999999999
Q ss_pred HHHH
Q 042075 1009 VVHQ 1012 (1033)
Q Consensus 1009 vl~~ 1012 (1033)
+++.
T Consensus 281 ll~h 284 (303)
T 1zy4_A 281 LLNS 284 (303)
T ss_dssp HHHS
T ss_pred HhCC
Confidence 9863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.15 Aligned_cols=259 Identities=18% Similarity=0.213 Sum_probs=175.6
Q ss_pred hhCCCCccc-eecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSAN-LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|.+.+ .||+|+||+||+|++..+++.||||++.... ....+....++.++||||+++++++.... ..+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence 356888855 6999999999999999999999999986421 22222333456679999999999975422 22446
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.++||||+++|+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQE--------RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEECCTTEEHHHHHHT--------C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCce
Confidence 8999999999999999964 2334689999999999999999999999 9999999999999976 456
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ..
T Consensus 170 ~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~ 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GM-KR 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hH-HH
Confidence 99999999987543322 12348999999999988899999999999999999999999986432211000 00 00
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.......... ......+++++.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 RIRLGQYGFP-----------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------CCC-----------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhccccccC-----------------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000000 00001234568999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=368.53 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=204.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeCC---CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDE---GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
...++|++.+.||+|+||.||+|.+.. .+..||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 345678899999999999999999854 35679999987533 334477899999999999999999999852
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
++..++||||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~ 528 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 528 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred -cCceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCC
Confidence 2357999999999999999953 334689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 529 ~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i 605 (656)
T 2j0j_A 529 CVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI 605 (656)
T ss_dssp EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH
T ss_pred CEEEEecCCCeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH
Confidence 99999999998765433222 122347789999999988899999999999999999997 99998632111 111000
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
.... +...+..+++.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 606 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 606 ENGE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC------------------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 0001112346689999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=343.36 Aligned_cols=268 Identities=23% Similarity=0.319 Sum_probs=199.0
Q ss_pred CHHHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 042075 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSG 779 (1033)
Q Consensus 702 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 779 (1033)
..++.....++|++.+.||+|+||.||+|++.. .||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM- 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-
Confidence 344444556789999999999999999999863 38999987432 233456788999999999999999999954
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (1033)
..+..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 100 ----~~~~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 100 ----SPPHLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFY 163 (319)
T ss_dssp ----CSSCEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEE
T ss_pred ----cCCceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEE
Confidence 44578999999999999999953 334689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCC---ccccccccccccccccccccCC---------CCCCcccchHHHHHHHHHHHhCCCC
Q 042075 860 DEEMIAHVGDFGLATFLPLSH---AQTSSIFAKGSIGYIAPEYGLG---------SEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 860 ~~~~~~kL~DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
+ ++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 8 6799999999987653211 1122223348999999999864 4578999999999999999999999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|..... .......... ..+.... ..++.++.+++.+||+.||++|||+.
T Consensus 243 ~~~~~~-----~~~~~~~~~~-----~~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~ 291 (319)
T 2y4i_B 243 FKTQPA-----EAIIWQMGTG-----MKPNLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFT 291 (319)
T ss_dssp SSSCCH-----HHHHHHHHTT-----CCCCCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred CCCCCH-----HHHHHHhccC-----CCCCCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 863211 1111100000 0000000 01123488999999999999999999
Q ss_pred HHHHHHHHHHHHhh
Q 042075 1008 NVVHQLQSIKNILL 1021 (1033)
Q Consensus 1008 evl~~L~~i~~~~~ 1021 (1033)
|+++.|+++.+...
T Consensus 292 ~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 292 KLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHTTC-----
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999887653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.60 Aligned_cols=279 Identities=21% Similarity=0.268 Sum_probs=199.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC-eEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC------ceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK-TIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN------LVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~----- 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence 468999999999999999999997666 79999998743 234567889999999997665 88888884
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe---
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL--- 859 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--- 859 (1033)
...+..++||||+ ++++.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+||++
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKE--------NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 4455889999999 6677777743 2334689999999999999999999999 99999999999999
Q ss_pred ----------------cCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 860 ----------------DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 860 ----------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 567899999999998654322 12348999999999999999999999999999999999
Q ss_pred CCCCCCccccCCccHHHHHhh--hCCcchhhhcc-------c--ccCCCchhhh-hccchhhhhhhhhhHHHHHHHHHHH
Q 042075 924 RKKPTDIMFEGDMNLHNFAKT--ALPDHVVDIVD-------S--TLLSDDEDLA-VHGNQRQRQARINSKIECLVAMARI 991 (1033)
Q Consensus 924 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~d-------~--~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 991 (1033)
|+.||......+ ........ ..+........ . .......... ....................++.++
T Consensus 235 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 313 (355)
T 2eu9_A 235 GFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313 (355)
T ss_dssp SSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence 999996432111 11111110 11111000000 0 0000000000 0000000000111122345679999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 042075 992 GVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 992 ~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+.+||+.||++|||+.|+++.
T Consensus 314 i~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 314 MRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=348.76 Aligned_cols=210 Identities=21% Similarity=0.276 Sum_probs=155.7
Q ss_pred CCCc-cceecccCceeEEEEEeC--CCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 712 GFTS-ANLIGAGSFGSVYKGILD--EGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 712 ~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.|++ .++||+|+||+||+|++. .+++.||||+++... ....+.+|+.++++++||||+++++++.. ..+...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence 4555 458999999999999975 467889999987543 23568899999999999999999999642 345578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEe----cCCCc
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL----DEEMI 864 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~ 864 (1033)
++||||++ ++|.+++....... .......+++.++..++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 99999996 58888875311100 011233589999999999999999999999 99999999999999 67789
Q ss_pred EEEeecccceecCCCCcc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 042075 865 AHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
+||+|||+|+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999999876433211 122234589999999998874 5899999999999999999999999643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.80 Aligned_cols=277 Identities=17% Similarity=0.237 Sum_probs=237.0
Q ss_pred cccccCCChhhHHHHHHHHHhcccCCCCCCCCC----CCCCCCcceeeeEecC-------CCCCeEEEEEcCCCCCCccc
Q 042075 32 TASTVAGNETDRLALLEFKSKITHDPLGVFGSW----NESIHFCQWHGVTCSR-------RQHQRVTILDLKSLKLAGYI 100 (1033)
Q Consensus 32 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~W----~~~~~~c~w~gv~C~~-------~~~~~v~~l~l~~~~l~g~~ 100 (1033)
.....++..+|++||++||+++..|+.+.+++| ....++|.|.||+|+. ....+|+.|+|++++++ .+
T Consensus 18 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 18 YFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp CCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred eeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hc
Confidence 344455668899999999999987888888999 4567899999999963 12357899999999998 78
Q ss_pred ccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccc--
Q 042075 101 SAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGS-- 178 (1033)
Q Consensus 101 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-- 178 (1033)
|+.++++++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .+|..++++++|++|+|++|.+.+.+|..+..
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~ 174 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc
Confidence 888889999999999999998 88999999999999999999998 88999999999999999999888889888765
Q ss_pred -------ccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCC
Q 042075 179 -------LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNI 251 (1033)
Q Consensus 179 -------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 251 (1033)
+++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..|+.+++|++|+|++|++.+.+|..+.++
T Consensus 175 ~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l 252 (328)
T 4fcg_A 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252 (328)
T ss_dssp -CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCC
T ss_pred chhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCC
Confidence 889999999999998 778888889999999999999985 66678889999999999999888888888888
Q ss_pred CceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 252 SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 252 ~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
++|+.|++++|.+.+.+|..+ ..+++|++|+|++|.+.+.+|..+.++++|+.+++..|.+.
T Consensus 253 ~~L~~L~L~~n~~~~~~p~~~-~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 253 APLKRLILKDCSNLLTLPLDI-HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCEEECTTCTTCCBCCTTG-GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCEEECCCCCchhhcchhh-hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888765 36888888888888888888888888888888888877665
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.36 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=191.0
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc------hhHHHHHHHHHHHHhc----CCCCceeEe
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH------GAFKSFIAECNTLKNI----RHRNLVKIL 774 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~ 774 (1033)
+.....++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344556789999999999999999999988999999999964322 1223456799999998 899999999
Q ss_pred eeeccccccCCCceeEEEEc-ccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCC
Q 042075 775 TACSGVDYQGNDFKALVFEF-MHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLK 853 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (1033)
+++ ...+..++|||| +.+++|.+++.. ...+++.++..++.||+.||+|||++ +|+|||||
T Consensus 105 ~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 166 (312)
T 2iwi_A 105 DWF-----ETQEGFMLVLERPLPAQDLFDYITE----------KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIK 166 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCS
T ss_pred EEE-----ecCCeEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCC
Confidence 994 445578999999 789999999942 34689999999999999999999999 99999999
Q ss_pred CCCeEec-CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCcc
Q 042075 854 PSNVLLD-EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPTDIM 931 (1033)
Q Consensus 854 p~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~vl~elltg~~p~~~~ 931 (1033)
|+||+++ +++.+||+|||+++....... ....|+..|+|||++.+..+. .++|||||||++|||++|+.||...
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999999 889999999999987654322 223489999999998776664 5899999999999999999998531
Q ss_pred ccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 932 FEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ....... .. +.....++.+++.+||+.||++|||++|+++
T Consensus 243 ~-------~~~~~~~----------~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 Q-------EILEAEL----------HF----------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-------HHHHTCC----------CC----------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-------HHhhhcc----------CC----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 0000000 00 0012345889999999999999999999987
Q ss_pred H
Q 042075 1012 Q 1012 (1033)
Q Consensus 1012 ~ 1012 (1033)
.
T Consensus 284 ~ 284 (312)
T 2iwi_A 284 D 284 (312)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=345.08 Aligned_cols=285 Identities=19% Similarity=0.252 Sum_probs=203.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-----------CCCceeEeeeec
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACS 778 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 778 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999999889999999998743 234467889999999886 899999999975
Q ss_pred cccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeE
Q 042075 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (1033)
... ......++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+++ ||+||||||+||+
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHH--------hhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeE
Confidence 332 2233689999999 8999999954 23345899999999999999999999843 8999999999999
Q ss_pred ec------CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 859 LD------EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 859 l~------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
++ ..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 44489999999998764322 12348999999999999999999999999999999999999997432
Q ss_pred cCC-----ccHHHHHhhh--CCcch-------hhhcccc-cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccC
Q 042075 933 EGD-----MNLHNFAKTA--LPDHV-------VDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSM 997 (1033)
Q Consensus 933 ~~~-----~~~~~~~~~~--~~~~~-------~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 997 (1033)
... ..+....... .+... ....+.. ...................+...+...++++.+++.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 111 0111111100 00000 0000000 0000000000000011112223345677889999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 042075 998 ESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 998 ~dP~~RPt~~evl~~ 1012 (1033)
.||++|||++|+++.
T Consensus 320 ~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 320 LDPRKRADAGGLVNH 334 (373)
T ss_dssp SSTTTCBCHHHHHTC
T ss_pred cCccccCCHHHHhhC
Confidence 999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=341.51 Aligned_cols=245 Identities=21% Similarity=0.236 Sum_probs=197.5
Q ss_pred HHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch------hHHHHHHHHHHHHhcC--CCCceeEeeeec
Q 042075 707 YNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG------AFKSFIAECNTLKNIR--HRNLVKILTACS 778 (1033)
Q Consensus 707 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 778 (1033)
....++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~- 117 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF- 117 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE-
Confidence 34457899999999999999999999989999999999753221 2245678999999995 59999999995
Q ss_pred cccccCCCceeEEEEcccC-CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCe
Q 042075 779 GVDYQGNDFKALVFEFMHN-RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNV 857 (1033)
Q Consensus 779 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 857 (1033)
..++..++||||+.+ ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 118 ----~~~~~~~lv~e~~~~~~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 180 (320)
T 3a99_A 118 ----ERPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI 180 (320)
T ss_dssp ----ECSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred ----ecCCcEEEEEEcCCCCccHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence 445578999999976 89999984 245689999999999999999999999 999999999999
Q ss_pred Eec-CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCC
Q 042075 858 LLD-EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD 935 (1033)
Q Consensus 858 ll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~ 935 (1033)
+++ +++.+||+|||+++....... ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 253 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 253 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred EEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence 999 788999999999987654322 12348999999999877665 688999999999999999999985311
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
....... ... ...++++.+++.+||+.||++|||++|+++.
T Consensus 254 ----~~~~~~~----------~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ----EIIRGQV----------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----HHHHCCC----------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hhhcccc----------ccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100000 000 0123458899999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.63 Aligned_cols=260 Identities=22% Similarity=0.254 Sum_probs=177.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHH-HHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .....++..|+. +++.++||||+++++++. .++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 468899999999999999999999899999999997543 233345566666 677789999999999953 4457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++ +|.+++.... ......+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVY-----SVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHH-----HTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecCC-ChHHHHHHHH-----hhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEE
Confidence 8999999975 8888774210 11245689999999999999999999985 28999999999999999999999
Q ss_pred eecccceecCCCCcccccccccccccccccccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYG----LGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
+|||+++......... ...||+.|+|||++ .+..++.++|||||||++|||++|+.||.......... .
T Consensus 168 ~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~ 240 (327)
T 3aln_A 168 CDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----T 240 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C
T ss_pred ccCCCceecccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----H
Confidence 9999998664332221 23489999999998 45678999999999999999999999986321111000 0
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........ .+... ....+++++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~-----~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 QVVKGDPP-----QLSNS------------------EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCSCCC-----CCCCC------------------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcCCCC-----CCCCc------------------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00000000 00000 000123568999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=357.30 Aligned_cols=286 Identities=22% Similarity=0.242 Sum_probs=204.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc-ccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~ 787 (1033)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|++++++++||||+++++++.... +..++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999989999999998753 3344577899999999999999999999865422 233667
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc---
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI--- 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--- 864 (1033)
.++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-------~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-------ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-------SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred EEEEEEeCCCCCHHHHHHhc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence 89999999999999999641 1233588899999999999999999999 9999999999999997664
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||.+.......... ...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....+...
T Consensus 163 vKL~DFG~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~ 235 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGK 235 (676)
T ss_dssp EEECSCCCCCBTTSCCCCC---CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTT
T ss_pred EEEcccccccccccccccc---cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhh
Confidence 9999999998765443222 2458999999999999999999999999999999999999986321 11111111
Q ss_pred hCCcchhh-hcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHHHH
Q 042075 945 ALPDHVVD-IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN-----VVHQLQSIKN 1018 (1033)
Q Consensus 945 ~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----vl~~L~~i~~ 1018 (1033)
........ .......+.... ... ...........++.+.+++.+||+.||++|||++| ..+.++.+.+
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~----~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKF----SSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CC------CCSCCCCSSSCCC----CSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhcccchhhhhhhhhcccccc----ccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 11000000 000000000000 000 00000011234577999999999999999999988 4455555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.29 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=244.7
Q ss_pred CcccEEEccCCCCCc--cCCccccCCCCCCEEEccc-CcccccCChhhhcCCCCcEEEccccccccccCcccccce-ece
Q 042075 379 TTLEVLLLDSNKIFG--NIPAAFGKFVKLLRLEMWN-NRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFN 454 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~ 454 (1033)
.+++.|++++|.+++ .+|..|.++++|++|++++ |.+.+.+|..|..+++|++|+|++|++++.+|..+..++ |++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 478999999999999 8999999999999999995 999999999999999999999999999999999999998 999
Q ss_pred eeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccc
Q 042075 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534 (1033)
Q Consensus 455 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (1033)
|+|++|.+++.+|..|..+++|++|+|++|++++.+|..+..+...|+.|++++|++++.+|..+..++ |+.|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 999999999999999999999999999999999999999999884459999999999999999999998 9999999999
Q ss_pred cccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc
Q 042075 535 LRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|++|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9999999999999999999999999977776 889999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCccc
Q 042075 615 GVFRNASITSVLGNLKLCGGTHE 637 (1033)
Q Consensus 615 ~~~~~~~~~~~~~n~~lcg~~~~ 637 (1033)
..+..+....+.+|+.+||.|++
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccccccChHHhcCCCCccCCCCC
Confidence 88899999999999999998876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.34 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=179.5
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCch-h-HHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHG-A-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..++|++.+.||+|+||.||+|++..+++.||||+++..... . .+.+.++..+++.++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCC
Confidence 356889999999999999999999989999999999754322 2 23344555678888999999999995 3455
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
..++||||+ ++.+..+... ....+++..+..++.|++.||+|||+ . ||+||||||+||+++.++.+
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR---------MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCE
T ss_pred cEEEEEecc-CCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCE
Confidence 889999999 5566555531 24568999999999999999999998 6 89999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
||+|||++.......... ...||+.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 165 kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKAKD---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241 (318)
T ss_dssp EECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred EEEECCCchhccCCcccc---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 999999997654432221 234899999999984 456889999999999999999999998632211111111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...... . .... ...++.++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~-~--------~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 242 VLQEEP-P--------LLPG--------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHSCC-C--------CCCS--------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HhccCC-C--------CCCc--------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111000 0 0000 00123558999999999999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=338.63 Aligned_cols=131 Identities=22% Similarity=0.264 Sum_probs=98.5
Q ss_pred hhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccc
Q 042075 502 IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581 (1033)
Q Consensus 502 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 581 (1033)
+.|++++|.+++..|..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N 328 (390)
T 3o6n_A 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328 (390)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred cEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCC
Confidence 44444444444455667777888999999999988 46777788899999999999998 67888888999999999999
Q ss_pred cccccCCcccccccccceeecCCCcCcccCCCcccccccccccccccccccCCcccc
Q 042075 582 NLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 582 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~ 638 (1033)
+|+.. | +..+++|+.|++++|++++.... ..+.......+.++...|+.+...
T Consensus 329 ~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~~ 381 (390)
T 3o6n_A 329 SIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQL 381 (390)
T ss_dssp CCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTCEE
T ss_pred cccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccccc
Confidence 99854 3 67788999999999999885432 344455555667777778765544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.67 Aligned_cols=241 Identities=10% Similarity=0.072 Sum_probs=183.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECCc
Confidence 57999999999999999999999889999999997543 23347789999999999999999999995 34557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||++|++|.++++. .....++.+++.|++.||+|||++ ||+||||||+||++++++.+||
T Consensus 106 ~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT------------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEE
T ss_pred EEEEEEecCCCCHHHHHhc------------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEE
Confidence 8999999999999999842 135567889999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+++| |++ .++.++|||||||++|||++|+.||......+....
T Consensus 171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------- 213 (286)
T 3uqc_A 171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------- 213 (286)
T ss_dssp CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------
T ss_pred Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------
Confidence 8443 333 368899999999999999999999964322110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhchhhc
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRIVS 1027 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~ 1027 (1033)
........... .......+++++.+++.+||+.||++| |+.|+++.|+++...........
T Consensus 214 ------~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~ 274 (286)
T 3uqc_A 214 ------AERDTAGQPIE------------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLG 274 (286)
T ss_dssp ------CCBCTTSCBCC------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---------
T ss_pred ------HHHHhccCCCC------------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCC
Confidence 00000000000 000011234668999999999999999 99999999999987665444433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=341.39 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=182.5
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
.|.+.++||+|+||+||.+... +++.||||++... ..+.+.+|+.+++++ +||||+++++++ ..++..++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 4555688999999999876544 6899999998643 235678999999987 899999999984 45568999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC--------
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-------- 862 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-------- 862 (1033)
||||+. |+|.+++....... ......++.++..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccc
Confidence 999995 69999996422111 0111123445678999999999999999 99999999999999754
Q ss_pred -----CcEEEeecccceecCCCCccc--cccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCCC
Q 042075 863 -----MIAHVGDFGLATFLPLSHAQT--SSIFAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVT-RKKP 927 (1033)
Q Consensus 863 -----~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~vl~ellt-g~~p 927 (1033)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 489999999999875543221 1223459999999999865 578999999999999999999 9999
Q ss_pred CCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042075 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007 (1033)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 1007 (1033)
|....... ............ . ........++++.+++.+||+.||++|||+.
T Consensus 240 f~~~~~~~---~~i~~~~~~~~~-------~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (434)
T 2rio_A 240 FGDKYSRE---SNIIRGIFSLDE-------M------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291 (434)
T ss_dssp TCSTTTHH---HHHHHTCCCCCC-------C------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCchhhH---HHHhcCCCCccc-------c------------------cccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence 86322111 111111100000 0 0001123567789999999999999999999
Q ss_pred HHHH
Q 042075 1008 NVVH 1011 (1033)
Q Consensus 1008 evl~ 1011 (1033)
||++
T Consensus 292 eil~ 295 (434)
T 2rio_A 292 KVLR 295 (434)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=336.03 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=180.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..+|.+.++||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++ ......
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence 34688899999999999664333 3688999999865332 2356899999999 899999999984 445578
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-----CC
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-----EM 863 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~ 863 (1033)
|+||||+. |+|.+++.. ........++..++.||+.||+|||++ +|+||||||+||+++. ..
T Consensus 94 ~lv~E~~~-g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQ---------KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEECCS-EEHHHHHHS---------SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEECCC-CCHHHHHHh---------cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCce
Confidence 99999995 699999964 222344445678999999999999999 9999999999999953 23
Q ss_pred cEEEeecccceecCCCCcc-ccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccH
Q 042075 864 IAHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNL 938 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 938 (1033)
.+||+|||+|+........ .......||+.|+|||++. ...++.++||||+||++|||++ |+.||...... .
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~ 237 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q 237 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H
Confidence 6889999999876543211 2222345999999999987 4567889999999999999999 99998522111 0
Q ss_pred HHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 939 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ........... ........+.+++.+||+.||++|||++||++
T Consensus 238 ~~~---~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ANI---LLGACSLDCLH------------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHH---HTTCCCCTTSC------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHH---HhccCCccccC------------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 00000000000 00123445789999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=337.95 Aligned_cols=259 Identities=16% Similarity=0.130 Sum_probs=187.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc---hhHHHHHHHHHHHHhcCC-CCceeEeee---------
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---GAFKSFIAECNTLKNIRH-RNLVKILTA--------- 776 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~--------- 776 (1033)
...|...+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.+++.++| +|......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999999999999999999873322 235788999999999977 322111111
Q ss_pred e------------ccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 042075 777 C------------SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQ 844 (1033)
Q Consensus 777 ~------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 844 (1033)
+ ...........+++|+++ +++|.++++..... ......+++..++.++.||++||+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 230 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY-- 230 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 0 000000122356777765 78999998421110 12345688999999999999999999999
Q ss_pred CCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcccccccccccccccccccc----------CCCCCCcccchHHH
Q 042075 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYG----------LGSEVSINGDVYSY 914 (1033)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSl 914 (1033)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||
T Consensus 231 -~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred -CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999999865432 222347 999999998 66678999999999
Q ss_pred HHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhh
Q 042075 915 GILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVA 994 (1033)
Q Consensus 915 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 994 (1033)
||++|||++|+.||........ ...++. .. ..+++++.+++.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~-------------~~~~~~----~~--------------------~~~~~~~~~li~~ 346 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG-------------SEWIFR----SC--------------------KNIPQPVRALLEG 346 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC-------------SGGGGS----SC--------------------CCCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhh-------------HHHHHh----hc--------------------ccCCHHHHHHHHH
Confidence 9999999999999863221110 000000 00 0123568999999
Q ss_pred ccCCCCCCCCCHHHHHHH--HHHHHH
Q 042075 995 CSMESPEDRMDMTNVVHQ--LQSIKN 1018 (1033)
Q Consensus 995 cl~~dP~~RPt~~evl~~--L~~i~~ 1018 (1033)
||+.||++|||+.|+++. ++++++
T Consensus 347 ~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HccCChhhCcCHHHHHhCHHHHHHHH
Confidence 999999999999888654 444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=355.52 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=195.6
Q ss_pred hCCCCccceecccCceeEEEEEeCC-CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ......+.+|++++++++||||++++++|..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999975 68999999986433 344567889999999999999999999976543222223
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||++ ||+||||||+||+++++ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence 699999999999998763 1589999999999999999999999 99999999999999886 8999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||....... .+
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~ 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cc
Confidence 999999876443 223489999999998765 4899999999999999999998875321110 00
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-DMTNVVHQLQSIKN 1018 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~ 1018 (1033)
... ......+.+.+++.+||+.||++|| +++++.+.+..+..
T Consensus 286 ------------~~~-----------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ------------EDD-----------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ------------TTC-----------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ------------ccc-----------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000 0112345689999999999999999 56777777777654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=314.44 Aligned_cols=237 Identities=18% Similarity=0.245 Sum_probs=180.9
Q ss_pred hCCCCcc-ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHH-HhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSA-NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|+.++ +..+||||+++++++... ...+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4567777 7899999999999999989999999998632 4567889888 555999999999986532 123557
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.++||||+++|+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEECCCCSCBHHHHHHH--------CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred EEEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence 8999999999999999964 2334689999999999999999999999 9999999999999997 789
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||++.... +..++.++||||+||++|||++|+.||........
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------- 206 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------- 206 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------
Confidence 9999999987532 23467889999999999999999999853211100
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.......+........ ......+++++.+++.+||+.||++|||++|+++.
T Consensus 207 --~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 207 --SPGMKTRIRMGQYEFP---------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---CCSCCSSCTTCCSSC---------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --hHHHHHHHhhccccCC---------------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000000000 00011235678999999999999999999999975
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=313.68 Aligned_cols=305 Identities=25% Similarity=0.372 Sum_probs=169.4
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
..+++|++|++++|.+. .+| .+..+++|++|+|++|.+++ +|. +.++++|++|++++|.+++ +| .+.++++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~ 114 (347)
T 4fmz_A 41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE 114 (347)
T ss_dssp HHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred hhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence 34566666677666665 333 36666677777777776663 333 6666677777777776663 32 4666666777
Q ss_pred eeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccc
Q 042075 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264 (1033)
Q Consensus 185 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l 264 (1033)
|++++|++++..+ +.++++|++|++++|.....++ .+..+++|++|++++|++++..+ +..+++|+.|++++|.+
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 7777666664332 6666667777776665443333 36666666666666666664332 55556666666666665
Q ss_pred cCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccc
Q 042075 265 QGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDL 344 (1033)
Q Consensus 265 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 344 (1033)
.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|++++.++ +..++
T Consensus 190 ~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~-------------------- 243 (347)
T 4fmz_A 190 EDISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLS-------------------- 243 (347)
T ss_dssp CCCGG---GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCT--------------------
T ss_pred ccccc---ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCC--------------------
Confidence 53222 3345556666666666554332 5555566666666665554332 33333
Q ss_pred hhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhh
Q 042075 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIG 424 (1033)
Q Consensus 345 ~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 424 (1033)
+|+.|++++|.+++. +.+..+++|++|++++|++++. +.+.
T Consensus 244 -----------------------------------~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~ 284 (347)
T 4fmz_A 244 -----------------------------------QLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLN 284 (347)
T ss_dssp -----------------------------------TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGG
T ss_pred -----------------------------------CCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhc
Confidence 344444444444432 2344555555555555555532 2355
Q ss_pred cCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccC
Q 042075 425 ELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT 487 (1033)
Q Consensus 425 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 487 (1033)
.+++|+.|+|++|++++..|..++.++ |++|+|++|.+++..| +..+++|++|++++|.|+
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 555555555555555555555555444 5555555555554444 556667777777777664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=336.20 Aligned_cols=307 Identities=23% Similarity=0.229 Sum_probs=226.1
Q ss_pred eEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcc
Q 042075 85 RVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 164 (1033)
.+..+++.++.+++..+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 45678888888876555567899999999999999998888899999999999999999999888899999999999999
Q ss_pred cccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCC
Q 042075 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244 (1033)
Q Consensus 165 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 244 (1033)
+|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.. ++.+++|+.|++++|.+++
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-- 206 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-- 206 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE--
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc--
Confidence 99999666666899999999999999999999999999999999999999999653 5678899999999998874
Q ss_pred cccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhc
Q 042075 245 PSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQ 324 (1033)
Q Consensus 245 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~ 324 (1033)
+...++|+.|++++|.+... |.. + .++|+.|+|++|.+++. +.+..+
T Consensus 207 ---l~~~~~L~~L~ls~n~l~~~-~~~-------------------------~--~~~L~~L~L~~n~l~~~-~~l~~l- 253 (597)
T 3oja_B 207 ---LAIPIAVEELDASHNSINVV-RGP-------------------------V--NVELTILKLQHNNLTDT-AWLLNY- 253 (597)
T ss_dssp ---EECCTTCSEEECCSSCCCEE-ECS-------------------------C--CSCCCEEECCSSCCCCC-GGGGGC-
T ss_pred ---ccCCchhheeeccCCccccc-ccc-------------------------c--CCCCCEEECCCCCCCCC-hhhccC-
Confidence 22334556666666655421 111 1 13455555555555432 111111
Q ss_pred cccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCC
Q 042075 325 RLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVK 404 (1033)
Q Consensus 325 ~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~ 404 (1033)
++|+.|+|++|.+++..|..|.++++
T Consensus 254 ------------------------------------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~ 279 (597)
T 3oja_B 254 ------------------------------------------------------PGLVEVDLSYNELEKIMYHPFVKMQR 279 (597)
T ss_dssp ------------------------------------------------------TTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred ------------------------------------------------------CCCCEEECCCCccCCCCHHHhcCccC
Confidence 34555566666666666666666777
Q ss_pred CCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCC
Q 042075 405 LLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483 (1033)
Q Consensus 405 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 483 (1033)
|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..++ |+.|+|++|.+++. | +..+++|+.|++++
T Consensus 280 L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 280 LERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSH 354 (597)
T ss_dssp CCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCS
T ss_pred CCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeC
Confidence 7777777777764 4555566677777777777766 4555555554 66666666666543 2 55667777888888
Q ss_pred CccCC
Q 042075 484 NNLTG 488 (1033)
Q Consensus 484 N~l~~ 488 (1033)
|.+++
T Consensus 355 N~~~~ 359 (597)
T 3oja_B 355 NDWDC 359 (597)
T ss_dssp SCEEH
T ss_pred CCCCC
Confidence 77763
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.83 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=146.4
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSV 187 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 187 (1033)
++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 45555666655555444555555555555555555555555555555555555555555555 4444443 45555555
Q ss_pred cccccCCCCCCCCCCCCCCcEEEcccCcCC--CcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLD--GSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 188 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++|++++..+..|.++++|++|++++|.++ +..|..|..+ +|++|++++|++++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~----------------------- 186 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG----------------------- 186 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-----------------------
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-----------------------
Confidence 555555444444555555555555555553 2344444444 44444444444442
Q ss_pred CccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccch
Q 042075 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345 (1033)
Q Consensus 266 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 345 (1033)
+|..++ ++|++|++++|++++..+..+..+++|++|++++|++++
T Consensus 187 --l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~------------------------------ 231 (332)
T 2ft3_A 187 --IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM------------------------------ 231 (332)
T ss_dssp --CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC------------------------------
T ss_pred --cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc------------------------------
Confidence 333222 456666666666666656666666666666666665553
Q ss_pred hhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhc
Q 042075 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE 425 (1033)
Q Consensus 346 ~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 425 (1033)
..+..|..+++|++|++++|+++ .+|..+..
T Consensus 232 ------------------------------------------------~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 232 ------------------------------------------------IENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp ------------------------------------------------CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred ------------------------------------------------CChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 33334455555555555555555 45555556
Q ss_pred CCCCcEEEccccccccccCcccccc-------eeceeeccccccC--CCCCCccCCCCcccEEecCCCc
Q 042075 426 LQNLRELRLQENRFLGNIPPSIGNL-------KLFNLQLSYNFLQ--GSIPSSLGQSETLTIIDLSNNN 485 (1033)
Q Consensus 426 l~~L~~L~L~~N~l~~~~p~~~~~l-------~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 485 (1033)
+++|+.|+|++|++++..+..|... .++.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 6666666666666655444444332 1556666666665 5566777777778888877774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=309.21 Aligned_cols=306 Identities=23% Similarity=0.363 Sum_probs=190.8
Q ss_pred cccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCcee
Q 042075 176 LGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 255 (1033)
Q Consensus 176 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1033)
+..+++|++|++++|.++ .+|. +..+++|++|++++|++++. +. |..+++|++|++++|++++ +| .+.+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~----- 108 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQN----- 108 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTT-----
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcC-----
Confidence 345666666666666665 3332 55666666666666666633 22 5556666666666665553 22 2333
Q ss_pred EEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCc
Q 042075 256 VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335 (1033)
Q Consensus 256 ~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~ 335 (1033)
+++|++|++++|++++. +. +..+++|++|++++|.....++.+..+
T Consensus 109 --------------------l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l------------ 154 (347)
T 4fmz_A 109 --------------------LTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLSPLSNM------------ 154 (347)
T ss_dssp --------------------CTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCGGGTTC------------
T ss_pred --------------------CCcCCEEECcCCcccCc-hh-hccCCceeEEECCCCCCcccccchhhC------------
Confidence 34444444444444422 22 445555555555555433222222211
Q ss_pred CCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcc
Q 042075 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRL 415 (1033)
Q Consensus 336 l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l 415 (1033)
++|+.|++++|.+.+..+ +..+++|++|++++|++
T Consensus 155 -------------------------------------------~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 155 -------------------------------------------TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp -------------------------------------------TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred -------------------------------------------CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 345555555555554333 66777788888888887
Q ss_pred cccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccc
Q 042075 416 SGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQL 494 (1033)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 494 (1033)
.+..+ +..+++|+.|++++|.+.+..+ +..++ |++|++++|.+++..+ +..+++|++|++++|+++
T Consensus 190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~------- 256 (347)
T 4fmz_A 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS------- 256 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-------
T ss_pred ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC-------
Confidence 74433 7777788888888877774433 44444 6666666666653332 555555555555555554
Q ss_pred cCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCC
Q 042075 495 LGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLS 574 (1033)
Q Consensus 495 ~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 574 (1033)
+ + +.+..+++|+.|++++|++++. +.+..+++|++|++++|++++..|..++.+++|+
T Consensus 257 ------------------~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 257 ------------------D-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp ------------------C-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred ------------------C-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 2 1 2456678888899999888853 4588888999999999999888888889999999
Q ss_pred ccccccccccccCCcccccccccceeecCCCcCc
Q 042075 575 VLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 575 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
.|+|++|++++..| +..+++|++|++++|+|+
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999999987666 788899999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=320.43 Aligned_cols=196 Identities=19% Similarity=0.192 Sum_probs=160.0
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--------chhHHHHHHHHHHHHhcC---------CCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--------HGAFKSFIAECNTLKNIR---------HRNLVK 772 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 772 (1033)
.++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45789999999999999999998 57999999997542 223477899999999886 666666
Q ss_pred Eeeeeccc-------------------------cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHH
Q 042075 773 ILTACSGV-------------------------DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827 (1033)
Q Consensus 773 l~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~ 827 (1033)
+.+++... ++..++..|+||||+++|++.+.+.+ ..+++.++..
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence 66543210 01135689999999999977766621 3579999999
Q ss_pred HHHHHHHHHHHHH-hCCCCCcEeccCCCCCeEecCCC--------------------cEEEeecccceecCCCCcccccc
Q 042075 828 IGIDVACALSYLH-HDCQPPIVHCDLKPSNVLLDEEM--------------------IAHVGDFGLATFLPLSHAQTSSI 886 (1033)
Q Consensus 828 i~~qi~~~L~~LH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~ 886 (1033)
++.||+.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 88 999999999999999887 8999999999876432
Q ss_pred ccccccccccccccCCCCCCcccchHHHHHH-HHHHHhCCCCCC
Q 042075 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGIL-LLELVTRKKPTD 929 (1033)
Q Consensus 887 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~v-l~elltg~~p~~ 929 (1033)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 234999999999998766 899999998777 788999999974
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-32 Score=302.98 Aligned_cols=178 Identities=22% Similarity=0.331 Sum_probs=92.6
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSV 187 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 187 (1033)
+.|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 45666666666666555555666666666666666666555666666666666666666665 4444433 45555555
Q ss_pred cccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCc
Q 042075 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGV 267 (1033)
Q Consensus 188 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 267 (1033)
++|++++..+..|.++++|++|++++|.++. .+..+..+.++++|+.|++++|.++ .
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~~~~~~~l~~L~~L~l~~n~l~-~ 185 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIENGAFQGMKKLSYIRIADTNIT-T 185 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcChhhccCCCCcCEEECCCCccc-c
Confidence 5555554444444555555555555555432 0133333444444444444444443 2
Q ss_pred cCccccccccccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 268 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
+|..++ ++|++|++++|++++..|..+..+++|++|++++|+++
T Consensus 186 l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 186 IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 333221 45555566666555555555555555555555444444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=299.19 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=192.6
Q ss_pred cceeeeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccC
Q 042075 71 CQWHGVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142 (1033)
Q Consensus 71 c~w~gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 142 (1033)
|+|+.+.|+... ...++.|+++++++++..+..+.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 799999997532 236889999999999877789999999999999999999888999999999999999999
Q ss_pred CCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccC--CCCCCCCCCCCCCcEEEcccCcCCCcC
Q 042075 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT--GSIPPSFGNLSSISFLFLSRNNLDGSI 220 (1033)
Q Consensus 143 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~ 220 (1033)
.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..|..|..+ +|++|++++|++++ +
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l 187 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-I 187 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-C
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-c
Confidence 998 7887776 89999999999999766677999999999999999996 4778889888 99999999999995 6
Q ss_pred CccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCC
Q 042075 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNA 300 (1033)
Q Consensus 221 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 300 (1033)
|..+. ++|++|+|++|++++..|..+.++++|+.|++++|++++..+ ..+..+++|++|+|++|+++ .+|..+..+
T Consensus 188 ~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 188 PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN-GSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT-TGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh-hHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 66554 789999999999998777788877777777777777764333 23335666666666666666 455556666
Q ss_pred CCccccccccccccC
Q 042075 301 SNLEVFQVNSNKLTG 315 (1033)
Q Consensus 301 ~~L~~L~Ls~N~l~~ 315 (1033)
++|++|++++|++++
T Consensus 264 ~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 264 KLLQVVYLHTNNITK 278 (332)
T ss_dssp TTCCEEECCSSCCCB
T ss_pred ccCCEEECCCCCCCc
Confidence 666666666665553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=294.38 Aligned_cols=294 Identities=18% Similarity=0.278 Sum_probs=188.4
Q ss_pred cccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEE
Q 042075 131 LRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLF 210 (1033)
Q Consensus 131 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 210 (1033)
..+|++++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 346888888888887 6776654 5788888888888866666788888888888888888877788888888888888
Q ss_pred cccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccC
Q 042075 211 LSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT 290 (1033)
Q Consensus 211 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 290 (1033)
|++|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.+.. .
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~ 160 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-----------------------S 160 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-----------------------G
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc-----------------------c
Confidence 8888887 4555443 577777777777775555555555555555555555531 1
Q ss_pred CCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCC
Q 042075 291 GAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLL 370 (1033)
Q Consensus 291 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~i 370 (1033)
+..+..+..+++|++|++++|+++..+.
T Consensus 161 ~~~~~~~~~l~~L~~L~l~~n~l~~l~~---------------------------------------------------- 188 (330)
T 1xku_A 161 GIENGAFQGMKKLSYIRIADTNITTIPQ---------------------------------------------------- 188 (330)
T ss_dssp GBCTTGGGGCTTCCEEECCSSCCCSCCS----------------------------------------------------
T ss_pred CcChhhccCCCCcCEEECCCCccccCCc----------------------------------------------------
Confidence 1334445555555555555555542211
Q ss_pred ccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccc
Q 042075 371 PACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450 (1033)
Q Consensus 371 p~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 450 (1033)
.+ .++|+.|++++|++++..|..|.++++|++|++++|++++..+..+..+++|++|+|++|+++ .+|..+..+
T Consensus 189 --~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 189 --GL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp --SC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred --cc---cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 11 135666777777777666777777777777777777777666667777777777777777776 555555555
Q ss_pred e-eceeeccccccCCCCCCccCCC------CcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCcccccc
Q 042075 451 K-LFNLQLSYNFLQGSIPSSLGQS------ETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLK 523 (1033)
Q Consensus 451 ~-L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~ 523 (1033)
+ |++|+|++|+|++..+..|... +.|+.|++++|.+.. ....|..|..+.
T Consensus 263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~-----------------------~~i~~~~f~~~~ 319 (330)
T 1xku_A 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY-----------------------WEIQPSTFRCVY 319 (330)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG-----------------------GGSCGGGGTTCC
T ss_pred CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc-----------------------cccCcccccccc
Confidence 4 5555555555555444444322 445555555555431 013455677777
Q ss_pred ccceEEccccc
Q 042075 524 NLEMLNVFENK 534 (1033)
Q Consensus 524 ~L~~L~Ls~N~ 534 (1033)
+++.++|++|+
T Consensus 320 ~l~~l~L~~N~ 330 (330)
T 1xku_A 320 VRAAVQLGNYK 330 (330)
T ss_dssp CGGGEEC----
T ss_pred ceeEEEecccC
Confidence 77777777774
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=301.66 Aligned_cols=291 Identities=21% Similarity=0.228 Sum_probs=221.1
Q ss_pred CCCCCCCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccC
Q 042075 63 SWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNN 142 (1033)
Q Consensus 63 ~W~~~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 142 (1033)
.|.....+|.|.|+ |+- ++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 22 ~~~~~~~~C~~~~~-c~~-----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CKG-----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp -----CCEECTTSE-EEC-----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCccCCCCCCCeE-eeC-----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 34445578999988 753 344555 4566554 58999999999999766668999999999999999
Q ss_pred CCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCC-CCCCCCCCCcEEEcccC-cCCCcC
Q 042075 143 SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRN-NLDGSI 220 (1033)
Q Consensus 143 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~ 220 (1033)
.+++..|..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 9998888899999999999999999995555558999999999999999995444 47899999999999999 577777
Q ss_pred CccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCC
Q 042075 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNA 300 (1033)
Q Consensus 221 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 300 (1033)
+..|+.+++|++|++++|++++..|..+.++++|++|++++|.++ .+|..++..+++|++|++++|++++..+..+...
T Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 245 (353)
T 2z80_A 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245 (353)
T ss_dssp TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccc
Confidence 889999999999999999999888999999999999999999886 5665555557777777777777775443322210
Q ss_pred CCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCc
Q 042075 301 SNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTT 380 (1033)
Q Consensus 301 ~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~ 380 (1033)
. . .+.
T Consensus 246 ~--------------------~-------------------------------------------------------~~~ 250 (353)
T 2z80_A 246 E--------------------T-------------------------------------------------------NSL 250 (353)
T ss_dssp ---------------------C-------------------------------------------------------CCC
T ss_pred c--------------------c-------------------------------------------------------cch
Confidence 0 0 022
Q ss_pred ccEEEccCCCCCc----cCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccC
Q 042075 381 LEVLLLDSNKIFG----NIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIP 444 (1033)
Q Consensus 381 L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 444 (1033)
++.++++++.+++ .+|..+.++++|++|++++|+++...+..|..+++|++|+|++|.+.+..|
T Consensus 251 l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 251 IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 3344444444443 356778888888888888888884433346888889999998888886544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-35 Score=348.48 Aligned_cols=395 Identities=20% Similarity=0.147 Sum_probs=209.3
Q ss_pred CCCCEEEecCCCccccCCcc-ccccccccEEecccCCCCC----CCCccccCCCCCcEEEcccccccCCCCCCcc-ccc-
Q 042075 108 SFLKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGG----EIPANISSCSNLIRVRLSSNELVGKIPSELG-SLS- 180 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~- 180 (1033)
++|++|||++|+++...... +..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 34556666666665432222 5556666666666666653 2345555666666666666666543222222 233
Q ss_pred ---ccceeeecccccCC----CCCCCCCCCCCCcEEEcccCcCCCcCCccccc-----cCCCCcccccccccCCC----C
Q 042075 181 ---KIEYFSVSYNNLTG----SIPPSFGNLSSISFLFLSRNNLDGSIPDTFGW-----LKNLVNLTMAQNRLSGT----I 244 (1033)
Q Consensus 181 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~ 244 (1033)
+|++|+|++|+++. .+|..|.++++|++|+|++|.+++..+..+.. .++|++|+|++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 46666666666663 34555666666777777776665433333322 34566667766666653 2
Q ss_pred cccccCCCceeEEeccCccccCccCccccc----cccccceeeecccccCCC----CCccCcCCCCccccccccccccCc
Q 042075 245 PSSIFNISSITVFDAGINQIQGVIPLDIGF----TLQNLQFFSVGRNQLTGA----IPPAISNASNLEVFQVNSNKLTGE 316 (1033)
Q Consensus 245 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 316 (1033)
+..+..+++|++|++++|.+....+..+.. ..++|++|+|++|.+++. ++..+..+++|+.|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 444555566666666666665333322221 133666666666666542 344445555555555555555421
Q ss_pred CcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCcc--
Q 042075 317 VPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN-- 394 (1033)
Q Consensus 317 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~-- 394 (1033)
... . ++..+....++|+.|++++|.+++.
T Consensus 243 ~~~--------------------------~-----------------------l~~~~~~~~~~L~~L~L~~n~l~~~~~ 273 (461)
T 1z7x_W 243 GMA--------------------------E-----------------------LCPGLLHPSSRLRTLWIWECGITAKGC 273 (461)
T ss_dssp HHH--------------------------H-----------------------HHHHHTSTTCCCCEEECTTSCCCHHHH
T ss_pred HHH--------------------------H-----------------------HHHHHhcCCCCceEEECcCCCCCHHHH
Confidence 000 0 0000000013444555555554432
Q ss_pred --CCccccCCCCCCEEEcccCcccccCChhhhcC-----CCCcEEEccccccccccCcccccceeceeeccccccCCCCC
Q 042075 395 --IPAAFGKFVKLLRLEMWNNRLSGTIPPAIGEL-----QNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIP 467 (1033)
Q Consensus 395 --~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p 467 (1033)
++..+.++++|++|++++|.++...+..+... ++|++|+|++|.+++.... .++
T Consensus 274 ~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-------------------~l~ 334 (461)
T 1z7x_W 274 GDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS-------------------HFS 334 (461)
T ss_dssp HHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-------------------HHH
T ss_pred HHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH-------------------HHH
Confidence 33444445555555555555543333333221 3444444444444321100 134
Q ss_pred CccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccc-cccccceEEcccccccc----ccCcc
Q 042075 468 SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG-NLKNLEMLNVFENKLRG----EIPRT 542 (1033)
Q Consensus 468 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~ 542 (1033)
..+..+++|++|++++|++++..+..+. ..+. ..++|+.|+|++|++++ .+|..
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~---------------------~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELC---------------------QGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHH---------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred HHHhhCCCccEEEccCCccccccHHHHH---------------------HHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 4556667888888888877632111110 0111 14678888999998886 67888
Q ss_pred cccccccceeecccccccCccccccc-----CcccCCccccccccccccCCccc
Q 042075 543 LGSCIKLELLQMQGNFLQGPIPSSLS-----SLRGLSVLDLSQNNLSGKIPEFL 591 (1033)
Q Consensus 543 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~ 591 (1033)
+..+++|++|+|++|++++.-...+. ...+|+.|++.+|.+....++.+
T Consensus 394 l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l 447 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447 (461)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence 88888999999999988754222221 12356667666666665444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-34 Score=338.28 Aligned_cols=358 Identities=19% Similarity=0.146 Sum_probs=199.2
Q ss_pred CCcEEEcccCcCCCcCCcc-ccccCCCCcccccccccCC----CCcccccCCCceeEEeccCccccCccCcccccccc--
Q 042075 205 SISFLFLSRNNLDGSIPDT-FGWLKNLVNLTMAQNRLSG----TIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQ-- 277 (1033)
Q Consensus 205 ~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~-- 277 (1033)
+|++|+|++|+++...... |..+++|++|+|++|++++ .++..+..+++|++|++++|.+....+..++..+.
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 4455555555554322222 4455555555555555543 23445555566666666666665443433443444
Q ss_pred --ccceeeecccccCC----CCCccCcCCCCccccccccccccCcCc-chhh-----hccccceeeecCcCCCCCCccch
Q 042075 278 --NLQFFSVGRNQLTG----AIPPAISNASNLEVFQVNSNKLTGEVP-YLEK-----LQRLSHFVITRNSLGSGEHRDLN 345 (1033)
Q Consensus 278 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~-----l~~L~~L~l~~N~l~~~~~~~~~ 345 (1033)
+|++|+|++|+++. .++..+..+++|++|++++|++++..+ .+.. ..+|++|++++|.++.....
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--- 160 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--- 160 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH---
Confidence 57788888887773 457778888888888888888765322 1211 12344444444433221100
Q ss_pred hhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccC-----CCCCCEEEcccCccccc--
Q 042075 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGK-----FVKLLRLEMWNNRLSGT-- 418 (1033)
Q Consensus 346 ~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~-----l~~L~~L~L~~N~l~~~-- 418 (1033)
.++..+.. .++|+.|++++|.++...+..+.. .++|++|++++|+++..
T Consensus 161 -----------------------~l~~~l~~-~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 216 (461)
T 1z7x_W 161 -----------------------PLASVLRA-KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216 (461)
T ss_dssp -----------------------HHHHHHHH-CTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred -----------------------HHHHHHhh-CCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence 01222222 257788888888876554444432 55788888888887753
Q ss_pred --CChhhhcCCCCcEEEcccccccccc-----Ccccccce-eceeeccccccCCC----CCCccCCCCcccEEecCCCcc
Q 042075 419 --IPPAIGELQNLRELRLQENRFLGNI-----PPSIGNLK-LFNLQLSYNFLQGS----IPSSLGQSETLTIIDLSNNNL 486 (1033)
Q Consensus 419 --~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~-L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 486 (1033)
++..+..+++|++|+|++|++.+.. +..+..++ |++|+|++|.+++. ++..+..+++|++|++++|++
T Consensus 217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 4666777788888888888776532 22222343 77777777777643 455566667777777777766
Q ss_pred CCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccc----cCcccccccccceeecccccccCc
Q 042075 487 TGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE----IPRTLGSCIKLELLQMQGNFLQGP 562 (1033)
Q Consensus 487 ~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (1033)
++..+..+.... ....++|+.|+|++|.+++. +|..+..+++|++|+|++|++++.
T Consensus 297 ~~~~~~~l~~~l--------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 297 GDEGARLLCETL--------------------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356 (461)
T ss_dssp HHHHHHHHHHHH--------------------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred chHHHHHHHHHh--------------------ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence 532211111100 00113556666666666543 344455556666666666666544
Q ss_pred ccccccC-----cccCCccccccccccc----cCCcccccccccceeecCCCcCcc
Q 042075 563 IPSSLSS-----LRGLSVLDLSQNNLSG----KIPEFLVGFQLLEYLNLSNNDFEG 609 (1033)
Q Consensus 563 ~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g 609 (1033)
.+..+.. .++|+.|+|++|++++ .+|..+..+++|++|++++|++++
T Consensus 357 ~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 4443332 4566666666666654 555556666666666666666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=301.53 Aligned_cols=296 Identities=21% Similarity=0.333 Sum_probs=182.4
Q ss_pred CCCCCCCCCCCCCCCcceeeeEecCC-----CCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccc
Q 042075 56 DPLGVFGSWNESIHFCQWHGVTCSRR-----QHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDR 130 (1033)
Q Consensus 56 ~~~~~~~~W~~~~~~c~w~gv~C~~~-----~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 130 (1033)
|....+++|....+||.|+|..|.-. ....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|. .
T Consensus 7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~ 79 (622)
T 3g06_A 7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L 79 (622)
T ss_dssp ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C
T ss_pred HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c
Confidence 33455678877788999977533210 0123667777777777 5666554 67777777777777 4555 4
Q ss_pred cccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEE
Q 042075 131 LRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLF 210 (1033)
Q Consensus 131 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 210 (1033)
+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|++|++++|++++ +|.. +++|++|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 567777777777776 4555 56777777777777763 444 45667777777777763 4443 36677777
Q ss_pred cccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccC
Q 042075 211 LSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT 290 (1033)
Q Consensus 211 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 290 (1033)
|++|++++ +|. .+++|+.|++++|++++ +| ..+++|+.|++++|.|++ +|. .+++|+.|++++|.++
T Consensus 148 Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~----~~~~L~~L~L~~N~l~ 214 (622)
T 3g06_A 148 VSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT----LPSELYKLWAYNNRLT 214 (622)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCS
T ss_pred CcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC----ccchhhEEECcCCccc
Confidence 77777764 343 23556666677776663 44 334555666666665553 332 1345555555555555
Q ss_pred CCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCC
Q 042075 291 GAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLL 370 (1033)
Q Consensus 291 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~i 370 (1033)
. +|.. +++|+.|++++|+|++ +
T Consensus 215 ~-l~~~---~~~L~~L~Ls~N~L~~------------------------------------------------------l 236 (622)
T 3g06_A 215 S-LPAL---PSGLKELIVSGNRLTS------------------------------------------------------L 236 (622)
T ss_dssp S-CCCC---CTTCCEEECCSSCCSC------------------------------------------------------C
T ss_pred c-cCCC---CCCCCEEEccCCccCc------------------------------------------------------C
Confidence 2 2221 2344444444444442 1
Q ss_pred ccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccc
Q 042075 371 PACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL 450 (1033)
Q Consensus 371 p~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 450 (1033)
| ...++|+.|++++|+|+. +|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++.+|..+..+
T Consensus 237 p----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 237 P----VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp C----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred C----CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 1 112467777777777774 443 5677888888888888 667788888888888888888887777766554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=278.72 Aligned_cols=246 Identities=21% Similarity=0.255 Sum_probs=185.5
Q ss_pred CcceeeeEecCCC--------CCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccc--cCCccccccccccEEec
Q 042075 70 FCQWHGVTCSRRQ--------HQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH--EIPSEFDRLRRLQVLAL 139 (1033)
Q Consensus 70 ~c~w~gv~C~~~~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L 139 (1033)
.|.|.+|.|+..+ ...++.|+|++++++...+..+.++++|++|+|++|+++. .+|..+..+++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 4899999998642 2357778888888774333456788888888888888763 34666777788888888
Q ss_pred ccCCCCCCCCccccCCCCCcEEEcccccccCCCC-CCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCC
Q 042075 140 HNNSIGGEIPANISSCSNLIRVRLSSNELVGKIP-SELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDG 218 (1033)
Q Consensus 140 s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 218 (1033)
++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|++|++++|++++..|..|.++++|++|+|++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 888887 567777788888888888888875544 567788888888888888887777778888888888888888875
Q ss_pred -cCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccC
Q 042075 219 -SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAI 297 (1033)
Q Consensus 219 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 297 (1033)
.+|..|..+++|++|+|++|++++..|..+.++++|+.|++++|++++. +...+..+++|++|+|++|++++..|..+
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL-DTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC-CSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc-ChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 5677788888888888888888877777788888888888888888743 33334567788888888888887777777
Q ss_pred cCCC-CccccccccccccCcC
Q 042075 298 SNAS-NLEVFQVNSNKLTGEV 317 (1033)
Q Consensus 298 ~~l~-~L~~L~Ls~N~l~~~~ 317 (1033)
..++ +|++|++++|++++..
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSG
T ss_pred HhhhccCCEEEccCCCeeccc
Confidence 7774 7888888888887653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-31 Score=291.92 Aligned_cols=269 Identities=15% Similarity=0.163 Sum_probs=222.3
Q ss_pred CCCCCCCCCCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCc-cccCCcccc-------cc
Q 042075 60 VFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSF-HHEIPSEFD-------RL 131 (1033)
Q Consensus 60 ~~~~W~~~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l 131 (1033)
...+|.....|+.|..+..... ..+++.+++.++.+ .+|..+... |+.|+|++|.+ .+.+|..+. ++
T Consensus 20 ~~~~~~~~~~c~~~~~~~~~~~-~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l 94 (312)
T 1wwl_A 20 PKPDWSSAFNCLGAADVELYGG-GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGI 94 (312)
T ss_dssp SSCCGGGGGGSSSCSEEEEEEE-EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTT
T ss_pred cccchHHHhhhhccccEEEEcc-CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCc
Confidence 3557876667877776544322 23577788888888 677666554 89999999999 557887776 79
Q ss_pred ccccEEecccCCCCCCCCccc--cCCCCCcEEEcccccccCCCCCCcccc-----cccceeeecccccCCCCCCCCCCCC
Q 042075 132 RRLQVLALHNNSIGGEIPANI--SSCSNLIRVRLSSNELVGKIPSELGSL-----SKIEYFSVSYNNLTGSIPPSFGNLS 204 (1033)
Q Consensus 132 ~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~ 204 (1033)
++|++|+|++|.+++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 999999999999999999987 8999999999999999976 8888888 8999999999999988889999999
Q ss_pred CCcEEEcccCcCCCc--CCccc--cccCCCCcccccccccCC--CCc-ccccCCCceeEEeccCccccCccCcccccccc
Q 042075 205 SISFLFLSRNNLDGS--IPDTF--GWLKNLVNLTMAQNRLSG--TIP-SSIFNISSITVFDAGINQIQGVIPLDIGFTLQ 277 (1033)
Q Consensus 205 ~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~ 277 (1033)
+|++|+|++|++.+. .|..+ +.+++|++|+|++|++++ .++ ..+.++++|++|++++|++++.+|...+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 999999999998765 33344 889999999999999983 223 33457899999999999999888766666789
Q ss_pred ccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCC
Q 042075 278 NLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGS 338 (1033)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~ 338 (1033)
+|++|+|++|+|+ .+|..+. ++|++|++++|+|++. |.+..+++|++|++++|.++.
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 9999999999999 7787776 8899999999999987 448888888888888888764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-31 Score=290.79 Aligned_cols=206 Identities=16% Similarity=0.210 Sum_probs=127.4
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCC-CCCCCcccc-------CCCCCcEEEcccccccCCCCCC
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSI-GGEIPANIS-------SCSNLIRVRLSSNELVGKIPSE 175 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 175 (1033)
++..++|+.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44556677777777777 667666554 77777777777 345666555 6777777777777777777766
Q ss_pred c--ccccccceeeecccccCCCCCCCCCCC-----CCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCC--Ccc
Q 042075 176 L--GSLSKIEYFSVSYNNLTGSIPPSFGNL-----SSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT--IPS 246 (1033)
Q Consensus 176 ~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~ 246 (1033)
+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|+.|+.+++|++|+|++|++.+. +|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 6777777777777777765 6666655 6777777777777766667777777777777777776654 233
Q ss_pred cc--cCCCceeEEeccCccccC--ccCccccccccccceeeecccccCCCCC-ccCcCCCCcccccccccccc
Q 042075 247 SI--FNISSITVFDAGINQIQG--VIPLDIGFTLQNLQFFSVGRNQLTGAIP-PAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 247 ~l--~~l~~L~~L~ls~N~l~~--~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
.+ .++++|++|++++|++++ .++..++..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 33 566666666666666652 2233333344555555555555554443 22333444444444444433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-32 Score=334.89 Aligned_cols=456 Identities=13% Similarity=0.114 Sum_probs=245.8
Q ss_pred CCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCc---cccCCcccc------------cccc
Q 042075 69 HFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSF---HHEIPSEFD------------RLRR 133 (1033)
Q Consensus 69 ~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~ 133 (1033)
-|++|.++.+... .++ .+.. ......+..+..+++|++|+|+++.. .+.+|..++ .+++
T Consensus 40 vck~W~~~~~~~~--~~l---~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 113 (592)
T 3ogk_B 40 VCRRWFKIDSETR--EHV---TMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113 (592)
T ss_dssp SCHHHHHHHHHHC--CEE---EESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HhHHHHHhhhccc--cEE---EEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCC
Confidence 3558999965432 122 2221 12223344556788899999988532 234554443 6788
Q ss_pred ccEEecccCCCCCCCCccccCC--CCCcEEEccccc-ccC-CCCCCcccccccceeeecccccCCC----CCCCCCCCCC
Q 042075 134 LQVLALHNNSIGGEIPANISSC--SNLIRVRLSSNE-LVG-KIPSELGSLSKIEYFSVSYNNLTGS----IPPSFGNLSS 205 (1033)
Q Consensus 134 L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~ 205 (1033)
|++|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+.++++
T Consensus 114 L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred CCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 8888888888876666666653 448888888876 211 1222234677888888888887655 2223446677
Q ss_pred CcEEEcccCcCCC----cCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc---CccCccccccccc
Q 042075 206 ISFLFLSRNNLDG----SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ---GVIPLDIGFTLQN 278 (1033)
Q Consensus 206 L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~---~~~p~~~~~~l~~ 278 (1033)
|++|+|++|.+++ .++..+..+++|++|+|++|.+.+ +|..+.++++|+.|+++.+... +..+.. ...+++
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~-l~~~~~ 271 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMN-LVFPRK 271 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSC-CCCCTT
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHH-hhcccc
Confidence 8888888888763 334445567777777777777774 5666777777777777643221 011111 123445
Q ss_pred cceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcce
Q 042075 279 LQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKW 358 (1033)
Q Consensus 279 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~ 358 (1033)
|+.|+++++.. +.+|..+..+++|++|++++|.+++.... ..+..+++|+.
T Consensus 272 L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~----------------------------~~~~~~~~L~~ 322 (592)
T 3ogk_B 272 LCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHC----------------------------TLIQKCPNLEV 322 (592)
T ss_dssp CCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHH----------------------------HHHTTCTTCCE
T ss_pred ccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHH----------------------------HHHHhCcCCCE
Confidence 55555554322 23444444555555555555554322110 01222333333
Q ss_pred eeecccccCCCCccccccccCcccEEEcc-----------CCCCCccC-CccccCCCCCCEEEcccCcccccCChhhhc-
Q 042075 359 FHININNFGGLLPACISNFSTTLEVLLLD-----------SNKIFGNI-PAAFGKFVKLLRLEMWNNRLSGTIPPAIGE- 425 (1033)
Q Consensus 359 l~l~~n~l~~~ip~~~~~~~~~L~~L~L~-----------~N~i~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~- 425 (1033)
|+++ +++.......+....++|+.|+++ .|.+++.. +..+..+++|++|+++.|++++..+..+..
T Consensus 323 L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~ 401 (592)
T 3ogk_B 323 LETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401 (592)
T ss_dssp EEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHH
T ss_pred Eecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhh
Confidence 3333 111111111111112334444444 13333221 111223444444444444444333333333
Q ss_pred CCCCcEEEccccccccccCcccccceeceeeccccccCCC-----CCCccCCCCcccEEecCCCc--cCCCCCccccCch
Q 042075 426 LQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGS-----IPSSLGQSETLTIIDLSNNN--LTGTIPPQLLGLS 498 (1033)
Q Consensus 426 l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~~~ 498 (1033)
+++|+.|+|+.+. ..|.+++. ++..+.++++|+.|++++|. +++.
T Consensus 402 ~~~L~~L~l~~~~-------------------~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~--------- 453 (592)
T 3ogk_B 402 LKNLCDFRLVLLD-------------------REERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL--------- 453 (592)
T ss_dssp CCSCCEEEEEECS-------------------CCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH---------
T ss_pred CCCCcEEEEeecC-------------------CCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH---------
Confidence 4444444443110 13344332 22234556777777776533 3311
Q ss_pred hHHhhhhccCccccCCcCCcc-ccccccceEEcccccccc-ccCcccccccccceeecccccccCc-ccccccCcccCCc
Q 042075 499 SLLIVLELSRNQLTGPIPNEV-GNLKNLEMLNVFENKLRG-EIPRTLGSCIKLELLQMQGNFLQGP-IPSSLSSLRGLSV 575 (1033)
Q Consensus 499 ~ll~~L~ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~ 575 (1033)
.+..+ ..+++|+.|+|++|++++ .++..+.++++|++|+|++|++++. ++..+..+++|+.
T Consensus 454 ----------------~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 517 (592)
T 3ogk_B 454 ----------------GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517 (592)
T ss_dssp ----------------HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCE
T ss_pred ----------------HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCe
Confidence 11111 125678888888888876 3455567788899999999988754 4444567889999
Q ss_pred cccccccccccCCccc-ccccccceeecCCCc
Q 042075 576 LDLSQNNLSGKIPEFL-VGFQLLEYLNLSNND 606 (1033)
Q Consensus 576 L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~ 606 (1033)
|+|++|++++.-...+ ..++.+....+..++
T Consensus 518 L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~ 549 (592)
T 3ogk_B 518 LWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549 (592)
T ss_dssp EEEESCBCCTTCTTGGGGCCTTEEEEEECCC-
T ss_pred eECcCCcCCHHHHHHHHHhCCCcEEEEecCcc
Confidence 9999999886544334 356777666665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=275.29 Aligned_cols=258 Identities=24% Similarity=0.260 Sum_probs=222.5
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCccccc--CChhhhcCCCCcEEEccccccccccCcccccce-ecee
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGT--IPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNL 455 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L 455 (1033)
++|+.|++++|+++...+..|.++++|++|+|++|+++.. .|..+..+++|++|+|++|.+. .+|..+..++ |++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 5899999999999977777789999999999999999833 4788889999999999999998 5777788887 9999
Q ss_pred eccccccCCCCC-CccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccC-CcCCccccccccceEEcccc
Q 042075 456 QLSYNFLQGSIP-SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-PIPNEVGNLKNLEMLNVFEN 533 (1033)
Q Consensus 456 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N 533 (1033)
++++|.+++..+ ..+..+++|++|++++|++++..|..+..+.++ +.|++++|.+++ .+|..+..+++|+.|+|++|
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC-CEEECCCCccccccchhHHhhCcCCCEEECCCC
Confidence 999999997765 689999999999999999997777777777777 999999999987 68999999999999999999
Q ss_pred ccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCccccccc-ccceeecCCCcCcccCC
Q 042075 534 KLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQ-LLEYLNLSNNDFEGMVP 612 (1033)
Q Consensus 534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p 612 (1033)
++++..|..|..+++|++|+|++|++++..+..+..+++|+.|||++|++++..|..+..++ +|++|+|++|++++..+
T Consensus 186 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 99988899999999999999999999988888899999999999999999999999999985 99999999999999766
Q ss_pred Ccccccccc---cccccccccccCCcccc
Q 042075 613 TEGVFRNAS---ITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 613 ~~~~~~~~~---~~~~~~n~~lcg~~~~~ 638 (1033)
......+.. ...+..+...|..|...
T Consensus 266 ~~~~~~~l~~~~~~~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 266 HQSFLQWIKDQRQLLVEVERMECATPSDK 294 (306)
T ss_dssp GHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred hHHHHHHHHhhhhhhccccccccCCchhh
Confidence 433222222 22233455566655543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=281.03 Aligned_cols=277 Identities=20% Similarity=0.235 Sum_probs=145.4
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSV 187 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 187 (1033)
+.....++++|+++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 33344555555555 4454443 25555555555555433335555555555555555555444455555555555555
Q ss_pred cccccCCCCCCCCCCCCCCcEEEcccCcCCCcCC-ccccccCCCCccccccc-ccCCCCcccccCCCceeEEeccCcccc
Q 042075 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQN-RLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 188 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++|++++..+..|+++++|++|+|++|++++..+ ..|..+++|++|++++| .++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~------------------------ 163 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT------------------------ 163 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC------------------------
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc------------------------
Confidence 5555553333334555555555555555553222 24444555555555444 233
Q ss_pred CccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc-hhhhccccceeeecCcCCCCCCccc
Q 042075 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGEHRDL 344 (1033)
Q Consensus 266 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~ 344 (1033)
.++...+..+++|++|++++|++++..|..+..+++|++|++++|+++..++. +..+
T Consensus 164 -~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~--------------------- 221 (353)
T 2z80_A 164 -KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT--------------------- 221 (353)
T ss_dssp -EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHT---------------------
T ss_pred -ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhc---------------------
Confidence 23223333455566666666666656666677777777777777766533322 1122
Q ss_pred hhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccc---cCCCCCCEEEcccCcccc----
Q 042075 345 NFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF---GKFVKLLRLEMWNNRLSG---- 417 (1033)
Q Consensus 345 ~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~---~~l~~L~~L~L~~N~l~~---- 417 (1033)
++|+.|++++|.+++..+..+ .....++.+++++|.+++
T Consensus 222 ----------------------------------~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~ 267 (353)
T 2z80_A 222 ----------------------------------SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267 (353)
T ss_dssp ----------------------------------TTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred ----------------------------------ccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence 234444444444443332222 224455666666666553
Q ss_pred cCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCC-ccCCCCcccEEecCCCccCCCCC
Q 042075 418 TIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPS-SLGQSETLTIIDLSNNNLTGTIP 491 (1033)
Q Consensus 418 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p 491 (1033)
.+|.++..+++|+.|+|++|+++ .+|. .|..+++|++|+|++|.+++..|
T Consensus 268 ~l~~~l~~l~~L~~L~Ls~N~l~------------------------~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 268 QVMKLLNQISGLLELEFSRNQLK------------------------SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHTCTTCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHHHHhcccCCCEEECCCCCCC------------------------ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 24455555555555555555544 3333 35788899999999999886543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=275.02 Aligned_cols=225 Identities=18% Similarity=0.232 Sum_probs=181.9
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeec
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQL 457 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~L 457 (1033)
+.++.|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..++.++ |++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 35666666666665 45556666666666666666666 56666666666666666666666 5666666665 666666
Q ss_pred cccccCCCCCCccC---------CCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceE
Q 042075 458 SYNFLQGSIPSSLG---------QSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528 (1033)
Q Consensus 458 s~N~l~~~~p~~~~---------~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L 528 (1033)
++|++.+.+|..+. ++++|++|+|++|+++ .+|..+..+.++ +.|++++|++++ +|..++.+++|+.|
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCCc-CchhhccCCCCCEE
Confidence 66666666666554 4889999999999998 888888888777 889999999985 67789999999999
Q ss_pred EccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCc
Q 042075 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
+|++|++.+.+|..|+++++|++|+|++|++.+.+|..++++++|+.|+|++|++.+.+|+.+.++++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988765
Q ss_pred c
Q 042075 609 G 609 (1033)
Q Consensus 609 g 609 (1033)
.
T Consensus 315 ~ 315 (328)
T 4fcg_A 315 Q 315 (328)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-31 Score=323.93 Aligned_cols=414 Identities=13% Similarity=0.057 Sum_probs=268.5
Q ss_pred ccccCCccccccccccEEecccCCC---CCCCCcccc------------CCCCCcEEEcccccccCCCCCCcccc--ccc
Q 042075 120 FHHEIPSEFDRLRRLQVLALHNNSI---GGEIPANIS------------SCSNLIRVRLSSNELVGKIPSELGSL--SKI 182 (1033)
Q Consensus 120 l~~~~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L 182 (1033)
+...++..+.++++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+..+ .+|
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L 140 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGC
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccC
Confidence 3334455667889999999987542 245555444 68889999999998876666666653 449
Q ss_pred ceeeecccc-cCC-CCCCCCCCCCCCcEEEcccCcCCCc----CCccccccCCCCcccccccccCC----CCcccccCCC
Q 042075 183 EYFSVSYNN-LTG-SIPPSFGNLSSISFLFLSRNNLDGS----IPDTFGWLKNLVNLTMAQNRLSG----TIPSSIFNIS 252 (1033)
Q Consensus 183 ~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~ 252 (1033)
++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|++++|.+++ .++..+.+++
T Consensus 141 ~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~ 220 (592)
T 3ogk_B 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220 (592)
T ss_dssp CEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCT
T ss_pred cEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCC
Confidence 999998886 221 1122233678889999998888765 33345567888888888888873 3444455677
Q ss_pred ceeEEeccCccccCccCccccccccccceeeecccccC---CCCCccCcCCCCccccccccccccCcCcchhhhccccce
Q 042075 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLT---GAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHF 329 (1033)
Q Consensus 253 ~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L 329 (1033)
+|+.|++++|.+.+ +| ..+..+++|++|+++.+... +..+..+..+++|+.|+++++.....+..+..
T Consensus 221 ~L~~L~L~~~~~~~-l~-~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~------- 291 (592)
T 3ogk_B 221 SLVSVKVGDFEILE-LV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF------- 291 (592)
T ss_dssp TCCEEECSSCBGGG-GH-HHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGG-------
T ss_pred CCcEEeccCccHHH-HH-HHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhh-------
Confidence 78888888877764 44 33445677777777653332 22334455555555555554322211111111
Q ss_pred eeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCC-ccccCCCCCCEE
Q 042075 330 VITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP-AAFGKFVKLLRL 408 (1033)
Q Consensus 330 ~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L 408 (1033)
.++|+.|++++|.+++... ..+.++++|++|
T Consensus 292 ------------------------------------------------~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L 323 (592)
T 3ogk_B 292 ------------------------------------------------AAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323 (592)
T ss_dssp ------------------------------------------------GGGCCEEEETTCCCCHHHHHHHHTTCTTCCEE
T ss_pred ------------------------------------------------cCCCcEEecCCCcCCHHHHHHHHHhCcCCCEE
Confidence 2456666666666554333 335677888888
Q ss_pred EcccCcccccCChhhhcCCCCcEEEcc-----------cccccccc-Ccccccce-eceeeccccccCCCCCCccCC-CC
Q 042075 409 EMWNNRLSGTIPPAIGELQNLRELRLQ-----------ENRFLGNI-PPSIGNLK-LFNLQLSYNFLQGSIPSSLGQ-SE 474 (1033)
Q Consensus 409 ~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~-p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~-l~ 474 (1033)
+++++...+.++..+..+++|++|+|+ .|.+++.. +.....++ |++|+++.|.+++..+..+.. ++
T Consensus 324 ~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~ 403 (592)
T 3ogk_B 324 ETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403 (592)
T ss_dssp EEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred eccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence 887433333444455667888888888 35555432 22223344 667777667666655555544 67
Q ss_pred cccEEecC----CCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccc--ccccccCccccc-cc
Q 042075 475 TLTIIDLS----NNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN--KLRGEIPRTLGS-CI 547 (1033)
Q Consensus 475 ~L~~L~Ls----~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~ 547 (1033)
+|+.|+++ .|++++ .|.. . .++..+..+++|+.|+|++| .+++..+..++. ++
T Consensus 404 ~L~~L~l~~~~~~n~l~~-~p~~-----~--------------~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITD-LPLD-----N--------------GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp SCCEEEEEECSCCSCCSS-CCCH-----H--------------HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred CCcEEEEeecCCCccccC-chHH-----H--------------HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 77777775 555552 2210 0 01223456789999999853 477666666654 88
Q ss_pred ccceeecccccccC-cccccccCcccCCcccccccccccc-CCcccccccccceeecCCCcCccc
Q 042075 548 KLELLQMQGNFLQG-PIPSSLSSLRGLSVLDLSQNNLSGK-IPEFLVGFQLLEYLNLSNNDFEGM 610 (1033)
Q Consensus 548 ~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~ 610 (1033)
+|++|+|++|++++ .++..+..+++|+.|+|++|++++. ++..+..+++|++|+|++|++++.
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 99999999999986 4566678899999999999999865 445556899999999999999865
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=281.98 Aligned_cols=247 Identities=19% Similarity=0.221 Sum_probs=126.6
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
..++.++++++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34444444444 3443332 34455555555554444444455555555555555554444444444555555555555
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCc
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 270 (1033)
++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++ |...+.+|.
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~------------------------~~~l~~i~~ 189 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE------------------------LKKLEYISE 189 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC------------------------CTTCCEECT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC------------------------CCCccccCh
Confidence 54444444444444555555555544443334444444444444444 222223444
Q ss_pred cccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhccc
Q 042075 271 DIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSL 350 (1033)
Q Consensus 271 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l 350 (1033)
..+..+++|++|+|++|++++. | .+..+++|+.|+|++|++++..|.
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~------------------------------- 236 (452)
T 3zyi_A 190 GAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPG------------------------------- 236 (452)
T ss_dssp TTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGG-------------------------------
T ss_pred hhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcc-------------------------------
Confidence 4444455555555555555532 2 355555566666555555533221
Q ss_pred ccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCc
Q 042075 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLR 430 (1033)
Q Consensus 351 ~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 430 (1033)
.+.. .++|+.|++++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+
T Consensus 237 ----------------------~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 293 (452)
T 3zyi_A 237 ----------------------SFHG-LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293 (452)
T ss_dssp ----------------------GGTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred ----------------------cccC-ccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence 0000 13455555555556556666667777777777777777766666667777777
Q ss_pred EEEccccccc
Q 042075 431 ELRLQENRFL 440 (1033)
Q Consensus 431 ~L~L~~N~l~ 440 (1033)
.|+|++|.+.
T Consensus 294 ~L~L~~Np~~ 303 (452)
T 3zyi_A 294 ELHLHHNPWN 303 (452)
T ss_dssp EEECCSSCEE
T ss_pred EEEccCCCcC
Confidence 7777777665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=266.59 Aligned_cols=235 Identities=23% Similarity=0.227 Sum_probs=145.1
Q ss_pred CCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccc-cCCCCCCccCCCCcccEEe
Q 042075 403 VKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNF-LQGSIPSSLGQSETLTIID 480 (1033)
Q Consensus 403 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 480 (1033)
++|++|++++|++++..+..|..+++|++|+|++|++++..|..|..++ |++|+|++|. +....|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 3455555555555544444455555555555555555544455555544 5555555554 4444455555566666666
Q ss_pred cCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeeccccccc
Q 042075 481 LSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ 560 (1033)
Q Consensus 481 Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (1033)
+++|++++..|..+..+.++ +.|++++|++++..+..|+.+++|+.|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCC-CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 66666654444444444444 55666666666555555677777777777777777555556777777777777777777
Q ss_pred CcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccccccccccccccCCcccc
Q 042075 561 GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 561 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~ 638 (1033)
+..|..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++..+......++.......+...|..|...
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHh
Confidence 777777777777777777777777666666777777777788888777766654444444444444555556555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=280.44 Aligned_cols=233 Identities=24% Similarity=0.245 Sum_probs=200.6
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeec
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQL 457 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~L 457 (1033)
++++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..++ |++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 5678888888888888888888888899999998888888788888888899999998888866666788887 888999
Q ss_pred cccccCCCCCCccCCCCcccEEecCCCccCCCCCc-cccCchhHHhhhhccCccccCCcCCccccccccceEEccccccc
Q 042075 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP-QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536 (1033)
Q Consensus 458 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (1033)
++|.+++..+..|..+++|++|+|++|+..+.+|. .+.++.++ +.|++++|+++ .+| .+..+++|+.|+|++|+++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~ 220 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL-RYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS 220 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC-CEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCC
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc-CeecCCCCcCc-ccc-ccCCCcccCEEECCCCccC
Confidence 99988877777888899999999988554445655 45556655 88999999988 455 4888999999999999999
Q ss_pred cccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCc
Q 042075 537 GEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
+..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..+..+++|+.|+|++|++.+...-.
T Consensus 221 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~ 298 (440)
T 3zyj_A 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298 (440)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred ccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCch
Confidence 888999999999999999999999988999999999999999999999888888899999999999999999876543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=276.44 Aligned_cols=235 Identities=22% Similarity=0.258 Sum_probs=151.0
Q ss_pred ccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccc
Q 042075 99 YISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGS 178 (1033)
Q Consensus 99 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 178 (1033)
.+|..+. +.++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|..
T Consensus 57 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 134 (440)
T 3zyj_A 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134 (440)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCS
T ss_pred cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhc
Confidence 4555443 56777788877777766677777777777777777777666667777777777777777777555556777
Q ss_pred ccccceeeecccccCCCCCCCCCCCCCCcEEEcccC-cCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEE
Q 042075 179 LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN-NLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVF 257 (1033)
Q Consensus 179 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 257 (1033)
+++|++|+|++|++++..+..|.++++|++|+|++| .+....+..|..+++|++|+|++|+++ .+|. +.
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~-------- 204 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LT-------- 204 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CT--------
T ss_pred cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cC--------
Confidence 777777777777777555566777777777777763 344333345555666666655555555 2221 11
Q ss_pred eccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCC
Q 042075 258 DAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLG 337 (1033)
Q Consensus 258 ~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~ 337 (1033)
.+++|++|+|++|++++..|..|..++
T Consensus 205 -----------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~------------------------------------ 231 (440)
T 3zyj_A 205 -----------------PLIKLDELDLSGNHLSAIRPGSFQGLM------------------------------------ 231 (440)
T ss_dssp -----------------TCSSCCEEECTTSCCCEECTTTTTTCT------------------------------------
T ss_pred -----------------CCcccCEEECCCCccCccChhhhccCc------------------------------------
Confidence 233444444444444433344443333
Q ss_pred CCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccc
Q 042075 338 SGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSG 417 (1033)
Q Consensus 338 ~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~ 417 (1033)
+|+.|++++|+|++..+..|.++++|++|+|++|+|++
T Consensus 232 ------------------------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 232 ------------------------------------------HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp ------------------------------------------TCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred ------------------------------------------cCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 34444555555555566677777788888888888887
Q ss_pred cCChhhhcCCCCcEEEccccccc
Q 042075 418 TIPPAIGELQNLRELRLQENRFL 440 (1033)
Q Consensus 418 ~~p~~~~~l~~L~~L~L~~N~l~ 440 (1033)
..+..|..+++|+.|+|++|.+.
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEE
T ss_pred cChhHhccccCCCEEEcCCCCcc
Confidence 77777788888888888888776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=279.83 Aligned_cols=248 Identities=20% Similarity=0.214 Sum_probs=193.1
Q ss_pred eeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccc
Q 042075 73 WHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI 152 (1033)
Q Consensus 73 w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 152 (1033)
|..|.|... +++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.|++..|..|
T Consensus 56 ~~~v~c~~~-------------~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 119 (452)
T 3zyi_A 56 FSKVVCTRR-------------GLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119 (452)
T ss_dssp SCEEECCSS-------------CCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred CcEEEECCC-------------CcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhc
Confidence 567777643 233 3444333 578888888888887778888888888888888888887777888
Q ss_pred cCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEccc-CcCCCcCCccccccCCCC
Q 042075 153 SSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR-NNLDGSIPDTFGWLKNLV 231 (1033)
Q Consensus 153 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~ 231 (1033)
.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++ |.+....+..|..+++|+
T Consensus 120 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~ 199 (452)
T 3zyi_A 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199 (452)
T ss_dssp TTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCC
T ss_pred cCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCC
Confidence 8888888888888888866666788888888888888888866667788888888888888 456555555788888888
Q ss_pred cccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccc
Q 042075 232 NLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311 (1033)
Q Consensus 232 ~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 311 (1033)
+|+|++|++++. | .+..+++|+.|+|++|++++..|. .+..+++|++|+|++|++++..|..|..+++|+.|+|++|
T Consensus 200 ~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 200 YLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPG-SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276 (452)
T ss_dssp EEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGG-GGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCccccc-c-cccccccccEEECcCCcCcccCcc-cccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence 888888888843 4 477788888888888888855454 4457888888888888888888888888888888888888
Q ss_pred cccCcCcc-hhhhccccceeeecCcCCCC
Q 042075 312 KLTGEVPY-LEKLQRLSHFVITRNSLGSG 339 (1033)
Q Consensus 312 ~l~~~~~~-l~~l~~L~~L~l~~N~l~~~ 339 (1033)
+|++.++. +..+++|+.|++++|.+...
T Consensus 277 ~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 277 NLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCCccChHHhccccCCCEEEccCCCcCCC
Confidence 88877664 67788888888888887653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=277.03 Aligned_cols=265 Identities=20% Similarity=0.199 Sum_probs=138.1
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 191 (1033)
.++++++.+...++..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..| +..+++|++|+|++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 34444444443333334445555555555555555444555555555555655555554333 5555555666666555
Q ss_pred cCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcc
Q 042075 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271 (1033)
Q Consensus 192 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~ 271 (1033)
+++.. ..++|++|++++|++++..+.. +++|++|++++|++++..|..+..+++|++|++++|.+++..|..
T Consensus 92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 163 (317)
T 3o53_A 92 VQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163 (317)
T ss_dssp EEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred ccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence 55322 1245666666666665443332 345556666666665544545555555555555555555443333
Q ss_pred ccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccc
Q 042075 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLT 351 (1033)
Q Consensus 272 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~ 351 (1033)
++..+++|++|+|++|++++. | ....++
T Consensus 164 ~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~-------------------------------------------------- 191 (317)
T 3o53_A 164 LAASSDTLEHLNLQYNFIYDV-K-GQVVFA-------------------------------------------------- 191 (317)
T ss_dssp GGGGTTTCCEEECTTSCCCEE-E-CCCCCT--------------------------------------------------
T ss_pred HhhccCcCCEEECCCCcCccc-c-cccccc--------------------------------------------------
Confidence 333344555555555554422 1 111133
Q ss_pred cccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcE
Q 042075 352 NATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRE 431 (1033)
Q Consensus 352 ~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 431 (1033)
+|+.|++++|+|++. |..+..+++|++|+|++|+++ .+|..+..+++|+.
T Consensus 192 ----------------------------~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~ 241 (317)
T 3o53_A 192 ----------------------------KLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241 (317)
T ss_dssp ----------------------------TCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE
T ss_pred ----------------------------cCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE
Confidence 444555555555433 223555666666666666666 34555666666666
Q ss_pred EEccccccc-cccCcccccce-eceeecc-ccccCCCCCC
Q 042075 432 LRLQENRFL-GNIPPSIGNLK-LFNLQLS-YNFLQGSIPS 468 (1033)
Q Consensus 432 L~L~~N~l~-~~~p~~~~~l~-L~~L~Ls-~N~l~~~~p~ 468 (1033)
|+|++|.+. +.+|..+..++ |+.|+++ .+.++|..|.
T Consensus 242 L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp EECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred EEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 666666666 55555555554 6666665 3344444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=259.02 Aligned_cols=244 Identities=21% Similarity=0.241 Sum_probs=203.6
Q ss_pred EEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccc
Q 042075 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSN 166 (1033)
Q Consensus 87 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 166 (1033)
+.++.++.+++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34556666666 345433 478999999999999877788999999999999999999888999999999999999999
Q ss_pred c-ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCc
Q 042075 167 E-LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245 (1033)
Q Consensus 167 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 245 (1033)
. ++...|..|..+++|++|++++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 876668899999999999999999998888899999999999999999998777889999999999999999997777
Q ss_pred ccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhcc
Q 042075 246 SSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325 (1033)
Q Consensus 246 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~ 325 (1033)
..+.++++|+.|++++|.+++..|..+ ..+++|++|+|++|++++..+..+..+++|++|++++|+++...+...-...
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHc-cCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence 778899999999999999987666544 4688999999999999987777788999999999999999876554333333
Q ss_pred ccceeeecC
Q 042075 326 LSHFVITRN 334 (1033)
Q Consensus 326 L~~L~l~~N 334 (1033)
++.+....+
T Consensus 250 l~~~~~~~~ 258 (285)
T 1ozn_A 250 LQKFRGSSS 258 (285)
T ss_dssp HHHCCSEEC
T ss_pred HHhcccccC
Confidence 443333333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=277.96 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=162.0
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSV 187 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 187 (1033)
..++.|++++|+++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35778888888887 6777665 67888888888887 5665 4677888888888877 4555 5677777888
Q ss_pred cccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCc
Q 042075 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGV 267 (1033)
Q Consensus 188 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 267 (1033)
++|++++ +|. .+++|+.|+|++|+|++ +|.. +++|++|+|++|++++ +|. .
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~----------------- 159 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---L----------------- 159 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---C-----------------
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---c-----------------
Confidence 8887774 343 45677777777777774 4442 3666666666666663 232 1
Q ss_pred cCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhh
Q 042075 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFL 347 (1033)
Q Consensus 268 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 347 (1033)
+.+|+.|++++|+|++ +| ..+++|+.|++++|++++.++.
T Consensus 160 --------~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~~---------------------------- 199 (622)
T 3g06_A 160 --------PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPTL---------------------------- 199 (622)
T ss_dssp --------CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCC----------------------------
T ss_pred --------cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCCc----------------------------
Confidence 2345555555555553 33 2345566666666655532211
Q ss_pred cccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCC
Q 042075 348 CSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQ 427 (1033)
Q Consensus 348 ~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 427 (1033)
.++|+.|++++|.++. +|. .+++|++|+|++|+|++ +| ..++
T Consensus 200 ------------------------------~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~ 241 (622)
T 3g06_A 200 ------------------------------PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPS 241 (622)
T ss_dssp ------------------------------CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCT
T ss_pred ------------------------------cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCC
Confidence 0234444445554442 222 12456666666666664 34 3446
Q ss_pred CCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccc
Q 042075 428 NLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQL 494 (1033)
Q Consensus 428 ~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 494 (1033)
+|+.|+|++|+|+ .+|. .+. |+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++.+|..+
T Consensus 242 ~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 242 ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp TCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred cCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 6667777777666 3444 222 666666666666 567777788888888888888876555433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=251.88 Aligned_cols=219 Identities=22% Similarity=0.301 Sum_probs=150.6
Q ss_pred CCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCC
Q 042075 68 IHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE 147 (1033)
Q Consensus 68 ~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 147 (1033)
.++|.|.|+.|+-. ..++.+++++++++. +|..+. +.|++|+|++|++++..+..|..+++|++|+|++|.++..
T Consensus 2 ~~~C~~~~~~C~c~--~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSCN--NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCCBGGGTCSBEEE--TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CccCCCCCCCCEeC--CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 47999999998643 234567888888874 555443 5677888888888766566777788888888888887754
Q ss_pred CCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCcccccc
Q 042075 148 IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWL 227 (1033)
Q Consensus 148 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 227 (1033)
.+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 44556777788888888887776555667777777777777777776666677777777777777777776666667777
Q ss_pred CCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccc
Q 042075 228 KNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307 (1033)
Q Consensus 228 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 307 (1033)
++|++|+|++|++++..+..+.++++|+.|++++ |++++..+..+..+++|+.|+
T Consensus 157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-------------------------N~l~~~~~~~~~~l~~L~~L~ 211 (270)
T 2o6q_A 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN-------------------------NQLKRVPEGAFDSLEKLKMLQ 211 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS-------------------------SCCSCCCTTTTTTCTTCCEEE
T ss_pred cccceeEecCCcCcEeChhHhccCCCcCEEECCC-------------------------CcCCcCCHHHhccccCCCEEE
Confidence 7777777777777755444455555555555554 444444444555566666666
Q ss_pred cccccccCc
Q 042075 308 VNSNKLTGE 316 (1033)
Q Consensus 308 Ls~N~l~~~ 316 (1033)
+++|++...
T Consensus 212 l~~N~~~c~ 220 (270)
T 2o6q_A 212 LQENPWDCT 220 (270)
T ss_dssp CCSSCBCCS
T ss_pred ecCCCeeCC
Confidence 666666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=271.40 Aligned_cols=269 Identities=18% Similarity=0.172 Sum_probs=164.1
Q ss_pred ceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeee
Q 042075 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVIT 332 (1033)
Q Consensus 253 ~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~ 332 (1033)
+++..+++.+.+. ..+..++..+++|++|+|++|++++..|..+..+++|++|++++|++++.++ +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECC
T ss_pred ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECc
Confidence 3455566666665 3344445556778888888888887777778888888888888888876544 4444444444444
Q ss_pred cCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEccc
Q 042075 333 RNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWN 412 (1033)
Q Consensus 333 ~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~ 412 (1033)
+|.++.. |. .++|+.|++++|++++..+.. +++|++|++++
T Consensus 89 ~n~l~~l-------------------------------~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~ 129 (317)
T 3o53_A 89 NNYVQEL-------------------------------LV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLAN 129 (317)
T ss_dssp SSEEEEE-------------------------------EE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCS
T ss_pred CCccccc-------------------------------cC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCC
Confidence 4433210 00 024444555555544433222 23344444444
Q ss_pred CcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCcc-CCCCcccEEecCCCccCCCCC
Q 042075 413 NRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSL-GQSETLTIIDLSNNNLTGTIP 491 (1033)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p 491 (1033)
|++++..+..+..+++ |++|+|++|.+++..|..+ ..+++|++|+|++|++++ +|
T Consensus 130 N~l~~~~~~~~~~l~~-----------------------L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~ 185 (317)
T 3o53_A 130 NKITMLRDLDEGCRSR-----------------------VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185 (317)
T ss_dssp SCCCSGGGBCTGGGSS-----------------------EEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EE
T ss_pred CCCCCccchhhhccCC-----------------------CCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cc
Confidence 4444444444444444 4444455555544444444 356778888888888762 21
Q ss_pred ccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcc
Q 042075 492 PQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLR 571 (1033)
Q Consensus 492 ~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 571 (1033)
. ...+++|+.|+|++|++++ +|..+..+++|++|+|++|+|+ .+|..+..++
T Consensus 186 ~--------------------------~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 186 G--------------------------QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp C--------------------------CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred c--------------------------ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 1 1125667777777777773 4455777777777777777777 5677777777
Q ss_pred cCCcccccccccc-ccCCcccccccccceeecC-CCcCcccCCCc
Q 042075 572 GLSVLDLSQNNLS-GKIPEFLVGFQLLEYLNLS-NNDFEGMVPTE 614 (1033)
Q Consensus 572 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls-~N~l~g~~p~~ 614 (1033)
+|+.|+|++|+++ +.+|..+..++.|+.|+++ .+.++|..|..
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 8888888888877 6677777777888888877 55677766654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=288.31 Aligned_cols=186 Identities=18% Similarity=0.032 Sum_probs=129.1
Q ss_pred eecccCceeEEEEEeCCCCeEEEEEEeeccC----------chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLH----------HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 718 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
..+.|+.|.+..++..-.|+.||||++.... ....+++.+|+++|+++ .|+||++++++ +++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence 3556667776666666668889999996431 12346799999999999 79999999999 56677
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..||||||++|++|.+++.. ...++.. +|+.||+.||+|+|++ |||||||||+|||++++|++|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----------~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----------GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----------TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence 99999999999999999953 3345543 5899999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
|+|||+|+......... ...+||+.|||||++.+ .+..++|+||+|++.+++.++..+
T Consensus 380 L~DFGlAr~~~~~~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDCSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC---CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCCccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 99999998765443222 22459999999999876 467889999999998888766544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=280.33 Aligned_cols=77 Identities=26% Similarity=0.271 Sum_probs=45.7
Q ss_pred cccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccc-cccCcccccce-eceeec
Q 042075 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFL-GNIPPSIGNLK-LFNLQL 457 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~-L~~L~L 457 (1033)
+|+.|+|++|.|++..| .|..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..+..+. ++.+++
T Consensus 192 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~ 269 (487)
T 3oja_A 192 KLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269 (487)
T ss_dssp TCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred CCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence 44445555555544333 35566666666666666663 4555666666777777777666 55566666665 666666
Q ss_pred c
Q 042075 458 S 458 (1033)
Q Consensus 458 s 458 (1033)
+
T Consensus 270 ~ 270 (487)
T 3oja_A 270 Q 270 (487)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=245.66 Aligned_cols=217 Identities=20% Similarity=0.225 Sum_probs=187.9
Q ss_pred cccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccc
Q 042075 100 ISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSL 179 (1033)
Q Consensus 100 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 179 (1033)
+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence 455443 579999999999998777799999999999999999997777789999999999999999998888899999
Q ss_pred cccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCc-CCccccccCCCCcccccccccCCCCcccccCCCcee---
Q 042075 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS-IPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT--- 255 (1033)
Q Consensus 180 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~--- 255 (1033)
++|++|++++|++++..+..++++++|++|+|++|++++. +|..|+.+++|++|+|++|++++..+..+..+.+|+
T Consensus 100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ 179 (276)
T 2z62_A 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179 (276)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccc
Confidence 9999999999999987777899999999999999999864 589999999999999999999988777887777766
Q ss_pred -EEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcch
Q 042075 256 -VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYL 320 (1033)
Q Consensus 256 -~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 320 (1033)
.|++++|.+++ +|...+ ...+|++|+|++|++++..+..+..+++|+.|++++|++++..+.+
T Consensus 180 l~L~ls~n~l~~-~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 180 LSLDLSLNPMNF-IQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp EEEECCSSCCCE-ECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred eeeecCCCcccc-cCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 89999999985 444444 2448999999999999777777899999999999999998776543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-29 Score=308.20 Aligned_cols=187 Identities=10% Similarity=0.093 Sum_probs=119.3
Q ss_pred CCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccc---cCCcc------------cccccc
Q 042075 69 HFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHH---EIPSE------------FDRLRR 133 (1033)
Q Consensus 69 ~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~---~~p~~------------~~~l~~ 133 (1033)
-|++|+++... ....+++...... .....+..+++|++|+|+++.... ..|.. +..+++
T Consensus 33 vck~W~~~~~~-----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 106 (594)
T 2p1m_B 33 VCKSWYEIERW-----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106 (594)
T ss_dssp SCHHHHHHHHH-----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHHHHHHhhhh-----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCC
Confidence 35579888221 2334555543322 112345678899999999976322 22221 346788
Q ss_pred ccEEecccCCCCCCCCcccc-CCCCCcEEEcccc-cccCC-CCCCcccccccceeeecccccCCCCCCCC----CCCCCC
Q 042075 134 LQVLALHNNSIGGEIPANIS-SCSNLIRVRLSSN-ELVGK-IPSELGSLSKIEYFSVSYNNLTGSIPPSF----GNLSSI 206 (1033)
Q Consensus 134 L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L 206 (1033)
|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|
T Consensus 107 L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L 186 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186 (594)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCC
T ss_pred CCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcC
Confidence 99999999988877776675 6889999999988 45432 34445578899999999988876544333 356688
Q ss_pred cEEEcccCc--CCC-cCCccccccCCCCccccccc-ccCCCCcccccCCCceeEEeccCc
Q 042075 207 SFLFLSRNN--LDG-SIPDTFGWLKNLVNLTMAQN-RLSGTIPSSIFNISSITVFDAGIN 262 (1033)
Q Consensus 207 ~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~ls~N 262 (1033)
++|+|++|. ++. .++..+..+++|++|+|++| .+. .+|..+.++++|+.|+++.+
T Consensus 187 ~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 187 VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBC
T ss_pred cEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccc
Confidence 888888886 221 01112234577888888777 343 36666666667777765443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=273.35 Aligned_cols=216 Identities=25% Similarity=0.181 Sum_probs=168.8
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeecc
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLS 458 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls 458 (1033)
++|+.|+|++|.|++..|..|.++++|++|+|++|.+++..| |..+++|++|+|++|.|++..+. ..|++|+|+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~ 107 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAA 107 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECc
Confidence 378888888888888777888888888888888888876655 78888888888888888754332 237888888
Q ss_pred ccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccc-cccccceEEcccccccc
Q 042075 459 YNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG-NLKNLEMLNVFENKLRG 537 (1033)
Q Consensus 459 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 537 (1033)
+|.|++..+.. +++|+.|+|++|++++..|..+..+.++ +.|+|++|.|++..|..+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 88888766543 4678888888888887667677666666 8888888888887777776 68888888888888885
Q ss_pred ccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCc
Q 042075 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
. |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|+++
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 184 V-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred c-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 5 32 3358888888888888885 44458888888888888888884 6777888888888888888887
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=241.40 Aligned_cols=210 Identities=20% Similarity=0.174 Sum_probs=148.2
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeec
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQL 457 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~L 457 (1033)
++|+.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..|..+..++ |++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 4566666666666666666666666666666666666655555666666666666666666655555555554 555555
Q ss_pred cccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccC-CcCCccccccccceEEccccccc
Q 042075 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG-PIPNEVGNLKNLEMLNVFENKLR 536 (1033)
Q Consensus 458 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~ 536 (1033)
++|.+.+..+..+..+++|++|++++|+++ + .+|..+..+++|+.|+|++|+++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ-------------------------SFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCC-------------------------CCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccc-------------------------eecCchhhccCCCCCEEECCCCCCC
Confidence 555555544445555555555555555544 3 24677788888999999999998
Q ss_pred cccCcccccccccc----eeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCC
Q 042075 537 GEIPRTLGSCIKLE----LLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVP 612 (1033)
Q Consensus 537 ~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 612 (1033)
+..+..|..+.+|+ .|++++|++++..+..+ ...+|+.|+|++|+|++..+..+..+++|+.|+|++|+++|..|
T Consensus 163 ~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp EECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 77777888888887 88999999985544444 44589999999999997767778899999999999999999887
Q ss_pred Cc
Q 042075 613 TE 614 (1033)
Q Consensus 613 ~~ 614 (1033)
.-
T Consensus 242 ~l 243 (276)
T 2z62_A 242 RI 243 (276)
T ss_dssp TT
T ss_pred ch
Confidence 54
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=233.66 Aligned_cols=192 Identities=19% Similarity=0.217 Sum_probs=161.4
Q ss_pred CCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCC
Q 042075 69 HFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEI 148 (1033)
Q Consensus 69 ~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 148 (1033)
+||.|.|++|... .+.+++++++++ .+|..+. +.++.|+|++|++++..|..|..+++|++|+|++|.|++..
T Consensus 3 ~Cp~~~gC~C~~~----~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 3 TCETVTGCTCNEG----KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp -CHHHHSSEEEGG----GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred cCCCCCceEcCCC----CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 6899999999542 235788888887 4666554 68899999999999888888999999999999999999888
Q ss_pred CccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccC
Q 042075 149 PANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLK 228 (1033)
Q Consensus 149 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 228 (1033)
|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|+.++
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 88889999999999999999877777888999999999999999977777788899999999999999977777888899
Q ss_pred CCCcccccccccCCCCcccccCCCceeEEeccCccccCc
Q 042075 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGV 267 (1033)
Q Consensus 229 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 267 (1033)
+|++|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999999999877777777788888888888877644
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-24 Score=231.31 Aligned_cols=203 Identities=21% Similarity=0.262 Sum_probs=129.9
Q ss_pred CCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecc
Q 042075 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189 (1033)
Q Consensus 110 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 189 (1033)
.+++++++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|+++...+..|.++++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 455666666665 3554443 3556666666666544444555556666666666655533333445555555555555
Q ss_pred cccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccC
Q 042075 190 NNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIP 269 (1033)
Q Consensus 190 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 269 (1033)
|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-------------------------~~~ 149 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-------------------------SLP 149 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-------------------------ccC
Confidence 5555444445555555555555555555544445555555555555555544 334
Q ss_pred ccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc-hhhhccccceeeecCcCCCCC
Q 042075 270 LDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRLSHFVITRNSLGSGE 340 (1033)
Q Consensus 270 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~ 340 (1033)
...+..+++|++|+|++|++++..+..|..+++|++|++++|++++.++. +..+++|+.|++++|.+....
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 44444567777778888888877777899999999999999999988775 788999999999999987653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-28 Score=298.41 Aligned_cols=420 Identities=15% Similarity=0.125 Sum_probs=217.6
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCC---CCCcc------------ccCCCCCcEEEcccccccCCCCCCc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG---EIPAN------------ISSCSNLIRVRLSSNELVGKIPSEL 176 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~---~~p~~------------~~~l~~L~~L~Ls~N~l~~~~p~~~ 176 (1033)
.+++++.... ..+..+.++++|++|+|+++.... ..|.. ...+++|++|+|++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555543322 122345667788888888765321 22221 1245566666666666654444444
Q ss_pred c-cccccceeeeccc-ccCCC-CCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCc
Q 042075 177 G-SLSKIEYFSVSYN-NLTGS-IPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS 253 (1033)
Q Consensus 177 ~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 253 (1033)
. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++..+ ...+++
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~--------------------~~~~~~ 185 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF--------------------PDTYTS 185 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGS--------------------CTTCCC
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHH--------------------hhcCCc
Confidence 3 4556666666655 33321 22222345555666665555554333333211 112334
Q ss_pred eeEEeccCccccCccCc----cccccccccceeeeccc-ccCCCCCccCcCCCCccccccc-------cccccCcCcchh
Q 042075 254 ITVFDAGINQIQGVIPL----DIGFTLQNLQFFSVGRN-QLTGAIPPAISNASNLEVFQVN-------SNKLTGEVPYLE 321 (1033)
Q Consensus 254 L~~L~ls~N~l~~~~p~----~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls-------~N~l~~~~~~l~ 321 (1033)
|+.|++++|. +.++. .+...+++|++|+|++| .+++ +|..+..+++|+.|+++ .|.+.+.++.+.
T Consensus 186 L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 186 LVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred CcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 4444444443 11111 11112345555555554 2222 44445555555555533 333333333344
Q ss_pred hhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCC-cccc
Q 042075 322 KLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP-AAFG 400 (1033)
Q Consensus 322 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p-~~~~ 400 (1033)
.+++|+.+. .+... ..+.+|..+. ..++|+.|++++|.+++... ..+.
T Consensus 263 ~~~~L~~Ls-----------------------------~~~~~-~~~~l~~~~~-~~~~L~~L~L~~~~l~~~~l~~~~~ 311 (594)
T 2p1m_B 263 GCKELRCLS-----------------------------GFWDA-VPAYLPAVYS-VCSRLTTLNLSYATVQSYDLVKLLC 311 (594)
T ss_dssp TCTTCCEEE-----------------------------CCBTC-CGGGGGGGHH-HHTTCCEEECTTCCCCHHHHHHHHT
T ss_pred cCCCccccc-----------------------------CCccc-chhhHHHHHH-hhCCCCEEEccCCCCCHHHHHHHHh
Confidence 444444331 11100 0111222221 23678888888888764432 3356
Q ss_pred CCCCCCEEEcccCccccc-CChhhhcCCCCcEEEcc---------ccccccccCcccc-cce-eceeeccccccCCCCCC
Q 042075 401 KFVKLLRLEMWNNRLSGT-IPPAIGELQNLRELRLQ---------ENRFLGNIPPSIG-NLK-LFNLQLSYNFLQGSIPS 468 (1033)
Q Consensus 401 ~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~-L~~L~Ls~N~l~~~~p~ 468 (1033)
++++|++|++++| +... ++.....+++|++|+|+ .|.+++.....+. .++ |+.|+++.|.+++..+.
T Consensus 312 ~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~ 390 (594)
T 2p1m_B 312 QCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALI 390 (594)
T ss_dssp TCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHH
T ss_pred cCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHH
Confidence 8899999999988 4422 33334458899999884 3455543333332 244 77777777777755544
Q ss_pred ccC-CCCcccEEecC--C----CccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCc
Q 042075 469 SLG-QSETLTIIDLS--N----NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541 (1033)
Q Consensus 469 ~~~-~l~~L~~L~Ls--~----N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (1033)
.+. .+++|+.|+++ + |+++ ..|.. ..++..+..+++|+.|+|++ .+++..+.
T Consensus 391 ~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~-------------------~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 391 TIARNRPNMTRFRLCIIEPKAPDYLT-LEPLD-------------------IGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp HHHHHCTTCCEEEEEESSTTCCCTTT-CCCTH-------------------HHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred HHHhhCCCcceeEeecccCCCccccc-CCchh-------------------hHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 444 46778888887 3 3443 11110 00111134456677777765 55555455
Q ss_pred cccc-ccccceeecccccccCcccccc-cCcccCCccccccccccccCCc-ccccccccceeecCCCcCc
Q 042075 542 TLGS-CIKLELLQMQGNFLQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPE-FLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 542 ~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~ 608 (1033)
.++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|++|++++|+++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 5554 6677777777777765555444 5567777777777777554443 3345677777777777763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=234.70 Aligned_cols=204 Identities=19% Similarity=0.230 Sum_probs=135.2
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 183 (1033)
+.++++++++++++|+++ .+|..+. +++++|+|++|.|++..|..|.++++|++|+|++|.+++. |.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 445666666677666666 4555443 4666777777777666666666677777777777776633 222 5666777
Q ss_pred eeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcc
Q 042075 184 YFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263 (1033)
Q Consensus 184 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~ 263 (1033)
+|+|++|+++ .+|..+.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777766 556666666777777777777776666667777777777777777765555555666666666666666
Q ss_pred ccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccC
Q 042075 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTG 315 (1033)
Q Consensus 264 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 315 (1033)
|+ .+|..++..+++|++|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus 160 l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 66 455555556777777777777777 566666667777777777777754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=232.09 Aligned_cols=205 Identities=20% Similarity=0.237 Sum_probs=119.1
Q ss_pred eEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcc
Q 042075 85 RVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS 164 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 164 (1033)
.++.+++.++.++. .+.+..+++|++|+|++|.+++ + +.+..+++|++|+|++|.+++..|..++++++|++|+|+
T Consensus 42 ~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 34555565555542 1235556666666666666654 2 355566666666666666665555555666666666666
Q ss_pred cccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCC
Q 042075 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTI 244 (1033)
Q Consensus 165 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 244 (1033)
+|++++..|..|..+++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|+.+++|++|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence 66666555555566666666666666666555555566666666666666666555555566666666666666666555
Q ss_pred cccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCC
Q 042075 245 PSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNAS 301 (1033)
Q Consensus 245 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 301 (1033)
|..+..+++|+.|++++|.+.+. +++|++|+++.|.++|.+|.+++.+.
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~~~--------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 198 DGVFDRLTSLQYIWLHDNPWDCT--------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCC--------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHHhCCcCCCEEEccCCCcccc--------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 55555666666666666655532 23455555555555555555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=232.95 Aligned_cols=203 Identities=25% Similarity=0.256 Sum_probs=140.7
Q ss_pred cCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeec
Q 042075 378 STTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQL 457 (1033)
Q Consensus 378 ~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~L 457 (1033)
.++++.+++++|.++. +|..+. ++++.|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus 9 l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------------ 73 (290)
T 1p9a_G 9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD------------ 73 (290)
T ss_dssp STTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC------------
T ss_pred cCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC------------
Confidence 3567777777777764 343332 5677777777777766667777777777777777776632221
Q ss_pred cccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccccc
Q 042075 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG 537 (1033)
Q Consensus 458 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (1033)
..+++|++|+|++|+++ .+|..+..+.++ +.|++++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 74 -------------~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 74 -------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp -------------SCCTTCCEEECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred -------------CCCCcCCEEECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence 34455555555555555 455545444444 555666666665555667778888888888888886
Q ss_pred ccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccC
Q 042075 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMV 611 (1033)
Q Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 611 (1033)
..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.+..
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 66667788888888888888888655566777888888888888887 67777777788888888888887654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=256.07 Aligned_cols=189 Identities=16% Similarity=0.123 Sum_probs=141.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHHhcCCCCceeEeeeecccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 781 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 781 (1033)
...+...+.||+|+||+||+|... ++.+++|+...... ...+++.+|++++++++||||+++..++.
T Consensus 335 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 409 (540)
T 3en9_A 335 KKRKIPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV--- 409 (540)
T ss_dssp -------------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE---
T ss_pred cccCCCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE---
Confidence 333445679999999999999654 67889998643211 11355899999999999999995544432
Q ss_pred ccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 782 YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 782 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
..+..++||||+++++|.++++. +..++.|+++||+|||++ +|+||||||+||++++
T Consensus 410 --~~~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 410 --DLDNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK 466 (540)
T ss_dssp --ETTTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS
T ss_pred --eCCccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC
Confidence 23356999999999999999942 458999999999999999 9999999999999998
Q ss_pred CCcEEEeecccceecCCCCccc-----cccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 862 EMIAHVGDFGLATFLPLSHAQT-----SSIFAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 862 ~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
.+||+|||+|+......... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999999875432211 1123459999999999887 56888899999999999988887776
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=223.28 Aligned_cols=197 Identities=15% Similarity=0.201 Sum_probs=160.4
Q ss_pred CCCCEEEecCCCccccCCccccccccccEEecccCC-CCCCCCccccCCCCCcEEEccc-ccccCCCCCCccccccccee
Q 042075 108 SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS-IGGEIPANISSCSNLIRVRLSS-NELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 185 (1033)
++|++|+|++|++++..+..|..+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 389999999999997777789999999999999997 8866666899999999999998 99997667889999999999
Q ss_pred eecccccCCCCCCCCCCCCCCc---EEEcccC-cCCCcCCccccccCCCC-cccccccccCCCCcccccCCCceeEEecc
Q 042075 186 SVSYNNLTGSIPPSFGNLSSIS---FLFLSRN-NLDGSIPDTFGWLKNLV-NLTMAQNRLSGTIPSSIFNISSITVFDAG 260 (1033)
Q Consensus 186 ~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~ls 260 (1033)
++++|++++ +|. |.++++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|...+..++|+.|+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 999999996 666 88888888 9999999 99987778899999999 9999999998 566655555788888888
Q ss_pred Ccc-ccCccCccccccc-cccceeeecccccCCCCCccCcCCCCccccccccc
Q 042075 261 INQ-IQGVIPLDIGFTL-QNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311 (1033)
Q Consensus 261 ~N~-l~~~~p~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 311 (1033)
+|+ ++ .+|...+..+ ++|++|++++|++++. |.. .+++|+.|+++++
T Consensus 188 ~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCcc-cCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 884 76 5555556566 7777777777777743 332 4556666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=227.21 Aligned_cols=205 Identities=20% Similarity=0.248 Sum_probs=180.3
Q ss_pred ccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccc
Q 042075 103 HVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKI 182 (1033)
Q Consensus 103 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 182 (1033)
.+..+++|+.|++++|.++. ++ .+..+++|++|+|++|.+++ + ..++++++|++|+|++|.+++..|..|.++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~-~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCccc-cc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 35578899999999999873 33 58899999999999999985 3 478999999999999999998777888999999
Q ss_pred ceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCc
Q 042075 183 EYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGIN 262 (1033)
Q Consensus 183 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 262 (1033)
++|+|++|++++..|..|+++++|++|+|++|++++..+..|+.+++|++|++++|++++..+..+.++++|+.|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 99999999999888888999999999999999999888888999999999999999999887878899999999999999
Q ss_pred cccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcc
Q 042075 263 QIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY 319 (1033)
Q Consensus 263 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 319 (1033)
++++..| ..+..+++|++|+|++|.+.+. +++|+.|+++.|+++|.+|.
T Consensus 192 ~l~~~~~-~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 192 QLKSVPD-GVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CCSCCCT-TTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred cCCccCH-HHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 9996544 5556789999999999998854 45799999999999988764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=235.08 Aligned_cols=226 Identities=15% Similarity=0.146 Sum_probs=181.4
Q ss_pred CCCCEEEecCCCcccc-CCc--cccccccccEEecccCCCCCCCCccc--cCCCCCcEEEcccccccCCCC----CCccc
Q 042075 108 SFLKVLDLHNNSFHHE-IPS--EFDRLRRLQVLALHNNSIGGEIPANI--SSCSNLIRVRLSSNELVGKIP----SELGS 178 (1033)
Q Consensus 108 ~~L~~L~L~~n~l~~~-~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 178 (1033)
..++.|.+.++.++.. +.. .+..+++|++|+|++|.+++..|..+ +.+++|++|+|++|++++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3578888988887642 111 12345779999999999999999988 899999999999999997665 34567
Q ss_pred ccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCc--C--CccccccCCCCcccccccccCCCCcc----cccC
Q 042075 179 LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS--I--PDTFGWLKNLVNLTMAQNRLSGTIPS----SIFN 250 (1033)
Q Consensus 179 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~ 250 (1033)
+++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .+|. .+.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 89999999999999988888999999999999999998752 2 334578999999999999997 3333 2467
Q ss_pred CCceeEEeccCccccCccCcccccc--ccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccc
Q 042075 251 ISSITVFDAGINQIQGVIPLDIGFT--LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSH 328 (1033)
Q Consensus 251 l~~L~~L~ls~N~l~~~~p~~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~ 328 (1033)
+++|++|||++|++++.+|..++.. +++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |.+..+++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccE
Confidence 8999999999999998877665532 379999999999999 6677664 7899999999999975 33677788888
Q ss_pred eeeecCcCCC
Q 042075 329 FVITRNSLGS 338 (1033)
Q Consensus 329 L~l~~N~l~~ 338 (1033)
|++++|.+++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 8888888764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=234.63 Aligned_cols=224 Identities=16% Similarity=0.152 Sum_probs=188.9
Q ss_pred eEEEEEcCCCCCCccccc---ccCCCCCCCEEEecCCCccccCCccc--cccccccEEecccCCCCCCCC----ccccCC
Q 042075 85 RVTILDLKSLKLAGYISA---HVGNLSFLKVLDLHNNSFHHEIPSEF--DRLRRLQVLALHNNSIGGEIP----ANISSC 155 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~~~~---~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~n~l~~~~p----~~~~~l 155 (1033)
++..+++.+..++...-. .+..+++|++|+|++|.+++.+|..+ ..+++|++|+|++|.+++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 466777777776542111 12345679999999999999999998 999999999999999998766 445689
Q ss_pred CCCcEEEcccccccCCCCCCcccccccceeeecccccCCC--C--CCCCCCCCCCcEEEcccCcCCCcCCc----ccccc
Q 042075 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGS--I--PPSFGNLSSISFLFLSRNNLDGSIPD----TFGWL 227 (1033)
Q Consensus 156 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 227 (1033)
++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..++++++|++|+|++|+++. ++. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988889999999999999999998752 2 2345789999999999999983 343 35788
Q ss_pred CCCCcccccccccCCCCcccccCC---CceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcc
Q 042075 228 KNLVNLTMAQNRLSGTIPSSIFNI---SSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLE 304 (1033)
Q Consensus 228 ~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 304 (1033)
++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..++ ++|++|+|++|+|++. |. +..+++|+
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 999999999999998889888877 69999999999999 7787764 7999999999999964 43 68889999
Q ss_pred ccccccccccC
Q 042075 305 VFQVNSNKLTG 315 (1033)
Q Consensus 305 ~L~Ls~N~l~~ 315 (1033)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999975
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-25 Score=253.79 Aligned_cols=177 Identities=21% Similarity=0.228 Sum_probs=102.1
Q ss_pred EEcCCCCCCcccccccCCCCCCCEEEecCCCccccCC----ccccccc-cccEEecccCCCCCCCCccccCC-----CCC
Q 042075 89 LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIP----SEFDRLR-RLQVLALHNNSIGGEIPANISSC-----SNL 158 (1033)
Q Consensus 89 l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l-----~~L 158 (1033)
.+++.++++|.++..+...++|++|||++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566667777666666666667777777777765544 5566666 67777777777766656555554 667
Q ss_pred cEEEcccccccCCCCCCcccc-----cccceeeecccccCCCCCCCC----CC-CCCCcEEEcccCcCCCcCC----ccc
Q 042075 159 IRVRLSSNELVGKIPSELGSL-----SKIEYFSVSYNNLTGSIPPSF----GN-LSSISFLFLSRNNLDGSIP----DTF 224 (1033)
Q Consensus 159 ~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p----~~~ 224 (1033)
++|+|++|++++..+..+... ++|++|+|++|++++..+..+ .. .++|++|+|++|++++..+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 777777777765555443332 566666666666665444332 22 2466666666666664322 222
Q ss_pred cccC-CCCcccccccccCCCCccccc----CC-CceeEEeccCcccc
Q 042075 225 GWLK-NLVNLTMAQNRLSGTIPSSIF----NI-SSITVFDAGINQIQ 265 (1033)
Q Consensus 225 ~~l~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~ls~N~l~ 265 (1033)
..++ +|++|+|++|++++..+..+. .+ ++|++|||++|.|+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 3333 566666666666544443322 22 34555555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-25 Score=253.56 Aligned_cols=263 Identities=14% Similarity=0.100 Sum_probs=150.1
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCC----ccccCCC-CCcEEEcccccccCCCCCCcccc-----cc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP----ANISSCS-NLIRVRLSSNELVGKIPSELGSL-----SK 181 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 181 (1033)
.++|+.|+++|.+|..+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 45677788887777766666678888888888775555 5666777 77777777777776666666654 66
Q ss_pred cceeeecccccCCCCCCCCC----CC-CCCcEEEcccCcCCCcCCccccc-----cCCCCcccccccccCCCCccc----
Q 042075 182 IEYFSVSYNNLTGSIPPSFG----NL-SSISFLFLSRNNLDGSIPDTFGW-----LKNLVNLTMAQNRLSGTIPSS---- 247 (1033)
Q Consensus 182 L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~---- 247 (1033)
|++|+|++|++++..+..+. .+ ++|++|+|++|+|++..+..+.. .++|++|+|++|++++..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 77777777776655544322 22 56666666666666544443332 135555555555555322111
Q ss_pred ccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCc----CC-CCccccccccccccCcCcchhh
Q 042075 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAIS----NA-SNLEVFQVNSNKLTGEVPYLEK 322 (1033)
Q Consensus 248 l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~~~l~~ 322 (1033)
+..++ .+|++|+|++|++++..+..+. .+ ++|++|+|++|++++....
T Consensus 162 l~~~~------------------------~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~--- 214 (362)
T 3goz_A 162 LAAIP------------------------ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA--- 214 (362)
T ss_dssp HHTSC------------------------TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH---
T ss_pred HhcCC------------------------ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH---
Confidence 11111 2455555555555444443322 22 3566666666655532110
Q ss_pred hccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCC----cc
Q 042075 323 LQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP----AA 398 (1033)
Q Consensus 323 l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p----~~ 398 (1033)
.++..+....++|+.|+|++|.|++..+ ..
T Consensus 215 ----------------------------------------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 248 (362)
T 3goz_A 215 ----------------------------------------------ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL 248 (362)
T ss_dssp ----------------------------------------------HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHT
T ss_pred ----------------------------------------------HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHH
Confidence 0111122222356666666666665433 33
Q ss_pred ccCCCCCCEEEcccCcccccC-------ChhhhcCCCCcEEEccccccccccCccc
Q 042075 399 FGKFVKLLRLEMWNNRLSGTI-------PPAIGELQNLRELRLQENRFLGNIPPSI 447 (1033)
Q Consensus 399 ~~~l~~L~~L~L~~N~l~~~~-------p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 447 (1033)
+..+++|++|+|++|.+.+.. +..+..+++|+.|||++|++.+..+..+
T Consensus 249 ~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 249 KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp TTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 456677888888888754333 3345667778888888888775544433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=231.22 Aligned_cols=244 Identities=18% Similarity=0.177 Sum_probs=198.8
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCc
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA 150 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 150 (1033)
|+|..|.|+.. +++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|.
T Consensus 9 C~~~~v~C~~~-------------~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 9 CSNRVFLCQES-------------KVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp EETTEEEEEST-------------TCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred eeCCEEEecCC-------------CCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 78888999754 344 456555 36899999999999965556899999999999999999776764
Q ss_pred -cccCCCCCcE-EEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEccc-CcCCCcCCcccccc
Q 042075 151 -NISSCSNLIR-VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR-NNLDGSIPDTFGWL 227 (1033)
Q Consensus 151 -~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l 227 (1033)
.|.++++|++ +++++|++++..|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence 6789998775 77778999977789999999999999999999987777788888899999966 67887777788877
Q ss_pred C-CCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccc
Q 042075 228 K-NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVF 306 (1033)
Q Consensus 228 ~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 306 (1033)
. .++.|+|++|+|+ .+|...+...+|+.|++++|+..+.+|.++|..+++|++|+|++|+|+...+..+.++++|+.+
T Consensus 153 ~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l 231 (350)
T 4ay9_X 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 231 (350)
T ss_dssp BSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECT
T ss_pred chhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhc
Confidence 5 6899999999999 6777777888999999986554458999988899999999999999997666677777777776
Q ss_pred ccccccccCcCcchhhhccccceeeecC
Q 042075 307 QVNSNKLTGEVPYLEKLQRLSHFVITRN 334 (1033)
Q Consensus 307 ~Ls~N~l~~~~~~l~~l~~L~~L~l~~N 334 (1033)
++. .++ ..|.+.++++|+.+++.++
T Consensus 232 ~~~--~l~-~lP~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 232 STY--NLK-KLPTLEKLVALMEASLTYP 256 (350)
T ss_dssp TCT--TCC-CCCCTTTCCSCCEEECSCH
T ss_pred cCC--CcC-cCCCchhCcChhhCcCCCC
Confidence 653 344 4556778888888877654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=222.92 Aligned_cols=203 Identities=19% Similarity=0.173 Sum_probs=177.9
Q ss_pred cCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc-ccCCCCCCcccccccceeeecc-cccCCCCCCCC
Q 042075 123 EIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE-LVGKIPSELGSLSKIEYFSVSY-NNLTGSIPPSF 200 (1033)
Q Consensus 123 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~ 200 (1033)
.+|. +. ++|++|+|++|++++..+..|+++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 43 389999999999997777789999999999999997 8866667899999999999999 99997777889
Q ss_pred CCCCCCcEEEcccCcCCCcCCccccccCCCC---ccccccc-ccCCCCcccccCCCcee-EEeccCccccCccCcccccc
Q 042075 201 GNLSSISFLFLSRNNLDGSIPDTFGWLKNLV---NLTMAQN-RLSGTIPSSIFNISSIT-VFDAGINQIQGVIPLDIGFT 275 (1033)
Q Consensus 201 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~ls~N~l~~~~p~~~~~~ 275 (1033)
.++++|++|++++|++++ +|+ |..+++|+ +|++++| ++++..+..+.++++|+ .|++++|+++ .+|...+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC
Confidence 999999999999999996 676 88999998 9999999 99977777899999999 9999999999 788877765
Q ss_pred ccccceeeecccc-cCCCCCccCcCC-CCccccccccccccCcCcchhhhccccceeeecC
Q 042075 276 LQNLQFFSVGRNQ-LTGAIPPAISNA-SNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRN 334 (1033)
Q Consensus 276 l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N 334 (1033)
.+|++|+|++|+ +++..+..|..+ ++|+.|++++|++++.++. .+++|+.|.++++
T Consensus 179 -~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 -TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp -CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred -CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 899999999995 997778889999 9999999999999976654 5667777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-24 Score=251.29 Aligned_cols=208 Identities=22% Similarity=0.361 Sum_probs=157.6
Q ss_pred CCCCCCCCCCc-----ceeee-EecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccc
Q 042075 61 FGSWNESIHFC-----QWHGV-TCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRL 134 (1033)
Q Consensus 61 ~~~W~~~~~~c-----~w~gv-~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 134 (1033)
+.+|..+.++| .|.|+ .|.. .+++.|+|+++++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHhccCCccccccchhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 45676556677 79999 7864 368889999999987 777663 78999999999998 677 457899
Q ss_pred cEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccC
Q 042075 135 QVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214 (1033)
Q Consensus 135 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 214 (1033)
++|+|++|.|++ +|. +.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence 999999999986 777 665 89999999999986 666 67899999999999985 565 5678999999999
Q ss_pred cCCCcCCccccccCCCCcccccccccCCCCcccccCCCce-------eEEeccCccccCccCccccccccccceeeeccc
Q 042075 215 NLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSI-------TVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRN 287 (1033)
Q Consensus 215 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N 287 (1033)
+|++ +|. |. ++|++|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..++. +++|++|+|++|
T Consensus 171 ~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~-l~~L~~L~L~~N 240 (571)
T 3cvr_A 171 QLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS-LDPTCTIILEDN 240 (571)
T ss_dssp CCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG-SCTTEEEECCSS
T ss_pred CCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc-CCCCCEEEeeCC
Confidence 9986 666 65 88888999999888 6666 443 55 67777777766 45655553 666666666666
Q ss_pred ccCCCCCccCcCC
Q 042075 288 QLTGAIPPAISNA 300 (1033)
Q Consensus 288 ~l~~~~p~~~~~l 300 (1033)
.+++.+|..+..+
T Consensus 241 ~l~~~~p~~l~~l 253 (571)
T 3cvr_A 241 PLSSRIRESLSQQ 253 (571)
T ss_dssp SCCHHHHHHHHHH
T ss_pred cCCCcCHHHHHHh
Confidence 6666666555544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-25 Score=251.23 Aligned_cols=212 Identities=15% Similarity=0.175 Sum_probs=115.2
Q ss_pred CCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCC--CCCCEEEecCCCccccCCccccccccccEEecccCCCCC
Q 042075 69 HFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNL--SFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146 (1033)
Q Consensus 69 ~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 146 (1033)
-|..|+++.|+.. .++.+|++++.+. +..+..+ +.++.|++++|.+.+..|. +..+++|++|+|++|.+++
T Consensus 35 vc~~W~~~~~~~~---~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 35 VCKRWYRLASDES---LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SCHHHHHHHTCST---TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHhcCch---hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 4568999988643 3455666665554 2334444 5566666666666554443 3455666666666666554
Q ss_pred C-CCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc-ccCCC-CCCCCCCCCCCcEEEcccC-cCCCc-CC
Q 042075 147 E-IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN-NLTGS-IPPSFGNLSSISFLFLSRN-NLDGS-IP 221 (1033)
Q Consensus 147 ~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p 221 (1033)
. +|..+.++++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence 3 5555555666666666666555555555555555555555555 34431 3333445555555555555 55432 34
Q ss_pred ccccccC-CCCccccccc--ccC-CCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccc-cCCCCCcc
Q 042075 222 DTFGWLK-NLVNLTMAQN--RLS-GTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ-LTGAIPPA 296 (1033)
Q Consensus 222 ~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~ 296 (1033)
..+..++ +|++|+|++| .++ +.+|..+.+ +++|++|++++|. +++..+..
T Consensus 188 ~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~-------------------------~~~L~~L~l~~~~~l~~~~~~~ 242 (336)
T 2ast_B 188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR-------------------------CPNLVHLDLSDSVMLKNDCFQE 242 (336)
T ss_dssp HHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH-------------------------CTTCSEEECTTCTTCCGGGGGG
T ss_pred HHHHhcccCCCEEEeCCCcccCCHHHHHHHHhh-------------------------CCCCCEEeCCCCCcCCHHHHHH
Confidence 4444555 5555555555 232 223333333 4555555555555 44445555
Q ss_pred CcCCCCcccccccccc
Q 042075 297 ISNASNLEVFQVNSNK 312 (1033)
Q Consensus 297 ~~~l~~L~~L~Ls~N~ 312 (1033)
+..+++|+.|++++|.
T Consensus 243 l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 243 FFQLNYLQHLSLSRCY 258 (336)
T ss_dssp GGGCTTCCEEECTTCT
T ss_pred HhCCCCCCEeeCCCCC
Confidence 5666666666666663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=207.63 Aligned_cols=186 Identities=20% Similarity=0.244 Sum_probs=127.4
Q ss_pred CCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCC
Q 042075 69 HFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEI 148 (1033)
Q Consensus 69 ~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 148 (1033)
..|.|.+|.|+..+ ++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 5 C~C~~~~v~c~~~~-------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (208)
T 2o6s_A 5 CSCSGTTVECYSQG-------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68 (208)
T ss_dssp CEEETTEEECCSSC-------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CEECCCEEEecCCC-------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence 34899999997642 22 233322 357788888888887655566777788888888888777555
Q ss_pred CccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccC
Q 042075 149 PANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLK 228 (1033)
Q Consensus 149 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 228 (1033)
+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..++
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 148 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCC
Confidence 55567777777777777777755555567777777777777777766666667777777777777777765555566666
Q ss_pred CCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCC
Q 042075 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASN 302 (1033)
Q Consensus 229 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 302 (1033)
+|++|+|++|.+.+ .+++|++|+++.|+++|.+|.+++.++.
T Consensus 149 ~L~~L~l~~N~~~~--------------------------------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 149 SLQYIWLHDNPWDC--------------------------------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TCCEEECCSCCBCC--------------------------------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CccEEEecCCCeec--------------------------------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 66666666665543 2345777777777777777777776654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.7e-22 Score=212.32 Aligned_cols=180 Identities=21% Similarity=0.275 Sum_probs=112.6
Q ss_pred CCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeec
Q 042075 109 FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVS 188 (1033)
Q Consensus 109 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 188 (1033)
..++++++++.++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3456666666666 4555554 466666777776666666666666666666666666666556666666666666666
Q ss_pred ccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCcc
Q 042075 189 YNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268 (1033)
Q Consensus 189 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 268 (1033)
+|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------------------ 153 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK------------------ 153 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT------------------
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCc------------------
Confidence 66666555566666666666666666666555555666666666666666666444444444
Q ss_pred CccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCc
Q 042075 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGE 316 (1033)
Q Consensus 269 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 316 (1033)
+++|++|+|++|++++..+..+..+++|+.|++++|++++.
T Consensus 154 -------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 154 -------LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp -------CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred -------CcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 44555555555555555555566666666666666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=222.37 Aligned_cols=198 Identities=23% Similarity=0.376 Sum_probs=151.8
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 183 (1033)
...+++|++|++++|.++. +| .+..+++|++|+|++|.+++ +|. +.++++|++|+|++|++++ +| .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 3457788888888888873 55 57888888888888888874 444 8888888888888888874 33 678888888
Q ss_pred eeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcc
Q 042075 184 YFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263 (1033)
Q Consensus 184 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~ 263 (1033)
+|++++|++++. |. +..+++|++|+|++|++++..+ ++.+++|++|+|++|++++..+ +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 888888888854 33 7888888888888888885443 7888888888888888885433 7788888888888888
Q ss_pred ccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCc
Q 042075 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP 318 (1033)
Q Consensus 264 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 318 (1033)
+++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++.+.
T Consensus 185 l~~~~~---l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 185 ISDISP---LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCCCGG---GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECCCE
T ss_pred cCcChh---hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecCCe
Confidence 875444 456788888888888888554 37788888888888888876543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=218.81 Aligned_cols=164 Identities=19% Similarity=0.133 Sum_probs=127.7
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc------------------hhHHHHHHHHHHHHhc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH------------------GAFKSFIAECNTLKNI 765 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 765 (1033)
..+......|.+.+.||+|+||.||+|++ .+++.||||+++.... .....+.+|+.+++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445566777889999999999999999 6899999999864221 1345688999999999
Q ss_pred CCCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042075 766 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQP 845 (1033)
Q Consensus 766 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 845 (1033)
+| +++.+++. .+..++||||++|++|.+ +.. .+...++.|++.||+|||+.
T Consensus 162 ~~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~--- 212 (282)
T 1zar_A 162 QG---LAVPKVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHR--- 212 (282)
T ss_dssp TT---SSSCCEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHT---
T ss_pred cC---CCcCeEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHC---
Confidence 84 55555431 135699999999999998 521 12346999999999999999
Q ss_pred CcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCC----------CCCCcccchHH
Q 042075 846 PIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG----------SEVSINGDVYS 913 (1033)
Q Consensus 846 ~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvwS 913 (1033)
||+||||||+||+++ ++.+||+|||+|+ .+..|+|||++.. ..|...+|+|.
T Consensus 213 giiHrDlkp~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEECSCCSTTSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCEeCCCCHHHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999999999 9999999999997 3455788988643 34555566654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-24 Score=245.14 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=162.5
Q ss_pred ccccccCcceeeecccccCCCCccc----cccccCcccEEEccCC---CCCccCCccc-------cCCCCCCEEEcccCc
Q 042075 349 SLTNATRLKWFHININNFGGLLPAC----ISNFSTTLEVLLLDSN---KIFGNIPAAF-------GKFVKLLRLEMWNNR 414 (1033)
Q Consensus 349 ~l~~~~~L~~l~l~~n~l~~~ip~~----~~~~~~~L~~L~L~~N---~i~~~~p~~~-------~~l~~L~~L~L~~N~ 414 (1033)
.+..+++|+.|+++.|.+++..+.. +.. .++|+.|+|++| ++++.+|..+ ..+++|++|+|++|+
T Consensus 27 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~-~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIAS-KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTT-CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHhcCCCccEEECCCCCCCHHHHHHHHHHHHh-CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3455666777777777766553333 222 256677777664 3334445444 566667777777777
Q ss_pred ccc----cCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCCccC-CC
Q 042075 415 LSG----TIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT-GT 489 (1033)
Q Consensus 415 l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ 489 (1033)
+++ .+|..+..+++|++|+|++|.+++..+..+... +. .+..|.+.+. .++|++|+|++|+++ +.
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~--~l~~~~~~~~-------~~~L~~L~L~~n~l~~~~ 175 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQ--ELAVNKKAKN-------APPLRSIICGRNRLENGS 175 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-HH--HHHHHHHHHT-------CCCCCEEECCSSCCTGGG
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-HH--HHhhhhhccc-------CCCCcEEECCCCCCCcHH
Confidence 665 355666666777777777776654333333221 00 0000111100 045555555555554 22
Q ss_pred CC---ccccCchhHHhhhhccCcccc--C---CcCCccccccccceEEccccccc----cccCcccccccccceeecccc
Q 042075 490 IP---PQLLGLSSLLIVLELSRNQLT--G---PIPNEVGNLKNLEMLNVFENKLR----GEIPRTLGSCIKLELLQMQGN 557 (1033)
Q Consensus 490 ~p---~~~~~~~~ll~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N 557 (1033)
+| ..+..+..+ +.|++++|+++ | ..|..+..+++|+.|+|++|+++ +.+|..+..+++|++|+|++|
T Consensus 176 ~~~l~~~l~~~~~L-~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n 254 (386)
T 2ca6_A 176 MKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254 (386)
T ss_dssp HHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred HHHHHHHHHhCCCc-CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCC
Confidence 22 122223333 55555555554 2 34557888999999999999996 678889999999999999999
Q ss_pred cccCc----ccccc--cCcccCCccccccccccc----cCCccc-ccccccceeecCCCcCcccCC
Q 042075 558 FLQGP----IPSSL--SSLRGLSVLDLSQNNLSG----KIPEFL-VGFQLLEYLNLSNNDFEGMVP 612 (1033)
Q Consensus 558 ~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~g~~p 612 (1033)
++++. +|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|+|++|++++..|
T Consensus 255 ~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99876 67777 449999999999999998 588888 678999999999999997554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.7e-22 Score=219.01 Aligned_cols=211 Identities=19% Similarity=0.305 Sum_probs=177.8
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 191 (1033)
.+.+..+.+++.+ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++. +. +..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCc
Confidence 3445566666433 3567899999999999998 566 689999999999999999854 44 9999999999999999
Q ss_pred cCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcc
Q 042075 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271 (1033)
Q Consensus 192 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~ 271 (1033)
+++. | .+.++++|++|+|++|++++. +. +..+++|++|++++|++++..+ +..+++|+.|++++|++++..+
T Consensus 97 l~~~-~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 97 LKNV-S-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp CSCC-G-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc-h-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 9864 4 588999999999999999964 43 8999999999999999996544 8899999999999999986444
Q ss_pred ccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCC
Q 042075 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGE 340 (1033)
Q Consensus 272 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~ 340 (1033)
+..+++|++|+|++|++++..+ +..+++|++|++++|++++.++ +..+++|+.|++++|.+...+
T Consensus 169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCC
T ss_pred -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCC
Confidence 5578999999999999986544 8899999999999999998765 788899999999999887644
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-24 Score=246.82 Aligned_cols=205 Identities=20% Similarity=0.264 Sum_probs=154.5
Q ss_pred CcccEEEccCCCCCc----cCCccccCCCCCCEEEcccCcccccCChhhhc----C---------CCCcEEEccccccc-
Q 042075 379 TTLEVLLLDSNKIFG----NIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGE----L---------QNLRELRLQENRFL- 440 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~l~- 440 (1033)
++|++|+|++|.+++ .+|..+.++++|++|+|++|.++...+..+.. + ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 689999999999987 57888999999999999999997555444444 4 89999999999997
Q ss_pred cccC---cccccce-eceeeccccccC--C---CCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccc
Q 042075 441 GNIP---PSIGNLK-LFNLQLSYNFLQ--G---SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQL 511 (1033)
Q Consensus 441 ~~~p---~~~~~l~-L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l 511 (1033)
+.+| ..+..++ |++|+|++|.++ | ..|..+..+++|++|+|++|+++.. +
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~------g--------------- 232 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL------G--------------- 232 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHH------H---------------
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcH------H---------------
Confidence 3444 3455554 777777777776 2 3444667777777777777776410 0
Q ss_pred cCCcCCccccccccceEEccccccccc----cCccc--ccccccceeecccccccC----cccccc-cCcccCCcccccc
Q 042075 512 TGPIPNEVGNLKNLEMLNVFENKLRGE----IPRTL--GSCIKLELLQMQGNFLQG----PIPSSL-SSLRGLSVLDLSQ 580 (1033)
Q Consensus 512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~ 580 (1033)
.+.+|..+..+++|+.|+|++|++++. +|..+ +.+++|++|+|++|++++ .+|..+ .++++|+.|+|++
T Consensus 233 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~ 312 (386)
T 2ca6_A 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312 (386)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccC
Confidence 023556677788999999999999866 56666 448999999999999997 488888 6789999999999
Q ss_pred ccccccCC--cccc-cccccceeecCC
Q 042075 581 NNLSGKIP--EFLV-GFQLLEYLNLSN 604 (1033)
Q Consensus 581 N~l~~~~p--~~~~-~l~~L~~L~ls~ 604 (1033)
|++++..| ..+. .++.++.+++..
T Consensus 313 N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 313 NRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp SBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred CcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 99998774 3333 456666555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=221.27 Aligned_cols=121 Identities=21% Similarity=0.251 Sum_probs=56.6
Q ss_pred EEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCC-CCCCCCCCCcE-EEccc
Q 042075 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISF-LFLSR 213 (1033)
Q Consensus 136 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~~ 213 (1033)
+++.++|+++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4444555554 444443 2345555555555553223345555555555555555443333 23445544432 33444
Q ss_pred CcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEec
Q 042075 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDA 259 (1033)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 259 (1033)
|+|++..|+.|..+++|++|++++|++++..+..+....++..|++
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l 135 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 135 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence 5555444555555555555555555555333333333333444444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-23 Score=252.12 Aligned_cols=261 Identities=20% Similarity=0.179 Sum_probs=125.8
Q ss_pred CChhhHHHHHHHHHhcccCCCCCCCCCCC-CCCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCC-----
Q 042075 38 GNETDRLALLEFKSKITHDPLGVFGSWNE-SIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLK----- 111 (1033)
Q Consensus 38 ~~~~~~~aLl~~k~~~~~~~~~~~~~W~~-~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~----- 111 (1033)
..+.++++|+++..+...+.+..-..|.. .+..+.|.+++++. .+|+.++|.++++... +..+.....|.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~ 204 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST---PLTPKIELFANGKDEA-NQALLQHKKLSQYSID 204 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC---CccceEEeeCCCCCcc-hhhHhhcCccCccccc
Confidence 45678999999999886555555667754 45678999999875 4799999998888763 33332222222
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 191 (1033)
.++++.|.+. ..|..|..+++|+.|+|++|.++ .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+
T Consensus 205 ~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 205 EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 2223333333 45677888888888888888887 77777778888888888888888 788888888888888888888
Q ss_pred cCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCc-eeEEeccCccccCccCc
Q 042075 192 LTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISS-ITVFDAGINQIQGVIPL 270 (1033)
Q Consensus 192 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~ls~N~l~~~~p~ 270 (1033)
|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++.+|..+..+.. +..++|++|.+++.+|.
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 88 66888888888888888888887 67777888888888888888888877777765432 23466777777766654
Q ss_pred cccccccccceeeeccc--------ccCCCCCccCcCCCCcccccccccccc
Q 042075 271 DIGFTLQNLQFFSVGRN--------QLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 271 ~~~~~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
.|+.|++++| .+.+..+..+..+.++....+++|-+.
T Consensus 360 -------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 -------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp -------C-----------------------------------------CCC
T ss_pred -------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3455666665 333333333444444555555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-22 Score=227.39 Aligned_cols=235 Identities=14% Similarity=0.148 Sum_probs=117.7
Q ss_pred cccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCc-CCccccccCCCCcccccccccCCCCcccccCCCceeEEe
Q 042075 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGS-IPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFD 258 (1033)
Q Consensus 180 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 258 (1033)
++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4444444554444444333 23445555555555554433 444445555555555555555444444444455555555
Q ss_pred ccCc-cccCccCccccccccccceeeeccc-ccCCC-CCccCcCCC-Ccccccccccc--ccCcCcchhhhccccceeee
Q 042075 259 AGIN-QIQGVIPLDIGFTLQNLQFFSVGRN-QLTGA-IPPAISNAS-NLEVFQVNSNK--LTGEVPYLEKLQRLSHFVIT 332 (1033)
Q Consensus 259 ls~N-~l~~~~p~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N~--l~~~~~~l~~l~~L~~L~l~ 332 (1033)
+++| .+++......+..+++|++|++++| .+++. ++..+..++ +|++|++++|. +++.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~---------------- 212 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS---------------- 212 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHH----------------
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHH----------------
Confidence 5554 3332111111223445555555555 44432 344445555 55555555553 2210
Q ss_pred cCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCC-CCccCCccccCCCCCCEEEcc
Q 042075 333 RNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNK-IFGNIPAAFGKFVKLLRLEMW 411 (1033)
Q Consensus 333 ~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~-i~~~~p~~~~~l~~L~~L~L~ 411 (1033)
.+|..+.. .++|+.|++++|. +++..+..+.++++|++|+++
T Consensus 213 ------------------------------------~l~~~~~~-~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~ 255 (336)
T 2ast_B 213 ------------------------------------DLSTLVRR-CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255 (336)
T ss_dssp ------------------------------------HHHHHHHH-CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ------------------------------------HHHHHHhh-CCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCC
Confidence 01111111 1456666666666 555566677777777778877
Q ss_pred cCc-ccccCChhhhcCCCCcEEEccccccccccCcccccc-e-eceeeccccccCCCCCCccCC
Q 042075 412 NNR-LSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-K-LFNLQLSYNFLQGSIPSSLGQ 472 (1033)
Q Consensus 412 ~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~-L~~L~Ls~N~l~~~~p~~~~~ 472 (1033)
+|. +.......+..+++|+.|+|++| ++ ...+..+ . +..|++++|++++..|..++.
T Consensus 256 ~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 256 RCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 774 22222225677778888888777 22 2233333 2 566666666666666665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=230.29 Aligned_cols=189 Identities=28% Similarity=0.360 Sum_probs=139.2
Q ss_pred cccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccc
Q 042075 380 TLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSY 459 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~ 459 (1033)
+++.|++++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.. .|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~-~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA-SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT-TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc-CCCEEECCC
Confidence 56777777777776 454442 67778888888777 455 446778888888888775 666 554 677888888
Q ss_pred cccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccccccc
Q 042075 460 NFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEI 539 (1033)
Q Consensus 460 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 539 (1033)
|.|++ +|. .+++|++|+|++|+|++ +|. .+.++ +.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L-~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSL-EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTC-CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCc-CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 88876 555 57788888888888884 665 23344 778888888885 666 65 78888888888888 66
Q ss_pred Cccccccccc-------ceeecccccccCcccccccCcccCCccccccccccccCCcccccccc
Q 042075 540 PRTLGSCIKL-------ELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQL 596 (1033)
Q Consensus 540 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 596 (1033)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 76 655 67 88888888888 67888888888888888888888888888877654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.7e-21 Score=200.66 Aligned_cols=166 Identities=23% Similarity=0.298 Sum_probs=123.6
Q ss_pred CCCCCCCCCCcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecc
Q 042075 61 FGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALH 140 (1033)
Q Consensus 61 ~~~W~~~~~~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 140 (1033)
..-|..+.+.|+|.+|.|+... ++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 9 ~~~~~~~~~~Cs~~~v~c~~~~-------------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 72 (229)
T 3e6j_A 9 HSAACPSQCSCSGTTVDCRSKR-------------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLG 72 (229)
T ss_dssp --CCCCTTCEEETTEEECTTSC-------------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred hhccCCCCCEEeCCEeEccCCC-------------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECC
Confidence 3355556789999999997542 22 4454443 778888888888887778888888888888888
Q ss_pred cCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcC
Q 042075 141 NNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220 (1033)
Q Consensus 141 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 220 (1033)
+|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..
T Consensus 73 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 73 SNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC
T ss_pred CCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC
Confidence 88887555566778888888888888888666666777888888888888887 66777777788888888888887666
Q ss_pred CccccccCCCCcccccccccCCC
Q 042075 221 PDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 221 p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
+..|..+++|+.|+|++|++.+.
T Consensus 152 ~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 152 HGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTTTTTCTTCCEEECTTSCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCCccCC
Confidence 66777777777777777777643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.4e-20 Score=191.51 Aligned_cols=180 Identities=19% Similarity=0.171 Sum_probs=106.1
Q ss_pred cEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeecccc
Q 042075 382 EVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYN 460 (1033)
Q Consensus 382 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N 460 (1033)
+.++++++.++.. |..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..++ |++|+|++|
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 3556666666533 3332 34667777777777765555666777777777777776644444445444 555555555
Q ss_pred ccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccC
Q 042075 461 FLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIP 540 (1033)
Q Consensus 461 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 540 (1033)
.+++..+..|..+++|++|+|++|+++ +..+..|..+++|+.|+|++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQ-------------------------SLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCc-------------------------ccCHhHhccCCcCCEEECCCCccceeCH
Confidence 555444455556666666666666555 2223334555666666666666665444
Q ss_pred cccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccc
Q 042075 541 RTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQL 596 (1033)
Q Consensus 541 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 596 (1033)
..|..+++|++|++++|.+.+ .+++|+.|+++.|+++|.+|+.++.++.
T Consensus 142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 456666666666666666553 3345666666666666666666665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-21 Score=198.64 Aligned_cols=183 Identities=17% Similarity=0.145 Sum_probs=138.0
Q ss_pred eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCcc-ccCchhHHhhhhccCccccCCcCCccccccccceEEc
Q 042075 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQ-LLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNV 530 (1033)
Q Consensus 452 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 530 (1033)
-+.+++++|.++ .+|..+. +.+++|+|++|+|++..|.. +..+..+ +.|+|++|+|++..|..|..+++|+.|+|
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L-~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQL-RKINFSNNKITDIEEGAFEGASGVNEILL 88 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCC-CEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence 345666666665 3454442 34567777777777443433 3444444 77777777777666778899999999999
Q ss_pred cccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCccc
Q 042075 531 FENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGM 610 (1033)
Q Consensus 531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 610 (1033)
++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99999988888899999999999999999988899999999999999999999988899999999999999999999998
Q ss_pred CCCcccccccccccccccccccCCcccc
Q 042075 611 VPTEGVFRNASITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 611 ~p~~~~~~~~~~~~~~~n~~lcg~~~~~ 638 (1033)
.+......+............|+.|...
T Consensus 169 c~l~~l~~~~~~~~~~~~~~~C~~P~~l 196 (220)
T 2v70_A 169 CYLAWLGEWLRKKRIVTGNPRCQKPYFL 196 (220)
T ss_dssp GGGHHHHHHHHHSCCBCCCCEEEESGGG
T ss_pred CchHHHHHHHHhcCccccCCccCCChHH
Confidence 8765443333322222233467777544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.3e-20 Score=191.30 Aligned_cols=155 Identities=21% Similarity=0.315 Sum_probs=118.7
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCc
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA 150 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 150 (1033)
|.|..|.|... +++ .+|..+. +.|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|.
T Consensus 11 C~~~~v~c~~~-------------~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 74 (220)
T 2v9t_B 11 CSNNIVDCRGK-------------GLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD 74 (220)
T ss_dssp EETTEEECTTS-------------CCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTT
T ss_pred ECCCEEEcCCC-------------CcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHH
Confidence 67777777643 333 3454443 6788888888888876666788888888888888888877788
Q ss_pred cccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCC
Q 042075 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL 230 (1033)
Q Consensus 151 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 230 (1033)
.|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..++.|..+++|
T Consensus 75 ~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 154 (220)
T 2v9t_B 75 AFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154 (220)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred HhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCC
Confidence 88888888888888888885555567778888888888888887777778888888888888888887777777777777
Q ss_pred CcccccccccC
Q 042075 231 VNLTMAQNRLS 241 (1033)
Q Consensus 231 ~~L~L~~N~l~ 241 (1033)
++|+|++|++.
T Consensus 155 ~~L~L~~N~~~ 165 (220)
T 2v9t_B 155 QTMHLAQNPFI 165 (220)
T ss_dssp CEEECCSSCEE
T ss_pred CEEEeCCCCcC
Confidence 77777777765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-22 Score=240.20 Aligned_cols=202 Identities=18% Similarity=0.185 Sum_probs=162.6
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCC-------------CCCCCCccccCCCCCcEEE-cccccccC
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS-------------IGGEIPANISSCSNLIRVR-LSSNELVG 170 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 170 (1033)
...++|+.|+|++|+++ .+|.++++|++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 66788888899988887 788888888889888887764 5566777777778887777 666644
Q ss_pred CCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccC
Q 042075 171 KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFN 250 (1033)
Q Consensus 171 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 250 (1033)
.+|+.+.+++|.++...+. .|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..+.+
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 3566667777777743322 48899999999986 676 899999999999999999 78889999
Q ss_pred CCceeEEeccCccccCccCccccccccccceeeecccccCCCC-CccCcCCCCccccccccccccCcCcchhh----hcc
Q 042075 251 ISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAI-PPAISNASNLEVFQVNSNKLTGEVPYLEK----LQR 325 (1033)
Q Consensus 251 l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~----l~~ 325 (1033)
+++|+.|+|++|+|++ +| .+..+++|++|+|++|+|++.. |..+..+++|+.|+|++|++++.+|.... +++
T Consensus 485 l~~L~~L~Ls~N~l~~-lp--~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~ 561 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD--GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG--GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred CCCCCEEECCCCCCCC-Cc--ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence 9999999999999986 66 3557899999999999999887 99999999999999999999998876433 455
Q ss_pred cccee
Q 042075 326 LSHFV 330 (1033)
Q Consensus 326 L~~L~ 330 (1033)
|+.|+
T Consensus 562 L~~L~ 566 (567)
T 1dce_A 562 VSSIL 566 (567)
T ss_dssp CSEEE
T ss_pred cCccC
Confidence 55553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=188.27 Aligned_cols=153 Identities=22% Similarity=0.322 Sum_probs=132.9
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46788889888 6777665 68999999999999777778999999999999999999888899999999999999999
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccC
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 266 (1033)
+|++..+..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|+|++..+..+..+++|+.|++++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 9997666778899999999999999998888999999999999999999997777778888888888888887763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=189.03 Aligned_cols=152 Identities=25% Similarity=0.314 Sum_probs=110.8
Q ss_pred EEcCCCCCCcccccccCCCCCCCEEEecCCCccccCC-ccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 89 LDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIP-SEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 89 l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
+++++++++ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 16 l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 92 (220)
T 2v70_A 16 VDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92 (220)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred eEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCc
Confidence 333444555 3555443 345788888888886644 357788888888888888886666678888888888888888
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCC
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
+++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.
T Consensus 93 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred cCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 8766666777788888888888888777777777777788888888877777677777777777777777776643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=198.17 Aligned_cols=173 Identities=19% Similarity=0.360 Sum_probs=91.9
Q ss_pred cccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcE
Q 042075 129 DRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISF 208 (1033)
Q Consensus 129 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 208 (1033)
..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..| +.++++|++|+|++|++++ +|. +.++++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCE
T ss_pred hhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCE
Confidence 34555555555555554 222 24555555555555555553222 5555555555555555553 222 555555555
Q ss_pred EEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccc
Q 042075 209 LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ 288 (1033)
Q Consensus 209 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~ 288 (1033)
|+|++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|++|+|++|+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~---l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP---LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG---GTTCTTCCEEECCSSC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh---hcCCCccCEEECCCCc
Confidence 55555555532 3455555555555555555533 345555555555555555554333 3345566666666666
Q ss_pred cCCCCCccCcCCCCccccccccccccCc
Q 042075 289 LTGAIPPAISNASNLEVFQVNSNKLTGE 316 (1033)
Q Consensus 289 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 316 (1033)
+++ +| .+..+++|+.|++++|+++..
T Consensus 190 i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 190 ISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 654 22 366666666666666666643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=198.77 Aligned_cols=173 Identities=18% Similarity=0.292 Sum_probs=129.9
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
..+++|++|++++|.++. +| .+..+++|++|+|++|++++..| +.++++|++|+|++|++++ +| .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 456777888888888774 34 47778888888888888875433 7788888888888888874 33 3778888888
Q ss_pred eeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccc
Q 042075 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264 (1033)
Q Consensus 185 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l 264 (1033)
|+|++|++++. ..+.++++|++|+|++|++++. ..++.+++|++|+|++|++++..| +..+++|+.|++++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 88888888753 3577788888888888888754 567788888888888888886544 77888888888888888
Q ss_pred cCccCccccccccccceeeecccccCCC
Q 042075 265 QGVIPLDIGFTLQNLQFFSVGRNQLTGA 292 (1033)
Q Consensus 265 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 292 (1033)
++ +|. +..+++|++|++++|+++..
T Consensus 191 ~~-l~~--l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 191 SD-LRA--LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CB-CGG--GTTCTTCSEEEEEEEEEECC
T ss_pred CC-Chh--hccCCCCCEEECcCCcccCC
Confidence 74 342 45688888888888888753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=217.80 Aligned_cols=192 Identities=19% Similarity=0.323 Sum_probs=132.1
Q ss_pred CCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeec
Q 042075 109 FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVS 188 (1033)
Q Consensus 109 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 188 (1033)
.+..++|+.+.+...++ +..|++|+.|+|++|.++ .+| .+..+++|++|+|++|++++..| +..+++|++|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34455566666654333 456777777777777776 344 46777777777777777775443 7777777777777
Q ss_pred ccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCcc
Q 042075 189 YNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268 (1033)
Q Consensus 189 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 268 (1033)
+|++++ +| .+..+++|++|+|++|+|++ + ..|..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|++..
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 777764 33 57777777777777777774 2 3477777777777777777754 56677777777777777777655
Q ss_pred CccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcC
Q 042075 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV 317 (1033)
Q Consensus 269 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 317 (1033)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+
T Consensus 170 ~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 170 P---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp G---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred h---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 5 44677777777777777753 35777888888888888887643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=203.59 Aligned_cols=149 Identities=21% Similarity=0.251 Sum_probs=87.2
Q ss_pred EcCCCCCCcccccccCCCCCCCEEEecCCCccccCCcccc-ccccccEEecccCCCCCCCCccccCCCCCcEEEcccccc
Q 042075 90 DLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFD-RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNEL 168 (1033)
Q Consensus 90 ~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 168 (1033)
++++++++. +|..+. +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 24 ~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l 100 (361)
T 2xot_A 24 SCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100 (361)
T ss_dssp ECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcC
Confidence 334444542 444332 3466677777777665555555 666677777777766655555666666666666666666
Q ss_pred cCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccc---cccCCCCcccccccccC
Q 042075 169 VGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTF---GWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 169 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~ 241 (1033)
++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..| ..+++|++|+|++|+|+
T Consensus 101 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 65555556666666666666666665556666666666666666666664333333 33444555555555444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=204.48 Aligned_cols=180 Identities=18% Similarity=0.206 Sum_probs=123.2
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCcccc-CCCCCcEEEcccccccCCCCCCcccccccceeeecc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANIS-SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 189 (1033)
+.+++++|+++ .+|..+. +.+++|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 47888888887 5776654 3578888888888876666676 788888888888888866667788888888888888
Q ss_pred cccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccC
Q 042075 190 NNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIP 269 (1033)
Q Consensus 190 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 269 (1033)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~------------------ 159 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG------------------ 159 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC--------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCc------------------
Confidence 88887666778888888888888888887777778888888888888887774322222100
Q ss_pred ccccccccccceeeecccccCCCCCccCcCCCC--ccccccccccccC
Q 042075 270 LDIGFTLQNLQFFSVGRNQLTGAIPPAISNASN--LEVFQVNSNKLTG 315 (1033)
Q Consensus 270 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~ 315 (1033)
..+++|++|+|++|+|++..+..+..+++ ++.|+|++|++..
T Consensus 160 ----~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 160 ----NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp ------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ----ccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 12444444455555554333344444444 3556666666653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-18 Score=183.87 Aligned_cols=154 Identities=25% Similarity=0.275 Sum_probs=124.0
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+.++.++++++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 45788888887 6776554 78889999999998888888888888999999999887555567788888888888888
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCcc
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 268 (1033)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|.+....
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 888777777888888888888888888 67888888888888888888888666666777777777777777776443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.6e-19 Score=211.61 Aligned_cols=185 Identities=18% Similarity=0.254 Sum_probs=144.3
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 183 (1033)
+..|++|+.|+|++|.+.. +| .|..+++|+.|+|++|.|++..| +..+++|++|+|++|.+++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 4567788888888888874 44 58888888888888888886544 8888888888888888874 43 688888888
Q ss_pred eeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcc
Q 042075 184 YFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263 (1033)
Q Consensus 184 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~ 263 (1033)
+|+|++|++++. +.+.++++|+.|+|++|+|++. ..|..+++|+.|+|++|+|++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 888888888853 3478888888888888888864 578888888888888888887666 8888888899999888
Q ss_pred ccCccCccccccccccceeeecccccCCCCCccCcCCCCc
Q 042075 264 IQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNL 303 (1033)
Q Consensus 264 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 303 (1033)
|++. | .+..+++|+.|+|++|.+++.....+..+..+
T Consensus 187 i~~l-~--~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~ 223 (605)
T 1m9s_A 187 ISDL-R--ALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223 (605)
T ss_dssp CCBC-G--GGTTCTTCSEEECCSEEEECCCCCCCSSCEEE
T ss_pred CCCC-h--HHccCCCCCEEEccCCcCcCCcccccccEEec
Confidence 8853 3 24568889999999999886544444444333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-19 Score=182.20 Aligned_cols=158 Identities=23% Similarity=0.276 Sum_probs=123.5
Q ss_pred cEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCC-ccccccccceEEccccccccccCcccccccccceeecc
Q 042075 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPN-EVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQ 555 (1033)
Q Consensus 477 ~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (1033)
+.+++++|+++ .+|..+.. . ++.|++++|+|++..+. .|+.+++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~-l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--H-TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--T-CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--C-CCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 56666666665 56655433 2 36677777777755543 47888999999999999998888899999999999999
Q ss_pred cccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccccccccccccccCCc
Q 042075 556 GNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGT 635 (1033)
Q Consensus 556 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~ 635 (1033)
+|+|++..|..|..+++|+.|+|++|+|++.+|..+..+++|++|+|++|+|+|..+......++....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999888888999999999999999999888999999999999999999999888765444444444556677778777
Q ss_pred ccc
Q 042075 636 HEF 638 (1033)
Q Consensus 636 ~~~ 638 (1033)
...
T Consensus 167 ~~l 169 (192)
T 1w8a_A 167 SKV 169 (192)
T ss_dssp TTT
T ss_pred hHH
Confidence 654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-21 Score=230.03 Aligned_cols=191 Identities=23% Similarity=0.256 Sum_probs=147.1
Q ss_pred cCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccc-------------cccccCcccccce-eceee-ccccccCC
Q 042075 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENR-------------FLGNIPPSIGNLK-LFNLQ-LSYNFLQG 464 (1033)
Q Consensus 400 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~-L~~L~-Ls~N~l~~ 464 (1033)
...++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..++.++ |+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56778888888888887 678888888888888887765 4556666666665 77776 5666543
Q ss_pred CCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccc
Q 042075 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLG 544 (1033)
Q Consensus 465 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 544 (1033)
+|+.+.+++|.++ .+|.. . ++.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+
T Consensus 424 ----------~L~~l~l~~n~i~-~l~~~-----~-L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVL-KMEYA-----D-VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHH-HHHHT-----T-CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhccccc-ccCcc-----C-ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 4555666666665 23321 1 3678888888885 665 888888888888888888 7888888
Q ss_pred cccccceeecccccccCcccccccCcccCCccccccccccccC-CcccccccccceeecCCCcCcccCCCc
Q 042075 545 SCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI-PEFLVGFQLLEYLNLSNNDFEGMVPTE 614 (1033)
Q Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~ 614 (1033)
++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..+..+++|+.|+|++|+|++.+|..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 88888888888888885 67 7888888888888888888776 888888888888888888888877753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=185.29 Aligned_cols=138 Identities=22% Similarity=0.180 Sum_probs=107.1
Q ss_pred CCCccceecccCceeEEEEEeCCCCeE--EEEEEeeccCch------------------------hHHHHHHHHHHHHhc
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTI--VAVKVFNLLHHG------------------------AFKSFIAECNTLKNI 765 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 765 (1033)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999657888 999997532111 113678999999999
Q ss_pred CCCCc--eeEeeeeccccccCCCceeEEEEcccC-C----chhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHH
Q 042075 766 RHRNL--VKILTACSGVDYQGNDFKALVFEFMHN-R----SLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838 (1033)
Q Consensus 766 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 838 (1033)
.|+++ +.++++ +..++||||+.+ | +|.++... .++.++..++.|++.|++|
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHH
Confidence 88754 334332 256899999942 4 66665421 2244577899999999999
Q ss_pred HH-hCCCCCcEeccCCCCCeEecCCCcEEEeecccceec
Q 042075 839 LH-HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL 876 (1033)
Q Consensus 839 LH-~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~ 876 (1033)
|| +. ||+||||||+|||+++ .++|+|||+|...
T Consensus 186 lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99 88 9999999999999988 9999999999864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.6e-19 Score=188.16 Aligned_cols=169 Identities=24% Similarity=0.283 Sum_probs=92.6
Q ss_pred CCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceee
Q 042075 107 LSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 186 (1033)
+.++..+++++|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..| +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 4445555666666653 22 4556666666666666665 344 45666666666666666663332 66666666666
Q ss_pred ecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccC
Q 042075 187 VSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQG 266 (1033)
Q Consensus 187 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 266 (1033)
|++|++++ +|.. .. ++|++|+|++|++++ ++ .+..+++|++|+|++|++++. | .+..+++|+.|++++|++++
T Consensus 92 L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 66666663 2322 22 566666666666664 22 355666666666666666533 2 45555555555555555553
Q ss_pred ccCccccccccccceeeecccccCC
Q 042075 267 VIPLDIGFTLQNLQFFSVGRNQLTG 291 (1033)
Q Consensus 267 ~~p~~~~~~l~~L~~L~L~~N~l~~ 291 (1033)
. ..+..+++|++|++++|.+++
T Consensus 165 ~---~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 165 T---GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp C---TTSTTCCCCCEEEEEEEEEEC
T ss_pred h---HHhccCCCCCEEeCCCCcccC
Confidence 3 222344555555555555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=185.69 Aligned_cols=167 Identities=16% Similarity=0.241 Sum_probs=142.3
Q ss_pred EEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccc
Q 042075 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165 (1033)
Q Consensus 86 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 165 (1033)
++.+++.++.+++.. .+..+++|++|++++|+++ .+| .+..+++|++|+|++|+|++..| +.++++|++|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 344566667776433 5778999999999999998 566 79999999999999999996544 99999999999999
Q ss_pred ccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCc
Q 042075 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245 (1033)
Q Consensus 166 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 245 (1033)
|++++ +|.... ++|++|+|++|++++. + .+.++++|++|+|++|+|++. + .++.+++|++|+|++|++++.
T Consensus 95 N~l~~-l~~~~~--~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-- 165 (263)
T 1xeu_A 95 NRLKN-LNGIPS--ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-- 165 (263)
T ss_dssp SCCSC-CTTCCC--SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred CccCC-cCcccc--CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence 99985 554333 9999999999999964 4 589999999999999999964 4 799999999999999999976
Q ss_pred ccccCCCceeEEeccCccccCc
Q 042075 246 SSIFNISSITVFDAGINQIQGV 267 (1033)
Q Consensus 246 ~~l~~l~~L~~L~ls~N~l~~~ 267 (1033)
..+..+++|+.|++++|.+.+.
T Consensus 166 ~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSTTCCCCCEEEEEEEEEECC
T ss_pred HHhccCCCCCEEeCCCCcccCC
Confidence 7788999999999999999854
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-18 Score=175.66 Aligned_cols=131 Identities=15% Similarity=0.293 Sum_probs=69.8
Q ss_pred cccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcE
Q 042075 129 DRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISF 208 (1033)
Q Consensus 129 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 208 (1033)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..|+++++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555555555555 444 4555555555555555443 2234555555566666655555545555555556666
Q ss_pred EEcccCcCCCcCCccccccCCCCcccccccc-cCCCCcccccCCCceeEEeccCcccc
Q 042075 209 LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNR-LSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 209 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
|+|++|++++..|..|+.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|+++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc
Confidence 6666666555555555555555555555555 33 333 3444444444444444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-19 Score=217.99 Aligned_cols=179 Identities=26% Similarity=0.255 Sum_probs=84.5
Q ss_pred cccEEEccCCCCCccCCccccCCCCCC-----EEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-ec
Q 042075 380 TLEVLLLDSNKIFGNIPAAFGKFVKLL-----RLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LF 453 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~~p~~~~~l~~L~-----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~ 453 (1033)
.++.|.|.+|.+... +..+....+|. .++++.|++. ..|..+..+++|+.|+|++|++. .+|..+..++ |+
T Consensus 174 ~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 174 LTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLT 250 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCS
T ss_pred ccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCC
Confidence 355566666665542 22221111111 2233344444 45666777777777777777776 5565555555 66
Q ss_pred eeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccc
Q 042075 454 NLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533 (1033)
Q Consensus 454 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 533 (1033)
+|+|++|.|+ .+|..|+.+++|++|+|++|+|+ .+|..+..+.++ ++|+|++|.|+ .+|..|+.+++|+.|+|++|
T Consensus 251 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 251 RLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQL-KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp CCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTC-SEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred EEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCC-CEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 6666666666 56666666667777777777666 566666555554 56666666665 45555666666666666666
Q ss_pred ccccccCcccccccc-cceeecccccccCcccc
Q 042075 534 KLRGEIPRTLGSCIK-LELLQMQGNFLQGPIPS 565 (1033)
Q Consensus 534 ~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 565 (1033)
+|++.+|..+..+.. +..|+|++|.++|.+|.
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 666655555544322 22355666666665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=176.68 Aligned_cols=153 Identities=18% Similarity=0.230 Sum_probs=120.8
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45677888888888888 566 6888888888888888765 3457888888888888888888777888888888888
Q ss_pred eeecccccCCCCCCCCCCCCCCcEEEcccCc-CCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcc
Q 042075 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNN-LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQ 263 (1033)
Q Consensus 185 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~ 263 (1033)
|++++|++++..|..|+++++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 8888888887777778888888888888887 65 455 68888888889998888885 33 66777777777777777
Q ss_pred cc
Q 042075 264 IQ 265 (1033)
Q Consensus 264 l~ 265 (1033)
|.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 65
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=8.3e-18 Score=171.65 Aligned_cols=130 Identities=22% Similarity=0.358 Sum_probs=83.6
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCc-cccCCCCCcEEEcccccccCCCCCCcccccccceeeecc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA-NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSY 189 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 189 (1033)
+++++++|+++ .+|..+.. +|++|+|++|+|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56677777775 56655543 667777777777644443 366666666666666666666666666666666666666
Q ss_pred cccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCC
Q 042075 190 NNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 190 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 666666666666666666666666666666666666666666666666666543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=169.06 Aligned_cols=159 Identities=21% Similarity=0.254 Sum_probs=118.9
Q ss_pred cEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccccceeeccc
Q 042075 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQG 556 (1033)
Q Consensus 477 ~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (1033)
+.+++++|+++ .+|..+. ..++.|++++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 45666666666 5665443 22367777777777 5677888889999999999999987778899999999999999
Q ss_pred ccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccccccccccccccCCcc
Q 042075 557 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTH 636 (1033)
Q Consensus 557 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~ 636 (1033)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...-.+...+........+...|..|.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~ 167 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPG 167 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCch
Confidence 99998888889999999999999999997666678899999999999999988665432222222222223335677776
Q ss_pred ccCC
Q 042075 637 EFRL 640 (1033)
Q Consensus 637 ~~~~ 640 (1033)
..+.
T Consensus 168 ~l~g 171 (193)
T 2wfh_A 168 EMAD 171 (193)
T ss_dssp GGTT
T ss_pred HHCC
Confidence 6543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=162.76 Aligned_cols=134 Identities=19% Similarity=0.173 Sum_probs=106.2
Q ss_pred CCCCCCEEEecCCCcc-ccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 106 NLSFLKVLDLHNNSFH-HEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 106 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
..++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3477888888888887 77888888888888888888888854 77888888888888888888767777777888888
Q ss_pred eeecccccCCCC-CCCCCCCCCCcEEEcccCcCCCcCC---ccccccCCCCcccccccccC
Q 042075 185 FSVSYNNLTGSI-PPSFGNLSSISFLFLSRNNLDGSIP---DTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 185 L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 241 (1033)
|+|++|++++.. +..+..+++|++|++++|.+++..+ ..|..+++|++|++++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 888888888543 2567788888888888888885544 46777888888888887776
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-17 Score=184.66 Aligned_cols=299 Identities=11% Similarity=0.077 Sum_probs=180.4
Q ss_pred CcccccccCC--CCCCCEEEecCCCccccCCccccc-cccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCC
Q 042075 97 AGYISAHVGN--LSFLKVLDLHNNSFHHEIPSEFDR-LRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIP 173 (1033)
Q Consensus 97 ~g~~~~~~~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 173 (1033)
.|.++..+.. +.+++.|.++++ +.+.--..+.. +++|++|||++|+|+ .....-+.++.+..+.+..|.+. +
T Consensus 12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~I~---~ 86 (329)
T 3sb4_A 12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANFVP---A 86 (329)
T ss_dssp TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTEEC---T
T ss_pred CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCccccccccccccccccccC---H
Confidence 3455554443 667888888764 22111122333 667888888888876 11111122233455555555332 3
Q ss_pred CCccc--------ccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCccccccccc----C
Q 042075 174 SELGS--------LSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL----S 241 (1033)
Q Consensus 174 ~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~ 241 (1033)
..|.+ +++|+.|+|.+ +++.+.+..|.++++|+.|++++|.+....+.+|..+.++..+.+..+.. .
T Consensus 87 ~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~ 165 (329)
T 3sb4_A 87 YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN 165 (329)
T ss_dssp TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred HHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence 45556 77888888877 77756666777777788888887777766677777766666666554321 2
Q ss_pred CCCcccccCCCcee-EEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcch
Q 042075 242 GTIPSSIFNISSIT-VFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYL 320 (1033)
Q Consensus 242 ~~~p~~l~~l~~L~-~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 320 (1033)
...+..+.++.+|+ .++++... .++..++ ..-....++..+.+.++-......
T Consensus 166 ~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~---------------------~~~~~~~~~~~l~~~~~l~~~~~~-- 219 (329)
T 3sb4_A 166 RWEHFAFIEGEPLETTIQVGAMG---KLEDEIM---------------------KAGLQPRDINFLTIEGKLDNADFK-- 219 (329)
T ss_dssp TTTTSCEEESCCCEEEEEECTTC---CHHHHHH---------------------HTTCCGGGCSEEEEEECCCHHHHH--
T ss_pred cccccccccccccceeEEecCCC---cHHHHHh---------------------hcccCccccceEEEeeeecHHHHH--
Confidence 22233344444444 22222111 1111110 000112233333333221110000
Q ss_pred hhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCcccc
Q 042075 321 EKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFG 400 (1033)
Q Consensus 321 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~ 400 (1033)
.+....++|+.+++++|+++.+.+.+|.
T Consensus 220 ----------------------------------------------------~l~~~~~~L~~l~L~~n~i~~I~~~aF~ 247 (329)
T 3sb4_A 220 ----------------------------------------------------LIRDYMPNLVSLDISKTNATTIPDFTFA 247 (329)
T ss_dssp ----------------------------------------------------HHHHHCTTCCEEECTTBCCCEECTTTTT
T ss_pred ----------------------------------------------------HHHHhcCCCeEEECCCCCcceecHhhhh
Confidence 0001125778888888888888888899
Q ss_pred CCCCCCEEEcccCcccccCChhhhcCCCCc-EEEccccccccccCcccccce-eceeeccccccCCCCCCccCCCCcccE
Q 042075 401 KFVKLLRLEMWNNRLSGTIPPAIGELQNLR-ELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETLTI 478 (1033)
Q Consensus 401 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 478 (1033)
++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ +++...+..|.++. |+.+++++|.++...+.+|.++++|+.
T Consensus 248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL 325 (329)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence 9999999999888 7777778899999998 999988 67766678888887 999999899998888889999999998
Q ss_pred Eec
Q 042075 479 IDL 481 (1033)
Q Consensus 479 L~L 481 (1033)
++.
T Consensus 326 ly~ 328 (329)
T 3sb4_A 326 IYK 328 (329)
T ss_dssp EEC
T ss_pred hcc
Confidence 864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-16 Score=157.95 Aligned_cols=135 Identities=21% Similarity=0.296 Sum_probs=95.6
Q ss_pred CcceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCC
Q 042075 70 FCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 70 ~c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
.|+|.+|.|+.. +++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..+
T Consensus 6 ~C~~~~l~~~~~-------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 6 SCSGTEIRCNSK-------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp EEETTEEECCSS-------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred EeCCCEEEecCC-------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 478999999754 222 233322 3577888888888876666667778888888888888876555
Q ss_pred ccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcC
Q 042075 150 ANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 220 (1033)
..|+++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+.+..
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 66677778888888888777666666777777777777777777655555677777777777777776543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=160.50 Aligned_cols=107 Identities=26% Similarity=0.367 Sum_probs=51.1
Q ss_pred CCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeec
Q 042075 109 FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVS 188 (1033)
Q Consensus 109 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 188 (1033)
.|++|+|++|+|+ .+|..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4555555555554 444455555555555555555554444444445555555555554444444444444444444444
Q ss_pred ccccCCCCCCCCCCCCCCcEEEcccCcC
Q 042075 189 YNNLTGSIPPSFGNLSSISFLFLSRNNL 216 (1033)
Q Consensus 189 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l 216 (1033)
+|+|++..+..|.++++|++|+|++|.+
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 4444433333344444444444444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=159.76 Aligned_cols=132 Identities=22% Similarity=0.215 Sum_probs=78.6
Q ss_pred ccccEEecccCCCC-CCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEE
Q 042075 132 RRLQVLALHNNSIG-GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLF 210 (1033)
Q Consensus 132 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 210 (1033)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56667777777766 56666666666666666666666643 5566666666666666666655555555566666666
Q ss_pred cccCcCCCcC-CccccccCCCCcccccccccCCCCc---ccccCCCceeEEeccCcccc
Q 042075 211 LSRNNLDGSI-PDTFGWLKNLVNLTMAQNRLSGTIP---SSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 211 L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~ls~N~l~ 265 (1033)
|++|+|++.. +..|..+++|++|++++|++++..+ ..+..+++|+.|+++.|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666666422 1455566666666666666654333 24444555555555444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.5e-17 Score=179.86 Aligned_cols=288 Identities=12% Similarity=0.085 Sum_probs=179.8
Q ss_pred ccccccEEecccCCCCCCCCccccC-CCCCcEEEccccccc--CCCCCCcccccccceeeecccccCCCCCCCCCC----
Q 042075 130 RLRRLQVLALHNNSIGGEIPANISS-CSNLIRVRLSSNELV--GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGN---- 202 (1033)
Q Consensus 130 ~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---- 202 (1033)
.+.+++.|.++++ +.+.--..+.. +++|++|||++|++. ...+.. ++.++.+.+..|.+ .+..|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~~aF~~~~~~ 95 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PAYAFSNVVNG 95 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CTTTTEEEETT
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CHHHhcccccc
Confidence 3678888888864 22111122333 677888888888887 222222 23355566665533 2455666
Q ss_pred ----CCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccc
Q 042075 203 ----LSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQN 278 (1033)
Q Consensus 203 ----l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~ 278 (1033)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++...+..|.++.++..+.++.+...
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~------------- 161 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY------------- 161 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH-------------
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh-------------
Confidence 77788888777 777666667777777777777777777555556666655555554442211
Q ss_pred cceeeecccccCCCCCccCcCCCCcc-ccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcc
Q 042075 279 LQFFSVGRNQLTGAIPPAISNASNLE-VFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLK 357 (1033)
Q Consensus 279 L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~ 357 (1033)
..........|.++.+|+ .+.+....- ....+.. . ...
T Consensus 162 --------~~~~~i~~~~f~~~~~L~~~i~~~~~~~--l~~~~~~-----------~---------------~~~----- 200 (329)
T 3sb4_A 162 --------RFKNRWEHFAFIEGEPLETTIQVGAMGK--LEDEIMK-----------A---------------GLQ----- 200 (329)
T ss_dssp --------HTSTTTTTSCEEESCCCEEEEEECTTCC--HHHHHHH-----------T---------------TCC-----
T ss_pred --------hccccccccccccccccceeEEecCCCc--HHHHHhh-----------c---------------ccC-----
Confidence 011112233445555555 333322110 0000000 0 000
Q ss_pred eeeecccccCCCCccccccccCcccEEEccCCCCCccCCccc-cCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccc
Q 042075 358 WFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF-GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQE 436 (1033)
Q Consensus 358 ~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 436 (1033)
..+++.+.+.++- .......+ ..+++|+.|+|++|+++.+.+.+|.++++|+.|+|++
T Consensus 201 --------------------~~~~~~l~~~~~l-~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 201 --------------------PRDINFLTIEGKL-DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp --------------------GGGCSEEEEEECC-CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred --------------------ccccceEEEeeee-cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 0233444444332 11111222 2478999999999999988888999999999999999
Q ss_pred cccccccCcccccce-ec-eeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCc-cccCchhHHhhh
Q 042075 437 NRFLGNIPPSIGNLK-LF-NLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP-QLLGLSSLLIVL 504 (1033)
Q Consensus 437 N~l~~~~p~~~~~l~-L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~ll~~L 504 (1033)
| ++...+..|.++. |+ .+++.+ .++.+.+.+|.++++|+.|++++|+++ .++. .|.++.++ +.+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~L-~~l 326 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVPS-KLI 326 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCCC-CEE
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcch-hhh
Confidence 8 7767778899998 99 999999 788788899999999999999999998 5555 55555554 544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.4e-17 Score=157.79 Aligned_cols=128 Identities=20% Similarity=0.191 Sum_probs=79.8
Q ss_pred CCCCCEEEecCCCcc-ccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccccee
Q 042075 107 LSFLKVLDLHNNSFH-HEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 185 (1033)
.++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++++++|++|+|++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 355666777777666 56666666666677777777666644 556666666666666666665566656566666666
Q ss_pred eecccccCCC-CCCCCCCCCCCcEEEcccCcCCCcCC---ccccccCCCCccccc
Q 042075 186 SVSYNNLTGS-IPPSFGNLSSISFLFLSRNNLDGSIP---DTFGWLKNLVNLTMA 236 (1033)
Q Consensus 186 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 236 (1033)
++++|++++. .+..++++++|++|++++|.+++..+ ..|..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 6666666642 23456666666666666666664443 355556666666554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.2e-16 Score=154.69 Aligned_cols=130 Identities=17% Similarity=0.232 Sum_probs=80.9
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45666666666 4454332 56667777777766555555666666666666666666544555666666666666666
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCC
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 66655555566666666666666666655555555666666666666666543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-16 Score=155.41 Aligned_cols=128 Identities=17% Similarity=0.202 Sum_probs=81.8
Q ss_pred cccccEEecccCCCC-CCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEE
Q 042075 131 LRRLQVLALHNNSIG-GEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFL 209 (1033)
Q Consensus 131 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 209 (1033)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356777777777776 66777777777777777777777644 566666777777777777766566655566666666
Q ss_pred EcccCcCCCc-CCccccccCCCCcccccccccCCCCc---ccccCCCceeEEecc
Q 042075 210 FLSRNNLDGS-IPDTFGWLKNLVNLTMAQNRLSGTIP---SSIFNISSITVFDAG 260 (1033)
Q Consensus 210 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~ls 260 (1033)
++++|++++. .+..++.+++|++|++++|++++..+ ..+..+++|+.||++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 6666666642 23556666666666666666664433 344555555555543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.8e-16 Score=172.27 Aligned_cols=143 Identities=14% Similarity=0.148 Sum_probs=102.8
Q ss_pred HHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc--------------hhHHH--------HHHHHHHHH
Q 042075 706 LYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH--------------GAFKS--------FIAECNTLK 763 (1033)
Q Consensus 706 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~ 763 (1033)
+.....-|++.+.||+|++|.||+|.+. +|+.||||+++.... ..... ..+|...+.
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3334445899999999999999999986 689999999753110 00111 234566666
Q ss_pred hcCCCCc--eeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh
Q 042075 764 NIRHRNL--VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH 841 (1033)
Q Consensus 764 ~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 841 (1033)
++.+.++ ...+++ ...++||||++|++|.++... .....++.|++.+|.|||+
T Consensus 169 rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~----------------~~~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV----------------PDPASLYADLIALILRLAK 223 (397)
T ss_dssp HHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC----------------SCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc----------------HHHHHHHHHHHHHHHHHHH
Confidence 6644332 222221 134799999999988776521 1235688999999999999
Q ss_pred CCCCCcEeccCCCCCeEecCCC----------cEEEeecccceecC
Q 042075 842 DCQPPIVHCDLKPSNVLLDEEM----------IAHVGDFGLATFLP 877 (1033)
Q Consensus 842 ~~~~~ivHrDlkp~NIll~~~~----------~~kL~DfG~a~~~~ 877 (1033)
. |||||||||.|||+++++ .+.|+||+-+....
T Consensus 224 ~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 224 H---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp T---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred C---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9 999999999999998776 38999999887543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-17 Score=171.89 Aligned_cols=135 Identities=24% Similarity=0.322 Sum_probs=78.9
Q ss_pred CCCCCCEEEecCCCccccCCc------cccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccc
Q 042075 106 NLSFLKVLDLHNNSFHHEIPS------EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSL 179 (1033)
Q Consensus 106 ~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 179 (1033)
....++.++++.+.++|.+|. .|..+++|++|+|++|.+++ +| .+.++++|++|+|++|.++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 344555555666666555554 66666666666666666664 55 5666666666666666666 555555556
Q ss_pred cccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCC-ccccccCCCCcccccccccCCCCc
Q 042075 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLSGTIP 245 (1033)
Q Consensus 180 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p 245 (1033)
++|++|+|++|++++ +| .+.++++|++|+|++|++++..+ +.+..+++|++|++++|++++.+|
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 666666666666664 33 35555666666666666653222 345555555555555555554433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.7e-15 Score=150.71 Aligned_cols=132 Identities=14% Similarity=0.168 Sum_probs=73.5
Q ss_pred cCCCCCCCEEEecCCCccccCCccccccc-cccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccc
Q 042075 104 VGNLSFLKVLDLHNNSFHHEIPSEFDRLR-RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKI 182 (1033)
Q Consensus 104 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 182 (1033)
+.+.++|++|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..++++++|++|+|++|++++..|..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445566666666666666 3343 33333 666666666666643 455666666666666666663333333566666
Q ss_pred ceeeecccccCCCCCC--CCCCCCCCcEEEcccCcCCCcCCcc----ccccCCCCcccccccccC
Q 042075 183 EYFSVSYNNLTGSIPP--SFGNLSSISFLFLSRNNLDGSIPDT----FGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 183 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 241 (1033)
++|+|++|+++ .+|. .+.++++|++|++++|.++ .+|.. +..+++|++|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 66666666664 3343 4555556666666666655 33442 555555555555555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.8e-15 Score=150.57 Aligned_cols=133 Identities=19% Similarity=0.246 Sum_probs=86.2
Q ss_pred cccccccccEEecccCCCCCCCCccccCCC-CCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCC
Q 042075 127 EFDRLRRLQVLALHNNSIGGEIPANISSCS-NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205 (1033)
Q Consensus 127 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 205 (1033)
.+.++.+|++|+|++|.++ .+|. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|++++..|..|.++++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4566777888888888877 4454 44444 777777777777743 56777777777777777777544444466777
Q ss_pred CcEEEcccCcCCCcCCc--cccccCCCCcccccccccCCCCccc----ccCCCceeEEeccCcccc
Q 042075 206 ISFLFLSRNNLDGSIPD--TFGWLKNLVNLTMAQNRLSGTIPSS----IFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 206 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~ls~N~l~ 265 (1033)
|++|+|++|+|+ .+|. .+..+++|++|++++|+++ .+|.. +..+++|+.||++.|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777777775 3444 6666777777777777766 33442 555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-16 Score=162.65 Aligned_cols=133 Identities=25% Similarity=0.275 Sum_probs=93.2
Q ss_pred ccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCcccccccc
Q 042075 469 SLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIK 548 (1033)
Q Consensus 469 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 548 (1033)
.+..+++|++|+|++|++++ +| .+..+..+ +.|++++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L-~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENL-RILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTC-CEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHH
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCC-CEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCC
Confidence 56666667777777776663 55 44444444 66666666666 456666667788888888888875 45 5778888
Q ss_pred cceeecccccccCccc-ccccCcccCCccccccccccccCCcc----------cccccccceeecCCCcCcc
Q 042075 549 LELLQMQGNFLQGPIP-SSLSSLRGLSVLDLSQNNLSGKIPEF----------LVGFQLLEYLNLSNNDFEG 609 (1033)
Q Consensus 549 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ls~N~l~g 609 (1033)
|++|++++|++++..+ ..+..+++|+.|++++|++++.+|.. +..+++|+.|| +|+++.
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888888874322 46788888888888888887776653 67788888776 666653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-13 Score=156.38 Aligned_cols=89 Identities=12% Similarity=0.096 Sum_probs=44.8
Q ss_pred CccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccceeceeeccccccCCCCCCccCCCC-
Q 042075 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSE- 474 (1033)
Q Consensus 396 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~- 474 (1033)
+.+|.++++|+.+++. +.++.+...+|.++++|+.++|.+| ++..-+..|.++.|+.+++++|.+....+..|.+++
T Consensus 293 ~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~~~l~~~~F~~~~~ 370 (401)
T 4fdw_A 293 PYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTPPQVFEKVWYGFPD 370 (401)
T ss_dssp TTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSCCBCCCSSCCCSCT
T ss_pred HHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCCcccccccccCCCC
Confidence 4455555555555555 2344444455555555555555433 333333444444445555555544444445555553
Q ss_pred cccEEecCCCcc
Q 042075 475 TLTIIDLSNNNL 486 (1033)
Q Consensus 475 ~L~~L~Ls~N~l 486 (1033)
+++.|++..+.+
T Consensus 371 ~l~~l~vp~~~~ 382 (401)
T 4fdw_A 371 DITVIRVPAESV 382 (401)
T ss_dssp TCCEEEECGGGH
T ss_pred CccEEEeCHHHH
Confidence 556666655544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-13 Score=156.00 Aligned_cols=149 Identities=12% Similarity=0.086 Sum_probs=72.4
Q ss_pred CCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCccccc
Q 042075 157 NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMA 236 (1033)
Q Consensus 157 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 236 (1033)
+|+.++|..| ++..-..+|.+ .+|+.+.+.+ .++.+.+..|.++++|+.++|++|+++.....+|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 3444444433 33222333433 2344444443 33333334444555555555555555433333343 3445555554
Q ss_pred ccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 237 QNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 237 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
.+ ++..-...|.++++|+.+++..| ++ .++...|.. .+|+.+.+ .|.++...+.+|.++++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 22 43333344445555555555443 22 445555544 56666666 34455455666777777777777666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=9.6e-14 Score=138.24 Aligned_cols=104 Identities=25% Similarity=0.346 Sum_probs=64.1
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 191 (1033)
.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3444444554 3444442 566666666666665556666666666666666666665555556666666666666666
Q ss_pred cCCCCCCCCCCCCCCcEEEcccCcCCC
Q 042075 192 LTGSIPPSFGNLSSISFLFLSRNNLDG 218 (1033)
Q Consensus 192 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 218 (1033)
|++..+..|.++++|++|+|++|.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 665555556666666667766666663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.4e-14 Score=139.57 Aligned_cols=104 Identities=23% Similarity=0.330 Sum_probs=72.0
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34566666664 5565553 66777777777777666777777777777777777777554555677777777777777
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCC
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLD 217 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 217 (1033)
+|++..+..|.++++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 777555555777777777777777776
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=9.3e-14 Score=138.36 Aligned_cols=108 Identities=19% Similarity=0.266 Sum_probs=85.1
Q ss_pred cccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcc
Q 042075 133 RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLS 212 (1033)
Q Consensus 133 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 212 (1033)
..+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578888888887 5777663 778888888888887777788888888888888888887767777888888888888
Q ss_pred cCcCCCcCCccccccCCCCcccccccccCCC
Q 042075 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGT 243 (1033)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 243 (1033)
+|+|++..++.|..+++|++|+|++|+++..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 8888876666787888888888888877743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=137.09 Aligned_cols=106 Identities=22% Similarity=0.314 Sum_probs=85.4
Q ss_pred ccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEccc
Q 042075 134 LQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR 213 (1033)
Q Consensus 134 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 213 (1033)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 367888888886 7787664 7888888888888877788888888888888888888876666678888888888888
Q ss_pred CcCCCcCCccccccCCCCcccccccccCC
Q 042075 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLSG 242 (1033)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 242 (1033)
|+|++..+..|..+++|++|+|++|++..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 88886666668888888888888888773
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.4e-12 Score=143.54 Aligned_cols=309 Identities=11% Similarity=0.029 Sum_probs=167.7
Q ss_pred cccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccc
Q 042075 102 AHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSK 181 (1033)
Q Consensus 102 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 181 (1033)
.+|.++++|+.+.|.. .++..-..+|.++++|+.++|.++ ++..-...|.++.+|+.+.+..+ +...-..+|.+...
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 4577788888888864 366444567888888888888755 55344566777888887777654 33244456666554
Q ss_pred cceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccC
Q 042075 182 IEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGI 261 (1033)
Q Consensus 182 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~ 261 (1033)
++....... .......|.++++|+.+.+.++..+ ....+|.++.+|+.+.+..| ++..-...+.++..|+.+.+..
T Consensus 142 ~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 443333222 2233456778888888888765433 55667778888888887766 4434455666777777776665
Q ss_pred ccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCC
Q 042075 262 NQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEH 341 (1033)
Q Consensus 262 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 341 (1033)
+... +.... ....+|+.+.+..+ ++......+..+.+|+.+.+..+..+-....+.....++.+....+.
T Consensus 218 ~~~~--i~~~~-~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~------ 287 (394)
T 4fs7_A 218 SLYY--LGDFA-LSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVI------ 287 (394)
T ss_dssp TCCE--ECTTT-TTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSE------
T ss_pred CceE--eehhh-cccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCcee------
Confidence 5432 22222 23355666665433 23233445666666666666555433111122222222222222111
Q ss_pred ccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCCh
Q 042075 342 RDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP 421 (1033)
Q Consensus 342 ~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 421 (1033)
++...+....+|+.+.+.++ ++.+...+|.++.+|+.+++.++ ++.+...
T Consensus 288 ----------------------------i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 337 (394)
T 4fs7_A 288 ----------------------------VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKR 337 (394)
T ss_dssp ----------------------------ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred ----------------------------eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHH
Confidence 22222222345555555433 44444555666666666666433 4444455
Q ss_pred hhhcCCCCcEEEccccccccccCcccccce-eceeecc
Q 042075 422 AIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLS 458 (1033)
Q Consensus 422 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls 458 (1033)
+|.++++|+.+++..| ++..-...|.++. |+.+++.
T Consensus 338 aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 338 SFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred hccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 5666666666655544 4333334444443 4444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.7e-12 Score=143.39 Aligned_cols=149 Identities=13% Similarity=0.089 Sum_probs=82.3
Q ss_pred cCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeeccccccCCCCCCccCC
Q 042075 394 NIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQ 472 (1033)
Q Consensus 394 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~ 472 (1033)
+...+|.++..|+.+.+..+... .....|..+..++.+....+.+. ...|..+. |+.+.+..+ ++..-..+|.+
T Consensus 244 i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~ 318 (394)
T 4fs7_A 244 LGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFES 318 (394)
T ss_dssp ECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTT
T ss_pred cccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcC
Confidence 34455666666666666655443 45556666666666665544321 12233333 444444433 33344455556
Q ss_pred CCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCccccccccccee
Q 042075 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELL 552 (1033)
Q Consensus 473 l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 552 (1033)
+++|+.+++.++ + +..-..+|.++++|+.+++..| ++..-..+|.+|.+|+.+
T Consensus 319 c~~L~~i~lp~~-v-------------------------~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 319 CTSLVSIDLPYL-V-------------------------EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKV 371 (394)
T ss_dssp CTTCCEECCCTT-C-------------------------CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEE
T ss_pred CCCCCEEEeCCc-c-------------------------cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEE
Confidence 666666655322 2 2223456667777777777665 554445677777777777
Q ss_pred ecccccccCcccccccCcccCCcc
Q 042075 553 QMQGNFLQGPIPSSLSSLRGLSVL 576 (1033)
Q Consensus 553 ~Ls~N~l~~~~p~~~~~l~~L~~L 576 (1033)
++..+ ++ .+..+|.++++|+.+
T Consensus 372 ~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 372 ELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EECCC-CE-EhhheecCCCCCcEE
Confidence 77654 33 344567777666543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3e-12 Score=143.74 Aligned_cols=107 Identities=21% Similarity=0.229 Sum_probs=57.4
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecC-CCccccCCccccccccccEEecccCCCCCCCC
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHN-NSFHHEIPSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
|.|.+|.|+.. ++|++ +|. +..+++|++|+|++ |.|++..|..|+.|++|++|+|++|+|++..|
T Consensus 8 C~~~~v~~~~~------------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 8 HGSSGLRCTRD------------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp SSSSCEECCSS------------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred ccCCEEEcCCC------------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 88888877532 13442 455 66666666666664 66665555555556666666666655555555
Q ss_pred ccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccccc
Q 042075 150 ANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNL 192 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 192 (1033)
..|++|++|++|+|++|+|++..+..|..++ |++|+|++|.+
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~ 115 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCc
Confidence 5555555555555555555533333333332 44444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=5.3e-12 Score=141.71 Aligned_cols=103 Identities=20% Similarity=0.221 Sum_probs=74.7
Q ss_pred EEecccC-CCCCCCCccccCCCCCcEEEccc-ccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEccc
Q 042075 136 VLALHNN-SIGGEIPANISSCSNLIRVRLSS-NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSR 213 (1033)
Q Consensus 136 ~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 213 (1033)
.++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577777 777 5777 77777788888875 777766667777777777777777777777777777777777777777
Q ss_pred CcCCCcCCccccccCCCCcccccccccC
Q 042075 214 NNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
|+|++..+..|..++ |++|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777765555565554 777777777665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=132.86 Aligned_cols=148 Identities=15% Similarity=0.079 Sum_probs=114.1
Q ss_pred HHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeecccccc
Q 042075 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 705 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 783 (1033)
.+....++|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+ .+..+.++++++.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----- 80 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----
Confidence 34556678999999999999999999864 578999998753222335688999999998 4677888888843
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC--------------------
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC-------------------- 843 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------- 843 (1033)
..+..|+||||++|.++.+.... ..+...++.+++++++.||+..
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred cCCceEEEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 34578999999999999876411 1123478899999999999810
Q ss_pred ------------------------------------CCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 844 ------------------------------------QPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 844 ------------------------------------~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1469999999999999876666799998775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.5e-13 Score=151.88 Aligned_cols=73 Identities=19% Similarity=0.189 Sum_probs=40.1
Q ss_pred ccccccceEEccccccccc----cCcccccccccceeecccccccCc----ccccccCcccCCccccccccccccCCccc
Q 042075 520 GNLKNLEMLNVFENKLRGE----IPRTLGSCIKLELLQMQGNFLQGP----IPSSLSSLRGLSVLDLSQNNLSGKIPEFL 591 (1033)
Q Consensus 520 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 591 (1033)
...++|++|||++|+|+.. ++..+...++|++|+|++|.|+.. ++..+...++|++|||++|.|+..-...+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3445566666666666532 234445555666666666666532 23334445666666666666664444333
Q ss_pred c
Q 042075 592 V 592 (1033)
Q Consensus 592 ~ 592 (1033)
.
T Consensus 260 ~ 260 (372)
T 3un9_A 260 R 260 (372)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-13 Score=152.74 Aligned_cols=160 Identities=18% Similarity=0.154 Sum_probs=110.6
Q ss_pred CCCCcEEEccccccccccCcccccc------eeceeeccccccCCCCCCcc-CCCCcccEEecCCCccCCCCCccccCch
Q 042075 426 LQNLRELRLQENRFLGNIPPSIGNL------KLFNLQLSYNFLQGSIPSSL-GQSETLTIIDLSNNNLTGTIPPQLLGLS 498 (1033)
Q Consensus 426 l~~L~~L~L~~N~l~~~~p~~~~~l------~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 498 (1033)
+++|+.|+|++|.++......+... .|++|+|++|.++......+ ..+++|+.|+|++|+|+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~----------- 139 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG----------- 139 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC-----------
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC-----------
Confidence 4678899999999875444433322 26666666666643222222 22445666666666554
Q ss_pred hHHhhhhccCccccCCcCCcc-----ccccccceEEcccccccc----ccCcccccccccceeecccccccCc----ccc
Q 042075 499 SLLIVLELSRNQLTGPIPNEV-----GNLKNLEMLNVFENKLRG----EIPRTLGSCIKLELLQMQGNFLQGP----IPS 565 (1033)
Q Consensus 499 ~ll~~L~ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 565 (1033)
......+ ...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++.
T Consensus 140 --------------~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 140 --------------PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp --------------HHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred --------------HHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 2111111 134679999999999974 2455567889999999999999853 366
Q ss_pred cccCcccCCcccccccccccc----CCcccccccccceeecCCCcCccc
Q 042075 566 SLSSLRGLSVLDLSQNNLSGK----IPEFLVGFQLLEYLNLSNNDFEGM 610 (1033)
Q Consensus 566 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~ 610 (1033)
.+...++|+.|||++|.|+.. ++..+...+.|++|+|++|+|+..
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 778889999999999999863 445556679999999999998753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-09 Score=124.62 Aligned_cols=109 Identities=12% Similarity=0.159 Sum_probs=63.0
Q ss_pred ccccccc-cccEEecccCCCCCCCCccccCCCCCcEEEccccc---ccCCCCCCcccccccceeeecccccCCCCCCCCC
Q 042075 126 SEFDRLR-RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE---LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG 201 (1033)
Q Consensus 126 ~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 201 (1033)
.+|.++. .|+.+.+..+ ++..-..+|.++++|+.+.++.|. ++..-..+|.++.+|+.+.+..+ ++......|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3455553 4666666543 553445566777777777776653 43223456666677776666544 3434445666
Q ss_pred CCCCCcEEEcccCcCCCcCCccccccCCCCcccccc
Q 042075 202 NLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQ 237 (1033)
Q Consensus 202 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 237 (1033)
++.+|+.+.+..+. .......|..+.+|+.+.+..
T Consensus 135 ~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~ 169 (394)
T 4gt6_A 135 HCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPD 169 (394)
T ss_dssp TCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCT
T ss_pred hhccccccccccee-eeecccceecccccccccccc
Confidence 77777777775433 324455666666666666544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.1e-09 Score=121.21 Aligned_cols=157 Identities=9% Similarity=0.108 Sum_probs=110.8
Q ss_pred cccCCCC-CCCEEEecCCCccccCCccccccccccEEecccCC---CCCCCCccccCCCCCcEEEcccccccCCCCCCcc
Q 042075 102 AHVGNLS-FLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNS---IGGEIPANISSCSNLIRVRLSSNELVGKIPSELG 177 (1033)
Q Consensus 102 ~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 177 (1033)
.+|.+.. .|+.+.+.++ ++..-..+|.++++|+.+.++.|. ++..-...|.++.+|+.+.+..+ ++..-...|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3566663 5899998754 665556789999999999998874 55444667888999998888755 5434456788
Q ss_pred cccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEE
Q 042075 178 SLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVF 257 (1033)
Q Consensus 178 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 257 (1033)
.+.+|+.+.+..+ +..+....|.++.+|+.+.+.++ ++.....+|.. .+|+.+.+..+-.. .-...+.++.+++..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 9999999999755 44366678889999999999866 44355556654 57888877654332 444566666777666
Q ss_pred eccCccc
Q 042075 258 DAGINQI 264 (1033)
Q Consensus 258 ~ls~N~l 264 (1033)
....+..
T Consensus 211 ~~~~~~~ 217 (394)
T 4gt6_A 211 TSDSESY 217 (394)
T ss_dssp EECCSSS
T ss_pred ccccccc
Confidence 6554443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.6e-10 Score=122.13 Aligned_cols=141 Identities=16% Similarity=0.090 Sum_probs=99.2
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC--ceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~ 785 (1033)
....+|.+....+.|..+.||++... +|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++. ..+
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~ 87 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEA 87 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECS
T ss_pred HhcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCC
Confidence 33445555444446667999999764 5677999997643 2356788999999985444 55677763 334
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC---------------------- 843 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------- 843 (1033)
+..++||||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME 149 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred CCCEEEEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 5689999999998884 211 01 1256777778888888641
Q ss_pred ---------------------------------CCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 844 ---------------------------------QPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 844 ---------------------------------~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
.++++|+|++|.||++++++.+.|+|||.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.91 E-value=3.5e-12 Score=134.71 Aligned_cols=179 Identities=15% Similarity=0.186 Sum_probs=84.6
Q ss_pred cCCChhhHHHHHHHHHhcccCCCCCCCCCCC--------------CCCCcceeeeEecCCCCCeEEEEEcCC---CCCCc
Q 042075 36 VAGNETDRLALLEFKSKITHDPLGVFGSWNE--------------SIHFCQWHGVTCSRRQHQRVTILDLKS---LKLAG 98 (1033)
Q Consensus 36 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~--------------~~~~c~w~gv~C~~~~~~~v~~l~l~~---~~l~g 98 (1033)
..+..-|++-|+.+-+.....|- ....|.. +...|+|.|+.|+.. ..+|+.+...+ ..+.|
T Consensus 30 ~~g~ky~k~~ll~~i~~~~~~~f-~p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~-~~ki~~~v~~~~~~~~~~~ 107 (267)
T 3rw6_A 30 PYGRKYDKAWLLSMIQSKCSVPF-TPIEFHYENTRAQFFVEDASTASALKAVNYKILDRE-NRRISIIINSSAPPHTILN 107 (267)
T ss_dssp TTGGGSCHHHHHHHHHHTCSSCC-CCEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTT-SCBCCCEEEECCCCHHHHT
T ss_pred cCccccCHHHHHHHHHHhCCCCc-EeEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCC-CCEEEEEEecCCCcccccc
Confidence 33556677777777666532221 1123321 112389999999875 45676655544 22333
Q ss_pred cccc-ccCCCCCCCEEEecCCCccccCC-ccccccccccE--EecccCCCCCCCCc----cccCCCCCcEEEcccccccC
Q 042075 99 YISA-HVGNLSFLKVLDLHNNSFHHEIP-SEFDRLRRLQV--LALHNNSIGGEIPA----NISSCSNLIRVRLSSNELVG 170 (1033)
Q Consensus 99 ~~~~-~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~--L~Ls~n~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~ 170 (1033)
.+.+ .+..++. .|....|.-++.++ +.|...+.|+. ++++.|... .++. ...++++|++|+|++|+|++
T Consensus 108 ~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~ 184 (267)
T 3rw6_A 108 ELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYR 184 (267)
T ss_dssp SCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCC
T ss_pred cCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCC
Confidence 3321 1111111 11111222222111 11333444444 555555432 2222 11345666666666666665
Q ss_pred --CCCCCcccccccceeeecccccCCCCCCCCCCCC--CCcEEEcccCcCCCcCC
Q 042075 171 --KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLS--SISFLFLSRNNLDGSIP 221 (1033)
Q Consensus 171 --~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p 221 (1033)
.+|..+..+++|++|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 185 l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 185 LDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3344555566666666666666543 1122222 55666666666554444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-10 Score=129.66 Aligned_cols=156 Identities=13% Similarity=0.184 Sum_probs=86.3
Q ss_pred CCeEEEEEcCCCCCCc-c-------cccccCCCCCCCEEEecCCCcc---------ccCCccccccccccEEecccCCCC
Q 042075 83 HQRVTILDLKSLKLAG-Y-------ISAHVGNLSFLKVLDLHNNSFH---------HEIPSEFDRLRRLQVLALHNNSIG 145 (1033)
Q Consensus 83 ~~~v~~l~l~~~~l~g-~-------~~~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~ 145 (1033)
..+|+.|.+..+...| . +..++..+++|+.|.+.++... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3467788877666553 2 2344567788999988765431 234455566788888888877311
Q ss_pred CCCCccccCCCCCcEEEcccccccCCCCCCcc--cccccceeeecc--cccCCCC-----CCCC--CCCCCCcEEEcccC
Q 042075 146 GEIPANISSCSNLIRVRLSSNELVGKIPSELG--SLSKIEYFSVSY--NNLTGSI-----PPSF--GNLSSISFLFLSRN 214 (1033)
Q Consensus 146 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~~-----p~~~--~~l~~L~~L~L~~N 214 (1033)
.+|. + .+++|++|+|..|.+....-..+. .+++|++|+|+. |...+.. ...+ ..+++|++|+|++|
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 2333 3 377888888887776533222333 577788887753 2221110 0111 23556666666666
Q ss_pred cCCCcCCcccc---ccCCCCcccccccccC
Q 042075 215 NLDGSIPDTFG---WLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 215 ~l~~~~p~~~~---~l~~L~~L~L~~N~l~ 241 (1033)
.+....+..+. .+++|++|+|+.|.++
T Consensus 263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 263 EEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp TTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred CCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 65532222222 2445555555555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=9.7e-10 Score=120.59 Aligned_cols=190 Identities=18% Similarity=0.148 Sum_probs=122.4
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCC--ceeEeeeeccccccCCCceeEEE
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRN--LVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
.+.++.|....||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++..+.. ...-...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4679999999999864 34889986532 3456788999999888 3332 4445444211 11112458999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD------------------------------ 842 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------ 842 (1033)
||++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988865331 2366777788888888888888861
Q ss_pred -------------------------CCCCcEeccCCCCCeEecC--CCcEEEeecccceecCCCCcccccccc---ccc-
Q 042075 843 -------------------------CQPPIVHCDLKPSNVLLDE--EMIAHVGDFGLATFLPLSHAQTSSIFA---KGS- 891 (1033)
Q Consensus 843 -------------------------~~~~ivHrDlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~---~gt- 891 (1033)
..+.++|+|++|.||++++ +..+.|+||+.+............... .+.
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 1246899999999999998 456889999998764322111000000 000
Q ss_pred ------ccc--cc-ccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 042075 892 ------IGY--IA-PEYGLGSEVSINGDVYSYGILLLELVTRKKPT 928 (1033)
Q Consensus 892 ------~~y--~a-PE~~~~~~~~~~sDvwSlG~vl~elltg~~p~ 928 (1033)
..| .. |+... ......+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 11 22111 1122358999999999999998875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.2e-09 Score=117.12 Aligned_cols=145 Identities=15% Similarity=0.164 Sum_probs=106.4
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEee--ccC-chhHHHHHHHHHHHHhcC--CCCceeEeeeeccccccCCCcee
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLH-HGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
..+.++.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+.. ..+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 4678999999999999875 4578888765 322 122356788999999996 456788888864321 224578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC-------------------------- 843 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------- 843 (1033)
+||||++|..+.+.. ...++..++..++.+++++|..||+..
T Consensus 118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 999999997775422 123677888899999999999999731
Q ss_pred -----------------------------CCCcEeccCCCCCeEecCCCc--EEEeeccccee
Q 042075 844 -----------------------------QPPIVHCDLKPSNVLLDEEMI--AHVGDFGLATF 875 (1033)
Q Consensus 844 -----------------------------~~~ivHrDlkp~NIll~~~~~--~kL~DfG~a~~ 875 (1033)
.+.++|||++|.||++++++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.75 E-value=7.9e-10 Score=123.28 Aligned_cols=205 Identities=12% Similarity=0.145 Sum_probs=103.0
Q ss_pred CCCCCEEEecCCCccc-c-------CCccccccccccEEecccCCCC---------CCCCccccCCCCCcEEEccccccc
Q 042075 107 LSFLKVLDLHNNSFHH-E-------IPSEFDRLRRLQVLALHNNSIG---------GEIPANISSCSNLIRVRLSSNELV 169 (1033)
Q Consensus 107 l~~L~~L~L~~n~l~~-~-------~p~~~~~l~~L~~L~Ls~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~ 169 (1033)
++.++.|.+....+.| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3456777777665553 2 1334566788888888765431 122233345566666666655211
Q ss_pred CCCCCCcccccccceeeecccccCCCCCCCCC--CCCCCcEEEccc--CcCCCcCCccccccCCCCcccccccccCCCCc
Q 042075 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFG--NLSSISFLFLSR--NNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245 (1033)
Q Consensus 170 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 245 (1033)
.++. + .+++|++|+|..|.++......+. .+++|++|+|+. |...+.. . +. .+.
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~----------------~~-~l~ 243 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--D----------------MN-VFR 243 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--C----------------GG-GTG
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--h----------------HH-HHH
Confidence 1222 2 245555555555554322111121 345555555532 1111100 0 00 000
Q ss_pred ccc--cCCCceeEEeccCccccCccCcccc--ccccccceeeecccccCCC----CCccCcCCCCccccccccccccCcC
Q 042075 246 SSI--FNISSITVFDAGINQIQGVIPLDIG--FTLQNLQFFSVGRNQLTGA----IPPAISNASNLEVFQVNSNKLTGEV 317 (1033)
Q Consensus 246 ~~l--~~l~~L~~L~ls~N~l~~~~p~~~~--~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 317 (1033)
..+ ..+++|++|+|++|.+....+..++ ..+++|++|+|+.|.|++. ++..+.++++|+.|++++|.++...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 111 1345666666666666533322222 1366788888888877653 3334456788888888888876432
Q ss_pred cchhhhcc--ccceeeecCc
Q 042075 318 PYLEKLQR--LSHFVITRNS 335 (1033)
Q Consensus 318 ~~l~~l~~--L~~L~l~~N~ 335 (1033)
...+.. ...++++.+.
T Consensus 324 --~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 324 --KKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp --HHHHHHHCCSEEECCSBC
T ss_pred --HHHHHHHcCCEEEecCCc
Confidence 222222 2557777776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.63 E-value=5.5e-07 Score=101.95 Aligned_cols=76 Identities=14% Similarity=0.175 Sum_probs=42.0
Q ss_pred CccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccc
Q 042075 517 NEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGF 594 (1033)
Q Consensus 517 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 594 (1033)
..|.++.+|+.+++.++.++..-..+|.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.+.
T Consensus 280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 34555666666666666665444456666666666666543 44334456666666666666544 442223444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.1e-06 Score=99.30 Aligned_cols=196 Identities=11% Similarity=-0.003 Sum_probs=89.9
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
..-.+|+.+.+.. .++..-..+|.++++|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++..-..+|.. .+|+.
T Consensus 43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~ 117 (379)
T 4h09_A 43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDD 117 (379)
T ss_dssp GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSE
T ss_pred ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCccc
Confidence 3344455555542 344233345566666666666433 442333444444 4555555432 33122223333 35666
Q ss_pred eeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCC------------CCcccccCCC
Q 042075 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSG------------TIPSSIFNIS 252 (1033)
Q Consensus 185 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~------------~~p~~l~~l~ 252 (1033)
+.+..+ ++......|.+. +|+.+.+..+ ++......|....+++.+.+..+.... .....+....
T Consensus 118 i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (379)
T 4h09_A 118 FEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK 194 (379)
T ss_dssp EECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC
T ss_pred ccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccc
Confidence 655543 221223334332 3444444432 232344455555555555444332210 1122233344
Q ss_pred ceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccc
Q 042075 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN 311 (1033)
Q Consensus 253 ~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 311 (1033)
++..+.+..+.- .+....+....+|+.+.+..+ ++......+.++.+|+.+.+..+
T Consensus 195 ~~~~~~~~~~~~--~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~ 250 (379)
T 4h09_A 195 TGTEFTIPSTVK--TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN 250 (379)
T ss_dssp CCSEEECCTTCC--EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT
T ss_pred ccccccccccee--EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC
Confidence 444444433221 233344445667777776544 34345566777777877777554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=1.4e-08 Score=107.22 Aligned_cols=79 Identities=25% Similarity=0.363 Sum_probs=48.6
Q ss_pred cccccceEEcccccccc--ccCcccccccccceeecccccccCcccccccCcc--cCCccccccccccccCCc-------
Q 042075 521 NLKNLEMLNVFENKLRG--EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLR--GLSVLDLSQNNLSGKIPE------- 589 (1033)
Q Consensus 521 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------- 589 (1033)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45667777777777775 3445566677777777777777643 3344444 666667777766665552
Q ss_pred ccccccccceee
Q 042075 590 FLVGFQLLEYLN 601 (1033)
Q Consensus 590 ~~~~l~~L~~L~ 601 (1033)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245566666554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=9.2e-09 Score=103.47 Aligned_cols=70 Identities=10% Similarity=0.096 Sum_probs=42.5
Q ss_pred cccccCCCCCCCEEEecCC-Ccccc----CCccccccccccEEecccCCCCCC----CCccccCCCCCcEEEccccccc
Q 042075 100 ISAHVGNLSFLKVLDLHNN-SFHHE----IPSEFDRLRRLQVLALHNNSIGGE----IPANISSCSNLIRVRLSSNELV 169 (1033)
Q Consensus 100 ~~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 169 (1033)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 4445666777888888887 77542 334455566777777777777532 2223334456666666666665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.8e-06 Score=92.54 Aligned_cols=145 Identities=17% Similarity=0.077 Sum_probs=100.9
Q ss_pred HhhCCCCccceecccCce-eEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFG-SVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 785 (1033)
....+|+. +.+..|..+ .||+.....++..+++|+... .....+.+|...++.+. +--+.++++++. .+
T Consensus 22 ~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~ 92 (272)
T 4gkh_A 22 ADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TP 92 (272)
T ss_dssp HHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred ccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----EC
Confidence 33445543 345556655 699988877778899998653 23466888999999883 334677777753 33
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC-----------------------
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD----------------------- 842 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------- 842 (1033)
+..++|||+++|.++.+.... ...+...++.++++.+..||+.
T Consensus 93 ~~~~lvme~l~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 93 DDAWLLTTAIPGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp TEEEEEEECCCSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred CeEEEEEEeeCCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 578999999999888776521 1122334666667777777742
Q ss_pred --------------------------------CCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 843 --------------------------------CQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 843 --------------------------------~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999887778999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.1e-06 Score=92.42 Aligned_cols=137 Identities=15% Similarity=0.101 Sum_probs=93.0
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCC---CceeEeeeeccccccCCCceeEEE
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHR---NLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
.+.++.|....||+. +..+++|+.+ .......+.+|+++++.+.+. .+.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 457888999999998 3457888853 223456789999999999642 3556666542 2345678999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD------------------------------ 842 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------ 842 (1033)
||++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 9999988876321 1123344444555555555555532
Q ss_pred ---------------------------CCCCcEeccCCCCCeEecC---CCc-EEEeeccccee
Q 042075 843 ---------------------------CQPPIVHCDLKPSNVLLDE---EMI-AHVGDFGLATF 875 (1033)
Q Consensus 843 ---------------------------~~~~ivHrDlkp~NIll~~---~~~-~kL~DfG~a~~ 875 (1033)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 58999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.21 E-value=5e-08 Score=98.03 Aligned_cols=94 Identities=13% Similarity=0.136 Sum_probs=55.3
Q ss_pred CCccccccccccEEecccC-CCCCC----CCccccCCCCCcEEEcccccccCC----CCCCcccccccceeeecccccCC
Q 042075 124 IPSEFDRLRRLQVLALHNN-SIGGE----IPANISSCSNLIRVRLSSNELVGK----IPSELGSLSKIEYFSVSYNNLTG 194 (1033)
Q Consensus 124 ~p~~~~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 194 (1033)
+...+...+.|++|+|++| .|+.. +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445666788888888888 77632 334455667788888888877532 22333444566666666666653
Q ss_pred C----CCCCCCCCCCCcEEEc--ccCcCC
Q 042075 195 S----IPPSFGNLSSISFLFL--SRNNLD 217 (1033)
Q Consensus 195 ~----~p~~~~~l~~L~~L~L--~~N~l~ 217 (1033)
. +...+...++|++|+| ++|.|.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2 2233444445555555 455554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.1e-05 Score=90.16 Aligned_cols=85 Identities=4% Similarity=-0.069 Sum_probs=56.6
Q ss_pred ccee-cccCceeEEEEEeC---C---CCeEEEEEEeeccC---chhHHHHHHHHHHHHhcC-C--CCceeEeeeeccccc
Q 042075 716 ANLI-GAGSFGSVYKGILD---E---GKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDY 782 (1033)
Q Consensus 716 ~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 782 (1033)
.+.| +.|....+|+.... + +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+..
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 3567 88999999998753 1 15678899865422 101245778999998883 3 35777887753221
Q ss_pred cCCCceeEEEEcccCCchhh
Q 042075 783 QGNDFKALVFEFMHNRSLEE 802 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~ 802 (1033)
..+..++||||++|.++.+
T Consensus 104 -~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp -TTSSCEEEEECCCCBCCCB
T ss_pred -ccCCceEEEEecCCCChhh
Confidence 1135689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.7e-05 Score=88.47 Aligned_cols=76 Identities=13% Similarity=0.106 Sum_probs=49.8
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCc-------hhHHHHHHHHHHHHhcCC--C-CceeEeeeeccccccCC
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-------GAFKSFIAECNTLKNIRH--R-NLVKILTACSGVDYQGN 785 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~ 785 (1033)
.+.+|.|..+.||++....+++.|+||....... ...+++..|.++++.+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 5689999999999998765677899998653211 123567789999988742 3 344555441 2
Q ss_pred CceeEEEEcccCC
Q 042075 786 DFKALVFEFMHNR 798 (1033)
Q Consensus 786 ~~~~lv~e~~~~g 798 (1033)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2457999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=8.8e-05 Score=82.27 Aligned_cols=152 Identities=18% Similarity=0.140 Sum_probs=81.6
Q ss_pred ceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC--CCceeEeeeecccc-ccCCCceeEEEE
Q 042075 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVD-YQGNDFKALVFE 793 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~~~~lv~e 793 (1033)
+.|+.|..+.||++... ++ .+++|+.... ..++..|+.+++.+.. -.+.+++....+.. ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET-TE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC-CC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778999999875 33 4889988642 2344456666666631 13444443211100 112446789999
Q ss_pred cccCCchh--------------hhcccCCCCcc-ccc---cccccCHHH-------------------------------
Q 042075 794 FMHNRSLE--------------EWLHPITREDE-TEE---APRSLNLLQ------------------------------- 824 (1033)
Q Consensus 794 ~~~~gsL~--------------~~l~~~~~~~~-~~~---~~~~l~~~~------------------------------- 824 (1033)
|++|.++. ..++....... ... ....-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986543 01111110000 000 000112211
Q ss_pred HHHHHHHHHHHHHHHHh----------CCCCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 825 RLDIGIDVACALSYLHH----------DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 825 ~~~i~~qi~~~L~~LH~----------~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
...+..++.+++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112234456677763 124589999999999999888889999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00018 Score=77.56 Aligned_cols=77 Identities=17% Similarity=0.074 Sum_probs=56.1
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-C--CCceeEeeeeccccccCCCcee
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
...++.+|.|..+.||+.+.. +|+.|++|+...........+..|+..|+.+. . -.+++++++. ..+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 344678999999999999986 67889999876444444456889999999883 2 2355555541 347
Q ss_pred EEEEcccCCc
Q 042075 790 LVFEFMHNRS 799 (1033)
Q Consensus 790 lv~e~~~~gs 799 (1033)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 9999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00027 Score=76.71 Aligned_cols=145 Identities=16% Similarity=0.130 Sum_probs=90.3
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC---CCCceeEeeeeccccccCCCceeEEE
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
.+.|+.|....+|+... ++..+++|+.... ....+..|++.|+.+. ...+++++.++. ..+..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence 46799999999999986 3567889987642 3467889999998883 356788887743 235789999
Q ss_pred EcccCCchhh-----------hcccCCC-Ccccc-----------ccccccCHHHHH---HHHH----------------
Q 042075 793 EFMHNRSLEE-----------WLHPITR-EDETE-----------EAPRSLNLLQRL---DIGI---------------- 830 (1033)
Q Consensus 793 e~~~~gsL~~-----------~l~~~~~-~~~~~-----------~~~~~l~~~~~~---~i~~---------------- 830 (1033)
||+++..+.. .++.... ..... .....-+|.+.. ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876521 1222211 00000 001112444322 1111
Q ss_pred HHHHH-HHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 831 DVACA-LSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 831 qi~~~-L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
++++. .+.|.. ...|.++|+|+.+.|++++.++ +.|+|++
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223321 2357899999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00069 Score=74.22 Aligned_cols=172 Identities=15% Similarity=0.103 Sum_probs=92.6
Q ss_pred CCCCHHHHHHhhCCCCc-----cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC--ce
Q 042075 699 PNISYQNLYNATDGFTS-----ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LV 771 (1033)
Q Consensus 699 ~~~~~~~l~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 771 (1033)
+.++.+++......|.+ .+.|+.|....+|+.... ++ .+++|+.... ...+.+..|+.+++.+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 45666777777777765 245677888999999875 33 5789988652 12245667888888773222 34
Q ss_pred eEeeeecccc-ccCCCceeEEEEcccCCchhh--------------hcccCCCCccccc--cccccCHHHHHH-------
Q 042075 772 KILTACSGVD-YQGNDFKALVFEFMHNRSLEE--------------WLHPITREDETEE--APRSLNLLQRLD------- 827 (1033)
Q Consensus 772 ~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~~~~~--~~~~l~~~~~~~------- 827 (1033)
+++....+.. ....+..+++|+|++|..+.. .++.......... ......|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 4443211100 011245689999999865421 0111100000000 000011221100
Q ss_pred -----HHHHHHHHHHHHHhC----CCCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 828 -----IGIDVACALSYLHHD----CQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 828 -----i~~qi~~~L~~LH~~----~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
+...+.+.++++++. ..++++|+|+.+.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 13479999999999999887666899998776
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.40 E-value=4.7e-05 Score=74.26 Aligned_cols=84 Identities=14% Similarity=0.139 Sum_probs=53.3
Q ss_pred cccceEEccccccccccCcccccccccceeeccccc-ccCcccccccCc----ccCCcccccccc-ccccCCcccccccc
Q 042075 523 KNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNF-LQGPIPSSLSSL----RGLSVLDLSQNN-LSGKIPEFLVGFQL 596 (1033)
Q Consensus 523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 596 (1033)
.+|+.||++++.++..--..+.++++|+.|+|+++. ++..--..++.+ ++|+.|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777665444556677777777777764 654433444543 367777777764 66544445666777
Q ss_pred cceeecCCCc
Q 042075 597 LEYLNLSNND 606 (1033)
Q Consensus 597 L~~L~ls~N~ 606 (1033)
|++|+|++.+
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.39 E-value=1.9e-05 Score=77.09 Aligned_cols=82 Identities=13% Similarity=0.169 Sum_probs=38.3
Q ss_pred cccEEecccCCCCCCCCccccCCCCCcEEEccccc-ccCCCCCCcccc----cccceeeecccc-cCCCCCCCCCCCCCC
Q 042075 133 RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE-LVGKIPSELGSL----SKIEYFSVSYNN-LTGSIPPSFGNLSSI 206 (1033)
Q Consensus 133 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 206 (1033)
+|++|||+++.|+..--..+.++++|++|+|++|. ++..--..++.+ ++|++|+|++|. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555565555554333445556666666666653 432111122222 245555555542 442211223444555
Q ss_pred cEEEcccC
Q 042075 207 SFLFLSRN 214 (1033)
Q Consensus 207 ~~L~L~~N 214 (1033)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00066 Score=77.48 Aligned_cols=80 Identities=11% Similarity=0.167 Sum_probs=50.2
Q ss_pred CCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCC---CCCcccchHHHHHHHHH
Q 042075 844 QPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLE 920 (1033)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~vl~e 920 (1033)
.+.++|||++|.||++++++ ++++||+.+..-....... .....-...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998776 9999999987532111100 0000012346677654321 11233566688888888
Q ss_pred HHhCC
Q 042075 921 LVTRK 925 (1033)
Q Consensus 921 lltg~ 925 (1033)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0013 Score=71.38 Aligned_cols=75 Identities=8% Similarity=0.068 Sum_probs=46.4
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCceeEE
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+.-.+.|+.|....+|++ +.+++|+....... .....+|+.+++.+. +.-..++++++ .+.-++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v 85 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMV 85 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEE
Confidence 333788999999999999 34889987643221 122356888888773 22224565542 1234689
Q ss_pred EEcc-cCCchh
Q 042075 792 FEFM-HNRSLE 801 (1033)
Q Consensus 792 ~e~~-~~gsL~ 801 (1033)
+||+ +|.++.
T Consensus 86 ~e~i~~g~~l~ 96 (301)
T 3dxq_A 86 TRYIAGAQTMS 96 (301)
T ss_dssp EECCTTCEECC
T ss_pred EeecCCCccCC
Confidence 9999 665553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0028 Score=72.58 Aligned_cols=76 Identities=16% Similarity=0.117 Sum_probs=49.5
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCc-eeEeeeeccccccCCCceeEEEEc
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
.+.|+.|-...+|++...+++..|++|+......... ...+|..+++.+...++ .++++++ . + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 4678889999999999864457899998754322211 22579999998854443 5666653 1 1 259999
Q ss_pred ccCCchh
Q 042075 795 MHNRSLE 801 (1033)
Q Consensus 795 ~~~gsL~ 801 (1033)
++|.++.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9886553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0012 Score=73.68 Aligned_cols=148 Identities=11% Similarity=0.139 Sum_probs=83.9
Q ss_pred cceecccCceeEEEEEeCC-------CCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCc
Q 042075 716 ANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+.+..|....+|++.... +++.|++|+..... .......+|.++++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP-----E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C---
Confidence 4578888899999998742 34789999864322 23455678999998883 333466666632 1
Q ss_pred eeEEEEcccCCchhhh-cc-------------cCCCCcccccccccc--CHHHHHHHHHHHHH-----------------
Q 042075 788 KALVFEFMHNRSLEEW-LH-------------PITREDETEEAPRSL--NLLQRLDIGIDVAC----------------- 834 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~-l~-------------~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~----------------- 834 (1033)
.+||||++|.++..- +. +.-..+. ...+.. -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 289999998665421 00 0000000 011111 23444444443321
Q ss_pred --HHHHHH----hC-CCCCcEeccCCCCCeEecCC----CcEEEeeccccee
Q 042075 835 --ALSYLH----HD-CQPPIVHCDLKPSNVLLDEE----MIAHVGDFGLATF 875 (1033)
Q Consensus 835 --~L~~LH----~~-~~~~ivHrDlkp~NIll~~~----~~~kL~DfG~a~~ 875 (1033)
.++.|. .. ....++|+|+.+.||+++++ +.+.++||..|..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 21 23479999999999999876 7899999988763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0053 Score=67.29 Aligned_cols=171 Identities=15% Similarity=0.126 Sum_probs=92.6
Q ss_pred CCCCCHHHHHHhhCCCCc-----cceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCC--Cc
Q 042075 698 FPNISYQNLYNATDGFTS-----ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHR--NL 770 (1033)
Q Consensus 698 ~~~~~~~~l~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 770 (1033)
+...+.+++....+.|.+ ...++ |....||++... +|+.+++|+.+... .....+..|..+++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 445666666665555533 24566 888899998764 45678999986332 1235667788888887422 24
Q ss_pred eeEeeeecccc-ccCCCceeEEEEcccCCchhh-----------h---cccCCCCccccccccccCHHH-----------
Q 042075 771 VKILTACSGVD-YQGNDFKALVFEFMHNRSLEE-----------W---LHPITREDETEEAPRSLNLLQ----------- 824 (1033)
Q Consensus 771 v~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~~~~~~~~~~l~~~~----------- 824 (1033)
++++.. .+.. ...++..++||||++|..+.. . ++....... .......++..
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQL-FIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSC-CSSSCBCSHHHHTHHHHHHHHT
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCC-CccCCCCCHHHHHhhHHHHHhh
Confidence 444443 1110 112346688999998855421 0 111000000 00001111111
Q ss_pred -----------HHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 825 -----------RLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 825 -----------~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
....+.+++..++.... ...+.++|+|+++.||+++ + .+.++||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222222222211 1234789999999999998 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0019 Score=73.69 Aligned_cols=74 Identities=16% Similarity=0.151 Sum_probs=50.2
Q ss_pred cceecccCceeEEEEEeCC-------CCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCc
Q 042075 716 ANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+.|+.|....||++.... +++.|++|+.... ...+.+.+|..+++.+. +.-..++++.+ . +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~-~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----S-G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T-T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C-C--
Confidence 4678889999999998753 2568999998432 11145567999998884 33335666653 1 1
Q ss_pred eeEEEEcccCCch
Q 042075 788 KALVFEFMHNRSL 800 (1033)
Q Consensus 788 ~~lv~e~~~~gsL 800 (1033)
.+|+||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00058 Score=63.50 Aligned_cols=58 Identities=22% Similarity=0.288 Sum_probs=32.8
Q ss_pred eeeccccccc-CcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCccc
Q 042075 551 LLQMQGNFLQ-GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGM 610 (1033)
Q Consensus 551 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 610 (1033)
.++.+++.|+ ..+|..+. ++|+.|||++|+|+...+..|..+++|++|+|++|++...
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 4455555554 23443322 2466666666666655455566666666777777766553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0023 Score=70.48 Aligned_cols=32 Identities=31% Similarity=0.277 Sum_probs=27.9
Q ss_pred CCCcEeccCCCCCeEecCC----CcEEEeeccccee
Q 042075 844 QPPIVHCDLKPSNVLLDEE----MIAHVGDFGLATF 875 (1033)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~----~~~kL~DfG~a~~ 875 (1033)
.+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3489999999999999874 6899999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.008 Score=66.18 Aligned_cols=31 Identities=23% Similarity=0.319 Sum_probs=27.8
Q ss_pred CCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 845 PPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
+.++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0059 Score=68.17 Aligned_cols=75 Identities=16% Similarity=0.200 Sum_probs=45.4
Q ss_pred cceecccCceeEEEEEeCCC--------CeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC-ceeEeeeeccccccCCC
Q 042075 716 ANLIGAGSFGSVYKGILDEG--------KTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN-LVKILTACSGVDYQGND 786 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~ 786 (1033)
.+.++.|....+|++....+ ++.+++|+....... ......|.++++.+...+ +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--------- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--------- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---------
Confidence 45678888899999987531 267889987543221 122467888888884323 44666542
Q ss_pred ceeEEEEcccCCch
Q 042075 787 FKALVFEFMHNRSL 800 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL 800 (1033)
.-++||||++|.++
T Consensus 108 ~~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 NGGRIEEWLYGDPL 121 (369)
T ss_dssp TTEEEEECCCSEEC
T ss_pred CCcEEEEEecCCcC
Confidence 12689999988654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0033 Score=58.30 Aligned_cols=35 Identities=26% Similarity=0.262 Sum_probs=15.6
Q ss_pred CcEEEcccCcCCCcCCccccccCCCCccccccccc
Q 042075 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240 (1033)
Q Consensus 206 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 240 (1033)
|++|+|++|+|+...++.|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433334444444444444444444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0074 Score=60.11 Aligned_cols=103 Identities=17% Similarity=0.128 Sum_probs=67.8
Q ss_pred CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecC
Q 042075 798 RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877 (1033)
Q Consensus 798 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~ 877 (1033)
-+|.+.|+ ..+.++++.+++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---
Confidence 47899985 3678899999999999999998877221011 1233456889999999888764 1111
Q ss_pred CCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 042075 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927 (1033)
Q Consensus 878 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p 927 (1033)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0233466888753 3456788899999999999975544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.00064 Score=67.56 Aligned_cols=109 Identities=13% Similarity=0.155 Sum_probs=65.4
Q ss_pred CcccEEEccCC-CCCc----cCCccccCCCCCCEEEcccCccccc----CChhhhcCCCCcEEEccccccccccCc----
Q 042075 379 TTLEVLLLDSN-KIFG----NIPAAFGKFVKLLRLEMWNNRLSGT----IPPAIGELQNLRELRLQENRFLGNIPP---- 445 (1033)
Q Consensus 379 ~~L~~L~L~~N-~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 445 (1033)
+.|+.|+|++| +|.. .+.+++..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|....-.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46777777764 6652 2345566667788888888888632 334455667788888888887643322
Q ss_pred ccccc-eeceeecccccc---CC----CCCCccCCCCcccEEecCCCccC
Q 042075 446 SIGNL-KLFNLQLSYNFL---QG----SIPSSLGQSETLTIIDLSNNNLT 487 (1033)
Q Consensus 446 ~~~~l-~L~~L~Ls~N~l---~~----~~p~~~~~l~~L~~L~Ls~N~l~ 487 (1033)
.+..- +|++|+|++|.. .. .+...+..-++|+.|+++.|.+.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 22222 277777765432 21 12234445567888888777653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.12 E-value=0.00031 Score=69.87 Aligned_cols=67 Identities=16% Similarity=0.152 Sum_probs=37.8
Q ss_pred ccCCCCCCCEEEecCC-Cccc----cCCccccccccccEEecccCCCCCCC----CccccCCCCCcEEEccccccc
Q 042075 103 HVGNLSFLKVLDLHNN-SFHH----EIPSEFDRLRRLQVLALHNNSIGGEI----PANISSCSNLIRVRLSSNELV 169 (1033)
Q Consensus 103 ~~~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~~L~~L~Ls~N~l~ 169 (1033)
.+.+-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|...- -..+..-+.|++|+|++|.|.
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3445567777777774 6643 13344555566777777777775321 122223455666666666665
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.036 Score=62.49 Aligned_cols=75 Identities=9% Similarity=0.090 Sum_probs=49.8
Q ss_pred cceecccCceeEEEEEeCCC-------CeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCc
Q 042075 716 ANLIGAGSFGSVYKGILDEG-------KTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++.+..|-...+|+...... ++.|++|+........ -+..+|..+++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~---------~ 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF---------P 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc---------C
Confidence 45788888999999987521 5779999875432222 23367888888883 33345555542 1
Q ss_pred eeEEEEcccCCch
Q 042075 788 KALVFEFMHNRSL 800 (1033)
Q Consensus 788 ~~lv~e~~~~gsL 800 (1033)
-+.||||++|.++
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.62 E-value=0.32 Score=54.58 Aligned_cols=30 Identities=27% Similarity=0.429 Sum_probs=25.2
Q ss_pred CcEeccCCCCCeEe------cCCCcEEEeeccccee
Q 042075 846 PIVHCDLKPSNVLL------DEEMIAHVGDFGLATF 875 (1033)
Q Consensus 846 ~ivHrDlkp~NIll------~~~~~~kL~DfG~a~~ 875 (1033)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566899999998863
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.84 E-value=0.12 Score=36.57 Aligned_cols=32 Identities=22% Similarity=0.242 Sum_probs=20.6
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhheeeeccccC
Q 042075 657 LKLALAIISGLIGLSLALSFLIICLVRKRKEN 688 (1033)
Q Consensus 657 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (1033)
..++.++++|++++++++..++++++||++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34677778777777776666566665555443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.31 E-value=0.11 Score=36.87 Aligned_cols=31 Identities=13% Similarity=0.126 Sum_probs=20.3
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhheeeecccc
Q 042075 657 LKLALAIISGLIGLSLALSFLIICLVRKRKE 687 (1033)
Q Consensus 657 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 687 (1033)
..++.++++|+++++++++.++++++||+++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3467778887777777666666666655543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=81.67 E-value=1 Score=31.86 Aligned_cols=24 Identities=13% Similarity=0.228 Sum_probs=9.6
Q ss_pred HHHHHHHHHHHHHHHhhheeeecc
Q 042075 662 AIISGLIGLSLALSFLIICLVRKR 685 (1033)
Q Consensus 662 ~i~~~~~~~~~~~~~~~~~~~~~~ 685 (1033)
+.++|++.++++.+.++++++||+
T Consensus 16 ~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 16 SAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhheehhh
Confidence 333444433333333344444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.49 E-value=2.7 Score=41.86 Aligned_cols=89 Identities=17% Similarity=0.209 Sum_probs=64.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCcccccccccccccccc
Q 042075 817 PRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896 (1033)
Q Consensus 817 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 896 (1033)
-...+..++++++..|+...++++.. +|--+.|+||+++.++.+++.-.|+-..+ +
T Consensus 75 ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~ 130 (215)
T 4ann_A 75 IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------D 130 (215)
T ss_dssp GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTB-------------------S
T ss_pred HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCC-------------------C
Confidence 34578899999999999988777654 78899999999999999999877654322 2
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 897 PE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
|. ..+...=.-.+=|++..+++++..|+.-..+
T Consensus 131 P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 131 PL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 21 1112222345667889999999988654443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1033 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-32 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-09 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 53/306 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 774
IG+GSFG+VYKG VAVK+ N+ ++F E L+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ A+V ++ SL LH +++ +DI A
Sbjct: 71 GYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQ 115
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
+ YLH I+H DLK +N+ L E++ +GDFGLAT GSI +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 895 IAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951
+APE + S DVY++GI+L EL+T + P ++ D ++
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQII 219
Query: 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011
+V LS D + C AM R+ C + ++R ++
Sbjct: 220 FMVGRGYLSPDLS--------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 1012 QLQSIK 1017
++ +
Sbjct: 266 SIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-49
Identities = 60/313 (19%), Positives = 114/313 (36%), Gaps = 39/313 (12%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 778
IG G FG V++G VAVK+F+ ++ AE +RH N++ + A +
Sbjct: 11 IGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67
Query: 779 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSY 838
+ LV ++ + SL ++L+ ++ + + + + A L++
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAH 115
Query: 839 LHHDC-----QPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP--LSHAQTSSIFAKGS 891
LH + +P I H DLK N+L+ + + D GLA + G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 892 IGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945
Y+APE S + D+Y+ G++ E+ R I + + ++ +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS- 234
Query: 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD 1005
+ + + R E L MA+I C + R+
Sbjct: 235 ----------DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 1006 MTNVVHQLQSIKN 1018
+ L +
Sbjct: 285 ALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-48
Identities = 62/313 (19%), Positives = 109/313 (34%), Gaps = 33/313 (10%)
Query: 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRH 767
D F + +GAG+ G V+K ++A K+ +L + I E L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+V A + ++ E M SL++ L R E
Sbjct: 64 PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----------LGK 108
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ I V L+YL I+H D+KPSN+L++ + DFG++ L S A +
Sbjct: 109 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--- 163
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947
G+ Y++PE G+ S+ D++S G+ L+E+ + P ++ L +
Sbjct: 164 -VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSME--------- 998
T + + I S+E
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 999 --SPEDRMDMTNV 1009
+P +R D+ +
Sbjct: 283 IKNPAERADLKQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 7e-47
Identities = 64/331 (19%), Positives = 127/331 (38%), Gaps = 64/331 (19%)
Query: 702 SYQNLYNATDGFTSA---------NLIGAGSFGSVYKGIL---DEGKTIVAVKVFNL-LH 748
++++ A F +IGAG FG V G L + + VA+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 749 HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 808
+ F++E + + H N++ + + ++ EFM N SL+ +L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLR--- 119
Query: 809 REDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868
+ ++Q + + +A + YL VH DL N+L++ ++ V
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170
Query: 869 DFGLATFLPLSHAQ---TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 925
DFGL+ FL + TS++ K I + APE + + DV+SYGI++ E+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 926 KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 985
+ + V++ ++ R+ ++C
Sbjct: 231 ER---PYWDMT----------NQDVINAIEQDY------------------RLPPPMDCP 259
Query: 986 VAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
A+ ++ + C + R +V+ L +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-47
Identities = 66/300 (22%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+GAG FG V+ G + T VAVK + +F+AE N +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + ++ E+M N SL ++L + L + + LD+ +A +
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+++ +H DL+ +N+L+ + + + DFGLA + + AK I + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDS 956
PE +I DV+S+GILL E+VT + + P+ + ++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVIQNLERG 226
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
+ ++ C + ++ C E PEDR + L+
Sbjct: 227 YRMVRPDN-------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-46
Identities = 71/320 (22%), Positives = 119/320 (37%), Gaps = 53/320 (16%)
Query: 717 NLIGAGSFGSVYKGILDEG---KTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVK 772
+IG G FG VY G L + K AVK N + G F+ E +K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+L C + +V +M + L ++ + + + G+ V
Sbjct: 93 LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQV 139
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLS--HAQTSSIFAKG 890
A + VH DL N +LDE+ V DFGLA + + + AK
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950
+ ++A E + + DV+S+G+LL EL+TR P D+N D
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTF--------DIT 244
Query: 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010
V ++ L E C + + + C E R + +V
Sbjct: 245 VYLLQGRRLLQPEY-------------------CPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 1011 HQLQSIKNILLGQRIVSNMQ 1030
++ +I + +G+ V
Sbjct: 286 SRISAIFSTFIGEHYVHVNA 305
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 71/302 (23%), Positives = 107/302 (35%), Gaps = 55/302 (18%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG G FG V G VAVK + ++F+AE + + +RH NLV++L
Sbjct: 13 QTIGKGEFGDVMLGDYR--GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ +V E+M SL ++L L L +DV A+
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 116
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
YL VH DL NVL+ E+ +A V DFGL + K + + A
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTA 168
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDS 956
PE + S DV+S+GILL E+ + + + L + + +D D
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD- 223
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
C A+ + C R + QL+ I
Sbjct: 224 --------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
Query: 1017 KN 1018
K
Sbjct: 258 KT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 58/264 (21%), Positives = 100/264 (37%), Gaps = 21/264 (7%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 768
+ + IG GS+G K I+ K + + + ++E N L+ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N+V+ + N +V E+ L + T+E + L+ L +
Sbjct: 64 NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRV 114
Query: 829 GIDVACALSYLH--HDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
+ AL H D ++H DLKP+NV LD + +GDFGLA L + +
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM------NLHN 940
G+ Y++PE + D++S G LL EL P + ++
Sbjct: 175 V--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232
Query: 941 FAKTALPDHVVDIVDSTLLSDDED 964
D + +I+ L D
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYH 256
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 24/266 (9%)
Query: 719 IGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG GSF +VYKG+ E VA L + F E LK ++H N+V+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+G LV E M + +L+ +L + L
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV----------LRSWCRQILKGL 125
Query: 837 SYLHHDCQPPIVHCDLKPSNVLL-DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+LH PPI+H DLK N+ + +GD GLAT S A+ G+ ++
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 180
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVD 955
APE + + DVY++G+ +LE+ T + P + N + D
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFD 235
Query: 956 STLLSDDEDLAVHGNQRQRQARINSK 981
+ + +++ ++ + R + K
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIK 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 1e-44
Identities = 70/337 (20%), Positives = 120/337 (35%), Gaps = 59/337 (17%)
Query: 700 NISYQNLYNATDGFTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNL-LHHGAFK 753
N +L + IG G+FG V++ E T+VAVK+
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 754 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-------- 805
F E + + N+VK+L C L+FE+M L E+L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 806 ------PITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLL 859
TR + P L+ ++L I VA ++YL VH DL N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173
Query: 860 DEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLL 919
E M+ + DFGL+ + + + I ++ PE + + DV++YG++L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 920 ELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN 979
E+ + + G + + D +L+ E+
Sbjct: 234 EIFSYGLQ---PYYGMAHEEVIYY---------VRDGNILACPEN--------------- 266
Query: 980 SKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
C + + + C + P DR ++ LQ +
Sbjct: 267 ----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
+G G FG V+ G + VA+K ++F+ E +K +RH LV++
Sbjct: 23 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
S + +V E+M SL ++L T + Q +D+ +A +
Sbjct: 81 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--------QLVDMAAQIASGM 126
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+Y+ VH DL+ +N+L+ E ++ V DFGLA + + T+ AK I + A
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 182
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDS 956
PE L +I DV+S+GILL EL T+ + M V+D V+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMV---------NREVLDQVER 229
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
R+ EC ++ + C + PE+R + L+
Sbjct: 230 GY------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-44
Identities = 61/318 (19%), Positives = 110/318 (34%), Gaps = 54/318 (16%)
Query: 704 QNLYNATDGFTSANL-IGAGSFGSVYKGILDEGKT--IVAVKVFNL-LHHGAFKSFIAEC 759
+ L+ D A++ +G G+FGSV +G+ K VA+KV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 760 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS 819
+ + + +V+++ C LV E L ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV---------GKREE 105
Query: 820 LNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFL-PL 878
+ + ++ V+ + YL VH DL NVLL A + DFGL+ L
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 879 SHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL 938
T+ K + + APE + S DV+SYG+ + E ++ + ++
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGP 219
Query: 939 HNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSME 998
A I + + C + + C +
Sbjct: 220 EVMAF---------IEQGKRMECPPE-------------------CPPELYALMSDCWIY 251
Query: 999 SPEDRMDMTNVVHQLQSI 1016
EDR D V ++++
Sbjct: 252 KWEDRPDFLTVEQRMRAC 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 68/300 (22%), Positives = 109/300 (36%), Gaps = 51/300 (17%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 776
IG+G FG V+ G VA+K + FI E + + H LV++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
C LVFEFM + L ++L E L + +DV +
Sbjct: 69 C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGM 114
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIA 896
+ + ++H DL N L+ E + V DFG+ F+ TSS K + + +
Sbjct: 115 ---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 170
Query: 897 PEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDS 956
PE S S DV+S+G+L+ E+ + K + + VV+ + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRS---------NSEVVEDIST 217
Query: 957 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016
L + +I C E PEDR + ++ QL I
Sbjct: 218 GFRLYKPRL------------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 1e-43
Identities = 72/327 (22%), Positives = 126/327 (38%), Gaps = 56/327 (17%)
Query: 690 NPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH 749
+PSSP +Y T + +G G +G VY+G+ + VAVK
Sbjct: 3 DPSSP-------NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DT 54
Query: 750 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 809
+ F+ E +K I+H NLV++L C ++ EFM +L ++L R
Sbjct: 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 810 EDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869
++ + L + ++ A+ YL + +H DL N L+ E + V D
Sbjct: 110 QEVSAV--------VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTD 929
FGL+ + T+ AK I + APE ++ SI DV+++G+LL E+ T
Sbjct: 159 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-- 215
Query: 930 IMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMA 989
+ G V ++++ R+ C +
Sbjct: 216 -PYPGID----------LSQVYELLEKDY------------------RMERPEGCPEKVY 246
Query: 990 RIGVACSMESPEDRMDMTNVVHQLQSI 1016
+ AC +P DR + +++
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-43
Identities = 61/329 (18%), Positives = 118/329 (35%), Gaps = 59/329 (17%)
Query: 698 FPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKS 754
+P + + + ++IG G+FG V K + + + + + +
Sbjct: 4 YPVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 755 FIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE- 812
F E L + H N++ +L AC + + L E+ + +L ++L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 813 -----TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867
+L+ Q L DVA + + Q +H DL N+L+ E +A +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
DFGL+ + +T + + ++A E S + N DV+SYG+LL E+V+
Sbjct: 169 ADFGLSRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 928 TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVA 987
+ G + K + R+ + C
Sbjct: 226 ---PYCGMTCAELYEKL----------------------------PQGYRLEKPLNCDDE 254
Query: 988 MARIGVACSMESPEDRMDMTNVVHQLQSI 1016
+ + C E P +R ++ L +
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 61/305 (20%), Positives = 108/305 (35%), Gaps = 55/305 (18%)
Query: 717 NLIGAGSFGSVYKGILDEGKT--IVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G+G+FG+V KG K VAVK+ +AE N ++ + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
++ C + LV E L ++L R + +++ V
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQV 116
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAKGS 891
+ + YL VH DL NVLL + A + DFGL+ L + K
Sbjct: 117 SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951
+ + APE + S DV+S+G+L+ E + + + G V
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRGMK----------GSEVT 220
Query: 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011
++ ++ R+ C M + C E+R V
Sbjct: 221 AML------------------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 1012 QLQSI 1016
+L++
Sbjct: 263 RLRNY 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 54/310 (17%)
Query: 713 FTSANLIGAGSFGSVYKGILDEG----KTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRH 767
T +IGAG FG VYKG+L + VA+K F+ E + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N++++ ++ E+M N +L+++L E ++LQ +
Sbjct: 69 HNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVG 114
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ +A + + VH DL N+L++ ++ V DFGL+ L T +
Sbjct: 115 MLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 888 A-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946
K I + APE + + DV+S+GI++ E++T +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------- 218
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
V+ ++ R+ + ++C A+ ++ + C + R
Sbjct: 219 NHEVMKAINDGF------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKF 260
Query: 1007 TNVVHQLQSI 1016
++V L +
Sbjct: 261 ADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 27/233 (11%)
Query: 703 YQNLY---NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAEC 759
Y+++ N D + +G G+FG VYK E + A KV + + ++ E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 760 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRS 819
+ L + H N+VK+L A + ++ EF +++ + E R
Sbjct: 61 DILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML---------ELERP 106
Query: 820 LNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLS 879
L Q + AL+YLH I+H DLK N+L + + DFG++ +
Sbjct: 107 LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
Query: 880 HAQTSSIFAKGSIGYIAPEYGLGSEVSING-----DVYSYGILLLELVTRKKP 927
+ S G+ ++APE + DV+S GI L+E+ + P
Sbjct: 164 IQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 64/318 (20%), Positives = 106/318 (33%), Gaps = 58/318 (18%)
Query: 718 LIGAGSFGSVYKGIL-----DEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNL 770
++G+G+FG V VAVK+ ++ ++E + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-------------PITREDETEEAP 817
V +L AC + L+FE+ L +L + E EE
Sbjct: 104 VNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 818 RSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLP 877
L L VA + +L VH DL NVL+ + + DFGLA +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937
A+ + ++APE +I DV+SYGILL E+ + + G
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPV 272
Query: 938 LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSM 997
NF K ++ + +++ + I +C
Sbjct: 273 DANFYK---------LIQNGF------------------KMDQPFYATEEIYIIMQSCWA 305
Query: 998 ESPEDRMDMTNVVHQLQS 1015
R N+ L
Sbjct: 306 FDSRKRPSFPNLTSFLGC 323
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 58/266 (21%), Positives = 102/266 (38%), Gaps = 38/266 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
+ F +G G FG+VY + K I+A+KV L G E ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
N++++ L+ E+ ++ L +++ DE +
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQ----------RTAT 110
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
++A ALSY H ++H D+KP N+LL + DFG + P S T
Sbjct: 111 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--- 164
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA-- 945
G++ Y+ PE G D++S G+L E + K P FE + + + +
Sbjct: 165 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV 219
Query: 946 -------LPDHVVDIVDSTLLSDDED 964
+ + D++ L +
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQ 245
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-42
Identities = 65/315 (20%), Positives = 103/315 (32%), Gaps = 53/315 (16%)
Query: 717 NLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRN 769
+GAG+FG V + + VAVK+ H ++ ++E L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH--------PITREDETEEAPRSLN 821
+V +L AC ++ E+ L +L T E+ +L+
Sbjct: 89 IVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
L L VA +++L +H DL N+LL I + DFGLA +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
A+ + ++APE + DV+SYGI L EL + D +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPE 1001
K R+ S M I C P
Sbjct: 261 IKEGF------------------------------RMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 1002 DRMDMTNVVHQLQSI 1016
R +V ++
Sbjct: 291 KRPTFKQIVQLIEKQ 305
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-41
Identities = 61/304 (20%), Positives = 110/304 (36%), Gaps = 51/304 (16%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
T +G G FG V G G+ VA+K+ FI E + N+ H LV+
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQ 63
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ C ++ E+M N L +L Q L++ DV
Sbjct: 64 LYGVC-----TKQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDV 109
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSI 892
A+ YL +H DL N L++++ + V DFGL+ ++ TSS+ +K +
Sbjct: 110 CEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPV 165
Query: 893 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVD 952
+ PE + S+ S D++++G+L+ E+ + K +E +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT----------NSETAE 212
Query: 953 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012
+ L L + I +C E ++R ++
Sbjct: 213 HIAQGLRLYRPHL------------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
Query: 1013 LQSI 1016
+ +
Sbjct: 255 ILDV 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-40
Identities = 56/311 (18%), Positives = 116/311 (37%), Gaps = 45/311 (14%)
Query: 713 FTSANLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIR 766
T + +G GSFG VY+G+ DE +T VA+K N F+ E + +K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
++V++L ++ E M L+ +L + +L + +
Sbjct: 82 CHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
+ ++A ++YL+ VH DL N ++ E+ +GDFG+ + +
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946
+ +++PE + DV+S+G++L E+ T + ++G N
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRF--- 247
Query: 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDM 1006
+++ LL ++ C + + C +P+ R
Sbjct: 248 ------VMEGGLLDKPDN-------------------CPDMLFELMRMCWQYNPKMRPSF 282
Query: 1007 TNVVHQLQSIK 1017
++ ++
Sbjct: 283 LEIISSIKEEM 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 54/252 (21%), Positives = 99/252 (39%), Gaps = 20/252 (7%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRN 769
+ + +G G++G V + + VAVK+ ++ ++ E K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
+VK + + + L E+ L + + P +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFF 109
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK 889
+ + YLH I H D+KP N+LLDE + DFGLAT ++ +
Sbjct: 110 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 890 GSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948
G++ Y+APE E + DV+S GI+L ++ + P D + ++ +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 949 HVVDIVDSTLLS 960
+ +DS L+
Sbjct: 227 NPWKKIDSAPLA 238
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 2e-40
Identities = 48/226 (21%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 702 SYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNT 761
S ++ + +T IG G+ G+VY + VA++ NL + I E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
++ ++ N+V L + D +V E++ SL + + E
Sbjct: 71 MRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVT---ETCMDEG------ 116
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
Q + + AL +LH ++H D+K N+LL + + DFG + +
Sbjct: 117 --QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
+ S++ G+ ++APE D++S GI+ +E++ + P
Sbjct: 172 KRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (376), Expect = 3e-40
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL---LHHGAFKSFIAECNTLKNIR 766
F+ IG GSFG+VY +VA+K + + ++ I E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H N ++ LV E+ + + + L ++
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIA 118
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
+ L+YLH ++H D+K N+LL E + +GDFG A+ + +++
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV--- 172
Query: 887 FAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKP 927
G+ ++APE L + DV+S GI +EL RK P
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 21/220 (9%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
+ F ++G GSF +V A+K+ ++ E + + + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
VK+ Q ++ + N L +++ I DET
Sbjct: 68 PFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------------- 109
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
A +S L + I+H DLKP N+LL+E+M + DFG A L Q +
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y++PE + D+++ G ++ +LV P
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 61/316 (19%), Positives = 117/316 (37%), Gaps = 55/316 (17%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGIL----DEGKTIVAVKVFNLLHHG-AFKSFIAECNTL 762
T+ F ++G+G+FG+VYKG+ ++ K VA+K A K + E +
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 763 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNL 822
++ + ++ ++L C L+ + M L +++ ++
Sbjct: 66 ASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVREHKDNIGSQY------- 112
Query: 823 LQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ 882
L+ + +A ++YL +VH DL NVL+ + DFGLA L +
Sbjct: 113 --LLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 883 TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942
+ K I ++A E L + DV+SYG+ + EL+T ++G
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA----- 219
Query: 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002
+ I++ R+ C + + I V C M +
Sbjct: 220 -----SEISSILEKGE------------------RLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 1003 RMDMTNVVHQLQSIKN 1018
R ++ + +
Sbjct: 257 RPKFRELIIEFSKMAR 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 68/306 (22%), Positives = 102/306 (33%), Gaps = 55/306 (17%)
Query: 719 IGAGSFGSVYKGILDEGK---TIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 772
+G GSFG V +G D VAVK L A FI E N + ++ HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 773 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDV 832
+ +V E SL + L + L + V
Sbjct: 76 LYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQV 120
Query: 833 ACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQ-TSSIFAKGS 891
A + YL +H DL N+LL + +GDFGL LP + K
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 892 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVV 951
+ APE S D + +G+ L E+ T + + G
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIG----------------- 217
Query: 952 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011
L+ + L + +R R +C + + V C PEDR +
Sbjct: 218 -------LNGSQILHKIDKEGERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 1012 QLQSIK 1017
L +
Sbjct: 268 FLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (363), Expect = 4e-38
Identities = 56/265 (21%), Positives = 102/265 (38%), Gaps = 31/265 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 770
D + +G G+FG V++ A K H ++ E T+ +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V + A + ++ +++EFM L E + + ++ + ++
Sbjct: 86 VNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMR 131
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFA 888
V L ++H + VH DLKP N++ + + DFGL L + S
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVT 185
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP---------TDIMFEGDMNLH 939
G+ + APE G V D++S G+L L++ P + D N+
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 940 NFAKTALPDHVVDIVDSTLLSDDED 964
+ A + + + D + LL+D
Sbjct: 246 DSAFSGISEDGKDFIRKLLLADPNT 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (350), Expect = 3e-37
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 23/287 (8%)
Query: 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIR 766
+D + ++G G V+ VAVKV + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H +V + G +V E++ +L + +H +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEGPMTPKR----------AI 114
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
++ D AL++ Q I+H D+KP+N+++ V DFG+A + S +
Sbjct: 115 EVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 887 FA-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945
A G+ Y++PE G V DVYS G +L E++T + P F GD + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 227
Query: 946 LPDHVVDIVDSTLLSDD-EDLAVHGNQRQRQARINSKIECLVAMARI 991
D + LS D + + + + + R + E + R+
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 59/312 (18%), Positives = 103/312 (33%), Gaps = 48/312 (15%)
Query: 717 NLIGAGSFGSVYKGIL-----DEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNL 770
+G G+FG V + VAVK+ H ++ ++E L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------PITREDETEEAPRSLNLLQ 824
V L G + ++ EF +L +L + + L L
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
+ VA + +L +H DL N+LL E+ + + DFGLA +
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944
A+ + ++APE +I DV+S+G+LL E+ + + G F +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRR 249
Query: 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004
+ D M + + C P R
Sbjct: 250 LKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRP 282
Query: 1005 DMTNVVHQLQSI 1016
+ +V L ++
Sbjct: 283 TFSELVEHLGNL 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 9e-37
Identities = 56/306 (18%), Positives = 105/306 (34%), Gaps = 60/306 (19%)
Query: 718 LIGAGSFGSVYKGIL---DEGKTIVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKI 773
IG G FG V++GI + VA+K + + F+ E T++ H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
+ + + ++ E L +L SL+L + ++
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLS 118
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
AL+YL VH D+ NVL+ +GDFGL+ ++ + K I
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD---MNLHNFAKTALPDHV 950
++APE + DV+ +G+ + E++ + + + N + +P +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010
+ + C P R T +
Sbjct: 235 PP----------------------------------TLYSLMTKCWAYDPSRRPRFTELK 260
Query: 1011 HQLQSI 1016
QL +I
Sbjct: 261 AQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 62/312 (19%), Positives = 105/312 (33%), Gaps = 48/312 (15%)
Query: 717 NLIGAGSFGSVYKGIL-------DEGKTIVAVKVFNL-LHHGAFKSFIAECNTLKNI-RH 767
+G G+FG V T VAVK+ I+E +K I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
+N++ +L AC + ++ E+ +L E+L S N ++L
Sbjct: 79 KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 828 IGIDVACA---LSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
V+CA + + +H DL NVL+ E+ + + DFGLA +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 885 SIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944
+ + + ++APE + DV+S+G+LL E+ T + + K
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEELFKL 249
Query: 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM 1004
H +D C + + C P R
Sbjct: 250 LKEGHRMDKPS---------------------------NCTNELYMMMRDCWHAVPSQRP 282
Query: 1005 DMTNVVHQLQSI 1016
+V L I
Sbjct: 283 TFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (347), Expect = 5e-36
Identities = 45/235 (19%), Positives = 90/235 (38%), Gaps = 26/235 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 770
D + +G+G+FG V++ + + K N + + E + + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
+ + A + L+ EF+ L + + ++ + ++
Sbjct: 89 INLHDAF-----EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMR 134
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFA 888
L ++H + IVH D+KP N++ + + + V DFGLAT L +
Sbjct: 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVT 188
Query: 889 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
+ + APE V D+++ G+L L++ P F G+ +L
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQN 239
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 6e-34
Identities = 50/257 (19%), Positives = 88/257 (34%), Gaps = 39/257 (15%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 773
+G GSFG V+ A+KV ++ + E L + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 774 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVA 833
Q ++ +++ L L R A
Sbjct: 70 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-------------AA 111
Query: 834 CALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
L + I++ DLKP N+LLD+ + DFG A ++P G+
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPD 166
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA-------- 945
YIAPE + + D +S+GIL+ E++ P F + + K
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFPP 222
Query: 946 -LPDHVVDIVDSTLLSD 961
+ V D++ + D
Sbjct: 223 FFNEDVKDLLSRLITRD 239
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-34
Identities = 59/281 (20%), Positives = 101/281 (35%), Gaps = 18/281 (6%)
Query: 705 NLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-GAFKSFIAECNTLK 763
+++ +T+ + IG G++G V + K VA+K + H + + E L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
RH N++ I + LV M L + L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSND 109
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
+ L Y+H ++H DLKPSN+LL+ + DFGLA H T
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 884 SSIFAK-GSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
+ + Y APE L S+ D++S G +L E+++ + D H
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 942 AKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 982
P L + + L++ + R+
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 56/263 (21%), Positives = 102/263 (38%), Gaps = 29/263 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTL-KNIR 766
+ F ++G GSFG V+ + A+K +L + + E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
H L + Q + V E+++ L + + D +
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR----------AT 106
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSI 886
++ L +L IV+ DLK N+LLD++ + DFG+ L A+T++
Sbjct: 107 FYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 163
Query: 887 FAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----TDIMFEGDMNLHNF 941
G+ YIAPE LG + + + D +S+G+LL E++ + P + +F + F
Sbjct: 164 --CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221
Query: 942 AKTALPDHVVDIVDSTLLSDDED 964
L D++ + + E
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEK 244
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 6e-33
Identities = 47/261 (18%), Positives = 87/261 (33%), Gaps = 23/261 (8%)
Query: 703 YQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL-LHHGAFKSFIAECNT 761
++ + D + +++G G+F V + +VA+K G S E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
L I+H N+V + + L+ + + L + +
Sbjct: 61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIV----------EKGFYT 105
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
+ V A+ YLH LDE+ + DFGL+
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 882 QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
+++ G+ GY+APE S D +S G++ L+ P F + + F
Sbjct: 166 LSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLF 218
Query: 942 AKTALPDHVVDIVDSTLLSDD 962
+ ++ D +SD
Sbjct: 219 EQILKAEYEFDSPYWDDISDS 239
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 27/228 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G FG V++ + K K + E + L RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
+ + ++FEF+ + E ++ + LN + + V AL
Sbjct: 71 -----ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHV--GDFGLATFLPLSHAQTSSIFAKGSIGYI 895
+LH I H D++P N++ + + +FG A L + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYY 170
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
APE VS D++S G L+ L++ P F + N
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQIIEN 214
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (315), Expect = 2e-32
Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 46/279 (16%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF---------KSFIAECNT 761
+ + ++G G V + I AVK+ ++ G+F ++ + E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 762 LKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSL 820
L+ + H N++++ + N F LVF+ M L ++L +L
Sbjct: 63 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLT----------EKVTL 107
Query: 821 NLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSH 880
+ + I + + LH + IVH DLKP N+LLD++M + DFG + L
Sbjct: 108 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
Query: 881 AQTSSIFAKGSIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKP------- 927
G+ Y+APE S + D++S G+++ L+ P
Sbjct: 165 KLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 928 --TDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDED 964
++ G+ + D V D+V L+ +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 30/233 (12%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLV 771
+ +G G F +VYK IVA+K L H G ++ + E L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 772 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+L A +LVF+FM + I
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-------------IKAY 105
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGS 891
+ L L + Q I+H DLKP+N+LLDE + + DFGLA + +
Sbjct: 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVT 163
Query: 892 IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
Y APE G+ + + D+++ G +L EL+ R GD +L +
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTR 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 65/311 (20%), Positives = 105/311 (33%), Gaps = 29/311 (9%)
Query: 717 NLIGAGSFGSVYKGI-LDEGKTIVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNL 770
IG G++G V+K L G VA+K + + +A L+ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 771 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGI 830
V++ C+ LVFE + + D+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123
Query: 831 DVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+ L +LH +VH DLKP N+L+ + DFGLA A TS +
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177
Query: 891 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950
++ Y APE L S + D++S G + E+ RK + D LP
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVV 1010
D L + I+ + L+ C +P R+ + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAKRISAYSAL 291
Query: 1011 -HQ-LQSIKNI 1019
H Q ++
Sbjct: 292 SHPYFQDLERC 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (320), Expect = 3e-32
Identities = 48/266 (18%), Positives = 91/266 (34%), Gaps = 37/266 (13%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH------HGAFKSFIAECNTLKN 764
+ F+ +IG G FG VY + + A+K + + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 765 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQ 824
+V + A D + + + M+ L L E +
Sbjct: 64 GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---------- 108
Query: 825 RLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTS 884
++ L ++H +V+ DLKP+N+LLDE + D GLA +
Sbjct: 109 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKK 161
Query: 885 SIFAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPTD--------IMFEGD 935
+ G+ GY+APE G + D +S G +L +L+ P +
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 936 MNLHNFAKTALPDHVVDIVDSTLLSD 961
+ + + + +++ L D
Sbjct: 222 LTMAVELPDSFSPELRSLLEGLLQRD 247
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-32
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 772
+T +IG GSFG VY+ L + +VA+K + E ++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 773 ILTAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
+ S + + + LV +++ H + ++L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-------QTLPVIYVKLYMYQ 130
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIFAKG 890
+ +L+Y+H I H D+KP N+LLD + + + DFG A L S I ++
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186
Query: 891 SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
Y APE G+ + + + DV+S G +L EL+ + F GD + +
Sbjct: 187 --YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVE 234
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 122 bits (306), Expect = 4e-31
Identities = 73/307 (23%), Positives = 117/307 (38%), Gaps = 10/307 (3%)
Query: 39 NETDRLALLEFKSKITHDPLGVFGSWNESIHFCQ--WHGVTCSRR-QHQRVTILDLKSLK 95
N D+ ALL+ K + + SW + C W GV C Q RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 96 LAGY--ISAHVGNLSFLKVLDLHNN-SFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI 152
L I + + NL +L L + + IP +L +L L + + ++ G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 153 SSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLS 212
S L+ + S N L G +P + SL + + N ++G+IP S+G+ S +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDI 272
N NL + +++N L G + + N + +
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 273 GFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVIT 332
N N++ G +P ++ L V+ N L GE+P LQR
Sbjct: 242 LSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299
Query: 333 RNSLGSG 339
N G
Sbjct: 300 NNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.6 bits (205), Expect = 7e-18
Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 19/298 (6%)
Query: 351 TNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN--IPAAFGKFVKLLRL 408
T+ W + + + + L L + IP++ L L
Sbjct: 31 TDCCNRTWLGVLCDT---------DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81
Query: 409 EMWNN-RLSGTIPPAIGELQNLRELRLQENRFLGNIPP-SIGNLKLFNLQLSYNFLQGSI 466
+ L G IPPAI +L L L + G IP L L SYN L G++
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 467 PSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLE 526
P S+ L I N ++G IP S L + +SRN+LTG IP NL
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201
Query: 527 MLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGK 586
+ ++ + + LS + LDL N + G
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL--NGLDLRNNRIYGT 259
Query: 587 IPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEFRLPTCS 644
+P+ L + L LN+S N+ G +P G + +++ N LCG LP C+
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT 313
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-31
Identities = 52/235 (22%), Positives = 96/235 (40%), Gaps = 25/235 (10%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG G+FG V+K + VA+K + G + + E L+ ++H N+V ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 775 TACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGID 831
C N K LVF+F + + + + +I
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------------FTLSEIKRV 122
Query: 832 VACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAK-- 889
+ L+ L++ + I+H D+K +NVL+ + + + DFGLA L+ + +
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 890 GSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
++ Y PE LG + D++ G ++ E+ TR +G+ H A
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLAL 233
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 35/246 (14%)
Query: 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH------HGAFKSFIAECNT 761
N D + + +G+G F V K A K + + E +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
LK I+H N++ + + L+ E + L ++L +E TEE
Sbjct: 67 LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLA--EKESLTEEEATEF- 118
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA----HVGDFGLATFLP 877
+ L+ +++ I H DLKP N++L + + + DFGLA +
Sbjct: 119 ----------LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 878 LSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937
+ + G+ ++APE + + D++S G++ L++ P F GD
Sbjct: 169 FGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK 221
Query: 938 LHNFAK 943
A
Sbjct: 222 QETLAN 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 9e-30
Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 27/227 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
IG+GSFG +Y G VA+K+ + E K ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
D+ +V E + + + R +L L + + +
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISRIE 117
Query: 838 YLHHDCQPPIVHCDLKPSNVL---LDEEMIAHVGDFGLATFLPLSHAQTSSIFAK----- 889
Y+H +H D+KP N L + + ++ DFGLA + + +
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 890 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDM 936
G+ Y + LG E S D+ S G +L+ P +
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (294), Expect = 1e-29
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 28/296 (9%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG G++G VYK + G+ A+K L G + I E + LK ++H N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
LVFE + + + +
Sbjct: 67 DVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT-------------AKSFLLQ 108
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
L+ + + ++H DLKP N+L++ E + DFGLA + + + + Y
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWY 166
Query: 895 IAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953
AP+ +GS+ S D++S G + E+V + E D + F P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 954 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNV 1009
+ L D + V+ + +++ P R+
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 42/249 (16%), Positives = 89/249 (35%), Gaps = 24/249 (9%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTA 776
++G G G V + + A+K+ E + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 777 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ Y G +V E + L + + ++ + +I + A+
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAI 124
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEEM---IAHVGDFGLATFLPLSHAQTSSIFAKGSIG 893
YLH I H D+KP N+L + I + DFG A + S +
Sbjct: 125 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCYTPY 178
Query: 894 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHVVDI 953
Y+APE + + D++S G+++ L+ P ++ + + +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 954 VDSTLLSDD 962
+ + +S++
Sbjct: 239 PEWSEVSEE 247
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 61/236 (25%), Positives = 92/236 (38%), Gaps = 26/236 (11%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 768
+ F IG G++G VYK +VA+K L G + I E + LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 769 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDI 828
N+VK+L + LVFEF+H + L
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-------- 108
Query: 829 GIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFA 888
L L ++H DLKP N+L++ E + DFGLA + +
Sbjct: 109 ----FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV- 163
Query: 889 KGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
++ Y APE LG + S D++S G + E+VTR+ F GD + +
Sbjct: 164 -VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFR 214
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (292), Expect = 3e-29
Identities = 43/309 (13%), Positives = 85/309 (27%), Gaps = 54/309 (17%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
IG GSFG +++G VA+K E T K + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALS 837
Q LV + + + ED + R ++ + +
Sbjct: 70 ----GQEGLHNVLVIDLLGP----------SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 838 YLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG-----DFGLATFLPLSHAQTSSIFAK--- 889
+H + +V+ D+KP N L+ + DFG+ F + + +
Sbjct: 116 SIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 890 --GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947
G+ Y++ LG E S D+ + G + + + + ++G N K
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS----LPWQGLKAATNKQKYERI 228
Query: 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT 1007
L + + + D
Sbjct: 229 GEKKQSTPLRELCAG---------------------FPEEFYKYMHYARNLAFDATPDYD 267
Query: 1008 NVVHQLQSI 1016
+ +
Sbjct: 268 YLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 8e-29
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 23/220 (10%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
+ F L+G G+FG V A+K+ ++ + E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
L + A Q +D V E+ + L L E
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEER------------- 106
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
A +S L + +V+ D+K N++LD++ + DFGL A +
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 927
G+ Y+APE ++ D + G+++ E++ + P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 24/229 (10%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 774
IG G++G+V+K E IVA+K L G S + E LK ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ LVFEF D E +S +
Sbjct: 68 DVL-----HSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSF-----------LFQ 109
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
L L ++H DLKP N+L++ + +FGLA + + S
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYR 168
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
S + D++S G + EL +P +F G+ +
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKR 214
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 51/260 (19%), Positives = 83/260 (31%), Gaps = 38/260 (14%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAF------KSFIAECNTLKNIR--HRN 769
L+G+G FGSVY GI VA+K + E LK +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 770 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIG 829
++++L + D L+ E +L
Sbjct: 71 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFF 116
Query: 830 IDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIFA 888
V A+ + ++H D+K N+L+D + DFG L +
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---- 169
Query: 889 KGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGD---MNLHNFAKT 944
G+ Y PE+ + V+S GILL ++V P FE D + F +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQ 225
Query: 945 ALPDHVVDIVDSTLLSDDED 964
+ ++ L D
Sbjct: 226 RVSSECQHLIRWCLALRPSD 245
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 31/242 (12%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGK---TIVAVKVFNLLH----HGAFKSFIAECNTLK 763
+ F ++G G++G V+ G + A+KV + E L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 764 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLL 823
+IR + L +Q L+ ++++ L L R E E
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130
Query: 824 QRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
+ I V + L H + I++ D+K N+LLD + DFGL+ +
Sbjct: 131 ----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETE 185
Query: 884 SSIFAKGSIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941
+ G+I Y+AP+ G + + D +S G+L+ EL+T P F D ++
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQ 241
Query: 942 AK 943
A+
Sbjct: 242 AE 243
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 1e-26
Identities = 52/248 (20%), Positives = 85/248 (34%), Gaps = 35/248 (14%)
Query: 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 767
D F +G GSFG V E A+K+ + ++ + + E L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 768 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLD 827
LVK+ + V E++ + L I R E
Sbjct: 101 PFLVKLEFSFKDNSNLYM-----VMEYVAGGEMFSHLRRIGRFSEPH----------ARF 145
Query: 828 IGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIF 887
+ YLH +++ DLKP N+L+D++ V DFG A + +
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWT 197
Query: 888 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD-----MNLHNFA 942
G+ +APE L + D ++ G+L+ E+ P F D
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSG 253
Query: 943 KTALPDHV 950
K P H
Sbjct: 254 KVRFPSHF 261
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 26/229 (11%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
IG+G+ G V VA+K + + K E +K + H+N++ +L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 776 ACSGVD-YQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ + LV E M + + E + + + C
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLC 130
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
+ +LH +H DLKPSN+++ + + DFGLA S T + + Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184
Query: 895 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
APE LG N D++S G ++ E+V K F G + + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 109 bits (272), Expect = 5e-26
Identities = 79/387 (20%), Positives = 144/387 (37%), Gaps = 32/387 (8%)
Query: 227 LKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGR 286
L + + + ++ T+ + ++ +T A I+ + ++ L NL +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE---YLNNLTQINFSN 75
Query: 287 NQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-------LEKLQRLSHFVITRNSLGSG 339
NQLT P + N + L +N+N++ P L I +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 340 EHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAF 399
+R ++++ + L G + + + LD + + +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 400 GKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLS 458
K L L NN++S P I NL EL L N+ ++ +L L +L L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 459 YNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNE 518
N + P L LT + L N ++ P L+ L + L N+ +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISP 302
Query: 519 VGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDL 578
+ NLKNL L ++ N + P + S KL+ L N + SSL++L ++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSA 358
Query: 579 SQNNLSGKIPEFLVGFQLLEYLNLSNN 605
N +S P L + L L++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 9e-22
Identities = 72/402 (17%), Positives = 139/402 (34%), Gaps = 40/402 (9%)
Query: 156 SNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215
+ ++ L + + L ++ + SI L++++ + S N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQ 77
Query: 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFT 275
L P L LV++ M + + I ++++T + +D
Sbjct: 78 LTDITP--LKNLTKLVDILM-----NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L NL + N ++ + + F + L L L I+ N
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD----LKPLANLTTLERLDISSN- 185
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+ D++ L LTN L + N + P T L+ L L+ N++
Sbjct: 186 ----KVSDISVLAKLTNLESLIATN---NQISDITPLG---ILTNLDELSLNGNQLKD-- 233
Query: 396 PAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNL 455
L L++ NN++S P + L L EL+L N+ P +
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
S S+L LT + L NN++ P + + L L + N+++
Sbjct: 292 LNENQLEDISPISNLKN---LTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD-- 343
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGN 557
+ + NL N+ L+ N++ P L + ++ L +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 81.2 bits (199), Expect = 8e-17
Identities = 64/391 (16%), Positives = 125/391 (31%), Gaps = 65/391 (16%)
Query: 131 LRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190
L L ++ + + + ++ + K + L+ + + S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPD---------------------------- 222
LT P NL+ + + ++ N + P
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 223 --------TFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGF 274
T + L LT Q G + + ++++T + V + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 275 TLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRN 334
L NL+ NQ++ P I +NL+ +N N+L + L L L+ + N
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANN 251
Query: 335 SLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN 394
+ + L L+ T+L + N + P T L+ N+
Sbjct: 252 QISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALT-----NLELNENQLE 298
Query: 395 IPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LF 453
+ L L ++ N +S P + L L+ L N+ S+ NL +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 454 NLQLSYNFLQGSIPSSLGQSETLTIIDLSNN 484
L +N + P L +T + L++
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.3 bits (189), Expect = 2e-15
Identities = 50/233 (21%), Positives = 84/233 (36%), Gaps = 17/233 (7%)
Query: 55 HDPLGVFGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLD 114
PL + + + L + +++ L+ L L
Sbjct: 168 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELS 225
Query: 115 LHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPS 174
L+ N L L L L NN I P +S + L ++L +N++ P
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 280
Query: 175 ELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLT 234
L L+ + ++ N L NL ++++L L NN+ P L L L
Sbjct: 281 -LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 235 MAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRN 287
A N++S SS+ N+++I AG NQI + PL L + +
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 3e-15
Identities = 79/389 (20%), Positives = 138/389 (35%), Gaps = 47/389 (12%)
Query: 77 TCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQV 136
T S+ +VT L L + V L+ L ++ NN P L +L
Sbjct: 37 TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 137 LALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI 196
+ ++NN I P + + + + + + +
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQI---------------TDIDPLKNLTNLNRL 137
Query: 197 PPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLT----MAQNRLSGTIPSSIFNIS 252
S +S IS L + S + LK L NLT + + + S + ++
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197
Query: 253 SITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNK 312
++ A NQI + PL I L L NQL +++ +NL + +N+
Sbjct: 198 NLESLIATNNQISDITPLGILTNLDELSLNG---NQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 313 LTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPA 372
++ P L L +L+ LG+ + +++ L LT T L+ + +
Sbjct: 253 ISNLAP-LSGLTKLTEL-----KLGANQISNISPLAGLTALTNLELNENQLEDI------ 300
Query: 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLREL 432
+ L L L N I P KL RL NN++S ++ L N+ L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 433 RLQENRFLGNIPPSIGNL-KLFNLQLSYN 460
N+ P + NL ++ L L+
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-26
Identities = 47/243 (19%), Positives = 89/243 (36%), Gaps = 26/243 (10%)
Query: 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNT 761
+ ++ + + + + +G+G++GSV + VAVK + K E
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 762 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLN 821
LK+++H N++ +L + + + L + + L
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLT 119
Query: 822 LLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHA 881
+ + L Y+H H DLKPSN+ ++E+ + DFGLA
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 882 QTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940
+ Y APE L + D++S G ++ EL+T + F G ++
Sbjct: 177 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQ 227
Query: 941 FAK 943
Sbjct: 228 LKL 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-25
Identities = 60/282 (21%), Positives = 105/282 (37%), Gaps = 28/282 (9%)
Query: 687 ENQNPSSPINSFPNISYQNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNL 746
+ N P + S+ + D + +G G + V++ I V VK+
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70
Query: 747 LHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH 805
+ K E L+N+R N++ + + ALVFE ++N ++
Sbjct: 71 VKK---KKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 806 PITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE-MI 864
+T D ++ AL Y H I+H D+KP NV++D E
Sbjct: 125 TLTDYD-------------IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRK 168
Query: 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVT 923
+ D+GLA F H S + PE + + + D++S G +L ++
Sbjct: 169 LRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 924 RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDL 965
RK+P + L AK + + D +D + D
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 3e-25
Identities = 45/220 (20%), Positives = 81/220 (36%), Gaps = 9/220 (4%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 777
+G G F +V+ T VA+K+ ++ E L+ + + K +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 778 S-GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACAL 836
+ + + F +H + E L + R + L+ I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 837 SYLHHDCQPPIVHCDLKPSNVLLDEE-MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYI 895
Y+H C I+H D+KP NVL++ ++ +A + + Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 896 APEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGD 935
+PE LG+ D++S L+ EL+T FE D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPD 232
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 8e-25
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 28/230 (12%)
Query: 718 LIGAGSFGSVYKGILDEGKTIVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 775
+G+G++G+V + VA+K K E LK++RH N++ +L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 776 ACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVAC 834
+ + + LV FM + H L + + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLK 132
Query: 835 ALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGY 894
L Y+H H DLKP N+ ++E+ + DFGLA A + + Y
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 895 IAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943
APE L + D++S G ++ E++T K F+G +L +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKE 230
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.3 bits (233), Expect = 2e-21
Identities = 60/271 (22%), Positives = 100/271 (36%), Gaps = 12/271 (4%)
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
+ N + N L L+L +NKI P AF VKL RL + N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 414 RLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQS 473
+L LQ LR + + ++ + + + L + G +
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 474 ETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
+ L+ I +++ N+T TIP GL L L L N++T + L NL L + N
Sbjct: 150 KKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 534 KLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSG------KI 587
+ +L + L L + N L +P L+ + + V+ L NN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 588 PEFLVGFQLLEYLNLSNNDFEGMVPTEGVFR 618
P + ++L +N + FR
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 25/297 (8%)
Query: 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDR 130
C V CS ++V +LDL NN +F
Sbjct: 10 CHLRVVQCSDLGLEKVPK----------------DLPPDTALLDLQNNKITEIKDGDFKN 53
Query: 131 LRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190
L+ L L L NN I P + L R+ LS N+L ++P ++ ++ V N
Sbjct: 54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHEN 110
Query: 191 NLTGSIPPSFGNLSSISFLFLSRNNLD--GSIPDTFGWLKNLVNLTMAQNRLSGTIPSSI 248
+T F L+ + + L N L G F +K L + +A ++ TIP +
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 169
Query: 249 FNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV 308
S+T N+I V + L NL + N ++ +++N +L +
Sbjct: 170 P--PSLTELHLDGNKITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226
Query: 309 NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININN 365
N+NKL L + + + N++ + D T + N
Sbjct: 227 NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 7e-16
Identities = 49/302 (16%), Positives = 93/302 (30%), Gaps = 23/302 (7%)
Query: 153 SSCS-NLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211
C +L V+ S L K+P +L + N +T F NL ++ L L
Sbjct: 6 FRCQCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271
N + P F L L L +++N+L + + V + I +++ +
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 122
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVI 331
+ + +G A L ++ +T L L+ +
Sbjct: 123 --LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHL 178
Query: 332 TRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI 391
N + + L L +L + ++ S +T L +N
Sbjct: 179 DGNKITKVDAASLKGLNNL--------AKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 392 FGNIPAAFGKFVKLLRLEMWNNRLSG------TIPPAIGELQNLRELRLQENRF-LGNIP 444
+P + + + NN +S P + + + L N I
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 445 PS 446
PS
Sbjct: 291 PS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.8 bits (177), Expect = 2e-14
Identities = 44/222 (19%), Positives = 68/222 (30%), Gaps = 8/222 (3%)
Query: 418 TIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQGSIPSSLGQSETL 476
+P + + L LQ N+ NLK L L L N + P + L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 477 TIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536
+ LS N L +P ++ L V E ++ + N + + +E+ K
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSS 139
Query: 537 GEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQL 596
G KL +++ + SL L L N ++ L G
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNN 196
Query: 597 LEYLNLSNNDFEGMVPTEGVFRNASITSVLGNLKLCGGTHEF 638
L L LS N + L N KL
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.6 bits (174), Expect = 6e-14
Identities = 58/315 (18%), Positives = 103/315 (32%), Gaps = 38/315 (12%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPY-LEKLQRL 326
+P D+ L + N++T N NL + +NK++ P L +L
Sbjct: 25 VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 327 SHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLL 386
+++N L L+ I + ++ + L
Sbjct: 82 ERLYLSKNQLKELPE------KMPKTLQELRVHENEITKVRKSVFNGLNQM--IVVELGT 133
Query: 387 DSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPS 446
+ K G AF KL + + + ++ TIP + +L EL L N+ S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 447 IGNL-KLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLE 505
+ L L L LS+N + SL + L + L+NN L P L + V+
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHKYIQVVY 248
Query: 506 LSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ--GPI 563
L N ++ N+ P + + N +Q
Sbjct: 249 LHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 564 PSSLSSLRGLSVLDL 578
PS+ + + + L
Sbjct: 291 PSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.4 bits (145), Expect = 3e-10
Identities = 30/153 (19%), Positives = 53/153 (34%), Gaps = 4/153 (2%)
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535
L ++ S+ L +P L +L+L N++T + NLKNL L + NK+
Sbjct: 12 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQ 595
P +KLE L + N L+ +L+ L V + + + L
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 596 LLEYLNLSNNDFEGMVPTEGVFRNASITSVLGN 628
++E + S +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 33/175 (18%), Positives = 57/175 (32%), Gaps = 9/175 (5%)
Query: 67 SIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPS 126
+ Q + L + + G L L L N +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAA 189
Query: 127 EFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFS 186
L L L L NSI ++++ +L + L++N+LV K+P L I+
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248
Query: 187 VSYNNLTG------SIPPSFGNLSSISFLFLSRNNLDGS--IPDTFGWLKNLVNL 233
+ NN++ P +S S + L N + P TF + +
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 2e-17
Identities = 29/177 (16%), Positives = 50/177 (28%), Gaps = 33/177 (18%)
Query: 717 NLIGAGSFGSVYKGILDEGKTIVAVKVFNL----------LHHGAFKSFIAECNTLKNIR 766
L+G G +V+ ++ VK + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRL 826
R L K+ Y A++ E + + L E
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE---------------- 107
Query: 827 DIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT 883
+ + ++ +H IVH DL NVL+ EE I + DF + + +
Sbjct: 108 -VLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 5e-17
Identities = 53/261 (20%), Positives = 80/261 (30%), Gaps = 31/261 (11%)
Query: 375 SNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNR-------------------- 414
+ + L N+I A+F L L + +N
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 415 -----LSGTIPPAIGELQNLRELRLQENRFLG-NIPPSIGNLKLFNLQLSYNFLQGSIPS 468
L P L L L L G L L L N LQ
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 469 SLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528
+ LT + L N ++ GL SL +L L +N++ P+ +L L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL-LHQNRVAHVHPHAFRDLGRLMTL 206
Query: 529 NVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP 588
+F N L L L+ L++ N + L S + + +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP 265
Query: 589 EFLVGFQLLEYLNLSNNDFEG 609
+ L G L L+ ND +G
Sbjct: 266 QRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 5e-15
Identities = 52/301 (17%), Positives = 99/301 (32%), Gaps = 36/301 (11%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
L ++P ++ +FL N + +F +NL L + N L+ ++
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
++ + D N + L L + R L P + L+
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 308 VNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367
+ N L + + L ++ N
Sbjct: 136 LQDNALQALPD-----------------------------DTFRDLGNLTHLFLHGNRIS 166
Query: 368 GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQ 427
+ +L+ LLL N++ P AF +L+ L ++ N LS A+ L+
Sbjct: 167 SVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 428 NLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLT 487
L+ LRL +N ++ + L + S + + S+P L + L+ N+L
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ 282
Query: 488 G 488
G
Sbjct: 283 G 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (180), Expect = 6e-15
Identities = 42/246 (17%), Positives = 73/246 (29%), Gaps = 11/246 (4%)
Query: 52 KITHDPLGVFGS------WNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVG 105
+I+H P F + + + + +L A
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
L L L L P F L LQ L L +N++ NL + L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFG 225
N + L ++ + N + P +F +L + L+L NNL +
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 226 WLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVG 285
L+ L L + N + + + F +++ +P L +
Sbjct: 223 PLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQR----LAGRDLKRLA 277
Query: 286 RNQLTG 291
N L G
Sbjct: 278 ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (174), Expect = 4e-14
Identities = 51/301 (16%), Positives = 87/301 (28%), Gaps = 38/301 (12%)
Query: 286 RNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLN 345
+ L A+P I + + ++ N+++ + + I D
Sbjct: 20 QQGLQ-AVPVGIP--AASQRIFLHGNRISHVPA--ASFRACRNLTILWLHSNVLARIDAA 74
Query: 346 FLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKL 405
L+ ++ N + + L L LD + P F L
Sbjct: 75 AFT---GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 406 LRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYNFLQG 464
L + +N L +L NL L L NR + L L L L N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKN 524
P + L + L NNL+ +P + L L L L+ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249
Query: 525 LEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLS 584
L+ +++ +P L G + L+ N+L
Sbjct: 250 LQKFRGSSSEVPCSLP---------------------------QRLAGRDLKRLAANDLQ 282
Query: 585 G 585
G
Sbjct: 283 G 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 5e-14
Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 2/228 (0%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
+ + LH N H + F R L +L LH+N + A + + L ++ LS N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 170 GKI-PSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLK 228
+ P+ L ++ + L P F L+++ +L+L N L DTF L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQ 288
NL +L + NR+S + + S+ N++ V P L L + N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANN 212
Query: 289 LTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSL 336
L+ A++ L+ ++N N + L F + + +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (164), Expect = 7e-13
Identities = 44/313 (14%), Positives = 90/313 (28%), Gaps = 38/313 (12%)
Query: 154 SCSN--LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211
C N + L +P + + + + N ++ SF +++ L+L
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWL 63
Query: 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLD 271
N L F L L L ++ N ++ + F+ +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 272 IGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVI 331
+ L LQ+ + N L + NL ++ N+++
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE------------- 170
Query: 332 TRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKI 391
+ L ++ N + P + + + L N +
Sbjct: 171 ----------------RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA-NNL 213
Query: 392 FGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451
A L L + +N A L++ R + ++P +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 452 LFNLQLSYNFLQG 464
L +L+ N LQG
Sbjct: 273 L--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 52/269 (19%), Positives = 86/269 (31%), Gaps = 9/269 (3%)
Query: 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLREL 432
C + T + +P + + L NR+S + +NL L
Sbjct: 8 CYNEPKVTTSC----PQQGLQAVPVGIPAASQRIFLH--GNRISHVPAASFRACRNLTIL 61
Query: 433 RLQENRFLGNIPPSIGNLKLFNLQLSYN--FLQGSIPSSLGQSETLTIIDLSNNNLTGTI 490
L N + L L + L+ P++ L + L L
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 491 PPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLE 550
P GL++L + L N L + +L NL L + N++ R L+
Sbjct: 122 PGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 551 LLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGM 610
L + N + P + L L L L NNLS E L + L+YL L++N +
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
Query: 611 VPTEGVFRNASITSVLGNLKLCGGTHEFR 639
++ + C
Sbjct: 241 CRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 63.7 bits (153), Expect = 3e-11
Identities = 53/327 (16%), Positives = 92/327 (28%), Gaps = 17/327 (5%)
Query: 180 SKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNR 239
+ ++ L+ S+P +L S L S N+L +P+ LK+L+
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 240 LSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISN 299
LS P + S + I +L+ L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 300 ASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWF 359
E+ + K + G+ +L L +L T +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 360 HIN----INNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRL 415
+ + L + + T L S F +L + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 416 SGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSET 475
S I +L EL + N+ L +P L+ L S+N L +P
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNK-LIELPALPPRLE--RLIASFNHLA-EVPELPQN--- 325
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLI 502
L + + N L P + L +
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 49/333 (14%), Positives = 88/333 (26%), Gaps = 27/333 (8%)
Query: 155 CSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214
+ L++ L +P L E S N+LT +P +L S+ +
Sbjct: 37 DRQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 215 NLDGSIP---------DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265
L P + L L N + + ++ Q
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 266 GVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQR 325
++ ++ + P + + +P+L +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLL 385
++ + T L LT+ L ++ +
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL----- 266
Query: 386 LDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP 445
N I + L L + NN+L +P L L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNH-LAEVPE 321
Query: 446 SIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTI 478
NLK L + YN L+ P E L +
Sbjct: 322 LPQNLK--QLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 22/92 (23%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 139 LHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP 198
+ N+ EI + +L + +S+N+L+ ++P+ L E S+N+L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPE 321
Query: 199 SFGNLSSISFLFLSRNNLDGSIPDTFGWLKNL 230
NL L + N L PD +++L
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 53/329 (16%), Positives = 106/329 (32%), Gaps = 19/329 (5%)
Query: 132 RRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNN 191
R+ L L+N + +P +L+ S N L ++P SL + + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 192 LTGSIP----PSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
L+ P N L ++ I LK L +L + ++
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
+ + +L+ G N L
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 308 VNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367
N K ++P + + +T L+ ++ + ++ N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 368 GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQ 427
+ + +LE L + +NK+ +PA + L RL N L+ +P Q
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLA-EVPE---LPQ 324
Query: 428 NLRELRLQENRF--LGNIPPSIGNLKLFN 454
NL++L ++ N +IP S+ +L++ +
Sbjct: 325 NLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 12/99 (12%)
Query: 506 LSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPS 565
N + I + +LE LNV NKL E+P LE L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPE 321
Query: 566 SLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604
+L+ L + N L + P+ + +E L +++
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIP---ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 20/122 (16%), Positives = 36/122 (29%), Gaps = 9/122 (7%)
Query: 61 FGSWNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSF 120
+ + I + L+ L++ NN
Sbjct: 237 TDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 296
Query: 121 HHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLS 180
E+P+ RL RL N + E+P NL ++ + N L + P S+
Sbjct: 297 -IELPALPPRLERLI---ASFNHL-AEVP---ELPQNLKQLHVEYNPLR-EFPDIPESVE 347
Query: 181 KI 182
+
Sbjct: 348 DL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 6e-06
Identities = 26/96 (27%), Positives = 36/96 (37%), Gaps = 10/96 (10%)
Query: 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPI 515
N I S +L +++SNN L +P L L S N L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNHLAE-V 319
Query: 516 PNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
P +NL+ L+V N LR E P S L +
Sbjct: 320 PEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 8/80 (10%)
Query: 531 FENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEF 590
+ N EI LE L + N L +P+ L L S N+L+ ++PE
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPEL 322
Query: 591 LVGFQLLEYLNLSNNDFEGM 610
Q L+ L++ N
Sbjct: 323 P---QNLKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 16/54 (29%), Positives = 26/54 (48%), Gaps = 6/54 (11%)
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLN 529
++L+N L+ ++P L S L S N LT +P +LK+L + N
Sbjct: 40 AHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVDN 87
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 5e-10
Identities = 47/205 (22%), Positives = 74/205 (36%), Gaps = 23/205 (11%)
Query: 423 IGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLS 482
+ ++ + E+ + L +PP + L LS N L ++L LT ++L
Sbjct: 6 VSKVASHLEVNCDKRN-LTALPPDLPKD-TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 483 NNNLTGTIPPQLLGLSSLLIVLELSR--------------------NQLTGPIPNEVGNL 522
LT L + L + N+LT + L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 523 KNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNN 582
L+ L + N+L+ P L KLE L + N L L+ L L L L +N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 583 LSGKIPEFLVGFQLLEYLNLSNNDF 607
L IP+ G LL + L N +
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 33/212 (15%), Positives = 68/212 (32%), Gaps = 10/212 (4%)
Query: 103 HVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVR 162
V ++ ++ + +P + + +L L N + A + + L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 163 LSSNE-LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIP 221
L E ++ L L ++ + +P L +++ L +S N L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQS----LPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 222 DTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQF 281
L L L + N L P + + N + + + L+NL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG-LENLDT 176
Query: 282 FSVGRNQLTGAIPPAISNASNLEVFQVNSNKL 313
+ N L IP + L ++ N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 40/191 (20%), Positives = 62/191 (32%), Gaps = 12/191 (6%)
Query: 76 VTCSRRQHQRV--------TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSE 127
V C +R + TIL L L + A + + L L+L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-- 72
Query: 128 FDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSV 187
L L L L +N + + + + +S N L L L +++ +
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
N L P + L L+ NNL L+NL L + +N L TIP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 248 IFNISSITVFD 258
F +
Sbjct: 191 FFGSHLLPFAF 201
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 38/202 (18%), Positives = 61/202 (30%), Gaps = 51/202 (25%)
Query: 469 SLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEML 528
+ + + ++ NLT +PP L +L LS N L + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 529 NV---------------------------------------------FENKLRGEIPRTL 543
N+ N+L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 544 GSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLS 603
+L+ L ++GN L+ P L+ L L L+ NNL+ L G + L+ L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 604 NNDFEGMVPTEGVFRNASITSV 625
N +G F + +
Sbjct: 181 ENSL--YTIPKGFFGSHLLPFA 200
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 33/188 (17%), Positives = 50/188 (26%), Gaps = 19/188 (10%)
Query: 268 IPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEV--PYLEKLQR 325
+P D+ ++ + N L + + L ++ +LT L L
Sbjct: 25 LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLK-------------WFHININNFGGLLPA 372
L SL + RL N LP
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLREL 432
+ + LE L L +N + L L + N L TIP L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200
Query: 433 RLQENRFL 440
L N +L
Sbjct: 201 FLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 38/213 (17%), Positives = 58/213 (27%), Gaps = 30/213 (14%)
Query: 347 LCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLL 406
+C ++ +N + L A + +L L N ++ A + +L
Sbjct: 3 ICEVSKVASHL--EVNCDKRN--LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 407 RLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQG-- 464
+L + T G L L L L N+ L L +S+N L
Sbjct: 59 QLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 465 ---------------------SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIV 503
++P L NN +P LL L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 504 LELSRNQLTGPIPNEVGNLKNLEMLNVFENKLR 536
L L N L IP L + N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 5e-09
Identities = 18/151 (11%), Positives = 41/151 (27%), Gaps = 3/151 (1%)
Query: 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPP-SFGNLSSISFLFLS 212
+R + + + L + + + L + L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDI 272
++ L PD F + L L ++ N L ++ S+ N + L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 273 GFTLQNLQFFSVGRNQLTGAIPPAISNASNL 303
+ V +L +++ N
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 22/143 (15%), Positives = 41/143 (28%), Gaps = 1/143 (0%)
Query: 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGP 514
L+ + + L +E LT + + N + + L L L + ++ L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 515 IPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLS 574
P+ L LN+ N L +T+ EL+ L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 575 VLDLSQNNLSGKIPEFLVGFQLL 597
+ + + L L
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 7e-09
Identities = 42/299 (14%), Positives = 88/299 (29%), Gaps = 31/299 (10%)
Query: 160 RVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNL-DG 218
+ L+ L + L S I F + + + F + + LS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 219 SIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQN 278
++ L NL++ RLS I +++ S++ +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS--------------- 106
Query: 279 LQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGS 338
A+ +S+ S L+ ++ E + +S + N G
Sbjct: 107 --------GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 339 GEHRDLNFLCSLTNATRLKWFHIN--INNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP 396
++ + L +L + + L I
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 397 AAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNL 455
G+ L L+++ GT+ + L L++ + F P+IGN K +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 1/104 (0%)
Query: 430 RELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGT 489
+ L L ++ + + + + +F+ + + +DLSN+ + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 490 IPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFEN 533
+L S L L L +L+ PI N + NL LN+
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 8e-07
Identities = 37/231 (16%), Positives = 68/231 (29%), Gaps = 37/231 (16%)
Query: 356 LKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGN-IPAAFGKFVKLLRLEMWNNR 414
+ F + L S F ++ + L ++ I + + + KL L + R
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 415 LSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQ------------------ 456
LS I + + NL L L L
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 457 ---------------LSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
N + + + + + L +DLS++ + Q + L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 502 IVLELSR-NQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLEL 551
L LSR + E+G + L+ L VF G + + L++
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 43/298 (14%), Positives = 89/298 (29%), Gaps = 36/298 (12%)
Query: 211 LSRNNLDGSIPDTFGWL--KNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268
L+ NL PD G L + ++ ++ + + F+ + D + I+
Sbjct: 7 LTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVST 62
Query: 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKL---TGEVPYLEKLQR 325
I LQ S+ +L+ I ++ SNL ++ L R
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 326 LSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLL 385
L ++ + +H + T+L N L + + + L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 386 LDSNKIFGNIPAAFGKFVKLLRLEMWN-NRLSGTIPPAIGELQNLRELRLQENRFLGNIP 444
DS + + F + L L + + +GE+ L+ L++ G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 445 PSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLI 502
E L + ++ ++ T P + + I
Sbjct: 243 LLK--------------------------EALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 49/268 (18%), Positives = 86/268 (32%), Gaps = 18/268 (6%)
Query: 87 TILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGG 146
LDL L ++ + + + + + F R+Q + L N+ I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 147 E-IPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSS 205
+ +S CS L + L L I + L S + ++S + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 206 ISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSG--------TIPSSIFNISSITVF 257
L+ + V+ T+ Q LSG + + + ++
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 258 DAGINQIQGVIPLDIGFTLQNLQFFSVGR-NQLTGAIPPAISNASNLEVFQVNSNKLTGE 316
D + + F L LQ S+ R + + L+ QV G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 317 VPYL-EKLQRL----SHF-VITRNSLGS 338
+ L E L L SHF I R ++G+
Sbjct: 241 LQLLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 7e-05
Identities = 32/207 (15%), Positives = 73/207 (35%), Gaps = 10/207 (4%)
Query: 407 RLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQG-S 465
L++ L + + + R + + ++ ++ LS + ++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 466 IPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIV-LELSRNQLTGPIPNEVGNLKN 524
+ L Q L + L L+ I L S+L+ + L + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 525 LEMLNV------FENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDL 578
L+ LN+ E ++ + + +L L + N + + + + L LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 579 SQN-NLSGKIPEFLVGFQLLEYLNLSN 604
S + L + L++L+LS
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSR 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 6e-08
Identities = 28/124 (22%), Positives = 50/124 (40%), Gaps = 5/124 (4%)
Query: 478 IIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG 537
++ L++ +LT + L L + L+LS N+L P + L+ LE+L +N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLV-THLDLSHNRLRALPP-ALAALRCLEVLQASDNA-LE 56
Query: 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLL 597
+ ELL Q L S L +L+L N+L + ++L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 598 EYLN 601
++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 6e-08
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 5/118 (4%)
Query: 408 LEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIP 467
L + + L T+ + +L + L L NR L +PP++ L+ + L +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNR-LRALPPALAALRCLEV-LQASDNALENV 58
Query: 468 SSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNL 525
+ L + L NN L + Q L L++L L N L L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 9e-07
Identities = 29/108 (26%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 503 VLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGP 562
VL L+ LT + + L + L++ N+LR P L + LE+LQ N L+
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 563 IPSSLSSLRGLSVLDLSQNNL-SGKIPEFLVGFQLLEYLNLSNNDFEG 609
+ L L N L + LV L LNL N
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 17/106 (16%), Positives = 37/106 (34%), Gaps = 5/106 (4%)
Query: 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP 245
+++ +LT + L ++ L LS N L P L+ L + + +
Sbjct: 4 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENV 58
Query: 246 SSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291
+ N+ + N++Q + + L ++ N L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 7/119 (5%)
Query: 209 LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268
L L+ +L ++ L + +L ++ NRL P+ + + + V A N ++ V
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 269 PLDIGFTLQNLQFFSVGRNQLTG-AIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRL 326
+ LQ L + N+L A + + L + + N L E E+L +
Sbjct: 60 GVANLPRLQEL---LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 16/107 (14%), Positives = 34/107 (31%), Gaps = 26/107 (24%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIR---------- 160
+VL L + + ++L + L L +N + P +++ L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 161 ------------VRLSSNELVG-KIPSELGSLSKIEYFSVSYNNLTG 194
+ L +N L L S ++ ++ N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.8 bits (117), Expect = 3e-07
Identities = 28/167 (16%), Positives = 53/167 (31%), Gaps = 4/167 (2%)
Query: 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNN 413
+N N G + + L L L N++ G P AF + L++ N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 414 RLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQS 473
++ L L+ L L +N+ +P S +L + +
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148
Query: 474 ETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG 520
E L L+ P ++ + + +L ++ N G
Sbjct: 149 EWLRKKSLNGGAARCGAPSKVRDVQ----IKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 7e-06
Identities = 32/181 (17%), Positives = 65/181 (35%), Gaps = 9/181 (4%)
Query: 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANI-SSCSNLIRVRLSSNELV 169
+D EIP + L L++N +G + +L+++ L N+L
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229
G P+ S I+ + N + F L + L L N + +P +F L +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 230 LVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQL 289
L +L +A N + + F + + P ++++Q + ++
Sbjct: 128 LTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSK----VRDVQIKDLPHSEF 182
Query: 290 T 290
Sbjct: 183 K 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 31/188 (16%), Positives = 55/188 (29%), Gaps = 37/188 (19%)
Query: 71 CQWHGVTCSRRQHQRV--------TILDLKSLKLAGYI-SAHVGNLSFLKVLD------- 114
C+ V C+ R + + T L L +L G L L L+
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 115 -----------------LHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSN 157
L N F L +L+ L L++N I +P + ++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 158 LIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD 217
L + L+SN + S++ P + + L +
Sbjct: 128 LTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
Query: 218 GSIPDTFG 225
S ++ G
Sbjct: 184 CSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 27/167 (16%), Positives = 50/167 (29%), Gaps = 30/167 (17%)
Query: 465 SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLL----------------------- 501
IP + T + L++N L L G L
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 502 -IVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQ 560
L+L N++ L L+ LN+++N++ +P + L L + N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 561 GPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDF 607
L L+ P + Q+ +L +++F
Sbjct: 140 C-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 24/138 (17%), Positives = 43/138 (31%), Gaps = 4/138 (2%)
Query: 64 WNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHE 123
E + + L L K+ + L LK L+L++N
Sbjct: 58 KLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117
Query: 124 IPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIE 183
+P F+ L L L L +N + L + L+ PS++ +
Sbjct: 118 MPGSFEHLNSLTSLNLASNPFNCNCHLAWFA-EWLRKKSLNGGAARCGAPSKVRDVQ--- 173
Query: 184 YFSVSYNNLTGSIPPSFG 201
+ ++ S S G
Sbjct: 174 IKDLPHSEFKCSSENSEG 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 16/84 (19%), Positives = 31/84 (36%), Gaps = 4/84 (4%)
Query: 476 LTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG----PIPNEVGNLKNLEMLNVF 531
+ +D+ L+ +LL L V+ L LT I + + L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 532 ENKLRGEIPRTLGSCIKLELLQMQ 555
N+L + ++ ++Q
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 110 LKVLDLHNNSFHHEIPSE-FDRLRRLQVLALHNNSIGGE----IPANISSCSNLIRVRLS 164
++ LD+ +E L++ QV+ L + + I + + L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTG 194
SNEL + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 19/81 (23%), Positives = 33/81 (40%), Gaps = 8/81 (9%)
Query: 451 KLFNLQLSYNFLQG----SIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGL----SSLLI 502
L L L+ + S+ ++L + +L +DLSNN L QL+ LL
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 503 VLELSRNQLTGPIPNEVGNLK 523
L L + + + + L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 16/97 (16%), Positives = 37/97 (38%), Gaps = 10/97 (10%)
Query: 524 NLEMLNVFENKLRGEIPRTLGSCIK-LELLQMQGNFLQG----PIPSSLSSLRGLSVLDL 578
+++ L++ +L L ++ +++++ L I S+L L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 579 SQNNLSGKIPEFLVGF-----QLLEYLNLSNNDFEGM 610
N L ++ ++ L+L N G
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 15/97 (15%), Positives = 29/97 (29%), Gaps = 23/97 (23%)
Query: 499 SLLIVLELSRNQLTG----PIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQM 554
S+L VL L+ ++ + + +L L++ N L L ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------ 422
Query: 555 QGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFL 591
L L L S ++ + L
Sbjct: 423 -------------QPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 545 SCIKLELLQMQGNFLQG----PIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGF-----Q 595
L +L + + + ++L + L LDLS N L LV
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 596 LLEYLNLSNNDFEGMVP 612
LLE L L + + +
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 11/87 (12%)
Query: 428 NLRELRLQENRF----LGNIPPSIGNLKLFNLQLSYNFLQG----SIPSSLGQSETLTII 479
+++ L +Q + P + + ++L L I S+L + L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQ--VVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 480 DLSNNNLTGTIPPQLL-GLSSLLIVLE 505
+L +N L +L GL + ++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 11/94 (11%)
Query: 403 VKLLRLEMWNNRLSGT-IPPAIGELQNLRELRLQENRF----LGNIPPSIGNLK-LFNLQ 456
+ + L++ LS + LQ + +RL + +I ++ L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 457 LSYNFLQGSIPSSLGQ-----SETLTIIDLSNNN 485
L N L + Q S + + L N
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 13/97 (13%), Positives = 28/97 (28%), Gaps = 9/97 (9%)
Query: 116 HNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE----IPANISSCSNLIRVRLSSNELVGK 171
+ L+VL L + + + A + + +L + LS+N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 172 IPSELGS-----LSKIEYFSVSYNNLTGSIPPSFGNL 203
+L +E + + + L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 15/93 (16%)
Query: 89 LDLKSLKLAGY------ISAHVGNLSFLKVLDLHNNSFHHE----IPSEFDRLRRLQVLA 138
LD++SL + + + L +V+ L + I S L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 139 LHNNSIGGEIPANI-----SSCSNLIRVRLSSN 166
L +N +G + + + ++ L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 13/91 (14%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 157 NLIRVRLSSNELVGKIPSEL-GSLSKIEYFSVSYNNLTG----SIPPSFGNLSSISFLFL 211
++ + + EL +EL L + + + LT I + +++ L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSG 242
N L + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.9 bits (117), Expect = 1e-06
Identities = 53/340 (15%), Positives = 103/340 (30%), Gaps = 26/340 (7%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGE----IPANISSCSNLIRVRLSS 165
LK+ + + + ++ + L N+IG E + NI+S +L S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 166 N---ELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPD 222
+ +IP L L + + + S FLS++ +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 223 TFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFF 282
L +A+ + N + G N+++ + T Q+ +
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 283 SVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHR 342
+ N + + L + Y ++L+ L T LGS
Sbjct: 189 ------------HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 343 DLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIP-----A 397
L ++ ++ A + L+ L L N+I +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 398 AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQEN 437
K LL LE+ NR S + E++ + R +
Sbjct: 297 IDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 40/311 (12%), Positives = 81/311 (26%), Gaps = 25/311 (8%)
Query: 165 SNELVGKIPSELGSLSKIEYFSVSYNNLTG----SIPPSFGNLSSISFLFLSRNNLDGSI 220
+ E + + L ++ +S N + + + + + S
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQ 280
+ L+ L+ + +L S + +
Sbjct: 76 DEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 135
Query: 281 FF--SVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSL-- 336
+ R A+ NA L N+L SH ++ +
Sbjct: 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195
Query: 337 --GSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISN---FSTTLEVLLLDSNKI 391
E + L L LK + N F L + ++ L L L+ +
Sbjct: 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255
Query: 392 FGNIPAA------FGKFVKLLRLEMWNNRLSGTIPPAIGE-----LQNLRELRLQENRFL 440
AA + + L L + N + + + +L L L NRF
Sbjct: 256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF- 314
Query: 441 GNIPPSIGNLK 451
+ ++
Sbjct: 315 SEEDDVVDEIR 325
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 38/332 (11%), Positives = 90/332 (27%), Gaps = 28/332 (8%)
Query: 186 SVSYNNLTG----SIPPSFGNLSSISFLFLSRNNLDG----SIPDTFGWLKNLVNLTMAQ 237
S+ + +T S+ S+ + LS N + + + K+L +
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 238 N---RLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIP 294
R+ IP ++ + + ++ ++ + L F L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 295 PAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNAT 354
+ + + L + RN L +G ++
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF------ 182
Query: 355 RLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNR 414
H ++ + L + L + + F L +
Sbjct: 183 ---QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 415 LSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQS- 473
S +G L + + + + N+ L L+L YN ++ +L
Sbjct: 240 KSWPNLRELGLNDC--LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 474 ----ETLTIIDLSNNNLTGTIPPQLLGLSSLL 501
L ++L+ N + + + +
Sbjct: 298 DEKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 34/217 (15%), Positives = 64/217 (29%), Gaps = 22/217 (10%)
Query: 402 FVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQLSYN 460
+++ + ++ T+ A +L + L + I + L L L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTG-VTTIEG-VQYLNNLIGLELKDN 73
Query: 461 FLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSR------------ 508
+ P T + + I + L +++
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 509 -NQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSL 567
I N + + + L + KL L+ N + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 568 SSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604
+SL L + L N +S P L L + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 26/216 (12%), Positives = 63/216 (29%), Gaps = 15/216 (6%)
Query: 276 LQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335
L N + G++ +T + ++ + +T + ++ L L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQ 74
Query: 336 LGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNI 395
+ + + +++ + + +V L +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 396 PAAFGKFVKLLRLEMW-------NNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIG 448
+ + L + + L L L+ +N+ P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 449 NLK-LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSN 483
+L L + L N + P L + L I+ L+N
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 40/233 (17%), Positives = 74/233 (31%), Gaps = 26/233 (11%)
Query: 227 LKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGR 286
L N + + ++ ++ T+ + ++ IT A + + + L NL +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ---YLNNLIGLELKD 72
Query: 287 NQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNF 346
NQ+ ++ NL S + S + D+
Sbjct: 73 NQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS---TQITDVTP 124
Query: 347 LCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLL 406
L L+N L I N L + + KL
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYL--------SIGNAQVSDLTPLANLSKLT 176
Query: 407 RLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLS 458
L+ +N++S P + L NL E+ L+ N+ P + N LF + L+
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 3e-05
Identities = 19/132 (14%), Positives = 41/132 (31%), Gaps = 7/132 (5%)
Query: 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165
N + LDL I + L + + +N I L + +++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 166 NELVGKIPSELGSLSKIEYFSVSYNNLTG-SIPPSFGNLSSISFLFLSRNN---LDGSIP 221
N + +L + ++ N+L +L S+++L + RN
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 222 DTFGWLKNLVNL 233
+ + L
Sbjct: 133 YVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 5e-04
Identities = 22/148 (14%), Positives = 46/148 (31%), Gaps = 8/148 (5%)
Query: 161 VRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSI 220
V+L++ L+ + + + + + I L + S N +
Sbjct: 1 VKLTAE-LIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--K 55
Query: 221 PDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQ 280
D F L+ L L + NR+ + +T N + + LD +L++L
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 281 FFSVG---RNQLTGAIPPAISNASNLEV 305
+ + I + V
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRV 143
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 25/152 (16%), Positives = 49/152 (32%), Gaps = 9/152 (5%)
Query: 433 RLQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPP 492
+L + ++ L L + I + + ID S+N +
Sbjct: 2 KLTAE-LIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 493 QLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG----EIPRTLGSCIK 548
LL L L ++ N++ L +L L + N L + +L S
Sbjct: 60 PLL---RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116
Query: 549 LELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
L +L+ + + + + VLD +
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 18/134 (13%), Positives = 41/134 (30%), Gaps = 5/134 (3%)
Query: 399 FGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKLFNLQLS 458
+ V+ L++ ++ I L + +N + + +L L ++
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-IRKLDGFPLLRRLKTLLVN 71
Query: 459 YNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELS---RNQLTGPI 515
N + LT + L+NN+L L L L +
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 516 PNEVGNLKNLEMLN 529
+ + + +L+
Sbjct: 132 LYVIYKVPQVRVLD 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 7/142 (4%)
Query: 79 SRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLA 138
S+R LDLK L+ + + VL+ ++ + + + L L
Sbjct: 17 SKRYDGSQQALDLKGLR----SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLN 71
Query: 139 LHNNSIGG--EIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI 196
L NN + ++ + + NL + LS NEL + + K+E + N+L+ +
Sbjct: 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131
Query: 197 PPSFGNLSSISFLFLSRNNLDG 218
+S+I F LDG
Sbjct: 132 RDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.002
Identities = 19/126 (15%), Positives = 43/126 (34%), Gaps = 7/126 (5%)
Query: 110 LKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELV 169
+ LDL ++ + VL ++ + + L+ + LS+N L
Sbjct: 24 QQALDLKGLRSDPDLVA----QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 170 GK--IPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWL 227
+ S + ++ ++S N L + L+L N+L + D ++
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 228 KNLVNL 233
+
Sbjct: 139 SAIRER 144
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 37/238 (15%), Positives = 74/238 (31%), Gaps = 11/238 (4%)
Query: 209 LFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVI 268
+ + IP +N + L +L + + + N + VI
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 269 PLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSH 328
D+ L L + + I P + + SN +P + K+ L
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 329 FVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDS 388
++ + + + +N G + T L+ L L
Sbjct: 130 VLLDIQD----NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 389 NKIFGNIPA-AFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPP 445
N +P F + L++ R+ ++P L+NL++LR + L +P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 29/234 (12%), Positives = 64/234 (27%), Gaps = 9/234 (3%)
Query: 188 SYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247
+ +T IP + L L F +L + ++QN + I +
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQ 307
+F+ + F + + N I + +
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT---GIKHLPDVHKIHSLQK 129
Query: 308 VNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFG 367
V + + + L ++ N T+L +++ NN
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 368 GLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPP 421
LP + + ++ +L + +I KL +N + +P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 10/81 (12%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 64 WNESIHFCQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHV-GNLSFLKVLDLHNNSFHH 122
++ + ++ L+L + V S +LD+ H
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 123 EIPSEFDRLRRLQVLALHNNS 143
+ L++L+ + +N
Sbjct: 216 LPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/65 (16%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 475 TLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534
+ + + +T IP L I L +L +LE + + +N
Sbjct: 9 SNRVFLCQESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 535 LRGEI 539
+ I
Sbjct: 65 VLEVI 69
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 37/204 (18%), Positives = 71/204 (34%), Gaps = 18/204 (8%)
Query: 402 FVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNL-KLFNLQLSYN 460
F + ++ + ++ + EL ++ ++ + I L + L L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 461 FLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG 520
L P + +L N ++ LSSL + +L L +++
Sbjct: 79 KLTDIKPLA----------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 521 NLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQ 580
L +L L T+ S + + I L+ L L L LS+
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187
Query: 581 NNLSGKIPEFLVGFQLLEYLNLSN 604
N++S L G + L+ L L +
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1033 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.36 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.09 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=427.32 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=204.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|+.+ ..||||+++.. .....+.+.+|++++++++|||||++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 468999999999999999999875 25999998743 3445678999999999999999999999853 235
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+++|+|.++++. ....+++.++..++.||++||+|||++ +||||||||+|||+++++.+||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence 7999999999999999953 335689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||+|+...............||+.|||||++.+ ..|+.++|||||||++|||+||+.||..............+.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 99999987654443333334569999999999864 358999999999999999999999986432111111111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILL 1021 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1021 (1033)
..+....+ .+..+++++.+++.+||+.||++||||+||++.|+.+++..+
T Consensus 226 ~~~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 226 YLSPDLSK---------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCCCCGGG---------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCcchh---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11111100 111245679999999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=426.72 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=203.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....+++.+|++++++++||||+++++++ .+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence 357999999999999999999999999999999997543 23346789999999999999999999995 445689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+||||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 79 ~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEc
Confidence 99999999999999994 345699999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+|+..............+||+.|||||++.+..+ +.++||||+||++|||++|+.||.........+.........
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~ 225 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence 9999997754443333344569999999999988876 578999999999999999999996433222222211111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.. .....++++.+++.+||+.||++|||++|+++
T Consensus 226 ~~------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LN------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ST------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00112355789999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=422.63 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=206.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++ ..++..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 4799999999999999999999999999999999866555667899999999999999999999995 44558999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||++||+|.+++.+ ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++++||+||
T Consensus 95 vmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence 9999999999998742 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+|+......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+........+.
T Consensus 161 G~a~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~-- 235 (293)
T d1yhwa1 161 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-- 235 (293)
T ss_dssp TTCEECCSTTCCB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC--
T ss_pred hhheeeccccccc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC--
Confidence 9999875443322 23459999999999999999999999999999999999999985321111 011111100000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+..+++++.+++.+||+.||++|||++|+++.
T Consensus 236 ---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ---------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111234568999999999999999999999763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=419.61 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=198.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++||||++++|+|. .++..+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceE
Confidence 357899999999999999999987 57789999997543 33478999999999999999999999964 345789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+++.. ....+++..+..++.|||+||+|||++ +|+||||||+||++++++.+||+|
T Consensus 77 lv~E~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~D 144 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 144 (263)
T ss_dssp EEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECS
T ss_pred EEEEecCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecc
Confidence 99999999999999853 345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+|+..|+...... ..+.........
T Consensus 145 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~-- 220 (263)
T d1sm2a_ 145 FGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR-- 220 (263)
T ss_dssp CC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCC--
T ss_pred cchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcCC--
Confidence 99998765443322 22345899999999999999999999999999999999954443211111 111111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
...+..+++++.+++.+||+.||++||||+||+++|+++++.
T Consensus 221 ----------------------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 ----------------------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 001112345689999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-48 Score=422.47 Aligned_cols=270 Identities=24% Similarity=0.406 Sum_probs=201.7
Q ss_pred CCCHHHHHHhh---------CCCCccceecccCceeEEEEEeCCCCe---EEEEEEeecc-CchhHHHHHHHHHHHHhcC
Q 042075 700 NISYQNLYNAT---------DGFTSANLIGAGSFGSVYKGILDEGKT---IVAVKVFNLL-HHGAFKSFIAECNTLKNIR 766 (1033)
Q Consensus 700 ~~~~~~l~~~~---------~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~ 766 (1033)
.+++++...++ ++|++.++||+|+||+||+|+++.+++ .||||++... .....++|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34555555554 356667899999999999999876554 5889987643 3344578999999999999
Q ss_pred CCCceeEeeeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042075 767 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPP 846 (1033)
Q Consensus 767 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (1033)
|||||+++++|. .++..++||||+++|+|.+++.. ....+++.++..++.||++||+|||++ +
T Consensus 86 HpnIv~l~g~~~-----~~~~~~iv~Ey~~~g~L~~~~~~---------~~~~l~~~~~~~i~~qia~gl~yLH~~---~ 148 (299)
T d1jpaa_ 86 HPNVIHLEGVVT-----KSTPVMIITEFMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLADM---N 148 (299)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCccEEEEEe-----eCCEEEEEEEecCCCcceeeecc---------ccCCCCHHHHHHHHHHHHHHHHHHhhC---C
Confidence 999999999963 44578999999999999998853 345689999999999999999999999 9
Q ss_pred cEeccCCCCCeEecCCCcEEEeecccceecCCCCccc---cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 847 IVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQT---SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
|+||||||+|||+++++++||+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||+|
T Consensus 149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t 228 (299)
T d1jpaa_ 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228 (299)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence 9999999999999999999999999998765433221 1222347899999999999999999999999999999998
Q ss_pred -CCCCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC
Q 042075 924 -RKKPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002 (1033)
Q Consensus 924 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1002 (1033)
|+.||..... .......... .+.+.+.++++++.+++.+||+.||++
T Consensus 229 ~g~~Pf~~~~~--~~~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 229 YGERPYWDMTN--QDVINAIEQD------------------------------YRLPPPMDCPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp TSCCTTTTCCH--HHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred CCCCCCCCCCH--HHHHHHHHcC------------------------------CCCCCCccchHHHHHHHHHHcCCCHhH
Confidence 8999863211 1111111100 001112234567899999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 042075 1003 RMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 1003 RPt~~evl~~L~~i~~ 1018 (1033)
||||+||++.|+++.+
T Consensus 277 RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 277 RPKFGQIVNTLDKMIR 292 (299)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHhc
Confidence 9999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=424.03 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=211.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++|||||+++++| ..++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCee
Confidence 4567899999999999999999999899999999987543 3457899999999999999999999995 345588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++||||+++|+|.+++.. .....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEeecccCcchHHHhhh--------ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEc
Confidence 999999999999999954 2446789999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
|||+|+........ ......|++.|+|||++.+..|+.++|||||||++|||++|..||....... ...+.......
T Consensus 158 DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~~- 234 (287)
T d1opja_ 158 DFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR- 234 (287)
T ss_dssp CCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCC-
T ss_pred cccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCCC-
Confidence 99999876544332 2223448899999999999999999999999999999999877764221111 11111111100
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
...+..+++++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 235 -----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 -----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -----------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111234668999999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=413.27 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=203.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 5799999999999999999999999999999998642 223456789999999999999999999994 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence 999999999999999994 345689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+....... ....||+.|||||++.+..++.++|||||||++|||++|+.||+... ..........
T Consensus 148 ~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~ 218 (263)
T d2j4za1 148 ADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISR 218 (263)
T ss_dssp CCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHT
T ss_pred cccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHHHc
Confidence 99999986654322 22459999999999999999999999999999999999999986321 1111111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... ..+..+++++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~----------------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VEF----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 000 000112456889999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=415.00 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=206.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||+++++|.+ +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 457889999999999999999987 67889999997543 334789999999999999999999998632 3578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+++.. .....+++.++++|+.||++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 99999999999998853 2345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+||..|+....... ...+......
T Consensus 153 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~--- 227 (272)
T d1qpca_ 153 FGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY--- 227 (272)
T ss_dssp CTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTC---
T ss_pred ccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcC---
Confidence 99999875443222 223458999999999998999999999999999999999766543221111 1111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
+...+..+++++.+++.+||+.||++||||+||++.|+.+-.
T Consensus 228 ---------------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 ---------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 000111234568999999999999999999999999998744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=415.51 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=194.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... +...+.+.+|++++++++|||||++++++.+ ..++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 367999999999999999999999999999999987542 3445678999999999999999999998642 23456
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCcEeccCCCCCeEecCCCcE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDC--QPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
.|+||||+++|+|.+++.+. ......+++.+++.++.||+.||+|||++. ..+|+||||||+|||+++++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 89999999999999998531 123457999999999999999999999871 1149999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
||+|||+|+......... ....||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.....
T Consensus 154 kl~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i 226 (269)
T d2java1 154 KLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKI 226 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH
T ss_pred EEeeccceeecccCCCcc--ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHH
Confidence 999999998765433222 224599999999999999999999999999999999999999863211 1111110
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. ...... .+..+++++.+++.+||+.||++|||++|+++
T Consensus 227 ~--------~~~~~~-------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 R--------EGKFRR-------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp H--------HTCCCC-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------cCCCCC-------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 000000 00112456899999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=418.22 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=204.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++ ..++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 4689999999999999999999999999999999876666778899999999999999999999995 44558999
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeec
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDF 870 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~Df 870 (1033)
||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 vmEy~~~g~L~~~~~~---------~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---------LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence 9999999999999842 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
|+|+....... ......||+.|+|||++. +..|+.++||||+||++|||++|+.||......+ .+.......
T Consensus 155 G~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~ 231 (288)
T d2jfla1 155 GVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSE 231 (288)
T ss_dssp TTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSC
T ss_pred hhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCC
Confidence 99986532211 122345999999999974 4568999999999999999999999986322111 111111100
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
. . ....+..+++++.+++.+||+.||++|||++|+++
T Consensus 232 ~-~----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 P-P----------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-C----------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-C----------------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 00011123456899999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=408.31 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=197.3
Q ss_pred CccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 714 TSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 714 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
+..++||+|+||+||+|++..+++.||+|+++.. .....+.+.+|++++++++|||||++++++... ...+...++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 5667899999999999999999999999998743 334456789999999999999999999997542 2334568999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec-CCCcEEEeec
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD-EEMIAHVGDF 870 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~Df 870 (1033)
|||+++|+|.++++ ....+++.++..++.||++||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus 91 mE~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCcHHHHHh----------ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 99999999999994 345689999999999999999999998 12399999999999996 5789999999
Q ss_pred ccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcch
Q 042075 871 GLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 871 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+|+....... ....||+.|||||++.+ .++.++||||+||++|||++|+.||.... ......+.......
T Consensus 160 Gla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 160 GLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVK 230 (270)
T ss_dssp TGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCC
T ss_pred CcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cHHHHHHHHHcCCC
Confidence 99986433222 22459999999999865 69999999999999999999999985321 11111111110000
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
... .+....+++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc--------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 000 00112345889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=416.06 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=202.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 5799999999999999999999989999999998742 233456789999999999999999999994 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhh----------ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence 999999999999999984 345799999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+...............||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..........
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~ 224 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIK 224 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHT
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHHHc
Confidence 99999998765444333334569999999999999999999999999999999999999986321 1111111100
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
... . .+...++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~------~----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 LEY------D----------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TCC------C----------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCC------C----------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 000 0 001123558899999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=423.48 Aligned_cols=200 Identities=26% Similarity=0.345 Sum_probs=176.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ....+++.+|+.++++++|||||+++++| ..++.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3578999999999999999999999999999999997543 33456789999999999999999999995 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
.|+||||+++|+|.+++. ....+++.++..++.|++.||+|||+ + ||+||||||+|||+++++++|
T Consensus 79 ~~iVmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp EEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEE
Confidence 999999999999999995 23468999999999999999999996 5 899999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDI 930 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~ 930 (1033)
|+|||+|+...... ....+||+.|||||++.+..|++++||||+||++|||++|+.||..
T Consensus 146 l~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 146 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred EeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999998653221 1224599999999999999999999999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=410.67 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=200.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC----eEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK----TIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
++.|++.++||+|+||+||+|.++.++ ..||||+++... .....++.+|++++++++|||||+++|+|. .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----c
Confidence 356888999999999999999987544 579999987533 334467899999999999999999999963 4
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
.+..++||||+.++++.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred CCceEEEEEecccCcchhhhhc---------ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCe
Confidence 4578999999999999998753 446799999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHh
Q 042075 865 AHVGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAK 943 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 943 (1033)
+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... .+...
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~ 224 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMK 224 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHH
Confidence 999999999876543322 2222345899999999999999999999999999999999976665322111 11111
Q ss_pred hhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 944 TALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 944 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
. +... .+.+.+..++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 225 ~---------i~~~------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 225 A---------INDG------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp H---------HHTT------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H---------Hhcc------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 0000 01111123456689999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=409.42 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCCCccce-ecccCceeEEEEEeCC--CCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANL-IGAGSFGSVYKGILDE--GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... ....+++.+|++++++++|||||+++++|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 45666774 9999999999998753 45689999997543 3445789999999999999999999998632 2
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++|+|.+++.. ....+++.++..++.||++||+|||++ +|+||||||+||++++++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 57999999999999999853 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 867 VGDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .........
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~ 227 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ 227 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence 9999999987554332 22223458999999999999999999999999999999998 8999863211 111111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.. +...+..+++++.+++.+||+.||++|||+.+|.+.|+.+....
T Consensus 228 ~~------------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GK------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 00 01111234567899999999999999999999999998775543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=401.18 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=208.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++++|. .++..+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceE
Confidence 468999999999999999999986 788999999986443 3478999999999999999999999963 445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.+++.. ....+++..+.+++.||++||+|||++ ||+||||||+||++++++.+||+|
T Consensus 76 iv~Ey~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D 143 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143 (258)
T ss_dssp EEEECCTTEEHHHHHHS---------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHhhhc---------cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence 99999999999999753 456789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+..... ...........
T Consensus 144 fG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~- 219 (258)
T d1k2pa_ 144 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR- 219 (258)
T ss_dssp CSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC-
T ss_pred chhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCC-
Confidence 9999876544332 2233458999999999999999999999999999999998 89998633211 11111111000
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
...+..+++++.+++.+||+.||++|||++|+++.|.+
T Consensus 220 -----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 -----------------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----------------------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 00111234568999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=418.17 Aligned_cols=254 Identities=21% Similarity=0.239 Sum_probs=189.6
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
..+.|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++ ..++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999999999999987533 23345678999999999999999999994 55668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec---CCCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD---EEMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~ 864 (1033)
.|+||||++||+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++. +++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEEECCCCSCBHHHHHH----------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeccCCCcHHHhhh----------cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence 999999999999999994 345699999999999999999999999 999999999999994 5789
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+|+......... ...||+.|||||++.+..|++++||||+||++|||++|+.||......+ ........
T Consensus 149 vkl~DFG~a~~~~~~~~~~---~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~ 224 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 224 (307)
T ss_dssp EEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTT
T ss_pred EEEeccceeEEccCCCeee---eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhcc
Confidence 9999999998764433222 2459999999999999999999999999999999999999996321110 01111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+.....++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEFD----------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCC----------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCC----------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00000 00011234568999999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=419.13 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=205.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC-----eEEEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK-----TIVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.++||+|+||+||+|++..++ ..||||++... .......+.+|+.+++++ +|||||+++++|
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 357899999999999999999986443 36999988643 334456789999999998 899999999995
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc-------------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVH 849 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (1033)
...+..++||||+++|+|.++++....... .......+++.+++.++.||++||+|||++ +|||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 445588999999999999999965332110 012235689999999999999999999999 9999
Q ss_pred ccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 042075 850 CDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPT 928 (1033)
Q Consensus 850 rDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~ 928 (1033)
|||||+||+++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444333334458999999999999999999999999999999998 89998
Q ss_pred CccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042075 929 DIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTN 1008 (1033)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1008 (1033)
..... ...+.+...... +++.+..+++++.+++.+||+.||++|||++|
T Consensus 268 ~~~~~-~~~~~~~~~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 268 PGIPV-DANFYKLIQNGF------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp TTCCC-SHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCH-HHHHHHHHhcCC------------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 63221 111222211111 01111224567899999999999999999999
Q ss_pred HHHHHHH
Q 042075 1009 VVHQLQS 1015 (1033)
Q Consensus 1009 vl~~L~~ 1015 (1033)
|+++|..
T Consensus 317 i~~~L~~ 323 (325)
T d1rjba_ 317 LTSFLGC 323 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=405.06 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=198.5
Q ss_pred ceecccCceeEEEEEeC--CCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEEE
Q 042075 717 NLIGAGSFGSVYKGILD--EGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 792 (1033)
Q Consensus 717 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 792 (1033)
++||+|+||+||+|.++ .+++.||||+++.. .....+++.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 57999999999999864 34678999998643 23345789999999999999999999999632 2478999
Q ss_pred EcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeeccc
Q 042075 793 EFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFGL 872 (1033)
Q Consensus 793 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 872 (1033)
||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence 9999999999984 345689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCcch
Q 042075 873 ATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPDHV 950 (1033)
Q Consensus 873 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 950 (1033)
|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..........
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~----- 226 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKG----- 226 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT-----
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcC-----
Confidence 9977544332 22233458999999999999999999999999999999998 8999863211 1111111110
Q ss_pred hhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 042075 951 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIK 1017 (1033)
Q Consensus 951 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 1017 (1033)
.+.+.+..+++++.+++.+||+.||++|||++||.+.|+..-
T Consensus 227 -------------------------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 227 -------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------------------------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 001111234567899999999999999999999999888753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-46 Score=418.30 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=207.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++ ..++..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 46899999999999999999999999999999999876666667899999999999999999999995 4556899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--CCCcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEMIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL 867 (1033)
+||||++||+|.+++.. ....+++.++..++.||+.||+|||++ |||||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHTC---------TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999853 345699999999999999999999999 999999999999996 4578999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+......... ...||+.|||||++.+..++.++||||+||++|||++|+.||..... ...+.........
T Consensus 168 ~DFG~a~~~~~~~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~ 243 (350)
T d1koaa2 168 IDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWN 243 (350)
T ss_dssp CCCTTCEECCTTSCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC
T ss_pred eecchheecccccccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC
Confidence 9999999875544332 24499999999999999999999999999999999999999863211 0111111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .. .....+++++.+++.+||+.||++|||++|+++.
T Consensus 244 ~------------~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 M------------DD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp S------------CC----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C------------Cc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 0001224568899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-46 Score=413.39 Aligned_cols=254 Identities=18% Similarity=0.242 Sum_probs=207.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||+++++ +..++..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEE
Confidence 3579999999999999999999998999999999987665566788899999999999999999999 45566899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec--CCCcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD--EEMIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL 867 (1033)
+||||++||+|.+++.. ....+++.++..|+.||+.||+|||++ ||+||||||+|||++ .++.+||
T Consensus 103 ivmE~~~gg~L~~~~~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 103 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCChHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEE
Confidence 99999999999998742 345699999999999999999999999 999999999999998 6789999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+......... ...||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+.........
T Consensus 171 ~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~ 246 (352)
T d1koba_ 171 IDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE 246 (352)
T ss_dssp CCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC
T ss_pred eecccceecCCCCcee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence 9999999876544332 234899999999999999999999999999999999999998632111 011111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. . ......++++.+++.+||+.||++|||++|+++.
T Consensus 247 ~~------~----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FD------E----------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CC------S----------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC------c----------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0 0001124568999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=410.25 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=198.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
+.|+..+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++ ..++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCE
Confidence 35899999999999999999999999999999987543 23346788999999999999999999995 34558
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||+++|++..++. ....+++.++..++.||+.||+|||++ ||+||||||+|||+++++++||
T Consensus 90 ~~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp EEEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence 999999999999987763 345699999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+|||+|+..... ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+ .+......
T Consensus 157 ~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~ 229 (309)
T d1u5ra_ 157 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (309)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred eecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence 999999865332 22459999999999864 468999999999999999999999985321110 01111110
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
..+ ... ...+++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~---------~~~---------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESP---------ALQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC---------CCS---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---------CCC---------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 000 000 0012356899999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=399.09 Aligned_cols=254 Identities=27% Similarity=0.367 Sum_probs=199.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+++.+|++++++++||||++++|+|. +..+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEE
Confidence 356888999999999999999985 778999999753 34478999999999999999999999873 3345679
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|.++++. .....+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|
T Consensus 78 lv~ey~~~g~L~~~l~~--------~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp EEECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecc
Confidence 99999999999999953 2334689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+++....... ...+|..|+|||++.+..+++++|||||||++|||+| |++||.... .......+....
T Consensus 147 fg~s~~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~~~-- 217 (262)
T d1byga_ 147 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY-- 217 (262)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTC--
T ss_pred cccceecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCC--
Confidence 999986543222 2347899999999999999999999999999999998 677775321 111111111110
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+++.+..+++++.+++.+||+.||++||||.|++++|++++..
T Consensus 218 ----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 ----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 0111112345689999999999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=405.15 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=203.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC------chhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 367999999999999999999999999999999986432 12357799999999999999999999994 5
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
+++..|+||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~----------~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS
T ss_pred ECCEEEEEEEcCCCccccchhc----------cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC
Confidence 5668999999999999999994 335699999999999999999999999 999999999999998776
Q ss_pred ----cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 864 ----IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 864 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
.+|++|||+|+......... ...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~ 223 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQE 223 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred CcccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHH
Confidence 59999999999875543322 2348999999999999999999999999999999999999986321 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
........ .. ... ......+++++.+++.+||+.||++|||++|+++
T Consensus 224 -~~~~i~~~--------~~-~~~---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 224 -TLANVSAV--------NY-EFE---------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HHHHHHTT--------CC-CCC---------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHhc--------CC-CCC---------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100000 00 000 0011123456889999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=410.97 Aligned_cols=275 Identities=24% Similarity=0.361 Sum_probs=211.8
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccCc-hhHHHHHHHHHHHHhcCCCCceeEeeee
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTAC 777 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 777 (1033)
.+++-..++|++.+.||+|+||+||+|+++ .+++.||||+++.... ...+++.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999999999999975 3568899999875433 3456799999999999999999999996
Q ss_pred ccccccCCCceeEEEEcccCCchhhhcccCCCCc--------------cccccccccCHHHHHHHHHHHHHHHHHHHhCC
Q 042075 778 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED--------------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDC 843 (1033)
Q Consensus 778 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 843 (1033)
. ..+..++||||+++|+|.++++...... ........+++.+++.|+.|++.||+|||++
T Consensus 86 ~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-
Confidence 4 4457899999999999999996432211 0112344689999999999999999999999
Q ss_pred CCCcEeccCCCCCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 042075 844 QPPIVHCDLKPSNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 923 (1033)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt 923 (1033)
+||||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 999999999999999999999999999987654443333334558999999999999999999999999999999999
Q ss_pred CC-CCCCccccCCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCC
Q 042075 924 RK-KPTDIMFEGDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPED 1002 (1033)
Q Consensus 924 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1002 (1033)
|. +||.... ..+........ . +...+..+++++.+++.+||+.||++
T Consensus 238 ~~~~p~~~~~-----~~e~~~~v~~~--------~-------------------~~~~p~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 238 YGLQPYYGMA-----HEEVIYYVRDG--------N-------------------ILACPENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp TTCCTTTTSC-----HHHHHHHHHTT--------C-------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cCCCCCCCCC-----HHHHHHHHHcC--------C-------------------CCCCCccchHHHHHHHHHHcCCChhH
Confidence 86 5664221 11111110000 0 00011123456899999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 042075 1003 RMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 1003 RPt~~evl~~L~~i~~ 1018 (1033)
||||.||+++|++|.+
T Consensus 286 RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 286 RPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCCHHHHHHHHHHTTC
T ss_pred CcCHHHHHHHHHHhcC
Confidence 9999999999998853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=404.66 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=201.3
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++++ ++.||||+++.... ..+.|.+|+.++++++|||||+++++|. ++..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeE
Confidence 4579999999999999999999984 46799999975433 3478999999999999999999999863 23578
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||+++|+|..++.. .....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++++||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence 99999999999999853 2345699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..|+.........+ ..+....
T Consensus 157 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~--- 231 (285)
T d1fmka3 157 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGY--- 231 (285)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTC---
T ss_pred cchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcC---
Confidence 9999876543322 2223458999999999999999999999999999999999776654221111111 1111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+.+.+.++++++.+++.+||+.||++|||+++|++.|+.....
T Consensus 232 ---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 ---------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 0011123456789999999999999999999999988876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=406.62 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=203.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCe----EEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKT----IVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
++|++.++||+|+||+||+|++..+++ +||+|+++.. .....+++.+|++++++++|||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987765 5888887643 33456789999999999999999999999743
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..+++|||+.+|+|.+++.. ....+++.++++++.|||.||+|||++ +|+||||||+||+++.++++
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHH---------TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred CCeeEEEEeccCCcccccccc---------cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 246889999999999998853 456789999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |++||+.... ..+......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~ 228 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK 228 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc
Confidence 9999999998765544443444558999999999999999999999999999999999 7888863211 111111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
.. +.+.+..+++++.+++.+||+.||++|||+.||++.|+.+..
T Consensus 229 ~~------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GE------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 10 111112345668999999999999999999999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=403.83 Aligned_cols=272 Identities=23% Similarity=0.297 Sum_probs=202.2
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.+.||+|+||+||+|++.. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++ .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----T 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee----c
Confidence 4679999999999999999999753 45789999987433 34456788888888887 689999999986 3
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSN 856 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (1033)
..+...++||||+++|+|.++++...... ........+++.++..++.||++||+|||++ +||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 44557899999999999999996432110 0011245689999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCccccCC
Q 042075 857 VLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK-KPTDIMFEGD 935 (1033)
Q Consensus 857 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~-~p~~~~~~~~ 935 (1033)
||+++++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||.... ..
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~ 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-ID 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CS
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-HH
Confidence 999999999999999998765554444444456999999999999999999999999999999999975 5664221 11
Q ss_pred ccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 936 MNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
..+.......... ..+..+++++.+++.+||+.||++|||++||+++|++
T Consensus 244 ~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 244 EEFCRRLKEGTRM------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHHHHHTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111111111110 0111234568999999999999999999999999999
Q ss_pred HHHH
Q 042075 1016 IKNI 1019 (1033)
Q Consensus 1016 i~~~ 1019 (1033)
+.++
T Consensus 294 ilq~ 297 (299)
T d1ywna1 294 LLQA 297 (299)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 8654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=399.63 Aligned_cols=265 Identities=20% Similarity=0.308 Sum_probs=203.7
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 467999999999999999999999999999999997432 334567899999999999999999999865432 2233
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||++|++|.+++. ....+++.++..++.||+.||+|||++ ||+||||||+||+++.++..+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccce
Confidence 5789999999999999884 345799999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 867 VGDFGLATFLPLSHA-QTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
++|||.+........ ........||+.|+|||++.+..+++++||||+||++|||+||+.||.... ....... .
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~-~ 226 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQ-H 226 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHH-H
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC----HHHHHHH-H
Confidence 999999876543322 222233459999999999999999999999999999999999999986321 1111111 0
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-DMTNVVHQLQSIK 1017 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~ 1017 (1033)
...... .+ .......++++.+++.+||+.||++|| |++++++.|.+++
T Consensus 227 ~~~~~~---~~---------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 VREDPI---PP---------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHCCCC---CG---------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhcCCC---CC---------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000000 00 000012345689999999999999999 8999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=398.19 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=198.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCC---CeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
.++|++.+.||+|+||+||+|++..+ +..||||+++... ....+.+.+|++++++++||||++++++|. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 35789999999999999999998643 4568999886433 344577999999999999999999999863 2
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
+..++||||+++|+|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+||++++++.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CeEEEEEEeccCCcHHhhhhc---------cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcE
Confidence 468999999999999998753 445689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 944 (1033)
||+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||...... ........
T Consensus 148 Kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~ 224 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN 224 (273)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred EEccchhheeccCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 999999998765433222 223448999999999999999999999999999999998 89998643221 11111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
.. +.+.+..+++++.+++.+||+.||++|||++||++.|+++.+..
T Consensus 225 ~~------------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 225 GE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 00 00111224567899999999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=399.85 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=208.2
Q ss_pred cceecccCceeEEEEEeCCC---CeEEEEEEeec-cCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeEE
Q 042075 716 ANLIGAGSFGSVYKGILDEG---KTIVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 791 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 791 (1033)
.++||+|+||+||+|++..+ ...||||+++. ......+++.+|++++++++||||++++|+|. ..++..++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence 46899999999999998653 34699999874 34445678999999999999999999999973 334578999
Q ss_pred EEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEeecc
Q 042075 792 FEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGDFG 871 (1033)
Q Consensus 792 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DfG 871 (1033)
|||+++|+|.++++. .....++.++++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhcc---------ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence 999999999999853 445677889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCcc
Q 042075 872 LATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPDH 949 (1033)
Q Consensus 872 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 949 (1033)
+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--- 252 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--- 252 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC---
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 99876544322 2222345899999999999999999999999999999999988887533222111111111000
Q ss_pred hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHhhhchhh
Q 042075 950 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNILLGQRIV 1026 (1033)
Q Consensus 950 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~ 1026 (1033)
...+..+++++.+++.+||+.||++||||.||++.|+++.+....+..+
T Consensus 253 ----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~ 301 (311)
T d1r0pa_ 253 ----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301 (311)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred ----------------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhch
Confidence 0011123456899999999999999999999999999998876665544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=404.06 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=204.5
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
.++|++++.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.++++++||||++++++ +.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----ecccc
Confidence 35799999999999999999999999999999999743 23345778899999999999999999999 45566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||++||+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+|||++++|.+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----------~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ccccceeccCCCchhhhhh----------cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence 8999999999999999984 345689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+|+........ ....+||+.|+|||++.+..|+.++||||+||++|||++|++||.... .....+...
T Consensus 146 l~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~i~ 218 (337)
T d1o6la_ 146 ITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELIL 218 (337)
T ss_dssp ECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH
T ss_pred EeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHHHHh
Confidence 9999999865433222 223459999999999999999999999999999999999999986321 111111110
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVHQ 1012 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1012 (1033)
... ...+...++++.+++.+||+.||++||+ ++|+++.
T Consensus 219 ~~~----------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 219 MEE----------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HCC----------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cCC----------------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 000 0001122455789999999999999995 7888763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=397.32 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=196.1
Q ss_pred CCCCccceecccCceeEEEEEeCCC---CeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEG---KTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 784 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 784 (1033)
++|++.+.||+|+||+||+|++..+ ...||||+++.. .....++|.+|++++++++||||++++|+|.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5689999999999999999987432 346899988643 33445789999999999999999999999632
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
+..++||||+++|++.+++.. ....+++..++.++.|||+||+|||++ +|+||||||+||+++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred -cchheeeeeecCcchhhhhhc---------ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccc
Confidence 256899999999999998853 445699999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCccc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQT-SSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 942 (1033)
+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+..
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~~~~ 224 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQIL 224 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HHHHH
Confidence 9999999999875543322 2223447889999999999999999999999999999998 899986321 11111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
....... .+++.+..++.++.+++.+||+.||++||||+||.+.|++.
T Consensus 225 ~~i~~~~--------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEG--------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSC--------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCC--------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111100 00011112345689999999999999999999999998875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-45 Score=391.69 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=201.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc---------hhHHHHHHHHHHHHhcC-CCCceeEeeeeccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH---------GAFKSFIAECNTLKNIR-HRNLVKILTACSGV 780 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 780 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|+.++++++ ||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~---- 78 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT---- 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee----
Confidence 689999999999999999999998999999999874321 12346889999999996 9999999999
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
+.+++..|+||||+++|+|.++++ ....+++.++..++.||+.||+|||++ ||+||||||+||+++
T Consensus 79 -~~~~~~~~ivmE~~~~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 79 -YETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD 144 (277)
T ss_dssp -EECSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -cccCcceEEEEEcCCCchHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc
Confidence 456678999999999999999994 345699999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
+++.+||+|||+|+......... ...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCeEEccchheeEccCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999999999875543322 2459999999998753 35788999999999999999999999632111
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+ ............ ........++++.+++.+||+.||++|||++||++
T Consensus 222 ~-~~~~i~~~~~~~----------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 L-MLRMIMSGNYQF----------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H-HHHHHHHTCCCC----------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-HHHHHHhCCCCC----------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 011111100000 00001123466899999999999999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-45 Score=398.22 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=202.5
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 5799999999999999999999999999999999742 233457789999999999999999999994 45668
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.|+||||++||+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCcccccccc----------ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence 999999999999999984 445678889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+...... ....||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..........
T Consensus 146 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~ 215 (316)
T d1fota_ 146 TDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILN 215 (316)
T ss_dssp CCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHH
T ss_pred ecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHc
Confidence 9999999764432 22459999999999999999999999999999999999999986321 1111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1012 (1033)
... ..+...++++.+++.+||+.||++|| |++|+++.
T Consensus 216 --------~~~--------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 216 --------AEL--------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------CCC--------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCC--------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 000 00011235588999999999999996 89998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=399.46 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=203.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ....+.+|++++++++||||++++++ +++++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-----FESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 4689999999999999999999999999999999976543 33568899999999999999999999 45566899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC--CcEEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE--MIAHV 867 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL 867 (1033)
+||||++||+|.++++. ....+++.++..++.||+.||+|||++ ||+||||||+|||++.+ ..+||
T Consensus 78 lvmE~~~gg~L~~~i~~---------~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence 99999999999999953 334689999999999999999999999 99999999999999854 48999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+++.......... ..+|+.|+|||...+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 146 ~DFG~~~~~~~~~~~~~---~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~ 221 (321)
T d1tkia_ 146 IEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT 221 (321)
T ss_dssp CCCTTCEECCTTCEEEE---EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC
T ss_pred cccchhhccccCCcccc---cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence 99999987654433222 34899999999999999999999999999999999999998632111 001111110000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. .. .....+++++.+++.+||+.||++|||++|+++.
T Consensus 222 ~-------------~~---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 F-------------DE---------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C-------------CH---------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-------------Ch---------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 0001234568999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=395.82 Aligned_cols=281 Identities=22% Similarity=0.280 Sum_probs=201.9
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCceeE
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 790 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 790 (1033)
++|...+.||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++||||++++++|.+.. ......++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 4677889999999999999997 4789999998743321 122334555556789999999999986432 22236799
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEeccCCCCCeEecCCCcE
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD-----CQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
||||+++|+|.++++. ..+++.++.+++.|+|.||+|+|+. +.++||||||||+|||+++++.+
T Consensus 79 v~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred EEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 9999999999999953 3589999999999999999999973 13499999999999999999999
Q ss_pred EEeecccceecCCCCcc--ccccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 042075 866 HVGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN 937 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~ 937 (1033)
||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 99999999877543322 122335699999999998764 3678899999999999999999887543222211
Q ss_pred HHHHHhhhCCc-chh-hhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 042075 938 LHNFAKTALPD-HVV-DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQS 1015 (1033)
Q Consensus 938 ~~~~~~~~~~~-~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1015 (1033)
+.......... ... ...+....+. ........++...+.+++.+||+.||++|||+.||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPN-------------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCC-------------CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCC-------------CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11110000000 000 0001111000 00111123456779999999999999999999999999999
Q ss_pred HHHH
Q 042075 1016 IKNI 1019 (1033)
Q Consensus 1016 i~~~ 1019 (1033)
+.+.
T Consensus 295 i~~~ 298 (303)
T d1vjya_ 295 LSQQ 298 (303)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-44 Score=402.51 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=197.1
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC---chhHHHHH---HHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH---HGAFKSFI---AECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.+.||+|+||.||+|++..+|+.||||+++... ......+. +|+++++.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 468999999999999999999999999999999986321 11122333 446677778899999999994 4
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.++..|+||||++||+|.+++. ....+++.++..++.||+.||+|||++ +||||||||+|||+++++
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 144 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSS
T ss_pred ECCEEEEEEEecCCCcHHHHHH----------hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCC
Confidence 5568999999999999999994 345688999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
.+||+|||+|+....... ....||+.|+|||++.. ..|+.++||||+||++|||+||+.||...... ......
T Consensus 145 ~iKl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~ 218 (364)
T d1omwa3 145 HVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEID 218 (364)
T ss_dssp CEEECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHH
T ss_pred cEEEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 999999999997654332 22459999999999875 56899999999999999999999999643211 111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMD-----MTNVVH 1011 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1011 (1033)
+....... ..+..+++++.+++.+||+.||++||| ++|+++
T Consensus 219 ~~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMAV----------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCCC----------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCCC----------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111100 000112356899999999999999999 678775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=398.95 Aligned_cols=258 Identities=19% Similarity=0.213 Sum_probs=200.6
Q ss_pred hCCCCccc-eecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 710 TDGFTSAN-LIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 710 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.++|.+.+ .||+|+||+||+|++..+++.||||+++.. +.+.+|++++.++ +|||||++++++.+. +..+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46898875 699999999999999989999999998642 4577899987665 899999999986432 133457
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC---CCc
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE---EMI 864 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 864 (1033)
.|+|||||+||+|.+++.. .....+++.++..|+.||+.||+|||++ ||+||||||+||++++ ++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~--------~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHS--------CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHh--------cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence 8999999999999999953 2335699999999999999999999999 9999999999999985 567
Q ss_pred EEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 865 AHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
+||+|||+|+......... ...||+.|+|||++.+..|+.++||||+||++|||+||+.||....... .......
T Consensus 153 ~Kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~- 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKT- 227 (335)
T ss_dssp EEECCCTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHH-
Confidence 9999999998775543322 2459999999999999999999999999999999999999996321111 0000000
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.... .... ........+++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~i~~-----------~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRM-----------GQYE------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCS-----------CSSS------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhc-----------CCCC------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0000 0000112345678999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=394.31 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=212.0
Q ss_pred hCCCCccceecccCceeEEEEEeC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHHhc-CCCCceeEeeeeccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILD-----EGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 782 (1033)
.++|++.++||+|+||.||+|++. .+++.||||+++... ......+.+|+.+++++ +|||||+++++|.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~---- 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---- 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe----
Confidence 468899999999999999999863 467899999997543 33456789999999999 7999999999963
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCcc--------ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDE--------TEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
.++..++||||+++|+|.++++....... .......+++.++..++.||++||+|||++ +||||||||
T Consensus 98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred -eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 44578999999999999999965332111 112345689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccC
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEG 934 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~ 934 (1033)
+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+..|+......
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999999876555444445566999999999999999999999999999999999955554322222
Q ss_pred CccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 042075 935 DMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQ 1014 (1033)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1014 (1033)
...+.+......... .+..+++.+.+++.+||+.||++||||+||+++|+
T Consensus 254 ~~~~~~~i~~~~~~~------------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp SHHHHHHHHHTCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC------------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222222222211110 11123456899999999999999999999999998
Q ss_pred HHH
Q 042075 1015 SIK 1017 (1033)
Q Consensus 1015 ~i~ 1017 (1033)
++.
T Consensus 304 ~~i 306 (311)
T d1t46a_ 304 KQI 306 (311)
T ss_dssp HHH
T ss_pred Hhh
Confidence 764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=392.69 Aligned_cols=270 Identities=23% Similarity=0.356 Sum_probs=206.9
Q ss_pred hCCCCccceecccCceeEEEEEeCCCC-------eEEEEEEeeccCc-hhHHHHHHHHHHHHhc-CCCCceeEeeeeccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGK-------TIVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILTACSGV 780 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 780 (1033)
.++|++.+.||+|+||.||+|+...++ ..||||+++.... ....++.+|+..+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 357889999999999999999975443 5799999975443 3457788999999998 8999999999964
Q ss_pred cccCCCceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 781 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 781 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
.++..++||||+++|+|.++++...... ........+++.+++.++.||+.||+|||++ +||||||||
T Consensus 90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 4558899999999999999996533211 1112346799999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPTDIMFE 933 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~ellt-g~~p~~~~~~ 933 (1033)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++||||||||+|||++ |++||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999997765554444445568999999999999999999999999999999998 6888753211
Q ss_pred CCccHHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042075 934 GDMNLHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQL 1013 (1033)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1013 (1033)
....+....... +..+..+++++.+++.+||+.||++||||.||++.|
T Consensus 244 --~~~~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 244 --EELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp --HHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 111111111000 000112345689999999999999999999999999
Q ss_pred HHHHHH
Q 042075 1014 QSIKNI 1019 (1033)
Q Consensus 1014 ~~i~~~ 1019 (1033)
+++.+.
T Consensus 292 ~~i~a~ 297 (299)
T d1fgka_ 292 DRIVAL 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-44 Score=399.44 Aligned_cols=245 Identities=19% Similarity=0.222 Sum_probs=202.0
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++|||||++++++ .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 5899999999999999999999999999999998642 223456789999999999999999999994 45568
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.++||||+.+|+|.+++. ....+++.++..++.||+.||+|||++ +||||||||+|||++.++++||
T Consensus 116 ~~~v~e~~~~g~l~~~l~----------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHh----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence 899999999999999994 335689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 868 GDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
+|||+|+...... ....||+.|||||++.+..++.++||||+||++|||+||+.||... .. .........
T Consensus 183 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~-~~~~~~i~~ 252 (350)
T d1rdqe_ 183 TDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QP-IQIYEKIVS 252 (350)
T ss_dssp CCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HHHHHHHHH
T ss_pred eeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CH-HHHHHHHhc
Confidence 9999999765332 2245999999999999999999999999999999999999998532 11 111111000
Q ss_pred cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042075 948 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1011 (1033)
. .. ..+..+++++.+++.+||+.||++|+ |++|+++
T Consensus 253 ~--------~~--------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 G--------KV--------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--------CC--------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--------CC--------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 00 00011245689999999999999994 8999886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=395.71 Aligned_cols=266 Identities=23% Similarity=0.378 Sum_probs=204.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeE--EEEEEeecc-CchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTI--VAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.++||+|+||+||+|+++.++.. ||||+++.. .....+++.+|+++++++ +|||||+++++|. .++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 4788899999999999999999877764 677777533 333456899999999999 7999999999964 345
Q ss_pred ceeEEEEcccCCchhhhcccCCCCc------cccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec
Q 042075 787 FKALVFEFMHNRSLEEWLHPITRED------ETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD 860 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (1033)
..++||||+++|+|.++++...... ........+++.++.+++.|||+||+|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 8899999999999999996421100 0012346799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCC-CCCccccCCccHH
Q 042075 861 EEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK-PTDIMFEGDMNLH 939 (1033)
Q Consensus 861 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~-p~~~~~~~~~~~~ 939 (1033)
.++.+||+|||+|+........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||... ...
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~ 233 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCA 233 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH
T ss_pred CCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHH
Confidence 9999999999999865432222 22348999999999999999999999999999999999765 55321 111
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNI 1019 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 1019 (1033)
+........ .++..+..+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 234 ~~~~~i~~~---------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKLPQG---------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHGGGT---------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHhc---------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111000 00111112346799999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=394.96 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=200.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc---CchhHHHHHHHHHHHH-hcCCCCceeEeeeeccccccCCC
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL---HHGAFKSFIAECNTLK-NIRHRNLVKILTACSGVDYQGND 786 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 786 (1033)
++|++.++||+|+||+||+|+++.+++.||||+++.. .....+.+..|..++. .++||||++++++ +..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE-----EccCC
Confidence 6899999999999999999999999999999999742 2233456677777765 6799999999999 45566
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~----------~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCcee
Confidence 8999999999999999994 345688999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
|+|||+|+......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......
T Consensus 144 l~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~ 216 (320)
T d1xjda_ 144 IADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIR 216 (320)
T ss_dssp ECCCTTCBCCCCTTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH
T ss_pred ccccchhhhcccccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 99999998654433222 22459999999999999999999999999999999999999986321 111111100
Q ss_pred CcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042075 947 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMT-NVVH 1011 (1033)
Q Consensus 947 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 1011 (1033)
... + ..+..+++++.+++.+||+.||++|||+. |+++
T Consensus 217 ~~~------~----------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 MDN------P----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HCC------C----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cCC------C----------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 000 0 00111245689999999999999999995 6754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=398.42 Aligned_cols=271 Identities=19% Similarity=0.330 Sum_probs=211.5
Q ss_pred hCCCCccceecccCceeEEEEEeCC-----CCeEEEEEEeecc-CchhHHHHHHHHHHHHhcCCCCceeEeeeecccccc
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDE-----GKTIVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 783 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 783 (1033)
.++|++.++||+|+||+||+|.+.. +++.||||+++.. .......+.+|++++++++||||++++++| .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence 4678899999999999999998852 3578999999753 334446789999999999999999999996 3
Q ss_pred CCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC
Q 042075 784 GNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM 863 (1033)
Q Consensus 784 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (1033)
.++..++||||+++|+|.+++...............+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 44578999999999999999864222111122334579999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCccccCCccHHHHH
Q 042075 864 IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK-KPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~ 942 (1033)
++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. +||... ...+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHH
Confidence 99999999998765544444344445899999999999999999999999999999999985 665421 111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHh
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKNIL 1020 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1020 (1033)
..... ... .+.+..+++++.+++.+||+.||++|||++||+++|++..+..
T Consensus 246 ~~i~~--------~~~-------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 246 RFVME--------GGL-------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HHHHT--------TCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHHh--------CCC-------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11100 000 0011123466999999999999999999999999998775533
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=389.97 Aligned_cols=273 Identities=24% Similarity=0.256 Sum_probs=195.3
Q ss_pred ccceecccCceeEEEEEeCCCCeEEEEEEeeccCc-----hhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 715 SANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 715 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.+++||+|+||+||+|+++.+++.||||+++.... ...+.+.+|+.++++++|||||++++++ ..++..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 46789999999999999999999999999864322 1235688999999999999999999994 5566899
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEee
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVGD 869 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (1033)
+||||++++++..+.. ....+++.++..++.||+.||+|||++ ||+||||||+|||+++++.+||+|
T Consensus 77 ivmE~~~~~~~~~~~~----------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD----------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHTT----------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ehhhhhcchHHhhhhh----------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccccc
Confidence 9999999888777663 345688899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+|+......... ....||+.|+|||++.+. .|+.++||||+||++|||++|++||......+ .+....+.....
T Consensus 144 FG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 144 FGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTP 220 (299)
T ss_dssp CGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred CccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCC
Confidence 99998665433222 224589999999998654 57999999999999999999999986322111 111111111111
Q ss_pred chhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 949 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 949 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
......+..-............ ..... ......+++.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPG-IPLHH---IFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCC-CCHHH---HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhccchhhhhccCCC-CChHH---hcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000000000000000 00000 001224568999999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=388.32 Aligned_cols=277 Identities=26% Similarity=0.332 Sum_probs=200.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||++++++ ..++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 68999999999999999999999899999999996432 22357889999999999999999999995 455689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
|+||||+.+ ++.+++.. .....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 77 ~iv~e~~~~-~~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSE-EHHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCC-chhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceec
Confidence 999999965 44444432 2455699999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh-C
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA-L 946 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~ 946 (1033)
|||.|+......... ....||+.|+|||.+.... ++.++||||+||++|||++|+.||......+ .+....... .
T Consensus 145 DFG~a~~~~~~~~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~ 221 (298)
T d1gz8a_ 145 DFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGT 221 (298)
T ss_dssp STTHHHHHCCCSBCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred cCCcceeccCCcccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 999998765433222 2245999999999877765 5789999999999999999999996432111 111111111 1
Q ss_pred Ccc-hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 PDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
+.. ........ ....... ................+++.+++.+||+.||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 222 PDEVVWPGVTSM-PDYKPSF----PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTTSTTGGGS-TTCCTTS----CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cchhhccccccc-ccccccc----ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111 11100000 0000000 0000000000111233568999999999999999999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8e-44 Score=393.80 Aligned_cols=294 Identities=28% Similarity=0.455 Sum_probs=272.7
Q ss_pred CCChhhHHHHHHHHHhcccCCCCCCCCCCCCCCCc--ceeeeEecCCC-CCeEEEEEcCCCCCCc--ccccccCCCCCCC
Q 042075 37 AGNETDRLALLEFKSKITHDPLGVFGSWNESIHFC--QWHGVTCSRRQ-HQRVTILDLKSLKLAG--YISAHVGNLSFLK 111 (1033)
Q Consensus 37 ~~~~~~~~aLl~~k~~~~~~~~~~~~~W~~~~~~c--~w~gv~C~~~~-~~~v~~l~l~~~~l~g--~~~~~~~~l~~L~ 111 (1033)
.|.++||+||++||+++. || ..+++|..++||| .|+||+|+..+ ..||+.|||++++++| .+|+++++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 589999999999999995 55 4689999888999 49999998753 4589999999999998 4789999999999
Q ss_pred EEEecC-CCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 112 VLDLHN-NSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 112 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+|+|++ |+++|.+|++|++|++|++|+|++|++++..|..+..+.+|+++++++|.+.+.+|..+.++++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCC-cEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccC
Q 042075 191 NLTGSIPPSFGNLSSI-SFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIP 269 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 269 (1033)
.++|.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++++.+++++|.+.+.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999888886 899999999999999999888655 79999999999999999999999999999999998776
Q ss_pred ccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCc
Q 042075 270 LDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNS 335 (1033)
Q Consensus 270 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~ 335 (1033)
. +..+++|++|+|++|+++|.+|..++++++|++|+|++|+|+|.+|.++++++|+.+++++|+
T Consensus 239 ~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 239 K--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp G--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred c--cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence 4 346899999999999999999999999999999999999999999988888889888888886
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=387.35 Aligned_cols=283 Identities=21% Similarity=0.247 Sum_probs=203.7
Q ss_pred hhCCCCccceecccCceeEEEEEeCCC-CeEEEEEEeeccC--chhHHHHHHHHHHHHhc---CCCCceeEeeeeccccc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEG-KTIVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDY 782 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~ 782 (1033)
..++|++++.||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999998644 7889999986432 22234566788887776 79999999999866555
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
......+++|||++++++..... .....+++..+..++.|++.||+|||++ +||||||||+|||++++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 152 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred ccCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCC
Confidence 56678899999998887765543 2456689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFA 942 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 942 (1033)
+.+||+|||.++...... ......||+.|+|||++.+..|+.++||||+||++|||++|++||...... ..+....
T Consensus 153 ~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~ 228 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKIL 228 (305)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred CCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 999999999998654332 223345999999999999999999999999999999999999999643211 1111111
Q ss_pred hhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 943 KTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 943 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
........... ........... .... ............+.+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~-~~~~~~~~~~~--~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 229 DVIGLPGEEDW-PRDVALPRQAF--HSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHCCCCGGGS-CTTCSSCGGGS--CCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhCCCchhcc-cccccchhhhh--cccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111100000 00000000000 0000 000000111234568899999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=384.90 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=194.3
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc------hhHHHHHHHHHHHHhcC--CCCceeEeeeeccccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH------GAFKSFIAECNTLKNIR--HRNLVKILTACSGVDY 782 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 782 (1033)
++|++.+.||+|+||+||+|++..+++.||||+++.... ....++.+|+.++++++ ||||++++++ +
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~-----~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-----F 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----E
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE-----E
Confidence 579999999999999999999999999999999874321 12244678999999996 8999999999 4
Q ss_pred cCCCceeEEEEcccC-CchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC
Q 042075 783 QGNDFKALVFEFMHN-RSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE 861 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (1033)
..++..++||||+.+ +++.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL 145 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET
T ss_pred eeCCeEEEEEEeccCcchHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEec
Confidence 556689999999976 67888874 345789999999999999999999999 9999999999999985
Q ss_pred -CCcEEEeecccceecCCCCccccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccCCccHH
Q 042075 862 -EMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPTDIMFEGDMNLH 939 (1033)
Q Consensus 862 -~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~ 939 (1033)
++.+||+|||+|+....... ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .
T Consensus 146 ~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~ 214 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------E 214 (273)
T ss_dssp TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------H
T ss_pred CCCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------h
Confidence 47999999999987543322 22459999999999887765 57789999999999999999998531 0
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
...+... ... ...++++.+++.+||+.||++|||++|+++.
T Consensus 215 ~i~~~~~----------~~~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 EIIRGQV----------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHCCC----------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhhccc----------CCC----------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111000 000 0123558999999999999999999999763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-43 Score=380.72 Aligned_cols=275 Identities=21% Similarity=0.263 Sum_probs=199.2
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|++.++||+|+||+||+|+++ +++.||||+++... ....+++.+|+.++++++||||+++++++ ..++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 68999999999999999999997 78999999996533 23357899999999999999999999994 455689
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
+++|||+.++.+..+.+ ....+++.++..++.||+.||+|||+. +||||||||+|||++.++.+|++
T Consensus 76 ~i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEec
Confidence 99999998877777763 346799999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.|.......... ....+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+.+.......
T Consensus 143 DfG~a~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~ 219 (286)
T d1ob3a_ 143 DFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGT 219 (286)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred ccccceecccCcccc--ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCC
Confidence 999998765433222 223489999999998764 56899999999999999999999996432211 11111111111
Q ss_pred cchhhhcccc-cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
.......+.. ........ ................+.+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPNF----TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGSTTCCTTC----CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhhhccccc----ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100000000 00000000 000000000111123456889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=385.36 Aligned_cols=287 Identities=18% Similarity=0.191 Sum_probs=201.0
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC-chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCc
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
.+++|++++.||+|+||+||+|++..+++.||||+++... ....+++.+|+++|++++||||+++++++....+.....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4568999999999999999999999999999999997543 344568899999999999999999999986554444444
Q ss_pred eeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEE
Q 042075 788 KALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHV 867 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (1033)
.+++ +|+.+|+|.++++. ..+++..+..++.||+.||+|||++ |||||||||+|||+++++.+||
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEE-EeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEE
Confidence 5555 55669999999942 3589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCcc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhh
Q 042075 868 GDFGLATFLPLSHAQ-TSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTA 945 (1033)
Q Consensus 868 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 945 (1033)
+|||+|+........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ........
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~ 229 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGIL 229 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhc
Confidence 999999876443322 12233458999999999855 4678999999999999999999999964322111 11111111
Q ss_pred CCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 946 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 946 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... ...................................++.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQ-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCH-HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCh-hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000 0000000000000000000000000000001123468899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=377.81 Aligned_cols=286 Identities=21% Similarity=0.278 Sum_probs=200.2
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeecccc---ccC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---YQG 784 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 784 (1033)
.++|+++++||+|+||+||+|++..+|+.||||+++.. .....+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999989999999998643 2334577899999999999999999999875432 123
Q ss_pred CCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCc
Q 042075 785 NDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMI 864 (1033)
Q Consensus 785 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (1033)
++..++||||++++.+..+.. ....++..++..++.|++.||+|||++ ||+||||||+||++++++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhhh----------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 457899999998877766552 445688899999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCcc--ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHH
Q 042075 865 AHVGDFGLATFLPLSHAQ--TSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNF 941 (1033)
Q Consensus 865 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 941 (1033)
+||+|||+++........ .......||+.|+|||++.+. .+++++||||+||++|||++|+.||...... ......
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i 234 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI 234 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHH
Confidence 999999999876543321 122224599999999998765 6899999999999999999999999642211 111111
Q ss_pred Hhhh--CCcchhhhcccc-cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 942 AKTA--LPDHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 942 ~~~~--~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.+.. .+.......+.. ........ ........... ......+.+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELV--KGQKRKVKDRL-KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CC--SSCCBCHHHHH-HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCChhhccccchhhhhhhhccc--ccccccchhhh-ccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111 111111111100 00000000 00000000000 111223467899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=383.91 Aligned_cols=286 Identities=19% Similarity=0.187 Sum_probs=199.2
Q ss_pred hhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCC
Q 042075 709 ATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 785 (1033)
Q Consensus 709 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 785 (1033)
..++|++++.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+++|++++|||||+++++|...+. ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999999999999999999743 33445678999999999999999999999754331 233
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...|+||||+ +.+|..+.+ ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccc
Confidence 4679999999 668887763 34699999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
|++|||.|+...... ....||+.|+|||++.+. .++.++||||+||++|||++|++||...... ..+......
T Consensus 161 kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~ 234 (346)
T d1cm8a_ 161 KILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKV 234 (346)
T ss_dssp EECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred ccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhc
Confidence 999999998764432 224589999999998764 5789999999999999999999998643211 111111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSI 1016 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 1016 (1033)
..... .+.................................+.+.+++.+||..||++|||++|+++. ++++
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 235 TGTPP-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HCCCC-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cCCCc-HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 11000 00000000000000000000000000000011223567899999999999999999999975 4443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=377.64 Aligned_cols=276 Identities=21% Similarity=0.251 Sum_probs=199.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccccCCCcee
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
++|+++++||+|+||+||+|++..+++.||||+++... .+++.+|+++|++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 57999999999999999999999999999999987533 467889999999995 9999999998642 3445789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEEe
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVG 868 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~ 868 (1033)
+||||+++++|.++. +.+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 999999999997765 2488999999999999999999999 999999999999998655 69999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||+|+......... ...+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.................-.
T Consensus 173 DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 999998775543322 23489999999998765 47999999999999999999999986432211111111110000
Q ss_pred cchhhhcccccCCC---chhhhhc--cchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042075 948 DHVVDIVDSTLLSD---DEDLAVH--GNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVH 1011 (1033)
Q Consensus 948 ~~~~~~~d~~l~~~---~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1011 (1033)
+...+......... ....... .................+++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 0000000 0000000111111223456899999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=370.72 Aligned_cols=277 Identities=20% Similarity=0.229 Sum_probs=205.1
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCce
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 788 (1033)
++|+++++||+|+||+||+|++..+++.||||+++... ....+++.+|+.++++++||||++++++| ......
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 58999999999999999999999999999999997433 34467889999999999999999999995 445588
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEEEe
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAHVG 868 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (1033)
++|+|++.++++..+++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeeccccccccccc----------cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeee
Confidence 99999999999988874 345688999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCccccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCC
Q 042075 869 DFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALP 947 (1033)
Q Consensus 869 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 947 (1033)
|||.|+.......... ...+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.........+.........
T Consensus 144 DFG~a~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 144 NFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhcccCCCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 9999998755433222 234788999999987665 6899999999999999999999974322211112221111111
Q ss_pred cc--hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 948 DH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 948 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
.. ............... ................+++.+++.+||+.||++||||+|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYP-----MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCC-----CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhhhhhhhhcccccccc-----cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 000000000000000 0000000111112234568899999999999999999998763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=372.49 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=201.8
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCCCcee
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 789 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 789 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.... .+++..|++++++++|++++..+..| ...++..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEE----EecCCEEE
Confidence 4679999999999999999999998999999999875432 24578999999999888776666554 34456789
Q ss_pred EEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEec---CCCcEE
Q 042075 790 LVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLD---EEMIAH 866 (1033)
Q Consensus 790 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~k 866 (1033)
+||||+ ++++.+.+.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ .+..+|
T Consensus 80 ivme~~-~~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEc-CCchhhhhhh---------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceee
Confidence 999999 5677666642 445789999999999999999999999 999999999999986 455799
Q ss_pred EeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccH--H
Q 042075 867 VGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNL--H 939 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~--~ 939 (1033)
|+|||+|+........ .......||+.|+|||++.+..+++++|||||||++|||++|+.||.......... .
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 9999999987543322 12223459999999999999999999999999999999999999996432211110 0
Q ss_pred HHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 042075 940 NFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSIKN 1018 (1033)
Q Consensus 940 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 1018 (1033)
.......... .......+++++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 227 ~~~~~~~~~~---------------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 227 RISEKKMSTP---------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHSC---------------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhhcccCCCC---------------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000000 000011245678999999999999999999999999888754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=379.24 Aligned_cols=282 Identities=21% Similarity=0.224 Sum_probs=198.8
Q ss_pred CCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCCceeE
Q 042075 712 GFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFKAL 790 (1033)
Q Consensus 712 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l 790 (1033)
+|+..++||+|+||+||+|++..+++.||||+++.... ...+|++++++++||||++++++|..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58889999999999999999999999999999975432 23479999999999999999999754322 33446789
Q ss_pred EEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCC-cEEEee
Q 042075 791 VFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEM-IAHVGD 869 (1033)
Q Consensus 791 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~D 869 (1033)
||||++++.+..+.+. ......+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~~-------~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY-------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHHH-------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHhh-------hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence 9999976644443321 12455799999999999999999999999 999999999999999775 899999
Q ss_pred cccceecCCCCccccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhCCc
Q 042075 870 FGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTALPD 948 (1033)
Q Consensus 870 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 948 (1033)
||+|+.......... ..||+.|+|||.+.+ ..++.++||||+||++|||++|++||......+ .+....+..-..
T Consensus 167 FG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 167 FGSAKQLVRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTP 242 (350)
T ss_dssp CTTCEECCTTSCCCS---CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred ccchhhccCCccccc---ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 999987754433322 348999999998765 578999999999999999999999996432111 111111110000
Q ss_pred c---hhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 042075 949 H---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ--LQSIK 1017 (1033)
Q Consensus 949 ~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~ 1017 (1033)
. ................ .... ..........+++.+++.+||+.||++|||+.|+++. +++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQI-----KAHP-WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHCC---CCCCCCC-----CCCC-GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hHHhhhhhccchhhcccccc-----ccCc-hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 0000000000000000 0000 0000011234568899999999999999999999874 45443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-41 Score=367.26 Aligned_cols=264 Identities=17% Similarity=0.184 Sum_probs=206.6
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC-CCceeEeeeeccccccCCCce
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDFK 788 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 788 (1033)
.++|++.+.||+|+||+||+|++..+++.||||+++.... .+.+.+|+++++.+.| +|++.+++++ ..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence 3589999999999999999999999999999999865332 3457789999999965 8999999884 445688
Q ss_pred eEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecC-----CC
Q 042075 789 ALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDE-----EM 863 (1033)
Q Consensus 789 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~ 863 (1033)
++||||+ +++|.++++. ....++..++..++.|++.||+|||++ ||+||||||+||+++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~---------~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHh---------hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence 9999998 7899998853 345689999999999999999999999 9999999999999974 56
Q ss_pred cEEEeecccceecCCCCcc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCcc-
Q 042075 864 IAHVGDFGLATFLPLSHAQ-----TSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMN- 937 (1033)
Q Consensus 864 ~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~- 937 (1033)
.+||+|||+|+........ .......||+.|||||++.+..+++++|||||||++|||++|+.||.........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999986543221 1222345999999999999999999999999999999999999999643221110
Q ss_pred -HHHHHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 042075 938 -LHNFAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQLQSI 1016 (1033)
Q Consensus 938 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 1016 (1033)
+............ ......+++++.+++..|++.+|++||+++.+.+.|+++
T Consensus 224 ~~~~i~~~~~~~~~---------------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 224 KYERIGEKKQSTPL---------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCh---------------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000000000000 000112456799999999999999999999999999887
Q ss_pred HHHh
Q 042075 1017 KNIL 1020 (1033)
Q Consensus 1017 ~~~~ 1020 (1033)
.+..
T Consensus 277 ~~~~ 280 (293)
T d1csna_ 277 LERL 280 (293)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 6654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=376.76 Aligned_cols=283 Identities=19% Similarity=0.157 Sum_probs=197.4
Q ss_pred hCCCCccceecccCceeEEEEEeCCCCeEEEEEEeecc--CchhHHHHHHHHHHHHhcCCCCceeEeeeeccccc-cCCC
Q 042075 710 TDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 786 (1033)
Q Consensus 710 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 786 (1033)
.++|++.++||+|+||+||+|++..+|+.||||+++.. .....+++.+|+.++++++||||+++++++...+. +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999743 23445678999999999999999999999754332 3456
Q ss_pred ceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcEE
Q 042075 787 FKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIAH 866 (1033)
Q Consensus 787 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (1033)
..|+||||+.++.+. .+. ..+++.++..++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEeccchHHHH-hhh------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccccee
Confidence 889999999765554 432 2478999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhhhC
Q 042075 867 VGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKTAL 946 (1033)
Q Consensus 867 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 946 (1033)
++|||.++........ ....+|+.|+|||++.+..+++++||||+||++|||++|+.||...... ...........
T Consensus 160 l~df~~~~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred eechhhhhcccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhcc
Confidence 9999998865443322 2244899999999999999999999999999999999999998632111 11111111111
Q ss_pred C----------cchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 947 P----------DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 947 ~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
. ....+..+..............................+++.+++.+||+.||++||||+|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 01111111111110000000000000111112234456778999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=379.21 Aligned_cols=284 Identities=18% Similarity=0.168 Sum_probs=199.6
Q ss_pred HhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccC--chhHHHHHHHHHHHHhcCCCCceeEeeeeccccccCC
Q 042075 708 NATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 708 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 785 (1033)
..+++|++.++||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||++++++.......+
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 34678999999999999999999999999999999997433 3345678899999999999999999998754433334
Q ss_pred CceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCCCcE
Q 042075 786 DFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEEMIA 865 (1033)
Q Consensus 786 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (1033)
...+++|+|+.+|+|.++++. ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CceEEEEEeecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccc
Confidence 455677788889999999842 3589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCccccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHHHHhh
Q 042075 866 HVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHNFAKT 944 (1033)
Q Consensus 866 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 944 (1033)
|++|||.|...... .....||+.|+|||...+. .++.++||||+||++|||++|+.||...... .........
T Consensus 161 kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~ 234 (348)
T d2gfsa1 161 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRL 234 (348)
T ss_dssp EECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH
T ss_pred cccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 99999999754322 2224489999999987765 4689999999999999999999998632111 011111111
Q ss_pred hCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042075 945 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 945 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1012 (1033)
..... .+.................................+++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 235 VGTPG-AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HCCCC-HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCC-hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 11000 00000000000000000000000000000001234568899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=371.98 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=198.4
Q ss_pred CCCCccceecccCceeEEEEEe---CCCCeEEEEEEeecc----CchhHHHHHHHHHHHHhcCC-CCceeEeeeeccccc
Q 042075 711 DGFTSANLIGAGSFGSVYKGIL---DEGKTIVAVKVFNLL----HHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDY 782 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 782 (1033)
++|++.++||+|+||+||+|+. +.+|+.||||+++.. .....+.+.+|++++++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 5799999999999999999987 446899999998632 22334678899999999976 8999999984
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCCCCeEecCC
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKPSNVLLDEE 862 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (1033)
......++||||+.+|+|.+++. ....++...+..++.||+.|++|+|++ +|+||||||+||+++.+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~----------~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 165 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred ccCCceeeeeecccccHHHHHHH----------hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC
Confidence 45568999999999999999994 345678889999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCccccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccCCccHHH
Q 042075 863 MIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPTDIMFEGDMNLHN 940 (1033)
Q Consensus 863 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 940 (1033)
+.+||+|||+|+.+....... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ ....
T Consensus 166 ~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~ 243 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAE 243 (322)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHH
T ss_pred CCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 999999999998765443322 2234599999999998764 46889999999999999999999997443222 1111
Q ss_pred HHhhhCCcchhhhcccccCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042075 941 FAKTALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSMESPEDRM-----DMTNVVH 1011 (1033)
Q Consensus 941 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1011 (1033)
........ ....+.++++++.+++.+||++||++|| |++|+++
T Consensus 244 i~~~~~~~----------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRILKS----------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhcccC----------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111000 0001112346689999999999999999 4788876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-36 Score=337.82 Aligned_cols=283 Identities=19% Similarity=0.205 Sum_probs=193.6
Q ss_pred CCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-----------CCCceeEeeeecc
Q 042075 711 DGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACSG 779 (1033)
Q Consensus 711 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 779 (1033)
.+|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999999999999997543 23467788999988875 5789999988642
Q ss_pred ccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeE
Q 042075 780 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVL 858 (1033)
Q Consensus 780 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIl 858 (1033)
......+++|+++..+........ ......+++..+..++.||+.||+|||+ . ||+||||||+|||
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIK-------KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVL 158 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHH-------HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEE
T ss_pred ---ccccceeeeeeecccccccccccc-------cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHee
Confidence 233455677776655443322211 1345678899999999999999999998 6 9999999999999
Q ss_pred ecCCC------cEEEeecccceecCCCCccccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 042075 859 LDEEM------IAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPTDIMF 932 (1033)
Q Consensus 859 l~~~~------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~vl~elltg~~p~~~~~ 932 (1033)
++.++ .++++|||.|....... ....||+.|+|||++....++.++||||+||+++||++|+.||....
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 98654 39999999998654322 22349999999999999999999999999999999999999986432
Q ss_pred cCCc--c---HHHHHhhh--CCcch-------hhhcccc-cCCCchhhhhccchhhhhhhhhhHHHHHHHHHHHHhhccC
Q 042075 933 EGDM--N---LHNFAKTA--LPDHV-------VDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMARIGVACSM 997 (1033)
Q Consensus 933 ~~~~--~---~~~~~~~~--~~~~~-------~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 997 (1033)
.... . ........ .+... ....+.. ...................+........+++.+++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 1110 0 11111100 00000 0000000 0000000000000011112223345567789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 042075 998 ESPEDRMDMTNVVHQ 1012 (1033)
Q Consensus 998 ~dP~~RPt~~evl~~ 1012 (1033)
.||++|||++|+++.
T Consensus 314 ~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNH 328 (362)
T ss_dssp SSTTTCBCHHHHHTC
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-33 Score=310.98 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=241.7
Q ss_pred cccEEEccCCCCCc--cCCccccCCCCCCEEEccc-CcccccCChhhhcCCCCcEEEccccccccccCcccccce-ecee
Q 042075 380 TLEVLLLDSNKIFG--NIPAAFGKFVKLLRLEMWN-NRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNL 455 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L 455 (1033)
+++.|+|++|.++| .+|..++++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+. |+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 68899999999987 4789999999999999996 899999999999999999999999999999999898887 9999
Q ss_pred eccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccc
Q 042075 456 QLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKL 535 (1033)
Q Consensus 456 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (1033)
++++|.+.+.+|..+++++.|+.+++++|+++|.+|..+..+..+++.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999999999999999999999999999999999999998888899999999999999999888655 799999999
Q ss_pred ccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcc
Q 042075 536 RGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEG 615 (1033)
Q Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 615 (1033)
.|.+|..++.+++|+.|++++|.+++.+| .++.+++|+.|||++|+|+|.+|+.+.++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997765 68999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccccccccCCccc
Q 042075 616 VFRNASITSVLGNLKLCGGTHE 637 (1033)
Q Consensus 616 ~~~~~~~~~~~~n~~lcg~~~~ 637 (1033)
.+..+....+.||+.+||.|++
T Consensus 289 ~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS
T ss_pred cCCCCCHHHhCCCccccCCCCC
Confidence 8899999999999999999875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.2e-28 Score=279.76 Aligned_cols=357 Identities=26% Similarity=0.373 Sum_probs=220.9
Q ss_pred EEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCc
Q 042075 136 VLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNN 215 (1033)
Q Consensus 136 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 215 (1033)
..+++.+.+++.++ ...+.+|++|++++|.|+ .+ +.+..+++|++|+|++|+|++..| |+++++|++|++++|+
T Consensus 26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence 44677777776554 356778899999998887 34 467788888888888888885433 7888888888888888
Q ss_pred CCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCc
Q 042075 216 LDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPP 295 (1033)
Q Consensus 216 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~ 295 (1033)
+++.. .++.+++|+.|++++|.+++..+ ...... +..+....|.+....+.
T Consensus 100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~-------------------------~~~~~~~~~~l~~~~~~ 150 (384)
T d2omza2 100 IADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTN-------------------------LNRLELSSNTISDISAL 150 (384)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTT-------------------------CSEEEEEEEEECCCGGG
T ss_pred ccccc--ccccccccccccccccccccccc--cccccc-------------------------ccccccccccccccccc
Confidence 87533 26777777777777777764322 122223 33333333333321111
Q ss_pred cCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccc
Q 042075 296 AISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACIS 375 (1033)
Q Consensus 296 ~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~ 375 (1033)
.................+ ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~----~~~~~~---------------------------------------------------- 174 (384)
T d2omza2 151 SGLTSLQQLSFGNQVTDL----KPLANL---------------------------------------------------- 174 (384)
T ss_dssp TTCTTCSEEEEEESCCCC----GGGTTC----------------------------------------------------
T ss_pred cccccccccccccccchh----hhhccc----------------------------------------------------
Confidence 111111111100000000 000000
Q ss_pred cccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-ece
Q 042075 376 NFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFN 454 (1033)
Q Consensus 376 ~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~ 454 (1033)
+.........|... ....+..+++++.+++++|.+++..| +...++|+.|++++|+++. + +.+..++ |+.
T Consensus 175 ---~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 245 (384)
T d2omza2 175 ---TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTD 245 (384)
T ss_dssp ---TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSE
T ss_pred ---cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccch
Confidence 11122222222221 23344555555566666665554332 3444556666666665553 2 2344444 566
Q ss_pred eeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccc
Q 042075 455 LQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENK 534 (1033)
Q Consensus 455 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (1033)
|++++|.+++..+ +..+++|++|++++|++++ +++ +..+..+ +.++++.|.+++. ..+..+++++.|++++|+
T Consensus 246 L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~-~~~-~~~~~~l-~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTAL-TNLELNENQLEDI--SPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTC-SEEECCSSCCSCC--GGGGGCTTCSEEECCSSC
T ss_pred hccccCccCCCCc--ccccccCCEeeccCcccCC-CCc-ccccccc-ccccccccccccc--cccchhcccCeEECCCCC
Confidence 6666666654332 5667777888888887773 332 4444444 6777788887752 357788889999999999
Q ss_pred cccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCC
Q 042075 535 LRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNN 605 (1033)
Q Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 605 (1033)
+++.. .+..+++|++|++++|+|++ +| .++++++|++|+|++|+|++.+| +.++++|++|+|++|
T Consensus 319 l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 98653 38889999999999999984 44 68999999999999999997654 888999999999987
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.8e-28 Score=275.59 Aligned_cols=356 Identities=22% Similarity=0.322 Sum_probs=192.5
Q ss_pred EecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccC
Q 042075 114 DLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT 193 (1033)
Q Consensus 114 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 193 (1033)
+++.+++++.++ ...+.+|++|++++|.|+ .+ ..+..+++|++|+|++|+|++ +| .|+++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccc
Confidence 444555555443 245566777777777666 33 346667777777777777763 33 2667777777777777776
Q ss_pred CCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcccc
Q 042075 194 GSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIG 273 (1033)
Q Consensus 194 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 273 (1033)
+..| ++++++|+.|++++|.+++..+ ......+..+....|.+....+..................+.. .
T Consensus 102 ~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 171 (384)
T d2omza2 102 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP------L 171 (384)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGG------G
T ss_pred cccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhh------h
Confidence 4432 6677777777777777764332 3344556666666666654333222222222222221111110 0
Q ss_pred ccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccc
Q 042075 274 FTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNA 353 (1033)
Q Consensus 274 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~ 353 (1033)
.............|... ....+..+++++.+++++|.+++..|. .
T Consensus 172 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~~-~-------------------------------- 216 (384)
T d2omza2 172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPL-G-------------------------------- 216 (384)
T ss_dssp TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGGG-G--------------------------------
T ss_pred ccccccccccccccccc--cccccccccccceeeccCCccCCCCcc-c--------------------------------
Confidence 01111222222222221 122233333333333333333322110 0
Q ss_pred cCcceeeecccccCCCCccccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEE
Q 042075 354 TRLKWFHININNFGGLLPACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELR 433 (1033)
Q Consensus 354 ~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 433 (1033)
..++|+.|++++|+++.. +.+..+++|+.|++++|++++.. .+..+++|+.|+
T Consensus 217 -----------------------~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 217 -----------------------ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp -----------------------GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred -----------------------ccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 113455555555555432 24555556666666666655432 255555566666
Q ss_pred ccccccccccCcccccceeceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccC
Q 042075 434 LQENRFLGNIPPSIGNLKLFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTG 513 (1033)
Q Consensus 434 L~~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~ 513 (1033)
+++|++++.. .+..++.++.++++.|++++ ++ .+..+..+ +.|++++|++++
T Consensus 270 l~~~~l~~~~-------------------------~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l-~~L~ls~n~l~~ 321 (384)
T d2omza2 270 LGANQISNIS-------------------------PLAGLTALTNLELNENQLED-IS-PISNLKNL-TYLTLYFNNISD 321 (384)
T ss_dssp CCSSCCCCCG-------------------------GGTTCTTCSEEECCSSCCSC-CG-GGGGCTTC-SEEECCSSCCSC
T ss_pred ccCcccCCCC-------------------------cccccccccccccccccccc-cc-ccchhccc-CeEECCCCCCCC
Confidence 6555554221 13344455555555555552 22 23333333 555666666654
Q ss_pred CcCCccccccccceEEccccccccccCcccccccccceeecccccccCcccccccCcccCCccccccc
Q 042075 514 PIPNEVGNLKNLEMLNVFENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQN 581 (1033)
Q Consensus 514 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 581 (1033)
.. .+..+++|+.|++++|+|++ ++ .++++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 322 l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 322 IS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Cc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 32 26677889999999998884 44 58889999999999999986554 888999999999988
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=5.5e-25 Score=240.75 Aligned_cols=275 Identities=21% Similarity=0.355 Sum_probs=148.2
Q ss_pred cccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcc
Q 042075 133 RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLS 212 (1033)
Q Consensus 133 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 212 (1033)
.++.+|-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4455666666665 5555543 456666666666653333456666666666666666665555566666666666666
Q ss_pred cCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCC
Q 042075 213 RNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGA 292 (1033)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 292 (1033)
+|+|+. +|..+ ...++.|++++|.+.+..+..+.....+..++...|... ....
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~-----------------------~~~~ 141 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-----------------------SSGI 141 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC-----------------------GGGB
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccc-----------------------ccCC
Confidence 666662 33322 234555555555555333333333333333333333221 0112
Q ss_pred CCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCcc
Q 042075 293 IPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPA 372 (1033)
Q Consensus 293 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~ 372 (1033)
.+..+..+++|+.+++++|.++.. |.
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~l------------------------------------------------------~~ 167 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITTI------------------------------------------------------PQ 167 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCSC------------------------------------------------------CS
T ss_pred CccccccccccCccccccCCcccc------------------------------------------------------Cc
Confidence 223334444444444444443311 11
Q ss_pred ccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCccccccee
Q 042075 373 CISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLKL 452 (1033)
Q Consensus 373 ~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~L 452 (1033)
. ..++|+.|++++|.+++..+..|.+++.+++|++++|++++..+.++.++++|++|+|++|+|+
T Consensus 168 ~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~------------ 232 (305)
T d1xkua_ 168 G---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV------------ 232 (305)
T ss_dssp S---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS------------
T ss_pred c---cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc------------
Confidence 1 1135666666666666666666777777777777777776666666666666666666666655
Q ss_pred ceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccc
Q 042075 453 FNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFE 532 (1033)
Q Consensus 453 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 532 (1033)
.+|.+|..+++|++|+|++|+|+ .++...+. .+..+..+.+|+.|+|++
T Consensus 233 ------------~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~------------------~~~~~~~~~~L~~L~L~~ 281 (305)
T d1xkua_ 233 ------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC------------------PPGYNTKKASYSGVSLFS 281 (305)
T ss_dssp ------------SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSS------------------CSSCCTTSCCCSEEECCS
T ss_pred ------------ccccccccccCCCEEECCCCccC-ccChhhcc------------------CcchhcccCCCCEEECCC
Confidence 34555666677777777777776 44432221 112233445566666666
Q ss_pred cccc
Q 042075 533 NKLR 536 (1033)
Q Consensus 533 N~l~ 536 (1033)
|.++
T Consensus 282 N~~~ 285 (305)
T d1xkua_ 282 NPVQ 285 (305)
T ss_dssp SSSC
T ss_pred CcCc
Confidence 6654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.8e-25 Score=244.69 Aligned_cols=291 Identities=23% Similarity=0.271 Sum_probs=230.9
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCc
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPA 150 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 150 (1033)
|.|++|.|+.. +++ .+|+.+. +.+++|+|++|+|+...+.+|.++++|++|++++|.++...|.
T Consensus 10 c~~~~~~C~~~-------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 10 CHLRVVQCSDL-------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EETTEEECTTS-------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred ecCCEEEecCC-------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh
Confidence 78999999754 344 4566553 6799999999999955556899999999999999999977788
Q ss_pred cccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCC--CcCCccccccC
Q 042075 151 NISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLD--GSIPDTFGWLK 228 (1033)
Q Consensus 151 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~ 228 (1033)
.|.++++|++|++++|+++ .+|..+. ..++.|++++|.+.+..+..+.....+..++...|... ...+..|..++
T Consensus 74 ~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~ 150 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150 (305)
T ss_dssp TTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred hhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccccc
Confidence 8999999999999999998 5666544 58899999999999776666777788899999988644 34567788999
Q ss_pred CCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccc
Q 042075 229 NLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQV 308 (1033)
Q Consensus 229 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 308 (1033)
+|+.+++++|+++ .+|..+ .++|+.|++++|.+.+..+. .+..+..+++|++++|.+++..+..+.++++|++|+|
T Consensus 151 ~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~-~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA-SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTG-GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChh-Hhhccccccccccccccccccccccccccccceeeec
Confidence 9999999999998 456554 57899999999999866554 4557889999999999999888899999999999999
Q ss_pred ccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCccccccccCcccEEEccC
Q 042075 309 NSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLPACISNFSTTLEVLLLDS 388 (1033)
Q Consensus 309 s~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~ 388 (1033)
++|+|+..++.+..+++|++|++++|+|+.++...+....... ...+|+.|+|++
T Consensus 227 ~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~-------------------------~~~~L~~L~L~~ 281 (305)
T d1xkua_ 227 NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT-------------------------KKASYSGVSLFS 281 (305)
T ss_dssp CSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCT-------------------------TSCCCSEEECCS
T ss_pred ccccccccccccccccCCCEEECCCCccCccChhhccCcchhc-------------------------ccCCCCEEECCC
Confidence 9999998877889999999999999998876544332221111 224677788888
Q ss_pred CCCC--ccCCccccCCCCCCEEE
Q 042075 389 NKIF--GNIPAAFGKFVKLLRLE 409 (1033)
Q Consensus 389 N~i~--~~~p~~~~~l~~L~~L~ 409 (1033)
|.+. .+.|.+|.-+.....++
T Consensus 282 N~~~~~~~~~~~f~~~~~~~~~~ 304 (305)
T d1xkua_ 282 NPVQYWEIQPSTFRCVYVRAAVQ 304 (305)
T ss_dssp SSSCGGGSCGGGGTTCCCGGGEE
T ss_pred CcCccCcCCHhHhcccccCcccc
Confidence 8765 45566776665555444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-25 Score=241.53 Aligned_cols=251 Identities=21% Similarity=0.213 Sum_probs=176.3
Q ss_pred EEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeec-cccc
Q 042075 384 LLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQL-SYNF 461 (1033)
Q Consensus 384 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~L-s~N~ 461 (1033)
++.++++++ .+|..+. +.+++|+|++|+|++..+.+|.++++|++|++++|++.+..+..+.... +..++. ..|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 345555554 3344332 3456666666666655555666666677777776666665555555554 555443 4556
Q ss_pred cCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccccCc
Q 042075 462 LQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGEIPR 541 (1033)
Q Consensus 462 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (1033)
++...|..|.++++|++|++++|.+.+..+..+.....+ +.+++++|+|++..+..|..+++|+.|++++|++++..+.
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhccc-chhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 666667777788888888888888774333334334444 7788888888866667788888889999999998877788
Q ss_pred ccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCcccCCCcccccccc
Q 042075 542 TLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGMVPTEGVFRNAS 621 (1033)
Q Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~ 621 (1033)
+|.++++|+++++++|++++..|..|..+++|+.||+++|++++..|..|..+++|++|+|++|++.+..+..+...+..
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~ 251 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHH
Confidence 88888999999999999988888888989999999999999988888888888899999999999988766543333444
Q ss_pred cccccccccccCCcccc
Q 042075 622 ITSVLGNLKLCGGTHEF 638 (1033)
Q Consensus 622 ~~~~~~n~~lcg~~~~~ 638 (1033)
......+...|..|.+.
T Consensus 252 ~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp HCCSEECCCBEEESGGG
T ss_pred hCcCCCCceEeCCchHH
Confidence 33334455556555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.3e-24 Score=235.05 Aligned_cols=224 Identities=22% Similarity=0.256 Sum_probs=194.4
Q ss_pred cCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcc-ccccc
Q 042075 91 LKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLS-SNELV 169 (1033)
Q Consensus 91 l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls-~N~l~ 169 (1033)
.++.+++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|.+.+..+..+.++..++.++.+ .|.++
T Consensus 18 c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 18 CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp CCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred cCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 3444565 5565543 568999999999996666789999999999999999998888888899999998875 56677
Q ss_pred CCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCccccc
Q 042075 170 GKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIF 249 (1033)
Q Consensus 170 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 249 (1033)
...|..|.++++|++|++++|.+....+..+....+|+.+++++|+|++..++.|..+++|++|++++|++++..+..+.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence 66688899999999999999999877788888999999999999999988888999999999999999999988888899
Q ss_pred CCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCc
Q 042075 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVP 318 (1033)
Q Consensus 250 ~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 318 (1033)
++++|+.+++++|++++..|. .+..+++|++|++++|++++..+..|..+++|++|++++|++...-+
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~-~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPH-AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccccchhhhhhccccccChh-HhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999999999999965554 45678999999999999998888899999999999999999987644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.9e-23 Score=220.64 Aligned_cols=200 Identities=27% Similarity=0.262 Sum_probs=129.7
Q ss_pred CcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce-eceeec
Q 042075 379 TTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK-LFNLQL 457 (1033)
Q Consensus 379 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-L~~L~L 457 (1033)
..+..++.++++++. +|..+. +++++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+|. ++.++ |++|+|
T Consensus 10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccc
Confidence 345556777777764 455443 46777888888877666677777888888888887776 2332 23333 555555
Q ss_pred cccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcccccccc
Q 042075 458 SYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRG 537 (1033)
Q Consensus 458 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (1033)
++|+++ ..+..+.++++|++|++++|++. +..+..+..+.+++.|++++|.+++
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~~~~l~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-------------------------SLPLGALRGLGELQELYLKGNELKT 138 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCC-------------------------CCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred cccccc-ccccccccccccccccccccccc-------------------------eeeccccccccccccccccccccce
Confidence 555554 23445555666666666666555 3344455556667777777777765
Q ss_pred ccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecCCCcCccc
Q 042075 538 EIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSNNDFEGM 610 (1033)
Q Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 610 (1033)
..+..+..+++|+.|++++|+|++..+..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|++.+.
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 55566666777777777777777666666777777777777777776 6676666777777777777777654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.8e-23 Score=219.30 Aligned_cols=195 Identities=18% Similarity=0.199 Sum_probs=131.3
Q ss_pred EEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccccc
Q 042075 88 ILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNE 167 (1033)
Q Consensus 88 ~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 167 (1033)
.+|.++++|+ .+|+.+. +.+++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|++|+
T Consensus 14 ~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSC
T ss_pred EEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccc
Confidence 3466666776 3565553 46778888888887655567777888888888888777 4443 4677777777777777
Q ss_pred ccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCccc
Q 042075 168 LVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 168 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 247 (1033)
++ .+|..+.++++|++|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++++|++++..+..
T Consensus 89 l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp CS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred cc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccc
Confidence 76 45667777777777777777777666666777777777777777777666666677777777777777777555555
Q ss_pred ccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCcccccccccccc
Q 042075 248 IFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLT 314 (1033)
Q Consensus 248 l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 314 (1033)
+..+++|++|||++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 168 ~~~l~~L~~L~Ls~N~L~--------------------------~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLY--------------------------TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTCTTCCEEECCSSCCC--------------------------CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccceeecccCCCc--------------------------ccChhHCCCCCCCEEEecCCCCC
Confidence 555555555555555554 34444555555666666666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.4e-22 Score=202.76 Aligned_cols=165 Identities=18% Similarity=0.131 Sum_probs=121.1
Q ss_pred CCccceecccCceeEEEEEeCCCCeEEEEEEeeccCc------------------hhHHHHHHHHHHHHhcCCCCceeEe
Q 042075 713 FTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHH------------------GAFKSFIAECNTLKNIRHRNLVKIL 774 (1033)
Q Consensus 713 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~ 774 (1033)
+.+.++||+|+||+||+|++. +|+.||||+++.... .......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999986 689999998752110 0123455788899999999999888
Q ss_pred eeeccccccCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCcEeccCCC
Q 042075 775 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHDCQPPIVHCDLKP 854 (1033)
Q Consensus 775 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (1033)
++. ..+++|||+++..+.++ +......++.|+++|++|||++ ||+||||||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP 131 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 131 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred Eec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence 762 23799999987655432 2234567999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeecccceecCCCCccccccccccccccccc--c---ccCCCCCCcccchHHHHHHH
Q 042075 855 SNVLLDEEMIAHVGDFGLATFLPLSHAQTSSIFAKGSIGYIAP--E---YGLGSEVSINGDVYSYGILL 918 (1033)
Q Consensus 855 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDvwSlG~vl 918 (1033)
+|||++++ .++|+|||.|.....+... .|... + .+..+.|+.++|+||..--+
T Consensus 132 ~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 132 YNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred hheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999865 4899999999865433221 11110 0 01235788999999976544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=4.5e-20 Score=205.52 Aligned_cols=315 Identities=25% Similarity=0.346 Sum_probs=172.0
Q ss_pred ccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEc
Q 042075 132 RRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211 (1033)
Q Consensus 132 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 211 (1033)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 46888999999987 67864 467888888888888 777654 46788888888887 44431 135788888
Q ss_pred ccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCC
Q 042075 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTG 291 (1033)
Q Consensus 212 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~ 291 (1033)
++|.++ .+|. ++.+++|++|++++|.++.. |.. ...+..+.+..+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~----------------------------~~~l~~l~~~~~~~~- 153 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL----------------------------PPSLEFIAAGNNQLE- 153 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC----------------------------CTTCCEEECCSSCCS-
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-ccc----------------------------cccccchhhcccccc-
Confidence 888877 4453 56677777777777766622 211 223334444433332
Q ss_pred CCCccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecccccCCCCc
Q 042075 292 AIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHININNFGGLLP 371 (1033)
Q Consensus 292 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~n~l~~~ip 371 (1033)
.+..+..++.++.+++++|.+...+...
T Consensus 154 -~~~~l~~l~~l~~L~l~~n~~~~~~~~~--------------------------------------------------- 181 (353)
T d1jl5a_ 154 -ELPELQNLPFLTAIYADNNSLKKLPDLP--------------------------------------------------- 181 (353)
T ss_dssp -SCCCCTTCTTCCEEECCSSCCSSCCCCC---------------------------------------------------
T ss_pred -ccccccccccceeccccccccccccccc---------------------------------------------------
Confidence 2233444555555555555544221100
Q ss_pred cccccccCcccEEEccCCCCCccCCccccCCCCCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccCcccccce
Q 042075 372 ACISNFSTTLEVLLLDSNKIFGNIPAAFGKFVKLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIPPSIGNLK 451 (1033)
Q Consensus 372 ~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 451 (1033)
...+.+...++.+. .+ ..+..++.|+.+++++|.... .+. ...++..+.+.+|.+.. .+..
T Consensus 182 -------~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~-~~~~----- 242 (353)
T d1jl5a_ 182 -------LSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPEL----- 242 (353)
T ss_dssp -------TTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCC-----
T ss_pred -------cccccccccccccc-cc-ccccccccccccccccccccc-ccc---ccccccccccccccccc-cccc-----
Confidence 11222333333332 11 123445556666666655542 222 22344555555554431 1111
Q ss_pred eceeeccccccCCCCCCccCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEcc
Q 042075 452 LFNLQLSYNFLQGSIPSSLGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVF 531 (1033)
Q Consensus 452 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (1033)
...+...++..|.+.+ ++ .+.......++..|.+.+ ++ ..+++|++|+|+
T Consensus 243 ---------------------~~~l~~~~~~~~~~~~-l~----~l~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 243 ---------------------PQSLTFLDVSENIFSG-LS----ELPPNLYYLNASSNEIRS-LC---DLPPSLEELNVS 292 (353)
T ss_dssp ---------------------CTTCCEEECCSSCCSE-ES----CCCTTCCEEECCSSCCSE-EC---CCCTTCCEEECC
T ss_pred ---------------------cccccccccccccccc-cc----cccchhcccccccCcccc-cc---ccCCCCCEEECC
Confidence 2234444444444331 11 111111233445555542 22 234677888888
Q ss_pred ccccccccCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCcccccccccceeecC
Q 042075 532 ENKLRGEIPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLS 603 (1033)
Q Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 603 (1033)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|+.. ..|+.|.+.
T Consensus 293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 293 NNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 88887 56643 456777888888887 56653 456778888888877 566533 245555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=3.7e-19 Score=197.97 Aligned_cols=136 Identities=25% Similarity=0.302 Sum_probs=70.2
Q ss_pred EEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEccc
Q 042075 86 VTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSS 165 (1033)
Q Consensus 86 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 165 (1033)
++.|||++++++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|++++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 345666666665 34432 345666666666666 455443 34556666666655 33321 12456666666
Q ss_pred ccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccC
Q 042075 166 NELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 166 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 241 (1033)
|.++ .+|. ++.+++|++|++++|.+.. .|.. ...+..+.+.++... .+..+..++.++.|++++|.+.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred cccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence 6665 3443 4556666666666665552 2221 234445555544443 2334455555555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.5e-19 Score=185.44 Aligned_cols=222 Identities=15% Similarity=0.205 Sum_probs=173.8
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCC-C
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEI-P 149 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p 149 (1033)
|.++.|.|... +++ .+|+.+. +.+++|+|++|+|+...+..|.++++|++|+|++|.+...+ +
T Consensus 8 C~~~~i~c~~~-------------~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 8 CSNRVFLCQES-------------KVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp ECSSEEEEESC-------------SCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred CcCCEEEEeCC-------------CCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence 66777777543 444 5665543 57899999999998655567999999999999999998655 4
Q ss_pred ccccCCCCCcEEEccc-ccccCCCCCCcccccccceeeecccccCCCCC-CCCCCCCCCcEEEcccCcCCCcCCcccccc
Q 042075 150 ANISSCSNLIRVRLSS-NELVGKIPSELGSLSKIEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRNNLDGSIPDTFGWL 227 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 227 (1033)
..|.+++++++|++.. |.+....+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+....+..|..+
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence 4688999999999874 67887778889999999999999999985433 235567778888888888987777788776
Q ss_pred C-CCCcccccccccCCCCcccccCCCceeEE-eccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccc
Q 042075 228 K-NLVNLTMAQNRLSGTIPSSIFNISSITVF-DAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEV 305 (1033)
Q Consensus 228 ~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L-~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 305 (1033)
+ .++.|++++|+++ .++...++..+++.+ ++++|+++ .+|.+.+..+++|++|+|++|+|+...+..|.++++|++
T Consensus 152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 229 (242)
T ss_dssp BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred cccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccccc
Confidence 5 7888999999998 455555666665554 57778887 678777878899999999999998666667888888888
Q ss_pred ccccc
Q 042075 306 FQVNS 310 (1033)
Q Consensus 306 L~Ls~ 310 (1033)
+++.+
T Consensus 230 l~~~~ 234 (242)
T d1xwdc1 230 RSTYN 234 (242)
T ss_dssp SSEES
T ss_pred CcCCC
Confidence 87754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=5.7e-19 Score=177.78 Aligned_cols=173 Identities=19% Similarity=0.277 Sum_probs=91.4
Q ss_pred EEEecCCCccccCCccccccccccEEecccCCCCCCC-CccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 112 VLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEI-PANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 112 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
+++.++++++ .+|..+. +++++|+|++|+|++.+ +..|+++++|++|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555555555 4454432 34555555555554322 333445555555555555555444555555555555555555
Q ss_pred ccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCc
Q 042075 191 NLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPL 270 (1033)
Q Consensus 191 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 270 (1033)
+|++..|..|.++++|++|+|++|+|++..|++|..+++|++|+|++ |.+....+.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~------------------------N~~~~~~~~ 144 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS------------------------NPFNCNCHL 144 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTT------------------------CCBCCSGGG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccc------------------------cccccccch
Confidence 55544444455555555555555555544444455455555554444 444433322
Q ss_pred cccccccccceeeecccccCCCCCccCcCCCCccccccccccccCc
Q 042075 271 DIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGE 316 (1033)
Q Consensus 271 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 316 (1033)
..+ ...++.+.+..|.++...|.. +..++.++|+.|.++-.
T Consensus 145 ~~~--~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 145 AWF--AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp HHH--HHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCC
T ss_pred HHH--hhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCC
Confidence 221 234566677777777666654 44567788888887643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=5e-19 Score=178.25 Aligned_cols=160 Identities=21% Similarity=0.269 Sum_probs=131.9
Q ss_pred cceeeeEecCCCCCeEEEEEcCCCCCCcccccccCCCCCCCEEEecCCCccccC-CccccccccccEEecccCCCCCCCC
Q 042075 71 CQWHGVTCSRRQHQRVTILDLKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEI-PSEFDRLRRLQVLALHNNSIGGEIP 149 (1033)
Q Consensus 71 c~w~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p 149 (1033)
|+|..|.|+. ++++ .+|+.+. +++++|+|++|+|++.+ +..|..+++|++|+|++|.+++..+
T Consensus 8 C~~~~v~Cs~-------------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 71 (192)
T d1w8aa_ 8 CEGTTVDCTG-------------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71 (192)
T ss_dssp EETTEEECTT-------------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred EcCCEEEEeC-------------CCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccc
Confidence 6677777754 3555 5676553 68999999999998754 5678999999999999999999999
Q ss_pred ccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCC
Q 042075 150 ANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKN 229 (1033)
Q Consensus 150 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 229 (1033)
..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.+.... +...-...
T Consensus 72 ~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~ 150 (192)
T d1w8aa_ 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEW 150 (192)
T ss_dssp TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHH
T ss_pred cccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhh
Confidence 99999999999999999999888889999999999999999999888899999999999999999998433 22222334
Q ss_pred CCcccccccccCCCCccc
Q 042075 230 LVNLTMAQNRLSGTIPSS 247 (1033)
Q Consensus 230 L~~L~L~~N~l~~~~p~~ 247 (1033)
++.+.+..|.++...|..
T Consensus 151 l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 151 LRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp HHHHCCSGGGCBBCSSTT
T ss_pred hhhhcccCCCeEeCCChh
Confidence 666777777777655543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2.1e-18 Score=180.87 Aligned_cols=200 Identities=16% Similarity=0.127 Sum_probs=114.1
Q ss_pred CCCEEEcccCcccccCChhhhcCCCCcEEEccccccccccC-cccccce-eceeecc-ccccCCCCCCccCCCCcccEEe
Q 042075 404 KLLRLEMWNNRLSGTIPPAIGELQNLRELRLQENRFLGNIP-PSIGNLK-LFNLQLS-YNFLQGSIPSSLGQSETLTIID 480 (1033)
Q Consensus 404 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~-L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~ 480 (1033)
++++|+|++|+|+...+.+|.++++|++|+|++|.+...+| ..|..+. ++++.+. .|++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 45555555555554444445555555555555555544332 2344443 4444443 3455555555666666666666
Q ss_pred cCCCccCCCCCccccCchhHHhhhhccCccccCCcCCcccccc-ccceEEccccccccccCcccccccccc-eeeccccc
Q 042075 481 LSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLK-NLEMLNVFENKLRGEIPRTLGSCIKLE-LLQMQGNF 558 (1033)
Q Consensus 481 Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~ 558 (1033)
+++|++....+.........+..+..+++.+....+..|..++ .++.|++++|+++. ++....+..++. .+++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhccccccccc
Confidence 6666665222222222222224444555566544445555554 67778888888874 443333444444 44577778
Q ss_pred ccCcccccccCcccCCccccccccccccCCcccccccccceeecCC
Q 042075 559 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEFLVGFQLLEYLNLSN 604 (1033)
Q Consensus 559 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 604 (1033)
|+...+..|.++++|+.|||++|+|+...+..|.+++.|+.+++.+
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 8744445578888888888888888855555677777777776644
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.3e-18 Score=177.37 Aligned_cols=188 Identities=21% Similarity=0.340 Sum_probs=94.6
Q ss_pred CCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccce
Q 042075 105 GNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEY 184 (1033)
Q Consensus 105 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 184 (1033)
+.|++|+.|++++|+++ .++ .+..+++|++|++++|.+++..| +.++++|++|++++|.++ .++ .+.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccc
Confidence 44555566666666555 232 35556666666666666553322 555566666666665554 222 3555555566
Q ss_pred eeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccc
Q 042075 185 FSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQI 264 (1033)
Q Consensus 185 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l 264 (1033)
+++++|...+..+ +...+.++.+.++++.+... ..+...++|++|++++|++++.. .+.++++|+.|++++
T Consensus 112 l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~--- 182 (227)
T d1h6ua2 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADD--- 182 (227)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS---
T ss_pred cccccccccccch--hccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCC---
Confidence 6665555543322 33445555555555555422 22444555555555555554221 244444444444444
Q ss_pred cCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccccccCcCcchhhhccccceeee
Q 042075 265 QGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVIT 332 (1033)
Q Consensus 265 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~ 332 (1033)
|++++. + .++++++|++|++++|++++.. .+..+++|+.|+++
T Consensus 183 ----------------------n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 183 ----------------------NKISDI-S-PLASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225 (227)
T ss_dssp ----------------------SCCCCC-G-GGGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEE
T ss_pred ----------------------CccCCC-h-hhcCCCCCCEEECcCCcCCCCc-ccccCCCCCEEEee
Confidence 444431 1 2445555555555555555432 24555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.6e-18 Score=176.25 Aligned_cols=205 Identities=20% Similarity=0.320 Sum_probs=122.4
Q ss_pred cEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccC
Q 042075 135 QVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214 (1033)
Q Consensus 135 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 214 (1033)
..++++.+.+++.+ .+..+.+|++|++++|.|+ .+ +.+.++++|++|++++|++++..| +.++++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33444444444322 2334444444555544444 22 234445555555555555443322 444555555555555
Q ss_pred cCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCccccccccccceeeecccccCCCCC
Q 042075 215 NLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIP 294 (1033)
Q Consensus 215 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p 294 (1033)
.++. ++ .|..+++|+.++++++...+. ..+...+.+..++++.+.+....+ +...++|++|++++|.++..
T Consensus 96 ~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 96 PLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP---LAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC--
T ss_pred cccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh---hccccccccccccccccccc--
Confidence 5442 22 344555555555555554432 223445555666666666553332 23567788888888888743
Q ss_pred ccCcCCCCccccccccccccCcCcchhhhccccceeeecCcCCCCCCccchhhcccccccCcceeeecc
Q 042075 295 PAISNASNLEVFQVNSNKLTGEVPYLEKLQRLSHFVITRNSLGSGEHRDLNFLCSLTNATRLKWFHINI 363 (1033)
Q Consensus 295 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~~~L~~l~l~~ 363 (1033)
..+.++++|+.|+|++|++++. +.+..+++|++|++++|++++. ..+.++++|+.+++++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i--------~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDV--------SPLANTSNLFIVTLTN 226 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBC--------GGGTTCTTCCEEEEEE
T ss_pred hhhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCC--------cccccCCCCCEEEeeC
Confidence 3488899999999999999874 5589999999999999998864 2467888999999863
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=5.3e-21 Score=221.31 Aligned_cols=211 Identities=22% Similarity=0.170 Sum_probs=112.8
Q ss_pred cccEEEccCCCCCcc----CCccccCCCCCCEEEcccCcccc-----cCChhhhcCCCCcEEEcccccccccc----Ccc
Q 042075 380 TLEVLLLDSNKIFGN----IPAAFGKFVKLLRLEMWNNRLSG-----TIPPAIGELQNLRELRLQENRFLGNI----PPS 446 (1033)
Q Consensus 380 ~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~ 446 (1033)
....+++..+.+... ....+...+.++.+++++|++.. ..+........++.|++++|.+.... ...
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 344555555544321 11223445566666666665431 12222333455666666666554321 111
Q ss_pred cccce-eceeeccccccCCCCCCc-----cCCCCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccc
Q 042075 447 IGNLK-LFNLQLSYNFLQGSIPSS-----LGQSETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVG 520 (1033)
Q Consensus 447 ~~~l~-L~~L~Ls~N~l~~~~p~~-----~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~ 520 (1033)
+.... ++.+++++|.+....... ......|+.+++++|.++..- + .. +...+.
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~---~---~~---------------l~~~~~ 337 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC---C---SH---------------FSSVLA 337 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG---H---HH---------------HHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhh---h---hh---------------cccccc
Confidence 22222 555555555543211111 012234555555555554110 0 00 111223
Q ss_pred cccccceEEccccccccc----cCcccc-cccccceeecccccccCc----ccccccCcccCCccccccccccccCCccc
Q 042075 521 NLKNLEMLNVFENKLRGE----IPRTLG-SCIKLELLQMQGNFLQGP----IPSSLSSLRGLSVLDLSQNNLSGKIPEFL 591 (1033)
Q Consensus 521 ~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 591 (1033)
..++|++|+|++|+++.. ++..+. ..+.|++|+|++|+|+.. ++..+..+++|++|||++|+|+......+
T Consensus 338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l 417 (460)
T d1z7xw1 338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417 (460)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence 445788889998888643 333333 456788999999988742 45566777889999999998875433333
Q ss_pred c-----cccccceeecCCCcCcccC
Q 042075 592 V-----GFQLLEYLNLSNNDFEGMV 611 (1033)
Q Consensus 592 ~-----~l~~L~~L~ls~N~l~g~~ 611 (1033)
. +...|+.|++++|.+....
T Consensus 418 ~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 418 VESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp HHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred HHHHHhCCCccCEEECCCCCCCHHH
Confidence 2 2346889999998887543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1e-17 Score=171.12 Aligned_cols=179 Identities=20% Similarity=0.366 Sum_probs=85.3
Q ss_pred EecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccC
Q 042075 114 DLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLT 193 (1033)
Q Consensus 114 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 193 (1033)
++..+.+++.++. ..+.+|++|++++|.+++ ++ .+..+++|++|+|++|++++ ++ .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 3444444443332 234555566666665552 22 25555566666666665553 22 2455556666666666555
Q ss_pred CCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCccccCccCcccc
Q 042075 194 GSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQGVIPLDIG 273 (1033)
Q Consensus 194 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 273 (1033)
+ +| .+.++++|+.|++++|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+++++++|++++..+ +
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~---l 174 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP---L 174 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG---G
T ss_pred c-cc-cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccccc---c
Confidence 2 33 25555556666666655542 2235555555555555555542 1223344444444444444442211 1
Q ss_pred ccccccceeeecccccCCCCCccCcCCCCccccccc
Q 042075 274 FTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVN 309 (1033)
Q Consensus 274 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 309 (1033)
..+++|+.|+|++|+|+. +| .+.++++|++|+|+
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 234444444444444442 22 24444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.8e-17 Score=169.10 Aligned_cols=166 Identities=19% Similarity=0.290 Sum_probs=121.0
Q ss_pred CCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCccccccccee
Q 042075 106 NLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYF 185 (1033)
Q Consensus 106 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 185 (1033)
.|..|+.|++++|.+++ ++ .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++ .+| .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccc
Confidence 45677788888888774 33 37778888888888888874 33 3677888888888888887 344 47778888888
Q ss_pred eecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 186 SVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 186 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++++|.+.. ++ .+.++++|+.+++++|.+++ +..+..+++|+++++++|++++. + .+.++++|+.|++++|+|+
T Consensus 118 ~l~~~~~~~-~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISD-IN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc-cc-cccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence 888887763 33 46777888888888888773 34567788888888888888753 3 3777888888888888887
Q ss_pred CccCccccccccccceeeecc
Q 042075 266 GVIPLDIGFTLQNLQFFSVGR 286 (1033)
Q Consensus 266 ~~~p~~~~~~l~~L~~L~L~~ 286 (1033)
. +|. +..+++|++|+|++
T Consensus 192 ~-l~~--l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LRA--LAGLKNLDVLELFS 209 (210)
T ss_dssp B-CGG--GTTCTTCSEEEEEE
T ss_pred C-Chh--hcCCCCCCEEEccC
Confidence 3 442 45678888888864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=4e-20 Score=213.82 Aligned_cols=109 Identities=20% Similarity=0.292 Sum_probs=63.6
Q ss_pred eEEEEEcCCCCCCcc-cccccCCCCCCCEEEecCCCccc----cCCccccccccccEEecccCCCCCC----CCcccc-C
Q 042075 85 RVTILDLKSLKLAGY-ISAHVGNLSFLKVLDLHNNSFHH----EIPSEFDRLRRLQVLALHNNSIGGE----IPANIS-S 154 (1033)
Q Consensus 85 ~v~~l~l~~~~l~g~-~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~-~ 154 (1033)
+++.||++++++++. +...+..++++++|+|++|+++. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 467777777777653 23334556777777777777652 2444556667777777777766421 111121 2
Q ss_pred CCCCcEEEcccccccCC----CCCCcccccccceeeecccccC
Q 042075 155 CSNLIRVRLSSNELVGK----IPSELGSLSKIEYFSVSYNNLT 193 (1033)
Q Consensus 155 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 193 (1033)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23567777777766532 2344555666666666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=6.1e-17 Score=163.70 Aligned_cols=126 Identities=25% Similarity=0.380 Sum_probs=56.4
Q ss_pred ccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEE
Q 042075 130 RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFL 209 (1033)
Q Consensus 130 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 209 (1033)
.+.++++|++++|.++ .++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 3445555555555554 222 24445555555555555543221 4455555555555555442 22 14445555555
Q ss_pred EcccCcCCCcCCccccccCCCCcccccccccCCCCcccccCCCceeEEeccCcccc
Q 042075 210 FLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 210 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++++|.+... +.+..+++|+.|++++|++.. ++ .+..+++|+.|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-cc-ccccccccccccccccccc
Confidence 5555554421 224444555555555554442 11 2333444444444444433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7.6e-17 Score=163.01 Aligned_cols=161 Identities=19% Similarity=0.343 Sum_probs=121.9
Q ss_pred cCCCCCCcccccccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccC
Q 042075 91 LKSLKLAGYISAHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVG 170 (1033)
Q Consensus 91 l~~~~l~g~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 170 (1033)
+..+++++.++ ...+.++++|++++|+++. ++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+.
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~- 97 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 97 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-
Confidence 44444444332 2356788889999988873 43 57888999999999999985433 888999999999999887
Q ss_pred CCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccCcCCCcCCccccccCCCCcccccccccCCCCcccccC
Q 042075 171 KIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIPSSIFN 250 (1033)
Q Consensus 171 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 250 (1033)
.++ .+.++++|+.|++++|.+.... .+.++++|+.|++++|++.. + +.+..+++|++|++++|++++. + .+.+
T Consensus 98 ~~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~ 170 (199)
T d2omxa2 98 DIT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLAN 170 (199)
T ss_dssp CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTT
T ss_pred ccc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccC
Confidence 444 4788899999999988887543 37788899999999999873 3 3588889999999999998854 2 3677
Q ss_pred CCceeEEeccCcccc
Q 042075 251 ISSITVFDAGINQIQ 265 (1033)
Q Consensus 251 l~~L~~L~ls~N~l~ 265 (1033)
+++|++|++++|+++
T Consensus 171 l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 171 LTTLERLDISSNKVS 185 (199)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CCCCCEEECCCCCCC
Confidence 777777777777766
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=4.6e-15 Score=136.44 Aligned_cols=102 Identities=20% Similarity=0.306 Sum_probs=64.0
Q ss_pred CEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeeccc
Q 042075 111 KVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYN 190 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 190 (1033)
|+|||++|+++ .+| .+..+++|++||+++|+|+ .+|..++.+++|++|++++|+|+ .+| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 45677777776 344 3666777777777777776 55666666777777777777766 333 3666666666666666
Q ss_pred ccCCCCC-CCCCCCCCCcEEEcccCcCC
Q 042075 191 NLTGSIP-PSFGNLSSISFLFLSRNNLD 217 (1033)
Q Consensus 191 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 217 (1033)
+++.... ..+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6663321 34556666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3e-15 Score=144.90 Aligned_cols=109 Identities=21% Similarity=0.188 Sum_probs=45.5
Q ss_pred ccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEE
Q 042075 130 RLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFL 209 (1033)
Q Consensus 130 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 209 (1033)
+..+|++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3344444444444444 33333344444444444444444 221 24444444444444444443222223344444444
Q ss_pred EcccCcCCCcCC-ccccccCCCCcccccccccC
Q 042075 210 FLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 210 ~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 241 (1033)
+|++|+|+.... ..+..+++|++|++++|+++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 444444442111 23344444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.1e-15 Score=144.79 Aligned_cols=129 Identities=16% Similarity=0.154 Sum_probs=108.4
Q ss_pred cccCCCCCCCEEEecCCCccccCCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccc
Q 042075 102 AHVGNLSFLKVLDLHNNSFHHEIPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSK 181 (1033)
Q Consensus 102 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 181 (1033)
+.+.+...|++|||++|+|+ .+|..+..+++|++|||++|.|+ .++ .|..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 44677889999999999998 56877788999999999999998 554 5899999999999999999554555678999
Q ss_pred cceeeecccccCCCCC-CCCCCCCCCcEEEcccCcCCCcCCc----cccccCCCCccc
Q 042075 182 IEYFSVSYNNLTGSIP-PSFGNLSSISFLFLSRNNLDGSIPD----TFGWLKNLVNLT 234 (1033)
Q Consensus 182 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 234 (1033)
|++|++++|+++.... ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 9999999999984322 46788999999999999998 4453 477788888877
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=9.6e-15 Score=134.24 Aligned_cols=103 Identities=25% Similarity=0.318 Sum_probs=83.5
Q ss_pred cEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEcccC
Q 042075 135 QVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFLSRN 214 (1033)
Q Consensus 135 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 214 (1033)
|+|||++|+|+ .+| .+.++++|++|++++|+|+ .+|+.|+.+++|++|++++|+|++ +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57899999998 555 4888999999999999998 678888889999999999999984 44 3888888999999999
Q ss_pred cCCCcC-CccccccCCCCcccccccccCC
Q 042075 215 NLDGSI-PDTFGWLKNLVNLTMAQNRLSG 242 (1033)
Q Consensus 215 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 242 (1033)
+|+... ...++.+++|++|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 888543 2567778888888888888763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=9.1e-15 Score=156.28 Aligned_cols=124 Identities=18% Similarity=0.152 Sum_probs=62.4
Q ss_pred CEEEecCCCccccCCcccccc--ccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCC-CCCCcccccccceeee
Q 042075 111 KVLDLHNNSFHHEIPSEFDRL--RRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGK-IPSELGSLSKIEYFSV 187 (1033)
Q Consensus 111 ~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 187 (1033)
++|||+++.+.. ..++.+ ..+..+.++...+. ..........+|++|||++|.+++. ++..+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCc---hHHHHHHhccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 356666666542 222222 12344555544443 2222233445666666666665532 2334556666666666
Q ss_pred cccccCCCCCCCCCCCCCCcEEEcccC-cCCCc-CCccccccCCCCccccccc
Q 042075 188 SYNNLTGSIPPSFGNLSSISFLFLSRN-NLDGS-IPDTFGWLKNLVNLTMAQN 238 (1033)
Q Consensus 188 s~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N 238 (1033)
++|.+++..+..++.+++|++|+|+++ .++.. +...+..+++|++|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 666665555555556666666666663 34311 1112234555666665553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2.7e-14 Score=152.50 Aligned_cols=183 Identities=14% Similarity=0.109 Sum_probs=86.1
Q ss_pred CCCceeEEeccCccccCccCccccccccccceeeecccccCCCCCccCcCCCCccccccccc-cccCc-Cc-chhhhccc
Q 042075 250 NISSITVFDAGINQIQGVIPLDIGFTLQNLQFFSVGRNQLTGAIPPAISNASNLEVFQVNSN-KLTGE-VP-YLEKLQRL 326 (1033)
Q Consensus 250 ~l~~L~~L~ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~~-~l~~l~~L 326 (1033)
...+|++||++++.+.......++..+++|++|+|+++.+++..+..+..+++|++|+++++ .++.. .. ....+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 34456666666666554433344555666777777777666555666666777777777763 45422 11 23445666
Q ss_pred cceeeecC-cCCCCCCccchhhcccc-cccCcceeeeccc--ccCCCCccccccccCcccEEEccCC-CCCccCCccccC
Q 042075 327 SHFVITRN-SLGSGEHRDLNFLCSLT-NATRLKWFHININ--NFGGLLPACISNFSTTLEVLLLDSN-KIFGNIPAAFGK 401 (1033)
Q Consensus 327 ~~L~l~~N-~l~~~~~~~~~~l~~l~-~~~~L~~l~l~~n--~l~~~ip~~~~~~~~~L~~L~L~~N-~i~~~~p~~~~~ 401 (1033)
++|+++++ .+++.. + ...+. .++.|+.+++++. ++....-..+....++|+.|++++| .+++.....+.+
T Consensus 124 ~~L~ls~c~~~~~~~---~--~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~ 198 (284)
T d2astb2 124 DELNLSWCFDFTEKH---V--QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198 (284)
T ss_dssp CEEECCCCTTCCHHH---H--HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred ccccccccccccccc---c--hhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcc
Confidence 66666653 222100 0 00011 1233444444321 1111111111112244555555543 344444444555
Q ss_pred CCCCCEEEccc-CcccccCChhhhcCCCCcEEEcccc
Q 042075 402 FVKLLRLEMWN-NRLSGTIPPAIGELQNLRELRLQEN 437 (1033)
Q Consensus 402 l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N 437 (1033)
+++|++|++++ +.++......++.+++|+.|+++++
T Consensus 199 ~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 199 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 55555555555 2344333444455555555555443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=2.9e-15 Score=150.37 Aligned_cols=113 Identities=26% Similarity=0.366 Sum_probs=58.7
Q ss_pred CCccccccccccEEecccCCCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCC
Q 042075 124 IPSEFDRLRRLQVLALHNNSIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNL 203 (1033)
Q Consensus 124 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 203 (1033)
+|.+|..+++|++|+|++|+|+ .++ .+.++++|++|+|++|.|+ .+|..+..+++|++|++++|+++. ++ .+.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccc
Confidence 3445555555556666655555 333 3555555666666655555 444444444555555555555552 22 24455
Q ss_pred CCCcEEEcccCcCCCcCC-ccccccCCCCcccccccccC
Q 042075 204 SSISFLFLSRNNLDGSIP-DTFGWLKNLVNLTMAQNRLS 241 (1033)
Q Consensus 204 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 241 (1033)
++|++|+|++|+|+.... +.|..+++|++|+|++|+++
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555552211 24455555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=3.4e-15 Score=164.88 Aligned_cols=236 Identities=17% Similarity=0.201 Sum_probs=130.1
Q ss_pred ccCCCCCCCEEEecCCCcccc----CCccccccccccEEecccCCCCCC----------CCccccCCCCCcEEEcccccc
Q 042075 103 HVGNLSFLKVLDLHNNSFHHE----IPSEFDRLRRLQVLALHNNSIGGE----------IPANISSCSNLIRVRLSSNEL 168 (1033)
Q Consensus 103 ~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----------~p~~~~~l~~L~~L~Ls~N~l 168 (1033)
.+.+.+.|+.|+|++|.+... +-..+...++|+.|+++++.+... +...+..+++|++|+|++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 344556666666666665432 223344556666666666544311 111234456666677766666
Q ss_pred cCC----CCCCcccccccceeeecccccCCCCCCC-------------CCCCCCCcEEEcccCcCCCc----CCcccccc
Q 042075 169 VGK----IPSELGSLSKIEYFSVSYNNLTGSIPPS-------------FGNLSSISFLFLSRNNLDGS----IPDTFGWL 227 (1033)
Q Consensus 169 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l 227 (1033)
+.. +...+...++|++|++++|.++...... ....+.|+.|++++|+++.. +...+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 532 2223345566667777666653110000 12345677777777776522 22234456
Q ss_pred CCCCcccccccccCCC-----CcccccCCCceeEEeccCccccCccCc---cccccccccceeeecccccCCCCCccC--
Q 042075 228 KNLVNLTMAQNRLSGT-----IPSSIFNISSITVFDAGINQIQGVIPL---DIGFTLQNLQFFSVGRNQLTGAIPPAI-- 297 (1033)
Q Consensus 228 ~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~ls~N~l~~~~p~---~~~~~l~~L~~L~L~~N~l~~~~p~~~-- 297 (1033)
++|++|+|++|+++.. +...+..+++|+.|++++|.++..-.. ......++|++|+|++|.|++.....+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 6777777777776531 233455667777777777776532111 112345677777777777764322222
Q ss_pred --c--CCCCccccccccccccCcC-----cch-hhhccccceeeecCcCCC
Q 042075 298 --S--NASNLEVFQVNSNKLTGEV-----PYL-EKLQRLSHFVITRNSLGS 338 (1033)
Q Consensus 298 --~--~l~~L~~L~Ls~N~l~~~~-----~~l-~~l~~L~~L~l~~N~l~~ 338 (1033)
. ..++|++|++++|+|+... ..+ .+.+.|+.|++++|.+..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 2 2356778888888776431 123 245678888888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.35 E-value=1.5e-14 Score=159.61 Aligned_cols=242 Identities=18% Similarity=0.184 Sum_probs=145.7
Q ss_pred cccccccCcceeeecccccCCCCccccc---cccCcccEEEccCCCCCcc----------CCccccCCCCCCEEEcccCc
Q 042075 348 CSLTNATRLKWFHININNFGGLLPACIS---NFSTTLEVLLLDSNKIFGN----------IPAAFGKFVKLLRLEMWNNR 414 (1033)
Q Consensus 348 ~~l~~~~~L~~l~l~~n~l~~~ip~~~~---~~~~~L~~L~L~~N~i~~~----------~p~~~~~l~~L~~L~L~~N~ 414 (1033)
..+.+.+.|+.+++++|.++..-...+. ...++|+.++++++..... +...+...++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3456677788888888877544322222 1225777888877654322 12334556778888888887
Q ss_pred cccc----CChhhhcCCCCcEEEccccccccccCcccc-------------cc-eeceeeccccccCCC----CCCccCC
Q 042075 415 LSGT----IPPAIGELQNLRELRLQENRFLGNIPPSIG-------------NL-KLFNLQLSYNFLQGS----IPSSLGQ 472 (1033)
Q Consensus 415 l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-------------~l-~L~~L~Ls~N~l~~~----~p~~~~~ 472 (1033)
++.. +...+...++|++|++++|.+.......+. .. .++.+++++|.++.. +...+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~ 184 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence 7643 333455677788888888776532111110 01 144444444444311 1112223
Q ss_pred CCcccEEecCCCccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccc----cCcccccccc
Q 042075 473 SETLTIIDLSNNNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE----IPRTLGSCIK 548 (1033)
Q Consensus 473 l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~ 548 (1033)
.+.|++|+|++|+++.. .+ ...+...+...++|+.|+|++|.++.. +...+..+++
T Consensus 185 ~~~L~~L~L~~n~i~~~---g~-----------------~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~ 244 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPE---GI-----------------EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244 (344)
T ss_dssp CTTCCEEECCSSCCCHH---HH-----------------HHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred hhhhccccccccccccc---cc-----------------ccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence 34444444444444310 00 001234567788999999999998643 4556778899
Q ss_pred cceeecccccccCcccccc----cC--cccCCcccccccccccc----CCcccc-cccccceeecCCCcCcc
Q 042075 549 LELLQMQGNFLQGPIPSSL----SS--LRGLSVLDLSQNNLSGK----IPEFLV-GFQLLEYLNLSNNDFEG 609 (1033)
Q Consensus 549 L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~g 609 (1033)
|++|+|++|.|++.-...+ .. .+.|+.||+++|+|+.. +...+. +.+.|++|+|++|.++.
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 9999999999986533333 22 36799999999998753 334443 56889999999999964
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.7e-12 Score=124.36 Aligned_cols=106 Identities=20% Similarity=0.175 Sum_probs=54.0
Q ss_pred cccEEecccCCCCCCCCccccCCCCCcEEEcccc-cccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEc
Q 042075 133 RLQVLALHNNSIGGEIPANISSCSNLIRVRLSSN-ELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211 (1033)
Q Consensus 133 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 211 (1033)
....++++++.+. .+|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.|..|.++++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3445555655555 45555555555566655444 254333344555555555555555555444455555555555555
Q ss_pred ccCcCCCcCCccccccCCCCccccccccc
Q 042075 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRL 240 (1033)
Q Consensus 212 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 240 (1033)
++|+|+...++.|..+ +|++|+|++|++
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred cCCCCcccChhhhccc-cccccccCCCcc
Confidence 5555553333333322 344555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=1.9e-14 Score=144.41 Aligned_cols=126 Identities=19% Similarity=0.244 Sum_probs=72.8
Q ss_pred ccEEecccC--CCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCCCCcEEEc
Q 042075 134 LQVLALHNN--SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLSSISFLFL 211 (1033)
Q Consensus 134 L~~L~Ls~n--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 211 (1033)
++.++++++ .++ .+|.++..+++|++|+|++|+|+ .++ .|.++++|++|+|++|+|+ .+|..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 444555543 233 44556677777777777777776 443 4667777777777777776 44444444456667777
Q ss_pred ccCcCCCcCCccccccCCCCcccccccccCCCCc-ccccCCCceeEEeccCcccc
Q 042075 212 SRNNLDGSIPDTFGWLKNLVNLTMAQNRLSGTIP-SSIFNISSITVFDAGINQIQ 265 (1033)
Q Consensus 212 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~ls~N~l~ 265 (1033)
++|+|+. + +.+..+++|++|++++|+++.... ..+..+++|+.|++++|.+.
T Consensus 101 ~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 101 SYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 7776663 2 235566666666666666653211 23445555555555555444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.9e-12 Score=122.63 Aligned_cols=91 Identities=18% Similarity=0.186 Sum_probs=46.0
Q ss_pred ccccccccccEEecccC-CCCCCCCccccCCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCCCCCCCCCC
Q 042075 126 SEFDRLRRLQVLALHNN-SIGGEIPANISSCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSIPPSFGNLS 204 (1033)
Q Consensus 126 ~~~~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 204 (1033)
..+..+++|++|++++| .|+..-+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+|+...+..|..+
T Consensus 25 ~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~- 103 (156)
T d2ifga3 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL- 103 (156)
T ss_dssp TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-
T ss_pred ccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc-
Confidence 33444444455555433 2443333445555555555555555554444555555555555555555553333334333
Q ss_pred CCcEEEcccCcCC
Q 042075 205 SISFLFLSRNNLD 217 (1033)
Q Consensus 205 ~L~~L~L~~N~l~ 217 (1033)
+|+.|+|++|.+.
T Consensus 104 ~l~~L~L~~Np~~ 116 (156)
T d2ifga3 104 SLQELVLSGNPLH 116 (156)
T ss_dssp CCCEEECCSSCCC
T ss_pred cccccccCCCccc
Confidence 4666666666664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=6.2e-09 Score=99.71 Aligned_cols=91 Identities=22% Similarity=0.212 Sum_probs=59.7
Q ss_pred cCCccccccccceEEccccccccc--cCcccccccccceeecccccccCcccccccCcccCCccccccccccccCCc---
Q 042075 515 IPNEVGNLKNLEMLNVFENKLRGE--IPRTLGSCIKLELLQMQGNFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE--- 589 (1033)
Q Consensus 515 ~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--- 589 (1033)
++..+..+++|+.|+|++|+|+.. ++..+..+++|+.|+|++|+++...+-.+....+|+.|+|++|++++....
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 334445677888888888888743 234566778888888888888743332344455678888888888765442
Q ss_pred ----ccccccccceeecCCCcC
Q 042075 590 ----FLVGFQLLEYLNLSNNDF 607 (1033)
Q Consensus 590 ----~~~~l~~L~~L~ls~N~l 607 (1033)
.+..+|+|+.|| ++.+
T Consensus 137 y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 137 YISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHHCCCCCEEC--cCCC
Confidence 245677777765 4444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=2.1e-07 Score=96.78 Aligned_cols=150 Identities=15% Similarity=0.070 Sum_probs=102.2
Q ss_pred HHHHHhhCCCCccceecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcC-CCCceeEeeeeccccc
Q 042075 704 QNLYNATDGFTSANLIGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 782 (1033)
Q Consensus 704 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 782 (1033)
.++.+..+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----- 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----- 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----
Confidence 35667777888777665566678999875 45667889876554444456788988888773 43356666663
Q ss_pred cCCCceeEEEEcccCCchhhhcccCCCCccccccccccCHHHHHHHHHHHHHHHHHHHhC--------------------
Q 042075 783 QGNDFKALVFEFMHNRSLEEWLHPITREDETEEAPRSLNLLQRLDIGIDVACALSYLHHD-------------------- 842 (1033)
Q Consensus 783 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------------------- 842 (1033)
..++..++||++++|.++.+.... ......++.++++.++.||+.
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~---------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTT---------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred ecCCceEEEEEecccccccccccc---------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 334578999999999888765421 011223455556666666632
Q ss_pred ------------------------------------CCCCcEeccCCCCCeEecCCCcEEEeeccccee
Q 042075 843 ------------------------------------CQPPIVHCDLKPSNVLLDEEMIAHVGDFGLATF 875 (1033)
Q Consensus 843 ------------------------------------~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~~ 875 (1033)
..+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012489999999999999877677999998763
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=3.7e-09 Score=101.36 Aligned_cols=90 Identities=17% Similarity=0.036 Sum_probs=50.7
Q ss_pred CCCCCcEEEcccccccCCCCCCcccccccceeeecccccCCCC--CCCCCCCCCCcEEEcccCcCCCcCCccccccCCCC
Q 042075 154 SCSNLIRVRLSSNELVGKIPSELGSLSKIEYFSVSYNNLTGSI--PPSFGNLSSISFLFLSRNNLDGSIPDTFGWLKNLV 231 (1033)
Q Consensus 154 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 231 (1033)
.+..+..|+...|... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3334444444444333 33334455667777777777776432 23345667777777777777743332333445677
Q ss_pred cccccccccCCCC
Q 042075 232 NLTMAQNRLSGTI 244 (1033)
Q Consensus 232 ~L~L~~N~l~~~~ 244 (1033)
.|++++|+++...
T Consensus 119 ~L~L~~Npl~~~~ 131 (162)
T d1koha1 119 ELWLDGNSLSDTF 131 (162)
T ss_dssp SCCCTTSTTSSSS
T ss_pred eeecCCCCcCcCc
Confidence 7777777776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=1.1e-05 Score=82.95 Aligned_cols=76 Identities=13% Similarity=0.090 Sum_probs=51.0
Q ss_pred eecccCc-eeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCC--CCceeEeeeeccccccCCCceeEEEEc
Q 042075 718 LIGAGSF-GSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVFEF 794 (1033)
Q Consensus 718 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~ 794 (1033)
.+..|.. +.||+.... ++..+++|...... ...+..|+..++.+.. -.+.+++.++ ..++..++||||
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEe
Confidence 4455553 679999875 56678889865432 2456778888887732 3356666663 334578999999
Q ss_pred ccCCchhh
Q 042075 795 MHNRSLEE 802 (1033)
Q Consensus 795 ~~~gsL~~ 802 (1033)
++|.++.+
T Consensus 88 i~G~~~~~ 95 (255)
T d1nd4a_ 88 VPGQDLLS 95 (255)
T ss_dssp CSSEETTT
T ss_pred eecccccc
Confidence 99876644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=4.3e-05 Score=83.60 Aligned_cols=77 Identities=14% Similarity=0.134 Sum_probs=50.3
Q ss_pred cceecccCceeEEEEEeCCCCeEEEEEEeecc-------CchhHHHHHHHHHHHHhc-CC--CCceeEeeeeccccccCC
Q 042075 716 ANLIGAGSFGSVYKGILDEGKTIVAVKVFNLL-------HHGAFKSFIAECNTLKNI-RH--RNLVKILTACSGVDYQGN 785 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~~ 785 (1033)
.+.||.|....||++....+++.|+||..... .+...++...|++.++.+ .+ ..+++++.+. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 45789999999999998877888999975421 111234566788888877 23 3466666552 2
Q ss_pred CceeEEEEcccCCc
Q 042075 786 DFKALVFEFMHNRS 799 (1033)
Q Consensus 786 ~~~~lv~e~~~~gs 799 (1033)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 24579999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.15 E-value=2.2e-05 Score=74.58 Aligned_cols=64 Identities=19% Similarity=0.216 Sum_probs=30.4
Q ss_pred CCCCCCEEEecCC-Ccccc----CCccccccccccEEecccCCCCCCCC----ccccCCCCCcEEEccccccc
Q 042075 106 NLSFLKVLDLHNN-SFHHE----IPSEFDRLRRLQVLALHNNSIGGEIP----ANISSCSNLIRVRLSSNELV 169 (1033)
Q Consensus 106 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~Ls~N~l~ 169 (1033)
+-+.|++|+|+++ .++.. +-..+...+.|++|+|++|.++.... ..+...+.|++|+|++|.++
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3456666666653 34321 22234444556666666665542111 12223344555555555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.00 E-value=0.0012 Score=69.68 Aligned_cols=74 Identities=12% Similarity=0.084 Sum_probs=47.2
Q ss_pred ceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC--ceeEeeeeccccccCCCceeEEEEcccCCc
Q 042075 724 FGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGNDFKALVFEFMHNRS 799 (1033)
Q Consensus 724 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gs 799 (1033)
--.||+++.. +|+.|++|+.+.... ..+++..|...+..+.... ++..+....+.....++..+.++++++|..
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3689999986 678899999875432 3466778998888874222 222222222222334556789999997744
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.97 E-value=0.0001 Score=69.79 Aligned_cols=107 Identities=13% Similarity=0.130 Sum_probs=61.1
Q ss_pred CcccEEEccCC-CCCcc----CCccccCCCCCCEEEcccCcccc----cCChhhhcCCCCcEEEccccccccccCc----
Q 042075 379 TTLEVLLLDSN-KIFGN----IPAAFGKFVKLLRLEMWNNRLSG----TIPPAIGELQNLRELRLQENRFLGNIPP---- 445 (1033)
Q Consensus 379 ~~L~~L~L~~N-~i~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 445 (1033)
++|+.|+|+++ .++.. +-.++...+.|++|+|++|.+.. .+...+...+.|+.|+|++|.+......
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 46677777653 45422 23355666778888888887763 2233455567788888888877643222
Q ss_pred ccccce-eceeeccccccCCC-------CCCccCCCCcccEEecCCCc
Q 042075 446 SIGNLK-LFNLQLSYNFLQGS-------IPSSLGQSETLTIIDLSNNN 485 (1033)
Q Consensus 446 ~~~~l~-L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 485 (1033)
.+...+ |++|+|++|.+... +...+..-++|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 222222 66666666654421 22233445667777776554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.33 E-value=0.0059 Score=66.12 Aligned_cols=75 Identities=17% Similarity=0.153 Sum_probs=51.7
Q ss_pred cceecccCceeEEEEEeCC-------CCeEEEEEEeeccCchhHHHHHHHHHHHHhc-CCCCceeEeeeeccccccCCCc
Q 042075 716 ANLIGAGSFGSVYKGILDE-------GKTIVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 787 (1033)
Q Consensus 716 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 787 (1033)
++.|+.|-.-.+|++.... ..+.|++++.-.. .. .....+|..+++.+ .+.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 4678999999999998753 2456888886532 22 23456899999988 3544567777742
Q ss_pred eeEEEEcccCCchh
Q 042075 788 KALVFEFMHNRSLE 801 (1033)
Q Consensus 788 ~~lv~e~~~~gsL~ 801 (1033)
-..||||++|.++.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 25899999875543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.16 E-value=0.00067 Score=63.89 Aligned_cols=117 Identities=17% Similarity=0.242 Sum_probs=77.0
Q ss_pred CCCCcccEEecCC-CccCCCCCccccCchhHHhhhhccCccccCCcCCccccccccceEEccccccccc----cCccccc
Q 042075 471 GQSETLTIIDLSN-NNLTGTIPPQLLGLSSLLIVLELSRNQLTGPIPNEVGNLKNLEMLNVFENKLRGE----IPRTLGS 545 (1033)
Q Consensus 471 ~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~ 545 (1033)
.+.++|++|+|++ |.++. .. +.. +-..+...++|+.|+|++|.++.. +-..+..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~---~~---~~~---------------l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~ 72 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPV---PT---LKA---------------CAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV 72 (166)
T ss_dssp TTCTTCCEEECTTCTTCCH---HH---HHH---------------HHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCH---HH---HHH---------------HHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhh
Confidence 4557888899887 44541 11 111 112344567788999999988643 2234566
Q ss_pred ccccceeecccccccCc----ccccccCcccCCc--cccccccccc----cCCcccccccccceeecCCCcCc
Q 042075 546 CIKLELLQMQGNFLQGP----IPSSLSSLRGLSV--LDLSQNNLSG----KIPEFLVGFQLLEYLNLSNNDFE 608 (1033)
Q Consensus 546 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~ 608 (1033)
.++++.|++++|.++.. +-..+...++|+. |++++|++.. .+.+.+...+.|+.|+++.|...
T Consensus 73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 78899999999988643 3356677788886 4556777754 34455667788999998877643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.09 E-value=0.027 Score=58.51 Aligned_cols=171 Identities=14% Similarity=0.041 Sum_probs=86.9
Q ss_pred CCCHHHHHHhhCCCCccce-----ecccCceeEEEEEeCCCCeEEEEEEeeccCchhHHHHHHHHHHHHhcCCCC--cee
Q 042075 700 NISYQNLYNATDGFTSANL-----IGAGSFGSVYKGILDEGKTIVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVK 772 (1033)
Q Consensus 700 ~~~~~~l~~~~~~y~~~~~-----lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 772 (1033)
..+.++++....+|.+.+. |..|---+.|+.+.. +| .+++|++.... ..+++..|++++..+...+ +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 4567888888888987544 446666889999876 34 48899986432 2345566777777773222 222
Q ss_pred Eeeeecccc-ccCCCceeEEEEcccCCchhhhc--------------ccCCCCcc-cccc----------------cccc
Q 042075 773 ILTACSGVD-YQGNDFKALVFEFMHNRSLEEWL--------------HPITREDE-TEEA----------------PRSL 820 (1033)
Q Consensus 773 l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l--------------~~~~~~~~-~~~~----------------~~~l 820 (1033)
.+....+.. ....+..+.++.+..+......- +....... .... ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 221111100 11123455677776654322110 00000000 0000 0000
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-CCCCCcEeccCCCCCeEecCCCcEEEeecccce
Q 042075 821 NLLQRLDIGIDVACALSYLHH-DCQPPIVHCDLKPSNVLLDEEMIAHVGDFGLAT 874 (1033)
Q Consensus 821 ~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~DfG~a~ 874 (1033)
........+..+...+...+. ....|+||+|+.++||+++++...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111111122222222222222 124489999999999999988877899999886
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.06 E-value=0.00016 Score=68.44 Aligned_cols=65 Identities=11% Similarity=0.115 Sum_probs=34.7
Q ss_pred CCCCCCCEEEecC-CCcccc----CCccccccccccEEecccCCCCCCCC----ccccCCCCCcEEEccccccc
Q 042075 105 GNLSFLKVLDLHN-NSFHHE----IPSEFDRLRRLQVLALHNNSIGGEIP----ANISSCSNLIRVRLSSNELV 169 (1033)
Q Consensus 105 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~Ls~N~l~ 169 (1033)
.+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++...- ..+...++|+.|++++|.+.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 4456677777776 445431 22334456667777777766653211 12334455666666665554
|